Citrus Sinensis ID: 024408
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 268 | 2.2.26 [Sep-21-2011] | |||||||
| Q2MHE4 | 390 | Serine/threonine-protein | no | no | 0.768 | 0.528 | 0.442 | 2e-44 | |
| Q55GU0 | 916 | Probable serine/threonine | yes | no | 0.697 | 0.204 | 0.386 | 2e-31 | |
| P18161 | 1155 | Dual specificity protein | no | no | 0.694 | 0.161 | 0.397 | 3e-31 | |
| Q55A09 | 1331 | Probable serine/threonine | no | no | 0.667 | 0.134 | 0.412 | 3e-31 | |
| Q54I36 | 1338 | Dual specificity protein | no | no | 0.690 | 0.138 | 0.405 | 2e-30 | |
| P80192 | 1104 | Mitogen-activated protein | yes | no | 0.686 | 0.166 | 0.365 | 1e-29 | |
| Q3U1V8 | 1077 | Mitogen-activated protein | yes | no | 0.686 | 0.170 | 0.365 | 1e-29 | |
| Q9FPR3 | 933 | Serine/threonine-protein | no | no | 0.686 | 0.197 | 0.400 | 8e-29 | |
| Q66HA1 | 850 | Mitogen-activated protein | no | no | 0.675 | 0.212 | 0.372 | 8e-29 | |
| Q95UN8 | 1161 | Mitogen-activated protein | yes | no | 0.682 | 0.157 | 0.362 | 8e-29 |
| >sp|Q2MHE4|HT1_ARATH Serine/threonine-protein kinase HT1 OS=Arabidopsis thaliana GN=HT1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 179 bits (454), Expect = 2e-44, Method: Compositional matrix adjust.
Identities = 96/217 (44%), Positives = 130/217 (59%), Gaps = 11/217 (5%)
Query: 4 QFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI 62
QFI ACK+P V I+TE +S G LR YL P L + + ALDI+R ME LHS G+
Sbjct: 149 QFIAACKKPPVYCIITEYMSQGNLRMYLNKKEPYSLSIETVLRLALDISRGMEYLHSQGV 208
Query: 63 IHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGE 122
IHRDLK NLLL ++++ +K+ADFG + E+ GTYRWMAPE+ +
Sbjct: 209 IHRDLKSNNLLLNDEMR-VKVADFGTSCLETQCREAKGNMGTYRWMAPEMI--------K 259
Query: 123 KKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS-AENVPEELSIIL 181
+K Y KVD YSF IVLWEL LPF+GM+ +QAA+A A KN RP + L+ ++
Sbjct: 260 EKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKNERPPLPASCQPALAHLI 319
Query: 182 TSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIPH 218
CW E+P+ RP+F+ I+ +L Y + P+ H
Sbjct: 320 KRCWSENPSKRPDFSNIVAVLEKYDECVKEGLPLTSH 356
|
Serine/threonine kinase involved in the control of stomatal movement in response to CO(2). Shows a reduced response to ABA or light compared to CO(2). Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum GN=DDB_G0267514 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 136 bits (343), Expect = 2e-31, Method: Compositional matrix adjust.
Identities = 77/199 (38%), Positives = 119/199 (59%), Gaps = 12/199 (6%)
Query: 6 IGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIH 64
+ AC P + +TE L GG+L L + + + +++ + A+ IA+ M LH G+IH
Sbjct: 724 MAACTAPPNLCFITEYLPGGSLYDALHSKKIK-MNMQLYKKLAIQIAQGMNYLHLSGVIH 782
Query: 65 RDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKK 124
RD+K NLLL E + +K+ DFGL++ +S + MT G+ WM+PEL GE
Sbjct: 783 RDIKSLNLLLDEHM-NVKICDFGLSKLKSKSTEMTKSIGSPIWMSPELL------MGED- 834
Query: 125 HYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENV-PEELSIILTS 183
Y KVD Y+F I+LWEL +LP+ G+ ++Q A A K++RP N P +LS ++ +
Sbjct: 835 -YTEKVDVYAFGIILWELGTGELPYSGLDSVQLALAVTTKSLRPPIPNAWPYQLSHLIQA 893
Query: 184 CWKEDPNARPNFTQIIQML 202
CW +DP RP+FT+I+ +L
Sbjct: 894 CWHQDPLKRPSFTEILNLL 912
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P18161|SPLB_DICDI Dual specificity protein kinase splB OS=Dictyostelium discoideum GN=splB PE=2 SV=2 | Back alignment and function description |
|---|
Score = 135 bits (340), Expect = 3e-31, Method: Composition-based stats.
Identities = 83/209 (39%), Positives = 116/209 (55%), Gaps = 23/209 (11%)
Query: 5 FIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDV----CVAIGFALDIARAMECLHSH 60
FIGAC +P I+TE ++GG+L L N V + + A D+A + LHS
Sbjct: 913 FIGACYKPA-CIITEYMAGGSLYNILHNPNSSTPKVKYSFPLVLKMATDMALGLLHLHSI 971
Query: 61 GIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY---RWMAPELYSTVT 117
I+HRDL +N+LL E L IK++DFGL+RE+S MT G RW PEL +
Sbjct: 972 TIVHRDLTSQNILLDE-LGNIKISDFGLSREKSREGSMTMTNGGICNPRWRPPELTKNL- 1029
Query: 118 LRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPE-- 175
HY+ KVD Y F++V+WE+L ++PF + QA+ A+ +RP +PE
Sbjct: 1030 ------GHYSEKVDVYCFSLVVWEILTGEIPFSDLDGSQASAQVAYAGLRPP---IPEYC 1080
Query: 176 --ELSIILTSCWKEDPNARPNFTQIIQML 202
EL ++LT CW+ DPN RP FT I+ L
Sbjct: 1081 DPELKLLLTQCWEADPNDRPPFTYIVNKL 1109
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|Q55A09|Y9963_DICDI Probable serine/threonine-protein kinase DDB_G0272254 OS=Dictyostelium discoideum GN=DDB_G0272254 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 135 bits (340), Expect = 3e-31, Method: Composition-based stats.
Identities = 83/201 (41%), Positives = 112/201 (55%), Gaps = 22/201 (10%)
Query: 14 MVIVTELLSGGTLRKYLLNMRPR------CLDVCVAIGFALDIARAMECLHSHGIIHRDL 67
M IV E L G L + L++ +P LD + + A DIAR M+ LH+ IIHRDL
Sbjct: 1143 MCIVMEFLPSGNLFE-LIHSKPSEQQQSIKLDSTLILAIAFDIARGMQHLHTRNIIHRDL 1201
Query: 68 KPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYN 127
K NLL+ + IK+AD G+ARE S T+ MT GT W APE+ LR + YN
Sbjct: 1202 KSSNLLMDKHF-NIKIADLGIARETSFTQTMTT-IGTVAWTAPEI-----LRH---ESYN 1251
Query: 128 HKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS-AENVPEELSIILTSCWK 186
K D YS+AIVL+ELL + P++G+ + A A K +RP +N ++ CW
Sbjct: 1252 QKADVYSYAIVLYELLTGEEPYQGIPPMNAGILVASKGLRPELPDNCDPNWKKLVVWCWS 1311
Query: 187 EDPNARPNFTQIIQMLLNYLS 207
EDPN RP+F +I NYL+
Sbjct: 1312 EDPNKRPSFEEIT----NYLT 1328
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54I36|PYK3_DICDI Dual specificity protein kinase pyk3 OS=Dictyostelium discoideum GN=pyk3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 132 bits (332), Expect = 2e-30, Method: Compositional matrix adjust.
Identities = 81/200 (40%), Positives = 118/200 (59%), Gaps = 15/200 (7%)
Query: 5 FIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIH 64
F+GAC +P I TE L GG+L +L+++ L+ + D++ ME LHS ++H
Sbjct: 1115 FMGACIDPP-CIFTEYLQGGSLYD-VLHIQKIKLNPLMMYKMIHDLSLGMEHLHSIQMLH 1172
Query: 65 RDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY-RWMAPELYSTVTLRQGEK 123
RDL +N+LL E K IK+ADFGLA +L++ MT T RW +PEL +
Sbjct: 1173 RDLTSKNILLDE-FKNIKIADFGLAT--TLSDDMTLSGITNPRWRSPELTKGLV------ 1223
Query: 124 KHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSA-ENVPEELSIILT 182
YN KVD YSF +V++E+ K+PFEG+ +A AAF+N RP+ + P L ++T
Sbjct: 1224 --YNEKVDVYSFGLVVYEIYTGKIPFEGLDGTASAAKAAFENYRPAIPPDCPVSLRKLIT 1281
Query: 183 SCWKEDPNARPNFTQIIQML 202
CW DP+ RP+FT+I+ L
Sbjct: 1282 KCWASDPSQRPSFTEILTEL 1301
|
Involved in the development. Negatively regulates tyrosine phosphorylation and activation state of dstC/STATc, probably by activating a dstC/STATc phosphatase. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|P80192|M3K9_HUMAN Mitogen-activated protein kinase kinase kinase 9 OS=Homo sapiens GN=MAP3K9 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 130 bits (326), Expect = 1e-29, Method: Compositional matrix adjust.
Identities = 76/208 (36%), Positives = 108/208 (51%), Gaps = 24/208 (11%)
Query: 7 GAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI--- 62
G C KEP + +V E GG L + L R + + + +A+ IAR M LH I
Sbjct: 208 GVCLKEPNLCLVMEFARGGPLNRVLSGKR---IPPDILVNWAVQIARGMNYLHDEAIVPI 264
Query: 63 IHRDLKPENLLLTEDL-------KTIKLADFGLAREESLTEMMTAETGTYRWMAPELYST 115
IHRDLK N+L+ + + K +K+ DFGLARE T M+A GTY WMAPE+
Sbjct: 265 IHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA-AGTYAWMAPEVIRA 323
Query: 116 VTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR-PSAENVP 174
+G D +S+ ++LWELL ++PF G+ L AY A + P P
Sbjct: 324 SMFSKGS--------DVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCP 375
Query: 175 EELSIILTSCWKEDPNARPNFTQIIQML 202
E + ++ CW DP++RP+FT I+ L
Sbjct: 376 EPFAKLMEDCWNPDPHSRPSFTNILDQL 403
|
Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. Plays an important role in the cascades of cellular responses evoked by changes in the environment. Once activated, acts as an upstream activator of the MKK/JNK signal transduction cascade through the phosphorylation of MAP2K4/MKK4 and MAP2K7/MKK7 which in turn activate the JNKs. The MKK/JNK signaling pathway regulates stress response via activator protein-1 (JUN) and GATA4 transcription factors. Plays also a role in mitochondrial death signaling pathway, including the release cytochrome c, leading to apoptosis. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q3U1V8|M3K9_MOUSE Mitogen-activated protein kinase kinase kinase 9 OS=Mus musculus GN=Map3k9 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 130 bits (326), Expect = 1e-29, Method: Compositional matrix adjust.
Identities = 76/208 (36%), Positives = 108/208 (51%), Gaps = 24/208 (11%)
Query: 7 GAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI--- 62
G C KEP + +V E GG L + L R + + + +A+ IAR M LH I
Sbjct: 201 GVCLKEPNLCLVMEFARGGPLNRVLSGKR---IPPDILVNWAVQIARGMNYLHDEAIVPI 257
Query: 63 IHRDLKPENLLLTEDL-------KTIKLADFGLAREESLTEMMTAETGTYRWMAPELYST 115
IHRDLK N+L+ + + K +K+ DFGLARE T M+A GTY WMAPE+
Sbjct: 258 IHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA-AGTYAWMAPEVIRA 316
Query: 116 VTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR-PSAENVP 174
+G D +S+ ++LWELL ++PF G+ L AY A + P P
Sbjct: 317 SMFSKGS--------DVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCP 368
Query: 175 EELSIILTSCWKEDPNARPNFTQIIQML 202
E + ++ CW DP++RP+FT I+ L
Sbjct: 369 EPFAKLMEDCWNPDPHSRPSFTSILDQL 396
|
Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. Plays an important role in the cascades of cellular responses evoked by changes in the environment. Once activated, acts as an upstream activator of the MKK/JNK signal transduction cascade through the phosphorylation of MAP2K4/MKK4 and MAP2K7/MKK7 which in turn activate the JNKs. The MKK/JNK signaling pathway regulates stress response via activator protein-1 (JUN) and GATA4 transcription factors. Plays also a role in mitochondrial death signaling pathway, including the release cytochrome c, leading to apoptosis. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q9FPR3|EDR1_ARATH Serine/threonine-protein kinase EDR1 OS=Arabidopsis thaliana GN=EDR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 127 bits (319), Expect = 8e-29, Method: Compositional matrix adjust.
Identities = 83/207 (40%), Positives = 118/207 (57%), Gaps = 23/207 (11%)
Query: 5 FIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRC-LDVCVAIGFALDIARAMECLHSHG- 61
F+GA + P + IVTE L G+L + L RP+ +D I ALD+A M CLH+
Sbjct: 729 FLGAVTRPPNLSIVTEFLPRGSLYRIL--HRPKSHIDERRRIKMALDVAMGMNCLHTSTP 786
Query: 62 -IIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET-GTYRWMAPELYSTVTLR 119
I+HRDLK NLL+ + +K+ DFGL+R + T + + T GT WMAPE+ LR
Sbjct: 787 TIVHRDLKTPNLLVDNNW-NVKVGDFGLSRLKHNTFLSSKSTAGTPEWMAPEV-----LR 840
Query: 120 QGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEEL-- 177
+ N K D YSF ++LWEL +LP+ GM+ +Q A F+N R +P+EL
Sbjct: 841 N---EPSNEKCDVYSFGVILWELATLRLPWRGMNPMQVVGAVGFQNRRLE---IPKELDP 894
Query: 178 --SIILTSCWKEDPNARPNFTQIIQML 202
I+ CW+ DPN RP+F Q+ ++L
Sbjct: 895 VVGRIILECWQTDPNLRPSFAQLTEVL 921
|
MAPKKK serine/threonine-protein kinase involved in the regulation of a MAP kinase cascade (probably including MPK3 and MPK6) that negatively regulates salicylic acid- (SA-) dependent defense responses, abscisic acid (ABA) signaling, and ethylene-induced senescence. Modulates also stress response (e.g. drought) signaling and cell death, in an ORE9-dependent manner. Functions at a point of cross talk between ethylene, ABA and SA signaling that impinges on senescence and cell death. In another hand, confers sensitivity to various pathogens such as the fungus Erysiphe cichoracearum, the oomycete Hyaloperonospora parasitica and the bacteria Pseudomonas syringae pv. tomato DC3000. Required for the resistance to some hemibiotrophic/necrotrophic fungal pathogens (e.g. Colletotrichum gloeosporioides, Colletotrichum higginsianum and Alternaria brassicicola) through the induction of defensins expression, probably by repressing MYC2, an inhibitor of defensin genes (PDFs). Together with KEG, may regulate endocytic trafficking and/or the formation of signaling complexes on trans-Golgi network (TGN)/ early endosome (EE) vesicles during stress responses. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q66HA1|M3K11_RAT Mitogen-activated protein kinase kinase kinase 11 OS=Rattus norvegicus GN=Map3k11 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 127 bits (319), Expect = 8e-29, Method: Composition-based stats.
Identities = 76/204 (37%), Positives = 109/204 (53%), Gaps = 23/204 (11%)
Query: 10 KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG---IIHRD 66
+EP + +V E +GG L + L R + V + +A+ IAR M LH +IHRD
Sbjct: 186 EEPNLCLVMEYAAGGPLSRALAGRR---VPPHVLVNWAVQIARGMHYLHCEALVPVIHRD 242
Query: 67 LKPENLLLTEDL-------KTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLR 119
LK N+LL + + KT+K+ DFGLARE T M+A GTY WMAPE+ T
Sbjct: 243 LKSNNILLLQPIEGDDMEHKTLKITDFGLAREWHKTTQMSA-AGTYAWMAPEVIKASTFS 301
Query: 120 QGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR-PSAENVPEELS 178
+G D +SF ++LWELL ++P+ G+ L AY A + P PE +
Sbjct: 302 KGS--------DVWSFGVLLWELLTGEVPYRGIDCLAVAYGVAVNKLTLPIPSTCPEPFA 353
Query: 179 IILTSCWKEDPNARPNFTQIIQML 202
++ CW +DP+ RP+F I+Q L
Sbjct: 354 QLMADCWAQDPHRRPDFASILQQL 377
|
Activates the JUN N-terminal pathway. Required for serum-stimulated cell proliferation and for mitogen and cytokine activation of MAPK14 (p38), MAPK3 (ERK) and MAPK8 (JNK1) through phosphorylation and activation of MAP2K4/MKK4 and MAP2K7/MKK7. Plays a role in mitogen-stimulated phosphorylation and activation of BRAF, but does not phosphorylate BRAF directly. Influences microtubule organization during the cell cycle. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q95UN8|M3KSL_DROME Mitogen-activated protein kinase kinase kinase OS=Drosophila melanogaster GN=slpr PE=1 SV=1 | Back alignment and function description |
|---|
Score = 127 bits (319), Expect = 8e-29, Method: Compositional matrix adjust.
Identities = 75/207 (36%), Positives = 109/207 (52%), Gaps = 24/207 (11%)
Query: 7 GACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG---II 63
G C + +V E GG+L + L P V + +A+ IAR M LH+ II
Sbjct: 206 GVCLNTKLCLVMEYARGGSLNRILAGKIP----PDVLVNWAIQIARGMNYLHNEAPMSII 261
Query: 64 HRDLKPENLLLTEDL-------KTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTV 116
HRDLK N+L+ E + KT+K+ DFGLARE T+ M+A GTY WM PE+ S
Sbjct: 262 HRDLKSSNVLIYEAIEGNHLQQKTLKITDFGLAREMYNTQRMSA-AGTYAWMPPEVISVS 320
Query: 117 TLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR-PSAENVPE 175
T Y+ D +S+ ++LWEL+ + P++G L AY A + P + PE
Sbjct: 321 T--------YSKFSDVWSYGVLLWELITGETPYKGFDPLSVAYGVAVNTLTLPIPKTCPE 372
Query: 176 ELSIILTSCWKEDPNARPNFTQIIQML 202
++ SCW+ DP+ RP F +I++ L
Sbjct: 373 TWGALMKSCWQTDPHKRPGFKEILKQL 399
|
Activates the JUN N-terminal pathway during dorsal closure. Drosophila melanogaster (taxid: 7227) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 268 | ||||||
| 255540509 | 351 | protein kinase atn1, putative [Ricinus c | 0.985 | 0.752 | 0.886 | 1e-137 | |
| 225456892 | 352 | PREDICTED: serine/threonine-protein kina | 0.988 | 0.752 | 0.871 | 1e-137 | |
| 449440628 | 353 | PREDICTED: serine/threonine-protein kina | 0.988 | 0.750 | 0.875 | 1e-137 | |
| 224140853 | 351 | predicted protein [Populus trichocarpa] | 0.988 | 0.754 | 0.856 | 1e-137 | |
| 224055579 | 351 | predicted protein [Populus trichocarpa] | 0.988 | 0.754 | 0.849 | 1e-135 | |
| 356516635 | 352 | PREDICTED: serine/threonine-protein kina | 0.988 | 0.752 | 0.860 | 1e-135 | |
| 255560936 | 353 | protein kinase atn1, putative [Ricinus c | 0.988 | 0.750 | 0.849 | 1e-134 | |
| 363808050 | 352 | uncharacterized protein LOC100804884 [Gl | 0.988 | 0.752 | 0.849 | 1e-132 | |
| 225452312 | 352 | PREDICTED: serine/threonine-protein kina | 0.988 | 0.752 | 0.833 | 1e-132 | |
| 357461809 | 352 | Serine/threonine protein kinase TNNI3K [ | 0.988 | 0.752 | 0.830 | 1e-130 |
| >gi|255540509|ref|XP_002511319.1| protein kinase atn1, putative [Ricinus communis] gi|223550434|gb|EEF51921.1| protein kinase atn1, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 494 bits (1273), Expect = e-137, Method: Compositional matrix adjust.
Identities = 235/265 (88%), Positives = 247/265 (93%), Gaps = 1/265 (0%)
Query: 4 QFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 63
+F+GACKEPVMVIVTELLSGGTLRKYLLNMRPRCL+ VAIGFALDIARAMECLHSHGII
Sbjct: 88 KFVGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLETRVAIGFALDIARAMECLHSHGII 147
Query: 64 HRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEK 123
HRDLKPENLLLT D KT+KLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEK
Sbjct: 148 HRDLKPENLLLTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEK 207
Query: 124 KHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTS 183
KHYNHKVD+YSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAE++PEELSIILTS
Sbjct: 208 KHYNHKVDAYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEDLPEELSIILTS 267
Query: 184 CWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIPHRIFNSENTILPPESPGTSSLMTVRD 243
CWKEDPN RPNF+QII MLLN+L+ IAPPEP IPHRIF SENT LPPESPGTSSLM V
Sbjct: 268 CWKEDPNTRPNFSQIIHMLLNHLAVIAPPEPAIPHRIFTSENTFLPPESPGTSSLMAVH- 326
Query: 244 DIGETPKAKMGDKPKSLFFCFNLCY 268
D GETPKAKM ++PK LFFCF CY
Sbjct: 327 DTGETPKAKMENQPKGLFFCFKQCY 351
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225456892|ref|XP_002280504.1| PREDICTED: serine/threonine-protein kinase HT1 [Vitis vinifera] gi|147839295|emb|CAN63533.1| hypothetical protein VITISV_011081 [Vitis vinifera] gi|297733702|emb|CBI14949.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 493 bits (1270), Expect = e-137, Method: Compositional matrix adjust.
Identities = 231/265 (87%), Positives = 246/265 (92%)
Query: 4 QFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 63
+FIG CKEPVMVIVTELL GGTLRKYLLNMRPRCLD +A+GFALDIARAMECLHSHGII
Sbjct: 88 KFIGVCKEPVMVIVTELLLGGTLRKYLLNMRPRCLDARIAVGFALDIARAMECLHSHGII 147
Query: 64 HRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEK 123
HRDLKPENL+LT D KT+KL DFGLAREESLTEMMTAETGTYRWMAPELYSTVTLR GEK
Sbjct: 148 HRDLKPENLILTADHKTVKLVDFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRHGEK 207
Query: 124 KHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTS 183
KHYN+KVD+YSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN+PEEL+IILTS
Sbjct: 208 KHYNNKVDAYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENLPEELAIILTS 267
Query: 184 CWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIPHRIFNSENTILPPESPGTSSLMTVRD 243
CWKEDPNARPNF+QI+QMLL+YLS I+PPEP IP R+F SENTILPPESPGTSSLM VRD
Sbjct: 268 CWKEDPNARPNFSQIVQMLLHYLSTISPPEPAIPSRVFASENTILPPESPGTSSLMAVRD 327
Query: 244 DIGETPKAKMGDKPKSLFFCFNLCY 268
D GETPK KM +KPK FFCFN CY
Sbjct: 328 DSGETPKVKMENKPKGFFFCFNQCY 352
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449440628|ref|XP_004138086.1| PREDICTED: serine/threonine-protein kinase HT1-like [Cucumis sativus] gi|449524138|ref|XP_004169080.1| PREDICTED: serine/threonine-protein kinase HT1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 493 bits (1270), Expect = e-137, Method: Compositional matrix adjust.
Identities = 232/265 (87%), Positives = 246/265 (92%)
Query: 4 QFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 63
+FIGACKEPVMVIVTELL GGTLRKYLLNMRPRCLD VA+GFALDIARAMECLHSHGII
Sbjct: 89 KFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDTRVAVGFALDIARAMECLHSHGII 148
Query: 64 HRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEK 123
HRDLKPENLLLT D KT+KLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEK
Sbjct: 149 HRDLKPENLLLTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEK 208
Query: 124 KHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTS 183
KHYNHKVD+YSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN+PEEL+IILTS
Sbjct: 209 KHYNHKVDAYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENLPEELAIILTS 268
Query: 184 CWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIPHRIFNSENTILPPESPGTSSLMTVRD 243
CW+ED NARPNF+QIIQMLLNYL I+PPEP+IP RIF SENT+ PPESPGTSSLM VRD
Sbjct: 269 CWQEDANARPNFSQIIQMLLNYLYTISPPEPVIPSRIFTSENTVFPPESPGTSSLMAVRD 328
Query: 244 DIGETPKAKMGDKPKSLFFCFNLCY 268
D G+TPKAKM + P+ FFC N CY
Sbjct: 329 DSGDTPKAKMENNPRGCFFCSNDCY 353
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224140853|ref|XP_002323793.1| predicted protein [Populus trichocarpa] gi|222866795|gb|EEF03926.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 492 bits (1266), Expect = e-137, Method: Compositional matrix adjust.
Identities = 227/265 (85%), Positives = 250/265 (94%)
Query: 4 QFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 63
+FIGACKEPVMVIVTELL GGTLRKYLLNMRPRCLD+ +A+GFALDIARAMECLHSHGII
Sbjct: 87 KFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDMRLAVGFALDIARAMECLHSHGII 146
Query: 64 HRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEK 123
HRDLKPENL+LT D KT+KLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLR GEK
Sbjct: 147 HRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRHGEK 206
Query: 124 KHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTS 183
KHYNHKVD+YSFAIVLWEL+HNKLPFEGMSNLQAAYAAAFKNVRPSAEN+PE+L++I+TS
Sbjct: 207 KHYNHKVDAYSFAIVLWELIHNKLPFEGMSNLQAAYAAAFKNVRPSAENLPEDLALIVTS 266
Query: 184 CWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIPHRIFNSENTILPPESPGTSSLMTVRD 243
CWKEDPNARPNF+QIIQMLL+YLS I+ P+P+IP RIF SEN +LPPESPGTSSLM VRD
Sbjct: 267 CWKEDPNARPNFSQIIQMLLHYLSTISAPKPVIPARIFTSENAVLPPESPGTSSLMAVRD 326
Query: 244 DIGETPKAKMGDKPKSLFFCFNLCY 268
D+GETP+ ++ DKPKS FFCFN CY
Sbjct: 327 DLGETPRTQIEDKPKSFFFCFNQCY 351
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224055579|ref|XP_002298549.1| predicted protein [Populus trichocarpa] gi|222845807|gb|EEE83354.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 486 bits (1250), Expect = e-135, Method: Compositional matrix adjust.
Identities = 225/265 (84%), Positives = 245/265 (92%)
Query: 4 QFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 63
+FIGACKEPVMVIVTELL GGTLRKYLLNMRPRCL++ VA GFALDIARAMECLHSHGII
Sbjct: 87 KFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLEMRVAFGFALDIARAMECLHSHGII 146
Query: 64 HRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEK 123
HRDLKPENL+LT D KT+KLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLR GEK
Sbjct: 147 HRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRHGEK 206
Query: 124 KHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTS 183
KHYNHKVD+YSFAIVLWEL+HNKLPFEGMSNLQAAYAAAFKNVRPSAEN+PE+L++I+TS
Sbjct: 207 KHYNHKVDAYSFAIVLWELIHNKLPFEGMSNLQAAYAAAFKNVRPSAENLPEDLALIVTS 266
Query: 184 CWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIPHRIFNSENTILPPESPGTSSLMTVRD 243
CWKEDPNARPNF+QIIQMLL+YLS I+ PEP IP RIF SEN + PPESPGTSSLM VRD
Sbjct: 267 CWKEDPNARPNFSQIIQMLLHYLSTISAPEPAIPARIFTSENAVFPPESPGTSSLMAVRD 326
Query: 244 DIGETPKAKMGDKPKSLFFCFNLCY 268
D GETP+ ++ DKP+ FFCFN CY
Sbjct: 327 DSGETPRTQIEDKPRGFFFCFNQCY 351
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356516635|ref|XP_003526999.1| PREDICTED: serine/threonine-protein kinase HT1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 485 bits (1248), Expect = e-135, Method: Compositional matrix adjust.
Identities = 228/265 (86%), Positives = 245/265 (92%)
Query: 4 QFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 63
+FIGACKEPVMVIVTELL GGTLRKYL +MRP+CLD VAIGFALDIARAMECLHSHGII
Sbjct: 88 KFIGACKEPVMVIVTELLLGGTLRKYLFSMRPKCLDRHVAIGFALDIARAMECLHSHGII 147
Query: 64 HRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEK 123
HRDLKP+NLLLTED KT+KLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEK
Sbjct: 148 HRDLKPDNLLLTEDQKTVKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEK 207
Query: 124 KHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTS 183
KHYNHKVD+YSFAIVLWELLHNK+PFEGMSNLQAAYAAAFKNVRPSAEN+PEEL++ILTS
Sbjct: 208 KHYNHKVDAYSFAIVLWELLHNKVPFEGMSNLQAAYAAAFKNVRPSAENLPEELAVILTS 267
Query: 184 CWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIPHRIFNSENTILPPESPGTSSLMTVRD 243
CW+EDPNARPNFTQIIQMLLNYL +APPEPMIP RIF+SENT+LPPESPGTSSLM RD
Sbjct: 268 CWQEDPNARPNFTQIIQMLLNYLYTVAPPEPMIPSRIFSSENTVLPPESPGTSSLMAKRD 327
Query: 244 DIGETPKAKMGDKPKSLFFCFNLCY 268
D G+TP+AK KP CF+ CY
Sbjct: 328 DTGDTPRAKDEIKPNGFLCCFSQCY 352
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255560936|ref|XP_002521481.1| protein kinase atn1, putative [Ricinus communis] gi|223539380|gb|EEF40971.1| protein kinase atn1, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 483 bits (1244), Expect = e-134, Method: Compositional matrix adjust.
Identities = 226/266 (84%), Positives = 248/266 (93%), Gaps = 1/266 (0%)
Query: 4 QFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 63
+FIGACKEPVMVIVTELL GGTLRKYLLN+RPR L++ VAIGFALDIARAMECLHSHGII
Sbjct: 88 KFIGACKEPVMVIVTELLLGGTLRKYLLNLRPRSLELHVAIGFALDIARAMECLHSHGII 147
Query: 64 HRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEK 123
HRDLKPENL+LT D KT+KLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLR GEK
Sbjct: 148 HRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRHGEK 207
Query: 124 KHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTS 183
KHYNHKVD+YSFAIVLWEL+HNKLPFEGMSNLQAAYAAAFKNVRPSA+++PEE+++I+TS
Sbjct: 208 KHYNHKVDAYSFAIVLWELIHNKLPFEGMSNLQAAYAAAFKNVRPSADDLPEEMAMIVTS 267
Query: 184 CWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIPHRIFNSENTILPPESPGTSSLMTVRD 243
CW+EDPNARPNFTQIIQMLL +LS I+PPEP+IP RIF SEN +LPPESPGTSSLM VRD
Sbjct: 268 CWQEDPNARPNFTQIIQMLLRFLSTISPPEPVIPARIFTSENAVLPPESPGTSSLMAVRD 327
Query: 244 DIGETPKAKMGD-KPKSLFFCFNLCY 268
D GETPK+KM D KP+ FFCFN CY
Sbjct: 328 DSGETPKSKMEDNKPRGFFFCFNQCY 353
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|363808050|ref|NP_001241956.1| uncharacterized protein LOC100804884 [Glycine max] gi|255636187|gb|ACU18435.1| unknown [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 478 bits (1229), Expect = e-132, Method: Compositional matrix adjust.
Identities = 225/265 (84%), Positives = 242/265 (91%)
Query: 4 QFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 63
+FIGACKEPVMVIVTELL GGTLRKYLL+MRP+CLD VAIG+ALDIARAMECLHSHGII
Sbjct: 88 KFIGACKEPVMVIVTELLLGGTLRKYLLSMRPKCLDRHVAIGYALDIARAMECLHSHGII 147
Query: 64 HRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEK 123
HRDLKP+NLLLTED KT+KL DFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEK
Sbjct: 148 HRDLKPDNLLLTEDQKTVKLVDFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEK 207
Query: 124 KHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTS 183
KHYNHKVD+YSFAIVLWELLHNK+PFEGMSNLQAAYAAAFKNVRPSAEN+PEEL++ILTS
Sbjct: 208 KHYNHKVDAYSFAIVLWELLHNKVPFEGMSNLQAAYAAAFKNVRPSAENLPEELAVILTS 267
Query: 184 CWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIPHRIFNSENTILPPESPGTSSLMTVRD 243
CW+ED NARPNFTQIIQMLLNYL +APPEPM P RIFNSENT+LPPESPGTSSLM RD
Sbjct: 268 CWQEDSNARPNFTQIIQMLLNYLYTVAPPEPMTPSRIFNSENTVLPPESPGTSSLMAKRD 327
Query: 244 DIGETPKAKMGDKPKSLFFCFNLCY 268
G+TP+AK KP CF+ CY
Sbjct: 328 GTGDTPRAKDEIKPNGFLCCFSQCY 352
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225452312|ref|XP_002272486.1| PREDICTED: serine/threonine-protein kinase HT1 [Vitis vinifera] gi|296087594|emb|CBI34850.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 476 bits (1225), Expect = e-132, Method: Compositional matrix adjust.
Identities = 221/265 (83%), Positives = 242/265 (91%)
Query: 4 QFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 63
+FIGACKEPVMVIVTELL GGTLRKYLLN+RPRCLD VA+GFALDIARAMECLHSHGII
Sbjct: 88 KFIGACKEPVMVIVTELLLGGTLRKYLLNLRPRCLDTKVAVGFALDIARAMECLHSHGII 147
Query: 64 HRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEK 123
HRDLKPENL+LT D KT+KLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLR GEK
Sbjct: 148 HRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRHGEK 207
Query: 124 KHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTS 183
KHYNHKVD+YSFAIVLWEL+HNKLPFEGMSNLQAAYAAAFKN+RPSAE++PE+L++I+TS
Sbjct: 208 KHYNHKVDAYSFAIVLWELVHNKLPFEGMSNLQAAYAAAFKNMRPSAEDLPEDLALIVTS 267
Query: 184 CWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIPHRIFNSENTILPPESPGTSSLMTVRD 243
CWKEDPN RPNF+QIIQMLL+YLS I+PPEPM+P R+F SEN +LPPESPGTSSLM VRD
Sbjct: 268 CWKEDPNTRPNFSQIIQMLLHYLSTISPPEPMVPPRVFTSENAVLPPESPGTSSLMAVRD 327
Query: 244 DIGETPKAKMGDKPKSLFFCFNLCY 268
GETPK M P+ F CFN CY
Sbjct: 328 GSGETPKTSMETNPRGCFSCFNHCY 352
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357461809|ref|XP_003601186.1| Serine/threonine protein kinase TNNI3K [Medicago truncatula] gi|355490234|gb|AES71437.1| Serine/threonine protein kinase TNNI3K [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 471 bits (1212), Expect = e-130, Method: Compositional matrix adjust.
Identities = 220/265 (83%), Positives = 240/265 (90%)
Query: 4 QFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 63
+FIGACKEPVMVIVTELLSGGTLRKYLLNMRP+CLD VAIGFALDI+RAMECLHSHGII
Sbjct: 88 KFIGACKEPVMVIVTELLSGGTLRKYLLNMRPKCLDTHVAIGFALDISRAMECLHSHGII 147
Query: 64 HRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEK 123
HRDLKP+NLLLTED T+KLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEK
Sbjct: 148 HRDLKPDNLLLTEDHGTVKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEK 207
Query: 124 KHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTS 183
KHYNHKVD+YSFAIV WELLHNK+PFEGMSNLQAAYAAAFKNVRP+A+++PEEL++ILTS
Sbjct: 208 KHYNHKVDAYSFAIVFWELLHNKVPFEGMSNLQAAYAAAFKNVRPNADHLPEELAVILTS 267
Query: 184 CWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIPHRIFNSENTILPPESPGTSSLMTVRD 243
CW+ED NARPNFTQIIQMLLNYL ++PP P IP RIF SENT+LPPESPGTSSLM RD
Sbjct: 268 CWQEDANARPNFTQIIQMLLNYLYTVSPPTPAIPSRIFTSENTLLPPESPGTSSLMAKRD 327
Query: 244 DIGETPKAKMGDKPKSLFFCFNLCY 268
D G+TP+ K KP CF+ CY
Sbjct: 328 DTGDTPRVKDEIKPNGFLCCFSQCY 352
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 268 | ||||||
| TAIR|locus:2157717 | 346 | AT5G50180 [Arabidopsis thalian | 0.988 | 0.765 | 0.830 | 8.8e-118 | |
| TAIR|locus:2168778 | 353 | AT5G40540 [Arabidopsis thalian | 0.973 | 0.739 | 0.757 | 2.8e-105 | |
| TAIR|locus:2091423 | 356 | ATN1 [Arabidopsis thaliana (ta | 0.966 | 0.727 | 0.750 | 2.3e-103 | |
| TAIR|locus:2180992 | 333 | AT5G01850 [Arabidopsis thalian | 0.828 | 0.666 | 0.687 | 3.7e-80 | |
| TAIR|locus:2173674 | 405 | AT5G66710 [Arabidopsis thalian | 0.925 | 0.612 | 0.552 | 5.2e-65 | |
| TAIR|locus:2101689 | 377 | AT3G50720 [Arabidopsis thalian | 0.720 | 0.511 | 0.548 | 3.8e-53 | |
| TAIR|locus:2061092 | 411 | AT2G24360 [Arabidopsis thalian | 0.705 | 0.459 | 0.480 | 5e-44 | |
| TAIR|locus:2126311 | 412 | AT4G31170 [Arabidopsis thalian | 0.705 | 0.458 | 0.475 | 2.5e-42 | |
| TAIR|locus:2154573 | 525 | AT5G58950 [Arabidopsis thalian | 0.708 | 0.361 | 0.427 | 2.6e-40 | |
| TAIR|locus:2121154 | 575 | STY46 "serine/threonine/tyrosi | 0.705 | 0.328 | 0.457 | 1.8e-39 |
| TAIR|locus:2157717 AT5G50180 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1160 (413.4 bits), Expect = 8.8e-118, P = 8.8e-118
Identities = 220/265 (83%), Positives = 235/265 (88%)
Query: 4 QFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 63
+FIGACKEPVMVIVTELL GGTLRKYLLN+RP CL+ VAIGFALDIAR MECLHSHGII
Sbjct: 82 KFIGACKEPVMVIVTELLQGGTLRKYLLNLRPACLETRVAIGFALDIARGMECLHSHGII 141
Query: 64 HRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEK 123
HRDLKPENLLLT D KT+KLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLR GEK
Sbjct: 142 HRDLKPENLLLTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRLGEK 201
Query: 124 KHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTS 183
KHYNHKVD+YSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAE++PEEL I+TS
Sbjct: 202 KHYNHKVDAYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAESLPEELGDIVTS 261
Query: 184 CWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIPHRIFNSENTILPPESPGTSSLMTVRD 243
CW EDPNARPNFT II++LLNYLS + P IP RI S+NT+LPP+SPGTSSLM D
Sbjct: 262 CWNEDPNARPNFTHIIELLLNYLSKVGSPISAIPQRILASKNTLLPPDSPGTSSLMAKLD 321
Query: 244 DIGETPKAKMGDKPKSLFFCFNLCY 268
+ GETPKAK DK K LFFCFN CY
Sbjct: 322 ECGETPKAKSEDKRKGLFFCFNQCY 346
|
|
| TAIR|locus:2168778 AT5G40540 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1042 (371.9 bits), Expect = 2.8e-105, P = 2.8e-105
Identities = 200/264 (75%), Positives = 231/264 (87%)
Query: 4 QFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 63
+FIGACKEP+MVIVTELL GGTLRKYL+++RP LD+ VA+G+ALDIARAMECLHSHG+I
Sbjct: 88 KFIGACKEPIMVIVTELLLGGTLRKYLVSLRPGSLDIRVAVGYALDIARAMECLHSHGVI 147
Query: 64 HRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEK 123
HRDLKPE+L+LT D KT+KLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLR GEK
Sbjct: 148 HRDLKPESLILTADYKTVKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRHGEK 207
Query: 124 KHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTS 183
KHYNHKVD+YSFAIVLWEL+HNKLPFEGMSNLQAAYAAAFKNVRPSA+++P++L++I+TS
Sbjct: 208 KHYNHKVDAYSFAIVLWELIHNKLPFEGMSNLQAAYAAAFKNVRPSADDLPKDLAMIVTS 267
Query: 184 CWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIP--HRIFNSENTILPPESPGTSSLMTV 241
CWKEDPN RPNFT+IIQMLL LS I+ E + P R+F+SENT+LPPESPGT SLMTV
Sbjct: 268 CWKEDPNDRPNFTEIIQMLLRCLSTISSTELVPPAIKRVFSSENTVLPPESPGTCSLMTV 327
Query: 242 RD-DIGETPKAKMGDKPKSLFFCF 264
RD D T ++ + FF F
Sbjct: 328 RDKDQIPTDANSAQNEVRGSFFFF 351
|
|
| TAIR|locus:2091423 ATN1 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1024 (365.5 bits), Expect = 2.3e-103, P = 2.3e-103
Identities = 199/265 (75%), Positives = 232/265 (87%)
Query: 4 QFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 63
+FIGACKEP+MVIVTELL GGTLRKYL+++RP+ LD+ +A+GFALDIARAMECLHSHGII
Sbjct: 88 KFIGACKEPMMVIVTELLLGGTLRKYLVSLRPKRLDIRLAVGFALDIARAMECLHSHGII 147
Query: 64 HRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEK 123
HRDLKPENL+L+ D KT+KLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEK
Sbjct: 148 HRDLKPENLILSADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEK 207
Query: 124 KHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTS 183
KHYNHKVD+YSFAIVLWEL+ NKLPFEGMSNLQAAYAAAFKN+RPSAE++P +L +I+TS
Sbjct: 208 KHYNHKVDAYSFAIVLWELILNKLPFEGMSNLQAAYAAAFKNLRPSAEDLPGDLEMIVTS 267
Query: 184 CWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIP--HRIFNSENTILPPESPGTSSLMTV 241
CWKEDPN RPNFT+IIQMLL YL+ ++ P+ + P R+F+SEN +L PESPGT SLM+V
Sbjct: 268 CWKEDPNERPNFTEIIQMLLRYLTTVSAPQIIPPPNRRVFSSENIVLSPESPGTCSLMSV 327
Query: 242 RD-DIG-ETPK-AKMGDKP-KSLFF 262
RD D+ +T A +K K FF
Sbjct: 328 RDGDVSRQTVNTADSSEKQTKGSFF 352
|
|
| TAIR|locus:2180992 AT5G01850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 805 (288.4 bits), Expect = 3.7e-80, P = 3.7e-80
Identities = 154/224 (68%), Positives = 185/224 (82%)
Query: 4 QFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 63
+FIGACK+P+MVIVTELL G +LRKYL ++RP+ L + +A+ FALDIARA+ CLH++GII
Sbjct: 80 KFIGACKDPLMVIVTELLPGMSLRKYLTSIRPQLLHLPLALSFALDIARALHCLHANGII 139
Query: 64 HRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEK 123
HRDLKP+NLLLTE+ K++KLADFGLAREES+TEMMTAETGTYRWMAPELYSTVTLRQGEK
Sbjct: 140 HRDLKPDNLLLTENHKSVKLADFGLAREESVTEMMTAETGTYRWMAPELYSTVTLRQGEK 199
Query: 124 KHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP-SAENVPEELSIILT 182
KHYN+KVD YSF IVLWELL N++PFEGMSNLQAAYAAAFK RP E + L+ I+
Sbjct: 200 KHYNNKVDVYSFGIVLWELLTNRMPFEGMSNLQAAYAAAFKQERPVMPEGISPSLAFIVQ 259
Query: 183 SCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPM-IPHRIFNSEN 225
SCW EDPN RP+F+QII++L +L + PP P +P N N
Sbjct: 260 SCWVEDPNMRPSFSQIIRLLNEFLLTLTPPPPQPLPETATNRTN 303
|
|
| TAIR|locus:2173674 AT5G66710 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 662 (238.1 bits), Expect = 5.2e-65, P = 5.2e-65
Identities = 142/257 (55%), Positives = 181/257 (70%)
Query: 4 QFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 63
+FIGAC EP ++I+TEL+ G TL+K++L++RP+ LD+ ++I FALDIAR ME L+++GII
Sbjct: 134 RFIGACIEPKLMIITELMEGNTLQKFMLSVRPKPLDLKLSISFALDIARGMEFLNANGII 193
Query: 64 HRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEK 123
HRDLKP N+LLT D K +KLADFGLAREE+ MT E GTYRWMAPEL+S TL GEK
Sbjct: 194 HRDLKPSNMLLTGDQKHVKLADFGLAREET-KGFMTFEAGTYRWMAPELFSYDTLEIGEK 252
Query: 124 KHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTS 183
KHY+HKVD YSFAIV WELL NK PF+G +N+ AYAA+ KN RPS EN+PE + IL S
Sbjct: 253 KHYDHKVDVYSFAIVFWELLTNKTPFKGKNNIFVAYAAS-KNQRPSVENLPEGVVSILQS 311
Query: 184 CWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIPHRIFNSENTILPPESPGTSSLMTVRD 243
CW E+P+ARP F +I L N L +++ NS+ I +S TSSL+ R
Sbjct: 312 CWAENPDARPEFKEITYSLTNLLRSLSSDTDATSS---NSKANIATEDS--TSSLVQERV 366
Query: 244 DIGETPKAKMGDKPKSL 260
+ + P KM K K L
Sbjct: 367 -VCDCPGLKMS-KTKKL 381
|
|
| TAIR|locus:2101689 AT3G50720 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 550 (198.7 bits), Expect = 3.8e-53, P = 3.8e-53
Identities = 107/195 (54%), Positives = 138/195 (70%)
Query: 4 QFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 63
+F+GAC EP ++IVTEL+ GGTL++++LN RP LD+ V++ FALDI+RAME LHS GII
Sbjct: 111 RFVGACIEPQLMIVTELVRGGTLQRFMLNSRPSPLDLKVSLSFALDISRAMEYLHSKGII 170
Query: 64 HRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEK 123
HRDL P N+L+T D+K +KLADFGLARE++L M T E GTYRWMAPE+ S LR GEK
Sbjct: 171 HRDLNPRNVLVTGDMKHVKLADFGLAREKTLGGM-TCEAGTYRWMAPEVCSREPLRIGEK 229
Query: 124 KHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTS 183
KHY+ K+D YSFA++ W LL NK PF + ++ Y + RPS N+P+E+ IL
Sbjct: 230 KHYDQKIDVYSFALIFWSLLTNKTPFSEIPSISIPYFVN-QGKRPSLSNIPDEVVPILEC 288
Query: 184 CWKEDPNARPNFTQI 198
CW D R F I
Sbjct: 289 CWAADSKTRLEFKDI 303
|
|
| TAIR|locus:2061092 AT2G24360 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 464 (168.4 bits), Expect = 5.0e-44, P = 5.0e-44
Identities = 97/202 (48%), Positives = 135/202 (66%)
Query: 4 QFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI 62
+FIGAC++P V IVTE GG++R++L + R + + +A+ ALD+AR M +H
Sbjct: 193 RFIGACRKPMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGRNF 252
Query: 63 IHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGE 122
IHRDLK +NLL++ D K+IK+ADFG+AR E TE MT ETGTYRWMAPE+ +
Sbjct: 253 IHRDLKSDNLLISAD-KSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMI--------Q 303
Query: 123 KKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN--VPEELSII 180
+ YN KVD YSF IVLWEL+ LPF+ M+ +QAA+A + VRP+ N +P LS I
Sbjct: 304 HRAYNQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNRGVRPTVPNDCLPV-LSDI 362
Query: 181 LTSCWKEDPNARPNFTQIIQML 202
+T CW +P RP F +++++L
Sbjct: 363 MTRCWDANPEVRPCFVEVVKLL 384
|
|
| TAIR|locus:2126311 AT4G31170 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 448 (162.8 bits), Expect = 2.5e-42, P = 2.5e-42
Identities = 96/202 (47%), Positives = 132/202 (65%)
Query: 4 QFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI 62
+FIGAC +P V IVTE GG++R++L + R + + +A+ ALD+AR M +H
Sbjct: 194 RFIGACIKPMVWCIVTEYAKGGSVRQFLTKRQNRAVPLKLAVMQALDVARGMAYVHERNF 253
Query: 63 IHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGE 122
IHRDLK +NLL++ D ++IK+ADFG+AR E TE MT ETGTYRWMAPE+ +
Sbjct: 254 IHRDLKSDNLLISAD-RSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMI--------Q 304
Query: 123 KKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS--AENVPEELSII 180
+ Y KVD YSF IVLWEL+ LPF+ M+ +QAA+A + VRP+ A+ +P L I
Sbjct: 305 HRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNRGVRPTVPADCLPV-LGEI 363
Query: 181 LTSCWKEDPNARPNFTQIIQML 202
+T CW DP RP F +I+ +L
Sbjct: 364 MTRCWDADPEVRPCFAEIVNLL 385
|
|
| TAIR|locus:2154573 AT5G58950 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 429 (156.1 bits), Expect = 2.6e-40, P = 2.6e-40
Identities = 86/201 (42%), Positives = 128/201 (63%)
Query: 4 QFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI 62
+F+GA K+P V ++T+ L G+LR +L R L + I FA+DIAR ME +HS I
Sbjct: 272 KFVGAYKDPPVYCVLTQYLPEGSLRSFLHKPENRSLPLKKLIEFAIDIARGMEYIHSRRI 331
Query: 63 IHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGE 122
IHRDLKPEN+L+ E+ +K+ADFG+A EE +M+ + GTYRWMAPE+ +
Sbjct: 332 IHRDLKPENVLIDEEFH-LKIADFGIACEEEYCDMLADDPGTYRWMAPEMI--------K 382
Query: 123 KKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAE-NVPEELSIIL 181
+K + K D YSF +VLWE++ +P+E M+ +QAA+A KN+RP+ + P + ++
Sbjct: 383 RKPHGRKADVYSFGLVLWEMVAGAIPYEDMNPIQAAFAVVHKNIRPAIPGDCPVAMKALI 442
Query: 182 TSCWKEDPNARPNFTQIIQML 202
CW P+ RP F QI+++L
Sbjct: 443 EQCWSVAPDKRPEFWQIVKVL 463
|
|
| TAIR|locus:2121154 STY46 "serine/threonine/tyrosine kinase 46" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 421 (153.3 bits), Expect = 1.8e-39, P = 1.8e-39
Identities = 92/201 (45%), Positives = 128/201 (63%)
Query: 4 QFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI 62
QFIGAC K P + IVTE + GG++ YL + + + A+DI + M LH + I
Sbjct: 349 QFIGACTKPPHLCIVTEFMPGGSVYDYL-HKQKGVFKLPTLFKVAIDICKGMSYLHQNNI 407
Query: 63 IHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGE 122
IHRDLK NLL+ E+ + +K+ADFG+AR ++ T +MTAETGTYRWMAPE+ E
Sbjct: 408 IHRDLKAANLLMDEN-EVVKVADFGVARVKAQTGVMTAETGTYRWMAPEVI--------E 458
Query: 123 KKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSA-ENVPEELSIIL 181
K Y+HK D +S+ IVLWELL KLP+E M+ LQAA K +RP+ +N +L+ +L
Sbjct: 459 HKPYDHKADVFSYGIVLWELLTGKLPYEYMTPLQAAVGVVQKGLRPTIPKNTHPKLAELL 518
Query: 182 TSCWKEDPNARPNFTQIIQML 202
W+ D RP+F++II+ L
Sbjct: 519 ERLWEHDSTQRPDFSEIIEQL 539
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | LOW CONFIDENCE prediction! |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00015979001 | SubName- Full=Putative uncharacterized protein (Chromosome chr17 scaffold_12, whole genome shotgun sequence); (352 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 268 | |||
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-56 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 6e-56 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-51 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-50 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-49 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-44 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-43 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-31 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-31 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-30 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-30 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-30 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-30 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-30 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-29 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-28 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-28 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-28 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-28 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 6e-28 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 7e-28 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-27 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-27 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-26 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-26 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-26 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-25 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-25 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 5e-25 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 8e-25 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 8e-25 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-24 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-24 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-24 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 5e-24 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 6e-24 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 6e-24 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-23 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-23 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-23 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-23 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-23 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 5e-23 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 9e-23 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 9e-23 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-22 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-22 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-22 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-22 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 4e-22 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 6e-22 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 8e-22 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-21 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-21 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-21 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-21 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-21 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-21 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-21 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-21 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-21 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-21 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-21 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 6e-21 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 6e-21 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 7e-21 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-20 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-20 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-20 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-20 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-20 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 9e-20 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-19 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-19 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-19 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-19 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 5e-19 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 5e-19 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 7e-19 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 7e-19 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-18 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-18 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-18 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-18 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-18 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-18 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-18 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-18 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-18 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-18 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-18 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-18 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 4e-18 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-18 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 7e-18 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 9e-18 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-17 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-17 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-17 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-17 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-17 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-17 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-17 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-17 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-17 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-17 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-17 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-17 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-17 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-17 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 6e-17 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 7e-17 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 9e-17 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-16 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-16 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-16 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-16 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-16 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-16 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-16 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-16 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-16 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 6e-16 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 8e-16 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 8e-16 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 9e-16 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 9e-16 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-15 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-15 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-15 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-15 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-15 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-15 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-15 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-15 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-15 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-15 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-15 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-15 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-15 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-15 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-15 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-15 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-15 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-15 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-15 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 7e-15 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 7e-15 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 8e-15 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 8e-15 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 8e-15 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-14 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-14 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-14 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-14 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-14 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-14 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-14 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-14 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-14 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-14 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-14 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-14 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-14 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-14 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 6e-14 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 6e-14 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 6e-14 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 8e-14 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 8e-14 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 9e-14 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 9e-14 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-13 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-13 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-13 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-13 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-13 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-13 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-13 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-13 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-13 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-13 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-13 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-13 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-13 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-13 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-13 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 5e-13 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 6e-13 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 6e-13 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 6e-13 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 6e-13 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 6e-13 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 7e-13 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 7e-13 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 8e-13 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 9e-13 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-12 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-12 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-12 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-12 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-12 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-12 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-12 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-12 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-12 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-12 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-12 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-12 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 6e-12 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 7e-12 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 7e-12 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 7e-12 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 7e-12 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 7e-12 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 8e-12 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 8e-12 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 8e-12 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-11 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-11 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-11 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-11 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-11 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-11 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-11 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-11 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-11 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-11 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-11 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-11 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-11 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-11 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-11 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 6e-11 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 6e-11 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 6e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 7e-11 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 8e-11 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 8e-11 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 8e-11 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 8e-11 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 9e-11 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 9e-11 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-10 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-10 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-10 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-10 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-10 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-10 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-10 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-10 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 6e-10 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 6e-10 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 6e-10 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 8e-10 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-09 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-09 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-09 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-09 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-09 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-09 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-09 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-09 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 9e-09 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 9e-09 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-08 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 1e-08 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-08 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-08 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-08 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-08 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-08 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-08 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 4e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 7e-08 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 8e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 8e-08 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-07 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-07 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-07 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-07 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 3e-07 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 3e-07 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-07 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 9e-07 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-06 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-06 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 3e-06 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 3e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 5e-06 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 1e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-05 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-05 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 4e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 6e-05 | |
| PRK09605 | 535 | PRK09605, PRK09605, bifunctional UGMP family prote | 7e-05 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 8e-05 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-04 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-04 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-04 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 5e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 0.004 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 0.004 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 180 bits (460), Expect = 3e-56
Identities = 75/204 (36%), Positives = 112/204 (54%), Gaps = 15/204 (7%)
Query: 4 QFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG 61
+ +G C +EP+M IV E + GG L YL RP+ L + + FAL IAR ME L S
Sbjct: 65 KLLGVCTEEEPLM-IVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN 123
Query: 62 IIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETG--TYRWMAPELYSTVTLR 119
IHRDL N L+ E+ +K++DFGL+R+ + + G RWMAPE +L+
Sbjct: 124 FIHRDLAARNCLVGEN-LVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPE-----SLK 177
Query: 120 QGEKKHYNHKVDSYSFAIVLWELLHN-KLPFEGMSNLQAAYAAAFKNVRPSAENVPEELS 178
+G+ + K D +SF ++LWE+ + P+ GMSN + P N P EL
Sbjct: 178 EGK---FTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNCPPELY 234
Query: 179 IILTSCWKEDPNARPNFTQIIQML 202
++ CW EDP RP F++++++L
Sbjct: 235 KLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 180 bits (458), Expect = 6e-56
Identities = 72/205 (35%), Positives = 110/205 (53%), Gaps = 18/205 (8%)
Query: 4 QFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVA--IGFALDIARAMECLHSH 60
+ +G C +E + IV E + GG L YL RP+ + ++ + FAL IAR ME L S
Sbjct: 65 KLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK---LSLSDLLSFALQIARGMEYLESK 121
Query: 61 GIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETG--TYRWMAPELYSTVTL 118
IHRDL N L+ E+ +K++DFGL+R+ + G RWMAPE +L
Sbjct: 122 NFIHRDLAARNCLVGEN-LVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPE-----SL 175
Query: 119 RQGEKKHYNHKVDSYSFAIVLWELLHN-KLPFEGMSNLQAAYAAAFKNVRPSAENVPEEL 177
++G+ + K D +SF ++LWE+ + P+ GMSN + P N P EL
Sbjct: 176 KEGK---FTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNCPPEL 232
Query: 178 SIILTSCWKEDPNARPNFTQIIQML 202
++ CW EDP RP F++++++L
Sbjct: 233 YDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 168 bits (429), Expect = 1e-51
Identities = 70/206 (33%), Positives = 106/206 (51%), Gaps = 19/206 (9%)
Query: 4 QFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG 61
+ +G C EP+ IVTE + GG L +L L + + AL IA+ ME L S
Sbjct: 65 RLLGVCTQGEPLY-IVTEYMPGGDLLDFLRK-HGEKLTLKDLLQMALQIAKGMEYLESKN 122
Query: 62 IIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY---RWMAPELYSTVTL 118
+HRDL N L+TE+L +K++DFGL+R+ + G +WMAPE L
Sbjct: 123 FVHRDLAARNCLVTENL-VVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPES-----L 176
Query: 119 RQGEKKHYNHKVDSYSFAIVLWELLHN-KLPFEGMSNLQAAYAAAFKNVRPSA-ENVPEE 176
+ G+ + K D +SF ++LWE+ + P+ GMSN + R EN P+E
Sbjct: 177 KDGK---FTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEV-LELLEDGYRLPRPENCPDE 232
Query: 177 LSIILTSCWKEDPNARPNFTQIIQML 202
L ++ CW DP RP F+++++ L
Sbjct: 233 LYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 165 bits (419), Expect = 5e-50
Identities = 71/214 (33%), Positives = 112/214 (52%), Gaps = 27/214 (12%)
Query: 4 QFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRP-------RCLDVCVAIGFALDIARAM 54
+ +G C +EP+ +V E + GG L YL RP L + + FA+ IA+ M
Sbjct: 60 RLLGVCTEEEPLY-LVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118
Query: 55 ECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY---RWMAPE 111
E L S +HRDL N L+ ED +K++DFGL+R+ + +TG RWMAPE
Sbjct: 119 EYLASKKFVHRDLAARNCLVGED-LVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE 177
Query: 112 LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHN-KLPFEGMSNLQ--AAYAAAFKNVRP 168
+L+ G + K D +SF ++LWE+ P+ G+SN + ++ +P
Sbjct: 178 -----SLKDG---IFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKP 229
Query: 169 SAENVPEELSIILTSCWKEDPNARPNFTQIIQML 202
E P+EL ++ SCW+ DP RP F+++++ L
Sbjct: 230 --EYCPDELYELMLSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 163 bits (415), Expect = 1e-49
Identities = 66/202 (32%), Positives = 92/202 (45%), Gaps = 15/202 (7%)
Query: 4 QFIGACKEPV-MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI 62
+ ++ + +V E GG L L L A + I A+E LHS GI
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGR--LSEDEARFYLRQILSALEYLHSKGI 118
Query: 63 IHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGE 122
+HRDLKPEN+LL ED +KLADFGLAR+ E +T GT +MAPE+
Sbjct: 119 VHRDLKPENILLDED-GHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLL-------- 169
Query: 123 KKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFK---NVRPSAENVPEELSI 179
K Y VD +S ++L+ELL K PF G L + K P ++ E
Sbjct: 170 GKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKD 229
Query: 180 ILTSCWKEDPNARPNFTQIIQM 201
++ +DP R + +Q
Sbjct: 230 LIRKLLVKDPEKRLTAEEALQH 251
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 149 bits (379), Expect = 4e-44
Identities = 75/206 (36%), Positives = 106/206 (51%), Gaps = 20/206 (9%)
Query: 4 QFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI 62
+ I A ++ + +V E GG L YL R L A AL I R +E LHS+GI
Sbjct: 62 RLIDAFEDKDHLYLVMEYCEGGDLFDYLS--RGGPLSEDEAKKIALQILRGLEYLHSNGI 119
Query: 63 IHRDLKPENLLLTEDLKTIKLADFGLAREESLT-EMMTAETGTYRWMAPELYSTVTLRQG 121
IHRDLKPEN+LL E+ +K+ADFGLA++ + +T GT +MAPE+ L G
Sbjct: 120 IHRDLKPENILLDENG-VVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEV-----LLGG 173
Query: 122 EKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAE-------NVP 174
Y KVD +S ++L+ELL K PF G N+ + + P E +
Sbjct: 174 --NGYGPKVDVWSLGVILYELLTGKPPFSG-ENILDQLQLIRRILGPPLEFDEPKWSSGS 230
Query: 175 EELSIILTSCWKEDPNARPNFTQIIQ 200
EE ++ C +DP+ RP +I+Q
Sbjct: 231 EEAKDLIKKCLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 2e-43
Identities = 59/201 (29%), Positives = 90/201 (44%), Gaps = 42/201 (20%)
Query: 4 QFIGACK-EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI 62
+ G + E + +V E GG+L+ L L + L I +E LHS+GI
Sbjct: 55 KLYGVFEDENHLYLVMEYCEGGSLKDLLKE-NEGKLSEDEILRILLQILEGLEYLHSNGI 113
Query: 63 IHRDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAETGTYRWMAPELYSTVTLRQG 121
IHRDLKPEN+LL D +KLADFGL++ S ++ GT +MAPE+
Sbjct: 114 IHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLL------- 166
Query: 122 EKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIIL 181
K +Y+ K D +S ++L+EL EL ++
Sbjct: 167 GKGYYSEKSDIWSLGVILYEL--------------------------------PELKDLI 194
Query: 182 TSCWKEDPNARPNFTQIIQML 202
++DP RP+ +I++ L
Sbjct: 195 RKMLQKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 1e-31
Identities = 63/205 (30%), Positives = 93/205 (45%), Gaps = 19/205 (9%)
Query: 4 QFIGAC--KEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH 60
++ G+ +E + I E +SGG+L LL + L V + I + LHS+
Sbjct: 63 RYYGSERDEEKNTLNIFLEYVSGGSLSS-LLKKFGK-LPEPVIRKYTRQILEGLAYLHSN 120
Query: 61 GIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET---GTYRWMAPELYSTVT 117
GI+HRD+K N+L+ D +KLADFG A+ E GT WMAPE+
Sbjct: 121 GIVHRDIKGANILVDSD-GVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEV----- 174
Query: 118 LRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA-YAAAFKNVRPS-AENVPE 175
+R E Y D +S + E+ K P+ + N AA Y P E++ E
Sbjct: 175 IRGEE---YGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSE 231
Query: 176 ELSIILTSCWKEDPNARPNFTQIIQ 200
E L C + DP RP +++Q
Sbjct: 232 EAKDFLRKCLRRDPKKRPTADELLQ 256
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 2e-31
Identities = 64/215 (29%), Positives = 105/215 (48%), Gaps = 24/215 (11%)
Query: 4 QFIGACK--EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCV--------AIGFALDIARA 53
+ +G +P +V++ EL++ G L+ YL + RP + I A +IA
Sbjct: 73 RLLGVVSTGQPTLVVM-ELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131
Query: 54 MECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY---RWMAP 110
M L + +HRDL N ++ EDL T+K+ DFG+ R+ T+ RWMAP
Sbjct: 132 MAYLAAKKFVHRDLAARNCMVAEDL-TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 111 ELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPS 169
E +L+ G + K D +SF +VLWE+ + P++G+SN +
Sbjct: 191 E-----SLKDG---VFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLDL 242
Query: 170 AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 204
EN P++L ++ CW+ +P RP F +I+ L +
Sbjct: 243 PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 1e-30
Identities = 71/212 (33%), Positives = 107/212 (50%), Gaps = 30/212 (14%)
Query: 4 QFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPR-----CLDVCVAIGFALDIARAMECL 57
Q G C K+ + IVTE ++ G L YL + + LD+C D+ AME L
Sbjct: 63 QLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMC------SDVCEAMEYL 116
Query: 58 HSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT---YRWMAPELYS 114
S+G IHRDL N L+ ED +K++DFGLAR L + T+ GT +W PE++
Sbjct: 117 ESNGFIHRDLAARNCLVGED-NVVKVSDFGLAR-YVLDDQYTSSQGTKFPVKWAPPEVFD 174
Query: 115 TVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAA--YAAAFKNVRPSAE 171
++ K D +SF +++WE+ K+P+E SN + +A ++ RP
Sbjct: 175 --------YSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKL- 225
Query: 172 NVPEELSIILTSCWKEDPNARPNFTQIIQMLL 203
P E+ I+ SCW E P RP F +++ L
Sbjct: 226 -APTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 1e-30
Identities = 72/206 (34%), Positives = 103/206 (50%), Gaps = 19/206 (9%)
Query: 4 QFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG 61
+ IG C K+P+ IV EL+ GG+L +L + R L V + +LD A ME L S
Sbjct: 56 KLIGVCVQKQPIY-IVMELVPGGSLLTFLRKKKNR-LTVKKLLQMSLDAAAGMEYLESKN 113
Query: 62 IIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT----YRWMAPELYSTVT 117
IHRDL N L+ E+ +K++DFG++REE + T G +W APE
Sbjct: 114 CIHRDLAARNCLVGEN-NVLKISDFGMSREEE-GGIYTVSDGLKQIPIKWTAPE-----A 166
Query: 118 LRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEE 176
L G Y + D +S+ I+LWE P+ GMSN Q P+ + PEE
Sbjct: 167 LNYGR---YTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEE 223
Query: 177 LSIILTSCWKEDPNARPNFTQIIQML 202
+ ++ CW DP RP+F++I L
Sbjct: 224 IYRLMLQCWAYDPENRPSFSEIYNEL 249
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 2e-30
Identities = 64/188 (34%), Positives = 95/188 (50%), Gaps = 14/188 (7%)
Query: 11 EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPE 70
EPV I+TEL+ G+L +L + + L V I A +A M L IHRDL
Sbjct: 75 EPVY-IITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAAR 133
Query: 71 NLLLTEDLKTIKLADFGLAREESLTEMMTAETGT-YRWMAPELYSTVTLRQGEKKHYNHK 129
N+L+ EDL K+ADFGLAR ++++ Y+W APE S ++ K
Sbjct: 134 NILVGEDL-VCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAAS--------HGTFSTK 184
Query: 130 VDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-PSAENVPEELSIILTSCWKE 187
D +SF I+L+E+ + ++P+ GM+N Y R P P+E+ I+ CW
Sbjct: 185 SDVWSFGILLYEMFTYGQVPYPGMNN-HEVYDQITAGYRMPCPAKCPQEIYKIMLECWAA 243
Query: 188 DPNARPNF 195
+P RP+F
Sbjct: 244 EPEDRPSF 251
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 3e-30
Identities = 65/209 (31%), Positives = 97/209 (46%), Gaps = 27/209 (12%)
Query: 2 REQFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRC--------LDVCVAIGFALDIARA 53
E F K + IV E GG L + + + LD V + AL
Sbjct: 65 YESFEEKGK---LCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALK---- 117
Query: 54 MECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAETGTYRWMAPEL 112
LHS I+HRD+KP+N+ LT + +KL DFG+++ S ++ GT +++PEL
Sbjct: 118 --YLHSRKILHRDIKPQNIFLTSN-GLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPEL 174
Query: 113 YSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN 172
+ K YN+K D +S VL+EL K PFEG + L+ A P
Sbjct: 175 C--------QNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQ 226
Query: 173 VPEELSIILTSCWKEDPNARPNFTQIIQM 201
EL +++S ++DP RP+ QI+Q
Sbjct: 227 YSSELRNLVSSLLQKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 4e-30
Identities = 68/192 (35%), Positives = 100/192 (52%), Gaps = 19/192 (9%)
Query: 10 KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKP 69
+EP+ IVTEL+ G+L +YL R L + I A +A M L + IHRDL
Sbjct: 73 EEPIY-IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAA 131
Query: 70 ENLLLTEDLKTIKLADFGLAR--EESLTEMMTAETGTYRWMAPE--LYSTVTLRQGEKKH 125
N+L+ E+ K+ADFGLAR +E + E +W APE LY+ ++
Sbjct: 132 RNVLVGENN-ICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSI------- 183
Query: 126 YNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-PSAENVPEELSIILTS 183
K D +SF I+L E++ + ++P+ GM+N + + R P P+EL I+
Sbjct: 184 ---KSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD-QGYRMPCPPGCPKELYDIMLD 239
Query: 184 CWKEDPNARPNF 195
CWKEDP+ RP F
Sbjct: 240 CWKEDPDDRPTF 251
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-29
Identities = 71/208 (34%), Positives = 107/208 (51%), Gaps = 27/208 (12%)
Query: 4 QFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVA---IGFALDIARAMECLH 58
Q +G P+ IVTE ++ G+L YL R R V +GFALD+ ME L
Sbjct: 64 QLLGVVLQGNPLY-IVTEYMAKGSLVDYL---RSRGRAVITLAQQLGFALDVCEGMEYLE 119
Query: 59 SHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY--RWMAPELYSTV 116
+HRDL N+L++EDL K++DFGLA+E S + ++G +W APE
Sbjct: 120 EKNFVHRDLAARNVLVSEDL-VAKVSDFGLAKEASQGQ----DSGKLPVKWTAPE----- 169
Query: 117 TLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-PSAENVP 174
LR +K ++ K D +SF I+LWE+ ++P+ + L+ K R + E P
Sbjct: 170 ALR---EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-LKDVVPHVEKGYRMEAPEGCP 225
Query: 175 EELSIILTSCWKEDPNARPNFTQIIQML 202
E+ ++ CW+ DP RP F Q+ + L
Sbjct: 226 PEVYKVMKDCWELDPAKRPTFKQLREQL 253
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 2e-28
Identities = 74/209 (35%), Positives = 105/209 (50%), Gaps = 23/209 (11%)
Query: 4 QFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG 61
+ IG C K+P+ IV EL+ GG +L PR L V I + A ME L S
Sbjct: 57 RLIGVCTQKQPIY-IVMELVQGGDFLTFLRTEGPR-LKVKELIQMVENAAAGMEYLESKH 114
Query: 62 IIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYR-----WMAPELYSTV 116
IHRDL N L+TE +K++DFG++REE + + A TG + W APE
Sbjct: 115 CIHRDLAARNCLVTEK-NVLKISDFGMSREEE--DGVYASTGGMKQIPVKWTAPE----- 166
Query: 117 TLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVR-PSAENVP 174
L G Y+ + D +SF I+LWE +P+ +SN Q A + VR P E P
Sbjct: 167 ALNYGR---YSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE-QGVRLPCPELCP 222
Query: 175 EELSIILTSCWKEDPNARPNFTQIIQMLL 203
+ + ++ CW+ DP RP+F+ + Q L
Sbjct: 223 DAVYRLMERCWEYDPGQRPSFSTVHQELQ 251
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-28
Identities = 72/224 (32%), Positives = 105/224 (46%), Gaps = 44/224 (19%)
Query: 6 IGACKE--PVMVIVTELLSGGTLRKYLLNMRPR----CLDVCVAIG----------FALD 49
+G C + P+ V+V E + G LR +L RP D FA
Sbjct: 82 LGVCTQEGPLYVVV-EYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQ 140
Query: 50 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETG---TYR 106
+AR ME L S IHRDL N+L+TED +K+ADFGLAR+ + T +
Sbjct: 141 VARGMEFLASKKCIHRDLAARNVLVTEDH-VMKIADFGLARDIHHIDYYRKTTNGRLPVK 199
Query: 107 WMAPE-LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL------HNKLPFEGM-SNLQAA 158
WMAPE L+ V Y H+ D +SF ++LWE+ + +P E + L+
Sbjct: 200 WMAPEALFDRV---------YTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEG 250
Query: 159 YAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 202
Y + +P N +EL ++ CW E P+ RP F Q+++ L
Sbjct: 251 Y----RMEKPQ--NCTQELYHLMRDCWHEVPSQRPTFKQLVEDL 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-28
Identities = 65/207 (31%), Positives = 97/207 (46%), Gaps = 29/207 (14%)
Query: 11 EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPE 70
PVM I+TE + G+L K+L + V +G IA M+ L +HRDL
Sbjct: 78 RPVM-IITEYMENGSLDKFLRENDGK-FTVGQLVGMLRGIASGMKYLSEMNYVHRDLAAR 135
Query: 71 NLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY---------RWMAPELYSTVTLRQG 121
N+L+ +L K++DFGL+R +E TY RW APE + R
Sbjct: 136 NILVNSNL-VCKVSDFGLSRRLEDSE------ATYTTKGGKIPIRWTAPE---AIAYR-- 183
Query: 122 EKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-PSAENVPEELSI 179
+ D +SF IV+WE++ + + P+ MSN Q A R P + P L
Sbjct: 184 ---KFTSASDVWSFGIVMWEVMSYGERPYWDMSN-QDVIKAVEDGYRLPPPMDCPSALYQ 239
Query: 180 ILTSCWKEDPNARPNFTQIIQMLLNYL 206
++ CW++D N RP F+QI+ L +
Sbjct: 240 LMLDCWQKDRNERPTFSQIVSTLDKMI 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 5e-28
Identities = 66/203 (32%), Positives = 105/203 (51%), Gaps = 19/203 (9%)
Query: 4 QFIGA--CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGF-ALDIARAMECLHSH 60
++ G+ K+ + IV E SGG+L+ LL + L I + ++ + +E LHS+
Sbjct: 61 KYYGSYLKKDELW-IVMEFCSGGSLKD-LLKSTNQTLTES-QIAYVCKELLKGLEYLHSN 117
Query: 61 GIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQ 120
GIIHRD+K N+LLT D + +KL DFGL+ + S T+ GT WMAPE+ +
Sbjct: 118 GIIHRDIKAANILLTSDGE-VKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVIN------ 170
Query: 121 GEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP---SAENVPEEL 177
K Y++K D +S I EL K P+ + ++A + A N P + E +E
Sbjct: 171 --GKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIA-TNGPPGLRNPEKWSDEF 227
Query: 178 SIILTSCWKEDPNARPNFTQIIQ 200
L C +++P RP Q+++
Sbjct: 228 KDFLKKCLQKNPEKRPTAEQLLK 250
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 6e-28
Identities = 69/193 (35%), Positives = 98/193 (50%), Gaps = 23/193 (11%)
Query: 11 EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPE 70
EP+ IVTE +S G+L +L + + L + + A IA M L S IHRDL
Sbjct: 74 EPIY-IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAAR 132
Query: 71 NLLLTEDLKTIKLADFGLAREESLTEMMTAETGT---YRWMAPE--LYSTVTLRQGEKKH 125
N+L+ E+L K+ADFGLAR E TA G +W APE Y T+
Sbjct: 133 NILVGENL-VCKIADFGLARLIEDDEY-TAREGAKFPIKWTAPEAANYGRFTI------- 183
Query: 126 YNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQ--AAYAAAFKNVRPSAENVPEELSIILT 182
K D +SF I+L E++ + ++P+ GM+N + ++ RP N PEEL ++
Sbjct: 184 ---KSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPP--NCPEELYDLML 238
Query: 183 SCWKEDPNARPNF 195
CW +DP RP F
Sbjct: 239 QCWDKDPEERPTF 251
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 7e-28
Identities = 63/179 (35%), Positives = 88/179 (49%), Gaps = 17/179 (9%)
Query: 17 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE 76
V E GG L +L + A +A +I A+E LHS GII+RDLKPEN+LL
Sbjct: 71 VLEYAPGGELFSHL--SKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDA 128
Query: 77 DLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNHKVDSYS 134
D IKL DFGLA+E S +E T GT ++APE V L +G Y VD +S
Sbjct: 129 D-GHIKLTDFGLAKELS-SEGSRTNTFCGTPEYLAPE----VLLGKG----YGKAVDWWS 178
Query: 135 FAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSA-ENVPEELSIILTSCWKEDPNAR 192
++L+E+L K PF + + Y E + E +++ ++DP R
Sbjct: 179 LGVLLYEMLTGKPPFYA-EDRKEIY-EKILKDPLRFPEFLSPEARDLISGLLQKDPTKR 235
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-27
Identities = 61/202 (30%), Positives = 93/202 (46%), Gaps = 13/202 (6%)
Query: 4 QFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 63
+ IG E + IV EL G LR YL + LD+ I ++ ++ A+ L S +
Sbjct: 71 KLIGVITENPVWIVMELAPLGELRSYLQVNKYS-LDLASLILYSYQLSTALAYLESKRFV 129
Query: 64 HRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY--RWMAPELYSTVTLRQG 121
HRD+ N+L++ +KL DFGL+R A G +WMAPE ++ R+
Sbjct: 130 HRDIAARNVLVS-SPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPE---SINFRR- 184
Query: 122 EKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSII 180
+ D + F + +WE+L PF+G+ N P N P L +
Sbjct: 185 ----FTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSL 240
Query: 181 LTSCWKEDPNARPNFTQIIQML 202
+T CW DP+ RP FT++ L
Sbjct: 241 MTKCWAYDPSKRPRFTELKAQL 262
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-27
Identities = 62/213 (29%), Positives = 93/213 (43%), Gaps = 30/213 (14%)
Query: 6 IGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVA--IGFALDIARAMECLHSHGII 63
IG CK +++V EL G L KYL R ++ V+ A +A M L S +
Sbjct: 62 IGVCKGEPLMLVMELAPLGPLLKYLKKRR----EIPVSDLKELAHQVAMGMAYLESKHFV 117
Query: 64 HRDLKPENLLLTEDLKTIKLADFGLAREESL---TEMMTAETG---TYRWMAPEL--YST 115
HRDL N+LL K++DFG++R +L ++ A T +W APE Y
Sbjct: 118 HRDLAARNVLLVNR-HQAKISDFGMSR--ALGAGSDYYRATTAGRWPLKWYAPECINYGK 174
Query: 116 VTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-PSAENV 173
++ K D +S+ + LWE + P+ M + A R P E
Sbjct: 175 ----------FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVI-AMLESGERLPRPEEC 223
Query: 174 PEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 206
P+E+ I+ SCWK P RP F+++
Sbjct: 224 PQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 106 bits (264), Expect = 1e-26
Identities = 60/200 (30%), Positives = 87/200 (43%), Gaps = 19/200 (9%)
Query: 14 MVIVTELLSGGTLRKYL-LNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENL 72
+ +V E + GG+L L R L A+ I A+E LHS GIIHRD+KPEN+
Sbjct: 73 LYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENI 132
Query: 73 LLTEDLKTIKLADFGLARE-------ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKH 125
LL D + +KL DFGLA+ S+ + + GT +MAPE+ L +
Sbjct: 133 LLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEV-----LLGLSLAY 187
Query: 126 YNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCW 185
+ D +S I L+ELL PFEG N A + ++ LS
Sbjct: 188 ASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLS------P 241
Query: 186 KEDPNARPNFTQIIQMLLNY 205
+ +++ LL
Sbjct: 242 SNPELISKAASDLLKKLLAK 261
|
Length = 384 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-26
Identities = 52/181 (28%), Positives = 82/181 (45%), Gaps = 13/181 (7%)
Query: 14 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 73
M +V +LL GG LR +L + +I A+E LHS GIIHRD+KP+N+L
Sbjct: 75 MYLVVDLLLGGDLRYHLSQKVK--FSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNIL 132
Query: 74 LTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSY 133
L E + + DF +A + + + T+ +GT +MAPE+ + Y+ VD +
Sbjct: 133 LDEQ-GHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCR--------QGYSVAVDWW 183
Query: 134 SFAIVLWELLHNKLPFEGMSN-LQAAYAAAFK-NVRPSAENVPEELSIILTSCWKEDPNA 191
S + +E L K P+ G S ++ A + E + + DP
Sbjct: 184 SLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLLERDPQK 243
Query: 192 R 192
R
Sbjct: 244 R 244
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 2e-26
Identities = 66/201 (32%), Positives = 102/201 (50%), Gaps = 16/201 (7%)
Query: 10 KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKP 69
KE + I+TE ++ G+L +L + + + I F+ IA M + IHRDL+
Sbjct: 72 KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRA 131
Query: 70 ENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY--RWMAPEL--YSTVTLRQGEKKH 125
N+L++E L K+ADFGLAR E E + +W APE + + T+
Sbjct: 132 ANVLVSESL-MCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTI------- 183
Query: 126 YNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSC 184
K D +SF I+L+E++ + K+P+ GMSN A P EN P+EL I+ +C
Sbjct: 184 ---KSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDIMKTC 240
Query: 185 WKEDPNARPNFTQIIQMLLNY 205
WKE RP F + +L ++
Sbjct: 241 WKEKAEERPTFDYLQSVLDDF 261
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-25
Identities = 64/210 (30%), Positives = 99/210 (47%), Gaps = 34/210 (16%)
Query: 4 QFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPR-----CLDVCVAIGFALDIARAMECL 57
Q G C K+ + IVTE +S G L YL R L++C D+ M L
Sbjct: 63 QLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCK------DVCEGMAYL 116
Query: 58 HSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT---YRWMAPE--L 112
S IHRDL N L+ + +K++DFGL+R L + T+ G+ RW PE L
Sbjct: 117 ESKQFIHRDLAARNCLVDDQG-CVKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLL 174
Query: 113 YSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAA--YAAAFKNVRPS 169
YS ++ K D ++F +++WE+ K+P+E +N + + + RP
Sbjct: 175 YSK----------FSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPH 224
Query: 170 AENVPEELSIILTSCWKEDPNARPNFTQII 199
+ E++ I+ SCW E RP F Q++
Sbjct: 225 LAS--EKVYAIMYSCWHEKAEERPTFQQLL 252
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 2e-25
Identities = 66/200 (33%), Positives = 99/200 (49%), Gaps = 18/200 (9%)
Query: 10 KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKP 69
+EP+ I+TE + G+L +L L + I A IA M + IHRDL+
Sbjct: 72 QEPIY-IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRA 130
Query: 70 ENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY--RWMAPEL--YSTVTLRQGEKKH 125
N+L++E L K+ADFGLAR E E + +W APE Y T T+
Sbjct: 131 ANILVSETL-CCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI------- 182
Query: 126 YNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSC 184
K D +SF I+L E++ + ++P+ GM+N + P +N PEEL ++ C
Sbjct: 183 ---KSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYELMRLC 239
Query: 185 WKEDPNARPNFTQIIQMLLN 204
WKE P RP F + ++ +L
Sbjct: 240 WKEKPEERPTF-EYLRSVLE 258
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 5e-25
Identities = 74/226 (32%), Positives = 108/226 (47%), Gaps = 36/226 (15%)
Query: 5 FIGACKE--PVMVIVTELLSGGTLRKYLLNMRPRCLDVCV--------------AIGFAL 48
+GAC + P+ VIV E S G LR+YL RP ++ C + A
Sbjct: 89 LLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAY 147
Query: 49 DIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETG---TY 105
+AR ME L S IHRDL N+L+TED +K+ADFGLAR+ + T
Sbjct: 148 QVARGMEYLASKKCIHRDLAARNVLVTED-NVMKIADFGLARDIHHIDYYKKTTNGRLPV 206
Query: 106 RWMAPE-LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEG--MSNLQAAYAA 161
+WMAPE L+ + Y H+ D +SF ++LWE+ P+ G + L
Sbjct: 207 KWMAPEALFDRI---------YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE 257
Query: 162 AFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 207
+ +PS N EL +++ CW P+ RP F Q+++ L L+
Sbjct: 258 GHRMDKPS--NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 8e-25
Identities = 67/207 (32%), Positives = 101/207 (48%), Gaps = 23/207 (11%)
Query: 6 IGACKE--PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 63
+GAC P++VI TE G L +L R L + + F+ +A+ M L S I
Sbjct: 105 LGACTIGGPILVI-TEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCI 163
Query: 64 HRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY---RWMAPE-LYSTVTLR 119
HRDL N+LLT K +K+ DFGLAR+ + +WMAPE +++ V
Sbjct: 164 HRDLAARNVLLTHG-KIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCV--- 219
Query: 120 QGEKKHYNHKVDSYSFAIVLWELLHNKL-PFEGM---SNLQAAYAAAFKNVRPSAENVPE 175
Y + D +S+ I+LWE+ P+ GM S ++ +P E+ P
Sbjct: 220 ------YTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQP--EHAPA 271
Query: 176 ELSIILTSCWKEDPNARPNFTQIIQML 202
E+ I+ +CW DP RP F QI+Q++
Sbjct: 272 EIYDIMKTCWDADPLKRPTFKQIVQLI 298
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 99.2 bits (247), Expect = 8e-25
Identities = 63/213 (29%), Positives = 105/213 (49%), Gaps = 29/213 (13%)
Query: 4 QFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI 62
Q +G C +EP I+TE ++ G L YL + ++ V + A I+ AME L
Sbjct: 66 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 125
Query: 63 IHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT--------YRWMAPELYS 114
IHRDL N L+ E+ +K+ADFGL+R +MT +T T +W APE +
Sbjct: 126 IHRDLAARNCLVGEN-HLVKVADFGLSR------LMTGDTYTAHAGAKFPIKWTAPESLA 178
Query: 115 TVTLRQGEKKHYNHKVDSYSFAIVLWEL-LHNKLPFEG--MSNLQAAYAAAFKNVRPSAE 171
++ K D ++F ++LWE+ + P+ G +S + ++ RP E
Sbjct: 179 YNK--------FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERP--E 228
Query: 172 NVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 204
P ++ ++ +CW+ +P+ RP+F +I Q
Sbjct: 229 GCPPKVYELMRACWQWNPSDRPSFAEIHQAFET 261
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 2e-24
Identities = 58/206 (28%), Positives = 99/206 (48%), Gaps = 20/206 (9%)
Query: 4 QFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI 62
Q G C ++ + IVTE + G L YL + + L + + D+ ME L +
Sbjct: 63 QLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGK-LSKDMLLSMCQDVCEGMEYLERNSF 121
Query: 63 IHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT---YRWMAPELYSTVTLR 119
IHRDL N L++ +K++DFG+ R L + T+ +G +W PE+++
Sbjct: 122 IHRDLAARNCLVS-STGVVKVSDFGMTR-YVLDDEYTSSSGAKFPVKWSPPEVFNF---- 175
Query: 120 QGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQA--AYAAAFKNVRPSAENVPEE 176
Y+ K D +SF +++WE+ K+PFE SN + + F+ RP
Sbjct: 176 ----SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKL--ASMT 229
Query: 177 LSIILTSCWKEDPNARPNFTQIIQML 202
+ ++ SCW E P RP F ++++ +
Sbjct: 230 VYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 2e-24
Identities = 63/201 (31%), Positives = 100/201 (49%), Gaps = 34/201 (16%)
Query: 14 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 73
+ IVTE ++ G+L YL + L + F+LD+ AME L ++ +HRDL N+L
Sbjct: 75 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVL 134
Query: 74 LTEDLKTIKLADFGLAREESLTEMMTAETGTY--RWMAPELYSTVTLRQGEKKHYNHKVD 131
++ED K++DFGL +E S T+ +TG +W APE LR+ K ++ K D
Sbjct: 135 VSED-NVAKVSDFGLTKEASSTQ----DTGKLPVKWTAPE-----ALRE---KKFSTKSD 181
Query: 132 SYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSAEN---------VPEELSIIL 181
+SF I+LWE+ ++P+ + K+V P E P + ++
Sbjct: 182 VWSFGILLWEIYSFGRVPYPRI---------PLKDVVPRVEKGYKMDAPDGCPPVVYDVM 232
Query: 182 TSCWKEDPNARPNFTQIIQML 202
CW D RP+F Q+ + L
Sbjct: 233 KQCWHLDAATRPSFLQLREQL 253
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 98.1 bits (245), Expect = 3e-24
Identities = 56/190 (29%), Positives = 94/190 (49%), Gaps = 17/190 (8%)
Query: 16 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 75
+V E + GG+L ++ ++ ++ + +E LHS +IHRD+K +N+LL+
Sbjct: 92 VVMEYMDGGSL-TDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLS 150
Query: 76 EDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDS 132
+D ++KLADFG A + LT+ + GT WMAPE+ +K Y KVD
Sbjct: 151 KD-GSVKLADFGFAAQ--LTKEKSKRNSVVGTPYWMAPEVIK--------RKDYGPKVDI 199
Query: 133 YSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP--SAENVPEELSIILTSCWKEDPN 190
+S I+ E+ + P+ L+A + K + P + E E L C +DP
Sbjct: 200 WSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPE 259
Query: 191 ARPNFTQIIQ 200
RP+ +++Q
Sbjct: 260 KRPSAEELLQ 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 5e-24
Identities = 62/211 (29%), Positives = 103/211 (48%), Gaps = 36/211 (17%)
Query: 11 EPVMVIVTELLSGGTLRKYLLNMRPRCLD--------VCVAIGFALDIARAMECLHSHGI 62
+P +V++ EL++ G L+ YL ++RP + + I A +IA M L++
Sbjct: 82 QPTLVVM-ELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKF 140
Query: 63 IHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYR----------WMAPEL 112
+HRDL N ++ D T+K+ DFG+ R+ ET YR WMAPE
Sbjct: 141 VHRDLAARNCMVAHDF-TVKIGDFGMTRD-------IYETDYYRKGGKGLLPVRWMAPE- 191
Query: 113 YSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSAE 171
+L+ G + D +SF +VLWE+ + P++G+SN Q +
Sbjct: 192 ----SLKDGVFTTSS---DMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPD 244
Query: 172 NVPEELSIILTSCWKEDPNARPNFTQIIQML 202
N PE ++ ++ CW+ +P RP F +I+ +L
Sbjct: 245 NCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 6e-24
Identities = 58/205 (28%), Positives = 87/205 (42%), Gaps = 33/205 (16%)
Query: 14 MVIVTELLSGGTLRKYLLNMRPRCLD---VCVAIGFALDIARAMECLHSHGIIHRDLKPE 70
+++VTEL G+L L +R L + +A+ IA M L S IHRDL
Sbjct: 70 LMMVTELAPLGSL---LDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAAR 126
Query: 71 NLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYR----------WMAPELYSTVTLRQ 120
N+LL D +K+ DFGL R E Y W APE T T
Sbjct: 127 NILLASD-DKVKIGDFGLMRALPQNEDH------YVMEEHLKVPFAWCAPESLRTRT--- 176
Query: 121 GEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-PSAENVPEELS 178
++H D + F + LWE+ + + P+ G+S Q + R E P+++
Sbjct: 177 -----FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIY 231
Query: 179 IILTSCWKEDPNARPNFTQIIQMLL 203
++ CW +P RP F + + L
Sbjct: 232 NVMLQCWAHNPADRPTFAALREFLP 256
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 6e-24
Identities = 62/191 (32%), Positives = 101/191 (52%), Gaps = 18/191 (9%)
Query: 16 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 75
IV EL+S G L +L + V + F+LD+A ME L S ++HRDL N+L++
Sbjct: 75 IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVS 134
Query: 76 EDLKTIKLADFGLAREESLTEMMTAETGTY--RWMAPELYSTVTLRQGEKKHYNHKVDSY 133
ED K++DFGLAR S M + +W APE L+ + ++ K D +
Sbjct: 135 EDG-VAKVSDFGLARVGS----MGVDNSKLPVKWTAPE-----ALKHKK---FSSKSDVW 181
Query: 134 SFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-PSAENVPEELSIILTSCWKEDPNA 191
S+ ++LWE+ + + P+ MS L+ K R E P ++ +++TSCW+ +P
Sbjct: 182 SYGVLLWEVFSYGRAPYPKMS-LKEVKECVEKGYRMEPPEGCPADVYVLMTSCWETEPKK 240
Query: 192 RPNFTQIIQML 202
RP+F ++ + L
Sbjct: 241 RPSFHKLREKL 251
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 1e-23
Identities = 73/232 (31%), Positives = 107/232 (46%), Gaps = 42/232 (18%)
Query: 5 FIGACKE--PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAI--------------GFAL 48
+G C + P+ VIV E + G LR++L RP D I A
Sbjct: 83 LLGVCTQEGPLYVIV-EYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAY 141
Query: 49 DIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETG---TY 105
+AR ME L S IHRDL N+L+TED +K+ADFGLAR + +
Sbjct: 142 QVARGMEYLESRRCIHRDLAARNVLVTED-NVMKIADFGLARGVHDIDYYKKTSNGRLPV 200
Query: 106 RWMAPE-LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL------HNKLPFEGMSNLQAA 158
+WMAPE L+ V Y H+ D +SF I++WE+ + +P E + L
Sbjct: 201 KWMAPEALFDRV---------YTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKL--- 248
Query: 159 YAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIA 210
+ +PS N EL +++ CW P RP F Q+++ L L+A++
Sbjct: 249 LREGHRMDKPS--NCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVS 298
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 1e-23
Identities = 60/199 (30%), Positives = 92/199 (46%), Gaps = 24/199 (12%)
Query: 14 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 73
+ I E SGGTL + L + R LD V + L + + LHSHGI+HRD+KP N+
Sbjct: 74 VYIFMEYCSGGTLEELLEH--GRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIF 131
Query: 74 LTEDLKTIKLADFGLA-----REESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNH 128
L IKL DFG A ++ E + + GT +MAPE+ G+ K +
Sbjct: 132 LD-HNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVI-----TGGKGKGHGR 185
Query: 129 KVDSYSFAIVLWELLHNKLPFEGMSN-LQAAYAAAFKNVRPSAENVPEELSI------IL 181
D +S V+ E+ K P+ + N Q + + +P P+ L + L
Sbjct: 186 AADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGH-KPPI---PDSLQLSPEGKDFL 241
Query: 182 TSCWKEDPNARPNFTQIIQ 200
C + DP RP ++++Q
Sbjct: 242 DRCLESDPKKRPTASELLQ 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 1e-23
Identities = 80/259 (30%), Positives = 120/259 (46%), Gaps = 43/259 (16%)
Query: 5 FIGACKE--PVMVIVTELLSGGTLRKYLLNMRPRCLDVCV--------------AIGFAL 48
+GAC + P+ V+V E S G LR+YL RP +D + A
Sbjct: 83 LLGACTQDGPLYVLV-EYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAY 141
Query: 49 DIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETG---TY 105
+AR ME L S IHRDL N+L+TED +K+ADFGLAR+ + T
Sbjct: 142 QVARGMEYLASQKCIHRDLAARNVLVTED-NVMKIADFGLARDVHNIDYYKKTTNGRLPV 200
Query: 106 RWMAPE-LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGM--SNLQAAYAA 161
+WMAPE L+ V Y H+ D +SF ++LWE+ P+ G+ L
Sbjct: 201 KWMAPEALFDRV---------YTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKE 251
Query: 162 AFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPM---IPH 218
+ +P+ N EL +I+ CW P+ RP F Q+++ L L+ + E + +P
Sbjct: 252 GHRMDKPA--NCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTSTDEYLDLSVPF 309
Query: 219 RIFNSENTILPPESPGTSS 237
++ P+SP + S
Sbjct: 310 EQYSPGC----PDSPSSCS 324
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 3e-23
Identities = 64/203 (31%), Positives = 101/203 (49%), Gaps = 22/203 (10%)
Query: 4 QFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG 61
+ IG C ++P+ IV EL+ GG +L + L + FALD A M L S
Sbjct: 56 KLIGVCTQRQPIY-IVMELVPGGDFLSFLRKKKDE-LKTKQLVKFALDAAAGMAYLESKN 113
Query: 62 IIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETG----TYRWMAPELYSTVT 117
IHRDL N L+ E+ +K++DFG++R+E + + + +G +W APE
Sbjct: 114 CIHRDLAARNCLVGEN-NVLKISDFGMSRQED--DGIYSSSGLKQIPIKWTAPE-----A 165
Query: 118 LRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSA-ENVPE 175
L G Y+ + D +S+ I+LWE P+ GM+N QA K R S + P+
Sbjct: 166 LNYGR---YSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVE-KGYRMSCPQKCPD 221
Query: 176 ELSIILTSCWKEDPNARPNFTQI 198
++ ++ CW P RP F+++
Sbjct: 222 DVYKVMQRCWDYKPENRPKFSEL 244
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 94.6 bits (236), Expect = 5e-23
Identities = 63/200 (31%), Positives = 86/200 (43%), Gaps = 41/200 (20%)
Query: 16 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 75
+V E L GG L L N+ LD VA + +I A+E LHS+GIIHRDLKP+N+L+
Sbjct: 70 LVMEYLPGGDLASLLENVG--SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILID 127
Query: 76 EDLKTIKLADFGLAREESLTEMMTAE---------TGTYRWMAPELYSTVTLRQGEKKHY 126
+ +KL DFGL++ + + GT ++APE V L QG +
Sbjct: 128 SN-GHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPE----VILGQG----H 178
Query: 127 NHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTS--C 184
+ VD +S +L+E L PF G E E IL
Sbjct: 179 SKTVDWWSLGCILYEFLVGIPPFHG-------------------ETPEEIFQNILNGKIE 219
Query: 185 WKEDPNARPNFTQIIQMLLN 204
W ED +I LL
Sbjct: 220 WPEDVEVSDEAIDLISKLLV 239
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 5e-23
Identities = 51/212 (24%), Positives = 100/212 (47%), Gaps = 27/212 (12%)
Query: 6 IGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDV---------CVAIGFALDIARAM 54
+G C EP ++ E G L+++L + + + VA+ IA M
Sbjct: 74 LGLCREAEP-HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVAL--CTQIALGM 130
Query: 55 ECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE--MMTAETGTYRWMAPEL 112
+ L + +HRDL N L++ + +K++ L+++ +E + RW+APE
Sbjct: 131 DHLSNARFVHRDLAARNCLVSSQRE-VKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPE- 188
Query: 113 YSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-PSA 170
+++ + ++ K D +SF +++WE+ +LPF G+S+ + + P
Sbjct: 189 ----AVQEDD---FSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVP 241
Query: 171 ENVPEELSIILTSCWKEDPNARPNFTQIIQML 202
E P L ++T CW +P RP+F++++ L
Sbjct: 242 EGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 9e-23
Identities = 63/206 (30%), Positives = 101/206 (49%), Gaps = 20/206 (9%)
Query: 4 QFIGACKEPV-MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI 62
Q G C E + +V E + G L YL R + +G LD+ M L S +
Sbjct: 63 QLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGK-FSQETLLGMCLDVCEGMAYLESSNV 121
Query: 63 IHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT---YRWMAPELYSTVTLR 119
IHRDL N L+ E+ + +K++DFG+ R L + T+ TGT +W +PE++S
Sbjct: 122 IHRDLAARNCLVGEN-QVVKVSDFGMTR-FVLDDQYTSSTGTKFPVKWSSPEVFSF---- 175
Query: 120 QGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAA--YAAAFKNVRPSAENVPEE 176
Y+ K D +SF +++WE+ K P+E SN + A F+ +P +
Sbjct: 176 ----SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRL--ASQS 229
Query: 177 LSIILTSCWKEDPNARPNFTQIIQML 202
+ ++ CWKE P RP+F+ ++ L
Sbjct: 230 VYELMQHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 9e-23
Identities = 65/214 (30%), Positives = 107/214 (50%), Gaps = 24/214 (11%)
Query: 6 IGAC--KEPVMVIVTELLSGGTLRKYLLNMR-----PRCLDVCVAIGFALDIARAMECLH 58
+G C EP +I+ EL+ GG L YL + R P L + + LD+A+ L
Sbjct: 65 LGVCLLNEPQYIIM-ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE 123
Query: 59 SHGIIHRDLKPENLLLTEDL----KTIKLADFGLAREESLTEMMTAETG---TYRWMAPE 111
IHRDL N L++E + +K+ DFGLAR+ ++ E RWMAPE
Sbjct: 124 QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPE 183
Query: 112 LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSA 170
+L G+ + + D +SF +++WE+L + P+ ++N +
Sbjct: 184 -----SLLDGK---FTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKP 235
Query: 171 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 204
EN P+++ ++T+CW +DP+ RP F +I ++L N
Sbjct: 236 ENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 1e-22
Identities = 65/201 (32%), Positives = 97/201 (48%), Gaps = 17/201 (8%)
Query: 10 KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKP 69
+EP+ IVTE + G+L +L + L + + A IA M + IHRDL+
Sbjct: 72 EEPIY-IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRA 130
Query: 70 ENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY--RWMAPE--LYSTVTLRQGEKKH 125
N+L+ ++L K+ADFGLAR E + + +W APE LY T+
Sbjct: 131 ANILVGDNL-VCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI------- 182
Query: 126 YNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSC 184
K D +SF I+L EL+ ++P+ GM N + P + PE L ++ C
Sbjct: 183 ---KSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMKLC 239
Query: 185 WKEDPNARPNFTQIIQMLLNY 205
WK+DP+ RP F I L +Y
Sbjct: 240 WKKDPDERPTFEYIQSFLEDY 260
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 2e-22
Identities = 67/201 (33%), Positives = 100/201 (49%), Gaps = 17/201 (8%)
Query: 10 KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKP 69
KEP+ +I TE ++ G+L +L + + I F+ IA M + IHRDL+
Sbjct: 72 KEPIYII-TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRA 130
Query: 70 ENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY--RWMAPEL--YSTVTLRQGEKKH 125
N+L++ L K+ADFGLAR E E + +W APE + + T+
Sbjct: 131 ANILVSASL-VCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTI------- 182
Query: 126 YNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSC 184
K D +SF I+L E++ + ++P+ GMSN + A P EN PEEL I+ C
Sbjct: 183 ---KSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRC 239
Query: 185 WKEDPNARPNFTQIIQMLLNY 205
WK P RP F I +L ++
Sbjct: 240 WKNRPEERPTFEYIQSVLDDF 260
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 2e-22
Identities = 58/187 (31%), Positives = 91/187 (48%), Gaps = 10/187 (5%)
Query: 14 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 73
++IV E GGTL +Y+ LD + F + I A+ +H+ I+HRDLK +N+L
Sbjct: 74 LMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNIL 133
Query: 74 LTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSY 133
L + +K+ DFG+++ S GT +++PEL E K YN K D +
Sbjct: 134 LDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELC--------EGKPYNQKSDIW 185
Query: 134 SFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR-PSAENVPEELSIILTSCWKEDPNAR 192
+ VL+EL K FE +NL A P ++ +L ++ S DP+ R
Sbjct: 186 ALGCVLYELASLKRAFEA-ANLPALVLKIMSGTFAPISDRYSPDLRQLILSMLNLDPSKR 244
Query: 193 PNFTQII 199
P +QI+
Sbjct: 245 PQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 2e-22
Identities = 66/214 (30%), Positives = 95/214 (44%), Gaps = 32/214 (14%)
Query: 6 IGAC-KEPVMVIVTELLSGGTLRKYLLNMRP--------------RCLDVCVAIGFALDI 50
+G C KE ++ E L+ G L ++L+ P LD + A+ I
Sbjct: 74 LGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQI 133
Query: 51 ARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE---ESLTEMMTAETGTYRW 107
A ME L SH +HRDL N L+ E L T+K++DFGL+R+ + + RW
Sbjct: 134 AAGMEYLSSHHFVHRDLAARNCLVGEGL-TVKISDFGLSRDIYSADYYRVQSKSLLPVRW 192
Query: 108 MAPE--LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKL-PFEGMSNLQAAYAAAFK 164
M PE LY T D +SF +VLWE+ L P+ G SN + +
Sbjct: 193 MPPEAILYGKFTTES----------DIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSR 242
Query: 165 NVRPSAENVPEELSIILTSCWKEDPNARPNFTQI 198
+ P E+ P + ++ CW E P RP F I
Sbjct: 243 QLLPCPEDCPARVYALMIECWNEIPARRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 4e-22
Identities = 66/208 (31%), Positives = 105/208 (50%), Gaps = 36/208 (17%)
Query: 11 EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCV--------AIGFALDIARAMECLHSHGI 62
+P +VI+ EL++ G L+ YL ++RP + V I A +IA M L+++
Sbjct: 82 QPTLVIM-ELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKF 140
Query: 63 IHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYR----------WMAPEL 112
+HRDL N ++ ED T+K+ DFG+ R+ ET YR WM+PE
Sbjct: 141 VHRDLAARNCMVAEDF-TVKIGDFGMTRD-------IYETDYYRKGGKGLLPVRWMSPE- 191
Query: 113 YSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSAE 171
+L+ G Y+ D +SF +VLWE+ + P++GMSN Q + +
Sbjct: 192 ----SLKDGVFTTYS---DVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLDKPD 244
Query: 172 NVPEELSIILTSCWKEDPNARPNFTQII 199
N P+ L ++ CW+ +P RP+F +II
Sbjct: 245 NCPDMLFELMRMCWQYNPKMRPSFLEII 272
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 6e-22
Identities = 67/208 (32%), Positives = 98/208 (47%), Gaps = 18/208 (8%)
Query: 4 QFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 63
Q E + IVTE +S G+L +L + R L + + A +A M + I
Sbjct: 65 QLYAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYI 124
Query: 64 HRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT---YRWMAPE--LYSTVTL 118
HRDL+ N+L+ + L K+ADFGLAR E TA G +W APE LY T+
Sbjct: 125 HRDLRSANILVGDGL-VCKIADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTI 182
Query: 119 RQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEEL 177
K D +SF I+L EL+ ++P+ GM+N + P ++ P L
Sbjct: 183 ----------KSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISL 232
Query: 178 SIILTSCWKEDPNARPNFTQIIQMLLNY 205
++ CWK+DP RP F + L +Y
Sbjct: 233 HELMLQCWKKDPEERPTFEYLQSFLEDY 260
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 8e-22
Identities = 61/205 (29%), Positives = 97/205 (47%), Gaps = 21/205 (10%)
Query: 12 PVMVIVTELLSGGTLRKYLLNMR----PRCLDVCVAIGFALDIARAMECLHSHGIIHRDL 67
P +++ + G L +LL R P L + + F +DIA ME L + IHRDL
Sbjct: 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDL 139
Query: 68 KPENLLLTEDLKTIKLADFGLARE---ESLTEMMTAETGTYRWMAPE-LYSTVTLRQGEK 123
N +L ED+ T+ +ADFGL+++ +W+A E L V
Sbjct: 140 AARNCMLREDM-TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRV------- 191
Query: 124 KHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-PSAENVPEELSIIL 181
Y K D ++F + +WE+ + P+ G+ N + Y R E+ +EL ++
Sbjct: 192 --YTSKSDVWAFGVTMWEIATRGQTPYPGVENHE-IYDYLRHGNRLKQPEDCLDELYDLM 248
Query: 182 TSCWKEDPNARPNFTQIIQMLLNYL 206
SCW+ DP RP FT++ ++L N L
Sbjct: 249 YSCWRADPKDRPTFTKLREVLENIL 273
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 1e-21
Identities = 54/224 (24%), Positives = 99/224 (44%), Gaps = 44/224 (19%)
Query: 4 QFIGACKEP---VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH 60
++ G C++P + ++ E L G+LR YL R + +++ + F+ I + M+ L S
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ-INLKRLLLFSSQICKGMDYLGSQ 128
Query: 61 GIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY----------RWMAP 110
IHRDL N+L+ + +K++DFGLA+ ++ + Y W AP
Sbjct: 129 RYIHRDLAARNILVESE-DLVKISDFGLAK------VLPEDKDYYYVKEPGESPIFWYAP 181
Query: 111 ELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL----HNKLP---FEGMSNLQAAYAAAF 163
E T ++ D +SF + L+EL ++ P F M +
Sbjct: 182 ECLRTSK--------FSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVT 233
Query: 164 KNVR--------PSAENVPEELSIILTSCWKEDPNARPNFTQII 199
+ + P + P+E+ ++ CW+ +P RP+F +I
Sbjct: 234 RLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLI 277
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 1e-21
Identities = 71/221 (32%), Positives = 106/221 (47%), Gaps = 36/221 (16%)
Query: 5 FIGACKE--PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALD------------- 49
+GAC + P+ VIV E S G LR+YL RP ++ I D
Sbjct: 86 LLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTY 144
Query: 50 -IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETG---TY 105
+AR ME L S IHRDL N+L+TE+ +K+ADFGLAR+ + + T
Sbjct: 145 QVARGMEYLASQKCIHRDLAARNVLVTEN-NVMKIADFGLARDVNNIDYYKKTTNGRLPV 203
Query: 106 RWMAPE-LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGM--SNLQAAYAA 161
+WMAPE L+ V Y H+ D +SF +++WE+ P+ G+ L
Sbjct: 204 KWMAPEALFDRV---------YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE 254
Query: 162 AFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 202
+ +P+ N EL +++ CW P+ RP F Q+++ L
Sbjct: 255 GHRMDKPA--NCTNELYMMMRDCWHAIPSHRPTFKQLVEDL 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 1e-21
Identities = 59/196 (30%), Positives = 95/196 (48%), Gaps = 12/196 (6%)
Query: 10 KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKP 69
+ ++I E +GGTL ++ + + + + + + I A+ +H GI+HRD+K
Sbjct: 70 DDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKT 129
Query: 70 ENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYN 127
N+ LT+ IKL DFG+++ +E AET GT +M+PEL QG K YN
Sbjct: 130 LNIFLTKA-GLIKLGDFGISKILG-SEYSMAETVVGTPYYMSPELC------QGVK--YN 179
Query: 128 HKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKE 187
K D ++ VL+ELL K F+ + L N P EL ++ S ++
Sbjct: 180 FKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQ 239
Query: 188 DPNARPNFTQIIQMLL 203
DP RP +++ L
Sbjct: 240 DPEKRPTADEVLDQPL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 2e-21
Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 37/205 (18%)
Query: 24 GTLRKYLLNMR------PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED 77
G L+ +L R P+ L + A+ IA M LH G+IH+D+ N ++ E+
Sbjct: 94 GNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEE 153
Query: 78 LKTIKLADFGLARE------ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVD 131
L+ +K+ D L+R+ L + E +WMA E +L K Y+ D
Sbjct: 154 LQ-VKITDNALSRDLFPMDYHCLGD---NENRPVKWMALE-----SL---VNKEYSSASD 201
Query: 132 SYSFAIVLWELL------HNKL-PFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSC 184
+SF ++LWEL+ + ++ PFE + L+ Y A N P+EL ++ C
Sbjct: 202 VWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQPI------NCPDELFAVMACC 255
Query: 185 WKEDPNARPNFTQIIQMLLNYLSAI 209
W DP RP+F+Q++Q L ++ + +
Sbjct: 256 WALDPEERPSFSQLVQCLTDFHAQL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 2e-21
Identities = 61/208 (29%), Positives = 100/208 (48%), Gaps = 29/208 (13%)
Query: 10 KEPVMVIVTELLSGGTLRKYLLNMRPRC---------------LDVCVAIGFALDIARAM 54
++PV ++ E L+ G L ++L+ P LD + A+ IA M
Sbjct: 79 EQPVCMLF-EYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGM 137
Query: 55 ECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY---RWMAPE 111
E L SH +H+DL N+L+ E L +K++D GL+RE + + + RWM PE
Sbjct: 138 EYLSSHFFVHKDLAARNILIGEQLH-VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPE 196
Query: 112 LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKL-PFEGMSNLQAAYAAAFKNVRPSA 170
+ G+ ++ D +SF +VLWE+ L P+ G SN + + + P +
Sbjct: 197 -----AIMYGK---FSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLLPCS 248
Query: 171 ENVPEELSIILTSCWKEDPNARPNFTQI 198
E+ P + ++T CW+E P+ RP F I
Sbjct: 249 EDCPPRMYSLMTECWQEGPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 2e-21
Identities = 56/187 (29%), Positives = 86/187 (45%), Gaps = 19/187 (10%)
Query: 22 SGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTI 81
S + RK LN P + I A +A M L +HRDL N L+ E++ +
Sbjct: 113 STSSARKCGLNPLPLSCTEQLCI--AKQVAAGMAYLSERKFVHRDLATRNCLVGENMV-V 169
Query: 82 KLADFGLAREESLTEMMTAETGTY---RWMAPE--LYSTVTLRQGEKKHYNHKVDSYSFA 136
K+ADFGL+R + A RWM PE Y+ T D +++
Sbjct: 170 KIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTES----------DVWAYG 219
Query: 137 IVLWELLHNKL-PFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNF 195
+VLWE+ + P+ GM++ + Y NV +N P EL ++ CW + P+ RP+F
Sbjct: 220 VVLWEIFSYGMQPYYGMAHEEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSF 279
Query: 196 TQIIQML 202
I ++L
Sbjct: 280 ASINRIL 286
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 2e-21
Identities = 67/206 (32%), Positives = 102/206 (49%), Gaps = 19/206 (9%)
Query: 3 EQFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI 62
E + K PVM IVTE + G+L +L + V +G IA M+ L G
Sbjct: 71 EGVVTKSK-PVM-IVTEYMENGSLDAFLRKHDGQ-FTVIQLVGMLRGIASGMKYLSDMGY 127
Query: 63 IHRDLKPENLLLTEDLKTIKLADFGLAR--EESLTEMMTAETGT--YRWMAPELYSTVTL 118
+HRDL N+L+ +L K++DFGL+R E+ T G RW APE +
Sbjct: 128 VHRDLAARNILVNSNL-VCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPE---AIAY 183
Query: 119 RQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-PSAENVPEE 176
R+ + D +S+ IV+WE++ + + P+ MSN Q A + R P+ + P
Sbjct: 184 RK-----FTSASDVWSYGIVMWEVMSYGERPYWEMSN-QDVIKAIEEGYRLPAPMDCPAA 237
Query: 177 LSIILTSCWKEDPNARPNFTQIIQML 202
L ++ CW++D N RP F QI+ +L
Sbjct: 238 LHQLMLDCWQKDRNERPKFEQIVSIL 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 90.3 bits (225), Expect = 2e-21
Identities = 52/202 (25%), Positives = 80/202 (39%), Gaps = 41/202 (20%)
Query: 17 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE 76
V E G L +Y+ LD +A +I A+E LHS GIIHRDLKPEN+LL +
Sbjct: 80 VLEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDK 137
Query: 77 DLKTIKLADFGLAREESLTEMMTAET---------------------GTYRWMAPELYST 115
D IK+ DFG A+ + GT +++PEL +
Sbjct: 138 D-MHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLN- 195
Query: 116 VTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSA----E 171
+K D ++ +++++L K PF G + F+ +
Sbjct: 196 -------EKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL-----TFQKILKLEYSFPP 243
Query: 172 NVPEELSIILTSCWKEDPNARP 193
N P + ++ DP R
Sbjct: 244 NFPPDAKDLIEKLLVLDPQDRL 265
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 3e-21
Identities = 54/187 (28%), Positives = 83/187 (44%), Gaps = 12/187 (6%)
Query: 16 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 75
IV E G L K L R R L F + I + LHS I+HRD+K NL L
Sbjct: 76 IVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLD 135
Query: 76 EDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNHKVDSY 133
+K+ D G+A+ S A T GT +++PEL E K YN K D +
Sbjct: 136 AYDN-VKIGDLGVAKLLS-DNTNFANTIVGTPYYLSPELC--------EDKPYNEKSDVW 185
Query: 134 SFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARP 193
+ +VL+E K PF+ + P ++ ++L+ ++ C +D RP
Sbjct: 186 ALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLTKDYRQRP 245
Query: 194 NFTQIIQ 200
+ Q+++
Sbjct: 246 DTFQLLR 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 4e-21
Identities = 65/226 (28%), Positives = 105/226 (46%), Gaps = 44/226 (19%)
Query: 4 QFIGACK--EPVMVIVTELLSGGTLRKYLLNMRP----------------------RCLD 39
+ GAC P+++IV E G+LR +L R R L
Sbjct: 67 KLYGACSQDGPLLLIV-EYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125
Query: 40 VCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR---EESLTE 96
+ I FA I+R M+ L ++HRDL N+L+ E + +K++DFGL+R EE
Sbjct: 126 MGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEG-RKMKISDFGLSRDVYEEDSYV 184
Query: 97 MMTAETGTYRWMAPE-LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMS- 153
+ +WMA E L+ + Y + D +SF ++LWE++ P+ G++
Sbjct: 185 KRSKGRIPVKWMAIESLFDHI---------YTTQSDVWSFGVLLWEIVTLGGNPYPGIAP 235
Query: 154 -NLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQI 198
L ++ RP EN EE+ ++ +CWK++P+ RP F I
Sbjct: 236 ERLFNLLKTGYRMERP--ENCSEEMYNLMLTCWKQEPDKRPTFADI 279
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 5e-21
Identities = 55/207 (26%), Positives = 98/207 (47%), Gaps = 32/207 (15%)
Query: 6 IGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHR 65
+G C + ++T+L+ G L Y+ N + + + + + IA+ M L ++HR
Sbjct: 75 LGICLSSQVQLITQLMPLGCLLDYVRNHKDN-IGSQYLLNWCVQIAKGMSYLEEKRLVHR 133
Query: 66 DLKPENLLLTEDLKT---IKLADFGLARE-ESLTEMMTAETGTY--RWMAPELYSTVTLR 119
DL N+L +KT +K+ DFGLA+ + + AE G +WMA E ++
Sbjct: 134 DLAARNVL----VKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALE-----SIL 184
Query: 120 QGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVRPSAENVPE--- 175
Y HK D +S+ + +WEL+ P+EG+ A ++ E +P+
Sbjct: 185 HRI---YTHKSDVWSYGVTVWELMTFGAKPYEGIP------AVEIPDLLEKGERLPQPPI 235
Query: 176 ---ELSIILTSCWKEDPNARPNFTQII 199
++ ++L CW D +RP F ++I
Sbjct: 236 CTIDVYMVLVKCWMIDAESRPTFKELI 262
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 6e-21
Identities = 51/201 (25%), Positives = 87/201 (43%), Gaps = 17/201 (8%)
Query: 3 EQFIGACKEPVMVIVTELLSGGTLRKYLLN--MRPRCLDVCVAIGFALDIARAMECLHSH 60
E F+ K + IV E G L K + + + + + + R ++ LH
Sbjct: 66 EAFLDGNK---LCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ 122
Query: 61 GIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMT-AETGTYRWMAPELYSTVTLR 119
I+HRDLK N+LL + +K+ D G+++ L + M + GT +MAPE++
Sbjct: 123 KILHRDLKSANILLVAN-DLVKIGDLGISK--VLKKNMAKTQIGTPHYMAPEVWK----- 174
Query: 120 QGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSI 179
+ Y++K D +S +L+E+ PFE S Y P ++L
Sbjct: 175 ---GRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQN 231
Query: 180 ILTSCWKEDPNARPNFTQIIQ 200
+ S + P RPN +I+
Sbjct: 232 FIRSMLQVKPKLRPNCDKILA 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 6e-21
Identities = 63/209 (30%), Positives = 95/209 (45%), Gaps = 16/209 (7%)
Query: 4 QFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 63
Q E + IVTE +S G+L +L + L + + A IA M + +
Sbjct: 65 QLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV 124
Query: 64 HRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY--RWMAPE--LYSTVTLR 119
HRDL+ N+L+ E+L K+ADFGLAR E + + +W APE LY T+
Sbjct: 125 HRDLRAANILVGENL-VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI- 182
Query: 120 QGEKKHYNHKVDSYSFAIVLWEL-LHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELS 178
K D +SF I+L EL ++P+ GM N + P PE L
Sbjct: 183 ---------KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH 233
Query: 179 IILTSCWKEDPNARPNFTQIIQMLLNYLS 207
++ CW+++P RP F + L +Y +
Sbjct: 234 DLMCQCWRKEPEERPTFEYLQAFLEDYFT 262
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 7e-21
Identities = 59/217 (27%), Positives = 96/217 (44%), Gaps = 32/217 (14%)
Query: 4 QFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPR-----CLDVCVAIGFALDIARAMEC 56
+ IG + P I+ EL++GG L+ +L RPR L + + A D+A+ +
Sbjct: 73 RLIGVSFERLPRF-ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131
Query: 57 LHSHGIIHRDLKPENLLLTED--LKTIKLADFGLAREESLTE--------MMTAETGTYR 106
L + IHRD+ N LLT + K+ADFG+AR+ M+ +
Sbjct: 132 LEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPI-----K 186
Query: 107 WMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKN 165
WM PE + + K D +SF ++LWE+ +P+ G +N +
Sbjct: 187 WMPPEAFLDGI--------FTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGG 238
Query: 166 VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 202
+ P + I+T CW+ P RPNF I++ +
Sbjct: 239 RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERI 275
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 1e-20
Identities = 59/172 (34%), Positives = 83/172 (48%), Gaps = 18/172 (10%)
Query: 38 LDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM 97
LD + F+ +A+ M L S IHRDL N+LLT + K+ DFGLAR+ +
Sbjct: 211 LDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHG-RITKICDFGLARDIR-NDS 268
Query: 98 MTAETGTYR----WMAPE-LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEG 151
G R WMAPE +++ V Y + D +S+ I+LWE+ P+ G
Sbjct: 269 NYVVKGNARLPVKWMAPESIFNCV---------YTFESDVWSYGILLWEIFSLGSSPYPG 319
Query: 152 MSNLQAAYAAAFKNVR-PSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 202
M Y + R S E P E+ I+ SCW DP RP F QI+Q++
Sbjct: 320 MPVDSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLI 371
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 2e-20
Identities = 63/218 (28%), Positives = 97/218 (44%), Gaps = 41/218 (18%)
Query: 9 CKEPVMV-------------IVTELLSGGTLRKYLLNM---------RPRCLDVCVAIGF 46
CK P +V I+ E GG L +L + R C + A+ F
Sbjct: 59 CKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNF 118
Query: 47 ALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGL-AREESLTEMMTAETGTY 105
LHSH +IHRDLK N+LLT D +KLADFG+ A+ +S + GT
Sbjct: 119 ----------LHSHKVIHRDLKAGNILLTLD-GDVKLADFGVSAKNKSTLQKRDTFIGTP 167
Query: 106 RWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN 165
WMAPE+ + T + Y++K D +S I L EL + P ++ ++ K+
Sbjct: 168 YWMAPEVVACETFKD---NPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKIL-KS 223
Query: 166 VRPSAENV---PEELSIILTSCWKEDPNARPNFTQIIQ 200
P+ + + L SC +DP+ RP ++++
Sbjct: 224 EPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 3e-20
Identities = 63/199 (31%), Positives = 98/199 (49%), Gaps = 20/199 (10%)
Query: 12 PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPEN 71
PVM I+TE + G L +L V +G IA M+ L +HRDL N
Sbjct: 79 PVM-IITEFMENGALDSFL-RQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARN 136
Query: 72 LLLTEDLKTIKLADFGLAR---EESLTEMMTAETG---TYRWMAPELYSTVTLRQGEKKH 125
+L+ +L K++DFGL+R +++ T+ G RW APE + R+
Sbjct: 137 ILVNSNL-VCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPE---AIAYRK----- 187
Query: 126 YNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-PSAENVPEELSIILTS 183
+ D +S+ IV+WE++ + + P+ MSN Q A ++ R P + P L ++
Sbjct: 188 FTSASDVWSYGIVMWEVMSYGERPYWDMSN-QDVINAIEQDYRLPPPMDCPTALHQLMLD 246
Query: 184 CWKEDPNARPNFTQIIQML 202
CW++D NARP F QI+ L
Sbjct: 247 CWQKDRNARPKFGQIVSTL 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 3e-20
Identities = 59/203 (29%), Positives = 93/203 (45%), Gaps = 20/203 (9%)
Query: 4 QFIGACK-EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI 62
Q++G + E + I EL+ GG+L K L V + I +E LH
Sbjct: 66 QYLGTEREEDNLYIFLELVPGGSLAKLLKKYGS--FPEPVIRLYTRQILLGLEYLHDRNT 123
Query: 63 IHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGE 122
+HRD+K N+L+ + +KLADFG+A++ + G+ WMAPE V +QG
Sbjct: 124 VHRDIKGANILVDTN-GVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPE----VIAQQGG 178
Query: 123 KKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR-PSAENVPEELSI-- 179
Y D +S + E+ K P+ S L+ AA FK R +P+ LS
Sbjct: 179 ---YGLAADIWSLGCTVLEMATGKPPW---SQLE-GVAAVFKIGRSKELPPIPDHLSDEA 231
Query: 180 --ILTSCWKEDPNARPNFTQIIQ 200
+ C + DP+ RP ++++
Sbjct: 232 KDFILKCLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 4e-20
Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 45/219 (20%)
Query: 16 IVTELLSGGTLRKYLLNMR---PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENL 72
+V E L GG L + + R + VC+A+ +A+ LH+ G+IHRD+K +++
Sbjct: 93 VVMEFLEGGALTDIVTHTRMNEEQIATVCLAV------LKALSFLHAQGVIHRDIKSDSI 146
Query: 73 LLTEDLKTIKLADFG--------LAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKK 124
LLT D +KL+DFG + R +SL GT WMAPE+ S +
Sbjct: 147 LLTSD-GRVKLSDFGFCAQVSKEVPRRKSL-------VGTPYWMAPEVIS--------RL 190
Query: 125 HYNHKVDSYSFAIVLWELLH------NKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELS 178
Y +VD +S I++ E++ N+ P + M ++ KN V L
Sbjct: 191 PYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKN----LHKVSPRLR 246
Query: 179 IILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIP 217
L DP R +++ +L+ PP ++P
Sbjct: 247 SFLDRMLVRDPAQRATAAELLNH--PFLAKAGPPSSIVP 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 9e-20
Identities = 53/188 (28%), Positives = 91/188 (48%), Gaps = 9/188 (4%)
Query: 14 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 73
+ IV E GG L K + R + + + I+ ++ +H I+HRD+K +N+
Sbjct: 74 LFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIF 133
Query: 74 LTEDLKTIKLADFGLARE-ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDS 132
L+++ KL DFG+AR+ E+ GT +++PE+ + + YN+K D
Sbjct: 134 LSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEIC--------QNRPYNNKTDI 185
Query: 133 YSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNAR 192
+S VL+EL K PFEG + Q P + N +L +++ +K P R
Sbjct: 186 WSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQLFKVSPRDR 245
Query: 193 PNFTQIIQ 200
P+ T I++
Sbjct: 246 PSITSILK 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 1e-19
Identities = 54/173 (31%), Positives = 85/173 (49%), Gaps = 20/173 (11%)
Query: 44 IGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETG 103
I ++ +AR ME L S IHRDL N+LL+E+ +K+ DFGLAR + + G
Sbjct: 176 ISYSFQVARGMEFLASRKCIHRDLAARNILLSEN-NVVKICDFGLAR-DIYKDPDYVRKG 233
Query: 104 TYR----WMAPE-LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQA 157
R WMAPE ++ V Y + D +SF ++LWE+ P+ G+ +
Sbjct: 234 DARLPLKWMAPESIFDKV---------YTTQSDVWSFGVLLWEIFSLGASPYPGV-QIDE 283
Query: 158 AYAAAFKN-VRPSA-ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 208
+ K R A E E+ I+ CW +P RP F++++++L + L
Sbjct: 284 EFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQE 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 1e-19
Identities = 42/134 (31%), Positives = 72/134 (53%), Gaps = 9/134 (6%)
Query: 16 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 75
+V L++GG L+ ++ N+ AI +A I +E LH I++RDLKPEN+LL
Sbjct: 70 LVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLL- 128
Query: 76 EDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSF 135
+D ++++D GLA E + + GT +MAPE+ + + Y+ VD ++
Sbjct: 129 DDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVL--------QGEVYDFSVDWFAL 180
Query: 136 AIVLWELLHNKLPF 149
L+E++ + PF
Sbjct: 181 GCTLYEMIAGRSPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 1e-19
Identities = 59/192 (30%), Positives = 94/192 (48%), Gaps = 20/192 (10%)
Query: 14 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFAL-DIARAMECLHSHGIIHRDLKPENL 72
+ I+ E GG+ L +P LD I F L ++ +E LH G IHRD+K N+
Sbjct: 74 LWIIMEYCGGGSCLDLL---KPGKLDE-TYIAFILREVLLGLEYLHEEGKIHRDIKAANI 129
Query: 73 LLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNHKV 130
LL+E+ +KLADFG++ + + T M T GT WMAPE+ ++Q Y+ K
Sbjct: 130 LLSEE-GDVKLADFGVSGQLTST-MSKRNTFVGTPFWMAPEV-----IKQSG---YDEKA 179
Query: 131 DSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAE--NVPEELSIILTSCWKED 188
D +S I EL + P + ++ + KN PS E + ++ C +D
Sbjct: 180 DIWSLGITAIELAKGEPPLSDLHPMRVLFLIP-KNNPPSLEGNKFSKPFKDFVSLCLNKD 238
Query: 189 PNARPNFTQIIQ 200
P RP+ ++++
Sbjct: 239 PKERPSAKELLK 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 3e-19
Identities = 65/219 (29%), Positives = 92/219 (42%), Gaps = 34/219 (15%)
Query: 5 FIGACKE---PVMVIVTELLSGGTLRKYL----------LNMRPRC--LDVCVAIGFALD 49
F G C E P+MV E + G L K+L + L + + A+
Sbjct: 73 FYGVCTEGDPPIMVF--EYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130
Query: 50 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY---R 106
IA M L S +HRDL N L+ DL +K+ DFG++R+ T+ T R
Sbjct: 131 IASGMVYLASQHFVHRDLATRNCLVGYDL-VVKIGDFGMSRDVYTTDYYRVGGHTMLPIR 189
Query: 107 WMAPE--LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAF 163
WM PE +Y T D +SF +VLWE+ + K P+ G+SN +
Sbjct: 190 WMPPESIMYRKFTTES----------DVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQ 239
Query: 164 KNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 202
+ P E+ I+ CWK DP R N I + L
Sbjct: 240 GRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERL 278
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 5e-19
Identities = 56/171 (32%), Positives = 89/171 (52%), Gaps = 20/171 (11%)
Query: 44 IGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETG 103
I ++ +AR ME L S IHRDL N+LL+E+ +K+ DFGLAR + + G
Sbjct: 177 ICYSFQVARGMEFLASRKCIHRDLAARNILLSEN-NVVKICDFGLAR-DIYKDPDYVRKG 234
Query: 104 TYR----WMAPE-LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQA 157
+ R WMAPE ++ V Y + D +SF ++LWE+ P+ G+ +
Sbjct: 235 SARLPLKWMAPESIFDKV---------YTTQSDVWSFGVLLWEIFSLGASPYPGV-QINE 284
Query: 158 AYAAAFKN-VRPSA-ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 206
+ K+ R A EN E+ I+ +CW+ DP RP F+ ++++L + L
Sbjct: 285 EFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLL 335
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 5e-19
Identities = 53/200 (26%), Positives = 90/200 (45%), Gaps = 19/200 (9%)
Query: 12 PVMVIVTELLSGGTLRKYLLNMR----PRCLDVCVAIGFALDIARAMECLHSHGIIHRDL 67
P+ +++ + G L +LL R P L + + F +DIA ME L S IHRDL
Sbjct: 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDL 139
Query: 68 KPENLLLTEDLKTIKLADFGLARE---ESLTEMMTAETGTYRWMAPE-LYSTVTLRQGEK 123
N +L E++ T+ +ADFGL+++ A +W+A E L V
Sbjct: 140 AARNCMLNENM-TVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNV------- 191
Query: 124 KHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILT 182
Y D ++F + +WE++ + P+ G+ N + N + E++ ++
Sbjct: 192 --YTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPPDCLEDVYELMC 249
Query: 183 SCWKEDPNARPNFTQIIQML 202
CW +P RP+F + L
Sbjct: 250 QCWSPEPKCRPSFQHLRDQL 269
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 7e-19
Identities = 57/168 (33%), Positives = 82/168 (48%), Gaps = 18/168 (10%)
Query: 46 FALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY 105
FA D+A M+ L IHRDL N+L+ E+L + K+ADFGL+R E + T
Sbjct: 124 FASDVATGMQYLSEKQFIHRDLAARNVLVGENLAS-KIADFGLSRGEEVYVKKTMGRLPV 182
Query: 106 RWMAPEL--YSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMS--NLQAAYA 160
RWMA E YS Y K D +SF ++LWE++ P+ GM+ L
Sbjct: 183 RWMAIESLNYSV----------YTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLP 232
Query: 161 AAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 208
++ +P N +E+ ++ CW++ P RP F QI L L A
Sbjct: 233 QGYRMEKP--RNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEA 278
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 83.0 bits (206), Expect = 7e-19
Identities = 57/198 (28%), Positives = 93/198 (46%), Gaps = 31/198 (15%)
Query: 16 IVTELLSGGTL---RKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPEN 71
IV E + GG+L K + + L A I + ++ LH+ IIHRD+KP N
Sbjct: 76 IVLEYMDGGSLADLLKKVGKIPEPVLAY-----IARQILKGLDYLHTKRHIIHRDIKPSN 130
Query: 72 LLLTEDLKTIKLADFGLAR--EESLTEMMTAETGTYRWMAPELYSTVTLR-QGEKKHYNH 128
LL+ +K+ADFG+++ E +L + T GT +M+PE R QGE Y++
Sbjct: 131 LLINSK-GEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPE-------RIQGE--SYSY 179
Query: 129 KVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV------RPSAENVPEELSIILT 182
D +S + L E K PF Q ++ + + AE E ++
Sbjct: 180 AADIWSLGLTLLECALGKFPFL--PPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFIS 237
Query: 183 SCWKEDPNARPNFTQIIQ 200
+C ++DP RP+ +++Q
Sbjct: 238 ACLQKDPKKRPSAAELLQ 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 1e-18
Identities = 53/175 (30%), Positives = 87/175 (49%), Gaps = 31/175 (17%)
Query: 44 IGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETG 103
+ F +AR ME L S +HRDL N+LL + K +K+ DFGLAR+ ++
Sbjct: 240 LSFTYQVARGMEFLASKNCVHRDLAARNVLLAQG-KIVKICDFGLARDIMHDSNYVSKGS 298
Query: 104 TY---RWMAPE-----LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGM-- 152
T+ +WMAPE LY+T++ D +S+ I+LWE+ P+ GM
Sbjct: 299 TFLPVKWMAPESIFDNLYTTLS-------------DVWSYGILLWEIFSLGGTPYPGMIV 345
Query: 153 -SNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNF---TQIIQMLL 203
S + ++ +P ++ +E+ I+ CW +P RP+F + I++ LL
Sbjct: 346 DSTFYNKIKSGYRMAKP--DHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 1e-18
Identities = 68/246 (27%), Positives = 103/246 (41%), Gaps = 45/246 (18%)
Query: 17 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE 76
V E ++GG L ++ R D A +A +I ++ LH GII+RDLK +N+LL
Sbjct: 74 VMEYVNGGDLMFHIQ--RSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDS 131
Query: 77 DLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNHKVDSYS 134
+ IK+ADFG+ + E + +T T GT ++APE+ + Y VD ++
Sbjct: 132 E-GHIKIADFGMCK-EGILGGVTTSTFCGTPDYIAPEIL------SYQP--YGPAVDWWA 181
Query: 135 FAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSI----ILTSCWKEDPN 190
++L+E+L + PFEG + + VR P LS IL S ++P
Sbjct: 182 LGVLLYEMLAGQSPFEGDDEDELFQSILEDEVR-----YPRWLSKEAKSILKSFLTKNPE 236
Query: 191 AR--------------PNFTQIIQMLLNYLSAIAPPEPMIPHRI--------FNSENTIL 228
R P F +I L P +P I R F E +L
Sbjct: 237 KRLGCLPTGEQDIKGHPFFREIDWDKLERKEIKPPFKPKIKGRFDVSNFDDEFTKEKPVL 296
Query: 229 PPESPG 234
P
Sbjct: 297 TPPDEA 302
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 1e-18
Identities = 61/204 (29%), Positives = 92/204 (45%), Gaps = 22/204 (10%)
Query: 6 IGAC--KEPVMVIVTELLSGGTLRKYLLN--MRPRCLDVCVAIGFALDIARAMECLHSHG 61
+G C E ++V + G LR ++ + P D+ IGF L +A+ ME L S
Sbjct: 62 LGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDL---IGFGLQVAKGMEYLASKK 118
Query: 62 IIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT-----YRWMAPELYSTV 116
+HRDL N +L E T+K+ADFGLAR+ E + T +WMA E T
Sbjct: 119 FVHRDLAARNCMLDESF-TVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQ 177
Query: 117 TLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR-PSAENVPE 175
+ K D +SF ++LWEL+ P + + R E P+
Sbjct: 178 K--------FTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPD 229
Query: 176 ELSIILTSCWKEDPNARPNFTQII 199
L ++ SCW P RP F++++
Sbjct: 230 PLYEVMLSCWHPKPEMRPTFSELV 253
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 2e-18
Identities = 58/194 (29%), Positives = 95/194 (48%), Gaps = 25/194 (12%)
Query: 23 GGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIK 82
T R L+N P L +GF+ +A ME L S +HRDL N+L+ E K +K
Sbjct: 222 ERTRRDTLINESP-ALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEG-KLVK 279
Query: 83 LADFGLAREESLTEMMTAETGTY---RWMAPE-----LYSTVTLRQGEKKHYNHKVDSYS 134
+ DFGLAR+ ++ T+ +WMAPE LY+T++ D +S
Sbjct: 280 ICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLS-------------DVWS 326
Query: 135 FAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSA-ENVPEELSIILTSCWKEDPNAR 192
F I+LWE+ P+ + + Y A + R + + +E+ I+ CW+E R
Sbjct: 327 FGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIR 386
Query: 193 PNFTQIIQMLLNYL 206
P+F+Q++ ++ + L
Sbjct: 387 PDFSQLVHLVGDLL 400
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 2e-18
Identities = 56/194 (28%), Positives = 90/194 (46%), Gaps = 15/194 (7%)
Query: 14 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 73
+I+TE + G L KYL + +G IA M+ L +HRDL N+L
Sbjct: 81 AMIITEYMENGALDKYLRDHDGE-FSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNIL 139
Query: 74 LTEDLKTIKLADFGLARE-ESLTEMMTAETG---TYRWMAPELYSTVTLRQGEKKHYNHK 129
+ +L+ K++DFGL+R E E +G RW APE + + +
Sbjct: 140 VNSNLEC-KVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAY--------RKFTSA 190
Query: 130 VDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKED 188
D +SF IV+WE++ + P+ MSN + A P+ + P + ++ CW++D
Sbjct: 191 SDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVYQLMLQCWQQD 250
Query: 189 PNARPNFTQIIQML 202
RP F I+ +L
Sbjct: 251 RARRPRFVDIVNLL 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 2e-18
Identities = 52/188 (27%), Positives = 85/188 (45%), Gaps = 19/188 (10%)
Query: 10 KEPVMVIVTELLSGGTLRKYLLNMRPRCLD---VCVAIGFALDIARAMECLHSHGIIHRD 66
K P + I+ E GG++R M+ + + V I L A++ +H G+IHRD
Sbjct: 73 KGPRLWIIMEYAEGGSVRTL---MKAGPIAEKYISVIIREVL---VALKYIHKVGVIHRD 126
Query: 67 LKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKH 125
+K N+L+T +KL DFG+A + + GT WMAPE+ + E K+
Sbjct: 127 IKAANILVTNTGN-VKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVIT-------EGKY 178
Query: 126 YNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY-AAAFKNVRPSAENVPEELSIILTSC 184
Y+ K D +S I ++E+ P+ + +A K R + L + +C
Sbjct: 179 YDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAAC 238
Query: 185 WKEDPNAR 192
E+P R
Sbjct: 239 LDEEPKER 246
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 2e-18
Identities = 60/209 (28%), Positives = 94/209 (44%), Gaps = 31/209 (14%)
Query: 4 QFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI 62
Q+ G ++ + I E + GG+++ L L V + I +E LHS+ I
Sbjct: 68 QYYGCLRDDETLSIFMEYMPGGSVKDQLKAYG--ALTETVTRKYTRQILEGVEYLHSNMI 125
Query: 63 IHRDLKPENLLLTEDLKTIKLADFGLARE----ESLTEMMTAETGTYRWMAPELYSTVTL 118
+HRD+K N +L + +KL DFG ++ S M + TGT WM+PE+ S
Sbjct: 126 VHRDIKGAN-ILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVIS---- 180
Query: 119 RQGEKKHYNHKVDSYSFAIVLWELLHNKLP---FEGMSNLQAAYAAAFK-NVRPSAENVP 174
GE Y K D +S + E+L K P FE M AA FK +P+ +P
Sbjct: 181 --GEG--YGRKADVWSVGCTVVEMLTEKPPWAEFEAM-------AAIFKIATQPTNPQLP 229
Query: 175 EELSII----LTSCWKEDPNARPNFTQII 199
+S L + E+ RP+ +++
Sbjct: 230 SHVSPDARNFLRRTFVENAKKRPSAEELL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 2e-18
Identities = 50/136 (36%), Positives = 77/136 (56%), Gaps = 12/136 (8%)
Query: 17 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE 76
V E L+GG L ++ + D A +A +I ++ LH GII+RDLK +N+LL +
Sbjct: 74 VMEYLNGGDLMFHIQSSGR--FDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDK 131
Query: 77 DLKTIKLADFGLAREESLTEMMTAE-TGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSF 135
D IK+ADFG+ +E E + GT ++APE+ +G+K YN VD +SF
Sbjct: 132 D-GHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEIL------KGQK--YNESVDWWSF 182
Query: 136 AIVLWELLHNKLPFEG 151
++L+E+L + PF G
Sbjct: 183 GVLLYEMLIGQSPFHG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 3e-18
Identities = 58/206 (28%), Positives = 89/206 (43%), Gaps = 51/206 (24%)
Query: 16 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFAL-DIARAMECLHSHGIIHRDLKPENLLL 74
+V LSGG+L + + PR I L ++ + +E LHS+G IHRD+K N+LL
Sbjct: 76 LVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILL 135
Query: 75 TEDLKTIKLADFGLAREESLTEMMTAET-------GTYRWMAPELYSTVTLRQGEKKHYN 127
ED ++K+ADFG++ SL + GT WMAPE+ + Y+
Sbjct: 136 GED-GSVKIADFGVS--ASLADGGDRTRKVRKTFVGTPCWMAPEVME-------QVHGYD 185
Query: 128 HKVDSYSFAIVLWELLHNKLPFEG-------MSNLQAA------------YAAAFKNVRP 168
K D +SF I EL P+ M LQ Y+ +F+
Sbjct: 186 FKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFRK--- 242
Query: 169 SAENVPEELSIILTSCWKEDPNARPN 194
+++ C ++DP+ RP
Sbjct: 243 -----------MISLCLQKDPSKRPT 257
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 3e-18
Identities = 45/104 (43%), Positives = 64/104 (61%), Gaps = 10/104 (9%)
Query: 49 DIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAE-TGTYRW 107
++A A++ LHS GII+RDLKPEN+LL E+ IKL DFGL++E E GT +
Sbjct: 106 ELALALDHLHSLGIIYRDLKPENILLDEE-GHIKLTDFGLSKESIDHEKKAYSFCGTVEY 164
Query: 108 MAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 151
MAPE V R+G + D +SF ++++E+L LPF+G
Sbjct: 165 MAPE----VVNRRG----HTQSADWWSFGVLMFEMLTGSLPFQG 200
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 4e-18
Identities = 60/192 (31%), Positives = 91/192 (47%), Gaps = 21/192 (10%)
Query: 16 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFAL-DIARAMECLHSHGIIHRDLKPENLLL 74
IV E G++ ++ + + L I L + +E LHS+ IHRD+K N+LL
Sbjct: 75 IVMEYCGAGSVSD-IMKITNKTLTE-EEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILL 132
Query: 75 TEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNHKVDS 132
E+ KLADFG++ + + T M T GT WMAPE V G YN+K D
Sbjct: 133 NEE-GQAKLADFGVSGQLTDT-MAKRNTVIGTPFWMAPE----VIQEIG----YNNKADI 182
Query: 133 YSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPE----ELSIILTSCWKED 188
+S I E+ K P+ + ++A + N P + PE E + + C +D
Sbjct: 183 WSLGITAIEMAEGKPPYSDIHPMRAIF--MIPNKPPPTLSDPEKWSPEFNDFVKKCLVKD 240
Query: 189 PNARPNFTQIIQ 200
P RP+ Q++Q
Sbjct: 241 PEERPSAIQLLQ 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 4e-18
Identities = 55/150 (36%), Positives = 76/150 (50%), Gaps = 12/150 (8%)
Query: 53 AMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPEL 112
+ LHSH IHRD+K N+LLTE T+KLADFG A SL + GT WMAPE
Sbjct: 127 GLAYLHSHERIHRDIKAGNILLTEP-GTVKLADFGSA---SLVSPANSFVGTPYWMAPE- 181
Query: 113 YSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN 172
V L E Y+ KVD +S I EL K P M+ + A Y A +N P+ +
Sbjct: 182 ---VILAMDE-GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-QNDSPTLSS 236
Query: 173 V--PEELSIILTSCWKEDPNARPNFTQIIQ 200
+ + SC ++ P RP+ ++++
Sbjct: 237 NDWSDYFRNFVDSCLQKIPQDRPSSEELLK 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 4e-18
Identities = 53/164 (32%), Positives = 81/164 (49%), Gaps = 18/164 (10%)
Query: 44 IGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETG 103
+ FA D+AR M+ L IHRDL N+L+ E+ K+ADFGL+R + + T
Sbjct: 127 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENY-VAKIADFGLSRGQEVYVKKTMGRL 185
Query: 104 TYRWMAPEL--YSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMS--NLQAA 158
RWMA E YS Y D +S+ ++LWE++ P+ GM+ L
Sbjct: 186 PVRWMAIESLNYSV----------YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 235
Query: 159 YAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 202
++ +P N +E+ ++ CW+E P RP+F QI+ L
Sbjct: 236 LPQGYRLEKPL--NCDDEVYDLMRQCWREKPYERPSFAQILVSL 277
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 81.7 bits (201), Expect = 4e-18
Identities = 63/207 (30%), Positives = 101/207 (48%), Gaps = 21/207 (10%)
Query: 16 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 75
+V E L+GG+L + C+D + +A+E LHS+ +IHRD+K +N+LL
Sbjct: 94 VVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG 150
Query: 76 EDLKTIKLADFGLAREESLTEMMTAE-TGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYS 134
D ++KL DFG + + + + GT WMAPE+ + +K Y KVD +S
Sbjct: 151 MD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT--------RKAYGPKVDIWS 201
Query: 135 FAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSII----LTSCWKEDPN 190
I+ E++ + P+ + L+A Y A N P +N PE+LS I L C D
Sbjct: 202 LGIMAIEMIEGEPPYLNENPLRALYLIA-TNGTPELQN-PEKLSAIFRDFLNRCLDMDVE 259
Query: 191 ARPNFTQIIQMLLNYLSAIAPPEPMIP 217
R + +++Q +L P + P
Sbjct: 260 KRGSAKELLQH--QFLKIAKPLSSLTP 284
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (200), Expect = 7e-18
Identities = 50/133 (37%), Positives = 68/133 (51%), Gaps = 14/133 (10%)
Query: 26 LRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLAD 85
L+KYL + RP L + + R + HSH I+HRDLKP+N+L+ D +KLAD
Sbjct: 84 LKKYL-DKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRD-GVLKLAD 141
Query: 86 FGLAREESLTEM-MTAETGT--YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWEL 142
FGLAR + T E T YR APE+ G KHY+ VD +S + E+
Sbjct: 142 FGLARAFGIPLRTYTHEVVTLWYR--APEIL------LGS-KHYSTAVDIWSVGCIFAEM 192
Query: 143 LHNKLPFEGMSNL 155
+ K F G S +
Sbjct: 193 ITGKPLFPGDSEI 205
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 9e-18
Identities = 53/201 (26%), Positives = 89/201 (44%), Gaps = 21/201 (10%)
Query: 13 VMVIVTELLSGGTLRKYLLNMRP--RCLDVCVAIGFALDIARAM-ECLH-----SHGIIH 64
+ IV E GG L + + + + ++ + A+ EC H + ++H
Sbjct: 75 TLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYEC-HNRSDPGNTVLH 133
Query: 65 RDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQGE 122
RDLKP N+ L + +KL DFGLA+ + A+T GT +M+PE +
Sbjct: 134 RDLKPANIFLDAN-NNVKLGDFGLAKILG-HDSSFAKTYVGTPYYMSPEQLN-------- 183
Query: 123 KKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILT 182
Y+ K D +S +++EL PF + LQ A R EL+ ++
Sbjct: 184 HMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSELNEVIK 243
Query: 183 SCWKEDPNARPNFTQIIQMLL 203
S DP+ RP+ +++Q+ L
Sbjct: 244 SMLNVDPDKRPSTEELLQLPL 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 1e-17
Identities = 52/158 (32%), Positives = 78/158 (49%), Gaps = 18/158 (11%)
Query: 46 FALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY 105
FA D+AR M+ L IHRDL N+L+ E+ K+ADFGL+R + + T
Sbjct: 117 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVA-KIADFGLSRGQEVYVKKTMGRLPV 175
Query: 106 RWMAPEL--YSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMS--NLQAAYA 160
RWMA E YS Y D +S+ ++LWE++ P+ GM+ L
Sbjct: 176 RWMAIESLNYSV----------YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 225
Query: 161 AAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQI 198
++ +P N +E+ ++ CW+E P RP+F QI
Sbjct: 226 QGYRLEKP--LNCDDEVYDLMRQCWREKPYERPSFAQI 261
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 1e-17
Identities = 58/231 (25%), Positives = 97/231 (41%), Gaps = 47/231 (20%)
Query: 4 QFIGAC-KEPVMVIVTELLSGGTLRKYL---------LNMRPRCLDVCVAIGFALDIARA 53
+ +G C +P + ++ E + G L ++L L + L + A IA
Sbjct: 83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASG 142
Query: 54 MECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY-------- 105
M L S +HRDL N L+ ++ TIK+ADFG++R + Y
Sbjct: 143 MRYLESLNFVHRDLATRNCLVGKNY-TIKIADFGMSRN--------LYSSDYYRVQGRAP 193
Query: 106 ---RWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWEL--LHNKLPFEGMSNLQAAYA 160
RWMA E ++ G+ + K D ++F + LWE+ L + P+E +++ Q
Sbjct: 194 LPIRWMAWE-----SVLLGK---FTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIEN 245
Query: 161 AAFKNVR-------PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 204
A P N P+++ ++ CW+ D RP F +I L
Sbjct: 246 AGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 1e-17
Identities = 57/184 (30%), Positives = 90/184 (48%), Gaps = 20/184 (10%)
Query: 16 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 75
I+ E G+LR+ ++ + VA+ + + + + LH G+IHRD+K N+L T
Sbjct: 76 IILEYAENGSLRQ-IIKKFGPFPESLVAV-YVYQVLQGLAYLHEQGVIHRDIKAANILTT 133
Query: 76 EDLKTIKLADFGLA-REESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYS 134
+D +KLADFG+A + +++ + GT WMAPE V G + D +S
Sbjct: 134 KD-GVVKLADFGVATKLNDVSKDDASVVGTPYWMAPE----VIEMSG----ASTASDIWS 184
Query: 135 FAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR----PSAENVPEELSIILTSCWKEDPN 190
+ ELL P+ +L AA F+ V+ P E + EL L C+++DPN
Sbjct: 185 LGCTVIELLTGNPPY---YDLNPM-AALFRIVQDDHPPLPEGISPELKDFLMQCFQKDPN 240
Query: 191 ARPN 194
RP
Sbjct: 241 LRPT 244
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 1e-17
Identities = 62/213 (29%), Positives = 88/213 (41%), Gaps = 40/213 (18%)
Query: 30 LLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 89
L+ R R L + + + + + HSHGI+HRDLKPENLL+ + +KLADFGLA
Sbjct: 87 LIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTE-GVLKLADFGLA 145
Query: 90 RE-ESLTEMMTAETGTYRWM-APELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKL 147
R S T T RW APEL + + Y+ VD +S + ELL +
Sbjct: 146 RSFGSPVRPYTHYVVT-RWYRAPEL--LLGDKG-----YSTPVDIWSVGCIFAELLSRRP 197
Query: 148 PFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 207
F G S + ++L I + DP P FT + NY
Sbjct: 198 LFPGKSEI-------------------DQLFKIFRTLGTPDPEVWPKFT---SLARNYKF 235
Query: 208 AIAPPEPMIPHRIFNSENTILPPESPGTSSLMT 240
+ M ++F P SP L++
Sbjct: 236 SFPKKAGMPLPKLF-------PNASPQALDLLS 261
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 2e-17
Identities = 56/212 (26%), Positives = 90/212 (42%), Gaps = 31/212 (14%)
Query: 4 QFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRC-LDVCVAIGFALDIARAMECLHS-H 60
F GA + I E + GG+L K L ++ R + I A + + + LH H
Sbjct: 63 GFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVA--VLKGLTYLHEKH 120
Query: 61 GIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMT-AETGTYRWMAPELYSTVTLR 119
IIHRD+KP N+L+ IKL DFG++ + L + GT +MAPE R
Sbjct: 121 KIIHRDVKPSNILVNS-RGQIKLCDFGVSGQ--LVNSLAKTFVGTSSYMAPE-------R 170
Query: 120 -QGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV---------RPS 169
QG Y+ K D +S + L EL + P+ F+ + R
Sbjct: 171 IQGN--DYSVKSDIWSLGLSLIELATGRFPY---PPENDPPDGIFELLQYIVNEPPPRLP 225
Query: 170 AENVPEELSIILTSCWKEDPNARPNFTQIIQM 201
+ + + C +DP RP++ ++++
Sbjct: 226 SGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-17
Identities = 46/133 (34%), Positives = 70/133 (52%), Gaps = 13/133 (9%)
Query: 19 ELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL 78
E + GG L YL N + +A +I A+E LHS I++RDLKPEN+LL ++
Sbjct: 81 EYVPGGELFSYLRNSGR--FSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKE- 137
Query: 79 KTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIV 138
IKL DFG A++ L + GT ++APE+ + K +N VD ++ I+
Sbjct: 138 GHIKLTDFGFAKK--LRDRTWTLCGTPEYLAPEVI--------QSKGHNKAVDWWALGIL 187
Query: 139 LWELLHNKLPFEG 151
++E+L PF
Sbjct: 188 IYEMLVGYPPFFD 200
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.5 bits (197), Expect = 2e-17
Identities = 50/188 (26%), Positives = 75/188 (39%), Gaps = 51/188 (27%)
Query: 50 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE-ES---LTEMMTAETGTY 105
I + + +H HG HRDLKPENLL++ +K+ADFGLARE S T+ ++ T Y
Sbjct: 108 ILQGLAHIHKHGFFHRDLKPENLLVSGPE-VVKIADFGLAREIRSRPPYTDYVS--TRWY 164
Query: 106 RWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS------------ 153
R APE + LR Y+ VD ++ ++ EL + F G S
Sbjct: 165 R--APE----ILLRST---SYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVL 215
Query: 154 --------------------NLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARP 193
+ + P+A E ++ + DP RP
Sbjct: 216 GTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNA---SPEAIDLIKDMLRWDPKKRP 272
Query: 194 NFTQIIQM 201
+Q +Q
Sbjct: 273 TASQALQH 280
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 2e-17
Identities = 57/180 (31%), Positives = 89/180 (49%), Gaps = 24/180 (13%)
Query: 32 NMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 91
+ P LD+ + F+ +A+ M+ L S IHRD+ N+LLT D + K+ DFGLAR+
Sbjct: 205 DSWP--LDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLT-DGRVAKICDFGLARD 261
Query: 92 ESLTEMMTAETGTYR----WMAPE-LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-N 145
+ + G R WMAPE ++ V Y + D +S+ I+LWE+
Sbjct: 262 -IMNDSNYVVKGNARLPVKWMAPESIFDCV---------YTVQSDVWSYGILLWEIFSLG 311
Query: 146 KLPFEGM---SNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 202
K P+ G+ S ++ RP + P E+ I+ CW +P RP F+QI Q++
Sbjct: 312 KSPYPGILVNSKFYKMVKRGYQMSRP--DFAPPEIYSIMKMCWNLEPTERPTFSQISQLI 369
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 2e-17
Identities = 42/137 (30%), Positives = 79/137 (57%), Gaps = 9/137 (6%)
Query: 14 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 73
+ +V L++GG L+ ++ N+ R L++ I ++ I + LHS I++RD+KPEN+L
Sbjct: 68 LCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVL 127
Query: 74 LTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSY 133
L +D +L+D GLA E + +T GT +MAPE+ +++ Y++ VD +
Sbjct: 128 L-DDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEIL--------KEEPYSYPVDWF 178
Query: 134 SFAIVLWELLHNKLPFE 150
+ ++E++ + PF+
Sbjct: 179 AMGCSIYEMVAGRTPFK 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-17
Identities = 54/154 (35%), Positives = 81/154 (52%), Gaps = 27/154 (17%)
Query: 14 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 73
+ +V E + GG L N+ +D+ + FA + A+E LH++GI+HRDLKP+NLL
Sbjct: 76 LCMVMEYVEGGDCATLLKNIGALPVDM-ARMYFA-ETVLALEYLHNYGIVHRDLKPDNLL 133
Query: 74 LTEDLKTIKLADFGLAR---------------EESLTEMMTAET-GTYRWMAPELYSTVT 117
+T + IKL DFGL++ E+ E + + GT ++APE V
Sbjct: 134 ITS-MGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPE----VI 188
Query: 118 LRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 151
LRQG Y VD ++ I+L+E L +PF G
Sbjct: 189 LRQG----YGKPVDWWAMGIILYEFLVGCVPFFG 218
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 2e-17
Identities = 63/193 (32%), Positives = 98/193 (50%), Gaps = 25/193 (12%)
Query: 16 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 75
+V E L+GG+L + C+D + +A+E LHS+ +IHRD+K +N+LL
Sbjct: 93 VVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG 149
Query: 76 EDLKTIKLADFG----LAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVD 131
D ++KL DFG + E+S M GT WMAPE+ + +K Y KVD
Sbjct: 150 MD-GSVKLTDFGFCAQITPEQSKRSTM---VGTPYWMAPEVVT--------RKAYGPKVD 197
Query: 132 SYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSII----LTSCWKE 187
+S I+ E++ + P+ + L+A Y A N P +N PE+LS I L C +
Sbjct: 198 IWSLGIMAIEMVEGEPPYLNENPLRALYLIA-TNGTPELQN-PEKLSAIFRDFLNRCLEM 255
Query: 188 DPNARPNFTQIIQ 200
D R + +++Q
Sbjct: 256 DVEKRGSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 79.1 bits (196), Expect = 3e-17
Identities = 49/135 (36%), Positives = 71/135 (52%), Gaps = 15/135 (11%)
Query: 16 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 75
+V E + GG L +L + VA +A + A+E LHS I++RDLKPENLLL
Sbjct: 78 LVMEYVPGGELFSHL--RKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLD 135
Query: 76 EDLKTIKLADFGLA-REESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYS 134
D IK+ DFG A R + T + GT ++APE + L +G Y VD ++
Sbjct: 136 SD-GYIKITDFGFAKRVKGRTYTL---CGTPEYLAPE----IILSKG----YGKAVDWWA 183
Query: 135 FAIVLWELLHNKLPF 149
I+++E+L PF
Sbjct: 184 LGILIYEMLAGYPPF 198
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 3e-17
Identities = 44/156 (28%), Positives = 79/156 (50%), Gaps = 23/156 (14%)
Query: 57 LHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE----SLTEMMTAETGTYRWMAPEL 112
LHS GI+HRDLK +NLL+ D K++DFG++++ + M+ + G+ WMAPE+
Sbjct: 124 LHSKGILHRDLKADNLLVDAD-GICKISDFGISKKSDDIYDNDQNMSMQ-GSVFWMAPEV 181
Query: 113 YSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN 172
+ + Y+ KVD +S V+ E+ + P+ + A + K P
Sbjct: 182 IHS------YSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPP--- 232
Query: 173 VPEELSIILTS--------CWKEDPNARPNFTQIIQ 200
+P ++S+ L+ C+ +P+ RP +++Q
Sbjct: 233 IPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 4e-17
Identities = 51/139 (36%), Positives = 79/139 (56%), Gaps = 12/139 (8%)
Query: 14 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 73
+ V E L+GG L ++ + D+ A +A +I ++ LHS GI++RDLK +N+L
Sbjct: 71 LFFVMEYLNGGDLMFHIQSCHK--FDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNIL 128
Query: 74 LTEDLKTIKLADFGLAREESLTEMMTAE-TGTYRWMAPELYSTVTLRQGEKKHYNHKVDS 132
L D IK+ADFG+ +E L + T GT ++APE+ G+K YN VD
Sbjct: 129 LDTD-GHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEIL------LGQK--YNTSVDW 179
Query: 133 YSFAIVLWELLHNKLPFEG 151
+SF ++L+E+L + PF G
Sbjct: 180 WSFGVLLYEMLIGQSPFHG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 6e-17
Identities = 55/193 (28%), Positives = 91/193 (47%), Gaps = 15/193 (7%)
Query: 14 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 73
M+IVTE +S G L +L + L +G +A M+ L G +H+ L +L
Sbjct: 81 MMIVTEYMSNGALDSFLRKHEGQ-LVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVL 139
Query: 74 LTEDLKTIKLADFGLAREESLTEMMTAETG--TYRWMAPELYSTVTLRQGEKKHYNHKVD 131
+ DL K++ F +E+ + T +G W APE ++ H++ D
Sbjct: 140 VNSDL-VCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPE-----AIQYH---HFSSASD 190
Query: 132 SYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-PSAENVPEELSIILTSCWKEDP 189
+SF IV+WE++ + + P+ MS Q A R P+ N P L ++ CW+++
Sbjct: 191 VWSFGIVMWEVMSYGERPYWDMSG-QDVIKAVEDGFRLPAPRNCPNLLHQLMLDCWQKER 249
Query: 190 NARPNFTQIIQML 202
RP F+QI +L
Sbjct: 250 GERPRFSQIHSIL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 7e-17
Identities = 65/208 (31%), Positives = 104/208 (50%), Gaps = 29/208 (13%)
Query: 16 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 75
+V E L+GG+L + C+D + +A++ LHS+ +IHRD+K +N+LL
Sbjct: 93 VVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLG 149
Query: 76 EDLKTIKLADFG----LAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVD 131
D ++KL DFG + E+S M GT WMAPE+ + +K Y KVD
Sbjct: 150 MD-GSVKLTDFGFCAQITPEQSKRSTM---VGTPYWMAPEVVT--------RKAYGPKVD 197
Query: 132 SYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSII----LTSCWKE 187
+S I+ E++ + P+ + L+A Y A N P +N PE LS + L C +
Sbjct: 198 IWSLGIMAIEMVEGEPPYLNENPLRALYLIA-TNGTPELQN-PERLSAVFRDFLNRCLEM 255
Query: 188 DPNARPNFTQIIQ----MLLNYLSAIAP 211
D + R + +++Q L LS++ P
Sbjct: 256 DVDRRGSAKELLQHPFLKLAKPLSSLTP 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 9e-17
Identities = 48/155 (30%), Positives = 75/155 (48%), Gaps = 17/155 (10%)
Query: 50 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE---ESLTEMMTAETGTYR 106
IA ME L SH ++H+DL N+L+ + L +K++D GL RE ++M R
Sbjct: 133 IAAGMEFLSSHHVVHKDLATRNVLVFDKL-NVKISDLGLFREVYAADYYKLMGNSLLPIR 191
Query: 107 WMAPE--LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKL-PFEGMSNLQAAYAAAF 163
WM+PE +Y ++ D +S+ +VLWE+ L P+ G SN
Sbjct: 192 WMSPEAIMYGKFSIDS----------DIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRN 241
Query: 164 KNVRPSAENVPEELSIILTSCWKEDPNARPNFTQI 198
+ V P ++ P + ++ CW E P+ RP F I
Sbjct: 242 RQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 76.9 bits (190), Expect = 1e-16
Identities = 41/100 (41%), Positives = 55/100 (55%), Gaps = 11/100 (11%)
Query: 53 AMECLHSHGIIHRDLKPENLLLTEDLKT-IKLADFGLAREESLTEMMTAETGTYRWMAPE 111
A E LH+ GII+RDLKPENLLL D +KL DFG A++ + GT ++APE
Sbjct: 105 AFEYLHNRGIIYRDLKPENLLL--DSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPE 162
Query: 112 LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 151
+ K Y+ VD +S I+L+ELL + PF
Sbjct: 163 II--------LNKGYDFSVDYWSLGILLYELLTGRPPFGE 194
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 1e-16
Identities = 61/226 (26%), Positives = 98/226 (43%), Gaps = 38/226 (16%)
Query: 4 QFIGACKE---PVMVIVTELLSGGTLRKYLLNMRPR-CLDVCVAIGFALDIARAMECLHS 59
++ G C E + ++ E + G+LR YL P+ L++ + FA I M LHS
Sbjct: 70 KYKGCCSEQGGKGLQLIMEYVPLGSLRDYL----PKHKLNLAQLLLFAQQICEGMAYLHS 125
Query: 60 HGIIHRDLKPENLLLTEDLKTIKLADFGLAR-----EESLTEMMTAETGTYRWMAPELYS 114
IHRDL N+LL D + +K+ DFGLA+ E ++ + W A E
Sbjct: 126 QHYIHRDLAARNVLLDND-RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF-WYAVECLK 183
Query: 115 TVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLP-------FEGMSNLQAAYAAAFKNVR 167
E K + D +SF + L+ELL + FE M + + +
Sbjct: 184 -------ENKFS-YASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIE 235
Query: 168 --------PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 205
P +N P+E+ I++ +CW+ + RP F +I +L
Sbjct: 236 LLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 1e-16
Identities = 43/113 (38%), Positives = 60/113 (53%), Gaps = 10/113 (8%)
Query: 46 FALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE--MMTAETG 103
F I R ++ LHS GI+HRD+KP NLL+ + +K+ DFGLAR E E MT E
Sbjct: 108 FLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCV-LKICDFGLARVEEPDESKHMTQEVV 166
Query: 104 TYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 156
T + APE+ +HY VD +S + ELL ++ F+ S +Q
Sbjct: 167 TQYYRAPEILMG-------SRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ 212
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-16
Identities = 54/174 (31%), Positives = 85/174 (48%), Gaps = 22/174 (12%)
Query: 44 IGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETG 103
I ++ +A+ ME L S IHRDL N+LL+E+ +K+ DFGLAR + + G
Sbjct: 182 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEN-NVVKICDFGLAR-DIYKDPDYVRKG 239
Query: 104 TYR----WMAPE-LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQA 157
R WMAPE ++ V Y + D +SF ++LWE+ P+ G+ +
Sbjct: 240 DARLPLKWMAPETIFDRV---------YTIQSDVWSFGVLLWEIFSLGASPYPGV-KIDE 289
Query: 158 AYAAAFKN---VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 208
+ K +R PE +L CW +P+ RP F+++++ L N L A
Sbjct: 290 EFCRRLKEGTRMRAPDYTTPEMYQTML-DCWHGEPSQRPTFSELVEHLGNLLQA 342
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-16
Identities = 61/221 (27%), Positives = 98/221 (44%), Gaps = 25/221 (11%)
Query: 4 QFIGACKE-PVMVIVTELLSGGTLRKYLLNMRPRC-----------LDVCVAIGFALDIA 51
+F G C E +++V E + G L K+L P L + A IA
Sbjct: 71 KFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIA 130
Query: 52 RAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY---RWM 108
M L S +HRDL N L+ E+L +K+ DFG++R+ T+ T RWM
Sbjct: 131 AGMVYLASQHFVHRDLATRNCLVGENL-LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189
Query: 109 APELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR 167
PE ++ R+ + + D +S +VLWE+ + K P+ +SN + V
Sbjct: 190 PPE---SIMYRK-----FTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVL 241
Query: 168 PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 208
P+E+ ++ CW+ +P+ R N +I +L N A
Sbjct: 242 QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 2e-16
Identities = 60/207 (28%), Positives = 92/207 (44%), Gaps = 32/207 (15%)
Query: 14 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 73
+ +V E L G+LR YL R R D + +A I + ME L S +HRDL N+L
Sbjct: 82 LRLVMEYLPYGSLRDYLQKHRERL-DHRKLLLYASQICKGMEYLGSKRYVHRDLATRNIL 140
Query: 74 LTEDLKTIKLADFGLAR-----EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNH 128
+ E +K+ DFGL + +E E+ + W APE + E K ++
Sbjct: 141 V-ESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIF-WYAPESLT-------ESK-FSV 190
Query: 129 KVDSYSFAIVLWELL----HNKLP----FEGMSNLQAAYAAAF-------KNVR-PSAEN 172
D +SF +VL+EL + P M N + + N R P+
Sbjct: 191 ASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPG 250
Query: 173 VPEELSIILTSCWKEDPNARPNFTQII 199
P E+ I+ CW DP+ RP+F+++
Sbjct: 251 CPAEIYAIMKECWNNDPSQRPSFSELA 277
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 2e-16
Identities = 58/192 (30%), Positives = 93/192 (48%), Gaps = 22/192 (11%)
Query: 16 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 75
IV + GG L K + R + + + I A++ +H I+HRD+K +N+ LT
Sbjct: 76 IVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLT 135
Query: 76 EDLKTIKLADFGLARE-ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYS 134
+D TIKL DFG+AR S E+ GT +++PE+ E + YN+K D ++
Sbjct: 136 KD-GTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEIC--------ENRPYNNKSDIWA 186
Query: 135 FAIVLWELLHNKLPFEG--MSNLQAAYAAAFKNVRPSAENVP----EELSIILTSCWKED 188
VL+E+ K FE M NL K +R S V +L +++ +K +
Sbjct: 187 LGCVLYEMCTLKHAFEAGNMKNL------VLKIIRGSYPPVSSHYSYDLRNLVSQLFKRN 240
Query: 189 PNARPNFTQIIQ 200
P RP+ I++
Sbjct: 241 PRDRPSVNSILE 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 3e-16
Identities = 66/210 (31%), Positives = 105/210 (50%), Gaps = 29/210 (13%)
Query: 14 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 73
+ +V E L+GG+L + C+D + +A+E LH++ +IHRD+K +N+L
Sbjct: 91 LFVVMEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVL 147
Query: 74 LTEDLKTIKLADFG----LAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK 129
L D ++KL DFG + E+S M GT WMAPE+ + +K Y K
Sbjct: 148 LGMD-GSVKLTDFGFCAQITPEQSKRSTM---VGTPYWMAPEVVT--------RKAYGPK 195
Query: 130 VDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSII----LTSCW 185
VD +S I+ E++ + P+ + L+A Y A N P +N PE+LS I L C
Sbjct: 196 VDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-TNGTPELQN-PEKLSPIFRDFLNRCL 253
Query: 186 KEDPNARPNFTQIIQ----MLLNYLSAIAP 211
+ D R + +++Q L LS++ P
Sbjct: 254 EMDVEKRGSAKELLQHPFLKLAKPLSSLTP 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 3e-16
Identities = 44/138 (31%), Positives = 73/138 (52%), Gaps = 9/138 (6%)
Query: 14 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 73
+ +V L++GG L+ ++ NM D A+ +A +I +E LH I++RDLKPEN+L
Sbjct: 75 LCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENIL 134
Query: 74 LTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSY 133
L +D I+++D GLA E E + GT +MAPE+ + + Y D +
Sbjct: 135 L-DDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVV--------KNERYTFSPDWW 185
Query: 134 SFAIVLWELLHNKLPFEG 151
+++E++ K PF
Sbjct: 186 GLGCLIYEMIEGKSPFRQ 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 6e-16
Identities = 43/155 (27%), Positives = 77/155 (49%), Gaps = 9/155 (5%)
Query: 50 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMT-AETGTYRWM 108
R + LH + +IHRD+K +N+LLT++ + +KL DFG++ + T GT WM
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLTKNAE-VKLVDFGVSAQLDSTLGRRNTFIGTPYWM 180
Query: 109 APELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP 168
APE+ + + Y+ + D +S I EL K P M ++A + +N P
Sbjct: 181 APEV---IACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIP-RNPPP 236
Query: 169 ---SAENVPEELSIILTSCWKEDPNARPNFTQIIQ 200
S EN ++ + ++ C ++ RP ++++
Sbjct: 237 TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 8e-16
Identities = 59/224 (26%), Positives = 97/224 (43%), Gaps = 36/224 (16%)
Query: 4 QFIGACKE-------PVMVIVTELLSGGTLRKYLLNMR----PRCLDVCVAIGFALDIAR 52
+ IG C + P V++ + G L +LL R P+ L + + F DIA
Sbjct: 64 RLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIAS 123
Query: 53 AMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA---------REESLTEMMTAETG 103
ME L S IHRDL N +L E++ + +ADFGL+ R+ + +M
Sbjct: 124 GMEYLSSKSFIHRDLAARNCMLNENM-NVCVADFGLSKKIYNGDYYRQGRIAKM------ 176
Query: 104 TYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWEL-LHNKLPFEGMSNLQAAYAAA 162
+W+A E + + Y K D +SF + +WE+ + P+ G+ N +
Sbjct: 177 PVKWIAIESLA--------DRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLR 228
Query: 163 FKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 206
N + + L +++SCW +P RP+F + L L
Sbjct: 229 QGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKAL 272
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 8e-16
Identities = 46/160 (28%), Positives = 79/160 (49%), Gaps = 12/160 (7%)
Query: 47 ALDIARAMECLHSH-GIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMM--TAETG 103
A+ I +A+E LHS +IHRD+KP N+L+ + + +KL DFG++ L + + T + G
Sbjct: 109 AVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQ-VKLCDFGISGY--LVDSVAKTIDAG 165
Query: 104 TYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAF 163
+MAPE + + +K Y+ K D +S I + EL + P++
Sbjct: 166 CKPYMAPERINP----ELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVV 221
Query: 164 KNVRPS--AENVPEELSIILTSCWKEDPNARPNFTQIIQM 201
+ P AE E + C K++ RPN+ +++Q
Sbjct: 222 EEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 9e-16
Identities = 47/164 (28%), Positives = 82/164 (50%), Gaps = 13/164 (7%)
Query: 50 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT---EMMTAETGTYR 106
I A++ +HS ++HRDLK N+ L IKL DFG +++ S + ++ ++ GT
Sbjct: 178 IVLALDEVHSRKMMHRDLKSANIFLMPT-GIIKLGDFGFSKQYSDSVSLDVASSFCGTPY 236
Query: 107 WMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV 166
++APEL+ E+K Y+ K D +S ++L+ELL PF+G S + +
Sbjct: 237 YLAPELW--------ERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKY 288
Query: 167 RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM-LLNYLSAI 209
P V + +L ++P RP Q++ L Y++ +
Sbjct: 289 DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYVANL 332
|
Length = 478 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 9e-16
Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 31/212 (14%)
Query: 16 IVTELLSGGTLRKYLLNMR---PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENL 72
+V E L GG L + + R + VC+A+ +A+ LH+ G+IHRD+K +++
Sbjct: 94 VVMEFLEGGALTDIVTHTRMNEEQIAAVCLAV------LKALSVLHAQGVIHRDIKSDSI 147
Query: 73 LLTEDLKTIKLADFGL-AREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVD 131
LLT D + +KL+DFG A+ + GT WMAPEL S + Y +VD
Sbjct: 148 LLTHDGR-VKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLP--------YGPEVD 198
Query: 132 SYSFAIVLWELLH------NKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCW 185
+S I++ E++ N+ P + M ++ KN V L L
Sbjct: 199 IWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKN----LHKVSPSLKGFLDRLL 254
Query: 186 KEDPNARPNFTQIIQMLLNYLSAIAPPEPMIP 217
DP R ++++ +L+ PP ++P
Sbjct: 255 VRDPAQRATAAELLKH--PFLAKAGPPSCIVP 284
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 1e-15
Identities = 52/217 (23%), Positives = 99/217 (45%), Gaps = 48/217 (22%)
Query: 4 QFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRC-----LDVCVAIGFALDIARAMECLH 58
+ +G C + ++T+L+ G L Y+ + L+ CV IA+ M L
Sbjct: 73 RLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV------QIAKGMNYLE 126
Query: 59 SHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY---------RWMA 109
++HRDL N+L+ + + +K+ DFGLA+ ++ A+ Y +WMA
Sbjct: 127 ERRLVHRDLAARNVLV-KTPQHVKITDFGLAK------LLGADEKEYHAEGGKVPIKWMA 179
Query: 110 PELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVRP 168
L + Y H+ D +S+ + +WEL+ P++G+ A+ ++
Sbjct: 180 --------LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP------ASEISSILE 225
Query: 169 SAENVPE------ELSIILTSCWKEDPNARPNFTQII 199
E +P+ ++ +I+ CW D ++RP F ++I
Sbjct: 226 KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 262
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 1e-15
Identities = 52/156 (33%), Positives = 74/156 (47%), Gaps = 22/156 (14%)
Query: 50 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR----EESLTEMMTAETGTY 105
+ R ++ LHSH I+HRDLKP+N+L+T D +K+ADFGLAR E +LT ++ T Y
Sbjct: 116 LLRGVDFLHSHRIVHRDLKPQNILVTSDG-QVKIADFGLARIYSFEMALTSVVV--TLWY 172
Query: 106 RWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN 165
R APE V L+ Y VD +S + EL + F G S F
Sbjct: 173 R--APE----VLLQS----SYATPVDMWSVGCIFAELFRRRPLFRGTSEAD-QLDKIFDV 221
Query: 166 V-RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQ 200
+ PS E P +S+ +S +F +
Sbjct: 222 IGLPSEEEWPRNVSLPRSSF---PSYTPRSFKSFVP 254
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 74.9 bits (185), Expect = 1e-15
Identities = 45/107 (42%), Positives = 57/107 (53%), Gaps = 13/107 (12%)
Query: 52 RAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAETGTYRWM-A 109
R +E LHS+ I+HRDLKP NLL+ D +KLADFGLAR S MT + T RW A
Sbjct: 113 RGLEYLHSNWILHRDLKPNNLLIASD-GVLKLADFGLARSFGSPNRKMTHQVVT-RWYRA 170
Query: 110 PEL-YSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL 155
PEL + +HY VD +S + ELL G S++
Sbjct: 171 PELLFGA--------RHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI 209
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 1e-15
Identities = 48/145 (33%), Positives = 75/145 (51%), Gaps = 24/145 (16%)
Query: 14 MVIVTELLSGGTLRKYLLNM--------RPRCLDVCVAIGFALDIARAMECLHSHGIIHR 65
+ +V +++GG LR ++ N+ PR A + I +E LH II+R
Sbjct: 68 LCLVMTIMNGGDLRYHIYNVDEENPGFPEPR------ACFYTAQIISGLEHLHQRRIIYR 121
Query: 66 DLKPENLLLTEDLKTIKLADFGLAREESLTEMMT-AETGTYRWMAPELYSTVTLRQGEKK 124
DLKPEN+LL D ++++D GLA E + T GT +MAPEL QGE+
Sbjct: 122 DLKPENVLLDND-GNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELL------QGEE- 173
Query: 125 HYNHKVDSYSFAIVLWELLHNKLPF 149
Y+ VD ++ + L+E++ + PF
Sbjct: 174 -YDFSVDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 1e-15
Identities = 42/113 (37%), Positives = 63/113 (55%), Gaps = 11/113 (9%)
Query: 49 DIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYR 106
+I A++ LH GII+RD+K EN+LL + + L DFGL++E E A + GT
Sbjct: 113 EIVLALDHLHQLGIIYRDIKLENILLDSE-GHVVLTDFGLSKEFLAEEEERAYSFCGTIE 171
Query: 107 WMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPF--EGMSNLQA 157
+MAPE+ +R G H + VD +S ++ +ELL PF +G N Q+
Sbjct: 172 YMAPEV-----IRGGSGGH-DKAVDWWSLGVLTFELLTGASPFTVDGEQNSQS 218
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 74.9 bits (185), Expect = 1e-15
Identities = 46/113 (40%), Positives = 58/113 (51%), Gaps = 20/113 (17%)
Query: 52 RAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR------EESLTEMMTAETGTY 105
+A++ +HS +IHRDLKP N+LL D +KLADFGLAR E ++T T
Sbjct: 118 KALKYIHSGNVIHRDLKPSNILLNSDC-RVKLADFGLARSLSELEENPENPVLTDYVAT- 175
Query: 106 RWM-APE--LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL 155
RW APE L ST Y VD +S +L E+L K F G S L
Sbjct: 176 RWYRAPEILLGST---------RYTKGVDMWSVGCILGEMLLGKPLFPGTSTL 219
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-15
Identities = 66/242 (27%), Positives = 107/242 (44%), Gaps = 42/242 (17%)
Query: 14 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 73
+ V E +GG L +L R R A + +I A+E LHS +++RD+K ENL+
Sbjct: 70 LCFVMEYANGGELFFHL--SRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLM 127
Query: 74 LTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNHKVD 131
L +D IK+ DFGL + E +++ T +T GT ++APE+ E Y VD
Sbjct: 128 LDKD-GHIKITDFGLCK-EGISDGATMKTFCGTPEYLAPEVL--------EDNDYGRAVD 177
Query: 132 SYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNA 191
+ +V++E++ +LPF + + + +R PE S +L K+DP
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKS-LLAGLLKKDPKQ 236
Query: 192 R----PNFTQIIQMLLNYLSAIAPPEPMIPHRIFNS-------ENTILPPESPGTSSLMT 240
R P+ + + HR F S + +LPP P +S +
Sbjct: 237 RLGGGPSDAKEVME----------------HRFFLSINWQDVVQKKLLPPFKPQVTSEVD 280
Query: 241 VR 242
R
Sbjct: 281 TR 282
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 74.4 bits (182), Expect = 2e-15
Identities = 51/149 (34%), Positives = 79/149 (53%), Gaps = 12/149 (8%)
Query: 57 LHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTV 116
LHSH +IHRD+K N+LLTE +KLADFG A S+ + GT WMAPE+ +
Sbjct: 141 LHSHNMIHRDIKAGNILLTEP-GQVKLADFGSA---SIASPANSFVGTPYWMAPEV--IL 194
Query: 117 TLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENV--P 174
+ +G+ Y+ KVD +S I EL K P M+ + A Y A +N P+ ++
Sbjct: 195 AMDEGQ---YDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-QNESPTLQSNEWS 250
Query: 175 EELSIILTSCWKEDPNARPNFTQIIQMLL 203
+ + SC ++ P RP ++++ +
Sbjct: 251 DYFRNFVDSCLQKIPQDRPTSEELLKHMF 279
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-15
Identities = 56/207 (27%), Positives = 91/207 (43%), Gaps = 27/207 (13%)
Query: 4 QFIGACKE-PVMVIVTELLSGGTLRKYLLNMRPRC-------------LDVCVAIGFALD 49
+F G C E +++V E + G L ++L + P L + + A
Sbjct: 71 RFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQ 130
Query: 50 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY---R 106
IA M L S +HRDL N L+ + L +K+ DFG++R+ T+ T R
Sbjct: 131 IASGMVYLASLHFVHRDLATRNCLVGQGL-VVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 107 WMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKN 165
WM PE ++ R+ + + D +SF +VLWE+ + K P+ +SN +A
Sbjct: 190 WMPPE---SILYRK-----FTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGR 241
Query: 166 VRPSAENVPEELSIILTSCWKEDPNAR 192
P E+ I+ CW+ +P R
Sbjct: 242 ELERPRTCPPEVYAIMQGCWQREPQQR 268
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 2e-15
Identities = 59/184 (32%), Positives = 95/184 (51%), Gaps = 21/184 (11%)
Query: 14 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 73
+ V E L+GG L + + + R D+ A +A +I ++ LHS GII+RDLK +N++
Sbjct: 71 LFFVMEFLNGGDL-MFHIQDKGR-FDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVM 128
Query: 74 LTEDLKTIKLADFGLAREESLTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDS 132
L D IK+ADFG+ +E + + GT ++APE+ QG K Y VD
Sbjct: 129 LDRD-GHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEIL------QGLK--YTFSVDW 179
Query: 133 YSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVP----EELSIILTSCWKED 188
+SF ++L+E+L + PF G + F+++R + P +E IL ++ D
Sbjct: 180 WSFGVLLYEMLIGQSPFHGDDEDE-----LFESIRVDTPHYPRWITKESKDILEKLFERD 234
Query: 189 PNAR 192
P R
Sbjct: 235 PTRR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 3e-15
Identities = 59/213 (27%), Positives = 91/213 (42%), Gaps = 52/213 (24%)
Query: 17 VTELLSGGTLRKYLLNMRP-RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 75
V + GG L + LL +P +CL VA +A ++ A+E LH GI++RDLKPEN+LL
Sbjct: 79 VMDYCPGGELFR-LLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLH 137
Query: 76 EDLKTIKLADFGLA----------------------REESLTEMMTAET--------GTY 105
E I L+DF L+ +E + E GT
Sbjct: 138 ES-GHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTE 196
Query: 106 RWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN 165
++APE+ S + VD ++ I+L+E+L+ PF+G SN F N
Sbjct: 197 EYIAPEVIS--------GDGHGSAVDWWTLGILLYEMLYGTTPFKG-SNRD----ETFSN 243
Query: 166 VR------PSAENVPEELSIILTSCWKEDPNAR 192
+ P + V ++ +DP+ R
Sbjct: 244 ILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKR 276
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 3e-15
Identities = 50/219 (22%), Positives = 80/219 (36%), Gaps = 46/219 (21%)
Query: 16 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 75
+V E + GG L L+ A + ++ A++ +H G IHRD+KP+N+L+
Sbjct: 78 LVMEYMPGGDLMNLLIRKD--VFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILID 135
Query: 76 EDLKTIKLADFGLA-------------REESLTEMMTAET-----------------GTY 105
D IKLADFGL + GT
Sbjct: 136 AD-GHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTP 194
Query: 106 RWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYA--AAF 163
++APE V Y + D +S ++L+E+L+ PF LQ Y +
Sbjct: 195 DYIAPE----VLRGTP----YGLECDWWSLGVILYEMLYGFPPFYS-DTLQETYNKIINW 245
Query: 164 KN--VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQ 200
K P V E ++ + + +F +I
Sbjct: 246 KESLRFPPDPPVSPEAIDLICRLLCDPEDRLGSFEEIKS 284
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 3e-15
Identities = 56/194 (28%), Positives = 93/194 (47%), Gaps = 17/194 (8%)
Query: 14 MVIVTELLSGGTLRKYLLNMRP--RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPEN 71
+ IV EL G L + + + + R + + + + A+E +HS I+HRD+KP N
Sbjct: 77 LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPAN 136
Query: 72 LLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNHK 129
+ +T +KL D GL R S ++ A + GT +M+PE + YN K
Sbjct: 137 VFITAT-GVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSPERI--------HENGYNFK 186
Query: 130 VDSYSFAIVLWELLHNKLPFEG-MSNLQAAYAAAFKNVRP--SAENVPEELSIILTSCWK 186
D +S +L+E+ + PF G NL + K P A++ EEL +++ C
Sbjct: 187 SDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSRCIN 246
Query: 187 EDPNARPNFTQIIQ 200
DP RP+ + ++Q
Sbjct: 247 PDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 3e-15
Identities = 54/197 (27%), Positives = 94/197 (47%), Gaps = 25/197 (12%)
Query: 16 IVTELLSGGTLRKYLLNMRP--------RCLDVCVAIGFALDIARAMECLHSHG-IIHRD 66
IV +L+ G L ++ +++ R ++ V + AL LH I+HRD
Sbjct: 86 IVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLAL------RYLHKEKRIVHRD 139
Query: 67 LKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 126
L P N++L ED K + + DFGLA+++ +T+ GT + PE+ + E Y
Sbjct: 140 LTPNNIMLGEDDK-VTITDFGLAKQKQPESKLTSVVGTILYSCPEIV------KNEP--Y 190
Query: 127 NHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENV-PEELSIILTSCW 185
K D ++F +L+++ + PF + L A P E + E+++ ++TSC
Sbjct: 191 GEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYSEDVTDVITSCL 250
Query: 186 KEDPNARPNFTQIIQML 202
D ARP+ Q+ M+
Sbjct: 251 TPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 4e-15
Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 23/208 (11%)
Query: 4 QFIGACKE-PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGF-ALDIARAMECLHSHG 61
Q++G+ E I E + GG+L L + D I F I ++ LH +
Sbjct: 69 QYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ 128
Query: 62 IIHRDLKPENLLLTEDLKTIKLADFG----LAREESLTEMMTAETGTYRWMAPELYSTVT 117
I+HRD+K +N+L+ +K++DFG LA TE TGT ++MAPE+
Sbjct: 129 IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETF---TGTLQYMAPEV----- 180
Query: 118 LRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA-YAAAFKNVRPSAENVPEE 176
+ +G + Y D +S + E+ K PF + QAA + + P +PE
Sbjct: 181 IDKGPRG-YGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHP---EIPES 236
Query: 177 LSI----ILTSCWKEDPNARPNFTQIIQ 200
LS + C++ DP+ R + ++Q
Sbjct: 237 LSAEAKNFILRCFEPDPDKRASAHDLLQ 264
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 73.3 bits (181), Expect = 4e-15
Identities = 39/113 (34%), Positives = 53/113 (46%), Gaps = 16/113 (14%)
Query: 50 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR----EESLTEMMTAETGT- 104
I R ++ LHS +IHRDLKP N+L+ + +K+ DFGLAR +E +T T
Sbjct: 112 ILRGLKYLHSANVIHRDLKPSNILVNSNC-DLKICDFGLARGVDPDEDEKGFLTEYVVTR 170
Query: 105 -YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 156
YR APEL Y +D +S + ELL K F G +
Sbjct: 171 WYR--APELL-------LSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYID 214
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 4e-15
Identities = 55/200 (27%), Positives = 94/200 (47%), Gaps = 12/200 (6%)
Query: 2 REQFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG 61
RE + G ++ ++ IV GG L L + + L + + + IA A++ LH
Sbjct: 65 RESWEG--EDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH 122
Query: 62 IIHRDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAETGTYRWMAPELYSTVTLRQ 120
I+HRDLK +N+ LT IK+ D G+AR E+ +M + GT +M+PEL+S
Sbjct: 123 ILHRDLKTQNVFLTRT-NIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSN----- 176
Query: 121 GEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSII 180
K YN+K D ++ ++E+ K F Y + P ++ EL +
Sbjct: 177 ---KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGEL 233
Query: 181 LTSCWKEDPNARPNFTQIIQ 200
+ + + P RP+ I++
Sbjct: 234 IATMLSKRPEKRPSVKSILR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 5e-15
Identities = 50/134 (37%), Positives = 72/134 (53%), Gaps = 12/134 (8%)
Query: 17 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE 76
V + ++GG L +L R R A +A +IA A+ LHS II+RDLKPEN+LL +
Sbjct: 74 VLDYVNGGELFFHL--QRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILL-D 130
Query: 77 DLKTIKLADFGLAREESLTEMMTAE-TGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSF 135
+ L DFGL +E T+ GT ++APE+ LR K+ Y+ VD +
Sbjct: 131 SQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEV-----LR---KQPYDRTVDWWCL 182
Query: 136 AIVLWELLHNKLPF 149
VL+E+L+ PF
Sbjct: 183 GAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 6e-15
Identities = 47/163 (28%), Positives = 78/163 (47%), Gaps = 20/163 (12%)
Query: 46 FALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY 105
F I + + LH+ GIIHRD+K N+L+ ++ IK++DFG++++ + T T
Sbjct: 111 FVRQILKGLNYLHNRGIIHRDIKGANILV-DNKGGIKISDFGISKKLEANSLSTK-TNGA 168
Query: 106 R--------WMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA 157
R WMAPE+ ++ Y K D +S ++ E+L K PF + LQA
Sbjct: 169 RPSLQGSVFWMAPEVV--------KQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA 220
Query: 158 AYAAAFKNVRPS-AENVPEELSIILTSCWKEDPNARPNFTQII 199
+ +N P N+ E L ++ D N RP +++
Sbjct: 221 IFKIG-ENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELL 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 7e-15
Identities = 44/103 (42%), Positives = 57/103 (55%), Gaps = 12/103 (11%)
Query: 50 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRW-M 108
I R ++ +HS GIIHRDLKP N+ + ED + +K+ DFGLAR + MT T RW
Sbjct: 127 ILRGLKYIHSAGIIHRDLKPSNIAVNEDCE-LKILDFGLAR--HTDDEMTGYVAT-RWYR 182
Query: 109 APELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 151
APE + L HYN VD +S ++ ELL K F G
Sbjct: 183 APE----IML---NWMHYNQTVDIWSVGCIMAELLTGKTLFPG 218
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 7e-15
Identities = 48/200 (24%), Positives = 89/200 (44%), Gaps = 14/200 (7%)
Query: 4 QFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 63
+ +G C + +VT+L+ G L Y+ + R + + + + IA+ M L ++
Sbjct: 73 RLLGICLTSTVQLVTQLMPYGCLLDYVRENKDR-IGSQDLLNWCVQIAKGMSYLEEVRLV 131
Query: 64 HRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETG---TYRWMAPELYSTVTLRQ 120
HRDL N+L+ + +K+ DFGLAR + E G +WMA L
Sbjct: 132 HRDLAARNVLV-KSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMA--------LES 182
Query: 121 GEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSI 179
+ + H+ D +S+ + +WEL+ P++G+ + P ++ +
Sbjct: 183 ILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDVYM 242
Query: 180 ILTSCWKEDPNARPNFTQII 199
I+ CW D RP F +++
Sbjct: 243 IMVKCWMIDSECRPRFRELV 262
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 8e-15
Identities = 59/218 (27%), Positives = 101/218 (46%), Gaps = 28/218 (12%)
Query: 4 QFIGACKE-PVMVIVTELLSGGTLRKYL----------LNMRPRC----LDVCVAIGFAL 48
+F G C + +++V E + G L K+L ++ +PR L + + A
Sbjct: 71 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 130
Query: 49 DIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY--- 105
IA M L S +HRDL N L+ +L +K+ DFG++R+ T+ T
Sbjct: 131 QIASGMVYLASQHFVHRDLATRNCLVGANL-LVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189
Query: 106 RWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFK 164
RWM PE ++ R+ + + D +SF ++LWE+ + K P+ +SN +
Sbjct: 190 RWMPPE---SIMYRK-----FTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQG 241
Query: 165 NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 202
V P+E+ I+ CW+ +P R N +I ++L
Sbjct: 242 RVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKIL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 8e-15
Identities = 50/209 (23%), Positives = 97/209 (46%), Gaps = 34/209 (16%)
Query: 4 QFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 63
+ +G C + +VT+L G+L ++ R LD + + + IA+ M L H ++
Sbjct: 73 RLLGICPGASLQLVTQLSPLGSLLDHVRQHRDS-LDPQRLLNWCVQIAKGMYYLEEHRMV 131
Query: 64 HRDLKPENLLLTEDLKTIKLADFGLA-------REESLTEMMTAETGTYRWMAPELYSTV 116
HR+L N+LL D +++ADFG+A ++ +E T +WMA E ++
Sbjct: 132 HRNLAARNILLKSDSI-VQIADFGVADLLYPDDKKYFYSEHKTP----IKWMALE---SI 183
Query: 117 TLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVRPSAENVPE 175
+ Y H+ D +S+ + +WE++ + P+ GM ++ E + +
Sbjct: 184 LFGR-----YTHQSDVWSYGVTVWEMMSYGAEPYAGM------RPHEVPDLLEKGERLAQ 232
Query: 176 ------ELSIILTSCWKEDPNARPNFTQI 198
++ +++ CW D N RP F ++
Sbjct: 233 PQICTIDVYMVMVKCWMIDENVRPTFKEL 261
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 8e-15
Identities = 50/136 (36%), Positives = 70/136 (51%), Gaps = 14/136 (10%)
Query: 16 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 75
VTELL GT LL RP L+ F I R ++ +HS G++HRDLKP N+L+
Sbjct: 87 FVTELL--GTDLHRLLTSRP--LEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILIN 142
Query: 76 EDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSF 135
E+ +K+ DFGLAR + MT T + APE+ T + Y+ +VD +S
Sbjct: 143 ENCD-LKICDFGLARIQD--PQMTGYVSTRYYRAPEIMLTW-------QKYDVEVDIWSA 192
Query: 136 AIVLWELLHNKLPFEG 151
+ E+L K F G
Sbjct: 193 GCIFAEMLEGKPLFPG 208
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 1e-14
Identities = 53/191 (27%), Positives = 82/191 (42%), Gaps = 22/191 (11%)
Query: 19 ELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL 78
E + GG R L N+ L A + ++ A++ LH G IHRDLKPEN L+
Sbjct: 81 EYVPGGDFRTLLNNLG--VLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDAS- 137
Query: 79 KTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIV 138
IKL DFGL++ + + G+ +MAPE+ +G+ Y+ VD +S +
Sbjct: 138 GHIKLTDFGLSKG--IVTYANSVVGSPDYMAPEVL------RGKG--YDFTVDYWSLGCM 187
Query: 139 LWELLHNKLPFEGMSNLQAAYAAA--FKNV--RPSAENVPEELSI----ILTSCWKEDPN 190
L+E L PF G S + +K RP ++ LS ++T +
Sbjct: 188 LYEFLCGFPPFSG-STPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSR 246
Query: 191 ARPNFTQIIQM 201
+ I
Sbjct: 247 RFGSLEDIKNH 257
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-14
Identities = 50/146 (34%), Positives = 77/146 (52%), Gaps = 12/146 (8%)
Query: 57 LHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTV 116
LHSH +IHRD+K N+LLTE +KLADFG A S + + GT WMAPE+ +
Sbjct: 137 LHSHNMIHRDIKAGNILLTEP-GQVKLADFGSA---SKSSPANSFVGTPYWMAPEV--IL 190
Query: 117 TLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN--VP 174
+ +G+ Y+ KVD +S I EL K P M+ + A Y A +N P+ ++
Sbjct: 191 AMDEGQ---YDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-QNDSPTLQSNEWT 246
Query: 175 EELSIILTSCWKEDPNARPNFTQIIQ 200
+ + C ++ P RP ++++
Sbjct: 247 DSFRGFVDYCLQKIPQERPASAELLR 272
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 2e-14
Identities = 56/193 (29%), Positives = 94/193 (48%), Gaps = 15/193 (7%)
Query: 10 KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKP 69
K+ + I+ E L GG+ L P LD +I + ++ LHS IHRD+K
Sbjct: 73 KDTKLWIIMEYLGGGSALDLL---EPGPLDETQIATILREILKGLDYLHSEKKIHRDIKA 129
Query: 70 ENLLLTEDLKTIKLADFGLAREESLTEMMTAE-TGTYRWMAPELYSTVTLRQGEKKHYNH 128
N+LL+E +KLADFG+A + + T++ GT WMAPE+ ++ Y+
Sbjct: 130 ANVLLSEH-GEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI--------KQSAYDS 180
Query: 129 KVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAE-NVPEELSIILTSCWKE 187
K D +S I EL + P + ++ + KN P+ E N + L + +C +
Sbjct: 181 KADIWSLGITAIELAKGEPPHSELHPMKVLFLIP-KNNPPTLEGNYSKPLKEFVEACLNK 239
Query: 188 DPNARPNFTQIIQ 200
+P+ RP ++++
Sbjct: 240 EPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-14
Identities = 59/185 (31%), Positives = 98/185 (52%), Gaps = 20/185 (10%)
Query: 16 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 75
++ + ++GG L +L + R R + V I ++ +I A+E LH GII+RD+K EN+LL
Sbjct: 82 LILDYINGGELFTHL-SQRERFKEQEVQI-YSGEIVLALEHLHKLGIIYRDIKLENILLD 139
Query: 76 EDLKTIKLADFGLARE--ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSY 133
+ + L DFGL++E E E + GT +MAP++ +R G+ H + VD +
Sbjct: 140 SN-GHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDI-----VRGGDGGH-DKAVDWW 192
Query: 134 SFAIVLWELLHNKLPF--EGMSNLQAAYAAAFKNVRPSAENVPEELSI----ILTSCWKE 187
S ++++ELL PF +G N QA + + + S P+E+S I+ +
Sbjct: 193 SMGVLMYELLTGASPFTVDGEKNSQAEIS---RRILKSEPPYPQEMSALAKDIIQRLLMK 249
Query: 188 DPNAR 192
DP R
Sbjct: 250 DPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-14
Identities = 40/138 (28%), Positives = 73/138 (52%), Gaps = 9/138 (6%)
Query: 14 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 73
+ +V +++GG L+ ++ NM + A+ +A +I +E LH ++RDLKPEN+L
Sbjct: 75 LCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENIL 134
Query: 74 LTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSY 133
L +D I+++D GLA + E + GT +MAPE+ + + Y D +
Sbjct: 135 L-DDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNN--------QRYTLSPDYW 185
Query: 134 SFAIVLWELLHNKLPFEG 151
+++E++ + PF G
Sbjct: 186 GLGCLIYEMIEGQSPFRG 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 2e-14
Identities = 49/205 (23%), Positives = 97/205 (47%), Gaps = 26/205 (12%)
Query: 4 QFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 63
+ +G C P + +VT+L+ G L Y+ + + + + + + IA+ M L ++
Sbjct: 73 RLLGVCLSPTIQLVTQLMPHGCLLDYVHEHKDN-IGSQLLLNWCVQIAKGMMYLEERRLV 131
Query: 64 HRDLKPENLLLTEDLKTIKLADFGLAR-EESLTEMMTAETGTY--RWMAPELYSTVTLRQ 120
HRDL N+L+ +K+ DFGLAR E + A+ G +WMA E
Sbjct: 132 HRDLAARNVLVKSP-NHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI------- 183
Query: 121 GEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVRPSAENVPE---- 175
+ + H+ D +S+ + +WEL+ P++G+ + ++ E +P+
Sbjct: 184 -HYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE------IPDLLEKGERLPQPPIC 236
Query: 176 --ELSIILTSCWKEDPNARPNFTQI 198
++ +++ CW D ++RP F ++
Sbjct: 237 TIDVYMVMVKCWMIDADSRPKFKEL 261
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 3e-14
Identities = 63/225 (28%), Positives = 102/225 (45%), Gaps = 26/225 (11%)
Query: 16 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 75
+V E GG L LLN D +A + ++ A+ +H G +HRD+KPEN+L+
Sbjct: 78 LVMEYQPGGDLLS-LLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLI- 135
Query: 76 EDLKTIKLADFGLAREESLTEMMTAE--TGTYRWMAPELYSTVTLRQGEKKHYNHKVDSY 133
+ IKLADFG A + +M+ ++ GT ++APE+ + T+ K Y + D +
Sbjct: 136 DRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLT--TMNGDGKGTYGVECDWW 193
Query: 134 SFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARP 193
S ++ +E+++ + PF + A + N+ N L + EDP
Sbjct: 194 SLGVIAYEMIYGRSPFH-----EGTSAKTYNNIM----NFQRFLK------FPEDPKVSS 238
Query: 194 NFTQIIQMLLNYLSAIAPPEPMIPHRIF-----NSENTILPPESP 233
+F +IQ LL E + H F N+ LPP P
Sbjct: 239 DFLDLIQSLLCGQKERLGYEGLCCHPFFSKIDWNNIRNSLPPFVP 283
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 3e-14
Identities = 46/150 (30%), Positives = 72/150 (48%), Gaps = 12/150 (8%)
Query: 11 EPVMVIVTELLSGGTLRKYLLNMR---PRCLDVCVAIGFALDIARAMECLHSHGIIHRDL 67
+P + +V E L L+K++ + R L F + + + H HG++HRDL
Sbjct: 78 KPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDL 136
Query: 68 KPENLLLTEDLKTIKLADFGLAREESL-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 126
KP+NLL+ + +K+AD GL R S+ + T E T + APE+ T HY
Sbjct: 137 KPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGST-------HY 189
Query: 127 NHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 156
+ VD +S + E+ + F G S LQ
Sbjct: 190 STPVDIWSVGCIFAEMSRKQPLFPGDSELQ 219
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 3e-14
Identities = 58/220 (26%), Positives = 93/220 (42%), Gaps = 38/220 (17%)
Query: 46 FALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE-SLTEMMTAETGT 104
+ +I A+ LHS +++RDLK ENL+L +D IK+ DFGL +E S M GT
Sbjct: 100 YGAEIVSALGYLHSCDVVYRDLKLENLMLDKD-GHIKITDFGLCKEGISDGATMKTFCGT 158
Query: 105 YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFK 164
++APE+ E Y VD + +V++E++ +LPF + + +
Sbjct: 159 PEYLAPEVL--------EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME 210
Query: 165 NVR-PSAENVPEELSIILTSCWKEDPNAR--------------PNFTQIIQMLLNYLSAI 209
+R P + E +L K+DP R F I + +
Sbjct: 211 EIRFPR--TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQDV-VQKKL 267
Query: 210 APP-EPMIPH----RIFNSENT-----ILPPESPGTSSLM 239
PP +P + R F+ E T I PP+ + L+
Sbjct: 268 EPPFKPQVTSETDTRYFDEEFTAQSITITPPDRYDSLGLL 307
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 3e-14
Identities = 56/197 (28%), Positives = 87/197 (44%), Gaps = 25/197 (12%)
Query: 16 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 75
+ E ++GG++ L V I + + R + LH + IIHRD+K NLL+
Sbjct: 80 LFVEWMAGGSVSHLLSKYGA--FKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLID 137
Query: 76 EDLKTIKLADFGLAREESLTEMMTAE-----TGTYRWMAPELYSTVTLRQGEKKHYNHKV 130
+ +++ADFG A + E GT +MAPE+ LR GE+ Y
Sbjct: 138 STGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEV-----LR-GEQ--YGRSC 189
Query: 131 DSYSFAIVLWELLHNKLPF--EGMSN-LQAAYAAAFKNVRPSAENVPEELSI----ILTS 183
D +S V+ E+ K P+ E SN L + A PS +PE LS +
Sbjct: 190 DVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPS---IPEHLSPGLRDVTLR 246
Query: 184 CWKEDPNARPNFTQIIQ 200
C + P RP ++++
Sbjct: 247 CLELQPEDRPPSRELLK 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-14
Identities = 51/134 (38%), Positives = 73/134 (54%), Gaps = 12/134 (8%)
Query: 17 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE 76
V + ++GG L +L R RC A +A ++A A+ LHS II+RDLKPEN+LL
Sbjct: 74 VLDYVNGGELFFHL--QRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDS 131
Query: 77 DLKTIKLADFGLAREESLTEMMTAE-TGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSF 135
+ L DFGL +E E T+ GT ++APE+ LR K+ Y+ VD +
Sbjct: 132 QGHVV-LTDFGLCKEGVEPEETTSTFCGTPEYLAPEV-----LR---KEPYDRTVDWWCL 182
Query: 136 AIVLWELLHNKLPF 149
VL+E+L+ PF
Sbjct: 183 GAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 4e-14
Identities = 44/152 (28%), Positives = 80/152 (52%), Gaps = 12/152 (7%)
Query: 53 AMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT---EMMTAETGTYRWMA 109
A+ +HS +IHRD+K N+LL + +KL DFG ++ + T ++ GT ++A
Sbjct: 155 AVHHVHSKHMIHRDIKSANILLCSN-GLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVA 213
Query: 110 PELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS 169
PE++ +K Y+ K D +S ++L+ELL K PF+G + + + P
Sbjct: 214 PEIW--------RRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPL 265
Query: 170 AENVPEELSIILTSCWKEDPNARPNFTQIIQM 201
++ E+ I+T+ DP RP+ ++++ M
Sbjct: 266 PPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297
|
Length = 496 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 4e-14
Identities = 52/151 (34%), Positives = 76/151 (50%), Gaps = 16/151 (10%)
Query: 57 LHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTV 116
LHSH +IHRD+K N+LL+E +KL DFG A S+ GT WMAPE+ +
Sbjct: 131 LHSHNMIHRDVKAGNILLSEP-GLVKLGDFGSA---SIMAPANXFVGTPYWMAPEV--IL 184
Query: 117 TLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP--SAENVP 174
+ +G+ Y+ KVD +S I EL K P M+ + A Y A +N P + +
Sbjct: 185 AMDEGQ---YDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-QNESPALQSGHWS 240
Query: 175 EELSIILTSCWKEDPNARPNFTQIIQMLLNY 205
E + SC ++ P RP ++LL +
Sbjct: 241 EYFRNFVDSCLQKIPQDRPT----SEVLLKH 267
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 5e-14
Identities = 58/212 (27%), Positives = 99/212 (46%), Gaps = 31/212 (14%)
Query: 16 IVTELLSGGTLRKYLLNMR---PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENL 72
+V E L GG L + + R + VC L + RA+ LH+ G+IHRD+K +++
Sbjct: 96 VVMEFLEGGALTDIVTHTRMNEEQIATVC------LSVLRALSYLHNQGVIHRDIKSDSI 149
Query: 73 LLTEDLKTIKLADFGL-AREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVD 131
LLT D + IKL+DFG A+ + GT WMAPE+ S + Y +VD
Sbjct: 150 LLTSDGR-IKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLP--------YGTEVD 200
Query: 132 SYSFAIVLWELLH------NKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCW 185
+S I++ E++ N+ P + M ++ K+ + + L ++L
Sbjct: 201 IWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLV--- 257
Query: 186 KEDPNARPNFTQIIQMLLNYLSAIAPPEPMIP 217
+P+ R +++Q +L PP ++P
Sbjct: 258 -REPSQRATAQELLQH--PFLKLAGPPSCIVP 286
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 6e-14
Identities = 49/187 (26%), Positives = 88/187 (47%), Gaps = 22/187 (11%)
Query: 14 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 73
+ +V L++GG L+ ++ +M + A+ +A +I +E LH I++RDLKPEN+L
Sbjct: 75 LCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENIL 134
Query: 74 LTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSY 133
L +D I+++D GLA + + GT +MAPE+ + + Y D +
Sbjct: 135 L-DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV--------KNERYTFSPDWW 185
Query: 134 SFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWK------- 186
+ +L+E++ + PF+ Q + V + V EE S + +
Sbjct: 186 ALGCLLYEMIAGQSPFQ-----QRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLL 240
Query: 187 -EDPNAR 192
+DP R
Sbjct: 241 CKDPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 6e-14
Identities = 43/141 (30%), Positives = 69/141 (48%), Gaps = 14/141 (9%)
Query: 14 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 73
V+V E + L + L + R L + + + + +H++GI+HRDLKP NLL
Sbjct: 74 FVLVMEYM-PSDLSEVLRD-EERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLL 131
Query: 74 LTEDLKTIKLADFGLAR--EESLTEMMTAETGTYRWMAPE-LYSTVTLRQGEKKHYNHKV 130
++ D +K+ADFGLAR E + + + T + APE LY + Y+ V
Sbjct: 132 ISAD-GVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYG--------ARKYDPGV 182
Query: 131 DSYSFAIVLWELLHNKLPFEG 151
D ++ + ELL+ F G
Sbjct: 183 DLWAVGCIFAELLNGSPLFPG 203
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 6e-14
Identities = 49/207 (23%), Positives = 88/207 (42%), Gaps = 16/207 (7%)
Query: 4 QFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 63
+ IG C+ ++V EL G L K+L + + + ++ M+ L +
Sbjct: 60 RMIGICEAESWMLVMELAELGPLNKFL--QKNKHVTEKNITELVHQVSMGMKYLEETNFV 117
Query: 64 HRDLKPENLLLTEDLKTIKLADFGLAR----EESLTEMMTAETGTYRWMAPELYSTVTLR 119
HRDL N+LL K++DFGL++ +E+ + T +W APE +
Sbjct: 118 HRDLAARNVLLVTQ-HYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYK-- 174
Query: 120 QGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELS 178
++ K D +SF +++WE + + P++GM + + P E+
Sbjct: 175 ------FSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMY 228
Query: 179 IILTSCWKEDPNARPNFTQIIQMLLNY 205
++ CW + RP F + L NY
Sbjct: 229 DLMKLCWTYGVDERPGFAVVELRLRNY 255
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 8e-14
Identities = 50/151 (33%), Positives = 76/151 (50%), Gaps = 15/151 (9%)
Query: 57 LHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET---GTYRWMAPELY 113
LH G IHRD+K N+LLTED +KLADFG++ + LT + GT WMAPE+
Sbjct: 117 LHETGKIHRDIKGANILLTED-GDVKLADFGVSAQ--LTATIAKRKSFIGTPYWMAPEVA 173
Query: 114 STVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENV 173
+ V + G Y+ K D ++ I EL + P + ++A + + N P
Sbjct: 174 A-VERKGG----YDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKD 228
Query: 174 PEELSII----LTSCWKEDPNARPNFTQIIQ 200
E+ S + + C +DP RP T+++Q
Sbjct: 229 KEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 8e-14
Identities = 39/95 (41%), Positives = 52/95 (54%), Gaps = 9/95 (9%)
Query: 57 LHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTV 116
LHS GIIHRDLKP N+++ D T+K+ DFGLAR + MMT T + APE V
Sbjct: 134 LHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPE----V 188
Query: 117 TLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 151
L G Y VD +S ++ E++ + F G
Sbjct: 189 ILGMG----YKENVDIWSVGCIMGEMIRGTVLFPG 219
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 9e-14
Identities = 40/112 (35%), Positives = 67/112 (59%), Gaps = 12/112 (10%)
Query: 42 VAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAE 101
A+ +A +IA + LHS GII+RDLK +N++L + IK+ADFG+ + E++ T
Sbjct: 102 HAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAE-GHIKIADFGMCK-ENIFGGKTTR 159
Query: 102 T--GTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 151
T GT ++APE+ + + Y VD ++F ++L+E+L + PF+G
Sbjct: 160 TFCGTPDYIAPEIIAY--------QPYGKSVDWWAFGVLLYEMLAGQPPFDG 203
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 9e-14
Identities = 42/136 (30%), Positives = 72/136 (52%), Gaps = 9/136 (6%)
Query: 14 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 73
+ +V +++GG L+ ++ NM D AI +A ++ +E L I++RDLKPEN+L
Sbjct: 75 LCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENIL 134
Query: 74 LTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSY 133
L +D I+++D GLA + E + GT +MAPE+ EK Y D +
Sbjct: 135 L-DDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVI------NNEK--YTFSPDWW 185
Query: 134 SFAIVLWELLHNKLPF 149
+++E++ + PF
Sbjct: 186 GLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-13
Identities = 51/188 (27%), Positives = 91/188 (48%), Gaps = 12/188 (6%)
Query: 14 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 73
+ IV E GG L + + R + + + + + ++ +H ++HRD+K +N+
Sbjct: 73 LYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIF 132
Query: 74 LTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNHKVD 131
LT++ K +KL DFG AR + + A T GT ++ PE++ E YN+K D
Sbjct: 133 LTQNGK-VKLGDFGSARLLT-SPGAYACTYVGTPYYVPPEIW--------ENMPYNNKSD 182
Query: 132 SYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNA 191
+S +L+EL K PF+ S + +P + EL ++ +K +P +
Sbjct: 183 IWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFKRNPRS 242
Query: 192 RPNFTQII 199
RP+ T I+
Sbjct: 243 RPSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-13
Identities = 53/187 (28%), Positives = 89/187 (47%), Gaps = 15/187 (8%)
Query: 16 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 75
I+ E L GG+ L +P L+ +I + ++ LHS IHRD+K N+LL+
Sbjct: 79 IIMEYLGGGSALDLL---KPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLS 135
Query: 76 EDLKTIKLADFGLAREESLTEMM-TAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYS 134
E +KLADFG+A + + T++ GT WMAPE+ ++ Y+ K D +S
Sbjct: 136 EQ-GDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI--------KQSAYDFKADIWS 186
Query: 135 FAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAE-NVPEELSIILTSCWKEDPNARP 193
I EL + P + ++ + KN P+ E + + +C +DP RP
Sbjct: 187 LGITAIELAKGEPPNSDLHPMRVLFLIP-KNSPPTLEGQYSKPFKEFVEACLNKDPRFRP 245
Query: 194 NFTQIIQ 200
++++
Sbjct: 246 TAKELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-13
Identities = 39/100 (39%), Positives = 55/100 (55%), Gaps = 10/100 (10%)
Query: 52 RAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPE 111
R ++ +HS GIIHRDLKP N+ + ED + +++ DFGLAR+ + MT T + APE
Sbjct: 129 RGLKYIHSAGIIHRDLKPSNVAVNEDCE-LRILDFGLARQAD--DEMTGYVATRWYRAPE 185
Query: 112 LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 151
+ HYN VD +S ++ ELL K F G
Sbjct: 186 IMLNWM-------HYNQTVDIWSVGCIMAELLKGKALFPG 218
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 1e-13
Identities = 52/208 (25%), Positives = 99/208 (47%), Gaps = 17/208 (8%)
Query: 4 QFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 63
+ IG C+ +++V E+ SGG L K+L + + V + ++ M+ L +
Sbjct: 59 RMIGVCEAEALMLVMEMASGGPLNKFLSGKKDE-ITVSNVVELMHQVSMGMKYLEGKNFV 117
Query: 64 HRDLKPENLLLTEDLKTIKLADFGLAR----EESLTEMMTAETGTYRWMAPELYSTVTLR 119
HRDL N+LL K++DFGL++ ++S + +A +W APE + R
Sbjct: 118 HRDLAARNVLLVNQ-HYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPE---CINFR 173
Query: 120 QGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQA-AYAAAFKNVRPSAENVPEEL 177
+ ++ + D +S+ I +WE + + P++ M + ++ K + AE P E+
Sbjct: 174 K-----FSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAE-CPPEM 227
Query: 178 SIILTSCWKEDPNARPNFTQIIQMLLNY 205
++ CW RPNF ++ + + Y
Sbjct: 228 YALMKDCWIYKWEDRPNFAKVEERMRTY 255
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 1e-13
Identities = 57/210 (27%), Positives = 96/210 (45%), Gaps = 27/210 (12%)
Query: 4 QFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI 62
Q++G C + + I E + GG++ L P L V + I + LH++ +
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGP--LPEPVFCKYTKQILDGVAYLHNNCV 123
Query: 63 IHRDLKPENLLLTEDLKTIKLADFGLARE-------ESLTEMMTAETGTYRWMAPELYST 115
+HRD+K N++L + IKL DFG AR + + M+ + GT WMAPE+ +
Sbjct: 124 VHRDIKGNNVMLMPN-GIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVIN- 181
Query: 116 VTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYA-AAFKNVRPSAENVP 174
+ Y K D +S ++E+ K P M L A + A + + P +P
Sbjct: 182 -------ESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPR---LP 231
Query: 175 EELSI----ILTSCWKEDPNARPNFTQIIQ 200
+ S +TSC D + RP+ Q+++
Sbjct: 232 DSFSAAAIDFVTSCLTRDQHERPSALQLLR 261
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 1e-13
Identities = 65/242 (26%), Positives = 104/242 (42%), Gaps = 38/242 (15%)
Query: 14 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 73
+ V E ++GG L ++ + R D A +A +I A+ LH GII+RDLK +N+L
Sbjct: 71 LFFVMEFVNGGDLMFHI--QKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVL 128
Query: 74 LTEDLKTIKLADFGLAREESLTEMMTAE-TGTYRWMAPELYSTVTLRQGEKKHYNHKVDS 132
L + KLADFG+ +E T+ GT ++APE+ ++ Y VD
Sbjct: 129 LDHE-GHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEIL--------QEMLYGPSVDW 179
Query: 133 YSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNAR 192
++ ++L+E+L PFE N + A + + ++ IL + ++P R
Sbjct: 180 WAMGVLLYEMLCGHAPFEA-ENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTMR 238
Query: 193 ---------------PNFTQIIQMLLNYLSAIAPP-EPMIPHR--------IFNSENTIL 228
P F ++ LN I PP P I R F E+ +L
Sbjct: 239 LGSLTLGGEEAILRHPFFKELDWEKLNR-RQIEPPFRPRIKSREDVSNFDPDFIKEDPVL 297
Query: 229 PP 230
P
Sbjct: 298 TP 299
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-13
Identities = 52/181 (28%), Positives = 90/181 (49%), Gaps = 15/181 (8%)
Query: 14 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 73
+ V E ++GG L +L R R + +I A++ LHS I++RDLK ENL+
Sbjct: 70 LCFVMEYVNGGELFFHL--SRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLM 127
Query: 74 LTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNHKVD 131
L +D IK+ DFGL + E +T+ T +T GT ++APE+ E Y VD
Sbjct: 128 LDKD-GHIKITDFGLCK-EGITDAATMKTFCGTPEYLAPEVL--------EDNDYGRAVD 177
Query: 132 SYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNA 191
+ +V++E++ +LPF + + ++++ + + +L+ +DPN
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIK-FPRTLSADAKSLLSGLLIKDPNK 236
Query: 192 R 192
R
Sbjct: 237 R 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 2e-13
Identities = 51/187 (27%), Positives = 75/187 (40%), Gaps = 45/187 (24%)
Query: 50 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY---R 106
+ +A+ HSH IIHRD+KPEN+L++E +KL DFG AR +L + Y R
Sbjct: 109 LLQAIAYCHSHNIIHRDIKPENILVSESG-VLKLCDFGFAR--ALRARPASPLTDYVATR 165
Query: 107 WM-APELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY------ 159
W APEL T +Y VD ++ ++ ELL + F G S++ Y
Sbjct: 166 WYRAPELLVGDT-------NYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCL 218
Query: 160 --------AAAFKNVRPSAENVPEELSII-----------------LTSCWKEDPNARPN 194
N R + PE L +C + DP R
Sbjct: 219 GPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLT 278
Query: 195 FTQIIQM 201
+++Q
Sbjct: 279 CDELLQH 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 2e-13
Identities = 50/138 (36%), Positives = 71/138 (51%), Gaps = 14/138 (10%)
Query: 16 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 75
++ E LSGG L +L R A + +I+ A+E LH GII+RDLKPEN+LL
Sbjct: 77 LILEYLSGGELFMHL--EREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLD 134
Query: 76 EDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNHKVDSY 133
+KL DFGL + ES+ E T GT +MAPE+ R G + VD +
Sbjct: 135 AQ-GHVKLTDFGLCK-ESIHEGTVTHTFCGTIEYMAPEILM----RSG----HGKAVDWW 184
Query: 134 SFAIVLWELLHNKLPFEG 151
S +++++L PF
Sbjct: 185 SLGALMYDMLTGAPPFTA 202
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-13
Identities = 43/135 (31%), Positives = 73/135 (54%), Gaps = 12/135 (8%)
Query: 17 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE 76
V E ++GG L + R R D + +A ++ A+ LH HG+I+RDLK +N+LL
Sbjct: 74 VMEYVNGGDLMFQI--QRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDA 131
Query: 77 DLKTIKLADFGLAREESLTEMMTAE-TGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSF 135
+ KLADFG+ +E L + T GT ++APE+ ++ Y VD ++
Sbjct: 132 E-GHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEIL--------QELEYGPSVDWWAL 182
Query: 136 AIVLWELLHNKLPFE 150
++++E++ + PFE
Sbjct: 183 GVLMYEMMAGQPPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-13
Identities = 40/106 (37%), Positives = 56/106 (52%), Gaps = 10/106 (9%)
Query: 50 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMA 109
I R ++ +HS IIHRDLKP NL + ED + +K+ DFGLAR + MT T + A
Sbjct: 129 ILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLARHTD--DEMTGYVATRWYRA 185
Query: 110 PELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL 155
PE+ HYN VD +S ++ ELL + F G ++
Sbjct: 186 PEIMLNWM-------HYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 224
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 3e-13
Identities = 49/152 (32%), Positives = 72/152 (47%), Gaps = 15/152 (9%)
Query: 4 QFIGACKEP---VMVIVTELLSGGTLRKYLLNMRPRCLDVC--VAIGFALDIARAMECLH 58
++ GA + + I E GG+L ++ R + V A + + + LH
Sbjct: 63 KYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH 122
Query: 59 SHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTL 118
S IIHRD+KP N+LLT +KL DFG++ E + T TGT +MAPE
Sbjct: 123 SRKIIHRDIKPSNILLTRK-GQVKLCDFGVSGELVNSLAGTF-TGTSFYMAPERI----- 175
Query: 119 RQGEKKHYNHKVDSYSFAIVLWELLHNKLPFE 150
QG K Y+ D +S + L E+ N+ PF
Sbjct: 176 -QG--KPYSITSDVWSLGLTLLEVAQNRFPFP 204
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 3e-13
Identities = 39/111 (35%), Positives = 57/111 (51%), Gaps = 8/111 (7%)
Query: 46 FALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL-TEMMTAETGT 104
+ I R + HSH ++HRDLKP+NLL+ +KLADFGLAR + T E T
Sbjct: 107 YLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVT 166
Query: 105 YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL 155
+ APE+ +HY+ VD +S + E+++ K F G S +
Sbjct: 167 LWYRAPEILLG-------SRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI 210
|
Length = 294 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 4e-13
Identities = 37/109 (33%), Positives = 60/109 (55%), Gaps = 7/109 (6%)
Query: 43 AIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET 102
A + ++ A++ +HS G IHRD+KP+N+LL + +KLADFG + M+ +T
Sbjct: 144 ARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKS-GHLKLADFGTCMKMDANGMVRCDT 202
Query: 103 --GTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPF 149
GT +++PE V QG +Y + D +S + L+E+L PF
Sbjct: 203 AVGTPDYISPE----VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 4e-13
Identities = 40/110 (36%), Positives = 65/110 (59%), Gaps = 10/110 (9%)
Query: 43 AIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAE- 101
A+ +A +IA + LHS GII+RDLK +N++L + IK+ADFG+ +E + T
Sbjct: 103 AVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSE-GHIKIADFGMCKENMWDGVTTKTF 161
Query: 102 TGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 151
GT ++APE+ + + Y VD ++F ++L+E+L + PFEG
Sbjct: 162 CGTPDYIAPEIIAY--------QPYGKSVDWWAFGVLLYEMLAGQAPFEG 203
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 5e-13
Identities = 48/161 (29%), Positives = 69/161 (42%), Gaps = 19/161 (11%)
Query: 16 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 75
+V E L+GG + + L A + ++ +E LH GIIHRD+KPENLL+
Sbjct: 74 LVMEYLNGGDCASLIKTLGG--LPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLID 131
Query: 76 EDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSF 135
+ +KL DFGL+R GT ++APE + D +S
Sbjct: 132 QT-GHLKLTDFGLSR---NGLENKKFVGTPDYLAPETI--------LGVGDDKMSDWWSL 179
Query: 136 AIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEE 176
V++E L PF + A F N+ N PEE
Sbjct: 180 GCVIFEFLFGYPPFHAETP-----DAVFDNILSRRINWPEE 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 6e-13
Identities = 43/113 (38%), Positives = 56/113 (49%), Gaps = 18/113 (15%)
Query: 46 FALDIARAMECLHSHGIIHRDLKPENLLLTE--DLKTIKLADFGLAR----EESLTEMMT 99
F I R ++ +HS ++HRDLKP NLLL DL K+ DFGLAR E T +T
Sbjct: 111 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDL---KICDFGLARIADPEHDHTGFLT 167
Query: 100 AETGTYRWM-APELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 151
T RW APE+ K Y +D +S +L E+L N+ F G
Sbjct: 168 EYVAT-RWYRAPEIMLN-------SKGYTKAIDIWSVGCILAEMLSNRPLFPG 212
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 6e-13
Identities = 56/195 (28%), Positives = 92/195 (47%), Gaps = 22/195 (11%)
Query: 16 IVTELLSGGTLRKYLLNM-----RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPE 70
I+ E GG + +L + P+ +C + A++ LHS IIHRDLK
Sbjct: 86 IMIEFCPGGAVDAIMLELDRGLTEPQIQVIC------RQMLEALQYLHSMKIIHRDLKAG 139
Query: 71 NLLLTEDLKTIKLADFGLAREESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK 129
N+LLT D IKLADFG++ + T + + GT WMAPE+ T++ Y++K
Sbjct: 140 NVLLTLD-GDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTP---YDYK 195
Query: 130 VDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSI----ILTSCW 185
D +S I L E+ + P ++ ++ A P + P + S+ L +
Sbjct: 196 ADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA--KSEPPTLSQPSKWSMEFRDFLKTAL 253
Query: 186 KEDPNARPNFTQIIQ 200
+ P RP+ Q+++
Sbjct: 254 DKHPETRPSAAQLLE 268
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 6e-13
Identities = 47/137 (34%), Positives = 74/137 (54%), Gaps = 12/137 (8%)
Query: 14 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 73
+ V + ++GG L +L R R A +A +IA A+ LHS I++RDLKPEN+L
Sbjct: 71 LYFVLDFVNGGELFFHL--QRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENIL 128
Query: 74 LTEDLKTIKLADFGLAREE-SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDS 132
L + + L DFGL +E + ++ T GT ++APE+ K+ Y++ VD
Sbjct: 129 L-DSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVI--------RKQPYDNTVDW 179
Query: 133 YSFAIVLWELLHNKLPF 149
+ VL+E+L+ PF
Sbjct: 180 WCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 6e-13
Identities = 52/173 (30%), Positives = 89/173 (51%), Gaps = 17/173 (9%)
Query: 11 EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCV--AIGFALDIARAMECLHSHGIIHRDLK 68
+ + +V E + GG L + N DV A + ++ A++ +HS G+IHRD+K
Sbjct: 115 DKYLYMVMEYMPGGDLVNLMSNY-----DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVK 169
Query: 69 PENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHY 126
P+N+LL + +KLADFG + T M+ +T GT +++PE+ + QG +Y
Sbjct: 170 PDNMLL-DKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKS----QGGDGYY 224
Query: 127 NHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSI 179
+ D +S + L+E+L PF S L Y+ + ++ N PE++ I
Sbjct: 225 GRECDWWSVGVFLFEMLVGDTPFYADS-LVGTYSKIMDH--KNSLNFPEDVEI 274
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.8 bits (164), Expect = 6e-13
Identities = 40/108 (37%), Positives = 57/108 (52%), Gaps = 18/108 (16%)
Query: 50 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAE------TG 103
+ ++ LHS+GI+HRD+K N+L+ D +KLADFGLAR T+ +A+ T
Sbjct: 109 LLEGLQYLHSNGILHRDIKGSNILINND-GVLKLADFGLAR--PYTKRNSADYTNRVITL 165
Query: 104 TYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 151
YR PEL G + Y +VD +S +L EL K F+G
Sbjct: 166 WYR--PPELL------LGATR-YGPEVDMWSVGCILAELFLGKPIFQG 204
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 7e-13
Identities = 49/137 (35%), Positives = 72/137 (52%), Gaps = 12/137 (8%)
Query: 14 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 73
+ V + ++GG L +L R RC A +A +IA A+ LHS I++RDLKPEN+L
Sbjct: 71 LYFVLDYINGGELFYHL--QRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENIL 128
Query: 74 LTEDLKTIKLADFGLAREESLTEMMTAE-TGTYRWMAPELYSTVTLRQGEKKHYNHKVDS 132
L + I L DFGL +E T+ GT ++APE+ K+ Y+ VD
Sbjct: 129 L-DSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVL--------HKQPYDRTVDW 179
Query: 133 YSFAIVLWELLHNKLPF 149
+ VL+E+L+ PF
Sbjct: 180 WCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 7e-13
Identities = 43/144 (29%), Positives = 80/144 (55%), Gaps = 22/144 (15%)
Query: 14 MVIVTELLSGGTLRKYLLNM----RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKP 69
+ V E ++GG L ++ + P+ A+ +A +I+ + LH GII+RDLK
Sbjct: 76 LYFVMEYVNGGDLMYHIQQVGKFKEPQ------AVFYAAEISVGLFFLHRRGIIYRDLKL 129
Query: 70 ENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYN 127
+N++L + IK+ADFG+ + E + + +T T GT ++APE+ + + Y
Sbjct: 130 DNVMLDSE-GHIKIADFGMCK-EHMVDGVTTRTFCGTPDYIAPEIIAY--------QPYG 179
Query: 128 HKVDSYSFAIVLWELLHNKLPFEG 151
VD +++ ++L+E+L + PF+G
Sbjct: 180 KSVDWWAYGVLLYEMLAGQPPFDG 203
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 8e-13
Identities = 44/133 (33%), Positives = 67/133 (50%), Gaps = 11/133 (8%)
Query: 48 LDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRW 107
+ R ++ LHSH ++HRDLKP+N+L+T IKLADFGLAR S +T+ T +
Sbjct: 117 FQLLRGLDFLHSHRVVHRDLKPQNILVTSS-GQIKLADFGLARIYSFQMALTSVVVTLWY 175
Query: 108 MAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR 167
APE+ L Q Y VD +S + E+ K F G S++ +
Sbjct: 176 RAPEV-----LLQSS---YATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDVIG 226
Query: 168 -PSAENVPEELSI 179
P E+ P ++++
Sbjct: 227 LPGEEDWPRDVAL 239
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 9e-13
Identities = 46/123 (37%), Positives = 61/123 (49%), Gaps = 19/123 (15%)
Query: 39 DVCVAIGFALDIAR------AMEC----LHSHGIIHRDLKPENLLLTEDLKTIKLADFGL 88
++C I LD R M C LHS GIIHRDLKP N+++ D T+K+ DFGL
Sbjct: 114 NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGL 172
Query: 89 AREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLP 148
AR + MMT T + APE V L G Y VD +S ++ E++ +
Sbjct: 173 ARTAGTSFMMTPYVVTRYYRAPE----VILGMG----YKENVDIWSVGCIMGEMIKGGVL 224
Query: 149 FEG 151
F G
Sbjct: 225 FPG 227
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 1e-12
Identities = 36/108 (33%), Positives = 57/108 (52%), Gaps = 11/108 (10%)
Query: 42 VAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAE 101
VA + ++ A E LHS II+RDLKPENLLL +K+ DFG A++ + +
Sbjct: 119 VAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNK-GHVKVTDFGFAKK--VPDRTFTL 175
Query: 102 TGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPF 149
GT ++APE+ + K + VD ++ ++L+E + PF
Sbjct: 176 CGTPEYLAPEVI--------QSKGHGKAVDWWTMGVLLYEFIAGYPPF 215
|
Length = 329 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-12
Identities = 51/186 (27%), Positives = 84/186 (45%), Gaps = 13/186 (6%)
Query: 16 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 75
I+ E L GG+ L R D +I + ++ LHS IHRD+K N+LL+
Sbjct: 79 IIMEYLGGGSALDLL---RAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLS 135
Query: 76 EDLKTIKLADFGLAREESLTEMMTAE-TGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYS 134
E +KLADFG+A + + T++ GT WMAPE+ ++ Y+ K D +S
Sbjct: 136 EQ-GDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI--------QQSAYDSKADIWS 186
Query: 135 FAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPN 194
I EL + P M ++ + N + + +C +DP+ RP
Sbjct: 187 LGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPT 246
Query: 195 FTQIIQ 200
++++
Sbjct: 247 AKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-12
Identities = 58/213 (27%), Positives = 97/213 (45%), Gaps = 33/213 (15%)
Query: 16 IVTELLSGGTLRKYLLNMR---PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENL 72
++ E L GG L + R + VC ++ +A+ LHS G+IHRD+K +++
Sbjct: 95 VLMEFLQGGALTDIVSQTRLNEEQIATVCESV------LQALCYLHSQGVIHRDIKSDSI 148
Query: 73 LLTEDLKTIKLADFGLAREESL-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVD 131
LLT D + +KL+DFG + S + GT WMAPE+ S + Y +VD
Sbjct: 149 LLTLDGR-VKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVIS--------RTPYGTEVD 199
Query: 132 SYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR----PSAEN---VPEELSIILTSC 184
+S I++ E++ + P+ S +Q A K +R P +N + L L
Sbjct: 200 IWSLGIMVIEMVDGEPPYFSDSPVQ-----AMKRLRDSPPPKLKNAHKISPVLRDFLERM 254
Query: 185 WKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIP 217
+P R +++ +L PE ++P
Sbjct: 255 LTREPQERATAQELLDH--PFLLQTGLPECLVP 285
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 2e-12
Identities = 38/107 (35%), Positives = 53/107 (49%), Gaps = 9/107 (8%)
Query: 46 FALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT-EMMTAETGT 104
F + R ++ +HS ++HRDLKP NLLL + +K+ DFGLAR S + MT T
Sbjct: 113 FLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARTTSEKGDFMTEYVVT 171
Query: 105 YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 151
+ APEL + Y +D +S + ELL K F G
Sbjct: 172 RWYRAPELLLNCS-------EYTTAIDVWSVGCIFAELLGRKPLFPG 211
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-12
Identities = 53/192 (27%), Positives = 89/192 (46%), Gaps = 15/192 (7%)
Query: 16 IVTELLSGGTLRKYLLNMRP--RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 73
IV EL G L + + + + R + + + + A+E +HS ++HRD+KP N+
Sbjct: 79 IVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVF 138
Query: 74 LTEDLKTIKLADFGLAR-EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDS 132
+T +KL D GL R S T + GT +M+PE + + YN K D
Sbjct: 139 ITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE--------RIHENGYNFKSDI 189
Query: 133 YSFAIVLWELLHNKLPFEG-MSNLQAAYAAAFKNVRP--SAENVPEELSIILTSCWKEDP 189
+S +L+E+ + PF G NL + + P +++ EEL ++ C DP
Sbjct: 190 WSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDP 249
Query: 190 NARPNFTQIIQM 201
RP+ T + +
Sbjct: 250 EKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-12
Identities = 40/99 (40%), Positives = 54/99 (54%), Gaps = 9/99 (9%)
Query: 57 LHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTV 116
LHS GIIHRDLKP N+++ D T+K+ DFGLAR MMT T + APE V
Sbjct: 139 LHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTACTNFMMTPYVVTRYYRAPE----V 193
Query: 117 TLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL 155
L G Y VD +S ++ EL+ + F+G ++
Sbjct: 194 ILGMG----YKENVDIWSVGCIMGELVKGSVIFQGTDHI 228
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-12
Identities = 55/182 (30%), Positives = 89/182 (48%), Gaps = 16/182 (8%)
Query: 14 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH-GIIHRDLKPENL 72
+ V E +GG L +L R R A + +I A++ LHS +++RDLK ENL
Sbjct: 70 LCFVMEYANGGELFFHL--SRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENL 127
Query: 73 LLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNHKV 130
+L +D IK+ DFGL + E + + T +T GT ++APE+ E Y V
Sbjct: 128 MLDKD-GHIKITDFGLCK-EGIKDGATMKTFCGTPEYLAPEVL--------EDNDYGRAV 177
Query: 131 DSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPN 190
D + +V++E++ +LPF + + + +R PE S +L+ K+DP
Sbjct: 178 DWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKS-LLSGLLKKDPK 236
Query: 191 AR 192
R
Sbjct: 237 QR 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-12
Identities = 39/136 (28%), Positives = 70/136 (51%), Gaps = 13/136 (9%)
Query: 17 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE 76
V E +GG L ++++ A+ +A + ++ LH + I++RDLK +NLLL
Sbjct: 80 VMEYAAGGDL---MMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDT 136
Query: 77 DLKTIKLADFGLAREESLTEMMTAE-TGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSF 135
+ +K+ADFGL +E T+ GT ++APE+ + + Y VD +
Sbjct: 137 E-GFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLT--------ETSYTRAVDWWGL 187
Query: 136 AIVLWELLHNKLPFEG 151
++++E+L + PF G
Sbjct: 188 GVLIYEMLVGESPFPG 203
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 3e-12
Identities = 47/123 (38%), Positives = 63/123 (51%), Gaps = 19/123 (15%)
Query: 39 DVCVAIGFALDIAR------AMEC----LHSHGIIHRDLKPENLLLTEDLKTIKLADFGL 88
++C I LD R M C LHS GIIHRDLKP N+++ D T+K+ DFGL
Sbjct: 107 NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGL 165
Query: 89 AREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLP 148
AR + MMT T + APE V L G Y VD +S ++ E++ +K+
Sbjct: 166 ARTAGTSFMMTPYVVTRYYRAPE----VILGMG----YKENVDIWSVGCIMGEMVRHKIL 217
Query: 149 FEG 151
F G
Sbjct: 218 FPG 220
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 3e-12
Identities = 49/188 (26%), Positives = 87/188 (46%), Gaps = 8/188 (4%)
Query: 16 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 75
+V E G++ + N + L +I R + LH H +IHRD+K +N+LLT
Sbjct: 86 LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT 145
Query: 76 EDLKTIKLADFGL-AREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYS 134
E+ + +KL DFG+ A+ + GT WMAPE+ + + Y+ K D +S
Sbjct: 146 ENAE-VKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEV---IACDENPDATYDFKSDLWS 201
Query: 135 FAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP--SAENVPEELSIILTSCWKEDPNAR 192
I E+ P M ++A + +N P ++ ++ + SC ++ + R
Sbjct: 202 LGITAIEMAEGAPPLCDMHPMRALFLIP-RNPAPRLKSKKWSKKFQSFIESCLVKNHSQR 260
Query: 193 PNFTQIIQ 200
P Q+++
Sbjct: 261 PTTEQLMK 268
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 3e-12
Identities = 44/117 (37%), Positives = 62/117 (52%), Gaps = 11/117 (9%)
Query: 53 AMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAP 110
A+E LH + I++RDLKPEN+LL I L DFGL++ LT+ T T GT ++AP
Sbjct: 108 ALEHLHKYDIVYRDLKPENILLDAT-GHIALCDFGLSKAN-LTDNKTTNTFCGTTEYLAP 165
Query: 111 ELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR 167
E V L ++K Y VD +S ++++E+ PF Q AF VR
Sbjct: 166 E----VLL---DEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVR 215
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 3e-12
Identities = 42/114 (36%), Positives = 58/114 (50%), Gaps = 9/114 (7%)
Query: 45 GFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAETG 103
L + R ++ LH + IIHRDLK NLLLT D +K+ADFGLAR + MT +
Sbjct: 112 CLMLQLLRGLQYLHENFIIHRDLKVSNLLLT-DKGCLKIADFGLARTYGLPAKPMTPKVV 170
Query: 104 TYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA 157
T + APEL T Y +D ++ +L ELL +K G S ++
Sbjct: 171 TLWYRAPELLLGCT-------TYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQ 217
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-12
Identities = 57/194 (29%), Positives = 92/194 (47%), Gaps = 20/194 (10%)
Query: 16 IVTELLSGGTLRKYLLNMR-----PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPE 70
I+ E +GG + +L + P+ VC A+ LH + IIHRDLK
Sbjct: 79 ILIEFCAGGAVDAVMLELERPLTEPQIRVVCK------QTLEALNYLHENKIIHRDLKAG 132
Query: 71 NLLLTEDLKTIKLADFGLAREESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK 129
N+L T D IKLADFG++ + + T + + GT WMAPE+ V + + Y++K
Sbjct: 133 NILFTLD-GDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEV---VMCETSKDRPYDYK 188
Query: 130 VDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPE---ELSIILTSCWK 186
D +S I L E+ + P ++ ++ A K+ P+ E L C +
Sbjct: 189 ADVWSLGITLIEMAQIEPPHHELNPMRVLLKIA-KSEPPTLAQPSRWSSEFKDFLKKCLE 247
Query: 187 EDPNARPNFTQIIQ 200
++ +AR TQ++Q
Sbjct: 248 KNVDARWTTTQLLQ 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 5e-12
Identities = 48/180 (26%), Positives = 77/180 (42%), Gaps = 13/180 (7%)
Query: 14 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 73
+ +V ++GG L +L R D+ A + ++ A+E LH +I+RDLKPEN+L
Sbjct: 68 LYLVLAFINGGELFHHL--QREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENIL 125
Query: 74 LTEDLKTIKLADFGLAR-EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDS 132
L + I L DFGL + + GT ++APEL Y VD
Sbjct: 126 L-DYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHG--------YTKAVDW 176
Query: 133 YSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNAR 192
++ ++L+E+L PF N+ Y + + + +L DP R
Sbjct: 177 WTLGVLLYEMLTGLPPFYD-ENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRR 235
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 6e-12
Identities = 42/113 (37%), Positives = 62/113 (54%), Gaps = 12/113 (10%)
Query: 49 DIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE--ESLTEMMTAETGTYR 106
+I A+E LH GI++RD+K EN+LL + + L DFGL++E E + GT
Sbjct: 113 EIILALEHLHKLGIVYRDIKLENILLDSE-GHVVLTDFGLSKEFLSEEKERTYSFCGTIE 171
Query: 107 WMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPF--EGMSNLQA 157
+MAPE+ +G+ H VD +S I+++ELL PF EG N Q+
Sbjct: 172 YMAPEII------RGKGGH-GKAVDWWSLGILIFELLTGASPFTLEGERNTQS 217
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 7e-12
Identities = 41/95 (43%), Positives = 52/95 (54%), Gaps = 10/95 (10%)
Query: 57 LHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTV 116
+HS GIIHRDLKP NL + ED + +K+ DFGLAR MT T + APE V
Sbjct: 133 IHSAGIIHRDLKPGNLAVNEDCE-LKILDFGLAR--HADAEMTGYVVTRWYRAPE----V 185
Query: 117 TLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 151
L HYN VD +S ++ E+L K F+G
Sbjct: 186 ILNW---MHYNQTVDIWSVGCIMAEMLTGKTLFKG 217
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 7e-12
Identities = 56/193 (29%), Positives = 92/193 (47%), Gaps = 15/193 (7%)
Query: 16 IVTELLSGGT---LRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENL 72
+V EL +GG+ L K LL R LD + ++ LH++ IIHRD+K N+
Sbjct: 101 LVLELCNGGSVTELVKGLLICGQR-LDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNI 159
Query: 73 LLTEDLKTIKLADFGLAREESLTEM-MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVD 131
LLT + +KL DFG++ + + T + GT WMAPE+ + Q Y+ + D
Sbjct: 160 LLTTE-GGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEV---IACEQQYDYSYDARCD 215
Query: 132 SYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPE----ELSIILTSCWKE 187
+S I EL P M ++ + +N P+ + PE + ++ C +
Sbjct: 216 VWSLGITAIELGDGDPPLFDMHPVKTLFKIP-RNPPPTLLH-PEKWCRSFNHFISQCLIK 273
Query: 188 DPNARPNFTQIIQ 200
D ARP+ T +++
Sbjct: 274 DFEARPSVTHLLE 286
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 7e-12
Identities = 57/211 (27%), Positives = 91/211 (43%), Gaps = 26/211 (12%)
Query: 5 FIGA-CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGI 62
F GA E + + E + G+L + P +++ I A+ + + L++ H I
Sbjct: 68 FYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKI--AVAVVEGLTYLYNVHRI 125
Query: 63 IHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGE 122
+HRD+KP N+L+ IKL DFG++ E + + GT +M+PE QG
Sbjct: 126 MHRDIKPSNILVNSR-GQIKLCDFGVS-GELINSIADTFVGTSTYMSPERI------QGG 177
Query: 123 KKHYNHKVDSYSFAIVLWELLHNKLPF---EGMSNLQAAYAAAFKNV---------RPSA 170
K Y K D +S I + EL K PF + Q + R +
Sbjct: 178 K--YTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPS 235
Query: 171 ENVPEELSIILTSCWKEDPNARPNFTQIIQM 201
+ PE+L + +C +DP RP Q+ M
Sbjct: 236 SDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 7e-12
Identities = 35/106 (33%), Positives = 61/106 (57%), Gaps = 7/106 (6%)
Query: 46 FALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--G 103
+ ++ A++ +HS G IHRD+KP+N+LL + +KLADFG + + M+ +T G
Sbjct: 147 YTAEVVLALDAIHSMGFIHRDVKPDNMLLDKS-GHLKLADFGTCMKMNKEGMVRCDTAVG 205
Query: 104 TYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPF 149
T +++PE+ + QG +Y + D +S + L+E+L PF
Sbjct: 206 TPDYISPEVLKS----QGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 7e-12
Identities = 50/145 (34%), Positives = 81/145 (55%), Gaps = 16/145 (11%)
Query: 14 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 73
+ V E +SGG L ++ R R L A ++ +I+ A+ LH GII+RDLK +N+L
Sbjct: 71 LFFVIEFVSGGDLMFHM--QRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVL 128
Query: 74 LTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNHKVD 131
L + IKL D+G+ + E + T T GT ++APE+ LR GE Y VD
Sbjct: 129 LDAE-GHIKLTDYGMCK-EGIRPGDTTSTFCGTPNYIAPEI-----LR-GED--YGFSVD 178
Query: 132 SYSFAIVLWELLHNKLPFE--GMSN 154
++ ++++E++ + PF+ GMS+
Sbjct: 179 WWALGVLMFEMMAGRSPFDIVGMSD 203
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 8e-12
Identities = 42/146 (28%), Positives = 73/146 (50%), Gaps = 7/146 (4%)
Query: 16 IVTELLSGGTLRKYLLNMRPRCL-DVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL 74
+V E G++ + N + L + +A +I R + LH+H +IHRD+K +N+LL
Sbjct: 96 LVMEFCGAGSVTDLVKNTKGNALKEDWIAY-ICREILRGLAHLHAHKVIHRDIKGQNVLL 154
Query: 75 TEDLKTIKLADFGL-AREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSY 133
TE+ + +KL DFG+ A+ + GT WMAPE+ + + Y+++ D +
Sbjct: 155 TENAE-VKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEV---IACDENPDATYDYRSDIW 210
Query: 134 SFAIVLWELLHNKLPFEGMSNLQAAY 159
S I E+ P M ++A +
Sbjct: 211 SLGITAIEMAEGAPPLCDMHPMRALF 236
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 8e-12
Identities = 41/129 (31%), Positives = 66/129 (51%), Gaps = 9/129 (6%)
Query: 26 LRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLAD 85
L+KY+ + LD + + + + + HSH ++HRDLKP+NLL+ + +KLAD
Sbjct: 84 LKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDRE-GALKLAD 142
Query: 86 FGLAREESL-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH 144
FGLAR + T E T + APE + L + Y+ VD +S + E+++
Sbjct: 143 FGLARAFGVPVRTYTHEVVTLWYRAPE----ILLGS---RQYSTPVDIWSIGCIFAEMVN 195
Query: 145 NKLPFEGMS 153
+ F G S
Sbjct: 196 RRPLFPGDS 204
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 8e-12
Identities = 35/113 (30%), Positives = 53/113 (46%), Gaps = 9/113 (7%)
Query: 31 LNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 90
L R R L + A+ I + LH+ IIHRD+K EN+ + D+ + + D G A+
Sbjct: 147 LTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFI-NDVDQVCIGDLGAAQ 205
Query: 91 EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL 143
+ GT APE+ + + YN K D +S IVL+E+L
Sbjct: 206 FPVVAPAFLGLAGTVETNAPEVLA--------RDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 1e-11
Identities = 45/165 (27%), Positives = 74/165 (44%), Gaps = 19/165 (11%)
Query: 4 QFIGACKEPV-MVIVTELLSGGTLRKYLLNMRP--RCLDVCVAIGFALDIARAMECLHSH 60
Q +G C E + ++V E G L+ YL + R + + A +IA + +H H
Sbjct: 59 QCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH 118
Query: 61 GIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY---RWMAPELYSTVT 117
+H DL N LT DL T+K+ D+G+ + + E RW+APEL V
Sbjct: 119 NFLHSDLALRNCFLTSDL-TVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPEL---VG 174
Query: 118 LRQG-----EKKHYNHKVDSYSFAIVLWELLHN-KLPFEGMSNLQ 156
G E+ + + ++ + LWEL N P+ +S+ +
Sbjct: 175 EFHGGLITAEQTKPS---NVWALGVTLWELFENAAQPYSHLSDRE 216
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 1e-11
Identities = 45/146 (30%), Positives = 74/146 (50%), Gaps = 13/146 (8%)
Query: 57 LHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR-EESLTEMMTAETGTYRWMAPELYST 115
+H I+HRDLK +N+ L +L +K+ DFG++R ++ T TGT +M+PE
Sbjct: 122 MHQRRILHRDLKAKNIFLKNNL--LKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALK- 178
Query: 116 VTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS-AENVP 174
QG Y+ K D +S +L+E+ FEG N + + PS E
Sbjct: 179 ---HQG----YDSKSDIWSLGCILYEMCCLAHAFEG-QNFLSVVLRIVEGPTPSLPETYS 230
Query: 175 EELSIILTSCWKEDPNARPNFTQIIQ 200
+L+ I+ S +DP+ RP+ +I++
Sbjct: 231 RQLNSIMQSMLNKDPSLRPSAAEILR 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-11
Identities = 55/194 (28%), Positives = 90/194 (46%), Gaps = 17/194 (8%)
Query: 16 IVTELLSGGT---LRKYLLNMRPRCLDVCVAIGFALDIA-RAMECLHSHGIIHRDLKPEN 71
+V EL +GG+ L K L R + +A + L A ++ LH + IHRD+K N
Sbjct: 97 LVLELCNGGSVTDLVKGFLKRGERMEEPIIA--YILHEALMGLQHLHVNKTIHRDVKGNN 154
Query: 72 LLLTEDLKTIKLADFGLAREESLTEM-MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKV 130
+LLT + +KL DFG++ + + T + GT WMAPE+ + Q Y+ +
Sbjct: 155 ILLTTE-GGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEV---IACEQQLDSTYDARC 210
Query: 131 DSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPE----ELSIILTSCWK 186
D +S I EL P + ++A + +N P+ PE E + + C
Sbjct: 211 DVWSLGITAIELGDGDPPLADLHPMRALFKIP-RNPPPTLHQ-PELWSNEFNDFIRKCLT 268
Query: 187 EDPNARPNFTQIIQ 200
+D RP + ++Q
Sbjct: 269 KDYEKRPTVSDLLQ 282
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 1e-11
Identities = 37/112 (33%), Positives = 54/112 (48%), Gaps = 15/112 (13%)
Query: 46 FALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE-----ESLTEMMTA 100
F + R ++ +HS +IHRDLKP NLL+ ED +++ DFG+AR MT
Sbjct: 112 FLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDC-ELRIGDFGMARGLSSSPTEHKYFMTE 170
Query: 101 ETGTYRWM-APELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 151
T RW APEL ++ Y +D +S + E+L + F G
Sbjct: 171 YVAT-RWYRAPELLLSL-------PEYTTAIDMWSVGCIFAEMLGRRQLFPG 214
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 1e-11
Identities = 51/173 (29%), Positives = 80/173 (46%), Gaps = 25/173 (14%)
Query: 44 IGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETG 103
+ AL IA M+ L S +HRDL N L+ E+L TIK+ADFG++R + +
Sbjct: 141 LHVALQIASGMKYLSSLNFVHRDLATRNCLVGENL-TIKIADFGMSRNLYAGDYYRIQGR 199
Query: 104 TY---RWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH--NKLPFEGMSNLQAA 158
RWMA E + G+ + D ++F + LWE+L + P+ +++ Q
Sbjct: 200 AVLPIRWMAWE-----CILMGK---FTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVI 251
Query: 159 YAAA--FKN-------VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 202
A F++ RP P+ L ++ CW D RP+F+ I L
Sbjct: 252 ENAGEFFRDQGRQVYLFRPPP--CPQGLYELMLQCWSRDCRERPSFSDIHAFL 302
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-11
Identities = 52/192 (27%), Positives = 88/192 (45%), Gaps = 15/192 (7%)
Query: 16 IVTELLSGGTLRKYLLNMRP--RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 73
IV EL G L + + + R + + + + A+E +HS ++HRD+KP N+
Sbjct: 79 IVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVF 138
Query: 74 LTEDLKTIKLADFGLAR-EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDS 132
+T +KL D GL R S T + GT +M+PE + + YN K D
Sbjct: 139 ITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE--------RIHENGYNFKSDI 189
Query: 133 YSFAIVLWELLHNKLPFEG--MSNLQAAYAAAFKNVRP-SAENVPEELSIILTSCWKEDP 189
+S +L+E+ + PF G M+ + P E+ E+L +++ C DP
Sbjct: 190 WSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDP 249
Query: 190 NARPNFTQIIQM 201
+ RP+ + Q+
Sbjct: 250 DQRPDIGYVHQI 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 62.6 bits (153), Expect = 2e-11
Identities = 41/107 (38%), Positives = 53/107 (49%), Gaps = 13/107 (12%)
Query: 52 RAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAETGT--YRWM 108
+ LH + I+HRDLK NLLL +K+ DFGLARE S + T T YR
Sbjct: 117 SGVAHLHDNWILHRDLKTSNLLLNNR-GILKICDFGLAREYGSPLKPYTQLVVTLWYR-- 173
Query: 109 APELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL 155
APEL G K+ Y+ +D +S + ELL K F G S +
Sbjct: 174 APELL------LGAKE-YSTAIDMWSVGCIFAELLTKKPLFPGKSEI 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-11
Identities = 37/99 (37%), Positives = 53/99 (53%), Gaps = 9/99 (9%)
Query: 58 HSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL-TEMMTAETGTYRWMAPELYSTV 116
HSH ++HRDLKP+NLL+ + IKLADFGLAR + T E T + APE+
Sbjct: 117 HSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 175
Query: 117 TLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL 155
K+Y+ VD +S + E++ + F G S +
Sbjct: 176 -------KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 2e-11
Identities = 57/215 (26%), Positives = 93/215 (43%), Gaps = 17/215 (7%)
Query: 4 QFIGACKEPV-MVIVTELLSGGTLRKYLLNMR---PRCLDVCVAIGFALDIARAMECLHS 59
Q +G C E + ++V E G L+ YL + R + V A ++A + LH
Sbjct: 59 QCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ 118
Query: 60 HGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE-MMTAETGTY--RWMAPELYSTV 116
IH DL N LT DL ++K+ D+GLA E+ + +T + RW+APEL
Sbjct: 119 ADFIHSDLALRNCQLTADL-SVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIR 177
Query: 117 TLRQGEKKHYNHKVDSYSFAIVLWELLHN-KLPFEGMSNLQA-AYAAAFKNVRPSAENVP 174
K K + +S + +WEL P+ +S+ Q ++++ +
Sbjct: 178 GQDLLPKDQ-TKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLD 236
Query: 175 EELSI----ILTSCWKEDPNARPNFTQIIQMLLNY 205
+ S ++ CW DP RP + + LL Y
Sbjct: 237 LKYSDRWYEVMQFCWL-DPETRPTAEE-VHELLTY 269
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 3e-11
Identities = 34/95 (35%), Positives = 52/95 (54%), Gaps = 11/95 (11%)
Query: 50 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWM- 108
+ ++++ +H +GI HRD+KPEN+L+ +D +KLADFG R T T RW
Sbjct: 109 LLKSLDHMHRNGIFHRDIKPENILIKDD--ILKLADFGSCRGIYSKPPYTEYIST-RWYR 165
Query: 109 APELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL 143
APE L G +Y K+D ++ V +E+L
Sbjct: 166 APE----CLLTDG---YYGPKMDIWAVGCVFFEIL 193
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 3e-11
Identities = 47/139 (33%), Positives = 77/139 (55%), Gaps = 14/139 (10%)
Query: 14 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 73
+ +V E ++GG L ++ R R L A +A +I A+ LH GII+RDLK +N+L
Sbjct: 71 LFLVIEYVNGGDLMFHM--QRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVL 128
Query: 74 LTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNHKVD 131
L D IKL D+G+ + E L T T GT ++APE+ +GE+ Y VD
Sbjct: 129 LDAD-GHIKLTDYGMCK-EGLGPGDTTSTFCGTPNYIAPEIL------RGEE--YGFSVD 178
Query: 132 SYSFAIVLWELLHNKLPFE 150
++ ++++E++ + PF+
Sbjct: 179 WWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 3e-11
Identities = 38/146 (26%), Positives = 63/146 (43%), Gaps = 12/146 (8%)
Query: 60 HGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMM--TAETGTYRWMAPELYSTVT 117
HG+IHRD+KP N+LL + +KL DFG++ L + T G +MAPE
Sbjct: 134 HGVIHRDVKPSNILL-DASGNVKLCDFGISGR--LVDSKAKTRSAGCAAYMAPERIDP-- 188
Query: 118 LRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGM-SNLQAAYAAAFKN--VRPSAENVP 174
Y+ + D +S I L EL + P++ + + + P E
Sbjct: 189 --PDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFS 246
Query: 175 EELSIILTSCWKEDPNARPNFTQIIQ 200
+ + C +D RP + +++Q
Sbjct: 247 PDFCSFVDLCLTKDHRKRPKYRELLQ 272
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 3e-11
Identities = 56/191 (29%), Positives = 95/191 (49%), Gaps = 20/191 (10%)
Query: 11 EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPE 70
E + V E ++GG L ++ R R L A ++ +I+ A+ LH GII+RDLK +
Sbjct: 68 ESRLFFVIEYVNGGDLMFHM--QRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLD 125
Query: 71 NLLLTEDLKTIKLADFGLAREESLTEMMTAE-TGTYRWMAPELYSTVTLRQGEKKHYNHK 129
N+LL + IKL D+G+ +E T+ GT ++APE+ +GE Y
Sbjct: 126 NVLLDSE-GHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEIL------RGED--YGFS 176
Query: 130 VDSYSFAIVLWELLHNKLPFE--GMSNL--QAAYAAAFKNVRPSAENVPEELSI----IL 181
VD ++ ++++E++ + PF+ G S+ Q F+ + +P LS+ +L
Sbjct: 177 VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVL 236
Query: 182 TSCWKEDPNAR 192
S +DP R
Sbjct: 237 KSFLNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 3e-11
Identities = 45/197 (22%), Positives = 82/197 (41%), Gaps = 15/197 (7%)
Query: 12 PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLH-SHGIIHRDLKPE 70
P + ++ E + G LR+ L + + L + A+D + + L+ +++L
Sbjct: 95 PRLSLILEYCTRGYLREVL--DKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSV 152
Query: 71 NLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKV 130
+ L+TE+ K K+ GL + S Y + ++ + + Y K
Sbjct: 153 SFLVTENYKL-KIICHGLEKILSSPPFKNVNFMVYF--SYKMLNDIF------SEYTIKD 203
Query: 131 DSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR--PSAENVPEELSIILTSCWKED 188
D YS +VLWE+ K+PFE ++ + Y + P E+ I+ +C D
Sbjct: 204 DIYSLGVVLWEIFTGKIPFENLT-TKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHD 262
Query: 189 PNARPNFTQIIQMLLNY 205
RPN +I+ L Y
Sbjct: 263 SIKRPNIKEILYNLSLY 279
|
Length = 283 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-11
Identities = 40/106 (37%), Positives = 58/106 (54%), Gaps = 10/106 (9%)
Query: 50 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMA 109
+ + ++ +H+ GIIHRDLKP NL + ED + +K+ DFGLAR+ MT T + A
Sbjct: 127 MLKGLKYIHAAGIIHRDLKPGNLAVNEDCE-LKILDFGLARQTD--SEMTGYVVTRWYRA 183
Query: 110 PELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL 155
PE V L HY VD +S ++ E+L K F+G +L
Sbjct: 184 PE----VILNW---MHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL 222
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 6e-11
Identities = 54/182 (29%), Positives = 83/182 (45%), Gaps = 39/182 (21%)
Query: 50 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAETGTYRWM 108
I R +E HSH IIHRD+KPEN+L+++ +KL DFG AR + E+ T T +
Sbjct: 109 ILRGIEFCHSHNIIHRDIKPENILVSQS-GVVKLCDFGFARTLAAPGEVYTDYVATRWYR 167
Query: 109 APELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY--------- 159
APEL G+ K Y VD ++ ++ E+L + F G S++ Y
Sbjct: 168 APELLV------GDTK-YGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNL 220
Query: 160 ----------AAAFKNVR-PSAENV-PEE-----LSII----LTSCWKEDPNARPNFTQI 198
F +R P + + P E LS + C + DP+ RP+ +Q+
Sbjct: 221 IPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQL 280
Query: 199 IQ 200
+
Sbjct: 281 LH 282
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 6e-11
Identities = 36/118 (30%), Positives = 59/118 (50%), Gaps = 10/118 (8%)
Query: 26 LRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLAD 85
L+KY + +D + F + + + HSH ++HRDLKP+NLL+ ++ +KLAD
Sbjct: 85 LKKYFDSCNGD-IDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKN-GELKLAD 142
Query: 86 FGLAREESL-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWEL 142
FGLAR + +AE T + P++ L Y+ +D +S + EL
Sbjct: 143 FGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL-------YSTSIDMWSAGCIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 6e-11
Identities = 52/205 (25%), Positives = 92/205 (44%), Gaps = 31/205 (15%)
Query: 16 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 75
++ E L G+L++YL + + +++ + +A+ I + M+ L S +HRDL N+L+
Sbjct: 85 LIMEFLPSGSLKEYLPRNKNK-INLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLV- 142
Query: 76 EDLKTIKLADFGLAR-----EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKV 130
E +K+ DFGL + +E T ++ + W APE + K Y
Sbjct: 143 ESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVF-WYAPECLI-------QSKFYIAS- 193
Query: 131 DSYSFAIVLWELL----------HNKLPFEGMSNLQAAYAAAFKNVR-----PSAENVPE 175
D +SF + L+ELL L G ++ Q + + P N PE
Sbjct: 194 DVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPE 253
Query: 176 ELSIILTSCWKEDPNARPNFTQIIQ 200
E+ ++ CW+ P+ R F +I+
Sbjct: 254 EVYQLMRKCWEFQPSKRTTFQNLIE 278
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 7e-11
Identities = 45/128 (35%), Positives = 60/128 (46%), Gaps = 9/128 (7%)
Query: 26 LRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLAD 85
LR YL + P L R ++ LH++ I+HRDLKPEN+L+T +KLAD
Sbjct: 93 LRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSG-GQVKLAD 151
Query: 86 FGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHN 145
FGLAR S +T T + APE+ T Y VD +S + E+
Sbjct: 152 FGLARIYSCQMALTPVVVTLWYRAPEVLLQST--------YATPVDMWSVGCIFAEMFRR 203
Query: 146 KLPFEGMS 153
K F G S
Sbjct: 204 KPLFCGNS 211
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 8e-11
Identities = 57/187 (30%), Positives = 87/187 (46%), Gaps = 31/187 (16%)
Query: 4 QFIGACKEP---VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH 60
Q+ G ++P + I E + GG+++ L + L V + I + LHS+
Sbjct: 68 QYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYG--ALTENVTRKYTRQILEGVSYLHSN 125
Query: 61 GIIHRDLKPENLLLTEDLKTIKLADFGLARE-----ESLTEMMTAETGTYRWMAPELYST 115
I+HRD+K N +L + + +KL DFG ++ S T M + TGT WM+PE+ S
Sbjct: 126 MIVHRDIKGAN-ILRDSVGNVKLGDFGASKRLQTICLSGTGMKSV-TGTPYWMSPEVIS- 182
Query: 116 VTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLP---FEGMSNLQAAYAAAFK-NVRPSAE 171
GE Y K D +S + E+L K P FE M AA FK +P+
Sbjct: 183 -----GEG--YGRKADIWSVGCTVVEMLTEKPPWAEFEAM-------AAIFKIATQPTNP 228
Query: 172 NVPEELS 178
+P +S
Sbjct: 229 VLPPHVS 235
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 8e-11
Identities = 55/186 (29%), Positives = 87/186 (46%), Gaps = 29/186 (15%)
Query: 4 QFIGACKEPV---MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH 60
Q+ G ++P + I E + GG+++ L L V + I + + LHS+
Sbjct: 68 QYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLHSN 125
Query: 61 GIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM----MTAETGTYRWMAPELYSTV 116
I+HRD+K N +L + +KL DFG ++ M + + TGT WM+PE+ S
Sbjct: 126 MIVHRDIKGAN-ILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVIS-- 182
Query: 117 TLRQGEKKHYNHKVDSYSFAIVLWELLHNKLP---FEGMSNLQAAYAAAFK-NVRPSAEN 172
GE Y K D +S A + E+L K P +E M AA FK +P+
Sbjct: 183 ----GEG--YGRKADVWSVACTVVEMLTEKPPWAEYEAM-------AAIFKIATQPTKPM 229
Query: 173 VPEELS 178
+P+ +S
Sbjct: 230 LPDGVS 235
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 8e-11
Identities = 52/210 (24%), Positives = 88/210 (41%), Gaps = 21/210 (10%)
Query: 4 QFIGAC-KEPVMVIVTEL--LSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECL-HS 59
+F GA +E I EL +S KY+ + + + A+ +A+ L
Sbjct: 67 KFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE 126
Query: 60 HGIIHRDLKPENLLLTEDLK-TIKLADFGLA--REESLTEMMTAETGTYRWMAPELYSTV 116
IIHRD+KP N+LL D IKL DFG++ +S+ + T + G +MAPE
Sbjct: 127 LKIIHRDVKPSNILL--DRNGNIKLCDFGISGQLVDSIAK--TRDAGCRPYMAPERIDPS 182
Query: 117 TLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL-----QAAYAAAFKNVRPSAE 171
R G Y+ + D +S I L+E+ K P+ +++ Q
Sbjct: 183 A-RDG----YDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEER 237
Query: 172 NVPEELSIILTSCWKEDPNARPNFTQIIQM 201
+ C +D + RP + ++++
Sbjct: 238 EFSPSFVNFINLCLIKDESKRPKYKELLEH 267
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 8e-11
Identities = 49/214 (22%), Positives = 89/214 (41%), Gaps = 41/214 (19%)
Query: 7 GACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDI----ARAMECLHSHGI 62
G C ++V E + G L +L + V++ + LD+ A A+ L +
Sbjct: 68 GVCVRDENIMVEEYVKFGPLDVFLHREKN-----NVSLHWKLDVAKQLASALHYLEDKKL 122
Query: 63 IHRDLKPENLLLT-EDLKT-----IKLADFGLAREESLTEMMTAETGTYR-----WMAPE 111
+H ++ +N+L+ L IKL+D G+ +T + R W+APE
Sbjct: 123 VHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP--------ITVLSREERVERIPWIAPE 174
Query: 112 LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHN-KLPFEGMSNLQAAYAAAFKNVRPSA 170
+ + D +SF L E+ N + P +S+ + ++ P
Sbjct: 175 CI------RNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLP-- 226
Query: 171 ENVPE--ELSIILTSCWKEDPNARPNFTQIIQML 202
+P+ EL+ ++ CW DP RP+F I++ L
Sbjct: 227 --MPDCAELANLINQCWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 9e-11
Identities = 49/172 (28%), Positives = 77/172 (44%), Gaps = 18/172 (10%)
Query: 11 EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPE 70
E + I E + GG+++ L L V + I M LHS+ I+HRD+K
Sbjct: 78 EKTLTIFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGA 135
Query: 71 NLLLTEDLKTIKLADFGLAREESLTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHY 126
N +L + +KL DFG ++ M + + TGT WM+PE+ S GE Y
Sbjct: 136 N-ILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVIS------GEG--Y 186
Query: 127 NHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELS 178
K D +S + E+L K P+ + A + A +P+ +P +S
Sbjct: 187 GRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIA---TQPTNPQLPSHIS 235
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 9e-11
Identities = 49/146 (33%), Positives = 76/146 (52%), Gaps = 11/146 (7%)
Query: 10 KEPVMVIVTELLSGGTLRKYLLNMRP-RCLDVCVAIGFALDIARAMECLHSHGIIHRDLK 68
+E + ++ E LS L+KYL ++ + +D + + I + + HS ++HRDLK
Sbjct: 70 QESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLK 128
Query: 69 PENLLLTEDLKTIKLADFGLAREESL-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYN 127
P+NLL+ ++ IKLADFGLAR + + T E T + APE V L G + Y+
Sbjct: 129 PQNLLI-DNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPE----VLL--GSPR-YS 180
Query: 128 HKVDSYSFAIVLWELLHNKLPFEGMS 153
VD +S + E+ K F G S
Sbjct: 181 TPVDIWSIGTIFAEMATKKPLFHGDS 206
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 1e-10
Identities = 58/224 (25%), Positives = 96/224 (42%), Gaps = 47/224 (20%)
Query: 9 CKEPVMVIVTELLSGGTLRKYLLNMRP---------RCLDVCVAIGFALDIARAMECLHS 59
+P+ +I TE + G L ++L P + I A IA M+ L S
Sbjct: 90 TSDPLCMI-TEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS 148
Query: 60 HGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY-----------RWM 108
+HRDL N L+ ++ TIK+ADFG++R +G Y RWM
Sbjct: 149 LNFVHRDLATRNCLVGKNY-TIKIADFGMSR--------NLYSGDYYRIQGRAVLPIRWM 199
Query: 109 APELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH--NKLPFEGMSNLQAAYAAA--FK 164
+ E ++ L + + D ++F + LWE+L + P+ +S+ Q F+
Sbjct: 200 SWE---SILLGK-----FTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFR 251
Query: 165 NVR-----PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 203
+ P P+ L ++ SCW+ + RP+F +I LL
Sbjct: 252 DQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 1e-10
Identities = 41/130 (31%), Positives = 57/130 (43%), Gaps = 9/130 (6%)
Query: 31 LNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 90
L PR + + +A+ H H IHRD+KPEN+L+T+ IKL DFG AR
Sbjct: 90 LEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQ-GQIKLCDFGFAR 148
Query: 91 EESLTEMMTAETGTYRWM-APELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPF 149
+ + RW APEL T Y VD ++ V ELL + +
Sbjct: 149 ILTGPGDDYTDYVATRWYRAPELLVGDT-------QYGPPVDVWAIGCVFAELLTGQPLW 201
Query: 150 EGMSNLQAAY 159
G S++ Y
Sbjct: 202 PGKSDVDQLY 211
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-10
Identities = 64/284 (22%), Positives = 96/284 (33%), Gaps = 76/284 (26%)
Query: 46 FALDIAR--------AMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGL--------- 88
F D+AR A+E +H G IHRD+KP+N+L+ D IKL DFGL
Sbjct: 98 FEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRD-GHIKLTDFGLCTGFRWTHD 156
Query: 89 ---------AREESL-----------TEMMTAE---------------TGTYRWMAPELY 113
R++S+ + E GT ++APE
Sbjct: 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPE-- 214
Query: 114 STVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAA----AFKNVRPS 169
V LR G Y D +S ++L+E+L + PF + + ++
Sbjct: 215 --VLLRTG----YTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQ 268
Query: 170 AENVPEELSIILTSCWKEDPNARPN---------FTQIIQMLLNYLSAIAPPEPMIPHRI 220
A+ E +IL C + N F + I AP P I H
Sbjct: 269 AKLSREASDLILRLCCGAEDRLGKNGADEIKAHPFFKGIDFASLIRRQKAPYIPKITHPT 328
Query: 221 FNSENTILPPESPGTSSLMTVRDDIGETPKAKMGDKPKSLFFCF 264
S + PE + D P + + F+ F
Sbjct: 329 DTSNFDPVDPEKLRSDDSGESSPDRNVKPNN--RKRTEHAFYEF 370
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-10
Identities = 39/119 (32%), Positives = 50/119 (42%), Gaps = 23/119 (19%)
Query: 48 LDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR---------------EE 92
L I + LH +HRDL P N+ + K+ADFGLAR
Sbjct: 126 LQILNGLNVLHKWYFMHRDLSPANIFIN-SKGICKIADFGLARRYGYPPYSDTLSKDETM 184
Query: 93 SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 151
E MT++ T + APEL L EK Y+ VD +S + ELL K F G
Sbjct: 185 QRREEMTSKVVTLWYRAPEL-----LMGAEK--YHFAVDMWSVGCIFAELLTGKPLFPG 236
|
Length = 335 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 2e-10
Identities = 39/112 (34%), Positives = 55/112 (49%), Gaps = 15/112 (13%)
Query: 46 FALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR-----EESLTEMMTA 100
F I ++ +HS ++HRDLKP NLL+ D + +K+ DFGLAR MT
Sbjct: 110 FIYQILCGLKYIHSANVLHRDLKPGNLLVNADCE-LKICDFGLARGFSENPGENAGFMTE 168
Query: 101 ETGTYRWM-APELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 151
T RW APE+ + + Y +D +S +L ELL K F+G
Sbjct: 169 YVAT-RWYRAPEIMLSF-------QSYTKAIDVWSVGCILAELLGRKPVFKG 212
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 3e-10
Identities = 52/191 (27%), Positives = 83/191 (43%), Gaps = 18/191 (9%)
Query: 16 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 75
++ E + GG+L + DV A I + LH I+HRD+KP NLL+
Sbjct: 149 VLLEFMDGGSLEGTHIADEQFLADV------ARQILSGIAYLHRRHIVHRDIKPSNLLI- 201
Query: 76 EDLKTIKLADFGLAREESLTEMM---TAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDS 132
K +K+ADFG++R L + M + GT +M+PE +T L G Y D
Sbjct: 202 NSAKNVKIADFGVSR--ILAQTMDPCNSSVGTIAYMSPERINT-DLNHGAYDGYAG--DI 256
Query: 133 YSFAIVLWELLHNKLPFE-GMSNLQAAYAAAFKNVRPSAE--NVPEELSIILTSCWKEDP 189
+S + + E + PF G A+ A +P E ++ C + +P
Sbjct: 257 WSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREFRHFISCCLQREP 316
Query: 190 NARPNFTQIIQ 200
R + Q++Q
Sbjct: 317 AKRWSAMQLLQ 327
|
Length = 353 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 3e-10
Identities = 35/111 (31%), Positives = 61/111 (54%), Gaps = 9/111 (8%)
Query: 46 FALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL-TEMMTAETGT 104
F + R + +H I+HRDLKP+NLL++ L +KLADFGLAR +S+ ++ ++E T
Sbjct: 108 FMFQLLRGLAYIHGQHILHRDLKPQNLLISY-LGELKLADFGLARAKSIPSQTYSSEVVT 166
Query: 105 YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL 155
+ P++ T Y+ +D + + E+L + F G+S++
Sbjct: 167 LWYRPPDVLLGAT-------DYSSALDIWGAGCIFIEMLQGQPAFPGVSDV 210
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 4e-10
Identities = 33/75 (44%), Positives = 51/75 (68%), Gaps = 3/75 (4%)
Query: 16 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 75
+V E L GG + K LL++ D +A+ + ++A A++ LH HGIIHRDLKP+N+L++
Sbjct: 81 LVMEYLIGGDV-KSLLHIYGY-FDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLIS 138
Query: 76 EDLKTIKLADFGLAR 90
+ IKL DFGL++
Sbjct: 139 NE-GHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 4e-10
Identities = 52/201 (25%), Positives = 83/201 (41%), Gaps = 29/201 (14%)
Query: 7 GACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRD 66
G ++ V E + G TLR+ L L L + A+ C H+ GI+HRD
Sbjct: 47 GEAPPGLLFAVFEYVPGRTLREVLAADGA--LPAGETGRLMLQVLDALACAHNQGIVHRD 104
Query: 67 LKPENLLL--TEDLKTIKLADFGLAR-----EESLTEMMTAET---GTYRWMAPELYSTV 116
LKP+N+++ T K+ DFG+ ++ +T T GT + APE
Sbjct: 105 LKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPE----- 159
Query: 117 TLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPE- 175
LR GE D Y++ ++ E L + +G S + Y + + P ++P
Sbjct: 160 QLR-GEPV--TPNSDLYAWGLIFLECLTGQRVVQGASVAEILY----QQLSPVDVSLPPW 212
Query: 176 ----ELSIILTSCWKEDPNAR 192
L +L +DP R
Sbjct: 213 IAGHPLGQVLRKALNKDPRQR 233
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 4e-10
Identities = 35/106 (33%), Positives = 60/106 (56%), Gaps = 9/106 (8%)
Query: 46 FALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY 105
+A +I +E +H+ +++RDLKP N+LL E ++++D GLA + S + A GT+
Sbjct: 102 YAAEIILGLEHMHNRFVVYRDLKPANILLDEH-GHVRISDLGLACDFS-KKKPHASVGTH 159
Query: 106 RWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 151
+MAPE+ L++G Y+ D +S +L++LL PF
Sbjct: 160 GYMAPEV-----LQKGVA--YDSSADWFSLGCMLFKLLRGHSPFRQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 6e-10
Identities = 36/111 (32%), Positives = 55/111 (49%), Gaps = 7/111 (6%)
Query: 46 FALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY 105
F + R + +H I+HRDLKP+NLL++ D +KLADFGLAR +S+ +
Sbjct: 108 FLFQLLRGLSYIHQRYILHRDLKPQNLLIS-DTGELKLADFGLARAKSVPSHTYSNEVVT 166
Query: 106 RWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 156
W P V L E Y+ +D + + E++ F GM ++Q
Sbjct: 167 LWYRP---PDVLLGSTE---YSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ 211
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 6e-10
Identities = 61/218 (27%), Positives = 96/218 (44%), Gaps = 23/218 (10%)
Query: 4 QFIGACKEPV-MVIVTELLSGGTLRKYLLNMRPRCL---DVCVAIGFALDIARAMECLHS 59
Q +G C E ++V E G L+ YL + R L D A +IA + LH
Sbjct: 59 QCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK 118
Query: 60 HGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY---RWMAPELYSTV 116
+ IH DL N LLT DL T+K+ D+GL+ + + + RW+APEL V
Sbjct: 119 NNFIHSDLALRNCLLTADL-TVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEV 177
Query: 117 ---TLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQA-AYAAAFKNVRPSAE 171
L + K N +S + +WEL P+ +S+ Q Y + ++
Sbjct: 178 HGNLLVVDQTKESN----VWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKP 233
Query: 172 NVPEELSI----ILTSCWKEDPNARPNFTQIIQMLLNY 205
+ LS ++ CW + P RP+ + + +LL+Y
Sbjct: 234 RLKLPLSDRWYEVMQFCWLQ-PEQRPSAEE-VHLLLSY 269
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 6e-10
Identities = 43/165 (26%), Positives = 66/165 (40%), Gaps = 21/165 (12%)
Query: 60 HGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLR 119
H I+HRD+KP N+L+ IKL DFG++ + + M + GT +M+PE
Sbjct: 119 HKIMHRDVKPSNILVNSR-GEIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERL------ 170
Query: 120 QGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSI 179
QG HY + D +S + L E+ + P A F E
Sbjct: 171 QGT--HYTVQSDIWSLGLSLVEMAIGRYPIPPPD--AKELEAMF-----GRPVSEGEAKE 221
Query: 180 ILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIPHRIFNSE 224
P++ I LL+Y+ + P P +P F+ E
Sbjct: 222 SHRPVSGHPPDSPRPMA--IFELLDYI--VNEPPPKLPSGAFSDE 262
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 8e-10
Identities = 37/120 (30%), Positives = 59/120 (49%), Gaps = 21/120 (17%)
Query: 46 FALDIARAMECLHSHGIIHRDLKPENLLL-TEDLKTIKLADFGLAR--------EESLTE 96
F + R ++ +HS ++HRDLKP N+ + TEDL +K+ DFGLAR + L+E
Sbjct: 119 FMYQLLRGLKYIHSANVLHRDLKPANVFINTEDL-VLKIGDFGLARIVDPHYSHKGYLSE 177
Query: 97 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 156
+ T YR +P L + +Y +D ++ + E+L K F G L+
Sbjct: 178 GLV--TKWYR--SPRLLLSPN-------NYTKAIDMWAAGCIFAEMLTGKPLFAGAHELE 226
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 1e-09
Identities = 41/169 (24%), Positives = 75/169 (44%), Gaps = 28/169 (16%)
Query: 62 IIHRDLKPENLLLTEDLKTI----------------KLADFGLAREESLTEMMTAETGTY 105
++HRDLKP+N+ L+ ++ I K+ DFGL++ + M + GT
Sbjct: 146 VLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTP 205
Query: 106 RWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN 165
+ +PEL E K Y+ K D ++ +++EL K PF +N + +
Sbjct: 206 YYWSPELLLH------ETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRG 259
Query: 166 VRPSAENVPEELSIILTSCWKEDPNARPNFTQII--QMLLNYLSAIAPP 212
+ +EL+I++ + RP+ Q + Q++ N + PP
Sbjct: 260 PDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKN----VGPP 304
|
Length = 1021 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-09
Identities = 51/223 (22%), Positives = 93/223 (41%), Gaps = 32/223 (14%)
Query: 4 QFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPR----------CLDVCVAIGFALDIAR 52
+ +G C + + ++TE + G L ++L + + + A+ IA
Sbjct: 81 RLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIAS 140
Query: 53 AMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY---RWMA 109
M+ L S +HRDL N L+ TIK+ADFG++R + + RWMA
Sbjct: 141 GMKYLASLNFVHRDLATRNCLVGNHY-TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMA 199
Query: 110 PELYSTVTLRQGEKKHYNHKVDSYSFAIVLWEL--LHNKLPFEGMSNLQAA------YAA 161
+ ++ L + + D ++F + LWE+ L + P+ +S+ Q +
Sbjct: 200 ---WESILLGK-----FTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRN 251
Query: 162 AFKNVRPSAENV-PEELSIILTSCWKEDPNARPNFTQIIQMLL 203
+ + S + P + ++ CW D RP F +I L
Sbjct: 252 QGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-09
Identities = 41/147 (27%), Positives = 72/147 (48%), Gaps = 13/147 (8%)
Query: 11 EPVMVIVTELLSGGTLRKYL-LNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKP 69
E +++V E + L+KY+ + LD F + + + H + ++HRDLKP
Sbjct: 70 ENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKP 128
Query: 70 ENLLLTEDLKTIKLADFGLAREESL-TEMMTAETGTYRWMAPE-LYSTVTLRQGEKKHYN 127
+NLL+ + +KLADFGLAR + + E T + AP+ L + T Y+
Sbjct: 129 QNLLINKR-GELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRT--------YS 179
Query: 128 HKVDSYSFAIVLWELLHNKLPFEGMSN 154
+D +S ++ E++ + F G +N
Sbjct: 180 TSIDIWSVGCIMAEMITGRPLFPGTNN 206
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 2e-09
Identities = 33/104 (31%), Positives = 50/104 (48%), Gaps = 18/104 (17%)
Query: 57 LHSHGIIHRDLKPENLLLTEDLK---TIKLADFGLAR--EESLTEMMTAE----TGTYRW 107
LHS+ ++HRDLKP N+L+ + +K+ D GLAR L + + T YR
Sbjct: 124 LHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYR- 182
Query: 108 MAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 151
APEL +HY +D ++ + ELL + F+G
Sbjct: 183 -APELLLGA-------RHYTKAIDIWAIGCIFAELLTLEPIFKG 218
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-09
Identities = 43/153 (28%), Positives = 73/153 (47%), Gaps = 19/153 (12%)
Query: 57 LHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT-EMMTAETGTYRWMAPELYST 115
LHS G +HRD+K N+LLT++ +KLADFG++ + + T + GT WMAPE+ +
Sbjct: 122 LHSKGKMHRDIKGANILLTDN-GHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAV 180
Query: 116 VTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS------ 169
K YN D ++ I EL + P + ++A + N +P
Sbjct: 181 -----ERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKM 235
Query: 170 --AENVPEELSIILTSCWKEDPNARPNFTQIIQ 200
+ + + + LT ++P RP +++Q
Sbjct: 236 KWSNSFHHFVKMALT----KNPKKRPTAEKLLQ 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-09
Identities = 40/113 (35%), Positives = 59/113 (52%), Gaps = 7/113 (6%)
Query: 57 LHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT-EMMTAETGTYRWMAPELYST 115
LHS G +HRD+K N+LLT D +KLADFG+A + + T + GT WMAPE+ +
Sbjct: 122 LHSKGKMHRDIKGANILLT-DNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEV-AA 179
Query: 116 VTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP 168
V G YN D ++ I EL + P + ++A + + N +P
Sbjct: 180 VEKNGG----YNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQP 228
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 56.0 bits (136), Expect = 3e-09
Identities = 28/94 (29%), Positives = 44/94 (46%), Gaps = 11/94 (11%)
Query: 57 LHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTV 116
LH H IIH D+K EN+L I L D+GL + GT + +PE
Sbjct: 125 LHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCY---DGTLDYFSPE----- 176
Query: 117 TLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFE 150
+ + +Y+ D ++ ++ +ELL K PF+
Sbjct: 177 ---KIKGHNYDVSFDWWAVGVLTYELLTGKHPFK 207
|
Length = 267 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-09
Identities = 35/104 (33%), Positives = 60/104 (57%), Gaps = 9/104 (8%)
Query: 46 FALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY 105
+A +I +E +H+ +++RDLKP N+LL E ++++D GLA + S + A GT+
Sbjct: 102 YATEIILGLEHMHNRFVVYRDLKPANILLDEH-GHVRISDLGLACDFS-KKKPHASVGTH 159
Query: 106 RWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPF 149
+MAPE+ L++G Y+ D +S +L++LL PF
Sbjct: 160 GYMAPEV-----LQKGTA--YDSSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-09
Identities = 60/209 (28%), Positives = 93/209 (44%), Gaps = 25/209 (11%)
Query: 46 FALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL-TEMMTAETGT 104
F I R + H ++HRDLKP+NLL+ E +KLADFGLAR +S+ T+ + E T
Sbjct: 109 FLYQILRGLAYCHRRKVLHRDLKPQNLLINER-GELKLADFGLARAKSVPTKTYSNEVVT 167
Query: 105 YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFK 164
+ P+ V L E Y+ ++D + + +E+ + F G S ++ F+
Sbjct: 168 LWYRPPD----VLLGSSE---YSTQIDMWGVGCIFFEMASGRPLFPG-STVEDELHLIFR 219
Query: 165 NV-RPSAENVP-----EELSIILTSCWKEDP--NARPNF-TQIIQMLLNYL----SAIAP 211
+ P+ E P +E +K P N P T+ I++L +L
Sbjct: 220 LLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRIS 279
Query: 212 PEPMIPHRIFNSENTILP--PESPGTSSL 238
E + H F S T + PES SL
Sbjct: 280 AEEAMKHAYFRSLGTRIHSLPESISIFSL 308
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 9e-09
Identities = 35/107 (32%), Positives = 55/107 (51%), Gaps = 9/107 (8%)
Query: 46 FALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL-TEMMTAETGT 104
F + R + H I+HRDLKP+NLL+ E +KLADFGLAR +S+ T+ + E T
Sbjct: 108 FMFQLLRGLSYCHKRKILHRDLKPQNLLINEK-GELKLADFGLARAKSVPTKTYSNEVVT 166
Query: 105 YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 151
+ P++ T Y+ +D + +L+E+ + F G
Sbjct: 167 LWYRPPDVLLGST-------EYSTPIDMWGVGCILYEMATGRPMFPG 206
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 9e-09
Identities = 23/49 (46%), Positives = 33/49 (67%), Gaps = 1/49 (2%)
Query: 46 FALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 94
F + R + H ++HRDLKP+NLL++E +KLADFGLAR +S+
Sbjct: 108 FLFQLLRGLAYCHQRRVLHRDLKPQNLLISE-RGELKLADFGLARAKSV 155
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 1e-08
Identities = 31/99 (31%), Positives = 55/99 (55%), Gaps = 6/99 (6%)
Query: 53 AMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFG--LAREESLTEMMTAETGTYRWMAP 110
A++ +H G +HRD+KP+N+LL ++ I+LADFG L T GT +++P
Sbjct: 114 AIDSVHQLGYVHRDIKPDNVLLDKN-GHIRLADFGSCLRLLADGTVQSNVAVGTPDYISP 172
Query: 111 ELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPF 149
E+ + + K Y + D +S + ++E+L+ + PF
Sbjct: 173 EILQAM---EDGKGRYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 1e-08
Identities = 26/77 (33%), Positives = 38/77 (49%), Gaps = 8/77 (10%)
Query: 14 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 73
+IV E + G L+ + + L++ IG + + LHS GIIH DL N++
Sbjct: 74 FIIVMEYIEGEPLKDLINSNGMEELELSREIGRL--VGK----LHSAGIIHGDLTTSNMI 127
Query: 74 LTEDLKTIKLADFGLAR 90
L+ I L DFGLA
Sbjct: 128 LSGG--KIYLIDFGLAE 142
|
Length = 211 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 2e-08
Identities = 37/116 (31%), Positives = 55/116 (47%), Gaps = 23/116 (19%)
Query: 46 FALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT- 104
F + RA++ +H+ + HRDLKP+N+L D K +K+ DFGLAR + +T T
Sbjct: 108 FLYQLLRALKYIHTANVFHRDLKPKNILANADCK-LKICDFGLAR------VAFNDTPTA 160
Query: 105 --------YRWM-APELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 151
RW APEL + + Y +D +S + E+L K F G
Sbjct: 161 IFWTDYVATRWYRAPELCGSFFSK------YTPAIDIWSIGCIFAEVLTGKPLFPG 210
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-08
Identities = 33/107 (30%), Positives = 55/107 (51%), Gaps = 9/107 (8%)
Query: 46 FALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL-TEMMTAETGT 104
F + R + H ++HRDLKP+NLL+ E +KLADFGLAR +S+ T+ + E T
Sbjct: 109 FLFQLLRGLNYCHRRKVLHRDLKPQNLLINER-GELKLADFGLARAKSIPTKTYSNEVVT 167
Query: 105 YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 151
+ P++ T Y+ ++D + + +E+ + F G
Sbjct: 168 LWYRPPDILLGST-------DYSTQIDMWGVGCIFYEMSTGRPLFPG 207
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-08
Identities = 33/110 (30%), Positives = 56/110 (50%), Gaps = 7/110 (6%)
Query: 46 FALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY 105
++ + RA+ +HS I HRDLKP+NLL+ + T+KL DFG A+ + + +
Sbjct: 175 YSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSR 234
Query: 106 RWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL 155
+ APEL T +Y +D +S ++ E++ F G S++
Sbjct: 235 FYRAPELMLGAT-------NYTTHIDLWSLGCIIAEMILGYPIFSGQSSV 277
|
Length = 440 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 2e-08
Identities = 26/61 (42%), Positives = 37/61 (60%), Gaps = 6/61 (9%)
Query: 57 LHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE-----MMTAETGTYRWMAPE 111
+H + I+HRD+K N+L+T+D +KLADFGLAR SL++ T T + PE
Sbjct: 135 IHRNKILHRDMKAANILITKD-GILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPE 193
Query: 112 L 112
L
Sbjct: 194 L 194
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 3e-08
Identities = 46/140 (32%), Positives = 67/140 (47%), Gaps = 15/140 (10%)
Query: 11 EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPE 70
E + +V E + GG +L R + V +A I E L S I++RDLKPE
Sbjct: 103 ESYLYLVLEFVIGGEFFTFL--RRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPE 160
Query: 71 NLLLTEDLKTIKLADFGLAREESLTEMMTAE-TGTYRWMAPELYSTVTLRQGEKKHYNHK 129
NLLL +D IK+ DFG A+ + + T GT ++APE + L G K
Sbjct: 161 NLLLDKD-GFIKMTDFGFAK---VVDTRTYTLCGTPEYIAPE----ILLNVGHGK----A 208
Query: 130 VDSYSFAIVLWELLHNKLPF 149
D ++ I ++E+L PF
Sbjct: 209 ADWWTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 3e-08
Identities = 39/142 (27%), Positives = 71/142 (50%), Gaps = 7/142 (4%)
Query: 14 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 73
+ +V + GG L L R L +A + ++ A++ +H +HRD+KP+N+L
Sbjct: 76 LYLVMDYYVGGDLLTLLSKFEDR-LPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNIL 134
Query: 74 LTEDLKTIKLADFG--LAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVD 131
+ + I+LADFG L E T + GT +++PE+ + + K Y + D
Sbjct: 135 MDMN-GHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAM---EDGKGKYGPECD 190
Query: 132 SYSFAIVLWELLHNKLPFEGMS 153
+S + ++E+L+ + PF S
Sbjct: 191 WWSLGVCMYEMLYGETPFYAES 212
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 4e-08
Identities = 52/202 (25%), Positives = 89/202 (44%), Gaps = 38/202 (18%)
Query: 15 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGF--ALDIARAMECLHSHGIIHRDLKPENL 72
++V E + G L L M + + F A +A A+ L ++H ++ +N+
Sbjct: 80 IMVEEFVEFGPLD---LFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNI 136
Query: 73 LL------TEDLKTIKLADFG-----LAREESLTEMMTAETGTYRWMAPELYSTVTLRQG 121
LL E IKL+D G L+R+E + + W+APE
Sbjct: 137 LLAREGIDGECGPFIKLSDPGIPITVLSRQECVERI--------PWIAPECVE------- 181
Query: 122 EKKHYNHKVDSYSFAIVLWELLHN-KLPFEG--MSNLQAAYAAAFKNVRPSAENVPEELS 178
+ K+ + D +SF LWE+ +N ++P + ++ + Y V PS + EL+
Sbjct: 182 DSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQCMLVTPSCK----ELA 237
Query: 179 IILTSCWKEDPNARPNFTQIIQ 200
++T C DPN RP F I++
Sbjct: 238 DLMTHCMNYDPNQRPFFRAIMR 259
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 7e-08
Identities = 37/110 (33%), Positives = 56/110 (50%), Gaps = 7/110 (6%)
Query: 46 FALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY 105
+ + +A+ H + I+HRD+KPENLL++ + +KL DFG AR +L+E A Y
Sbjct: 105 YIYQLIKAIHWCHKNDIVHRDIKPENLLISHN-DVLKLCDFGFAR--NLSEGSNANYTEY 161
Query: 106 RWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL 155
+A Y + L G Y VD +S +L EL + F G S +
Sbjct: 162 --VATRWYRSPELLLGAP--YGKAVDMWSVGCILGELSDGQPLFPGESEI 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 8e-08
Identities = 52/207 (25%), Positives = 90/207 (43%), Gaps = 20/207 (9%)
Query: 5 FIGA-CKEPVMVIVTELLSGGTLRK-YLLNMRPRCLDVCVAIGFALDIARAMECL-HSHG 61
F GA E + + E + G+L K Y + + V + + ++ L H
Sbjct: 64 FYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN 123
Query: 62 IIHRDLKPENLLLTEDLKTIKLADFGLA--REESLTEMMTAETGTYRWMAPELYSTVTLR 119
IIHRD+KP N+L+ + +KL DFG++ SL + G +MAPE +
Sbjct: 124 IIHRDVKPTNVLVNGN-GQVKLCDFGVSGNLVASLAK---TNIGCQSYMAPERIKSGGPN 179
Query: 120 QGEKKHYNHKVDSYSFAIVLWELLHNKLPF--EGMSNLQAAYAAAFKNVRPSAENVPEEL 177
Q Y + D +S + + E+ + P+ E +N+ A +A P+ +P
Sbjct: 180 Q--NPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPT---LPSGY 234
Query: 178 SI----ILTSCWKEDPNARPNFTQIIQ 200
S + C + PN RP + Q+++
Sbjct: 235 SDDAQDFVAKCLNKIPNRRPTYAQLLE 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 8e-08
Identities = 30/99 (30%), Positives = 54/99 (54%), Gaps = 6/99 (6%)
Query: 53 AMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFG--LAREESLTEMMTAETGTYRWMAP 110
A+ +H +HRD+KP+N+LL + I+LADFG L + T + GT +++P
Sbjct: 114 AIHSIHQLHYVHRDIKPDNVLLDMN-GHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISP 172
Query: 111 ELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPF 149
E+ + G+ Y + D +S + ++E+L+ + PF
Sbjct: 173 EILQAMEDGMGK---YGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 1e-07
Identities = 36/136 (26%), Positives = 58/136 (42%), Gaps = 48/136 (35%)
Query: 53 AMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGL------AREESLTEMMT------- 99
A++ +H G IHRD+KP+NLLL IKL+DFGL + +++
Sbjct: 113 AIDSIHKLGYIHRDIKPDNLLLDAK-GHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNF 171
Query: 100 -------------AET-------------GTYRWMAPELYSTVTLRQGEKKHYNHKVDSY 133
AET GT ++APE++ + YN + D +
Sbjct: 172 LDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFL--------QTGYNKECDWW 223
Query: 134 SFAIVLWELLHNKLPF 149
S ++++E+L PF
Sbjct: 224 SLGVIMYEMLVGYPPF 239
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 1e-07
Identities = 33/114 (28%), Positives = 52/114 (45%), Gaps = 20/114 (17%)
Query: 54 MECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR--EESLTEMMTAETGT---Y--- 105
+ LH + I+HRD+K N+L+ ++ +K+ADFGLAR + G Y
Sbjct: 128 INYLHENHILHRDIKAANILI-DNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNL 186
Query: 106 ---RWM-APELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL 155
RW PEL GE++ Y VD + V E+ + +G S++
Sbjct: 187 VVTRWYRPPELLL------GERR-YTTAVDIWGIGCVFAEMFTRRPILQGKSDI 233
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 2e-07
Identities = 51/201 (25%), Positives = 87/201 (43%), Gaps = 31/201 (15%)
Query: 15 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL 74
++V E + G+L YL +++ + A +A A+ L G+ H ++ +N+LL
Sbjct: 75 IMVQEYVKFGSLDTYL-KKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLL 133
Query: 75 T--EDLKT-----IKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYN 127
ED KT IKL+D G++ E++ W+ PE ++ +
Sbjct: 134 IREEDRKTGNPPFIKLSDPGISITVLPKEILLERI---PWVPPECIE-------NPQNLS 183
Query: 128 HKVDSYSFAIVLWELLHNKLPFEG----MSNLQAAYAAAFKNVRPSAENVPE--ELSIIL 181
D +SF LWE+ F G +S L + F R P+ EL+ ++
Sbjct: 184 LAADKWSFGTTLWEI------FSGGDKPLSALDSQKKLQFYEDRHQLP-APKWTELANLI 236
Query: 182 TSCWKEDPNARPNFTQIIQML 202
C +P+ RP+F II+ L
Sbjct: 237 NQCMDYEPDFRPSFRAIIRDL 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 3e-07
Identities = 41/134 (30%), Positives = 63/134 (47%), Gaps = 16/134 (11%)
Query: 16 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 75
I TE + GG+L Y R + V A+ + + + L S I+HRD+KP N+L+
Sbjct: 76 ICTEFMDGGSLDVY------RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVN 129
Query: 76 EDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSF 135
+KL DFG++ + + + GT +MAPE S GE+ Y D +S
Sbjct: 130 TR-GQVKLCDFGVST-QLVNSIAKTYVGTNAYMAPERIS------GEQ--YGIHSDVWSL 179
Query: 136 AIVLWELLHNKLPF 149
I EL + P+
Sbjct: 180 GISFMELALGRFPY 193
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 49.1 bits (118), Expect = 3e-07
Identities = 21/77 (27%), Positives = 35/77 (45%), Gaps = 11/77 (14%)
Query: 14 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 73
IV E + G L+ + ++ IG + + LH GI+H DL N++
Sbjct: 72 KTIVMEYIEGKPLKDV---IEEGNDELLREIGRL--VGK----LHKAGIVHGDLTTSNII 122
Query: 74 LTEDLKTIKLADFGLAR 90
+ +D + L DFGL +
Sbjct: 123 VRDD--KLYLIDFGLGK 137
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 3e-07
Identities = 68/284 (23%), Positives = 110/284 (38%), Gaps = 78/284 (27%)
Query: 14 MVIVTELLSGGTLRKYLLNMR--PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPEN 71
+ V + + GG + L+ M P L A + ++ A+E +H G IHRD+KP+N
Sbjct: 76 LYFVMDYIPGGDMMSLLIRMEVFPEVL----ARFYIAELTLAIESVHKMGFIHRDIKPDN 131
Query: 72 LLLTEDLKTIKLADFGLA------------------REESLT---------------EMM 98
+L+ D IKL DFGL R++S+ +
Sbjct: 132 ILIDLD-GHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLK 190
Query: 99 TAE---------------TGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL 143
T E GT ++APE V LR+G Y D +S ++L+E+L
Sbjct: 191 TLEQRATKQHQRCLAHSLVGTPNYIAPE----VLLRKG----YTQLCDWWSVGVILFEML 242
Query: 144 HNKLPF----EGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWK----------EDP 189
+ PF + L+ ++ P + PE + +I C +D
Sbjct: 243 VGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDI 302
Query: 190 NARPNFTQIIQMLLNYLSAIAPPEPMIPHRIFNSENTILPPESP 233
A P F++ + + + AP P I H + S + ESP
Sbjct: 303 KAHPFFSE-VDFSSDIRTQPAPYVPKISHPMDTSNFDPVEEESP 345
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 4e-07
Identities = 55/220 (25%), Positives = 94/220 (42%), Gaps = 34/220 (15%)
Query: 16 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECL-HSHGIIHRDLKPENLLL 74
I E + GG+L + L + ++ + A + R + L H I+HRD+KP N+L+
Sbjct: 80 ICMEHMDGGSLDQVLKEAKRIPEEILGKVSIA--VLRGLAYLREKHQIMHRDVKPSNILV 137
Query: 75 TEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYS 134
IKL DFG++ + + M + GT +M+PE + + HY+ + D +S
Sbjct: 138 NSR-GEIKLCDFGVS-GQLIDSMANSFVGTRSYMSPE--------RLQGTHYSVQSDIWS 187
Query: 135 FAIVLWELLHNKLPF--EGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNAR 192
+ L EL + P L+A + + V E P +S + P R
Sbjct: 188 MGLSLVELAIGRYPIPPPDAKELEAIFG---RPVVDGEEGEPHSISP------RPRPPGR 238
Query: 193 P--------NFTQIIQMLLNYLSAIAPPEPMIPHRIFNSE 224
P I LL+Y+ + P P +P+ +F +
Sbjct: 239 PVSGHGMDSRPAMAIFELLDYI--VNEPPPKLPNGVFTPD 276
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 9e-07
Identities = 18/40 (45%), Positives = 28/40 (70%)
Query: 50 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 89
I A++ LHS GI+HRD+KP+N++ +E + K+ D G A
Sbjct: 264 ILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAA 303
|
Length = 566 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-06
Identities = 44/167 (26%), Positives = 73/167 (43%), Gaps = 17/167 (10%)
Query: 60 HGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLR 119
H I+HRD+KP N+L+ IKL DFG++ + + M + GT +M+PE
Sbjct: 123 HKIMHRDVKPSNILVNSR-GEIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERL------ 174
Query: 120 QGEKKHYNHKVDSYSFAIVLWELLHNKLPF--EGMSNLQAAYAAAFKNVRPSAENVPEEL 177
QG HY+ + D +S + L E+ + P L+ + + P+
Sbjct: 175 QG--THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEG-DPAESETSPRP 231
Query: 178 SIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIPHRIFNSE 224
P++RP I LL+Y+ + P P +P +F +E
Sbjct: 232 RPPGRPLSSYGPDSRPPMA--IFELLDYI--VNEPPPKLPSGVFGAE 274
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-06
Identities = 53/223 (23%), Positives = 86/223 (38%), Gaps = 63/223 (28%)
Query: 14 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 73
+ V + + GG + L+ M D+ A + ++ A+E +H G IHRD+KP+N+L
Sbjct: 76 LYFVMDYIPGGDMMSLLIRMGIFPEDL--ARFYIAELTCAVESVHKMGFIHRDIKPDNIL 133
Query: 74 LTEDLKTIKLADFGLA------------------REESLTEMMTAE-------------- 101
+ D IKL DFGL R++S+
Sbjct: 134 IDRD-GHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPL 192
Query: 102 ----------------TGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHN 145
GT ++APE V LR G Y D +S ++L+E+L
Sbjct: 193 ERRAARQHQRCLAHSLVGTPNYIAPE----VLLRTG----YTQLCDWWSVGVILYEMLVG 244
Query: 146 KLPFEGMSNLQAAYAA----AFKNVRPSAENVPEELSIILTSC 184
+ PF + L+ ++ P A+ PE +I+ C
Sbjct: 245 QPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC 287
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 2e-06
Identities = 28/82 (34%), Positives = 41/82 (50%), Gaps = 19/82 (23%)
Query: 16 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIAR--------AMECLHSHGIIHRDL 67
++ E L GG L L+ F+ D+ R A+E +H G IHRD+
Sbjct: 78 LIMEFLPGGDLMTMLIKYDT----------FSEDVTRFYMAECVLAIEAVHKLGFIHRDI 127
Query: 68 KPENLLLTEDLKTIKLADFGLA 89
KP+N+L+ IKL+DFGL+
Sbjct: 128 KPDNILIDRG-GHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 3e-06
Identities = 23/91 (25%), Positives = 34/91 (37%), Gaps = 11/91 (12%)
Query: 8 ACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDL 67
+IV E + G L+ L D+ +G + + LH GI+H DL
Sbjct: 68 DVDPDNGLIVMEYIEGELLKDAL---EEARPDLLREVG--RLVGK----LHKAGIVHGDL 118
Query: 68 KPENLLLTEDLKTIKLADFGLAREESLTEMM 98
N++L+ I DFGL E
Sbjct: 119 TTSNIILSGG--RIYFIDFGLGEFSDEVEDK 147
|
Length = 204 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 3e-06
Identities = 39/152 (25%), Positives = 65/152 (42%), Gaps = 21/152 (13%)
Query: 16 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 75
+++ ++ G+ L P + + R + LH +G IHR++K ++L++
Sbjct: 76 VISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILIS 135
Query: 76 ED-LKTIKLADFGLAREESLT----------EMMTAETGTYRWMAPELYSTVTLRQGEKK 124
D L ++ GL+ SL + T W++PEL LRQ +
Sbjct: 136 GDGLVSLS----GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPEL-----LRQ-DLY 185
Query: 125 HYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 156
YN K D YS I EL ++PF+ M Q
Sbjct: 186 GYNVKSDIYSVGITACELATGRVPFQDMLRTQ 217
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 3e-06
Identities = 45/172 (26%), Positives = 74/172 (43%), Gaps = 47/172 (27%)
Query: 14 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 73
+ ++ E L GG + L M+ L + + A++ +H G IHRD+KP+NLL
Sbjct: 76 LYLIMEFLPGGDMMTLL--MKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLL 133
Query: 74 LTEDLKTIKLADFGLA-------REE----------------SLTEMMTAET-------- 102
L + +KL+DFGL R E ++ AET
Sbjct: 134 L-DSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQL 192
Query: 103 -----GTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPF 149
GT ++APE++ ++ G YN D +S ++++E+L PF
Sbjct: 193 AFSTVGTPDYIAPEVF----MQTG----YNKLCDWWSLGVIMYEMLIGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 3e-06
Identities = 32/108 (29%), Positives = 45/108 (41%), Gaps = 18/108 (16%)
Query: 53 AMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWM---- 108
A+ LH GIIHRD+K EN+ L E + L DFG A + + Y W
Sbjct: 197 ALAYLHGRGIIHRDVKTENIFLDEPENAV-LGDFGAACK---LDAHPDTPQCYGWSGTLE 252
Query: 109 --APELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN 154
+PEL + Y K D +S +VL+E+ + G
Sbjct: 253 TNSPELLALDP--------YCAKTDIWSAGLVLFEMSVKNVTLFGKQV 292
|
Length = 392 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 5e-06
Identities = 45/172 (26%), Positives = 74/172 (43%), Gaps = 47/172 (27%)
Query: 14 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 73
+ ++ E L GG + L M+ L + + A++ +H G IHRD+KP+NLL
Sbjct: 76 LYLIMEFLPGGDMMTLL--MKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLL 133
Query: 74 LTEDLKTIKLADFGLA-------REE----------------SLTEMMTAET-------- 102
L + +KL+DFGL R E ++ AET
Sbjct: 134 L-DAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQL 192
Query: 103 -----GTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPF 149
GT ++APE++ ++ G YN D +S ++++E+L PF
Sbjct: 193 AYSTVGTPDYIAPEVF----MQTG----YNKLCDWWSLGVIMYEMLIGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 1e-05
Identities = 23/51 (45%), Positives = 31/51 (60%), Gaps = 1/51 (1%)
Query: 39 DVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 89
D+ V G + + LH GI+HRD+KPENLL+T D +K+ DFG A
Sbjct: 307 DINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVD-GQVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 2e-05
Identities = 39/116 (33%), Positives = 54/116 (46%), Gaps = 16/116 (13%)
Query: 31 LNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT--EDLKTIKLADFG- 87
L R R L + A + A++ +H GIIHRD+K EN+L+ ED I L DFG
Sbjct: 250 LGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPED---ICLGDFGA 306
Query: 88 --LAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWE 141
AR T GT APE+ + G+ Y VD +S +V++E
Sbjct: 307 ACFARGSWSTPFHYGIAGTVDTNAPEVLA------GDP--YTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 31/118 (26%), Positives = 49/118 (41%), Gaps = 26/118 (22%)
Query: 50 IARAMECLHSHGIIHRDLKPENLLL---------------TEDLKTIKLADFGLAREESL 94
I +E +HS G++HRDLKP+N+LL + L+ L D +
Sbjct: 122 ICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNIC 181
Query: 95 TEMMTAE---TGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPF 149
MT GT +MAPE L + D Y+ ++L+++L P+
Sbjct: 182 YSSMTIPGKIVGTPDYMAPE-----RLLGVPA---SESTDIYALGVILYQMLTLSFPY 231
|
Length = 932 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 4e-05
Identities = 38/139 (27%), Positives = 61/139 (43%), Gaps = 19/139 (13%)
Query: 11 EPVMVIVTELLSGGTLRKYL---LNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDL 67
E + +V + GG L ++ LN+ C+ +A ++ A++ LH GI+ RDL
Sbjct: 57 EDSVFLVLQHAEGGKLWSHISKFLNIPEECVKR-----WAAEMVVALDALHREGIVCRDL 111
Query: 68 KPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYN 127
P N+LL +D I+L F E + + E + APE+ G
Sbjct: 112 NPNNILL-DDRGHIQLTYFSRWSE--VEDSCDGEAVENMYCAPEV--------GGISEET 160
Query: 128 HKVDSYSFAIVLWELLHNK 146
D +S +L+ELL K
Sbjct: 161 EACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 6e-05
Identities = 37/119 (31%), Positives = 55/119 (46%), Gaps = 14/119 (11%)
Query: 36 RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA--REES 93
R + +C + + RA++ LH + IIHRD+K EN+ + + L DFG A +
Sbjct: 177 RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHP-GDVCLGDFGAACFPVDI 235
Query: 94 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL--HNKLPFE 150
GT APEL + + Y VD +S IVL+E+ H+ L FE
Sbjct: 236 NANKYYGWAGTIATNAPELLA--------RDPYGPAVDIWSAGIVLFEMATCHDSL-FE 285
|
Length = 391 |
| >gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Score = 43.3 bits (103), Expect = 7e-05
Identities = 26/83 (31%), Positives = 39/83 (46%), Gaps = 12/83 (14%)
Query: 14 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 73
IV E + GG K +L P ++ +G +A+ LH GI+H DL N +
Sbjct: 411 KTIVMEYI-GGKDLKDVLEGNP---ELVRKVG--EIVAK----LHKAGIVHGDLTTSNFI 460
Query: 74 LTEDLKTIKLADFGLAREESLTE 96
+ +D + L DFGL + L E
Sbjct: 461 VRDD--RLYLIDFGLGKYSDLIE 481
|
Length = 535 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 8e-05
Identities = 33/96 (34%), Positives = 46/96 (47%), Gaps = 10/96 (10%)
Query: 58 HSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR--EESLTEMMTAETGTYRWMAPELYST 115
H +HRD+K N+LL + IKLADFGLAR + T + T + PEL
Sbjct: 133 HKKNFLHRDIKCSNILLNNKGQ-IKLADFGLARLYNSEESRPYTNKVITLWYRPPELL-- 189
Query: 116 VTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 151
GE++ Y +D +S +L EL K F+
Sbjct: 190 ----LGEER-YGPAIDVWSCGCILGELFTKKPIFQA 220
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 2e-04
Identities = 50/212 (23%), Positives = 85/212 (40%), Gaps = 37/212 (17%)
Query: 7 GAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHR 65
G C + ++V E + G L L + R + V I A +A A+ L ++H
Sbjct: 83 GVCVRGSENIMVEEFVEHGPLDVCLRKEKGR-VPVAWKITVAQQLASALSYLEDKNLVHG 141
Query: 66 DLKPENLLLTE------DLKTIKLADFG-----LAREESLTEMMTAETGTYRWMAPELYS 114
++ +N+LL IKL+D G L+REE + + W+APE
Sbjct: 142 NVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREERVERI--------PWIAPECVP 193
Query: 115 TVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVP 174
+ D +SF L E+ F+G L+ + + +P
Sbjct: 194 GGN-------SLSTAADKWSFGTTLLEIC-----FDGEVPLKERTPSEKERFYEKKHRLP 241
Query: 175 E----ELSIILTSCWKEDPNARPNFTQIIQML 202
E EL+ +++ C +P RP+F I++ L
Sbjct: 242 EPSCKELATLISQCLTYEPTQRPSFRTILRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 2e-04
Identities = 33/125 (26%), Positives = 56/125 (44%), Gaps = 14/125 (11%)
Query: 32 NMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT---EDLKTIKLADFGL 88
N +P L + I + LH++ ++HRDLKP N+L+ + +K+AD G
Sbjct: 99 NKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158
Query: 89 AR--EESLTEMMTAE--TGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH 144
AR L + + T+ + APEL +HY +D ++ + ELL
Sbjct: 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGA-------RHYTKAIDIWAIGCIFAELLT 211
Query: 145 NKLPF 149
++ F
Sbjct: 212 SEPIF 216
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 3e-04
Identities = 33/125 (26%), Positives = 56/125 (44%), Gaps = 14/125 (11%)
Query: 32 NMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT---EDLKTIKLADFGL 88
N +P L + I + LH++ ++HRDLKP N+L+ + +K+AD G
Sbjct: 99 NKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158
Query: 89 AR--EESLTEMMTAE--TGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH 144
AR L + + T+ + APEL +HY +D ++ + ELL
Sbjct: 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGA-------RHYTKAIDIWAIGCIFAELLT 211
Query: 145 NKLPF 149
++ F
Sbjct: 212 SEPIF 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 5e-04
Identities = 36/120 (30%), Positives = 60/120 (50%), Gaps = 16/120 (13%)
Query: 42 VAIGFAL-DIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA--------REE 92
+AI F L D+ A++ +HS G IHR +K ++LL+ D K + L+ + R+
Sbjct: 101 LAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGK-VVLSGLRYSVSMIKHGKRQR 159
Query: 93 SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGM 152
+ + + W++PE+ L+Q + YN K D YS I EL + +PF+ M
Sbjct: 160 VVHDFPKSSVKNLPWLSPEV-----LQQ-NLQGYNEKSDIYSVGITACELANGHVPFKDM 213
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.004
Identities = 31/103 (30%), Positives = 45/103 (43%), Gaps = 14/103 (13%)
Query: 53 AMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPEL 112
A+E +H +IHRD+K EN+ L D K + L DFG A + E Y W+
Sbjct: 279 AVEYIHDKKLIHRDIKLENIFLNCDGKIV-LGDFGTA----MPFEKEREAFDYGWVG--- 330
Query: 113 YSTVTLRQGE---KKHYNHKVDSYSFAIVLWELL-HNKLPFEG 151
TV E Y D +S ++L ++L H+ P
Sbjct: 331 --TVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGD 371
|
Length = 501 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 37.0 bits (86), Expect = 0.004
Identities = 33/150 (22%), Positives = 50/150 (33%), Gaps = 24/150 (16%)
Query: 64 HRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEK 123
HR K N+LLT D L G + + Y +MAPE+ +
Sbjct: 34 HRQAKSGNILLTWDGL---LKLDGSV---AFKTPEQSRPDPY-FMAPEVIQGQS------ 80
Query: 124 KHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTS 183
Y K D YS I L+E L +LP+ L A + P +
Sbjct: 81 --YTEKADIYSLGITLYEALDYELPYNEERELSAILEILLN---GMPADDPRD------R 129
Query: 184 CWKEDPNARPNFTQIIQMLLNYLSAIAPPE 213
E +A +F +++ + L
Sbjct: 130 SNLEGVSAARSFEDFMRLCASRLPQRREAA 159
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 268 | |||
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.98 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.98 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.98 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.98 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.98 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.97 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.96 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.95 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.95 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.93 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.92 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.91 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.91 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.89 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.85 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.84 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.84 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.83 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.82 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.81 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.81 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.81 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.72 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.69 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.68 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.67 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.66 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.63 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.63 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.6 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.54 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.5 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.43 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.43 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.41 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.41 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.4 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.37 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.31 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.26 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.23 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.22 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.19 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.17 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.16 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.11 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.1 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.03 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.02 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.0 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.98 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.86 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.85 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.82 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.76 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.71 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.7 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.53 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.52 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.13 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.09 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.89 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.89 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.87 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.57 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.57 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.49 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.49 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.18 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.15 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.14 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.12 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 96.93 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.86 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.66 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.4 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.38 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 95.73 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 95.44 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 95.41 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.35 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 95.29 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 95.26 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 94.93 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 94.85 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 94.73 | |
| PLN02236 | 344 | choline kinase | 94.59 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 94.16 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 93.87 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 93.75 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 93.64 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 93.58 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 93.45 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 93.41 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 93.08 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 93.05 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 93.0 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 92.96 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 92.71 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 92.68 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 91.99 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 91.52 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 91.51 | |
| PRK06149 | 972 | hypothetical protein; Provisional | 90.99 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 90.67 |
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=300.32 Aligned_cols=190 Identities=27% Similarity=0.426 Sum_probs=165.5
Q ss_pred CceeEEEee-cCC-cEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEEeCC
Q 024408 1 MREQFIGAC-KEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLTED 77 (268)
Q Consensus 1 ~~v~l~g~~-~~~-~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~gi~H~Dikp~Nill~~~ 77 (268)
.+|.+||.+ ..+ .+.++||||+||||++++...+. +++....+++.++++||.|||+ ++|+||||||+|||+...
T Consensus 138 yIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~~g~--i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNsk 215 (364)
T KOG0581|consen 138 YIVGFYGAFYSNGEEISICMEYMDGGSLDDILKRVGR--IPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSK 215 (364)
T ss_pred CeeeEeEEEEeCCceEEeehhhcCCCCHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccC
Confidence 479999999 455 49999999999999999987655 9999999999999999999996 899999999999999998
Q ss_pred CCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-----
Q 024408 78 LKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGM----- 152 (268)
Q Consensus 78 ~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~----- 152 (268)
|.+||+|||.+...... ...+.+||..|||||.+.+ ..|+.++||||||++++|+.+|+.||...
T Consensus 216 -GeVKicDFGVS~~lvnS-~a~tfvGT~~YMsPERi~g--------~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~ 285 (364)
T KOG0581|consen 216 -GEVKICDFGVSGILVNS-IANTFVGTSAYMSPERISG--------ESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYL 285 (364)
T ss_pred -CCEEeccccccHHhhhh-hcccccccccccChhhhcC--------CcCCcccceecccHHHHHHhhCCCCCCCcCCCCC
Confidence 79999999999876555 5578899999999999865 78999999999999999999999999763
Q ss_pred ChHHHHHHHHhccCCCCCCC-CcHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 024408 153 SNLQAAYAAAFKNVRPSAEN-VPEELSIILTSCWKEDPNARPNFTQIIQML 202 (268)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~~p~~Rps~~~~~~~l 202 (268)
...+....+........+.. ++++++.++..||++||.+||+++|+++|-
T Consensus 286 ~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hp 336 (364)
T KOG0581|consen 286 DIFELLCAIVDEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHP 336 (364)
T ss_pred CHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCH
Confidence 33444444444444444555 999999999999999999999999999983
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=298.99 Aligned_cols=205 Identities=47% Similarity=0.797 Sum_probs=179.2
Q ss_pred CceeEEEeecCC--cEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC-CeecCCCCCCEEEeCC
Q 024408 1 MREQFIGACKEP--VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG-IIHRDLKPENLLLTED 77 (268)
Q Consensus 1 ~~v~l~g~~~~~--~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~g-i~H~Dikp~Nill~~~ 77 (268)
|||+|+|+|.++ ..++||||++||+|.+++.+..+..++...++.|+.||+.|++|||+++ |+|||||++|||++.+
T Consensus 100 NIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~ 179 (362)
T KOG0192|consen 100 NIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLK 179 (362)
T ss_pred CeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCC
Confidence 799999999766 5899999999999999998854445999999999999999999999999 9999999999999988
Q ss_pred CCCeEEecCCCccccccc-cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH
Q 024408 78 LKTIKLADFGLAREESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 156 (268)
Q Consensus 78 ~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~ 156 (268)
..++||+|||+++..... .......||+.|||||++.+. ...++.++||||||+++|||+||+.||.+....+
T Consensus 180 ~~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~------~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~ 253 (362)
T KOG0192|consen 180 GKTLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGE------KSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQ 253 (362)
T ss_pred CCEEEECCCccceeeccccccccCCCCCccccChhhhcCC------CCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHH
Confidence 338999999999865544 344447899999999999741 3679999999999999999999999999999877
Q ss_pred HHHHHHhccCCCC-CCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhcCC
Q 024408 157 AAYAAAFKNVRPS-AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAP 211 (268)
Q Consensus 157 ~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~~~~ 211 (268)
...........+. +..+++.+..++.+||..||.+||++.+++..|+.+......
T Consensus 254 ~~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 254 VASAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred HHHHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 7777766666655 556999999999999999999999999999999988776544
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=302.52 Aligned_cols=192 Identities=29% Similarity=0.453 Sum_probs=170.9
Q ss_pred CceeEEEeecC-CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGACKE-PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~~~-~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|||+|++++++ ++.|||.|+|..++|.+++.+++. ++|.+++.+++||+.||.|||+++|+|||||..|+++++++
T Consensus 79 nIV~f~~~FEDs~nVYivLELC~~~sL~el~Krrk~--ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~- 155 (592)
T KOG0575|consen 79 NIVQFYHFFEDSNNVYIVLELCHRGSLMELLKRRKP--LTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENM- 155 (592)
T ss_pred cEEeeeeEeecCCceEEEEEecCCccHHHHHHhcCC--CCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcC-
Confidence 79999999955 689999999999999999986555 99999999999999999999999999999999999999995
Q ss_pred CeEEecCCCccccc-cccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREES-LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
++||+|||+|.... +.....+.+||+.|.|||++.. ...+..+||||+|||+|-|+.|++||+. +..+..
T Consensus 156 ~VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k--------~gHsfEvDiWSlGcvmYtLL~G~PPFet-k~vket 226 (592)
T KOG0575|consen 156 NVKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNK--------SGHSFEVDIWSLGCVMYTLLVGRPPFET-KTVKET 226 (592)
T ss_pred cEEecccceeeeecCcccccceecCCCcccChhHhcc--------CCCCCchhhhhhhhHHHhhhhCCCCccc-chHHHH
Confidence 89999999998655 4477788999999999999963 5668899999999999999999999998 444555
Q ss_pred HHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhH
Q 024408 159 YAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 206 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 206 (268)
+..+.......+..++.+.++||..+|+.||.+|||+.+++.| .++
T Consensus 227 y~~Ik~~~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h--~Ff 272 (592)
T KOG0575|consen 227 YNKIKLNEYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH--PFF 272 (592)
T ss_pred HHHHHhcCcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC--Hhh
Confidence 6566666666677999999999999999999999999999998 455
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=297.42 Aligned_cols=197 Identities=26% Similarity=0.322 Sum_probs=165.6
Q ss_pred CceeEEEeecC-CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCC--
Q 024408 1 MREQFIGACKE-PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED-- 77 (268)
Q Consensus 1 ~~v~l~g~~~~-~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~-- 77 (268)
++|++.+++.. +..||||||++||+|.+++-.++. +.+..-..+++|++.||.|||++||+||||||+|||+..+
T Consensus 237 ~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~vv~nk~--l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e 314 (475)
T KOG0615|consen 237 NIVRIKDFFEVPDSSYMVLEYVEGGELFDKVVANKY--LREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAE 314 (475)
T ss_pred CEEEEeeeeecCCceEEEEEEecCccHHHHHHhccc--cccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCc
Confidence 58999999955 577999999999999999987665 8888889999999999999999999999999999999755
Q ss_pred CCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 024408 78 LKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA 157 (268)
Q Consensus 78 ~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~ 157 (268)
.-.+||+|||+|+.......+.+.+||+.|.|||++.... ...+..+.|+||+||++|-+++|.+||.+......
T Consensus 315 ~~llKItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg-----~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s 389 (475)
T KOG0615|consen 315 DCLLKITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKG-----VEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS 389 (475)
T ss_pred ceEEEecccchhhccccceehhhhcCCccccChhheecCC-----eecccchheeeeccceEEEEeccCCCcccccCCcc
Confidence 1268999999999888888899999999999999997521 12344589999999999999999999976444332
Q ss_pred HHHHHh----ccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 024408 158 AYAAAF----KNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 204 (268)
Q Consensus 158 ~~~~~~----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~ 204 (268)
....+. ....+....++++..++|.+||..||++||++.++++|-|-
T Consensus 390 l~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~ 440 (475)
T KOG0615|consen 390 LKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWF 440 (475)
T ss_pred HHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhh
Confidence 222222 22234567889999999999999999999999999999654
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=292.47 Aligned_cols=199 Identities=33% Similarity=0.602 Sum_probs=178.0
Q ss_pred CceeEEEeecC-CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGACKE-PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~~~-~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
++|+|+|+|.+ +.++|||||++.|+|.++|+...+..+...+.+.++.||++|++||+++++|||||-+.|||++++ .
T Consensus 262 ~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~-~ 340 (468)
T KOG0197|consen 262 KLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDED-L 340 (468)
T ss_pred CeEEEEEEEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccC-c
Confidence 58999999965 569999999999999999998666679999999999999999999999999999999999999999 6
Q ss_pred CeEEecCCCccccccccc--cccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 024408 80 TIKLADFGLAREESLTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQ 156 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~~~~ 156 (268)
.+||+|||+|+...++.- .....-...|.|||.+.. ..++.+|||||||++|||++| |+.||.++.+.+
T Consensus 341 ~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~--------~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e 412 (468)
T KOG0197|consen 341 VVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNY--------GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE 412 (468)
T ss_pred eEEEcccccccccCCCceeecCCCCCCceecCHHHHhh--------CCcccccceeehhhhHHHHhccCCCCCCCCCHHH
Confidence 999999999995433322 122223567999999975 779999999999999999998 999999999999
Q ss_pred HHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 024408 157 AAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 208 (268)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 208 (268)
.......+...+.+..+|.++.+++..||..+|++|||++.+...++++...
T Consensus 413 v~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 413 VLELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred HHHHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 9999999999999999999999999999999999999999999988887654
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-42 Score=278.77 Aligned_cols=189 Identities=32% Similarity=0.412 Sum_probs=161.9
Q ss_pred ceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCC
Q 024408 2 REQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT 80 (268)
Q Consensus 2 ~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~ 80 (268)
+|+|+=.+ ..+.+|||+||+.||.|.-+|++.+. |++..+.-++.+|+.||.|||++||+||||||+|||++.+ |+
T Consensus 87 iv~l~ysFQt~~kLylVld~~~GGeLf~hL~~eg~--F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~-GH 163 (357)
T KOG0598|consen 87 IVKLIYSFQTEEKLYLVLDYLNGGELFYHLQREGR--FSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQ-GH 163 (357)
T ss_pred EeeeEEecccCCeEEEEEeccCCccHHHHHHhcCC--cchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCC-Cc
Confidence 45555555 66789999999999999999998766 9999999999999999999999999999999999999999 79
Q ss_pred eEEecCCCccccc-cccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 024408 81 IKLADFGLAREES-LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY 159 (268)
Q Consensus 81 ~kl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~ 159 (268)
++|+|||+++... ......+.+||+.|||||++.+ ..++..+|.||||+++|||++|.+||.+.+..+...
T Consensus 164 i~LtDFgL~k~~~~~~~~t~tfcGT~eYmAPEil~~--------~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~ 235 (357)
T KOG0598|consen 164 IKLTDFGLCKEDLKDGDATRTFCGTPEYMAPEILLG--------KGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYD 235 (357)
T ss_pred EEEeccccchhcccCCCccccccCCccccChHHHhc--------CCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHH
Confidence 9999999999543 3445667899999999999975 678999999999999999999999999866555544
Q ss_pred HHHhccCCCCCCCCcHHHHHHHHhccccCCCCCC----CHHHHHHH
Q 024408 160 AAAFKNVRPSAENVPEELSIILTSCWKEDPNARP----NFTQIIQM 201 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp----s~~~~~~~ 201 (268)
..........+..++.+.+++++++|..||++|. ++.++.+|
T Consensus 236 ~I~~~k~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~H 281 (357)
T KOG0598|consen 236 KILKGKLPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRH 281 (357)
T ss_pred HHhcCcCCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcC
Confidence 4444443555566999999999999999999994 67777665
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-42 Score=290.10 Aligned_cols=189 Identities=28% Similarity=0.397 Sum_probs=163.6
Q ss_pred ceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCC
Q 024408 2 REQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT 80 (268)
Q Consensus 2 ~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~ 80 (268)
+|+|+--+ ++..+|+|+||++||+|.++|.+.+. |++..++.++.+|+.||+|||++|||||||||+|||++.+ ++
T Consensus 136 ivkLy~TFQD~~sLYFvLe~A~nGdll~~i~K~Gs--fde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~d-mh 212 (604)
T KOG0592|consen 136 IVKLYFTFQDEESLYFVLEYAPNGDLLDLIKKYGS--FDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKD-GH 212 (604)
T ss_pred eEEEEEEeecccceEEEEEecCCCcHHHHHHHhCc--chHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCC-Cc
Confidence 68888888 55689999999999999999998876 9999999999999999999999999999999999999999 59
Q ss_pred eEEecCCCcccccccc------------c--cccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCC
Q 024408 81 IKLADFGLAREESLTE------------M--MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNK 146 (268)
Q Consensus 81 ~kl~Dfg~a~~~~~~~------------~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~ 146 (268)
++|+|||.|+...... . ..+++||..|.+||++.. ...+.++|+|+|||++|.|+.|+
T Consensus 213 ikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~--------~~~~~~sDiWAlGCilyQmlaG~ 284 (604)
T KOG0592|consen 213 IKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLND--------SPAGPSSDLWALGCILYQMLAGQ 284 (604)
T ss_pred EEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcC--------CCCCcccchHHHHHHHHHHhcCC
Confidence 9999999997332211 1 145789999999999975 67788999999999999999999
Q ss_pred CCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 024408 147 LPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 202 (268)
Q Consensus 147 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l 202 (268)
+||.+...-. ..+.+......-++.+++.+++||+++|..||.+|++..+|.+|.
T Consensus 285 PPFra~Neyl-iFqkI~~l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 285 PPFRAANEYL-IFQKIQALDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred CCCccccHHH-HHHHHHHhcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence 9999855433 334444455556888999999999999999999999999999984
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=281.30 Aligned_cols=191 Identities=28% Similarity=0.441 Sum_probs=163.9
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCC-C
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED-L 78 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~-~ 78 (268)
|+|+|+.++ ..+++|||||||+||+|.++|++++. +++.++..++.||+.||++||+++|+||||||.|||++.+ .
T Consensus 70 nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi~~~~~--l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~ 147 (429)
T KOG0595|consen 70 NIVRLLDCIEDDDFIYLVMEYCNGGDLSDYIRRRGR--LPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTAR 147 (429)
T ss_pred ceeeEEEEEecCCeEEEEEEeCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCC
Confidence 689999999 56799999999999999999998776 9999999999999999999999999999999999999764 1
Q ss_pred ----CCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh
Q 024408 79 ----KTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN 154 (268)
Q Consensus 79 ----~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~ 154 (268)
-.+||+|||+|+.........+.+|++-|||||++.. ++|+.|+|+||+|+++|++++|+.||.....
T Consensus 148 ~~~~~~LKIADFGfAR~L~~~~~a~tlcGSplYMAPEV~~~--------~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~ 219 (429)
T KOG0595|consen 148 NDTSPVLKIADFGFARFLQPGSMAETLCGSPLYMAPEVIMS--------QQYDAKADLWSIGTILYQCLTGKPPFDAETP 219 (429)
T ss_pred CCCCceEEecccchhhhCCchhHHHHhhCCccccCHHHHHh--------ccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence 2589999999998888877888999999999999964 7899999999999999999999999998666
Q ss_pred HHHHHHHHhccC--CCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 155 LQAAYAAAFKNV--RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 155 ~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
.+.......... ...+..+++...+++...+..++.+|-+..+...+
T Consensus 220 ~eL~~~~~k~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~ 268 (429)
T KOG0595|consen 220 KELLLYIKKGNEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDH 268 (429)
T ss_pred HHHHHHHhccccccCchhhhccCchhhhhhHHHhcCccccCchHHhhhh
Confidence 655443333222 22345566778899999999999999888777655
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=287.04 Aligned_cols=196 Identities=27% Similarity=0.415 Sum_probs=168.6
Q ss_pred CceeEEEeec-CCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGACK-EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~~-~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|+++++.+.. ...+++||||+.||+|.++|.+.++ +.+.++..++.|+++|++|||++||+||||||+|||++.+.+
T Consensus 81 nI~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~~~g~--l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~ 158 (370)
T KOG0583|consen 81 NIIRLLEVFATPTKIYIVMEYCSGGDLFDYIVNKGR--LKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEG 158 (370)
T ss_pred CEeEEEEEEecCCeEEEEEEecCCccHHHHHHHcCC--CChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCC
Confidence 6899999994 4579999999999999999998444 999999999999999999999999999999999999998745
Q ss_pred CeEEecCCCcccc-ccccccccCCCccceeccccccccccccCCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 024408 80 TIKLADFGLAREE-SLTEMMTAETGTYRWMAPELYSTVTLRQGEKK-HYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA 157 (268)
Q Consensus 80 ~~kl~Dfg~a~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~-~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~ 157 (268)
++||+|||++... .......+.+||+.|+|||++.+ .. .-+.++||||+|+++|.|++|+.||.+... ..
T Consensus 159 ~~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~-------~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~-~~ 230 (370)
T KOG0583|consen 159 NLKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSG-------KGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV-PN 230 (370)
T ss_pred CEEEeccccccccCCCCCcccCCCCCcccCCHHHhCC-------CCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH-HH
Confidence 9999999999976 46677788999999999999975 22 446899999999999999999999998443 34
Q ss_pred HHHHHhccCCCCCCCC-cHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 024408 158 AYAAAFKNVRPSAENV-PEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 208 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~-~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 208 (268)
............+..+ +.+++.++.+||..||.+|+++.+++++ .+++.
T Consensus 231 l~~ki~~~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h--~w~~~ 280 (370)
T KOG0583|consen 231 LYRKIRKGEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEH--PWFQK 280 (370)
T ss_pred HHHHHhcCCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhC--hhhcc
Confidence 4444555555566777 9999999999999999999999999977 44443
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=293.99 Aligned_cols=192 Identities=29% Similarity=0.451 Sum_probs=174.9
Q ss_pred CceeEEEeecC-CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGACKE-PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~~~-~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
||++||....+ .++|+|.||++||.|++++.+.++ +++.++.+++.||+.|+.|||..+|+|||+||+|+|++.. +
T Consensus 73 nVl~LydVwe~~~~lylvlEyv~gGELFdylv~kG~--l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~-~ 149 (786)
T KOG0588|consen 73 NVLRLYDVWENKQHLYLVLEYVPGGELFDYLVRKGP--LPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVK-N 149 (786)
T ss_pred CeeeeeeeeccCceEEEEEEecCCchhHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcc-c
Confidence 68999999954 689999999999999999998776 9999999999999999999999999999999999999998 4
Q ss_pred CeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 024408 80 TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY 159 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~ 159 (268)
++||+|||+|.....+....+.+|.+.|++||++.+ +.+.+.++||||.|++||.|++|++||.+ ++.....
T Consensus 150 nIKIADFGMAsLe~~gklLeTSCGSPHYA~PEIV~G-------~pYdG~~sDVWSCGVILfALLtG~LPFdD-dNir~LL 221 (786)
T KOG0588|consen 150 NIKIADFGMASLEVPGKLLETSCGSPHYAAPEIVSG-------RPYDGRPSDVWSCGVILFALLTGKLPFDD-DNIRVLL 221 (786)
T ss_pred CEeeeccceeecccCCccccccCCCcccCCchhhcC-------CCCCCCccccchhHHHHHHHHhCCCCCCC-ccHHHHH
Confidence 699999999998888888899999999999999987 34567899999999999999999999997 5666666
Q ss_pred HHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 024408 160 AAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 203 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~ 203 (268)
.+........+..++.+.++||.+||..||.+|.|+++|++|.+
T Consensus 222 lKV~~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~ 265 (786)
T KOG0588|consen 222 LKVQRGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPF 265 (786)
T ss_pred HHHHcCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCch
Confidence 66666666678999999999999999999999999999999965
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=281.06 Aligned_cols=192 Identities=26% Similarity=0.387 Sum_probs=169.9
Q ss_pred CceeEEEeec-CC-cEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCC
Q 024408 1 MREQFIGACK-EP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL 78 (268)
Q Consensus 1 ~~v~l~g~~~-~~-~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~ 78 (268)
|+|+|...+. .+ .+++|||||+ .+|+++++.+ ++.|++..+..|++||++||+|+|.+|+.|||+||+|||+..+
T Consensus 70 niikL~Evi~d~~~~L~fVfE~Md-~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~- 146 (538)
T KOG0661|consen 70 NIIKLKEVIRDNDRILYFVFEFMD-CNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGN- 146 (538)
T ss_pred cchhhHHHhhccCceEeeeHHhhh-hhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEeccc-
Confidence 5788888884 44 7999999996 8999999987 6679999999999999999999999999999999999999966
Q ss_pred CCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 79 KTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 79 ~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
..+||+|||+|+........+..+.|.||+|||++.. .+.|+.+.|+||+||+++|+.+-++-|++.+..++.
T Consensus 147 ~~iKiaDFGLARev~SkpPYTeYVSTRWYRAPEvLLr-------s~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi 219 (538)
T KOG0661|consen 147 DVIKIADFGLAREVRSKPPYTEYVSTRWYRAPEVLLR-------SGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQI 219 (538)
T ss_pred ceeEecccccccccccCCCcchhhhcccccchHHhhh-------ccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHH
Confidence 4899999999998887777788899999999999874 578999999999999999999999999999988888
Q ss_pred HHHHhccCCCCC-----------------------------CCCcHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 024408 159 YAAAFKNVRPSA-----------------------------ENVPEELSIILTSCWKEDPNARPNFTQIIQML 202 (268)
Q Consensus 159 ~~~~~~~~~~~~-----------------------------~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l 202 (268)
++++.-...|.. ..++.++.++|.+|+..||.+|||+.+++++.
T Consensus 220 ~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 220 YKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred HHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 877665444432 23567899999999999999999999999983
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=271.28 Aligned_cols=195 Identities=27% Similarity=0.428 Sum_probs=162.9
Q ss_pred CceeEEEe-e-cCCc-EEEEEEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHH--CC--CeecCCCCCC
Q 024408 1 MREQFIGA-C-KEPV-MVIVTELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHS--HG--IIHRDLKPEN 71 (268)
Q Consensus 1 ~~v~l~g~-~-~~~~-~~lV~e~~~ggsL~~~i~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~--~g--i~H~Dikp~N 71 (268)
|+|+++++ + ++.. ++||||||++|+|.+.|+.. .++.+++.++|+++.|++.||++||+ .. |+||||||.|
T Consensus 79 NIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaN 158 (375)
T KOG0591|consen 79 NIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPAN 158 (375)
T ss_pred hHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchh
Confidence 67888884 3 4444 89999999999999999764 34569999999999999999999999 44 9999999999
Q ss_pred EEEeCCCCCeEEecCCCcccccccc-ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 024408 72 LLLTEDLKTIKLADFGLAREESLTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFE 150 (268)
Q Consensus 72 ill~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~ 150 (268)
|+++.+ |.+||+|||+++...... ...+.+|||.||+||.+.. ..|+++|||||+||++|||+.-+.||.
T Consensus 159 IFl~~~-gvvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~--------~~Y~~kSDiWslGCllyEMcaL~~PF~ 229 (375)
T KOG0591|consen 159 IFLTAN-GVVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHE--------SGYNFKSDIWSLGCLLYEMCALQSPFY 229 (375)
T ss_pred eEEcCC-CceeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhc--------CCCCcchhHHHHHHHHHHHHhcCCCcc
Confidence 999999 799999999999755443 3456789999999999865 678999999999999999999999999
Q ss_pred CCChHHHHHHHHhccCCCCC-CCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 024408 151 GMSNLQAAYAAAFKNVRPSA-ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 204 (268)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~ 204 (268)
+..-.+...++......+.+ ..++..+..||..|+..|++.||+.-.++..+..
T Consensus 230 g~n~~~L~~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 230 GDNLLSLCKKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred cccHHHHHHHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 97555555555555555566 7789999999999999999999986555554443
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=280.01 Aligned_cols=196 Identities=26% Similarity=0.427 Sum_probs=162.5
Q ss_pred CceeEEEee--cCC-cEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCC
Q 024408 1 MREQFIGAC--KEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED 77 (268)
Q Consensus 1 ~~v~l~g~~--~~~-~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~ 77 (268)
++|+.+|.. .++ .+++.|||++||||.+++.+.+. .+++..+..+..|+++||.|||++|++||||||+|||++..
T Consensus 75 ~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~ 153 (313)
T KOG0198|consen 75 NIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPS 153 (313)
T ss_pred CEEeeCCccccccCeeeEeeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCC
Confidence 578999974 333 68999999999999999999876 59999999999999999999999999999999999999983
Q ss_pred CCCeEEecCCCcccccc----ccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCC-C
Q 024408 78 LKTIKLADFGLAREESL----TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG-M 152 (268)
Q Consensus 78 ~~~~kl~Dfg~a~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~-~ 152 (268)
.+.+||+|||+++.... ........||+.|||||++.. +......+|||||||++.||+||+.||.. .
T Consensus 154 ~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~-------g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~ 226 (313)
T KOG0198|consen 154 NGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRN-------GEVARRESDIWSLGCTVVEMLTGKPPWSEFF 226 (313)
T ss_pred CCeEEeccCccccccccccccccccccccCCccccCchhhcC-------CCcCCccchhhhcCCEEEeccCCCCcchhhc
Confidence 26999999999986442 223446789999999999863 12233589999999999999999999987 3
Q ss_pred ChHHHHHHHHhcc-CCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 024408 153 SNLQAAYAAAFKN-VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 204 (268)
Q Consensus 153 ~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~ 204 (268)
...+......... ....+..++++.+++|.+|+..||.+|||+.++++|...
T Consensus 227 ~~~~~~~~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~ 279 (313)
T KOG0198|consen 227 EEAEALLLIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL 279 (313)
T ss_pred chHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence 4344444444333 234577899999999999999999999999999998644
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=290.40 Aligned_cols=189 Identities=29% Similarity=0.493 Sum_probs=164.9
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|+|+++.-+ .++.+|+||||++||+|.|.+.... +++.++..+++++++||+|||.+||+|||||.+|||++.+ |
T Consensus 331 NiVnfl~Sylv~deLWVVMEym~ggsLTDvVt~~~---~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~-g 406 (550)
T KOG0578|consen 331 NIVNFLDSYLVGDELWVVMEYMEGGSLTDVVTKTR---MTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMD-G 406 (550)
T ss_pred HHHHHHHHhcccceeEEEEeecCCCchhhhhhccc---ccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccC-C
Confidence 466666666 4578999999999999999997643 9999999999999999999999999999999999999999 6
Q ss_pred CeEEecCCCcccccccc-ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESLTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.+||+|||++....... .-.+.+||+.|||||+.. +..|+.+.||||||+|++||+.|.+||-...+.+..
T Consensus 407 ~vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVvt--------rk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAl 478 (550)
T KOG0578|consen 407 SVKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVVT--------RKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL 478 (550)
T ss_pred cEEEeeeeeeeccccccCccccccCCCCccchhhhh--------hcccCccccchhhhhHHHHHhcCCCCccCCChHHHH
Confidence 99999999998765544 346778999999999985 488999999999999999999999999876777776
Q ss_pred HHHHhccCCC--CCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 159 YAAAFKNVRP--SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 159 ~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
+......... .++.+++++++++.+||..|+.+|+++.++|+|
T Consensus 479 yLIa~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 479 YLIATNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred HHHhhcCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 6655444333 367899999999999999999999999999998
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=262.75 Aligned_cols=186 Identities=30% Similarity=0.427 Sum_probs=162.7
Q ss_pred ceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCC
Q 024408 2 REQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT 80 (268)
Q Consensus 2 ~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~ 80 (268)
+|+|++-+ +..+++|||||++||.|..++++.++ |++..++-++.||+.||+|||+++|++||+||+|||+|.+ |.
T Consensus 106 lv~l~~t~~d~~~lymvmeyv~GGElFS~Lrk~~r--F~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~-G~ 182 (355)
T KOG0616|consen 106 LVKLYGTFKDNSNLYMVMEYVPGGELFSYLRKSGR--FSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQN-GH 182 (355)
T ss_pred eEEEEEeeccCCeEEEEEeccCCccHHHHHHhcCC--CCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccC-Cc
Confidence 68899888 55799999999999999999998776 9999999999999999999999999999999999999999 79
Q ss_pred eEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 024408 81 IKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYA 160 (268)
Q Consensus 81 ~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~ 160 (268)
+||+|||+|+..... ..+.+||+.|+|||++.. +.++.++|.||||+++|||+.|.+||.+....+ .+.
T Consensus 183 iKitDFGFAK~v~~r--T~TlCGTPeYLAPEii~s--------k~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~-iY~ 251 (355)
T KOG0616|consen 183 IKITDFGFAKRVSGR--TWTLCGTPEYLAPEIIQS--------KGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ-IYE 251 (355)
T ss_pred EEEEeccceEEecCc--EEEecCCccccChHHhhc--------CCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH-HHH
Confidence 999999999875443 567899999999999965 678889999999999999999999999866644 445
Q ss_pred HHhccCCCCCCCCcHHHHHHHHhccccCCCCC-----CCHHHHHHH
Q 024408 161 AAFKNVRPSAENVPEELSIILTSCWKEDPNAR-----PNFTQIIQM 201 (268)
Q Consensus 161 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R-----ps~~~~~~~ 201 (268)
.+.......+..++.++++|+..+|+.|-.+| ....+|..|
T Consensus 252 KI~~~~v~fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H 297 (355)
T KOG0616|consen 252 KILEGKVKFPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNH 297 (355)
T ss_pred HHHhCcccCCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccC
Confidence 55555555688899999999999999999999 344556555
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=261.55 Aligned_cols=191 Identities=26% Similarity=0.382 Sum_probs=161.7
Q ss_pred CceeEEEeecC-CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGACKE-PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~~~-~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|+|.|+..|.+ ..++||+|||+ -++.+-+.+.... ++...+.++++|++.|+.|||+++++||||||+|||++.+ +
T Consensus 62 NLVnLiEVFrrkrklhLVFE~~d-hTvL~eLe~~p~G-~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~-g 138 (396)
T KOG0593|consen 62 NLVNLIEVFRRKRKLHLVFEYCD-HTVLHELERYPNG-VPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQN-G 138 (396)
T ss_pred hHHHHHHHHHhcceeEEEeeecc-hHHHHHHHhccCC-CCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecC-C
Confidence 57888889955 57899999997 5777777775544 9999999999999999999999999999999999999999 7
Q ss_pred CeEEecCCCccccc-cccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREES-LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.+||||||+|+... +.......+.|.||+|||.+.+ ...|+...||||+||++.||++|.+.|++.+..++.
T Consensus 139 vvKLCDFGFAR~L~~pgd~YTDYVATRWYRaPELLvG-------DtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQL 211 (396)
T KOG0593|consen 139 VVKLCDFGFARTLSAPGDNYTDYVATRWYRAPELLVG-------DTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQL 211 (396)
T ss_pred cEEeccchhhHhhcCCcchhhhhhhhhhccChhhhcc-------cCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHH
Confidence 99999999999765 5555666788999999999975 468999999999999999999999999998888877
Q ss_pred HHHHhccCC--------------------CC----------CCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 159 YAAAFKNVR--------------------PS----------AENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 159 ~~~~~~~~~--------------------~~----------~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
+.+...... |. ...++..+.+++..||..||.+|++.++++.|
T Consensus 212 y~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 212 YLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred HHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 655432211 11 12345678899999999999999999999976
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=271.82 Aligned_cols=192 Identities=26% Similarity=0.397 Sum_probs=174.6
Q ss_pred CceeEEEee-cCCc-EEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCC
Q 024408 1 MREQFIGAC-KEPV-MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL 78 (268)
Q Consensus 1 ~~v~l~g~~-~~~~-~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~ 78 (268)
++|...+.+ .++. ++|||+||+||+|.+.|.+.++..|+++.+..|+.|++.|+.|||++.|+|||||+.||+++.+
T Consensus 64 ~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~- 142 (426)
T KOG0589|consen 64 NIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKD- 142 (426)
T ss_pred CeeeeccchhcCCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhcccc-
Confidence 466777777 4455 8999999999999999998887779999999999999999999999999999999999999998
Q ss_pred CCeEEecCCCcccccccc-ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 024408 79 KTIKLADFGLAREESLTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA 157 (268)
Q Consensus 79 ~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~ 157 (268)
+.|+|+|||+|+...... ...+.+||+.|++||++.+ ..|+.++|+|||||++|||++-+++|.+.+....
T Consensus 143 ~~VkLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil~d--------~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~L 214 (426)
T KOG0589|consen 143 KKVKLGDFGLAKILNPEDSLASTVVGTPYYMCPEILSD--------IPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSEL 214 (426)
T ss_pred CceeecchhhhhhcCCchhhhheecCCCcccCHHHhCC--------CCCCccCcchhhcchHHHHHhcccccCccchHHH
Confidence 688999999999766665 6678899999999999975 7889999999999999999999999999777777
Q ss_pred HHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 158 AYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
..........|.+..++.+++.+|..|+..+|..||++.+++.+
T Consensus 215 i~ki~~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 215 ILKINRGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred HHHHhhccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 77777777788999999999999999999999999999999986
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=269.13 Aligned_cols=198 Identities=30% Similarity=0.565 Sum_probs=159.4
Q ss_pred CceeEEEeecC--CcEEEEEEcCCCCCHHHHHHhcC--------------------------------------------
Q 024408 1 MREQFIGACKE--PVMVIVTELLSGGTLRKYLLNMR-------------------------------------------- 34 (268)
Q Consensus 1 ~~v~l~g~~~~--~~~~lV~e~~~ggsL~~~i~~~~-------------------------------------------- 34 (268)
|+|+++|+|.. +.+++||||++||+|.+++....
T Consensus 72 niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (338)
T cd05102 72 NVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQP 151 (338)
T ss_pred ceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCcccccccc
Confidence 68999999843 46899999999999999997532
Q ss_pred ----------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCCeEEecCCCcccccccc--
Q 024408 35 ----------------PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE-- 96 (268)
Q Consensus 35 ----------------~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~~kl~Dfg~a~~~~~~~-- 96 (268)
...+++.++..++.|++.||+|||++||+||||||+||+++.+ +.++|+|||+++......
T Consensus 152 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~-~~~kl~DfG~a~~~~~~~~~ 230 (338)
T cd05102 152 STSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSEN-NVVKICDFGLARDIYKDPDY 230 (338)
T ss_pred ccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCC-CcEEEeecccccccccCcch
Confidence 1237888999999999999999999999999999999999988 699999999997533221
Q ss_pred -ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhc-cCCCCCCCC
Q 024408 97 -MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFK-NVRPSAENV 173 (268)
Q Consensus 97 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~ 173 (268)
......++..|+|||++.+ ..++.++||||||+++|||++ |..||.+....+........ .....+..+
T Consensus 231 ~~~~~~~~~~~y~aPE~~~~--------~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (338)
T cd05102 231 VRKGSARLPLKWMAPESIFD--------KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENA 302 (338)
T ss_pred hcccCCCCCccccCcHHhhc--------CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCC
Confidence 1123345678999998854 567889999999999999997 99999875543333322222 222335678
Q ss_pred cHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHh
Q 024408 174 PEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 207 (268)
Q Consensus 174 ~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 207 (268)
++++.+++.+||..||.+||++.++++.|+..+.
T Consensus 303 ~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 303 TPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 8999999999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=247.58 Aligned_cols=201 Identities=24% Similarity=0.334 Sum_probs=169.3
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|+|+|++++ ..+.+.||+||++ .+|+..|+... ..++..++..|+.++++||+|||++.|+||||||+|+|++.+ |
T Consensus 62 nIi~LiD~F~~~~~l~lVfEfm~-tdLe~vIkd~~-i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~-g 138 (318)
T KOG0659|consen 62 NIIELIDVFPHKSNLSLVFEFMP-TDLEVVIKDKN-IILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSD-G 138 (318)
T ss_pred chhhhhhhccCCCceEEEEEecc-ccHHHHhcccc-cccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCC-C
Confidence 689999999 6678999999997 79999997744 459999999999999999999999999999999999999999 7
Q ss_pred CeEEecCCCccccccccc-cccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESLTEM-MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.+|++|||+|+....... ....+.|.||+|||.+.+ ...|+...|+||.||++.||+.|.+-|++.++.++.
T Consensus 139 ~lKiADFGLAr~f~~p~~~~~~~V~TRWYRAPELLfG-------sr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL 211 (318)
T KOG0659|consen 139 QLKIADFGLARFFGSPNRIQTHQVVTRWYRAPELLFG-------SRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQL 211 (318)
T ss_pred cEEeecccchhccCCCCcccccceeeeeccChHHhcc-------chhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHH
Confidence 999999999997665443 344578999999999986 467899999999999999999999999998887776
Q ss_pred HHHHhccCCCCCC---------------------------CCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhcCC
Q 024408 159 YAAAFKNVRPSAE---------------------------NVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAP 211 (268)
Q Consensus 159 ~~~~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~~~~ 211 (268)
.........|.+. ..+.+..+++.+|+..||.+|.++.|++++ .++...+.
T Consensus 212 ~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~--~yf~~~P~ 289 (318)
T KOG0659|consen 212 SKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH--PYFKSLPL 289 (318)
T ss_pred HHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc--hhhhcCCC
Confidence 6655544444322 234567899999999999999999999998 66666444
Q ss_pred CC
Q 024408 212 PE 213 (268)
Q Consensus 212 ~~ 213 (268)
|.
T Consensus 290 pt 291 (318)
T KOG0659|consen 290 PT 291 (318)
T ss_pred CC
Confidence 33
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=276.92 Aligned_cols=192 Identities=33% Similarity=0.638 Sum_probs=170.2
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|+|+|.|+| .-+.+|||||||..|-|.+.|+.... +.......|..+|+.|++|||.+.|+|||||.-||||..+ .
T Consensus 173 NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLka~~~--itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~-d 249 (904)
T KOG4721|consen 173 NIITFKGVCTQSPCYCIIMEFCAQGQLYEVLKAGRP--ITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYD-D 249 (904)
T ss_pred ceeeEeeeecCCceeEEeeeccccccHHHHHhccCc--cCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeecc-c
Confidence 789999999 56899999999999999999987544 9999999999999999999999999999999999999988 5
Q ss_pred CeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 024408 80 TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY 159 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~ 159 (268)
.|||+|||.++.......+.++.||..|||||+++. ..-+.+.|||||||+||||+||..||.+.+.....+
T Consensus 250 ~VKIsDFGTS~e~~~~STkMSFaGTVaWMAPEvIrn--------ePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIw 321 (904)
T KOG4721|consen 250 VVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVIRN--------EPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIW 321 (904)
T ss_pred eEEeccccchHhhhhhhhhhhhhhhHhhhCHHHhhc--------CCcccccceehhHHHHHHHHhcCCCccccchheeEE
Confidence 899999999998777677778899999999999975 667889999999999999999999999876555444
Q ss_pred HHHhcc-CCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 024408 160 AAAFKN-VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 203 (268)
Q Consensus 160 ~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~ 203 (268)
-..... ..+.+..+|..++-||+.||+-+|.+||++++++.||.
T Consensus 322 GVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hld 366 (904)
T KOG4721|consen 322 GVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLD 366 (904)
T ss_pred eccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHh
Confidence 332222 34567889999999999999999999999999999986
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=261.69 Aligned_cols=195 Identities=23% Similarity=0.338 Sum_probs=161.9
Q ss_pred CceeEEEeecC-----CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEE
Q 024408 1 MREQFIGACKE-----PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLL 74 (268)
Q Consensus 1 ~~v~l~g~~~~-----~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~gi~H~Dikp~Nill 74 (268)
|+|+++|++.+ ...++||||++||+|.+++.+... +++.....++.+++.||.|||+ .+++||||||+||++
T Consensus 79 nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~--~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill 156 (283)
T PHA02988 79 NILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKD--LSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLV 156 (283)
T ss_pred CEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhhCCC--CChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEE
Confidence 68999999843 378999999999999999987544 8999999999999999999998 499999999999999
Q ss_pred eCCCCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh
Q 024408 75 TEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN 154 (268)
Q Consensus 75 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~ 154 (268)
+.+ +.+||+|||+++...... ....|+..|+|||++.+ ....++.++||||||+++|||++|+.||.+...
T Consensus 157 ~~~-~~~kl~dfg~~~~~~~~~--~~~~~~~~y~aPE~~~~------~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~ 227 (283)
T PHA02988 157 TEN-YKLKIICHGLEKILSSPP--FKNVNFMVYFSYKMLND------IFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT 227 (283)
T ss_pred CCC-CcEEEcccchHhhhcccc--ccccCcccccCHHHhhh------ccccccchhhhhHHHHHHHHHHHCCCCCCCCCH
Confidence 988 699999999997543322 34568899999999853 124678899999999999999999999998765
Q ss_pred HHHHHHHHhccCCC-CCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhH
Q 024408 155 LQAAYAAAFKNVRP-SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 206 (268)
Q Consensus 155 ~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 206 (268)
.+...........+ .+..++..+.+++.+||+.||++|||+.++++.|+.+.
T Consensus 228 ~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 228 KEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred HHHHHHHHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 55444333333332 34478999999999999999999999999999998764
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=262.20 Aligned_cols=193 Identities=24% Similarity=0.378 Sum_probs=158.9
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++.+ .++..++||||++||+|.+++.......+++..+..++.|++.||+|||++|++||||||+||+++.+ +
T Consensus 61 ~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~-~ 139 (285)
T cd05631 61 FVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDR-G 139 (285)
T ss_pred cEEEEEEEEccCCeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCC-C
Confidence 478888888 55689999999999999998876555559999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH---
Q 024408 80 TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ--- 156 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~--- 156 (268)
.++|+|||++.............|+..|+|||++.+ ..++.++||||||+++|+|++|+.||.......
T Consensus 140 ~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~ 211 (285)
T cd05631 140 HIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINN--------EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKRE 211 (285)
T ss_pred CEEEeeCCCcEEcCCCCeecCCCCCCCccCHhhhcC--------CCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHH
Confidence 899999999986544333345578999999999864 567889999999999999999999998654322
Q ss_pred HHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCC-----HHHHHHHH
Q 024408 157 AAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPN-----FTQIIQML 202 (268)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~~~~~~l 202 (268)
................++.++.+++.+||..||.+||+ ++++++|-
T Consensus 212 ~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~ 262 (285)
T cd05631 212 EVDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHP 262 (285)
T ss_pred HHHHHhhcccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCH
Confidence 11222222223345678899999999999999999997 88998874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=269.35 Aligned_cols=189 Identities=26% Similarity=0.387 Sum_probs=158.4
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ .++++++||||++||+|.+++.+.+. +++.++..++.|++.||+|||++||+||||||+||+++.+ +
T Consensus 56 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~-~ 132 (323)
T cd05571 56 FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERV--FSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKD-G 132 (323)
T ss_pred CCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCC-C
Confidence 578888888 55689999999999999999987544 9999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccc-ccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESL-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.+||+|||+++.... ........||+.|+|||++.+ ..++.++||||||+++|+|++|+.||...+.....
T Consensus 133 ~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~ 204 (323)
T cd05571 133 HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED--------NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF 204 (323)
T ss_pred CEEEeeCCCCcccccCCCcccceecCccccChhhhcC--------CCCCccccCcccchhhhhhhcCCCCCCCCCHHHHH
Confidence 999999999975322 223344579999999999864 56788999999999999999999999875544333
Q ss_pred HHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 024408 159 YAAAFKNVRPSAENVPEELSIILTSCWKEDPNARP-----NFTQIIQM 201 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~~~~~ 201 (268)
.. ........+..++.++.++|.+||..||++|| ++.++++|
T Consensus 205 ~~-~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 205 EL-ILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred HH-HHcCCCCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 32 33333344567899999999999999999999 89999987
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=266.31 Aligned_cols=189 Identities=28% Similarity=0.432 Sum_probs=156.1
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ .+++.++||||++||+|.+++.+... +++.++..++.|++.||+|||++|++||||||+||+++.+ +
T Consensus 57 ~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~-~ 133 (316)
T cd05620 57 FLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGR--FDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRD-G 133 (316)
T ss_pred CccCeeEEEEeCCEEEEEECCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCC-C
Confidence 478899988 55689999999999999999977544 8999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccc-ccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESL-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.++|+|||+++.... ........||..|+|||++.+ ..++.++||||||+++|+|++|+.||.+....+..
T Consensus 134 ~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~ 205 (316)
T cd05620 134 HIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQG--------LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELF 205 (316)
T ss_pred CEEeCccCCCeecccCCCceeccCCCcCccCHHHHcC--------CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHH
Confidence 999999999874322 223345678999999999864 56788999999999999999999999876544333
Q ss_pred HHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCH-HHHHHH
Q 024408 159 YAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNF-TQIIQM 201 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~-~~~~~~ 201 (268)
. .........+..++.+++++|.+||..||.+||++ +++++|
T Consensus 206 ~-~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h 248 (316)
T cd05620 206 E-SIRVDTPHYPRWITKESKDILEKLFERDPTRRLGVVGNIRGH 248 (316)
T ss_pred H-HHHhCCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 3 23333333455688999999999999999999997 466655
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=264.02 Aligned_cols=189 Identities=25% Similarity=0.359 Sum_probs=158.6
Q ss_pred ceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCC
Q 024408 2 REQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT 80 (268)
Q Consensus 2 ~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~ 80 (268)
||+|+=.+ +.+++||||||++||++..+|.+.+. +++..+..++.+++.||+.||+.|++||||||+|+|||.+ |+
T Consensus 203 vVKLyYsFQD~~~LYLiMEylPGGD~mTLL~~~~~--L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~-GH 279 (550)
T KOG0605|consen 203 VVKLYYSFQDKEYLYLIMEYLPGGDMMTLLMRKDT--LTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAK-GH 279 (550)
T ss_pred EEEEEEEecCCCeeEEEEEecCCccHHHHHHhcCc--CchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCC-CC
Confidence 78888888 55699999999999999999998666 9999999999999999999999999999999999999999 79
Q ss_pred eEEecCCCcccccc----------------------c-cc-------------------------cccCCCccceecccc
Q 024408 81 IKLADFGLAREESL----------------------T-EM-------------------------MTAETGTYRWMAPEL 112 (268)
Q Consensus 81 ~kl~Dfg~a~~~~~----------------------~-~~-------------------------~~~~~gt~~y~aPE~ 112 (268)
+||+|||++..... . .. ..+.+|||-|+|||+
T Consensus 280 iKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEV 359 (550)
T KOG0605|consen 280 IKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEV 359 (550)
T ss_pred EeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHH
Confidence 99999999841100 0 00 013469999999999
Q ss_pred ccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH---hccCCCCCCCCcHHHHHHHHhccccCC
Q 024408 113 YSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAA---FKNVRPSAENVPEELSIILTSCWKEDP 189 (268)
Q Consensus 113 ~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~l~~li~~~l~~~p 189 (268)
+.+ ..|+..+|.|||||++|||+.|.+||.+..+.+....+. .....|....++.+..++|.+||. ||
T Consensus 360 ll~--------kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~ 430 (550)
T KOG0605|consen 360 LLG--------KGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DP 430 (550)
T ss_pred Hhc--------CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CH
Confidence 975 668999999999999999999999999877665544333 233456677788999999999999 99
Q ss_pred CCCC---CHHHHHHHH
Q 024408 190 NARP---NFTQIIQML 202 (268)
Q Consensus 190 ~~Rp---s~~~~~~~l 202 (268)
.+|. .++||..|.
T Consensus 431 ~~RLG~~G~~EIK~HP 446 (550)
T KOG0605|consen 431 ENRLGSKGAEEIKKHP 446 (550)
T ss_pred HHhcCcccHHHHhcCC
Confidence 9996 588888774
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=262.78 Aligned_cols=190 Identities=26% Similarity=0.385 Sum_probs=158.0
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ .++.+++||||++||+|.+++.+... +++..+..++.|++.||+|||++|++||||||+|||++.+ +
T Consensus 56 ~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~ 132 (323)
T cd05595 56 FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV--FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD-G 132 (323)
T ss_pred CCcceeeEEecCCEEEEEEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCC-C
Confidence 578888888 55689999999999999999876544 9999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccc-ccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESL-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.++|+|||++..... ........|++.|+|||++.+ ..++.++|+||||+++|+|++|+.||...+.....
T Consensus 133 ~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~ 204 (323)
T cd05595 133 HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED--------NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF 204 (323)
T ss_pred CEEecccHHhccccCCCCccccccCCcCcCCcccccC--------CCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHH
Confidence 999999999875322 222334578999999999864 56788999999999999999999999876554433
Q ss_pred HHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCC-----CHHHHHHHH
Q 024408 159 YAAAFKNVRPSAENVPEELSIILTSCWKEDPNARP-----NFTQIIQML 202 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~~~~~l 202 (268)
.... ......+..+++++.++|.+||..||.+|+ ++.++++|-
T Consensus 205 ~~~~-~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~ 252 (323)
T cd05595 205 ELIL-MEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR 252 (323)
T ss_pred HHHh-cCCCCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCC
Confidence 3322 222334567899999999999999999998 899998873
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=254.17 Aligned_cols=195 Identities=25% Similarity=0.474 Sum_probs=162.3
Q ss_pred CceeEEEeecCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCC
Q 024408 1 MREQFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT 80 (268)
Q Consensus 1 ~~v~l~g~~~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~ 80 (268)
++++++|++.++..++||||+++++|.+++.+... +++..+..++.|++.||+|||++|++||||||.||+++.+ +.
T Consensus 57 ~i~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~-~~ 133 (257)
T cd05116 57 YIVRMIGICEAESWMLVMELAELGPLNKFLQKNKH--VTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQ-HY 133 (257)
T ss_pred CcceEEEEEcCCCcEEEEecCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCC-Ce
Confidence 57899999987888999999999999999976543 9999999999999999999999999999999999999988 68
Q ss_pred eEEecCCCccccccccc----cccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChH
Q 024408 81 IKLADFGLAREESLTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNL 155 (268)
Q Consensus 81 ~kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~~~ 155 (268)
++|+|||++........ .....++..|+|||.+.. ..++.++|+||||+++||+++ |..||......
T Consensus 134 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 205 (257)
T cd05116 134 AKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNY--------YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN 205 (257)
T ss_pred EEECCCccccccCCCCCeeeecCCCCCCccccCHhHhcc--------CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999975433221 112234578999998753 457789999999999999998 99999876655
Q ss_pred HHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhH
Q 024408 156 QAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 206 (268)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 206 (268)
+...........+.+..+++++.++|.+||+.||.+||++.+|.+.|++++
T Consensus 206 ~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~~ 256 (257)
T cd05116 206 EVTQMIESGERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNYY 256 (257)
T ss_pred HHHHHHHCCCCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhccc
Confidence 544444443344456778999999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=249.19 Aligned_cols=199 Identities=22% Similarity=0.359 Sum_probs=171.6
Q ss_pred CceeEEEeecC-CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGACKE-PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~~~-~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
++|+|.+.+.. .+.++|+|.|+.|.|+|++...-. +++.....++.|++.|++|||.++|+||||||+|||+++++
T Consensus 84 ~II~l~D~yes~sF~FlVFdl~prGELFDyLts~Vt--lSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~- 160 (411)
T KOG0599|consen 84 YIIDLQDVYESDAFVFLVFDLMPRGELFDYLTSKVT--LSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNM- 160 (411)
T ss_pred cEEEeeeeccCcchhhhhhhhcccchHHHHhhhhee--ecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeecccc-
Confidence 46889999955 588999999999999999987555 99999999999999999999999999999999999999995
Q ss_pred CeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 024408 80 TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY 159 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~ 159 (268)
+++|+|||++............+||++|.|||.+.+..+.. ...|+...|.||.|+++|-|+.|.+||......--..
T Consensus 161 ~i~isDFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~--~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR 238 (411)
T KOG0599|consen 161 NIKISDFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYEN--HPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLR 238 (411)
T ss_pred ceEEeccceeeccCCchhHHHhcCCCcccChhheeeecccC--CCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHH
Confidence 89999999999888888888899999999999997643322 3457889999999999999999999998655444444
Q ss_pred HHHhcc---CCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 024408 160 AAAFKN---VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 204 (268)
Q Consensus 160 ~~~~~~---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~ 204 (268)
.++.+. ..|...+++...+++|.+||+.||.+|.|+++++.|-..
T Consensus 239 ~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff 286 (411)
T KOG0599|consen 239 MIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFF 286 (411)
T ss_pred HHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHH
Confidence 444443 345567889999999999999999999999999998554
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=260.02 Aligned_cols=192 Identities=26% Similarity=0.387 Sum_probs=167.6
Q ss_pred CceeEEEeecC-CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGACKE-PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~~~-~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
++|+++..+.. +.++|||||..||.|+|+|.+++. +++.++..+++||++|+.|||.++++|||||.+|||+|.+ +
T Consensus 114 hII~IyEVFENkdKIvivMEYaS~GeLYDYiSer~~--LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N-~ 190 (668)
T KOG0611|consen 114 HIIQIYEVFENKDKIVIVMEYASGGELYDYISERGS--LSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQN-N 190 (668)
T ss_pred ceeehhhhhcCCceEEEEEEecCCccHHHHHHHhcc--ccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCC-C
Confidence 46888888855 589999999999999999998877 9999999999999999999999999999999999999999 6
Q ss_pred CeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 024408 80 TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY 159 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~ 159 (268)
++||+|||++..+.......+++|++-|.+||++++. -.-++..|.||||++||-|+.|..||++.+......
T Consensus 191 NiKIADFGLSNly~~~kfLqTFCGSPLYASPEIvNG~-------PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvr 263 (668)
T KOG0611|consen 191 NIKIADFGLSNLYADKKFLQTFCGSPLYASPEIVNGT-------PYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVR 263 (668)
T ss_pred CeeeeccchhhhhccccHHHHhcCCcccCCccccCCC-------CCCCCccchhhHHHHHHHHhhcccccCCchHHHHHH
Confidence 9999999999988888888999999999999999862 344678999999999999999999999866554444
Q ss_pred HHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 024408 160 AAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 204 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~ 204 (268)
++..+... .+.-|.....+|++||..||++|.|+.+|..|.|-
T Consensus 264 QIs~GaYr--EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWv 306 (668)
T KOG0611|consen 264 QISRGAYR--EPETPSDASGLIRWMLMVNPERRATIEDIASHWWV 306 (668)
T ss_pred Hhhccccc--CCCCCchHHHHHHHHHhcCcccchhHHHHhhhhee
Confidence 43333222 33456788999999999999999999999999874
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=276.73 Aligned_cols=192 Identities=26% Similarity=0.415 Sum_probs=162.4
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED 77 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~ 77 (268)
|+|++++++ .+++.+|||||++||+|.+++.+. ....+++.++..++.|++.||.|||++||+||||||+|||++.+
T Consensus 126 niv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~ 205 (478)
T PTZ00267 126 GIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPT 205 (478)
T ss_pred CEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCC
Confidence 589999999 567899999999999999988653 23358999999999999999999999999999999999999988
Q ss_pred CCCeEEecCCCcccccccc---ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh
Q 024408 78 LKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN 154 (268)
Q Consensus 78 ~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~ 154 (268)
+.+||+|||+++...... ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.....
T Consensus 206 -~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~ 276 (478)
T PTZ00267 206 -GIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWER--------KRYSKKADMWSLGVILYELLTLHRPFKGPSQ 276 (478)
T ss_pred -CcEEEEeCcCceecCCccccccccccCCCccccCHhHhCC--------CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 699999999998543322 2334569999999998854 5678899999999999999999999987666
Q ss_pred HHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 155 LQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
.+...........+.+..++.++.++|.+||..||++||++.+++.+
T Consensus 277 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 277 REIMQQVLYGKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred HHHHHHHHhCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 55555544444555567788999999999999999999999999764
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=264.37 Aligned_cols=189 Identities=29% Similarity=0.436 Sum_probs=156.7
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++.+ .+++.++||||++||+|.+++..... +++.++..++.|++.||.|||++||+||||||+||+++.+ +
T Consensus 57 ~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~--~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~-~ 133 (316)
T cd05592 57 FLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGR--FDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKD-G 133 (316)
T ss_pred CccceeeEEEcCCEEEEEEcCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCC-C
Confidence 578889888 55689999999999999999987554 9999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccc-ccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESL-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.+||+|||+++.... ........||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+....+..
T Consensus 134 ~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~ 205 (316)
T cd05592 134 HIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKG--------QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELF 205 (316)
T ss_pred CEEEccCcCCeECCCCCCccccccCCccccCHHHHcC--------CCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 999999999975322 223344578999999999864 45788999999999999999999999876654433
Q ss_pred HHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHH-HHHHH
Q 024408 159 YAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFT-QIIQM 201 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~-~~~~~ 201 (268)
.. ........+..++.++.+++.+||..||.+||++. +++++
T Consensus 206 ~~-i~~~~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05592 206 DS-ILNDRPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQH 248 (316)
T ss_pred HH-HHcCCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 33 33333344567889999999999999999999875 66565
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=264.03 Aligned_cols=195 Identities=23% Similarity=0.304 Sum_probs=164.8
Q ss_pred CceeEEEeecC---CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCC
Q 024408 1 MREQFIGACKE---PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED 77 (268)
Q Consensus 1 ~~v~l~g~~~~---~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~ 77 (268)
|||+|.|...+ +.+|||+|||+ -+|.-++...+ -.|++.++..++.||+.||+|||++||+|||||.+||||+++
T Consensus 177 NIikL~eivt~~~~~siYlVFeYMd-hDL~GLl~~p~-vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~ 254 (560)
T KOG0600|consen 177 NIIKLEEIVTSKLSGSIYLVFEYMD-HDLSGLLSSPG-VKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNN 254 (560)
T ss_pred cccceeeEEEecCCceEEEEEeccc-chhhhhhcCCC-cccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCC
Confidence 78999999833 48999999997 58998887633 349999999999999999999999999999999999999999
Q ss_pred CCCeEEecCCCccccccc--cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH
Q 024408 78 LKTIKLADFGLAREESLT--EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL 155 (268)
Q Consensus 78 ~~~~kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~ 155 (268)
|.+||+|||+|+.+... ....+.+.|.||+|||.+.+ ...|+.+.|+||.||++.||++|++.+++....
T Consensus 255 -G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG-------~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEv 326 (560)
T KOG0600|consen 255 -GVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLG-------ATSYGTAVDLWSVGCILAELFLGKPILQGRTEV 326 (560)
T ss_pred -CCEEeccccceeeccCCCCcccccceEEeeccChHHhcC-------CcccccceeehhhhHHHHHHHcCCCCcCCccHH
Confidence 79999999999954443 34667788999999999986 468999999999999999999999999998877
Q ss_pred HHHHHHHhccCCCCC----------------------------CCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHh
Q 024408 156 QAAYAAAFKNVRPSA----------------------------ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 207 (268)
Q Consensus 156 ~~~~~~~~~~~~~~~----------------------------~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 207 (268)
++...+......|.. ..++....+|+..+|..||.+|.|+.+++++ +++.
T Consensus 327 eQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s--eyF~ 404 (560)
T KOG0600|consen 327 EQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS--EYFT 404 (560)
T ss_pred HHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC--cccc
Confidence 776655443322221 2356778889999999999999999999987 5663
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=259.99 Aligned_cols=195 Identities=25% Similarity=0.454 Sum_probs=165.4
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|||+.+..+ .+..+|+||.||.+||+.+.+...-+..+++..+..+++++++||.|||.+|.+|||||+.||||+.+ |
T Consensus 85 NIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~d-G 163 (516)
T KOG0582|consen 85 NIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSD-G 163 (516)
T ss_pred CcceEEEEEEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCC-C
Confidence 678888887 67789999999999999999998777779999999999999999999999999999999999999999 7
Q ss_pred CeEEecCCCccccccc-c---c-cccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh
Q 024408 80 TIKLADFGLAREESLT-E---M-MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN 154 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~-~---~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~ 154 (268)
.|||+|||.+-..... . . ..+.+||++|||||++.. ....|+.++||||||++..||.+|..||..+.+
T Consensus 164 ~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q------~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP 237 (516)
T KOG0582|consen 164 TVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQ------QLHGYDFKADIWSFGITACELAHGHAPFSKYPP 237 (516)
T ss_pred cEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhh------cccCccchhhhhhhhHHHHHHhcCCCCcccCCh
Confidence 9999999976522111 1 1 156689999999999643 246689999999999999999999999999998
Q ss_pred HHHHHHHHhccCCC---------CCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 024408 155 LQAAYAAAFKNVRP---------SAENVPEELSIILTSCWKEDPNARPNFTQIIQML 202 (268)
Q Consensus 155 ~~~~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l 202 (268)
.+............ ....++..+++++..||..||.+|||+.+++++-
T Consensus 238 mkvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~ 294 (516)
T KOG0582|consen 238 MKVLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHA 294 (516)
T ss_pred HHHHHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccH
Confidence 88777655444321 1234667899999999999999999999999873
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=253.30 Aligned_cols=199 Identities=25% Similarity=0.360 Sum_probs=167.6
Q ss_pred CceeEEEeecC-----CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEe
Q 024408 1 MREQFIGACKE-----PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 75 (268)
Q Consensus 1 ~~v~l~g~~~~-----~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~ 75 (268)
++|+++..+.. .++.+|||+++||.|+..|++++...|++.++.+|+.||..|+.|||+.+|.||||||+|+|..
T Consensus 116 ~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt 195 (400)
T KOG0604|consen 116 HIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYT 195 (400)
T ss_pred ceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeee
Confidence 57888888753 4789999999999999999999988899999999999999999999999999999999999996
Q ss_pred CC--CCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 024408 76 ED--LKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS 153 (268)
Q Consensus 76 ~~--~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~ 153 (268)
.+ ...+||+|||+|+.........+.+-|+.|.|||++.. ..|+...|+||+|+++|-|++|.+||.+..
T Consensus 196 ~t~~na~lKLtDfGFAK~t~~~~~L~TPc~TPyYvaPevlg~--------eKydkscdmwSlgVimYIlLCGyPPFYS~h 267 (400)
T KOG0604|consen 196 TTSPNAPLKLTDFGFAKETQEPGDLMTPCFTPYYVAPEVLGP--------EKYDKSCDMWSLGVIMYILLCGYPPFYSNH 267 (400)
T ss_pred cCCCCcceEecccccccccCCCccccCCcccccccCHHHhCc--------hhcCCCCCccchhHHHHHhhcCCCcccccC
Confidence 43 24689999999998776677778889999999999854 668899999999999999999999997655
Q ss_pred hHH---HHHH----HHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHh
Q 024408 154 NLQ---AAYA----AAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 207 (268)
Q Consensus 154 ~~~---~~~~----~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 207 (268)
... .... .......+....++++.+++|+.+|+.+|.+|.|+.+++++-|-...
T Consensus 268 g~aispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~ 328 (400)
T KOG0604|consen 268 GLAISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQY 328 (400)
T ss_pred CccCChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccc
Confidence 321 1111 12233344566788999999999999999999999999998654333
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=261.47 Aligned_cols=190 Identities=26% Similarity=0.390 Sum_probs=157.8
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ .++.+++||||++||+|.+++..... +++.++..++.|++.||+|||++||+||||||+|||++.+ +
T Consensus 56 ~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~-~ 132 (328)
T cd05593 56 FLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERV--FSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKD-G 132 (328)
T ss_pred CCcceEEEEEcCCEEEEEEeCCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCC-C
Confidence 478888888 55689999999999999999876544 9999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccc-ccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESL-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.+||+|||+++.... ........||+.|+|||++.+ ..++.++||||||+++|+|++|+.||...+..+..
T Consensus 133 ~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~ 204 (328)
T cd05593 133 HIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLED--------NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF 204 (328)
T ss_pred cEEEecCcCCccCCCcccccccccCCcCccChhhhcC--------CCCCccCCccccchHHHHHhhCCCCCCCCCHHHHH
Confidence 999999999875322 222344578999999999854 56788999999999999999999999875544333
Q ss_pred HHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCC-----CHHHHHHHH
Q 024408 159 YAAAFKNVRPSAENVPEELSIILTSCWKEDPNARP-----NFTQIIQML 202 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~~~~~l 202 (268)
.. ........+..++.++.++|.+||..||.+|+ ++.++++|.
T Consensus 205 ~~-~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~ 252 (328)
T cd05593 205 EL-ILMEDIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHS 252 (328)
T ss_pred HH-hccCCccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCC
Confidence 22 22223334567889999999999999999997 899999874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=251.40 Aligned_cols=196 Identities=24% Similarity=0.515 Sum_probs=161.9
Q ss_pred CceeEEEeecCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCC
Q 024408 1 MREQFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT 80 (268)
Q Consensus 1 ~~v~l~g~~~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~ 80 (268)
++|+++|+|..+..++||||++|++|.+++..... .+++.+++.++.|++.||.|||++|++||||||+||+++.+ +.
T Consensus 56 ~ii~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~-~~ 133 (257)
T cd05115 56 YIVRMIGVCEAEALMLVMEMASGGPLNKFLSGKKD-EITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQ-HY 133 (257)
T ss_pred CeEEEEEEEcCCCeEEEEEeCCCCCHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCC-Cc
Confidence 57899999987889999999999999999875433 49999999999999999999999999999999999999988 68
Q ss_pred eEEecCCCccccccccc----cccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChH
Q 024408 81 IKLADFGLAREESLTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNL 155 (268)
Q Consensus 81 ~kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~~~ 155 (268)
++|+|||++........ .....++..|+|||.+.+ ..++.++|+||||+++|++++ |..||.+....
T Consensus 134 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~ 205 (257)
T cd05115 134 AKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINF--------RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP 205 (257)
T ss_pred EEeccCCccccccCCccceeccCCCCCCcccCCHHHHcc--------CCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH
Confidence 99999999974332211 111223568999998753 457789999999999999996 99999887665
Q ss_pred HHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhH
Q 024408 156 QAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 206 (268)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 206 (268)
..............+..+++++.+++.+||..+|++||++.++.+.|+.++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~~ 256 (257)
T cd05115 206 EVMSFIEQGKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTYY 256 (257)
T ss_pred HHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhhc
Confidence 554444444444456678899999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=264.34 Aligned_cols=189 Identities=27% Similarity=0.392 Sum_probs=157.6
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ ..+.+++||||++||+|.+++.+... +++..+..++.|++.||.|||++|++||||||+||+++.+ +
T Consensus 57 ~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~~~~~--l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~-~ 133 (320)
T cd05590 57 FLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRR--FDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHE-G 133 (320)
T ss_pred chhceeeEEEcCCEEEEEEcCCCCchHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCC-C
Confidence 578899988 45689999999999999999987554 9999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccc-cccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREES-LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.++|+|||+++... .........||+.|+|||++.+ ..++.++|+||||+++|+|++|+.||......+..
T Consensus 134 ~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~ 205 (320)
T cd05590 134 HCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQE--------MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLF 205 (320)
T ss_pred cEEEeeCCCCeecCcCCCcccccccCccccCHHHHcC--------CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHH
Confidence 99999999987532 2223344578999999998854 55788999999999999999999999876654433
Q ss_pred HHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCH------HHHHHH
Q 024408 159 YAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNF------TQIIQM 201 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~------~~~~~~ 201 (268)
.. ........+..++.++.++|.+||..||.+||++ +++++|
T Consensus 206 ~~-i~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 206 EA-ILNDEVVYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred HH-HhcCCCCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 33 3333334456789999999999999999999998 777766
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=261.74 Aligned_cols=189 Identities=26% Similarity=0.342 Sum_probs=155.9
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
++|++++.+ ..+..++||||++||+|.+++.+.+. +++..+..++.|++.||.|||++|++||||||+|||++.+ +
T Consensus 57 ~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~-~ 133 (323)
T cd05575 57 FLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERS--FPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQ-G 133 (323)
T ss_pred CCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCC-C
Confidence 578888888 45688999999999999999987544 9999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccc-ccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESL-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.+||+|||+++.... ........||+.|+|||++.+ ..++.++||||||+++|+|++|..||......+..
T Consensus 134 ~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~ 205 (323)
T cd05575 134 HVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRK--------QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMY 205 (323)
T ss_pred cEEEeccCCCcccccCCCccccccCChhhcChhhhcC--------CCCCccccccccchhhhhhhcCCCCCCCCCHHHHH
Confidence 999999999875322 223344578999999999864 55788999999999999999999999876554433
Q ss_pred HHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCH----HHHHHH
Q 024408 159 YAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNF----TQIIQM 201 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~----~~~~~~ 201 (268)
.. ...........++..+.++|.+||+.||.+||++ .+++++
T Consensus 206 ~~-i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~ 251 (323)
T cd05575 206 DN-ILNKPLRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNH 251 (323)
T ss_pred HH-HHcCCCCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcC
Confidence 33 3333333456679999999999999999999987 466654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=271.34 Aligned_cols=187 Identities=25% Similarity=0.435 Sum_probs=159.4
Q ss_pred ceeEEEeec-CCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCC
Q 024408 2 REQFIGACK-EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT 80 (268)
Q Consensus 2 ~v~l~g~~~-~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~ 80 (268)
+++|++++. .+++|.||||+.||++..++ +. ..|++..+.-+++.++.||+|||++||+|||||.+|||+|.. |.
T Consensus 431 L~~L~~~fQT~~~l~fvmey~~Ggdm~~~~-~~--~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~e-Gh 506 (694)
T KOG0694|consen 431 LVNLFSCFQTKEHLFFVMEYVAGGDLMHHI-HT--DVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTE-GH 506 (694)
T ss_pred EeecccccccCCeEEEEEEecCCCcEEEEE-ec--ccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEccc-Cc
Confidence 467888884 46899999999999944333 22 339999999999999999999999999999999999999999 79
Q ss_pred eEEecCCCccccc-cccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 024408 81 IKLADFGLAREES-LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY 159 (268)
Q Consensus 81 ~kl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~ 159 (268)
+||+|||+++..- ......+.+||+.|+|||++.+ ..|+++.|.|||||++|||+.|..||++.+. +...
T Consensus 507 ~kiADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e--------~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE-ee~F 577 (694)
T KOG0694|consen 507 VKIADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTE--------QSYTRAVDWWGLGVLLYEMLVGESPFPGDDE-EEVF 577 (694)
T ss_pred EEecccccccccCCCCCccccccCChhhcChhhhcc--------CcccchhhHHHHHHHHHHHHcCCCCCCCCCH-HHHH
Confidence 9999999999644 5667788999999999999975 7899999999999999999999999998554 4444
Q ss_pred HHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 024408 160 AAAFKNVRPSAENVPEELSIILTSCWKEDPNARPN-----FTQIIQM 201 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~~~~~~ 201 (268)
..+.......+..++.+...|++++|..+|++|.. +.+|..|
T Consensus 578 dsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~h 624 (694)
T KOG0694|consen 578 DSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKH 624 (694)
T ss_pred HHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhC
Confidence 45555556668889999999999999999999964 4566554
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=261.60 Aligned_cols=189 Identities=26% Similarity=0.317 Sum_probs=154.7
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
++|++++.+ ..+..++||||++|++|.+++.+... +++.++..++.|++.||.|||++|++||||||+||+++.+ +
T Consensus 57 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~-~ 133 (321)
T cd05603 57 FLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERC--FLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQ-G 133 (321)
T ss_pred CccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCC-C
Confidence 578899888 55689999999999999998876544 8999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccc-cccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREES-LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.+||+|||+++... .........||+.|+|||++.+ ..++.++||||||+++|+|++|..||...+..+..
T Consensus 134 ~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~ 205 (321)
T cd05603 134 HVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRK--------EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMY 205 (321)
T ss_pred CEEEccCCCCccCCCCCCccccccCCcccCCHHHhcC--------CCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHH
Confidence 99999999987532 2223344578999999999854 45778999999999999999999999876544333
Q ss_pred HHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHH----HHHHH
Q 024408 159 YAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFT----QIIQM 201 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~----~~~~~ 201 (268)
..........+...+.++.++|.+||+.+|.+|++.. +++++
T Consensus 206 -~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~ 251 (321)
T cd05603 206 -DNILHKPLQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNH 251 (321)
T ss_pred -HHHhcCCCCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCC
Confidence 3333333444567789999999999999999998753 55544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=254.44 Aligned_cols=195 Identities=32% Similarity=0.585 Sum_probs=162.1
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRP--------------RCLDVCVAIGFALDIARAMECLHSHGIIHR 65 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~--------------~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~ 65 (268)
+++++++++ .++..+++|||++|++|.+++..... ..+++.+++.++.|++.||.|||++|++|+
T Consensus 69 ~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~ 148 (283)
T cd05048 69 NIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHR 148 (283)
T ss_pred ccceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeecc
Confidence 478999998 45678999999999999999976422 348899999999999999999999999999
Q ss_pred CCCCCCEEEeCCCCCeEEecCCCcccccccc---ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHH
Q 024408 66 DLKPENLLLTEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWEL 142 (268)
Q Consensus 66 Dikp~Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~l 142 (268)
||||+||+++++ +.++|+|||+++...... ......++..|+|||.+.+ ..++.++|+||||+++|||
T Consensus 149 dlkp~Nil~~~~-~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~sDv~slG~il~el 219 (283)
T cd05048 149 DLAARNCLVGEG-LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILY--------GKFTTESDIWSFGVVLWEI 219 (283)
T ss_pred ccccceEEEcCC-CcEEECCCcceeeccccccccccCCCcccccccCHHHhcc--------CcCchhhhHHHHHHHHHHH
Confidence 999999999988 689999999997533221 1223456788999998754 5578899999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 024408 143 LH-NKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 204 (268)
Q Consensus 143 l~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~ 204 (268)
++ |..||.+....+...........+.+..+++++.+++.+||+.||.+||++.+++++|+.
T Consensus 220 ~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 220 FSYGLQPYYGFSNQEVIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 98 999998866655544444444445567889999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=255.32 Aligned_cols=191 Identities=26% Similarity=0.388 Sum_probs=162.1
Q ss_pred ceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCC
Q 024408 2 REQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT 80 (268)
Q Consensus 2 ~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~ 80 (268)
+..||+.+ .+++.|||||||+||+|..+++++..+.|++..++-++.+++.||+|||..|||+|||||+|||+.++ |+
T Consensus 139 lPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvred-GH 217 (459)
T KOG0610|consen 139 LPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVRED-GH 217 (459)
T ss_pred cchhhheeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecC-Cc
Confidence 45788888 45689999999999999999999999999999999999999999999999999999999999999999 79
Q ss_pred eEEecCCCccccc----------------------------------c-c----------------------cccccCCC
Q 024408 81 IKLADFGLAREES----------------------------------L-T----------------------EMMTAETG 103 (268)
Q Consensus 81 ~kl~Dfg~a~~~~----------------------------------~-~----------------------~~~~~~~g 103 (268)
+.|+||.++.... . . ....+.+|
T Consensus 218 IMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVG 297 (459)
T KOG0610|consen 218 IMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVG 297 (459)
T ss_pred EEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccc
Confidence 9999999873100 0 0 01224579
Q ss_pred ccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCC-CCCCCCcHHHHHHHH
Q 024408 104 TYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR-PSAENVPEELSIILT 182 (268)
Q Consensus 104 t~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~ 182 (268)
|..|.|||++++ ..-+.+.|.|+||+++|||+.|..||.+....+....+...... +....++..+++||+
T Consensus 298 ThEYlAPEvI~G--------~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr 369 (459)
T KOG0610|consen 298 THEYLAPEVIRG--------EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIR 369 (459)
T ss_pred ccccccceeeec--------CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHH
Confidence 999999999976 34467899999999999999999999998877776666554433 344577899999999
Q ss_pred hccccCCCCCCC----HHHHHHH
Q 024408 183 SCWKEDPNARPN----FTQIIQM 201 (268)
Q Consensus 183 ~~l~~~p~~Rps----~~~~~~~ 201 (268)
++|.+||.+|.. +++|.+|
T Consensus 370 ~LLvKdP~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 370 KLLVKDPSKRLGSKRGAAEIKRH 392 (459)
T ss_pred HHhccChhhhhccccchHHhhcC
Confidence 999999999987 8999887
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=262.86 Aligned_cols=189 Identities=24% Similarity=0.346 Sum_probs=157.0
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
++|++++++ .++..++||||++||+|.+++.+.+. +++..+..++.|++.||.|||++|++||||||+||+++.+ +
T Consensus 54 ~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~-~ 130 (312)
T cd05585 54 FIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGR--FDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQ-G 130 (312)
T ss_pred cEeceeeEEecCCeEEEEEcCCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCC-C
Confidence 578899988 55689999999999999999987544 9999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccc-ccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESL-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.++|+|||+++.... ........||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+....+..
T Consensus 131 ~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~ 202 (312)
T cd05585 131 HIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLG--------HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMY 202 (312)
T ss_pred cEEEEECcccccCccCCCccccccCCcccCCHHHHcC--------CCCCCccceechhHHHHHHHhCCCCcCCCCHHHHH
Confidence 999999999975322 222344578999999999864 56788999999999999999999999875544433
Q ss_pred HHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCC---HHHHHHH
Q 024408 159 YAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPN---FTQIIQM 201 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps---~~~~~~~ 201 (268)
. .........+..+++++.++|.+||..||.+||+ +.++++|
T Consensus 203 ~-~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 203 R-KILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred H-HHHcCCCCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 3 3333333446678899999999999999999975 6777776
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=261.84 Aligned_cols=185 Identities=26% Similarity=0.343 Sum_probs=153.7
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ .++..++||||++||+|.+++.+... +++..+..++.|++.||.|||++|++||||||+||+++.+ +
T Consensus 57 ~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~-~ 133 (325)
T cd05602 57 FLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERC--FLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQ-G 133 (325)
T ss_pred CCCceeEEEEcCCeEEEEEeCCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCC-C
Confidence 578888888 55689999999999999999987544 8899999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccc-cccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREES-LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.++|+|||+++... .........||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+....+..
T Consensus 134 ~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~ 205 (325)
T cd05602 134 HIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHK--------QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY 205 (325)
T ss_pred CEEEccCCCCcccccCCCCcccccCCccccCHHHHcC--------CCCCCccccccccHHHHHHhcCCCCCCCCCHHHHH
Confidence 99999999997532 2223345579999999998864 56788999999999999999999999876554433
Q ss_pred HHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHH
Q 024408 159 YAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQ 197 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 197 (268)
... ..........++..+.++|.+||+.||.+|+++.+
T Consensus 206 ~~i-~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~ 243 (325)
T cd05602 206 DNI-LNKPLQLKPNITNSARHLLEGLLQKDRTKRLGAKD 243 (325)
T ss_pred HHH-HhCCcCCCCCCCHHHHHHHHHHcccCHHHCCCCCC
Confidence 332 23333345678999999999999999999998763
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=263.86 Aligned_cols=192 Identities=27% Similarity=0.339 Sum_probs=155.1
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ .++.+++||||++||+|.+++.+... +++.++..++.|++.||.|||++|++||||||+|||++.+ +
T Consensus 66 ~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~-~ 142 (332)
T cd05614 66 FLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDN--FSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSE-G 142 (332)
T ss_pred CcccEEEEEecCCEEEEEEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCC-C
Confidence 467888888 55688999999999999999987554 9999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccc--cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---h
Q 024408 80 TIKLADFGLAREESLT--EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS---N 154 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~---~ 154 (268)
.++|+|||+++..... .......||..|+|||++.+ ...++.++||||||+++|+|++|+.||.... .
T Consensus 143 ~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 215 (332)
T cd05614 143 HVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRG-------KGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT 215 (332)
T ss_pred CEEEeeCcCCccccccCCCccccccCCccccCHHHhcC-------CCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC
Confidence 9999999999753222 12234578999999999853 2346778999999999999999999996422 1
Q ss_pred HHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCC-----CHHHHHHHH
Q 024408 155 LQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARP-----NFTQIIQML 202 (268)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~~~~~l 202 (268)
.............+.+..++..+.+++.+||..||++|| +++++++|-
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~ 268 (332)
T cd05614 216 QSEVSRRILKCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHP 268 (332)
T ss_pred HHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCC
Confidence 122222233333344567899999999999999999999 788898874
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=261.85 Aligned_cols=188 Identities=26% Similarity=0.398 Sum_probs=155.7
Q ss_pred ceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCC
Q 024408 2 REQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT 80 (268)
Q Consensus 2 ~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~ 80 (268)
++++++++ ..+.+|+||||++||+|.+++..... +++..+..++.|++.||+|||++|++||||||+|||++.+ +.
T Consensus 63 i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~--~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~-~~ 139 (324)
T cd05587 63 LTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGK--FKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAE-GH 139 (324)
T ss_pred eeeeEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCC-CC
Confidence 56778877 45689999999999999999977554 8999999999999999999999999999999999999988 69
Q ss_pred eEEecCCCccccc-cccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 024408 81 IKLADFGLAREES-LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY 159 (268)
Q Consensus 81 ~kl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~ 159 (268)
++|+|||++.... .........||+.|+|||++.+ ..++.++|+||+|+++|+|++|+.||.+....+...
T Consensus 140 ~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~ 211 (324)
T cd05587 140 IKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAY--------QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQ 211 (324)
T ss_pred EEEeecCcceecCCCCCceeeecCCccccChhhhcC--------CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 9999999987432 2223344578999999999864 557889999999999999999999998766544433
Q ss_pred HHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCH-----HHHHHH
Q 024408 160 AAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNF-----TQIIQM 201 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~-----~~~~~~ 201 (268)
.. .......+..++.++.+++.+||..||.+|++. +++++|
T Consensus 212 ~i-~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 212 SI-MEHNVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred HH-HcCCCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 33 333334466789999999999999999999976 677665
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=260.61 Aligned_cols=189 Identities=28% Similarity=0.404 Sum_probs=157.3
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ .+++.++||||++||+|.+++..... +++.++..++.|++.||.|||++|++||||||+||+++.+ +
T Consensus 62 ~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~--l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~-~ 138 (333)
T cd05600 62 WLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGV--LSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDAS-G 138 (333)
T ss_pred CCccEEEEEEcCCEEEEEEeCCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCC-C
Confidence 578999998 55689999999999999999976554 8999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 024408 80 TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY 159 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~ 159 (268)
.+||+|||++..... ......||+.|+|||++.+ ..++.++||||||+++|+|++|..||......+...
T Consensus 139 ~~kL~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~ 208 (333)
T cd05600 139 HIKLTDFGLSKGIVT--YANSVVGSPDYMAPEVLRG--------KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWE 208 (333)
T ss_pred CEEEEeCcCCccccc--ccCCcccCccccChhHhcC--------CCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHH
Confidence 999999999985433 2345578999999999864 467889999999999999999999998765544333
Q ss_pred HHHhcc---CCCCC----CCCcHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 024408 160 AAAFKN---VRPSA----ENVPEELSIILTSCWKEDPNARPNFTQIIQML 202 (268)
Q Consensus 160 ~~~~~~---~~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l 202 (268)
...... ..+.. ..++.++.++|.+||..+|.+||++.+++++.
T Consensus 209 ~i~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~ 258 (333)
T cd05600 209 NLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHP 258 (333)
T ss_pred HHHhccccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCc
Confidence 222111 11111 25689999999999999999999999999984
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=262.68 Aligned_cols=190 Identities=26% Similarity=0.373 Sum_probs=158.3
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ .++.+++||||++||+|.+++.+... +++..+..++.|++.||.|||++|++||||||+||+++.+ +
T Consensus 57 ~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~-~ 133 (321)
T cd05591 57 FLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRK--FDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAE-G 133 (321)
T ss_pred CccceeeEEEcCCeEEEEEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCC-C
Confidence 478899998 55689999999999999999976554 9999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccc-ccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESL-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.++|+|||++..... ........|++.|+|||++.+ ..++.++|+||||+++|+|++|+.||......+..
T Consensus 134 ~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~ 205 (321)
T cd05591 134 HCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQE--------LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLF 205 (321)
T ss_pred CEEEeecccceecccCCccccccccCccccCHHHHcC--------CCCCCccceechhHHHHHHhcCCCCCCCCCHHHHH
Confidence 999999999875322 222344568999999998854 56788999999999999999999999876654443
Q ss_pred HHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCC-------CHHHHHHHH
Q 024408 159 YAAAFKNVRPSAENVPEELSIILTSCWKEDPNARP-------NFTQIIQML 202 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-------s~~~~~~~l 202 (268)
.. ........+..++.++.+++.+||..||++|+ ++.++++|.
T Consensus 206 ~~-i~~~~~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp 255 (321)
T cd05591 206 ES-ILHDDVLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHP 255 (321)
T ss_pred HH-HHcCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCC
Confidence 33 33333334556889999999999999999999 888898874
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=259.51 Aligned_cols=189 Identities=28% Similarity=0.410 Sum_probs=158.0
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ ..+++++||||++||+|.+++.+... +++.++..++.|++.||.|||++|++||||||+||+++.+ +
T Consensus 57 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~-~ 133 (318)
T cd05570 57 FLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGR--FDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSE-G 133 (318)
T ss_pred CccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCC-C
Confidence 578899988 55689999999999999999987554 9999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccc-ccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESL-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.++|+|||+++.... ........|+..|+|||++.+ ..++.++|+||||+++|+|++|+.||.........
T Consensus 134 ~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~ 205 (318)
T cd05570 134 HIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSY--------QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELF 205 (318)
T ss_pred cEEecccCCCeecCcCCCcccceecCccccCHHHhcC--------CCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHH
Confidence 999999999874322 222334568999999999864 56788999999999999999999999876544433
Q ss_pred HHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCH-----HHHHHH
Q 024408 159 YAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNF-----TQIIQM 201 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~-----~~~~~~ 201 (268)
.. ........+..++.++.++|.+||..||.+||++ .+++++
T Consensus 206 ~~-i~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 206 QS-ILEDEVRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred HH-HHcCCCCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 32 3333333456789999999999999999999999 888876
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=261.72 Aligned_cols=188 Identities=23% Similarity=0.314 Sum_probs=158.3
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
++|++++.+ .++..++||||++||+|.+++.+.+. +++..+..++.|++.||+|||++|++||||||+||+++.+ +
T Consensus 79 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~-~ 155 (329)
T PTZ00263 79 FIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGR--FPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNK-G 155 (329)
T ss_pred CCCcEEEEEEcCCEEEEEEcCCCCChHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCC-C
Confidence 578999998 55689999999999999999987554 8999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 024408 80 TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY 159 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~ 159 (268)
.+||+|||+++..... .....|++.|+|||++.+ ..++.++||||||+++|+|++|..||.+....+...
T Consensus 156 ~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~ 225 (329)
T PTZ00263 156 HVKVTDFGFAKKVPDR--TFTLCGTPEYLAPEVIQS--------KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYE 225 (329)
T ss_pred CEEEeeccCceEcCCC--cceecCChhhcCHHHHcC--------CCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 9999999999864332 234578999999999864 456789999999999999999999998765544333
Q ss_pred HHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCC-----HHHHHHHH
Q 024408 160 AAAFKNVRPSAENVPEELSIILTSCWKEDPNARPN-----FTQIIQML 202 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~~~~~~l 202 (268)
. ........+..++..++++|.+||..||.+|++ ++++++|-
T Consensus 226 ~-i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp 272 (329)
T PTZ00263 226 K-ILAGRLKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHP 272 (329)
T ss_pred H-HhcCCcCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCC
Confidence 3 333333445668899999999999999999986 78888874
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=251.71 Aligned_cols=195 Identities=26% Similarity=0.473 Sum_probs=161.0
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
++++++|++ .++..++||||++||+|.+++..... .+++.+++.++.|++.||+|||++|++||||||+||+++.+ +
T Consensus 67 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~-~ 144 (266)
T cd05064 67 NIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEG-QLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSD-L 144 (266)
T ss_pred CcCeEEEEEecCCCcEEEEEeCCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCC-C
Confidence 589999998 55689999999999999999986433 48999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccccccc--ccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 024408 80 TIKLADFGLAREESLTEMM--TAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQ 156 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~~~~ 156 (268)
.++++|||.+......... ....++..|+|||.+.+ ..++.++||||||+++|++++ |..||......+
T Consensus 145 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~ 216 (266)
T cd05064 145 VCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQY--------HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD 216 (266)
T ss_pred cEEECCCcccccccccchhcccCCCCceeecCHHHHhh--------CCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH
Confidence 9999999987653222111 12335678999998854 567889999999999999775 999998876655
Q ss_pred HHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHh
Q 024408 157 AAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 205 (268)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~ 205 (268)
...........+.+..++..+.+++.+||+.+|.+||++.++++.|...
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 217 VIKAVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred HHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 4444444444456778899999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=250.79 Aligned_cols=196 Identities=29% Similarity=0.526 Sum_probs=161.1
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ .++.+++||||+++++|.+++.......+++..++.++.|++.||+|||++|++||||||+||+++++ +
T Consensus 63 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~-~ 141 (263)
T cd05052 63 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN-H 141 (263)
T ss_pred ChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCC-C
Confidence 478899998 55688999999999999999987655569999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccccccc--ccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 024408 80 TIKLADFGLAREESLTEMM--TAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQ 156 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~~~~ 156 (268)
.++|+|||++......... ....++..|+|||.+.+ ..++.++||||||+++|+|++ |..||.+....+
T Consensus 142 ~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~ 213 (263)
T cd05052 142 LVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY--------NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 213 (263)
T ss_pred cEEeCCCccccccccceeeccCCCCCccccCCHHHhcc--------CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 9999999999754332211 11233567999998754 557789999999999999998 999998765544
Q ss_pred HHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHh
Q 024408 157 AAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 205 (268)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~ 205 (268)
.............+..++.++.+++.+||..+|++||++.++++.|+.+
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 214 VYELLEKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred HHHHHHCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 3333333333445677899999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=258.72 Aligned_cols=189 Identities=25% Similarity=0.329 Sum_probs=157.6
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ .++.+++||||++||+|.+++.+.+. +++..+..++.|++.||+|||++|++||||||+||+++.+ +
T Consensus 62 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~-~ 138 (291)
T cd05612 62 FIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGR--FSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKE-G 138 (291)
T ss_pred cHhhhHhhhccCCeEEEEEeCCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCC-C
Confidence 467888888 45688999999999999999987554 9999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 024408 80 TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY 159 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~ 159 (268)
.++|+|||+++..... .....|++.|+|||++.+ ..++.++||||||+++|+|++|+.||.+........
T Consensus 139 ~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~ 208 (291)
T cd05612 139 HIKLTDFGFAKKLRDR--TWTLCGTPEYLAPEVIQS--------KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYE 208 (291)
T ss_pred CEEEEecCcchhccCC--cccccCChhhcCHHHHcC--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 9999999999854322 234578999999998854 456789999999999999999999998766544433
Q ss_pred HHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCC-----HHHHHHHHH
Q 024408 160 AAAFKNVRPSAENVPEELSIILTSCWKEDPNARPN-----FTQIIQMLL 203 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~~~~~~l~ 203 (268)
... ......+..++..++++|.+||..||.+||+ +.++++|.+
T Consensus 209 ~i~-~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~ 256 (291)
T cd05612 209 KIL-AGKLEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRW 256 (291)
T ss_pred HHH-hCCcCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCcc
Confidence 332 2333345667899999999999999999995 899988843
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=261.68 Aligned_cols=190 Identities=27% Similarity=0.370 Sum_probs=158.3
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|++++++++ .++..++||||++|++|.+++.+.+. +.+..+..++.|++.||+|||++|++||||||+||+++.+ +
T Consensus 61 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~-~ 137 (323)
T cd05584 61 FIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGI--FMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQ-G 137 (323)
T ss_pred chhceeeEEecCCeEEEEEeCCCCchHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC-C
Confidence 578899988 55689999999999999999987554 8899999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccc-cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.+||+|||+++..... .......|++.|+|||++.+ ..++.++||||||+++|+|++|+.||.........
T Consensus 138 ~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~ 209 (323)
T cd05584 138 HVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMR--------SGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTI 209 (323)
T ss_pred CEEEeeCcCCeecccCCCcccccCCCccccChhhccC--------CCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHH
Confidence 9999999998743222 22234568999999999864 45678999999999999999999999876654433
Q ss_pred HHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCC-----CHHHHHHHH
Q 024408 159 YAAAFKNVRPSAENVPEELSIILTSCWKEDPNARP-----NFTQIIQML 202 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~~~~~l 202 (268)
... .......+..+++.+.++|.+||..+|.+|| ++.+++++-
T Consensus 210 ~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~ 257 (323)
T cd05584 210 DKI-LKGKLNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHP 257 (323)
T ss_pred HHH-HcCCCCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCC
Confidence 332 2333344667889999999999999999999 899998874
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=253.03 Aligned_cols=199 Identities=28% Similarity=0.504 Sum_probs=164.0
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRP--------------RCLDVCVAIGFALDIARAMECLHSHGIIHR 65 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~--------------~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~ 65 (268)
+++++++++ .++..++||||++|++|.+++..... ..+++..++.++.|++.||+|||++|++||
T Consensus 68 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~ 147 (291)
T cd05094 68 HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHR 147 (291)
T ss_pred CcceEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence 578999999 55688999999999999999976431 238899999999999999999999999999
Q ss_pred CCCCCCEEEeCCCCCeEEecCCCcccccccc---ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHH
Q 024408 66 DLKPENLLLTEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWEL 142 (268)
Q Consensus 66 Dikp~Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~l 142 (268)
||||+||+++.+ +.++|+|||++....... ......++..|+|||.+.+ ..++.++|+||||+++|+|
T Consensus 148 dlkp~Nil~~~~-~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~el 218 (291)
T cd05094 148 DLATRNCLVGAN-LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY--------RKFTTESDVWSFGVILWEI 218 (291)
T ss_pred ccCcceEEEccC-CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhcc--------CCCCchhhHHHHHHHHHHH
Confidence 999999999988 699999999997543221 1223456788999998754 5678899999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 024408 143 LH-NKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 208 (268)
Q Consensus 143 l~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 208 (268)
++ |+.||......+................++..+.+++.+||..+|.+||++.++++.|.+....
T Consensus 219 ~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 219 FTYGKQPWFQLSNTEVIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred HhCCCCCCCCCCHHHHHHHHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 98 9999987665554444333333344566789999999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=247.33 Aligned_cols=215 Identities=27% Similarity=0.319 Sum_probs=172.5
Q ss_pred CceeEEEeecC---CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCC
Q 024408 1 MREQFIGACKE---PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED 77 (268)
Q Consensus 1 ~~v~l~g~~~~---~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~ 77 (268)
|+|++-...-+ +.+|||||||+ -+|..++...+. +|...++..++.|++.||+|||.+.|+|||||++|+|+...
T Consensus 136 NIV~vkEVVvG~~~d~iy~VMe~~E-hDLksl~d~m~q-~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~ 213 (419)
T KOG0663|consen 136 NIVEVKEVVVGSNMDKIYIVMEYVE-HDLKSLMETMKQ-PFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHK 213 (419)
T ss_pred CeeeeEEEEeccccceeeeeHHHHH-hhHHHHHHhccC-CCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccC
Confidence 44555444422 45899999997 699999988774 49999999999999999999999999999999999999988
Q ss_pred CCCeEEecCCCccccccc-cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH
Q 024408 78 LKTIKLADFGLAREESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 156 (268)
Q Consensus 78 ~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~ 156 (268)
|.+||+|||+|+.++.. ......+.|.||+|||.+.+ ...|+.+.|+||+||++.|++++++-|.+....+
T Consensus 214 -G~lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG-------~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~d 285 (419)
T KOG0663|consen 214 -GILKIADFGLAREYGSPLKPYTPLVVTLWYRAPELLLG-------AKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEID 285 (419)
T ss_pred -CcEEecccchhhhhcCCcccCcceEEEeeecCHHHhcC-------CcccCcchhhhhHHHHHHHHHhcCCCCCCCchHH
Confidence 79999999999987665 34455678999999999986 4678999999999999999999999999988777
Q ss_pred HHHHHHhccCCCCCC-------------------------------CCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHh
Q 024408 157 AAYAAAFKNVRPSAE-------------------------------NVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 205 (268)
Q Consensus 157 ~~~~~~~~~~~~~~~-------------------------------~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~ 205 (268)
+...+......|... .+++.-.+++..+|.+||.+|.|+.+.++| .+
T Consensus 286 Ql~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h--~~ 363 (419)
T KOG0663|consen 286 QLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH--EY 363 (419)
T ss_pred HHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc--cc
Confidence 766655444333211 134677889999999999999999999999 77
Q ss_pred HhhcCCC--CCCCCCccccCCCCc
Q 024408 206 LSAIAPP--EPMIPHRIFNSENTI 227 (268)
Q Consensus 206 ~~~~~~~--~~~~~~~~~~~~~~~ 227 (268)
+...+.| +...|.+...++...
T Consensus 364 F~e~P~p~~P~~~Pt~P~k~~~~~ 387 (419)
T KOG0663|consen 364 FRETPLPIDPSMFPTWPAKSEQQR 387 (419)
T ss_pred cccCCCCCChhhcCCCcccccccc
Confidence 7764444 345555554444433
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=263.12 Aligned_cols=190 Identities=25% Similarity=0.425 Sum_probs=155.8
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ .++.+++||||++||+|.+++.+.+. +++..+..++.|++.||.|||++|++||||||+||+++.+ +
T Consensus 57 ~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~--l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~-~ 133 (329)
T cd05588 57 FLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRK--LPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAE-G 133 (329)
T ss_pred CCCceEEEEEcCCEEEEEEeCCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCC-C
Confidence 578999998 55688999999999999999876544 9999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccc-ccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----
Q 024408 80 TIKLADFGLAREE-SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS----- 153 (268)
Q Consensus 80 ~~kl~Dfg~a~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~----- 153 (268)
.++|+|||+++.. ..........||..|+|||++.+ ..++.++|+||||+++|+|++|+.||....
T Consensus 134 ~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~ 205 (329)
T cd05588 134 HIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRG--------EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNP 205 (329)
T ss_pred CEEECcCccccccccCCCccccccCCccccCHHHHcC--------CCCCCccceechHHHHHHHHHCCCCcccccccccc
Confidence 9999999998742 22223345578999999999864 567789999999999999999999996321
Q ss_pred ---hHHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCC------HHHHHHH
Q 024408 154 ---NLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPN------FTQIIQM 201 (268)
Q Consensus 154 ---~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps------~~~~~~~ 201 (268)
..+.............+..++.++.++|.+||+.||.+|++ +.++++|
T Consensus 206 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 206 DQNTEDYLFQVILEKQIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred cccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 11222233333333446678899999999999999999987 6788877
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=256.50 Aligned_cols=191 Identities=27% Similarity=0.382 Sum_probs=156.0
Q ss_pred CceeEEEeec------CCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEE
Q 024408 1 MREQFIGACK------EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL 74 (268)
Q Consensus 1 ~~v~l~g~~~------~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill 74 (268)
|+++++++|. +..+++||||++ ++|.+++.......+++.++..++.|++.||.|||++|++||||||+||++
T Consensus 65 niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~ 143 (290)
T cd07862 65 NVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV 143 (290)
T ss_pred CcceEEEEEecccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE
Confidence 5789999873 346899999996 699999987655569999999999999999999999999999999999999
Q ss_pred eCCCCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh
Q 024408 75 TEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN 154 (268)
Q Consensus 75 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~ 154 (268)
+.+ +.++|+|||+++............|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||.+...
T Consensus 144 ~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DiwslG~il~el~~g~~~f~~~~~ 214 (290)
T cd07862 144 TSS-GQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ--------SSYATPVDLWSVGCIFAEMFRRKPLFRGSSD 214 (290)
T ss_pred cCC-CCEEEccccceEeccCCcccccccccccccChHHHhC--------CCCCCccchHHHHHHHHHHHcCCCCcCCCCH
Confidence 988 6999999999986544444445678999999998854 4577899999999999999999999987665
Q ss_pred HHHHHHHHhccCCC--------------------------CCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 155 LQAAYAAAFKNVRP--------------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 155 ~~~~~~~~~~~~~~--------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
.+...........+ ....++..+.+++.+||+.||++||++.++++|
T Consensus 215 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 215 VDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred HHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 44433322111100 013467788999999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=262.97 Aligned_cols=192 Identities=26% Similarity=0.354 Sum_probs=156.2
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++.+ .....++||||++||+|.+++.+.+. +++..+..++.|++.||+|||++||+||||||+|||++.+ +
T Consensus 57 ~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~-~ 133 (330)
T cd05586 57 FIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGR--FSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDAT-G 133 (330)
T ss_pred cCcceEEEEecCCeEEEEEcCCCCChHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCC-C
Confidence 467788887 45689999999999999999986544 9999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccc-ccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESL-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.++|+|||++..... ........||..|+|||++.+ ...++.++||||||+++|+|++|+.||......+..
T Consensus 134 ~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~ 206 (330)
T cd05586 134 HIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLD-------EKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMY 206 (330)
T ss_pred CEEEecCCcCcCCCCCCCCccCccCCccccCHHHHcC-------CCCCCCccceeccccEEEEeccCCCCCCCCCHHHHH
Confidence 999999999875322 223345679999999998853 234678999999999999999999999876554443
Q ss_pred HHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCC----CHHHHHHHH
Q 024408 159 YAAAFKNVRPSAENVPEELSIILTSCWKEDPNARP----NFTQIIQML 202 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp----s~~~~~~~l 202 (268)
..............++.++.++|.+||..||.+|| ++.++++|-
T Consensus 207 ~~i~~~~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~ 254 (330)
T cd05586 207 RNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHP 254 (330)
T ss_pred HHHHcCCCCCCCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCc
Confidence 33333333333345789999999999999999998 678887763
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=254.21 Aligned_cols=203 Identities=31% Similarity=0.477 Sum_probs=163.6
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRP--------------RCLDVCVAIGFALDIARAMECLHSHGIIHR 65 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~--------------~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~ 65 (268)
+++++++++ .++..++||||+++++|.+++..... ..+++..++.++.|++.||+|||++|++||
T Consensus 64 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~ 143 (297)
T cd05089 64 NIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHR 143 (297)
T ss_pred chhheEEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence 478899998 45678999999999999999976431 248899999999999999999999999999
Q ss_pred CCCCCCEEEeCCCCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-
Q 024408 66 DLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH- 144 (268)
Q Consensus 66 Dikp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~- 144 (268)
||||+||+++.+ +.+||+|||++..............+..|+|||.+.+ ..++.++||||||+++|+|++
T Consensus 144 dlkp~Nill~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwSlG~il~el~t~ 214 (297)
T cd05089 144 DLAARNVLVGEN-LASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNY--------SVYTTKSDVWSFGVLLWEIVSL 214 (297)
T ss_pred cCCcceEEECCC-CeEEECCcCCCccccceeccCCCCcCccccCchhhcc--------CCCCchhhHHHHHHHHHHHHcC
Confidence 999999999988 6899999999874322211122233557999998753 557889999999999999997
Q ss_pred CCCCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhcCCC
Q 024408 145 NKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPP 212 (268)
Q Consensus 145 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~~~~~ 212 (268)
|..||.+....+...........+.+..++.++.+++.+||..+|.+||+++++++.|..........
T Consensus 215 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~~ 282 (297)
T cd05089 215 GGTPYCGMTCAELYEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKAY 282 (297)
T ss_pred CCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhccc
Confidence 99999876655544443333333445678899999999999999999999999999999888765433
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=261.51 Aligned_cols=198 Identities=27% Similarity=0.384 Sum_probs=159.8
Q ss_pred CceeEEEeecCC---cEEEEEEcCCCCCHHHHHHhcCCCC-CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeC
Q 024408 1 MREQFIGACKEP---VMVIVTELLSGGTLRKYLLNMRPRC-LDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE 76 (268)
Q Consensus 1 ~~v~l~g~~~~~---~~~lV~e~~~ggsL~~~i~~~~~~~-~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~ 76 (268)
|||+||.+.+++ .+|||+|||..|.+...= ..+. +++.++++++.+++.||+|||.+||+||||||+|+|++.
T Consensus 169 nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~ 245 (576)
T KOG0585|consen 169 NVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSS 245 (576)
T ss_pred CeeEEEEeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcC
Confidence 799999999764 799999999988775432 2333 899999999999999999999999999999999999999
Q ss_pred CCCCeEEecCCCcccc------ccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 024408 77 DLKTIKLADFGLAREE------SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFE 150 (268)
Q Consensus 77 ~~~~~kl~Dfg~a~~~------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~ 150 (268)
+ |++||+|||.+... +.........||+.|+|||.+.+.. .....+.+.||||+|++||.|+.|+.||-
T Consensus 246 ~-g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~----~~~~~g~a~DiWalGVTLYCllfG~~PF~ 320 (576)
T KOG0585|consen 246 D-GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGN----SFSYSGFALDIWALGVTLYCLLFGQLPFF 320 (576)
T ss_pred C-CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCC----CccccchhhhhhhhhhhHHHhhhccCCcc
Confidence 9 79999999998744 2233344568999999999886521 12345678999999999999999999998
Q ss_pred CCChHHHHHHHHhccC-CCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhH
Q 024408 151 GMSNLQAAYAAAFKNV-RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 206 (268)
Q Consensus 151 ~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 206 (268)
+....+....+..... .|..+.+.+.++++|.+||.+||++|.+..+|..|.+...
T Consensus 321 ~~~~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~ 377 (576)
T KOG0585|consen 321 DDFELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTR 377 (576)
T ss_pred cchHHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceecc
Confidence 7554444444333332 2334557899999999999999999999999999987543
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=264.62 Aligned_cols=197 Identities=30% Similarity=0.529 Sum_probs=158.5
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcC---------------------------------------------
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMR--------------------------------------------- 34 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~--------------------------------------------- 34 (268)
|+|+++|+| .++..++||||++||+|.+++....
T Consensus 103 nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (374)
T cd05106 103 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYV 182 (374)
T ss_pred ceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhccccccccccccccccccc
Confidence 589999999 4568899999999999999986532
Q ss_pred -----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCCeEEecCCCccc
Q 024408 35 -----------------------PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 91 (268)
Q Consensus 35 -----------------------~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~~kl~Dfg~a~~ 91 (268)
...+++.+++.++.|++.||.|||++|++||||||+||+++.+ +.++|+|||+++.
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~-~~~kL~DfGla~~ 261 (374)
T cd05106 183 EMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDG-RVAKICDFGLARD 261 (374)
T ss_pred ccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCC-CeEEEeeceeeee
Confidence 1237888999999999999999999999999999999999987 6899999999975
Q ss_pred cccccc---cccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcc-C
Q 024408 92 ESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKN-V 166 (268)
Q Consensus 92 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~-~ 166 (268)
...... .....++..|+|||++.. ..++.++||||||+++|+|++ |+.||................ .
T Consensus 262 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~ 333 (374)
T cd05106 262 IMNDSNYVVKGNARLPVKWMAPESIFD--------CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQ 333 (374)
T ss_pred ccCCcceeeccCCCCccceeCHHHhcC--------CCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccC
Confidence 332211 122235568999998853 567889999999999999997 999998755443333333222 2
Q ss_pred CCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhH
Q 024408 167 RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 206 (268)
Q Consensus 167 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 206 (268)
...+...++++.+++.+||+.||.+||++.++++.|++.+
T Consensus 334 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 334 MSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred ccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 2334557899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=250.61 Aligned_cols=198 Identities=24% Similarity=0.472 Sum_probs=162.2
Q ss_pred CceeEEEeecCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCC
Q 024408 1 MREQFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT 80 (268)
Q Consensus 1 ~~v~l~g~~~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~ 80 (268)
|+|+++|++.++..++|+||+++|+|.+++..... .+++..+..++.|++.||.|||++|++||||||+||+++++ +.
T Consensus 70 ~iv~~~~~~~~~~~~~i~e~~~~gsL~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~-~~ 147 (279)
T cd05111 70 YIVRLLGICPGASLQLVTQLSPLGSLLDHVRQHRD-SLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSD-SI 147 (279)
T ss_pred CcceEEEEECCCccEEEEEeCCCCcHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCC-Cc
Confidence 57999999987788999999999999999976443 38999999999999999999999999999999999999988 68
Q ss_pred eEEecCCCcccccccc---ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 024408 81 IKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQ 156 (268)
Q Consensus 81 ~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~~~~ 156 (268)
+||+|||+++...... ......++..|++||.+.+ ..++.++||||||+++||+++ |..||.+.....
T Consensus 148 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~--------~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~ 219 (279)
T cd05111 148 VQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILF--------GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE 219 (279)
T ss_pred EEEcCCccceeccCCCcccccCCCCCcccccCHHHhcc--------CCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 9999999997543221 1223346778999998854 557889999999999999998 999998765544
Q ss_pred HHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 024408 157 AAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 208 (268)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 208 (268)
...........+.+..++.++.+++.+||..||.+||++.++++.|....+.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 220 VPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred HHHHHHCCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 3232222233334556788999999999999999999999999988876653
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=263.87 Aligned_cols=188 Identities=24% Similarity=0.331 Sum_probs=158.9
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
++|+++|++ .++..++||||++||+|.+++.+... +++..+..++.|++.||.|||++|++||||||+|||++.+ +
T Consensus 92 ~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~-~ 168 (340)
T PTZ00426 92 FCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKR--FPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKD-G 168 (340)
T ss_pred CCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCC-C
Confidence 588999999 55689999999999999999987554 9999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 024408 80 TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY 159 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~ 159 (268)
.++|+|||++...... .....||+.|+|||++.+ ..++.++|+||||+++|+|++|..||.+........
T Consensus 169 ~ikL~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~ 238 (340)
T PTZ00426 169 FIKMTDFGFAKVVDTR--TYTLCGTPEYIAPEILLN--------VGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQ 238 (340)
T ss_pred CEEEecCCCCeecCCC--cceecCChhhcCHHHHhC--------CCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHH
Confidence 9999999999754322 234578999999999864 456789999999999999999999998765543333
Q ss_pred HHHhccCCCCCCCCcHHHHHHHHhccccCCCCCC-----CHHHHHHHH
Q 024408 160 AAAFKNVRPSAENVPEELSIILTSCWKEDPNARP-----NFTQIIQML 202 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~~~~~l 202 (268)
. ........+..+++.+.++|++||+.||.+|+ +++++++|.
T Consensus 239 ~-i~~~~~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp 285 (340)
T PTZ00426 239 K-ILEGIIYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHP 285 (340)
T ss_pred H-HhcCCCCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCC
Confidence 3 33333344667889999999999999999995 899999884
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=240.12 Aligned_cols=193 Identities=27% Similarity=0.359 Sum_probs=164.5
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeC--C
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE--D 77 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~--~ 77 (268)
++|+|..-. .+++.|||+|+++|++|..-|-++.- +++..+..++.||+.+|.|||.+||+|||+||+|+++.. +
T Consensus 71 ~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV~R~~--ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~ 148 (355)
T KOG0033|consen 71 NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF--YSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAK 148 (355)
T ss_pred cEeehhhhhcccceeEEEEecccchHHHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccC
Confidence 467777777 56789999999999999977765533 899999999999999999999999999999999999953 3
Q ss_pred CCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 024408 78 LKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA 157 (268)
Q Consensus 78 ~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~ 157 (268)
...+||+|||+|.............||+.|+|||+++ +..|+..+|||+-|+++|-|+.|.+||.+.+....
T Consensus 149 ~A~vKL~~FGvAi~l~~g~~~~G~~GtP~fmaPEvvr--------kdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rl 220 (355)
T KOG0033|consen 149 GAAVKLADFGLAIEVNDGEAWHGFAGTPGYLSPEVLK--------KDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL 220 (355)
T ss_pred CCceeecccceEEEeCCccccccccCCCcccCHHHhh--------cCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHH
Confidence 3468999999999877666666778999999999996 47889999999999999999999999998666555
Q ss_pred HHHHHhccC---CCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 024408 158 AYAAAFKNV---RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 203 (268)
Q Consensus 158 ~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~ 203 (268)
..++..... .+....++++.++++++||..||.+|.|+.|.++|-|
T Consensus 221 ye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpW 269 (355)
T KOG0033|consen 221 YEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPW 269 (355)
T ss_pred HHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCch
Confidence 555544333 3456788999999999999999999999999999865
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=258.49 Aligned_cols=190 Identities=25% Similarity=0.414 Sum_probs=156.2
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ ..+.+++||||++||+|.+++...+. +++..+..++.|++.||+|||++|++||||||+||+++.+ +
T Consensus 57 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~-~ 133 (327)
T cd05617 57 FLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRK--LPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDAD-G 133 (327)
T ss_pred CEeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCC-C
Confidence 478899988 55689999999999999999876544 9999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccc-cccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC------
Q 024408 80 TIKLADFGLAREES-LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGM------ 152 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~------ 152 (268)
.++|+|||+++... .........||+.|+|||++.+ ..++.++|+||||+++|+|++|..||...
T Consensus 134 ~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~ 205 (327)
T cd05617 134 HIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRG--------EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDM 205 (327)
T ss_pred CEEEeccccceeccCCCCceecccCCcccCCHHHHCC--------CCCCchheeehhHHHHHHHHhCCCCCCccCCCccc
Confidence 99999999987422 2233345679999999999864 56788999999999999999999999532
Q ss_pred ChHHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCC------HHHHHHH
Q 024408 153 SNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPN------FTQIIQM 201 (268)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps------~~~~~~~ 201 (268)
...+.............+..++..+.+++.+||..||.+|++ +.++++|
T Consensus 206 ~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 206 NTEDYLFQVILEKPIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred ccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 222233333334444456678899999999999999999997 4677776
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=257.70 Aligned_cols=189 Identities=23% Similarity=0.363 Sum_probs=156.7
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|++++++++ ..+..|+||||++|++|..++.+ ..+++..+..++.|++.||.|||++|++||||||+||+++.+ +
T Consensus 63 ~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~-~ 138 (324)
T cd05589 63 FLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTE-G 138 (324)
T ss_pred ChhceeeEEEcCCEEEEEEcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCC-C
Confidence 578999998 55689999999999999988854 239999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccc-ccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESL-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.+||+|||+++.... ........|++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+....+..
T Consensus 139 ~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~ 210 (324)
T cd05589 139 FVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTE--------TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVF 210 (324)
T ss_pred cEEeCcccCCccCCCCCCcccccccCccccCHhHhcC--------CCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 999999999874322 222345678999999999864 56788999999999999999999999876654443
Q ss_pred HHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCC-----CHHHHHHHH
Q 024408 159 YAAAFKNVRPSAENVPEELSIILTSCWKEDPNARP-----NFTQIIQML 202 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~~~~~l 202 (268)
.... ......+..++..+.++|.+||..||.+|| ++.+++++.
T Consensus 211 ~~i~-~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~ 258 (324)
T cd05589 211 DSIV-NDEVRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQP 258 (324)
T ss_pred HHHH-hCCCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCC
Confidence 3332 223334567899999999999999999999 678887763
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=258.78 Aligned_cols=189 Identities=29% Similarity=0.431 Sum_probs=156.1
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ .++..++||||++||+|.+++.+... +++.++..++.|++.||.|||++|++||||||+||+++.+ +
T Consensus 57 ~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~--~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~-~ 133 (316)
T cd05619 57 FLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHK--FDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTD-G 133 (316)
T ss_pred cCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCC-C
Confidence 578899998 55688999999999999999986544 8999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccc-ccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESL-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.++|+|||++..... ........||..|+|||++.+ ..++.++|+||+|+++|+|++|..||.+....+..
T Consensus 134 ~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~ 205 (316)
T cd05619 134 HIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLG--------QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELF 205 (316)
T ss_pred CEEEccCCcceECCCCCCceeeecCCccccCHHHHcC--------CCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 999999999874322 222344578999999999864 56788999999999999999999999876654433
Q ss_pred HHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHH-HHHHH
Q 024408 159 YAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFT-QIIQM 201 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~-~~~~~ 201 (268)
... .......+..++.++.+++.+||..||.+||++. +++++
T Consensus 206 ~~i-~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05619 206 QSI-RMDNPCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQH 248 (316)
T ss_pred HHH-HhCCCCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcC
Confidence 332 2222233456889999999999999999999996 67665
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=259.94 Aligned_cols=190 Identities=27% Similarity=0.391 Sum_probs=157.4
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEEeCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLTEDL 78 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~gi~H~Dikp~Nill~~~~ 78 (268)
+++++++++ .++.+++||||++||+|.+++.+... +++..+..++.|++.||.|||+ +|++||||||+||+++.+
T Consensus 56 ~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~- 132 (325)
T cd05594 56 FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERV--FSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD- 132 (325)
T ss_pred CCCceEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCC-
Confidence 477888888 55689999999999999999876544 9999999999999999999997 799999999999999988
Q ss_pred CCeEEecCCCccccc-cccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 024408 79 KTIKLADFGLAREES-LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA 157 (268)
Q Consensus 79 ~~~kl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~ 157 (268)
+.+||+|||+++... .........||+.|+|||++.+ ..++.++||||||+++|+|++|..||........
T Consensus 133 ~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~ 204 (325)
T cd05594 133 GHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLED--------NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL 204 (325)
T ss_pred CCEEEecCCCCeecCCCCcccccccCCcccCCHHHHcc--------CCCCCccccccccceeeeeccCCCCCCCCCHHHH
Confidence 699999999987432 2223344579999999999854 5678899999999999999999999987554333
Q ss_pred HHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCC-----CHHHHHHHH
Q 024408 158 AYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARP-----NFTQIIQML 202 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~~~~~l 202 (268)
.. .........+..+++++.++|.+||+.||.+|+ ++.++++|.
T Consensus 205 ~~-~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~ 253 (325)
T cd05594 205 FE-LILMEEIRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHK 253 (325)
T ss_pred HH-HHhcCCCCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCC
Confidence 33 222333334567899999999999999999996 899999874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=247.88 Aligned_cols=197 Identities=30% Similarity=0.490 Sum_probs=162.7
Q ss_pred CceeEEEeecCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCC
Q 024408 1 MREQFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT 80 (268)
Q Consensus 1 ~~v~l~g~~~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~ 80 (268)
+++++++.+.+...++||||+++|+|.+++.+.....+++..+..++.|++.||+|||++|++|+||||+||+++++ +.
T Consensus 62 ~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~-~~ 140 (262)
T cd05071 62 KLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN-LV 140 (262)
T ss_pred CcceEEEEECCCCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCC-Cc
Confidence 57889998877788999999999999999987555558999999999999999999999999999999999999988 68
Q ss_pred eEEecCCCccccccccc--cccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 024408 81 IKLADFGLAREESLTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQA 157 (268)
Q Consensus 81 ~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~ 157 (268)
++|+|||.++....... .....++..|+|||...+ ..++.++|+||||+++|++++ |..||.+....+.
T Consensus 141 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~ 212 (262)
T cd05071 141 CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY--------GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV 212 (262)
T ss_pred EEeccCCceeeccccccccccCCcccceecCHhHhcc--------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH
Confidence 99999999975433221 122345678999998753 567889999999999999999 8889987655444
Q ss_pred HHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhH
Q 024408 158 AYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 206 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 206 (268)
..........+....++..+.+++.+|++.+|.+||++.++++.|++++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 213 LDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred HHHHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 4333333333445678899999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=263.34 Aligned_cols=190 Identities=26% Similarity=0.388 Sum_probs=157.6
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ .+++.++||||++|++|.+++.+.+. +++..+..++.|++.||+|||++|++||||||+||+++.+ +
T Consensus 62 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~-~ 138 (350)
T cd05573 62 WIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDV--FPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDAD-G 138 (350)
T ss_pred CccchhhheecCCeEEEEEcCCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCC-C
Confidence 477888888 55689999999999999999987643 9999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccccc------------------------------ccccCCCccceeccccccccccccCCCCCCCch
Q 024408 80 TIKLADFGLAREESLTE------------------------------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK 129 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~ 129 (268)
.++|+|||++....... ......||+.|+|||++.+ ..++.+
T Consensus 139 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~ 210 (350)
T cd05573 139 HIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG--------TPYGLE 210 (350)
T ss_pred CEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcC--------CCCCCc
Confidence 99999999997543322 2234568999999999864 467889
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh---ccCCCCCCCCcHHHHHHHHhccccCCCCCCC-HHHHHHHH
Q 024408 130 VDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAF---KNVRPSAENVPEELSIILTSCWKEDPNARPN-FTQIIQML 202 (268)
Q Consensus 130 ~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-~~~~~~~l 202 (268)
+|||||||++|+|++|+.||.............. ....+....+++++.++|.+||. ||.+||+ +.++++|.
T Consensus 211 ~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp 286 (350)
T cd05573 211 CDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHP 286 (350)
T ss_pred eeeEecchhhhhhccCCCCCCCCCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCC
Confidence 9999999999999999999988665444333332 11223344479999999999997 9999999 99999984
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=250.60 Aligned_cols=199 Identities=29% Similarity=0.509 Sum_probs=163.9
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCC-----------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRP-----------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLK 68 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~-----------~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dik 68 (268)
+++++++++ .++..++||||+++++|.+++...+. ..+++.+++.++.|++.||+|||++|++|||||
T Consensus 68 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlk 147 (288)
T cd05093 68 HIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLA 147 (288)
T ss_pred CcceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccC
Confidence 578999999 55689999999999999999975431 248999999999999999999999999999999
Q ss_pred CCCEEEeCCCCCeEEecCCCcccccccc---ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-
Q 024408 69 PENLLLTEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH- 144 (268)
Q Consensus 69 p~Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~- 144 (268)
|+||+++.+ +.++|+|||++....... ......++..|+|||.+.+ ..++.++|+||||+++|+|++
T Consensus 148 p~Nili~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~sDiwslG~il~~l~t~ 218 (288)
T cd05093 148 TRNCLVGEN-LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY--------RKFTTESDVWSLGVVLWEIFTY 218 (288)
T ss_pred cceEEEccC-CcEEeccCCccccccCCceeecCCCCCccccccCHHHhcc--------CCCCchhhHHHHHHHHHHHHhC
Confidence 999999988 699999999997543221 1122345778999998854 567889999999999999998
Q ss_pred CCCCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 024408 145 NKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 208 (268)
Q Consensus 145 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 208 (268)
|..||.......................++.++.+++.+||+.||.+||++.+++..|++....
T Consensus 219 g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 219 GKQPWYQLSNNEVIECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred CCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 9999987665554444444444444567889999999999999999999999999999887754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=249.47 Aligned_cols=197 Identities=30% Similarity=0.506 Sum_probs=158.4
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRP--------------RCLDVCVAIGFALDIARAMECLHSHGIIHR 65 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~--------------~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~ 65 (268)
+++++++++ .++..++||||+++|+|.+++..... ..+++.++..++.|++.||+|||++|++||
T Consensus 57 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~ 136 (270)
T cd05047 57 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHR 136 (270)
T ss_pred CeeeEEEEEecCCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeec
Confidence 578999999 45678999999999999999976431 237899999999999999999999999999
Q ss_pred CCCCCCEEEeCCCCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-
Q 024408 66 DLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH- 144 (268)
Q Consensus 66 Dikp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~- 144 (268)
||||+||+++.+ +.++++|||++..............+..|+|||.+.. ..++.++|+||||+++|+|++
T Consensus 137 dikp~nili~~~-~~~kl~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~--------~~~~~~~Di~slG~il~el~~~ 207 (270)
T cd05047 137 DLAARNILVGEN-YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY--------SVYTTNSDVWSYGVLLWEIVSL 207 (270)
T ss_pred ccccceEEEcCC-CeEEECCCCCccccchhhhccCCCCccccCChHHHcc--------CCCCchhhHHHHHHHHHHHHcC
Confidence 999999999988 6999999999864332221222234567999998753 557889999999999999997
Q ss_pred CCCCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhH
Q 024408 145 NKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 206 (268)
Q Consensus 145 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 206 (268)
|..||.+....+.............+..++.++.+++.+|+..+|.+||++.+++..|...+
T Consensus 208 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 208 GGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CCCCccccCHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 99999876554433333222233345567889999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=261.23 Aligned_cols=190 Identities=25% Similarity=0.418 Sum_probs=155.3
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
++|++++++ .++..++||||++||+|.+++.+... +++..+..++.|++.||+|||++|++||||||+||+++.+ +
T Consensus 57 ~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~~~~--l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~-~ 133 (329)
T cd05618 57 FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRK--LPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE-G 133 (329)
T ss_pred cCCceeeEEEeCCEEEEEEeCCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCC-C
Confidence 578999998 55689999999999999998876544 9999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccc-cccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----
Q 024408 80 TIKLADFGLAREES-LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS----- 153 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~----- 153 (268)
.++|+|||+++... .........||..|+|||++.+ ..++.++|+||||+++|+|++|+.||....
T Consensus 134 ~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~ 205 (329)
T cd05618 134 HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG--------EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP 205 (329)
T ss_pred CEEEeeCCccccccCCCCccccccCCccccCHHHHcC--------CCCCCccceecccHHHHHHhhCCCCCccCCCcCCc
Confidence 99999999997532 2222344578999999999864 567789999999999999999999995211
Q ss_pred ---hHHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCC------HHHHHHH
Q 024408 154 ---NLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPN------FTQIIQM 201 (268)
Q Consensus 154 ---~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps------~~~~~~~ 201 (268)
................+..++..+.++|.+||..||.+||+ +.++++|
T Consensus 206 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 206 DQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred ccccHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 11122223333333446678899999999999999999998 5788776
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=252.78 Aligned_cols=192 Identities=26% Similarity=0.377 Sum_probs=154.6
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ .+.+.++||||++|++|.+++.......+++..+..++.|++.||+|||+.|++||||||+||+++.+ +
T Consensus 54 ~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~-~ 132 (277)
T cd05607 54 FIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQ-G 132 (277)
T ss_pred cEEEEEEEEecCCeEEEEEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCC-C
Confidence 578888888 55688999999999999999877665569999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH---
Q 024408 80 TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ--- 156 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~--- 156 (268)
.++|+|||++.............|+..|+|||++.+ ..++.++|+||+|+++|+|++|+.||.......
T Consensus 133 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~ 204 (277)
T cd05607 133 NCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKE--------EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKE 204 (277)
T ss_pred CEEEeeceeeeecCCCceeeccCCCCCccCHHHHcc--------CCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHH
Confidence 899999999876544333344578999999999864 457889999999999999999999997543211
Q ss_pred HHHHH-HhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 157 AAYAA-AFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 157 ~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
..... ...........++.++++++.+||+.||.+||+++++++.
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ 250 (277)
T cd05607 205 ELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDD 250 (277)
T ss_pred HHHHHhhccccccccccCCHHHHHHHHHHhccCHhhCCCCccchhh
Confidence 11111 1111122234688999999999999999999999665543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=247.19 Aligned_cols=194 Identities=30% Similarity=0.515 Sum_probs=162.1
Q ss_pred CceeEEEeecCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCC
Q 024408 1 MREQFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT 80 (268)
Q Consensus 1 ~~v~l~g~~~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~ 80 (268)
++|+++|++.++..++||||+++++|.+++.+.. .+++..+..++.|++.||.|||+.|++|+||||+||+++.+ +.
T Consensus 57 ~iv~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~-~~ 133 (257)
T cd05060 57 CIVRLIGVCKGEPLMLVMELAPLGPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNR-HQ 133 (257)
T ss_pred CeeeEEEEEcCCceEEEEEeCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCC-Cc
Confidence 5789999998888999999999999999998765 39999999999999999999999999999999999999988 69
Q ss_pred eEEecCCCcccccccccc----ccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChH
Q 024408 81 IKLADFGLAREESLTEMM----TAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNL 155 (268)
Q Consensus 81 ~kl~Dfg~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~~~ 155 (268)
++|+|||+++........ ....++..|+|||.+.+ ..++.++|+||||+++|++++ |..||......
T Consensus 134 ~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~ 205 (257)
T cd05060 134 AKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINY--------GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA 205 (257)
T ss_pred EEeccccccceeecCCcccccccCccccccccCHHHhcC--------CCCCccchHHHHHHHHHHHHcCCCCCcccCCHH
Confidence 999999999754322211 11123467999998754 557889999999999999998 99999877665
Q ss_pred HHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHh
Q 024408 156 QAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 205 (268)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~ 205 (268)
+...........+.+..++..+.+++.+||..+|++||++.++++.|+..
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 206 EVIAMLESGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred HHHHHHHcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 54444444434455677889999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=254.35 Aligned_cols=200 Identities=30% Similarity=0.498 Sum_probs=160.3
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMR--------------PRCLDVCVAIGFALDIARAMECLHSHGIIHR 65 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~--------------~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~ 65 (268)
++++++|++ .++..++||||++|++|.+++.+.. ...+++.+++.++.|++.||+|||++|++||
T Consensus 69 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~ 148 (303)
T cd05088 69 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHR 148 (303)
T ss_pred CcceEEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCcccc
Confidence 578999999 5568999999999999999997643 1248899999999999999999999999999
Q ss_pred CCCCCCEEEeCCCCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-
Q 024408 66 DLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH- 144 (268)
Q Consensus 66 Dikp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~- 144 (268)
||||+||+++.+ +.++|+|||++.............++..|+|||.+.+ ..++.++||||||+++|+|++
T Consensus 149 dlkp~Nili~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~ellt~ 219 (303)
T cd05088 149 DLAARNILVGEN-YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY--------SVYTTNSDVWSYGVLLWEIVSL 219 (303)
T ss_pred ccchheEEecCC-CcEEeCccccCcccchhhhcccCCCcccccCHHHHhc--------cCCcccccchhhhhHHHHHHhc
Confidence 999999999988 6899999999874322222222234567999998753 456789999999999999998
Q ss_pred CCCCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhc
Q 024408 145 NKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 209 (268)
Q Consensus 145 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~~ 209 (268)
|..||......+.............+..++.++.+++.+||+.+|++||++.++++.+...+...
T Consensus 220 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~ 284 (303)
T cd05088 220 GGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 284 (303)
T ss_pred CCCCcccCChHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 99999876554433322222222334567899999999999999999999999999998776553
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=247.81 Aligned_cols=195 Identities=32% Similarity=0.516 Sum_probs=161.7
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++.+ .++..++||||++|++|.+++.+.....+++.++..++.|++.||+|||++|++|+||||+||+++.+ +
T Consensus 62 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~-~ 140 (261)
T cd05072 62 KLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSES-L 140 (261)
T ss_pred CeeeEEEEEcCCCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCC-C
Confidence 578899888 45678999999999999999987655569999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccccc--cccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 024408 80 TIKLADFGLAREESLTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQ 156 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~~~~ 156 (268)
.++|+|||++........ .....++..|+|||.+.. ..++.++|+||||+++|+|++ |..||.......
T Consensus 141 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~ 212 (261)
T cd05072 141 MCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF--------GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD 212 (261)
T ss_pred cEEECCCccceecCCCceeccCCCccceecCCHHHhcc--------CCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH
Confidence 899999999985433221 122345678999998753 457789999999999999998 999998766555
Q ss_pred HHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 024408 157 AAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 204 (268)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~ 204 (268)
...........+....++.++.+++.+|+..+|++||+++++.+.|++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 213 VMSALQRGYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred HHHHHHcCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 444444344444556788999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=262.90 Aligned_cols=189 Identities=30% Similarity=0.426 Sum_probs=163.8
Q ss_pred CceeEEEeecC-CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGACKE-PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~~~-~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|||+++.+++. .++|+|.||+.| +|..+|.+.+. ++++.+..++.+++.||.|||+++|+|||+||.|||++.+ +
T Consensus 62 niv~m~esfEt~~~~~vVte~a~g-~L~~il~~d~~--lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~-~ 137 (808)
T KOG0597|consen 62 NIVEMLESFETSAHLWVVTEYAVG-DLFTILEQDGK--LPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKG-G 137 (808)
T ss_pred chhhHHHhhcccceEEEEehhhhh-hHHHHHHhccC--CCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCC-C
Confidence 68899999955 589999999975 99999998776 9999999999999999999999999999999999999998 6
Q ss_pred CeEEecCCCcccccccc-ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESLTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.+|++|||+|+...... ...+..||+.|||||...+ +.|+..+|+|||||++||+..|++||....-.+..
T Consensus 138 ~~KlcdFg~Ar~m~~~t~vltsikGtPlYmAPElv~e--------~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv 209 (808)
T KOG0597|consen 138 TLKLCDFGLARAMSTNTSVLTSIKGTPLYMAPELVEE--------QPYDHTSDLWSLGCILYELYVGQPPFYARSITQLV 209 (808)
T ss_pred ceeechhhhhhhcccCceeeeeccCcccccCHHHHcC--------CCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHH
Confidence 99999999999766544 3455679999999999864 78999999999999999999999999875444433
Q ss_pred HHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 024408 159 YAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 202 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l 202 (268)
. .+.......+...+..+..+++.+|.+||.+|.++.+++.|-
T Consensus 210 ~-~I~~d~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~Hp 252 (808)
T KOG0597|consen 210 K-SILKDPVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHP 252 (808)
T ss_pred H-HHhcCCCCCcccccHHHHHHHHHHhhcChhhcccHHHHhcCh
Confidence 3 333444444668899999999999999999999999999873
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=259.69 Aligned_cols=188 Identities=27% Similarity=0.403 Sum_probs=156.3
Q ss_pred ceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCC
Q 024408 2 REQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT 80 (268)
Q Consensus 2 ~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~ 80 (268)
++++++++ .++.+++||||++||+|.+++...+. +++.++..++.|++.||+|||++|++||||||+|||++.+ +.
T Consensus 63 i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~-~~ 139 (323)
T cd05616 63 LTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGR--FKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSE-GH 139 (323)
T ss_pred EeeEEEEEecCCEEEEEEcCCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCC-Cc
Confidence 56788888 55689999999999999999977554 9999999999999999999999999999999999999988 69
Q ss_pred eEEecCCCcccccc-ccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 024408 81 IKLADFGLAREESL-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY 159 (268)
Q Consensus 81 ~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~ 159 (268)
+||+|||+++.... ........||+.|+|||++.+ ..++.++|+||||+++|+|++|+.||.+........
T Consensus 140 ~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~ 211 (323)
T cd05616 140 IKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAY--------QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ 211 (323)
T ss_pred EEEccCCCceecCCCCCccccCCCChhhcCHHHhcC--------CCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHH
Confidence 99999999975332 223345578999999999864 567889999999999999999999998866544443
Q ss_pred HHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCH-----HHHHHH
Q 024408 160 AAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNF-----TQIIQM 201 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~-----~~~~~~ 201 (268)
... ......+..++.++.+++.+||..+|.+|++. .++++|
T Consensus 212 ~i~-~~~~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 212 SIM-EHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred HHH-hCCCCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 333 33333456789999999999999999999974 667665
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=254.75 Aligned_cols=198 Identities=23% Similarity=0.492 Sum_probs=163.3
Q ss_pred CceeEEEeecCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCC
Q 024408 1 MREQFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT 80 (268)
Q Consensus 1 ~~v~l~g~~~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~ 80 (268)
|+++++|+|..+..++|+||+++|+|.+++..... .+++..++.++.|++.||+|||++|++||||||+||+++.+ +.
T Consensus 70 niv~~~g~~~~~~~~~v~e~~~~g~l~~~l~~~~~-~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~-~~ 147 (316)
T cd05108 70 HVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTP-QH 147 (316)
T ss_pred CCCeEEEEEcCCCceeeeecCCCCCHHHHHHhccc-cCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCC-Cc
Confidence 68999999987788999999999999999987543 38899999999999999999999999999999999999988 68
Q ss_pred eEEecCCCcccccccccc---ccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 024408 81 IKLADFGLAREESLTEMM---TAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQ 156 (268)
Q Consensus 81 ~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~~~~ 156 (268)
+||+|||+++........ ....++..|++||.+.+ ..++.++||||||+++|||++ |..||.+....+
T Consensus 148 ~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~--------~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~ 219 (316)
T cd05108 148 VKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILH--------RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 219 (316)
T ss_pred EEEccccccccccCCCcceeccCCccceeecChHHhcc--------CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 999999999854432221 12234668999998854 567889999999999999997 999998765544
Q ss_pred HHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 024408 157 AAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 208 (268)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 208 (268)
...........+.+..++..+.+++.+||..+|.+||++.+++..+......
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 220 ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred HHHHHhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 3333333333445667889999999999999999999999999998877654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=247.49 Aligned_cols=195 Identities=31% Similarity=0.540 Sum_probs=163.0
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ ..+..++||||+++++|.+++.+.....+++.++..++.|++.||.|||++|++|+||+|+||+++++ +
T Consensus 63 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~-~ 141 (261)
T cd05148 63 HLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGED-L 141 (261)
T ss_pred chhheeeeEecCCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCC-c
Confidence 478899998 55688999999999999999987665669999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccccc-cccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 024408 80 TIKLADFGLAREESLTEM-MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQA 157 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~ 157 (268)
.++|+|||.+........ .....++..|++||.+.. ..++.++|+||||+++|+|++ |+.||......+.
T Consensus 142 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~--------~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~ 213 (261)
T cd05148 142 VCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASH--------GTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEV 213 (261)
T ss_pred eEEEccccchhhcCCccccccCCCCceEecCHHHHcc--------CCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHH
Confidence 999999999975433221 123345678999998753 557789999999999999998 8999987665554
Q ss_pred HHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 024408 158 AYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 204 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~ 204 (268)
..........+.+..+++.+.+++.+||+.||.+||++.++++.|+.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 214 YDQITAGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred HHHHHhCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 44444444445567889999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=257.91 Aligned_cols=189 Identities=26% Similarity=0.326 Sum_probs=155.4
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++.+ .++..++||||++||+|.+++.+... +++.++..++.|++.||.|||++|++||||||+||+++.+ +
T Consensus 57 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~-~ 133 (325)
T cd05604 57 FLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERS--FPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQ-G 133 (325)
T ss_pred CCccEEEEEecCCEEEEEEcCCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCC-C
Confidence 578899888 55689999999999999999876544 9999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccc-cccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREES-LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.++|+|||+++... .........|+..|+|||++.+ ..++.++||||||+++|+|++|..||...+..+..
T Consensus 134 ~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~ 205 (325)
T cd05604 134 HVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRK--------QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMY 205 (325)
T ss_pred CEEEeecCCcccCCCCCCCcccccCChhhCCHHHHcC--------CCCCCcCccccccceehhhhcCCCCCCCCCHHHHH
Confidence 99999999987532 2223345578999999999864 55778999999999999999999999876554433
Q ss_pred HHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHH----HHHHH
Q 024408 159 YAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFT----QIIQM 201 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~----~~~~~ 201 (268)
... ...........+..+.++|.+||..+|.+||+++ ++++|
T Consensus 206 ~~~-~~~~~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h 251 (325)
T cd05604 206 DNI-LHKPLVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEH 251 (325)
T ss_pred HHH-HcCCccCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcC
Confidence 332 2233333456889999999999999999999875 55554
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=246.46 Aligned_cols=195 Identities=30% Similarity=0.496 Sum_probs=160.9
Q ss_pred CceeEEEeecCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCC
Q 024408 1 MREQFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT 80 (268)
Q Consensus 1 ~~v~l~g~~~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~ 80 (268)
+++++++++.++..++||||+++++|.+++.+.....+++..+..++.|++.||.|||+.|++|+||||+||+++.+ +.
T Consensus 62 ~i~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~-~~ 140 (260)
T cd05069 62 KLVPLYAVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDN-LV 140 (260)
T ss_pred CeeeEEEEEcCCCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCC-Ce
Confidence 46889999877788999999999999999987655558999999999999999999999999999999999999988 68
Q ss_pred eEEecCCCccccccccc--cccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 024408 81 IKLADFGLAREESLTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQA 157 (268)
Q Consensus 81 ~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~ 157 (268)
++|+|||++........ .....++..|+|||.+.+ ..++.++|+||||+++|++++ |..||.+....+.
T Consensus 141 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~--------~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~ 212 (260)
T cd05069 141 CKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY--------GRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREV 212 (260)
T ss_pred EEECCCccceEccCCcccccCCCccchhhCCHHHhcc--------CCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 99999999975432211 122345678999998753 557889999999999999999 8999987665544
Q ss_pred HHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 024408 158 AYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 204 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~ 204 (268)
..........+.....+..+.+++.+||..||.+||+++++++.|++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 213 LEQVERGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred HHHHHcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 43333333334456788999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=261.44 Aligned_cols=191 Identities=25% Similarity=0.362 Sum_probs=153.4
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
++|++++++ .++++++||||++||+|.+++.+.+. +++..+..++.|++.||+|||++||+||||||+|||++.+ +
T Consensus 62 ~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~--~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~-~ 138 (381)
T cd05626 62 WVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEV--FPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLD-G 138 (381)
T ss_pred CeeeeEEEEecCCEEEEEEecCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCC-C
Confidence 578999999 55689999999999999999987554 9999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccc------------------------------------------------cccccCCCccceeccc
Q 024408 80 TIKLADFGLAREESLT------------------------------------------------EMMTAETGTYRWMAPE 111 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~------------------------------------------------~~~~~~~gt~~y~aPE 111 (268)
.++|+|||+++..... ....+..||+.|+|||
T Consensus 139 ~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE 218 (381)
T cd05626 139 HIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPE 218 (381)
T ss_pred CEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHH
Confidence 9999999997532100 0012346999999999
Q ss_pred cccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc---cCCCCCCCCcHHHHHHHHhc--cc
Q 024408 112 LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFK---NVRPSAENVPEELSIILTSC--WK 186 (268)
Q Consensus 112 ~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~--l~ 186 (268)
++.+ ..++.++|||||||++|||++|..||......+........ ...+....+++++.++|.+| +.
T Consensus 219 ~~~~--------~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~ 290 (381)
T cd05626 219 VLLR--------KGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSA 290 (381)
T ss_pred HHcC--------CCCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCc
Confidence 9854 55788999999999999999999999876655444433321 12233446789999999984 45
Q ss_pred cCCCCCCCHHHHHHHH
Q 024408 187 EDPNARPNFTQIIQML 202 (268)
Q Consensus 187 ~~p~~Rps~~~~~~~l 202 (268)
.++..|+++.++++|-
T Consensus 291 ~~~~~R~~~~~~l~hp 306 (381)
T cd05626 291 EERLGRNGADDIKAHP 306 (381)
T ss_pred ccccCCCCHHHHhcCc
Confidence 5666799999999984
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=260.68 Aligned_cols=196 Identities=33% Similarity=0.544 Sum_probs=157.5
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCC--------------------------------------------
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRP-------------------------------------------- 35 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~-------------------------------------------- 35 (268)
|+|+++|+| .++..++||||++||+|.+++.+...
T Consensus 100 nIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 179 (375)
T cd05104 100 NIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVV 179 (375)
T ss_pred ceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccc
Confidence 689999999 55688999999999999999975321
Q ss_pred -----------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCCeEEecC
Q 024408 36 -----------------------------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADF 86 (268)
Q Consensus 36 -----------------------------~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~~kl~Df 86 (268)
..+++..++.++.|++.||.|||++|++||||||+||+++.+ +.++|+||
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~-~~~kl~Df 258 (375)
T cd05104 180 PTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHG-RITKICDF 258 (375)
T ss_pred ccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECC-CcEEEecC
Confidence 237888999999999999999999999999999999999987 68999999
Q ss_pred CCccccccccc---cccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 024408 87 GLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAA 162 (268)
Q Consensus 87 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~ 162 (268)
|+++....... .....++..|+|||++.+ ..++.++||||||+++|+|++ |..||.............
T Consensus 259 G~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~ 330 (375)
T cd05104 259 GLARDIRNDSNYVVKGNARLPVKWMAPESIFN--------CVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMI 330 (375)
T ss_pred ccceeccCcccccccCCCCCCcceeChhHhcC--------CCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHH
Confidence 99975433221 112334567999999864 567889999999999999998 889997765443333333
Q ss_pred hcc-CCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHh
Q 024408 163 FKN-VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 205 (268)
Q Consensus 163 ~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~ 205 (268)
... ....+...+.++.+++.+||..||++||++.++++.|+..
T Consensus 331 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 331 KEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred HhCccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 322 2233456788999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=259.26 Aligned_cols=189 Identities=29% Similarity=0.423 Sum_probs=156.7
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|++++++++ .++.+|+||||++||+|.+++.+... +++..+..++.|++.||+|||++|++||||||+||+++.+ +
T Consensus 59 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~-~ 135 (318)
T cd05582 59 FIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVM--FTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEE-G 135 (318)
T ss_pred CcccEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCC-C
Confidence 578999998 55689999999999999999976544 9999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccc-cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.++|+|||+++..... .......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||......+..
T Consensus 136 ~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~ 207 (318)
T cd05582 136 HIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNR--------RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETM 207 (318)
T ss_pred cEEEeeccCCcccCCCCCceecccCChhhcCHHHHcC--------CCCCCccceeccceEeeeeccCCCCCCCCCHHHHH
Confidence 9999999999754333 22344578999999998854 45678999999999999999999999876654443
Q ss_pred HHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 024408 159 YAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPN-----FTQIIQM 201 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~~~~~~ 201 (268)
.... ......+..++..+.++|++||+.||.+||+ ..+++++
T Consensus 208 ~~i~-~~~~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~ 254 (318)
T cd05582 208 TMIL-KAKLGMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRH 254 (318)
T ss_pred HHHH-cCCCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCC
Confidence 3332 2223345678899999999999999999999 5556654
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=263.36 Aligned_cols=190 Identities=24% Similarity=0.360 Sum_probs=153.4
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++.+ .++++++||||++||+|.+++.+.+. +++..+..++.|++.||+|||++||+||||||+||+++.+ +
T Consensus 62 ~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~~--~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~-~ 138 (376)
T cd05598 62 WVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGI--FEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRD-G 138 (376)
T ss_pred CcceEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCC-C
Confidence 578999998 55689999999999999999987544 8999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccc--------------------------------------------cccccCCCccceeccccccc
Q 024408 80 TIKLADFGLAREESLT--------------------------------------------EMMTAETGTYRWMAPELYST 115 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~--------------------------------------------~~~~~~~gt~~y~aPE~~~~ 115 (268)
.++|+|||++...... .......||+.|+|||++.+
T Consensus 139 ~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 218 (376)
T cd05598 139 HIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR 218 (376)
T ss_pred CEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC
Confidence 9999999997421100 00113468999999999864
Q ss_pred cccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc---cCCCCCCCCcHHHHHHHHhccccCCCCC
Q 024408 116 VTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFK---NVRPSAENVPEELSIILTSCWKEDPNAR 192 (268)
Q Consensus 116 ~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~~p~~R 192 (268)
..++.++|||||||++|+|++|+.||.+....+........ ...+....++.++.++|.+|+ .+|.+|
T Consensus 219 --------~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R 289 (376)
T cd05598 219 --------TGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDR 289 (376)
T ss_pred --------CCCCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhc
Confidence 55788999999999999999999999886654443332221 112234467899999999976 599999
Q ss_pred C---CHHHHHHHH
Q 024408 193 P---NFTQIIQML 202 (268)
Q Consensus 193 p---s~~~~~~~l 202 (268)
+ ++.++++|-
T Consensus 290 ~~~~t~~ell~h~ 302 (376)
T cd05598 290 LGKNGADEIKAHP 302 (376)
T ss_pred CCCCCHHHHhCCC
Confidence 9 899999884
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=246.08 Aligned_cols=195 Identities=30% Similarity=0.495 Sum_probs=161.4
Q ss_pred CceeEEEeecCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCC
Q 024408 1 MREQFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT 80 (268)
Q Consensus 1 ~~v~l~g~~~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~ 80 (268)
+++++++++.+...++||||+++++|.+++.......+++.++..++.+++.||.|||++|++|+||||+||+++++ +.
T Consensus 62 ~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~-~~ 140 (260)
T cd05070 62 KLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDG-LV 140 (260)
T ss_pred ceEEEEeEECCCCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCC-ce
Confidence 46889999877788999999999999999987555558999999999999999999999999999999999999988 68
Q ss_pred eEEecCCCccccccccc--cccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 024408 81 IKLADFGLAREESLTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQA 157 (268)
Q Consensus 81 ~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~ 157 (268)
++|+|||++........ .....++..|+|||.+.+ ..++.++|+||||+++|++++ |..||.+....+.
T Consensus 141 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~ 212 (260)
T cd05070 141 CKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY--------GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREV 212 (260)
T ss_pred EEeCCceeeeeccCcccccccCCCCCccccChHHHhc--------CCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence 99999999975433221 112235568999998753 557789999999999999999 8999987665554
Q ss_pred HHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 024408 158 AYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 204 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~ 204 (268)
..........+.+...+..+.+++.+|+..+|++|||++++.+.|++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 213 LEQVERGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred HHHHHcCCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 44433333444566788999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=251.91 Aligned_cols=191 Identities=25% Similarity=0.348 Sum_probs=152.7
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|++++++++ .++..++||||++ ++|.+++...+. .+++..+..++.|++.||+|||++||+||||||+||+++.+ +
T Consensus 64 niv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~-~ 140 (288)
T cd07871 64 NIVTLHDIIHTERCLTLVFEYLD-SDLKQYLDNCGN-LMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEK-G 140 (288)
T ss_pred CEeeEEEEEcCCCeEEEEEeCCC-cCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCC-C
Confidence 588999998 5567899999997 599999876543 38999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccc-ccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESL-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.+||+|||+++.... ........+++.|+|||++.+ ...++.++|+||+|+++|+|++|+.||.+....+..
T Consensus 141 ~~kl~DfG~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~ 213 (288)
T cd07871 141 ELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLG-------STEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEEL 213 (288)
T ss_pred CEEECcCcceeeccCCCccccCceecccccChHHhcC-------CcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 999999999975332 222334568999999998753 245788999999999999999999999876544433
Q ss_pred HHHHhccC--------------------CC---------CCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 159 YAAAFKNV--------------------RP---------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 159 ~~~~~~~~--------------------~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
........ .+ ....++.++.++|.+||..||.+|||++++++|
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 214 HLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred HHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 22211100 00 013467889999999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=245.60 Aligned_cols=193 Identities=30% Similarity=0.536 Sum_probs=158.8
Q ss_pred CceeEEEee--cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCC
Q 024408 1 MREQFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL 78 (268)
Q Consensus 1 ~~v~l~g~~--~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~ 78 (268)
++++++|++ .++..++||||+++++|.+++.+.....+++..++.++.|++.||+|||++|++||||||+||+++.+
T Consensus 60 ~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~- 138 (256)
T cd05082 60 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSED- 138 (256)
T ss_pred CeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCC-
Confidence 478899876 33578999999999999999987665568999999999999999999999999999999999999988
Q ss_pred CCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 024408 79 KTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQA 157 (268)
Q Consensus 79 ~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~ 157 (268)
+.++|+|||+++...... ....++..|+|||.+.+ ..++.++||||||+++|+|++ |+.||......+.
T Consensus 139 ~~~kl~dfg~~~~~~~~~--~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~ 208 (256)
T cd05082 139 NVAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALRE--------KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV 208 (256)
T ss_pred CcEEecCCccceeccccC--CCCccceeecCHHHHcc--------CCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 699999999987533221 23344568999998753 557789999999999999997 9999987555444
Q ss_pred HHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 024408 158 AYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 204 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~ 204 (268)
...............++..+.+++.+|+..+|++||++.++++.|+.
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 209 VPRVEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred HHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 33333333333456789999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=259.54 Aligned_cols=197 Identities=31% Similarity=0.486 Sum_probs=153.8
Q ss_pred CceeEEEeec-CC-cEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCCCCEEEe
Q 024408 1 MREQFIGACK-EP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG---IIHRDLKPENLLLT 75 (268)
Q Consensus 1 ~~v~l~g~~~-~~-~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~g---i~H~Dikp~Nill~ 75 (268)
|+|+|+|||. ++ ..+||+||+++|||.+++.......++|.++++|+.+++.||+|||... |+|||||++|||+|
T Consensus 132 Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD 211 (361)
T KOG1187|consen 132 NLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLD 211 (361)
T ss_pred CcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeEC
Confidence 7899999995 45 4999999999999999998755425999999999999999999999965 99999999999999
Q ss_pred CCCCCeEEecCCCcccccc-ccccccC-CCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 024408 76 EDLKTIKLADFGLAREESL-TEMMTAE-TGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS 153 (268)
Q Consensus 76 ~~~~~~kl~Dfg~a~~~~~-~~~~~~~-~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~ 153 (268)
++ ..+||+|||+|+.... .....+. .||.+|++||.+.. +..+.++||||||++++|+++|+.+.....
T Consensus 212 ~~-~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~--------g~lt~KsDVySFGVvllElitgr~~~d~~~ 282 (361)
T KOG1187|consen 212 ED-FNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYAST--------GKLTEKSDVYSFGVVLLELITGRKAVDQSR 282 (361)
T ss_pred CC-CCEEccCccCcccCCccccceeeecCCCCccCChhhhcc--------CCcCcccccccchHHHHHHHhCCcccCCCC
Confidence 98 4999999999976554 3333333 89999999998864 678899999999999999999998776422
Q ss_pred -----hHHHHHH-HH-----hccCCCCC--CCCc-----HHHHHHHHhccccCCCCCCCHHHHHHHHHHhH
Q 024408 154 -----NLQAAYA-AA-----FKNVRPSA--ENVP-----EELSIILTSCWKEDPNARPNFTQIIQMLLNYL 206 (268)
Q Consensus 154 -----~~~~~~~-~~-----~~~~~~~~--~~~~-----~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 206 (268)
....+.. .. .....+.. ...+ ..+..+..+|++.+|.+||++.++++.|+...
T Consensus 283 ~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 283 PRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred CcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 1111111 11 11112221 2333 23556778899999999999999999885433
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=261.52 Aligned_cols=201 Identities=32% Similarity=0.576 Sum_probs=175.0
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|||+|||++ .+.-+++|||+|+||+|.++|++.+. .++..+...++.+.+.||+|||+++++||||-..|+|++.+ +
T Consensus 222 NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~-~ 299 (474)
T KOG0194|consen 222 NVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKK-G 299 (474)
T ss_pred CEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCC-C
Confidence 799999999 56678999999999999999998765 49999999999999999999999999999999999999998 5
Q ss_pred CeEEecCCCccccccccccc-cCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 024408 80 TIKLADFGLAREESLTEMMT-AETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQA 157 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~ 157 (268)
.+||+|||+++......... ...-...|+|||.+.. +.++.++||||+|+++||+.+ |..||.+....+.
T Consensus 300 ~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~--------~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v 371 (474)
T KOG0194|consen 300 VVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNT--------GIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEV 371 (474)
T ss_pred eEEeCccccccCCcceeeccccccCcceecChhhhcc--------CccccccchhheeeeEEeeeccCCCCCCCCCHHHH
Confidence 78999999998755333222 2234678999999975 688999999999999999998 8889999998888
Q ss_pred HHHH-HhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhcCC
Q 024408 158 AYAA-AFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAP 211 (268)
Q Consensus 158 ~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~~~~ 211 (268)
.... ......+.+...|.++..++..|+..+|++||++.++.+.++........
T Consensus 372 ~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 372 KAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred HHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 7777 44666667788899999999999999999999999999999888766544
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=250.76 Aligned_cols=199 Identities=33% Similarity=0.583 Sum_probs=161.5
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRP--------------RCLDVCVAIGFALDIARAMECLHSHGIIHR 65 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~--------------~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~ 65 (268)
++++++++| .++..++||||+++|+|.+++..... ..+++.+++.++.|++.||+|||++|++||
T Consensus 85 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~ 164 (307)
T cd05098 85 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHR 164 (307)
T ss_pred CEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence 578999999 55688999999999999999986432 248899999999999999999999999999
Q ss_pred CCCCCCEEEeCCCCCeEEecCCCccccccccc---cccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHH
Q 024408 66 DLKPENLLLTEDLKTIKLADFGLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWEL 142 (268)
Q Consensus 66 Dikp~Nill~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~l 142 (268)
||||+||+++.+ +.++|+|||.++....... .....++..|+|||.+.+ ..++.++|+||||+++|+|
T Consensus 165 dlkp~Nill~~~-~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwslG~~l~el 235 (307)
T cd05098 165 DLAARNVLVTED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD--------RIYTHQSDVWSFGVLLWEI 235 (307)
T ss_pred cccHHheEEcCC-CcEEECCCcccccccccchhhccccCCCccceeChHHhcc--------CCCCcHHHHHHHHHHHHHH
Confidence 999999999988 6999999999875432211 112234568999998854 5578899999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 024408 143 LH-NKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 208 (268)
Q Consensus 143 l~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 208 (268)
++ |..||.+....+.............+..++.++.+++.+||..+|.+||++.++++.|..++..
T Consensus 236 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 236 FTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred HcCCCCCCCcCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 98 8889977554443333333333344567889999999999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=235.75 Aligned_cols=193 Identities=24% Similarity=0.335 Sum_probs=169.6
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|+.++||++ +....||++||..+|+|+..++......+++..+..++.|++.||.|||.++|+||||||+|+|++.+ +
T Consensus 83 nilrlY~~fhd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~-~ 161 (281)
T KOG0580|consen 83 NILRLYGYFHDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSA-G 161 (281)
T ss_pred cHHhhhhheeccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCC-C
Confidence 678899999 55689999999999999999997666669999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 024408 80 TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY 159 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~ 159 (268)
.+|++|||-+.... ...-.+.+||.-|.+||+..+ ...+...|+|++|++.||++.|.+||++.. ....+
T Consensus 162 ~lkiAdfGwsV~~p-~~kR~tlcgt~dyl~pEmv~~--------~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-~~etY 231 (281)
T KOG0580|consen 162 ELKIADFGWSVHAP-SNKRKTLCGTLDYLPPEMVEG--------RGHDKFVDLWSLGVLCYEFLVGLPPFESQS-HSETY 231 (281)
T ss_pred CeeccCCCceeecC-CCCceeeecccccCCHhhcCC--------CCccchhhHHHHHHHHHHHHhcCCchhhhh-hHHHH
Confidence 99999999998655 444467899999999999865 566789999999999999999999999876 44455
Q ss_pred HHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 024408 160 AAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 204 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~ 204 (268)
+.........+..++.+.+++|.+|+..+|.+|....++++|.+-
T Consensus 232 krI~k~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI 276 (281)
T KOG0580|consen 232 KRIRKVDLKFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWI 276 (281)
T ss_pred HHHHHccccCCcccChhHHHHHHHHhccCccccccHHHHhhhHHH
Confidence 555555555578999999999999999999999999999999654
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=249.13 Aligned_cols=193 Identities=33% Similarity=0.598 Sum_probs=156.7
Q ss_pred CceeEEEeec-CCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGACK-EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~~-~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|+++++|+|. .+..++||||+++|+|.++|.......+++.++..|+.|++.||.|||+++++|++|+++||+++.+ +
T Consensus 62 ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~-~ 140 (259)
T PF07714_consen 62 NIVKLYGFCIENEPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSN-G 140 (259)
T ss_dssp TBE-EEEEEESSSSEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETT-T
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-c
Confidence 6899999995 5679999999999999999998744559999999999999999999999999999999999999998 6
Q ss_pred CeEEecCCCccccccc---cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChH
Q 024408 80 TIKLADFGLAREESLT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNL 155 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~~~ 155 (268)
.+||+|||++...... ...........|+|||.+.. ..++.++||||||+++||+++ |+.||.+....
T Consensus 141 ~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--------~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~ 212 (259)
T PF07714_consen 141 QVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKD--------GEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNE 212 (259)
T ss_dssp EEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHH--------SEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHH
T ss_pred ccccccccccccccccccccccccccccccccccccccc--------ccccccccccccccccccccccccccccccccc
Confidence 9999999999865221 12233456788999999864 447889999999999999999 78999888766
Q ss_pred HHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 024408 156 QAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 202 (268)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l 202 (268)
+...........+.+..++..+.+++..||..+|++||++.++++.|
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 213 EIIEKLKQGQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HHHHHHHTTEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred cccccccccccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 65555555555556778999999999999999999999999999875
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=247.20 Aligned_cols=198 Identities=23% Similarity=0.491 Sum_probs=161.4
Q ss_pred CceeEEEeecCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCC
Q 024408 1 MREQFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT 80 (268)
Q Consensus 1 ~~v~l~g~~~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~ 80 (268)
++++++|+|.....+++|||+++|+|.+++..... .+++.+++.++.|++.||+|||++|++||||||+||+++++ +.
T Consensus 70 ~i~~~~~~~~~~~~~l~~~~~~~g~l~~~l~~~~~-~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~-~~ 147 (279)
T cd05109 70 YVCRLLGICLTSTVQLVTQLMPYGCLLDYVRENKD-RIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSP-NH 147 (279)
T ss_pred CCceEEEEEcCCCcEEEEEcCCCCCHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCC-Cc
Confidence 47889999987788999999999999999976433 39999999999999999999999999999999999999887 68
Q ss_pred eEEecCCCcccccccccc---ccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 024408 81 IKLADFGLAREESLTEMM---TAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQ 156 (268)
Q Consensus 81 ~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~~~~ 156 (268)
++|+|||+++........ ....++..|+|||.+.+ ..++.++||||||+++||+++ |..||.......
T Consensus 148 ~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 219 (279)
T cd05109 148 VKITDFGLARLLDIDETEYHADGGKVPIKWMALESILH--------RRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE 219 (279)
T ss_pred EEECCCCceeecccccceeecCCCccchhhCCHHHhcc--------CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 999999999854332211 12234678999998854 557889999999999999998 899998765544
Q ss_pred HHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 024408 157 AAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 208 (268)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 208 (268)
...........+.+..++..+.+++.+||..||++||++.++++.|......
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 220 IPDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred HHHHHHCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 3333333333444567889999999999999999999999999988776543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=263.94 Aligned_cols=189 Identities=25% Similarity=0.426 Sum_probs=162.5
Q ss_pred ceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCC
Q 024408 2 REQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT 80 (268)
Q Consensus 2 ~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~ 80 (268)
+.+.||.+ .+..++++||||.||++.+.+..... +++..+.-++.+++.||.|+|.++.+|||||+.||++..+ +.
T Consensus 73 it~yygsyl~g~~LwiiMey~~gGsv~~lL~~~~~--~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~-g~ 149 (467)
T KOG0201|consen 73 ITEYYGSYLKGTKLWIIMEYCGGGSVLDLLKSGNI--LDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSES-GD 149 (467)
T ss_pred HHhhhhheeecccHHHHHHHhcCcchhhhhccCCC--CccceeeeehHHHHHHhhhhhhcceecccccccceeEecc-Cc
Confidence 45778887 56688999999999999999976443 5899999999999999999999999999999999999998 79
Q ss_pred eEEecCCCccccccc-cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 024408 81 IKLADFGLAREESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY 159 (268)
Q Consensus 81 ~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~ 159 (268)
+||+|||.+-..... ....+++||+.|||||++.+ ..|+.++||||||++.+||.+|.+|+.+..+.....
T Consensus 150 vkl~DfgVa~ql~~~~~rr~tfvGTPfwMAPEVI~~--------~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf 221 (467)
T KOG0201|consen 150 VKLADFGVAGQLTNTVKRRKTFVGTPFWMAPEVIKQ--------SGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF 221 (467)
T ss_pred EEEEecceeeeeechhhccccccccccccchhhhcc--------ccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE
Confidence 999999999754443 33378899999999999974 678999999999999999999999999888755544
Q ss_pred HHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 160 AAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
.+...........+++.+++++..||..||+.||++.++++|
T Consensus 222 lIpk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 222 LIPKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred eccCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 444444444456889999999999999999999999999986
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=254.46 Aligned_cols=191 Identities=23% Similarity=0.395 Sum_probs=154.3
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCCEEEeCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH-GIIHRDLKPENLLLTEDL 78 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-gi~H~Dikp~Nill~~~~ 78 (268)
+++++++++ .++..++||||++|++|.+++.+... +++..+..++.|++.||.|||++ +++||||||+||+++.+
T Consensus 64 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~- 140 (331)
T cd06649 64 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKR--IPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSR- 140 (331)
T ss_pred CCCeEEEEEEECCEEEEEeecCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCC-
Confidence 588999998 56789999999999999999987554 99999999999999999999986 69999999999999988
Q ss_pred CCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 79 KTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 79 ~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
+.++|+|||++...... ......|+..|+|||++.+ ..++.++|+||||+++|+|++|+.||......+..
T Consensus 141 ~~~kl~Dfg~~~~~~~~-~~~~~~g~~~y~aPE~~~~--------~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~ 211 (331)
T cd06649 141 GEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQG--------THYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELE 211 (331)
T ss_pred CcEEEccCccccccccc-ccccCCCCcCcCCHhHhcC--------CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 69999999998754322 2234578999999999864 56788999999999999999999999764432221
Q ss_pred HHHH---------------------------------------------hccCCC--CCCCCcHHHHHHHHhccccCCCC
Q 024408 159 YAAA---------------------------------------------FKNVRP--SAENVPEELSIILTSCWKEDPNA 191 (268)
Q Consensus 159 ~~~~---------------------------------------------~~~~~~--~~~~~~~~l~~li~~~l~~~p~~ 191 (268)
.... .....+ ....++.++.++|.+||..||++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~ 291 (331)
T cd06649 212 AIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAE 291 (331)
T ss_pred HHhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCccc
Confidence 1100 000001 11246789999999999999999
Q ss_pred CCCHHHHHHHHH
Q 024408 192 RPNFTQIIQMLL 203 (268)
Q Consensus 192 Rps~~~~~~~l~ 203 (268)
||++.++++|.+
T Consensus 292 Rpt~~ell~h~~ 303 (331)
T cd06649 292 RADLKMLMNHTF 303 (331)
T ss_pred CCCHHHHhcChH
Confidence 999999999854
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=251.15 Aligned_cols=201 Identities=33% Similarity=0.581 Sum_probs=162.8
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRP--------------RCLDVCVAIGFALDIARAMECLHSHGIIHR 65 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~--------------~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~ 65 (268)
++++++++| .++..++||||+++|+|.+++.+... ..+++.++..++.|++.||.|||++|++||
T Consensus 79 ~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~ 158 (334)
T cd05100 79 NIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHR 158 (334)
T ss_pred CeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence 578999999 55678999999999999999976421 237888999999999999999999999999
Q ss_pred CCCCCCEEEeCCCCCeEEecCCCccccccccc---cccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHH
Q 024408 66 DLKPENLLLTEDLKTIKLADFGLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWEL 142 (268)
Q Consensus 66 Dikp~Nill~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~l 142 (268)
||||+||+++.+ +.++|+|||+++....... .....++..|+|||++.+ ..++.++||||||+++|+|
T Consensus 159 dlkp~Nill~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~el 229 (334)
T cd05100 159 DLAARNVLVTED-NVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFD--------RVYTHQSDVWSFGVLLWEI 229 (334)
T ss_pred ccccceEEEcCC-CcEEECCcccceecccccccccccCCCcCceEcCHHHhcc--------CCcCchhhhHHHHHHHHHH
Confidence 999999999988 6999999999975433211 122234567999998854 5678899999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhcC
Q 024408 143 LH-NKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIA 210 (268)
Q Consensus 143 l~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~~~ 210 (268)
++ |..||.+....+.............+..++.++.+++.+||..+|.+||++.++++.|+.......
T Consensus 230 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~ 298 (334)
T cd05100 230 FTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS 298 (334)
T ss_pred HhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcC
Confidence 98 889998766544444333333334456778999999999999999999999999999998875443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=257.97 Aligned_cols=197 Identities=24% Similarity=0.340 Sum_probs=157.8
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ .++..++||||++||+|.+++.+... .+++..+..++.|++.||.|||++|++||||||+||+++.+ +
T Consensus 62 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~-~ 139 (330)
T cd05601 62 WIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYED-QFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRT-G 139 (330)
T ss_pred CCcceeeEEecCCeEEEEECCCCCCCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCC-C
Confidence 467888888 45689999999999999999987533 39999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccccc--cccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 024408 80 TIKLADFGLAREESLTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA 157 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~ 157 (268)
.+||+|||++........ .....||+.|+|||++...... ....++.++||||||+++|+|++|+.||........
T Consensus 140 ~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~ 217 (330)
T cd05601 140 HIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGD--GKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT 217 (330)
T ss_pred CEEeccCCCCeECCCCCceeeecccCCccccCHHHhcccccc--ccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH
Confidence 999999999975433221 2334689999999998642211 135677899999999999999999999987655444
Q ss_pred HHHHHhcc---CCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 024408 158 AYAAAFKN---VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 202 (268)
Q Consensus 158 ~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l 202 (268)
........ ..+....++.++.+++..||. +|.+||++.++++|-
T Consensus 218 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~ 264 (330)
T cd05601 218 YNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHP 264 (330)
T ss_pred HHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCC
Confidence 33332221 123344678999999999998 999999999999873
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=253.01 Aligned_cols=196 Identities=23% Similarity=0.353 Sum_probs=152.8
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|++++++++ .+...++||||++ ++|.+++.+... .+++..+..++.|++.||+|||++|++||||||+||+++.+ +
T Consensus 64 niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~-~ 140 (303)
T cd07869 64 NIVLLHDIIHTKETLTLVFEYVH-TDLCQYMDKHPG-GLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDT-G 140 (303)
T ss_pred CcCeEEEEEecCCeEEEEEECCC-cCHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-C
Confidence 578999998 5568899999995 789888876433 38999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccc-ccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESL-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.+||+|||++..... ........+++.|+|||++.+ ...++.++|+||+|+++|+|++|..||.+.......
T Consensus 141 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~ 213 (303)
T cd07869 141 ELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLG-------STEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQ 213 (303)
T ss_pred CEEECCCCcceeccCCCccCCCCcccCCCCChHHHcC-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHH
Confidence 999999999874332 222334568899999998753 245678999999999999999999999876544332
Q ss_pred HHHHhcc-CCC----------------------C---------CCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhH
Q 024408 159 YAAAFKN-VRP----------------------S---------AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 206 (268)
Q Consensus 159 ~~~~~~~-~~~----------------------~---------~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 206 (268)
....... ..+ . ....++.+.+++.+||..||.+|||+.++++| .++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h--~~f 291 (303)
T cd07869 214 LERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH--EYF 291 (303)
T ss_pred HHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC--ccc
Confidence 2211110 000 0 01245678999999999999999999999998 444
Q ss_pred hh
Q 024408 207 SA 208 (268)
Q Consensus 207 ~~ 208 (268)
..
T Consensus 292 ~~ 293 (303)
T cd07869 292 SD 293 (303)
T ss_pred cc
Confidence 43
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=244.57 Aligned_cols=197 Identities=28% Similarity=0.419 Sum_probs=164.8
Q ss_pred ceeEEEeecC-C------cEEEEEEcCCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCE
Q 024408 2 REQFIGACKE-P------VMVIVTELLSGGTLRKYLLNMRP--RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENL 72 (268)
Q Consensus 2 ~v~l~g~~~~-~------~~~lV~e~~~ggsL~~~i~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Ni 72 (268)
+|+|++++.. . .+++|+||++ -+|.+++..... ..++...+..++.||+.||+|||++||+||||||.||
T Consensus 73 iv~L~dv~~~~~~~~~~~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNl 151 (323)
T KOG0594|consen 73 IVRLHDVIHTSNNHRGIGKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNL 151 (323)
T ss_pred eEEEEeeeeecccccccceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceE
Confidence 7899999843 3 6899999996 799999988664 3588899999999999999999999999999999999
Q ss_pred EEeCCCCCeEEecCCCccccc-cccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 024408 73 LLTEDLKTIKLADFGLAREES-LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 151 (268)
Q Consensus 73 ll~~~~~~~kl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~ 151 (268)
+++++ |.+||+|||+|+... +.....+.++|.+|+|||++.+ ...|+...|+||+||+++||++++.-|.+
T Consensus 152 Li~~~-G~lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlG-------s~~Ys~~vDiWs~GcIfaEm~~~~~LFpG 223 (323)
T KOG0594|consen 152 LISSS-GVLKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLG-------STSYSTSVDIWSLGCIFAEMFTRRPLFPG 223 (323)
T ss_pred EECCC-CcEeeeccchHHHhcCCcccccccEEEeeccCHHHhcC-------CCcCCCCcchHhHHHHHHHHHhCCCCCCC
Confidence 99998 799999999999665 3444667789999999999986 34689999999999999999999999999
Q ss_pred CChHHHHHHHHhccCCCCCCC-----------------------------CcHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 024408 152 MSNLQAAYAAAFKNVRPSAEN-----------------------------VPEELSIILTSCWKEDPNARPNFTQIIQML 202 (268)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~l~~li~~~l~~~p~~Rps~~~~~~~l 202 (268)
....++...+......|.... ..+...+++.+||.++|.+|.|++.+++|
T Consensus 224 ~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h- 302 (323)
T KOG0594|consen 224 DSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH- 302 (323)
T ss_pred CcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC-
Confidence 888776666555444443211 12478889999999999999999999998
Q ss_pred HHhHhhc
Q 024408 203 LNYLSAI 209 (268)
Q Consensus 203 ~~~~~~~ 209 (268)
.++...
T Consensus 303 -~yf~~~ 308 (323)
T KOG0594|consen 303 -PYFSEL 308 (323)
T ss_pred -hhhccc
Confidence 455443
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=247.15 Aligned_cols=194 Identities=30% Similarity=0.547 Sum_probs=158.0
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCC--------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRP--------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPEN 71 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~--------~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~N 71 (268)
+++++++++ .+...++||||+++++|.+++.+... ..+++..++.++.|++.||.|||+.|++|+||||+|
T Consensus 70 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~N 149 (277)
T cd05062 70 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARN 149 (277)
T ss_pred CeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchhe
Confidence 578999999 45688999999999999999976332 236788899999999999999999999999999999
Q ss_pred EEEeCCCCCeEEecCCCccccccccc---cccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCC
Q 024408 72 LLLTEDLKTIKLADFGLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKL 147 (268)
Q Consensus 72 ill~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~ 147 (268)
|+++.+ +.++|+|||+++....... .....++..|+|||.+.+ ..++.++|+||||+++|+|++ |..
T Consensus 150 il~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~el~~~~~~ 220 (277)
T cd05062 150 CMVAED-FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD--------GVFTTYSDVWSFGVVLWEIATLAEQ 220 (277)
T ss_pred EEEcCC-CCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhc--------CCcCchhHHHHHHHHHHHHHcCCCC
Confidence 999988 6899999999874322211 122345778999998853 557889999999999999998 788
Q ss_pred CCCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 024408 148 PFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 203 (268)
Q Consensus 148 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~ 203 (268)
||......+.............+..++..+.+++.+||+.+|++||++.++++.|+
T Consensus 221 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 221 PYQGMSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred CCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 99876655444433444444456678899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=247.98 Aligned_cols=196 Identities=30% Similarity=0.553 Sum_probs=160.2
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCee
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMR---------------PRCLDVCVAIGFALDIARAMECLHSHGIIH 64 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~---------------~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H 64 (268)
|+|+++|++ .+...++||||+++++|.+++.... ...+++.++..++.|++.||.|||++|++|
T Consensus 68 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H 147 (283)
T cd05090 68 NIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVH 147 (283)
T ss_pred CeeeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeeh
Confidence 578999998 5568899999999999999986432 123788999999999999999999999999
Q ss_pred cCCCCCCEEEeCCCCCeEEecCCCcccccccc---ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHH
Q 024408 65 RDLKPENLLLTEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWE 141 (268)
Q Consensus 65 ~Dikp~Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ 141 (268)
|||||+||+++++ +.++|+|||+++...... ......++..|+|||.+.+ ..++.++|+||||+++|+
T Consensus 148 ~dlkp~nili~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~il~e 218 (283)
T cd05090 148 KDLAARNILIGEQ-LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMY--------GKFSSDSDIWSFGVVLWE 218 (283)
T ss_pred hccccceEEEcCC-CcEEeccccccccccCCcceecccCCCccceecChHHhcc--------CCCCchhhhHHHHHHHHH
Confidence 9999999999988 689999999997543221 1233345678999998853 457889999999999999
Q ss_pred HHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHh
Q 024408 142 LLH-NKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 205 (268)
Q Consensus 142 ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~ 205 (268)
|++ |..||.+................+.+..++..+.+++.+||+.||.+||++.+++++|..+
T Consensus 219 l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05090 219 IFSFGLQPYYGFSNQEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRSW 283 (283)
T ss_pred HHcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhcC
Confidence 998 9999987655444444444444455677899999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=264.45 Aligned_cols=201 Identities=33% Similarity=0.602 Sum_probs=168.8
Q ss_pred CceeEEEeecCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCC
Q 024408 1 MREQFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT 80 (268)
Q Consensus 1 ~~v~l~g~~~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~ 80 (268)
|++=|+|||..+.+.+|..+|+|.+|+.+|...+.+ |+..+.+.|+.|+++|+.|||.++|+|||||..||++.++ +.
T Consensus 449 NIlLFMG~~~~p~~AIiTqwCeGsSLY~hlHv~etk-fdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~-~k 526 (678)
T KOG0193|consen 449 NILLFMGACMNPPLAIITQWCEGSSLYTHLHVQETK-FDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHED-LK 526 (678)
T ss_pred hheeeehhhcCCceeeeehhccCchhhhhccchhhh-hhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccC-Cc
Confidence 678899999887779999999999999999876654 9999999999999999999999999999999999999998 79
Q ss_pred eEEecCCCccccc---cccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 024408 81 IKLADFGLAREES---LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA 157 (268)
Q Consensus 81 ~kl~Dfg~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~ 157 (268)
|||+|||++.... .........|...|||||+++.. ....|++++||||||+++|||++|..||......+.
T Consensus 527 VkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmq-----d~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqI 601 (678)
T KOG0193|consen 527 VKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQ-----DDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQI 601 (678)
T ss_pred EEEecccceeeeeeeccccccCCCccchhhhcHHHHhhc-----ccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhhe
Confidence 9999999997322 22233455688899999999741 246799999999999999999999999995444444
Q ss_pred HHHHHhccCCCC----CCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 024408 158 AYAAAFKNVRPS----AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 208 (268)
Q Consensus 158 ~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 208 (268)
.+....+...+. ...+++++++|+..||..++++||.+.+|+..|+..+..
T Consensus 602 ifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 602 IFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred EEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 444444433332 456788999999999999999999999999998887764
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=256.99 Aligned_cols=194 Identities=23% Similarity=0.382 Sum_probs=171.4
Q ss_pred CceeEEEeecC-CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGACKE-PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~~~-~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|+|+||...+. ..+|||+|+-+||+|+|+|.++... +.+..+.+++.||+.|+.|||+..+|||||||+|+.+-+..|
T Consensus 78 NiVRLYEViDTQTKlyLiLELGD~GDl~DyImKHe~G-l~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlG 156 (864)
T KOG4717|consen 78 NIVRLYEVIDTQTKLYLILELGDGGDLFDYIMKHEEG-LNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLG 156 (864)
T ss_pred CeeeeeehhcccceEEEEEEecCCchHHHHHHhhhcc-ccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecC
Confidence 78999999954 5799999999999999999987654 999999999999999999999999999999999999988888
Q ss_pred CeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 024408 80 TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY 159 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~ 159 (268)
-+||.|||++..+.+.....+.+|...|.|||++.+ .....++.||||||++||-|++|+.||+.....+...
T Consensus 157 lVKLTDFGFSNkf~PG~kL~TsCGSLAYSAPEILLG-------DsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLT 229 (864)
T KOG4717|consen 157 LVKLTDFGFSNKFQPGKKLTTSCGSLAYSAPEILLG-------DSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLT 229 (864)
T ss_pred ceEeeeccccccCCCcchhhcccchhhccCchhhhc-------CccCCcchhhhHHHHHHHHHHhCCCccccccchhhhh
Confidence 999999999998888888899999999999999986 2344578999999999999999999999877666544
Q ss_pred HHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 024408 160 AAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 203 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~ 203 (268)
.++ ......+..++.+++++|..||..||++|.+.++|..+-|
T Consensus 230 mIm-DCKYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~W 272 (864)
T KOG4717|consen 230 MIM-DCKYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSW 272 (864)
T ss_pred hhh-cccccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcccc
Confidence 432 3333447788999999999999999999999999998743
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=268.80 Aligned_cols=199 Identities=31% Similarity=0.581 Sum_probs=176.2
Q ss_pred CceeEEEeec-CCcEEEEEEcCCCCCHHHHHHhcCC--------CC----CCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q 024408 1 MREQFIGACK-EPVMVIVTELLSGGTLRKYLLNMRP--------RC----LDVCVAIGFALDIARAMECLHSHGIIHRDL 67 (268)
Q Consensus 1 ~~v~l~g~~~-~~~~~lV~e~~~ggsL~~~i~~~~~--------~~----~~~~~~~~~~~~l~~~l~~lH~~gi~H~Di 67 (268)
|||+|+|.|. ++-.+||+||+..|||.++|..+.+ .. ++..+.+.++.||+.|++||-++.+|||||
T Consensus 550 nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDL 629 (774)
T KOG1026|consen 550 NIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDL 629 (774)
T ss_pred CeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccch
Confidence 7999999994 4578999999999999999986543 12 889999999999999999999999999999
Q ss_pred CCCCEEEeCCCCCeEEecCCCccccccccc---cccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh
Q 024408 68 KPENLLLTEDLKTIKLADFGLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH 144 (268)
Q Consensus 68 kp~Nill~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~ 144 (268)
-..|+|++++. .|||+|||+++.....+- .....-..+|||||.+.. +.++.+|||||+||++||+++
T Consensus 630 ATRNCLVge~l-~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly--------~kFTteSDVWs~GVvLWEIFs 700 (774)
T KOG1026|consen 630 ATRNCLVGENL-VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILY--------GKFTTESDVWSFGVVLWEIFS 700 (774)
T ss_pred hhhhceeccce-EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhc--------Ccccchhhhhhhhhhhhhhhc
Confidence 99999999995 999999999995433221 112234679999999875 789999999999999999998
Q ss_pred -CCCCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 024408 145 -NKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 208 (268)
Q Consensus 145 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 208 (268)
|+.||.+..+.++..........+.++.+|.++..|+..||+.+|.+||++.+|-..|+.+...
T Consensus 701 yG~QPy~glSn~EVIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 701 YGKQPYYGLSNQEVIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred cccCcccccchHHHHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 9999999999999998888888899999999999999999999999999999999999987765
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=251.43 Aligned_cols=192 Identities=26% Similarity=0.388 Sum_probs=158.1
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++.+ .++++++||||++||+|.+++.......+++..+..++.|++.||.|||++|++||||||+||+++++ +
T Consensus 61 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~-~ 139 (285)
T cd05605 61 FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDY-G 139 (285)
T ss_pred CEeeeeeeecCCCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCC-C
Confidence 478888888 45689999999999999999876555569999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 024408 80 TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY 159 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~ 159 (268)
.++|+|||++.............|+..|+|||++.+ ..++.++|+||+|+++|++++|+.||.+........
T Consensus 140 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~ 211 (285)
T cd05605 140 HIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKN--------ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKRE 211 (285)
T ss_pred CEEEeeCCCceecCCCCccccccCCCCccCcHHhcC--------CCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHH
Confidence 999999999986544333345578999999999854 567888999999999999999999998754432221
Q ss_pred ---HHHhccCCCCCCCCcHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 024408 160 ---AAAFKNVRPSAENVPEELSIILTSCWKEDPNARP-----NFTQIIQM 201 (268)
Q Consensus 160 ---~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~~~~~ 201 (268)
..........+..++..+.+++.+||..||.+|| ++++++++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 212 EVERRVKEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred HHHHHhhhcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 1122222233456889999999999999999999 88899887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=255.75 Aligned_cols=190 Identities=23% Similarity=0.375 Sum_probs=151.3
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++.+ .+..+++||||++||+|.+++.+.+. +++..+..++.|++.||+|||++||+||||||+|||++.+ +
T Consensus 62 ~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~-~ 138 (363)
T cd05628 62 WVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDT--LTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSK-G 138 (363)
T ss_pred CcceEEEEEecCCeEEEEEcCCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCC-C
Confidence 478899998 45689999999999999999987554 9999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccccc------------------------------------ccccCCCccceeccccccccccccCCC
Q 024408 80 TIKLADFGLAREESLTE------------------------------------MMTAETGTYRWMAPELYSTVTLRQGEK 123 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~ 123 (268)
.++|+|||+++...... ......||+.|+|||++.+
T Consensus 139 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-------- 210 (363)
T cd05628 139 HVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ-------- 210 (363)
T ss_pred CEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC--------
Confidence 99999999986422110 0123479999999999864
Q ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc---CCCCCCCCcHHHHHHHHhccc--cCCCCCCCHHHH
Q 024408 124 KHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN---VRPSAENVPEELSIILTSCWK--EDPNARPNFTQI 198 (268)
Q Consensus 124 ~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~--~~p~~Rps~~~~ 198 (268)
..++.++|+||||+++|+|++|+.||.+....+......... ..+....+++++.++|.+++. .++..||+++++
T Consensus 211 ~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei 290 (363)
T cd05628 211 TGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEI 290 (363)
T ss_pred CCCCCchhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHH
Confidence 557889999999999999999999998766554443333211 122234578899999998654 233456899999
Q ss_pred HHH
Q 024408 199 IQM 201 (268)
Q Consensus 199 ~~~ 201 (268)
++|
T Consensus 291 ~~h 293 (363)
T cd05628 291 KTN 293 (363)
T ss_pred hCC
Confidence 998
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=244.58 Aligned_cols=192 Identities=28% Similarity=0.504 Sum_probs=158.1
Q ss_pred CceeEEEeec-CCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGACK-EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~~-~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
++++++|++. ....++||||+++|+|.+++..... .+++.+++.++.|++.||+|||+.|++|+||||+||+++.+ +
T Consensus 60 ~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~-~ 137 (256)
T cd05113 60 KLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQ-G 137 (256)
T ss_pred CeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCC-C
Confidence 5789999994 4578999999999999999976443 48999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccccc--cccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 024408 80 TIKLADFGLAREESLTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQ 156 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~~~~ 156 (268)
.+||+|||.++....... .....++..|++||.+.+ ..++.++|+||||+++|+|++ |..||......+
T Consensus 138 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~--------~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~ 209 (256)
T cd05113 138 CVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLY--------SKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE 209 (256)
T ss_pred CEEECCCccceecCCCceeecCCCccChhhCCHHHHhc--------CcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH
Confidence 899999999875433221 112235678999998853 457889999999999999998 999998766554
Q ss_pred HHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 024408 157 AAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 202 (268)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l 202 (268)
.................+..+.+++.+||..+|.+||++.++++.+
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~ 255 (256)
T cd05113 210 TVEKVSQGLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSI 255 (256)
T ss_pred HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence 4444444444444566789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=244.26 Aligned_cols=195 Identities=33% Similarity=0.525 Sum_probs=160.4
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ .++..++||||++|++|.+++.......+++.++..++.|++.||.+||++|++|+||||+||+++.+ +
T Consensus 62 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~-~ 140 (261)
T cd05068 62 KLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGEN-N 140 (261)
T ss_pred CccceeEEEecCCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCC-C
Confidence 578899988 45678999999999999999987654559999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccccccc--cCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 024408 80 TIKLADFGLAREESLTEMMT--AETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQ 156 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~~~~ 156 (268)
.++|+|||++.......... ....+..|+|||.+.+ ..++.++|+||||+++++|++ |+.||.+.....
T Consensus 141 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 212 (261)
T cd05068 141 ICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALY--------NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE 212 (261)
T ss_pred CEEECCcceEEEccCCcccccCCCcCceeccCcccccc--------CCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 89999999998644222111 1122457999998754 557889999999999999999 999998766554
Q ss_pred HHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 024408 157 AAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 204 (268)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~ 204 (268)
...........+....++..+.+++.+|++.+|.+||++.++++.|++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 213 VLQQVDQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred HHHHHHcCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 444433333344566788999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=243.15 Aligned_cols=192 Identities=28% Similarity=0.537 Sum_probs=157.6
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ .++..++||||++||+|.+++..... .+++..++.++.|++.||.|||++|++|+||||+||+++.+ +
T Consensus 60 ~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~-~ 137 (256)
T cd05114 60 KLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQG-KLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSST-G 137 (256)
T ss_pred CceeEEEEEccCCCEEEEEEcCCCCcHHHHHHhCcc-CCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCC-C
Confidence 578999999 45688999999999999999976433 38999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccccccc--ccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 024408 80 TIKLADFGLAREESLTEMM--TAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQ 156 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~~~~ 156 (268)
.++++|||.++........ ....++..|+|||.+.+ ..++.++|+||||+++|++++ |+.||......+
T Consensus 138 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~ 209 (256)
T cd05114 138 VVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNF--------SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE 209 (256)
T ss_pred eEEECCCCCccccCCCceeccCCCCCchhhCChhhccc--------CccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 8999999998753322211 12234568999998854 457789999999999999999 899998766555
Q ss_pred HHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 024408 157 AAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 202 (268)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l 202 (268)
.............+...+..+.+++.+||..+|++||++.++++.|
T Consensus 210 ~~~~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 210 VVEMISRGFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred HHHHHHCCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 5444444434444566788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=244.52 Aligned_cols=192 Identities=27% Similarity=0.394 Sum_probs=160.0
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ .++..++||||++|++|.+++.......+++.+++.++.+++.||.|||++|++|+||||+||+++.+ +
T Consensus 60 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~-~ 138 (256)
T cd08529 60 YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAY-D 138 (256)
T ss_pred CeehheeeeccCCEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCC-C
Confidence 578889998 55689999999999999999987645569999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccccc-ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESLTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.++|+|||+++...... ......|+..|+|||++.+ ..++.++|+||||+++++|++|+.||.........
T Consensus 139 ~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~ 210 (256)
T cd08529 139 NVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCED--------KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALI 210 (256)
T ss_pred CEEEcccccceeccCccchhhccccCccccCHHHhcC--------CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 99999999987543322 2234467889999998864 45678999999999999999999999876654444
Q ss_pred HHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 159 YAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
.........+....++..+.+++.+||+.+|++||++.+++++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 211 LKIIRGVFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred HHHHcCCCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 4333333344455788999999999999999999999999876
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=244.50 Aligned_cols=195 Identities=29% Similarity=0.508 Sum_probs=161.9
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
++++++|.+ .++..++||||++|++|.+++..... .+++.+++.++.|++.||+|||++|++|+||||+||+++.+ +
T Consensus 66 ~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~-~ 143 (266)
T cd05033 66 NIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDG-KFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSN-L 143 (266)
T ss_pred CcceEeEEEecCCceEEEEEcCCCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCC-C
Confidence 578899988 55688999999999999999977543 48999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccc-ccc--cccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChH
Q 024408 80 TIKLADFGLAREESL-TEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNL 155 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~-~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~~~ 155 (268)
.++++|||++..... ... .....++..|+|||.+.+ ..++.++|+||||+++|++++ |..||......
T Consensus 144 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~--------~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~ 215 (266)
T cd05033 144 VCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAY--------RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ 215 (266)
T ss_pred CEEECccchhhcccccccceeccCCCCCccccChhhhcc--------CCCccccchHHHHHHHHHHHccCCCCCCCCCHH
Confidence 899999999986531 111 112234578999998854 457889999999999999998 99999876665
Q ss_pred HHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHh
Q 024408 156 QAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 205 (268)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~ 205 (268)
+...........+....++..+.+++.+||+.+|++||++.+++++|..+
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 216 DVIKAVEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 55444444444455677899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=243.68 Aligned_cols=192 Identities=32% Similarity=0.591 Sum_probs=157.4
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ ..+..++||||++|++|.+++..... .+++..++.++.|++.||.|||++|++||||||+||+++.+ +
T Consensus 60 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~-~ 137 (256)
T cd05059 60 NLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKG-KLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGED-N 137 (256)
T ss_pred CEEEEEEEEcCCCceEEEEecCCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCC-C
Confidence 578999998 45688999999999999999976543 48999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccccccc--ccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 024408 80 TIKLADFGLAREESLTEMM--TAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQ 156 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~~~~ 156 (268)
.++++|||+++........ ....++..|+|||.+.+ ..++.++|+||||+++|++++ |..||......+
T Consensus 138 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~--------~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~ 209 (256)
T cd05059 138 VVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDY--------SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE 209 (256)
T ss_pred cEEECCcccceecccccccccCCCCCCccccCHHHhcc--------CCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH
Confidence 8999999998754322111 11123457999998854 557789999999999999998 899998766555
Q ss_pred HHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 024408 157 AAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 202 (268)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l 202 (268)
.............+..++.++.+++.+||..+|++||++.++++.|
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 210 VVESVSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred HHHHHHcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 4444433333445667899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=244.44 Aligned_cols=194 Identities=34% Similarity=0.614 Sum_probs=162.7
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcC-------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCE
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMR-------PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENL 72 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~-------~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Ni 72 (268)
+++++++++ .+...++||||++|++|.+++.... ...+++.+++.++.|++.||++||++|++|+||+|+||
T Consensus 57 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~ni 136 (262)
T cd00192 57 NVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNC 136 (262)
T ss_pred ChheeeeeecCCCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceE
Confidence 478899998 4468899999999999999998752 23499999999999999999999999999999999999
Q ss_pred EEeCCCCCeEEecCCCccccccc---cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCC
Q 024408 73 LLTEDLKTIKLADFGLAREESLT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLP 148 (268)
Q Consensus 73 ll~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p 148 (268)
+++.+ +.++|+|||.+...... .......++..|+|||.+.. ..++.++|+||||+++|+|++ |..|
T Consensus 137 li~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~~g~~p 207 (262)
T cd00192 137 LVGED-LVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKD--------GIFTSKSDVWSFGVLLWEIFTLGATP 207 (262)
T ss_pred EECCC-CcEEEcccccccccccccccccccCCCcCccccCHHHhcc--------CCcchhhccHHHHHHHHHHHhcCCCC
Confidence 99998 69999999999864433 22234457889999998754 467889999999999999999 6999
Q ss_pred CCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 024408 149 FEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 203 (268)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~ 203 (268)
|......+.............+..++.++.+++.+||..+|.+||++.+++++|+
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 208 YPGLSNEEVLEYLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred CCCCCHHHHHHHHHcCCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 9887665554444444444556778999999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=246.88 Aligned_cols=194 Identities=30% Similarity=0.532 Sum_probs=160.1
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCC------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRP------------RCLDVCVAIGFALDIARAMECLHSHGIIHRDL 67 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~------------~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Di 67 (268)
+++++++++ .++..++||||++|++|.+++...+. ..+++.++..++.|++.||.+||++|++||||
T Consensus 69 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dl 148 (280)
T cd05049 69 NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDL 148 (280)
T ss_pred CchheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecccc
Confidence 478899998 55689999999999999999976431 34889999999999999999999999999999
Q ss_pred CCCCEEEeCCCCCeEEecCCCcccccccc---ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh
Q 024408 68 KPENLLLTEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH 144 (268)
Q Consensus 68 kp~Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~ 144 (268)
||+||+++.+ +.++|+|||++....... ......++..|+|||.+.+ ..++.++||||||+++|+|++
T Consensus 149 kp~nili~~~-~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~e~~~ 219 (280)
T cd05049 149 ATRNCLVGYD-LVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMY--------RKFTTESDVWSFGVVLWEIFT 219 (280)
T ss_pred ccceEEEcCC-CeEEECCcccceecccCcceecCCCCcccceecChhhhcc--------CCcchhhhHHHHHHHHHHHHh
Confidence 9999999988 699999999987432221 1223345778999998864 567889999999999999998
Q ss_pred -CCCCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 024408 145 -NKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 203 (268)
Q Consensus 145 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~ 203 (268)
|..||.+....+.............+..++..+.+++.+||..||++||++.++++.|+
T Consensus 220 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 220 YGKQPWYGLSNEEVIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred cCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 99999876655544444444444446678999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=262.93 Aligned_cols=195 Identities=23% Similarity=0.315 Sum_probs=152.6
Q ss_pred CceeEEEeecC---------CcEEEEEEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCC
Q 024408 1 MREQFIGACKE---------PVMVIVTELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKP 69 (268)
Q Consensus 1 ~~v~l~g~~~~---------~~~~lV~e~~~ggsL~~~i~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp 69 (268)
|+|++++++.. .++++||||++ ++|.+++... ....+++..++.++.|++.||+|||++||+||||||
T Consensus 120 niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp 198 (440)
T PTZ00036 120 NIIFLKDYYYTECFKKNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKP 198 (440)
T ss_pred CCcceeeeEeecccccCCCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCH
Confidence 56788776521 15779999996 6888877642 234599999999999999999999999999999999
Q ss_pred CCEEEeCCCCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 024408 70 ENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPF 149 (268)
Q Consensus 70 ~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~ 149 (268)
+|||++.+.+.+||+|||+++............||+.|+|||++.+ ...++.++|||||||++|+|++|.+||
T Consensus 199 ~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwSlGvil~elltG~~pf 271 (440)
T PTZ00036 199 QNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLG-------ATNYTTHIDLWSLGCIIAEMILGYPIF 271 (440)
T ss_pred HHEEEcCCCCceeeeccccchhccCCCCcccCCCCcCccCHHHhcC-------CCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 9999987645799999999986544444445678999999998753 245788999999999999999999999
Q ss_pred CCCChHHHHHHHHhccCCC----------------------------CCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 150 EGMSNLQAAYAAAFKNVRP----------------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
.+....+...........+ .+...+.++.++|.+||..||.+||++.++++|
T Consensus 272 ~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 272 SGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred CCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 8765544333222111000 123467899999999999999999999999998
Q ss_pred HH
Q 024408 202 LL 203 (268)
Q Consensus 202 l~ 203 (268)
-+
T Consensus 352 p~ 353 (440)
T PTZ00036 352 PF 353 (440)
T ss_pred hh
Confidence 43
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=248.95 Aligned_cols=197 Identities=34% Similarity=0.579 Sum_probs=160.4
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMR--------------PRCLDVCVAIGFALDIARAMECLHSHGIIHR 65 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~--------------~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~ 65 (268)
+++++++++ .++..++||||+++|+|.+++.+.. ...+++..++.++.|++.||.|||++|++||
T Consensus 77 ~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~ 156 (293)
T cd05053 77 NIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHR 156 (293)
T ss_pred CeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence 578999998 4568999999999999999997532 2358999999999999999999999999999
Q ss_pred CCCCCCEEEeCCCCCeEEecCCCccccccccc---cccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHH
Q 024408 66 DLKPENLLLTEDLKTIKLADFGLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWEL 142 (268)
Q Consensus 66 Dikp~Nill~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~l 142 (268)
||||+||+++.+ +.++|+|||+++....... .....++..|+|||.+.+ ..++.++||||||+++|++
T Consensus 157 dlkp~Nil~~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~el 227 (293)
T cd05053 157 DLAARNVLVTED-HVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD--------RVYTHQSDVWSFGVLLWEI 227 (293)
T ss_pred ccceeeEEEcCC-CeEEeCccccccccccccceeccCCCCCCccccCHHHhcc--------CCcCcccceeehhhHHHHH
Confidence 999999999988 6999999999985433211 122234567999998753 5577899999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhH
Q 024408 143 LH-NKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 206 (268)
Q Consensus 143 l~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 206 (268)
++ |..||.+....+.............+..++..+.+++.+||..||++|||+.++++.|.+..
T Consensus 228 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 228 FTLGGSPYPGIPVEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred hcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 97 99999876655444433333333445677899999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=241.87 Aligned_cols=193 Identities=33% Similarity=0.573 Sum_probs=156.3
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
++++++++| .+...++||||++|++|.+++.+... .+++.+++.++.|++.||+|||++|++|+||||+||+++.+ +
T Consensus 54 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~-~ 131 (252)
T cd05084 54 NIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGP-RLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEK-N 131 (252)
T ss_pred CcceEEEEEcCCCCeEEEEeeccCCcHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCC-C
Confidence 578999999 55678999999999999999976443 38999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccccccc---cCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChH
Q 024408 80 TIKLADFGLAREESLTEMMT---AETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNL 155 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~~~ 155 (268)
.++|+|||++.......... ....+..|+|||.+.+ ..++.++|+||||+++|++++ |..||......
T Consensus 132 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~ 203 (252)
T cd05084 132 VLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNY--------GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ 203 (252)
T ss_pred cEEECccccCcccccccccccCCCCCCceeecCchhhcC--------CCCChHHHHHHHHHHHHHHHhCCCCCccccCHH
Confidence 89999999987533221111 1122457999998854 457889999999999999997 88999776654
Q ss_pred HHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 024408 156 QAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 203 (268)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~ 203 (268)
............+.+..++..+.+++.+||..+|++||++.++++.|.
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 204 QTREAIEQGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 443433333334456678899999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=248.00 Aligned_cols=199 Identities=31% Similarity=0.571 Sum_probs=161.5
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRP--------------RCLDVCVAIGFALDIARAMECLHSHGIIHR 65 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~--------------~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~ 65 (268)
+++++++++ .+...++||||+++|+|.+++.+... ..+++.++..++.|++.||.|||++|++||
T Consensus 82 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~ 161 (304)
T cd05101 82 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHR 161 (304)
T ss_pred CchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence 578999998 45678999999999999999976422 247888999999999999999999999999
Q ss_pred CCCCCCEEEeCCCCCeEEecCCCcccccccc---ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHH
Q 024408 66 DLKPENLLLTEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWEL 142 (268)
Q Consensus 66 Dikp~Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~l 142 (268)
||||+||+++.+ +.++|+|||+++...... ......++..|+|||++.+ ..++.++||||||+++|++
T Consensus 162 dlkp~Nili~~~-~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~el 232 (304)
T cd05101 162 DLAARNVLVTEN-NVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFD--------RVYTHQSDVWSFGVLMWEI 232 (304)
T ss_pred ccccceEEEcCC-CcEEECCCccceecccccccccccCCCCCceeeCchhhcc--------CCCCchhhHHHHHHHHHHH
Confidence 999999999988 699999999998543221 1122345678999998854 4577899999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 024408 143 LH-NKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 208 (268)
Q Consensus 143 l~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 208 (268)
++ |..||.+....+.............+..++..+.+++.+||..+|.+||++.++++.|..++..
T Consensus 233 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 233 FTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred HcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 98 7888877655444433333333334567889999999999999999999999999999887754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=247.49 Aligned_cols=193 Identities=24% Similarity=0.370 Sum_probs=154.0
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED 77 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~ 77 (268)
+++++++++ .+...++||||++||+|.+++... ....+++..+..++.|++.||.|||++|++||||||+||+++.+
T Consensus 54 ~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~ 133 (280)
T cd05608 54 FIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDND 133 (280)
T ss_pred cEeeeeEEEcCCCeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC
Confidence 467888887 456799999999999999888542 23459999999999999999999999999999999999999987
Q ss_pred CCCeEEecCCCcccccccc-ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH
Q 024408 78 LKTIKLADFGLAREESLTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 156 (268)
Q Consensus 78 ~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~ 156 (268)
+.++|+|||++....... ......|++.|+|||++.+ ..++.++|+||+|+++|+|++|+.||.......
T Consensus 134 -~~~~l~dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~ 204 (280)
T cd05608 134 -GNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQG--------EEYDFSVDYFALGVTLYEMIAARGPFRARGEKV 204 (280)
T ss_pred -CCEEEeeCccceecCCCCccccccCCCcCccCHHHhcC--------CCCCccccHHHHHHHHHHHHhCCCCCCCCCcch
Confidence 689999999987533222 2234578999999999864 567789999999999999999999997643221
Q ss_pred ---HHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCC-----CHHHHHHHH
Q 024408 157 ---AAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARP-----NFTQIIQML 202 (268)
Q Consensus 157 ---~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~~~~~l 202 (268)
.............+..++..+.+++.+||+.||.+|| +++++++|-
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~ 258 (280)
T cd05608 205 ENKELKQRILNDSVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHP 258 (280)
T ss_pred hHHHHHHhhcccCCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcCh
Confidence 1111122222233456889999999999999999999 778888873
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=252.95 Aligned_cols=198 Identities=30% Similarity=0.556 Sum_probs=158.8
Q ss_pred CceeEEEeec--CCcEEEEEEcCCCCCHHHHHHhcCC-------------------------------------------
Q 024408 1 MREQFIGACK--EPVMVIVTELLSGGTLRKYLLNMRP------------------------------------------- 35 (268)
Q Consensus 1 ~~v~l~g~~~--~~~~~lV~e~~~ggsL~~~i~~~~~------------------------------------------- 35 (268)
|+++++|+|. +..+++||||++|++|.++|.....
T Consensus 72 niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (337)
T cd05054 72 NVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDK 151 (337)
T ss_pred chhheeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCc
Confidence 5789999883 3578999999999999999864321
Q ss_pred ----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCCeEEecCCCcccccccc---
Q 024408 36 ----------------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE--- 96 (268)
Q Consensus 36 ----------------~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~~kl~Dfg~a~~~~~~~--- 96 (268)
..+++..+..++.|++.||+|||++||+||||||+||+++.+ +.++|+|||+++......
T Consensus 152 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~-~~vkL~DfG~a~~~~~~~~~~ 230 (337)
T cd05054 152 SLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSEN-NVVKICDFGLARDIYKDPDYV 230 (337)
T ss_pred chhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCC-CcEEEeccccchhcccCcchh
Confidence 248899999999999999999999999999999999999987 689999999998543221
Q ss_pred ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcc-CCCCCCCCc
Q 024408 97 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKN-VRPSAENVP 174 (268)
Q Consensus 97 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~ 174 (268)
......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+......... ....+...+
T Consensus 231 ~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (337)
T cd05054 231 RKGDARLPLKWMAPESIFD--------KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYAT 302 (337)
T ss_pred hccCCCCCccccCcHHhcC--------CCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCC
Confidence 1223345678999998854 567889999999999999997 999997644333332222222 223345678
Q ss_pred HHHHHHHHhccccCCCCCCCHHHHHHHHHHhHh
Q 024408 175 EELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 207 (268)
Q Consensus 175 ~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 207 (268)
.++.+++.+||+.+|++||++.+++++|...++
T Consensus 303 ~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 303 PEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 899999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=256.91 Aligned_cols=190 Identities=23% Similarity=0.356 Sum_probs=154.5
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ .++++++||||++||+|.+++...+. +++.++..++.|++.||+|||++|++||||||+|||++.+ +
T Consensus 62 ~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~-~ 138 (364)
T cd05599 62 WVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDT--FTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAK-G 138 (364)
T ss_pred CCcceEEEEEcCCeEEEEECCCCCcHHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCC-C
Confidence 578999998 55689999999999999999987554 9999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccccc---------------------------------------ccccCCCccceecccccccccccc
Q 024408 80 TIKLADFGLAREESLTE---------------------------------------MMTAETGTYRWMAPELYSTVTLRQ 120 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~---------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~ 120 (268)
.++|+|||++....... ......||+.|+|||++..
T Consensus 139 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----- 213 (364)
T cd05599 139 HIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ----- 213 (364)
T ss_pred CEEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC-----
Confidence 99999999986422110 0112468999999998854
Q ss_pred CCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc---CCCCCCCCcHHHHHHHHhccccCCCCCCC---
Q 024408 121 GEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN---VRPSAENVPEELSIILTSCWKEDPNARPN--- 194 (268)
Q Consensus 121 ~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~~p~~Rps--- 194 (268)
..++.++|||||||++|+|++|..||.+....+......... ..+....+++++.++|.+|+. +|.+|++
T Consensus 214 ---~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~ 289 (364)
T cd05599 214 ---TGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNG 289 (364)
T ss_pred ---CCCCCeeeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCC
Confidence 567889999999999999999999998866554433332211 122234578999999999996 9999997
Q ss_pred HHHHHHHH
Q 024408 195 FTQIIQML 202 (268)
Q Consensus 195 ~~~~~~~l 202 (268)
+.++++|-
T Consensus 290 ~~~ll~h~ 297 (364)
T cd05599 290 VNEIKSHP 297 (364)
T ss_pred HHHHhcCC
Confidence 99999874
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=245.32 Aligned_cols=199 Identities=28% Similarity=0.345 Sum_probs=161.9
Q ss_pred CceeEEEeecC------CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEE
Q 024408 1 MREQFIGACKE------PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL 74 (268)
Q Consensus 1 ~~v~l~g~~~~------~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill 74 (268)
|+|.+.....- .-+|+|+|++ +.+|.+.|+.... ++...+..+++|++.||.|+|+.||+|||+||.|+++
T Consensus 82 NIi~l~di~~p~~~~~f~DvYiV~elM-etDL~~iik~~~~--L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~ 158 (359)
T KOG0660|consen 82 NIIGLLDIFRPPSRDKFNDVYLVFELM-ETDLHQIIKSQQD--LTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLL 158 (359)
T ss_pred CcceEEeecccccccccceeEEehhHH-hhHHHHHHHcCcc--ccHHHHHHHHHHHHHhcchhhcccccccccchhheee
Confidence 56677776632 2589999999 5899999987655 9999999999999999999999999999999999999
Q ss_pred eCCCCCeEEecCCCcccccc---ccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 024408 75 TEDLKTIKLADFGLAREESL---TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 151 (268)
Q Consensus 75 ~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~ 151 (268)
+.+ ..+|++|||+|+.... ...++..+.|.||+|||++.. ...|+.+.||||+||++.||++|++-|.+
T Consensus 159 n~~-c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~-------~~~Yt~aiDiWSvGCI~AEmL~gkplFpG 230 (359)
T KOG0660|consen 159 NAD-CDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLN-------SSEYTKAIDIWSVGCILAEMLTGKPLFPG 230 (359)
T ss_pred ccC-CCEEeccccceeeccccCcccchhcceeeeeecCHHHHhc-------cccccchhhhhhhhHHHHHHHcCCCCCCC
Confidence 999 4899999999997653 444556678999999999864 36799999999999999999999999998
Q ss_pred CChHHHHHHHHhccCCCC------------------------------CCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 152 MSNLQAAYAAAFKNVRPS------------------------------AENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
.+...+..........|. .++.++...+++.+||..||.+|+|++|.++|
T Consensus 231 ~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 231 KDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred CchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 776555443333222221 13567889999999999999999999999998
Q ss_pred HHHhHhhcCCC
Q 024408 202 LLNYLSAIAPP 212 (268)
Q Consensus 202 l~~~~~~~~~~ 212 (268)
.++...-.+
T Consensus 311 --PYl~~~hdp 319 (359)
T KOG0660|consen 311 --PYLAPYHDP 319 (359)
T ss_pred --hhhhhhcCC
Confidence 455544333
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=248.71 Aligned_cols=199 Identities=32% Similarity=0.577 Sum_probs=161.1
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRP--------------RCLDVCVAIGFALDIARAMECLHSHGIIHR 65 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~--------------~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~ 65 (268)
++++++++| .++..++||||+++|+|.+++..... ..+++.++..++.|++.||.|||++|++||
T Consensus 79 ~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~ 158 (314)
T cd05099 79 NIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHR 158 (314)
T ss_pred CeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence 578999999 45678999999999999999976421 348899999999999999999999999999
Q ss_pred CCCCCCEEEeCCCCCeEEecCCCccccccccc---cccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHH
Q 024408 66 DLKPENLLLTEDLKTIKLADFGLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWEL 142 (268)
Q Consensus 66 Dikp~Nill~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~l 142 (268)
||||+||+++.+ +.++|+|||+++....... .....++..|+|||.+.+ ..++.++|+||||+++|++
T Consensus 159 dlkp~Nill~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DiwslG~~l~el 229 (314)
T cd05099 159 DLAARNVLVTED-NVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD--------RVYTHQSDVWSFGILMWEI 229 (314)
T ss_pred cccceeEEEcCC-CcEEEccccccccccccccccccccCCCCccccCHHHHcc--------CCcCccchhhHHHHHHHHH
Confidence 999999999988 6899999999985432111 112234467999998853 5678899999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 024408 143 LH-NKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 208 (268)
Q Consensus 143 l~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 208 (268)
++ |..||......+.............+..++.++.+++.+||..+|++||++.++++.|......
T Consensus 230 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 296 (314)
T cd05099 230 FTLGGSPYPGIPVEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296 (314)
T ss_pred HhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence 98 8899987655444333333333334567788999999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=249.16 Aligned_cols=194 Identities=28% Similarity=0.489 Sum_probs=153.7
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCC-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRP-----------------RCLDVCVAIGFALDIARAMECLHSHGI 62 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~-----------------~~~~~~~~~~~~~~l~~~l~~lH~~gi 62 (268)
|+|+++|++ .++..++||||++||+|.+++..... ..+++.+++.++.|++.||.|||+.|+
T Consensus 80 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i 159 (304)
T cd05096 80 NIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNF 159 (304)
T ss_pred CeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCc
Confidence 589999999 55678999999999999999865321 236788999999999999999999999
Q ss_pred eecCCCCCCEEEeCCCCCeEEecCCCcccccccc---ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHH
Q 024408 63 IHRDLKPENLLLTEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVL 139 (268)
Q Consensus 63 ~H~Dikp~Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l 139 (268)
+||||||+||+++.+ +.+||+|||+++...... ......++..|+|||++.+ ..++.++||||||+++
T Consensus 160 vH~dlkp~Nill~~~-~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~~l 230 (304)
T cd05096 160 VHRDLATRNCLVGEN-LTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILM--------GKFTTASDVWAFGVTL 230 (304)
T ss_pred cccCcchhheEEcCC-ccEEECCCccceecccCceeEecCcCCCCccccCHHHHhc--------CCCCchhhhHHHHHHH
Confidence 999999999999988 699999999997543221 1223345788999998754 5578899999999999
Q ss_pred HHHHh--CCCCCCCCChHHHHHHHHhc-------cCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 024408 140 WELLH--NKLPFEGMSNLQAAYAAAFK-------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 203 (268)
Q Consensus 140 ~~ll~--g~~p~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~ 203 (268)
|+|++ +..||......+........ .....+..+++.+.+++.+||..+|.+||++.++.+.|+
T Consensus 231 ~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 231 WEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred HHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 99986 56788776544433222110 111224567899999999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=251.28 Aligned_cols=190 Identities=24% Similarity=0.291 Sum_probs=149.4
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ .++..++||||+++++|..+.... ..+++..+..++.|++.||.|||+.|++||||||+||+++.+ +
T Consensus 61 ~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~-~ 137 (287)
T cd07848 61 NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMP--NGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHN-D 137 (287)
T ss_pred cccchhhhEecCCEEEEEEecCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC-C
Confidence 578888888 556899999999876665544332 349999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccccc--ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 024408 80 TIKLADFGLAREESLTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA 157 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~ 157 (268)
.++|+|||++....... ......|+..|+|||++.+ ..++.++|+||+|+++|+|++|+.||.+....+.
T Consensus 138 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~ 209 (287)
T cd07848 138 VLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLG--------APYGKAVDMWSVGCILGELSDGQPLFPGESEIDQ 209 (287)
T ss_pred cEEEeeccCcccccccccccccccccccccCCcHHHcC--------CCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence 99999999998643221 2233468999999998864 4578899999999999999999999987654433
Q ss_pred HHHHHhcc--------------------CCCC-----------CCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 158 AYAAAFKN--------------------VRPS-----------AENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 158 ~~~~~~~~--------------------~~~~-----------~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
........ ..+. ...++.++.++|.+||+.||++||+++++++|
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 210 LFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred HHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 22211100 0000 12367889999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=246.50 Aligned_cols=195 Identities=27% Similarity=0.491 Sum_probs=160.5
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMR--------------PRCLDVCVAIGFALDIARAMECLHSHGIIHR 65 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~--------------~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~ 65 (268)
++|+++|++ ..+..++++||+++++|.+++.... ...+++..+..++.|++.||.|||++|++||
T Consensus 69 ~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~ 148 (283)
T cd05091 69 NIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHK 148 (283)
T ss_pred CcCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCcccc
Confidence 578999999 4467899999999999999985321 1248889999999999999999999999999
Q ss_pred CCCCCCEEEeCCCCCeEEecCCCcccccccc---ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHH
Q 024408 66 DLKPENLLLTEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWEL 142 (268)
Q Consensus 66 Dikp~Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~l 142 (268)
||||+||+++.+ +.+||+|||+++...... ......+++.|+|||.+.+ ..++.++||||||+++|||
T Consensus 149 dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~~l~el 219 (283)
T cd05091 149 DLATRNVLVFDK-LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMY--------GKFSIDSDIWSYGVVLWEV 219 (283)
T ss_pred ccchhheEecCC-CceEecccccccccccchheeeccCccCCccccCHHHHhc--------CCCCcchhHHHHHHHHHHH
Confidence 999999999987 689999999987543222 1223345778999998753 5578899999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 024408 143 LH-NKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 204 (268)
Q Consensus 143 l~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~ 204 (268)
++ |..||.+....+...........+.+..++..+.+++..||+.+|.+||++++++..|+.
T Consensus 220 ~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 220 FSYGLQPYCGYSNQDVIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 98 888998766655544444444555577899999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=243.54 Aligned_cols=198 Identities=30% Similarity=0.521 Sum_probs=163.9
Q ss_pred CceeEEEeecCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCC
Q 024408 1 MREQFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT 80 (268)
Q Consensus 1 ~~v~l~g~~~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~ 80 (268)
++++++|++.++..++||||+++++|.+++.+... .+++.+++.++.+++.||.|||+.|++|+||||+||+++.+ +.
T Consensus 68 ~i~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~-~~ 145 (270)
T cd05056 68 HIVKLIGVITENPVWIVMELAPLGELRSYLQVNKY-SLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSP-DC 145 (270)
T ss_pred chhceeEEEcCCCcEEEEEcCCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecC-CC
Confidence 57899999988888999999999999999976443 48999999999999999999999999999999999999988 68
Q ss_pred eEEecCCCcccccccccc--ccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 024408 81 IKLADFGLAREESLTEMM--TAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQA 157 (268)
Q Consensus 81 ~kl~Dfg~a~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~ 157 (268)
++++|||+++........ ....++..|+|||.+.. ..++.++|+||||+++|++++ |..||......+.
T Consensus 146 ~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~ 217 (270)
T cd05056 146 VKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINF--------RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV 217 (270)
T ss_pred eEEccCceeeecccccceecCCCCccccccChhhhcc--------CCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH
Confidence 999999998754332211 12234467999998753 457789999999999999986 9999987766555
Q ss_pred HHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 024408 158 AYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 208 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 208 (268)
..........+.+..++..+.+++.+|+..+|.+||++.++++.|.+....
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 218 IGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred HHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 444444444455678899999999999999999999999999999886643
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=257.84 Aligned_cols=190 Identities=23% Similarity=0.342 Sum_probs=152.1
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
++|++++++ ..+++|+||||++||+|.+++...+. +++..+..++.|++.||+|||++||+||||||+|||++.+ +
T Consensus 62 ~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~--~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~-~ 138 (377)
T cd05629 62 WVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDT--FSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRG-G 138 (377)
T ss_pred CcceEEEEEEcCCeeEEEEeCCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCC-C
Confidence 578999999 45689999999999999999986544 9999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccccc------------------------------------------------ccccCCCccceeccc
Q 024408 80 TIKLADFGLAREESLTE------------------------------------------------MMTAETGTYRWMAPE 111 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~------------------------------------------------~~~~~~gt~~y~aPE 111 (268)
.++|+|||+++...... ......||+.|+|||
T Consensus 139 ~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 218 (377)
T cd05629 139 HIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPE 218 (377)
T ss_pred CEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHH
Confidence 99999999986321100 001246899999999
Q ss_pred cccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc---cCCCCCCCCcHHHHHHHHhccccC
Q 024408 112 LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFK---NVRPSAENVPEELSIILTSCWKED 188 (268)
Q Consensus 112 ~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~~ 188 (268)
++.+ ..++.++|||||||++|||++|..||.+....+........ ...+....++.++.++|.+||. +
T Consensus 219 ~~~~--------~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~ 289 (377)
T cd05629 219 IFLQ--------QGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-N 289 (377)
T ss_pred HHcc--------CCCCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-C
Confidence 9854 56788999999999999999999999876654433332221 1122234578999999999997 6
Q ss_pred CCCC---CCHHHHHHHH
Q 024408 189 PNAR---PNFTQIIQML 202 (268)
Q Consensus 189 p~~R---ps~~~~~~~l 202 (268)
|.+| +++.++++|.
T Consensus 290 ~~~r~~r~~~~~~l~hp 306 (377)
T cd05629 290 AENRLGRGGAHEIKSHP 306 (377)
T ss_pred HhhcCCCCCHHHHhcCC
Confidence 6665 5999999984
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=254.18 Aligned_cols=188 Identities=24% Similarity=0.395 Sum_probs=154.3
Q ss_pred ceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCC
Q 024408 2 REQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT 80 (268)
Q Consensus 2 ~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~ 80 (268)
++++++++ .++.+++||||++||+|.+++.+.+. +++.++..++.|++.||+|||++|++||||||+||+++.+ +.
T Consensus 63 i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~~--l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~-~~ 139 (323)
T cd05615 63 LTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGK--FKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSE-GH 139 (323)
T ss_pred hhheeeEEecCCEEEEEEcCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCC-CC
Confidence 56777777 45689999999999999999977554 9999999999999999999999999999999999999988 69
Q ss_pred eEEecCCCccccccc-cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 024408 81 IKLADFGLAREESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY 159 (268)
Q Consensus 81 ~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~ 159 (268)
++|+|||+++..... .......||+.|+|||++.+ ..++.++|+||+|+++|+|++|+.||.+........
T Consensus 140 ikL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~ 211 (323)
T cd05615 140 IKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAY--------QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQ 211 (323)
T ss_pred EEEeccccccccCCCCccccCccCCccccCHHHHcC--------CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 999999998753322 22334568999999998854 557889999999999999999999998866544433
Q ss_pred HHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCH-----HHHHHH
Q 024408 160 AAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNF-----TQIIQM 201 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~-----~~~~~~ 201 (268)
... ......+..++.++.+++.+||..+|.+|++. .++++|
T Consensus 212 ~i~-~~~~~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05615 212 SIM-EHNVSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREH 257 (323)
T ss_pred HHH-hCCCCCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcC
Confidence 332 33333456788999999999999999999974 556555
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=243.27 Aligned_cols=195 Identities=30% Similarity=0.504 Sum_probs=162.5
Q ss_pred CceeEEEeecCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCC
Q 024408 1 MREQFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT 80 (268)
Q Consensus 1 ~~v~l~g~~~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~ 80 (268)
+++++++++.++..++||||++|++|.+++....+..+++.++..++.|++.||+|||+.|++|+||||+||+++.+ +.
T Consensus 62 ~i~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~-~~ 140 (260)
T cd05067 62 RLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSET-LC 140 (260)
T ss_pred CeeeEEEEEccCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCC-CC
Confidence 46888888877789999999999999999987665569999999999999999999999999999999999999988 68
Q ss_pred eEEecCCCccccccccc--cccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 024408 81 IKLADFGLAREESLTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQA 157 (268)
Q Consensus 81 ~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~ 157 (268)
++++|||++........ .....++..|+|||.+.. ..++.++|+||||+++|++++ |+.||.+....+.
T Consensus 141 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~--------~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~ 212 (260)
T cd05067 141 CKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY--------GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV 212 (260)
T ss_pred EEEccCcceeecCCCCcccccCCcccccccCHHHhcc--------CCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHH
Confidence 99999999975442211 122345678999998854 456789999999999999998 9999987665554
Q ss_pred HHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 024408 158 AYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 204 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~ 204 (268)
..........+.....+.++.+++.+||..+|++||++.++++.|++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 213 IQNLERGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred HHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 44433333445566788999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=246.25 Aligned_cols=198 Identities=29% Similarity=0.548 Sum_probs=160.9
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcC----------------------CCCCCHHHHHHHHHHHHHHHHHH
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMR----------------------PRCLDVCVAIGFALDIARAMECL 57 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~----------------------~~~~~~~~~~~~~~~l~~~l~~l 57 (268)
++|++++.| .++..++||||++|++|.+++.... ...+++.+++.++.|++.||.||
T Consensus 64 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~L 143 (290)
T cd05045 64 HVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYL 143 (290)
T ss_pred CEeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHH
Confidence 578999998 5567899999999999999986531 12478999999999999999999
Q ss_pred HHCCCeecCCCCCCEEEeCCCCCeEEecCCCccccccccc---cccCCCccceeccccccccccccCCCCCCCchhhHHH
Q 024408 58 HSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYS 134 (268)
Q Consensus 58 H~~gi~H~Dikp~Nill~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws 134 (268)
|++|++||||||+||+++++ +.++|+|||+++....... .....++..|+|||.+.+ ..++.++||||
T Consensus 144 H~~~ivH~dikp~nill~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~--------~~~~~~~Di~s 214 (290)
T cd05045 144 AEMKLVHRDLAARNVLVAEG-RKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD--------HIYTTQSDVWS 214 (290)
T ss_pred HHCCeehhhhhhheEEEcCC-CcEEeccccccccccCccchhcccCCCCCccccCHHHHcc--------CCcchHhHHHH
Confidence 99999999999999999988 6999999999975322211 122345678999998753 45788999999
Q ss_pred HHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHh
Q 024408 135 FAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 207 (268)
Q Consensus 135 lG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 207 (268)
||+++++|++ |..||.+....+...........+.+..++.++.+++.+||+.+|.+||+++++++.|++.+.
T Consensus 215 lG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 215 FGVLLWEIVTLGGNPYPGIAPERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred HHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 9999999998 999998765544433333333334466788999999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=258.35 Aligned_cols=189 Identities=25% Similarity=0.389 Sum_probs=152.8
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
++|++++.+ .++.+++||||++||+|.+++.+.+. +++..+..++.|++.||+|||++||+||||||+|||++.+ +
T Consensus 62 ~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~--~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~-g 138 (382)
T cd05625 62 WVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGI--FPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRD-G 138 (382)
T ss_pred cCCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC-C
Confidence 578999999 55689999999999999999977544 8999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccc------------------------------------------------cccccCCCccceeccc
Q 024408 80 TIKLADFGLAREESLT------------------------------------------------EMMTAETGTYRWMAPE 111 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~------------------------------------------------~~~~~~~gt~~y~aPE 111 (268)
.++|+|||++...... ....+..||+.|+|||
T Consensus 139 ~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE 218 (382)
T cd05625 139 HIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPE 218 (382)
T ss_pred CEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHH
Confidence 9999999997521100 0012346899999999
Q ss_pred cccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc---cCCCCCCCCcHHHHHHHHhccccC
Q 024408 112 LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFK---NVRPSAENVPEELSIILTSCWKED 188 (268)
Q Consensus 112 ~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~~ 188 (268)
++.+ ..++.++|||||||++|||++|+.||......+........ ...+....+++++.++|.+|+ .+
T Consensus 219 ~~~~--------~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~ 289 (382)
T cd05625 219 VLLR--------TGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RG 289 (382)
T ss_pred HhcC--------CCCCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cC
Confidence 9864 55788999999999999999999999886655444333321 122334567899999999976 49
Q ss_pred CCCCCC---HHHHHHH
Q 024408 189 PNARPN---FTQIIQM 201 (268)
Q Consensus 189 p~~Rps---~~~~~~~ 201 (268)
|.+|++ +.++++|
T Consensus 290 p~~R~~~~~~~ei~~h 305 (382)
T cd05625 290 PEDRLGKNGADEIKAH 305 (382)
T ss_pred HhHcCCCCCHHHHhcC
Confidence 999987 8888887
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=258.67 Aligned_cols=194 Identities=23% Similarity=0.354 Sum_probs=157.1
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ .+.+.++||||++||+|.+++.+. .+++..+..++.|++.||+|||++||+||||||+|||++.+ +
T Consensus 104 ~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~-~ 179 (370)
T cd05596 104 WIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKS-G 179 (370)
T ss_pred CcceEEEEEecCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCC-C
Confidence 578899888 456899999999999999998653 38899999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccccc--ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 024408 80 TIKLADFGLAREESLTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA 157 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~ 157 (268)
.+||+|||++....... ......||+.|+|||++.+. .....++.++|+||||+++|+|++|+.||.+......
T Consensus 180 ~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~ 255 (370)
T cd05596 180 HLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQ----GGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT 255 (370)
T ss_pred CEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccC----CCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHH
Confidence 99999999997543322 22345799999999988541 1124578899999999999999999999987665443
Q ss_pred HHHHHhcc---CCCCCCCCcHHHHHHHHhccccCCCC--CCCHHHHHHHH
Q 024408 158 AYAAAFKN---VRPSAENVPEELSIILTSCWKEDPNA--RPNFTQIIQML 202 (268)
Q Consensus 158 ~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~~p~~--Rps~~~~~~~l 202 (268)
........ ..+....++.++.++|.+||..+|.+ |+++.++++|.
T Consensus 256 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~ 305 (370)
T cd05596 256 YSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHP 305 (370)
T ss_pred HHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCc
Confidence 33332221 12233467899999999999999988 99999999984
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=243.46 Aligned_cols=196 Identities=28% Similarity=0.505 Sum_probs=157.8
Q ss_pred CceeEEEeecC-------CcEEEEEEcCCCCCHHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCC
Q 024408 1 MREQFIGACKE-------PVMVIVTELLSGGTLRKYLLNM----RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKP 69 (268)
Q Consensus 1 ~~v~l~g~~~~-------~~~~lV~e~~~ggsL~~~i~~~----~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp 69 (268)
++++++|+|.+ ...++||||+++|+|.+++... ....+++..+..++.|++.||+|||++|++||||||
T Consensus 61 ~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp 140 (272)
T cd05075 61 NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAA 140 (272)
T ss_pred CcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccch
Confidence 57899998732 2468999999999999988532 223489999999999999999999999999999999
Q ss_pred CCEEEeCCCCCeEEecCCCccccccccc---cccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-C
Q 024408 70 ENLLLTEDLKTIKLADFGLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-N 145 (268)
Q Consensus 70 ~Nill~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g 145 (268)
+||+++.+ +.++|+|||+++....... .....++..|++||.+.+ ..++.++|+||||+++|++++ |
T Consensus 141 ~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--------~~~~~~~Di~slG~il~el~~~g 211 (272)
T cd05075 141 RNCMLNEN-MNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLAD--------RVYTTKSDVWSFGVTMWEIATRG 211 (272)
T ss_pred hheEEcCC-CCEEECCCCcccccCcccceecCCcccCCcccCCHHHccC--------CCcChHHHHHHHHHHHHHHHcCC
Confidence 99999988 6899999999986433221 122245678999998854 567889999999999999999 8
Q ss_pred CCCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHh
Q 024408 146 KLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 205 (268)
Q Consensus 146 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~ 205 (268)
..||......+...........+....++..+.++|.+||..||++||++.++++.|+..
T Consensus 212 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 212 QTPYPGVENSEIYDYLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 899987665544443333333344567889999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=241.46 Aligned_cols=197 Identities=30% Similarity=0.532 Sum_probs=156.8
Q ss_pred CceeEEEeec--CCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCC
Q 024408 1 MREQFIGACK--EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL 78 (268)
Q Consensus 1 ~~v~l~g~~~--~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~ 78 (268)
++++++|+|. ++..++||||+.+++|.+++.+... ..++..+..++.|++.||.|||+.|++||||||+||+++.+
T Consensus 57 ~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~- 134 (262)
T cd05058 57 NVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETH-NPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDES- 134 (262)
T ss_pred CcceEEEEeecCCCCcEEEEecCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCC-
Confidence 5789999873 4568999999999999999976443 27788889999999999999999999999999999999988
Q ss_pred CCeEEecCCCcccccccc-----ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 024408 79 KTIKLADFGLAREESLTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGM 152 (268)
Q Consensus 79 ~~~kl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~ 152 (268)
+.++|+|||+++...... ......++..|+|||.+.+ ..++.++||||||+++|+|++ |.+||...
T Consensus 135 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~el~~~~~~~~~~~ 206 (262)
T cd05058 135 FTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQT--------QKFTTKSDVWSFGVLLWELMTRGAPPYPDV 206 (262)
T ss_pred CcEEECCccccccccCCcceeecccccCcCCccccChhHhcc--------CccchHHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 689999999997432211 1122345678999998753 457889999999999999999 46677765
Q ss_pred ChHHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHh
Q 024408 153 SNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 207 (268)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 207 (268)
...+...........+.+..++..+.+++..||..+|++||++.++++.|++.+.
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 207 DSFDITVYLLQGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred CHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 5544333333322333355678999999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=254.54 Aligned_cols=192 Identities=30% Similarity=0.416 Sum_probs=168.1
Q ss_pred CceeEEEeecC-CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCC-
Q 024408 1 MREQFIGACKE-PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL- 78 (268)
Q Consensus 1 ~~v~l~g~~~~-~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~- 78 (268)
|+|+|++.++. ...++|||+++||.|.+.|... . +++..+..++.|++.++.|||+.|++||||||+|+|+....
T Consensus 97 niv~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~-~--~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~ 173 (382)
T KOG0032|consen 97 NIVQLKDAFEDPDSVYLVMELCEGGELFDRIVKK-H--YSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDE 173 (382)
T ss_pred CEEEEEEEEEcCCeEEEEEEecCCchHHHHHHHc-c--CCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccC
Confidence 68999999954 5899999999999999999887 2 99999999999999999999999999999999999996432
Q ss_pred --CCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH
Q 024408 79 --KTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 156 (268)
Q Consensus 79 --~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~ 156 (268)
+.++++|||++............+||+.|+|||++.. ..++...|+||+|+++|.|++|..||.+.....
T Consensus 174 ~~~~ik~~DFGla~~~~~~~~~~~~~Gtp~y~APEvl~~--------~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~ 245 (382)
T KOG0032|consen 174 GSGRIKLIDFGLAKFIKPGERLHTIVGTPEYVAPEVLGG--------RPYGDEVDVWSIGVILYILLSGVPPFWGETEFE 245 (382)
T ss_pred CCCcEEEeeCCCceEccCCceEeeecCCccccCchhhcC--------CCCCcccchhHHHHHHHHHhhCCCCCcCCChhH
Confidence 3799999999998777667788899999999999964 678999999999999999999999999877666
Q ss_pred HHHHHHhccC---CCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 024408 157 AAYAAAFKNV---RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 203 (268)
Q Consensus 157 ~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~ 203 (268)
.......... .+....++..++++|+.|+..||.+|+++.++++|.|
T Consensus 246 ~~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpW 295 (382)
T KOG0032|consen 246 IFLAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPW 295 (382)
T ss_pred HHHHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCcc
Confidence 5555544433 3446778899999999999999999999999999844
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=256.52 Aligned_cols=198 Identities=30% Similarity=0.534 Sum_probs=159.7
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcC---------------------------------------------
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMR--------------------------------------------- 34 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~--------------------------------------------- 34 (268)
|+|+++|+| .++..+|||||++||+|.++|.+..
T Consensus 102 nIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (400)
T cd05105 102 NIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMK 181 (400)
T ss_pred CeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccc
Confidence 689999999 4568999999999999999986532
Q ss_pred -------------------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q 024408 35 -------------------------------------------------PRCLDVCVAIGFALDIARAMECLHSHGIIHR 65 (268)
Q Consensus 35 -------------------------------------------------~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~ 65 (268)
...+++.++..++.|++.||.|||++|++||
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~ 261 (400)
T cd05105 182 QADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHR 261 (400)
T ss_pred cccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCC
Confidence 1247888899999999999999999999999
Q ss_pred CCCCCCEEEeCCCCCeEEecCCCcccccccc---ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHH
Q 024408 66 DLKPENLLLTEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWEL 142 (268)
Q Consensus 66 Dikp~Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~l 142 (268)
||||+||+++.+ +.++|+|||+++...... ......++..|+|||.+.+ ..++.++||||||+++|+|
T Consensus 262 dikp~Nill~~~-~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DiwSlGvil~el 332 (400)
T cd05105 262 DLAARNVLLAQG-KIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFD--------NLYTTLSDVWSYGILLWEI 332 (400)
T ss_pred CCChHhEEEeCC-CEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcC--------CCCCchhhHHHHHHHHHHH
Confidence 999999999988 689999999997533221 1223346778999998854 5578899999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHHHhc-cCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHh
Q 024408 143 LH-NKLPFEGMSNLQAAYAAAFK-NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 207 (268)
Q Consensus 143 l~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 207 (268)
++ |..||............... ...+.+..++.++.+++.+||..+|++||++.++.+.|+..+.
T Consensus 333 lt~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 333 FSLGGTPYPGMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred HHCCCCCCcccchhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 97 99999875443333332222 2334456788999999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=247.02 Aligned_cols=196 Identities=32% Similarity=0.554 Sum_probs=159.6
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ ..+..++||||++||+|.+++.+.....+++.++..++.|++.||+|||++|++|+||||+||+++.+ +
T Consensus 100 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~-~ 178 (302)
T cd05055 100 NIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHG-K 178 (302)
T ss_pred CcceEEEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCC-C
Confidence 578999998 55689999999999999999986554458999999999999999999999999999999999999987 6
Q ss_pred CeEEecCCCcccccccc---ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChH
Q 024408 80 TIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNL 155 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~~~ 155 (268)
.++++|||+++...... ......++..|+|||.+.+ ..++.++||||+|+++|++++ |..||.+....
T Consensus 179 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~ 250 (302)
T cd05055 179 IVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFN--------CVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD 250 (302)
T ss_pred eEEECCCcccccccCCCceeecCCCCcccccCCHhhhcc--------CCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch
Confidence 89999999997543221 1122345678999998854 557889999999999999998 99999876544
Q ss_pred HHHHHHHhcc-CCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHh
Q 024408 156 QAAYAAAFKN-VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 205 (268)
Q Consensus 156 ~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~ 205 (268)
.......... ....+...+.++.+++.+||..+|++||++.++++.|.+.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 251 SKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 4333332222 2233456789999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=240.32 Aligned_cols=193 Identities=31% Similarity=0.565 Sum_probs=159.6
Q ss_pred CceeEEEeec-CCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGACK-EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~~-~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
++++++|++. +...++||||+++++|.+++.......+++..+..++.|++.||.|||++|++|+||||+||+++.+ +
T Consensus 61 ~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~-~ 139 (256)
T cd05039 61 NLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSED-L 139 (256)
T ss_pred ceeeeEEEEcCCCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCC-C
Confidence 5789999994 6688999999999999999987665569999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~ 158 (268)
.++|+|||.++....... ....+..|+|||.+.. ..++.++|+||||++++++++ |..||......+..
T Consensus 140 ~~~l~d~g~~~~~~~~~~--~~~~~~~~~ape~~~~--------~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~ 209 (256)
T cd05039 140 VAKVSDFGLAKEASQGQD--SGKLPVKWTAPEALRE--------KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV 209 (256)
T ss_pred CEEEcccccccccccccc--cCCCcccccCchhhcC--------CcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 899999999986532221 3344668999998753 456789999999999999997 99999876544433
Q ss_pred HHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 024408 159 YAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 204 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~ 204 (268)
...........+..+++.+.+++.+||..+|.+||++.++++.|+.
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 210 PHVEKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred HHHhcCCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 3333222333356678999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=243.25 Aligned_cols=191 Identities=26% Similarity=0.430 Sum_probs=157.9
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
++++++|++ .++..++||||++|++|.+++.+... +++..+..++.|++.||.|||+.|++|+||+|+||+++.+ +
T Consensus 65 ~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~-~ 141 (263)
T cd06625 65 RIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGA--LTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSA-G 141 (263)
T ss_pred CeeeeEEEEccCCeEEEEEEECCCCcHHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-C
Confidence 578999999 55689999999999999999987554 8999999999999999999999999999999999999987 6
Q ss_pred CeEEecCCCcccccccccc----ccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH
Q 024408 80 TIKLADFGLAREESLTEMM----TAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL 155 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~ 155 (268)
.++|+|||+++........ ....++..|+|||.+.+ ..++.++|+||||+++|++++|+.||......
T Consensus 142 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~~g~~p~~~~~~~ 213 (263)
T cd06625 142 NVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISG--------EGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM 213 (263)
T ss_pred CEEEeecccceeccccccccccccCCCcCccccCcceecc--------CCCCchhhhHHHHHHHHHHHhCCCCccccchH
Confidence 9999999998753322111 23457889999999864 44788999999999999999999999876554
Q ss_pred HHHHHHHhc-cCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 024408 156 QAAYAAAFK-NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 202 (268)
Q Consensus 156 ~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l 202 (268)
......... .....+..++..+.++|.+||..+|.+||++.+++++.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~ 261 (263)
T cd06625 214 AAIFKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHF 261 (263)
T ss_pred HHHHHHhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCC
Confidence 443333222 22234567889999999999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=245.24 Aligned_cols=194 Identities=31% Similarity=0.537 Sum_probs=159.2
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCC--------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRP--------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPEN 71 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~--------~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~N 71 (268)
++++++|++ .....++||||+++++|.+++..... ..+++..++.++.|++.||.|||++|++||||||+|
T Consensus 70 ~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~n 149 (277)
T cd05032 70 HVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARN 149 (277)
T ss_pred ceeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChhe
Confidence 578999998 55688999999999999999975332 237888999999999999999999999999999999
Q ss_pred EEEeCCCCCeEEecCCCcccccccc---ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCC
Q 024408 72 LLLTEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKL 147 (268)
Q Consensus 72 ill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~ 147 (268)
|+++.+ +.++|+|||+++...... ......++..|+|||.+.+ ..++.++|+||||+++|++++ |..
T Consensus 150 ill~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~t~g~~ 220 (277)
T cd05032 150 CMVAED-LTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD--------GVFTTKSDVWSFGVVLWEMATLAEQ 220 (277)
T ss_pred EEEcCC-CCEEECCcccchhhccCcccccCCCCCccccccCHHHHhc--------CCCCcccchHHHHHHHHHhhccCCC
Confidence 999988 699999999987533222 1223356788999998753 557889999999999999998 999
Q ss_pred CCCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 024408 148 PFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 203 (268)
Q Consensus 148 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~ 203 (268)
||.+....+.............+..++.++.+++.+||..+|++|||+.++++.|+
T Consensus 221 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 221 PYQGLSNEEVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred CCccCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 99876655544444433334456678999999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=243.46 Aligned_cols=192 Identities=25% Similarity=0.409 Sum_probs=161.3
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++.+ .++.+++||||++|++|.+++.......+++..+..++.|++.||.+||++|++|+||||+||+++.+ +
T Consensus 59 ~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~-~ 137 (255)
T cd08219 59 NIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQN-G 137 (255)
T ss_pred CcceEEEEEEECCEEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCC-C
Confidence 578899988 55689999999999999999976555568999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccccc-ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESLTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.++++|||.+....... ......|+..|+|||++.+ ..++.++|+||||+++|+|++|..||.........
T Consensus 138 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--------~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~ 209 (255)
T cd08219 138 KVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWEN--------MPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLI 209 (255)
T ss_pred cEEEcccCcceeecccccccccccCCccccCHHHHcc--------CCcCchhhhhhhchhheehhhccCCCCCCCHHHHH
Confidence 99999999987543322 2234568889999998854 45778999999999999999999999876655544
Q ss_pred HHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 159 YAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
.........+.+..++..+.+++.+||..||++||++.+++..
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 210 LKVCQGSYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHHhcCCCCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 4444444455567788999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=264.69 Aligned_cols=180 Identities=28% Similarity=0.472 Sum_probs=152.9
Q ss_pred cEEEEEEcCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCCeEEecCCCcc
Q 024408 13 VMVIVTELLSGGTLRKYLLNMR--PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 90 (268)
Q Consensus 13 ~~~lV~e~~~ggsL~~~i~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~~kl~Dfg~a~ 90 (268)
.+++||||++||+|.+++.... ...+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+++
T Consensus 113 ~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~-~~vkL~DFGls~ 191 (496)
T PTZ00283 113 MIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSN-GLVKLGDFGFSK 191 (496)
T ss_pred EEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCC-CCEEEEecccCe
Confidence 3689999999999999997532 2459999999999999999999999999999999999999988 699999999997
Q ss_pred ccccc---cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCC
Q 024408 91 EESLT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR 167 (268)
Q Consensus 91 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 167 (268)
..... .......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||......+...........
T Consensus 192 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--------~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~ 263 (496)
T PTZ00283 192 MYAATVSDDVGRTFCGTPYYVAPEIWRR--------KPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYD 263 (496)
T ss_pred eccccccccccccccCCcceeCHHHhCC--------CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC
Confidence 53321 22345579999999999864 56788999999999999999999999886655555544444555
Q ss_pred CCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 168 PSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 168 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
+.+..+++++.+++.+||..||.+||++.+++++
T Consensus 264 ~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 264 PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 5677889999999999999999999999999886
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=244.80 Aligned_cols=194 Identities=28% Similarity=0.493 Sum_probs=158.7
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCC-------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRP-------------RCLDVCVAIGFALDIARAMECLHSHGIIHRD 66 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~-------------~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~D 66 (268)
+++++++++ .++..++||||+++++|.+++..... ..+++.+++.++.|++.||+|||++|++|||
T Consensus 68 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~d 147 (280)
T cd05092 68 HIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRD 147 (280)
T ss_pred CCceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeeccc
Confidence 578899998 45678999999999999999976532 2488999999999999999999999999999
Q ss_pred CCCCCEEEeCCCCCeEEecCCCccccccccc---cccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHH
Q 024408 67 LKPENLLLTEDLKTIKLADFGLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL 143 (268)
Q Consensus 67 ikp~Nill~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll 143 (268)
|||+||+++++ +.++|+|||++........ .....++..|+|||.+.+ ..++.++|+||||+++|+|+
T Consensus 148 lkp~nil~~~~-~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~ 218 (280)
T cd05092 148 LATRNCLVGQG-LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY--------RKFTTESDIWSFGVVLWEIF 218 (280)
T ss_pred ccHhhEEEcCC-CCEEECCCCceeEcCCCceeecCCCccccccccCHHHhcc--------CCcCchhhHHHHHHHHHHHH
Confidence 99999999987 6999999999874332211 122334678999998754 55788999999999999999
Q ss_pred h-CCCCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 024408 144 H-NKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 203 (268)
Q Consensus 144 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~ 203 (268)
+ |..||......+.............+..++..+.+++.+||..||.+||++.++++.|+
T Consensus 219 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 219 TYGKQPWYQLSNTEAIECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred cCCCCCCccCCHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 8 99999876655544444333334445678899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=240.83 Aligned_cols=193 Identities=31% Similarity=0.571 Sum_probs=159.7
Q ss_pred CceeEEEeecCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCC
Q 024408 1 MREQFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT 80 (268)
Q Consensus 1 ~~v~l~g~~~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~ 80 (268)
+++++++++..+..++||||++|++|.+++.......+++.+++.++.|++.||.|||++|++||||||+||+++.+ +.
T Consensus 60 ~i~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~-~~ 138 (254)
T cd05083 60 NLVRLLGVILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSED-GV 138 (254)
T ss_pred CcCeEEEEEcCCCcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCC-Cc
Confidence 57899999977778999999999999999987655568999999999999999999999999999999999999988 68
Q ss_pred eEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 024408 81 IKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAY 159 (268)
Q Consensus 81 ~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~ 159 (268)
++|+|||++...... ......+..|+|||.+.+ ..++.++|+||||+++|+|++ |..||......+...
T Consensus 139 ~kl~Dfg~~~~~~~~--~~~~~~~~~y~~pe~~~~--------~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~ 208 (254)
T cd05083 139 AKVSDFGLARVGSMG--VDNSKLPVKWTAPEALKH--------KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKE 208 (254)
T ss_pred EEECCCccceecccc--CCCCCCCceecCHHHhcc--------CCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHH
Confidence 999999998753322 122334568999998753 557789999999999999997 999998766554444
Q ss_pred HHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 024408 160 AAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 204 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~ 204 (268)
.............++..+.+++.+||+.+|++||+++++++.|++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 209 CVEKGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred HHhCCCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 333333333356788999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=244.31 Aligned_cols=195 Identities=29% Similarity=0.521 Sum_probs=156.5
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEE
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRP-----RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL 74 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill 74 (268)
++++++|++ ..+..++||||++|++|.+++.+... ..+++..++.++.|++.||+|||++|++|+||||+||++
T Consensus 70 ~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~ 149 (277)
T cd05036 70 NIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLL 149 (277)
T ss_pred CEeeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEE
Confidence 578999988 55678999999999999999976532 248999999999999999999999999999999999999
Q ss_pred eCCC--CCeEEecCCCccccccccc---cccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCC
Q 024408 75 TEDL--KTIKLADFGLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLP 148 (268)
Q Consensus 75 ~~~~--~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p 148 (268)
+.+. ..++|+|||+++....... ......+..|+|||++.+ ..++.++||||||+++|+|++ |..|
T Consensus 150 ~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DiwslG~il~el~~~g~~p 221 (277)
T cd05036 150 TCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLD--------GIFTSKTDVWSFGVLLWEIFSLGYMP 221 (277)
T ss_pred eccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhc--------CCcCchhHHHHHHHHHHHHHcCCCCC
Confidence 8642 3589999999985422211 112233568999998854 567889999999999999997 9999
Q ss_pred CCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 024408 149 FEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 203 (268)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~ 203 (268)
|....................+..++..+.+++.+|++.+|++||++.+++++|.
T Consensus 222 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 222 YPGRTNQEVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred CCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 9876654443333333333345678899999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=240.88 Aligned_cols=192 Identities=27% Similarity=0.436 Sum_probs=158.5
Q ss_pred CceeEEEeec--CCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCC
Q 024408 1 MREQFIGACK--EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL 78 (268)
Q Consensus 1 ~~v~l~g~~~--~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~ 78 (268)
+++++++.+. +..+++||||++|++|.+++.......+++.+++.++.+++.||++||++|++|+||||+||+++.+
T Consensus 60 ~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~- 138 (257)
T cd08223 60 NIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRT- 138 (257)
T ss_pred CeeeeeeeecCCCCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecC-
Confidence 4677888763 3468999999999999999987555569999999999999999999999999999999999999988
Q ss_pred CCeEEecCCCccccccc-cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 024408 79 KTIKLADFGLAREESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA 157 (268)
Q Consensus 79 ~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~ 157 (268)
+.++|+|||++...... .......+++.|+|||++.+ ..++.++|+||||++++++++|+.||...+....
T Consensus 139 ~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~ 210 (257)
T cd08223 139 NIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSN--------KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL 210 (257)
T ss_pred CcEEEecccceEEecccCCccccccCCcCccChhHhcC--------CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH
Confidence 69999999998754322 22334568899999998854 5567899999999999999999999987655444
Q ss_pred HHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 158 AYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
............+..++..+.+++.+|++.+|++||++.+++++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 211 VYRIIEGKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred HHHHHhcCCCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 34333333334456788999999999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=241.28 Aligned_cols=195 Identities=28% Similarity=0.484 Sum_probs=159.2
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++.|++ ..+..++||||+++++|.+++.... ..+++.++..++.|++.||+|||+.|++|+||||+||+++.+ +
T Consensus 67 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~-~ 144 (268)
T cd05063 67 NIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSN-L 144 (268)
T ss_pred CeeEEEEEEccCCCcEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCC-C
Confidence 578999998 4568899999999999999997643 348999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccccc--c--ccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCh
Q 024408 80 TIKLADFGLAREESLTEM--M--TAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSN 154 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~--~--~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~~ 154 (268)
.++++|||++........ . .....+..|+|||.+.+ ..++.++|+||||+++|++++ |..||.....
T Consensus 145 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~ 216 (268)
T cd05063 145 ECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAY--------RKFTSASDVWSFGIVMWEVMSFGERPYWDMSN 216 (268)
T ss_pred cEEECCCccceecccccccceeccCCCcCceecCHHHhhc--------CCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH
Confidence 899999999874332211 1 11123457999998854 457889999999999999997 9999987665
Q ss_pred HHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHh
Q 024408 155 LQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 205 (268)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~ 205 (268)
.+...........+....++.++.+++.+||..+|++||++.++++.|++.
T Consensus 217 ~~~~~~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 217 HEVMKAINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 554444443344455667889999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=270.94 Aligned_cols=200 Identities=32% Similarity=0.563 Sum_probs=173.8
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEE
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMR-----PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL 74 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~-----~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill 74 (268)
|||+|+|.| ..+..++++|||.||+|..+|++.. ...++..+.+.++.+++.|+.||+++++|||||-..|+|+
T Consensus 756 Niv~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL 835 (1025)
T KOG1095|consen 756 NIVSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLL 835 (1025)
T ss_pred ceeeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheee
Confidence 799999999 5557899999999999999999852 2349999999999999999999999999999999999999
Q ss_pred eCCCCCeEEecCCCcccccccc--cccc-CCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 024408 75 TEDLKTIKLADFGLAREESLTE--MMTA-ETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFE 150 (268)
Q Consensus 75 ~~~~~~~kl~Dfg~a~~~~~~~--~~~~-~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~ 150 (268)
+.. ..+||+|||+|+...... .... ..-...|||||.+.. +.++.++||||||+++||+++ |..||.
T Consensus 836 ~~~-r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d--------~iFtskSDvWsFGVllWEifslG~~PY~ 906 (1025)
T KOG1095|consen 836 DER-RVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKD--------GIFTSKSDVWSFGVLLWEIFSLGATPYP 906 (1025)
T ss_pred ccc-CcEEEcccchhHhhhhchheeccCccccceecCCHHHHhh--------cccccccchhhhHHHHHHHHhCCCCCCC
Confidence 998 599999999999332221 1111 123468999999964 789999999999999999998 999999
Q ss_pred CCChHHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhc
Q 024408 151 GMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 209 (268)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~~ 209 (268)
+.++.+...........+.+..+|..+.++|..||+.+|++||++..+++.+....+..
T Consensus 907 ~~~n~~v~~~~~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~ 965 (1025)
T KOG1095|consen 907 SRSNFEVLLDVLEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA 965 (1025)
T ss_pred CcchHHHHHHHHhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence 99999988877777788889999999999999999999999999999999887766543
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=241.44 Aligned_cols=193 Identities=28% Similarity=0.430 Sum_probs=161.8
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++.+ .++..++||||++|++|.+++.+.....+++..+..++.+++.||.|||++|++|+||+|+||+++++.+
T Consensus 60 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~ 139 (256)
T cd08220 60 NIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKM 139 (256)
T ss_pred chhheeeeEecCCEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC
Confidence 467788877 5568999999999999999998765556899999999999999999999999999999999999987645
Q ss_pred CeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 024408 80 TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY 159 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~ 159 (268)
.++++|||.+.............++..|+|||.+.+ ...+.++|+||+|+++|+|++|..||..........
T Consensus 140 ~~~l~d~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~ 211 (256)
T cd08220 140 VVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEG--------KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVL 211 (256)
T ss_pred EEEEccCCCceecCCCccccccccCCcccCchhccC--------CCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHH
Confidence 689999999986554443344568899999998853 456778999999999999999999998766555444
Q ss_pred HHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 160 AAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
........+....++..+.+++.+||..+|.+||++.+++++
T Consensus 212 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 212 KIMSGTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred HHHhcCCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 444444445566789999999999999999999999999886
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=240.17 Aligned_cols=193 Identities=27% Similarity=0.434 Sum_probs=163.0
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ .++..++||||++|++|.+++.+.....+++.++..++.|++.||.|||+.|++|+||+|+||+++++ +
T Consensus 60 ~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~-~ 138 (256)
T cd08221 60 NIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKA-G 138 (256)
T ss_pred CeeEEEeEEecCCeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCC-C
Confidence 578999998 55688999999999999999987644558999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccccc-ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESLTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.+||+|||++....... ......++..|+|||.+.+ ..++.++|+||||+++++|++|..||......+..
T Consensus 139 ~~kl~d~~~~~~~~~~~~~~~~~~~~~~y~ape~~~~--------~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~ 210 (256)
T cd08221 139 LIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQG--------VKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLV 210 (256)
T ss_pred CEEECcCcceEEcccccccccccCCCccccCHhhcCC--------CCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 89999999987543322 2334568999999998754 44677899999999999999999999876655555
Q ss_pred HHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 024408 159 YAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 202 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l 202 (268)
.........+....++.++.+++.+||..+|.+||++.++++++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 211 VKIVQGNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred HHHHcCCCCCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 55555555555677889999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=242.75 Aligned_cols=197 Identities=30% Similarity=0.554 Sum_probs=158.7
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCC--------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRP--------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPEN 71 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~--------~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~N 71 (268)
+++++++.+ .....++||||++||+|.+++.+... ...+...+..++.|++.||.|||++|++||||||+|
T Consensus 70 ~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~n 149 (288)
T cd05061 70 HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARN 149 (288)
T ss_pred CeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChhe
Confidence 478999998 45578999999999999999976331 235677889999999999999999999999999999
Q ss_pred EEEeCCCCCeEEecCCCccccccccc---cccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCC
Q 024408 72 LLLTEDLKTIKLADFGLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKL 147 (268)
Q Consensus 72 ill~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~ 147 (268)
|+++.+ +.++|+|||+++....... .....++..|+|||.+.+ ..++.++|+||||+++|++++ |..
T Consensus 150 ili~~~-~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~--------~~~~~~~DvwslG~~l~el~~~~~~ 220 (288)
T cd05061 150 CMVAHD-FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD--------GVFTTSSDMWSFGVVLWEITSLAEQ 220 (288)
T ss_pred EEEcCC-CcEEECcCCccccccccccccccCCCcccccccCHHHhcc--------CCCChHhHHHHHHHHHHHHHhCCCC
Confidence 999988 6999999999874332211 122345678999998753 557889999999999999998 788
Q ss_pred CCCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhH
Q 024408 148 PFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 206 (268)
Q Consensus 148 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 206 (268)
||.+....+.............+..++..+.+++.+||+.+|++||++.++++.+++.+
T Consensus 221 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 221 PYQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred CCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 99876655443333333333445677899999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=241.75 Aligned_cols=196 Identities=30% Similarity=0.543 Sum_probs=159.4
Q ss_pred CceeEEEeecC-C------cEEEEEEcCCCCCHHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCC
Q 024408 1 MREQFIGACKE-P------VMVIVTELLSGGTLRKYLLNM----RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKP 69 (268)
Q Consensus 1 ~~v~l~g~~~~-~------~~~lV~e~~~ggsL~~~i~~~----~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp 69 (268)
++++++|++.+ + ..++||||+++|+|.+++... ....+++..+..++.|++.||.|||++|++||||||
T Consensus 62 ~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp 141 (273)
T cd05035 62 NVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAA 141 (273)
T ss_pred CeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccch
Confidence 57899998843 2 379999999999999998543 223589999999999999999999999999999999
Q ss_pred CCEEEeCCCCCeEEecCCCccccccccc---cccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-C
Q 024408 70 ENLLLTEDLKTIKLADFGLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-N 145 (268)
Q Consensus 70 ~Nill~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g 145 (268)
+||+++++ +.++|+|||+++....... .....++..|+|||.+.+ ..++.++||||||+++|||++ |
T Consensus 142 ~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--------~~~~~~~Dv~SlG~il~el~~~g 212 (273)
T cd05035 142 RNCMLRED-MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD--------RVYTSKSDVWAFGVTMWEIATRG 212 (273)
T ss_pred heEEECCC-CeEEECCccceeeccccccccccccccCCccccCHhhccc--------CCCCcccchHHHHHHHHHHHhCC
Confidence 99999988 6899999999985432221 112234678999998753 567889999999999999999 8
Q ss_pred CCCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHh
Q 024408 146 KLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 205 (268)
Q Consensus 146 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~ 205 (268)
..||.+....+.............+..++..+.+++.+||+.||++||++.++++.|+++
T Consensus 213 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 213 QTPYPGVENHEIYDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCCCCCCCHHHHHHHHHcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 999987666555444444444445677899999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=252.19 Aligned_cols=191 Identities=24% Similarity=0.301 Sum_probs=149.3
Q ss_pred CceeEEEeecC------CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEE
Q 024408 1 MREQFIGACKE------PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL 74 (268)
Q Consensus 1 ~~v~l~g~~~~------~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill 74 (268)
|++++++++.. ...++||||+ +++|.+++.+... +++..+..++.|++.||.|||++|++||||||+||++
T Consensus 60 niv~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~--~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll 136 (338)
T cd07859 60 DIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDD--LTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILA 136 (338)
T ss_pred CEeeecceEeccCCCCCceEEEEEecC-CCCHHHHHHhccc--CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE
Confidence 57888888732 2479999999 4799999976554 9999999999999999999999999999999999999
Q ss_pred eCCCCCeEEecCCCcccccccc----ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 024408 75 TEDLKTIKLADFGLAREESLTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFE 150 (268)
Q Consensus 75 ~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~ 150 (268)
+.+ +.+||+|||+++...... ......|+..|+|||++.+ ....++.++||||||+++|+|++|+.||.
T Consensus 137 ~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~------~~~~~~~~~DvwSlGvvl~el~tg~~pf~ 209 (338)
T cd07859 137 NAD-CKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS------FFSKYTPAIDIWSIGCIFAEVLTGKPLFP 209 (338)
T ss_pred CCC-CcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhc------cccccCchhHHHHHHHHHHHHHcCCCCCC
Confidence 988 699999999997532211 1234578999999998743 12457889999999999999999999997
Q ss_pred CCChHHHHHHHHh-------------------------ccCCC-----CCCCCcHHHHHHHHhccccCCCCCCCHHHHHH
Q 024408 151 GMSNLQAAYAAAF-------------------------KNVRP-----SAENVPEELSIILTSCWKEDPNARPNFTQIIQ 200 (268)
Q Consensus 151 ~~~~~~~~~~~~~-------------------------~~~~~-----~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~ 200 (268)
+............ ....+ ....+++.+.+++.+||..||++||++.++++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 210 GKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred CCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 6543221110000 00000 12346788999999999999999999999999
Q ss_pred H
Q 024408 201 M 201 (268)
Q Consensus 201 ~ 201 (268)
+
T Consensus 290 h 290 (338)
T cd07859 290 D 290 (338)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=255.07 Aligned_cols=196 Identities=24% Similarity=0.346 Sum_probs=150.9
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|+|++++++ .+...++|||++ +++|.+++..... +++.+++.++.|++.||.|||++||+||||||+||+++.+ +
T Consensus 144 nIv~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~--l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~-~ 219 (391)
T PHA03212 144 SIIQLKGTFTYNKFTCLILPRY-KTDLYCYLAAKRN--IAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHP-G 219 (391)
T ss_pred CCCCEeEEEEECCeeEEEEecC-CCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCC-C
Confidence 689999998 456789999999 4799999876544 8999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccc--ccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH--
Q 024408 80 TIKLADFGLAREESL--TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL-- 155 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~-- 155 (268)
.++|+|||+++.... ........||+.|+|||++.+ ..++.++||||||+++|+|++|+.||......
T Consensus 220 ~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~ 291 (391)
T PHA03212 220 DVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLAR--------DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDG 291 (391)
T ss_pred CEEEEeCCcccccccccccccccccCccCCCChhhhcC--------CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccc
Confidence 899999999974322 122234579999999999854 56788999999999999999999876432110
Q ss_pred -----HHHHH-------------------------H-Hhc-cCCCC-------CCCCcHHHHHHHHhccccCCCCCCCHH
Q 024408 156 -----QAAYA-------------------------A-AFK-NVRPS-------AENVPEELSIILTSCWKEDPNARPNFT 196 (268)
Q Consensus 156 -----~~~~~-------------------------~-~~~-~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~ 196 (268)
..... . ... ...+. ...++.++.++|.+||..||.+|||+.
T Consensus 292 ~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~ 371 (391)
T PHA03212 292 DCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAE 371 (391)
T ss_pred cCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHH
Confidence 00000 0 000 00000 113467899999999999999999999
Q ss_pred HHHHHHHHhHhhcC
Q 024408 197 QIIQMLLNYLSAIA 210 (268)
Q Consensus 197 ~~~~~l~~~~~~~~ 210 (268)
+++++ .++....
T Consensus 372 elL~h--p~f~~~~ 383 (391)
T PHA03212 372 ALLDF--AAFQDIP 383 (391)
T ss_pred HHhcC--hhhccCC
Confidence 99998 4455433
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=237.70 Aligned_cols=193 Identities=30% Similarity=0.562 Sum_probs=157.0
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
++++++++| ..+..++||||++|++|.+++..... .+++.++..++.+++.||.|+|++|++|+||||+||+++.+ +
T Consensus 53 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~-~ 130 (250)
T cd05085 53 NIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKD-ELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGEN-N 130 (250)
T ss_pred CcCeEEEEEecCCccEEEEECCCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCC-C
Confidence 578999999 45678999999999999999876443 38999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccccccc--ccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 024408 80 TIKLADFGLAREESLTEMM--TAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQ 156 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~~~~ 156 (268)
.++|+|||++......... ....++..|+|||.+.+ ..++.++|+||||+++|++++ |..||.......
T Consensus 131 ~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~ 202 (250)
T cd05085 131 VLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNY--------GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ 202 (250)
T ss_pred eEEECCCccceeccccccccCCCCCCcccccCHHHhcc--------CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH
Confidence 8999999998753322111 12234567999998854 457789999999999999998 999998766554
Q ss_pred HHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 024408 157 AAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 203 (268)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~ 203 (268)
.............+..++..+.+++.+|+..+|++||++.++++.|.
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 203 AREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 44433333333445678899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=241.38 Aligned_cols=194 Identities=30% Similarity=0.594 Sum_probs=157.6
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEE
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMR-----PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL 74 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~-----~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill 74 (268)
++++++|++ ..+..++||||++|++|.+++.+.. ...+++.++..++.|++.||.|||+++++|+||||+||++
T Consensus 60 ~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~ 139 (269)
T cd05044 60 NIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLV 139 (269)
T ss_pred CeeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEE
Confidence 578999998 5568899999999999999997532 2338899999999999999999999999999999999999
Q ss_pred eCCCC-----CeEEecCCCcccccccc---ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-C
Q 024408 75 TEDLK-----TIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-N 145 (268)
Q Consensus 75 ~~~~~-----~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g 145 (268)
+.+ + .++++|||++....... ......++..|+|||.+.+ ..++.++||||||+++|+|++ |
T Consensus 140 ~~~-~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~il~ellt~g 210 (269)
T cd05044 140 SEK-GYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLD--------GKFTTQSDVWSFGVLMWEILTLG 210 (269)
T ss_pred ecC-CCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHcc--------CCcccchhHHHHHHHHHHHHHcC
Confidence 876 4 79999999987533221 1122345678999998854 557889999999999999998 9
Q ss_pred CCCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 024408 146 KLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 203 (268)
Q Consensus 146 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~ 203 (268)
..||......+................+|..+.++|.+||..+|.+||++.++++.|+
T Consensus 211 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 211 QQPYPALNNQEVLQHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred CCCCcccCHHHHHHHHhcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 9999876655544333333333445678899999999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=241.31 Aligned_cols=198 Identities=25% Similarity=0.515 Sum_probs=163.3
Q ss_pred CceeEEEeecCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCC
Q 024408 1 MREQFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT 80 (268)
Q Consensus 1 ~~v~l~g~~~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~ 80 (268)
|+++++|+|.++..++||||+++|+|.+++.+.... +++..+..++.|++.||+|||++|++|+||||+||+++.+ +.
T Consensus 70 ~i~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~-~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~-~~ 147 (279)
T cd05057 70 HVVRLLGICLSSQVQLITQLMPLGCLLDYVRNHKDN-IGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTP-QH 147 (279)
T ss_pred CcceEEEEEecCceEEEEecCCCCcHHHHHHhccCC-CCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCC-Ce
Confidence 578999999778899999999999999999875433 9999999999999999999999999999999999999887 68
Q ss_pred eEEecCCCcccccccccc---ccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 024408 81 IKLADFGLAREESLTEMM---TAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQ 156 (268)
Q Consensus 81 ~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~~~~ 156 (268)
++|+|||+++........ ....++..|+|||.+.. ..++.++|+||||+++|++++ |..||.+....+
T Consensus 148 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~ 219 (279)
T cd05057 148 VKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILH--------RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE 219 (279)
T ss_pred EEECCCcccccccCcccceecCCCcccccccCHHHhhc--------CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH
Confidence 999999999754322211 11223567999998753 557789999999999999998 999998866554
Q ss_pred HHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 024408 157 AAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 208 (268)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 208 (268)
...........+.+..++..+.+++.+||..+|.+||++.++++.|....+.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 220 IPDLLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred HHHHHhCCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 4443333333445566788999999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=246.89 Aligned_cols=194 Identities=23% Similarity=0.370 Sum_probs=157.5
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++.+ .++..++||||++|++|.+++.......+++.++..++.|++.||.|||+.|++||||||+||+++.+ +
T Consensus 61 ~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~-~ 139 (285)
T cd05630 61 FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDH-G 139 (285)
T ss_pred CeeeeeEEEecCCEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCC-C
Confidence 467888888 55689999999999999999976555569999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH---
Q 024408 80 TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ--- 156 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~--- 156 (268)
.++|+|||++.............|+..|+|||++.+ ..++.++|+||+|+++|+|++|+.||.......
T Consensus 140 ~~~l~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~ 211 (285)
T cd05630 140 HIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKN--------ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE 211 (285)
T ss_pred CEEEeeccceeecCCCccccCCCCCccccChHHHcC--------CCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHH
Confidence 899999999875443333344578999999999864 567889999999999999999999998643221
Q ss_pred HHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCC-----HHHHHHHHH
Q 024408 157 AAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPN-----FTQIIQMLL 203 (268)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~~~~~~l~ 203 (268)
................+++++.+++.+||+.||.+||+ +.++++|-+
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~ 263 (285)
T cd05630 212 EVERLVKEVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPL 263 (285)
T ss_pred HHHhhhhhhhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChh
Confidence 11111111122234568899999999999999999999 889998743
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=255.99 Aligned_cols=192 Identities=28% Similarity=0.310 Sum_probs=159.5
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeC-CC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE-DL 78 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~-~~ 78 (268)
|+|++++++ ..+++|||+|+++ -+|+++|+.++..+++...++.++.||+.||.+||+.||||+||||+|||+.. +.
T Consensus 249 n~Vrm~d~F~fr~HlciVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r 327 (586)
T KOG0667|consen 249 NIVRMLDYFYFRNHLCIVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKR 327 (586)
T ss_pred eEEEeeeccccccceeeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCc
Confidence 579999999 7789999999994 89999999988888999999999999999999999999999999999999953 33
Q ss_pred CCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 79 KTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 79 ~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
..+||+|||.+........ +.+.+..|+|||++.+ ..|+.+.|||||||+++||++|.+.|.+.+..++.
T Consensus 328 ~~vKVIDFGSSc~~~q~vy--tYiQSRfYRAPEVILG--------lpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl 397 (586)
T KOG0667|consen 328 SRIKVIDFGSSCFESQRVY--TYIQSRFYRAPEVILG--------LPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQL 397 (586)
T ss_pred CceeEEecccccccCCcce--eeeeccccccchhhcc--------CCCCCccceeehhhhHHhHhcCccccCCCCHHHHH
Confidence 4799999999987554432 6678899999999986 67899999999999999999999888887765554
Q ss_pred HHHHhccCCCC---------------------------------------------------C----------C-CCcHH
Q 024408 159 YAAAFKNVRPS---------------------------------------------------A----------E-NVPEE 176 (268)
Q Consensus 159 ~~~~~~~~~~~---------------------------------------------------~----------~-~~~~~ 176 (268)
..+......|. + . .-...
T Consensus 398 ~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~ 477 (586)
T KOG0667|consen 398 ARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKL 477 (586)
T ss_pred HHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHH
Confidence 43332111100 0 0 01246
Q ss_pred HHHHHHhccccCCCCCCCHHHHHHHHH
Q 024408 177 LSIILTSCWKEDPNARPNFTQIIQMLL 203 (268)
Q Consensus 177 l~~li~~~l~~~p~~Rps~~~~~~~l~ 203 (268)
+.++|.+||..||.+|+|..+.++|-+
T Consensus 478 F~dflk~~L~~dP~~R~tp~qal~Hpf 504 (586)
T KOG0667|consen 478 FIDFLKRCLEWDPAERITPAQALNHPF 504 (586)
T ss_pred HHHHHHHHhccCchhcCCHHHHhcCcc
Confidence 889999999999999999999999854
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=246.90 Aligned_cols=192 Identities=22% Similarity=0.333 Sum_probs=152.9
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ .++..++||||++ ++|.+++...+. .+++..+..++.|++.||.|||++|++||||||+||+++.+ +
T Consensus 65 ~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~-~ 141 (309)
T cd07872 65 NIVTLHDIVHTDKSLTLVFEYLD-KDLKQYMDDCGN-IMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINER-G 141 (309)
T ss_pred CcceEEEEEeeCCeEEEEEeCCC-CCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-C
Confidence 578999999 5568999999996 589998876543 38999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccc-cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.++|+|||++...... .......++..|+|||.+.+ ...++.++|+||||+++|+|++|+.||.+....+..
T Consensus 142 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~ 214 (309)
T cd07872 142 ELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLG-------SSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDEL 214 (309)
T ss_pred CEEECccccceecCCCccccccccccccccCCHHHhC-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 9999999999753322 22234467899999998753 245678999999999999999999999876543332
Q ss_pred HHHHhccC--------------------CC---------CCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 024408 159 YAAAFKNV--------------------RP---------SAENVPEELSIILTSCWKEDPNARPNFTQIIQML 202 (268)
Q Consensus 159 ~~~~~~~~--------------------~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l 202 (268)
........ .+ ....+++++.++|.+||..||.+|||+.++++|.
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~ 287 (309)
T cd07872 215 HLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHA 287 (309)
T ss_pred HHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcCh
Confidence 22111000 00 1134678999999999999999999999999973
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=249.49 Aligned_cols=190 Identities=23% Similarity=0.387 Sum_probs=151.8
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCCEEEeCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH-GIIHRDLKPENLLLTEDL 78 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-gi~H~Dikp~Nill~~~~ 78 (268)
++|+++|+| .+++.++||||++|++|.+++.+.+. +++..+..++.+++.||.|||++ +++|+||||+||+++.+
T Consensus 64 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~- 140 (333)
T cd06650 64 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSR- 140 (333)
T ss_pred cccceeEEEEECCEEEEEEecCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCC-
Confidence 589999999 56689999999999999999987554 89999999999999999999985 79999999999999988
Q ss_pred CCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 79 KTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 79 ~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
+.+||+|||++...... ......|+..|+|||++.+ ..++.++|+||||+++|++++|+.||......+..
T Consensus 141 ~~~kL~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~ 211 (333)
T cd06650 141 GEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQG--------THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELE 211 (333)
T ss_pred CCEEEeeCCcchhhhhh-ccccCCCCccccCHHHhcC--------CCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHH
Confidence 68999999998753222 2234468999999999854 45788999999999999999999999754332211
Q ss_pred HHH-------------------------------------------HhccCCCC--CCCCcHHHHHHHHhccccCCCCCC
Q 024408 159 YAA-------------------------------------------AFKNVRPS--AENVPEELSIILTSCWKEDPNARP 193 (268)
Q Consensus 159 ~~~-------------------------------------------~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rp 193 (268)
... ......+. ...++.++.+++.+||..||++||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rp 291 (333)
T cd06650 212 LMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERA 291 (333)
T ss_pred HHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCc
Confidence 100 00000010 123568899999999999999999
Q ss_pred CHHHHHHHH
Q 024408 194 NFTQIIQML 202 (268)
Q Consensus 194 s~~~~~~~l 202 (268)
++.+++++-
T Consensus 292 t~~ell~h~ 300 (333)
T cd06650 292 DLKQLMVHA 300 (333)
T ss_pred CHHHHhhCH
Confidence 999999883
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=245.35 Aligned_cols=202 Identities=23% Similarity=0.328 Sum_probs=168.5
Q ss_pred CceeEEEeec---CC---cEEEEEEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCE
Q 024408 1 MREQFIGACK---EP---VMVIVTELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENL 72 (268)
Q Consensus 1 ~~v~l~g~~~---~~---~~~lV~e~~~ggsL~~~i~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Ni 72 (268)
|+|+|+-++. +. +..+||||++ .+|.+.++.. .+..++.-.+.-+.+||++||.|||+.||+||||||.|+
T Consensus 78 NIV~L~~~f~~~~~~d~~~lnlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNl 156 (364)
T KOG0658|consen 78 NIVRLLYFFSSSTESDEVYLNLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNL 156 (364)
T ss_pred CeeeEEEEEEecCCCchhHHHHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheE
Confidence 6888888872 22 5689999997 7999999852 233488999999999999999999999999999999999
Q ss_pred EEeCCCCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 024408 73 LLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGM 152 (268)
Q Consensus 73 ll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~ 152 (268)
|+|.+.+.+||||||.|+.........+...|..|+|||.+.+ ...|+.+.||||.||++.||+.|++-|.+.
T Consensus 157 LvD~~tg~LKicDFGSAK~L~~~epniSYicSRyYRaPELifg-------a~~Yt~~IDiWSaGCV~aELl~g~plFpG~ 229 (364)
T KOG0658|consen 157 LVDPDTGVLKICDFGSAKVLVKGEPNISYICSRYYRAPELIFG-------ATEYTTSIDIWSAGCVMAELLKGQPLFPGD 229 (364)
T ss_pred EEcCCCCeEEeccCCcceeeccCCCceeEEEeccccCHHHHcC-------ccccCceeEEhhhhHHHHHHhcCCcccCCC
Confidence 9999888999999999998777777777888999999999986 578999999999999999999999999997
Q ss_pred ChHHHHHHHHhccCCCC----------------------------CCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 024408 153 SNLQAAYAAAFKNVRPS----------------------------AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 204 (268)
Q Consensus 153 ~~~~~~~~~~~~~~~~~----------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~ 204 (268)
+..++......-...|. ....+++..+++.++|.++|.+|.++.+++.| .
T Consensus 230 s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h--~ 307 (364)
T KOG0658|consen 230 SSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH--P 307 (364)
T ss_pred CHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc--h
Confidence 77666554443222221 13467899999999999999999999999987 5
Q ss_pred hHhhcCCC
Q 024408 205 YLSAIAPP 212 (268)
Q Consensus 205 ~~~~~~~~ 212 (268)
+++....+
T Consensus 308 fFdelr~~ 315 (364)
T KOG0658|consen 308 FFDELRDP 315 (364)
T ss_pred hhHHhhCc
Confidence 55554443
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=238.59 Aligned_cols=194 Identities=28% Similarity=0.507 Sum_probs=159.7
Q ss_pred CceeEEEeecCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCC
Q 024408 1 MREQFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT 80 (268)
Q Consensus 1 ~~v~l~g~~~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~ 80 (268)
+++++++.+.+...++||||+++++|.+++.+.....+++..++.++.|++.||+|||++|++|+||||+||+++.+ +.
T Consensus 57 ~iv~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~-~~ 135 (257)
T cd05040 57 NLIRLYGVVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASD-DK 135 (257)
T ss_pred CccceeEEEcCCeEEEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecC-CE
Confidence 57889999866889999999999999999987653458999999999999999999999999999999999999988 69
Q ss_pred eEEecCCCcccccccc----ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChH
Q 024408 81 IKLADFGLAREESLTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNL 155 (268)
Q Consensus 81 ~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~~~ 155 (268)
++|+|||++....... ......++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||......
T Consensus 136 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~--------~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 207 (257)
T cd05040 136 VKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRT--------RTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS 207 (257)
T ss_pred EEeccccccccccccccceecccCCCCCceecCHHHhcc--------cCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999997543321 1123356788999998754 567889999999999999998 99999876655
Q ss_pred HHHHHHHh-ccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 024408 156 QAAYAAAF-KNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 203 (268)
Q Consensus 156 ~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~ 203 (268)
+....... ....+.+...|..+.+++.+||..+|++||++.++++.|.
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 208 QILKKIDKEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred HHHHHHHhcCCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 54333332 2222334567899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=261.05 Aligned_cols=195 Identities=25% Similarity=0.442 Sum_probs=166.1
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHh-cCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLN-MRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL 78 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~-~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~ 78 (268)
|+|+.+|.| +++++-+.||-++||||.++++. .++-.=.+.++-.+..||++||.|||++.|||||||.+|+|+..-.
T Consensus 633 NIVrYLGs~senGf~kIFMEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTyS 712 (1226)
T KOG4279|consen 633 NIVRYLGSVSENGFFKIFMEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYS 712 (1226)
T ss_pred hHHHHhhccCCCCeEEEEeecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeecc
Confidence 689999999 66788999999999999999975 3332238889999999999999999999999999999999998776
Q ss_pred CCeEEecCCCccc-cccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 024408 79 KTIKLADFGLARE-ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA 157 (268)
Q Consensus 79 ~~~kl~Dfg~a~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~ 157 (268)
|.+||+|||.++. ........++.||..|||||++..+ ...|+.++|||||||++.||.||++||......+.
T Consensus 713 GvlKISDFGTsKRLAginP~TETFTGTLQYMAPEvIDqG------~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA 786 (1226)
T KOG4279|consen 713 GVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDQG------PRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA 786 (1226)
T ss_pred ceEEecccccchhhccCCccccccccchhhhChHhhccC------CcCCCchhhhhhccceeEeeccCCCCeeecCChhH
Confidence 8999999999974 4455667889999999999998642 34688999999999999999999999987665554
Q ss_pred HHHH--HhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 158 AYAA--AFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 158 ~~~~--~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
.... ..+...+.+..++.+.+.+|.+|+.++|.+||++.++++.
T Consensus 787 AMFkVGmyKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 787 AMFKVGMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred hhhhhcceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 4332 3344556688899999999999999999999999999875
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=264.97 Aligned_cols=199 Identities=24% Similarity=0.358 Sum_probs=160.8
Q ss_pred CceeEEEee--c----C--CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCC
Q 024408 1 MREQFIGAC--K----E--PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG--IIHRDLKPE 70 (268)
Q Consensus 1 ~~v~l~g~~--~----~--~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~g--i~H~Dikp~ 70 (268)
|||++++.. . . -+.+|+||||.||+|-|++.++....|++.++++|++++++|+++||... |+|||||-+
T Consensus 96 nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiE 175 (738)
T KOG1989|consen 96 NIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIE 175 (738)
T ss_pred ceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhh
Confidence 688888832 1 1 15789999999999999999877766999999999999999999999998 999999999
Q ss_pred CEEEeCCCCCeEEecCCCcccccccc-c---------cccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHH
Q 024408 71 NLLLTEDLKTIKLADFGLAREESLTE-M---------MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLW 140 (268)
Q Consensus 71 Nill~~~~~~~kl~Dfg~a~~~~~~~-~---------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~ 140 (268)
||||+.+ |..||||||.|....... . .....-|+.|++||++.-.. +...+.|+|||||||+||
T Consensus 176 NvLls~~-g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlys-----g~pI~eKsDIWALGclLY 249 (738)
T KOG1989|consen 176 NVLLSAD-GNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYS-----GLPIGEKSDIWALGCLLY 249 (738)
T ss_pred heEEcCC-CCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhc-----CCCCcchhHHHHHHHHHH
Confidence 9999998 799999999997432221 0 01123589999999986432 466889999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHh-ccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhc
Q 024408 141 ELLHNKLPFEGMSNLQAAYAAAF-KNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 209 (268)
Q Consensus 141 ~ll~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~~ 209 (268)
-|+....||++..... +.. ....|....++..+.+||+.||+.||++||++.++++.+..+....
T Consensus 250 kLCy~t~PFe~sg~la----Ilng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 250 KLCYFTTPFEESGKLA----ILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred HHHHhCCCcCcCccee----EEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 9999999998743222 122 2233445788999999999999999999999999999988776544
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=239.92 Aligned_cols=195 Identities=29% Similarity=0.512 Sum_probs=159.8
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ .++..++||||++|++|.+++.+... .+++.++..++.|++.||.+||++|++||||||+||+++.+ +
T Consensus 66 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~-~ 143 (267)
T cd05066 66 NIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDG-QFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSN-L 143 (267)
T ss_pred CcceEEEEEecCCccEEEEEcCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCC-C
Confidence 578999998 55688999999999999999976543 38999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccccc----cccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCh
Q 024408 80 TIKLADFGLAREESLTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSN 154 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~~ 154 (268)
.++++|||++........ .....++..|++||.+.+ ..++.++|+||||+++|++++ |..||.....
T Consensus 144 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~--------~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~ 215 (267)
T cd05066 144 VCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY--------RKFTSASDVWSYGIVMWEVMSYGERPYWEMSN 215 (267)
T ss_pred eEEeCCCCcccccccccceeeecCCCccceeecCHhHhcc--------CccCchhhhHHHHHHHHHHhcCCCCCcccCCH
Confidence 899999999975433211 111223568999998854 567889999999999999886 9999987665
Q ss_pred HHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHh
Q 024408 155 LQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 205 (268)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~ 205 (268)
.+...........+....++..+.+++.+|++.+|.+||++.++++.|.+.
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 216 QDVIKAIEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred HHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 544443333333455567889999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=244.45 Aligned_cols=191 Identities=27% Similarity=0.343 Sum_probs=153.7
Q ss_pred CceeEEEeecC------CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEE
Q 024408 1 MREQFIGACKE------PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL 74 (268)
Q Consensus 1 ~~v~l~g~~~~------~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill 74 (268)
|++++++++.. ...++||||++ ++|.+++.......+++.++..++.|++.||.|||++|++||||||+||++
T Consensus 63 ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili 141 (288)
T cd07863 63 NIVRLMDVCATSRTDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV 141 (288)
T ss_pred CeeeeeeeeccccCCCCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 57888888742 35799999997 699999987655559999999999999999999999999999999999999
Q ss_pred eCCCCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh
Q 024408 75 TEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN 154 (268)
Q Consensus 75 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~ 154 (268)
+.+ +.++|+|||+++............++..|+|||++.+ ..++.++|+||+|+++|+|++|.+||.+...
T Consensus 142 ~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~ 212 (288)
T cd07863 142 TSG-GQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQ--------STYATPVDMWSVGCIFAEMFRRKPLFCGNSE 212 (288)
T ss_pred CCC-CCEEECccCccccccCcccCCCccccccccCchHhhC--------CCCCCcchhhhHHHHHHHHHhCCcCcCCCCH
Confidence 988 6999999999986544433345578999999998854 5578899999999999999999999977554
Q ss_pred HHHHHHHHhccCC--------------------------CCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 155 LQAAYAAAFKNVR--------------------------PSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 155 ~~~~~~~~~~~~~--------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
............. .....++..+.++|.+||..||++||++.+++.|
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 213 ADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred HHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 4332222111000 0113467889999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=252.35 Aligned_cols=197 Identities=24% Similarity=0.346 Sum_probs=155.5
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
.||+||+|- .++++||||||-+ -+|.++|++.... .+.-.+..+..|++.|+.++|++||||.||||.|+|+-. |
T Consensus 421 ~IIqL~DYEv~d~~lYmvmE~Gd-~DL~kiL~k~~~~-~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk--G 496 (677)
T KOG0596|consen 421 KIIQLYDYEVTDGYLYMVMECGD-IDLNKILKKKKSI-DPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK--G 496 (677)
T ss_pred eEEEEeeeeccCceEEEEeeccc-ccHHHHHHhccCC-CchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe--e
Confidence 479999998 7789999999985 7999999886654 333377888999999999999999999999999999976 4
Q ss_pred CeEEecCCCcccccccc---ccccCCCccceecccccccccccc---CCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 024408 80 TIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQ---GEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS 153 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~---~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~ 153 (268)
.+||+|||+|.....+. ...+.+||+.||+||.+....... ......++++|||||||+||+|+.|+.||....
T Consensus 497 ~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~ 576 (677)
T KOG0596|consen 497 RLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII 576 (677)
T ss_pred eEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH
Confidence 89999999998654432 345678999999999987654432 112347789999999999999999999998765
Q ss_pred hHHHHHHHHhccCC--CCCCCCc-HHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 154 NLQAAYAAAFKNVR--PSAENVP-EELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 154 ~~~~~~~~~~~~~~--~~~~~~~-~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
+............. +.+..-+ .++.++++.||..||++||+..++++|
T Consensus 577 n~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 577 NQIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred HHHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 44443333333322 1122212 349999999999999999999999997
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=255.73 Aligned_cols=194 Identities=24% Similarity=0.366 Sum_probs=155.2
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ .+++.++||||++||+|.+++... .+++..+..++.|++.||+|||++||+||||||+|||++.+ +
T Consensus 104 ~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~-~ 179 (370)
T cd05621 104 WVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKH-G 179 (370)
T ss_pred CEeeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCC-C
Confidence 578999998 556899999999999999999653 38999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccccc--ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 024408 80 TIKLADFGLAREESLTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA 157 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~ 157 (268)
.+||+|||++....... ...+..||+.|+|||++.+. .....++.++|+||+|+++|+|++|+.||........
T Consensus 180 ~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~----~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~ 255 (370)
T cd05621 180 HLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQ----GGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT 255 (370)
T ss_pred CEEEEecccceecccCCceecccCCCCcccCCHHHHhcc----CCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHH
Confidence 99999999998643322 22355799999999998641 1123477899999999999999999999987665444
Q ss_pred HHHHHhccC---CCCCCCCcHHHHHHHHhccccCCCC--CCCHHHHHHHH
Q 024408 158 AYAAAFKNV---RPSAENVPEELSIILTSCWKEDPNA--RPNFTQIIQML 202 (268)
Q Consensus 158 ~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~~p~~--Rps~~~~~~~l 202 (268)
......... .+....++..+++++..||..++.+ |+++.++++|-
T Consensus 256 ~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp 305 (370)
T cd05621 256 YSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHP 305 (370)
T ss_pred HHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCc
Confidence 333332221 1223457899999999999865544 89999999984
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=243.96 Aligned_cols=192 Identities=24% Similarity=0.391 Sum_probs=157.0
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++.+++.+ .++..++||||++|++|.+++...+...+++..+..++.|++.||.|||++||+||||||+||+++.+ +
T Consensus 61 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~-~ 139 (285)
T cd05632 61 FVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDY-G 139 (285)
T ss_pred CceeEEEEEecCCEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCC-C
Confidence 467788777 56689999999999999999877655569999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 024408 80 TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY 159 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~ 159 (268)
.++|+|||++.............|+..|+|||.+.+ ..++.++|+||+|+++|++++|..||..........
T Consensus 140 ~~kl~Dfg~~~~~~~~~~~~~~~g~~~~~aPE~~~~--------~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~ 211 (285)
T cd05632 140 HIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNN--------QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKRE 211 (285)
T ss_pred CEEEecCCcceecCCCCcccCCCCCcCccChHHhcC--------CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 899999999875443333345578999999999854 567889999999999999999999998755433222
Q ss_pred HH---HhccCCCCCCCCcHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 024408 160 AA---AFKNVRPSAENVPEELSIILTSCWKEDPNARPN-----FTQIIQM 201 (268)
Q Consensus 160 ~~---~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~~~~~~ 201 (268)
.. ...........++.++.+++..||+.||.+||+ +.+++++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 212 EVDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred HHHHhhhccccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 11 112222234568899999999999999999999 7788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=238.85 Aligned_cols=195 Identities=33% Similarity=0.525 Sum_probs=161.3
Q ss_pred CceeEEEeecC-CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGACKE-PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~~~-~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++.. ...++||||++|++|.+++.+.....+++.++..++.+++.||.|||++|++|+||||+||+++.+ +
T Consensus 62 ~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~-~ 140 (261)
T cd05034 62 KLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGEN-L 140 (261)
T ss_pred CEeeeeeeeecCCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCC-C
Confidence 46889999854 688999999999999999987665569999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccccc--cccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 024408 80 TIKLADFGLAREESLTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQ 156 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~~~~ 156 (268)
.++++|||.+........ .....++..|+|||.+.+ ..++.++|+||+|++++++++ |+.||.+.....
T Consensus 141 ~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~ 212 (261)
T cd05034 141 VCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANY--------GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE 212 (261)
T ss_pred CEEECccccceeccchhhhhhhccCCCccccCHHHhcc--------CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 999999999875432211 112234568999998754 557889999999999999998 999998766555
Q ss_pred HHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 024408 157 AAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 204 (268)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~ 204 (268)
...........+.+...+.++.+++.+|+..+|++||+++++++.|+.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 213 VLEQVERGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred HHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 444444333445566778999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=238.39 Aligned_cols=195 Identities=31% Similarity=0.507 Sum_probs=160.9
Q ss_pred CceeEEEeecCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCC
Q 024408 1 MREQFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT 80 (268)
Q Consensus 1 ~~v~l~g~~~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~ 80 (268)
+++++.+.+.+...++||||+++++|.+++.+.....+++.++..++.|++.||.|||+.|++|+||||+||+++.+ +.
T Consensus 62 ~i~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~-~~ 140 (260)
T cd05073 62 KLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSAS-LV 140 (260)
T ss_pred CcceEEEEEcCCCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCC-Cc
Confidence 47888899866888999999999999999987655568999999999999999999999999999999999999988 69
Q ss_pred eEEecCCCccccccccc--cccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 024408 81 IKLADFGLAREESLTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQA 157 (268)
Q Consensus 81 ~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~ 157 (268)
++|+|||.+........ .....++..|+|||.+.. ..++.++|+||||+++|++++ |..||.+.+....
T Consensus 141 ~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~ 212 (260)
T cd05073 141 CKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF--------GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV 212 (260)
T ss_pred EEECCCcceeeccCCCcccccCCcccccccCHhHhcc--------CCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence 99999999875332211 112245577999998853 557788999999999999998 9999987665544
Q ss_pred HHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 024408 158 AYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 204 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~ 204 (268)
..........+.....+.++.+++.+|+..+|++||++.++.+.|+.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 213 IRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred HHHHhCCCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 44333333344566788999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=252.79 Aligned_cols=192 Identities=23% Similarity=0.346 Sum_probs=150.1
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|+|++++++ .++.+++||||++|++|.+.. ..++..+..++.|++.||.|||++|++||||||+|||++.+ +
T Consensus 133 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-~ 205 (353)
T PLN00034 133 NVVKCHDMFDHNGEIQVLLEFMDGGSLEGTH------IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSA-K 205 (353)
T ss_pred CcceeeeEeccCCeEEEEEecCCCCcccccc------cCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCC-C
Confidence 578999999 456899999999999986532 26678889999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccc-cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH--
Q 024408 80 TIKLADFGLAREESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ-- 156 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~-- 156 (268)
.+||+|||+++..... .......||..|+|||++.... ......+.++||||||+++|+|++|+.||......+
T Consensus 206 ~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~ 282 (353)
T PLN00034 206 NVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDL---NHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWA 282 (353)
T ss_pred CEEEcccccceecccccccccccccCccccCcccccccc---ccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHH
Confidence 9999999999754322 2234457899999999874311 012334568999999999999999999997432211
Q ss_pred -HHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 024408 157 -AAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 202 (268)
Q Consensus 157 -~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l 202 (268)
................++.++.++|.+||..||++||++.++++|-
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp 329 (353)
T PLN00034 283 SLMCAICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHP 329 (353)
T ss_pred HHHHHHhccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 1111222223334567889999999999999999999999999983
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=240.64 Aligned_cols=190 Identities=27% Similarity=0.480 Sum_probs=157.3
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
++++++|++ ..++.++||||++|++|.+++.+.+. +++..+..++.|++.||+|||++|++||||+|+||+++.+ +
T Consensus 67 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~-~ 143 (267)
T cd06628 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGA--FEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNK-G 143 (267)
T ss_pred CeeeEEEEEEeCCccEEEEEecCCCCHHHHHHhccC--ccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCC-C
Confidence 578999998 55688999999999999999987544 8999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccccc-------ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 024408 80 TIKLADFGLAREESLTE-------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGM 152 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~ 152 (268)
.++|+|||.++...... ......|+..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...
T Consensus 144 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~--------~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 215 (267)
T cd06628 144 GIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQ--------TSYTRKADIWSLGCLVVEMLTGKHPFPDC 215 (267)
T ss_pred CEEecccCCCcccccccccCCccccccccCCCcCccChhHhcc--------CCCCchhhhHHHHHHHHHHhhCCCCCCCc
Confidence 89999999987543211 1123357889999998854 45678899999999999999999999876
Q ss_pred ChHHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 153 SNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
.................+..++..+.++|.+||+.+|.+||++.+++++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 216 TQLQAIFKIGENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred cHHHHHHHHhccCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 6554444333333334456788999999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=241.07 Aligned_cols=197 Identities=25% Similarity=0.409 Sum_probs=158.3
Q ss_pred CceeEEEeecC-------CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEE
Q 024408 1 MREQFIGACKE-------PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 73 (268)
Q Consensus 1 ~~v~l~g~~~~-------~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nil 73 (268)
|+++++|++.. ..+++||||+++++|.+++.......+++..+..++.|++.||+|||++|++|+||||+||+
T Consensus 64 ~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nil 143 (272)
T cd06637 64 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVL 143 (272)
T ss_pred CeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEE
Confidence 57889998842 36899999999999999998765556999999999999999999999999999999999999
Q ss_pred EeCCCCCeEEecCCCccccccc-cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 024408 74 LTEDLKTIKLADFGLAREESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGM 152 (268)
Q Consensus 74 l~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~ 152 (268)
++++ +.++|+|||++...... .......|+..|+|||++.+.. .....++.++|+||+|+++|+|++|+.||...
T Consensus 144 i~~~-~~~~l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~---~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~ 219 (272)
T cd06637 144 LTEN-AEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDE---NPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 219 (272)
T ss_pred ECCC-CCEEEccCCCceecccccccCCcccccccccCHhHhcccc---CcCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 9988 68999999999754322 2234456889999999885311 11245778999999999999999999999766
Q ss_pred ChHHHHHHHHhcc-CCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 153 SNLQAAYAAAFKN-VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 153 ~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
............. .......++.++.+++.+||..+|.+||++.+++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 220 HPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred CHHHHHHHHhcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 5444333322221 122245678999999999999999999999999886
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=254.43 Aligned_cols=195 Identities=24% Similarity=0.386 Sum_probs=155.1
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++.+ .+++.++||||++||+|.+++... .+++..+..++.|++.||+|||++||+||||||+||+++.+ +
T Consensus 104 ~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~-~ 179 (371)
T cd05622 104 WVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKS-G 179 (371)
T ss_pred CCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCC-C
Confidence 578999998 556899999999999999998653 28999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccccc--ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 024408 80 TIKLADFGLAREESLTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA 157 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~ 157 (268)
.+||+|||++....... ......||+.|+|||++... .....++.++||||||+++|+|++|..||.+......
T Consensus 180 ~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~ 255 (371)
T cd05622 180 HLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQ----GGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT 255 (371)
T ss_pred CEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhcc----CCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHH
Confidence 99999999997543322 22355799999999998641 1123478899999999999999999999987655443
Q ss_pred HHHHHhcc---CCCCCCCCcHHHHHHHHhccccCCCC--CCCHHHHHHHHH
Q 024408 158 AYAAAFKN---VRPSAENVPEELSIILTSCWKEDPNA--RPNFTQIIQMLL 203 (268)
Q Consensus 158 ~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~~p~~--Rps~~~~~~~l~ 203 (268)
........ ..+....++..++++|..||..++.+ |+++.++++|.+
T Consensus 256 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~ 306 (371)
T cd05622 256 YSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF 306 (371)
T ss_pred HHHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcc
Confidence 33333221 12334568899999999999844443 789999999853
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=244.22 Aligned_cols=198 Identities=23% Similarity=0.507 Sum_probs=160.9
Q ss_pred CceeEEEeecCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCC
Q 024408 1 MREQFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT 80 (268)
Q Consensus 1 ~~v~l~g~~~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~ 80 (268)
|+++++|+|..+..++|+||+++|+|.+++..... .+++..++.++.|++.||.|||++|++|+||||+||+++.+ +.
T Consensus 70 niv~~~~~~~~~~~~~v~e~~~~g~l~~~~~~~~~-~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~-~~ 147 (303)
T cd05110 70 HLVRLLGVCLSPTIQLVTQLMPHGCLLDYVHEHKD-NIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSP-NH 147 (303)
T ss_pred CcccEEEEEcCCCceeeehhcCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCC-Cc
Confidence 58999999977778899999999999999976543 38999999999999999999999999999999999999887 68
Q ss_pred eEEecCCCccccccccc---cccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 024408 81 IKLADFGLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQ 156 (268)
Q Consensus 81 ~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~~~~ 156 (268)
+||+|||+++....... .....++..|++||.+.+ ..++.++||||||+++|++++ |..||.+.....
T Consensus 148 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~ 219 (303)
T cd05110 148 VKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHY--------RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE 219 (303)
T ss_pred eEEccccccccccCcccccccCCCccccccCCHHHhcc--------CCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 99999999985432221 112335678999998753 557889999999999999997 899998755433
Q ss_pred HHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 024408 157 AAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 208 (268)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 208 (268)
...........+.+..++..+.+++..||..+|++||+++++++.|+.....
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 220 IPDLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred HHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 3332223333344566788999999999999999999999999999886544
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=238.88 Aligned_cols=195 Identities=29% Similarity=0.499 Sum_probs=158.2
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|++++.+++ .++..++||||++|++|.+++....+ .+++.+++.++.|++.||.|||++|++|+||||+||+++.+ +
T Consensus 66 ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~-~ 143 (269)
T cd05065 66 NIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDG-QFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSN-L 143 (269)
T ss_pred CcceEEEEECCCCceEEEEecCCCCcHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCC-C
Confidence 578999998 45678999999999999999976433 48999999999999999999999999999999999999987 6
Q ss_pred CeEEecCCCcccccccccc---cc-C--CCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 024408 80 TIKLADFGLAREESLTEMM---TA-E--TGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGM 152 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~~---~~-~--~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~ 152 (268)
.++++|||++......... .. . ..+..|+|||.+.+ ..++.++||||||+++||+++ |..||...
T Consensus 144 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~DvwslG~~l~e~l~~g~~p~~~~ 215 (269)
T cd05065 144 VCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY--------RKFTSASDVWSYGIVMWEVMSYGERPYWDM 215 (269)
T ss_pred cEEECCCccccccccCccccccccccCCCcceeecCHhHhcc--------CcccchhhhhhhHHHHHHHhcCCCCCCCCC
Confidence 8999999998743322111 11 1 12457999998753 557789999999999999886 99999876
Q ss_pred ChHHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHh
Q 024408 153 SNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 205 (268)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~ 205 (268)
...+...........+.+..++..+.+++.+||..+|.+||++.+++..|+..
T Consensus 216 ~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 216 SNQDVINAIEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred CHHHHHHHHHcCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 65554444433334455667889999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=239.24 Aligned_cols=189 Identities=22% Similarity=0.394 Sum_probs=150.9
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
++|+++|++ .++..++||||+++|+|.+++...+. .+++..++.++.|++.||+|||++|++||||||+||+++.+..
T Consensus 60 ~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~ 138 (258)
T cd05078 60 HLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKN-LINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREED 138 (258)
T ss_pred ChhheeeEEEeCCCcEEEEecCCCCcHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccc
Confidence 578999999 44688999999999999999986544 4899999999999999999999999999999999999987632
Q ss_pred -------CeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCC-CCCCC
Q 024408 80 -------TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNK-LPFEG 151 (268)
Q Consensus 80 -------~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~-~p~~~ 151 (268)
.++++|||++...... ....++..|+|||++.+ ...++.++|+||||+++|++++|. .|+..
T Consensus 139 ~~~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~~l~~l~~g~~~~~~~ 208 (258)
T cd05078 139 RKTGNPPFIKLSDPGISITVLPK---EILLERIPWVPPECIEN-------PQNLSLAADKWSFGTTLWEIFSGGDKPLSA 208 (258)
T ss_pred cccCCCceEEecccccccccCCc---hhccccCCccCchhccC-------CCCCCchhhHHHHHHHHHHHHcCCCCChhh
Confidence 2799999998754322 23467889999998853 234678899999999999999984 66655
Q ss_pred CChHHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 024408 152 MSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 202 (268)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l 202 (268)
........ ........+...+.++.+++.+||+.+|++||+++++++.|
T Consensus 209 ~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 209 LDSQKKLQ--FYEDRHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred ccHHHHHH--HHHccccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 44333222 11222333445668899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=238.82 Aligned_cols=189 Identities=23% Similarity=0.387 Sum_probs=149.1
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|+|+++|++ .+...++||||+++++|..++.+... .+++..++.++.|++.||+|||++|++||||||+||+++.+..
T Consensus 65 ~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~ 143 (262)
T cd05077 65 HIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSD-VLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGI 143 (262)
T ss_pred CEeeEEEEEecCCCCEEEEecccCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCc
Confidence 589999999 45578999999999999998875433 3899999999999999999999999999999999999976521
Q ss_pred ------CeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHH-hCCCCCCCC
Q 024408 80 ------TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGM 152 (268)
Q Consensus 80 ------~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll-~g~~p~~~~ 152 (268)
.++++|||++...... ....++..|+|||.+.. ...++.++||||||+++|+|+ .|..|+...
T Consensus 144 ~~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~~l~el~~~~~~p~~~~ 213 (262)
T cd05077 144 DGECGPFIKLSDPGIPITVLSR---QECVERIPWIAPECVED-------SKNLSIAADKWSFGTTLWEICYNGEIPLKDK 213 (262)
T ss_pred cCCCCceeEeCCCCCCccccCc---ccccccccccChhhhcC-------CCCCCchhHHHHHHHHHHHHHhCCCCCCCCc
Confidence 2899999998753322 23457888999998752 245778999999999999998 588888764
Q ss_pred ChHHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 024408 153 SNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 202 (268)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l 202 (268)
...+... ............+.++.+++.+||+.||.+||++.++++.+
T Consensus 214 ~~~~~~~--~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 214 TLAEKER--FYEGQCMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred chhHHHH--HHhcCccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 4332221 11112222334567899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=239.60 Aligned_cols=189 Identities=22% Similarity=0.362 Sum_probs=150.0
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCC-
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL- 78 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~- 78 (268)
|+++++|+| .++..++||||++||+|.+++.+..+ .+++..+..++.|++.||+|||++|++||||||+||+++...
T Consensus 77 niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 77 HLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKG-RVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGL 155 (274)
T ss_pred CeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCc
Confidence 689999999 55688999999999999999876433 489999999999999999999999999999999999997531
Q ss_pred -----CCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHH-hCCCCCCCC
Q 024408 79 -----KTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGM 152 (268)
Q Consensus 79 -----~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll-~g~~p~~~~ 152 (268)
..++++|||.+...... ....++..|+|||.+.+ ...++.++|+||||+++||++ +|..||...
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~-------~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 225 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPG-------GNSLSTAADKWSFGTTLLEICFDGEVPLKER 225 (274)
T ss_pred ccCccceeeecCCccccccccc---cccccCCcccCchhhcC-------CCCCCcHHHHHHHHHHHHHHHhCCCCCcccc
Confidence 24899999988643221 22356788999998753 245788999999999999985 699999775
Q ss_pred ChHHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 024408 153 SNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 202 (268)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l 202 (268)
...+..... ......+...+..+.++|.+||..+|++||++.++++.|
T Consensus 226 ~~~~~~~~~--~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 226 TPSEKERFY--EKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred ChHHHHHHH--HhccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 543322211 112222344567899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=246.84 Aligned_cols=196 Identities=20% Similarity=0.307 Sum_probs=154.2
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ .++.+++||||++||+|.+++.+... .+++..+..++.|++.||.|||++|++||||||+||+++.+ +
T Consensus 62 ~i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~-~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~-~ 139 (332)
T cd05623 62 WITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFED-RLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMN-G 139 (332)
T ss_pred CEeeEEEEEecCCEEEEEEeccCCCcHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCC-C
Confidence 467888888 55689999999999999999987433 38999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccccc--ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 024408 80 TIKLADFGLAREESLTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA 157 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~ 157 (268)
.++|+|||++....... ......||+.|+|||++.... .....++.++||||||+++|+|++|+.||......+.
T Consensus 140 ~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~ 216 (332)
T cd05623 140 HIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAME---DGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET 216 (332)
T ss_pred CEEEeecchheecccCCcceecccccCccccCHHHHhccc---cCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHH
Confidence 99999999987533222 122357899999999885311 1124578899999999999999999999987665554
Q ss_pred HHHHHhccC----CCCCCCCcHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 024408 158 AYAAAFKNV----RPSAENVPEELSIILTSCWKEDPNA--RPNFTQIIQM 201 (268)
Q Consensus 158 ~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~~p~~--Rps~~~~~~~ 201 (268)
......... ......++.++.+++++|+..++.+ |+++.++++|
T Consensus 217 ~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 217 YGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred HHHHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 444332221 1123467899999999998665444 6899999998
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=251.36 Aligned_cols=190 Identities=23% Similarity=0.386 Sum_probs=151.9
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++.+ .++++++||||++||+|.+++.+.+. +++..+..++.|++.||+|||++|++||||||+||+++.+ +
T Consensus 62 ~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~--l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~-~ 138 (360)
T cd05627 62 WVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDT--LSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAK-G 138 (360)
T ss_pred CEeeEEEEEEcCCEEEEEEeCCCCccHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCC-C
Confidence 468888888 55689999999999999999987554 9999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccccc------------------------------------ccccCCCccceeccccccccccccCCC
Q 024408 80 TIKLADFGLAREESLTE------------------------------------MMTAETGTYRWMAPELYSTVTLRQGEK 123 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~ 123 (268)
.++|+|||++....... ......||+.|+|||++.+
T Consensus 139 ~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-------- 210 (360)
T cd05627 139 HVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ-------- 210 (360)
T ss_pred CEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC--------
Confidence 99999999986321110 0123468999999999864
Q ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc---CCCCCCCCcHHHHHHHHhccccCCCCCCC---HHH
Q 024408 124 KHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN---VRPSAENVPEELSIILTSCWKEDPNARPN---FTQ 197 (268)
Q Consensus 124 ~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~~p~~Rps---~~~ 197 (268)
..++.++|+|||||++|+|++|+.||.+.............. ..+....++.+++++|.+++. ||.+|++ +.+
T Consensus 211 ~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~e 289 (360)
T cd05627 211 TGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEE 289 (360)
T ss_pred CCCCCcceeccccceeeecccCCCCCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHH
Confidence 567889999999999999999999998766554433332211 112233478899999999774 9999984 788
Q ss_pred HHHHH
Q 024408 198 IIQML 202 (268)
Q Consensus 198 ~~~~l 202 (268)
+++|-
T Consensus 290 i~~hp 294 (360)
T cd05627 290 IKSHP 294 (360)
T ss_pred HhcCC
Confidence 88873
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=257.56 Aligned_cols=188 Identities=21% Similarity=0.269 Sum_probs=146.8
Q ss_pred ceeEEEeecC--CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEEeCCC
Q 024408 2 REQFIGACKE--PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLTEDL 78 (268)
Q Consensus 2 ~v~l~g~~~~--~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~gi~H~Dikp~Nill~~~~ 78 (268)
++++++++.. ++.++|||++ |++|.+++.+.+. +++..+..++.|++.||.|||+ .||+||||||+|||++.+.
T Consensus 193 i~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~~~--l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~ 269 (467)
T PTZ00284 193 LMKIQRYFQNETGHMCIVMPKY-GPCLLDWIMKHGP--FSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSD 269 (467)
T ss_pred eeeeEEEEEcCCceEEEEEecc-CCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCC
Confidence 5778888743 4789999999 7899999987544 9999999999999999999998 5999999999999997652
Q ss_pred C---------------CeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHH
Q 024408 79 K---------------TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL 143 (268)
Q Consensus 79 ~---------------~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll 143 (268)
. .+||+|||.+..... ......||+.|+|||++.+ ..++.++|||||||++|||+
T Consensus 270 ~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~--~~~~~~gt~~Y~APE~~~~--------~~~~~~~DiwSlGvil~ell 339 (467)
T PTZ00284 270 TVVDPVTNRALPPDPCRVRICDLGGCCDERH--SRTAIVSTRHYRSPEVVLG--------LGWMYSTDMWSMGCIIYELY 339 (467)
T ss_pred cccccccccccCCCCceEEECCCCccccCcc--ccccccCCccccCcHHhhc--------CCCCcHHHHHHHHHHHHHHH
Confidence 1 489999998864322 2345678999999999864 56788999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHhccC-------------------------CCC----------------CCCCcHHHHHHHH
Q 024408 144 HNKLPFEGMSNLQAAYAAAFKNV-------------------------RPS----------------AENVPEELSIILT 182 (268)
Q Consensus 144 ~g~~p~~~~~~~~~~~~~~~~~~-------------------------~~~----------------~~~~~~~l~~li~ 182 (268)
+|+.||.+....+.......... .+. .....+.+.+||.
T Consensus 340 tG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~ 419 (467)
T PTZ00284 340 TGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIY 419 (467)
T ss_pred hCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHH
Confidence 99999987654432221111000 000 0011356789999
Q ss_pred hccccCCCCCCCHHHHHHHH
Q 024408 183 SCWKEDPNARPNFTQIIQML 202 (268)
Q Consensus 183 ~~l~~~p~~Rps~~~~~~~l 202 (268)
+||..||++||+++|+++|-
T Consensus 420 ~mL~~dP~~R~ta~e~L~Hp 439 (467)
T PTZ00284 420 GLLHYDRQKRLNARQMTTHP 439 (467)
T ss_pred HhCCcChhhCCCHHHHhcCc
Confidence 99999999999999999983
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=239.94 Aligned_cols=197 Identities=28% Similarity=0.395 Sum_probs=158.2
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++.+ .++..++||||++|++|.+++.+.. ..+++..+..++.|++.||.|||+.|++||||||+||+++.+ +
T Consensus 63 ~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~-~ 140 (282)
T cd06643 63 NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE-RPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLD-G 140 (282)
T ss_pred CeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccC-C
Confidence 578999988 5568899999999999999886533 349999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccc-cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.++++|||++...... .......++..|+|||++.... .....++.++|+||+|+++|+|++|+.||......+..
T Consensus 141 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~ 217 (282)
T cd06643 141 DIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCET---SKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVL 217 (282)
T ss_pred CEEEccccccccccccccccccccccccccCHhhccccC---CCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHH
Confidence 9999999998753322 2223456889999999875311 12345678999999999999999999999876654444
Q ss_pred HHHHhccC--CCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 024408 159 YAAAFKNV--RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 202 (268)
Q Consensus 159 ~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l 202 (268)
........ ...+..++.++.++|.+||..+|.+||++.+++++.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 263 (282)
T cd06643 218 LKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP 263 (282)
T ss_pred HHHhhcCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence 33332221 223456889999999999999999999999999874
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=239.43 Aligned_cols=193 Identities=28% Similarity=0.484 Sum_probs=152.3
Q ss_pred CceeEEEeecC---CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCC
Q 024408 1 MREQFIGACKE---PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED 77 (268)
Q Consensus 1 ~~v~l~g~~~~---~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~ 77 (268)
++++++|++.. ...++||||+++++|.+++... .+++.+++.++.|++.||.|||++|++||||||+||+++++
T Consensus 67 ~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~ 143 (283)
T cd05080 67 NIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDND 143 (283)
T ss_pred CEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCC
Confidence 57899998832 3689999999999999999753 29999999999999999999999999999999999999988
Q ss_pred CCCeEEecCCCccccccccc----cccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 024408 78 LKTIKLADFGLAREESLTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS 153 (268)
Q Consensus 78 ~~~~kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~ 153 (268)
+.++|+|||+++....... .....++..|+|||.+.. ..++.++||||||+++|+|++|..||....
T Consensus 144 -~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~--------~~~~~~~Di~slG~~l~el~tg~~p~~~~~ 214 (283)
T cd05080 144 -RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKE--------NKFSYASDVWSFGVTLYELLTHCDSKQSPP 214 (283)
T ss_pred -CcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcc--------cCCCcccccHHHHHHHHHHHhCCCCCCCCc
Confidence 6899999999975433221 122245667999998753 457789999999999999999999986432
Q ss_pred hHHH--------------HHH-HHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHh
Q 024408 154 NLQA--------------AYA-AAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 205 (268)
Q Consensus 154 ~~~~--------------~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~ 205 (268)
.... ... .......+.+..++.++.+++..||..+|++||+++++++.|+.+
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 215 KKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred chhhhhhcccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 1100 000 001111233556789999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=246.15 Aligned_cols=196 Identities=17% Similarity=0.332 Sum_probs=152.2
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|+|++++++ .++..++||||+++|+|.+++.......+++..+..++.|++.||.|||++|++||||||+||+++.+ +
T Consensus 60 niv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~-~ 138 (327)
T cd08227 60 NIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVD-G 138 (327)
T ss_pred CeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecC-C
Confidence 689999999 56689999999999999999977554559999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccc--------cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 024408 80 TIKLADFGLAREESLT--------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 151 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~ 151 (268)
.++++||+........ .......++..|+|||++.+ ....++.++||||||+++|+|++|+.||..
T Consensus 139 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 139 KVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQ------NLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred cEEEcccchhhccccccccccccccccccccceecccChHHhhc------ccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 8999999865422111 01122346778999999853 113578899999999999999999999986
Q ss_pred CChHHHHHHHHhccC---------------------------------------------CCCCCCCcHHHHHHHHhccc
Q 024408 152 MSNLQAAYAAAFKNV---------------------------------------------RPSAENVPEELSIILTSCWK 186 (268)
Q Consensus 152 ~~~~~~~~~~~~~~~---------------------------------------------~~~~~~~~~~l~~li~~~l~ 186 (268)
....+.......... .+....+++.+.+++.+||.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 292 (327)
T cd08227 213 MPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQ 292 (327)
T ss_pred cchhHHHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHh
Confidence 544332222111100 00112346789999999999
Q ss_pred cCCCCCCCHHHHHHHHH
Q 024408 187 EDPNARPNFTQIIQMLL 203 (268)
Q Consensus 187 ~~p~~Rps~~~~~~~l~ 203 (268)
.||++|||+++++++.+
T Consensus 293 ~dP~~Rpt~~ell~~p~ 309 (327)
T cd08227 293 RNPDARPSASTLLNHSF 309 (327)
T ss_pred hCchhcCCHHHHhcChh
Confidence 99999999999999743
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=247.99 Aligned_cols=189 Identities=26% Similarity=0.343 Sum_probs=148.6
Q ss_pred CceeEEEeecC-------CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEE
Q 024408 1 MREQFIGACKE-------PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 73 (268)
Q Consensus 1 ~~v~l~g~~~~-------~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nil 73 (268)
|++++++++.. ...++||||++ ++|.+.+.. .+++..+..++.|++.||.|||++||+||||||+||+
T Consensus 81 niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl 155 (359)
T cd07876 81 NIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 155 (359)
T ss_pred CEeeeeeeeccCCCccccceeEEEEeCCC-cCHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEE
Confidence 57889998732 24799999996 577777643 2889999999999999999999999999999999999
Q ss_pred EeCCCCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 024408 74 LTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS 153 (268)
Q Consensus 74 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~ 153 (268)
++.+ +.++|+|||+++............||..|+|||++.+ ..++.++||||||+++|+|++|+.||.+.+
T Consensus 156 ~~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~DiwSlG~il~el~tg~~pf~~~~ 226 (359)
T cd07876 156 VKSD-CTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILG--------MGYKENVDIWSVGCIMGELVKGSVIFQGTD 226 (359)
T ss_pred ECCC-CCEEEecCCCccccccCccCCCCcccCCCCCchhccC--------CCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 9988 6999999999986444444445678999999999864 567889999999999999999999998765
Q ss_pred hHHHHHHHHhcc--------------------CCC---------------------CCCCCcHHHHHHHHhccccCCCCC
Q 024408 154 NLQAAYAAAFKN--------------------VRP---------------------SAENVPEELSIILTSCWKEDPNAR 192 (268)
Q Consensus 154 ~~~~~~~~~~~~--------------------~~~---------------------~~~~~~~~l~~li~~~l~~~p~~R 192 (268)
............ ..+ .....+..++++|.+||..||++|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R 306 (359)
T cd07876 227 HIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKR 306 (359)
T ss_pred HHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccC
Confidence 432211111000 000 011235678999999999999999
Q ss_pred CCHHHHHHHHH
Q 024408 193 PNFTQIIQMLL 203 (268)
Q Consensus 193 ps~~~~~~~l~ 203 (268)
||+.++++|.+
T Consensus 307 ~t~~e~l~hp~ 317 (359)
T cd07876 307 ISVDEALRHPY 317 (359)
T ss_pred CCHHHHhcCch
Confidence 99999999843
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=266.41 Aligned_cols=195 Identities=22% Similarity=0.386 Sum_probs=157.3
Q ss_pred CceeEEEeecC---CcEEEEEEcCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC-------CCeecCCC
Q 024408 1 MREQFIGACKE---PVMVIVTELLSGGTLRKYLLNMR--PRCLDVCVAIGFALDIARAMECLHSH-------GIIHRDLK 68 (268)
Q Consensus 1 ~~v~l~g~~~~---~~~~lV~e~~~ggsL~~~i~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~-------gi~H~Dik 68 (268)
++|++++++.+ ..+||||||+++|+|.++|.... ...+++..++.|+.||+.||.|||+. +|+|||||
T Consensus 73 NIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLK 152 (1021)
T PTZ00266 73 NIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLK 152 (1021)
T ss_pred CcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCc
Confidence 58999998732 46899999999999999997632 23499999999999999999999984 49999999
Q ss_pred CCCEEEeCC----------------CCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhH
Q 024408 69 PENLLLTED----------------LKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDS 132 (268)
Q Consensus 69 p~Nill~~~----------------~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dv 132 (268)
|+|||++.+ ...+||+|||++.............||+.|+|||++.+ ....++.++||
T Consensus 153 PeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~g------e~~~~s~KSDV 226 (1021)
T PTZ00266 153 PQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLH------ETKSYDDKSDM 226 (1021)
T ss_pred HHHeEeecCccccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhc------cCCCCCchhHH
Confidence 999999642 12489999999986544444445679999999998853 12457889999
Q ss_pred HHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 133 YSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 133 wslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
|||||++|+|++|..||........................+.++.+||..||..+|.+||++.+++.+
T Consensus 227 WSLG~ILYELLTGk~PF~~~~~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 227 WALGCIIYELCSGKTPFHKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred HHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 999999999999999998766555444443333333345678999999999999999999999999976
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=234.38 Aligned_cols=193 Identities=34% Similarity=0.591 Sum_probs=156.3
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ ...+.++||||++|++|.+++.+... .+++..+..++.+++.||.|||++|++||||+|+||+++.+ +
T Consensus 53 ~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~-~ 130 (251)
T cd05041 53 NIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKN-RLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGEN-N 130 (251)
T ss_pred CeEEEEEEEecCCCeEEEEEcCCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCC-C
Confidence 468899998 55688999999999999999976433 38999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccccccc---ccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChH
Q 024408 80 TIKLADFGLAREESLTEMM---TAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNL 155 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~~~ 155 (268)
.++|+|||++......... ....++..|+|||.+.+ ..++.++|+||||+++|++++ |..||......
T Consensus 131 ~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~ 202 (251)
T cd05041 131 VLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNY--------GRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ 202 (251)
T ss_pred cEEEeeccccccccCCcceeccccCcceeccCChHhhcc--------CCCCcchhHHHHHHHHHHHHhccCCCCccCCHH
Confidence 9999999999754321111 12233567999998754 457889999999999999998 88899776654
Q ss_pred HHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 024408 156 QAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 203 (268)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~ 203 (268)
............+.+..++.++.+++.+||..+|.+||++.++++.|+
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 203 QTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHHHHhcCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 433333333333445678899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=241.08 Aligned_cols=197 Identities=24% Similarity=0.389 Sum_probs=156.7
Q ss_pred CceeEEEeec-------CCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEE
Q 024408 1 MREQFIGACK-------EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 73 (268)
Q Consensus 1 ~~v~l~g~~~-------~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nil 73 (268)
+++++++++. +.+.++||||+++|+|.+++.......+++..+..++.|++.||.|||+.|++|+||+|+||+
T Consensus 74 ~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nil 153 (282)
T cd06636 74 NIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVL 153 (282)
T ss_pred cEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEE
Confidence 5788888873 347899999999999999998765556899999999999999999999999999999999999
Q ss_pred EeCCCCCeEEecCCCccccccc-cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 024408 74 LTEDLKTIKLADFGLAREESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGM 152 (268)
Q Consensus 74 l~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~ 152 (268)
++.+ +.++|+|||++...... .......|+..|+|||.+.... .....++.++|+||||+++|+|++|..||...
T Consensus 154 i~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~---~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~ 229 (282)
T cd06636 154 LTEN-AEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDE---NPDATYDYRSDIWSLGITAIEMAEGAPPLCDM 229 (282)
T ss_pred ECCC-CCEEEeeCcchhhhhccccCCCcccccccccCHhhcCccc---CcCcCCCcccchhHHHHHHHHHHhCCCCcccc
Confidence 9988 68999999998754321 2233456889999999875311 11345678899999999999999999999776
Q ss_pred ChHHHHHHHHhcc-CCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 153 SNLQAAYAAAFKN-VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 153 ~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
............. .......++.++.++|.+||..||.+||++.+++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 230 HPMRALFLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred CHHhhhhhHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 5444333222111 112234688999999999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=240.20 Aligned_cols=194 Identities=25% Similarity=0.400 Sum_probs=153.9
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++.+ .++..++||||+++++|.+++.+.+. +++.++..++.|++.||.|||+.|++||||+|+||+++.+ +
T Consensus 67 ~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~-~ 143 (267)
T cd06646 67 NIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGP--LSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDN-G 143 (267)
T ss_pred CeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCC-C
Confidence 578899988 56688999999999999999976544 8999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccccc-ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESLTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.++|+|||++....... ......++..|+|||.+... ....++.++|+||+|+++|+|++|+.||......+..
T Consensus 144 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-----~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~ 218 (267)
T cd06646 144 DVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVE-----KNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL 218 (267)
T ss_pred CEEECcCccceeecccccccCccccCccccCHhHcccc-----cCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh
Confidence 89999999998543221 22334688899999987431 1244677899999999999999999999765433322
Q ss_pred HHHHhccCCC----CCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 024408 159 YAAAFKNVRP----SAENVPEELSIILTSCWKEDPNARPNFTQIIQML 202 (268)
Q Consensus 159 ~~~~~~~~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l 202 (268)
.........+ ....++..+.+++++||..+|++||+++++++++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 219 FLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred eeeecCCCCCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 2111111111 1235678999999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=252.84 Aligned_cols=197 Identities=31% Similarity=0.555 Sum_probs=175.8
Q ss_pred CceeEEEeecCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCC
Q 024408 1 MREQFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT 80 (268)
Q Consensus 1 ~~v~l~g~~~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~ 80 (268)
++|+|||.|.+...|+|||+++-|.|..+++.++.. ++......+++||..||+|||+..++||||-..|||+... ..
T Consensus 452 hIikLIGv~~e~P~WivmEL~~~GELr~yLq~nk~s-L~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp-~C 529 (974)
T KOG4257|consen 452 HIIKLIGVCVEQPMWIVMELAPLGELREYLQQNKDS-LPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSP-QC 529 (974)
T ss_pred chhheeeeeeccceeEEEecccchhHHHHHHhcccc-chHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCc-ce
Confidence 479999999888899999999999999999987655 9999999999999999999999999999999999999988 58
Q ss_pred eEEecCCCccccccccccccCC--CccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 024408 81 IKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQA 157 (268)
Q Consensus 81 ~kl~Dfg~a~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~ 157 (268)
+||+|||+++......-..... -...|||||.++- ..++.++|||.||+++||++. |..||.+..+.+.
T Consensus 530 VKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINf--------RrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV 601 (974)
T KOG4257|consen 530 VKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINF--------RRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV 601 (974)
T ss_pred eeecccchhhhccccchhhccccccceeecCccccch--------hcccchhhHHHHHHHHHHHHHhcCCccccccccce
Confidence 9999999999655543332223 3568999998864 568889999999999999987 9999999998888
Q ss_pred HHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHh
Q 024408 158 AYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 207 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 207 (268)
......+...|.++.||+.+..++.+||.++|.+||.+.++...|.+.+.
T Consensus 602 I~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 602 IGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred EEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 77778888899999999999999999999999999999999999887766
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=236.98 Aligned_cols=199 Identities=26% Similarity=0.430 Sum_probs=153.0
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRP---RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE 76 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~ 76 (268)
|+++++|.| .....++||||+++|+|.+++..... ...++..+..++.|++.||+|||++|++||||||+||+++.
T Consensus 56 nii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~ 135 (269)
T cd05042 56 NVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTA 135 (269)
T ss_pred CcceEEEEECCCCceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecC
Confidence 689999999 45678999999999999999977542 23567888999999999999999999999999999999998
Q ss_pred CCCCeEEecCCCcccccccc---ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 024408 77 DLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGM 152 (268)
Q Consensus 77 ~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~ 152 (268)
+ +.+||+|||++....... ......++..|+|||++...... .....++.++|+||||+++|+|++ |..||...
T Consensus 136 ~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~ 213 (269)
T cd05042 136 D-LSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQD-LLPKDQTKKSNIWSLGVTMWELFTAADQPYPDL 213 (269)
T ss_pred C-CcEEEeccccccccccchheeccCCCCCcccccCHHHHhhcccc-ccccccchhhHHHHHHHHHHHHHhCCCCCCCcC
Confidence 8 699999999987432221 11223456789999987531110 012456789999999999999998 78899876
Q ss_pred ChHHHHHHHHhccCC----C-CCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 024408 153 SNLQAAYAAAFKNVR----P-SAENVPEELSIILTSCWKEDPNARPNFTQIIQML 202 (268)
Q Consensus 153 ~~~~~~~~~~~~~~~----~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l 202 (268)
...+........... + ....++..+.+++..|+ .||++||+++++++.|
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 214 SDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred CHHHHHHHHhhccCccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 655443333322211 1 13467888999999998 5999999999999876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=235.55 Aligned_cols=193 Identities=36% Similarity=0.679 Sum_probs=159.7
Q ss_pred CceeEEEeec-CCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGACK-EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~~-~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++. .+..++||||++|++|.+++.......+++.++..++.|++.||++||+.|++|+||+|+||+++.+ +
T Consensus 62 ~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~-~ 140 (258)
T smart00219 62 NIVKLLGVCTEEEPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGEN-L 140 (258)
T ss_pred chheEEEEEcCCCeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccC-C
Confidence 4789999994 4688999999999999999987554448999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccccccc--cCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 024408 80 TIKLADFGLAREESLTEMMT--AETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQ 156 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~~~~ 156 (268)
.++++|||++.......... ...++..|+|||.+.. ..++.++|+||||+++++|++ |..||......+
T Consensus 141 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~--------~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~ 212 (258)
T smart00219 141 VVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKD--------GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE 212 (258)
T ss_pred eEEEcccCCceecccccccccccCCCcccccChHHhcc--------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 89999999997544332111 1236789999998743 567889999999999999998 888998766555
Q ss_pred HHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 024408 157 AAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 202 (268)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l 202 (268)
...........+....++.++.+++.+|+..+|++|||+.++++.|
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 213 VLEYLKKGYRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred HHHHHhcCCCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 5544444444555667899999999999999999999999998753
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=237.67 Aligned_cols=198 Identities=27% Similarity=0.505 Sum_probs=160.2
Q ss_pred CceeEEEeecC--CcEEEEEEcCCCCCHHHHHHhcCC------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCE
Q 024408 1 MREQFIGACKE--PVMVIVTELLSGGTLRKYLLNMRP------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENL 72 (268)
Q Consensus 1 ~~v~l~g~~~~--~~~~lV~e~~~ggsL~~~i~~~~~------~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Ni 72 (268)
++++++|++.+ ...++++||+++++|.+++..... ..+++.+++.++.|++.||+|||++|++|+||||+||
T Consensus 69 ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~ni 148 (280)
T cd05043 69 NILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNC 148 (280)
T ss_pred CCCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhE
Confidence 57899999843 578999999999999999976432 3489999999999999999999999999999999999
Q ss_pred EEeCCCCCeEEecCCCccccccccc---cccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCC
Q 024408 73 LLTEDLKTIKLADFGLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLP 148 (268)
Q Consensus 73 ll~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p 148 (268)
+++.+ +.++++|||+++....... .....++..|+|||.+.+ ..++.++||||||+++|++++ |+.|
T Consensus 149 l~~~~-~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~--------~~~~~~~Di~slG~~l~el~~~g~~p 219 (280)
T cd05043 149 VIDEE-LQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVN--------KEYSSASDVWSFGVLLWELMTLGQTP 219 (280)
T ss_pred EEcCC-CcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhc--------CCCCchhhHHHhHHHHHHHhcCCCCC
Confidence 99988 6999999999975432211 122345678999998853 457889999999999999998 9999
Q ss_pred CCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHh
Q 024408 149 FEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 207 (268)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 207 (268)
|......+................+++++.+++.+||..+|++||++.++++.|.+...
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 220 YVEIDPFEMAAYLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred cCcCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 98765544333222222223345678999999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=240.47 Aligned_cols=191 Identities=23% Similarity=0.337 Sum_probs=153.5
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++.+++.+ .++..++||||++|++|.+++...+. +++.++..++.|++.||.|||++|++|+||||+||+++.+ +
T Consensus 58 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~--l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~-~ 134 (279)
T cd05633 58 FIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGV--FSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEH-G 134 (279)
T ss_pred cEeEEEEEEecCCeEEEEEecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCC-C
Confidence 357777777 55688999999999999999986554 9999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH--HH
Q 024408 80 TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL--QA 157 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~--~~ 157 (268)
.++++|||++....... .....|+..|+|||.+.. +..++.++|+||+|+++|+|++|..||...... ..
T Consensus 135 ~~~l~dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 206 (279)
T cd05633 135 HVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQK-------GTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE 206 (279)
T ss_pred CEEEccCCcceeccccC-ccCcCCCcCccCHHHhcC-------CCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH
Confidence 99999999987543322 233468999999998742 244678999999999999999999999753321 11
Q ss_pred HHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCC-----CHHHHHHHH
Q 024408 158 AYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARP-----NFTQIIQML 202 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~~~~~l 202 (268)
............+..++.++.++|.+||..||.+|| +++++++|.
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~ 256 (279)
T cd05633 207 IDRMTLTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHV 256 (279)
T ss_pred HHHHhhcCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCc
Confidence 111122222233566889999999999999999999 699999984
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=243.60 Aligned_cols=197 Identities=22% Similarity=0.344 Sum_probs=153.3
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ .++++++||||++||+|.+++.+... .+++.++..++.|++.||+|||++|++||||||+|||++.+ +
T Consensus 62 ~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~-~ 139 (331)
T cd05597 62 WITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFED-RLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKN-G 139 (331)
T ss_pred CCCceEEEEecCCeEEEEEecCCCCcHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCC-C
Confidence 478888888 55689999999999999999976433 39999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccccc--cccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 024408 80 TIKLADFGLAREESLTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA 157 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~ 157 (268)
.++|+|||++........ .....||+.|+|||++.... .....++.++||||+|+++|+|++|+.||.+....+.
T Consensus 140 ~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~ 216 (331)
T cd05597 140 HIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAME---DGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET 216 (331)
T ss_pred CEEEEECCceeecCCCCCccccceeccccccCHHHHhhcc---ccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHH
Confidence 999999999875433221 12246899999999985311 0124567889999999999999999999987655444
Q ss_pred HHHHHhcc----CCCCCCCCcHHHHHHHHhccccCCC--CCCCHHHHHHHH
Q 024408 158 AYAAAFKN----VRPSAENVPEELSIILTSCWKEDPN--ARPNFTQIIQML 202 (268)
Q Consensus 158 ~~~~~~~~----~~~~~~~~~~~l~~li~~~l~~~p~--~Rps~~~~~~~l 202 (268)
........ ..+....++..++++|++||..++. .|+++.++++|-
T Consensus 217 ~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp 267 (331)
T cd05597 217 YGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHP 267 (331)
T ss_pred HHHHHcCCCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCC
Confidence 33332211 1122345789999999998865443 378999999984
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=239.59 Aligned_cols=194 Identities=29% Similarity=0.542 Sum_probs=157.1
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCC--------------------CCCCHHHHHHHHHHHHHHHHHHHH
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRP--------------------RCLDVCVAIGFALDIARAMECLHS 59 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~--------------------~~~~~~~~~~~~~~l~~~l~~lH~ 59 (268)
++++++|+| .++..++||||+++++|.+++..... ..+++.+++.++.|++.||.|||+
T Consensus 69 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~ 148 (288)
T cd05050 69 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE 148 (288)
T ss_pred chheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh
Confidence 478999998 45678999999999999999975321 237888999999999999999999
Q ss_pred CCCeecCCCCCCEEEeCCCCCeEEecCCCcccccccc---ccccCCCccceeccccccccccccCCCCCCCchhhHHHHH
Q 024408 60 HGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFA 136 (268)
Q Consensus 60 ~gi~H~Dikp~Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG 136 (268)
+|++||||||+||+++.+ +.++|+|||++....... .......+..|+|||.+.+ ..++.++||||||
T Consensus 149 ~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG 219 (288)
T cd05050 149 RKFVHRDLATRNCLVGEN-MVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFY--------NRYTTESDVWAYG 219 (288)
T ss_pred CCeecccccHhheEecCC-CceEECccccceecccCccccccCCCccChhhcCHHHHhc--------CCCCchhHHHHHH
Confidence 999999999999999988 699999999987433221 1122234567999998753 5678899999999
Q ss_pred HHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 024408 137 IVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 203 (268)
Q Consensus 137 ~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~ 203 (268)
+++|+|++ |..||.+....+...........+.+..++.++.+++.+||+.+|.+||++.++++.|+
T Consensus 220 ~il~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 220 VVLWEIFSYGMQPYYGMAHEEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred HHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 99999997 88899876655544443333334446678899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=238.10 Aligned_cols=188 Identities=23% Similarity=0.322 Sum_probs=154.2
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++.+ .++..++||||++|++|.+++.+.. .+++.++..++.|++.||.|||+.|++||||||+||+++.+.+
T Consensus 70 ~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~ 147 (267)
T PHA03390 70 NFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKD 147 (267)
T ss_pred CEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCC
Confidence 578999998 5668999999999999999998755 4999999999999999999999999999999999999998844
Q ss_pred CeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH-
Q 024408 80 TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA- 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~- 158 (268)
.++++|||++...... ....++..|+|||++.+ ..++.++|+||+|+++|+|++|..||.........
T Consensus 148 ~~~l~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~--------~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~ 216 (267)
T PHA03390 148 RIYLCDYGLCKIIGTP---SCYDGTLDYFSPEKIKG--------HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDL 216 (267)
T ss_pred eEEEecCccceecCCC---ccCCCCCcccChhhhcC--------CCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhH
Confidence 8999999998754322 23467899999999854 45678999999999999999999999754432211
Q ss_pred --HHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCC-HHHHHHH
Q 024408 159 --YAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPN-FTQIIQM 201 (268)
Q Consensus 159 --~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-~~~~~~~ 201 (268)
.........+....+++.+.++|.+||+.+|.+||+ ++++++|
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 217 ESLLKRQQKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred HHHHHhhcccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 111112222345578999999999999999999995 6999876
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=253.95 Aligned_cols=189 Identities=24% Similarity=0.352 Sum_probs=156.2
Q ss_pred CceeEEEeecC-CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGACKE-PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~~~-~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|++++.+.+.+ .+.|+|||++.|+-|.+.|...+. +. .++..|+.+|+.|+.|||++|++|||+||+|||++++.+
T Consensus 377 niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~~~--~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g 453 (612)
T KOG0603|consen 377 NIVKSHDVYEDGKEIYLVMELLDGGELLRRIRSKPE--FC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAG 453 (612)
T ss_pred cceeecceecCCceeeeeehhccccHHHHHHHhcch--hH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCC
Confidence 57889999954 589999999999999998876443 33 788889999999999999999999999999999953337
Q ss_pred CeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 024408 80 TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY 159 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~ 159 (268)
+++|+|||.++..... ..+.+-|..|.|||++.. ..|+.++|+||||++||+|++|+.||..........
T Consensus 454 ~lrltyFG~a~~~~~~--~~tp~~t~~y~APEvl~~--------~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~ 523 (612)
T KOG0603|consen 454 HLRLTYFGFWSELERS--CDTPALTLQYVAPEVLAI--------QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIH 523 (612)
T ss_pred cEEEEEechhhhCchh--hcccchhhcccChhhhcc--------CCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHH
Confidence 8999999999875554 445567899999999863 789999999999999999999999998755442222
Q ss_pred HHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 024408 160 AAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 204 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~ 204 (268)
... . ..+....++.+.+++|++||+.||.+|+++.++..|-+.
T Consensus 524 ~~i-~-~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 524 TRI-Q-MPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred Hhh-c-CCccccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 221 1 112237889999999999999999999999999998554
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=237.13 Aligned_cols=190 Identities=28% Similarity=0.501 Sum_probs=156.7
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ ..+..++||||++|++|.+++.+... +++..+..++.|++.||+|||+.|++|+||+|+||+++.+ +
T Consensus 63 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~-~ 139 (265)
T cd06631 63 NIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGP--LPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPN-G 139 (265)
T ss_pred CEeeEeeEeecCCeEEEEEecCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCC-C
Confidence 578999999 55688999999999999999977554 8999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccc-------ccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 024408 80 TIKLADFGLAREESL-------TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGM 152 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~ 152 (268)
.++|+|||++..... ........++..|+|||.+.+ ..++.++|+||||+++|++++|..||...
T Consensus 140 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--------~~~~~~~Dv~slG~~~~~l~~g~~p~~~~ 211 (265)
T cd06631 140 IIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINE--------SGYGRKSDIWSIGCTVFEMATGKPPLASM 211 (265)
T ss_pred eEEeccchhhHhhhhccccccccccccccCCCccccChhhhcC--------CCCcchhhHHHHHHHHHHHHhCCCccccC
Confidence 999999999874321 112233468899999998854 45678999999999999999999999876
Q ss_pred ChHHHHHHHHhc--cCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 153 SNLQAAYAAAFK--NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 153 ~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
+........... .....+..++.++.++|++||..+|.+||++.+++++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 212 DRLAAMFYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred ChHHHHHHhhhccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 654443332222 2223456788999999999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=248.01 Aligned_cols=197 Identities=30% Similarity=0.548 Sum_probs=159.0
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCC--------------------------------------------
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRP-------------------------------------------- 35 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~-------------------------------------------- 35 (268)
|+|+++|+| .++..++||||++||+|.+++.+.+.
T Consensus 102 niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (401)
T cd05107 102 NIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDM 181 (401)
T ss_pred CeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCcccccc
Confidence 689999999 55688999999999999999975321
Q ss_pred ----------------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCe
Q 024408 36 ----------------------------------------------------RCLDVCVAIGFALDIARAMECLHSHGII 63 (268)
Q Consensus 36 ----------------------------------------------------~~~~~~~~~~~~~~l~~~l~~lH~~gi~ 63 (268)
..+++..++.++.|++.||+|||++|++
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iv 261 (401)
T cd05107 182 SKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCV 261 (401)
T ss_pred CCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcC
Confidence 2367788899999999999999999999
Q ss_pred ecCCCCCCEEEeCCCCCeEEecCCCcccccccc---ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHH
Q 024408 64 HRDLKPENLLLTEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLW 140 (268)
Q Consensus 64 H~Dikp~Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~ 140 (268)
||||||+||+++.+ +.++|+|||+++...... ......++..|+|||.+.. ..++.++|+||||+++|
T Consensus 262 Hrdlkp~NiLl~~~-~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwslGvil~ 332 (401)
T cd05107 262 HRDLAARNVLICEG-KLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFN--------NLYTTLSDVWSFGILLW 332 (401)
T ss_pred cccCCcceEEEeCC-CEEEEEecCcceecccccccccCCCcCCCCceeChHHhcC--------CCCCcHhHHHHHHHHHH
Confidence 99999999999987 689999999997532211 1123356788999998854 45788999999999999
Q ss_pred HHHh-CCCCCCCCChHHHHHHHHhcc-CCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhH
Q 024408 141 ELLH-NKLPFEGMSNLQAAYAAAFKN-VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 206 (268)
Q Consensus 141 ~ll~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 206 (268)
||++ |..||......+......... ..+.+..++.++.+++.+||..+|.+||+++++++.|+..+
T Consensus 333 e~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 333 EIFTLGGTPYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HHHHcCCCCCCCCCchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 9998 889997755444433332222 23345678899999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=236.81 Aligned_cols=194 Identities=25% Similarity=0.447 Sum_probs=159.7
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEEeC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLTE 76 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~-~gi~H~Dikp~Nill~~ 76 (268)
+++++++++ .++..++||||++|++|.+++... ....+++..++.++.|++.||.|||+ .|++|+||+|+||+++.
T Consensus 70 ~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~ 149 (269)
T cd08528 70 NIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGE 149 (269)
T ss_pred CeeeEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECC
Confidence 578999998 556899999999999999988542 23349999999999999999999996 78999999999999998
Q ss_pred CCCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH
Q 024408 77 DLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 156 (268)
Q Consensus 77 ~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~ 156 (268)
+ +.++|+|||.+.............++..|++||.+.+ ..++.++|+||||+++|+|++|+.||.......
T Consensus 150 ~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~--------~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~ 220 (269)
T cd08528 150 D-DKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKN--------EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS 220 (269)
T ss_pred C-CcEEEecccceeecccccccccccCcccCcChhhhcC--------CCCchHHHHHHHHHHHHHHHhCCCcccccCHHH
Confidence 8 6899999999986544433445578899999998854 457889999999999999999999998765544
Q ss_pred HHHHHHhccCCCC-CCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 024408 157 AAYAAAFKNVRPS-AENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 203 (268)
Q Consensus 157 ~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~ 203 (268)
...........+. ...++..+.+++.+||..||++||++.++..++.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 221 LATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred HHHHHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 4443333333333 2367899999999999999999999999998874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=241.76 Aligned_cols=190 Identities=28% Similarity=0.471 Sum_probs=155.1
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++.+ .+++.++||||++|++|.+++.+. .+++.++..++.|++.||+|||++|++|+||||+||+++.+ +
T Consensus 78 ~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~-~ 153 (296)
T cd06654 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD-G 153 (296)
T ss_pred CEeeEEEEEEeCCEEEEeecccCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCC-C
Confidence 578999988 556899999999999999998642 38899999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccccc-ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESLTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.++|+|||++....... ......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.........
T Consensus 154 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~ 225 (296)
T cd06654 154 SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR--------KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL 225 (296)
T ss_pred CEEECccccchhccccccccCcccCCccccCHHHHcC--------CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhH
Confidence 99999999987533222 2233468899999998753 45678999999999999999999999876554333
Q ss_pred HHHHhccC--CCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 024408 159 YAAAFKNV--RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 202 (268)
Q Consensus 159 ~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l 202 (268)
........ .+.+..++..+.+++.+||..+|++||++.+++++-
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~ 271 (296)
T cd06654 226 YLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQ 271 (296)
T ss_pred HHHhcCCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhCh
Confidence 32222211 122456788999999999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=237.97 Aligned_cols=193 Identities=25% Similarity=0.412 Sum_probs=154.4
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++.+ .++..++||||++|++|.+++...+. +++.+++.++.|++.||.|||++|++|+||||+||+++.+ +
T Consensus 67 ~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~-~ 143 (267)
T cd06645 67 NIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGP--LSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDN-G 143 (267)
T ss_pred CeeeEEEEEEeCCEEEEEEeccCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-C
Confidence 578899988 56789999999999999999976554 9999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccc-cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.++|+|||++...... .......|+..|+|||++... ....++.++|+||||+++|+|++|..||.........
T Consensus 144 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~ 218 (267)
T cd06645 144 HVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVE-----RKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL 218 (267)
T ss_pred CEEECcceeeeEccCcccccccccCcccccChhhhccc-----cCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH
Confidence 8999999998743322 222345789999999987421 1245678999999999999999999999765543333
Q ss_pred HHHHhccCCCC----CCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 159 YAAAFKNVRPS----AENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 159 ~~~~~~~~~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
.........+. ...++..+.+++.+||..+|++||++.+++++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 219 FLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred HhhhccCCCCCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 32222222111 22467889999999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=239.83 Aligned_cols=194 Identities=28% Similarity=0.548 Sum_probs=155.7
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCC---------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRP---------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPE 70 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~---------~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~ 70 (268)
+++++++++ .++..++||||+++++|.+++.+... ..+++..++.++.|++.||.|||++|++|+||||+
T Consensus 80 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~ 159 (296)
T cd05051 80 NIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATR 159 (296)
T ss_pred CEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchh
Confidence 578999999 45789999999999999999977541 24899999999999999999999999999999999
Q ss_pred CEEEeCCCCCeEEecCCCcccccccc---ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh--C
Q 024408 71 NLLLTEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH--N 145 (268)
Q Consensus 71 Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~--g 145 (268)
||+++.+ +.++|+|||+++...... ......++..|+|||.+.+ ..++.++||||||+++|+|++ +
T Consensus 160 Nili~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~~l~el~~~~~ 230 (296)
T cd05051 160 NCLVGKN-YTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL--------GKFTTKSDVWAFGVTLWEILTLCR 230 (296)
T ss_pred ceeecCC-CceEEccccceeecccCcceeecCcCCCCceecCHHHhhc--------CCCCccchhhhhHHHHHHHHhcCC
Confidence 9999988 699999999987533221 1223346778999998753 467889999999999999998 6
Q ss_pred CCCCCCCChHHHHHHHHhc-------cCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 024408 146 KLPFEGMSNLQAAYAAAFK-------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 203 (268)
Q Consensus 146 ~~p~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~ 203 (268)
..||......+........ ...+.+..++.++.+++.+||+.||.+||++.++++.|+
T Consensus 231 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 231 EQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred CCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 7888765544433322211 112234456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=244.78 Aligned_cols=199 Identities=29% Similarity=0.538 Sum_probs=157.0
Q ss_pred CceeEEEeec--CCcEEEEEEcCCCCCHHHHHHhcCC-------------------------------------------
Q 024408 1 MREQFIGACK--EPVMVIVTELLSGGTLRKYLLNMRP------------------------------------------- 35 (268)
Q Consensus 1 ~~v~l~g~~~--~~~~~lV~e~~~ggsL~~~i~~~~~------------------------------------------- 35 (268)
|+|+++|+|. +...++||||++||+|.+++.....
T Consensus 72 niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (343)
T cd05103 72 NVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSG 151 (343)
T ss_pred cHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhcccccccccccccc
Confidence 5788999883 3468999999999999999875321
Q ss_pred ----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCCeEEecCCCccccc
Q 024408 36 ----------------------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 93 (268)
Q Consensus 36 ----------------------~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~~kl~Dfg~a~~~~ 93 (268)
..+++.++..++.|++.||+|||++|++||||||.||+++.+ +.++|+|||++....
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~-~~~kl~dfg~~~~~~ 230 (343)
T cd05103 152 FVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEN-NVVKICDFGLARDIY 230 (343)
T ss_pred ccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCC-CcEEEEecccccccc
Confidence 236788899999999999999999999999999999999988 699999999987532
Q ss_pred ccc---ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH-hccCCC
Q 024408 94 LTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAA-FKNVRP 168 (268)
Q Consensus 94 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~-~~~~~~ 168 (268)
... ......++..|+|||.+.+ ..++.++|+||||+++|++++ |..||............. .....+
T Consensus 231 ~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 302 (343)
T cd05103 231 KDPDYVRKGDARLPLKWMAPETIFD--------RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR 302 (343)
T ss_pred cCcchhhcCCCCCCcceECcHHhcC--------CCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCC
Confidence 221 1122345678999998754 567889999999999999997 999997654333322222 222223
Q ss_pred CCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 024408 169 SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 208 (268)
Q Consensus 169 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 208 (268)
.+...++++.+++.+||..+|.+||++.+++++|...++.
T Consensus 303 ~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 303 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 3455778999999999999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=243.89 Aligned_cols=197 Identities=20% Similarity=0.294 Sum_probs=153.5
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ .+++.|+||||++||+|.+++.+... .+++..+..++.|++.||+|||++||+||||||+||+++.+ +
T Consensus 62 ~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~~-~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~-~ 139 (331)
T cd05624 62 WITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFED-RLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMN-G 139 (331)
T ss_pred CEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCC-C
Confidence 467888888 55689999999999999999987433 38999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccccc--cccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 024408 80 TIKLADFGLAREESLTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA 157 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~ 157 (268)
.+||+|||++........ .....|++.|+|||++.+... ..+.++.++|+||+|+++|+|++|+.||......+.
T Consensus 140 ~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~ 216 (331)
T cd05624 140 HIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMED---GMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET 216 (331)
T ss_pred CEEEEeccceeeccCCCceeeccccCCcccCCHHHHhcccc---CCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHH
Confidence 899999999975433222 223468999999998854210 113567899999999999999999999987665444
Q ss_pred HHHHHhccC----CCCCCCCcHHHHHHHHhccccCCCC--CCCHHHHHHHH
Q 024408 158 AYAAAFKNV----RPSAENVPEELSIILTSCWKEDPNA--RPNFTQIIQML 202 (268)
Q Consensus 158 ~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~~p~~--Rps~~~~~~~l 202 (268)
......... ......++.++++++.+||..++.+ |++++++++|.
T Consensus 217 ~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~ 267 (331)
T cd05624 217 YGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHA 267 (331)
T ss_pred HHHHHcCCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCC
Confidence 333322211 1123457899999999999876554 46889998873
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=235.06 Aligned_cols=191 Identities=26% Similarity=0.479 Sum_probs=158.3
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ .++..++||||++|++|.+++.+... +++..+..++.|++.||.|||+.|++|+||+|+||+++.+ +
T Consensus 63 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~-~ 139 (258)
T cd06632 63 NIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGS--FPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTN-G 139 (258)
T ss_pred CchheeeeEecCCeEEEEEEecCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-C
Confidence 578899998 55688999999999999999987554 8999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 024408 80 TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY 159 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~ 159 (268)
.++|+|||.+.............++..|++||.+.. ...++.++|+||||+++|++++|+.||......+...
T Consensus 140 ~~kl~d~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-------~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~ 212 (258)
T cd06632 140 VVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQ-------QGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVF 212 (258)
T ss_pred CEEEccCccceeccccccccccCCCcceeCHHHhcC-------CCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHH
Confidence 999999999875444333345678899999998753 1237889999999999999999999997766444444
Q ss_pred HHHh-ccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 160 AAAF-KNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 160 ~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
.... ......+..++..+.+++.+||..+|.+||++.+++.+
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 213 KIGRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred HHHhcccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 3333 22223355678999999999999999999999999876
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=238.62 Aligned_cols=196 Identities=28% Similarity=0.409 Sum_probs=155.4
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++.+ .++..++||||++|++|..++.+... .+++..+..++.|++.||.|||++|++||||||+||+++.+ +
T Consensus 70 ~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~-~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~-~ 147 (292)
T cd06644 70 YIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDR-GLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLD-G 147 (292)
T ss_pred cEeeeEEEEEeCCeEEEEEecCCCCcHHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCC-C
Confidence 578999988 56689999999999999988765433 38999999999999999999999999999999999999887 6
Q ss_pred CeEEecCCCccccccc-cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.++|+|||++...... .......++..|+|||.+.+... ....++.++|+||||+++|+|++|..||.........
T Consensus 148 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~ 224 (292)
T cd06644 148 DIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETM---KDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL 224 (292)
T ss_pred CEEEccCccceeccccccccceecCCccccCceeeccccc---cCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHH
Confidence 9999999998743222 22234467889999998753111 1244678899999999999999999999876544333
Q ss_pred HHHHhccC--CCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 159 YAAAFKNV--RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 159 ~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
........ ...+..++.++.++|.+||..+|++||++.+++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 225 LKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred HHHhcCCCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 33222111 12245678899999999999999999999999987
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=235.57 Aligned_cols=191 Identities=28% Similarity=0.434 Sum_probs=156.0
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
++++++|.+ .++..++|+||++|++|.+++..... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.+ +
T Consensus 59 ~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~-~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~-~ 136 (256)
T cd06612 59 YIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNK-TLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEE-G 136 (256)
T ss_pred cEeeeeeeeecCCcEEEEEecCCCCcHHHHHHhCcc-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCC-C
Confidence 578999998 55689999999999999999976443 48999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccccc-ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESLTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.++|+|||++....... ......++..|+|||.+.+ ..++.++|+||+|+++|+|++|+.||.........
T Consensus 137 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~ 208 (256)
T cd06612 137 QAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQE--------IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI 208 (256)
T ss_pred cEEEcccccchhcccCccccccccCCccccCHHHHhc--------CCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh
Confidence 89999999988644332 2233457889999998864 45778999999999999999999999876554433
Q ss_pred HHHHhccCC--CCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 159 YAAAFKNVR--PSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 159 ~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
......... .....++..+.++|.+||+.+|++||++.+++++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 209 FMIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred hhhccCCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 322221111 1234567899999999999999999999999876
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=238.07 Aligned_cols=189 Identities=27% Similarity=0.448 Sum_probs=156.6
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++.+ .+...++|+||++|++|.+++... .+++..+..++.|++.||.|||++|++|+||+|+||+++++ +
T Consensus 60 ~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~-~ 135 (274)
T cd06609 60 YITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEE-G 135 (274)
T ss_pred CeeeeeEEEEECCeEEEEEEeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCC-C
Confidence 578889988 556889999999999999999764 49999999999999999999999999999999999999998 6
Q ss_pred CeEEecCCCccccccc-cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.++++|||+++..... .......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.........
T Consensus 136 ~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~ 207 (274)
T cd06609 136 DVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQ--------SGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVL 207 (274)
T ss_pred CEEEcccccceeecccccccccccCCccccChhhhcc--------CCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHH
Confidence 9999999999765433 22334567889999999864 45788999999999999999999999876544433
Q ss_pred HHHHhccCCCCCCC-CcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 159 YAAAFKNVRPSAEN-VPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 159 ~~~~~~~~~~~~~~-~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
.............. ++.++.+++.+||..+|++||++++++++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 208 FLIPKNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred HHhhhcCCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 33222222222333 78999999999999999999999999987
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=234.85 Aligned_cols=190 Identities=22% Similarity=0.353 Sum_probs=150.5
Q ss_pred CceeEEEeecCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC-
Q 024408 1 MREQFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK- 79 (268)
Q Consensus 1 ~~v~l~g~~~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~- 79 (268)
++++++|++..+..++||||++||+|.+++..... .+++..+..++.|++.||.|||++|++||||||+||+++.+..
T Consensus 62 ~i~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~ 140 (259)
T cd05037 62 HLVKLYGVCVRDENIMVEEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLN 140 (259)
T ss_pred chhheeeEEecCCcEEEEEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccc
Confidence 57899999855778999999999999999987553 4899999999999999999999999999999999999987621
Q ss_pred -----CeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 024408 80 -----TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMS 153 (268)
Q Consensus 80 -----~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~ 153 (268)
.++++|||++..... .....++..|+|||.+.+ ....++.++|+||||+++|++++ |..||....
T Consensus 141 ~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~~y~aPE~~~~------~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~ 211 (259)
T cd05037 141 EGYVPFIKLSDPGIPITVLS---REERVERIPWIAPECIRN------GQASLTIAADKWSFGTTLLEICSNGEEPLSTLS 211 (259)
T ss_pred cCCceeEEeCCCCccccccc---ccccccCCCccChhhhcC------CCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC
Confidence 699999999986433 223456778999999864 11367889999999999999999 577887654
Q ss_pred hHHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 024408 154 NLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 202 (268)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l 202 (268)
......... .....+......+.+++.+||..+|.+||++.++++.|
T Consensus 212 ~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 212 SSEKERFYQ--DQHRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred chhHHHHHh--cCCCCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 332222111 11112222337899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=235.01 Aligned_cols=192 Identities=27% Similarity=0.417 Sum_probs=161.0
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ ..++.++||||++|++|.+++.......+++.++..++.|++.||.|||++|++|+||+|+||+++.+ +
T Consensus 60 ~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~-~ 138 (256)
T cd08218 60 NIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKD-G 138 (256)
T ss_pred CeeeeEeeecCCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCC-C
Confidence 578899998 45688999999999999999987554458999999999999999999999999999999999999987 6
Q ss_pred CeEEecCCCcccccccc-ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESLTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.++++|||++....... ......|+..|+|||.+.+ ...+.++|+||||++++++++|+.||......+..
T Consensus 139 ~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--------~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~ 210 (256)
T cd08218 139 TIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICEN--------RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLV 210 (256)
T ss_pred CEEEeeccceeecCcchhhhhhccCCccccCHHHhCC--------CCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHH
Confidence 89999999997543322 1223467889999998854 45677899999999999999999999876655555
Q ss_pred HHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 159 YAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
.........+.+..++.++.++|.+||+.+|.+||++.+++++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 211 LKIIRGSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred HHHhcCCCCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 5544444445567788999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=244.72 Aligned_cols=190 Identities=25% Similarity=0.395 Sum_probs=161.7
Q ss_pred eeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCCe
Q 024408 3 EQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTI 81 (268)
Q Consensus 3 v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~~ 81 (268)
|.|-=.+ .-+.+||||..|.||+|.=+|.+.++..|++..++-++.+|+.||++||+.+||+||+||+|||+|+. |++
T Consensus 248 VslaYAfeTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~-Ghv 326 (591)
T KOG0986|consen 248 VSLAYAFETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDH-GHV 326 (591)
T ss_pred EEEeeeecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccC-CCe
Confidence 4443334 34589999999999999999999887789999999999999999999999999999999999999998 799
Q ss_pred EEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH---HH
Q 024408 82 KLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ---AA 158 (268)
Q Consensus 82 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~---~~ 158 (268)
+|+|.|+|............+||.+|||||++.+ ..|+.+.|.|||||++|||+.|+.||....... ..
T Consensus 327 RISDLGLAvei~~g~~~~~rvGT~GYMAPEvl~n--------e~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEv 398 (591)
T KOG0986|consen 327 RISDLGLAVEIPEGKPIRGRVGTVGYMAPEVLQN--------EVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEV 398 (591)
T ss_pred EeeccceEEecCCCCccccccCcccccCHHHHcC--------CcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHH
Confidence 9999999998888777777799999999999975 569999999999999999999999997644332 22
Q ss_pred HHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 024408 159 YAAAFKNVRPSAENVPEELSIILTSCWKEDPNARP-----NFTQIIQM 201 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~~~~~ 201 (268)
.+.........+..++++.+.|.+.+|..||.+|. .++++.+|
T Consensus 399 drr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~H 446 (591)
T KOG0986|consen 399 DRRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEH 446 (591)
T ss_pred HHHHhcchhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhC
Confidence 23333444445688999999999999999999995 45677776
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=252.67 Aligned_cols=198 Identities=27% Similarity=0.425 Sum_probs=167.6
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
++|+|++.+ .++.++++.|||.||-+...+-..+. .+++.++..+++|++.||.|||+++|+|||||..|||++.+ |
T Consensus 90 ~ivkLl~ayy~enkLwiliEFC~GGAVDaimlEL~r-~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~Tld-G 167 (1187)
T KOG0579|consen 90 VIVKLLSAYYFENKLWILIEFCGGGAVDAIMLELGR-VLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLD-G 167 (1187)
T ss_pred HHHHHHHHHhccCceEEEEeecCCchHhHHHHHhcc-ccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEec-C
Confidence 356777776 77889999999999999887776554 49999999999999999999999999999999999999999 7
Q ss_pred CeEEecCCCccccc-cccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREES-LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.++|+|||.+-... .-....+++||+.|||||+..+... ....|+.++||||||++|.||..+.+|.....+..+.
T Consensus 168 dirLADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET~---KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVl 244 (1187)
T KOG0579|consen 168 DIRLADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCETF---KDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL 244 (1187)
T ss_pred cEeeecccccccchhHHhhhccccCCcccccchheeeccc---cCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHH
Confidence 99999999875422 2223457799999999999876443 2367899999999999999999999999988888777
Q ss_pred HHHHhccCCC--CCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 024408 159 YAAAFKNVRP--SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 203 (268)
Q Consensus 159 ~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~ 203 (268)
..+....... .+..++..+.+++.+||..||..||+++++++|-+
T Consensus 245 lKiaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpf 291 (1187)
T KOG0579|consen 245 LKIAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPF 291 (1187)
T ss_pred HHHhhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcc
Confidence 7665444332 36789999999999999999999999999998743
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=231.66 Aligned_cols=192 Identities=26% Similarity=0.440 Sum_probs=157.7
Q ss_pred ceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEEeCCCC
Q 024408 2 REQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 2 ~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~gi~H~Dikp~Nill~~~~~ 79 (268)
+|+.+|++ .+.-.++.||.+ +..+..++.+. ..++++.-+-++...++.||.||-+ +||+|||+||+|||+|+. |
T Consensus 153 IV~c~GyFi~n~dV~IcMelM-s~C~ekLlkri-k~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~-G 229 (391)
T KOG0983|consen 153 IVQCFGYFITNTDVFICMELM-STCAEKLLKRI-KGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDER-G 229 (391)
T ss_pred eeeeeeEEeeCchHHHHHHHH-HHHHHHHHHHh-cCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccC-C
Confidence 68899999 555678999999 35555555554 3459999999999999999999987 489999999999999999 7
Q ss_pred CeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 024408 80 TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY 159 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~ 159 (268)
++|+||||++-...+........|-+.|||||.+.. .....|..++||||||+.++||.||+.||.+-+..-...
T Consensus 230 niKlCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp-----~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~l 304 (391)
T KOG0983|consen 230 NIKLCDFGISGRLVDSKAHTRSAGCAAYMAPERIDP-----PDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVL 304 (391)
T ss_pred CEEeecccccceeecccccccccCCccccCccccCC-----CCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHH
Confidence 999999999987666666666788999999998863 224678899999999999999999999998855443334
Q ss_pred HHHhccCCCC---CCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 160 AAAFKNVRPS---AENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 160 ~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
.+......|. ...+++.+++++..||..|+.+||.+.++++|
T Consensus 305 tkvln~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 305 TKVLNEEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred HHHHhcCCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 3343333343 23489999999999999999999999999997
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=237.62 Aligned_cols=195 Identities=24% Similarity=0.451 Sum_probs=152.3
Q ss_pred CceeEEEeecC---CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCC
Q 024408 1 MREQFIGACKE---PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED 77 (268)
Q Consensus 1 ~~v~l~g~~~~---~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~ 77 (268)
+++++.|++.. ...++||||++|++|.+++.+... .+++.++..++.|++.||+|||++|++||||||+||+++.+
T Consensus 67 ~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~-~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~ 145 (284)
T cd05079 67 NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKN-KINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESE 145 (284)
T ss_pred CeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCC
Confidence 57888998843 468999999999999999976433 48999999999999999999999999999999999999988
Q ss_pred CCCeEEecCCCccccccccc----cccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 024408 78 LKTIKLADFGLAREESLTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS 153 (268)
Q Consensus 78 ~~~~kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~ 153 (268)
+.++|+|||+++....... .....++..|+|||++.+ ..++.++|+||||+++|++++++.|.....
T Consensus 146 -~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~--------~~~~~~~Di~slG~il~ellt~~~~~~~~~ 216 (284)
T cd05079 146 -HQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQ--------SKFYIASDVWSFGVTLYELLTYCDSESSPM 216 (284)
T ss_pred -CCEEECCCccccccccCccceeecCCCCCCccccCHHHhcc--------CCCCccccchhhhhhhhhhhcCCCCCcccc
Confidence 6899999999975433221 123456778999998753 457789999999999999999766542210
Q ss_pred --------------hHH-HHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHh
Q 024408 154 --------------NLQ-AAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 205 (268)
Q Consensus 154 --------------~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~ 205 (268)
... ...........+.+..++..+.+++.+||+.+|++||++.++++.++..
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 217 TLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred chhhhhcccccccccHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 000 0111111222334567889999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=237.90 Aligned_cols=190 Identities=28% Similarity=0.477 Sum_probs=156.5
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
++++++|.+ .++..++||||++|++|.+++.+. .+++.++..++.+++.||++||++|++|+||||+||+++.+ +
T Consensus 77 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~-~ 152 (296)
T cd06655 77 NIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMD-G 152 (296)
T ss_pred ceeeeeeeEecCceEEEEEEecCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-C
Confidence 578999998 556899999999999999988653 38999999999999999999999999999999999999987 6
Q ss_pred CeEEecCCCcccccccc-ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESLTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.++|+|||++....... ......++..|+|||.+.+ ..++.++|+||||+++|++++|+.||.........
T Consensus 153 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~ 224 (296)
T cd06655 153 SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR--------KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL 224 (296)
T ss_pred CEEEccCccchhcccccccCCCcCCCccccCcchhcC--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 99999999987533322 2233468889999998753 45678999999999999999999999876655443
Q ss_pred HHHHhccC--CCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 024408 159 YAAAFKNV--RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 202 (268)
Q Consensus 159 ~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l 202 (268)
........ ...+..+++.+.++|.+||..+|.+||++.+++.+-
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~ 270 (296)
T cd06655 225 YLIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHP 270 (296)
T ss_pred HHHHhcCCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhCh
Confidence 33322211 123456789999999999999999999999999983
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=238.10 Aligned_cols=192 Identities=28% Similarity=0.378 Sum_probs=152.3
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRP-RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL 78 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~ 78 (268)
++++++|++ .++..++||||++ ++|.+++..... ..+++..++.++.|++.||+|||++|++|+||||+||+++.+
T Consensus 60 ~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~- 137 (285)
T cd07861 60 NIVCLQDVLMQESRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNK- 137 (285)
T ss_pred CEeeeEEEEeeCCeEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCC-
Confidence 578999999 5568999999997 689998876433 459999999999999999999999999999999999999988
Q ss_pred CCeEEecCCCcccccccc-ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 024408 79 KTIKLADFGLAREESLTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA 157 (268)
Q Consensus 79 ~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~ 157 (268)
+.++|+|||++....... ......++..|+|||++.+ ...++.++|+||||+++++|++|+.||.+......
T Consensus 138 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~ 210 (285)
T cd07861 138 GVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLG-------SPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ 210 (285)
T ss_pred CcEEECcccceeecCCCcccccCCcccccccChHHhcC-------CCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH
Confidence 699999999987543221 2233467889999998753 23467899999999999999999999987554333
Q ss_pred HHHHHhccC----------------------------CCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 158 AYAAAFKNV----------------------------RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 158 ~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
......... ......+++++.++|.+||..||.+|||+.+++++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 211 LFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 222111000 01123578899999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=232.41 Aligned_cols=192 Identities=29% Similarity=0.548 Sum_probs=154.5
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ .+...++||||++|++|.+++..... .+++..++.++.+++.||++||++|++|+||||+||+++.+ +
T Consensus 60 ~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~-~ 137 (256)
T cd05112 60 KLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRG-KFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGEN-Q 137 (256)
T ss_pred CeeeEEEEEccCCceEEEEEcCCCCcHHHHHHhCcc-CCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCC-C
Confidence 468899998 55688999999999999999976443 38999999999999999999999999999999999999987 6
Q ss_pred CeEEecCCCccccccccc--cccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 024408 80 TIKLADFGLAREESLTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQ 156 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~~~~ 156 (268)
.++|+|||++........ .....++..|+|||.+.+ ..++.++|+||||+++|++++ |..||.......
T Consensus 138 ~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~--------~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 209 (256)
T cd05112 138 VVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSF--------SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE 209 (256)
T ss_pred eEEECCCcceeecccCcccccCCCccchhhcCHhHhcc--------CCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH
Confidence 899999999875332211 112234578999998754 457789999999999999998 999998755444
Q ss_pred HHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 024408 157 AAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 202 (268)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l 202 (268)
.............+...+..+.+++.+||..+|++||++.++++.|
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 210 VVETINAGFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred HHHHHhCCCCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 3333322223333555789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=235.23 Aligned_cols=194 Identities=29% Similarity=0.440 Sum_probs=156.2
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
++++++|.+ .++..++||||++|++|.+++.... ..+++.++..++.|++.||.|||++|++|+||+|+||+++.+ +
T Consensus 61 ~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~-~ 138 (262)
T cd06613 61 NIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTED-G 138 (262)
T ss_pred ChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCC-C
Confidence 578999988 5668999999999999999987652 239999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccccc-ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESLTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.++|+|||++....... ......++..|+|||.+.+. ....++.++|+||+|+++|+|++|..||.........
T Consensus 139 ~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~-----~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~ 213 (262)
T cd06613 139 DVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVE-----RKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRAL 213 (262)
T ss_pred CEEECccccchhhhhhhhccccccCCccccCchhhccc-----ccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 89999999987543322 22345678899999987541 0125678999999999999999999999876655544
Q ss_pred HHHHhccCCC----CCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 159 YAAAFKNVRP----SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 159 ~~~~~~~~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
.........+ ....++.++.+++.+||..+|.+||++.+++.+
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 214 FLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred HHHHhccCCCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 4333321111 133457889999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=262.68 Aligned_cols=187 Identities=26% Similarity=0.393 Sum_probs=155.5
Q ss_pred eecCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCCeEEecCC
Q 024408 8 ACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFG 87 (268)
Q Consensus 8 ~~~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~~kl~Dfg 87 (268)
+-++.++|+||||++||+|..++.+... +++.-++.++..++.||.-+|+.|+|||||||+|||+|.. |++||+|||
T Consensus 144 FQD~~~LYlVMdY~pGGDlltLlSk~~~--~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~-GHikLADFG 220 (1317)
T KOG0612|consen 144 FQDERYLYLVMDYMPGGDLLTLLSKFDR--LPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKS-GHIKLADFG 220 (1317)
T ss_pred hcCccceEEEEecccCchHHHHHhhcCC--ChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEeccc-CcEeeccch
Confidence 3467799999999999999999998873 9999999999999999999999999999999999999999 799999999
Q ss_pred Ccccccccc--ccccCCCccceeccccccccccccCCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc
Q 024408 88 LAREESLTE--MMTAETGTYRWMAPELYSTVTLRQGEK-KHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFK 164 (268)
Q Consensus 88 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~-~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~ 164 (268)
.+-....++ .....+|||-|.+||++... +.+ +.|++..|.||+|+++|||+.|..||...+-.+..-.++..
T Consensus 221 sClkm~~dG~V~s~~aVGTPDYISPEvLqs~----~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~h 296 (1317)
T KOG0612|consen 221 SCLKMDADGTVRSSVAVGTPDYISPEVLQSQ----GDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNH 296 (1317)
T ss_pred hHHhcCCCCcEEeccccCCCCccCHHHHHhh----cCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhch
Confidence 987655443 34566899999999999763 333 78999999999999999999999999875544444444333
Q ss_pred ---cCCCCCCCCcHHHHHHHHhccccCCCCCCC---HHHHHHHH
Q 024408 165 ---NVRPSAENVPEELSIILTSCWKEDPNARPN---FTQIIQML 202 (268)
Q Consensus 165 ---~~~~~~~~~~~~l~~li~~~l~~~p~~Rps---~~~~~~~l 202 (268)
...|....+|.+.++||.+.+ .+|+.|-. +.++..|.
T Consensus 297 k~~l~FP~~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~Hp 339 (1317)
T KOG0612|consen 297 KESLSFPDETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNHP 339 (1317)
T ss_pred hhhcCCCcccccCHHHHHHHHHHh-cChhhhcccccHHHHHhCc
Confidence 122334568999999999877 45777776 99998884
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=241.44 Aligned_cols=197 Identities=27% Similarity=0.422 Sum_probs=155.9
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++.+ .+++.++||||++|++|.+++.. . .+++.++..++.|++.||.|||++|++||||||+||+++.+ +
T Consensus 80 ~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~--~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~-~ 155 (292)
T cd06658 80 NVVDMYNSYLVGDELWVVMEFLEGGALTDIVTH-T--RMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSD-G 155 (292)
T ss_pred cHHHHHHheecCCeEEEEEeCCCCCcHHHHHhc-C--CCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCC-C
Confidence 456777777 55789999999999999998854 2 38999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccccc-ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESLTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.++|+|||++....... ......|+..|+|||.+.+ ..++.++|+||+|+++|++++|+.||.........
T Consensus 156 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~ 227 (292)
T cd06658 156 RIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISR--------LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAM 227 (292)
T ss_pred CEEEccCcchhhcccccccCceeecCccccCHHHHcc--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 99999999987433221 2233468899999998753 45678999999999999999999999876654433
Q ss_pred HHHHhc--cCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhcCC
Q 024408 159 YAAAFK--NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAP 211 (268)
Q Consensus 159 ~~~~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~~~~ 211 (268)
...... ...+.....+..+.+++.+|+..||.+||++++++++ .++....+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~--~~~~~~~~ 280 (292)
T cd06658 228 RRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQH--PFLKLAGP 280 (292)
T ss_pred HHHHhcCCCccccccccCHHHHHHHHHHccCChhHCcCHHHHhhC--hhhhccCC
Confidence 322211 1112234578899999999999999999999999997 44444333
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=248.66 Aligned_cols=188 Identities=26% Similarity=0.318 Sum_probs=149.0
Q ss_pred CceeEEEeecC-------CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEE
Q 024408 1 MREQFIGACKE-------PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 73 (268)
Q Consensus 1 ~~v~l~g~~~~-------~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nil 73 (268)
+++++++.+.. ...++||||++ ++|.+.+.. .+++..+..++.|++.||+|||++||+||||||+||+
T Consensus 84 ~ii~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIl 158 (364)
T cd07875 84 NIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 158 (364)
T ss_pred CccccceeecccccccccCeEEEEEeCCC-CCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEE
Confidence 46778877632 25799999996 688888753 2889999999999999999999999999999999999
Q ss_pred EeCCCCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 024408 74 LTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS 153 (268)
Q Consensus 74 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~ 153 (268)
++.+ +.+||+|||+++............+|..|+|||++.+ ..++.++||||||+++|+|++|+.||.+.+
T Consensus 159 l~~~-~~~kL~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 229 (364)
T cd07875 159 VKSD-CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG--------MGYKENVDIWSVGCIMGEMIKGGVLFPGTD 229 (364)
T ss_pred ECCC-CcEEEEeCCCccccCCCCcccCCcccCCcCCHHHHhC--------CCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Confidence 9988 6999999999986554444455678999999999864 567889999999999999999999998766
Q ss_pred hHHHHHHHHhccCCC-----------------------------------------CCCCCcHHHHHHHHhccccCCCCC
Q 024408 154 NLQAAYAAAFKNVRP-----------------------------------------SAENVPEELSIILTSCWKEDPNAR 192 (268)
Q Consensus 154 ~~~~~~~~~~~~~~~-----------------------------------------~~~~~~~~l~~li~~~l~~~p~~R 192 (268)
..+...........+ .....+..++++|.+||..||.+|
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R 309 (364)
T cd07875 230 HIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKR 309 (364)
T ss_pred HHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccC
Confidence 544332221110000 011124578999999999999999
Q ss_pred CCHHHHHHHH
Q 024408 193 PNFTQIIQML 202 (268)
Q Consensus 193 ps~~~~~~~l 202 (268)
||+.++++|-
T Consensus 310 ~t~~e~L~hp 319 (364)
T cd07875 310 ISVDEALQHP 319 (364)
T ss_pred CCHHHHhcCc
Confidence 9999999983
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=247.35 Aligned_cols=188 Identities=26% Similarity=0.317 Sum_probs=149.0
Q ss_pred CceeEEEeecC-------CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEE
Q 024408 1 MREQFIGACKE-------PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 73 (268)
Q Consensus 1 ~~v~l~g~~~~-------~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nil 73 (268)
+++++++++.. ...++||||++ ++|.+.+.. .+++..+..++.|++.||.|||++|++||||||+||+
T Consensus 77 niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nil 151 (355)
T cd07874 77 NIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 151 (355)
T ss_pred chhceeeeeeccccccccceeEEEhhhhc-ccHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEE
Confidence 57888888732 24799999996 578877753 2889999999999999999999999999999999999
Q ss_pred EeCCCCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 024408 74 LTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS 153 (268)
Q Consensus 74 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~ 153 (268)
++.+ +.+||+|||+++............||..|+|||++.+ ..++.++|+||||+++|+|++|+.||.+.+
T Consensus 152 l~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~DiwslG~il~el~~g~~pf~~~~ 222 (355)
T cd07874 152 VKSD-CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG--------MGYKENVDIWSVGCIMGEMVRHKILFPGRD 222 (355)
T ss_pred ECCC-CCEEEeeCcccccCCCccccCCccccCCccCHHHHcC--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9988 6999999999986554444455678999999999864 557889999999999999999999998765
Q ss_pred hHHHHHHHHhccCC-----------------------------------------CCCCCCcHHHHHHHHhccccCCCCC
Q 024408 154 NLQAAYAAAFKNVR-----------------------------------------PSAENVPEELSIILTSCWKEDPNAR 192 (268)
Q Consensus 154 ~~~~~~~~~~~~~~-----------------------------------------~~~~~~~~~l~~li~~~l~~~p~~R 192 (268)
..+........... ......+.+++++|.+||..||.+|
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R 302 (355)
T cd07874 223 YIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKR 302 (355)
T ss_pred HHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhc
Confidence 43332211110000 0012235678999999999999999
Q ss_pred CCHHHHHHHH
Q 024408 193 PNFTQIIQML 202 (268)
Q Consensus 193 ps~~~~~~~l 202 (268)
||+.++++|.
T Consensus 303 ps~~ell~hp 312 (355)
T cd07874 303 ISVDEALQHP 312 (355)
T ss_pred CCHHHHhcCc
Confidence 9999999983
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=236.82 Aligned_cols=191 Identities=27% Similarity=0.444 Sum_probs=156.7
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++.+ .++..++||||++|++|.+++... .+++.++..++.|++.||.+||++|++|+||+|+||+++.+ +
T Consensus 63 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~---~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~-~ 138 (277)
T cd06640 63 YVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAG---PFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQ-G 138 (277)
T ss_pred CEeeEEEEEEECCEEEEEEecCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCC-C
Confidence 578999998 556899999999999999998642 38999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccccc-ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESLTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.++++|||++....... ......++..|+|||.+.+ ...+.++|+||||+++|+|++|..||.........
T Consensus 139 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~apE~~~~--------~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~ 210 (277)
T cd06640 139 DVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQ--------SAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL 210 (277)
T ss_pred CEEEcccccceeccCCccccccccCcccccCHhHhcc--------CCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh
Confidence 89999999997543322 2223457889999998854 45788999999999999999999999876654443
Q ss_pred HHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 024408 159 YAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 203 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~ 203 (268)
..............++..+.+++.+||..+|.+||++.+++.+-+
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 255 (277)
T cd06640 211 FLIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKF 255 (277)
T ss_pred hhhhcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChH
Confidence 332222222334567889999999999999999999999999844
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=237.14 Aligned_cols=196 Identities=29% Similarity=0.410 Sum_probs=157.8
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++.+ .++..++||||++|++|.+++.+.+. .+++.++..++.|++.||.|||++|++|+||+|+||+++.+ +
T Consensus 63 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~-~ 140 (280)
T cd06611 63 NIVGLYEAYFYENKLWILIEFCDGGALDSIMLELER-GLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLD-G 140 (280)
T ss_pred ceeEEEEEEecCCeEEEEeeccCCCcHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCC-C
Confidence 578999998 55688999999999999999876443 49999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccc-cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.++|+|||++...... .......++..|++||.+.... .....++.++|+||||+++|+|++|+.||.........
T Consensus 141 ~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~---~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~ 217 (280)
T cd06611 141 DVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACET---FKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVL 217 (280)
T ss_pred CEEEccCccchhhcccccccceeecchhhcCHHHHhhcc---cCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHH
Confidence 9999999998643322 2223446889999999875311 11244677899999999999999999999876655444
Q ss_pred HHHHhccC--CCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 159 YAAAFKNV--RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 159 ~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
........ ...+..++.++.++|.+||..+|.+||++.+++++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 218 LKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred HHHhcCCCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 33322211 12245678999999999999999999999999997
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=235.33 Aligned_cols=196 Identities=26% Similarity=0.422 Sum_probs=155.6
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED 77 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~ 77 (268)
+++++++++ .++..++||||++|++|.+++... ....+++.+++.++.|++.||.|||++|++|+||||+||+++.+
T Consensus 63 ~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~ 142 (267)
T cd08229 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITAT 142 (267)
T ss_pred chhhhhheeEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC
Confidence 578888888 556889999999999999998742 22348999999999999999999999999999999999999988
Q ss_pred CCCeEEecCCCcccccccc-ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH
Q 024408 78 LKTIKLADFGLAREESLTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 156 (268)
Q Consensus 78 ~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~ 156 (268)
+.++++|||++....... ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.......
T Consensus 143 -~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ape~~~~--------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~ 213 (267)
T cd08229 143 -GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE--------NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL 213 (267)
T ss_pred -CCEEECcchhhhccccCCcccccccCCcCccCHHHhcC--------CCccchhhHHHHHHHHHHHHhCCCCcccccchH
Confidence 699999999987543322 2233468889999998854 456788999999999999999999997543221
Q ss_pred -HHHHHHhcc-CCC-CCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHh
Q 024408 157 -AAYAAAFKN-VRP-SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 205 (268)
Q Consensus 157 -~~~~~~~~~-~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~ 205 (268)
......... ..+ ....++.++.+++.+||..+|.+|||+.++++.+.+.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 214 YSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred HHHhhhhhcCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 111111111 111 2345788999999999999999999999999988764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=237.77 Aligned_cols=192 Identities=24% Similarity=0.387 Sum_probs=156.2
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++.+ .++..++||||++|++|.+++.+.....+++.++..++.|++.||.|||++|++|+||+|+||+++++ +
T Consensus 54 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~-~ 132 (277)
T cd05577 54 FIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDH-G 132 (277)
T ss_pred CEeeeeeEEecCCeEEEEEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCC-C
Confidence 478888888 55689999999999999999987665569999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH---H
Q 024408 80 TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL---Q 156 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~---~ 156 (268)
.++|+|||.+.............++..|+|||.+.+ ..++.++|+||+|+++++|++|+.||...... .
T Consensus 133 ~~~l~dfg~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~ 204 (277)
T cd05577 133 NVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQG--------EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE 204 (277)
T ss_pred CEEEccCcchhhhccCCccccccCCCCcCCHHHhcC--------CCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH
Confidence 999999999875443333344567889999998754 44778999999999999999999999765431 1
Q ss_pred HHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 024408 157 AAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARP-----NFTQIIQM 201 (268)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~~~~~ 201 (268)
.............+..+++.+.++|.+||+.+|.+|| ++.++++|
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h 254 (277)
T cd05577 205 ELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREH 254 (277)
T ss_pred HHHhccccccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence 1122222222334556789999999999999999999 77778776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=233.25 Aligned_cols=196 Identities=26% Similarity=0.428 Sum_probs=156.2
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMR--PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED 77 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~ 77 (268)
+++++++.+ .++..++||||++|++|.+++.+.. ...+++.+++.++.+++.||.|||+.|++|+||+|+||+++.+
T Consensus 63 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~ 142 (267)
T cd08224 63 NVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITAT 142 (267)
T ss_pred CeeeeeeeeecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCC
Confidence 468888888 5568899999999999999987532 2348999999999999999999999999999999999999988
Q ss_pred CCCeEEecCCCcccccccc-ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH-
Q 024408 78 LKTIKLADFGLAREESLTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL- 155 (268)
Q Consensus 78 ~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~- 155 (268)
+.++++|||++....... ......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||......
T Consensus 143 -~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~--------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 213 (267)
T cd08224 143 -GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE--------NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL 213 (267)
T ss_pred -CcEEEeccceeeeccCCCcccceecCCccccCHHHhcc--------CCCCchhcHHHHHHHHHHHHHCCCCcccCCccH
Confidence 689999999987533221 2233467889999998754 45778999999999999999999999653321
Q ss_pred -HHHHHHHhccCCCCCC-CCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHh
Q 024408 156 -QAAYAAAFKNVRPSAE-NVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 205 (268)
Q Consensus 156 -~~~~~~~~~~~~~~~~-~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~ 205 (268)
+...........+.+. .++..+.++|.+||..+|++||++.++++.++..
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 214 YSLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred HHHHhhhhcCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 1111111222223333 6788999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=237.18 Aligned_cols=194 Identities=27% Similarity=0.507 Sum_probs=153.8
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCC---------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRP---------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPE 70 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~---------~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~ 70 (268)
+++++++++ .++..++||||++|++|.+++.+... ..+++.++..++.|++.||+|||++|++|+||||+
T Consensus 80 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~ 159 (296)
T cd05095 80 NIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATR 159 (296)
T ss_pred CcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChh
Confidence 578999998 55688999999999999999976432 23778899999999999999999999999999999
Q ss_pred CEEEeCCCCCeEEecCCCccccccccc---cccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh--C
Q 024408 71 NLLLTEDLKTIKLADFGLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH--N 145 (268)
Q Consensus 71 Nill~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~--g 145 (268)
||+++.+ +.++|+|||+++....... .....++..|++||...+ ..++.++|+||||+++|||++ |
T Consensus 160 Nili~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--------~~~~~~~DiwSlG~~l~el~~~~~ 230 (296)
T cd05095 160 NCLVGKN-YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL--------GKFTTASDVWAFGVTLWEILTLCK 230 (296)
T ss_pred eEEEcCC-CCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhc--------CCccchhhhhHHHHHHHHHHHhCC
Confidence 9999987 6899999999875432211 112234578999997653 457889999999999999998 7
Q ss_pred CCCCCCCChHHHHHHHH-------hccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 024408 146 KLPFEGMSNLQAAYAAA-------FKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 203 (268)
Q Consensus 146 ~~p~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~ 203 (268)
..||......+...... .....+.+..++..+.+++.+||+.||.+||++.++++.|+
T Consensus 231 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 231 EQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred CCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 78887655443322111 11122345667899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=241.58 Aligned_cols=192 Identities=29% Similarity=0.435 Sum_probs=155.3
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++.+ .++..++||||+.|++|.+++.+.....+++..+..++.|++.||+|||+.|++|+||||+||+++.+ +
T Consensus 62 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~-~ 140 (316)
T cd05574 62 FLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHES-G 140 (316)
T ss_pred CchhheeeeecCCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCC-C
Confidence 478888888 45688999999999999999987655569999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccccc------------------------------ccccCCCccceeccccccccccccCCCCCCCch
Q 024408 80 TIKLADFGLAREESLTE------------------------------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK 129 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~ 129 (268)
.++|+|||++....... ......|+..|+|||++.+ ..++.+
T Consensus 141 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~ 212 (316)
T cd05574 141 HIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG--------DGHGSA 212 (316)
T ss_pred CEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC--------CCCCch
Confidence 99999999986432211 0112357889999999864 456789
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccC-CCCCCCCcHHHHHHHHhccccCCCCCCC----HHHHHHH
Q 024408 130 VDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV-RPSAENVPEELSIILTSCWKEDPNARPN----FTQIIQM 201 (268)
Q Consensus 130 ~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps----~~~~~~~ 201 (268)
+||||||+++|+|++|..||................. .+.....+..+.+++.+||..+|++||+ +++++.+
T Consensus 213 ~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 213 VDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred HHHHHHHHHHHHHhhCCCCCCCCchHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 9999999999999999999987665444433332221 1223337899999999999999999999 8888876
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=234.29 Aligned_cols=196 Identities=26% Similarity=0.413 Sum_probs=155.5
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED 77 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~ 77 (268)
+++++++++ ..+..++||||+++++|.+++... ....+++..+..++.|++.||.|||++|++|+||||+||+++.+
T Consensus 63 ~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~ 142 (267)
T cd08228 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITAT 142 (267)
T ss_pred ceeeeeeeEEECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCC
Confidence 478899888 556889999999999999988643 22348999999999999999999999999999999999999988
Q ss_pred CCCeEEecCCCcccccccc-ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH-
Q 024408 78 LKTIKLADFGLAREESLTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL- 155 (268)
Q Consensus 78 ~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~- 155 (268)
+.++++|||++....... ......++..|+|||.+.+ ...+.++|+||+|+++|+|++|+.||......
T Consensus 143 -~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--------~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~ 213 (267)
T cd08228 143 -GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE--------NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL 213 (267)
T ss_pred -CCEEECccccceeccchhHHHhcCCCCccccChhhhcc--------CCCCchhhHHHHHHHHHHHhcCCCCCccccccH
Confidence 689999999987543322 2234468889999998854 45678899999999999999999999654322
Q ss_pred HHHHHHHhc-cCCCC-CCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHh
Q 024408 156 QAAYAAAFK-NVRPS-AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 205 (268)
Q Consensus 156 ~~~~~~~~~-~~~~~-~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~ 205 (268)
......... ...+. ...++..+.+++.+||..+|++||++.++++.++..
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 214 FSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred HHHHHHHhcCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 122222221 11222 235778999999999999999999999999988753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=237.16 Aligned_cols=190 Identities=24% Similarity=0.343 Sum_probs=153.7
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ .++..++||||++|++|.+++.+.+. +++..+..++.|++.||.|||++|++||||||+||+++.+ +
T Consensus 58 ~i~~~~~~~~~~~~~~~v~e~~~g~~L~~~l~~~~~--l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~-~ 134 (278)
T cd05606 58 FIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV--FSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEH-G 134 (278)
T ss_pred cEeeeeeeeecCCEEEEEEecCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCC-C
Confidence 357788877 45688999999999999999876543 9999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH--HH
Q 024408 80 TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL--QA 157 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~--~~ 157 (268)
.++|+|||++....... .....|+..|+|||.+.. ...++.++|+||+|+++|+|++|+.||...... ..
T Consensus 135 ~~kl~dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~ 206 (278)
T cd05606 135 HVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQK-------GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE 206 (278)
T ss_pred CEEEccCcCccccCccC-CcCcCCCcCCcCcHHhcC-------CCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH
Confidence 99999999987543222 234578999999999753 234778899999999999999999999765321 11
Q ss_pred HHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 024408 158 AYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARP-----NFTQIIQM 201 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~~~~~ 201 (268)
............+..++..+.+++.+||..+|.+|| ++.+++++
T Consensus 207 ~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 207 IDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred HHHHhhccCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 122222222334556789999999999999999999 99999886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=237.29 Aligned_cols=191 Identities=26% Similarity=0.433 Sum_probs=155.3
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ .++..++||||++|++|.+++.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.+ +
T Consensus 63 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~-~ 138 (277)
T cd06642 63 YITRYYGSYLKGTKLWIIMEYLGGGSALDLLKP---GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQ-G 138 (277)
T ss_pred ccHhhhcccccCCceEEEEEccCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCC-C
Confidence 578889988 55689999999999999998864 238999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccccc-ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESLTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.++++|||++....... ......++..|+|||.+.+ ..++.++|+||||+++|++++|+.|+.........
T Consensus 139 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~ 210 (277)
T cd06642 139 DVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ--------SAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL 210 (277)
T ss_pred CEEEccccccccccCcchhhhcccCcccccCHHHhCc--------CCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHH
Confidence 99999999997543322 1223467889999998854 45778999999999999999999999765544433
Q ss_pred HHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 024408 159 YAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 203 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~ 203 (268)
..............++.++.+++.+||..+|++||++.+++.+.+
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 255 (277)
T cd06642 211 FLIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKF 255 (277)
T ss_pred hhhhcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHH
Confidence 322222222234467889999999999999999999999999743
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=233.91 Aligned_cols=200 Identities=26% Similarity=0.408 Sum_probs=151.4
Q ss_pred CceeEEEeec-CCcEEEEEEcCCCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeC
Q 024408 1 MREQFIGACK-EPVMVIVTELLSGGTLRKYLLNMRP---RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE 76 (268)
Q Consensus 1 ~~v~l~g~~~-~~~~~lV~e~~~ggsL~~~i~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~ 76 (268)
++++++|++. ....++||||++||+|.+++..... ...++..+..++.|++.||+|||++|++|+||||+||+++.
T Consensus 56 ~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~ 135 (269)
T cd05087 56 NLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTA 135 (269)
T ss_pred CEeeEEEEEcCCCCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcC
Confidence 5789999994 4578999999999999999975432 23677888899999999999999999999999999999998
Q ss_pred CCCCeEEecCCCccccccccc---cccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 024408 77 DLKTIKLADFGLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGM 152 (268)
Q Consensus 77 ~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~ 152 (268)
+ +.++|+|||++........ .....++..|+|||++...... .....++.++|+||||+++|+|++ |..||...
T Consensus 136 ~-~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~ 213 (269)
T cd05087 136 D-LTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGN-LLVVDQTKESNVWSLGVTIWELFELGSQPYRHL 213 (269)
T ss_pred C-CcEEECCccccccccCcceeecCCCcCCcccccCHhHhcccccc-ccccCCCccchhHHHHHHHHHHHhCCCCCCCCC
Confidence 8 6899999999974332211 1223567889999988531100 001235779999999999999996 99999876
Q ss_pred ChHHHHHHHHhccCC----CC-CCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 024408 153 SNLQAAYAAAFKNVR----PS-AENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 203 (268)
Q Consensus 153 ~~~~~~~~~~~~~~~----~~-~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~ 203 (268)
...+........... +. ....+..+.+++..|+ .+|++||++++++..|+
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 214 SDEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred ChHHHHHHHhhcccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 655443322221111 11 2246788999999999 68999999999998763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=276.25 Aligned_cols=193 Identities=27% Similarity=0.391 Sum_probs=162.2
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|+|+.+|.- +++..+|-||||+||+|.+.+...+. .++.....+..|++.|+.|||+.|||||||||.||+++.+ |
T Consensus 1295 NlV~YyGVEvHRekv~IFMEyC~~GsLa~ll~~gri--~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~-g 1371 (1509)
T KOG4645|consen 1295 NLVRYYGVEVHREKVYIFMEYCEGGSLASLLEHGRI--EDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFN-G 1371 (1509)
T ss_pred cccccCceeecHHHHHHHHHHhccCcHHHHHHhcch--hhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecC-C
Confidence 678999997 77788999999999999999876433 7777778889999999999999999999999999999998 6
Q ss_pred CeEEecCCCccccccc-----cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh
Q 024408 80 TIKLADFGLAREESLT-----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN 154 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~ 154 (268)
.+|++|||.|...... .......||+.|||||++.+.. .+.-..++|||||||++.||+||+.||...++
T Consensus 1372 ~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~-----~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn 1446 (1509)
T KOG4645|consen 1372 LIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTK-----GKGHGGAADIWSLGCVVLEMATGKRPWAELDN 1446 (1509)
T ss_pred cEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccc-----cCCCCcchhhhcccceEEEeecCCCchhhccc
Confidence 9999999999854332 2334668999999999997622 23345689999999999999999999987664
Q ss_pred H-HHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 155 L-QAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 155 ~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
. +.++...-....+.+..++++-+++|..||..||++|.++.|++++
T Consensus 1447 e~aIMy~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1447 EWAIMYHVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred hhHHHhHHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 3 5555555555566678899999999999999999999999999887
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=237.18 Aligned_cols=198 Identities=24% Similarity=0.389 Sum_probs=154.7
Q ss_pred CceeEEEeec------CCcEEEEEEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCE
Q 024408 1 MREQFIGACK------EPVMVIVTELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENL 72 (268)
Q Consensus 1 ~~v~l~g~~~------~~~~~lV~e~~~ggsL~~~i~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Ni 72 (268)
|++++++++. +++.++||||++|++|.+++... ....+++..+..++.|++.||.|||+++++||||||+||
T Consensus 76 ~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~ni 155 (286)
T cd06638 76 NVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNI 155 (286)
T ss_pred CeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhE
Confidence 5789999872 34689999999999999988642 223489999999999999999999999999999999999
Q ss_pred EEeCCCCCeEEecCCCcccccccc-ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 024408 73 LLTEDLKTIKLADFGLAREESLTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 151 (268)
Q Consensus 73 ll~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~ 151 (268)
+++.+ +.++|+|||++....... ......|+..|+|||.+.... .....++.++|+||+|+++|+|++|+.||..
T Consensus 156 li~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~ 231 (286)
T cd06638 156 LLTTE-GGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQ---QLDSTYDARCDVWSLGITAIELGDGDPPLAD 231 (286)
T ss_pred EECCC-CCEEEccCCceeecccCCCccccccCCCcccChhhhchhh---hccccccchhhhhhHHHHHHHHhcCCCCCCC
Confidence 99988 689999999987543222 223446899999999875311 0124577899999999999999999999987
Q ss_pred CChHHHHHHHHhcc--CCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 024408 152 MSNLQAAYAAAFKN--VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 202 (268)
Q Consensus 152 ~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l 202 (268)
.............. ....+..++..+.+++.+||..||++||++.++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 232 LHPMRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred CchhHHHhhccccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 65443332221111 1112344678999999999999999999999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=236.24 Aligned_cols=197 Identities=26% Similarity=0.412 Sum_probs=154.9
Q ss_pred CceeEEEeecC-------CcEEEEEEcCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCC
Q 024408 1 MREQFIGACKE-------PVMVIVTELLSGGTLRKYLLNMR--PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPEN 71 (268)
Q Consensus 1 ~~v~l~g~~~~-------~~~~lV~e~~~ggsL~~~i~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~N 71 (268)
++++++|++.+ .++++||||+++++|.+++.... +..+++..+..++.|++.||.|||++|++|+||+|+|
T Consensus 64 ~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~n 143 (275)
T cd06608 64 NIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQN 143 (275)
T ss_pred ChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHH
Confidence 57889999843 24899999999999999987643 3459999999999999999999999999999999999
Q ss_pred EEEeCCCCCeEEecCCCccccccc-cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 024408 72 LLLTEDLKTIKLADFGLAREESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFE 150 (268)
Q Consensus 72 ill~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~ 150 (268)
|+++.+ +.++|+|||++...... .......|+..|+|||.+..... ....++.++|+||||+++|++++|+.||.
T Consensus 144 i~~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~~~~~~Dv~slG~il~~l~~g~~p~~ 219 (275)
T cd06608 144 ILLTKN-AEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQ---PDASYDARSDVWSLGITAIELADGKPPLC 219 (275)
T ss_pred EEEccC-CeEEECCCccceecccchhhhcCccccccccCHhHhccccc---ccCCccccccHHHhHHHHHHHHhCCCCcc
Confidence 999988 68999999998753322 22234568889999998753211 12456788999999999999999999998
Q ss_pred CCChHHHHHHHHhccCC--CCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 151 GMSNLQAAYAAAFKNVR--PSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 151 ~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
................. .....+++.+.++|.+||..||++|||+.+++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 220 DMHPMRALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred ccchHHHHHHhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 65544333332222111 1123467899999999999999999999999876
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=247.32 Aligned_cols=192 Identities=29% Similarity=0.397 Sum_probs=151.5
Q ss_pred CceeEEEeecC-C-----cEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEE
Q 024408 1 MREQFIGACKE-P-----VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL 74 (268)
Q Consensus 1 ~~v~l~g~~~~-~-----~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill 74 (268)
|++++++++.. + ..++||||+. ++|.+.+..... +++..+..++.|++.||.|||++|++||||||+||++
T Consensus 60 niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~--l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili 136 (372)
T cd07853 60 NVLSALDILQPPHIDPFEEIYVVTELMQ-SDLHKIIVSPQP--LSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLV 136 (372)
T ss_pred CcCCHhheecCCCccccceEEEEeeccc-cCHHHHHhcCCC--CCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEE
Confidence 57888888843 3 6899999995 689988866443 9999999999999999999999999999999999999
Q ss_pred eCCCCCeEEecCCCccccccc--cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 024408 75 TEDLKTIKLADFGLAREESLT--EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGM 152 (268)
Q Consensus 75 ~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~ 152 (268)
+.+ +.+||+|||+++..... .......++..|+|||.+.+ ...++.++||||+|+++|+|++|+.||.+.
T Consensus 137 ~~~-~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~il~el~~g~~pf~~~ 208 (372)
T cd07853 137 NSN-CVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMG-------SRHYTSAVDIWSVGCIFAELLGRRILFQAQ 208 (372)
T ss_pred CCC-CCEEeccccceeecccCccccCCCCCcCCCcCCHHHHcC-------CCCCCcHHHHHhHHHHHHHHHcCCCCCCCC
Confidence 988 69999999999754322 12233467899999998854 234678999999999999999999999876
Q ss_pred ChHHHHHHHHhc-----------------------cCC--------CCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 153 SNLQAAYAAAFK-----------------------NVR--------PSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 153 ~~~~~~~~~~~~-----------------------~~~--------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
...+........ ... ......++++.++|.+||..||.+||++.++++|
T Consensus 209 ~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 209 SPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred CHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 544332221110 000 1123457889999999999999999999999998
Q ss_pred HH
Q 024408 202 LL 203 (268)
Q Consensus 202 l~ 203 (268)
.+
T Consensus 289 p~ 290 (372)
T cd07853 289 PY 290 (372)
T ss_pred Hh
Confidence 43
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=234.17 Aligned_cols=194 Identities=24% Similarity=0.515 Sum_probs=156.2
Q ss_pred CceeEEEeec-CCcEEEEEEcCCCCCHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCE
Q 024408 1 MREQFIGACK-EPVMVIVTELLSGGTLRKYLLNMRP-------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENL 72 (268)
Q Consensus 1 ~~v~l~g~~~-~~~~~lV~e~~~ggsL~~~i~~~~~-------~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Ni 72 (268)
+++++++++. ....++||||+++++|.+++..... ..+++..+..++.|++.||+|||++|++||||||+||
T Consensus 69 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Ni 148 (275)
T cd05046 69 NVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNC 148 (275)
T ss_pred ceeeeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceE
Confidence 5789999994 4678999999999999999986552 1489999999999999999999999999999999999
Q ss_pred EEeCCCCCeEEecCCCccccccc--cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 024408 73 LLTEDLKTIKLADFGLAREESLT--EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPF 149 (268)
Q Consensus 73 ll~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~ 149 (268)
+++.+ +.++++|||++...... .......++..|+|||.+.+ ...+.++||||||+++|++++ |..||
T Consensus 149 li~~~-~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Di~slG~~l~~l~~~~~~p~ 219 (275)
T cd05046 149 LVSSQ-REVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQE--------DDFSTKSDVWSFGVLMWEVFTQGELPF 219 (275)
T ss_pred EEeCC-CcEEEcccccccccCcccccccCCceeEEeecChhhhcc--------CCCCchhhHHHHHHHHHHHHhCCCCCc
Confidence 99988 68999999998743221 11223356778999998753 456788999999999999998 88899
Q ss_pred CCCChHHHHHHHHhccC-CCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 024408 150 EGMSNLQAAYAAAFKNV-RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 203 (268)
Q Consensus 150 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~ 203 (268)
................. .+....++..+.+++.+||..+|.+||++.+++..|+
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 220 YGLSDEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred cccchHHHHHHHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 76555443333322221 2335578899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=237.51 Aligned_cols=187 Identities=27% Similarity=0.371 Sum_probs=156.9
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++.+ .++..++||||++|++|.+++..... +++..+..++.|++.||.|||++|++|+||+|.||+++.+ +
T Consensus 62 ~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~--l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~-~ 138 (290)
T cd05580 62 FLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGR--FPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSD-G 138 (290)
T ss_pred CccceeeEEEcCCeEEEEEecCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCC-C
Confidence 578899998 55689999999999999999987644 9999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 024408 80 TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY 159 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~ 159 (268)
.++|+|||++...... .....+++.|+|||.+.+ ...+.++|+||||+++|+|++|..||..........
T Consensus 139 ~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~ 208 (290)
T cd05580 139 YIKITDFGFAKRVKGR--TYTLCGTPEYLAPEIILS--------KGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYE 208 (290)
T ss_pred CEEEeeCCCccccCCC--CCCCCCCccccChhhhcC--------CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 9999999999864433 234568899999998754 456778999999999999999999998765433333
Q ss_pred HHHhccCCCCCCCCcHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 024408 160 AAAFKNVRPSAENVPEELSIILTSCWKEDPNARP-----NFTQIIQM 201 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~~~~~ 201 (268)
.......+.+..++..+.++|.+||..||.+|+ ++++++++
T Consensus 209 -~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 209 -KILEGKVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred -HHhcCCccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 233333444567789999999999999999999 88888877
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=235.35 Aligned_cols=190 Identities=25% Similarity=0.308 Sum_probs=150.9
Q ss_pred CceeEEEee-cC--CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCC
Q 024408 1 MREQFIGAC-KE--PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED 77 (268)
Q Consensus 1 ~~v~l~g~~-~~--~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~ 77 (268)
|+++++|++ .+ +.+++||||++ ++|.+.+.... ..+++.+++.++.|++.||+|||++|++||||+|+||+++.
T Consensus 59 ~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~- 135 (282)
T cd07831 59 NILRLIEVLFDRKTGRLALVFELMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD- 135 (282)
T ss_pred CccceEEEEecCCCCcEEEEEecCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-
Confidence 578899998 44 68899999996 68988887643 34899999999999999999999999999999999999998
Q ss_pred CCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 024408 78 LKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA 157 (268)
Q Consensus 78 ~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~ 157 (268)
+.++|+|||++.............++..|+|||.+.. ...++.++|+||||+++|+|++|..||.+.+..+.
T Consensus 136 -~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~ 207 (282)
T cd07831 136 -DILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLT-------DGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQ 207 (282)
T ss_pred -CCeEEEecccccccccCCCcCCCCCCcccCChhHhhc-------CCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHH
Confidence 6999999999986544333344567889999997642 24567899999999999999999999987654332
Q ss_pred HHHHHhccCC----------------------------CCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 158 AYAAAFKNVR----------------------------PSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 158 ~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
.......... .....++.++.++|.+||..+|.+||++.+++++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 208 IAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred HHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 2211110000 0013467899999999999999999999999986
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=239.65 Aligned_cols=191 Identities=24% Similarity=0.414 Sum_probs=152.3
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEEeCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLTEDL 78 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~gi~H~Dikp~Nill~~~~ 78 (268)
++++++|++ .+++.++||||++|++|.+++.+.+. +++..+..++.|++.||.|||+ .+++|+||||+||+++.+
T Consensus 60 ~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~- 136 (308)
T cd06615 60 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSR- 136 (308)
T ss_pred CCCeEEEEEeeCCEEEEEeeccCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecC-
Confidence 578999998 56789999999999999999987644 8999999999999999999998 599999999999999988
Q ss_pred CCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 79 KTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 79 ~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
+.++|+|||++...... ......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...+.....
T Consensus 137 ~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~aPE~~~~--------~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~ 207 (308)
T cd06615 137 GEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQG--------THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELE 207 (308)
T ss_pred CcEEEccCCCccccccc-ccccCCCCcCccChhHhcC--------CCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHH
Confidence 68999999998754322 2234578899999998753 45778999999999999999999998654322211
Q ss_pred HHHHh-----------------------------------ccCCCC--CCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 159 YAAAF-----------------------------------KNVRPS--AENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 159 ~~~~~-----------------------------------~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
..... ....+. ...++.++++++.+||..+|++||++.+++++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 208 AMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred HhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 10000 000011 12367789999999999999999999999998
Q ss_pred HH
Q 024408 202 LL 203 (268)
Q Consensus 202 l~ 203 (268)
.+
T Consensus 288 ~~ 289 (308)
T cd06615 288 PF 289 (308)
T ss_pred hh
Confidence 54
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=236.03 Aligned_cols=194 Identities=25% Similarity=0.469 Sum_probs=152.8
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCC----------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRP----------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKP 69 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~----------~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp 69 (268)
+++++++++ .++..++||||++|++|.+++..... ..+++.+++.++.|++.||+|||++|++|+||||
T Consensus 78 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp 157 (295)
T cd05097 78 NIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLAT 157 (295)
T ss_pred CcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccCh
Confidence 578999999 55688999999999999999965321 1378899999999999999999999999999999
Q ss_pred CCEEEeCCCCCeEEecCCCcccccccc---ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh--
Q 024408 70 ENLLLTEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-- 144 (268)
Q Consensus 70 ~Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-- 144 (268)
+||+++.+ +.+||+|||++....... ......++..|+|||.+.+ ..++.++|+||||+++++|++
T Consensus 158 ~Nill~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwSlG~~l~el~~~~ 228 (295)
T cd05097 158 RNCLVGNH-YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL--------GKFTTASDVWAFGVTLWEMFTLC 228 (295)
T ss_pred hhEEEcCC-CcEEecccccccccccCcceeccCcCcCceeecChhhhcc--------CCcCchhhHHHHHHHHHHHHHcC
Confidence 99999987 689999999987533221 1122344678999998754 557889999999999999988
Q ss_pred CCCCCCCCChHHHHHHHHh-------ccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 024408 145 NKLPFEGMSNLQAAYAAAF-------KNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 203 (268)
Q Consensus 145 g~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~ 203 (268)
+..||......+....... .........+++.+.+++.+|+..+|++||++.++++.|.
T Consensus 229 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 229 KEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred CCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 6678876554332222111 1112234567899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=232.96 Aligned_cols=192 Identities=25% Similarity=0.394 Sum_probs=158.0
Q ss_pred CceeEEEeec---CCcEEEEEEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHH-----HCCCeecCCCCC
Q 024408 1 MREQFIGACK---EPVMVIVTELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLH-----SHGIIHRDLKPE 70 (268)
Q Consensus 1 ~~v~l~g~~~---~~~~~lV~e~~~ggsL~~~i~~~--~~~~~~~~~~~~~~~~l~~~l~~lH-----~~gi~H~Dikp~ 70 (268)
+++++++++. +...++||||++|++|.+++... ....+++.+++.++.|++.||.+|| +.+++|+||+|+
T Consensus 60 ~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~ 139 (265)
T cd08217 60 NIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPA 139 (265)
T ss_pred ccceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHH
Confidence 5788888762 24679999999999999999764 2345999999999999999999999 899999999999
Q ss_pred CEEEeCCCCCeEEecCCCccccccccc-cccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 024408 71 NLLLTEDLKTIKLADFGLAREESLTEM-MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPF 149 (268)
Q Consensus 71 Nill~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~ 149 (268)
||+++.+ +.++++|||++........ .....++..|+|||.+.. ..++.++|+||||+++++|++|+.||
T Consensus 140 nili~~~-~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~--------~~~~~~~Dv~slG~il~~l~~g~~p~ 210 (265)
T cd08217 140 NIFLDAN-NNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNH--------MSYDEKSDIWSLGCLIYELCALSPPF 210 (265)
T ss_pred HEEEecC-CCEEEecccccccccCCcccccccccCCCccChhhhcC--------CCCCchhHHHHHHHHHHHHHHCCCcc
Confidence 9999988 6999999999986544332 334568999999998854 45778999999999999999999999
Q ss_pred CCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 150 EGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
....................+..++..+.+++.+||..+|.+||++.+++++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 211 TARNQLQLASKIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred cCcCHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 8766444333333333334456788999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=238.31 Aligned_cols=193 Identities=22% Similarity=0.336 Sum_probs=153.1
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|++++++++ .++..++||||++ ++|.+++.+... .+++..+..++.|++.||.|||++|++|+||||+||+++.+ +
T Consensus 65 nI~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~-~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~-~ 141 (301)
T cd07873 65 NIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGN-SINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINER-G 141 (301)
T ss_pred CcceEEEEEecCCeEEEEEeccc-cCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCC-C
Confidence 588999999 4568899999996 699998876543 48999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccccc-ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESLTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.++|+|||++....... ......++..|+|||.+.+ ...++.++||||||+++|+|++|+.||...+..+..
T Consensus 142 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-------~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~ 214 (301)
T cd07873 142 ELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLG-------STDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQL 214 (301)
T ss_pred cEEECcCcchhccCCCCCcccccceeecccCcHHHhC-------CCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 99999999997533222 2234467889999998753 235678999999999999999999999876543332
Q ss_pred HHHHhccC--------------------CC---------CCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 024408 159 YAAAFKNV--------------------RP---------SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 203 (268)
Q Consensus 159 ~~~~~~~~--------------------~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~ 203 (268)
........ .+ ....+++.++++|.+||..||.+|||+.++++|-+
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~ 288 (301)
T cd07873 215 HFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPY 288 (301)
T ss_pred HHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 21111000 00 01356788999999999999999999999999743
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=236.20 Aligned_cols=189 Identities=26% Similarity=0.411 Sum_probs=154.2
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ .+++.++|+||++|++|.+++.+ . .+++..+..++.|++.||++||++|++||||+|+||+++.+ +
T Consensus 77 ~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-~--~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~-~ 152 (285)
T cd06648 77 NIVEMYSSYLVGDELWVVMEFLEGGALTDIVTH-T--RMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSD-G 152 (285)
T ss_pred ChheEEEEEEcCCeEEEEEeccCCCCHHHHHHh-C--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCC-C
Confidence 578999988 55689999999999999999976 3 38999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccccc-ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESLTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.++++|||.+....... ......|+..|+|||.+.+ ..++.++|+||+|+++|+|++|+.||.........
T Consensus 153 ~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~ 224 (285)
T cd06648 153 RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISR--------LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAM 224 (285)
T ss_pred cEEEcccccchhhccCCcccccccCCccccCHHHhcC--------CCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHH
Confidence 99999999887433221 2233468899999998854 45678999999999999999999999775544433
Q ss_pred HHHHhccCCC--CCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 159 YAAAFKNVRP--SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 159 ~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
.......... ....++..+.+++.+||..+|++||++.+++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 225 KRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred HHHHhcCCCCCcccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 3322221111 123478899999999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=232.47 Aligned_cols=180 Identities=28% Similarity=0.446 Sum_probs=153.4
Q ss_pred cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCCeEEecCCCc
Q 024408 10 KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 89 (268)
Q Consensus 10 ~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~~kl~Dfg~a 89 (268)
..+.+|.||||..||.|+-++.+... |++..+.-+..+|+.||.|||+++|++||+|.+|.|++.+ |++||+|||++
T Consensus 239 t~drlCFVMeyanGGeLf~HLsrer~--FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkD-GHIKitDFGLC 315 (516)
T KOG0690|consen 239 TQDRLCFVMEYANGGELFFHLSRERV--FSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKD-GHIKITDFGLC 315 (516)
T ss_pred cCceEEEEEEEccCceEeeehhhhhc--ccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccC-CceEeeecccc
Confidence 55789999999999999999987544 9999999999999999999999999999999999999999 79999999999
Q ss_pred cccc-cccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCC
Q 024408 90 REES-LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP 168 (268)
Q Consensus 90 ~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 168 (268)
+... ......+.+||+.|+|||++.. ..|+++.|.|.+|+++|||++|+.||...+.... ...+......
T Consensus 316 KE~I~~g~t~kTFCGTPEYLAPEVleD--------nDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kL-FeLIl~ed~k 386 (516)
T KOG0690|consen 316 KEEIKYGDTTKTFCGTPEYLAPEVLED--------NDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKL-FELILMEDLK 386 (516)
T ss_pred hhcccccceeccccCChhhcCchhhcc--------ccccceeehhhhhHHHHHHHhccCcccccchhHH-HHHHHhhhcc
Confidence 9643 4556788999999999999964 6789999999999999999999999987554333 3333333334
Q ss_pred CCCCCcHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 024408 169 SAENVPEELSIILTSCWKEDPNARP-----NFTQIIQM 201 (268)
Q Consensus 169 ~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~~~~~ 201 (268)
-+..++++.+.++..+|..||.+|. ++.+|.++
T Consensus 387 FPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 387 FPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred CCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 4778999999999999999999993 46666665
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=236.00 Aligned_cols=191 Identities=26% Similarity=0.355 Sum_probs=152.0
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ .....++||||+++++|..++..... +++..+..++.|++.||+|||+.|++|+||||+||+++++ +
T Consensus 61 ~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~-~ 137 (286)
T cd07847 61 NLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRG--VPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQ-G 137 (286)
T ss_pred CEeeeeeEEeeCCEEEEEEeccCccHHHHHHhCCCC--CCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCC-C
Confidence 578999998 45588999999998888777655433 9999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccccc-ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESLTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.++|+|||++....... ......++..|+|||.+.+ ...++.++|+||||+++|+|++|..||.+....+..
T Consensus 138 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~ 210 (286)
T cd07847 138 QIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVG-------DTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQL 210 (286)
T ss_pred cEEECccccceecCCCcccccCcccccccCCHHHHhC-------CCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 99999999998544332 2233457889999998753 234678999999999999999999999876654433
Q ss_pred HHHHhcc--------------------CCCC----------CCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 159 YAAAFKN--------------------VRPS----------AENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 159 ~~~~~~~--------------------~~~~----------~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
....... ..+. ...++..+.+++.+||..+|++||++.+++.+
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 211 YLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred HHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 3221100 0000 13467889999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=233.24 Aligned_cols=195 Identities=25% Similarity=0.394 Sum_probs=153.2
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPR-CLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL 78 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~-~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~ 78 (268)
++++++|++ .++..++||||++|++|.+++...... ..++..+..++.|++.||+|||++|++||||||+||+++.+.
T Consensus 66 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~ 145 (268)
T cd06624 66 NIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYS 145 (268)
T ss_pred CeeeeeeeeccCCEEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC
Confidence 578999999 556889999999999999999864322 138889999999999999999999999999999999998754
Q ss_pred CCeEEecCCCccccccc-cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 024408 79 KTIKLADFGLAREESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA 157 (268)
Q Consensus 79 ~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~ 157 (268)
+.++|+|||++...... .......++..|+|||.+.. ....++.++|+||+|+++|+|++|+.||........
T Consensus 146 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~------~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~ 219 (268)
T cd06624 146 GVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDK------GPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA 219 (268)
T ss_pred CeEEEecchhheecccCCCccccCCCCccccChhhhcc------ccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh
Confidence 68999999998753322 12233457889999998753 123467899999999999999999999976443222
Q ss_pred HH-HHH-hccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 158 AY-AAA-FKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 158 ~~-~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
.. ... .......+..+++++.+++.+||..+|.+||++.+++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 220 AMFKVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred hHhhhhhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 21 111 122223355678999999999999999999999999986
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=232.87 Aligned_cols=193 Identities=27% Similarity=0.447 Sum_probs=159.6
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++.+ .+...++|+||++|++|.+++.+.....+++..+..++.|++.||.|||+.|++|+||||+||+++++..
T Consensus 60 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~ 139 (257)
T cd08225 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGM 139 (257)
T ss_pred ChhhhhheeccCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCC
Confidence 578889888 5568899999999999999998765555899999999999999999999999999999999999988744
Q ss_pred CeEEecCCCcccccccc-ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESLTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.++++|||.+....... ......|++.|+|||.+.+ ..++.++|+||||++++++++|..||......+..
T Consensus 140 ~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~--------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~ 211 (257)
T cd08225 140 VAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQN--------RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLV 211 (257)
T ss_pred eEEecccccchhccCCcccccccCCCccccCHHHHcC--------CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHH
Confidence 57999999987543322 1223468889999998753 45678999999999999999999999876555544
Q ss_pred HHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 159 YAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
.........+....++.++.+++.+||..+|++||++.+++.+
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 212 LKICQGYFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred HHHhcccCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 4444444444556778999999999999999999999999886
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=245.49 Aligned_cols=190 Identities=24% Similarity=0.324 Sum_probs=146.0
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|+|++++++ .++..++|||++. ++|.+++.... ..+++.++..++.|++.||.|||++||+||||||+||+++.+ +
T Consensus 118 ~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~-~ 194 (357)
T PHA03209 118 SVIRMKDTLVSGAITCMVLPHYS-SDLYTYLTKRS-RPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDV-D 194 (357)
T ss_pred CCcChhheEEeCCeeEEEEEccC-CcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-C
Confidence 578999998 5567899999995 79999887643 349999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCC-CCCChH--H
Q 024408 80 TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPF-EGMSNL--Q 156 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~-~~~~~~--~ 156 (268)
.++|+|||+++............||..|+|||++.+ ..++.++||||||+++|||+++..++ ...... .
T Consensus 195 ~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~ 266 (357)
T PHA03209 195 QVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLAR--------DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEE 266 (357)
T ss_pred CEEEecCccccccccCcccccccccccccCCeecCC--------CCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHH
Confidence 899999999975433333345578999999999864 56788999999999999999855443 321111 0
Q ss_pred -------HHHHHHhc-cCC--------------------------------CCCCCCcHHHHHHHHhccccCCCCCCCHH
Q 024408 157 -------AAYAAAFK-NVR--------------------------------PSAENVPEELSIILTSCWKEDPNARPNFT 196 (268)
Q Consensus 157 -------~~~~~~~~-~~~--------------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 196 (268)
........ ... .....++..+.++|.+||+.||.+|||+.
T Consensus 267 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~ 346 (357)
T PHA03209 267 YVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAE 346 (357)
T ss_pred HHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHH
Confidence 00000000 000 00123466778899999999999999999
Q ss_pred HHHHH
Q 024408 197 QIIQM 201 (268)
Q Consensus 197 ~~~~~ 201 (268)
++++|
T Consensus 347 e~l~h 351 (357)
T PHA03209 347 EILNY 351 (357)
T ss_pred HHhcC
Confidence 99998
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=232.90 Aligned_cols=191 Identities=26% Similarity=0.373 Sum_probs=156.6
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++.+ .+...++||||++|++|.+++.+... +++..+..++.|++.||.|||++|++|+||+|+||+++.+ +
T Consensus 54 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~-~ 130 (262)
T cd05572 54 FIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGL--FDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSN-G 130 (262)
T ss_pred CEeeeeeeEEcCCccEEEEecCCCCcHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCC-C
Confidence 578899988 55688999999999999999987544 8999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--hHHH
Q 024408 80 TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS--NLQA 157 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~--~~~~ 157 (268)
.++|+|||.+.............++..|++||.+.. ..++.++|+||+|+++|++++|..||.... ..+.
T Consensus 131 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~--------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~ 202 (262)
T cd05572 131 YVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILN--------KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEI 202 (262)
T ss_pred CEEEeeCCcccccCcccccccccCCcCccChhHhcC--------CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHH
Confidence 999999999986544333334567889999998753 456788999999999999999999997655 3333
Q ss_pred HHHHHh-ccCCCCCCCCcHHHHHHHHhccccCCCCCCC-----HHHHHHHH
Q 024408 158 AYAAAF-KNVRPSAENVPEELSIILTSCWKEDPNARPN-----FTQIIQML 202 (268)
Q Consensus 158 ~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~~~~~~l 202 (268)
...... ......+...+.++.++|.+||..+|.+||+ +++++++-
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~ 253 (262)
T cd05572 203 YNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHK 253 (262)
T ss_pred HHHHhccCCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcCh
Confidence 222221 2223334556899999999999999999999 88888873
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=230.73 Aligned_cols=200 Identities=24% Similarity=0.393 Sum_probs=151.9
Q ss_pred CceeEEEeec-CCcEEEEEEcCCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCC
Q 024408 1 MREQFIGACK-EPVMVIVTELLSGGTLRKYLLNMRP--RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED 77 (268)
Q Consensus 1 ~~v~l~g~~~-~~~~~lV~e~~~ggsL~~~i~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~ 77 (268)
++|+++|.|. ....++||||++||+|.+++.+... ...++..+..++.|++.||+|||+++++||||||+||+++.+
T Consensus 56 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~ 135 (268)
T cd05086 56 NILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSD 135 (268)
T ss_pred chhheEEEecCCCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCC
Confidence 5789999994 4578999999999999999986432 336778888999999999999999999999999999999988
Q ss_pred CCCeEEecCCCccccccc---cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 024408 78 LKTIKLADFGLAREESLT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMS 153 (268)
Q Consensus 78 ~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~ 153 (268)
+.++|+|||++...... .......++..|+|||++..... ......++.++||||||+++|+|++ |..||....
T Consensus 136 -~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~ 213 (268)
T cd05086 136 -LTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHG-GLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS 213 (268)
T ss_pred -ccEEecccccccccCcchhhhcccCCcCcccccCchhcccccC-ccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC
Confidence 68999999998642211 11223467889999998753111 0112345778999999999999997 577887665
Q ss_pred hHHHHHHHHhccC----CC-CCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 024408 154 NLQAAYAAAFKNV----RP-SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 203 (268)
Q Consensus 154 ~~~~~~~~~~~~~----~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~ 203 (268)
..+.......... .+ ....++..+.+++..|| .+|++||+++++++.|.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 214 DREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred HHHHHHHHHhhcccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 5443333222211 11 23457788999999999 67999999999988763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=234.98 Aligned_cols=191 Identities=26% Similarity=0.374 Sum_probs=152.9
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ .+...++||||+ |++|.+++.... ..+++.+++.++.|++.||+|||+.|++|+||||+||+++.+ +
T Consensus 60 ~i~~~~~~~~~~~~~~~v~e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~-~ 136 (286)
T cd07832 60 YVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISAD-G 136 (286)
T ss_pred CCcceeeEEecCCeeEEEeccc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCC-C
Confidence 578899988 556889999999 999999987644 449999999999999999999999999999999999999987 6
Q ss_pred CeEEecCCCcccccccc--ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 024408 80 TIKLADFGLAREESLTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA 157 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~ 157 (268)
.++++|||++....... ......++..|+|||.+.+ ...++.++||||+|+++++|++|.++|.+......
T Consensus 137 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~ 209 (286)
T cd07832 137 VLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYG-------ARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQ 209 (286)
T ss_pred cEEEeeeeecccccCCCCCccccccCcccccCceeeec-------cccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHH
Confidence 89999999988544332 2334568899999998753 23467899999999999999999888876554332
Q ss_pred HHHHHhccCCC-----------------------------CCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 158 AYAAAFKNVRP-----------------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 158 ~~~~~~~~~~~-----------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
..........+ .....+.++.++|.+||..+|.+||+++++++|
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 210 LAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred HHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 22211111000 013456889999999999999999999999987
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=236.75 Aligned_cols=191 Identities=27% Similarity=0.436 Sum_probs=151.0
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++.+ .+++.++||||++|++|.+++...+. +++..+..++.|++.||.|||++|++||||||+||+++.+ +
T Consensus 62 ~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~-~ 138 (305)
T cd05609 62 FVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGA--LPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSM-G 138 (305)
T ss_pred CeeeeEEEEecCCEEEEEEecCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCC-C
Confidence 578999988 55678999999999999999977544 8999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccccc----------------ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHH
Q 024408 80 TIKLADFGLAREESLTE----------------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL 143 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~----------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll 143 (268)
.++++|||+++...... ......++..|+|||.+.+ ..++.++|+||||+++|+++
T Consensus 139 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~vl~el~ 210 (305)
T cd05609 139 HIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILR--------QGYGKPVDWWAMGIILYEFL 210 (305)
T ss_pred CEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccC--------CCCCchhhHHHHHHHHHHHH
Confidence 99999999986311100 0112356788999998753 45788999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHhccC-CC-CCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 024408 144 HNKLPFEGMSNLQAAYAAAFKNV-RP-SAENVPEELSIILTSCWKEDPNARPNFTQIIQML 202 (268)
Q Consensus 144 ~g~~p~~~~~~~~~~~~~~~~~~-~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l 202 (268)
+|..||.+....+.......... .+ ....++.++.++|.+||+.+|++||+..++.+.+
T Consensus 211 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll 271 (305)
T cd05609 211 VGCVPFFGDTPEELFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVK 271 (305)
T ss_pred hCCCCCCCCCHHHHHHHHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHH
Confidence 99999987655444433332221 11 2236789999999999999999999854444433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=234.04 Aligned_cols=195 Identities=27% Similarity=0.459 Sum_probs=150.6
Q ss_pred CceeEEEeec---CCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCC
Q 024408 1 MREQFIGACK---EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED 77 (268)
Q Consensus 1 ~~v~l~g~~~---~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~ 77 (268)
++++++|++. ....++||||++|++|.+++.+... .+++..+..++.|++.||+|||++|++||||||+||+++.+
T Consensus 66 ~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~ 144 (284)
T cd05081 66 NIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRE-RLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESE 144 (284)
T ss_pred CeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHhcCc-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCC
Confidence 5789999873 2468999999999999999976433 38999999999999999999999999999999999999988
Q ss_pred CCCeEEecCCCccccccccc----cccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 024408 78 LKTIKLADFGLAREESLTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS 153 (268)
Q Consensus 78 ~~~~kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~ 153 (268)
+.++|+|||++........ .....++..|+|||.+.+ ..++.++|+||||++++||++|..++....
T Consensus 145 -~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~el~~~~~~~~~~~ 215 (284)
T cd05081 145 -NRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTE--------SKFSVASDVWSFGVVLYELFTYSDKSCSPP 215 (284)
T ss_pred -CeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhcc--------CCcChHHHHHHHHHHHHHHhhcCCcCCCcc
Confidence 6899999999985432211 111223456999998854 557889999999999999999876654322
Q ss_pred hHHH---------------HHH-HHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHh
Q 024408 154 NLQA---------------AYA-AAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 205 (268)
Q Consensus 154 ~~~~---------------~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~ 205 (268)
.... ... .......+....++.++.+++.+||..+|++|||+.++++.|+.+
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 216 AEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred hhhhhhcccccccccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 1100 000 111112233566889999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=237.64 Aligned_cols=191 Identities=34% Similarity=0.539 Sum_probs=154.4
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ .....++||||+++++|.+++..... +++.++..++.|++.||.+||++|++|+||||+||+++.+ +
T Consensus 59 ~i~~~~~~~~~~~~~~~v~~~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~-~ 135 (260)
T PF00069_consen 59 NIVQILDVFQDDNYLYIVMEYCPGGSLQDYLQKNKP--LSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDEN-G 135 (260)
T ss_dssp TBCHEEEEEEESSEEEEEEEEETTEBHHHHHHHHSS--BBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTT-S
T ss_pred cccccccccccccccccccccccccccccccccccc--cccccccccccccccccccccccccccccccccccccccc-c
Confidence 578889998 56789999999998899999985444 9999999999999999999999999999999999999977 6
Q ss_pred CeEEecCCCcccc-ccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREE-SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.++|+|||.+... ..........++..|+|||++.. ....+.++|+||||+++++|++|..||.........
T Consensus 136 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~ 208 (260)
T PF00069_consen 136 EVKLIDFGSSVKLSENNENFNPFVGTPEYMAPEVLQQ-------GKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQL 208 (260)
T ss_dssp EEEESSGTTTEESTSTTSEBSSSSSSGGGSCHHHHTT-------TSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccc-------cccccccccccccccccccccccccccccccchhhh
Confidence 9999999999752 23334455678999999999851 267788999999999999999999999876322222
Q ss_pred HHHH--hc-c---CCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 159 YAAA--FK-N---VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 159 ~~~~--~~-~---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
.... .. . ........+.++.++|.+||+.||++||++.+++++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 209 EIIEKILKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp HHHHHHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred hhhhhcccccccccccccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1111 11 0 111112234899999999999999999999999886
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=233.58 Aligned_cols=190 Identities=24% Similarity=0.430 Sum_probs=153.2
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
++++++|++ .++..++||||++|++|.+++... .+++..++.++.|++.||.|||+.|++|+||+|+||+++.+ +
T Consensus 63 ~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~-~ 138 (277)
T cd06917 63 NITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNT-G 138 (277)
T ss_pred CeeeEeeeeeeCCEEEEEEecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCC-C
Confidence 578999998 556889999999999999998653 48999999999999999999999999999999999999987 6
Q ss_pred CeEEecCCCcccccccc-ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESLTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.++++|||++....... ......|+..|+|||.+.+ ...++.++|+||||+++|+|++|..||.........
T Consensus 139 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~ 211 (277)
T cd06917 139 NVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITE-------GKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM 211 (277)
T ss_pred CEEEccCCceeecCCCccccccccCCcceeCHHHhcc-------CCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhh
Confidence 99999999987543322 2233468889999998753 244678999999999999999999999875543332
Q ss_pred HHHHhccCCCC-CCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 159 YAAAFKNVRPS-AENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 159 ~~~~~~~~~~~-~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
........... ...++.++.+++.+||..||++||++.+++++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 212 MLIPKSKPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred hccccCCCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 21111111111 22378899999999999999999999999986
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=231.59 Aligned_cols=187 Identities=25% Similarity=0.331 Sum_probs=153.0
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++.+ .++..++||||++|++|.+++..... +++..+..++.|++.||.|||+.|++|+||+|+||+++++ +
T Consensus 58 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~-~ 134 (260)
T cd05611 58 YVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGG--LPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQT-G 134 (260)
T ss_pred CeeeeeeeEEcCCeEEEEEeccCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC-C
Confidence 578999998 55689999999999999999987554 8999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 024408 80 TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY 159 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~ 159 (268)
.++|+|||++..... .....++..|++||.+.+ ..++.++|+||+|+++|++++|..||......+...
T Consensus 135 ~~~l~dfg~~~~~~~---~~~~~~~~~y~~pe~~~~--------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~ 203 (260)
T cd05611 135 HLKLTDFGLSRNGLE---NKKFVGTPDYLAPETILG--------VGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFD 203 (260)
T ss_pred cEEEeecccceeccc---cccCCCCcCccChhhhcC--------CCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 999999999875332 234467889999998754 346889999999999999999999998766544333
Q ss_pred HHHhccC---CCCCCCCcHHHHHHHHhccccCCCCCCCH---HHHHHH
Q 024408 160 AAAFKNV---RPSAENVPEELSIILTSCWKEDPNARPNF---TQIIQM 201 (268)
Q Consensus 160 ~~~~~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~---~~~~~~ 201 (268)
....... ......++..+.+++.+||..+|++||++ .+++.|
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 204 NILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred HHHhcccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence 3222221 11234678999999999999999999965 566555
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=237.99 Aligned_cols=189 Identities=28% Similarity=0.477 Sum_probs=153.6
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ .+++.++||||++|++|.+++.+. .+++.++..++.|++.||.|||+.|++||||||+||+++.+ +
T Consensus 77 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~-~ 152 (297)
T cd06656 77 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMD-G 152 (297)
T ss_pred CEeeEEEEEecCCEEEEeecccCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-C
Confidence 578999998 556899999999999999998652 38899999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccccc-ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESLTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.++|+|||++....... ......+++.|+|||.+.+ ..++.++|+||||+++|++++|..||.........
T Consensus 153 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~ 224 (297)
T cd06656 153 SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR--------KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL 224 (297)
T ss_pred CEEECcCccceEccCCccCcCcccCCccccCHHHHcC--------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhe
Confidence 99999999987543322 1233467889999998853 55678999999999999999999999765443322
Q ss_pred HHHHhccC--CCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 159 YAAAFKNV--RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 159 ~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
........ ...+..++..+.+++.+||..+|.+||++++++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 225 YLIATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred eeeccCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 22111111 11245678899999999999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=246.14 Aligned_cols=190 Identities=24% Similarity=0.301 Sum_probs=149.2
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
++|++++++ .+...++|||++. ++|.+++.... .+++.+++.++.|++.||.|||++||+||||||+|||++.+ +
T Consensus 147 ~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~--~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~-~ 222 (392)
T PHA03207 147 AIINLIHAYRWKSTVCMVMPKYK-CDLFTYVDRSG--PLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEP-E 222 (392)
T ss_pred CccceeeeEeeCCEEEEEehhcC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCC-C
Confidence 578999988 5568999999995 79999995443 39999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccccc---ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH-
Q 024408 80 TIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL- 155 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~- 155 (268)
.++|+|||++....... ......||..|+|||++.+ ..++.++||||||+++|+|++|+.||.+....
T Consensus 223 ~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~ 294 (392)
T PHA03207 223 NAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLAL--------DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKS 294 (392)
T ss_pred CEEEccCccccccCcccccccccccccccCccCHhHhcC--------CCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCC
Confidence 99999999997533221 1234578999999999864 56788999999999999999999999654321
Q ss_pred --HHHHHHHh-------------------------ccCCC--------CCCCCcHHHHHHHHhccccCCCCCCCHHHHHH
Q 024408 156 --QAAYAAAF-------------------------KNVRP--------SAENVPEELSIILTSCWKEDPNARPNFTQIIQ 200 (268)
Q Consensus 156 --~~~~~~~~-------------------------~~~~~--------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~ 200 (268)
........ ....+ ....++.++.++|.+||..||++||++.+++.
T Consensus 295 ~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~ 374 (392)
T PHA03207 295 SSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILS 374 (392)
T ss_pred cHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhh
Confidence 00000000 00000 01234678889999999999999999999999
Q ss_pred HH
Q 024408 201 ML 202 (268)
Q Consensus 201 ~l 202 (268)
+-
T Consensus 375 ~p 376 (392)
T PHA03207 375 LP 376 (392)
T ss_pred Cc
Confidence 83
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=230.61 Aligned_cols=190 Identities=28% Similarity=0.429 Sum_probs=156.6
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEEeCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLTEDL 78 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~gi~H~Dikp~Nill~~~~ 78 (268)
+++++++++ ..+..++||||++|++|.+++.+... +++..++.++.|++.||++||+ +|++|+||+|+||+++.+
T Consensus 60 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~- 136 (264)
T cd06623 60 YVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGK--IPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSK- 136 (264)
T ss_pred CeeeEEEEEccCCeEEEEEEecCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCC-
Confidence 578899998 45688999999999999999987643 9999999999999999999999 999999999999999988
Q ss_pred CCeEEecCCCcccccccccc-ccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--hH
Q 024408 79 KTIKLADFGLAREESLTEMM-TAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS--NL 155 (268)
Q Consensus 79 ~~~kl~Dfg~a~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~--~~ 155 (268)
+.++|+|||.+......... ....++..|+|||.+.+ ..++.++|+||||+++|++++|..||.... ..
T Consensus 137 ~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~--------~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~ 208 (264)
T cd06623 137 GEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQG--------ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSF 208 (264)
T ss_pred CCEEEccCccceecccCCCcccceeecccccCHhhhCC--------CCCCchhhHHHHHHHHHHHHhCCCCCccccccCH
Confidence 69999999998854433222 24467889999998754 467889999999999999999999997764 22
Q ss_pred HHHHHH-HhccCCCCCCC-CcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 156 QAAYAA-AFKNVRPSAEN-VPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 156 ~~~~~~-~~~~~~~~~~~-~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
...... ........... ++..+.++|..||..+|++||++.+++++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 209 FELMQAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred HHHHHHHhcCCCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 222222 22222233444 78999999999999999999999999997
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=235.83 Aligned_cols=196 Identities=29% Similarity=0.343 Sum_probs=153.9
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ .++..++||||+ +++|.+++.... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.+ +
T Consensus 63 ~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~-~ 139 (298)
T cd07841 63 NIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASD-G 139 (298)
T ss_pred CChhhhheeecCCEEEEEEccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCC-C
Confidence 578899998 456899999999 899999997654 249999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccc-cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.++|+|||++...... .......++..|+|||.+.+ ...++.++|+||||++++++++|.++|.+.......
T Consensus 140 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~ 212 (298)
T cd07841 140 VLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFG-------ARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQL 212 (298)
T ss_pred CEEEccceeeeeccCCCccccccccceeeeCHHHHhC-------CCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHH
Confidence 9999999999854432 22233456788999998743 245678999999999999999998888765543322
Q ss_pred HHHHhccCCC---------------------------CCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 024408 159 YAAAFKNVRP---------------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 208 (268)
Q Consensus 159 ~~~~~~~~~~---------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 208 (268)
.........+ .....+..+.++|.+||..+|++||++.+++++ .++..
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~--~~~~~ 287 (298)
T cd07841 213 GKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH--PYFSN 287 (298)
T ss_pred HHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC--ccccC
Confidence 2221110000 013456789999999999999999999999997 44444
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=234.25 Aligned_cols=197 Identities=25% Similarity=0.384 Sum_probs=154.3
Q ss_pred CceeEEEeecC------CcEEEEEEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCE
Q 024408 1 MREQFIGACKE------PVMVIVTELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENL 72 (268)
Q Consensus 1 ~~v~l~g~~~~------~~~~lV~e~~~ggsL~~~i~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Ni 72 (268)
|++++++++.. +..++||||++|++|.+++... ....+++..++.++.|++.||++||+.|++|+||||+||
T Consensus 80 ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~ni 159 (291)
T cd06639 80 NVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNI 159 (291)
T ss_pred CeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHE
Confidence 57889998842 3589999999999999988642 233489999999999999999999999999999999999
Q ss_pred EEeCCCCCeEEecCCCcccccccc-ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 024408 73 LLTEDLKTIKLADFGLAREESLTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 151 (268)
Q Consensus 73 ll~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~ 151 (268)
+++.+ +.++|+|||++....... ......|+..|+|||.+.... .....++.++|+||||+++|+|++|+.||..
T Consensus 160 li~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~~~~~Di~slGvi~~el~~g~~p~~~ 235 (291)
T cd06639 160 LLTTE-GGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQ---QYDYSYDARCDVWSLGITAIELGDGDPPLFD 235 (291)
T ss_pred EEcCC-CCEEEeecccchhcccccccccCccCCccccChhhhcCCC---CcccccCCccchHHHHHHHHHHhhCCCCCCC
Confidence 99988 689999999987543222 223446788999999875311 0112467899999999999999999999987
Q ss_pred CChHHHHHHHHhccCC--CCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 152 MSNLQAAYAAAFKNVR--PSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 152 ~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
................ ..+..++..+.++|.+||+.+|++||++.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 236 MHPVKTLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred CcHHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 6554443332222111 1234567889999999999999999999999987
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=235.80 Aligned_cols=189 Identities=17% Similarity=0.267 Sum_probs=146.2
Q ss_pred ceeEEEeecCC-----cEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeC
Q 024408 2 REQFIGACKEP-----VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE 76 (268)
Q Consensus 2 ~v~l~g~~~~~-----~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~ 76 (268)
++++++++... +.+++||++ ..++.+.+..... .++..+..++.|++.||+|||++|++||||||+|||++.
T Consensus 85 i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~ 161 (294)
T PHA02882 85 IPKYYGCGSFKRCRMYYRFILLEKL-VENTKEIFKRIKC--KNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDG 161 (294)
T ss_pred CCcEEEeeeEecCCceEEEEEEehh-ccCHHHHHHhhcc--CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC
Confidence 56777765321 458899998 4688887765433 678889999999999999999999999999999999998
Q ss_pred CCCCeEEecCCCccccccc--------cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 024408 77 DLKTIKLADFGLAREESLT--------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLP 148 (268)
Q Consensus 77 ~~~~~kl~Dfg~a~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p 148 (268)
+ +.++|+|||+++..... .......||+.|+|||++.+ ..++.++||||||+++++|++|+.|
T Consensus 162 ~-~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~--------~~~~~~~DiwSlG~~l~el~~g~~P 232 (294)
T PHA02882 162 N-NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG--------ACVTRRGDLESLGYCMLKWAGIKLP 232 (294)
T ss_pred C-CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCC--------CCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 7 68999999999754221 11123468999999998864 5678999999999999999999999
Q ss_pred CCCCChHHHHHH-------HHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 024408 149 FEGMSNLQAAYA-------AAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 202 (268)
Q Consensus 149 ~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l 202 (268)
|.+......... ............++..+.+++..|+..+|++||++.++++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 233 WKGFGHNGNLIHAAKCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred CCccccchHHHHHhHHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 987632211110 011111223456789999999999999999999999999875
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=231.67 Aligned_cols=193 Identities=26% Similarity=0.439 Sum_probs=156.0
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRP-RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL 78 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~ 78 (268)
+++++++.+ .++..++|||+++|++|.+++..... ..+++..+..++.|++.||.+||++|++|+||+|+||+++++
T Consensus 60 ~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~- 138 (267)
T cd06610 60 NVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGED- 138 (267)
T ss_pred CEEEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCC-
Confidence 478888888 55688999999999999999976433 459999999999999999999999999999999999999988
Q ss_pred CCeEEecCCCccccccccc-----cccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 024408 79 KTIKLADFGLAREESLTEM-----MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS 153 (268)
Q Consensus 79 ~~~kl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~ 153 (268)
+.++|+|||++........ .....|+..|++||.+.. ....+.++|+||||+++++|++|+.||....
T Consensus 139 ~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~-------~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~ 211 (267)
T cd06610 139 GSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQ-------VHGYDFKADIWSFGITAIELATGAAPYSKYP 211 (267)
T ss_pred CCEEEcccchHHHhccCccccccccccccCChhhcChHHHcc-------ccCcCcccchHhHhHHHHHHHhCCCCccccC
Confidence 6899999999874333221 133468889999998754 1357789999999999999999999998765
Q ss_pred hHHHHHHHHhccCCCC-----CCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 154 NLQAAYAAAFKNVRPS-----AENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 154 ~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
................ ...+++.+.+++.+||..||++||++.++++|
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 212 PMKVLMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred hhhhHHHHhcCCCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 5443333322221111 13577899999999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=250.15 Aligned_cols=191 Identities=28% Similarity=0.415 Sum_probs=165.9
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|.|+.-||+ .+...|||||||- ||-.|++.-.+ +++-+.++..|+.+.+.||+|||+.+.+|||||..|||+++. |
T Consensus 87 ntieYkgCyLre~TaWLVMEYCl-GSAsDlleVhk-KplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~-g 163 (948)
T KOG0577|consen 87 NTIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEP-G 163 (948)
T ss_pred CcccccceeeccchHHHHHHHHh-ccHHHHHHHHh-ccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCC-C
Confidence 567888998 5567899999995 78888887544 459999999999999999999999999999999999999998 7
Q ss_pred CeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 024408 80 TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY 159 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~ 159 (268)
.|||+|||.|....+. .+++|||.|||||++..+. .+.|+-+.||||||++..||...++|+..+......+
T Consensus 164 ~VKLaDFGSAsi~~PA---nsFvGTPywMAPEVILAMD-----EGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALY 235 (948)
T KOG0577|consen 164 LVKLADFGSASIMAPA---NSFVGTPYWMAPEVILAMD-----EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY 235 (948)
T ss_pred eeeeccccchhhcCch---hcccCCccccchhHheecc-----ccccCCccceeeccchhhhhhhcCCCccCchHHHHHH
Confidence 9999999999875544 5789999999999987643 5789999999999999999999999999988887777
Q ss_pred HHHhccC-CCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 024408 160 AAAFKNV-RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 202 (268)
Q Consensus 160 ~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l 202 (268)
.+..... ......++..++.++..||+.-|.+|||.++++.|.
T Consensus 236 HIAQNesPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~ 279 (948)
T KOG0577|consen 236 HIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHR 279 (948)
T ss_pred HHHhcCCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcc
Confidence 6654433 334677999999999999999999999999999873
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=231.58 Aligned_cols=189 Identities=26% Similarity=0.467 Sum_probs=152.0
Q ss_pred CceeEEEeecC---CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCC
Q 024408 1 MREQFIGACKE---PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED 77 (268)
Q Consensus 1 ~~v~l~g~~~~---~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~ 77 (268)
++++++|++.+ +.+++||||++|++|.+++.+... +++..++.++.|++.||.|||+.|++|+||+|+||+++.+
T Consensus 65 ~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~--l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~ 142 (266)
T cd06651 65 RIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGA--LTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSA 142 (266)
T ss_pred CeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCC
Confidence 57889998743 468999999999999999986554 8999999999999999999999999999999999999988
Q ss_pred CCCeEEecCCCccccccc----cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 024408 78 LKTIKLADFGLAREESLT----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS 153 (268)
Q Consensus 78 ~~~~kl~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~ 153 (268)
+.++|+|||+++..... .......++..|+|||.+.+ ..++.++|+||+|+++|++++|+.||....
T Consensus 143 -~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~i~~el~~g~~pf~~~~ 213 (266)
T cd06651 143 -GNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISG--------EGYGRKADVWSLGCTVVEMLTEKPPWAEYE 213 (266)
T ss_pred -CCEEEccCCCccccccccccCCccccCCccccccCHHHhCC--------CCCCchhhhHHHHHHHHHHHHCCCCccccc
Confidence 68999999998743221 11123457889999998854 557789999999999999999999998765
Q ss_pred hHHHHHHHHhccCCCC-CCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 154 NLQAAYAAAFKNVRPS-AENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 154 ~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
..............+. +..++..+.+++ .||..+|++||+++++++|
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 214 AMAAIFKIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred hHHHHHHHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 5544443332222222 445678889998 5777899999999999987
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=249.30 Aligned_cols=192 Identities=29% Similarity=0.377 Sum_probs=168.1
Q ss_pred CceeEEEeec-CCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGACK-EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~~-~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|+|+|+++.. ...+|+||||+.||.+++++.+++. ..+..+..++.|+++|++|||+++|+|||||++|||++.++
T Consensus 116 nIvkl~~v~~t~~~lylV~eya~~ge~~~yl~~~gr--~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~m- 192 (596)
T KOG0586|consen 116 NIVKLFSVIETEATLYLVMEYASGGELFDYLVKHGR--MKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENM- 192 (596)
T ss_pred ceeeeeeeeeecceeEEEEEeccCchhHHHHHhccc--chhhhhhhhhHHHHHHHHHHhhcceeccccchhhccccccc-
Confidence 6899999994 6799999999999999999998777 77799999999999999999999999999999999999996
Q ss_pred CeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 024408 80 TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY 159 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~ 159 (268)
++||+|||++..........+.+|++.|+|||++.+ ....++..|+||+|+++|-|+.|.+||++..-.....
T Consensus 193 nikIaDfgfS~~~~~~~~lqt~cgsppyAaPEl~~g-------~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~ 265 (596)
T KOG0586|consen 193 NIKIADFGFSTFFDYGLMLQTFCGSPPYAAPELFNG-------KKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRP 265 (596)
T ss_pred ceeeeccccceeecccccccccCCCCCccChHhhcC-------cccCCcceehhhhhhhheeeeecccccCCcccccccc
Confidence 799999999998887778889999999999999976 3467889999999999999999999999755444333
Q ss_pred HHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 024408 160 AAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 203 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~ 203 (268)
..... ....+..++.++.++|+++|.++|.+|++.+++.++.|
T Consensus 266 rvl~g-k~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W 308 (596)
T KOG0586|consen 266 RVLRG-KYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRW 308 (596)
T ss_pred hheee-eecccceeechhHHHHHHhhccCccccCCHHHhhhhcc
Confidence 33222 23345667889999999999999999999999998865
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=244.66 Aligned_cols=199 Identities=30% Similarity=0.513 Sum_probs=174.7
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|+|||+|.| .++-+|||.|||..|+|.|+|++..+.-++.-..+.++.||.+|++||..++++||||-..|+|++++ .
T Consensus 324 NLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEn-h 402 (1157)
T KOG4278|consen 324 NLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN-H 402 (1157)
T ss_pred cHHHHhhhhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhcccccc-c
Confidence 689999999 67789999999999999999999877768888889999999999999999999999999999999999 5
Q ss_pred CeEEecCCCccccccccccccCC---CccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChH
Q 024408 80 TIKLADFGLAREESLTEMMTAET---GTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNL 155 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~~~~~~---gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~~~ 155 (268)
.+|++|||+++....+.- .... -...|.|||.+.. ..++.++|||+||++|||+.| |..||.+.+..
T Consensus 403 iVKvADFGLsRlMtgDTY-TAHAGAKFPIKWTAPEsLAy--------NtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS 473 (1157)
T KOG4278|consen 403 IVKVADFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAY--------NTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS 473 (1157)
T ss_pred eEEeeccchhhhhcCCce-ecccCccCcccccCcccccc--------cccccchhhHHHHHHHHHHHhcCCCCCCCccHH
Confidence 899999999996543321 1122 2467999998865 567889999999999999988 89999998888
Q ss_pred HHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhc
Q 024408 156 QAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 209 (268)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~~ 209 (268)
++............++.||+.+.+|++.||+..|.+||+++++-+.++..+.+.
T Consensus 474 qVY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~s 527 (1157)
T KOG4278|consen 474 QVYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSS 527 (1157)
T ss_pred HHHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccc
Confidence 887777777777889999999999999999999999999999999998777643
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=258.08 Aligned_cols=199 Identities=23% Similarity=0.329 Sum_probs=155.2
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcC---------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMR---------PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPE 70 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~---------~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~ 70 (268)
|+|++++++ .++..++||||++||+|.+++.+.. ....+...++.++.|++.||+|||++|++||||||+
T Consensus 63 NIVkl~~v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPe 142 (932)
T PRK13184 63 GIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPD 142 (932)
T ss_pred CcCeEEEEEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchh
Confidence 578999999 5568899999999999999987521 123567788999999999999999999999999999
Q ss_pred CEEEeCCCCCeEEecCCCccccccc-------------------cccccCCCccceeccccccccccccCCCCCCCchhh
Q 024408 71 NLLLTEDLKTIKLADFGLAREESLT-------------------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVD 131 (268)
Q Consensus 71 Nill~~~~~~~kl~Dfg~a~~~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~D 131 (268)
||+++.+ +.++|+|||+++..... .......||+.|+|||.+.+ ..++.++|
T Consensus 143 NILLd~d-g~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g--------~~~S~kSD 213 (932)
T PRK13184 143 NILLGLF-GEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG--------VPASESTD 213 (932)
T ss_pred eEEEcCC-CCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC--------CCCCcHhH
Confidence 9999988 68999999999754110 00112468999999998864 56788999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCC--CCCCCCcHHHHHHHHhccccCCCCCC-CHHHHHHHHHHhHhh
Q 024408 132 SYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR--PSAENVPEELSIILTSCWKEDPNARP-NFTQIIQMLLNYLSA 208 (268)
Q Consensus 132 vwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rp-s~~~~~~~l~~~~~~ 208 (268)
|||||+++|+|++|..||.................. .....+|+.+.+++.+||..||++|| +++++++.|+.++..
T Consensus 214 IWSLGVILyELLTG~~PF~~~~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 214 IYALGVILYQMLTLSFPYRRKKGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred HHHHHHHHHHHHHCCCCCCCcchhhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 999999999999999999875443332221111111 11246789999999999999999996 567777778777654
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=235.71 Aligned_cols=191 Identities=23% Similarity=0.346 Sum_probs=147.5
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ ..+..++|+||++ ++|.+++..... .+++..++.++.|++.||.|||++|++||||||+||+++.+ +
T Consensus 60 ~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~-~ 136 (284)
T cd07839 60 NIVRLYDVLHSDKKLTLVFEYCD-QDLKKYFDSCNG-DIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKN-G 136 (284)
T ss_pred CeeeHHHHhccCCceEEEEecCC-CCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCC-C
Confidence 467888887 4568899999996 689888875433 39999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccc-cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.++|+|||+++..... .......++..|+|||.+.+ ...++.++|+||||+++|+|++|..|+.........
T Consensus 137 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~ 209 (284)
T cd07839 137 ELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG-------AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ 209 (284)
T ss_pred cEEECccchhhccCCCCCCcCCCccccCCcChHHHhC-------CcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHH
Confidence 9999999999754332 22234467889999998753 234678999999999999999998886433322221
Q ss_pred HHHHhcc-----------------C------------CCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 159 YAAAFKN-----------------V------------RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 159 ~~~~~~~-----------------~------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
....... . ......++++++++|.+||..||.+|||++++++|
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 210 LKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred HHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 1111000 0 01123467899999999999999999999999886
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=230.41 Aligned_cols=192 Identities=27% Similarity=0.472 Sum_probs=154.3
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
++++++|++ ..+..++||||++|++|.+++.+.+. +++..+..++.|++.||.+||++|++|+||+|+||+++.+ +
T Consensus 69 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~-~ 145 (272)
T cd06629 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGR--FEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDAD-G 145 (272)
T ss_pred CcceEEEEeccCCceEEEEecCCCCcHHHHHhhccC--CCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCC-C
Confidence 578999998 44688999999999999999987643 9999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccccc---ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH
Q 024408 80 TIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 156 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~ 156 (268)
.++++|||++....... ......++..|+|||.+.. ....++.++|+||||++++++++|..||.......
T Consensus 146 ~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~------~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~ 219 (272)
T cd06629 146 ICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHS------YSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA 219 (272)
T ss_pred eEEEeeccccccccccccccccccccCCccccCHHHhcc------ccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH
Confidence 99999999997533211 1233457889999998753 11246789999999999999999999997655544
Q ss_pred HHHHHHhccCCC-----CCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 157 AAYAAAFKNVRP-----SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 157 ~~~~~~~~~~~~-----~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
...........+ ....++.++.+++.+||..+|.+||++.+++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 220 AMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred HHHHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 333222211111 123568899999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=227.22 Aligned_cols=191 Identities=32% Similarity=0.523 Sum_probs=156.7
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++.+ .+...++|+||++|++|.+++.... ..+++..+..++.|++.||.+||++|++|+||+|+||+++.+ +
T Consensus 58 ~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~-~ 135 (253)
T cd05122 58 NIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSD-G 135 (253)
T ss_pred CEeEEEEEEecCCeEEEEEecCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccC-C
Confidence 478899988 4567899999999999999998753 349999999999999999999999999999999999999987 6
Q ss_pred CeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 024408 80 TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY 159 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~ 159 (268)
.++|+|||.+.............++..|+|||.+.. ...+.++|+||||++++++++|..||...+......
T Consensus 136 ~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~--------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~ 207 (253)
T cd05122 136 EVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVING--------KPYDYKADIWSLGITAIELAEGKPPYSELPPMKALF 207 (253)
T ss_pred eEEEeeccccccccccccccceecCCcccCHHHHcC--------CCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHH
Confidence 999999999986544332345568899999998854 346789999999999999999999998765444433
Q ss_pred HHHhccCCCC--CCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 160 AAAFKNVRPS--AENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 160 ~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
.......... ...++..+.++|.+||..||++||++.+++++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 208 KIATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred HHHhcCCCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 3332222222 22348899999999999999999999999876
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=237.25 Aligned_cols=193 Identities=20% Similarity=0.219 Sum_probs=143.7
Q ss_pred CceeEEEeec---CCcEEEEEEcCCCCCHHHHHHhcC-------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCC
Q 024408 1 MREQFIGACK---EPVMVIVTELLSGGTLRKYLLNMR-------PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPE 70 (268)
Q Consensus 1 ~~v~l~g~~~---~~~~~lV~e~~~ggsL~~~i~~~~-------~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~ 70 (268)
|+|++++++. +...++||||+. ++|.+++.... ...+++..+..++.|++.||.|||++|++||||||+
T Consensus 59 niv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~ 137 (317)
T cd07868 59 NVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPA 137 (317)
T ss_pred CCcceeeeEecCCCcEEEEEEeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHH
Confidence 5788999873 246899999995 69999886422 224899999999999999999999999999999999
Q ss_pred CEEEeC---CCCCeEEecCCCcccccccc----ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHH
Q 024408 71 NLLLTE---DLKTIKLADFGLAREESLTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL 143 (268)
Q Consensus 71 Nill~~---~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll 143 (268)
|||+.. ..+.+||+|||+++...... ......||+.|+|||++.+ ...++.++|+||+|+++|+|+
T Consensus 138 Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~el~ 210 (317)
T cd07868 138 NILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLG-------ARHYTKAIDIWAIGCIFAELL 210 (317)
T ss_pred HEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcC-------CCCcCchhhHHHHHHHHHHHH
Confidence 999942 22589999999997543221 1234578999999998854 235788999999999999999
Q ss_pred hCCCCCCCCChH---------HHHHHHHhccC---------------------------C----------CCCCCCcHHH
Q 024408 144 HNKLPFEGMSNL---------QAAYAAAFKNV---------------------------R----------PSAENVPEEL 177 (268)
Q Consensus 144 ~g~~p~~~~~~~---------~~~~~~~~~~~---------------------------~----------~~~~~~~~~l 177 (268)
+|+.||...... ........... . ......+..+
T Consensus 211 ~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (317)
T cd07868 211 TSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKA 290 (317)
T ss_pred hCCCCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHH
Confidence 999999643210 00000000000 0 0001234568
Q ss_pred HHHHHhccccCCCCCCCHHHHHHH
Q 024408 178 SIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 178 ~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
.++|.+||..||.+|||++++++|
T Consensus 291 ~dli~~mL~~dP~~R~t~~e~l~h 314 (317)
T cd07868 291 FHLLQKLLTMDPIKRITSEQAMQD 314 (317)
T ss_pred HHHHHHHhccCcccCCCHHHHhcC
Confidence 899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=232.02 Aligned_cols=192 Identities=28% Similarity=0.475 Sum_probs=157.4
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++.+ .++..++|+||++|++|.+++.... ..+++..+..++.+++.||.+||+.|++|+||+|+||+++.+ +
T Consensus 76 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~-~ 153 (286)
T cd06614 76 NIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKD-G 153 (286)
T ss_pred CeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCC-C
Confidence 578899998 5678999999999999999998765 249999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccccc-ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESLTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.++|+|||++....... ......++..|++||.+.+ ..++.++|+||||+++|+|++|+.||.........
T Consensus 154 ~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~ 225 (286)
T cd06614 154 SVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKR--------KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRAL 225 (286)
T ss_pred CEEECccchhhhhccchhhhccccCCcccCCHhHhcC--------CCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 99999999886433221 2233457889999998753 45678999999999999999999999876655444
Q ss_pred HHHHhccCCC--CCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 024408 159 YAAAFKNVRP--SAENVPEELSIILTSCWKEDPNARPNFTQIIQML 202 (268)
Q Consensus 159 ~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l 202 (268)
.......... ....++..+.++|.+||+.+|.+||++.+++++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 271 (286)
T cd06614 226 FLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHP 271 (286)
T ss_pred HHHHhcCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhCh
Confidence 4333322222 2334789999999999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=232.88 Aligned_cols=186 Identities=27% Similarity=0.458 Sum_probs=149.1
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
++++++|.+ .++..++||||++|++|..+. .+++..+..++.|++.||.|||+.|++|+||||+||+++.+ +
T Consensus 60 ~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~-~ 132 (279)
T cd06619 60 YIIGFYGAFFVENRISICTEFMDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTR-G 132 (279)
T ss_pred CeeeEEEEEEECCEEEEEEecCCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCC-C
Confidence 578999998 556889999999999996542 27899999999999999999999999999999999999998 6
Q ss_pred CeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH---
Q 024408 80 TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ--- 156 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~--- 156 (268)
.++|+|||++...... ......|+..|+|||++.+ ..++.++|+||||+++|+|++|+.||.......
T Consensus 133 ~~~l~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~ 203 (279)
T cd06619 133 QVKLCDFGVSTQLVNS-IAKTYVGTNAYMAPERISG--------EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL 203 (279)
T ss_pred CEEEeeCCcceecccc-cccCCCCChhhcCceeecC--------CCCCCcchHHHHHHHHHHHHhCCCCchhhccccccc
Confidence 9999999999754332 2234578999999998864 457889999999999999999999996532211
Q ss_pred ---HHHHHHhccCCC--CCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 024408 157 ---AAYAAAFKNVRP--SAENVPEELSIILTSCWKEDPNARPNFTQIIQML 202 (268)
Q Consensus 157 ---~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l 202 (268)
...........+ .....++++.+++.+||..+|.+||++++++++.
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~ 254 (279)
T cd06619 204 MPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHP 254 (279)
T ss_pred chHHHHHHHhccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCc
Confidence 111111111111 2345778999999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=235.99 Aligned_cols=190 Identities=26% Similarity=0.379 Sum_probs=154.4
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
++++++|.+ .++..++||||++|++|.+++.. ..+++.+++.++.|++.||.|||++|++|+||||+||+++.+ +
T Consensus 79 ~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~-~ 154 (297)
T cd06659 79 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLD-G 154 (297)
T ss_pred chhhhhhheeeCCeEEEEEecCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccC-C
Confidence 467888887 56789999999999999998754 238999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccccc-ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESLTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.++|+|||++....... ......|+..|+|||.+.+ ..++.++|+||+|+++++|++|+.||......+..
T Consensus 155 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~ 226 (297)
T cd06659 155 RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISR--------TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM 226 (297)
T ss_pred cEEEeechhHhhcccccccccceecCccccCHHHHcc--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 99999999987433222 2234568899999998854 45778999999999999999999999876554443
Q ss_pred HHHHhccC--CCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 024408 159 YAAAFKNV--RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 202 (268)
Q Consensus 159 ~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l 202 (268)
........ ......++..+.++|.+||..+|.+||++.+++++-
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~ 272 (297)
T cd06659 227 KRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHP 272 (297)
T ss_pred HHHhccCCCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhCh
Confidence 33221111 112345788999999999999999999999999973
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=240.39 Aligned_cols=188 Identities=26% Similarity=0.327 Sum_probs=147.4
Q ss_pred CceeEEEeecC-------CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEE
Q 024408 1 MREQFIGACKE-------PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 73 (268)
Q Consensus 1 ~~v~l~g~~~~-------~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nil 73 (268)
++|++++++.. ...+++||++ |++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+
T Consensus 75 ~iv~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil 150 (343)
T cd07878 75 NVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVA 150 (343)
T ss_pred chhhhhhhhcccccccccCcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEE
Confidence 46677776632 3579999999 7899988753 23999999999999999999999999999999999999
Q ss_pred EeCCCCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 024408 74 LTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS 153 (268)
Q Consensus 74 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~ 153 (268)
++.+ +.+||+|||+++..... .....|+..|+|||++.+ ...++.++||||||+++|+|++|+.||.+..
T Consensus 151 ~~~~-~~~kl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 220 (343)
T cd07878 151 VNED-CELRILDFGLARQADDE--MTGYVATRWYRAPEIMLN-------WMHYNQTVDIWSVGCIMAELLKGKALFPGND 220 (343)
T ss_pred ECCC-CCEEEcCCccceecCCC--cCCccccccccCchHhcC-------CccCCchhhhHhHHHHHHHHHHCCCCCCCCC
Confidence 9988 69999999999864332 234578999999998853 2457889999999999999999999998755
Q ss_pred hHHHHHHHHhccCCC------------------------------CCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 024408 154 NLQAAYAAAFKNVRP------------------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQML 202 (268)
Q Consensus 154 ~~~~~~~~~~~~~~~------------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l 202 (268)
..+...........+ .....++.+.++|.+||..||.+|||+.++++|-
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp 299 (343)
T cd07878 221 YIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHP 299 (343)
T ss_pred HHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence 433322211110000 0123456788999999999999999999999983
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=233.38 Aligned_cols=195 Identities=27% Similarity=0.459 Sum_probs=153.4
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCCEEEeC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHSH-GIIHRDLKPENLLLTE 76 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~-gi~H~Dikp~Nill~~ 76 (268)
++|++++++ .++..++||||++ |+|.+++... ....+++..++.++.|++.||+|||++ +++||||||+||+++.
T Consensus 61 ~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~ 139 (283)
T cd06617 61 YTVTFYGALFREGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINR 139 (283)
T ss_pred CeeeeeEEEecCCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECC
Confidence 578999999 5568999999996 7898888653 224599999999999999999999998 9999999999999998
Q ss_pred CCCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-H
Q 024408 77 DLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN-L 155 (268)
Q Consensus 77 ~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~-~ 155 (268)
+ +.+||+|||++.............++..|+|||.+.+.. ....++.++|+||+|+++|+|++|+.||..... .
T Consensus 140 ~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~ 214 (283)
T cd06617 140 N-GQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPEL----NQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF 214 (283)
T ss_pred C-CCEEEeecccccccccccccccccCCccccChhhcCCcc----cccccCccccchhhHHHHHHHHhCCCCCCccccCH
Confidence 8 699999999998644333333356888999999875311 114467889999999999999999999975332 2
Q ss_pred HHHHHHHhccCCC-CCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 156 QAAYAAAFKNVRP-SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 156 ~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
+............ ....++.++.++|.+||..+|.+||++.+++++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 215 QQLKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred HHHHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 2222222221111 134578999999999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=245.11 Aligned_cols=188 Identities=26% Similarity=0.495 Sum_probs=165.3
Q ss_pred CceeEEEee-cC--CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCCEEEe
Q 024408 1 MREQFIGAC-KE--PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG--IIHRDLKPENLLLT 75 (268)
Q Consensus 1 ~~v~l~g~~-~~--~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~g--i~H~Dikp~Nill~ 75 (268)
|+|+||... +. .++.+|.|++..|+|+.|+.+.+. ++...+..|++||+.||.|||++. |+|||||.+||+|+
T Consensus 102 NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~~~--vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFin 179 (632)
T KOG0584|consen 102 NIIRFYDSWVDTDNKTINFITELFTSGTLREYRKKHRR--VNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVN 179 (632)
T ss_pred ceeeeeeheecCCCceeeeeeecccCCcHHHHHHHhcc--CCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEc
Confidence 689999886 33 368999999999999999998877 999999999999999999999986 99999999999999
Q ss_pred CCCCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH
Q 024408 76 EDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL 155 (268)
Q Consensus 76 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~ 155 (268)
.+.|.|||+|+|+|........ .+.+|||.|||||+.- ..|....||||||++++||+|+..||..-.+.
T Consensus 180 G~~G~VKIGDLGLAtl~r~s~a-ksvIGTPEFMAPEmYE---------E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~ 249 (632)
T KOG0584|consen 180 GNLGEVKIGDLGLATLLRKSHA-KSVIGTPEFMAPEMYE---------ENYNELVDVYAFGMCMLEMVTSEYPYSECTNP 249 (632)
T ss_pred CCcCceeecchhHHHHhhcccc-ceeccCccccChHHHh---------hhcchhhhhhhhhHHHHHHHhccCChhhhCCH
Confidence 9889999999999986554433 4479999999999983 68999999999999999999999999887777
Q ss_pred HHHHHHHhccCCCC--CCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 156 QAAYAAAFKNVRPS--AENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 156 ~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
.+.+++......|. ..--.+++++||.+||.. ..+|+++.+++++
T Consensus 250 AQIYKKV~SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 250 AQIYKKVTSGIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred HHHHHHHHcCCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 77787777777664 223358999999999999 9999999999987
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=231.64 Aligned_cols=191 Identities=24% Similarity=0.409 Sum_probs=152.7
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++.+ ..+..++||||++|++|.+++.+.+. +++..+..++.|++.||.|||++|++|+||+|+||+++.+..
T Consensus 64 ~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~ 141 (268)
T cd06630 64 HIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGA--FKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQ 141 (268)
T ss_pred ceehhhceeccCCeEEEEEeccCCCcHHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC
Confidence 578899998 55688999999999999999987554 899999999999999999999999999999999999987644
Q ss_pred CeEEecCCCcccccccc-----ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh
Q 024408 80 TIKLADFGLAREESLTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN 154 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~ 154 (268)
.++|+|||.+....... ......++..|+|||.+.+ ..++.++|+||+|++++++++|..||.....
T Consensus 142 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~--------~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~ 213 (268)
T cd06630 142 RLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRG--------EQYGRSCDVWSVGCVIIEMATAKPPWNAEKH 213 (268)
T ss_pred EEEEcccccccccccccccCCccccccccccceeCHhHhcc--------CCCCcccchHHHHHHHHHHHhCCCCCCCCCC
Confidence 69999999987543321 1123457889999998754 4567899999999999999999999965432
Q ss_pred HHHHH---HHHh-ccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 155 LQAAY---AAAF-KNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 155 ~~~~~---~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
..... .... ......+..+++++.+++.+||..+|.+||++.+++++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 214 SNHLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred cchHHHHHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 21111 1111 11222345678999999999999999999999999976
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=246.21 Aligned_cols=190 Identities=22% Similarity=0.275 Sum_probs=146.0
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|||++++++ .++..++|||++. ++|.+++..... .+++.+++.++.|++.||.|||++||+||||||+|||++.+ +
T Consensus 221 nIv~l~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~-~ 297 (461)
T PHA03211 221 AVLALLDVRVVGGLTCLVLPKYR-SDLYTYLGARLR-PLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGP-E 297 (461)
T ss_pred CCCcEEEEEEECCEEEEEEEccC-CCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCC-C
Confidence 689999998 5668899999995 799998876433 49999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccccc---ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh--
Q 024408 80 TIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN-- 154 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~-- 154 (268)
.++|+|||+++...... ......||..|+|||++.+ ..++.++|||||||++|||++|..++.....
T Consensus 298 ~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--------~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~ 369 (461)
T PHA03211 298 DICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAG--------DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGD 369 (461)
T ss_pred CEEEcccCCceecccccccccccccCCCcCCcCHHHHcC--------CCCCchHHHHHHHHHHHHHHHcCCCcccCCccc
Confidence 89999999997533221 1223468999999999864 5578899999999999999987754422110
Q ss_pred -----HHHHHHHHhccC--------------------------CCC--------CCCCcHHHHHHHHhccccCCCCCCCH
Q 024408 155 -----LQAAYAAAFKNV--------------------------RPS--------AENVPEELSIILTSCWKEDPNARPNF 195 (268)
Q Consensus 155 -----~~~~~~~~~~~~--------------------------~~~--------~~~~~~~l~~li~~~l~~~p~~Rps~ 195 (268)
............ .+. ...++..+.+||.+||..||.+|||+
T Consensus 370 ~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa 449 (461)
T PHA03211 370 ERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSA 449 (461)
T ss_pred ccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCH
Confidence 011111110000 000 01345678999999999999999999
Q ss_pred HHHHHH
Q 024408 196 TQIIQM 201 (268)
Q Consensus 196 ~~~~~~ 201 (268)
.|+++|
T Consensus 450 ~elL~h 455 (461)
T PHA03211 450 AELLRL 455 (461)
T ss_pred HHHhhC
Confidence 999998
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=242.43 Aligned_cols=191 Identities=25% Similarity=0.368 Sum_probs=166.8
Q ss_pred ceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCC
Q 024408 2 REQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT 80 (268)
Q Consensus 2 ~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~ 80 (268)
+|+||--+ +.++.|++||-|-||.|+..+++++. |+..++.-++..+++|++|||++||++|||||+|.+++.+ |-
T Consensus 482 IvrLYrTfrd~kyvYmLmEaClGGElWTiLrdRg~--Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~-Gy 558 (732)
T KOG0614|consen 482 IVRLYRTFRDSKYVYMLMEACLGGELWTILRDRGS--FDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNR-GY 558 (732)
T ss_pred HHHHHHHhccchhhhhhHHhhcCchhhhhhhhcCC--cccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccC-Cc
Confidence 46777777 45689999999999999999998777 9999999999999999999999999999999999999999 79
Q ss_pred eEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 024408 81 IKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYA 160 (268)
Q Consensus 81 ~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~ 160 (268)
+||.|||+|+.........+++||+.|.|||++.+ +.-+.+.|.||||+++|||++|.+||.+.++......
T Consensus 559 ~KLVDFGFAKki~~g~KTwTFcGTpEYVAPEIILn--------KGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ 630 (732)
T KOG0614|consen 559 LKLVDFGFAKKIGSGRKTWTFCGTPEYVAPEIILN--------KGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNL 630 (732)
T ss_pred eEEeehhhHHHhccCCceeeecCCcccccchhhhc--------cCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHH
Confidence 99999999998888888889999999999999875 3346789999999999999999999999888776555
Q ss_pred HHhccCC-CCCCCCcHHHHHHHHhccccCCCCCCC-----HHHHHHHHH
Q 024408 161 AAFKNVR-PSAENVPEELSIILTSCWKEDPNARPN-----FTQIIQMLL 203 (268)
Q Consensus 161 ~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~~~~~~l~ 203 (268)
+...... ..+..++....++|+++...+|.+|.. +.+|..|.|
T Consensus 631 ILkGid~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~W 679 (732)
T KOG0614|consen 631 ILKGIDKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRW 679 (732)
T ss_pred HHhhhhhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhh
Confidence 4443322 236788899999999999999999964 788888865
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=229.43 Aligned_cols=189 Identities=25% Similarity=0.422 Sum_probs=151.8
Q ss_pred CceeEEEeecC---CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCC
Q 024408 1 MREQFIGACKE---PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED 77 (268)
Q Consensus 1 ~~v~l~g~~~~---~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~ 77 (268)
++++++|++.+ ..+++||||++|++|.+++.+... +++..+..++.|++.||++||++|++|+||||+||+++.+
T Consensus 65 ~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~ 142 (265)
T cd06652 65 RIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGA--LTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSV 142 (265)
T ss_pred CeeeEEeEeccCCCceEEEEEEecCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCC
Confidence 47889998743 367899999999999999986544 8899999999999999999999999999999999999988
Q ss_pred CCCeEEecCCCccccccc----cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 024408 78 LKTIKLADFGLAREESLT----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS 153 (268)
Q Consensus 78 ~~~~kl~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~ 153 (268)
+.++|+|||++...... .......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||....
T Consensus 143 -~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 213 (265)
T cd06652 143 -GNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISG--------EGYGRKADIWSVGCTVVEMLTEKPPWAEFE 213 (265)
T ss_pred -CCEEECcCccccccccccccccccccCCCCccccChhhhcC--------CCCCcchhHHHHHHHHHHHhhCCCCCCccc
Confidence 69999999998743221 11233468889999998853 456789999999999999999999998765
Q ss_pred hHHHHHHHHhccC-CCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 154 NLQAAYAAAFKNV-RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 154 ~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
............. ...+...+..+.++|.+|+. +|++||++++++++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 214 AMAAIFKIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred hHHHHHHHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 4444333222222 22345567889999999994 99999999999886
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=222.52 Aligned_cols=200 Identities=23% Similarity=0.369 Sum_probs=154.1
Q ss_pred CceeEEEee-cC-----CcEEEEEEcCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCC
Q 024408 1 MREQFIGAC-KE-----PVMVIVTELLSGGTLRKYLLNMR--PRCLDVCVAIGFALDIARAMECLHSHG--IIHRDLKPE 70 (268)
Q Consensus 1 ~~v~l~g~~-~~-----~~~~lV~e~~~ggsL~~~i~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~g--i~H~Dikp~ 70 (268)
||++++.++ .+ .+.|||+.|+..|||.+.|.+.. +..+++.+++.|+.++++||++||+.. +.||||||.
T Consensus 79 ~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~ 158 (302)
T KOG2345|consen 79 NVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPA 158 (302)
T ss_pred chHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcc
Confidence 355566655 22 25899999999999999998753 335999999999999999999999998 999999999
Q ss_pred CEEEeCCCCCeEEecCCCccccccccc----------cccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHH
Q 024408 71 NLLLTEDLKTIKLADFGLAREESLTEM----------MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLW 140 (268)
Q Consensus 71 Nill~~~~~~~kl~Dfg~a~~~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~ 140 (268)
||+++++ +.+++.|||.+........ ......|..|+|||.+..- .....+.+.|||||||++|
T Consensus 159 NILls~~-~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk-----~~~ti~ertDIWSLGCtLY 232 (302)
T KOG2345|consen 159 NILLSDS-GLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVK-----SHCTITERTDIWSLGCTLY 232 (302)
T ss_pred eeEecCC-CceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecc-----cCcccccccchhhhhHHHH
Confidence 9999987 6999999999875433221 1123468899999998641 2356788999999999999
Q ss_pred HHHhCCCCCCCCChH--HHHHHHH-hccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhH
Q 024408 141 ELLHNKLPFEGMSNL--QAAYAAA-FKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 206 (268)
Q Consensus 141 ~ll~g~~p~~~~~~~--~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 206 (268)
.|+.|..||+..-.. ....... -....|....+++.+.++|+.||+.||.+||++.+++..+.+..
T Consensus 233 a~mf~~sPfe~~~~~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 233 AMMFGESPFERIYQQGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred HHHHcCCcchHHhhcCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 999999999631110 0000011 12223445568999999999999999999999999999987653
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=230.85 Aligned_cols=193 Identities=26% Similarity=0.357 Sum_probs=152.9
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ .++..++||||++ ++|.+++.......+++..+..++.|++.||+|||++|++|+||+|+||+++.+.+
T Consensus 62 ~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~ 140 (294)
T PLN00009 62 NIVRLQDVVHSEKRLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTN 140 (294)
T ss_pred CEeeEEEEEecCCeEEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCC
Confidence 578999999 5568999999995 68999887665555789999999999999999999999999999999999986545
Q ss_pred CeEEecCCCccccccc-cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.+||+|||++...... .......++..|+|||.+.+ ...++.++|+||+|+++|+|++|..||......+..
T Consensus 141 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-------~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~ 213 (294)
T PLN00009 141 ALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLG-------SRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDEL 213 (294)
T ss_pred EEEEcccccccccCCCccccccCceeecccCHHHHhC-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 7999999999754322 22233467889999998753 235678999999999999999999999876554433
Q ss_pred HHHHhccCCC----------------------------CCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 159 YAAAFKNVRP----------------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 159 ~~~~~~~~~~----------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
.........+ ....+++.+.+++.+||+.+|++||++.+++++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 214 FKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred HHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 3221110000 023567889999999999999999999999987
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=235.70 Aligned_cols=196 Identities=22% Similarity=0.401 Sum_probs=153.2
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ .++..+++|||+++++|.+++.+.....+++..+..++.|++.||+|||++||+||||||+||+++.+ +
T Consensus 60 ~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~-~ 138 (314)
T cd08216 60 NILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGD-G 138 (314)
T ss_pred chhhhhheeecCCeEEEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecC-C
Confidence 578888888 55688999999999999999987655559999999999999999999999999999999999999987 6
Q ss_pred CeEEecCCCccccccc--------cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 024408 80 TIKLADFGLAREESLT--------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 151 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~ 151 (268)
.++++|||.+...... .......++..|+|||++.. ....++.++|+||+|+++|+|++|..||..
T Consensus 139 ~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~~Diws~G~il~el~~g~~pf~~ 212 (314)
T cd08216 139 KVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQ------NLQGYNEKSDIYSVGITACELANGHVPFKD 212 (314)
T ss_pred ceEEecCccceeeccccccccccccccccccccccccCHHHhcC------CCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999988643211 11223456788999998853 123467899999999999999999999987
Q ss_pred CChHHHHHHHHhccCC---------------------------------CCCCCCcHHHHHHHHhccccCCCCCCCHHHH
Q 024408 152 MSNLQAAYAAAFKNVR---------------------------------PSAENVPEELSIILTSCWKEDPNARPNFTQI 198 (268)
Q Consensus 152 ~~~~~~~~~~~~~~~~---------------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~ 198 (268)
................ .....++.++.+++.+||..||++||++.++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~l 292 (314)
T cd08216 213 MPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQL 292 (314)
T ss_pred CCHHHHHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHH
Confidence 6544333222211100 0011234678899999999999999999999
Q ss_pred HHHHH
Q 024408 199 IQMLL 203 (268)
Q Consensus 199 ~~~l~ 203 (268)
+++.+
T Consensus 293 l~~p~ 297 (314)
T cd08216 293 LNHSF 297 (314)
T ss_pred hcCch
Confidence 99844
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=226.24 Aligned_cols=190 Identities=28% Similarity=0.510 Sum_probs=159.2
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ .++..++||||++|++|.+++.+... +++..++.++.|++.||.+||++|++|+||+|+||+++.+ +
T Consensus 60 ~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~--l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~-~ 136 (254)
T cd06627 60 NIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGP--FPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKD-G 136 (254)
T ss_pred CccEEEEEEEeCCEEEEEEecCCCCcHHHHHHhccC--CCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCC-C
Confidence 467888888 45688999999999999999987644 9999999999999999999999999999999999999987 6
Q ss_pred CeEEecCCCccccccccc-cccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESLTEM-MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.++|+|||.+........ .....++..|++||.+.+ ...+.++|+||+|++++++++|..||.........
T Consensus 137 ~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~--------~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~ 208 (254)
T cd06627 137 VVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEM--------SGASTASDIWSLGCTVIELLTGNPPYYDLNPMAAL 208 (254)
T ss_pred CEEEeccccceecCCCcccccccccchhhcCHhhhcC--------CCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHH
Confidence 999999999985443322 233467889999998754 34678999999999999999999999876655555
Q ss_pred HHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 159 YAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
...........+..++..+.+++.+||..+|++||++.+++.+
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 209 FRIVQDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred HHHhccCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 5444444444566788999999999999999999999999865
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=227.08 Aligned_cols=192 Identities=31% Similarity=0.483 Sum_probs=160.3
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMR--PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED 77 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~ 77 (268)
+++++.+.+ .++..++||||++|++|.+++.+.. ...+++.++..++.+++.||.+||++|++|+||+|+||+++.+
T Consensus 60 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~ 139 (258)
T cd08215 60 NIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSN 139 (258)
T ss_pred ChhheEEEEecCCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCC
Confidence 467788877 5568899999999999999998753 3459999999999999999999999999999999999999987
Q ss_pred CCCeEEecCCCcccccccc-ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH
Q 024408 78 LKTIKLADFGLAREESLTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 156 (268)
Q Consensus 78 ~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~ 156 (268)
+.++|+|||.+....... ......|++.|+|||.+.. ..++.++|+||+|++++++++|..||......+
T Consensus 140 -~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~--------~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~ 210 (258)
T cd08215 140 -GLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQN--------KPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE 210 (258)
T ss_pred -CcEEECCccceeecccCcceecceeeeecccChhHhcc--------CCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH
Confidence 699999999997544332 2234468889999998753 457788999999999999999999998766555
Q ss_pred HHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 157 AAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
...........+.+..++..+.+++.+||..+|++||++.+++++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 211 LALKILKGQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 444444444555566788999999999999999999999999886
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=229.67 Aligned_cols=189 Identities=28% Similarity=0.456 Sum_probs=155.3
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ .+++.++||||++|++|.+++... .+++..+..++.+++.|+.+||++|++|+||+|+||+++.+ +
T Consensus 63 ~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~---~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~-~ 138 (277)
T cd06641 63 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEH-G 138 (277)
T ss_pred CEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCC-C
Confidence 578999998 556899999999999999998642 38999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccccc-ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESLTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.++++|||++....... ......++..|+|||.+.+ ...+.++|+||+|+++|++++|..||.........
T Consensus 139 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~ 210 (277)
T cd06641 139 EVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ--------SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVL 210 (277)
T ss_pred CEEEeecccceecccchhhhccccCCccccChhhhcc--------CCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHH
Confidence 89999999987543322 1233467889999998854 45677899999999999999999999875544433
Q ss_pred HHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 159 YAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
..............++.++.+++.+||..+|.+||++.+++++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 211 FLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred HHHhcCCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 3322222223345678999999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=232.06 Aligned_cols=192 Identities=27% Similarity=0.407 Sum_probs=153.0
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEEeCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLTEDL 78 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~gi~H~Dikp~Nill~~~~ 78 (268)
+++++++.+ ..+.+++||||++|++|.+++.+.+. +++..+..++.+++.||.|||+ .|++|+||+|+||+++++
T Consensus 64 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~- 140 (284)
T cd06620 64 YIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGP--IPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSR- 140 (284)
T ss_pred CcceEeeeEecCCEEEEEEecCCCCCHHHHHHhccC--CCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCC-
Confidence 578999999 55689999999999999999877544 8999999999999999999997 699999999999999988
Q ss_pred CCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH---
Q 024408 79 KTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL--- 155 (268)
Q Consensus 79 ~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~--- 155 (268)
+.++|+|||++...... ......|+..|+|||++.+ ..++.++|+||||+++|++++|..||......
T Consensus 141 ~~~~l~d~gl~~~~~~~-~~~~~~~~~~~~aPE~~~~--------~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~ 211 (284)
T cd06620 141 GQIKLCDFGVSGELINS-IADTFVGTSTYMSPERIQG--------GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDG 211 (284)
T ss_pred CcEEEccCCcccchhhh-ccCccccCcccCCHHHHcc--------CCCCccchHHHHHHHHHHHHhCCCCCcccchhhhh
Confidence 68999999998643222 1234568999999998754 46778999999999999999999999764431
Q ss_pred --------HHHHHHHhccCCCC-CCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 024408 156 --------QAAYAAAFKNVRPS-AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 204 (268)
Q Consensus 156 --------~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~ 204 (268)
.............. ...++.++.+++.+|+..||.+||++.+++++...
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~ 269 (284)
T cd06620 212 QDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPF 269 (284)
T ss_pred hhhhhHHHHHHHHHhhccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence 11111111111111 22377899999999999999999999999987533
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-33 Score=231.79 Aligned_cols=193 Identities=26% Similarity=0.356 Sum_probs=150.4
Q ss_pred CceeEEEeecC-Cc-----EEEEEEcCCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCC
Q 024408 1 MREQFIGACKE-PV-----MVIVTELLSGGTLRKYLLNMR---PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPEN 71 (268)
Q Consensus 1 ~~v~l~g~~~~-~~-----~~lV~e~~~ggsL~~~i~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~N 71 (268)
+++++++++.. +. .++||||++ ++|.+++.... ...+++..++.++.|++.||.|||++|++||||+|+|
T Consensus 62 ~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~n 140 (295)
T cd07837 62 YIVRLLDVEHVEEKNGKPSLYLVFEYLD-SDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQN 140 (295)
T ss_pred CccceeeeEeecCCCCCceEEEEeeccC-cCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHH
Confidence 57888988843 33 799999997 48999886543 2358999999999999999999999999999999999
Q ss_pred EEEeCCCCCeEEecCCCccccccc-cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 024408 72 LLLTEDLKTIKLADFGLAREESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFE 150 (268)
Q Consensus 72 ill~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~ 150 (268)
|+++.+.+.++|+|||++...... .......+++.|+|||.+.+ ...++.++|+||||+++|+|++|..||.
T Consensus 141 il~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~~Di~slG~~l~~l~~g~~~~~ 213 (295)
T cd07837 141 LLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLG-------STHYSTPVDIWSVGCIFAEMSRKQPLFP 213 (295)
T ss_pred EEEecCCCeEEEeecccceecCCCccccCCcccccCCCChHHhhC-------CCCCCchHHHHHHHHHHHHHHcCCCCCC
Confidence 999983379999999998754322 22233456889999998753 2346789999999999999999999998
Q ss_pred CCChHHHHHHHHhccCCC---------------------------CCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 151 GMSNLQAAYAAAFKNVRP---------------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
+................+ ....+++++.++|.+||..||.+||++.+++.+
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 214 GDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred CCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 765544333221110000 013578899999999999999999999999886
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=231.01 Aligned_cols=190 Identities=26% Similarity=0.452 Sum_probs=152.7
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEEeCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLTEDL 78 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~gi~H~Dikp~Nill~~~~ 78 (268)
+++++++.+ .++..++||||++|++|.+++.... ..+++..+..++.|++.||+|||+ .|++|+||||+||+++++
T Consensus 60 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~- 137 (265)
T cd06605 60 YIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSR- 137 (265)
T ss_pred chhhhheeeecCCEEEEEEEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCC-
Confidence 467788888 5578999999999999999998753 349999999999999999999999 999999999999999997
Q ss_pred CCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----h
Q 024408 79 KTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS----N 154 (268)
Q Consensus 79 ~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~----~ 154 (268)
+.++|+|||.+........ ....++..|+|||.+.+ ..++.++|+||||++++++++|..||.... .
T Consensus 138 ~~~~l~d~g~~~~~~~~~~-~~~~~~~~y~~PE~~~~--------~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~ 208 (265)
T cd06605 138 GQIKLCDFGVSGQLVNSLA-KTFVGTSSYMAPERIQG--------NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG 208 (265)
T ss_pred CCEEEeecccchhhHHHHh-hcccCChhccCHHHHcC--------CCCCchhhHHHHHHHHHHHHhCCCCCCcccccccc
Confidence 6999999999875433222 22678889999998854 467889999999999999999999997542 1
Q ss_pred HHHHHHHHhccCCC-CCCC-CcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 155 LQAAYAAAFKNVRP-SAEN-VPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 155 ~~~~~~~~~~~~~~-~~~~-~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
.............+ .+.. ++.++.++|.+||..+|++||++.+++.+
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 209 IFELLQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred HHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 11111112222222 2222 78899999999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=251.22 Aligned_cols=198 Identities=29% Similarity=0.518 Sum_probs=177.2
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|+|+|.|.. +..-..+|.|||++|+|+.+|+++.+. |+.-+...+++.|+.|+.||.+.|+|||||-..|||++.+ -
T Consensus 691 NIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGq-ftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsn-L 768 (996)
T KOG0196|consen 691 NIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQ-FTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSN-L 768 (996)
T ss_pred cEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCc-eEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccc-e
Confidence 789999999 556789999999999999999988766 9999999999999999999999999999999999999999 4
Q ss_pred CeEEecCCCcccccccc-cc-ccCCC--ccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCh
Q 024408 80 TIKLADFGLAREESLTE-MM-TAETG--TYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSN 154 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~-~~-~~~~g--t~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~~ 154 (268)
.+|++|||+++...++. .. .+..| ..+|.|||.+.. ..++.++||||+|+++||.+. |..||-++++
T Consensus 769 vCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~--------RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN 840 (996)
T KOG0196|consen 769 VCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAY--------RKFTSASDVWSYGIVMWEVMSYGERPYWDMSN 840 (996)
T ss_pred EEEeccccceeecccCCCccccccCCccceeecChhHhhh--------cccCchhhccccceEEEEecccCCCcccccch
Confidence 89999999999543332 22 22223 468999999865 678899999999999999876 9999999999
Q ss_pred HHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 024408 155 LQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 208 (268)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 208 (268)
.++...+..+...|.+.++|..+.+|+..||++|..+||.+.||+..|.++++.
T Consensus 841 QdVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 841 QDVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred HHHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 999999999999999999999999999999999999999999999999998865
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=231.78 Aligned_cols=190 Identities=28% Similarity=0.379 Sum_probs=155.7
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|++++++.+ .+...++||||+.|++|.+++.... .+++.++..++.|++.||.|||++|++|+||+|+||+++++ +
T Consensus 61 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~-~ 137 (258)
T cd05578 61 FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKV--KFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQ-G 137 (258)
T ss_pred ChHHHHHhhcCCCeEEEEEeCCCCCCHHHHHHhcC--CcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCC-C
Confidence 456777777 4457999999999999999998753 39999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh--HHH
Q 024408 80 TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN--LQA 157 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~--~~~ 157 (268)
.++|+|||.+.............|+..|+|||.+.+ ..++.++|+||||+++|++++|..||..... ...
T Consensus 138 ~~~l~d~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~ 209 (258)
T cd05578 138 HVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCR--------QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQ 209 (258)
T ss_pred CEEEeecccccccCCCccccccCCChhhcCHHHHcc--------cCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHH
Confidence 999999999886544433345568889999998864 4477899999999999999999999987553 222
Q ss_pred HHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCH--HHHHHH
Q 024408 158 AYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNF--TQIIQM 201 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~--~~~~~~ 201 (268)
............+..++..+.++|.+||..||.+||+. ++++++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~ 255 (258)
T cd05578 210 IRAKQETADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNH 255 (258)
T ss_pred HHHHhccccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcC
Confidence 22222223344566788999999999999999999999 776654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-33 Score=230.89 Aligned_cols=192 Identities=26% Similarity=0.382 Sum_probs=152.3
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ .++..++||||+. ++|.+++.......+++..+..++.|++.||+|||+.|++|+||+|+||+++.+ +
T Consensus 60 ~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~-~ 137 (284)
T cd07860 60 NIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTE-G 137 (284)
T ss_pred CCcchhhhcccCCcEEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-C
Confidence 578899998 5568999999995 689999977655569999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccccc-ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESLTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.++|+|||++....... ......++..|+|||.+.+ ...++.++|+||||+++|+|++|+.||.........
T Consensus 138 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~ 210 (284)
T cd07860 138 AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG-------CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 210 (284)
T ss_pred CEEEeeccchhhcccCccccccccccccccCCeEEec-------CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 99999999987543222 2233456889999998753 133577899999999999999999999775543332
Q ss_pred HHHHhccCCC----------------------------CCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 159 YAAAFKNVRP----------------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 159 ~~~~~~~~~~----------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
.........+ ....++.+++++|.+||+.||.+||++++++++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 211 FRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 2221111000 023467889999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=228.08 Aligned_cols=191 Identities=25% Similarity=0.398 Sum_probs=159.1
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMR--PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED 77 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~ 77 (268)
+++++.+++ .+...++||||++|++|.+++.+.. ...+++..++.++.+++.||++||+.|++|+||+|+||+++.+
T Consensus 60 ~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~ 139 (256)
T cd08530 60 NIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVAN 139 (256)
T ss_pred CchhhhhhhccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecC
Confidence 456677776 5568899999999999999987632 2448999999999999999999999999999999999999987
Q ss_pred CCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 024408 78 LKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA 157 (268)
Q Consensus 78 ~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~ 157 (268)
+.++|+|||++...... ......++..|++||.+.+ ..++.++|+||||++++++++|+.||...+....
T Consensus 140 -~~~kl~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~--------~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~ 209 (256)
T cd08530 140 -DLVKIGDLGISKVLKKN-MAKTQIGTPHYMAPEVWKG--------RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDL 209 (256)
T ss_pred -CcEEEeeccchhhhccC-CcccccCCccccCHHHHCC--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 68999999999765443 3334568889999998754 4567889999999999999999999988766554
Q ss_pred HHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 158 AYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
..........+....++.++.+++.+||..+|++||++.+++++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 210 RYKVQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred HHHHhcCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 44444444444556788999999999999999999999999876
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=227.11 Aligned_cols=193 Identities=30% Similarity=0.451 Sum_probs=152.7
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
++++++|.+ ..+..++|+||++|++|.+++.+... +++..+..++.+++.||.|||+.|++|+||+|+||+++++ +
T Consensus 60 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~-~ 136 (264)
T cd06626 60 NLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRI--LDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHN-G 136 (264)
T ss_pred ChhheeeeEecCCEEEEEEecCCCCcHHHHHhhcCC--CChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-C
Confidence 468899988 55688999999999999999986543 8899999999999999999999999999999999999987 6
Q ss_pred CeEEecCCCcccccccccc-----ccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh
Q 024408 80 TIKLADFGLAREESLTEMM-----TAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN 154 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~ 154 (268)
.++|+|||++......... ....++..|+|||.+.+.. ....+.++|+||||++++++++|+.||.....
T Consensus 137 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-----~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~ 211 (264)
T cd06626 137 VIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGK-----GKGHGRAADIWSLGCVVLEMATGKRPWSELDN 211 (264)
T ss_pred CEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCC-----CCCCCcccchHHHHHHHHHHHhCCCCccCCcc
Confidence 9999999998754332221 1245788999999986411 13377899999999999999999999976543
Q ss_pred HHHH-HHHHhccCC--CCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 155 LQAA-YAAAFKNVR--PSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 155 ~~~~-~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
.... ......... +....++..+.+++.+||+.+|.+||++.+++.+
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 212 EFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred hHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 3222 222222111 1223448899999999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=232.05 Aligned_cols=199 Identities=21% Similarity=0.365 Sum_probs=155.6
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEEeCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMR-PRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLTED 77 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~-~gi~H~Dikp~Nill~~~ 77 (268)
+++++++.+ .++++++||||++|++|.+++.... ...+++..+..++.+++.||.|||+ .|++|+||||+||+++.+
T Consensus 60 ~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~ 139 (286)
T cd06622 60 YIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGN 139 (286)
T ss_pred cHHhhhhheecCCeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCC
Confidence 467888888 5678999999999999999887632 2249999999999999999999997 599999999999999987
Q ss_pred CCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 024408 78 LKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA 157 (268)
Q Consensus 78 ~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~ 157 (268)
+.++|+|||++...... ......++..|+|||.+.+.... ....++.++|+||||+++|+|++|+.||........
T Consensus 140 -~~~~l~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~--~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~ 215 (286)
T cd06622 140 -GQVKLCDFGVSGNLVAS-LAKTNIGCQSYMAPERIKSGGPN--QNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANI 215 (286)
T ss_pred -CCEEEeecCCcccccCC-ccccCCCccCccCcchhcCCCCC--ccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhH
Confidence 69999999998754322 22344678899999988542111 123467899999999999999999999976443222
Q ss_pred HHH---HHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 024408 158 AYA---AAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 203 (268)
Q Consensus 158 ~~~---~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~ 203 (268)
... .........+..++.++.++|.+||..+|.+||++.+++++.+
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~ 264 (286)
T cd06622 216 FAQLSAIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPW 264 (286)
T ss_pred HHHHHHHhhcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChh
Confidence 111 1122223335568899999999999999999999999999743
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=232.97 Aligned_cols=194 Identities=25% Similarity=0.432 Sum_probs=150.4
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHH---hcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCCEEEe
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLL---NMRPRCLDVCVAIGFALDIARAMECLHSH-GIIHRDLKPENLLLT 75 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~---~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-gi~H~Dikp~Nill~ 75 (268)
++|+++|++ .++..++||||+. ++|.++.. ......+++..+..++.+++.||+|||+. |++||||||+||+++
T Consensus 64 ~iv~~~~~~~~~~~~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~ 142 (288)
T cd06616 64 YIVKFYGALFREGDCWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLD 142 (288)
T ss_pred CEeeeeeEEecCCcEEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEc
Confidence 578999988 5567899999995 57665432 23334599999999999999999999985 999999999999999
Q ss_pred CCCCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH
Q 024408 76 EDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL 155 (268)
Q Consensus 76 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~ 155 (268)
.+ +.++|+|||++.............|+..|+|||.+.+. ....++.++|+||+|+++|++++|+.||......
T Consensus 143 ~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~ 216 (288)
T cd06616 143 RN-GNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPS-----ARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSV 216 (288)
T ss_pred cC-CcEEEeecchhHHhccCCccccccCccCccCHHHhccc-----cccCCcchhhhhHHHHHHHHHHhCCCCchhcchH
Confidence 87 68999999999754443333445688999999988641 0135788999999999999999999999765422
Q ss_pred HHHHHHHhccCCC-----CCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 156 QAAYAAAFKNVRP-----SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 156 ~~~~~~~~~~~~~-----~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
............+ ....++.++.+++.+||..+|.+||++++++++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 217 FDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred HHHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 2221111111111 123478899999999999999999999999997
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=227.46 Aligned_cols=183 Identities=23% Similarity=0.259 Sum_probs=145.9
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ ..+..++||||++||+|.+++.+... +++..+..++.|++.||.|||++|++||||||+||+++.+ +
T Consensus 46 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~-~ 122 (237)
T cd05576 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLN--IPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDR-G 122 (237)
T ss_pred ceeehhhheecCCeEEEEEecCCCCCHHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCC-C
Confidence 467888887 45688999999999999999987554 9999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 024408 80 TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY 159 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~ 159 (268)
.++++|||.+...... .....++..|+|||.+.. ..++.++|+||+|+++|++++|..|+.......
T Consensus 123 ~~~l~df~~~~~~~~~--~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~--- 189 (237)
T cd05576 123 HIQLTYFSRWSEVEDS--CDGEAVENMYCAPEVGGI--------SEETEACDWWSLGAILFELLTGKTLVECHPSGI--- 189 (237)
T ss_pred CEEEecccchhccccc--cccCCcCccccCCcccCC--------CCCCchhhHHHHHHHHHHHHHCcchhhcCchhc---
Confidence 8999999987654332 223455678999998753 456789999999999999999998875422110
Q ss_pred HHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCH-----HHHHHH
Q 024408 160 AAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNF-----TQIIQM 201 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~-----~~~~~~ 201 (268)
........+..++..++++|.+||+.||.+||++ +++++|
T Consensus 190 --~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 234 (237)
T cd05576 190 --NTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSH 234 (237)
T ss_pred --ccccccCCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcC
Confidence 0011112345678999999999999999999986 555544
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=231.65 Aligned_cols=192 Identities=28% Similarity=0.309 Sum_probs=151.3
Q ss_pred CceeEEEeecC---CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCC
Q 024408 1 MREQFIGACKE---PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED 77 (268)
Q Consensus 1 ~~v~l~g~~~~---~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~ 77 (268)
+++++++++.+ +..++||||++ ++|.+++.... ..+++.+++.++.|++.||+|||+.|++||||||+||+++.+
T Consensus 67 ~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~ 144 (309)
T cd07845 67 NIVELKEVVVGKHLDSIFLVMEYCE-QDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDK 144 (309)
T ss_pred CCcceEEEEecCCCCeEEEEEecCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC
Confidence 47888998733 46899999996 68999887643 349999999999999999999999999999999999999988
Q ss_pred CCCeEEecCCCcccccccc-ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH
Q 024408 78 LKTIKLADFGLAREESLTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 156 (268)
Q Consensus 78 ~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~ 156 (268)
+.++|+|||++....... ......++..|+|||.+.+ ...++.++|+||||+++|+|++|..||...+..+
T Consensus 145 -~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~ 216 (309)
T cd07845 145 -GCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLG-------CTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE 216 (309)
T ss_pred -CCEEECccceeeecCCccCCCCcccccccccChhhhcC-------CCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 699999999998544321 2223345788999998753 2456789999999999999999999998766554
Q ss_pred HHHHHHhccCCC---------------------C--------CCCCcHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 024408 157 AAYAAAFKNVRP---------------------S--------AENVPEELSIILTSCWKEDPNARPNFTQIIQML 202 (268)
Q Consensus 157 ~~~~~~~~~~~~---------------------~--------~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l 202 (268)
...........+ . ....++.+.++|.+||..||++||++.++++|-
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~ 291 (309)
T cd07845 217 QLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESS 291 (309)
T ss_pred HHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 433222211000 0 122578899999999999999999999999983
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=235.21 Aligned_cols=196 Identities=20% Similarity=0.342 Sum_probs=152.2
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|++++++++ .++..++||||+.+++|.+++.+.....+++..+..++.|++.||+|||++|++||||||+||+++.+ +
T Consensus 60 niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~-~ 138 (328)
T cd08226 60 NIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGD-G 138 (328)
T ss_pred CcceEeeeEecCCceEEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCC-C
Confidence 578999999 55688999999999999999987655569999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccccc--------cccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 024408 80 TIKLADFGLAREESLTEM--------MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 151 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~ 151 (268)
.++++||+.+........ .....++..|++||++.+ ....++.++|+||+|+++|+|++|..||..
T Consensus 139 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~~DiwslG~~l~el~~g~~p~~~ 212 (328)
T cd08226 139 LVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQ------DLYGYNVKSDIYSVGITACELATGRVPFQD 212 (328)
T ss_pred cEEEechHHHhhhhccCccccccccccccccCccCccChhhhcC------CCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 899999986532111100 011234567999999853 123467899999999999999999999987
Q ss_pred CChHHHHHHHHhccC----------------------------------------------CCCCCCCcHHHHHHHHhcc
Q 024408 152 MSNLQAAYAAAFKNV----------------------------------------------RPSAENVPEELSIILTSCW 185 (268)
Q Consensus 152 ~~~~~~~~~~~~~~~----------------------------------------------~~~~~~~~~~l~~li~~~l 185 (268)
............... .+....++..+.+++++||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 292 (328)
T cd08226 213 MLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCL 292 (328)
T ss_pred cChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHc
Confidence 654433322211100 0112235678999999999
Q ss_pred ccCCCCCCCHHHHHHHHH
Q 024408 186 KEDPNARPNFTQIIQMLL 203 (268)
Q Consensus 186 ~~~p~~Rps~~~~~~~l~ 203 (268)
..||++|||+.+++++.+
T Consensus 293 ~~dP~~Rpta~e~l~~~~ 310 (328)
T cd08226 293 QQDPEKRPSASSLLSHAF 310 (328)
T ss_pred cCCcccCCCHHHHhhCHH
Confidence 999999999999999854
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=229.73 Aligned_cols=192 Identities=27% Similarity=0.383 Sum_probs=152.8
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ .++..++||||++ ++|.+++.......+++..+..++.|++.||+|||++|++|+||+|+||+++.+ +
T Consensus 59 ~iv~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~-~ 136 (283)
T cd07835 59 NIVRLLDVVHSENKLYLVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDRE-G 136 (283)
T ss_pred CccCHhheeccCCeEEEEEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCC-C
Confidence 468888888 5568999999995 799999987664459999999999999999999999999999999999999987 6
Q ss_pred CeEEecCCCccccccc-cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.++|+|||++...... .......++..|+|||++.+ ...++.++|+||||+++|+|++|+.||.........
T Consensus 137 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 209 (283)
T cd07835 137 ALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG-------SRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQL 209 (283)
T ss_pred cEEEeecccccccCCCccccCccccccCCCCCceeec-------CcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 9999999999754322 12233456889999998753 234678899999999999999999999876554332
Q ss_pred HHHHhccC----------------------------CCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 159 YAAAFKNV----------------------------RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 159 ~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
........ ......++..+.++|.+||+.+|.+||++++++++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 210 FRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred HHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 22111100 01134567899999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=229.88 Aligned_cols=195 Identities=26% Similarity=0.487 Sum_probs=153.8
Q ss_pred CceeEEEeecC---CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCC
Q 024408 1 MREQFIGACKE---PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED 77 (268)
Q Consensus 1 ~~v~l~g~~~~---~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~ 77 (268)
+++++++++.. .+.++||||++|++|.+++..... .+++.++..++.|++.||+|||++|++|+||||+||+++.+
T Consensus 67 ~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~ 145 (284)
T cd05038 67 NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRD-QINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESE 145 (284)
T ss_pred ChheEEeeeecCCCCceEEEEecCCCCCHHHHHHhCcc-ccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCC
Confidence 46888998843 478999999999999999987543 39999999999999999999999999999999999999988
Q ss_pred CCCeEEecCCCccccccccc----cccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 024408 78 LKTIKLADFGLAREESLTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS 153 (268)
Q Consensus 78 ~~~~kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~ 153 (268)
+.++|+|||.+........ .....++..|++||.+.+ ..++.++|+||||+++++|++|..|+....
T Consensus 146 -~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~--------~~~~~~~Di~slG~~l~el~tg~~p~~~~~ 216 (284)
T cd05038 146 -DLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRT--------SKFSSASDVWSFGVTLYELFTYGDPSQSPP 216 (284)
T ss_pred -CCEEEcccccccccccCCcceeccCCCCCcccccCcHHHcc--------CCCCcccchHHHhhhhheeeccCCCccccc
Confidence 6999999999986442211 112234567999998754 457788999999999999999998876432
Q ss_pred hHH--------------HHHHH-HhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHh
Q 024408 154 NLQ--------------AAYAA-AFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 205 (268)
Q Consensus 154 ~~~--------------~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~ 205 (268)
... ..... ......+.+..++.++.+++.+||..+|.+||++.++++.|+..
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 217 AEFLRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred chhccccccccccccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 211 11111 11222333556788999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=233.00 Aligned_cols=179 Identities=28% Similarity=0.449 Sum_probs=156.6
Q ss_pred eeEEEeecC-CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCCe
Q 024408 3 EQFIGACKE-PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTI 81 (268)
Q Consensus 3 v~l~g~~~~-~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~~ 81 (268)
++|..++.. +.+|.||||+.||+|--+|++.++ +.+..+.-++.+|+-||-+||++||++||||.+|||++.. |++
T Consensus 413 ~qlHScFQTmDRLyFVMEyvnGGDLMyhiQQ~Gk--FKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~e-GHi 489 (683)
T KOG0696|consen 413 VQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGK--FKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSE-GHI 489 (683)
T ss_pred HHHHHHhhhhhheeeEEEEecCchhhhHHHHhcc--cCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccC-Cce
Confidence 455556643 689999999999999999998877 9999999999999999999999999999999999999999 799
Q ss_pred EEecCCCccccc-cccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 024408 82 KLADFGLAREES-LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYA 160 (268)
Q Consensus 82 kl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~ 160 (268)
||+|||+++... ......+.+||+.|+|||++.. +.|+.+.|.||+|++||||+.|++||++.+..+ ..+
T Consensus 490 Ki~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~Y--------qPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e-lF~ 560 (683)
T KOG0696|consen 490 KIADFGMCKENIFDGVTTKTFCGTPDYIAPEIIAY--------QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE-LFQ 560 (683)
T ss_pred EeeecccccccccCCcceeeecCCCcccccceEEe--------cccccchhHHHHHHHHHHHHcCCCCCCCCCHHH-HHH
Confidence 999999999644 3445678899999999999975 788999999999999999999999999865544 444
Q ss_pred HHhccCCCCCCCCcHHHHHHHHhccccCCCCCC
Q 024408 161 AAFKNVRPSAENVPEELSIILTSCWKEDPNARP 193 (268)
Q Consensus 161 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 193 (268)
.+.......+..++.+...+....|...|.+|.
T Consensus 561 aI~ehnvsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 561 AIMEHNVSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred HHHHccCcCcccccHHHHHHHHHHhhcCCcccc
Confidence 555556667889999999999999999999993
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=234.92 Aligned_cols=193 Identities=20% Similarity=0.255 Sum_probs=143.0
Q ss_pred CceeEEEeec---CCcEEEEEEcCCCCCHHHHHHhcC-------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCC
Q 024408 1 MREQFIGACK---EPVMVIVTELLSGGTLRKYLLNMR-------PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPE 70 (268)
Q Consensus 1 ~~v~l~g~~~---~~~~~lV~e~~~ggsL~~~i~~~~-------~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~ 70 (268)
|+|++++++. +...++||||+. ++|.+++.... ...+++..+..++.|++.||.|||++|++||||||+
T Consensus 59 niv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~ 137 (317)
T cd07867 59 NVIALQKVFLSHSDRKVWLLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPA 137 (317)
T ss_pred CeeeEEEEEeccCCCeEEEEEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHH
Confidence 5789999872 347899999995 68988875321 224889999999999999999999999999999999
Q ss_pred CEEEeC---CCCCeEEecCCCcccccccc----ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHH
Q 024408 71 NLLLTE---DLKTIKLADFGLAREESLTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL 143 (268)
Q Consensus 71 Nill~~---~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll 143 (268)
||++.. ..+.+||+|||+++...... ......||..|+|||++.+ ...++.++||||||+++|+|+
T Consensus 138 Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwSlG~il~el~ 210 (317)
T cd07867 138 NILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLG-------ARHYTKAIDIWAIGCIFAELL 210 (317)
T ss_pred HEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcC-------CCccCcHHHHHhHHHHHHHHH
Confidence 999942 22589999999998543321 1233467899999998853 245788999999999999999
Q ss_pred hCCCCCCCCChH---------HHHHHHHhc--------------c-----------------------CCCCCCCCcHHH
Q 024408 144 HNKLPFEGMSNL---------QAAYAAAFK--------------N-----------------------VRPSAENVPEEL 177 (268)
Q Consensus 144 ~g~~p~~~~~~~---------~~~~~~~~~--------------~-----------------------~~~~~~~~~~~l 177 (268)
+|+.||...... ......... . ........+..+
T Consensus 211 tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (317)
T cd07867 211 TSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKV 290 (317)
T ss_pred hCCCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHH
Confidence 999998643211 000000000 0 000011234568
Q ss_pred HHHHHhccccCCCCCCCHHHHHHH
Q 024408 178 SIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 178 ~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
.+++.+||..||.+|||+.|+++|
T Consensus 291 ~~ll~~~l~~dP~~R~t~~e~l~h 314 (317)
T cd07867 291 FLLLQKLLTMDPTKRITSEQALQD 314 (317)
T ss_pred HHHHHHHhccCcccccCHHHHhcC
Confidence 889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=224.27 Aligned_cols=190 Identities=31% Similarity=0.470 Sum_probs=157.2
Q ss_pred CceeEEEeec-C--CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCC
Q 024408 1 MREQFIGACK-E--PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED 77 (268)
Q Consensus 1 ~~v~l~g~~~-~--~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~ 77 (268)
+++++++.+. . ...++||||++|++|.+++.+.. .+++..++.++.+++.||+|||+.|++|+||+|+||+++.+
T Consensus 60 ~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~ 137 (260)
T cd06606 60 NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSD 137 (260)
T ss_pred CEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCC
Confidence 5788898884 4 57899999999999999998765 49999999999999999999999999999999999999987
Q ss_pred CCCeEEecCCCccccccccc---cccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh
Q 024408 78 LKTIKLADFGLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN 154 (268)
Q Consensus 78 ~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~ 154 (268)
+.++|+|||.+........ .....++..|+|||.+.+ ...+.++|+||||+++++|++|..||.....
T Consensus 138 -~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~--------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 208 (260)
T cd06606 138 -GVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG--------EEYGRAADIWSLGCTVIEMATGKPPWSELGN 208 (260)
T ss_pred -CCEEEcccccEEecccccccccccCCCCCccccCHhhhcC--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 6999999999986554432 345578899999998854 4478899999999999999999999987652
Q ss_pred HHHHHHHHh--ccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 155 LQAAYAAAF--KNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 155 ~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
......... ......+..++..+.+++.+|+..+|.+||++.+++++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 209 PMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred hHHHHHhccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 222221111 22233456678999999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=229.41 Aligned_cols=196 Identities=26% Similarity=0.410 Sum_probs=156.3
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++.+ .+++.++||||++|++|.+++... .+++..+..++.|++.||+|||++|++|+||+|+||+++.+ +
T Consensus 78 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~-~ 153 (292)
T cd06657 78 NVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHD-G 153 (292)
T ss_pred chhheeeEEEeCCEEEEEEecCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-C
Confidence 468888888 567899999999999999987542 38999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccccc-ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESLTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.++|+|||++....... ......++..|++||.+.+ ..++.++|+||+|+++|+|++|..||......+..
T Consensus 154 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~pE~~~~--------~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~ 225 (292)
T cd06657 154 RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISR--------LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM 225 (292)
T ss_pred CEEEcccccceecccccccccccccCccccCHHHhcC--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 89999999987543221 2233467889999998753 45678999999999999999999999875544332
Q ss_pred HHHHhcc--CCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhcC
Q 024408 159 YAAAFKN--VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIA 210 (268)
Q Consensus 159 ~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~~~ 210 (268)
....... .......++..+.+++.+||..+|.+||++.+++++ .++....
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~--~~~~~~~ 277 (292)
T cd06657 226 KMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH--PFLAKAG 277 (292)
T ss_pred HHHHhhCCcccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcC--hHHhccC
Confidence 2221111 112234578899999999999999999999999997 5555443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=225.23 Aligned_cols=196 Identities=27% Similarity=0.502 Sum_probs=153.9
Q ss_pred CceeEEEeecCC-------cEEEEEEcCCCCCHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCC
Q 024408 1 MREQFIGACKEP-------VMVIVTELLSGGTLRKYLLNMR----PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKP 69 (268)
Q Consensus 1 ~~v~l~g~~~~~-------~~~lV~e~~~ggsL~~~i~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp 69 (268)
++++++|++... ..++++||+++|+|.+++.... ...+++..+..++.|++.||+|||++|++||||||
T Consensus 62 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp 141 (273)
T cd05074 62 NVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAA 141 (273)
T ss_pred CcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccch
Confidence 578899987321 3478999999999998875321 22478999999999999999999999999999999
Q ss_pred CCEEEeCCCCCeEEecCCCcccccccc---ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-C
Q 024408 70 ENLLLTEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-N 145 (268)
Q Consensus 70 ~Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g 145 (268)
+||+++.+ +.++++|||.++...... ......++..|++||.+.. ..++.++||||||+++|+|++ |
T Consensus 142 ~nili~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--------~~~~~~sDi~slG~il~el~~~g 212 (273)
T cd05074 142 RNCMLNEN-MTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLAD--------NVYTTHSDVWAFGVTMWEIMTRG 212 (273)
T ss_pred hhEEEcCC-CCEEECcccccccccCCcceecCCCccCchhhcCHhHHhc--------CccchhhhhHHHHHHHHHHhhCC
Confidence 99999887 689999999988543221 1122345578999998753 456789999999999999998 8
Q ss_pred CCCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHh
Q 024408 146 KLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 205 (268)
Q Consensus 146 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~ 205 (268)
..||.+......................+..+.+++.+||+.+|++||++.++++.|+++
T Consensus 213 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 213 QTPYAGVENSEIYNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 899987655443333333333333456789999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=234.72 Aligned_cols=188 Identities=26% Similarity=0.328 Sum_probs=148.4
Q ss_pred CceeEEEeecC-------CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEE
Q 024408 1 MREQFIGACKE-------PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 73 (268)
Q Consensus 1 ~~v~l~g~~~~-------~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nil 73 (268)
+++++++++.. ...++||||+. ++|.+.+... +++..+..++.|++.||+|||++|++||||||+||+
T Consensus 76 ~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil 150 (353)
T cd07850 76 NIIGLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 150 (353)
T ss_pred CCcceeeeeccCCCccccCcEEEEEeccC-CCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEE
Confidence 57888888732 25799999995 6899888642 889999999999999999999999999999999999
Q ss_pred EeCCCCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 024408 74 LTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS 153 (268)
Q Consensus 74 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~ 153 (268)
++.+ +.++|+|||+++............++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+
T Consensus 151 ~~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwslG~~l~~l~~g~~pf~~~~ 221 (353)
T cd07850 151 VKSD-CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG--------MGYKENVDIWSVGCIMGEMIRGTVLFPGTD 221 (353)
T ss_pred ECCC-CCEEEccCccceeCCCCCCCCCCcccccccCHHHHhC--------CCCCCchhhHhHHHHHHHHHHCCCCCCCCC
Confidence 9988 6999999999986544433344567889999998854 567889999999999999999999998655
Q ss_pred hHHHHHHHHhccCC--------------------C----------------------CCCCCcHHHHHHHHhccccCCCC
Q 024408 154 NLQAAYAAAFKNVR--------------------P----------------------SAENVPEELSIILTSCWKEDPNA 191 (268)
Q Consensus 154 ~~~~~~~~~~~~~~--------------------~----------------------~~~~~~~~l~~li~~~l~~~p~~ 191 (268)
.............. + .....+..++++|.+||..||.+
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 301 (353)
T cd07850 222 HIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEK 301 (353)
T ss_pred HHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhh
Confidence 43222111100000 0 01134567899999999999999
Q ss_pred CCCHHHHHHHH
Q 024408 192 RPNFTQIIQML 202 (268)
Q Consensus 192 Rps~~~~~~~l 202 (268)
||++.+++++-
T Consensus 302 R~t~~eiL~~~ 312 (353)
T cd07850 302 RISVDDALQHP 312 (353)
T ss_pred CcCHHHHhcCh
Confidence 99999999973
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-32 Score=229.39 Aligned_cols=195 Identities=28% Similarity=0.427 Sum_probs=156.7
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
++|+++|++ .+...++||||+. |+|.+.+..... .+++.++..++.+++.||.|||++|++||||+|+||+++.+ +
T Consensus 86 ~iv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~~~~-~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~-~ 162 (317)
T cd06635 86 NSIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKK-PLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEP-G 162 (317)
T ss_pred CEEEEEEEEeeCCeEEEEEeCCC-CCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCC-C
Confidence 578999998 4567899999996 588887765433 38999999999999999999999999999999999999887 6
Q ss_pred CeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 024408 80 TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY 159 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~ 159 (268)
.++|+|||++...... ....++..|+|||.+... ..+.++.++|+||+|+++|+|++|+.||..........
T Consensus 163 ~~kl~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~-----~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~ 234 (317)
T cd06635 163 QVKLADFGSASIASPA---NSFVGTPYWMAPEVILAM-----DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY 234 (317)
T ss_pred CEEEecCCCccccCCc---ccccCCccccChhhhhcC-----CCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHH
Confidence 9999999998753322 344678899999987421 12456789999999999999999999998765544444
Q ss_pred HHHhccC-CCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhH
Q 024408 160 AAAFKNV-RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 206 (268)
Q Consensus 160 ~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 206 (268)
....... ......+++.+.+++.+||+.+|.+||++.++++++....
T Consensus 235 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 235 HIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred HHHhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 3333222 2234567889999999999999999999999999876544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=226.55 Aligned_cols=199 Identities=24% Similarity=0.388 Sum_probs=157.1
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCC--
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED-- 77 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~-- 77 (268)
|+++||.++ ++..+|||||-+.||+|..+|+++.. |++.++.++..+|+.||.+||.+||.|||+||+|||-...
T Consensus 137 nilqLiefFEdd~~FYLVfEKm~GGplLshI~~~~~--F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~ 214 (463)
T KOG0607|consen 137 NILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQKRKH--FNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNK 214 (463)
T ss_pred cHHHHHHHhcccceEEEEEecccCchHHHHHHHhhh--ccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCC
Confidence 678999999 55689999999999999999998766 9999999999999999999999999999999999999643
Q ss_pred CCCeEEecCCCccccccc--------cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 024408 78 LKTIKLADFGLAREESLT--------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPF 149 (268)
Q Consensus 78 ~~~~kl~Dfg~a~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~ 149 (268)
-.-+||+||.+....... ....+.+|+..|||||+..-.. +....|+.+.|.||||+++|-|+.|.+||
T Consensus 215 vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv---~qA~~YDKrCDlwSLGvIlYImLsGYpPF 291 (463)
T KOG0607|consen 215 VSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFV---DQATFYDKRCDLWSLGVILYIMLSGYPPF 291 (463)
T ss_pred cCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhc---cccccccccccHHHHHHHHHHHHhCCCCc
Confidence 235899999998632211 1234567899999999875322 23467888999999999999999999999
Q ss_pred CCCChH----------HHHHHHHh--------ccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 024408 150 EGMSNL----------QAAYAAAF--------KNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 204 (268)
Q Consensus 150 ~~~~~~----------~~~~~~~~--------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~ 204 (268)
.+.-.. ....+... .........++.+.++++..+|..++.+|-++.+++++.+.
T Consensus 292 vG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~ 364 (463)
T KOG0607|consen 292 VGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWV 364 (463)
T ss_pred cCccCCcCCccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccc
Confidence 653321 11111111 11222356788999999999999999999999999997553
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=227.52 Aligned_cols=191 Identities=28% Similarity=0.360 Sum_probs=152.6
Q ss_pred CceeEEEeecC-Cc-----EEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEE
Q 024408 1 MREQFIGACKE-PV-----MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL 74 (268)
Q Consensus 1 ~~v~l~g~~~~-~~-----~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill 74 (268)
++++++|++.. +. .++||||++ ++|.+++.......+++..++.++.|++.||.|||+.|++|+||+|+||++
T Consensus 62 ~i~~~~~~~~~~~~~~~~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili 140 (287)
T cd07838 62 NIVRLLDVCHGPRTDRELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILV 140 (287)
T ss_pred CcceEEEEEeeccCCCCceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEE
Confidence 57889999843 44 899999996 589999887555459999999999999999999999999999999999999
Q ss_pred eCCCCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh
Q 024408 75 TEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN 154 (268)
Q Consensus 75 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~ 154 (268)
+.+ +.++|+|||++.............++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||.+...
T Consensus 141 ~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~PE~~~~--------~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~ 211 (287)
T cd07838 141 TSD-GQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQ--------SSYATPVDMWSVGCIFAELFRRRPLFRGTSE 211 (287)
T ss_pred ccC-CCEEEeccCcceeccCCcccccccccccccChHHhcc--------CCCCCcchhhhHHHHHHHHHhCCCcccCCCh
Confidence 998 7999999999976544433334457889999998854 4567889999999999999999999987655
Q ss_pred HHHHHHHHhccCCC--------------------------CCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 155 LQAAYAAAFKNVRP--------------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 155 ~~~~~~~~~~~~~~--------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
.+...........+ ....++..+.++|.+||..||.+||++.+++.+
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 212 ADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred HHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 44333222111000 012345778899999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=229.82 Aligned_cols=191 Identities=25% Similarity=0.284 Sum_probs=150.7
Q ss_pred CceeEEEee-cC--CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCC
Q 024408 1 MREQFIGAC-KE--PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED 77 (268)
Q Consensus 1 ~~v~l~g~~-~~--~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~ 77 (268)
|++++++++ .. ...++||||++ ++|.+++..... .+++.++..++.|++.||+|||++|++|+||||+||+++.+
T Consensus 65 ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~ 142 (293)
T cd07843 65 NIVTVKEVVVGSNLDKIYMVMEYVE-HDLKSLMETMKQ-PFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNR 142 (293)
T ss_pred CEEEEEEEEEecCCCcEEEEehhcC-cCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCC
Confidence 578899987 34 68999999996 599999876443 49999999999999999999999999999999999999988
Q ss_pred CCCeEEecCCCccccccc-cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH
Q 024408 78 LKTIKLADFGLAREESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 156 (268)
Q Consensus 78 ~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~ 156 (268)
+.++|+|||++...... .......++..|+|||.+.+ ....+.++|+||||+++++|++|..||......+
T Consensus 143 -~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~ 214 (293)
T cd07843 143 -GILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLG-------AKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEID 214 (293)
T ss_pred -CcEEEeecCceeeccCCccccccccccccccCchhhcC-------CccccchhhHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 69999999998854433 22233457889999998753 1335788999999999999999999998765443
Q ss_pred HHHHHHhccC-----------------------------CCC-CCC-CcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 157 AAYAAAFKNV-----------------------------RPS-AEN-VPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 157 ~~~~~~~~~~-----------------------------~~~-~~~-~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
.......... ... +.. +++.+.++|++||+.+|++||++.+++++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 215 QLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred HHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 3222111000 000 111 47889999999999999999999999886
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=229.02 Aligned_cols=191 Identities=26% Similarity=0.367 Sum_probs=149.5
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ .++..++||||++++.|..++.+.. .+++.++..++.|++.||.|||++|++|+||+|+||+++.+ +
T Consensus 61 ~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~-~ 137 (288)
T cd07833 61 NIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPG--GLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSES-G 137 (288)
T ss_pred CeeehhheEEECCEEEEEEecCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC-C
Confidence 578899998 5567999999998766665554433 39999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccccc--ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 024408 80 TIKLADFGLAREESLTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA 157 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~ 157 (268)
.++|+|||++....... ......++..|+|||++.. ...++.++|+||||+++|++++|+.||......+.
T Consensus 138 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-------~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~ 210 (288)
T cd07833 138 VLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVG-------DTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQ 210 (288)
T ss_pred CEEEEeeecccccCCCccccccCcccccCCcCCchhcC-------CCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 99999999988544332 2334567889999999864 12677899999999999999999999976544332
Q ss_pred HHHHHhcc--------------------C--C---------CCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 158 AYAAAFKN--------------------V--R---------PSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 158 ~~~~~~~~--------------------~--~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
........ . . ..+..++.++.++|++||..+|++||++++++++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 211 LYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred HHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 22211100 0 0 0122347889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=231.12 Aligned_cols=191 Identities=27% Similarity=0.419 Sum_probs=150.1
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ .++..++||||+++++|.++...... +++.++..++.|++.||.|||+.|++|+||+|+||+++.+ +
T Consensus 61 ~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~-~ 137 (286)
T cd07846 61 NLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG--LDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQS-G 137 (286)
T ss_pred chhhHHHhcccCCeEEEEEecCCccHHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCC-C
Confidence 467888888 45689999999999888887765433 8999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccc-cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.++|+|||++...... .......++..|+|||.+.+ ...++.++||||||+++++|++|+.||......+..
T Consensus 138 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~ 210 (286)
T cd07846 138 VVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVG-------DTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQL 210 (286)
T ss_pred cEEEEeeeeeeeccCCccccCcccceeeccCcHHhcc-------ccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHH
Confidence 9999999998754332 22233467889999998753 234677899999999999999999999765543322
Q ss_pred HHHHh--c------------------cCCC----------CCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 159 YAAAF--K------------------NVRP----------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 159 ~~~~~--~------------------~~~~----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
..... . ...+ ....++..+.+++.+||..+|++||++.+++++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 211 YHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred HHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 21110 0 0000 123567889999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=228.15 Aligned_cols=192 Identities=27% Similarity=0.392 Sum_probs=152.8
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
++++++|++ .++..++||||+ +|+|.+++.......+++.++..++.|++.+|.|||++|++|+||+|+||+++.+ +
T Consensus 59 ~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~-~ 136 (283)
T cd07830 59 NIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGP-E 136 (283)
T ss_pred CchhHHHHhhcCCcEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCC-C
Confidence 467778887 556889999999 7899999987654459999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 024408 80 TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY 159 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~ 159 (268)
.++|+|||++.............++..|+|||++.. ...++.++|+||||+++++|++|+.||......+...
T Consensus 137 ~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~ 209 (283)
T cd07830 137 VVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLR-------STSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLY 209 (283)
T ss_pred CEEEeecccceeccCCCCcCCCCCcccccCceeeec-------CcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHH
Confidence 999999999986554433344568889999998743 2346789999999999999999999997655433322
Q ss_pred HHHhccCCC-----------------------------CCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 160 AAAFKNVRP-----------------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 160 ~~~~~~~~~-----------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
........+ .....+..+.++|++||..+|++||++.+++.+
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 210 KICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred HHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 211100000 011235789999999999999999999999876
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-32 Score=229.01 Aligned_cols=192 Identities=30% Similarity=0.430 Sum_probs=154.0
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|++++.|+| .++..++||||++ |+|.+++..... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.+ +
T Consensus 76 niv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~~~~-~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~-~ 152 (307)
T cd06607 76 NTIEYKGCYLREHTAWLVMEYCL-GSASDILEVHKK-PLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEP-G 152 (307)
T ss_pred CEEEEEEEEEeCCeEEEEHHhhC-CCHHHHHHHccc-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCC-C
Confidence 578999999 5567899999996 688888765433 49999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 024408 80 TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY 159 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~ 159 (268)
.++|+|||++...... ....++..|+|||++.+. ....++.++||||||+++|+|++|+.||..........
T Consensus 153 ~~kL~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~-----~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~ 224 (307)
T cd06607 153 TVKLADFGSASLVSPA---NSFVGTPYWMAPEVILAM-----DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY 224 (307)
T ss_pred CEEEeecCcceecCCC---CCccCCccccCceeeecc-----CCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHH
Confidence 9999999998754322 234678899999987421 12457789999999999999999999998765544433
Q ss_pred HHHhccC-CCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 024408 160 AAAFKNV-RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 203 (268)
Q Consensus 160 ~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~ 203 (268)
....... ......++..+.++|.+||..+|++||++.+++.+.+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 269 (307)
T cd06607 225 HIAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRF 269 (307)
T ss_pred HHhcCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChh
Confidence 3222211 1123457889999999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-32 Score=226.68 Aligned_cols=191 Identities=22% Similarity=0.347 Sum_probs=146.5
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ .++..++||||+. ++|.+++.... ..+++..+..++.|++.||.|||++|++|+||||+||+++.+ +
T Consensus 64 ni~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~-~ 140 (291)
T cd07870 64 NIVLLHDIIHTKETLTFVFEYMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYL-G 140 (291)
T ss_pred CEeEEEEEEecCCeEEEEEeccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCC-C
Confidence 578899998 5568899999995 78888776543 238888999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccc-cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.++|+|||+++..... .......++..|+|||.+.+ ...++.++|+||||+++|+|++|..||.........
T Consensus 141 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~ 213 (291)
T cd07870 141 ELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLG-------ATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQ 213 (291)
T ss_pred cEEEeccccccccCCCCCCCCCccccccccCCceeec-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHH
Confidence 9999999998753322 12233457889999998753 234677899999999999999999999765432221
Q ss_pred HHHHhcc-C---------------------C---C-------CCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 159 YAAAFKN-V---------------------R---P-------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 159 ~~~~~~~-~---------------------~---~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
....... . . + .....+..+.+++.+|+..||.+|||+.+++.|
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 214 LEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred HHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 1111000 0 0 0 001125688999999999999999999999876
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=227.25 Aligned_cols=192 Identities=23% Similarity=0.343 Sum_probs=151.4
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMR-PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL 78 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~ 78 (268)
|++++++++ ..+..++||||++ ++|.+++.... ...+++.++..++.|++.||.|||++|++|+||||+||+++++
T Consensus 59 ~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~- 136 (284)
T cd07836 59 NIVRLHDVIHTENKLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKR- 136 (284)
T ss_pred CEeeeeeeEeeCCcEEEEEecCC-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCC-
Confidence 578999998 5568899999997 58999887644 2348999999999999999999999999999999999999988
Q ss_pred CCeEEecCCCccccccc-cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 024408 79 KTIKLADFGLAREESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA 157 (268)
Q Consensus 79 ~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~ 157 (268)
+.++++|||++...... .......++..|++||.+.+ ...++.++|+||||+++|++++|+.||.+....+.
T Consensus 137 ~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-------~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~ 209 (284)
T cd07836 137 GELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLG-------SRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQ 209 (284)
T ss_pred CcEEEeecchhhhhcCCccccccccccccccChHHhcC-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence 69999999999754322 12233457889999998753 23467899999999999999999999987654433
Q ss_pred HHHHHhccCCC----------------------------CCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 158 AYAAAFKNVRP----------------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 158 ~~~~~~~~~~~----------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
..........+ .....++.+++++.+|++.||.+||++.+++++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 210 LLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred HHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 22221111000 012457889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=229.83 Aligned_cols=190 Identities=28% Similarity=0.466 Sum_probs=153.0
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++.+ .++..++|+||++|++|.+++.+. .+++.++..++.|++.||.|||++|++|+||+|+||+++.+ +
T Consensus 77 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~-~ 152 (293)
T cd06647 77 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD-G 152 (293)
T ss_pred CeeehhheeeeCCcEEEEEecCCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCC-C
Confidence 578888988 456789999999999999998753 38899999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccccc-ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESLTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.++|+|||++....... ......+++.|++||.+.. ..++.++|+||||+++|++++|+.||.........
T Consensus 153 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~ 224 (293)
T cd06647 153 SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR--------KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL 224 (293)
T ss_pred CEEEccCcceecccccccccccccCChhhcCchhhcc--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhe
Confidence 89999999886433322 2233468889999998854 45678999999999999999999999865543332
Q ss_pred HHHHhcc--CCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 024408 159 YAAAFKN--VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 202 (268)
Q Consensus 159 ~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l 202 (268)
....... .......++..+.+++.+||..+|.+||++.+++.|-
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~ 270 (293)
T cd06647 225 YLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHP 270 (293)
T ss_pred eehhcCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence 2211111 1112345678899999999999999999999999983
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=227.58 Aligned_cols=191 Identities=22% Similarity=0.379 Sum_probs=147.3
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ .+++.++||||++ ++|.+++.+... .+++..+..++.|++.||.|||++|++||||||+||+++.+ +
T Consensus 64 ~i~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~-~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~-~ 140 (291)
T cd07844 64 NIVTLHDIIHTKKTLTLVFEYLD-TDLKQYMDDCGG-GLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISER-G 140 (291)
T ss_pred ceeeEEEEEecCCeEEEEEecCC-CCHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCC-C
Confidence 578899998 4568999999997 599999876544 48999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccccc-ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESLTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.++|+|||+++...... ......++..|+|||.+.+ ...++.++||||+|+++|+|++|+.||.+.......
T Consensus 141 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~ 213 (291)
T cd07844 141 ELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLG-------STEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQ 213 (291)
T ss_pred CEEECccccccccCCCCccccccccccccCCcHHhhc-------CcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHH
Confidence 99999999987533221 1223356789999998753 234678999999999999999999999765422111
Q ss_pred HHHHhcc-C--------------------------C---CCCCCCc--HHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 159 YAAAFKN-V--------------------------R---PSAENVP--EELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 159 ~~~~~~~-~--------------------------~---~~~~~~~--~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
....... . . .....++ ..+.+++.+||..+|++||++.+++++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 214 LHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred HHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 1111000 0 0 0011233 788899999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=230.70 Aligned_cols=190 Identities=26% Similarity=0.393 Sum_probs=160.1
Q ss_pred ceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCC
Q 024408 2 REQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT 80 (268)
Q Consensus 2 ~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~ 80 (268)
||+.||-+ ++.-+|+|||||..||+.|.++-+ ++.+++.++..++...++||+|||...-+|||||..|||+..+ |.
T Consensus 90 VVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R~R-~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~-G~ 167 (502)
T KOG0574|consen 90 VVKYYGSYFKHSDLWIVMEYCGAGSISDIMRAR-RKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTD-GI 167 (502)
T ss_pred hhhhhhhhccCCceEeehhhcCCCcHHHHHHHh-cCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEccc-ch
Confidence 78888876 778899999999999999988764 3459999999999999999999999999999999999999888 79
Q ss_pred eEEecCCCccccccccc-cccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 024408 81 IKLADFGLAREESLTEM-MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY 159 (268)
Q Consensus 81 ~kl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~ 159 (268)
.||+|||.|-...+.-. ..+..||+-|||||++.. -.|..++||||||++..||..|++||.+..+.....
T Consensus 168 AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI~E--------IGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF 239 (502)
T KOG0574|consen 168 AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIEE--------IGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF 239 (502)
T ss_pred hhhhhccccchhhhhHHhhCccccCcccccHHHHHH--------hccchhhhHhhhcchhhhhhcCCCCcccccccceeE
Confidence 99999999976544433 356689999999999965 457789999999999999999999998877655433
Q ss_pred HHHhccCC--CCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 160 AAAFKNVR--PSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 160 ~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
........ ..++.++.++.++++.||..+|++|.|+.++++|
T Consensus 240 MIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 240 MIPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred eccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 32222111 1256788999999999999999999999999987
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-32 Score=223.87 Aligned_cols=189 Identities=25% Similarity=0.421 Sum_probs=153.8
Q ss_pred CceeEEEeecC---CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCC
Q 024408 1 MREQFIGACKE---PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED 77 (268)
Q Consensus 1 ~~v~l~g~~~~---~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~ 77 (268)
++++++|++.+ +.+++||||++|++|.+++...+. +++..+..++.|++.||.|||++|++|+||||+||+++.+
T Consensus 65 ~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~--l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~ 142 (264)
T cd06653 65 RIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGA--LTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSA 142 (264)
T ss_pred CcceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCC
Confidence 47889998743 368999999999999999986554 8999999999999999999999999999999999999988
Q ss_pred CCCeEEecCCCccccccc----cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 024408 78 LKTIKLADFGLAREESLT----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS 153 (268)
Q Consensus 78 ~~~~kl~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~ 153 (268)
+.++|+|||+++..... .......++..|+|||.+.+ ...+.++|+||||++++++++|+.||....
T Consensus 143 -~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 213 (264)
T cd06653 143 -GNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISG--------EGYGRKADVWSVACTVVEMLTEKPPWAEYE 213 (264)
T ss_pred -CCEEECccccccccccccccCccccccCCcccccCHhhhcC--------CCCCccccHHHHHHHHHHHHhCCCCCCccC
Confidence 68999999999753221 11223468899999998854 456788999999999999999999998765
Q ss_pred hHHHHHHHHhccC-CCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 154 NLQAAYAAAFKNV-RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 154 ~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
............. ...+..++.++.+++.+||. ++.+||+..++++|
T Consensus 214 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 214 AMAAIFKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred HHHHHHHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 5554443332222 22366788999999999999 57999999998876
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=228.83 Aligned_cols=196 Identities=24% Similarity=0.433 Sum_probs=152.1
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEEeCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLTEDL 78 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~gi~H~Dikp~Nill~~~~ 78 (268)
++++++|+| .++..++||||+. ++|.+++..... .+++..+..++.|++.||+|||+ .|++||||+|+||+++++
T Consensus 75 ~i~~~~~~~~~~~~~~~v~e~~~-~~l~~l~~~~~~-~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~- 151 (296)
T cd06618 75 YIVKCYGYFITDSDVFICMELMS-TCLDKLLKRIQG-PIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDAS- 151 (296)
T ss_pred chHhhheeeecCCeEEEEeeccC-cCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCC-
Confidence 468899999 5568999999994 688887766433 59999999999999999999997 599999999999999987
Q ss_pred CCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 79 KTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 79 ~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
+.++|+|||++.............++..|+|||.+.+.. ....++.++|+||||+++|+|++|+.||.........
T Consensus 152 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~ 227 (296)
T cd06618 152 GNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPD----PNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEV 227 (296)
T ss_pred CCEEECccccchhccCCCcccCCCCCccccCHhhcCCCC----CccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHH
Confidence 699999999987544333333345788999999885411 0234678999999999999999999999764332222
Q ss_pred HHHHhccCC---CCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 024408 159 YAAAFKNVR---PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 203 (268)
Q Consensus 159 ~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~ 203 (268)
......... +....++.++.+++.+||..||.+||++.+++++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~ 275 (296)
T cd06618 228 LTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPF 275 (296)
T ss_pred HHHHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence 222222211 122347889999999999999999999999999843
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=226.58 Aligned_cols=190 Identities=29% Similarity=0.421 Sum_probs=150.8
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++.+ .+...++||||++|++|.+++.+.+. +++..+..++.|++.||+|||++|++|+||+|+||+++.+ +
T Consensus 54 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~-~ 130 (265)
T cd05579 54 YVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVGS--LDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSN-G 130 (265)
T ss_pred chhHHHHheecCcEEEEEEecCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCC-C
Confidence 456777777 45678999999999999999987553 9999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccccc---------ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 024408 80 TIKLADFGLAREESLTE---------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFE 150 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~ 150 (268)
.++|+|||++....... ......++..|++||.... ...+.++|+||||++++++++|..||.
T Consensus 131 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~--------~~~~~~~Dv~slG~~~~~l~~g~~p~~ 202 (265)
T cd05579 131 HLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILG--------QGHSKTVDWWSLGCILYEFLVGIPPFH 202 (265)
T ss_pred CEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcC--------CCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence 99999999987533221 1223457889999998754 446789999999999999999999998
Q ss_pred CCChHHHHHHHHhccC-CCCCCCCcHHHHHHHHhccccCCCCCCCH---HHHHHH
Q 024408 151 GMSNLQAAYAAAFKNV-RPSAENVPEELSIILTSCWKEDPNARPNF---TQIIQM 201 (268)
Q Consensus 151 ~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~---~~~~~~ 201 (268)
.....+.......... .+....++..+.+++.+||+.+|.+||++ .+++++
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 203 GETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred CCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 7665444333322111 11222348999999999999999999999 555554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-32 Score=226.12 Aligned_cols=192 Identities=29% Similarity=0.417 Sum_probs=150.3
Q ss_pred CceeEEEeec-C--CcEEEEEEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEe
Q 024408 1 MREQFIGACK-E--PVMVIVTELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 75 (268)
Q Consensus 1 ~~v~l~g~~~-~--~~~~lV~e~~~ggsL~~~i~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~ 75 (268)
++++++|++. + +.+++||||++|++|.+++... ....+++..+..++.|++.||.|||+.|++|+||+|+||+++
T Consensus 60 ~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~ 139 (287)
T cd06621 60 YIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLT 139 (287)
T ss_pred CeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEe
Confidence 5789999883 2 3689999999999999987642 234489999999999999999999999999999999999999
Q ss_pred CCCCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-
Q 024408 76 EDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN- 154 (268)
Q Consensus 76 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~- 154 (268)
.+ +.++|+|||++........ ....++..|++||.+.+ ..++.++|+||||+++|+|++|..||.....
T Consensus 140 ~~-~~~~l~dfg~~~~~~~~~~-~~~~~~~~y~~pE~~~~--------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~ 209 (287)
T cd06621 140 RK-GQVKLCDFGVSGELVNSLA-GTFTGTSFYMAPERIQG--------KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEP 209 (287)
T ss_pred cC-CeEEEeecccccccccccc-ccccCCccccCHHHhcC--------CCCCchhhHHHHHHHHHHHHhCCCCCCcccCC
Confidence 88 6899999999875433221 23457889999998754 5577899999999999999999999976421
Q ss_pred ---HHHHHHHHhccCCCC-------CCCCcHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 024408 155 ---LQAAYAAAFKNVRPS-------AENVPEELSIILTSCWKEDPNARPNFTQIIQML 202 (268)
Q Consensus 155 ---~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l 202 (268)
.............+. ...+++.+.+++.+||..+|.+||++.+++++-
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~ 267 (287)
T cd06621 210 PLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHP 267 (287)
T ss_pred CCChHHHHHHHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCc
Confidence 111111111111111 124567899999999999999999999999974
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=225.33 Aligned_cols=191 Identities=25% Similarity=0.403 Sum_probs=153.6
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED 77 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~ 77 (268)
+++++++++ .++..++||||++|++|.+++.+. ....+++.+++.++.|++.||.|||++|++|+||+|+||+++.+
T Consensus 63 ~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~~ 142 (260)
T cd08222 63 AIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNN 142 (260)
T ss_pred cHHHHHHHHhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeecC
Confidence 466777887 456789999999999999998752 23359999999999999999999999999999999999999764
Q ss_pred CCCeEEecCCCccccccc-cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH
Q 024408 78 LKTIKLADFGLAREESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 156 (268)
Q Consensus 78 ~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~ 156 (268)
.++++|||.+...... .......++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||.......
T Consensus 143 --~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--------~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~ 212 (260)
T cd08222 143 --LLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKH--------QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLS 212 (260)
T ss_pred --CEeecccCceeecCCCcccccCCCCCcCccCHHHHcc--------CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH
Confidence 6999999998754322 22234567889999998753 446778999999999999999999997655444
Q ss_pred HHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 157 AAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
.............+..++.++.++|.+||..+|++||++.+++++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 213 VVLRIVEGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred HHHHHHcCCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 333333333333355778999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-32 Score=226.87 Aligned_cols=192 Identities=24% Similarity=0.341 Sum_probs=152.3
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ .+...++||||++|++|.+++..... +++..+..++.|++.||.|||++|++||||+|+||+++.+ +
T Consensus 66 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~-~ 142 (290)
T cd05613 66 FLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRER--FKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSN-G 142 (290)
T ss_pred ChhceeeEeecCCeEEEEEecCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCC-C
Confidence 467788887 45678999999999999999987544 8999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccccc--ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh---
Q 024408 80 TIKLADFGLAREESLTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN--- 154 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~--- 154 (268)
.++|+|||++....... ......|+..|+|||.+.. ....++.++|+||||+++|+|++|..||.....
T Consensus 143 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~ 216 (290)
T cd05613 143 HVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRG------GDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS 216 (290)
T ss_pred CEEEeeCccceecccccccccccccCCcccCChhhccC------CCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc
Confidence 99999999997543322 2223468899999998753 123456789999999999999999999964221
Q ss_pred HHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 024408 155 LQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARP-----NFTQIIQM 201 (268)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~~~~~ 201 (268)
.............+.+..++..+.+++.+||..+|.+|| +..+++++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 217 QAEISRRILKSEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred HHHHHHHhhccCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 122222222333444567889999999999999999997 77888776
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-31 Score=229.76 Aligned_cols=191 Identities=25% Similarity=0.319 Sum_probs=151.1
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ .+++.++||||++ ++|.+++..... +++..+..++.|++.||+|||+.|++|+||+|+||+++.+ +
T Consensus 81 ~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~--~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~-~ 156 (335)
T PTZ00024 81 NIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIR--LTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSK-G 156 (335)
T ss_pred ceeeeeEEEecCCcEEEEEeccc-cCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCC-C
Confidence 578889998 5678999999996 699999976444 9999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccc---------------ccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh
Q 024408 80 TIKLADFGLAREESL---------------TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH 144 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~---------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~ 144 (268)
.++|+|||++..... ........++..|+|||.+.+ ...++.++|+||||+++|+|++
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slG~~l~el~t 229 (335)
T PTZ00024 157 ICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMG-------AEKYHFAVDMWSVGCIFAELLT 229 (335)
T ss_pred CEEECCccceeecccccccccccccccccccccccccccccCCCCChhccc-------CCCCCcHHHHHHHHHHHHHHHh
Confidence 999999999875431 111122346788999998853 2346789999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHhccCCC---------------------------CCCCCcHHHHHHHHhccccCCCCCCCHHH
Q 024408 145 NKLPFEGMSNLQAAYAAAFKNVRP---------------------------SAENVPEELSIILTSCWKEDPNARPNFTQ 197 (268)
Q Consensus 145 g~~p~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 197 (268)
|..||.+....+...........+ .....+..+.++|.+||..+|++||++++
T Consensus 230 g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~ 309 (335)
T PTZ00024 230 GKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKE 309 (335)
T ss_pred CCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHH
Confidence 999998766544332222111000 01245788999999999999999999999
Q ss_pred HHHHH
Q 024408 198 IIQML 202 (268)
Q Consensus 198 ~~~~l 202 (268)
++.+.
T Consensus 310 ~l~~~ 314 (335)
T PTZ00024 310 ALKHE 314 (335)
T ss_pred HhcCc
Confidence 99973
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=240.88 Aligned_cols=192 Identities=28% Similarity=0.520 Sum_probs=170.7
Q ss_pred CceeEEEeecCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCC
Q 024408 1 MREQFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT 80 (268)
Q Consensus 1 ~~v~l~g~~~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~ 80 (268)
++|+|||...+..+.||||+++.|||.+.|++.....|-......++.||+.|+.||.++++|||||-..|+++... ..
T Consensus 172 hliRLyGvVl~qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasp-rt 250 (1039)
T KOG0199|consen 172 HLIRLYGVVLDQPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASP-RT 250 (1039)
T ss_pred ceeEEeeeeccchhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheeccc-ce
Confidence 58999999988889999999999999999998666679999999999999999999999999999999999999876 59
Q ss_pred eEEecCCCcccccccccccc----CCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChH
Q 024408 81 IKLADFGLAREESLTEMMTA----ETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNL 155 (268)
Q Consensus 81 ~kl~Dfg~a~~~~~~~~~~~----~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~~~ 155 (268)
+||+|||+.+.....+.... ......|+|||.++. ..++.++|||++|+++|||++ |..||.+....
T Consensus 251 VKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh--------~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~ 322 (1039)
T KOG0199|consen 251 VKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRH--------RKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI 322 (1039)
T ss_pred eeeecccceeccCCCCcceEecCCCcCcccccCHhHhcc--------ccccccchhhhhhhhHHhhhccCCCCCCCCCHH
Confidence 99999999985444333222 234578999999975 678999999999999999998 88999999998
Q ss_pred HHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 156 QAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
+...........+.++.+++.+.+++..||..+|.+||++..|.+.
T Consensus 323 qIL~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 323 QILKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred HHHHhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 8888887777888899999999999999999999999999999854
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-32 Score=225.96 Aligned_cols=191 Identities=28% Similarity=0.379 Sum_probs=152.1
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ .+...++||||++ ++|.+++.... ..+++.++..++.|++.||.|||++|++|+||||+||+++.+ +
T Consensus 59 ~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~-~ 135 (283)
T cd05118 59 NIIKLLDVFRHKGDLYLVFEFMD-TDLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTE-G 135 (283)
T ss_pred CcchHHHhhccCCCEEEEEeccC-CCHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCC-C
Confidence 467788887 5568899999996 59999887643 349999999999999999999999999999999999999987 6
Q ss_pred CeEEecCCCcccccccc-ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESLTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.++|+|||.+....... ......++..|+|||.+.+ ...++.++|+||||+++|++++|+.||...+..+..
T Consensus 136 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-------~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~ 208 (283)
T cd05118 136 VLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLG-------DKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQL 208 (283)
T ss_pred cEEEeeeeeeEecCCCcccccCccCcccccCcHHHhc-------CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 89999999987544332 2233467889999998753 235788999999999999999999999876654433
Q ss_pred HHHHhccCCC-----------------------------CCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 159 YAAAFKNVRP-----------------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 159 ~~~~~~~~~~-----------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
.........+ ....++.++.++|.+||..||.+||++.+++.+
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 209 FKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred HHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 2222111110 112467889999999999999999999999886
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-32 Score=224.42 Aligned_cols=191 Identities=25% Similarity=0.303 Sum_probs=150.0
Q ss_pred CceeEEEee-cC--CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCC
Q 024408 1 MREQFIGAC-KE--PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED 77 (268)
Q Consensus 1 ~~v~l~g~~-~~--~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~ 77 (268)
+++++++++ .. +..++||||++ ++|.+++.+.. ..+++.+++.++.|++.||++||++|++|+||+|+||+++++
T Consensus 59 ~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~ 136 (287)
T cd07840 59 NIVRLKEIVTSKGKGSIYMVFEYMD-HDLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINND 136 (287)
T ss_pred CeeeheeeEecCCCCcEEEEecccc-ccHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCC
Confidence 578889998 44 58999999997 59999887653 349999999999999999999999999999999999999988
Q ss_pred CCCeEEecCCCcccccccc--ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH
Q 024408 78 LKTIKLADFGLAREESLTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL 155 (268)
Q Consensus 78 ~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~ 155 (268)
+.++++|||++....... ......++..|+|||.+.+ ...++.++||||||+++|+|++|+.||......
T Consensus 137 -~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-------~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~ 208 (287)
T cd07840 137 -GVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLG-------ATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL 208 (287)
T ss_pred -CCEEEccccceeeccCCCcccccccccccccCCceeeEc-------cccCChHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 699999999998544332 1233456788999997753 234678999999999999999999999875543
Q ss_pred HHHHHHHhccCCC-----------------------------CCCC-CcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 156 QAAYAAAFKNVRP-----------------------------SAEN-VPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 156 ~~~~~~~~~~~~~-----------------------------~~~~-~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
............+ .... ++.++.+++.+||..+|.+||++.+++++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 209 EQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred HHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 3222211110000 0011 37889999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-32 Score=220.75 Aligned_cols=188 Identities=34% Similarity=0.430 Sum_probs=153.4
Q ss_pred ceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCC
Q 024408 2 REQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT 80 (268)
Q Consensus 2 ~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~ 80 (268)
++++++.+ .++..++||||+++++|.+++..... +++..+..++.|++.||.+||+.|++|+||+|+||+++.+ +.
T Consensus 55 i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~--l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~-~~ 131 (250)
T cd05123 55 IVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGR--FSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDAD-GH 131 (250)
T ss_pred HHHHHHHeecCCeeEEEEecCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCC-Cc
Confidence 55666676 45688999999999999999987544 8999999999999999999999999999999999999988 68
Q ss_pred eEEecCCCccccccc-cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 024408 81 IKLADFGLAREESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY 159 (268)
Q Consensus 81 ~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~ 159 (268)
++|+|||++...... .......++..|++||...+ ...+.++|+||||+++|++++|..||...+..+. .
T Consensus 132 ~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~--------~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~-~ 202 (250)
T cd05123 132 IKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLG--------KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEI-Y 202 (250)
T ss_pred EEEeecCcceecccCCCcccCCcCCccccChHHhCC--------CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH-H
Confidence 999999999754332 23344567889999998854 4467889999999999999999999977654332 2
Q ss_pred HHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCH---HHHHHH
Q 024408 160 AAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNF---TQIIQM 201 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~---~~~~~~ 201 (268)
........+.+...+..+.+++.+||..||++||++ .+++++
T Consensus 203 ~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~ 247 (250)
T cd05123 203 EKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAH 247 (250)
T ss_pred HHHhcCCCCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhC
Confidence 233333344566678999999999999999999999 566554
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-31 Score=225.37 Aligned_cols=190 Identities=29% Similarity=0.439 Sum_probs=153.4
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ .+...++||||+. |+|.+++..... .+++.++..++.|++.||.|||++|++|+||+|+||+++.+ +
T Consensus 82 ~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~-~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~-~ 158 (313)
T cd06633 82 NTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHKK-PLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEP-G 158 (313)
T ss_pred CCccEEEEEEeCCEEEEEEecCC-CCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCC-C
Confidence 578899998 5567899999995 688888865433 48999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 024408 80 TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY 159 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~ 159 (268)
.++|+|||++..... .....|+..|+|||.+... ....++.++|+||||+++|+|++|..||..........
T Consensus 159 ~~kL~dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~-----~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~ 230 (313)
T cd06633 159 QVKLADFGSASKSSP---ANSFVGTPYWMAPEVILAM-----DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY 230 (313)
T ss_pred CEEEeecCCCcccCC---CCCccccccccChhhcccc-----CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 899999999864322 2345688899999987421 12456789999999999999999999998766554444
Q ss_pred HHHhccCC-CCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 160 AAAFKNVR-PSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 160 ~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
........ .....++..+.+++.+||+.+|.+||++.+++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 231 HIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred HHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 33322222 2234577889999999999999999999999987
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-32 Score=225.98 Aligned_cols=194 Identities=24% Similarity=0.321 Sum_probs=151.4
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++.+ .++..++||||++|++|.+++..... +++..+..++.|++.||.|||+.|++|+||+|.||+++.+ +
T Consensus 66 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~-~ 142 (288)
T cd05583 66 FLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREH--FTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSE-G 142 (288)
T ss_pred chhhhheeeecCCEEEEEEecCCCCcHHHHHhhcCC--cCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCC-C
Confidence 356677776 55678999999999999999876543 8999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccccc--cccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh---
Q 024408 80 TIKLADFGLAREESLTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN--- 154 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~--- 154 (268)
.++++|||+++....... .....|+..|++||.+.+. ....+.++|+||||+++|+|++|..||.....
T Consensus 143 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~ 216 (288)
T cd05583 143 HVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGG------SGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS 216 (288)
T ss_pred CEEEEECccccccccccccccccccCCccccCHHHhcCC------CCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch
Confidence 899999999875333221 2234578899999987541 12357789999999999999999999964221
Q ss_pred HHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 024408 155 LQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 203 (268)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~ 203 (268)
.............+.+..++..+.+++.+||+.+|++|||+.++.+.|+
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~ 265 (288)
T cd05583 217 QSEISRRILKSKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKN 265 (288)
T ss_pred HHHHHHHHHccCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence 1122222333334556678899999999999999999999776655543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-32 Score=228.59 Aligned_cols=192 Identities=19% Similarity=0.241 Sum_probs=146.3
Q ss_pred CceeEEEee-cC--CcEEEEEEcCCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEE
Q 024408 1 MREQFIGAC-KE--PVMVIVTELLSGGTLRKYLLNMR---PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL 74 (268)
Q Consensus 1 ~~v~l~g~~-~~--~~~~lV~e~~~ggsL~~~i~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill 74 (268)
+++++++++ .. ...++||||++ ++|.+++.... ...+++..++.++.|++.||+|||++|++||||||+||++
T Consensus 63 ~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~ 141 (316)
T cd07842 63 NVVSLVEVFLEHADKSVYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILV 141 (316)
T ss_pred CccceEEEEeCCCCceEEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEE
Confidence 578999998 44 57899999996 68888775432 2258999999999999999999999999999999999999
Q ss_pred eC----CCCCeEEecCCCccccccccc----cccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCC
Q 024408 75 TE----DLKTIKLADFGLAREESLTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNK 146 (268)
Q Consensus 75 ~~----~~~~~kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~ 146 (268)
+. + +.+||+|||++........ .....++..|+|||.+.+ ...++.++|+||||+++++|++|+
T Consensus 142 ~~~~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slG~~l~~l~~~~ 213 (316)
T cd07842 142 MGEGPER-GVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLG-------ARHYTKAIDIWAIGCIFAELLTLE 213 (316)
T ss_pred cCCCCcc-ceEEECCCccccccCCCcccccccCCccccccccCHHHHhC-------CCCCCcHHHHHHHHHHHHHHHhcC
Confidence 88 6 6899999999875432211 223457889999998753 234678999999999999999999
Q ss_pred CCCCCCChHH---------HHHHHHh------------------------ccCCCCC------------CCCcHHHHHHH
Q 024408 147 LPFEGMSNLQ---------AAYAAAF------------------------KNVRPSA------------ENVPEELSIIL 181 (268)
Q Consensus 147 ~p~~~~~~~~---------~~~~~~~------------------------~~~~~~~------------~~~~~~l~~li 181 (268)
.||....... ....... ....... ...+.++.+++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 293 (316)
T cd07842 214 PIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLL 293 (316)
T ss_pred CCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHH
Confidence 9997543221 0000000 0000001 14567899999
Q ss_pred HhccccCCCCCCCHHHHHHH
Q 024408 182 TSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 182 ~~~l~~~p~~Rps~~~~~~~ 201 (268)
.+||..||++||++.+++++
T Consensus 294 ~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 294 RKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHhcCCcccCcCHHHHhcC
Confidence 99999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=240.43 Aligned_cols=193 Identities=19% Similarity=0.226 Sum_probs=144.9
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMR---PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE 76 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~ 76 (268)
|+|++++++ .++..++|+|++ +++|.+++.... .......++..++.|++.||.|||++||+||||||+|||++.
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~ 302 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNC 302 (501)
T ss_pred CcCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC
Confidence 689999999 556889999999 478888876432 112446778889999999999999999999999999999998
Q ss_pred CCCCeEEecCCCcccccccc--ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCC-CCCCCC
Q 024408 77 DLKTIKLADFGLAREESLTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKL-PFEGMS 153 (268)
Q Consensus 77 ~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~-p~~~~~ 153 (268)
+ +.+||+|||+++...... ......||..|+|||++.+ ..++.++|||||||++|||++|.. |+....
T Consensus 303 ~-~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlGvil~ell~~~~~p~~~~~ 373 (501)
T PHA03210 303 D-GKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAG--------DGYCEITDIWSCGLILLDMLSHDFCPIGDGG 373 (501)
T ss_pred C-CCEEEEeCCCceecCcccccccccccCCcCCCCchhhcC--------CCCCcHHHHHHHHHHHHHHHHCCCCCccCCC
Confidence 8 699999999998544322 2234579999999999864 567889999999999999999875 443221
Q ss_pred --hHHHHHHHHhcc----------------------CCC---------CCCCCcHHHHHHHHhccccCCCCCCCHHHHHH
Q 024408 154 --NLQAAYAAAFKN----------------------VRP---------SAENVPEELSIILTSCWKEDPNARPNFTQIIQ 200 (268)
Q Consensus 154 --~~~~~~~~~~~~----------------------~~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~ 200 (268)
............ ... ....++..+.++|.+||..||.+||++.|++.
T Consensus 374 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 374 GKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred CCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 111111111000 000 01235567888899999999999999999999
Q ss_pred HHH
Q 024408 201 MLL 203 (268)
Q Consensus 201 ~l~ 203 (268)
+-+
T Consensus 454 hp~ 456 (501)
T PHA03210 454 LPL 456 (501)
T ss_pred Chh
Confidence 743
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=226.19 Aligned_cols=193 Identities=28% Similarity=0.407 Sum_probs=154.1
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
++++++|++ .+...++||||+. |+|.+.+.... ..+++.++..++.|++.||.|||++|++||||+|+||+++.+ +
T Consensus 76 ~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~-~ 152 (308)
T cd06634 76 NTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP-G 152 (308)
T ss_pred CcccEEEEEEcCCeeEEEEEccC-CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCC-C
Confidence 478899998 5567899999996 68888776543 338999999999999999999999999999999999999987 6
Q ss_pred CeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 024408 80 TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY 159 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~ 159 (268)
.++++|||++...... ....++..|+|||.+.+. .....+.++||||||+++|+|++|..||..........
T Consensus 153 ~~kl~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~-----~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~ 224 (308)
T cd06634 153 LVKLGDFGSASIMAPA---NXFVGTPYWMAPEVILAM-----DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY 224 (308)
T ss_pred cEEECCcccceeecCc---ccccCCccccCHHHHhhc-----ccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHH
Confidence 9999999998754322 334678899999987431 12346778999999999999999999997765544443
Q ss_pred HHHhccCC-CCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 024408 160 AAAFKNVR-PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 204 (268)
Q Consensus 160 ~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~ 204 (268)
........ .....++..+.++|.+||..+|.+||++.+++++.+.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~ 270 (308)
T cd06634 225 HIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 270 (308)
T ss_pred HHhhcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccc
Confidence 33322222 2244678899999999999999999999999998443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.7e-32 Score=225.09 Aligned_cols=189 Identities=28% Similarity=0.410 Sum_probs=154.3
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ .++..++||||++|++|.+++.+.+. +++..++.++.|++.||.+||+.|++|+||+|+||+++.+ +
T Consensus 63 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~-~ 139 (280)
T cd05581 63 GIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGS--LDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKD-M 139 (280)
T ss_pred CchhHHHHhcCCceEEEEEcCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCC-C
Confidence 467778887 44688999999999999999987654 9999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccccc---------------------ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHH
Q 024408 80 TIKLADFGLAREESLTE---------------------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIV 138 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~---------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~ 138 (268)
.++++|||++....... ......++..|+|||++.. ...+.++|+||||++
T Consensus 140 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~--------~~~~~~~Di~slG~~ 211 (280)
T cd05581 140 HIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE--------KPAGKSSDLWALGCI 211 (280)
T ss_pred CEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCC--------CCCChhhhHHHHHHH
Confidence 99999999987433221 1123357889999998754 457789999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCH----HHHHHH
Q 024408 139 LWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNF----TQIIQM 201 (268)
Q Consensus 139 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~----~~~~~~ 201 (268)
++++++|+.||........... ........+..+++.+.+++.+||..+|.+||++ +++++|
T Consensus 212 l~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 212 IYQMLTGKPPFRGSNEYLTFQK-ILKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred HHHHHhCCCCCCCccHHHHHHH-HHhcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 9999999999987654333222 2233333456778999999999999999999999 888775
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.9e-32 Score=229.30 Aligned_cols=191 Identities=28% Similarity=0.341 Sum_probs=151.8
Q ss_pred CceeEEEeecCC------cEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEE
Q 024408 1 MREQFIGACKEP------VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL 74 (268)
Q Consensus 1 ~~v~l~g~~~~~------~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill 74 (268)
++++++|++..+ .+++||||++ ++|.+++.+.. .+++..++.++.+++.||.+||++|++|+||||.||++
T Consensus 60 ~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili 136 (330)
T cd07834 60 NIIGLLDILRPPSPEDFNDVYIVTELME-TDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILV 136 (330)
T ss_pred chhhhhhhhcccCcccccceEEEecchh-hhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 456777777432 6899999996 68999987654 49999999999999999999999999999999999999
Q ss_pred eCCCCCeEEecCCCcccccccc----ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 024408 75 TEDLKTIKLADFGLAREESLTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFE 150 (268)
Q Consensus 75 ~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~ 150 (268)
+.+ +.++|+|||++....... ......++..|+|||.+.+ ...++.++|+||||+++|+|++|..||.
T Consensus 137 ~~~-~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~sDi~slG~il~~l~~g~~pf~ 208 (330)
T cd07834 137 NSN-CDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLS-------SSRYTKAIDIWSVGCIFAELLTRKPLFP 208 (330)
T ss_pred cCC-CCEEEcccCceEeecccccccccccccccccCcCCceeeec-------ccCCCcchhHHHHHHHHHHHHcCCCCcC
Confidence 988 799999999998644432 2334567889999999864 1267889999999999999999999998
Q ss_pred CCChHHHHHHHHhccCCC------------------------------CCCCCcHHHHHHHHhccccCCCCCCCHHHHHH
Q 024408 151 GMSNLQAAYAAAFKNVRP------------------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQ 200 (268)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~ 200 (268)
+....+...........+ ....++..+.++|.+||..+|.+||++.++++
T Consensus 209 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 288 (330)
T cd07834 209 GRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA 288 (330)
T ss_pred CCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 765443322221111100 02346788999999999999999999999999
Q ss_pred HH
Q 024408 201 ML 202 (268)
Q Consensus 201 ~l 202 (268)
+.
T Consensus 289 ~~ 290 (330)
T cd07834 289 HP 290 (330)
T ss_pred Cc
Confidence 83
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-32 Score=244.44 Aligned_cols=197 Identities=24% Similarity=0.391 Sum_probs=168.4
Q ss_pred CceeEEEeec------CCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEE
Q 024408 1 MREQFIGACK------EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL 74 (268)
Q Consensus 1 ~~v~l~g~~~------~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill 74 (268)
||+.++|++. ++.+|||||||.|||.-|++.+..+..+.|..+..|++.++.|+.+||.+.++|||||-.|||+
T Consensus 77 nv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLL 156 (953)
T KOG0587|consen 77 NVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLL 156 (953)
T ss_pred CcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEE
Confidence 6899999972 3589999999999999999998877789999999999999999999999999999999999999
Q ss_pred eCCCCCeEEecCCCcccccc-ccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 024408 75 TEDLKTIKLADFGLAREESL-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS 153 (268)
Q Consensus 75 ~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~ 153 (268)
+.+ +.+|++|||.+..... .....+.+||+.|||||++.+. +.....|+.++|+||||++..||..|.+|+.++.
T Consensus 157 T~e-~~VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~---e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmH 232 (953)
T KOG0587|consen 157 TEN-AEVKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACD---ESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMH 232 (953)
T ss_pred ecc-CcEEEeeeeeeeeeecccccccCcCCCcccccceeeecc---cCCCCCcccccchhhccceeehhcCCCCCccCcc
Confidence 999 7999999999875443 3344677899999999999763 2334668889999999999999999999999988
Q ss_pred hHHHHHHHHhccCCC--CCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 154 NLQAAYAAAFKNVRP--SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 154 ~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
+......+....... .+..+++++.++|..||..|..+||+..++++|
T Consensus 233 PmraLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 233 PMRALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred hhhhhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 776655443322211 156789999999999999999999999999876
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.2e-32 Score=230.65 Aligned_cols=192 Identities=26% Similarity=0.364 Sum_probs=148.5
Q ss_pred CceeEEEeec-----CCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEe
Q 024408 1 MREQFIGACK-----EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 75 (268)
Q Consensus 1 ~~v~l~g~~~-----~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~ 75 (268)
+++++++++. ...+++||||+. ++|.+++...+. +++..+..++.|++.||+|||++|++||||||+||+++
T Consensus 65 ~iv~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~ 141 (334)
T cd07855 65 NIIAIRDILRPPGADFKDVYVVMDLME-SDLHHIIHSDQP--LTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVN 141 (334)
T ss_pred CccCHHHhccccCCCCceEEEEEehhh-hhHHHHhccCCC--CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc
Confidence 4566666652 246899999995 699999876544 99999999999999999999999999999999999999
Q ss_pred CCCCCeEEecCCCccccccccc-----cccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 024408 76 EDLKTIKLADFGLAREESLTEM-----MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFE 150 (268)
Q Consensus 76 ~~~~~~kl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~ 150 (268)
.+ +.++|+|||++........ .....++..|+|||.+.. ...++.++|+||||+++|+|++|+.||.
T Consensus 142 ~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-------~~~~~~~~Di~slG~~l~el~~g~~pf~ 213 (334)
T cd07855 142 ED-CELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLS-------LPEYTTAIDMWSVGCIFAEMLGRRQLFP 213 (334)
T ss_pred CC-CcEEecccccceeecccCcCCCcccccccccccccChHHhcC-------CcccccccchHHHHHHHHHHHcCCCccC
Confidence 88 6999999999975332211 123468889999998753 2346789999999999999999999997
Q ss_pred CCChHHHHHHHHhc----------------------cC---CCC-----CCCCcHHHHHHHHhccccCCCCCCCHHHHHH
Q 024408 151 GMSNLQAAYAAAFK----------------------NV---RPS-----AENVPEELSIILTSCWKEDPNARPNFTQIIQ 200 (268)
Q Consensus 151 ~~~~~~~~~~~~~~----------------------~~---~~~-----~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~ 200 (268)
+.+........... .. ... ....+.++.++|.+||+.+|.+||++.+++.
T Consensus 214 ~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 214 GKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred CCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 75543221111100 00 000 1346789999999999999999999999999
Q ss_pred HHH
Q 024408 201 MLL 203 (268)
Q Consensus 201 ~l~ 203 (268)
+.+
T Consensus 294 ~~~ 296 (334)
T cd07855 294 HPF 296 (334)
T ss_pred Chh
Confidence 844
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=229.89 Aligned_cols=190 Identities=25% Similarity=0.300 Sum_probs=148.6
Q ss_pred CceeEEEeecC------CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEE
Q 024408 1 MREQFIGACKE------PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL 74 (268)
Q Consensus 1 ~~v~l~g~~~~------~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill 74 (268)
+++++++++.. ...++||||+. ++|.+++...+. +++..+..++.|++.||.|||++|++||||||+||++
T Consensus 65 ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~--l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~ 141 (337)
T cd07858 65 NVIAIKDIMPPPHREAFNDVYIVYELMD-TDLHQIIRSSQT--LSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLL 141 (337)
T ss_pred CccchHHheecccccccCcEEEEEeCCC-CCHHHHHhcCCC--CCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE
Confidence 46777777632 24799999995 799999876544 9999999999999999999999999999999999999
Q ss_pred eCCCCCeEEecCCCccccccc-cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 024408 75 TEDLKTIKLADFGLAREESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS 153 (268)
Q Consensus 75 ~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~ 153 (268)
+.+ +.++|+|||++...... .......++..|+|||.+.. ...++.++|+||||+++|+|++|+.||.+.+
T Consensus 142 ~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 213 (337)
T cd07858 142 NAN-CDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLN-------CSEYTTAIDVWSVGCIFAELLGRKPLFPGKD 213 (337)
T ss_pred cCC-CCEEECcCccccccCCCcccccccccccCccChHHHhc-------CCCCCCcccHHHHHHHHHHHHcCCCCCCCCC
Confidence 988 69999999999854332 22234467889999998753 1347789999999999999999999997654
Q ss_pred hHHHHHHHHh------------------------ccC------CCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 154 NLQAAYAAAF------------------------KNV------RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 154 ~~~~~~~~~~------------------------~~~------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
.......... ... ......+++++.++|++||+.+|.+||++.+++++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 214 YVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred hHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 3211110000 000 00124578899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.9e-31 Score=225.26 Aligned_cols=189 Identities=27% Similarity=0.331 Sum_probs=149.1
Q ss_pred CceeEEEeecC---CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCC
Q 024408 1 MREQFIGACKE---PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED 77 (268)
Q Consensus 1 ~~v~l~g~~~~---~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~ 77 (268)
++++++|+|.. ...++||||++ ++|.+++.+. .+++..+..++.|++.||+|||++|++|+||||+||+++.+
T Consensus 68 ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~ 143 (337)
T cd07852 68 NIVKLLNVIKAENDKDIYLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSD 143 (337)
T ss_pred CccceeeeeccCCCceEEEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC
Confidence 57899998742 36899999996 6999998764 48999999999999999999999999999999999999998
Q ss_pred CCCeEEecCCCcccccccc------ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 024408 78 LKTIKLADFGLAREESLTE------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 151 (268)
Q Consensus 78 ~~~~kl~Dfg~a~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~ 151 (268)
+.++|+|||++....... ......|+..|+|||.+.+ ....+.++|+||||+++|+|++|+.||.+
T Consensus 144 -~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~sDi~slG~~l~el~tg~~pf~~ 215 (337)
T cd07852 144 -CRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLG-------STRYTKGVDMWSVGCILGEMLLGKPLFPG 215 (337)
T ss_pred -CcEEEeeccchhccccccccccCcchhcccccccccCceeeec-------cccccccchHHHHHHHHHHHHhCCCCCCC
Confidence 699999999987433221 2233468899999998753 24567789999999999999999999976
Q ss_pred CChHHHHHHHHhccC------------------------------CCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 152 MSNLQAAYAAAFKNV------------------------------RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 152 ~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
............... ......++.++.++|.+||+.+|.+||++.+++++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 216 TSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred CChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 554332221111100 00123368899999999999999999999999987
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-31 Score=224.00 Aligned_cols=191 Identities=21% Similarity=0.282 Sum_probs=145.0
Q ss_pred CceeEEEeecC---------CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCC
Q 024408 1 MREQFIGACKE---------PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPEN 71 (268)
Q Consensus 1 ~~v~l~g~~~~---------~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~N 71 (268)
++++++++|.. ...++||||+. ++|.+.+.+.. ..+++.+++.++.|++.||+|||++|++|+||||+|
T Consensus 72 ~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~n 149 (310)
T cd07865 72 NVVNLIEICRTKATPYNRYKGSFYLVFEFCE-HDLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAAN 149 (310)
T ss_pred CccceEEEEecccccccCCCceEEEEEcCCC-cCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHH
Confidence 46888888733 24599999995 68998887643 248999999999999999999999999999999999
Q ss_pred EEEeCCCCCeEEecCCCcccccccc-----ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCC
Q 024408 72 LLLTEDLKTIKLADFGLAREESLTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNK 146 (268)
Q Consensus 72 ill~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~ 146 (268)
|+++.+ +.++|+|||++....... ......++..|+|||.+.+ ...++.++|+||||+++|+|++|.
T Consensus 150 il~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~~l~el~t~~ 221 (310)
T cd07865 150 ILITKD-GILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLG-------ERDYGPPIDMWGAGCIMAEMWTRS 221 (310)
T ss_pred EEECCC-CcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcC-------CcccCchhhhHHHHHHHHHHHhCC
Confidence 999988 699999999997543221 1123457788999998753 133577899999999999999999
Q ss_pred CCCCCCChHHHHHHHHhcc--C------------------CCC-----------CCCCcHHHHHHHHhccccCCCCCCCH
Q 024408 147 LPFEGMSNLQAAYAAAFKN--V------------------RPS-----------AENVPEELSIILTSCWKEDPNARPNF 195 (268)
Q Consensus 147 ~p~~~~~~~~~~~~~~~~~--~------------------~~~-----------~~~~~~~l~~li~~~l~~~p~~Rps~ 195 (268)
.||................ . .+. ....+..+.++|.+||..||.+||++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~ 301 (310)
T cd07865 222 PIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDA 301 (310)
T ss_pred CCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCH
Confidence 9997655432221111100 0 000 01124677899999999999999999
Q ss_pred HHHHHH
Q 024408 196 TQIIQM 201 (268)
Q Consensus 196 ~~~~~~ 201 (268)
+++++|
T Consensus 302 ~e~l~h 307 (310)
T cd07865 302 DTALNH 307 (310)
T ss_pred HHHhcC
Confidence 999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.8e-31 Score=223.66 Aligned_cols=191 Identities=23% Similarity=0.251 Sum_probs=148.1
Q ss_pred CceeEEEeecC-C----------cEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCC
Q 024408 1 MREQFIGACKE-P----------VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKP 69 (268)
Q Consensus 1 ~~v~l~g~~~~-~----------~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp 69 (268)
++++++|++.+ . ++++||||++| +|.+.+.... ..+++.++..++.|++.||+|||+.|++|+||||
T Consensus 67 ~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p 144 (302)
T cd07864 67 NIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGL-VHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKC 144 (302)
T ss_pred CeeeeeheecCcchhhhccccCCcEEEEEcccCc-cHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCH
Confidence 57888888743 2 68999999974 8888776543 3499999999999999999999999999999999
Q ss_pred CCEEEeCCCCCeEEecCCCcccccccc--ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCC
Q 024408 70 ENLLLTEDLKTIKLADFGLAREESLTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKL 147 (268)
Q Consensus 70 ~Nill~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~ 147 (268)
+||+++++ +.++|+|||++....... ......++..|+|||.+.+ ....+.++||||||+++++|++|+.
T Consensus 145 ~nili~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-------~~~~~~~~Di~slG~~~~el~~g~~ 216 (302)
T cd07864 145 SNILLNNK-GQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLG-------EERYGPAIDVWSCGCILGELFTKKP 216 (302)
T ss_pred HHEEECCC-CcEEeCcccccccccCCcccccccceeccCccChHHhcC-------CCCCCchhHHHHHHHHHHHHHhCCC
Confidence 99999988 699999999997543322 1122345778999998743 1345778999999999999999999
Q ss_pred CCCCCChHHHHHHHHhccCC-----------------------------CCCCCCcHHHHHHHHhccccCCCCCCCHHHH
Q 024408 148 PFEGMSNLQAAYAAAFKNVR-----------------------------PSAENVPEELSIILTSCWKEDPNARPNFTQI 198 (268)
Q Consensus 148 p~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~ 198 (268)
||......+........... .....++..+.+++.+||..+|.+||++.++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~i 296 (302)
T cd07864 217 IFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEA 296 (302)
T ss_pred CCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence 99865544332222111000 0123468899999999999999999999999
Q ss_pred HHH
Q 024408 199 IQM 201 (268)
Q Consensus 199 ~~~ 201 (268)
+++
T Consensus 297 l~~ 299 (302)
T cd07864 297 LNS 299 (302)
T ss_pred hcC
Confidence 876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-33 Score=220.85 Aligned_cols=193 Identities=23% Similarity=0.389 Sum_probs=158.5
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCCEEEe
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLN---MRPRCLDVCVAIGFALDIARAMECLHSH-GIIHRDLKPENLLLT 75 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~---~~~~~~~~~~~~~~~~~l~~~l~~lH~~-gi~H~Dikp~Nill~ 75 (268)
++|++||.+ .++-.|+.||+++ .||..+-.. -....+++.-.-++....+.||.||-.. .|+||||||+|||++
T Consensus 124 ~IVkfyGa~F~EGdcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILld 202 (361)
T KOG1006|consen 124 NIVKFYGALFSEGDCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLD 202 (361)
T ss_pred HHHHHhhhhhcCCceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEe
Confidence 478999998 7888999999996 677665432 3344599999999999999999999864 899999999999999
Q ss_pred CCCCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH
Q 024408 76 EDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL 155 (268)
Q Consensus 76 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~ 155 (268)
.. |.+||||||++-............|-..|||||.+.. ....|..+|||||||++++|+.||..||.+.+..
T Consensus 203 r~-G~vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p------~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~sv 275 (361)
T KOG1006|consen 203 RH-GDVKLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDP------SDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSV 275 (361)
T ss_pred cC-CCEeeecccchHhHHHHHHhhhccCCccccChhccCC------ccCCcchhhhhhhhcceEeeeecCCCCcchHHHH
Confidence 98 7999999999987666666667788899999999864 2346889999999999999999999999986654
Q ss_pred HHHHHHHhccCCCC------CCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 156 QAAYAAAFKNVRPS------AENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 156 ~~~~~~~~~~~~~~------~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
-...........|. .-+++..+..+|..||.+|...||.+.+++++
T Consensus 276 feql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 276 FEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred HHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 43333333333332 23478899999999999999999999999886
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=227.60 Aligned_cols=189 Identities=26% Similarity=0.354 Sum_probs=145.1
Q ss_pred CceeEEEeecC------CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEE
Q 024408 1 MREQFIGACKE------PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL 74 (268)
Q Consensus 1 ~~v~l~g~~~~------~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill 74 (268)
+++++++++.. ...++||||++ ++|.+++.. ..+++..+..++.|++.||++||++|++||||||+||++
T Consensus 64 niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill 139 (336)
T cd07849 64 NIIGILDIIRPPSFESFNDVYIVQELME-TDLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 139 (336)
T ss_pred CcCchhheeecccccccceEEEEehhcc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE
Confidence 46777777632 24799999996 689888754 239999999999999999999999999999999999999
Q ss_pred eCCCCCeEEecCCCcccccccc----ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 024408 75 TEDLKTIKLADFGLAREESLTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFE 150 (268)
Q Consensus 75 ~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~ 150 (268)
+.+ +.++|+|||++....... ......|+..|+|||.+.+ ...++.++||||+|+++|+|++|+.||.
T Consensus 140 ~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DvwslGvil~el~~G~~~f~ 211 (336)
T cd07849 140 NTN-CDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLN-------SKGYTKAIDIWSVGCILAEMLSNRPLFP 211 (336)
T ss_pred CCC-CCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhC-------CCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 988 699999999987533221 1123467899999998643 2456789999999999999999999997
Q ss_pred CCChHHHHHHHHhcc------------------------CCC------CCCCCcHHHHHHHHhccccCCCCCCCHHHHHH
Q 024408 151 GMSNLQAAYAAAFKN------------------------VRP------SAENVPEELSIILTSCWKEDPNARPNFTQIIQ 200 (268)
Q Consensus 151 ~~~~~~~~~~~~~~~------------------------~~~------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~ 200 (268)
+.+............ ..+ .....+.++.+++.+||..+|.+||++.++++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~ 291 (336)
T cd07849 212 GKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALA 291 (336)
T ss_pred CCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 654322111110000 000 01245678999999999999999999999999
Q ss_pred H
Q 024408 201 M 201 (268)
Q Consensus 201 ~ 201 (268)
+
T Consensus 292 h 292 (336)
T cd07849 292 H 292 (336)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-32 Score=231.53 Aligned_cols=196 Identities=24% Similarity=0.467 Sum_probs=163.0
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|||+|.|.| .++-+++|+||+++|+|.+++.++....+.-.....++.||+.|++||.+.+++||||.+.|+|++.+ .
T Consensus 596 NIveLvGVC~~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e-~ 674 (807)
T KOG1094|consen 596 NIVELLGVCVQDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGE-F 674 (807)
T ss_pred CeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCc-c
Confidence 799999999 66778999999999999999998755444556667799999999999999999999999999999999 5
Q ss_pred CeEEecCCCcccccccc---ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHH--hCCCCCCCCCh
Q 024408 80 TIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL--HNKLPFEGMSN 154 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll--~g~~p~~~~~~ 154 (268)
++||+|||+++...... .....+-..+|||+|.+.. ++++.++|+|++|+++||++ +...||..+.+
T Consensus 675 ~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsill--------gkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~ 746 (807)
T KOG1094|consen 675 TIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILL--------GKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD 746 (807)
T ss_pred cEEecCcccccccccCCceeeecceeeeeeehhHHHHHh--------ccccchhhhhhhHHHHHHHHHHHhhCchhhhhH
Confidence 99999999999433222 1122344689999998865 78899999999999999985 57889998887
Q ss_pred HHHHHHHHhccCC-------CCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHh
Q 024408 155 LQAAYAAAFKNVR-------PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 205 (268)
Q Consensus 155 ~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~ 205 (268)
.+........... ..+..+|+.+.+++.+||..+-.+||+++++..+|.+.
T Consensus 747 e~vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 747 EQVVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred HHHHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 7766654433322 23677899999999999999999999999999988763
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=220.12 Aligned_cols=191 Identities=27% Similarity=0.357 Sum_probs=150.0
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
++++++|++ ..+..++||||++ ++|.+++.+.. ..+++..+..++.+++.||++||++|++|+||+|+||+++++ +
T Consensus 59 ~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~-~ 135 (282)
T cd07829 59 NIVKLLDVIHTERKLYLVFEYCD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRD-G 135 (282)
T ss_pred CHHHHHhhhhcCCceEEEecCcC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCC-C
Confidence 456778887 4468999999997 69999998753 239999999999999999999999999999999999999998 6
Q ss_pred CeEEecCCCcccccccc-ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESLTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.++|+|||.+....... ......++..|+|||.+.+ ...++.++|+||||++++++++|..||.........
T Consensus 136 ~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~ 208 (282)
T cd07829 136 VLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLG-------SKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQL 208 (282)
T ss_pred CEEEecCCcccccCCCccccCccccCcCcCChHHhcC-------CcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHH
Confidence 99999999997544332 2233456788999998754 236778999999999999999999999775543332
Q ss_pred HHHHhccC-------------------C---------CCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 159 YAAAFKNV-------------------R---------PSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 159 ~~~~~~~~-------------------~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
........ . ......+..+.++|.+||..+|++||++.+++.+
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 209 FKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred HHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 22111000 0 0012347789999999999999999999999886
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=228.00 Aligned_cols=175 Identities=30% Similarity=0.382 Sum_probs=141.0
Q ss_pred cEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCCeEEecCCCcccc
Q 024408 13 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 92 (268)
Q Consensus 13 ~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~~kl~Dfg~a~~~ 92 (268)
..++|+||+ |++|.+++.. ..+++..+..++.|++.||+|||++|++||||+|+||+++.+ +.++|+|||++...
T Consensus 94 ~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~-~~~kL~dfg~~~~~ 168 (343)
T cd07851 94 DVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNED-CELKILDFGLARHT 168 (343)
T ss_pred cEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC-CCEEEccccccccc
Confidence 389999999 6899999875 239999999999999999999999999999999999999988 69999999999864
Q ss_pred ccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCC----
Q 024408 93 SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP---- 168 (268)
Q Consensus 93 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~---- 168 (268)
... .....++..|+|||.+.+ ...++.++||||||+++|++++|+.||.+................+
T Consensus 169 ~~~--~~~~~~~~~y~aPE~~~~-------~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 239 (343)
T cd07851 169 DDE--MTGYVATRWYRAPEIMLN-------WMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEEL 239 (343)
T ss_pred ccc--ccCCcccccccCHHHHhC-------CCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Confidence 332 234467889999998753 1356789999999999999999999998755443322211111000
Q ss_pred --------------------------CCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 169 --------------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 169 --------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
....+++++.++|.+||..+|++|||+.+++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 240 LQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 012457899999999999999999999999987
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=222.92 Aligned_cols=190 Identities=26% Similarity=0.335 Sum_probs=146.5
Q ss_pred CceeEEEeec---C--CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEe
Q 024408 1 MREQFIGACK---E--PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 75 (268)
Q Consensus 1 ~~v~l~g~~~---~--~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~ 75 (268)
+++++++.+. . ...+++|||+. ++|.+++..... +++..++.++.|++.||+|||++|++||||||+||+++
T Consensus 63 ~iv~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~ 139 (332)
T cd07857 63 NITCLYDMDIVFPGNFNELYLYEELME-ADLHQIIRSGQP--LTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVN 139 (332)
T ss_pred ChheeeeeeeeccccCCcEEEEEeccc-CCHHHHHhcCCC--CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEc
Confidence 5778888642 1 35789999995 799999876444 99999999999999999999999999999999999999
Q ss_pred CCCCCeEEecCCCcccccccc-----ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 024408 76 EDLKTIKLADFGLAREESLTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFE 150 (268)
Q Consensus 76 ~~~~~~kl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~ 150 (268)
.+ +.++|+|||+++...... ......|+..|+|||.+.+ ...++.++|+||+|+++|++++|..||.
T Consensus 140 ~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-------~~~~~~~~Di~slGv~l~~l~~g~~pf~ 211 (332)
T cd07857 140 AD-CELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLS-------FQSYTKAIDVWSVGCILAELLGRKPVFK 211 (332)
T ss_pred CC-CCEEeCcCCCceecccccccccccccCcccCccccCcHHHhC-------CCCCCcHHHHHHHHHHHHHHHhCCcCCC
Confidence 88 699999999997433211 1223468899999998743 2346789999999999999999999997
Q ss_pred CCChHHHHHHHHhc-------------------------cCC-----CCCCCCcHHHHHHHHhccccCCCCCCCHHHHHH
Q 024408 151 GMSNLQAAYAAAFK-------------------------NVR-----PSAENVPEELSIILTSCWKEDPNARPNFTQIIQ 200 (268)
Q Consensus 151 ~~~~~~~~~~~~~~-------------------------~~~-----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~ 200 (268)
.............. ... ......+..+.+++.+||+.||.+||++.+++.
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 212 GKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred CCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 65432211110000 000 012335788999999999999999999999998
Q ss_pred H
Q 024408 201 M 201 (268)
Q Consensus 201 ~ 201 (268)
+
T Consensus 292 ~ 292 (332)
T cd07857 292 H 292 (332)
T ss_pred C
Confidence 7
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=227.35 Aligned_cols=184 Identities=24% Similarity=0.317 Sum_probs=141.2
Q ss_pred CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCCeEEecCCCccc
Q 024408 12 PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 91 (268)
Q Consensus 12 ~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~~kl~Dfg~a~~ 91 (268)
...++||||++ ++|.+++.+. .+++..+..++.|++.||.|||+.|++||||||+||+++...+.++++|||+++.
T Consensus 89 ~~~~lv~e~~~-~~L~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~~~~ 164 (342)
T cd07854 89 NSVYIVQEYME-TDLANVLEQG---PLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARI 164 (342)
T ss_pred ceEEEEeeccc-ccHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCccccee
Confidence 35799999996 6999888642 3899999999999999999999999999999999999986546789999999874
Q ss_pred ccccc----ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc--
Q 024408 92 ESLTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN-- 165 (268)
Q Consensus 92 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~-- 165 (268)
..... ......++..|+|||.+.. ...++.++|+||||+++|+|++|+.||.+..............
T Consensus 165 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~ 237 (342)
T cd07854 165 VDPHYSHKGYLSEGLVTKWYRSPRLLLS-------PNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV 237 (342)
T ss_pred cCCccccccccccccccccccCHHHHhC-------ccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 32211 1122357889999997642 2456789999999999999999999998765433322211100
Q ss_pred ---------------------CCC------CCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 024408 166 ---------------------VRP------SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 208 (268)
Q Consensus 166 ---------------------~~~------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 208 (268)
..+ ....++.++.+++.+||..||.+||++.+++.+ .+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h--~~~~~ 305 (342)
T cd07854 238 VREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH--PYMSC 305 (342)
T ss_pred CChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC--Ccccc
Confidence 000 023567889999999999999999999999987 44443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=238.20 Aligned_cols=198 Identities=31% Similarity=0.567 Sum_probs=165.3
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcC------C--------CCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMR------P--------RCLDVCVAIGFALDIARAMECLHSHGIIHR 65 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~------~--------~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~ 65 (268)
|+|.|+|+| ..+..++|+||+..|+|.++++... . ..++..+.+.++.||+.|++||+++.++||
T Consensus 363 niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHR 442 (609)
T KOG0200|consen 363 NIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHR 442 (609)
T ss_pred chhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccch
Confidence 689999999 5568999999999999999998765 0 128889999999999999999999999999
Q ss_pred CCCCCCEEEeCCCCCeEEecCCCccccccccccc--cCC--CccceeccccccccccccCCCCCCCchhhHHHHHHHHHH
Q 024408 66 DLKPENLLLTEDLKTIKLADFGLAREESLTEMMT--AET--GTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWE 141 (268)
Q Consensus 66 Dikp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~--~~~--gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ 141 (268)
||-..|||++.+ ..+|++|||+|+......... ... -...|||||.+.. ..++.++||||+|+++||
T Consensus 443 DLAaRNVLi~~~-~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~--------~~ft~kSDVWSfGI~L~E 513 (609)
T KOG0200|consen 443 DLAARNVLITKN-KVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD--------RVFTSKSDVWSFGILLWE 513 (609)
T ss_pred hhhhhhEEecCC-CEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc--------CcccccchhhHHHHHHHH
Confidence 999999999998 699999999999544332221 122 2346999999864 678999999999999999
Q ss_pred HHh-CCCCCCCCC-hHHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHh
Q 024408 142 LLH-NKLPFEGMS-NLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 207 (268)
Q Consensus 142 ll~-g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 207 (268)
+++ |..||.+.. ..+.......+.....+..++.++.++++.||+.+|++||++.++.+.+...+.
T Consensus 514 ifsLG~~PYp~~~~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 514 IFTLGGTPYPGIPPTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred HhhCCCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 998 899999865 333333344455557788999999999999999999999999999999988654
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-31 Score=213.23 Aligned_cols=190 Identities=36% Similarity=0.496 Sum_probs=156.0
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
++++++|.+ .....++||||+++++|.+++..... +++..++.++.+++.++.+||+.|++|+||+|.||+++.+ +
T Consensus 48 ~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~-~ 124 (244)
T smart00220 48 NIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKRGR--LSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDED-G 124 (244)
T ss_pred cHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhccC--CCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCC-C
Confidence 456778888 44688999999998899999987554 8999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 024408 80 TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY 159 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~ 159 (268)
.++++|||.+.............++..|++||.+.. ...+.++|+||+|++++++++|..||..........
T Consensus 125 ~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~--------~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~ 196 (244)
T smart00220 125 HVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVLLG--------KGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELF 196 (244)
T ss_pred cEEEccccceeeeccccccccccCCcCCCCHHHHcc--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence 999999999986555444455678889999998853 456779999999999999999999998744333333
Q ss_pred HHHhccCCCC-CCC--CcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 160 AAAFKNVRPS-AEN--VPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 160 ~~~~~~~~~~-~~~--~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
.......... ... ++.++.+++.+|+..+|++||++.+++++
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~ 241 (244)
T smart00220 197 KKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQH 241 (244)
T ss_pred HHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHHHHhhC
Confidence 3333222222 222 88999999999999999999999999874
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=220.96 Aligned_cols=191 Identities=23% Similarity=0.275 Sum_probs=144.4
Q ss_pred CceeEEEeec---------CCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCC
Q 024408 1 MREQFIGACK---------EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPEN 71 (268)
Q Consensus 1 ~~v~l~g~~~---------~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~N 71 (268)
+++++++++. ...+++||||+. ++|.+.+.... ..+++.++..++.|+++||.|||++|++|+||||+|
T Consensus 68 ~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~-~~l~~~~~~~~-~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~n 145 (311)
T cd07866 68 NVVPLIDMAVERPDKSKRKRGSVYMVTPYMD-HDLSGLLENPS-VKLTESQIKCYMLQLLEGINYLHENHILHRDIKAAN 145 (311)
T ss_pred CccchhhheecccccccccCceEEEEEecCC-cCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 3566666552 235799999996 68888776543 349999999999999999999999999999999999
Q ss_pred EEEeCCCCCeEEecCCCccccccccc------------cccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHH
Q 024408 72 LLLTEDLKTIKLADFGLAREESLTEM------------MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVL 139 (268)
Q Consensus 72 ill~~~~~~~kl~Dfg~a~~~~~~~~------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l 139 (268)
|+++++ +.++|+|||++........ .....++..|+|||.+.+ ...++.++||||||+++
T Consensus 146 il~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slG~il 217 (311)
T cd07866 146 ILIDNQ-GILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLG-------ERRYTTAVDIWGIGCVF 217 (311)
T ss_pred EEECCC-CCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhC-------CCccCchhHhHHHHHHH
Confidence 999988 6999999999974322111 122356788999998753 23467889999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHhccCCC-----------------------------CCCCCcHHHHHHHHhccccCCC
Q 024408 140 WELLHNKLPFEGMSNLQAAYAAAFKNVRP-----------------------------SAENVPEELSIILTSCWKEDPN 190 (268)
Q Consensus 140 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~l~~li~~~l~~~p~ 190 (268)
|+|++|+.||.+................+ ....+++.+.++|.+||..||.
T Consensus 218 ~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~ 297 (311)
T cd07866 218 AEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPY 297 (311)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcc
Confidence 99999999998755543322211110000 0123446789999999999999
Q ss_pred CCCCHHHHHHH
Q 024408 191 ARPNFTQIIQM 201 (268)
Q Consensus 191 ~Rps~~~~~~~ 201 (268)
+|||+.+++.+
T Consensus 298 ~R~t~~ell~~ 308 (311)
T cd07866 298 KRLTASDALEH 308 (311)
T ss_pred cCcCHHHHhcC
Confidence 99999999876
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=224.69 Aligned_cols=188 Identities=24% Similarity=0.379 Sum_probs=146.8
Q ss_pred ceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCC
Q 024408 2 REQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT 80 (268)
Q Consensus 2 ~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~ 80 (268)
||+||=-+ +.+++|+||||++||++-.+|-+.+- |++..++.++.++.+|+++.|..|++||||||+|||||.+ |+
T Consensus 691 VVrLyySFQDkdnLYFVMdYIPGGDmMSLLIrmgI--FeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrd-GH 767 (1034)
T KOG0608|consen 691 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGI--FEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRD-GH 767 (1034)
T ss_pred eEEEEEEeccCCceEEEEeccCCccHHHHHHHhcc--CHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccC-Cc
Confidence 68887777 55799999999999999999988766 9999999999999999999999999999999999999999 79
Q ss_pred eEEecCCCccccc---------ccc----------------------------------ccccCCCccceeccccccccc
Q 024408 81 IKLADFGLAREES---------LTE----------------------------------MMTAETGTYRWMAPELYSTVT 117 (268)
Q Consensus 81 ~kl~Dfg~a~~~~---------~~~----------------------------------~~~~~~gt~~y~aPE~~~~~~ 117 (268)
|||.|||++.... ... ..-..+||+.|+|||++..
T Consensus 768 IKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r-- 845 (1034)
T KOG0608|consen 768 IKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLAR-- 845 (1034)
T ss_pred eeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcc--
Confidence 9999999984110 000 0012369999999999963
Q ss_pred cccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHhccCCCCCCCCcHHHHHHHHhccccCCCCCC-
Q 024408 118 LRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYA---AAFKNVRPSAENVPEELSIILTSCWKEDPNARP- 193 (268)
Q Consensus 118 ~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp- 193 (268)
..++..+|.||.|++||||+.|+.||.+....+..++ +......+....++.+..++|.++. -.++.|.
T Consensus 846 ------~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~RLG 918 (1034)
T KOG0608|consen 846 ------TGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLC-CSADSRLG 918 (1034)
T ss_pred ------cCccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHh-cChhhhhc
Confidence 6678899999999999999999999977655443332 2222334456778889888888744 2455553
Q ss_pred --CHHHHHHH
Q 024408 194 --NFTQIIQM 201 (268)
Q Consensus 194 --s~~~~~~~ 201 (268)
..++|..|
T Consensus 919 kng~d~vKaH 928 (1034)
T KOG0608|consen 919 KNGADQVKAH 928 (1034)
T ss_pred ccchhhhhcC
Confidence 34456555
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=220.47 Aligned_cols=190 Identities=22% Similarity=0.263 Sum_probs=150.9
Q ss_pred ceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCC---
Q 024408 2 REQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED--- 77 (268)
Q Consensus 2 ~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~--- 77 (268)
.|++.+|+ ..++.|+|+|.+ |-|+++++..++..+++...+..+++|+++++++||+.+++|.||||+|||+.+.
T Consensus 153 cv~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~ 231 (415)
T KOG0671|consen 153 CVQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYF 231 (415)
T ss_pred EEeeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceE
Confidence 36788888 568999999999 7899999999888889999999999999999999999999999999999999321
Q ss_pred ----------------CCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHH
Q 024408 78 ----------------LKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWE 141 (268)
Q Consensus 78 ----------------~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ 141 (268)
...++|+|||.|....... .+.+.|..|+|||++.+ -.++..+||||+||+|+|
T Consensus 232 ~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h--s~iVsTRHYRAPEViLg--------LGwS~pCDvWSiGCIL~E 301 (415)
T KOG0671|consen 232 KTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH--STIVSTRHYRAPEVILG--------LGWSQPCDVWSIGCILVE 301 (415)
T ss_pred EEeccCCccceeccCCCcceEEEecCCcceeccCc--ceeeeccccCCchheec--------cCcCCccCceeeeeEEEE
Confidence 1258999999998644333 55678999999999987 456778999999999999
Q ss_pred HHhCCCCCCCCChHHHHHH--HHhccC-------------------------------------CCC------CCCCcHH
Q 024408 142 LLHNKLPFEGMSNLQAAYA--AAFKNV-------------------------------------RPS------AENVPEE 176 (268)
Q Consensus 142 ll~g~~p~~~~~~~~~~~~--~~~~~~-------------------------------------~~~------~~~~~~~ 176 (268)
+.+|...|++-++.+-... .+.+.. .|. ...--.+
T Consensus 302 lytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~ 381 (415)
T KOG0671|consen 302 LYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQ 381 (415)
T ss_pred eeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhH
Confidence 9999998887665442211 111000 000 0001135
Q ss_pred HHHHHHhccccCCCCCCCHHHHHHHH
Q 024408 177 LSIILTSCWKEDPNARPNFTQIIQML 202 (268)
Q Consensus 177 l~~li~~~l~~~p~~Rps~~~~~~~l 202 (268)
+.+||++||..||.+|+|+.|++.|-
T Consensus 382 LfDLl~~mL~fDP~~RiTl~EAL~Hp 407 (415)
T KOG0671|consen 382 LFDLLRRMLEFDPARRITLREALSHP 407 (415)
T ss_pred HHHHHHHHHccCccccccHHHHhcCH
Confidence 88899999999999999999999983
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=222.31 Aligned_cols=186 Identities=26% Similarity=0.329 Sum_probs=144.9
Q ss_pred CceeEEEeecC-------CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEE
Q 024408 1 MREQFIGACKE-------PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 73 (268)
Q Consensus 1 ~~v~l~g~~~~-------~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nil 73 (268)
+++++++++.. ..+++||||+. .+|.+++. ..+++..+..++.|++.||+|||++|++||||||+||+
T Consensus 75 niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIl 149 (342)
T cd07879 75 NVIGLLDVFTSAVSGDEFQDFYLVMPYMQ-TDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLA 149 (342)
T ss_pred CccchhheecccccCCCCceEEEEecccc-cCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEE
Confidence 56788888742 24699999995 57877652 23899999999999999999999999999999999999
Q ss_pred EeCCCCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 024408 74 LTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS 153 (268)
Q Consensus 74 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~ 153 (268)
++.+ +.++|+|||+++..... .....++..|+|||.+.+ ...++.++|+||||+++|+|++|+.||.+..
T Consensus 150 l~~~-~~~kL~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slGvil~el~~g~~pf~~~~ 219 (342)
T cd07879 150 VNED-CELKILDFGLARHADAE--MTGYVVTRWYRAPEVILN-------WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 219 (342)
T ss_pred ECCC-CCEEEeeCCCCcCCCCC--CCCceeeecccChhhhcC-------ccccCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9988 69999999999754322 233467889999998753 2346789999999999999999999998765
Q ss_pred hHHHHHHHHhcc------------------------CCCC------CCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 154 NLQAAYAAAFKN------------------------VRPS------AENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 154 ~~~~~~~~~~~~------------------------~~~~------~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
............ ..+. ....+..+.++|.+||+.||.+||++.+++.|
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h 297 (342)
T cd07879 220 YLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH 297 (342)
T ss_pred HHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 433222111100 0000 12466789999999999999999999999987
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=222.07 Aligned_cols=192 Identities=27% Similarity=0.327 Sum_probs=148.5
Q ss_pred CceeEEEeecC-------CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEE
Q 024408 1 MREQFIGACKE-------PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 73 (268)
Q Consensus 1 ~~v~l~g~~~~-------~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nil 73 (268)
+++++++++.. ...++|++++ |++|.+++... .+++..+..++.|++.||+|||++|++||||||+||+
T Consensus 77 ~iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl 152 (345)
T cd07877 77 NVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLA 152 (345)
T ss_pred cccceeeeeeecccccccccEEEEehhc-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEE
Confidence 46788887732 2478999988 78999887642 3899999999999999999999999999999999999
Q ss_pred EeCCCCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 024408 74 LTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS 153 (268)
Q Consensus 74 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~ 153 (268)
++++ +.++|+|||++...... .....++..|+|||.+.+ ...++.++|+||||+++|+|++|+.||....
T Consensus 153 l~~~-~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~-------~~~~~~~~DvwslG~il~el~~g~~pf~~~~ 222 (345)
T cd07877 153 VNED-CELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLN-------WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 222 (345)
T ss_pred EcCC-CCEEEeccccccccccc--ccccccCCCccCHHHHhC-------ccCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9988 69999999998754322 234467889999998743 2356788999999999999999999997655
Q ss_pred hHHHHHHHHhcc------------------------CCC------CCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 024408 154 NLQAAYAAAFKN------------------------VRP------SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 203 (268)
Q Consensus 154 ~~~~~~~~~~~~------------------------~~~------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~ 203 (268)
............ ..+ .....+.++.++|.+||..||.+||++.+++++-
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~- 301 (345)
T cd07877 223 HIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA- 301 (345)
T ss_pred HHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcCh-
Confidence 433221111100 000 0123577899999999999999999999999983
Q ss_pred HhHhh
Q 024408 204 NYLSA 208 (268)
Q Consensus 204 ~~~~~ 208 (268)
++..
T Consensus 302 -~f~~ 305 (345)
T cd07877 302 -YFAQ 305 (345)
T ss_pred -hhhh
Confidence 4444
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-30 Score=220.76 Aligned_cols=187 Identities=25% Similarity=0.316 Sum_probs=147.3
Q ss_pred CceeEEEeecC-C------cEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEE
Q 024408 1 MREQFIGACKE-P------VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 73 (268)
Q Consensus 1 ~~v~l~g~~~~-~------~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nil 73 (268)
+++++++++.. + .+++||||+ |++|.+++.. ..+++..+..++.|++.||+|||+.|++||||||+||+
T Consensus 75 ~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nil 150 (343)
T cd07880 75 NVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLA 150 (343)
T ss_pred CccceeeeecCCccccccceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 57888888743 2 458999999 7899988864 23999999999999999999999999999999999999
Q ss_pred EeCCCCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 024408 74 LTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS 153 (268)
Q Consensus 74 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~ 153 (268)
++.+ +.++++|||++...... .....++..|++||.+.+ ...++.++|+||||+++|++++|..||.+..
T Consensus 151 l~~~-~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 220 (343)
T cd07880 151 VNED-CELKILDFGLARQTDSE--MTGYVVTRWYRAPEVILN-------WMHYTQTVDIWSVGCIMAEMLTGKPLFKGHD 220 (343)
T ss_pred EcCC-CCEEEeecccccccccC--ccccccCCcccCHHHHhC-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9988 68999999999754322 233467889999998753 1346789999999999999999999998655
Q ss_pred hHHHHHHHHhccC---------------------C---------CCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 154 NLQAAYAAAFKNV---------------------R---------PSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 154 ~~~~~~~~~~~~~---------------------~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
............. . .....++..+.++|.+||..||.+||++.+++.+
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 221 HLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred HHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 4322221111000 0 0123567889999999999999999999999987
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-31 Score=247.78 Aligned_cols=190 Identities=18% Similarity=0.244 Sum_probs=136.7
Q ss_pred ceeEEEee--------cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEE
Q 024408 2 REQFIGAC--------KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 73 (268)
Q Consensus 2 ~v~l~g~~--------~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nil 73 (268)
|.+++++| .+..++++|||+ +++|.++|.... ..+++.+++.++.||+.||.|||++||+||||||+|||
T Consensus 35 ~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~NiL 112 (793)
T PLN00181 35 VRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD-RSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCFV 112 (793)
T ss_pred HHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc-ccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhEE
Confidence 44566655 123678889998 579999997543 34999999999999999999999999999999999999
Q ss_pred EeCC------------------CCCeEEecCCCccccccc-----------------cccccCCCccceecccccccccc
Q 024408 74 LTED------------------LKTIKLADFGLAREESLT-----------------EMMTAETGTYRWMAPELYSTVTL 118 (268)
Q Consensus 74 l~~~------------------~~~~kl~Dfg~a~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~ 118 (268)
++.. .+.+|++|||+++..... .......||++|+|||++.+
T Consensus 113 l~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~--- 189 (793)
T PLN00181 113 MSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNG--- 189 (793)
T ss_pred EcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhcc---
Confidence 9542 135677777777532110 00012357889999999864
Q ss_pred ccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHH
Q 024408 119 RQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQI 198 (268)
Q Consensus 119 ~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~ 198 (268)
..++.++|||||||++|||++|..|+....... .........+...........++.+||..+|.+||++.++
T Consensus 190 -----~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~ei 262 (793)
T PLN00181 190 -----SSSNCASDVYRLGVLLFELFCPVSSREEKSRTM--SSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSEL 262 (793)
T ss_pred -----CCCCchhhhhhHHHHHHHHhhCCCchhhHHHHH--HHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHHH
Confidence 567889999999999999999988875422111 1111111111111223456788999999999999999999
Q ss_pred HHHHH
Q 024408 199 IQMLL 203 (268)
Q Consensus 199 ~~~l~ 203 (268)
+++.+
T Consensus 263 l~h~~ 267 (793)
T PLN00181 263 LQSEF 267 (793)
T ss_pred hhchh
Confidence 98643
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=193.92 Aligned_cols=191 Identities=26% Similarity=0.359 Sum_probs=159.0
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|+|+|++.. .++.+.+|+|||+ .+|.++.....+. ++.+.+..++.|++.||.++|+++++|||+||.|.+|..+ |
T Consensus 62 nivrl~dvlhsdkkltlvfe~cd-qdlkkyfdslng~-~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~n-g 138 (292)
T KOG0662|consen 62 NIVRLHDVLHSDKKLTLVFEFCD-QDLKKYFDSLNGD-LDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRN-G 138 (292)
T ss_pred ceeehhhhhccCceeEEeHHHhh-HHHHHHHHhcCCc-CCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccC-C
Confidence 689999998 5678999999995 7999988765443 9999999999999999999999999999999999999999 7
Q ss_pred CeEEecCCCcccccccc-ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 024408 80 TIKLADFGLAREESLTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQA 157 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~ 157 (268)
.+|++|||+++....+. .....+.|.+|.+|.++.+ .+.|+.+.|+||-||++.|+.. |++.|++.+..++
T Consensus 139 elkladfglarafgipvrcysaevvtlwyrppdvlfg-------akly~tsidmwsagcifaelanagrplfpg~dvddq 211 (292)
T KOG0662|consen 139 ELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG-------AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ 211 (292)
T ss_pred cEEecccchhhhcCCceEeeeceeeeeeccCcceeee-------eehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHH
Confidence 99999999999766554 4455678999999999986 4678899999999999999976 7888888777666
Q ss_pred HHHHHhccCCCCCCC----------------------------CcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 158 AYAAAFKNVRPSAEN----------------------------VPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~----------------------------~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
..++......+.... +...-+++++++|.-+|.+|.+++..+++
T Consensus 212 lkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 212 LKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred HHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 655544333333211 22356789999999999999999999887
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-29 Score=215.22 Aligned_cols=188 Identities=28% Similarity=0.362 Sum_probs=147.1
Q ss_pred CceeEEEee-c-CCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCC
Q 024408 1 MREQFIGAC-K-EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL 78 (268)
Q Consensus 1 ~~v~l~g~~-~-~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~ 78 (268)
+++++++++ . +...++||||+ +++|.+++... .+++..+..++.|++.||.|||++|++|+||+|.||+++.+
T Consensus 70 niv~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~- 144 (328)
T cd07856 70 NIISLSDIFISPLEDIYFVTELL-GTDLHRLLTSR---PLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINEN- 144 (328)
T ss_pred CeeeEeeeEecCCCcEEEEeehh-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCC-
Confidence 578999987 3 45789999999 67999888642 38888999999999999999999999999999999999987
Q ss_pred CCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 79 KTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 79 ~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
+.++|+|||.+...... .....++..|+|||.+.+ ...++.++|+||||+++|++++|+.||.........
T Consensus 145 ~~~~l~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~ 215 (328)
T cd07856 145 CDLKICDFGLARIQDPQ--MTGYVSTRYYRAPEIMLT-------WQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQF 215 (328)
T ss_pred CCEEeCccccccccCCC--cCCCcccccccCceeeec-------cCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 68999999998753322 233467889999998743 245788999999999999999999999765532211
Q ss_pred HHHHh-----------------------cc----CCC---CCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 024408 159 YAAAF-----------------------KN----VRP---SAENVPEELSIILTSCWKEDPNARPNFTQIIQML 202 (268)
Q Consensus 159 ~~~~~-----------------------~~----~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l 202 (268)
..... .. ..+ ....++..+.++|.+||..+|++||++.+++.+-
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~ 289 (328)
T cd07856 216 SIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHP 289 (328)
T ss_pred HHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCC
Confidence 10000 00 000 1134678999999999999999999999999873
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=210.60 Aligned_cols=188 Identities=26% Similarity=0.433 Sum_probs=156.5
Q ss_pred eeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCCe
Q 024408 3 EQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTI 81 (268)
Q Consensus 3 v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~~ 81 (268)
|-|..++ .+..+++|.||++||+|--+++++.+ ++++.+.-+..+|+.||.|||++||+.||||.+|+|++.. |++
T Consensus 314 vglhscfqtesrlffvieyv~ggdlmfhmqrqrk--lpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldae-ghi 390 (593)
T KOG0695|consen 314 VGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRK--LPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAE-GHI 390 (593)
T ss_pred EehhhhhcccceEEEEEEEecCcceeeehhhhhc--CcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccC-Cce
Confidence 3444555 45689999999999999888887655 9999999999999999999999999999999999999998 799
Q ss_pred EEecCCCcccc-ccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCC-------CC
Q 024408 82 KLADFGLAREE-SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG-------MS 153 (268)
Q Consensus 82 kl~Dfg~a~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~-------~~ 153 (268)
||.|+|+++.. .+.....+.+||+.|.|||++++ ..|+.+.|.|+||++++||..|+.||.- ..
T Consensus 391 kltdygmcke~l~~gd~tstfcgtpnyiapeilrg--------eeygfsvdwwalgvlmfemmagrspfdivgm~n~d~n 462 (593)
T KOG0695|consen 391 KLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRG--------EEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMN 462 (593)
T ss_pred eecccchhhcCCCCCcccccccCCCcccchhhhcc--------cccCceehHHHHHHHHHHHHcCCCCcceecCCCcccc
Confidence 99999999853 45566788899999999999975 7899999999999999999999999952 22
Q ss_pred hHHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCC------CHHHHHHH
Q 024408 154 NLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARP------NFTQIIQM 201 (268)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp------s~~~~~~~ 201 (268)
..+...+.+.......+..++-....+++.-|+.||++|. .++++..|
T Consensus 463 tedylfqvilekqiriprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h 516 (593)
T KOG0695|consen 463 TEDYLFQVILEKQIRIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSH 516 (593)
T ss_pred hhHHHHHHHhhhcccccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcc
Confidence 2333445555555566777888888899999999999993 34555554
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-30 Score=198.71 Aligned_cols=162 Identities=24% Similarity=0.301 Sum_probs=126.7
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCCeEEecCCCccccccccccccCCC
Q 024408 24 GTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETG 103 (268)
Q Consensus 24 gsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~g 103 (268)
|||.+++..++. .+++.+++.++.|++.||.|||+++ ||+||+++.+ +.+++ ||++...... ...|
T Consensus 1 GsL~~~l~~~~~-~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~-~~~~~--fG~~~~~~~~----~~~g 66 (176)
T smart00750 1 VSLADILEVRGR-PLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWD-GLLKL--DGSVAFKTPE----QSRV 66 (176)
T ss_pred CcHHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCc-cceee--ccceEeeccc----cCCC
Confidence 689999986443 4999999999999999999999999 9999999988 58888 9998754332 2268
Q ss_pred ccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCC-------CCCCcH-
Q 024408 104 TYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS-------AENVPE- 175 (268)
Q Consensus 104 t~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~-------~~~~~~- 175 (268)
++.|+|||++.+ ..++.++||||||+++|||++|+.||..................+. ...++.
T Consensus 67 ~~~y~aPE~~~~--------~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 138 (176)
T smart00750 67 DPYFMAPEVIQG--------QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAA 138 (176)
T ss_pred cccccChHHhcC--------CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhh
Confidence 899999999864 5678899999999999999999999976443322222221111111 122333
Q ss_pred -HHHHHHHhccccCCCCCCCHHHHHHHHHHhHh
Q 024408 176 -ELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 207 (268)
Q Consensus 176 -~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 207 (268)
.+.+++.+||..+|.+||++.++++++.....
T Consensus 139 ~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 139 RSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred hhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 69999999999999999999999999876543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=201.37 Aligned_cols=181 Identities=23% Similarity=0.308 Sum_probs=144.8
Q ss_pred cEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCCeEEecCCCcccc
Q 024408 13 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 92 (268)
Q Consensus 13 ~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~~kl~Dfg~a~~~ 92 (268)
.+||||++|+ -+|.-++.+..-+ ++..++.+++.+++.||.|+|.+.|+|||+|+.|+||+.+ +.++|+|||+++..
T Consensus 98 t~ylVf~~ce-hDLaGlLsn~~vr-~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~d-gilklADFGlar~f 174 (376)
T KOG0669|consen 98 TFYLVFDFCE-HDLAGLLSNRKVR-FSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKD-GILKLADFGLARAF 174 (376)
T ss_pred eeeeeHHHhh-hhHHHHhcCcccc-ccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCC-ceEEeeccccccce
Confidence 5899999997 6999999876443 9999999999999999999999999999999999999998 79999999999744
Q ss_pred cccc-----ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh--cc
Q 024408 93 SLTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAF--KN 165 (268)
Q Consensus 93 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~--~~ 165 (268)
+... .....+.|.+|++||.+.+ ...|+.+.|+|+-||++.||++|.+-+.+....+....+.. +.
T Consensus 175 s~~~n~~kprytnrvvTLwYrppEllLG-------~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs 247 (376)
T KOG0669|consen 175 STSKNVVKPRYTNRVVTLWYRPPELLLG-------DREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGS 247 (376)
T ss_pred ecccccCCCCcccceeeeecCCHHHhhc-------ccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhcc
Confidence 3322 2344567999999999986 46789999999999999999999988877655444332221 11
Q ss_pred CCC-------------------CC-------------CCCcHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 024408 166 VRP-------------------SA-------------ENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 203 (268)
Q Consensus 166 ~~~-------------------~~-------------~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~ 203 (268)
..+ .+ -.-.++..+++..+|..||.+|+++.++++|..
T Consensus 248 ~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~ 317 (376)
T KOG0669|consen 248 ITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDF 317 (376)
T ss_pred CCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhh
Confidence 100 00 011246788999999999999999999999843
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-30 Score=247.38 Aligned_cols=189 Identities=26% Similarity=0.358 Sum_probs=143.6
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCCCCEEEeC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLH---SHGIIHRDLKPENLLLTE 76 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~gi~H~Dikp~Nill~~ 76 (268)
|+|+++|+| .++..++||||++||+|.+++.. +++.++..++.|++.||+||| +.+++||||||+||+++.
T Consensus 744 nIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~ 818 (968)
T PLN00113 744 NIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDG 818 (968)
T ss_pred CcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECC
Confidence 689999999 55678999999999999999963 889999999999999999999 669999999999999987
Q ss_pred CCCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh--
Q 024408 77 DLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN-- 154 (268)
Q Consensus 77 ~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~-- 154 (268)
+ ...++. ||.+...... ....++..|+|||++.+ ..++.++||||+|+++|||++|+.||.....
T Consensus 819 ~-~~~~~~-~~~~~~~~~~---~~~~~t~~y~aPE~~~~--------~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~ 885 (968)
T PLN00113 819 K-DEPHLR-LSLPGLLCTD---TKCFISSAYVAPETRET--------KDITEKSDIYGFGLILIELLTGKSPADAEFGVH 885 (968)
T ss_pred C-CceEEE-eccccccccC---CCccccccccCcccccC--------CCCCcccchhhHHHHHHHHHhCCCCCCcccCCC
Confidence 7 456654 5555432211 23367899999998854 5678899999999999999999999853211
Q ss_pred --HHHHHHHHhc------cCCCCC-------CCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHh
Q 024408 155 --LQAAYAAAFK------NVRPSA-------ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 207 (268)
Q Consensus 155 --~~~~~~~~~~------~~~~~~-------~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 207 (268)
.......... ...+.. .....++.+++.+||+.+|++||+++++++.|+...+
T Consensus 886 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 886 GSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred CcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 1111111000 001110 0112357788999999999999999999999987654
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-30 Score=205.68 Aligned_cols=202 Identities=22% Similarity=0.265 Sum_probs=151.3
Q ss_pred CceeEEEee-c-CCcEEEEEEcCCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEe
Q 024408 1 MREQFIGAC-K-EPVMVIVTELLSGGTLRKYLLNMR---PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 75 (268)
Q Consensus 1 ~~v~l~g~~-~-~~~~~lV~e~~~ggsL~~~i~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~ 75 (268)
|||.|...+ . +...+||+||.+ -+|++.|.-+. .+.++...+..++.||+.|+.|||++=|+||||||.|||+.
T Consensus 88 nvi~Lv~Vfl~~d~~v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvm 166 (438)
T KOG0666|consen 88 NVISLVKVFLSHDKKVWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVM 166 (438)
T ss_pred cchhHHHHHhccCceEEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEe
Confidence 566777776 3 568999999997 69999986532 24599999999999999999999999999999999999996
Q ss_pred CC---CCCeEEecCCCcccccccc----ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 024408 76 ED---LKTIKLADFGLAREESLTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLP 148 (268)
Q Consensus 76 ~~---~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p 148 (268)
.+ .|++||+|||+++.+...- .....+.|.||+|||.+.+ ...|+.+.|+||+||++.||++-.+-
T Consensus 167 gdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLG-------a~hYT~AiDvWAiGCIfaElLtl~Pl 239 (438)
T KOG0666|consen 167 GDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLG-------ARHYTKAIDVWAIGCIFAELLTLEPL 239 (438)
T ss_pred ccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcc-------cccccchhhhHHHHHHHHHHHccCcc
Confidence 44 3689999999999654332 1233467999999999986 57899999999999999999998766
Q ss_pred CCCCCh---------HHHHHHHHhccCCCCCC------------------------------------CCcHHHHHHHHh
Q 024408 149 FEGMSN---------LQAAYAAAFKNVRPSAE------------------------------------NVPEELSIILTS 183 (268)
Q Consensus 149 ~~~~~~---------~~~~~~~~~~~~~~~~~------------------------------------~~~~~l~~li~~ 183 (268)
|.+... .++..++......|... .-++...+++.+
T Consensus 240 F~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~k 319 (438)
T KOG0666|consen 240 FKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQK 319 (438)
T ss_pred ccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHH
Confidence 643221 11112222111112111 113346679999
Q ss_pred ccccCCCCCCCHHHHHHHHHHhHhhcCCC
Q 024408 184 CWKEDPNARPNFTQIIQMLLNYLSAIAPP 212 (268)
Q Consensus 184 ~l~~~p~~Rps~~~~~~~l~~~~~~~~~~ 212 (268)
+|.+||.+|.|+.+.+++ .++...+.|
T Consensus 320 lL~yDP~kRIta~qAleh--~yF~~d~lp 346 (438)
T KOG0666|consen 320 LLTYDPIKRITAEQALEH--PYFTEDPLP 346 (438)
T ss_pred HhccCchhhccHHHHhcc--cccccCCCC
Confidence 999999999999999998 555544333
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-29 Score=231.95 Aligned_cols=87 Identities=36% Similarity=0.609 Sum_probs=79.2
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
++|++++.+ .+.++||||||+.|++|.+++...+. +++..++.++.||+.||.|||.+||+||||||+|||++.+ +
T Consensus 65 ~Iv~~~~~~~~~~~~~lVmEy~~g~~L~~li~~~~~--l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~-g 141 (669)
T cd05610 65 FIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGY--FDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNE-G 141 (669)
T ss_pred CcCeEEEEEEECCEEEEEEeCCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCC-C
Confidence 478888888 55689999999999999999976554 8999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcc
Q 024408 80 TIKLADFGLAR 90 (268)
Q Consensus 80 ~~kl~Dfg~a~ 90 (268)
.++|+|||+++
T Consensus 142 ~vkL~DFGls~ 152 (669)
T cd05610 142 HIKLTDFGLSK 152 (669)
T ss_pred CEEEEeCCCCc
Confidence 99999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-30 Score=230.92 Aligned_cols=189 Identities=21% Similarity=0.233 Sum_probs=131.6
Q ss_pred CCcEEEEEEcCCCCCHHHHHHhcCCC------------------CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCE
Q 024408 11 EPVMVIVTELLSGGTLRKYLLNMRPR------------------CLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENL 72 (268)
Q Consensus 11 ~~~~~lV~e~~~ggsL~~~i~~~~~~------------------~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Ni 72 (268)
++..++||||+.+++|.+++...... ......+..++.|++.||+|||++||+||||||+||
T Consensus 207 ~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NI 286 (566)
T PLN03225 207 EDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNI 286 (566)
T ss_pred CCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHE
Confidence 45789999999999999998754210 112345678999999999999999999999999999
Q ss_pred EEeCCCCCeEEecCCCcccccc--ccccccCCCccceeccccccccccccCC--------------CCCCCchhhHHHHH
Q 024408 73 LLTEDLKTIKLADFGLAREESL--TEMMTAETGTYRWMAPELYSTVTLRQGE--------------KKHYNHKVDSYSFA 136 (268)
Q Consensus 73 ll~~~~~~~kl~Dfg~a~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~--------------~~~~~~~~DvwslG 136 (268)
|++.+.+.+||+|||+++.... ........+++.|+|||.+......... ...+..++||||+|
T Consensus 287 Ll~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlG 366 (566)
T PLN03225 287 IFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 366 (566)
T ss_pred EEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHH
Confidence 9987546899999999974322 2223456789999999966432111100 01244567999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHhcc----------CCCC-----------CCCCcHHHHHHHHhccccCCCCCCCH
Q 024408 137 IVLWELLHNKLPFEGMSNLQAAYAAAFKN----------VRPS-----------AENVPEELSIILTSCWKEDPNARPNF 195 (268)
Q Consensus 137 ~~l~~ll~g~~p~~~~~~~~~~~~~~~~~----------~~~~-----------~~~~~~~l~~li~~~l~~~p~~Rps~ 195 (268)
|++|||+++..+... ............ ..+. .........+||.+||..||.+|||+
T Consensus 367 viL~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta 444 (566)
T PLN03225 367 LIFLQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISA 444 (566)
T ss_pred HHHHHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCH
Confidence 999999997766442 111111110000 0000 01112345589999999999999999
Q ss_pred HHHHHH
Q 024408 196 TQIIQM 201 (268)
Q Consensus 196 ~~~~~~ 201 (268)
.++++|
T Consensus 445 ~e~L~H 450 (566)
T PLN03225 445 KAALAH 450 (566)
T ss_pred HHHhCC
Confidence 999998
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-30 Score=234.86 Aligned_cols=179 Identities=30% Similarity=0.466 Sum_probs=133.0
Q ss_pred cEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCCeEEecCCCcccc
Q 024408 13 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 92 (268)
Q Consensus 13 ~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~~kl~Dfg~a~~~ 92 (268)
.+||-||||+..+|+++|.++... -.....|+++++|+.||.|+|++|++||||||.||+++.+ +.|||+|||+|...
T Consensus 670 ~LYIQMEyCE~~ll~~iI~~N~~~-~~~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFLd~~-~~VKIGDFGLAt~~ 747 (1351)
T KOG1035|consen 670 ILYIQMEYCEKTLLRDIIRRNHFN-SQRDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFLDSR-NSVKIGDFGLATDL 747 (1351)
T ss_pred EEEEEHhhhhhhHHHHHHHhcccc-hhhHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEEcCC-CCeeecccccchhh
Confidence 689999999976777777654431 1477899999999999999999999999999999999988 69999999999641
Q ss_pred -------------------ccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 024408 93 -------------------SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS 153 (268)
Q Consensus 93 -------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~ 153 (268)
......+..+||.-|+|||++.+.. ...|+.+.|+||||++++||+. ||...-
T Consensus 748 ~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~-----~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM 819 (1351)
T KOG1035|consen 748 KENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS-----SNKYNSKIDMYSLGIVLFEMLY---PFGTSM 819 (1351)
T ss_pred hhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc-----cccccchhhhHHHHHHHHHHhc---cCCchH
Confidence 0111234567999999999986522 1368999999999999999974 465322
Q ss_pred hHHHHHHHHhccCCCCCCC----CcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 154 NLQAAYAAAFKNVRPSAEN----VPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~----~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
..............|.+.. --+.-..+|++|++.||.+|||+.++++.
T Consensus 820 ERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s 871 (1351)
T KOG1035|consen 820 ERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNS 871 (1351)
T ss_pred HHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhc
Confidence 2222222222222222211 12455679999999999999999999874
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=207.87 Aligned_cols=187 Identities=27% Similarity=0.343 Sum_probs=153.7
Q ss_pred CceeEEEeec-C------CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEE
Q 024408 1 MREQFIGACK-E------PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 73 (268)
Q Consensus 1 ~~v~l~g~~~-~------~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nil 73 (268)
|+|+++.++. . ...|+||||++ .+|.+.+.. . ++-.++..+++|++.|+.|||+.||+||||||+||+
T Consensus 76 nii~l~n~ftP~~~l~~~~e~y~v~e~m~-~nl~~vi~~--e--lDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsniv 150 (369)
T KOG0665|consen 76 NIISLLNVFTPQKTLEEFQEVYLVMELMD-ANLCQVILM--E--LDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIV 150 (369)
T ss_pred ceeeeeeccCccccHHHHHhHHHHHHhhh-hHHHHHHHH--h--cchHHHHHHHHHHHHHHHHHHhcceeecccCcccce
Confidence 5677777772 1 25799999996 799999873 2 888999999999999999999999999999999999
Q ss_pred EeCCCCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 024408 74 LTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS 153 (268)
Q Consensus 74 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~ 153 (268)
+..+ ..+||.|||+|+....+-.....+.|..|.|||++.+ ..+....||||+||++.||++|+.-|.+.+
T Consensus 151 v~~~-~~lKi~dfg~ar~e~~~~~mtpyVvtRyyrapevil~--------~~~ke~vdiwSvGci~gEli~~~Vlf~g~d 221 (369)
T KOG0665|consen 151 VNSD-CTLKILDFGLARTEDTDFMMTPYVVTRYYRAPEVILG--------MGYKENVDIWSVGCIMGELILGTVLFPGKD 221 (369)
T ss_pred ecch-hheeeccchhhcccCcccccCchhheeeccCchheec--------cCCcccchhhhhhhHHHHHhhceEEecCch
Confidence 9998 5999999999998776655566788999999999976 348889999999999999999999998776
Q ss_pred hHHHHHHHHhccCCCCC-----------------------------------------CCCcHHHHHHHHhccccCCCCC
Q 024408 154 NLQAAYAAAFKNVRPSA-----------------------------------------ENVPEELSIILTSCWKEDPNAR 192 (268)
Q Consensus 154 ~~~~~~~~~~~~~~~~~-----------------------------------------~~~~~~l~~li~~~l~~~p~~R 192 (268)
..++..+.......+.+ ..-...+++++.+||..||++|
T Consensus 222 ~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~R 301 (369)
T KOG0665|consen 222 HIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKR 301 (369)
T ss_pred HHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhc
Confidence 65554444333222211 0112457889999999999999
Q ss_pred CCHHHHHHH
Q 024408 193 PNFTQIIQM 201 (268)
Q Consensus 193 ps~~~~~~~ 201 (268)
.+++++++|
T Consensus 302 isv~daL~H 310 (369)
T KOG0665|consen 302 ISVDDALRH 310 (369)
T ss_pred ccHHHHhcC
Confidence 999999998
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-30 Score=228.05 Aligned_cols=198 Identities=24% Similarity=0.484 Sum_probs=171.4
Q ss_pred CceeEEEeecCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCC
Q 024408 1 MREQFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT 80 (268)
Q Consensus 1 ~~v~l~g~~~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~ 80 (268)
|+++|+|+|....+-||++|+++|+|.|+++.++.. +..+..+.|++||++|+.|||++.++||||-..|||+... +.
T Consensus 759 nl~RLLgvc~~s~~qlvtq~mP~G~LlDyvr~hr~~-igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP-~h 836 (1177)
T KOG1025|consen 759 NLLRLLGVCMLSTLQLVTQLMPLGCLLDYVREHRDN-IGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSP-NH 836 (1177)
T ss_pred hHHHHhhhcccchHHHHHHhcccchHHHHHHHhhcc-ccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCC-Ce
Confidence 579999999888899999999999999999986554 8999999999999999999999999999999999999887 69
Q ss_pred eEEecCCCccccccccccc-cC--CCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 024408 81 IKLADFGLAREESLTEMMT-AE--TGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQ 156 (268)
Q Consensus 81 ~kl~Dfg~a~~~~~~~~~~-~~--~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~~~~ 156 (268)
+|+.|||+++....+.... .. .-.+.|+|-|.+.. ..+++++||||+|+++||++| |..|+.+....+
T Consensus 837 vkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~--------~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e 908 (1177)
T KOG1025|consen 837 VKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRI--------RKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE 908 (1177)
T ss_pred EEEEecchhhccCcccccccccccccCcHHHHHHHhhc--------cCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH
Confidence 9999999999654443222 11 22456888887753 678999999999999999998 999999988877
Q ss_pred HHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 024408 157 AAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 208 (268)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 208 (268)
...........+.++.++.++..++.+||..|+..||+++++...+....+.
T Consensus 909 I~dlle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 909 IPDLLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred hhHHHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 7666666777788999999999999999999999999999999988876654
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.2e-30 Score=223.23 Aligned_cols=197 Identities=29% Similarity=0.433 Sum_probs=149.5
Q ss_pred CceeEEEeecCC-------cEEEEEEcCCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCE
Q 024408 1 MREQFIGACKEP-------VMVIVTELLSGGTLRKYLLNMRP-RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENL 72 (268)
Q Consensus 1 ~~v~l~g~~~~~-------~~~lV~e~~~ggsL~~~i~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Ni 72 (268)
|+|++.|.-++. ..++|||||.||||+..+.+..+ .++++.+.+.++.++..||.|||++||+||||||.||
T Consensus 72 NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NI 151 (732)
T KOG4250|consen 72 NIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNI 151 (732)
T ss_pred hhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcE
Confidence 577777776443 35899999999999999987543 4599999999999999999999999999999999999
Q ss_pred EEeCCC-C--CeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 024408 73 LLTEDL-K--TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPF 149 (268)
Q Consensus 73 ll~~~~-~--~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~ 149 (268)
++.... | ..||+|||.|+..+......+..||..|.+||+.-. .+.|+...|.||||+++|+++||..||
T Consensus 152 vl~~Gedgq~IyKLtDfG~Arel~d~s~~~S~vGT~~YLhPel~E~-------q~~y~~tVDLWS~GvtlY~caTG~lPF 224 (732)
T KOG4250|consen 152 VLQIGEDGQSIYKLTDFGAARELDDNSLFTSLVGTEEYLHPELYER-------QKKYTATVDLWSFGVTLYECATGELPF 224 (732)
T ss_pred EEeecCCCceEEeeecccccccCCCCCeeeeecCchhhcChHHHhh-------ccCcCceeehhhhhhHHHHHhccCCCC
Confidence 994321 2 368999999999888888899999999999998742 367889999999999999999999999
Q ss_pred CCCChH----HHHHHHHhccCCC--------------------CCCCCcH----HHHHHHHhccccCCCCCC--CHHHHH
Q 024408 150 EGMSNL----QAAYAAAFKNVRP--------------------SAENVPE----ELSIILTSCWKEDPNARP--NFTQII 199 (268)
Q Consensus 150 ~~~~~~----~~~~~~~~~~~~~--------------------~~~~~~~----~l~~li~~~l~~~p~~Rp--s~~~~~ 199 (268)
...... +..+......... .+..+++ .+..++..+|..+|.+|- ...+..
T Consensus 225 ~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~F 304 (732)
T KOG4250|consen 225 IPFGGPKNNKEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFF 304 (732)
T ss_pred CcCCCccccchhhhhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHH
Confidence 543322 2333333222211 1122222 344577778888999987 444444
Q ss_pred HHHHH
Q 024408 200 QMLLN 204 (268)
Q Consensus 200 ~~l~~ 204 (268)
..+..
T Consensus 305 a~~~d 309 (732)
T KOG4250|consen 305 AEVDD 309 (732)
T ss_pred HHHHH
Confidence 44333
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=192.21 Aligned_cols=154 Identities=29% Similarity=0.448 Sum_probs=126.7
Q ss_pred ceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCCEEEeCC
Q 024408 2 REQFIGAC-KEPVMVIVTELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHSH-GIIHRDLKPENLLLTED 77 (268)
Q Consensus 2 ~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~-gi~H~Dikp~Nill~~~ 77 (268)
.|.|+|.. +++..++.||.++ -||..+-.+- .+..+++.-+-+++..++.||+|||++ .++|||+||+|||++.+
T Consensus 107 ~V~FyGa~~regdvwIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~ 185 (282)
T KOG0984|consen 107 TVHFYGALFREGDVWICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYD 185 (282)
T ss_pred EEEeehhhhccccEEEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccC
Confidence 47889987 6778999999995 7888776542 334599999999999999999999986 89999999999999999
Q ss_pred CCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-HH
Q 024408 78 LKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN-LQ 156 (268)
Q Consensus 78 ~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~-~~ 156 (268)
|++|+||||++-...++.......|-..|+|||.+... .....|+.++||||||++++||.+++.||+.... .+
T Consensus 186 -GqVKiCDFGIsG~L~dSiAkt~daGCkpYmaPEri~~e----~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~ 260 (282)
T KOG0984|consen 186 -GQVKICDFGISGYLVDSIAKTMDAGCKPYMAPERINPE----LNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQ 260 (282)
T ss_pred -CcEEEcccccceeehhhhHHHHhcCCCccCChhhcCcc----cCcccceeehhhhhhhhhhhhhhhccccccccCCHHH
Confidence 79999999999866666555556788899999998652 2234789999999999999999999999987543 34
Q ss_pred HHHHH
Q 024408 157 AAYAA 161 (268)
Q Consensus 157 ~~~~~ 161 (268)
+..+.
T Consensus 261 qLkqv 265 (282)
T KOG0984|consen 261 QLKQV 265 (282)
T ss_pred HHHHH
Confidence 44333
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-30 Score=218.72 Aligned_cols=193 Identities=22% Similarity=0.318 Sum_probs=160.2
Q ss_pred ceeEEEeecC-CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeC--CC
Q 024408 2 REQFIGACKE-PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE--DL 78 (268)
Q Consensus 2 ~v~l~g~~~~-~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~--~~ 78 (268)
+|.|.-.|+. +..++|||-+. |+..+.|-..+..++++.....++.||+.||.|||-++|+|+||||+|||+.. +.
T Consensus 625 iV~le~M~ET~ervFVVMEKl~-GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~F 703 (888)
T KOG4236|consen 625 IVNLECMFETPERVFVVMEKLH-GDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPF 703 (888)
T ss_pred eeEEEEeecCCceEEEEehhhc-chHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCC
Confidence 5667777755 47899999995 67666666555556999999999999999999999999999999999999964 34
Q ss_pred CCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 79 KTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 79 ~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.++||||||+|+.........+.+||+.|+|||+++. +.|.++-|+||+|+++|--+.|..||.......+.
T Consensus 704 PQvKlCDFGfARiIgEksFRrsVVGTPAYLaPEVLrn--------kGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQ 775 (888)
T KOG4236|consen 704 PQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRN--------KGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQ 775 (888)
T ss_pred CceeeccccceeecchhhhhhhhcCCccccCHHHHhh--------ccccccccceeeeEEEEEEecccccCCCccchhHH
Confidence 5899999999998888777788899999999999975 67888999999999999999999999765554443
Q ss_pred HHHHhccC-CCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 024408 159 YAAAFKNV-RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 203 (268)
Q Consensus 159 ~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~ 203 (268)
.+...... ......++.+..++|..+|+.+=.+|.+.++.+.|.|
T Consensus 776 IQNAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~W 821 (888)
T KOG4236|consen 776 IQNAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPW 821 (888)
T ss_pred hhccccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchh
Confidence 33333223 3336778999999999999999999999998887754
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=205.77 Aligned_cols=194 Identities=24% Similarity=0.355 Sum_probs=153.5
Q ss_pred ceeEEEee--cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC--CCeecCCCCCCEEEeC-
Q 024408 2 REQFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH--GIIHRDLKPENLLLTE- 76 (268)
Q Consensus 2 ~v~l~g~~--~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~--gi~H~Dikp~Nill~~- 76 (268)
+|++|+++ +.+.+|-|+|||+|.+|.-++.+++- +++.++..|+.||+.||.||.+. -|+|-||||.|||+-+
T Consensus 529 IVKlYDyfslDtdsFCTVLEYceGNDLDFYLKQhkl--mSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~G 606 (775)
T KOG1151|consen 529 IVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHKL--MSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNG 606 (775)
T ss_pred eeeeeeeeeeccccceeeeeecCCCchhHHHHhhhh--hhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecC
Confidence 68999998 44578999999999999999988665 99999999999999999999987 4999999999999953
Q ss_pred -CCCCeEEecCCCcccccccc--------ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCC
Q 024408 77 -DLKTIKLADFGLAREESLTE--------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKL 147 (268)
Q Consensus 77 -~~~~~kl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~ 147 (268)
..|.+||.|||+++....+. ......||.||++||++.-.. .....+.+.||||+|+++|.++.|+.
T Consensus 607 tacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgk----ePPKIsnKVDVWSvGVIFyQClYGrK 682 (775)
T KOG1151|consen 607 TACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGK----EPPKISNKVDVWSVGVIFYQCLYGRK 682 (775)
T ss_pred cccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCC----CCCccccceeeEeeehhhhhhhccCC
Confidence 34689999999998543321 223456999999999886421 12356789999999999999999999
Q ss_pred CCCCCChHHHHHHH-----HhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 148 PFEGMSNLQAAYAA-----AFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 148 p~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
||...-..+..... ......|..+.++.+...+|++||++.-++|.+..++..+
T Consensus 683 PFGhnqsQQdILqeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~d 741 (775)
T KOG1151|consen 683 PFGHNQSQQDILQENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACD 741 (775)
T ss_pred CCCCchhHHHHHhhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence 99763322222211 1122234466788999999999999999999888877654
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-28 Score=203.98 Aligned_cols=202 Identities=30% Similarity=0.419 Sum_probs=150.7
Q ss_pred CceeEEEeecC-C----cEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---------CCeecC
Q 024408 1 MREQFIGACKE-P----VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH---------GIIHRD 66 (268)
Q Consensus 1 ~~v~l~g~~~~-~----~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---------gi~H~D 66 (268)
|+++|+|+-++ . .++||+||.+.|||.++|..+- ++|....+++..++.||+|||+. .|+|||
T Consensus 265 nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~nt---isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRD 341 (534)
T KOG3653|consen 265 NILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLKANT---ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRD 341 (534)
T ss_pred hHHHhhchhccCCccccceeEEeeeccCCcHHHHHHhcc---ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCcccccc
Confidence 57888888743 2 7899999999999999998743 99999999999999999999974 699999
Q ss_pred CCCCCEEEeCCCCCeEEecCCCccccccccc---cccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHH
Q 024408 67 LKPENLLLTEDLKTIKLADFGLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL 143 (268)
Q Consensus 67 ikp~Nill~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll 143 (268)
||..|||+.++ .++.|+|||+|........ ....+||.+|||||++-+...-+. ...-.+.||||+|.++||++
T Consensus 342 lkSkNVLvK~D-lTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d--~~Afkr~DvYamgLVLWEi~ 418 (534)
T KOG3653|consen 342 LKSKNVLVKND-LTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQD--RDAFKRIDVYAMGLVLWEIA 418 (534)
T ss_pred ccccceEEccC-CcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhccccc--HHHHHHHHHHHHHHHHHHHH
Confidence 99999999999 6999999999986544322 233689999999999975322221 12224789999999999999
Q ss_pred hCC------------CCCCC-----CChHHHHHHHHhccCCCCC------CCCcHHHHHHHHhccccCCCCCCCHHHHHH
Q 024408 144 HNK------------LPFEG-----MSNLQAAYAAAFKNVRPSA------ENVPEELSIILTSCWKEDPNARPNFTQIIQ 200 (268)
Q Consensus 144 ~g~------------~p~~~-----~~~~~~~~~~~~~~~~~~~------~~~~~~l~~li~~~l~~~p~~Rps~~~~~~ 200 (268)
++. .||+. ..-.+.......+..+|.. ..-...+++.+..||..|++.|.|+.=+-+
T Consensus 419 SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~e 498 (534)
T KOG3653|consen 419 SRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEE 498 (534)
T ss_pred hhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHH
Confidence 753 23321 1111122222333333432 122467899999999999999999998888
Q ss_pred HHHHhHhh
Q 024408 201 MLLNYLSA 208 (268)
Q Consensus 201 ~l~~~~~~ 208 (268)
.+.+....
T Consensus 499 R~~~l~~~ 506 (534)
T KOG3653|consen 499 RMAELMML 506 (534)
T ss_pred HHHHHhcc
Confidence 87776543
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=224.75 Aligned_cols=193 Identities=24% Similarity=0.333 Sum_probs=144.9
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeC-
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRP--RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE- 76 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~- 76 (268)
|||+++|.- ++.++|++.|+|. .+|.|++..... ....--..+.++.|+++||++||+.+|+||||||.||||..
T Consensus 564 NviRyyc~E~d~qF~YIalELC~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~ 642 (903)
T KOG1027|consen 564 NVIRYYCSEQDRQFLYIALELCA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVP 642 (903)
T ss_pred ceEEEEeeccCCceEEEEehHhh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEcc
Confidence 789999888 5568999999995 899999987411 10111345778899999999999999999999999999975
Q ss_pred --C-CCCeEEecCCCccccccccc----cccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhC-CCC
Q 024408 77 --D-LKTIKLADFGLAREESLTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHN-KLP 148 (268)
Q Consensus 77 --~-~~~~kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g-~~p 148 (268)
+ ..+++|+|||+++....... ..+..||-+|+|||++.. .....+.|||||||++|+.++| ..|
T Consensus 643 ~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~--------~~~~~avDiFslGCvfyYvltgG~Hp 714 (903)
T KOG1027|consen 643 SADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLRE--------DRKTQAVDIFSLGCVFYYVLTGGSHP 714 (903)
T ss_pred CCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhc--------cccCcccchhhcCceEEEEecCCccC
Confidence 2 24789999999986544322 334579999999999975 3445589999999999999985 899
Q ss_pred CCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 024408 149 FEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 202 (268)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l 202 (268)
|.+....+...................+..++|.+|+..+|..||++.+++.|.
T Consensus 715 FGd~~~R~~NIl~~~~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HP 768 (903)
T KOG1027|consen 715 FGDSLERQANILTGNYTLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHP 768 (903)
T ss_pred CCchHHhhhhhhcCccceeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCC
Confidence 986544333322111111111111112899999999999999999999999874
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.4e-28 Score=186.62 Aligned_cols=191 Identities=20% Similarity=0.319 Sum_probs=152.3
Q ss_pred CceeEEEeecCC---cEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCC
Q 024408 1 MREQFIGACKEP---VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED 77 (268)
Q Consensus 1 ~~v~l~g~~~~~---~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~ 77 (268)
|+|+|++...++ ...||+||+++.+...+-.. ++...+..++.+++.||.|||++||.|||+||.|++|+..
T Consensus 94 NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~t-----l~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~ 168 (338)
T KOG0668|consen 94 NIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLYPT-----LTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHE 168 (338)
T ss_pred CeeehhhhhcCccccCchhHhhhhccccHHHHhhh-----hchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechh
Confidence 688999998664 67899999998887776543 8888999999999999999999999999999999999976
Q ss_pred CCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CChHH
Q 024408 78 LKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG-MSNLQ 156 (268)
Q Consensus 78 ~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~-~~~~~ 156 (268)
...++|+|+|+|....+.......+.+..|--||.+.. -..|..+-|+|||||++..|+..+.||-. .++.+
T Consensus 169 ~rkLrlIDWGLAEFYHp~~eYnVRVASRyfKGPELLVd-------y~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~D 241 (338)
T KOG0668|consen 169 LRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD-------YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD 241 (338)
T ss_pred hceeeeeecchHhhcCCCceeeeeeehhhcCCchheee-------chhccccHHHHHHHHHHHHHHhccCcccCCCCCHH
Confidence 66899999999998777666666677888899999864 35678899999999999999999988743 33333
Q ss_pred HHHHHHhcc---------------CCC--------------------C-CCCCcHHHHHHHHhccccCCCCCCCHHHHHH
Q 024408 157 AAYAAAFKN---------------VRP--------------------S-AENVPEELSIILTSCWKEDPNARPNFTQIIQ 200 (268)
Q Consensus 157 ~~~~~~~~~---------------~~~--------------------~-~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~ 200 (268)
+...+..-. ..+ . ..-.+++..+++.++|.+|-.+|+|++|.+.
T Consensus 242 QLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 242 QLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 322211100 000 0 1224588999999999999999999999999
Q ss_pred HHH
Q 024408 201 MLL 203 (268)
Q Consensus 201 ~l~ 203 (268)
|..
T Consensus 322 Hpy 324 (338)
T KOG0668|consen 322 HPY 324 (338)
T ss_pred Cch
Confidence 844
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-27 Score=207.77 Aligned_cols=199 Identities=21% Similarity=0.203 Sum_probs=140.4
Q ss_pred eeEEEeec---------CCcEEEEEEcCCCCCHHHHHHhcCC----------------------CCCCHHHHHHHHHHHH
Q 024408 3 EQFIGACK---------EPVMVIVTELLSGGTLRKYLLNMRP----------------------RCLDVCVAIGFALDIA 51 (268)
Q Consensus 3 v~l~g~~~---------~~~~~lV~e~~~ggsL~~~i~~~~~----------------------~~~~~~~~~~~~~~l~ 51 (268)
++++|+|. ++..+|||||+++++|.+++..... ..+++..+..++.|++
T Consensus 240 ~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~ql~ 319 (507)
T PLN03224 240 AEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVL 319 (507)
T ss_pred hhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHHHHH
Confidence 46677663 3468999999999999999864211 1246678899999999
Q ss_pred HHHHHHHHCCCeecCCCCCCEEEeCCCCCeEEecCCCccccccccccc--cCCCccceeccccccccccccCC-------
Q 024408 52 RAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMT--AETGTYRWMAPELYSTVTLRQGE------- 122 (268)
Q Consensus 52 ~~l~~lH~~gi~H~Dikp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~------- 122 (268)
.||.|||+++++||||||+||+++.+ +.++|+|||++.......... ...+++.|+|||.+......+..
T Consensus 320 ~aL~~lH~~~ivHrDLKp~NILl~~~-~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~ 398 (507)
T PLN03224 320 TGLRKLHRIGIVHRDIKPENLLVTVD-GQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAA 398 (507)
T ss_pred HHHHHHHHCCeecCCCchHhEEECCC-CcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCCCCCCccchhhhhh
Confidence 99999999999999999999999988 689999999997543322212 22457899999987542111100
Q ss_pred -------CCCCCchhhHHHHHHHHHHHHhCCC-CCCCCChHHHHHH----------HHh--ccCCCCCCCCcHHHHHHHH
Q 024408 123 -------KKHYNHKVDSYSFAIVLWELLHNKL-PFEGMSNLQAAYA----------AAF--KNVRPSAENVPEELSIILT 182 (268)
Q Consensus 123 -------~~~~~~~~DvwslG~~l~~ll~g~~-p~~~~~~~~~~~~----------~~~--~~~~~~~~~~~~~l~~li~ 182 (268)
......+.|+||+||++++|++|.. |+........... ... ....+.....++...+++.
T Consensus 399 ~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~~~d~~s~~~~dLi~ 478 (507)
T PLN03224 399 LLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDFSLLDRNKEAGWDLAC 478 (507)
T ss_pred hhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCcccccccChHHHHHHH
Confidence 0011234699999999999999875 6654322211111 000 1111223456789999999
Q ss_pred hccccCC---CCCCCHHHHHHHH
Q 024408 183 SCWKEDP---NARPNFTQIIQML 202 (268)
Q Consensus 183 ~~l~~~p---~~Rps~~~~~~~l 202 (268)
+||..+| .+|+|++++++|-
T Consensus 479 ~LL~~~~~~~~~RlSa~eaL~Hp 501 (507)
T PLN03224 479 KLITKRDQANRGRLSVGQALSHR 501 (507)
T ss_pred HHhccCCCCcccCCCHHHHhCCC
Confidence 9999766 6899999999984
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-27 Score=197.91 Aligned_cols=201 Identities=27% Similarity=0.456 Sum_probs=149.0
Q ss_pred CceeEEEee-c-CC---cEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC--------CCeecCC
Q 024408 1 MREQFIGAC-K-EP---VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH--------GIIHRDL 67 (268)
Q Consensus 1 ~~v~l~g~~-~-~~---~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~--------gi~H~Di 67 (268)
|+..||+.- . ++ .++||.+|.+.|||+|+|.+. .++....++++..++.||+|||.. .|.||||
T Consensus 266 NILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r~---tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDl 342 (513)
T KOG2052|consen 266 NILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNRN---TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDL 342 (513)
T ss_pred hhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhhc---cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhcccc
Confidence 455666665 2 22 789999999999999999872 299999999999999999999964 5999999
Q ss_pred CCCCEEEeCCCCCeEEecCCCccccccc-----cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHH
Q 024408 68 KPENLLLTEDLKTIKLADFGLAREESLT-----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWEL 142 (268)
Q Consensus 68 kp~Nill~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~l 142 (268)
|..|||+..+ +.+.|+|+|+|...... ......+||.+|||||++...- +...-+.-..+||||||.++||+
T Consensus 343 KSKNILVKkn-~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdeti--n~~~Fesyk~ADIYafgLVlWEi 419 (513)
T KOG2052|consen 343 KSKNILVKKN-GTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETI--NMKHFESYKRADIYAFGLVLWEI 419 (513)
T ss_pred ccccEEEccC-CcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhc--ChhhhhhhhHHHHHHHHHHHHHH
Confidence 9999999999 79999999999754332 3345678999999999986411 00111223478999999999999
Q ss_pred HhC----------CCCCCCCChHHHHHHH-----HhccCCCC-CCCCc-----HHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 143 LHN----------KLPFEGMSNLQAAYAA-----AFKNVRPS-AENVP-----EELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 143 l~g----------~~p~~~~~~~~~~~~~-----~~~~~~~~-~~~~~-----~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
..+ ++||.+.-+.+..... ......|. +..+. ..+.++++.||..||..|-|+--+.+.
T Consensus 420 arRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKt 499 (513)
T KOG2052|consen 420 ARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKT 499 (513)
T ss_pred HHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHH
Confidence 752 4687654433322222 22333333 22221 457789999999999999999999888
Q ss_pred HHHhHh
Q 024408 202 LLNYLS 207 (268)
Q Consensus 202 l~~~~~ 207 (268)
|.+..+
T Consensus 500 l~~l~~ 505 (513)
T KOG2052|consen 500 LAKLSN 505 (513)
T ss_pred HHHHhc
Confidence 877654
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-26 Score=190.79 Aligned_cols=198 Identities=26% Similarity=0.481 Sum_probs=166.0
Q ss_pred CceeEEEeec--CCcEEEEEEcCCCCCHHHHHHhcC------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCE
Q 024408 1 MREQFIGACK--EPVMVIVTELLSGGTLRKYLLNMR------PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENL 72 (268)
Q Consensus 1 ~~v~l~g~~~--~~~~~lV~e~~~ggsL~~~i~~~~------~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Ni 72 (268)
|+.+..|.+- ..+.+.++.+..-|+|..+++..+ .+.++..+...++.|++.|++|||+.|++|.||-..|.
T Consensus 348 nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNC 427 (563)
T KOG1024|consen 348 NLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNC 427 (563)
T ss_pred CccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcc
Confidence 4667788883 357899999998899999998322 24577888899999999999999999999999999999
Q ss_pred EEeCCCCCeEEecCCCcccccccc-c-c-ccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCC
Q 024408 73 LLTEDLKTIKLADFGLAREESLTE-M-M-TAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLP 148 (268)
Q Consensus 73 ll~~~~~~~kl~Dfg~a~~~~~~~-~-~-~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p 148 (268)
+|++. -++||+|=.+++..-+.. . . ...--...||+||.+.. ..|+.++|+||||+++|||.+ |+.|
T Consensus 428 vIdd~-LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n--------~~yssasDvWsfGVllWELmtlg~~P 498 (563)
T KOG1024|consen 428 VIDDQ-LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQN--------SHYSSASDVWSFGVLLWELMTLGKLP 498 (563)
T ss_pred eehhh-eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhh--------hhhcchhhhHHHHHHHHHHHhcCCCC
Confidence 99988 599999999888432211 1 1 11112457999999865 789999999999999999998 9999
Q ss_pred CCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHh
Q 024408 149 FEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 207 (268)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 207 (268)
|...++.+.......+.....+-++|.++..++..||...|++||+++|++..|.++-.
T Consensus 499 yaeIDPfEm~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ 557 (563)
T KOG1024|consen 499 YAEIDPFEMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHT 557 (563)
T ss_pred ccccCHHHHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence 99999988888777788888899999999999999999999999999999999887643
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-27 Score=198.57 Aligned_cols=74 Identities=32% Similarity=0.469 Sum_probs=68.2
Q ss_pred CceeEEEeecC-----CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCCEEE
Q 024408 1 MREQFIGACKE-----PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH-GIIHRDLKPENLLL 74 (268)
Q Consensus 1 ~~v~l~g~~~~-----~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-gi~H~Dikp~Nill 74 (268)
+||+|++.+.. .++|||+|++ |.+|..+|.....+.++...+.+|++|++.||.|||.+ ||+|.||||+|||+
T Consensus 143 ~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 143 CVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL 221 (590)
T ss_pred eeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence 58999999943 2899999999 89999999998888899999999999999999999986 89999999999999
Q ss_pred e
Q 024408 75 T 75 (268)
Q Consensus 75 ~ 75 (268)
.
T Consensus 222 ~ 222 (590)
T KOG1290|consen 222 C 222 (590)
T ss_pred e
Confidence 3
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-28 Score=192.78 Aligned_cols=180 Identities=29% Similarity=0.409 Sum_probs=143.6
Q ss_pred cEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCCeEEecCCCcccc
Q 024408 13 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 92 (268)
Q Consensus 13 ~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~~kl~Dfg~a~~~ 92 (268)
.+|+|.|++. .+|.+.|-... .++...+.-+++||+.||.|||+.||+||||||.|.|++.|. .+||+|||+++..
T Consensus 131 EiYV~TELmQ-SDLHKIIVSPQ--~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNC-vLKICDFGLARve 206 (449)
T KOG0664|consen 131 ELYVLTELMQ-SDLHKIIVSPQ--ALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNC-ILKICDFGLARTW 206 (449)
T ss_pred HHHHHHHHHH-hhhhheeccCC--CCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCc-eEEeccccccccc
Confidence 4678889985 68888876543 399999999999999999999999999999999999999994 8999999999965
Q ss_pred cccc--ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCC
Q 024408 93 SLTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSA 170 (268)
Q Consensus 93 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 170 (268)
..+. .+...+.|..|+|||++.+ ...|+.+.||||+||++.||+.++..|....+.+....+......|..
T Consensus 207 e~d~~~hMTqEVVTQYYRAPEiLMG-------aRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~ 279 (449)
T KOG0664|consen 207 DQRDRLNMTHEVVTQYYRAPELLMG-------ARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQ 279 (449)
T ss_pred chhhhhhhHHHHHHHHhccHHHhhc-------chhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcH
Confidence 5443 3444567899999999976 467899999999999999999999888877766655544433332221
Q ss_pred ---------------------C------------CCcHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 024408 171 ---------------------E------------NVPEELSIILTSCWKEDPNARPNFTQIIQMLL 203 (268)
Q Consensus 171 ---------------------~------------~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~ 203 (268)
+ .-.-+...++..++..+|++|.+.++.+.++.
T Consensus 280 EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 280 EAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred HHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 1 11235667888899999999999999888753
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.7e-27 Score=184.30 Aligned_cols=180 Identities=27% Similarity=0.369 Sum_probs=134.8
Q ss_pred CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEE-eCCCCCeEEecCCCcc
Q 024408 12 PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL-TEDLKTIKLADFGLAR 90 (268)
Q Consensus 12 ~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill-~~~~~~~kl~Dfg~a~ 90 (268)
++++.+|||++-|+|..-+.. .++-+.....++.|+++||.|||++++||||||.+|||| +.+..++||||||+.+
T Consensus 95 d~YvF~qE~aP~gdL~snv~~---~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~ 171 (378)
T KOG1345|consen 95 DAYVFVQEFAPRGDLRSNVEA---AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTR 171 (378)
T ss_pred ceEEEeeccCccchhhhhcCc---ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeeccccc
Confidence 578999999999999998865 338899999999999999999999999999999999999 4555699999999998
Q ss_pred ccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHhccCC
Q 024408 91 EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYA---AAFKNVR 167 (268)
Q Consensus 91 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~---~~~~~~~ 167 (268)
..+..... .-.+..|.+||...... ..+....+.+|+|.||+++|.+++|..||+.....+..+. .......
T Consensus 172 k~g~tV~~--~~~~~~y~~pe~~~~~~---ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~ 246 (378)
T KOG1345|consen 172 KVGTTVKY--LEYVNNYHAPELCDTVV---NEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKN 246 (378)
T ss_pred ccCceehh--hhhhcccCCcHHHhhcc---ccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccC
Confidence 65543222 22356788998775432 1234456789999999999999999999985433322221 1111111
Q ss_pred C----CCCCCcHHHHHHHHhccccCCCCCCCHHHHH
Q 024408 168 P----SAENVPEELSIILTSCWKEDPNARPNFTQII 199 (268)
Q Consensus 168 ~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~ 199 (268)
+ ....+++.+..+.++-|..++++|--..+..
T Consensus 247 ~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~k 282 (378)
T KOG1345|consen 247 PALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAK 282 (378)
T ss_pred ccCchhhcccCHHHHHHHHHhcCCcccccchhHHHH
Confidence 1 1345678889999999999999994433333
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.2e-25 Score=187.72 Aligned_cols=202 Identities=26% Similarity=0.348 Sum_probs=157.1
Q ss_pred eeEEEee--cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCC--
Q 024408 3 EQFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL-- 78 (268)
Q Consensus 3 v~l~g~~--~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~-- 78 (268)
.++++.. .+.+.++||+.+ |.+|.++......+.++..+++.++.|++.+|++||+.|++||||||.|++++...
T Consensus 83 ~~~~~~G~~~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~ 161 (322)
T KOG1164|consen 83 PKLLDHGRSTEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRS 161 (322)
T ss_pred CEEEEeccCCCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCc
Confidence 3555665 344789999999 89999988776656699999999999999999999999999999999999998652
Q ss_pred --CCeEEecCCCcc--cccccc--------c-cccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhC
Q 024408 79 --KTIKLADFGLAR--EESLTE--------M-MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHN 145 (268)
Q Consensus 79 --~~~kl~Dfg~a~--~~~~~~--------~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g 145 (268)
..+.++|||+++ ...... . .....||..|++++++.+ ...++++|+|||++++.++..|
T Consensus 162 ~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~--------~e~~r~DDles~~Y~l~el~~g 233 (322)
T KOG1164|consen 162 EVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG--------IEQGRRDDLESLFYMLLELLKG 233 (322)
T ss_pred ccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCC--------CccCCchhhhhHHHHHHHHhcC
Confidence 368999999998 321111 1 123459999999998865 7788999999999999999999
Q ss_pred CCCCCCCChHHHHH---HHHhccCCC-CCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhcCCCC
Q 024408 146 KLPFEGMSNLQAAY---AAAFKNVRP-SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPE 213 (268)
Q Consensus 146 ~~p~~~~~~~~~~~---~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~~~~~~ 213 (268)
..||.......... ......... .....+.++..+...+-..+..++|++..+...++..........
T Consensus 234 ~LPW~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~~~~ 305 (322)
T KOG1164|consen 234 SLPWEALEMTDLKSKFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSEGSKE 305 (322)
T ss_pred CCCCccccccchHHHHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhcCCCC
Confidence 99997765432221 111111111 234466889999998889999999999999999988877653333
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.6e-27 Score=204.84 Aligned_cols=193 Identities=25% Similarity=0.391 Sum_probs=161.9
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|+|-++|-+ .+..++++||||.||+|.+.-+-.+ ++++.++...++..++||+|||++|-+|||||-.||+++.. +
T Consensus 73 nivay~gsylr~dklwicMEycgggslQdiy~~Tg--plselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~-g 149 (829)
T KOG0576|consen 73 NIVAYFGSYLRRDKLWICMEYCGGGSLQDIYHVTG--PLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDE-G 149 (829)
T ss_pred ChHHHHhhhhhhcCcEEEEEecCCCcccceeeecc--cchhHHHHHHHhhhhccchhhhcCCcccccccccceeeccc-C
Confidence 566677777 5678999999999999998665444 49999999999999999999999999999999999999988 7
Q ss_pred CeEEecCCCcccccccc-ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESLTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.+|++|||.+-...... ...++.||+.|||||+..- ++++.|...+|+|++|+...|+-.-++|-.+..+.+..
T Consensus 150 DvklaDfgvsaqitati~KrksfiGtpywmapEvaav-----erkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l 224 (829)
T KOG0576|consen 150 DVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAV-----ERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRAL 224 (829)
T ss_pred ceeecccCchhhhhhhhhhhhcccCCccccchhHHHH-----HhcccccccccccccccchhhhhhcCCcccccchHHHH
Confidence 99999999987554433 2356799999999998753 34577899999999999999998888888777777766
Q ss_pred HHHHhccCCCC----CCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 159 YAAAFKNVRPS----AENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 159 ~~~~~~~~~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
........++. ...+++.+.++++.+|..+|++||+++.++.|
T Consensus 225 ~LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h 271 (829)
T KOG0576|consen 225 FLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQH 271 (829)
T ss_pred HHhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence 65555555443 45688999999999999999999999988765
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.1e-27 Score=199.16 Aligned_cols=182 Identities=26% Similarity=0.358 Sum_probs=146.4
Q ss_pred cCCcEEEEEEcCCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCCeEEecCCC
Q 024408 10 KEPVMVIVTELLSGGTLRKYLLNMRP-RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGL 88 (268)
Q Consensus 10 ~~~~~~lV~e~~~ggsL~~~i~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~~kl~Dfg~ 88 (268)
..+++|||+|-+ ..+|.+.|.+.+. -++....+..++.|++.||..|-..||+|.||||+|||+.++.+.+||||||.
T Consensus 505 hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGS 583 (752)
T KOG0670|consen 505 HKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGS 583 (752)
T ss_pred hcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcc
Confidence 557899999999 4899999998664 35889999999999999999999999999999999999998877899999999
Q ss_pred ccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCC-
Q 024408 89 AREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR- 167 (268)
Q Consensus 89 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~- 167 (268)
|......... ....+.-|.|||++.+ ..|....|+||+||+||||.||+..|++..+.+-....+.....
T Consensus 584 A~~~~eneit-PYLVSRFYRaPEIiLG--------~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~ 654 (752)
T KOG0670|consen 584 ASFASENEIT-PYLVSRFYRAPEIILG--------LPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKF 654 (752)
T ss_pred cccccccccc-HHHHHHhccCcceeec--------CcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCC
Confidence 9876655432 2345678999999986 56788899999999999999999999887765433222111100
Q ss_pred CC----------------------------------------C-----------CCC-------cHHHHHHHHhccccCC
Q 024408 168 PS----------------------------------------A-----------ENV-------PEELSIILTSCWKEDP 189 (268)
Q Consensus 168 ~~----------------------------------------~-----------~~~-------~~~l~~li~~~l~~~p 189 (268)
|. + ..+ -..+++|+..||.+||
T Consensus 655 p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP 734 (752)
T KOG0670|consen 655 PNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDP 734 (752)
T ss_pred cHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccCh
Confidence 00 0 001 2468899999999999
Q ss_pred CCCCCHHHHHHH
Q 024408 190 NARPNFTQIIQM 201 (268)
Q Consensus 190 ~~Rps~~~~~~~ 201 (268)
.+|.+..+.+.|
T Consensus 735 ~KRit~nqAL~H 746 (752)
T KOG0670|consen 735 EKRITVNQALKH 746 (752)
T ss_pred hhcCCHHHHhcC
Confidence 999999999987
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-25 Score=175.24 Aligned_cols=213 Identities=21% Similarity=0.287 Sum_probs=170.9
Q ss_pred CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeC--CCCCeEEecCCCc
Q 024408 12 PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE--DLKTIKLADFGLA 89 (268)
Q Consensus 12 ~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~--~~~~~kl~Dfg~a 89 (268)
.+-.||||++ |.||.++..-. .+.++..+++-++-|++.-++|+|.++++||||||+|+|++- ..+.+.++|||+|
T Consensus 84 ~ynvlVMdLL-GPsLEdLfnfC-~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLa 161 (341)
T KOG1163|consen 84 DYNVLVMDLL-GPSLEDLFNFC-SRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLA 161 (341)
T ss_pred ccceeeeecc-CccHHHHHHHH-hhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccch
Confidence 4669999999 89999987654 344999999999999999999999999999999999999963 3457899999999
Q ss_pred cccccc--------cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH--HH
Q 024408 90 REESLT--------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA--AY 159 (268)
Q Consensus 90 ~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~--~~ 159 (268)
+.+.+. .......||..|++-..+.+ .+.++++|+.|+|+++.++..|..||++...... .+
T Consensus 162 Kky~d~~t~~HIpyre~r~ltGTaRYASinAh~g--------~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKy 233 (341)
T KOG1163|consen 162 KKYRDIRTRQHIPYREDRNLTGTARYASINAHLG--------IEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKY 233 (341)
T ss_pred hhhccccccccCccccCCccceeeeehhhhhhhh--------hhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHH
Confidence 854332 22345579999999887754 5668899999999999999999999998765432 22
Q ss_pred HHHhccCCC-----CCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhcCCCCCCCCCccccCCCCcCCCCCCC
Q 024408 160 AAAFKNVRP-----SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIPHRIFNSENTILPPESPG 234 (268)
Q Consensus 160 ~~~~~~~~~-----~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (268)
..+.+.... ....+|.++...+..|-..-.++.|++..+.+.++.++.......+..-+|.+-..++.....++.
T Consensus 234 EkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~iyDW~~lkqk~~q~~~~~~ 313 (341)
T KOG1163|consen 234 EKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYDYIYDWTMLKQKSQQSGRSRD 313 (341)
T ss_pred HHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCCeEeeHHHHHHHhhcccCCCc
Confidence 222222111 256789999999999999999999999999999999999999999998888876655554444433
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-25 Score=176.75 Aligned_cols=160 Identities=34% Similarity=0.570 Sum_probs=136.3
Q ss_pred CceeEEEeecC-CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeC-CC
Q 024408 1 MREQFIGACKE-PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE-DL 78 (268)
Q Consensus 1 ~~v~l~g~~~~-~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~-~~ 78 (268)
+++++++++.. ...++|||+++|++|.+++.... ..++...++.++.+++.+|.+||+.|++|+||+|.||+++. +
T Consensus 52 ~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~- 129 (215)
T cd00180 52 NIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDN- 129 (215)
T ss_pred CeeeEeeeeecCCeEEEEEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCC-
Confidence 36788888844 67899999999999999998653 23899999999999999999999999999999999999998 6
Q ss_pred CCeEEecCCCcccccccc-ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 024408 79 KTIKLADFGLAREESLTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA 157 (268)
Q Consensus 79 ~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~ 157 (268)
+.++++|||.+....... ......+...|++||.... ....+.+.|+|++|++++++
T Consensus 130 ~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-------~~~~~~~~D~~~lg~~~~~l--------------- 187 (215)
T cd00180 130 GKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLG-------KGYYSEKSDIWSLGVILYEL--------------- 187 (215)
T ss_pred CcEEEecCCceEEccCCcchhhcccCCCCccChhHhcc-------cCCCCchhhhHHHHHHHHHH---------------
Confidence 689999999997544332 1233457889999998753 12667889999999999998
Q ss_pred HHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 158 AYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
..+.+++..|+..+|.+||++.+++++
T Consensus 188 -----------------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 -----------------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred -----------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 789999999999999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-24 Score=174.75 Aligned_cols=198 Identities=22% Similarity=0.342 Sum_probs=161.3
Q ss_pred cEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeC----CCCCeEEecCCC
Q 024408 13 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE----DLKTIKLADFGL 88 (268)
Q Consensus 13 ~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~----~~~~~kl~Dfg~ 88 (268)
+-.||||++ |.||+|+..=.++ .|+..++..++.|++.-++++|++.+|.|||||+|+||+. +.+.+.++|||+
T Consensus 98 ~NiLVidLL-GPSLEDLFD~CgR-~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGm 175 (449)
T KOG1165|consen 98 YNILVIDLL-GPSLEDLFDLCGR-RFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGM 175 (449)
T ss_pred hhhhhhhhh-CcCHHHHHHHhcC-cccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccc
Confidence 558999999 8999998765544 4999999999999999999999999999999999999964 334689999999
Q ss_pred ccccccccc--------cccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH--HHH
Q 024408 89 AREESLTEM--------MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL--QAA 158 (268)
Q Consensus 89 a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~--~~~ 158 (268)
|+.+.+... ..+..||.+||+-..+.+ .+.++++|+.|||.|+++++.|.+||.+.+.. ...
T Consensus 176 AK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlG--------rEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~k 247 (449)
T KOG1165|consen 176 AKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLG--------REQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEK 247 (449)
T ss_pred hhhhcCccccccCccccccccccceeeeEeecccc--------chhhhhhhHHHhhhhhhhhccCCCccccccCcchHHH
Confidence 987655443 345679999999988875 67788999999999999999999999886643 233
Q ss_pred HHHHhccCCCC-----CCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhcCCCCCCCCCcc
Q 024408 159 YAAAFKNVRPS-----AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIPHRI 220 (268)
Q Consensus 159 ~~~~~~~~~~~-----~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~~~~~~~~~~~~~ 220 (268)
++++....... ...+|.++...++..-..+..+-|+++-+...+.+.+.......+-.-+|.
T Consensus 248 YeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~Dg~yDW~ 314 (449)
T KOG1165|consen 248 YEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDDGEYDWM 314 (449)
T ss_pred HHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCccccccccc
Confidence 33333222221 467899999999999999999999999999999999988877665544444
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-25 Score=193.26 Aligned_cols=139 Identities=23% Similarity=0.350 Sum_probs=122.0
Q ss_pred CceeEEEee-cCCcEEEEEEcC-CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELL-SGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL 78 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~-~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~ 78 (268)
|+++++.++ +++++||+||-. +|-+|+++|....+ +++.++..|+.|++.|+++||++||+|||||-+|+.++.+
T Consensus 630 NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~kp~--m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~- 706 (772)
T KOG1152|consen 630 NILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFKPR--MDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSN- 706 (772)
T ss_pred chhhhhheeecCCeeEEEecCCCCCcchhhhhhccCc--cchHHHHHHHHHHHhccccccccCceecccccccEEEecC-
Confidence 689999999 557999999987 57899999987655 9999999999999999999999999999999999999999
Q ss_pred CCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 024408 79 KTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFE 150 (268)
Q Consensus 79 ~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~ 150 (268)
|-+||+|||.|... ...+...++||..|+|||++.+ ....+..-|||+||+++|-++....||.
T Consensus 707 g~~klidfgsaa~~-ksgpfd~f~gtv~~aapevl~g-------~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 707 GFVKLIDFGSAAYT-KSGPFDVFVGTVDYAAPEVLGG-------EKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred CeEEEeeccchhhh-cCCCcceeeeeccccchhhhCC-------CccCCCcchhhhhhheeeEEEeccCCCc
Confidence 79999999998643 3344567899999999999976 2445667799999999999999888885
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.7e-25 Score=182.17 Aligned_cols=189 Identities=23% Similarity=0.356 Sum_probs=143.8
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|++++.++. .++...+||||++..+-.++... ++..++..+++.++.||.++|.+||+||||||.|++++...+
T Consensus 96 ni~~~~~~~rnnd~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~ 170 (418)
T KOG1167|consen 96 NIIKLNGCFRNNDQVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQ 170 (418)
T ss_pred hhhcchhhhccCCeeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccC
Confidence 578888888 56789999999999999998865 889999999999999999999999999999999999998777
Q ss_pred CeEEecCCCcccc-----------------cc----------------cc------------ccccCCCccceecccccc
Q 024408 80 TIKLADFGLAREE-----------------SL----------------TE------------MMTAETGTYRWMAPELYS 114 (268)
Q Consensus 80 ~~kl~Dfg~a~~~-----------------~~----------------~~------------~~~~~~gt~~y~aPE~~~ 114 (268)
+-.|+|||+|... .. .. ......||++|+|||++.
T Consensus 171 rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~ 250 (418)
T KOG1167|consen 171 RGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLF 250 (418)
T ss_pred CceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHh
Confidence 8899999998510 00 00 001234899999999986
Q ss_pred ccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHH------------HH--------------------
Q 024408 115 TVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL-QAAY------------AA-------------------- 161 (268)
Q Consensus 115 ~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~-~~~~------------~~-------------------- 161 (268)
. -...+.+.||||.|++++.+++++.||-..... .... +.
T Consensus 251 k-------~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e 323 (418)
T KOG1167|consen 251 R-------CPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPE 323 (418)
T ss_pred h-------ccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHH
Confidence 4 245577899999999999999999998422210 0000 00
Q ss_pred ---HhccC-----CC----------CCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 162 ---AFKNV-----RP----------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 162 ---~~~~~-----~~----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
..... .+ .....+..+.+++.+|+..||.+|.++++.+.|
T Consensus 324 ~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 324 LRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred HHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 00000 00 012234578899999999999999999999997
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.4e-23 Score=167.37 Aligned_cols=152 Identities=36% Similarity=0.492 Sum_probs=123.9
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ ..+..++|+|++++++|.+++...... +++..+..++.+++.++.+||+.|++|+||+|.||+++.+ +
T Consensus 58 ~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~-~ 135 (225)
T smart00221 58 NIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRKKGGK-LSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMD-G 135 (225)
T ss_pred ChhhheeeeecCCceEEEEeccCCCCHHHHHHhcccC-CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-C
Confidence 467788888 446889999999999999999865432 7899999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccccc--ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CChHH
Q 024408 80 TIKLADFGLAREESLTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG-MSNLQ 156 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~-~~~~~ 156 (268)
.++|+|||.+....... ......++..|++||.+. ....++.++|+|+||++++++++|+.||.. .....
T Consensus 136 ~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-------~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~ 208 (225)
T smart00221 136 LVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLL-------GGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTS 208 (225)
T ss_pred CEEEeeCceeeEecCcccccccceeccCCcCCHhHhc-------CCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHH
Confidence 99999999988654432 334456788999999873 124566699999999999999999999976 44443
Q ss_pred HHHHH
Q 024408 157 AAYAA 161 (268)
Q Consensus 157 ~~~~~ 161 (268)
.....
T Consensus 209 ~~~~~ 213 (225)
T smart00221 209 LLSDV 213 (225)
T ss_pred HHHHH
Confidence 44433
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.2e-23 Score=188.51 Aligned_cols=180 Identities=24% Similarity=0.346 Sum_probs=141.8
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCCeEEecCCCccccccc
Q 024408 16 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 95 (268)
Q Consensus 16 lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~~kl~Dfg~a~~~~~~ 95 (268)
-+||||++ +|+.++...+. +...++-.++.|++.||.|+|+.|+.|||+|++|+++..+ +.+|++|||.+.....+
T Consensus 398 ~~mE~~~~-Dlf~~~~~~~~--~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~-g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 398 QSMEYCPY-DLFSLVMSNGK--LTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTEN-GILKIIDFGAASVFRYP 473 (601)
T ss_pred hhhhcccH-HHHHHHhcccc--cchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecC-CceEEeecCcceeeccC
Confidence 34999998 99999987644 8999999999999999999999999999999999999999 69999999998743222
Q ss_pred -----cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh-cc----
Q 024408 96 -----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAF-KN---- 165 (268)
Q Consensus 96 -----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~-~~---- 165 (268)
.......|+..|+|||++.+. ....+..||||.|+++..|++|+.||......+....... ..
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~-------~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~ 546 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGK-------EYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNI 546 (601)
T ss_pred cchhhhhhcCcccCCcCcCccccccc-------ccCcchhhhhhccceEEEEecCCCccccccccccchhhhcccccccc
Confidence 223455789999999999752 2334568999999999999999999976555444321111 11
Q ss_pred ---CCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 024408 166 ---VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 208 (268)
Q Consensus 166 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 208 (268)
.......+|...+.+|.+||+.+|.+|.++++|++. .|++.
T Consensus 547 ~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d--~W~~~ 590 (601)
T KOG0590|consen 547 FEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND--EWIRS 590 (601)
T ss_pred ccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC--hHhhh
Confidence 111134577889999999999999999999999987 44443
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=9e-21 Score=157.45 Aligned_cols=187 Identities=22% Similarity=0.308 Sum_probs=137.4
Q ss_pred cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeC---CCCCeEEecC
Q 024408 10 KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE---DLKTIKLADF 86 (268)
Q Consensus 10 ~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~---~~~~~kl~Df 86 (268)
+...+|+||..++ -+|.+++-.+. .+.....-++.|+++|+.|||.+||.|||+|.+|||+.- ....+.++||
T Consensus 314 ~~~tlylvMkrY~-~tLr~yl~~~~---~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDF 389 (598)
T KOG4158|consen 314 EPKTLYLVMKRYR-QTLREYLWTRH---RSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADF 389 (598)
T ss_pred CCceEEEehhcch-hhHHHHHhcCC---CchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEccc
Confidence 4457899999996 79999997643 566777889999999999999999999999999999942 2236789999
Q ss_pred CCcccccc-------ccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH-H
Q 024408 87 GLAREESL-------TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA-A 158 (268)
Q Consensus 87 g~a~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~-~ 158 (268)
|.+..... ........|...-||||+....+.-. ....-.++|.|+.|.+.||++....||.+...... .
T Consensus 390 GCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~--avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~ 467 (598)
T KOG4158|consen 390 GCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPN--AVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDT 467 (598)
T ss_pred ceeeeccccccccccccccccCCCcceecchhhhhcCCCCc--eeeccchhhhhhhhhhHHHHhccCCcccccchheech
Confidence 98752211 11122345788899999986533111 12233589999999999999999999976322211 1
Q ss_pred HHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 024408 159 YAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 202 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l 202 (268)
..-......+.+..+|+.+++++..+|+.||.+|++..-..+.+
T Consensus 468 r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 468 RTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred hhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHH
Confidence 11223334556788999999999999999999999866554443
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.84 E-value=8.1e-22 Score=161.60 Aligned_cols=170 Identities=22% Similarity=0.366 Sum_probs=112.9
Q ss_pred cEEEEEEcCCCCCHHHHHHh---cCCC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCCeEEecCC
Q 024408 13 VMVIVTELLSGGTLRKYLLN---MRPR--CLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFG 87 (268)
Q Consensus 13 ~~~lV~e~~~ggsL~~~i~~---~~~~--~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~~kl~Dfg 87 (268)
+.+++|+-+. +||.+++.- .... .+.......+..|+++.+++||..|++|+||+|+|++++.+ |.++|+||+
T Consensus 113 n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~nfll~~~-G~v~Lg~F~ 190 (288)
T PF14531_consen 113 NRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKPENFLLDQD-GGVFLGDFS 190 (288)
T ss_dssp SEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE-TT-S-EEE--GG
T ss_pred hhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccceeeEEEcCC-CCEEEcChH
Confidence 4588999995 799988643 2221 13344456667899999999999999999999999999999 799999999
Q ss_pred CccccccccccccCCCccceeccccccccc-cccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccC
Q 024408 88 LAREESLTEMMTAETGTYRWMAPELYSTVT-LRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV 166 (268)
Q Consensus 88 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~ 166 (268)
........... ...+..|.|||...... +.+ ....++.+.|.|+||+++|.|+++..||........... ..
T Consensus 191 ~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~-~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~----~f 263 (288)
T PF14531_consen 191 SLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQ-NNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW----DF 263 (288)
T ss_dssp GEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHH-SEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG----GG
T ss_pred HHeecCceeec--cCCCcccCChhhhhhhcccCc-ccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc----cc
Confidence 88765544332 34457899999764321 111 234578899999999999999999999975432211110 23
Q ss_pred CCCCCCCcHHHHHHHHhccccCCCCC
Q 024408 167 RPSAENVPEELSIILTSCWKEDPNAR 192 (268)
Q Consensus 167 ~~~~~~~~~~l~~li~~~l~~~p~~R 192 (268)
..+. ++|+.++.||..+|+.||.+|
T Consensus 264 ~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 264 SRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred hhcC-CcCHHHHHHHHHHccCCcccC
Confidence 3344 899999999999999999987
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.6e-19 Score=152.26 Aligned_cols=196 Identities=30% Similarity=0.414 Sum_probs=149.6
Q ss_pred CceeEEEeecC-CcEEEEEEcCCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCC
Q 024408 1 MREQFIGACKE-PVMVIVTELLSGGTLRKYLLNMRP-RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL 78 (268)
Q Consensus 1 ~~v~l~g~~~~-~~~~lV~e~~~ggsL~~~i~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~ 78 (268)
+++++.+.+.. ...+++++++.|++|.+++..... ..+....+..++.|++.++.++|+.|++|||+||+||+++...
T Consensus 59 ~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~ 138 (384)
T COG0515 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDG 138 (384)
T ss_pred ceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCC
Confidence 35677777743 447999999999999977765432 1499999999999999999999999999999999999999873
Q ss_pred CCeEEecCCCcccccccc-------ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 024408 79 KTIKLADFGLAREESLTE-------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 151 (268)
Q Consensus 79 ~~~kl~Dfg~a~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~ 151 (268)
..++++|||.++...... ......|+..|++||.+.+.. ........|+||+|++++++++|..||..
T Consensus 139 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~-----~~~~~~~~D~~s~g~~~~~~~~~~~p~~~ 213 (384)
T COG0515 139 RVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLS-----LAYASSSSDIWSLGITLYELLTGLPPFEG 213 (384)
T ss_pred CeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCC-----CCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 369999999997433322 345668999999999885310 14677899999999999999999999877
Q ss_pred CCh---HHHHHHHHhccCCC-C----CCCC----cHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 152 MSN---LQAAYAAAFKNVRP-S----AENV----PEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 152 ~~~---~~~~~~~~~~~~~~-~----~~~~----~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
... .............+ . .... ...+.+++..++..+|..|.+..+....
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 214 EKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred CCccccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 653 23333333332322 1 1111 1578999999999999999998887765
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.4e-21 Score=165.09 Aligned_cols=168 Identities=30% Similarity=0.497 Sum_probs=127.1
Q ss_pred cEEEEEEcCCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCCeEEecCCCccc
Q 024408 13 VMVIVTELLSGGTLRKYLLNMR-PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 91 (268)
Q Consensus 13 ~~~lV~e~~~ggsL~~~i~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~~kl~Dfg~a~~ 91 (268)
++++.|++|.-.+|.+||.++. ...-++.....++.|++.|+.| +|.+|+|+||.||+...+ ..+||.|||+...
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d-~q~kIgDFgl~ts 405 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDD-DQLKIGDFGLVTS 405 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccc-hhhhhhhhhheee
Confidence 6899999999999999997543 3347788889999999999999 999999999999999888 5899999999875
Q ss_pred ccccc-------ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHh
Q 024408 92 ESLTE-------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHN-KLPFEGMSNLQAAYAAAF 163 (268)
Q Consensus 92 ~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g-~~p~~~~~~~~~~~~~~~ 163 (268)
..... ......||.+||+||.+.+ ..|+.++||||||++++|++.. ...++. ........
T Consensus 406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g--------~~y~~kvdIyaLGlil~EL~~~f~T~~er----~~t~~d~r 473 (516)
T KOG1033|consen 406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRG--------QQYSEKVDIYALGLILAELLIQFSTQFER----IATLTDIR 473 (516)
T ss_pred cccCCcccchhhhhhhcccccccCCHHHHhh--------hhhhhhcchhhHHHHHHHHHHHhccHHHH----HHhhhhhh
Confidence 44333 3455689999999999875 7899999999999999999872 222211 11112222
Q ss_pred ccCCC--CCCCCcHHHHHHHHhccccCCCCCCCHHH
Q 024408 164 KNVRP--SAENVPEELSIILTSCWKEDPNARPNFTQ 197 (268)
Q Consensus 164 ~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 197 (268)
....| .....| +-..++.+++...|.+||++.+
T Consensus 474 ~g~ip~~~~~d~p-~e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 474 DGIIPPEFLQDYP-EEYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred cCCCChHHhhcCc-HHHHHHHHhcCCCcccCchHHH
Confidence 22222 122232 3457999999999999994433
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.7e-20 Score=146.34 Aligned_cols=193 Identities=30% Similarity=0.519 Sum_probs=153.2
Q ss_pred CceeEEEeec-CCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCCEEEeCC
Q 024408 1 MREQFIGACK-EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG--IIHRDLKPENLLLTED 77 (268)
Q Consensus 1 ~~v~l~g~~~-~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~g--i~H~Dikp~Nill~~~ 77 (268)
|+...+|.|. -+++.++..|++-|||+..+.+......+..++.+++.+++.|++|||+.. |.---+....++++++
T Consensus 248 nilpvlgacnsppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmided 327 (448)
T KOG0195|consen 248 NILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDED 327 (448)
T ss_pred chhhhhhhccCCCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecch
Confidence 5667889994 468999999999999999999877777899999999999999999999874 4455678889999987
Q ss_pred CCCeEE--ecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH
Q 024408 78 LKTIKL--ADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL 155 (268)
Q Consensus 78 ~~~~kl--~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~ 155 (268)
. +.+| +|--++.. .....-.+.|++||.+... .....-+++|+|||++++|||.|...||.+..+.
T Consensus 328 l-tarismad~kfsfq------e~gr~y~pawmspealqrk-----ped~n~raadmwsfaillwel~trevpfadlspm 395 (448)
T KOG0195|consen 328 L-TARISMADTKFSFQ------EVGRAYSPAWMSPEALQRK-----PEDLNIRAADMWSFAILLWELNTREVPFADLSPM 395 (448)
T ss_pred h-hhheecccceeeee------ccccccCcccCCHHHHhcC-----chhcchhhhhHHHHHHHHHHhhccccccccCCch
Confidence 3 5444 33222211 1122346889999988531 2233456889999999999999999999998888
Q ss_pred HHHHHHHhccCC-CCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHh
Q 024408 156 QAAYAAAFKNVR-PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 205 (268)
Q Consensus 156 ~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~ 205 (268)
+.-.+...+... ..++.++..+..++.-|+..||.+||.+..++-.|++.
T Consensus 396 ecgmkialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 396 ECGMKIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred hhhhhhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 876666555544 45788999999999999999999999999999888764
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.1e-21 Score=176.93 Aligned_cols=183 Identities=21% Similarity=0.250 Sum_probs=132.5
Q ss_pred CCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCCeEEecCCCcc
Q 024408 11 EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 90 (268)
Q Consensus 11 ~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~~kl~Dfg~a~ 90 (268)
+...|||-+|+. -+|+|.|..+.- +..-+...|+.|++.||..||..||+|||||.+|||++.. +.+.|+||...+
T Consensus 93 ~kAAylvRqyvk-hnLyDRlSTRPF--L~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSW-NW~~LtDFAsFK 168 (1431)
T KOG1240|consen 93 DKAAYLVRQYVK-HNLYDRLSTRPF--LVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSW-NWLYLTDFASFK 168 (1431)
T ss_pred hHHHHHHHHHHh-hhhhhhhccchH--HHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeee-chhhhhcccccC
Confidence 345688899995 699999987665 8888889999999999999999999999999999999998 799999998876
Q ss_pred ccccc--c------ccccCCCccceeccccccccc--cccCCC-CCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 024408 91 EESLT--E------MMTAETGTYRWMAPELYSTVT--LRQGEK-KHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAA 158 (268)
Q Consensus 91 ~~~~~--~------~~~~~~gt~~y~aPE~~~~~~--~~~~~~-~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~ 158 (268)
....+ + ...+..-..+|.|||.+.... ...... ...+++.||||+||+++||++ |+++|.- . +.
T Consensus 169 PtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L-S--QL- 244 (1431)
T KOG1240|consen 169 PTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL-S--QL- 244 (1431)
T ss_pred CccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH-H--HH-
Confidence 32211 1 112233456899999876422 111111 226789999999999999987 7888752 1 11
Q ss_pred HHHHhc-cCCCC---CCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 159 YAAAFK-NVRPS---AENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 159 ~~~~~~-~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
..-... ...+. ...-...++.+|..|++.||.+|.++++.++.
T Consensus 245 ~aYr~~~~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 245 LAYRSGNADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HhHhccCccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 000000 00000 11122468999999999999999999999875
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.5e-20 Score=162.70 Aligned_cols=172 Identities=28% Similarity=0.433 Sum_probs=141.7
Q ss_pred eeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCCe
Q 024408 3 EQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTI 81 (268)
Q Consensus 3 v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~~ 81 (268)
|++.-.+ .+...++++++..||+|...+.+... +.+.....+...++-+++++|+.|++|||+|++||+++.+ |++
T Consensus 60 v~lhyafqt~~kl~l~ld~~rgg~lft~l~~~~~--f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~-Ghi 136 (612)
T KOG0603|consen 60 VKLHYAFQTDGKLYLILDFLRGGDLFTRLSKEVM--FDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLE-GHI 136 (612)
T ss_pred eeeeeeeccccchhHhhhhcccchhhhccccCCc--hHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeeccc-Ccc
Confidence 3333333 45578999999999999998876555 8888999999999999999999999999999999999999 799
Q ss_pred EEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 024408 82 KLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAA 161 (268)
Q Consensus 82 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~ 161 (268)
++.|||+++........ +||..|||||++++ ...++|.||+|++.++|++|..||.. + ....
T Consensus 137 ~~tdfglske~v~~~~~---cgt~eymApEI~~g----------h~~a~D~ws~gvl~felltg~~pf~~----~-~~~~ 198 (612)
T KOG0603|consen 137 KLTDFGLSKEAVKEKIA---CGTYEYRAPEIING----------HLSAADWWSFGVLAFELLTGTLPFGG----D-TMKR 198 (612)
T ss_pred ccCCchhhhHhHhhhhc---ccchhhhhhHhhhc----------cCCcccchhhhhhHHHHhhCCCCCch----H-HHHH
Confidence 99999999865544332 89999999999863 35578999999999999999999987 2 2223
Q ss_pred HhccCCCCCCCCcHHHHHHHHhccccCCCCCCCH
Q 024408 162 AFKNVRPSAENVPEELSIILTSCWKEDPNARPNF 195 (268)
Q Consensus 162 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~ 195 (268)
+.......+..++...++++..++..+|.+|...
T Consensus 199 Il~~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 199 ILKAELEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred HhhhccCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 3333445577788899999999999999999644
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.6e-19 Score=157.10 Aligned_cols=204 Identities=31% Similarity=0.478 Sum_probs=153.0
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCC-eecCCCCCCEEEeCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI-IHRDLKPENLLLTEDL 78 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi-~H~Dikp~Nill~~~~ 78 (268)
|+.+|+|.| .++..+.|-+||.-|+|.|.+..... .+++.-...+.++++.||+|+|..-| .|+.++..|.+++..-
T Consensus 8 n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~-~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nClvd~~w 86 (484)
T KOG1023|consen 8 NLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDI-KLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNCLVDSRW 86 (484)
T ss_pred hhhhheeeEecCCceEEEEeeecCccHHhHHhcccc-CccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccceeeeeE
Confidence 578899999 67789999999999999999987433 38899999999999999999998765 9999999999999884
Q ss_pred CCeEEecCCCccccccc---cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--
Q 024408 79 KTIKLADFGLAREESLT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS-- 153 (268)
Q Consensus 79 ~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~-- 153 (268)
.+|++|||+....... .......-..-|.|||.++...... .....+.+.|+||+|++++|+++...||....
T Consensus 87 -~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~-~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~ 164 (484)
T KOG1023|consen 87 -VLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQS-LESALTQKGDIYSFGIIMYEILFRSGPFDLRNLV 164 (484)
T ss_pred -EEEechhhhcccccccccccccchhHHHHhccCHHHhccccccc-ccccccccCCeehHHHHHHHHHhccCcccccccc
Confidence 8999999998754321 1111122346789999997632211 11335778999999999999999999996522
Q ss_pred --hHHHHHHHHhccC---CCC---CCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHh
Q 024408 154 --NLQAAYAAAFKNV---RPS---AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 207 (268)
Q Consensus 154 --~~~~~~~~~~~~~---~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 207 (268)
..+.......... .|. ....++++..++..||..+|.+||+++++...++....
T Consensus 165 ~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 165 EDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred CChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 1122222222111 221 11455679999999999999999999999888766544
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.3e-17 Score=128.21 Aligned_cols=130 Identities=15% Similarity=0.162 Sum_probs=94.4
Q ss_pred ceeEEEeecCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC-CCCCEEEeCCCCC
Q 024408 2 REQFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDL-KPENLLLTEDLKT 80 (268)
Q Consensus 2 ~v~l~g~~~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Di-kp~Nill~~~~~~ 80 (268)
+++++++ +..+++|||+.|.+|.+.+.. ....++.|++.+|.++|++||+|||| ||+|||++.+ +.
T Consensus 64 vP~ll~~---~~~~lvmeyI~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~-g~ 130 (218)
T PRK12274 64 TPRLLHW---DGRHLDRSYLAGAAMYQRPPR---------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQED-GS 130 (218)
T ss_pred CCEEEEE---cCEEEEEeeecCccHHhhhhh---------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCC-CC
Confidence 4566665 346999999999999764321 11357789999999999999999999 7999999887 68
Q ss_pred eEEecCCCcccccccccc--------------ccCCCccceeccccccccccccCCCCCCC-chhhHHHHHHHHHHHHhC
Q 024408 81 IKLADFGLAREESLTEMM--------------TAETGTYRWMAPELYSTVTLRQGEKKHYN-HKVDSYSFAIVLWELLHN 145 (268)
Q Consensus 81 ~kl~Dfg~a~~~~~~~~~--------------~~~~gt~~y~aPE~~~~~~~~~~~~~~~~-~~~DvwslG~~l~~ll~g 145 (268)
++|+|||++......... .-...++.|++|+...-. ...+ .+.+.++.|+.+|.++|+
T Consensus 131 i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l-------~~~~~~~~~w~~~g~~~~~~~~~ 203 (218)
T PRK12274 131 PAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVL-------KRTSWIRELWFATGKPVYRFVTR 203 (218)
T ss_pred EEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhh-------ccchhHHHHHHHhcchHHHHHhc
Confidence 999999999844332210 011256777777754321 1222 466888999999999999
Q ss_pred CCCCCC
Q 024408 146 KLPFEG 151 (268)
Q Consensus 146 ~~p~~~ 151 (268)
..+.-+
T Consensus 204 ~~~~~~ 209 (218)
T PRK12274 204 RVLHWE 209 (218)
T ss_pred cCCccc
Confidence 887643
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=6.4e-17 Score=138.16 Aligned_cols=94 Identities=27% Similarity=0.279 Sum_probs=73.2
Q ss_pred CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC-CCCCEEEeCCCCCeEEecCCCcc
Q 024408 12 PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDL-KPENLLLTEDLKTIKLADFGLAR 90 (268)
Q Consensus 12 ~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Di-kp~Nill~~~~~~~kl~Dfg~a~ 90 (268)
+..+|||||++|++|.. +. . .. ...++.+++.||.|||++||+|||| ||+|||++.+ +.++|+|||+|+
T Consensus 91 ~~~~LVmE~~~G~~L~~-~~---~--~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~-~~ikLiDFGlA~ 160 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHL-AR---P--HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPD-GEAAVIDFQLAS 160 (365)
T ss_pred CCcEEEEEccCCCCHHH-hC---c--cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCC-CCEEEEECccce
Confidence 45799999999999963 21 1 11 1467899999999999999999999 9999999877 689999999998
Q ss_pred ccccccc---------cccCCCccceeccccccc
Q 024408 91 EESLTEM---------MTAETGTYRWMAPELYST 115 (268)
Q Consensus 91 ~~~~~~~---------~~~~~gt~~y~aPE~~~~ 115 (268)
....... ..+..++..|.+||.+..
T Consensus 161 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 161 VFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred ecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 5433221 124467888999998864
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.68 E-value=9e-17 Score=147.61 Aligned_cols=136 Identities=33% Similarity=0.508 Sum_probs=108.3
Q ss_pred HHHHHHHHHHHCCCeecCCCCCCEEEeCCCCCeEEecCCCcccccccc----------------ccccCCCccceecccc
Q 024408 49 DIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE----------------MMTAETGTYRWMAPEL 112 (268)
Q Consensus 49 ~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~~kl~Dfg~a~~~~~~~----------------~~~~~~gt~~y~aPE~ 112 (268)
+++.+++|+|+-||+|||+||+|.+|+.= |++|+.|||+.+...... ..+..+||+.|.|||+
T Consensus 151 dmvla~Eylh~ygivhrdlkpdnllIT~m-GhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeV 229 (1205)
T KOG0606|consen 151 DMVLAVEYLHSYGIVHRDLKPDNLLITSM-GHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEV 229 (1205)
T ss_pred hhhHHhHhhccCCeecCCCCCCcceeeec-ccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhh
Confidence 34789999999999999999999999976 799999999986221110 1123479999999999
Q ss_pred ccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh--ccCCCCCCCCcHHHHHHHHhccccCCC
Q 024408 113 YSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAF--KNVRPSAENVPEELSIILTSCWKEDPN 190 (268)
Q Consensus 113 ~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~~p~ 190 (268)
+.. +.|+...|.|++|+++|+.+-|..||.+....+..-.... ..+.......+++.++++.++|+.+|.
T Consensus 230 ilr--------qgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~ 301 (1205)
T KOG0606|consen 230 ILR--------QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPL 301 (1205)
T ss_pred hhh--------hccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccCcCCCHHHHHHHHHHHHhChH
Confidence 863 6788899999999999999999999998665554333332 223344567789999999999999999
Q ss_pred CCC
Q 024408 191 ARP 193 (268)
Q Consensus 191 ~Rp 193 (268)
.|-
T Consensus 302 ~Rl 304 (1205)
T KOG0606|consen 302 CRL 304 (1205)
T ss_pred hhc
Confidence 994
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.67 E-value=4.3e-16 Score=144.91 Aligned_cols=176 Identities=24% Similarity=0.323 Sum_probs=131.7
Q ss_pred CCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeC------CCCCeEEe
Q 024408 11 EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE------DLKTIKLA 84 (268)
Q Consensus 11 ~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~------~~~~~kl~ 84 (268)
.+..+||+||.+-|||.+++... +.+++..+..+..|++..|++||..+|||+||||+|+||.. +...++|+
T Consensus 766 ~~~S~lv~ey~~~Gtlld~~N~~--~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 766 QNASVLVSEYSPYGTLLDLINTN--KVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred CCcceeeeeccccccHHHhhccC--CCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEE
Confidence 34579999999999999999844 44999999999999999999999999999999999999942 22468999
Q ss_pred cCCCcccc---ccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 024408 85 DFGLAREE---SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAA 161 (268)
Q Consensus 85 Dfg~a~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~ 161 (268)
|||-+... .+........+|..+-.+|+..+ ..++.+.|.|.|+.+++-|+.|+.- + .+
T Consensus 844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~g--------rpWtYq~DyfGlAa~~h~mLFG~y~-------q---~~ 905 (974)
T KOG1166|consen 844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREG--------RPWTYQIDYFGLAATVHVMLFGKYM-------E---VK 905 (974)
T ss_pred ecccceeeeEcCCCcEEeeeeccccchhHHHhcC--------CCCchhhhhHHHHHHHHHHHHHHHH-------H---hc
Confidence 99998632 22334455678889999998865 6678899999999999999998631 1 11
Q ss_pred HhccCCCCCCCCc-----HHHHHHHHhccccCCCCCCCHHHHHHHHHHhHh
Q 024408 162 AFKNVRPSAENVP-----EELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 207 (268)
Q Consensus 162 ~~~~~~~~~~~~~-----~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 207 (268)
....+.. ..+++ ....+++..+|+.|-..=|...++...++..+.
T Consensus 906 ~g~~~~~-~~~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~ 955 (974)
T KOG1166|consen 906 NGSSWMV-KTNFPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLA 955 (974)
T ss_pred CCcceec-cccchhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHH
Confidence 1111111 11122 235568888888555555788888877776654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.66 E-value=2e-16 Score=124.25 Aligned_cols=74 Identities=23% Similarity=0.283 Sum_probs=64.0
Q ss_pred EEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH-HHCCCeecCCCCCCEEEeCCCCCeEEecCCCcccc
Q 024408 15 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECL-HSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 92 (268)
Q Consensus 15 ~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~l-H~~gi~H~Dikp~Nill~~~~~~~kl~Dfg~a~~~ 92 (268)
+|||||++|++|...+.... .+++.++..++.|++.+|.++ |+.|++||||||+||+++. +.++|+|||+|...
T Consensus 93 ~iVmE~i~g~~l~~~~~~~~--~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~--~~v~LiDFG~a~~~ 167 (190)
T cd05147 93 VLVMEFIGDDGWAAPRLKDA--PLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYHD--GKLYIIDVSQSVEH 167 (190)
T ss_pred EEEEEEeCCCCCcchhhhcC--CCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEEC--CcEEEEEccccccC
Confidence 89999999887765543333 389999999999999999999 7999999999999999984 58999999999753
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.63 E-value=9.5e-16 Score=120.61 Aligned_cols=76 Identities=24% Similarity=0.204 Sum_probs=64.0
Q ss_pred EEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEEeCCCCCeEEecCCCcccc
Q 024408 14 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 92 (268)
Q Consensus 14 ~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~gi~H~Dikp~Nill~~~~~~~kl~Dfg~a~~~ 92 (268)
.+|||||++|+++........ .++..++..++.+++.++.++|+ +|++||||||+||+++ + +.++|+|||++...
T Consensus 92 ~~lVmE~~~g~~~~~~~l~~~--~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~-~~~~liDFG~a~~~ 167 (190)
T cd05145 92 NVLVMEFIGDDGSPAPRLKDV--PLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-D-GKPYIIDVSQAVEL 167 (190)
T ss_pred CEEEEEEecCCCchhhhhhhc--cCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-C-CCEEEEEcccceec
Confidence 389999998876554332222 38889999999999999999999 9999999999999998 5 68999999999764
Q ss_pred c
Q 024408 93 S 93 (268)
Q Consensus 93 ~ 93 (268)
.
T Consensus 168 ~ 168 (190)
T cd05145 168 D 168 (190)
T ss_pred C
Confidence 3
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.63 E-value=3.2e-16 Score=125.08 Aligned_cols=101 Identities=17% Similarity=0.291 Sum_probs=75.7
Q ss_pred CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCCeEEecCCCccc
Q 024408 12 PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 91 (268)
Q Consensus 12 ~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~~kl~Dfg~a~~ 91 (268)
+..+|||||++|.+|.++.. +++. ...+++.+|..+|+.|++|||+||+||+++.+ + ++++|||....
T Consensus 116 ~~~~lvmEyi~G~tL~~~~~------~~~~----~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~-g-i~liDfg~~~~ 183 (232)
T PRK10359 116 HTYIMLIEYIEGVELNDMPE------ISED----VKAKIKASIESLHQHGMVSGDPHKGNFIVSKN-G-LRIIDLSGKRC 183 (232)
T ss_pred CCeEEEEEEECCccHHHhhh------ccHH----HHHHHHHHHHHHHHcCCccCCCChHHEEEeCC-C-EEEEECCCccc
Confidence 35799999999999988732 3332 45699999999999999999999999999987 5 99999998875
Q ss_pred cccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHH
Q 024408 92 ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL 143 (268)
Q Consensus 92 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll 143 (268)
......... ... ...+..++|+||||+++..+.
T Consensus 184 ~~e~~a~d~-----------~vl--------er~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 184 TAQRKAKDR-----------IDL--------ERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred ccchhhHHH-----------HHH--------HhHhcccccccceeEeehHHH
Confidence 432221110 111 123446899999999987653
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.60 E-value=6.6e-17 Score=146.61 Aligned_cols=193 Identities=24% Similarity=0.351 Sum_probs=151.2
Q ss_pred CceeEEEeecC-CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH-HCCCeecCCCCCCEEEeCCC
Q 024408 1 MREQFIGACKE-PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLH-SHGIIHRDLKPENLLLTEDL 78 (268)
Q Consensus 1 ~~v~l~g~~~~-~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH-~~gi~H~Dikp~Nill~~~~ 78 (268)
|++.+++.-.+ ...+++++|.+|+++.+.+........+...+..++.|+..++.|+| ..|+.|+|+||+|.+++.+
T Consensus 82 n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s- 160 (601)
T KOG0590|consen 82 NTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDES- 160 (601)
T ss_pred cccccCCccCCCcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccC-
Confidence 45666777644 47799999999999999984322224777888889999999999999 9999999999999999988
Q ss_pred C-CeEEecCCCcccccc-c---cccccCCC-ccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 024408 79 K-TIKLADFGLAREESL-T---EMMTAETG-TYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGM 152 (268)
Q Consensus 79 ~-~~kl~Dfg~a~~~~~-~---~~~~~~~g-t~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~ 152 (268)
+ .+++.|||+|..... . .......| ++.|++||...+ ........|+||.|+++..+++|..||...
T Consensus 161 ~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~-------~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~ 233 (601)
T KOG0590|consen 161 GSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSG-------KAYRGPSVDVWSLGIVLSAMLTGELPWDFP 233 (601)
T ss_pred CCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccc-------hhhcCCCcccccccccccccccCCCCcccc
Confidence 5 899999999986544 2 22344567 999999999864 245677889999999999999999999765
Q ss_pred ChHHHHHHHHhcc----CCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 153 SNLQAAYAAAFKN----VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 153 ~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
......+...... .......++....+++.+++..+|..|.+.+++...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d 286 (601)
T KOG0590|consen 234 SRKDGRYSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLD 286 (601)
T ss_pred ccccccceeecccccccccCccccCChhhhhcccccccCCchhcccccccccc
Confidence 5444332222222 123356677889999999999999999999988765
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.54 E-value=2.7e-14 Score=113.41 Aligned_cols=85 Identities=13% Similarity=0.154 Sum_probs=66.4
Q ss_pred CceeEEEeecCC----cE-EEEEEc--CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHH-HHHHHCCCeecCCCCCCE
Q 024408 1 MREQFIGACKEP----VM-VIVTEL--LSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAM-ECLHSHGIIHRDLKPENL 72 (268)
Q Consensus 1 ~~v~l~g~~~~~----~~-~lV~e~--~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l-~~lH~~gi~H~Dikp~Ni 72 (268)
|+++++|++.++ .. .+|||| +.+++|.+++.+. . +++. ..++.+++.++ +|||+++|+||||||+||
T Consensus 62 nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~~-~--~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NI 136 (210)
T PRK10345 62 GIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQC-R--YEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNI 136 (210)
T ss_pred ccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHcc-c--ccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHE
Confidence 689999999554 33 488999 5579999999652 2 6665 35678888888 999999999999999999
Q ss_pred EEeCC---CCCeEEecCCCcc
Q 024408 73 LLTED---LKTIKLADFGLAR 90 (268)
Q Consensus 73 ll~~~---~~~~kl~Dfg~a~ 90 (268)
+++.. ...++|+||+.+.
T Consensus 137 Ll~~~~~~~~~~~LiDg~G~~ 157 (210)
T PRK10345 137 LCQRISESEVIPVVCDNIGES 157 (210)
T ss_pred EEeccCCCCCcEEEEECCCCc
Confidence 99742 2379999955443
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.50 E-value=4.9e-14 Score=114.38 Aligned_cols=74 Identities=26% Similarity=0.297 Sum_probs=63.7
Q ss_pred EEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC-CeecCCCCCCEEEeCCCCCeEEecCCCccc
Q 024408 14 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG-IIHRDLKPENLLLTEDLKTIKLADFGLARE 91 (268)
Q Consensus 14 ~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~g-i~H~Dikp~Nill~~~~~~~kl~Dfg~a~~ 91 (268)
.++||||++|++|........ .+...++..++.|++.+|++||++| ++||||||+||+++ + +.++++|||.+..
T Consensus 123 ~~lV~E~~~g~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-~-~~i~LiDFg~a~~ 197 (237)
T smart00090 123 NVLVMEFIGGDGLPAPRLKDV--EPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-D-GKVVIIDVSQSVE 197 (237)
T ss_pred ceEEEEEecCCcccccccccC--CcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-C-CCEEEEEChhhhc
Confidence 489999999888877653322 2667778899999999999999999 99999999999999 4 6899999999875
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.43 E-value=6.9e-13 Score=105.96 Aligned_cols=74 Identities=34% Similarity=0.531 Sum_probs=64.9
Q ss_pred cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCCeEEecCCCc
Q 024408 10 KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 89 (268)
Q Consensus 10 ~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~~kl~Dfg~a 89 (268)
..+..++||||++|++|.+++.... . +...++.+++.+|.++|+.|++|+|++|.||+++ + +.++++|||.+
T Consensus 70 ~~~~~~lv~e~~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~-~~~~liDf~~a 141 (211)
T PRK14879 70 DPENFIIVMEYIEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-G-GKIYLIDFGLA 141 (211)
T ss_pred eCCCCEEEEEEeCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-C-CCEEEEECCcc
Confidence 4456789999999999999986522 2 7888999999999999999999999999999999 4 58999999998
Q ss_pred cc
Q 024408 90 RE 91 (268)
Q Consensus 90 ~~ 91 (268)
..
T Consensus 142 ~~ 143 (211)
T PRK14879 142 EF 143 (211)
T ss_pred cC
Confidence 75
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.43 E-value=6.6e-13 Score=108.00 Aligned_cols=82 Identities=26% Similarity=0.277 Sum_probs=64.6
Q ss_pred ceeEEEeec--CCc---EEEEEEcCCC-CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEe
Q 024408 2 REQFIGACK--EPV---MVIVTELLSG-GTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 75 (268)
Q Consensus 2 ~v~l~g~~~--~~~---~~lV~e~~~g-gsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~ 75 (268)
+++.++++. ... .++|||+++| .+|.+++.+. .+++.. +.+++.+|.+||++||+||||||.|||++
T Consensus 104 vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~ 176 (239)
T PRK01723 104 VPRPIAARVVRHGLFYRADILIERIEGARDLVALLQEA---PLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLD 176 (239)
T ss_pred CceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhcC---CCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEc
Confidence 355666642 222 3599999997 6999988642 255543 56899999999999999999999999998
Q ss_pred CCCCCeEEecCCCccc
Q 024408 76 EDLKTIKLADFGLARE 91 (268)
Q Consensus 76 ~~~~~~kl~Dfg~a~~ 91 (268)
.+ +.++|+|||.+..
T Consensus 177 ~~-~~v~LIDfg~~~~ 191 (239)
T PRK01723 177 PD-GKFWLIDFDRGEL 191 (239)
T ss_pred CC-CCEEEEECCCccc
Confidence 87 5899999999875
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.41 E-value=6.1e-13 Score=105.35 Aligned_cols=70 Identities=24% Similarity=0.273 Sum_probs=60.4
Q ss_pred cEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCCeEEecCCCccc
Q 024408 13 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 91 (268)
Q Consensus 13 ~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~~kl~Dfg~a~~ 91 (268)
..++||||++|++|.+.... .....++.+++.++.++|+.|++||||||+||+++.+ +.++|+|||++..
T Consensus 105 ~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~-~~~~liDfg~~~~ 174 (198)
T cd05144 105 RHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDD-EKIYIIDWPQMVS 174 (198)
T ss_pred CceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCC-CcEEEEECCcccc
Confidence 45899999999998765421 3456788999999999999999999999999999987 6999999999964
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.41 E-value=8.4e-13 Score=104.54 Aligned_cols=71 Identities=30% Similarity=0.491 Sum_probs=61.2
Q ss_pred cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCCeEEecCCCc
Q 024408 10 KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 89 (268)
Q Consensus 10 ~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~~kl~Dfg~a 89 (268)
..+..++||||++|++|.+++..... .++.+++.+|.+||+.|++|+|++|.||+++ + +.++++|||.+
T Consensus 68 ~~~~~~lv~e~~~g~~l~~~~~~~~~---------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~-~~~~liDfg~a 136 (199)
T TIGR03724 68 DPDNKTIVMEYIEGKPLKDVIEEGND---------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-D-DKLYLIDFGLG 136 (199)
T ss_pred ECCCCEEEEEEECCccHHHHHhhcHH---------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-C-CcEEEEECCCC
Confidence 34456899999999999998754211 7889999999999999999999999999999 4 68999999998
Q ss_pred cc
Q 024408 90 RE 91 (268)
Q Consensus 90 ~~ 91 (268)
..
T Consensus 137 ~~ 138 (199)
T TIGR03724 137 KY 138 (199)
T ss_pred cC
Confidence 75
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.40 E-value=8.5e-13 Score=119.73 Aligned_cols=70 Identities=29% Similarity=0.463 Sum_probs=61.5
Q ss_pred cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCCeEEecCCCc
Q 024408 10 KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 89 (268)
Q Consensus 10 ~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~~kl~Dfg~a 89 (268)
.+...++||||++|++|.+++. ....++.+++.+|.+||+.|++||||||+||+++ + +.++|+|||++
T Consensus 407 ~~~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~-~-~~~~liDFGla 474 (535)
T PRK09605 407 DPEEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-D-DRLYLIDFGLG 474 (535)
T ss_pred eCCCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE-C-CcEEEEeCccc
Confidence 3446789999999999999885 3467899999999999999999999999999994 3 58999999999
Q ss_pred cc
Q 024408 90 RE 91 (268)
Q Consensus 90 ~~ 91 (268)
+.
T Consensus 475 ~~ 476 (535)
T PRK09605 475 KY 476 (535)
T ss_pred cc
Confidence 75
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.37 E-value=7.7e-13 Score=108.21 Aligned_cols=177 Identities=19% Similarity=0.268 Sum_probs=119.9
Q ss_pred cEEEEEEcCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCCEEEeCCCCCeEEecCCC
Q 024408 13 VMVIVTELLSGGTLRKYLLNMR--PRCLDVCVAIGFALDIARAMECLHSHG--IIHRDLKPENLLLTEDLKTIKLADFGL 88 (268)
Q Consensus 13 ~~~lV~e~~~ggsL~~~i~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~g--i~H~Dikp~Nill~~~~~~~kl~Dfg~ 88 (268)
...++.||+..|+|.++|++.+ .+.+......+|+.||+.||.|||+-. ++|+++..+.|++..+ +-+|+.--.-
T Consensus 146 rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~n-gLIkig~~ap 224 (458)
T KOG1266|consen 146 RVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHN-GLIKIGSVAP 224 (458)
T ss_pred ceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCC-ceEEecccCc
Confidence 5789999999999999998743 345888899999999999999999975 9999999999999977 5676543211
Q ss_pred ccccc-----cccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHH
Q 024408 89 AREES-----LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPF-EGMSNLQAAYAAA 162 (268)
Q Consensus 89 a~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~-~~~~~~~~~~~~~ 162 (268)
..... .........+-++|.+||.-. ....+..+|||++|+..++|..+...- .+.+.........
T Consensus 225 ~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~--------~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia 296 (458)
T KOG1266|consen 225 DSTHPSVNSTREAEKSVNTSLPGFSAPESGT--------TTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIA 296 (458)
T ss_pred cccchhhhhhhHhhhhccccCCccccCCcCc--------ccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhh
Confidence 11100 111122345678899998532 245667899999999999997765431 1111111100000
Q ss_pred hccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 024408 163 FKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 202 (268)
Q Consensus 163 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l 202 (268)
. ...-.. ..--+.++.+|+...|..||++++++.|.
T Consensus 297 ~-~i~~le---n~lqr~~i~kcl~~eP~~rp~ar~llfHp 332 (458)
T KOG1266|consen 297 N-VIIGLE---NGLQRGSITKCLEGEPNGRPDARLLLFHP 332 (458)
T ss_pred h-heeecc---CccccCcCcccccCCCCCCcchhhhhcCc
Confidence 0 000000 11224678999999999999999998764
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.31 E-value=2e-12 Score=113.35 Aligned_cols=187 Identities=24% Similarity=0.218 Sum_probs=136.3
Q ss_pred eEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHH----HHHHHHHCCCeecCCCCCCEEEeCCC
Q 024408 4 QFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIAR----AMECLHSHGIIHRDLKPENLLLTEDL 78 (268)
Q Consensus 4 ~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~----~l~~lH~~gi~H~Dikp~Nill~~~~ 78 (268)
+..... .++..++-.|++ |.+|.++....... ++...++..+.+... ||.++|+.+++|-|+||.||++..+.
T Consensus 182 ~~~~~~e~~~~lfiqtE~~-~~sl~~~~~~~~~~-~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~ 259 (524)
T KOG0601|consen 182 RDSPAWEGSGILFIQTELC-GESLQSYCHTPCNF-LPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDW 259 (524)
T ss_pred ccCcccccCCcceeeeccc-cchhHHhhhccccc-CCchhhhhHHhhhhhcccccccccCCCcccccccchhheeccccc
Confidence 333444 446789999999 68999988764443 888899999999999 99999999999999999999998874
Q ss_pred CCeEEecCCCcccccccccc------ccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 024408 79 KTIKLADFGLAREESLTEMM------TAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGM 152 (268)
Q Consensus 79 ~~~kl~Dfg~a~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~ 152 (268)
..++++|||+.......... ....|...|++||..+ +.++..+|+|++|.++.+..++..+....
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~---------~l~~~~~di~sl~ev~l~~~l~~~~~~~g 330 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN---------GLATFASDIFSLGEVILEAILGSHLPSVG 330 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc---------cccchHhhhcchhhhhHhhHhhcccccCC
Confidence 47899999998865544321 2225778999999985 56788999999999999998876554332
Q ss_pred ChHHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 153 SNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
.....................+.++...+..|++.++..|++.+.+..+
T Consensus 331 ~~~~W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 331 KNSSWSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred CCCCccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 1111000000001111233455677778999999999999998877664
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.26 E-value=1.2e-11 Score=96.81 Aligned_cols=75 Identities=27% Similarity=0.304 Sum_probs=58.9
Q ss_pred cEEEEEEcCCCCCHHH-HHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEEeCCCCCeEEecCCCcc
Q 024408 13 VMVIVTELLSGGTLRK-YLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLTEDLKTIKLADFGLAR 90 (268)
Q Consensus 13 ~~~lV~e~~~ggsL~~-~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~gi~H~Dikp~Nill~~~~~~~kl~Dfg~a~ 90 (268)
..++||||++|+++.. .+.... .. .++..++.+++.++.++|. .|++|+||||+||+++ + +.++++|||.+.
T Consensus 89 ~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~-~~~~liDfg~a~ 162 (187)
T cd05119 89 RHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-D-GKVYIIDVPQAV 162 (187)
T ss_pred CCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-C-CcEEEEECcccc
Confidence 3589999999854332 121111 11 6778899999999999999 9999999999999999 5 689999999997
Q ss_pred ccc
Q 024408 91 EES 93 (268)
Q Consensus 91 ~~~ 93 (268)
...
T Consensus 163 ~~~ 165 (187)
T cd05119 163 EID 165 (187)
T ss_pred ccc
Confidence 533
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.23 E-value=1e-11 Score=114.95 Aligned_cols=175 Identities=27% Similarity=0.330 Sum_probs=135.4
Q ss_pred CCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCCeEEecCCCcc
Q 024408 11 EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 90 (268)
Q Consensus 11 ~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~~kl~Dfg~a~ 90 (268)
+...+||++|+.|++|...++..+. .+.+-+......+..++++||...+.|+|++|.|+++..+ +..++.|||...
T Consensus 876 rsP~~L~~~~~~~~~~~Skl~~~~~--~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~-gh~~l~~~~t~~ 952 (1205)
T KOG0606|consen 876 RSPLPLVGHYLNGGDLPSKLHNSGC--LSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYD-GHRPLTDFGTLS 952 (1205)
T ss_pred CCCcchhhHHhccCCchhhhhcCCC--cccccccchhHHHHhhhhccccchhhcccccccchhhccc-CCcccCcccccc
Confidence 4568999999999999999987663 7777778888999999999999999999999999999888 689999998432
Q ss_pred ccc-------c-------------------------ccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHH
Q 024408 91 EES-------L-------------------------TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIV 138 (268)
Q Consensus 91 ~~~-------~-------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~ 138 (268)
... . ........||+.|.+||...+ ..-+..+|+|+.|++
T Consensus 953 ~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg--------~~hgs~ad~~~~g~~ 1024 (1205)
T KOG0606|consen 953 KVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLG--------RRHGSAADWWSSGVC 1024 (1205)
T ss_pred ccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccc--------ccCCCcchhhhhhhh
Confidence 100 0 011223468999999998875 444667899999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHhcc--CCCCCCCCcHHHHHHHHhccccCCCCCCCHH
Q 024408 139 LWELLHNKLPFEGMSNLQAAYAAAFKN--VRPSAENVPEELSIILTSCWKEDPNARPNFT 196 (268)
Q Consensus 139 l~~ll~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 196 (268)
+++.++|..||......+......... +...+...+.+..+++...+..++.+|-.+.
T Consensus 1025 l~e~l~g~pp~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1025 LFEVLTGIPPFNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred hhhhhcCCCCCCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 999999999998766554433222211 1222456678999999999999999997766
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.22 E-value=3.1e-10 Score=96.27 Aligned_cols=200 Identities=17% Similarity=0.297 Sum_probs=136.0
Q ss_pred EEeecCCcEEEEEEcCCCCC-HHHHHHh---c-CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCC
Q 024408 6 IGACKEPVMVIVTELLSGGT-LRKYLLN---M-RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT 80 (268)
Q Consensus 6 ~g~~~~~~~~lV~e~~~ggs-L~~~i~~---~-~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~ 80 (268)
+|--.+..+.++|..++|.. +.++..- + .-..+.|.-.++.++.++.+.+.||+.|.+-+|++++|+|++++ +.
T Consensus 77 ~G~~~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~-~~ 155 (637)
T COG4248 77 HGGRRGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDD-SK 155 (637)
T ss_pred hCCCccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecC-ce
Confidence 33334445788899998652 2222211 1 11238889999999999999999999999999999999999988 68
Q ss_pred eEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCh-----
Q 024408 81 IKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHN-KLPFEGMSN----- 154 (268)
Q Consensus 81 ~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g-~~p~~~~~~----- 154 (268)
+.|.|-........+......+|...|.+||.-.-.+. .+...+...|.|.||+++++++.| +.||.+...
T Consensus 156 V~LVdsDsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf---~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap 232 (637)
T COG4248 156 VVLVDSDSFQINANGTLHLCPVGVSEFTPPELQTLPSF---VGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAP 232 (637)
T ss_pred EEEEcccceeeccCCceEecccCccccCCHHHhccccc---cccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCC
Confidence 89988554433333333445578899999997542111 123456678999999999999885 889865321
Q ss_pred --HHHHH--------HHHhccCCCC-----CCCCcHHHHHHHHhcccc--CCCCCCCHHHHHHHHHHhHhhc
Q 024408 155 --LQAAY--------AAAFKNVRPS-----AENVPEELSIILTSCWKE--DPNARPNFTQIIQMLLNYLSAI 209 (268)
Q Consensus 155 --~~~~~--------~~~~~~~~~~-----~~~~~~~l~~li~~~l~~--~p~~Rps~~~~~~~l~~~~~~~ 209 (268)
.+... ........+. ...+++.+..+..+|+.. ++.-||+++.++..|......+
T Consensus 233 ~p~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L 304 (637)
T COG4248 233 NPLETDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQL 304 (637)
T ss_pred CcchhhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhh
Confidence 11010 0111111222 234678899999999854 4678999999998887666554
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.19 E-value=6.1e-11 Score=88.96 Aligned_cols=80 Identities=21% Similarity=0.305 Sum_probs=66.4
Q ss_pred ceeEEEeec-CCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCCCCEEEeCC
Q 024408 2 REQFIGACK-EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH---GIIHRDLKPENLLLTED 77 (268)
Q Consensus 2 ~v~l~g~~~-~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---gi~H~Dikp~Nill~~~ 77 (268)
+++++++.. .+..+++|||++|+++..+ +......++.+++.+|..+|.. +++|+|++|+||+++..
T Consensus 55 ~p~~~~~~~~~~~~~~v~e~~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~ 125 (155)
T cd05120 55 VPKVLASGESDGWSYLLMEWIEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDG 125 (155)
T ss_pred CCeEEEEcCCCCccEEEEEecCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECC
Confidence 456777773 4578999999998877653 4566677889999999999985 79999999999999986
Q ss_pred CCCeEEecCCCccc
Q 024408 78 LKTIKLADFGLARE 91 (268)
Q Consensus 78 ~~~~kl~Dfg~a~~ 91 (268)
+.++++|||.+..
T Consensus 126 -~~~~l~Df~~~~~ 138 (155)
T cd05120 126 -KILGIIDWEYAGY 138 (155)
T ss_pred -cEEEEEecccccC
Confidence 6899999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.17 E-value=1.4e-10 Score=90.77 Aligned_cols=76 Identities=17% Similarity=0.210 Sum_probs=58.9
Q ss_pred cEEEEEEcCCCCCHHH-HHHhcCCCCCCHHHHHHHHHHHHHHHHHH-HHCCCeecCCCCCCEEEeCCCCCeEEecCCCcc
Q 024408 13 VMVIVTELLSGGTLRK-YLLNMRPRCLDVCVAIGFALDIARAMECL-HSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 90 (268)
Q Consensus 13 ~~~lV~e~~~ggsL~~-~i~~~~~~~~~~~~~~~~~~~l~~~l~~l-H~~gi~H~Dikp~Nill~~~~~~~kl~Dfg~a~ 90 (268)
.-+|||||+.|+.+.. .+.+ ..++..+...+..+++.+|..| |+.|++|+||++.||++++ +.+.++|||.+.
T Consensus 98 ~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL~~~--~~v~iIDF~qav 172 (197)
T cd05146 98 KHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNMLWHD--GKVWFIDVSQSV 172 (197)
T ss_pred CCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEC--CcEEEEECCCce
Confidence 3489999996544422 2222 1256667778889999999998 8999999999999999975 479999999887
Q ss_pred ccc
Q 024408 91 EES 93 (268)
Q Consensus 91 ~~~ 93 (268)
...
T Consensus 173 ~~~ 175 (197)
T cd05146 173 EPT 175 (197)
T ss_pred eCC
Confidence 543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.16 E-value=1.7e-10 Score=87.80 Aligned_cols=72 Identities=29% Similarity=0.448 Sum_probs=61.0
Q ss_pred ecCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCCeEEecCCC
Q 024408 9 CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGL 88 (268)
Q Consensus 9 ~~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~~kl~Dfg~ 88 (268)
++.+.-.|+|||++|..|.+.+... ...++..+-.-+.-||..||+|+||.++||++..+ .+.++|||+
T Consensus 69 vD~~~~~I~me~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~--~i~~IDfGL 137 (204)
T COG3642 69 VDPDNGLIVMEYIEGELLKDALEEA---------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG--RIYFIDFGL 137 (204)
T ss_pred EcCCCCEEEEEEeCChhHHHHHHhc---------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCC--cEEEEECCc
Confidence 3445568999999999998888764 25567788888899999999999999999999876 599999999
Q ss_pred ccc
Q 024408 89 ARE 91 (268)
Q Consensus 89 a~~ 91 (268)
+..
T Consensus 138 g~~ 140 (204)
T COG3642 138 GEF 140 (204)
T ss_pred ccc
Confidence 974
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.11 E-value=5.1e-10 Score=92.20 Aligned_cols=79 Identities=23% Similarity=0.221 Sum_probs=65.8
Q ss_pred cEEEEEEcCCCC-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeC------CCCCeEEec
Q 024408 13 VMVIVTELLSGG-TLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE------DLKTIKLAD 85 (268)
Q Consensus 13 ~~~lV~e~~~gg-sL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~------~~~~~kl~D 85 (268)
..+||||+++|. +|.+++.+......+......++.+++..+..||+.|++|+|+++.|||++. +...+.++|
T Consensus 109 ~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LID 188 (268)
T PRK15123 109 TSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVID 188 (268)
T ss_pred eeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEE
Confidence 478999999875 8999986533334667788899999999999999999999999999999975 124789999
Q ss_pred CCCccc
Q 024408 86 FGLARE 91 (268)
Q Consensus 86 fg~a~~ 91 (268)
|+.+..
T Consensus 189 l~r~~~ 194 (268)
T PRK15123 189 LHRAQI 194 (268)
T ss_pred CCcccc
Confidence 998853
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.10 E-value=5e-10 Score=85.03 Aligned_cols=80 Identities=30% Similarity=0.377 Sum_probs=64.7
Q ss_pred CcEEEEEEcCCC-CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCCe--EEecCCC
Q 024408 12 PVMVIVTELLSG-GTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTI--KLADFGL 88 (268)
Q Consensus 12 ~~~~lV~e~~~g-gsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~~--kl~Dfg~ 88 (268)
..-.|+|||++| .++.+++...............++..+-+.+.-||.++++|+||..+||++..+.+.+ .++|||+
T Consensus 83 ~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgl 162 (229)
T KOG3087|consen 83 YGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGL 162 (229)
T ss_pred CCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecc
Confidence 334799999985 4888998875544344444478899999999999999999999999999997665555 8999999
Q ss_pred ccc
Q 024408 89 ARE 91 (268)
Q Consensus 89 a~~ 91 (268)
+..
T Consensus 163 s~~ 165 (229)
T KOG3087|consen 163 SSV 165 (229)
T ss_pred hhc
Confidence 875
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.03 E-value=5.6e-10 Score=98.56 Aligned_cols=76 Identities=28% Similarity=0.384 Sum_probs=59.1
Q ss_pred cEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHH-HHHHHHHCCCeecCCCCCCEEEeCCCCCeEEecCCCccc
Q 024408 13 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIAR-AMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 91 (268)
Q Consensus 13 ~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~-~l~~lH~~gi~H~Dikp~Nill~~~~~~~kl~Dfg~a~~ 91 (268)
..+|||||++|++|.+....... ..+ ...++..++. .+..+|..|++|+|+||.||+++.+ +.++++|||++..
T Consensus 232 ~~vLvmE~i~G~~L~~~~~~~~~-~~~---~~~ia~~~~~~~l~ql~~~g~~H~D~hPgNilv~~~-g~i~liDfG~~~~ 306 (437)
T TIGR01982 232 ERVLTMEWIDGIPLSDIAALDEA-GLD---RKALAENLARSFLNQVLRDGFFHADLHPGNIFVLKD-GKIIALDFGIVGR 306 (437)
T ss_pred CceEEEEeECCcccccHHHHHhc-CCC---HHHHHHHHHHHHHHHHHhCCceeCCCCcccEEECCC-CcEEEEeCCCeeE
Confidence 45899999999999987654221 132 2345555555 4788999999999999999999888 6999999999975
Q ss_pred cc
Q 024408 92 ES 93 (268)
Q Consensus 92 ~~ 93 (268)
..
T Consensus 307 l~ 308 (437)
T TIGR01982 307 LS 308 (437)
T ss_pred CC
Confidence 44
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.02 E-value=1.1e-10 Score=102.57 Aligned_cols=183 Identities=19% Similarity=0.178 Sum_probs=130.8
Q ss_pred EeecCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCCeEEecC
Q 024408 7 GACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADF 86 (268)
Q Consensus 7 g~~~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~~kl~Df 86 (268)
+|......++--|||+|+++...+.-. ..+++...+.+..|++.++.++|+..++|+|++|+||++.++++..++.||
T Consensus 334 ~W~~~r~~~ip~e~~~~~s~~l~~~~~--~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~ 411 (524)
T KOG0601|consen 334 SWSQLRQGYIPLEFCEGGSSSLRSVTS--QMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDF 411 (524)
T ss_pred CccccccccCchhhhcCcchhhhhHHH--HhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccc
Confidence 444445677999999999988776322 238889999999999999999999999999999999999886557889999
Q ss_pred CCccccccccccccCCCccceec-cccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc
Q 024408 87 GLAREESLTEMMTAETGTYRWMA-PELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN 165 (268)
Q Consensus 87 g~a~~~~~~~~~~~~~gt~~y~a-PE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~ 165 (268)
|.+...... .....+..++.| .|++.. ...+..+.|+++||..+.+.+++..--.... .+......
T Consensus 412 ~~~t~~~~~--~~~~~~~~r~~p~~~~~~e-------~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~----~~~~i~~~ 478 (524)
T KOG0601|consen 412 GCWTRLAFS--SGVFHHIDRLYPIAEILLE-------DYPHLSKADIFSLGLSVDEAITGSPLSESGV----QSLTIRSG 478 (524)
T ss_pred cccccccee--cccccccccccccchhhcc-------ccccccccccccccccccccccCcccCcccc----cceeeecc
Confidence 998641111 112233344442 444432 3566779999999999999999865322211 11222233
Q ss_pred CCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 024408 166 VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 204 (268)
Q Consensus 166 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~ 204 (268)
..+........+..+.+.+...++..||.+.++..+...
T Consensus 479 ~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 479 DTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred cccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 344444555788889999999999999999888776544
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.00 E-value=1.1e-09 Score=84.18 Aligned_cols=76 Identities=29% Similarity=0.336 Sum_probs=58.1
Q ss_pred eeEEEeecCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCC-----eecCCCCCCEEEeCC
Q 024408 3 EQFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI-----IHRDLKPENLLLTED 77 (268)
Q Consensus 3 v~l~g~~~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi-----~H~Dikp~Nill~~~ 77 (268)
.+++++..+ ..++||||++|.++.+. . . ....++.+++.+|..||+.++ +|+|++|.||+++ +
T Consensus 56 P~~~~~~~~-~~~lv~e~i~G~~l~~~-----~--~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~ 123 (170)
T cd05151 56 PKLYYFDPE-TGVLITEFIEGSELLTE-----D--F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-D 123 (170)
T ss_pred CceEEEeCC-CCeEEEEecCCCccccc-----c--c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-C
Confidence 355655533 34899999999887653 0 1 112356799999999999985 9999999999999 4
Q ss_pred CCCeEEecCCCccc
Q 024408 78 LKTIKLADFGLARE 91 (268)
Q Consensus 78 ~~~~kl~Dfg~a~~ 91 (268)
+.++++|||.+..
T Consensus 124 -~~~~liDf~~a~~ 136 (170)
T cd05151 124 -GRLWLIDWEYAGM 136 (170)
T ss_pred -CeEEEEecccccC
Confidence 4799999999864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.98 E-value=2.8e-09 Score=84.85 Aligned_cols=77 Identities=32% Similarity=0.420 Sum_probs=65.9
Q ss_pred cEEEEEEcCCCC-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCC--CCeEEecCCCc
Q 024408 13 VMVIVTELLSGG-TLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL--KTIKLADFGLA 89 (268)
Q Consensus 13 ~~~lV~e~~~gg-sL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~--~~~kl~Dfg~a 89 (268)
..+||+|+++|. +|.+++.+... .+......++.+++..+.-||++|++|+|+++.|||++.+. ..+.++||+-+
T Consensus 91 ~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~ 168 (206)
T PF06293_consen 91 RSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRM 168 (206)
T ss_pred eEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhc
Confidence 358999999874 89999987444 66777888999999999999999999999999999998772 26899999887
Q ss_pred cc
Q 024408 90 RE 91 (268)
Q Consensus 90 ~~ 91 (268)
+.
T Consensus 169 ~~ 170 (206)
T PF06293_consen 169 RF 170 (206)
T ss_pred ee
Confidence 64
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.86 E-value=4.5e-08 Score=87.54 Aligned_cols=126 Identities=17% Similarity=0.213 Sum_probs=93.5
Q ss_pred ceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH-HCCCeecCCCCCCEEEeCCCC
Q 024408 2 REQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLH-SHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 2 ~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH-~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++... .++.+|||+|-+ .-|..++.+ +....+..-+.||+.||.+|| +.+++|++|.-..|+++.. |
T Consensus 71 Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~-----l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~-G 142 (690)
T KOG1243|consen 71 ILSYLDTTEEEGTLYLVTERV--RPLETVLKE-----LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNES-G 142 (690)
T ss_pred hhhhhhhhcccCceEEEeecc--ccHHHHHHH-----hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCC-C
Confidence 45566665 456899999999 478888877 346666777899999999998 5679999999999999999 7
Q ss_pred CeEEecCCCccccccccc-cccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhC
Q 024408 80 TIKLADFGLAREESLTEM-MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHN 145 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g 145 (268)
..||++|.++........ .....-...|..|+.+.. -.-..|.|.||+++++++.|
T Consensus 143 eWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~----------s~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 143 EWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDP----------SEWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cEEEeeeEEEeccccCCcccccchhhhcccChhhcCc----------cccchhhhhHHHHHHHHhCc
Confidence 999999998864333221 111122234666665421 12356999999999999988
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.85 E-value=9.3e-10 Score=98.39 Aligned_cols=150 Identities=17% Similarity=0.276 Sum_probs=105.2
Q ss_pred HHHHHHHHHHHHHHHHHC-CCeecCCCCCCEEEeCCCCCeEEecCCCcccccccc----------ccccCCCccceeccc
Q 024408 43 AIGFALDIARAMECLHSH-GIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE----------MMTAETGTYRWMAPE 111 (268)
Q Consensus 43 ~~~~~~~l~~~l~~lH~~-gi~H~Dikp~Nill~~~~~~~kl~Dfg~a~~~~~~~----------~~~~~~gt~~y~aPE 111 (268)
...=+.+++.|+.++|.. ++||++|.|++|.++.+ +..|++.|+.+....... ...-......|.+||
T Consensus 101 ~f~nl~~v~dgl~flh~sAk~VH~ni~p~~i~~na~-~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE 179 (700)
T KOG2137|consen 101 GFANLGNVADGLAFLHRSAKVVHGNIQPEAIVVNAN-GDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPE 179 (700)
T ss_pred hhhhhhcccchhhhhccCcceeecccchhheeeccC-cceeeccchhhhccCCCCccccccCCCCCChhhccCcccccch
Confidence 333455677899999975 89999999999999998 799999999876322210 111113456799999
Q ss_pred cccccccccCCCCCCCchhhHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHhcc---CCCCCCCCcHHHHHHHHhcccc
Q 024408 112 LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKN---VRPSAENVPEELSIILTSCWKE 187 (268)
Q Consensus 112 ~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll-~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~ 187 (268)
.+.+ ...+.++|+||+|+++|.+. .|+.-+................ ..-....+|+++++=+.+++..
T Consensus 180 ~~~~--------~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~ 251 (700)
T KOG2137|consen 180 YLLG--------TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNG 251 (700)
T ss_pred hhcc--------ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcC
Confidence 9864 55678999999999999988 4555544332222111111111 1112467899999999999999
Q ss_pred CCCCCCCHHHHHHH
Q 024408 188 DPNARPNFTQIIQM 201 (268)
Q Consensus 188 ~p~~Rps~~~~~~~ 201 (268)
+..-||++..+...
T Consensus 252 ~~~~rp~~~~l~~~ 265 (700)
T KOG2137|consen 252 DSAVRPTLDLLLSI 265 (700)
T ss_pred CcccCcchhhhhcc
Confidence 99999977776654
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.82 E-value=9.3e-08 Score=85.93 Aligned_cols=74 Identities=20% Similarity=0.259 Sum_probs=51.4
Q ss_pred cEEEEEEcCCCCCHHHHH--HhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCC---CCeEEec
Q 024408 13 VMVIVTELLSGGTLRKYL--LNMRP--RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL---KTIKLAD 85 (268)
Q Consensus 13 ~~~lV~e~~~ggsL~~~i--~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~---~~~kl~D 85 (268)
..+|||||++|+.|.+.- ...+. ..+.+..+..++.| +...|++|+|+||.||+++.+. ++++++|
T Consensus 235 ~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q-------if~~GffHaDpHPGNIlv~~~g~~~~~i~llD 307 (537)
T PRK04750 235 ETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ-------VFRDGFFHADMHPGNIFVSYDPPENPRYIALD 307 (537)
T ss_pred CceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH-------HHhCCeeeCCCChHHeEEecCCCCCCeEEEEe
Confidence 357999999999998742 22211 01333333333333 4569999999999999998772 2899999
Q ss_pred CCCccccc
Q 024408 86 FGLAREES 93 (268)
Q Consensus 86 fg~a~~~~ 93 (268)
||+....+
T Consensus 308 FGivg~l~ 315 (537)
T PRK04750 308 FGIVGSLN 315 (537)
T ss_pred cceEEECC
Confidence 99997543
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.76 E-value=8.5e-09 Score=80.38 Aligned_cols=73 Identities=30% Similarity=0.402 Sum_probs=49.6
Q ss_pred EEEEEcCC--CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHH-HHHCCCeecCCCCCCEEEeCCCCCeEEecCCCccc
Q 024408 15 VIVTELLS--GGTLRKYLLNMRPRCLDVCVAIGFALDIARAMEC-LHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 91 (268)
Q Consensus 15 ~lV~e~~~--ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~-lH~~gi~H~Dikp~Nill~~~~~~~kl~Dfg~a~~ 91 (268)
+|||||++ |..+..+... . ++......++.+++..+.. +|..|++|+|+.+.||+++++ .+.++|||.+..
T Consensus 82 ~ivME~I~~~G~~~~~l~~~-~---~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~--~~~iIDf~qav~ 155 (188)
T PF01163_consen 82 VIVMEYIGEDGVPLPRLKDV-D---LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG--KVYIIDFGQAVD 155 (188)
T ss_dssp EEEEE--EETTEEGGCHHHC-G---GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT--CEEE--GTTEEE
T ss_pred EEEEEecCCCccchhhHHhc-c---ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc--eEEEEecCccee
Confidence 79999997 5555443322 1 2244556677888885555 579999999999999999986 799999998875
Q ss_pred cc
Q 024408 92 ES 93 (268)
Q Consensus 92 ~~ 93 (268)
..
T Consensus 156 ~~ 157 (188)
T PF01163_consen 156 SS 157 (188)
T ss_dssp TT
T ss_pred cC
Confidence 33
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.71 E-value=5.2e-08 Score=76.98 Aligned_cols=67 Identities=30% Similarity=0.450 Sum_probs=53.9
Q ss_pred cEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCCeEEecCCCccc
Q 024408 13 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 91 (268)
Q Consensus 13 ~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~~kl~Dfg~a~~ 91 (268)
..+|||||++|..|.+... +++ .+...+.+++..+|+.|++|+|.+|.|++++.+ .++++||+..+.
T Consensus 117 ~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~--~i~iID~~~k~~ 183 (229)
T PF06176_consen 117 SYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN--GIRIIDTQGKRM 183 (229)
T ss_pred EEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC--cEEEEECccccc
Confidence 4579999999988876532 333 244567788999999999999999999999966 599999987754
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.70 E-value=2.3e-07 Score=80.97 Aligned_cols=170 Identities=13% Similarity=0.136 Sum_probs=117.7
Q ss_pred CceeEEEeec-----CCcEEEEEEcCC-CCCHHHHHHhcC-------------CCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 024408 1 MREQFIGACK-----EPVMVIVTELLS-GGTLRKYLLNMR-------------PRCLDVCVAIGFALDIARAMECLHSHG 61 (268)
Q Consensus 1 ~~v~l~g~~~-----~~~~~lV~e~~~-ggsL~~~i~~~~-------------~~~~~~~~~~~~~~~l~~~l~~lH~~g 61 (268)
|+|+|-..+. +--+++|++|++ -++|.++-.... +...++..+|.++.|+..||.++|+.|
T Consensus 334 NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG 413 (655)
T KOG3741|consen 334 NVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG 413 (655)
T ss_pred ceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC
Confidence 4566655543 336899999998 457888654321 224888999999999999999999999
Q ss_pred CeecCCCCCCEEEeCCCCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHH
Q 024408 62 IIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWE 141 (268)
Q Consensus 62 i~H~Dikp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ 141 (268)
+..+-|.+.+|+++.++ ++++...|+......+. .+ -+ +--.+.|.-.||.+++.
T Consensus 414 LAck~L~~~kIlv~G~~-RIriS~C~i~Dvl~~d~-----------~~--~l-----------e~~Qq~D~~~lG~ll~a 468 (655)
T KOG3741|consen 414 LACKTLDLKKILVTGKM-RIRISGCGIMDVLQEDP-----------TE--PL-----------ESQQQNDLRDLGLLLLA 468 (655)
T ss_pred ceeecccHhHeEeeCcc-eEEEecccceeeecCCC-----------Cc--ch-----------hHHhhhhHHHHHHHHHH
Confidence 99999999999999885 88887766654322221 01 11 11236799999999999
Q ss_pred HHhCCCC-CCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 024408 142 LLHNKLP-FEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 203 (268)
Q Consensus 142 ll~g~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~ 203 (268)
|.||..- +..... +... .......++.++++++......++++ -++.+++.++-
T Consensus 469 LAt~~~ns~~~d~~-~~s~------~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~~ 523 (655)
T KOG3741|consen 469 LATGTENSNRTDST-QSSH------LTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMIG 523 (655)
T ss_pred Hhhcccccccccch-HHHH------HHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHHH
Confidence 9998542 222111 1110 11124467788999999998888887 56777776543
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.53 E-value=2.4e-07 Score=74.21 Aligned_cols=87 Identities=26% Similarity=0.403 Sum_probs=64.8
Q ss_pred ceeEEEeecC----CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH------------------
Q 024408 2 REQFIGACKE----PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS------------------ 59 (268)
Q Consensus 2 ~v~l~g~~~~----~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~------------------ 59 (268)
+.++++++.+ +..++||||++|.+|.+.+.. ..++..+...++.+++.+|..||+
T Consensus 59 vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~ 135 (223)
T cd05154 59 VPKVLALCEDPSVLGTPFYVMERVDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYL 135 (223)
T ss_pred CCCEEEECCCCCccCCceEEEEEeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchH
Confidence 4556777754 356899999999988776532 126677777777777777777773
Q ss_pred --------------------------------------CCCeecCCCCCCEEEeCC-CCCeEEecCCCccc
Q 024408 60 --------------------------------------HGIIHRDLKPENLLLTED-LKTIKLADFGLARE 91 (268)
Q Consensus 60 --------------------------------------~gi~H~Dikp~Nill~~~-~~~~kl~Dfg~a~~ 91 (268)
.+++|+|+++.||+++.+ .+.+.++||+.+..
T Consensus 136 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 136 ERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 246899999999999883 24678999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.52 E-value=6.4e-07 Score=70.54 Aligned_cols=78 Identities=15% Similarity=0.140 Sum_probs=65.0
Q ss_pred cEEEEEEcCCC-CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCC--eEEecCCCc
Q 024408 13 VMVIVTELLSG-GTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT--IKLADFGLA 89 (268)
Q Consensus 13 ~~~lV~e~~~g-gsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~--~kl~Dfg~a 89 (268)
..+||+|-++| .||.+++.+..-...+......++.+++..+.-||+.|+.|+|+.+.||+++.+ +. +.++||.-+
T Consensus 99 rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~-g~~~v~lIDlEk~ 177 (216)
T PRK09902 99 RALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTE-GKAEAGFLDLEKS 177 (216)
T ss_pred EEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCC-CCeeEEEEEhhcc
Confidence 46899998742 589998876443346788888999999999999999999999999999999855 35 999999877
Q ss_pred cc
Q 024408 90 RE 91 (268)
Q Consensus 90 ~~ 91 (268)
+.
T Consensus 178 r~ 179 (216)
T PRK09902 178 RR 179 (216)
T ss_pred ch
Confidence 64
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.13 E-value=4.8e-06 Score=67.58 Aligned_cols=72 Identities=29% Similarity=0.307 Sum_probs=56.3
Q ss_pred CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCCeEEecCCCccc
Q 024408 12 PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 91 (268)
Q Consensus 12 ~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~~kl~Dfg~a~~ 91 (268)
+.-.+||||++|--|...- ++.+..-.++..|+.-+..+-..|++|+|+++-||+++++ |.+.++||--+..
T Consensus 180 nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~d-g~~~vIDwPQ~v~ 251 (304)
T COG0478 180 NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTED-GDIVVIDWPQAVP 251 (304)
T ss_pred ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecC-CCEEEEeCccccc
Confidence 3458999999987665432 2345555667777777777779999999999999999998 6899999976654
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.09 E-value=1.2e-05 Score=62.92 Aligned_cols=84 Identities=21% Similarity=0.263 Sum_probs=67.1
Q ss_pred ceeEEEeecCCcEEEEEEcCCCCCHHHH---HHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCCCCEEEe
Q 024408 2 REQFIGACKEPVMVIVTELLSGGTLRKY---LLNMRPRCLDVCVAIGFALDIARAMECLHS---HGIIHRDLKPENLLLT 75 (268)
Q Consensus 2 ~v~l~g~~~~~~~~lV~e~~~ggsL~~~---i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~gi~H~Dikp~Nill~ 75 (268)
+.+++|.|.+ ++|.||...+++... +.+.. ..+|..+.+++.+++..+++++. ..+.-.|++++|+-++
T Consensus 22 ~pk~lG~CG~---~~v~E~~~~~~~~~~~~~l~~~~--~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcDv~~~nfgv~ 96 (188)
T PF12260_consen 22 FPKLLGSCGR---FYVVEYVGAGSLYGIYRPLSQFL--QSPWEQRAKIALQLLELLEELDHGPLGFFYLCDVSPDNFGVN 96 (188)
T ss_pred CCCeeeECCC---EEEEEeecCcccccccccccccc--ccCHHHHHHHHHHHHHHHHHHhcCCCCcEEEeecchHHeEEe
Confidence 5789999954 678999976666431 11111 27899999999999999999998 3577799999999999
Q ss_pred CCCCCeEEecCCCccc
Q 024408 76 EDLKTIKLADFGLARE 91 (268)
Q Consensus 76 ~~~~~~kl~Dfg~a~~ 91 (268)
++ +++|++|.+.+..
T Consensus 97 ~~-~~lk~iDld~v~~ 111 (188)
T PF12260_consen 97 DD-GRLKLIDLDDVFV 111 (188)
T ss_pred CC-CcEEEEechhcch
Confidence 88 6999999988753
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.89 E-value=9.4e-05 Score=70.80 Aligned_cols=170 Identities=15% Similarity=0.141 Sum_probs=112.9
Q ss_pred EEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCC---CEEEeCCCCCeEEe--cCCCc
Q 024408 15 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPE---NLLLTEDLKTIKLA--DFGLA 89 (268)
Q Consensus 15 ~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~---Nill~~~~~~~kl~--Dfg~a 89 (268)
.+..++|.+.++...++.-.. ++..+.+.+..++.+||.++|+....|.-+... +.-.+.. +..... ||+..
T Consensus 262 ~v~~~~~s~~~~~~~~q~v~~--i~~~~~r~~~~~~~~GL~~~h~~~l~~v~L~~s~~~~~~~~~e-~~~~~sl~~~~ss 338 (1351)
T KOG1035|consen 262 DVLQEICSKVELRSLLQSVGS--IPLETLRILHQKLLEGLAYLHSLSLEHVVLSASSSKESTVDGE-GVVAISLSDFDSS 338 (1351)
T ss_pred HHHHhhcCccchHHHHhhccc--cCHHHHHHHHHHHhhhHHHHHHhccceeEEecccccccccCcc-ceeecchhhhccc
Confidence 355678888888888877555 899999999999999999999996555444443 2222222 244444 88877
Q ss_pred cccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCC
Q 024408 90 REESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS 169 (268)
Q Consensus 90 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 169 (268)
..............+..+.++|.... .........|+|.+|.....+..|..+-........ . .
T Consensus 339 ~~l~d~~~~~~~~~~~~~~~~e~~~~------~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~~~~~--------~--l 402 (1351)
T KOG1035|consen 339 KPLPDNEKSFSDLLAEIRNADEDLKE------NTAKKSRLTDLWCLGLLLLQLSQGEDISEKSAVPVS--------L--L 402 (1351)
T ss_pred ccCCCcccchhhcCcccccccccccc------ccchhhhhhHHHHHHHHHhhhhhcCcccccccchhh--------h--h
Confidence 76555544444455566777776643 123344557999999999999887654221110000 0 0
Q ss_pred CCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 024408 170 AENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 203 (268)
Q Consensus 170 ~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~ 203 (268)
.........+...+|+..+.++|++..+++.+.-
T Consensus 403 ~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f 436 (1351)
T KOG1035|consen 403 DVLSTSELLDALPKCLDEDSEERLSALELLTHPF 436 (1351)
T ss_pred ccccchhhhhhhhhhcchhhhhccchhhhhhchh
Confidence 1111126788999999999999999999999743
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.89 E-value=3.4e-05 Score=62.00 Aligned_cols=74 Identities=24% Similarity=0.270 Sum_probs=55.0
Q ss_pred EEEEEEcCCCCCH--HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEEeCCCCCeEEecCCCcc
Q 024408 14 MVIVTELLSGGTL--RKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLTEDLKTIKLADFGLAR 90 (268)
Q Consensus 14 ~~lV~e~~~ggsL--~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~gi~H~Dikp~Nill~~~~~~~kl~Dfg~a~ 90 (268)
-.|||||+. ..- .-.|.. -.+...++..+..++++.+.-|-. .|++|+||+.-|||+.. +.+.++|||-|.
T Consensus 141 nVLvMEfIg-~~g~pAP~LkD---v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~~--~~p~iID~~QaV 214 (268)
T COG1718 141 NVLVMEFIG-DDGLPAPRLKD---VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVHD--GEPYIIDVSQAV 214 (268)
T ss_pred CeEEEEecc-CCCCCCCCccc---CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEEC--CeEEEEECcccc
Confidence 379999994 331 011111 124444688888999999998887 89999999999999994 489999999887
Q ss_pred ccc
Q 024408 91 EES 93 (268)
Q Consensus 91 ~~~ 93 (268)
...
T Consensus 215 ~~~ 217 (268)
T COG1718 215 TID 217 (268)
T ss_pred ccC
Confidence 543
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.00091 Score=60.22 Aligned_cols=78 Identities=22% Similarity=0.286 Sum_probs=55.9
Q ss_pred CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCCeEEecCCCccc
Q 024408 12 PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 91 (268)
Q Consensus 12 ~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~~kl~Dfg~a~~ 91 (268)
+..+|+|||++|-.+.+...-.. ..++...+.....++. +..+-..|+.|.|.+|.||++..+ +++.+.|||+...
T Consensus 239 ~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f--~~q~~~dgffHaDpHpGNi~v~~~-g~i~~lDfGi~g~ 314 (517)
T COG0661 239 TRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF--LRQLLRDGFFHADPHPGNILVRSD-GRIVLLDFGIVGR 314 (517)
T ss_pred CCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH--HHHHHhcCccccCCCccceEEecC-CcEEEEcCcceec
Confidence 45689999999999998753222 2266444433322221 344445899999999999999999 7999999999875
Q ss_pred cc
Q 024408 92 ES 93 (268)
Q Consensus 92 ~~ 93 (268)
..
T Consensus 315 l~ 316 (517)
T COG0661 315 LD 316 (517)
T ss_pred CC
Confidence 43
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.00037 Score=56.87 Aligned_cols=30 Identities=20% Similarity=0.215 Sum_probs=25.7
Q ss_pred CCeecCCCCCCEEEeCCCCCeEEecCCCccc
Q 024408 61 GIIHRDLKPENLLLTEDLKTIKLADFGLARE 91 (268)
Q Consensus 61 gi~H~Dikp~Nill~~~~~~~kl~Dfg~a~~ 91 (268)
.++|+|+.|.||+++++ +.+.|+||+.+..
T Consensus 164 ~l~HgD~~~~Nil~~~~-~~~~iIDwe~a~~ 193 (244)
T cd05150 164 VVTHGDACLPNIIVDPG-KFSGFIDLGRLGV 193 (244)
T ss_pred EEECCCCCCccEEEeCC-cEEEEEEcccccc
Confidence 58999999999999986 4678999988753
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.0006 Score=55.04 Aligned_cols=29 Identities=21% Similarity=0.219 Sum_probs=25.3
Q ss_pred CCeecCCCCCCEEEeCCCCCeEEecCCCccc
Q 024408 61 GIIHRDLKPENLLLTEDLKTIKLADFGLARE 91 (268)
Q Consensus 61 gi~H~Dikp~Nill~~~~~~~kl~Dfg~a~~ 91 (268)
.++|+|++|.||+++++ + +.++||+.+..
T Consensus 154 ~~~HgD~~~~Nii~~~~-~-~~iIDwe~a~~ 182 (226)
T TIGR02172 154 TCLHGDFQIGNLITSGK-G-TYWIDLGDFGY 182 (226)
T ss_pred ceEecCCCCCcEEEcCC-C-cEEEechhcCc
Confidence 47899999999999887 4 89999998864
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.49 E-value=1.6e-05 Score=71.46 Aligned_cols=200 Identities=17% Similarity=0.112 Sum_probs=121.2
Q ss_pred eEEEee-cCCcEEEEEEcCCCC-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCCe
Q 024408 4 QFIGAC-KEPVMVIVTELLSGG-TLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTI 81 (268)
Q Consensus 4 ~l~g~~-~~~~~~lV~e~~~gg-sL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~~ 81 (268)
..++-+ .+++.+++|+++.++ +-...+.. ....+.+-+...+++.-+.+++++|+.--+|+| ||+..+. ..
T Consensus 298 ~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~-se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~~--~~ 370 (829)
T KOG0576|consen 298 RYLEDYDGEDYLWIPMRICSTGRSSALEMTV-SEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSEE--EV 370 (829)
T ss_pred cccccCCcccccchhhhhhcCCccccccCCh-hhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccccc--cc
Confidence 334444 345889999999876 22222211 111255566667778888899999998778988 8887764 68
Q ss_pred EEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 024408 82 KLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAA 161 (268)
Q Consensus 82 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~ 161 (268)
+..||+............+..+++.+++||+... ..+....|+|++|.-..++--|.+|-..... .....
T Consensus 371 ~~~~~~v~~~L~~~~~~~t~~~~~~~~~pev~~~--------~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~~--~~~~~ 440 (829)
T KOG0576|consen 371 KLLDFAVPPQLTRTMKPRTAIGTPEPLAPEVIQE--------NTIDGCPDSGSLAVSAIQMAPGLPPRSSPPA--VLPMI 440 (829)
T ss_pred ccccccCCcccCcccccccCCCCCCCCCchhhcc--------cccccCCCccCCCcchhhcCCCCCCCCCCcc--ccCCC
Confidence 9999999886665555567789999999998754 5567788999999877777767665432100 00000
Q ss_pred HhccCCCCC---CCCcHHHH-HHHHhccccCCCCCCCHHHHHHHHHHhHhhcCCCCCCCCCcccc
Q 024408 162 AFKNVRPSA---ENVPEELS-IILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIPHRIFN 222 (268)
Q Consensus 162 ~~~~~~~~~---~~~~~~l~-~li~~~l~~~p~~Rps~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (268)
......+.. ..+.+... ++...|+...|..|+......-+ +.+...+.-.-....|+.+
T Consensus 441 g~~p~s~~L~~~~aw~~~~~~~~~~~~~~g~P~~pkv~mgacfs--KvfngCpl~i~~aaswIhp 503 (829)
T KOG0576|consen 441 GNGPNSPMLTDKSAWSPVFHRDFPAPCLNGLPPTPKVHMGACFS--KVFNGCPLRIHCAASWIHP 503 (829)
T ss_pred CCCCCccccchhhhcCcccccCCcccccCCCCCCCcchhhHHHH--HHhccCcccceecccccCc
Confidence 000000000 01111112 35566777778777776655443 5555544444444444433
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.00039 Score=62.47 Aligned_cols=78 Identities=23% Similarity=0.278 Sum_probs=54.1
Q ss_pred CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHH-HHHHHHCCCeecCCCCCCEEEeC---CCCCeEEecCC
Q 024408 12 PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARA-MECLHSHGIIHRDLKPENLLLTE---DLKTIKLADFG 87 (268)
Q Consensus 12 ~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~-l~~lH~~gi~H~Dikp~Nill~~---~~~~~kl~Dfg 87 (268)
...+|+|||++|..+.|.-.- ....++...+. ..+.++ ++.+=..|++|+|=+|.||++.. ....+.+.|||
T Consensus 275 t~RVLtME~~~G~~i~Dl~~i-~~~gi~~~~i~---~~l~~~~~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhG 350 (538)
T KOG1235|consen 275 TKRVLTMEYVDGIKINDLDAI-DKRGISPHDIL---NKLVEAYLEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHG 350 (538)
T ss_pred cceEEEEEecCCccCCCHHHH-HHcCCCHHHHH---HHHHHHHHHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEccc
Confidence 457999999999988764321 12226666444 344443 23344678999999999999983 33689999999
Q ss_pred Cccccc
Q 024408 88 LAREES 93 (268)
Q Consensus 88 ~a~~~~ 93 (268)
+.....
T Consensus 351 l~~~is 356 (538)
T KOG1235|consen 351 LYAVIS 356 (538)
T ss_pred cccccc
Confidence 987543
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.0011 Score=53.73 Aligned_cols=31 Identities=32% Similarity=0.476 Sum_probs=25.3
Q ss_pred CCCeecCCCCCCEEEeCCCCCeEEecCCCccc
Q 024408 60 HGIIHRDLKPENLLLTEDLKTIKLADFGLARE 91 (268)
Q Consensus 60 ~gi~H~Dikp~Nill~~~~~~~kl~Dfg~a~~ 91 (268)
.+++|+|+++.||+++++ +..-|+||+.+..
T Consensus 164 ~~l~HGD~~~~Nvlv~~~-~i~giIDw~~a~~ 194 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDG-RLSAVIDFGCLGV 194 (235)
T ss_pred ceEEeCCCCCCcEEEECC-CEEEEEeCcccCc
Confidence 358999999999999865 3456999998754
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.15 E-value=0.0022 Score=61.59 Aligned_cols=31 Identities=29% Similarity=0.545 Sum_probs=25.0
Q ss_pred CCeecCCCCCCEEEeCCCCC-eEEecCCCccc
Q 024408 61 GIIHRDLKPENLLLTEDLKT-IKLADFGLARE 91 (268)
Q Consensus 61 gi~H~Dikp~Nill~~~~~~-~kl~Dfg~a~~ 91 (268)
.++|+|+++.|++++.+.+. +-|+||+++..
T Consensus 226 ~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 226 GIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred ceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 59999999999999853234 56999999864
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.14 E-value=3.5e-05 Score=75.60 Aligned_cols=128 Identities=13% Similarity=0.074 Sum_probs=94.5
Q ss_pred cEEEEEEcCCCCCHHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHHC-----CCeecCCCCCCEEEeCCCCCeEEec
Q 024408 13 VMVIVTELLSGGTLRKYLLNMRPR--CLDVCVAIGFALDIARAMECLHSH-----GIIHRDLKPENLLLTEDLKTIKLAD 85 (268)
Q Consensus 13 ~~~lV~e~~~ggsL~~~i~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~-----gi~H~Dikp~Nill~~~~~~~kl~D 85 (268)
..+.+++|+.+|.+.+.|.+.-.+ ...+.-+.....+.+.+..-+|+. -.+|+++|+-|.+|..+. ++++.+
T Consensus 1305 ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny-~v~~gk 1383 (2724)
T KOG1826|consen 1305 EEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNY-NVKLGK 1383 (2724)
T ss_pred HHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCC-cccccc
Confidence 457889999999999998764332 233333433334446677777754 278999999999999884 899999
Q ss_pred CCCcc-ccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 024408 86 FGLAR-EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPF 149 (268)
Q Consensus 86 fg~a~-~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~ 149 (268)
+|+.+ ............+++.|+.++..+. -.++.++|+|..|+.+|....|..+|
T Consensus 1384 ~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~--------ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1384 GGLDKIKNPVLSFFGLELCSPIYVLQLIKNE--------IKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred cccccccCchHhhhhhhhCCHHHHHHHHHHH--------HhhhhHHHHHHHHHHHHHHhcccHHH
Confidence 99999 4333444455677888999988764 45666799999999999988776665
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.0051 Score=48.48 Aligned_cols=81 Identities=26% Similarity=0.344 Sum_probs=55.9
Q ss_pred ceeEEEeecCC-cEEEEEEcCCC------CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEE
Q 024408 2 REQFIGACKEP-VMVIVTELLSG------GTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL 74 (268)
Q Consensus 2 ~v~l~g~~~~~-~~~lV~e~~~g------gsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill 74 (268)
+.+++|+.+.+ -..+|+|.+.+ .+|.+++.+. . ++. ... ..+-.-..+|-+.+|+.+|++|.||++
T Consensus 79 i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~-~--~~~-~~~---~~L~~f~~~l~~~~Iv~~dl~~~NIv~ 151 (199)
T PF10707_consen 79 IPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG-G--LTE-ELR---QALDEFKRYLLDHHIVIRDLNPHNIVV 151 (199)
T ss_pred cccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC-C--ccH-HHH---HHHHHHHHHHHHcCCeecCCCcccEEE
Confidence 46789999654 57889987742 2688888542 2 555 333 344445678889999999999999999
Q ss_pred eCCC--C-CeEEec-CCCc
Q 024408 75 TEDL--K-TIKLAD-FGLA 89 (268)
Q Consensus 75 ~~~~--~-~~kl~D-fg~a 89 (268)
.... . .+.|+| ||..
T Consensus 152 ~~~~~~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 152 QRRDSGEFRLVLIDGLGEK 170 (199)
T ss_pred EecCCCceEEEEEeCCCCc
Confidence 6431 2 577887 4443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.0033 Score=50.41 Aligned_cols=32 Identities=34% Similarity=0.413 Sum_probs=20.8
Q ss_pred CCCeecCCCCCCEEEeCCCCCeEEecCCCccc
Q 024408 60 HGIIHRDLKPENLLLTEDLKTIKLADFGLARE 91 (268)
Q Consensus 60 ~gi~H~Dikp~Nill~~~~~~~kl~Dfg~a~~ 91 (268)
.+++|+|+.+.||+++...+.+.|+||+.+..
T Consensus 166 ~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 166 PVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp EEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred cEEEEeccccccceeeeccceeEEEecccceE
Confidence 36999999999999993324667999987753
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.86 E-value=0.00098 Score=55.95 Aligned_cols=71 Identities=27% Similarity=0.340 Sum_probs=53.8
Q ss_pred CCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCCeEEecCCCcc
Q 024408 11 EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 90 (268)
Q Consensus 11 ~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~~kl~Dfg~a~ 90 (268)
...-++|||+++|-.|.+.-.- .+.. .+...++.-+.-|-.+|++|+|..--||+++++ +.++++||--..
T Consensus 180 ~~RH~Vvmelv~g~Pl~~v~~v-----~d~~---~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd-~~i~vIDFPQmv 250 (465)
T KOG2268|consen 180 HNRHCVVMELVDGYPLRQVRHV-----EDPP---TLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDD-DKIVVIDFPQMV 250 (465)
T ss_pred ccceeeHHHhhcccceeeeeec-----CChH---HHHHHHHHHHHHHHHcCceecccchheeEEecC-CCEEEeechHhh
Confidence 3456899999998887664211 2233 345566666788899999999999999999987 589999997553
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.66 E-value=0.0039 Score=53.20 Aligned_cols=71 Identities=18% Similarity=0.253 Sum_probs=57.8
Q ss_pred CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCCEEEeCCCCCeEEecCCCcc
Q 024408 12 PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH-GIIHRDLKPENLLLTEDLKTIKLADFGLAR 90 (268)
Q Consensus 12 ~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-gi~H~Dikp~Nill~~~~~~~kl~Dfg~a~ 90 (268)
.+.|++|++. |++|.-. . . ...+++..++.+.+..+.-+..+ -.-|||+.-.||+|+ + |++.|+||-+++
T Consensus 299 ~y~yl~~kdh-gt~is~i-k---~--~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~-GnvtLIDfklsR 369 (488)
T COG5072 299 LYLYLHFKDH-GTPISII-K---A--DRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-E-GNVTLIDFKLSR 369 (488)
T ss_pred eEEEEEEecC-Cceeeee-e---c--ccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-c-CceEEEEeeeee
Confidence 3778999998 6776432 1 1 56788899999999888888765 578999999999999 4 699999999998
Q ss_pred c
Q 024408 91 E 91 (268)
Q Consensus 91 ~ 91 (268)
.
T Consensus 370 l 370 (488)
T COG5072 370 L 370 (488)
T ss_pred c
Confidence 5
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.40 E-value=0.0075 Score=50.98 Aligned_cols=33 Identities=24% Similarity=0.454 Sum_probs=28.2
Q ss_pred CCeecCCCCCCEEEeCCCCCeEEecCCCcccccc
Q 024408 61 GIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 94 (268)
Q Consensus 61 gi~H~Dikp~Nill~~~~~~~kl~Dfg~a~~~~~ 94 (268)
.++|+|+++.|++++++ +.+-|+||+++...++
T Consensus 199 ~lvHGD~~~gNlii~~~-~~~gVlDwe~~~lGDP 231 (321)
T COG3173 199 VLVHGDYRPGNLIIDPG-RPTGVLDWELATLGDP 231 (321)
T ss_pred eeeeCCcccCCEEEeCC-CeeEEEeccccccCCc
Confidence 58999999999999988 4588999999976443
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.38 E-value=0.0079 Score=53.61 Aligned_cols=72 Identities=14% Similarity=0.082 Sum_probs=46.5
Q ss_pred chhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCC-----------CCCCcHHHHHHHHhccccCCCCCCCHH
Q 024408 128 HKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS-----------AENVPEELSIILTSCWKEDPNARPNFT 196 (268)
Q Consensus 128 ~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~l~~li~~~l~~~p~~Rps~~ 196 (268)
+++|||++|.++.++.-|...+......+...........+. .-.++..+..+...|+-..|..||...
T Consensus 110 pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~ 189 (725)
T KOG1093|consen 110 PKSDVWSLGFIILELYLGISLEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPM 189 (725)
T ss_pred cchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchh
Confidence 589999999999999988776665554443332222222111 112455677788889988888887554
Q ss_pred HHH
Q 024408 197 QII 199 (268)
Q Consensus 197 ~~~ 199 (268)
++.
T Consensus 190 ~~~ 192 (725)
T KOG1093|consen 190 ELS 192 (725)
T ss_pred HHh
Confidence 443
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=95.73 E-value=0.021 Score=48.32 Aligned_cols=30 Identities=40% Similarity=0.652 Sum_probs=26.3
Q ss_pred CCCeecCCCCCCEEEeCCCCCeEEecCCCcc
Q 024408 60 HGIIHRDLKPENLLLTEDLKTIKLADFGLAR 90 (268)
Q Consensus 60 ~gi~H~Dikp~Nill~~~~~~~kl~Dfg~a~ 90 (268)
.+++|+|+++.||+++.+ +...|+||+.+.
T Consensus 187 ~~l~HgD~~~~Nvl~~~~-~~~~vIDfd~~~ 216 (307)
T TIGR00938 187 RGVIHADLFPDNVLFDGD-SVKGVIDFYFAC 216 (307)
T ss_pred CccCCCCCCcCcEEEECC-ceEEEeeccccc
Confidence 589999999999999887 456899998875
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=95.44 E-value=0.02 Score=46.25 Aligned_cols=31 Identities=26% Similarity=0.439 Sum_probs=26.3
Q ss_pred CCeecCCCCCCEEEeCCCCCeEEecCCCccc
Q 024408 61 GIIHRDLKPENLLLTEDLKTIKLADFGLARE 91 (268)
Q Consensus 61 gi~H~Dikp~Nill~~~~~~~kl~Dfg~a~~ 91 (268)
+++|+|+++.||+++++.+.+.++||..|..
T Consensus 171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred EEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 6999999999999997225799999988753
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.41 E-value=0.036 Score=47.08 Aligned_cols=31 Identities=35% Similarity=0.568 Sum_probs=26.0
Q ss_pred CCCeecCCCCCCEEEeCCCCCeEEecCCCccc
Q 024408 60 HGIIHRDLKPENLLLTEDLKTIKLADFGLARE 91 (268)
Q Consensus 60 ~gi~H~Dikp~Nill~~~~~~~kl~Dfg~a~~ 91 (268)
.|++|+|+++.||+++.+ +..-++||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~~-~~~~iIDf~~~~~ 217 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGD-RLSGFIDFYFACN 217 (319)
T ss_pred cccCCCCCCCCcEEEECC-ceEEEEecccccC
Confidence 389999999999999865 3457999998863
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.35 E-value=0.043 Score=46.31 Aligned_cols=29 Identities=28% Similarity=0.573 Sum_probs=25.2
Q ss_pred CCCeecCCCCCCEEEeCCCCCeEEecCCCcc
Q 024408 60 HGIIHRDLKPENLLLTEDLKTIKLADFGLAR 90 (268)
Q Consensus 60 ~gi~H~Dikp~Nill~~~~~~~kl~Dfg~a~ 90 (268)
.+++|+|+++.||+++.+ .+.++||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~--~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKDN--EVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeCC--cEEEEECcccc
Confidence 478999999999999874 68999998775
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=95.29 E-value=0.032 Score=46.82 Aligned_cols=31 Identities=35% Similarity=0.540 Sum_probs=26.3
Q ss_pred CCCeecCCCCCCEEEeCCCCCeEEecCCCccc
Q 024408 60 HGIIHRDLKPENLLLTEDLKTIKLADFGLARE 91 (268)
Q Consensus 60 ~gi~H~Dikp~Nill~~~~~~~kl~Dfg~a~~ 91 (268)
.+++|+|++|.||+++++ +.+.|+||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~-~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGD-ELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCC-ceEEEeehhhhcC
Confidence 479999999999999986 4568999988753
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=95.26 E-value=0.035 Score=46.06 Aligned_cols=47 Identities=32% Similarity=0.357 Sum_probs=35.1
Q ss_pred HHHHHHHHHHHHHHHHC--CCeecCCCCCCEEEeCCCCCeEEecCCCccc
Q 024408 44 IGFALDIARAMECLHSH--GIIHRDLKPENLLLTEDLKTIKLADFGLARE 91 (268)
Q Consensus 44 ~~~~~~l~~~l~~lH~~--gi~H~Dikp~Nill~~~~~~~kl~Dfg~a~~ 91 (268)
.+.+..+-.++.-.+.. -++|+|+.|+|++.++. +.++|+||..|..
T Consensus 135 ~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~-~~l~LIDWEyAg~ 183 (269)
T COG0510 135 RKKLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDK-GGLFLIDWEYAGL 183 (269)
T ss_pred HHHHHHHHHHhhhcCCCceeeecCCCCccceEEcCC-CcEEEEecccCCC
Confidence 33444555555555544 58999999999999986 5899999988864
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=94.93 E-value=0.074 Score=40.95 Aligned_cols=67 Identities=27% Similarity=0.303 Sum_probs=46.9
Q ss_pred EEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC-CCCEEEeCCCCCeEEecCCCccc
Q 024408 15 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLK-PENLLLTEDLKTIKLADFGLARE 91 (268)
Q Consensus 15 ~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dik-p~Nill~~~~~~~kl~Dfg~a~~ 91 (268)
++.|||++|-.|.++-.. .+..+ ...+++.-.-|-..||-|+.|. |...++.++ +.+.|+||..|+.
T Consensus 88 ~i~me~i~G~~L~~~~~~-----~~rk~----l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~-~~~~iIDFd~At~ 155 (201)
T COG2112 88 FIRMEYIDGRPLGKLEIG-----GDRKH----LLRVLEKAYKLDRLGIEHGELSRPWKNVLVND-RDVYIIDFDSATF 155 (201)
T ss_pred hhhhhhhcCcchhhhhhc-----ccHHH----HHHHHHHHHHHHHhccchhhhcCCceeEEecC-CcEEEEEccchhh
Confidence 455999998898876532 12222 3456666667778899999998 444444444 3799999999874
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.85 E-value=0.029 Score=43.64 Aligned_cols=31 Identities=23% Similarity=0.433 Sum_probs=26.0
Q ss_pred CCeecCCCCCCEEEeCCCCCeEEecCCCccccc
Q 024408 61 GIIHRDLKPENLLLTEDLKTIKLADFGLAREES 93 (268)
Q Consensus 61 gi~H~Dikp~Nill~~~~~~~kl~Dfg~a~~~~ 93 (268)
..+|+|+.|.|++++++ .++++||+.+...+
T Consensus 78 ~p~H~D~~~~N~~~~~~--~~~lIDwe~a~~gD 108 (188)
T PRK10271 78 APLHMDVHAGNLVHSAS--GLRLIDWEYAGDGD 108 (188)
T ss_pred eeecCCCCCccEEEECC--CEEEEeCCcccCCC
Confidence 46999999999999876 48999999987533
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=94.73 E-value=0.023 Score=47.82 Aligned_cols=31 Identities=35% Similarity=0.453 Sum_probs=26.2
Q ss_pred CCeecCCCCCCEEEeCC---CCCeEEecCCCccc
Q 024408 61 GIIHRDLKPENLLLTED---LKTIKLADFGLARE 91 (268)
Q Consensus 61 gi~H~Dikp~Nill~~~---~~~~kl~Dfg~a~~ 91 (268)
+++|+|+.+.||+++.+ .+.+.++||+.+..
T Consensus 180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 58999999999999873 24799999988853
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=94.59 E-value=0.045 Score=47.14 Aligned_cols=31 Identities=29% Similarity=0.583 Sum_probs=26.6
Q ss_pred CCeecCCCCCCEEEeCCCCCeEEecCCCccc
Q 024408 61 GIIHRDLKPENLLLTEDLKTIKLADFGLARE 91 (268)
Q Consensus 61 gi~H~Dikp~Nill~~~~~~~kl~Dfg~a~~ 91 (268)
.++|+|+++.||++++..+.+.++||..+..
T Consensus 201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 201 GFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred eEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 5899999999999986435799999988863
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=94.16 E-value=0.044 Score=45.00 Aligned_cols=29 Identities=31% Similarity=0.512 Sum_probs=25.5
Q ss_pred CCeecCCCCCCEEEeCCCCCeEEecCCCccc
Q 024408 61 GIIHRDLKPENLLLTEDLKTIKLADFGLARE 91 (268)
Q Consensus 61 gi~H~Dikp~Nill~~~~~~~kl~Dfg~a~~ 91 (268)
.++|+|+.|.||+++++ + +.++||+.+..
T Consensus 147 ~l~H~Dl~~~Nil~~~~-~-~~lIDwE~a~~ 175 (256)
T TIGR02721 147 APLHMDVHAYNLVVTPQ-G-LKLIDWEYASD 175 (256)
T ss_pred eeecCCCCcCcEEEeCC-C-CEEEeccccCc
Confidence 58999999999999886 3 78999998864
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.87 E-value=0.098 Score=44.36 Aligned_cols=37 Identities=27% Similarity=0.313 Sum_probs=25.9
Q ss_pred HHHHHHHHHHHHHHHHHH----HCCCeecCCCCCCEEEeCC
Q 024408 41 CVAIGFALDIARAMECLH----SHGIIHRDLKPENLLLTED 77 (268)
Q Consensus 41 ~~~~~~~~~l~~~l~~lH----~~gi~H~Dikp~Nill~~~ 77 (268)
+-+..++.|++.-.-.+- ..+.+|-||||+|||+-++
T Consensus 279 ~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds 319 (444)
T PHA03111 279 EYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDS 319 (444)
T ss_pred HHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecC
Confidence 345567777776554442 3469999999999999543
|
|
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=93.75 E-value=0.16 Score=39.95 Aligned_cols=32 Identities=28% Similarity=0.390 Sum_probs=25.9
Q ss_pred CCCeecCCCCCCEEEeCCC-C---CeEEecCCCccc
Q 024408 60 HGIIHRDLKPENLLLTEDL-K---TIKLADFGLARE 91 (268)
Q Consensus 60 ~gi~H~Dikp~Nill~~~~-~---~~kl~Dfg~a~~ 91 (268)
..++|||+.+.|+++..+. + .+.++||..+..
T Consensus 120 ~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~~ 155 (196)
T smart00587 120 NVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSHY 155 (196)
T ss_pred eEEeeCCCCccceeeccCCCCCccceEEEecccCCc
Confidence 4689999999999997542 2 588999988864
|
subfamily of choline kinases |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.64 E-value=0.11 Score=44.42 Aligned_cols=30 Identities=40% Similarity=0.618 Sum_probs=25.3
Q ss_pred CeecCCCCCCEEEeCCCCCeEEecCCCccc
Q 024408 62 IIHRDLKPENLLLTEDLKTIKLADFGLARE 91 (268)
Q Consensus 62 i~H~Dikp~Nill~~~~~~~kl~Dfg~a~~ 91 (268)
++|+|+.|.||+++.+...+.++||+-+..
T Consensus 199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred eeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 999999999999998732378999998863
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=93.58 E-value=0.19 Score=43.37 Aligned_cols=74 Identities=26% Similarity=0.278 Sum_probs=54.7
Q ss_pred EEEEEEcCCCCCHHH--HHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEEeCCCCCeEEecCCCcc
Q 024408 14 MVIVTELLSGGTLRK--YLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLTEDLKTIKLADFGLAR 90 (268)
Q Consensus 14 ~~lV~e~~~ggsL~~--~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~gi~H~Dikp~Nill~~~~~~~kl~Dfg~a~ 90 (268)
-+|||+|+ |++=+- .|. ...++...+..+-.+++.-+.-|-+ .++||.||.--|+|+... .+.++|.+-+.
T Consensus 239 hVLVM~Fl-Grdgw~aPkLK---d~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~LyhdG--~lyiIDVSQSV 312 (520)
T KOG2270|consen 239 HVLVMEFL-GRDGWAAPKLK---DASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHDG--KLYIIDVSQSV 312 (520)
T ss_pred ceEeeeec-cCCCCcCcccc---cccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEECC--EEEEEEccccc
Confidence 47999999 443221 221 2237777888888888888877754 579999999999999875 79999988876
Q ss_pred ccc
Q 024408 91 EES 93 (268)
Q Consensus 91 ~~~ 93 (268)
...
T Consensus 313 E~D 315 (520)
T KOG2270|consen 313 EHD 315 (520)
T ss_pred cCC
Confidence 543
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=93.45 E-value=0.074 Score=42.56 Aligned_cols=36 Identities=25% Similarity=0.367 Sum_probs=30.4
Q ss_pred HHHHHHHHH--CCCeecCCCCCCEEEeCCCCCeEEecCC
Q 024408 51 ARAMECLHS--HGIIHRDLKPENLLLTEDLKTIKLADFG 87 (268)
Q Consensus 51 ~~~l~~lH~--~gi~H~Dikp~Nill~~~~~~~kl~Dfg 87 (268)
+.+|...|+ .+.+|+|..|+|||-+.. |.+||.|=+
T Consensus 151 i~~L~~fH~~~~~~lHGD~np~NiM~D~~-G~lKlVDP~ 188 (308)
T PF07387_consen 151 IKDLMDFHSENQHCLHGDCNPDNIMCDKF-GYLKLVDPV 188 (308)
T ss_pred HHHHHHhhccCCCeecCCCChhheeecCC-CCEEecChh
Confidence 567788895 479999999999999988 799999843
|
The function of this family is unknown. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=93.41 E-value=0.066 Score=44.61 Aligned_cols=31 Identities=32% Similarity=0.575 Sum_probs=25.2
Q ss_pred CCeecCCCCCCEEEeCCCCCeEEecCCCccc
Q 024408 61 GIIHRDLKPENLLLTEDLKTIKLADFGLARE 91 (268)
Q Consensus 61 gi~H~Dikp~Nill~~~~~~~kl~Dfg~a~~ 91 (268)
.++|+|+++.||+++++....-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999987522346999998865
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=93.08 E-value=0.15 Score=43.12 Aligned_cols=30 Identities=20% Similarity=0.243 Sum_probs=26.7
Q ss_pred CCeecCCCCCCEEEeCCCCCeEEecCCCccc
Q 024408 61 GIIHRDLKPENLLLTEDLKTIKLADFGLARE 91 (268)
Q Consensus 61 gi~H~Dikp~Nill~~~~~~~kl~Dfg~a~~ 91 (268)
+++|+|+.++|++++.+ +.+.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~-~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDET-RGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCC-CCEEEEEhhhccc
Confidence 79999999999999887 5789999988864
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=93.05 E-value=0.19 Score=42.84 Aligned_cols=52 Identities=25% Similarity=0.288 Sum_probs=33.1
Q ss_pred HHHHHHHHHHHHHHHHHH----HCCCeecCCCCCCEEEeCCC-----------------CCeEEecCCCcccc
Q 024408 41 CVAIGFALDIARAMECLH----SHGIIHRDLKPENLLLTEDL-----------------KTIKLADFGLAREE 92 (268)
Q Consensus 41 ~~~~~~~~~l~~~l~~lH----~~gi~H~Dikp~Nill~~~~-----------------~~~kl~Dfg~a~~~ 92 (268)
+-+..++.|++.-.--+- ..+.+|-||||+|||+-++. -.++|.||.+++..
T Consensus 275 ~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~ 347 (434)
T PF05445_consen 275 EYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQVA 347 (434)
T ss_pred HHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHhc
Confidence 344556666655432221 34699999999999994331 14567888887643
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=93.00 E-value=0.051 Score=43.23 Aligned_cols=30 Identities=40% Similarity=0.633 Sum_probs=20.0
Q ss_pred CCeecCCCCCCEEE-eCCCCCeEEecCCCccc
Q 024408 61 GIIHRDLKPENLLL-TEDLKTIKLADFGLARE 91 (268)
Q Consensus 61 gi~H~Dikp~Nill-~~~~~~~kl~Dfg~a~~ 91 (268)
.+.|+|+.+.||++ +.+ +.++++||..|..
T Consensus 144 v~cHnDl~~~Nil~~~~~-~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKD-GEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSS-SCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCC-CeEEEecHHHHhh
Confidence 58999999999999 444 6999999998863
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=92.96 E-value=0.22 Score=42.64 Aligned_cols=30 Identities=33% Similarity=0.475 Sum_probs=25.7
Q ss_pred CeecCCCCCCEEEeCCCCCeEEecCCCccc
Q 024408 62 IIHRDLKPENLLLTEDLKTIKLADFGLARE 91 (268)
Q Consensus 62 i~H~Dikp~Nill~~~~~~~kl~Dfg~a~~ 91 (268)
+.|.|+.+.||+++++.+.++++||+.|..
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 799999999999986546899999988853
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=92.71 E-value=0.37 Score=38.08 Aligned_cols=56 Identities=30% Similarity=0.504 Sum_probs=41.3
Q ss_pred cEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCCeEEecCCCc
Q 024408 13 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 89 (268)
Q Consensus 13 ~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~~kl~Dfg~a 89 (268)
..-||.||.+... .+.... +.++.+-+..+|..||+-+|+++.|.. + | +|+|||.+
T Consensus 151 ~~aIVKD~v~~~~-----------~~~~~~----~~~~~~dl~~~~k~gI~~~Dv~~~ny~---~-G--~lvDfs~~ 206 (207)
T PF13095_consen 151 IRAIVKDFVPDDP-----------PLQIRD----IPQMLRDLKILHKLGIVPRDVKPRNYR---G-G--KLVDFSSS 206 (207)
T ss_pred cEEEEEeecCCcc-----------ccchhH----HHHHHHHHHHHHHCCeeeccCcccccc---C-C--EEEecccC
Confidence 3467888876443 133333 457777788999999999999999987 2 2 89999864
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=92.68 E-value=0.16 Score=44.45 Aligned_cols=31 Identities=26% Similarity=0.422 Sum_probs=26.6
Q ss_pred HCCCeecCCCCCCEEEeCCCCCeEEecCCCccc
Q 024408 59 SHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 91 (268)
Q Consensus 59 ~~gi~H~Dikp~Nill~~~~~~~kl~Dfg~a~~ 91 (268)
.+.++|||++|.|||++++ ..|++|..+|..
T Consensus 226 ~~aLlHGDlHtGSI~v~~~--~~kvIDpEFAfy 256 (409)
T PRK12396 226 AQALIHGDLHTGSVFVKND--STKVIDPEFAFY 256 (409)
T ss_pred chhhccCcCCCCCEEecCC--ceEEEccccccc
Confidence 4579999999999999987 689999887753
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=91.99 E-value=0.42 Score=47.32 Aligned_cols=32 Identities=38% Similarity=0.511 Sum_probs=25.9
Q ss_pred CCCeecCCCCCCEEEeCCC-CCeE-EecCCCccc
Q 024408 60 HGIIHRDLKPENLLLTEDL-KTIK-LADFGLARE 91 (268)
Q Consensus 60 ~gi~H~Dikp~Nill~~~~-~~~k-l~Dfg~a~~ 91 (268)
.+++|+|+++.||+++.+. +++. |+|||.+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 4799999999999998762 1454 999998864
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=91.52 E-value=0.28 Score=43.03 Aligned_cols=30 Identities=27% Similarity=0.429 Sum_probs=26.1
Q ss_pred CCCeecCCCCCCEEEeCCCCCeEEecCCCccc
Q 024408 60 HGIIHRDLKPENLLLTEDLKTIKLADFGLARE 91 (268)
Q Consensus 60 ~gi~H~Dikp~Nill~~~~~~~kl~Dfg~a~~ 91 (268)
..++|||+++.||++..+ .++++||.++..
T Consensus 223 ~~l~HgDl~~gni~~~~~--~~~viD~E~a~~ 252 (401)
T PRK09550 223 EALLHGDLHTGSIFVTEE--ETKVIDPEFAFY 252 (401)
T ss_pred CceeeccCCcccEEeeCC--CcEEEecccccc
Confidence 469999999999999876 589999988764
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=91.51 E-value=0.31 Score=41.66 Aligned_cols=29 Identities=31% Similarity=0.358 Sum_probs=24.3
Q ss_pred CCCeecCCCCCCEEEeCCCCCeEEecCCCccc
Q 024408 60 HGIIHRDLKPENLLLTEDLKTIKLADFGLARE 91 (268)
Q Consensus 60 ~gi~H~Dikp~Nill~~~~~~~kl~Dfg~a~~ 91 (268)
.+++|+|+.+.||+++ + .+.++||+.+..
T Consensus 196 ~~liHgD~h~~NvL~~-d--~~~iIDFDd~~~ 224 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D--GPHFVDLDDARM 224 (325)
T ss_pred ccceecCCCchhcccc-C--CcEEEeCCCCCC
Confidence 4799999999999994 3 478999998863
|
|
| >PRK06149 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=90.99 E-value=0.3 Score=48.18 Aligned_cols=31 Identities=23% Similarity=0.293 Sum_probs=25.1
Q ss_pred CCCeecCCCCCCEEEeCCC-CC---eEEecCCCcc
Q 024408 60 HGIIHRDLKPENLLLTEDL-KT---IKLADFGLAR 90 (268)
Q Consensus 60 ~gi~H~Dikp~Nill~~~~-~~---~kl~Dfg~a~ 90 (268)
.|++|+|+++.||+++.+. +. .-|+|||.+.
T Consensus 208 ~g~IH~Dl~~~Nilv~~~~~~~~~v~giIDFgD~~ 242 (972)
T PRK06149 208 LQAVHLDITDDNVVGSRDADGRWQPDGVIDFGDLV 242 (972)
T ss_pred ccccCCCCCcccEEEcCCCCCCcceeEEEEcccch
Confidence 5899999999999998652 22 3699999885
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=90.67 E-value=0.17 Score=43.73 Aligned_cols=30 Identities=23% Similarity=0.378 Sum_probs=25.6
Q ss_pred CCCeecCCCCCCEEEeCCCCCeEEecCCCccc
Q 024408 60 HGIIHRDLKPENLLLTEDLKTIKLADFGLARE 91 (268)
Q Consensus 60 ~gi~H~Dikp~Nill~~~~~~~kl~Dfg~a~~ 91 (268)
..++|||+.+.||+++++ .++++|+..+..
T Consensus 192 ~~llHGDl~~gNi~~~~~--~~~~iD~e~~~~ 221 (370)
T TIGR01767 192 ETLLHGDLHSGSIFVSEH--ETKVIDPEFAFY 221 (370)
T ss_pred ceeeeccCCcccEEEcCC--CCEEEcCccccc
Confidence 469999999999999876 578999987764
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 268 | ||||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-29 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-24 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-24 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-24 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-24 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-24 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-24 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-24 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-23 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-23 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-23 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-23 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-23 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-23 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-23 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 6e-23 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-23 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-22 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-22 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-22 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-22 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-21 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-21 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-21 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-21 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-21 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-21 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-21 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-21 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-21 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-21 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-21 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-21 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-21 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-21 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-21 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-21 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-21 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-21 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-21 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 5e-21 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 5e-21 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 5e-21 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-21 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 6e-21 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 7e-21 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 8e-21 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 8e-21 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 9e-21 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 9e-21 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 9e-21 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-21 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-20 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-20 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-20 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-20 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-20 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-20 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-20 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-20 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-20 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-20 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-20 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-20 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-20 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-20 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-20 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-20 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-20 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-20 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-20 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-20 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-20 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-20 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-20 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-20 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-20 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-20 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-20 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-20 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-20 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-20 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-20 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-20 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-20 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-20 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-20 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-20 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-20 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-20 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-20 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-20 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-20 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-20 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 4e-20 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 4e-20 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-20 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 5e-20 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 5e-20 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 5e-20 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 5e-20 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 5e-20 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 5e-20 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 5e-20 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 5e-20 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-20 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-20 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 6e-20 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 8e-20 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-20 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-20 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 8e-20 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 9e-20 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 9e-20 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 9e-20 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 9e-20 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 9e-20 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-20 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-19 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-19 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-19 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-19 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-19 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-19 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-19 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-19 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-19 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-19 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-19 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-19 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-19 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-19 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-19 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-19 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-19 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-19 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-19 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-19 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-19 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-19 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-19 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-19 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-19 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-19 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-19 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-19 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-19 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 5e-19 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-19 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 5e-19 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 5e-19 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 5e-19 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-19 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 5e-19 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 5e-19 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-19 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 5e-19 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 5e-19 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 5e-19 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 5e-19 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 6e-19 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 6e-19 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-19 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 7e-19 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 8e-19 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-18 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-18 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-18 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-18 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-18 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-18 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 5e-18 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 5e-18 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 5e-18 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-18 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 5e-18 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 6e-18 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 6e-18 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 9e-18 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-17 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-17 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-17 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-17 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-17 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-17 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-17 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-17 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-17 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-17 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-17 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-17 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-17 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-17 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-17 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-17 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-17 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-17 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-17 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-17 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-17 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-17 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-17 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-17 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-17 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-17 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-17 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-17 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-17 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 5e-17 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 5e-17 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 5e-17 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 6e-17 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 6e-17 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 7e-17 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 8e-17 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 9e-17 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 9e-17 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-17 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-16 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-16 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-16 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-16 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-16 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-16 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-16 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-16 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-16 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-16 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-16 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-16 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-16 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-16 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-16 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-16 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-16 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-16 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-16 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-16 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 6e-16 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 6e-16 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 8e-16 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 8e-16 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 8e-16 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 8e-16 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 8e-16 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 9e-16 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 9e-16 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 9e-16 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 9e-16 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 9e-16 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 9e-16 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-15 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-15 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-15 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-15 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-15 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-15 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-15 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-15 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-15 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-15 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-15 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-15 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-15 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-15 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-15 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-15 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-15 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 4e-15 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-15 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 5e-15 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 6e-15 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 8e-15 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 8e-15 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 8e-15 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 8e-15 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 8e-15 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 8e-15 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 9e-15 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-14 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-14 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-14 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-14 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-14 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-14 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-14 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-14 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-14 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-14 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-14 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-14 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-14 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-14 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-14 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-14 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-14 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 6e-14 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 6e-14 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 6e-14 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 6e-14 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 6e-14 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 6e-14 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 6e-14 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 7e-14 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-14 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 7e-14 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 7e-14 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 8e-14 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 8e-14 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 9e-14 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 9e-14 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 9e-14 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-13 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-13 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-13 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-13 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-13 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-13 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-13 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-13 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-13 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-13 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-13 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-13 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-13 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-13 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-13 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-13 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-13 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-13 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-13 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-13 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-13 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-13 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-13 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-13 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-13 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-13 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-13 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-13 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-13 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-13 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-13 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-13 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-13 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-13 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-13 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-13 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-13 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-13 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-13 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-13 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-13 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-13 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-13 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-13 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-13 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-13 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-13 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-13 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-13 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-13 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-13 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-13 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-13 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-13 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-13 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-13 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-13 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 4e-13 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-13 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-13 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-13 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-13 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 5e-13 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 5e-13 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 5e-13 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 6e-13 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 6e-13 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 6e-13 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 6e-13 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 6e-13 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-13 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 6e-13 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 6e-13 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 6e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-13 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-13 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 7e-13 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 7e-13 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-13 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-13 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-13 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 8e-13 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 8e-13 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-13 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 9e-13 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 9e-13 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-12 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-12 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-12 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-12 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-12 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-12 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-12 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-12 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-12 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-12 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-12 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-12 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-12 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-12 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-12 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-12 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-12 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-12 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-12 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-12 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-12 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-12 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-12 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-12 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-12 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-12 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-12 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-12 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-12 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-12 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-12 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-12 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-12 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-12 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-12 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-12 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-12 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 5e-12 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 5e-12 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 5e-12 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 5e-12 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 5e-12 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 5e-12 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 5e-12 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-12 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 5e-12 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-12 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 5e-12 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 5e-12 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 5e-12 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-12 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 5e-12 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 6e-12 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 6e-12 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 6e-12 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 6e-12 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 6e-12 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-12 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 7e-12 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 7e-12 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 7e-12 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-12 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 7e-12 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 7e-12 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 7e-12 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 7e-12 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 8e-12 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 8e-12 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-12 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 8e-12 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 8e-12 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 8e-12 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 8e-12 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-12 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 8e-12 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 9e-12 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 9e-12 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-11 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-11 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-11 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-11 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-11 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-11 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-11 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-11 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-11 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-11 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-11 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-11 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-11 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-11 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-11 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-11 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-11 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-11 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-11 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-11 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-11 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-11 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-11 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-11 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-11 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-11 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-11 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-11 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-11 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-11 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-11 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-11 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-11 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-11 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-11 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-11 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-11 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-11 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-11 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 3e-11 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-11 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-11 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-11 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-11 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-11 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-11 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-11 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-11 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-11 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-11 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-11 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-11 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-11 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-11 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-11 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-11 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-11 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-11 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 4e-11 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-11 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-11 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-11 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-11 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-11 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-11 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 4e-11 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-11 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-11 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-11 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-11 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-11 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-11 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 4e-11 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-11 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 4e-11 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-11 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 4e-11 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-11 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 4e-11 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-11 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 4e-11 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-11 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 5e-11 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 5e-11 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 5e-11 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-11 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 5e-11 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 5e-11 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-11 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-11 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 5e-11 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 5e-11 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 6e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 6e-11 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 6e-11 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 6e-11 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 6e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 7e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 7e-11 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 7e-11 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 7e-11 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 7e-11 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-11 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 7e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 7e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-11 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 8e-11 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 8e-11 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 8e-11 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 9e-11 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 9e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 9e-11 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 9e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-10 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-10 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-10 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-10 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-10 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-10 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-10 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-10 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-10 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-10 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-10 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-10 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-10 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-10 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-10 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-10 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-10 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-10 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-10 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-10 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-10 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-10 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-10 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-10 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-10 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-10 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-10 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-10 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-10 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-10 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-10 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-10 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-10 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-10 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-10 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-10 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-10 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-10 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-10 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-10 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-10 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-10 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-10 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-10 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-10 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-10 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-10 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-10 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-10 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-10 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-10 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-10 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-10 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-10 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-10 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-10 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-10 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-10 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-10 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-10 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-10 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-10 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-10 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-10 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-10 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-10 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-10 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-10 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-10 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 5e-10 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 5e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-10 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 5e-10 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-10 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-10 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 6e-10 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 6e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 6e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 6e-10 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 7e-10 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 8e-10 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 8e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 8e-10 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-10 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-10 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 9e-10 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 9e-10 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 9e-10 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 9e-10 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 9e-10 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-09 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-09 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-09 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-09 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-09 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-09 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-09 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 2e-09 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-09 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-09 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-09 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-09 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-09 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-09 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-09 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-09 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-09 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-09 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-09 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-09 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-09 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-09 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-09 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-09 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-09 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-09 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-09 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-09 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-09 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-09 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-09 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-09 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-09 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-09 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-09 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-09 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-09 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-09 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-09 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-09 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-09 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-09 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-09 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-09 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-09 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-09 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-09 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 4e-09 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-09 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 6e-09 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-09 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 6e-09 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-09 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-09 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 7e-09 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 7e-09 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-09 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-09 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 7e-09 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 7e-09 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 7e-09 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-09 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 7e-09 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 7e-09 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 7e-09 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 7e-09 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 7e-09 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-09 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 8e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 8e-09 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 8e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 9e-09 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-09 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 9e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-08 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-08 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-08 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-08 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-08 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-08 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-08 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-08 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-08 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-08 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-08 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-08 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-08 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 3e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-08 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-08 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-08 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-08 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-08 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-08 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-08 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-08 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 4e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 4e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 4e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 4e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-08 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 5e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 5e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 5e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 5e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 5e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 5e-08 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 5e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 6e-08 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 6e-08 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 6e-08 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 6e-08 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-08 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 6e-08 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 6e-08 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 6e-08 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 7e-08 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 7e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 7e-08 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 7e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 7e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 7e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 7e-08 | ||
| 2c47_A | 313 | Structure Of Casein Kinase 1 Gamma 2 Length = 313 | 7e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 7e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-08 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 8e-08 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 8e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 8e-08 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 8e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 8e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 8e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 8e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 8e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 9e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 9e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 9e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 9e-08 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 9e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-07 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-07 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-07 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-07 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-07 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-07 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-07 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-07 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-07 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-07 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-07 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-07 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 3e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-07 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 3e-07 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 3e-07 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 3e-07 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 3e-07 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 3e-07 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-07 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-07 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 3e-07 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 3e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-07 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 3e-07 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 3e-07 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 3e-07 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-07 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 3e-07 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 3e-07 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 4e-07 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 4e-07 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 4e-07 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 4e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-07 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 4e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-07 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 4e-07 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 4e-07 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 4e-07 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 4e-07 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 4e-07 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 5e-07 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 5e-07 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 5e-07 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 5e-07 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 5e-07 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 5e-07 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-07 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 5e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 6e-07 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 7e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 7e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 7e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 7e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 7e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 8e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 8e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 8e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 8e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 8e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 8e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 8e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 9e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 9e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 9e-07 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-06 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-06 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-06 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-06 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-06 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-06 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-06 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-06 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 2e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-06 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 3e-06 |
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 274 bits (703), Expect = 2e-92
Identities = 75/222 (33%), Positives = 114/222 (51%), Gaps = 19/222 (8%)
Query: 4 QFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRC-LDVCVAIGFALDIARAMECLHSHG 61
F+GA + P + IVTE LS G+L + L R LD + A D+A+ M LH+
Sbjct: 98 LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN 157
Query: 62 --IIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE-MMTAETGTYRWMAPELYSTVTL 118
I+HR+LK NLL+ + T+K+ DFGL+R ++ T + GT WMAPE+
Sbjct: 158 PPIVHRNLKSPNLLVDKK-YTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVL----- 211
Query: 119 RQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSA-ENVPEEL 177
+ N K D YSF ++LWEL + P+ ++ Q A FK R N+ ++
Sbjct: 212 ---RDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQV 268
Query: 178 SIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIPHR 219
+ I+ CW +P RP+F I+ +L + + PP P+R
Sbjct: 269 AAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPP----PNR 306
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 272 bits (697), Expect = 1e-91
Identities = 70/248 (28%), Positives = 117/248 (47%), Gaps = 21/248 (8%)
Query: 4 QFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRC-LDVCVAIGFALDIARAMECLHSH-- 60
+ GAC PV +V E GG+L L P A+ + L ++ + LHS
Sbjct: 65 KLYGACLNPVC-LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQP 123
Query: 61 -GIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLR 119
+IHRDLKP NLLL +K+ DFG A + + MT G+ WMAPE++
Sbjct: 124 KALIHRDLKPPNLLLVAGGTVLKICDFGTACD--IQTHMTNNKGSAAWMAPEVF------ 175
Query: 120 QGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL-QAAYAAAFKNVRPS-AENVPEEL 177
E +Y+ K D +S+ I+LWE++ + PF+ + A RP +N+P+ +
Sbjct: 176 --EGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPI 233
Query: 178 SIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIPHRIFNSENTILPPESPGTSS 237
++T CW +DP+ RP+ +I++++ + + + + + +S LPP G
Sbjct: 234 ESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHS----LPPGEDGRVE 289
Query: 238 LMTVRDDI 245
+
Sbjct: 290 PYVDFAEF 297
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 268 bits (686), Expect = 4e-90
Identities = 60/208 (28%), Positives = 103/208 (49%), Gaps = 19/208 (9%)
Query: 4 QFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG-- 61
+ G P +V E + G L LL+ + + V + LDIA +E + +
Sbjct: 87 KLYGLMHNPPR-MVMEFVPCGDLYHRLLD-KAHPIKWSVKLRLMLDIALGIEYMQNQNPP 144
Query: 62 IIHRDLKPENLLLTEDLK----TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVT 117
I+HRDL+ N+ L + K+ADFGL+++ ++ G ++WMAPE
Sbjct: 145 IVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS--VHSVSGLLGNFQWMAPETIG--- 199
Query: 118 LRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAA--FKNVRPS-AENVP 174
E++ Y K D+YSFA++L+ +L + PF+ S + + + +RP+ E+ P
Sbjct: 200 ---AEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCP 256
Query: 175 EELSIILTSCWKEDPNARPNFTQIIQML 202
L ++ CW DP RP+F+ I++ L
Sbjct: 257 PRLRNVIELCWSGDPKKRPHFSYIVKEL 284
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 265 bits (679), Expect = 9e-89
Identities = 55/209 (26%), Positives = 98/209 (46%), Gaps = 14/209 (6%)
Query: 4 QFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI 62
F+GAC P + I+T L G TL + + + LDV A +I + M LH+ GI
Sbjct: 93 LFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIV-LDVNKTRQIAQEIVKGMGYLHAKGI 151
Query: 63 IHRDLKPENLLLTEDLKTIKLADFGLAREESLT------EMMTAETGTYRWMAPELYSTV 116
+H+DLK +N+ D + + DFGL + + + + G +APE+ +
Sbjct: 152 LHKDLKSKNVFY--DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQL 209
Query: 117 TL-RQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP--SAENV 173
+ + +K ++ D ++ + +EL + PF+ + ++P S +
Sbjct: 210 SPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMG-TGMKPNLSQIGM 268
Query: 174 PEELSIILTSCWKEDPNARPNFTQIIQML 202
+E+S IL CW + RP FT+++ ML
Sbjct: 269 GKEISDILLFCWAFEQEERPTFTKLMDML 297
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 262 bits (673), Expect = 2e-88
Identities = 54/205 (26%), Positives = 95/205 (46%), Gaps = 16/205 (7%)
Query: 4 QFIGACKEPV---MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH 60
+GAC+ P ++T + G+L L +D A+ FALD+AR M LH+
Sbjct: 71 PVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL 130
Query: 61 G--IIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTL 118
I L ++++ ED+ T +++ + W+APE L
Sbjct: 131 EPLIPRHALNSRSVMIDEDM-TARISMADVKFSFQ----SPGRMYAPAWVAPEA-----L 180
Query: 119 RQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSA-ENVPEEL 177
++ + D +SFA++LWEL+ ++PF +SN++ A + +RP+ + +
Sbjct: 181 QKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHV 240
Query: 178 SIILTSCWKEDPNARPNFTQIIQML 202
S ++ C EDP RP F I+ +L
Sbjct: 241 SKLMKICMNEDPAKRPKFDMIVPIL 265
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 261 bits (668), Expect = 9e-88
Identities = 72/211 (34%), Positives = 106/211 (50%), Gaps = 24/211 (11%)
Query: 4 QFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG- 61
G C KEP + +V E GG L + L + + + + +A+ IAR M LH
Sbjct: 70 ALRGVCLKEPNLCLVMEFARGGPLNRVL---SGKRIPPDILVNWAVQIARGMNYLHDEAI 126
Query: 62 --IIHRDLKPENLLLTEDL-------KTIKLADFGLAREESLTEMMTAETGTYRWMAPEL 112
IIHRDLK N+L+ + + K +K+ DFGLARE T M+A G Y WMAPE+
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA-AGAYAWMAPEV 185
Query: 113 YSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS-AE 171
++ D +S+ ++LWELL ++PF G+ L AY A +
Sbjct: 186 I--------RASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPS 237
Query: 172 NVPEELSIILTSCWKEDPNARPNFTQIIQML 202
PE + ++ CW DP++RP+FT I+ L
Sbjct: 238 TCPEPFAKLMEDCWNPDPHSRPSFTNILDQL 268
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 259 bits (663), Expect = 1e-86
Identities = 64/207 (30%), Positives = 104/207 (50%), Gaps = 15/207 (7%)
Query: 4 QFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 63
F+G P + IVT+ G +L +L + ++ I A AR M+ LH+ II
Sbjct: 84 LFMGYSTAPQLAIVTQWCEGSSLYHHLHASETK-FEMKKLIDIARQTARGMDYLHAKSII 142
Query: 64 HRDLKPENLLLTEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQ 120
HRDLK N+ L ED T+K+ DFGLA E+S +G+ WMAPE+ +R
Sbjct: 143 HRDLKSNNIFLHEDN-TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEV-----IRM 196
Query: 121 GEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAA-AFKNVRPSA----ENVPE 175
+ Y+ + D Y+F IVL+EL+ +LP+ ++N ++ P N P+
Sbjct: 197 QDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPK 256
Query: 176 ELSIILTSCWKEDPNARPNFTQIIQML 202
+ ++ C K+ + RP+F +I+ +
Sbjct: 257 RMKRLMAECLKKKRDERPSFPRILAEI 283
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 226 bits (577), Expect = 2e-73
Identities = 66/233 (28%), Positives = 95/233 (40%), Gaps = 28/233 (12%)
Query: 4 QFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI 62
+FIG K+ + +TE + GGTLR + +M + + FA DIA M LHS I
Sbjct: 71 KFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQ-YPWSQRVSFAKDIASGMAYLHSMNI 129
Query: 63 IHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM---------------MTAETGTYRW 107
IHRDL N L+ E+ + +ADFGLAR + G W
Sbjct: 130 IHRDLNSHNCLVRENK-NVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188
Query: 108 MAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFK-NV 166
MAPE+ + + Y+ KVD +SF IVL E++ + + +
Sbjct: 189 MAPEM-----ING---RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL 240
Query: 167 RPSA-ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIPH 218
N P I C DP RP+F ++ L +A P+ P
Sbjct: 241 DRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGPQ 293
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 207 bits (530), Expect = 2e-66
Identities = 56/238 (23%), Positives = 93/238 (39%), Gaps = 45/238 (18%)
Query: 4 QFIGAC-----KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLH 58
FI + + ++T G+L YL + LD + L IA + LH
Sbjct: 66 GFIASDMTSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIASGLAHLH 122
Query: 59 S--------HGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMM-----TAETGTY 105
I HRDLK +N+L+ ++ +AD GLA S + GT
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNG-QCCIADLGLAVMHSQSTNQLDVGNNPRVGTK 181
Query: 106 RWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL----------HNKLPFEGMSNL 155
R+MAPE+ Q + +VD ++F +VLWE+ K PF +
Sbjct: 182 RYMAPEVLDETI--QVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPN 239
Query: 156 QAAY-----AAAFKNVRPS------AENVPEELSIILTSCWKEDPNARPNFTQIIQML 202
++ RP+ ++ L+ ++ CW ++P+AR +I + L
Sbjct: 240 DPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTL 297
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 208 bits (530), Expect = 5e-66
Identities = 54/245 (22%), Positives = 95/245 (38%), Gaps = 47/245 (19%)
Query: 4 QFIGACKEPV-----MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLH 58
FI A + + ++T+ G+L YL + LD + A + LH
Sbjct: 95 GFIAADIKGTGSWTQLYLITDYHENGSLYDYL---KSTTLDAKSMLKLAYSSVSGLCHLH 151
Query: 59 SH--------GIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM-----MTAETGTY 105
+ I HRDLK +N+L+ ++ T +AD GLA + GT
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKKNG-TCCIADLGLAVKFISDTNEVDIPPNTRVGTK 210
Query: 106 RWMAPE-LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL----------HNKLPFEGMSN 154
R+M PE L ++ + D YSF ++LWE+ +LP+ +
Sbjct: 211 RYMPPEVLDESLNRNHFQ---SYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVP 267
Query: 155 LQAAY-----AAAFKNVRPS------AENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 203
+Y K +RPS ++ ++ ++T CW +P +R ++ + L
Sbjct: 268 SDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA 327
Query: 204 NYLSA 208
+
Sbjct: 328 KMSES 332
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 7e-61
Identities = 55/239 (23%), Positives = 91/239 (38%), Gaps = 47/239 (19%)
Query: 4 QFIGACK-----EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLH 58
FI A + +V++ G+L YL + V I AL A + LH
Sbjct: 100 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLH 156
Query: 59 SH--------GIIHRDLKPENLLLTEDLKTIKLADFGLAREES-----LTEMMTAETGTY 105
I HRDLK +N+L+ ++ T +AD GLA + GT
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADLGLAVRHDSATDTIDIAPNHRVGTK 215
Query: 106 RWMAPE-LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL----------HNKLPFEGMSN 154
R+MAPE L ++ ++ E + D Y+ +V WE+ +LP+ +
Sbjct: 216 RYMAPEVLDDSINMKHFE---SFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 272
Query: 155 LQAAY-----AAAFKNVRPSAEN------VPEELSIILTSCWKEDPNARPNFTQIIQML 202
+ + +RP+ N ++ I+ CW + AR +I + L
Sbjct: 273 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 331
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 3e-55
Identities = 58/264 (21%), Positives = 92/264 (34%), Gaps = 56/264 (21%)
Query: 4 QFIGACKEPVMV------IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECL 57
+FI + +V E G+L KYL D + A + R + L
Sbjct: 71 RFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL---SLHTSDWVSSCRLAHSVTRGLAYL 127
Query: 58 HS---------HGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM---------MT 99
H+ I HRDL N+L+ D T ++DFGL+ + +
Sbjct: 128 HTELPRGDHYKPAISHRDLNSRNVLVKNDG-TCVISDFGLSMRLTGNRLVRPGEEDNAAI 186
Query: 100 AETGTYRWMAPE-LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH---NKLPFEGMSNL 155
+E GT R+MAPE L V LR E +VD Y+ ++ WE+ + P E +
Sbjct: 187 SEVGTIRYMAPEVLEGAVNLRDXE--SALKQVDMYALGLIYWEIFMRCTDLFPGESVPEY 244
Query: 156 QAAYAA---------------AFKNVRP-------SAENVPEELSIILTSCWKEDPNARP 193
Q A+ + + RP L + CW +D AR
Sbjct: 245 QMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARL 304
Query: 194 NFTQIIQMLLNYLSAIAPPEPMIP 217
+ + + + + P
Sbjct: 305 TAQXAEERMAELMMIWERNKSVSP 328
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 1e-53
Identities = 60/239 (25%), Positives = 88/239 (36%), Gaps = 47/239 (19%)
Query: 4 QFIGACKEP-----VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLH 58
QFIGA K + ++T G+L +L + + A +AR + LH
Sbjct: 82 QFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL---KANVVSWNELCHIAETMARGLAYLH 138
Query: 59 SH----------GIIHRDLKPENLLLTEDLKTIKLADFGLAR---EESLTEMMTAETGTY 105
I HRD+K +N+LL +L T +ADFGLA + GT
Sbjct: 139 EDIPGLKDGHKPAISHRDIKSKNVLLKNNL-TACIADFGLALKFEAGKSAGDTHGQVGTR 197
Query: 106 RWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-----------HNKLPFEGM-- 152
R+MAPE+ Q + ++D Y+ +VLWEL LPFE
Sbjct: 198 RYMAPEVLEGAINFQRD---AFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG 254
Query: 153 ---SNLQAAYAAAFKNVRPSAEN------VPEELSIILTSCWKEDPNARPNFTQIIQML 202
S K RP + L + CW D AR + + + +
Sbjct: 255 QHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERI 313
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 1e-47
Identities = 68/224 (30%), Positives = 108/224 (48%), Gaps = 29/224 (12%)
Query: 4 QFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI 62
+ +EP+ I+TE + G+L +L L + + A IA M +
Sbjct: 72 RLYAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 130
Query: 63 IHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT---YRWMAPELYSTVTLR 119
IHRDL+ N+L+++ L + K+ADFGLAR E TA G +W APE +
Sbjct: 131 IHRDLRAANILVSDTL-SCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPE-----AIN 183
Query: 120 QGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-----PSAENV 173
G + K D +SF I+L E++ H ++P+ GM+N + +N+ +N
Sbjct: 184 YG---TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-----VIQNLERGYRMVRPDNC 235
Query: 174 PEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAP---PEP 214
PEEL ++ CWKE P RP F + +L ++ +A P+P
Sbjct: 236 PEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQYQPQP 279
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 1e-47
Identities = 68/210 (32%), Positives = 97/210 (46%), Gaps = 27/210 (12%)
Query: 4 QFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG 61
+ IG C K+P+ IV EL+ GG +L R L V + D A ME L S
Sbjct: 176 RLIGVCTQKQPIY-IVMELVQGGDFLTFLRTEGAR-LRVKTLLQMVGDAAAGMEYLESKC 233
Query: 62 IIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT---YRWMAPELYSTVTL 118
IHRDL N L+TE +K++DFG++REE+ + +W APE L
Sbjct: 234 CIHRDLAARNCLVTEKN-VLKISDFGMSREEADGVYAASGGLRQVPVKWTAPE-----AL 287
Query: 119 RQGEKKHYNHKVDSYSFAIVLWELLHN-KLPFEGMSNLQAAYAAAFKNVR-----PSAEN 172
G Y+ + D +SF I+LWE P+ +SN Q + V P E
Sbjct: 288 NYG---RYSSESDVWSFGILLWETFSLGASPYPNLSNQQ-----TREFVEKGGRLPCPEL 339
Query: 173 VPEELSIILTSCWKEDPNARPNFTQIIQML 202
P+ + ++ CW +P RP+F+ I Q L
Sbjct: 340 CPDAVFRLMEQCWAYEPGQRPSFSTIYQEL 369
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 2e-47
Identities = 63/213 (29%), Positives = 97/213 (45%), Gaps = 16/213 (7%)
Query: 4 QFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI 62
Q +EP+ IVTE +S G+L +L + L + + A IA M +
Sbjct: 243 QLYAVVSEEPIY-IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 301
Query: 63 IHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT--YRWMAPELYSTVTLRQ 120
+HRDL+ N+L+ E+L K+ADFGLAR E + +W APE
Sbjct: 302 VHRDLRAANILVGENL-VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY----- 355
Query: 121 GEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-PSAENVPEELS 178
+ K D +SF I+L EL ++P+ GM N + + R P PE L
Sbjct: 356 ---GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-VLDQVERGYRMPCPPECPESLH 411
Query: 179 IILTSCWKEDPNARPNFTQIIQMLLNYLSAIAP 211
++ CW+++P RP F + L +Y ++ P
Sbjct: 412 DLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 444
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 7e-47
Identities = 72/220 (32%), Positives = 106/220 (48%), Gaps = 18/220 (8%)
Query: 4 QFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI 62
+ KEP+ I+TE ++ G+L +L + + I F+ IA M +
Sbjct: 247 KLHAVVTKEPIY-IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNY 305
Query: 63 IHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT---YRWMAPELYSTVTLR 119
IHRDL+ N+L++ L K+ADFGLAR E TA G +W APE +
Sbjct: 306 IHRDLRAANILVSASL-VCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPEAIN----- 358
Query: 120 QGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-PSAENVPEEL 177
+ K D +SF I+L E++ + ++P+ GMSN + A + R P EN PEEL
Sbjct: 359 ---FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE-VIRALERGYRMPRPENCPEEL 414
Query: 178 SIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIP 217
I+ CWK P RP F I +L ++ +A IP
Sbjct: 415 YNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQYEEIP 454
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 1e-46
Identities = 61/216 (28%), Positives = 102/216 (47%), Gaps = 27/216 (12%)
Query: 4 QFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG 61
Q +G C + P I+TE ++ G L YL + + V + A I+ AME L
Sbjct: 73 QLLGVCTREPPFY-IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 131
Query: 62 IIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT---YRWMAPELYSTVTL 118
IHRDL N L+ E+ +K+ADFGL+R + + TA G +W APE +L
Sbjct: 132 FIHRDLAARNCLVGENH-LVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPE-----SL 184
Query: 119 RQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-----PSAEN 172
++ K D ++F ++LWE+ + P+ G+ Q ++ + E
Sbjct: 185 AYN---KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-----VYELLEKDYRMERPEG 236
Query: 173 VPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 208
PE++ ++ +CW+ +P+ RP+F +I Q
Sbjct: 237 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 2e-46
Identities = 63/213 (29%), Positives = 97/213 (45%), Gaps = 16/213 (7%)
Query: 4 QFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI 62
Q +EP+ IVTE +S G+L +L + L + + A IA M +
Sbjct: 326 QLYAVVSEEPIY-IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 384
Query: 63 IHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT--YRWMAPELYSTVTLRQ 120
+HRDL+ N+L+ E+L K+ADFGLAR E + +W APE
Sbjct: 385 VHRDLRAANILVGENL-VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY----- 438
Query: 121 GEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-PSAENVPEELS 178
+ K D +SF I+L EL ++P+ GM N + + R P PE L
Sbjct: 439 ---GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-VLDQVERGYRMPCPPECPESLH 494
Query: 179 IILTSCWKEDPNARPNFTQIIQMLLNYLSAIAP 211
++ CW+++P RP F + L +Y ++ P
Sbjct: 495 DLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 527
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 2e-46
Identities = 57/210 (27%), Positives = 99/210 (47%), Gaps = 22/210 (10%)
Query: 4 QFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG 61
Q +G ++ + IVTE ++ G+L YL + L + F+LD+ AME L +
Sbjct: 250 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN 309
Query: 62 IIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT---YRWMAPELYSTVTL 118
+HRDL N+L++ED K++DFGL +E S + + +W APE
Sbjct: 310 FVHRDLAARNVLVSEDN-VAKVSDFGLTKEAS-----STQDTGKLPVKWTAPEALR---- 359
Query: 119 RQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-PSAENVPEE 176
+K ++ K D +SF I+LWE+ ++P+ + K + + + P
Sbjct: 360 ----EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-VVPRVEKGYKMDAPDGCPPA 414
Query: 177 LSIILTSCWKEDPNARPNFTQIIQMLLNYL 206
+ ++ +CW D RP F Q+ + L +
Sbjct: 415 VYDVMKNCWHLDAATRPTFLQLREQLEHIR 444
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 6e-46
Identities = 58/215 (26%), Positives = 101/215 (46%), Gaps = 30/215 (13%)
Query: 4 QFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG 61
Q +G ++ + IVTE ++ G+L YL + L + F+LD+ AME L +
Sbjct: 78 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN 137
Query: 62 IIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT---YRWMAPELYSTVTL 118
+HRDL N+L++ED K++DFGL +E S + + +W APE L
Sbjct: 138 FVHRDLAARNVLVSEDN-VAKVSDFGLTKEAS-----STQDTGKLPVKWTAPE-----AL 186
Query: 119 RQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-----PSAEN 172
R+ ++ K D +SF I+LWE+ ++P+ + V + +
Sbjct: 187 REK---KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-----VVPRVEKGYKMDAPDG 238
Query: 173 VPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 207
P + ++ +CW D RP+F Q+ + L + +
Sbjct: 239 CPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 6e-46
Identities = 62/212 (29%), Positives = 102/212 (48%), Gaps = 19/212 (8%)
Query: 4 QFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG 61
Q +G C + P I+TE ++ G L YL + + V + A I+ AME L
Sbjct: 280 QLLGVCTREPPFY-IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 338
Query: 62 IIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT---YRWMAPELYSTVTL 118
IHR+L N L+ E+ +K+ADFGL+R + + TA G +W APE +
Sbjct: 339 FIHRNLAARNCLVGENH-LVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLA---- 392
Query: 119 RQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-PSAENVPEE 176
++ K D ++F ++LWE+ + P+ G+ Q Y K+ R E PE+
Sbjct: 393 ----YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYELLEKDYRMERPEGCPEK 447
Query: 177 LSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 208
+ ++ +CW+ +P+ RP+F +I Q
Sbjct: 448 VYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 6e-45
Identities = 51/211 (24%), Positives = 92/211 (43%), Gaps = 22/211 (10%)
Query: 4 QFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI 62
+ +G C V ++T+L+ G L Y+ + + + + + IA+ M L +
Sbjct: 81 RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQIAKGMNYLEDRRL 138
Query: 63 IHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT---YRWMAPE--LYSTVT 117
+HRDL N+L+ +K+ DFGLA+ E G +WMA E L+
Sbjct: 139 VHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-- 195
Query: 118 LRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-PSAENVPE 175
Y H+ D +S+ + +WEL+ P++G+ + + K R P
Sbjct: 196 --------YTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLPQPPICTI 246
Query: 176 ELSIILTSCWKEDPNARPNFTQIIQMLLNYL 206
++ +I+ CW D ++RP F ++I
Sbjct: 247 DVYMIMRKCWMIDADSRPKFRELIIEFSKMA 277
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 7e-45
Identities = 69/235 (29%), Positives = 104/235 (44%), Gaps = 40/235 (17%)
Query: 4 QFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVA--------------IGFA 47
+GAC P+ VI E S G LR+YL RP ++ +
Sbjct: 105 NLLGACTQDGPLYVI-VEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCT 163
Query: 48 LDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT--- 104
+AR ME L S IHRDL N+L+TE+ +K+ADFGLAR+ + + T
Sbjct: 164 YQLARGMEYLASQKCIHRDLAARNVLVTENN-VMKIADFGLARDINNIDYYKKTTNGRLP 222
Query: 105 YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAF 163
+WMAPE L Y H+ D +SF +++WE+ P+ G+ + F
Sbjct: 223 VKWMAPE-----ALFDRV---YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL-----F 269
Query: 164 KNVR-----PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPE 213
K ++ N EL +++ CW P+ RP F Q+++ L L+ E
Sbjct: 270 KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEE 324
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 7e-45
Identities = 58/223 (26%), Positives = 95/223 (42%), Gaps = 28/223 (12%)
Query: 4 QFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG 61
IG E + ++ + G L +++ + + V I F L +AR ME L
Sbjct: 86 ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN-PTVKDLISFGLQVARGMEYLAEQK 144
Query: 62 IIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY-----RWMAPELYSTV 116
+HRDL N +L E T+K+ADFGLAR+ E + + + +W A E
Sbjct: 145 FVHRDLAARNCMLDESF-TVKVADFGLARDILDREYYSVQQHRHARLPVKWTALE----- 198
Query: 117 TLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-----PSA 170
+L+ + K D +SF ++LWELL P+ + + P
Sbjct: 199 SLQTYR---FTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDL-----THFLAQGRRLPQP 250
Query: 171 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPE 213
E P+ L ++ CW+ DP RP F ++ + +SA+
Sbjct: 251 EYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDH 293
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-44
Identities = 62/216 (28%), Positives = 98/216 (45%), Gaps = 29/216 (13%)
Query: 4 QFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI 62
+ IG + PV I+ EL + G LR +L + LD+ I +A ++ A+ L S
Sbjct: 80 KLIGVITENPVW-IIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAYLESKRF 137
Query: 63 IHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY--RWMAPE--LYSTVTL 118
+HRD+ N+L++ + +KL DFGL+R + A G +WMAPE +
Sbjct: 138 VHRDIAARNVLVSSND-CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF----- 191
Query: 119 RQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-----PSAEN 172
+ + D + F + +WE+L H PF+G+ N + P N
Sbjct: 192 -----RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV-----IGRIENGERLPMPPN 241
Query: 173 VPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 208
P L ++T CW DP+ RP FT++ L L
Sbjct: 242 CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-44
Identities = 60/216 (27%), Positives = 101/216 (46%), Gaps = 32/216 (14%)
Query: 4 QFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG 61
Q G C + P+ I+TE ++ G L YL MR R + D+ AME L S
Sbjct: 83 QLYGVCTKQRPIF-IITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLESKQ 140
Query: 62 IIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT---YRWMAPE--LYSTV 116
+HRDL N L+ + +K++DFGL+R E T+ G+ RW PE +YS
Sbjct: 141 FLHRDLAARNCLVNDQG-VVKVSDFGLSRYVLDDEY-TSSVGSKFPVRWSPPEVLMYSK- 197
Query: 117 TLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-----PSA 170
++ K D ++F +++WE+ K+P+E +N + +++
Sbjct: 198 ---------FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET-----AEHIAQGLRLYRP 243
Query: 171 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 206
E++ I+ SCW E + RP F ++ +L+ +
Sbjct: 244 HLASEKVYTIMYSCWHEKADERPTFKILLSNILDVM 279
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-44
Identities = 61/218 (27%), Positives = 94/218 (43%), Gaps = 32/218 (14%)
Query: 4 QFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG 61
+F G C + P+ IVTE +S G L YL + L+ + D+ M L SH
Sbjct: 67 KFYGVCSKEYPIY-IVTEYISNGCLLNYLRSHGKG-LEPSQLLEMCYDVCEGMAFLESHQ 124
Query: 62 IIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT---YRWMAPE--LYSTV 116
IHRDL N L+ DL +K++DFG+ R + + GT +W APE Y
Sbjct: 125 FIHRDLAARNCLVDRDL-CVKVSDFGMTRYVLDDQ-YVSSVGTKFPVKWSAPEVFHYFK- 181
Query: 117 TLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-----PSA 170
Y+ K D ++F I++WE+ K+P++ +N + V
Sbjct: 182 ---------YSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE-----VVLKVSQGHRLYRP 227
Query: 171 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 208
+ + I+ SCW E P RP F Q++ +
Sbjct: 228 HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 2e-44
Identities = 60/218 (27%), Positives = 98/218 (44%), Gaps = 32/218 (14%)
Query: 4 QFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG 61
Q G C + P+ +VTE + G L YL R +G LD+ M L
Sbjct: 67 QLYGVCLEQAPIC-LVTEFMEHGCLSDYLRTQRGL-FAAETLLGMCLDVCEGMAYLEEAC 124
Query: 62 IIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT---YRWMAPE--LYSTV 116
+IHRDL N L+ E+ IK++DFG+ R + T+ TGT +W +PE +S
Sbjct: 125 VIHRDLAARNCLVGENQ-VIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFSR- 181
Query: 117 TLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-----PSA 170
Y+ K D +SF +++WE+ K+P+E SN + +++
Sbjct: 182 ---------YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV-----VEDISTGFRLYKP 227
Query: 171 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 208
+ I+ CW+E P RP F+++++ L +
Sbjct: 228 RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 3e-44
Identities = 75/260 (28%), Positives = 112/260 (43%), Gaps = 45/260 (17%)
Query: 4 QFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVA--------------IGFA 47
+GAC P+ VI E S G LR+YL RP L+ + A
Sbjct: 139 NLLGACTQDGPLYVI-VEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCA 197
Query: 48 LDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT--- 104
+AR ME L S IHRDL N+L+TED +K+ADFGLAR+ + T
Sbjct: 198 YQVARGMEYLASKKCIHRDLAARNVLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLP 256
Query: 105 YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAF 163
+WMAPE L Y H+ D +SF ++LWE+ P+ G+ + F
Sbjct: 257 VKWMAPE-----ALFDRI---YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL-----F 303
Query: 164 KNVR-----PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIPH 218
K ++ N EL +++ CW P+ RP F Q+++ L ++ + E
Sbjct: 304 KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE----- 358
Query: 219 RIFNSENTILPPESPGTSSL 238
+ + + P T +L
Sbjct: 359 MGYYHHHHHHDYDIPTTENL 378
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 5e-44
Identities = 69/235 (29%), Positives = 104/235 (44%), Gaps = 40/235 (17%)
Query: 4 QFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVA--------------IGFA 47
+GAC P+ VI E S G LR+YL RP ++ +
Sbjct: 151 NLLGACTQDGPLYVI-VEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCT 209
Query: 48 LDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT--- 104
+AR ME L S IHRDL N+L+TE+ +K+ADFGLAR+ + + T
Sbjct: 210 YQLARGMEYLASQKCIHRDLAARNVLVTENN-VMKIADFGLARDINNIDYYKKTTNGRLP 268
Query: 105 YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAF 163
+WMAPE L Y H+ D +SF +++WE+ P+ G+ + F
Sbjct: 269 VKWMAPE-----ALFDRV---YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL-----F 315
Query: 164 KNVR-----PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPE 213
K ++ N EL +++ CW P+ RP F Q+++ L L+ E
Sbjct: 316 KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEE 370
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 6e-44
Identities = 58/223 (26%), Positives = 95/223 (42%), Gaps = 28/223 (12%)
Query: 4 QFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG 61
+G C E ++V + G LR ++ N V IGF L +A+ M+ L S
Sbjct: 90 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-PTVKDLIGFGLQVAKGMKYLASKK 148
Query: 62 IIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY-----RWMAPELYSTV 116
+HRDL N +L E T+K+ADFGLAR+ E + T +WMA E
Sbjct: 149 FVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE----- 202
Query: 117 TLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-----PSA 170
+L+ + + K D +SF ++LWEL+ P+ ++ +
Sbjct: 203 SLQTQK---FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI-----TVYLLQGRRLLQP 254
Query: 171 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPE 213
E P+ L ++ CW RP+F++++ + S
Sbjct: 255 EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 297
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-43
Identities = 57/248 (22%), Positives = 104/248 (41%), Gaps = 25/248 (10%)
Query: 4 QFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI 62
+ +G C V ++T+L+ G L Y+ + + + + + IA+ M L +
Sbjct: 81 RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQIAKGMNYLEDRRL 138
Query: 63 IHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT---YRWMAPE--LYSTVT 117
+HRDL N+L+ +K+ DFGLA+ E G +WMA E L+
Sbjct: 139 VHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-- 195
Query: 118 LRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-PSAENVPE 175
Y H+ D +S+ + +WEL+ P++G+ + + K R P
Sbjct: 196 --------YTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLPQPPICTI 246
Query: 176 ELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIPHRIFNSENTILPPESPGT 235
++ +I+ CW D ++RP F ++I P+ + + + P +S
Sbjct: 247 DVYMIMVKCWMIDADSRPKFRELIIEFSKMARD---PQRYLVIQGDERMHLPSPTDSNFY 303
Query: 236 SSLMTVRD 243
+LM D
Sbjct: 304 RALMDEED 311
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 3e-43
Identities = 64/245 (26%), Positives = 109/245 (44%), Gaps = 35/245 (14%)
Query: 4 QFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG 61
+ G +P+M I+TE + G L K+L V +G IA M+ L +
Sbjct: 110 RLEGVISKYKPMM-IITEYMENGALDKFLREKDGE-FSVLQLVGMLRGIAAGMKYLANMN 167
Query: 62 IIHRDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAETGT---YRWMAPE--LYST 115
+HRDL N+L+ +L K++DFGL+R E E +G RW APE Y
Sbjct: 168 YVHRDLAARNILVNSNL-VCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY-- 224
Query: 116 VTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-----PS 169
+ + D +SF IV+WE++ + + P+ +SN + K + P+
Sbjct: 225 --------RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV-----MKAINDGFRLPT 271
Query: 170 AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIPHRIFNSENTILP 229
+ P + ++ CW+++ RP F I+ +L + A P+ + F+ +I
Sbjct: 272 PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA---PDSLKTLADFDPRVSIRL 328
Query: 230 PESPG 234
P + G
Sbjct: 329 PSTSG 333
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 3e-43
Identities = 68/249 (27%), Positives = 112/249 (44%), Gaps = 40/249 (16%)
Query: 4 QFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRC--------LDVCVAIGFALDIARA 53
+ +G +P +VI EL++ G L+ YL ++RP + I A +IA
Sbjct: 92 RLLGVVSQGQPTLVI-MELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150
Query: 54 MECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY---RWMAP 110
M L+++ +HRDL N ++ ED T+K+ DFG+ R+ T+ RWM+P
Sbjct: 151 MAYLNANKFVHRDLAARNCMVAEDF-TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 209
Query: 111 ELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-- 167
E +L+ G + D +SF +VLWE+ + P++G+SN Q + V
Sbjct: 210 E-----SLKDGV---FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV-----LRFVMEG 256
Query: 168 ---PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIPHRIFNSE 224
+N P+ L ++ CW+ +P RP+F +II + + EP F
Sbjct: 257 GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM------EPGFREVSFYYS 310
Query: 225 NTILPPESP 233
PE
Sbjct: 311 EENKLPEPE 319
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 3e-43
Identities = 59/216 (27%), Positives = 92/216 (42%), Gaps = 29/216 (13%)
Query: 4 QFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI 62
+ IG +EP I+ EL G L YL + L V + ++L I +AM L S
Sbjct: 77 KLIGIIEEEPTW-IIMELYPYGELGHYLERNKNS-LKVLTLVLYSLQICKAMAYLESINC 134
Query: 63 IHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY--RWMAPE--LYSTVTL 118
+HRD+ N+L+ +KL DFGL+R + A +WM+PE +
Sbjct: 135 VHRDIAVRNILVASPE-CVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRR--- 190
Query: 119 RQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-----PSAEN 172
+ D + FA+ +WE+L K PF + N + P +
Sbjct: 191 -------FTTASDVWMFAVCMWEILSFGKQPFFWLENKDV-----IGVLEKGDRLPKPDL 238
Query: 173 VPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 208
P L ++T CW DP+ RP FT+++ L +
Sbjct: 239 CPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 4e-43
Identities = 62/214 (28%), Positives = 98/214 (45%), Gaps = 25/214 (11%)
Query: 4 QFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI 62
+ IG + PV I+ EL + G LR +L + LD+ I +A ++ A+ L S
Sbjct: 455 KLIGVITENPVW-IIMELCTLGELRSFLQVRKFS-LDLASLILYAYQLSTALAYLESKRF 512
Query: 63 IHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY--RWMAPELYSTVTLRQ 120
+HRD+ N+L++ + +KL DFGL+R + A G +WMAPE ++
Sbjct: 513 VHRDIAARNVLVSSND-CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE-----SINF 566
Query: 121 GEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-----PSAENVP 174
+ D + F + +WE+L H PF+G+ N + P N P
Sbjct: 567 R---RFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-----VIGRIENGERLPMPPNCP 618
Query: 175 EELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 208
L ++T CW DP+ RP FT++ L L
Sbjct: 619 PTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 4e-43
Identities = 54/251 (21%), Positives = 98/251 (39%), Gaps = 26/251 (10%)
Query: 4 QFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI 62
+ +G C + +VT+ L G+L ++ R L + + + + IA+ M L HG+
Sbjct: 79 RLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGA-LGPQLLLNWGVQIAKGMYYLEEHGM 136
Query: 63 IHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT---YRWMAPELYSTVTLR 119
+HR+L N+LL +++ADFG+A + + +WMA E
Sbjct: 137 VHRNLAARNVLLKSPS-QVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHF---- 191
Query: 120 QGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-PSAENVPEEL 177
Y H+ D +S+ + +WEL+ P+ G+ + K R + ++
Sbjct: 192 ----GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE-VPDLLEKGERLAQPQICTIDV 246
Query: 178 SIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIPHRIFNSENTILPPESPGTSS 237
+++ CW D N RP F ++ P R + P +PG
Sbjct: 247 YMVMVKCWMIDENIRPTFKELANEFTRMARD--------PPRYLVIKRESGPGIAPGPEP 298
Query: 238 LMTVRDDIGET 248
+ E
Sbjct: 299 HGLTNKKLEEV 309
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 5e-43
Identities = 58/223 (26%), Positives = 95/223 (42%), Gaps = 28/223 (12%)
Query: 4 QFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG 61
+G C E ++V + G LR ++ N V IGF L +A+ M+ L S
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-PTVKDLIGFGLQVAKGMKFLASKK 212
Query: 62 IIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY-----RWMAPELYSTV 116
+HRDL N +L E T+K+ADFGLAR+ E + T +WMA E
Sbjct: 213 FVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE----- 266
Query: 117 TLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-----PSA 170
+L+ + + K D +SF ++LWEL+ P+ ++ +
Sbjct: 267 SLQTQK---FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI-----TVYLLQGRRLLQP 318
Query: 171 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPE 213
E P+ L ++ CW RP+F++++ + S
Sbjct: 319 EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 361
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 5e-43
Identities = 50/187 (26%), Positives = 82/187 (43%), Gaps = 14/187 (7%)
Query: 16 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 75
I E GTL +++ R LD +A+ I + ++ +HS +I+RDLKP N+ L
Sbjct: 97 IQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLV 156
Query: 76 EDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSF 135
+ K +K+ DFGL T GT R+M+PE + Y +VD Y+
Sbjct: 157 DT-KQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQI--------SSQDYGKEVDLYAL 207
Query: 136 AIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNF 195
++L ELLH S + + ++ +L + P RPN
Sbjct: 208 GLILAELLHVCDTAFETSKF---FTDLRDGIISD--IFDKKEKTLLQKLLSKKPEDRPNT 262
Query: 196 TQIIQML 202
++I++ L
Sbjct: 263 SEILRTL 269
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 1e-42
Identities = 67/228 (29%), Positives = 96/228 (42%), Gaps = 33/228 (14%)
Query: 4 QFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVA----------------IG 45
+GAC P +VI TE G L +L R + + +
Sbjct: 91 NLLGACTIGGPTLVI-TEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 46 FALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT- 104
F+ +A+ M L S IHRDL N+LLT K+ DFGLAR+ +
Sbjct: 150 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGR-ITKICDFGLARDIKNDSNYVVKGNAR 208
Query: 105 --YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAA 161
+WMAPE ++ Y + D +S+ I LWEL P+ GM Y
Sbjct: 209 LPVKWMAPE-----SIFNCV---YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 260
Query: 162 AFKNVR-PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 208
+ R S E+ P E+ I+ +CW DP RP F QI+Q++ +S
Sbjct: 261 IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 1e-42
Identities = 60/236 (25%), Positives = 100/236 (42%), Gaps = 24/236 (10%)
Query: 4 QFIGAC-------KEPVMVIVTELLSGGTLRKYLLNMRP----RCLDVCVAIGFALDIAR 52
+ +G + P+ +++ + G L +LL R L + + F +DIA
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 53 AMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT---YRWMA 109
ME L S IHRDL N +L ED+ T+ +ADFGL+R+ + + +W+A
Sbjct: 149 GMEYLSSRNFIHRDLAARNCMLAEDM-TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLA 207
Query: 110 PELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVRP 168
E +L Y D ++F + +WE++ + P+ G+ N + N
Sbjct: 208 LE-----SLADNL---YTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLK 259
Query: 169 SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIPHRIFNSE 224
EE+ ++ CW DP RP+FT + L N L ++ N E
Sbjct: 260 QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDPLYINIE 315
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 2e-42
Identities = 56/219 (25%), Positives = 92/219 (42%), Gaps = 26/219 (11%)
Query: 4 QFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI 62
+ G P+ +VTEL G+L L + + +A+ +A M L S
Sbjct: 85 RLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGH-FLLGTLSRYAVQVAEGMGYLESKRF 142
Query: 63 IHRDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAETGT---YRWMAPE--LYSTV 116
IHRDL NLLL +K+ DFGL R + + + W APE T
Sbjct: 143 IHRDLAARNLLLATRD-LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT- 200
Query: 117 TLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-PSAENVP 174
++H D++ F + LWE+ + + P+ G++ Q + + R P E+ P
Sbjct: 201 ---------FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCP 251
Query: 175 EELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPE 213
+++ ++ CW P RP F L ++L P +
Sbjct: 252 QDIYNVMVQCWAHKPEDRPTFVA----LRDFLLEAQPTD 286
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-42
Identities = 56/225 (24%), Positives = 98/225 (43%), Gaps = 33/225 (14%)
Query: 4 QFIGAC------KEPVMVIVTELLSGGTLRKYLLNMRPRC----LDVCVAIGFALDIARA 53
+ +G C P +++ + G L YLL R + + + F +DIA
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 54 MECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT---YRWMAP 110
ME L + +HRDL N +L +D+ T+ +ADFGL+++ + +W+A
Sbjct: 160 MEYLSNRNFLHRDLAARNCMLRDDM-TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAI 218
Query: 111 ELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-- 167
E +L Y K D ++F + +WE+ P+ G+ N + + +
Sbjct: 219 E-----SLADRV---YTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE-----MYDYLLHG 265
Query: 168 ---PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 209
E+ +EL I+ SCW+ DP RP F+ + L L ++
Sbjct: 266 HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-42
Identities = 53/217 (24%), Positives = 94/217 (43%), Gaps = 23/217 (10%)
Query: 4 QFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI 62
+ IG C E +M +V E+ GG L K+L+ R + V ++ M+ L
Sbjct: 74 RLIGVCQAEALM-LVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYLEEKNF 131
Query: 63 IHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMM-TAETGT---YRWMAPE--LYSTV 116
+HRDL N+LL K++DFGL++ + TA + +W APE +
Sbjct: 132 VHRDLAARNVLLVNRH-YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK- 189
Query: 117 TLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-PSAENVP 174
++ + D +S+ + +WE L + + P++ M + A + R P
Sbjct: 190 ---------FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV-MAFIEQGKRMECPPECP 239
Query: 175 EELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAP 211
EL +++ CW RP+F + Q + ++A
Sbjct: 240 PELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 276
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-42
Identities = 57/232 (24%), Positives = 98/232 (42%), Gaps = 44/232 (18%)
Query: 4 QFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVA--------------IGFA 47
+F G C +P++ +V E + G L K+L P + + + A
Sbjct: 81 KFYGVCGDGDPLI-MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 48 LDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY-- 105
IA M L S +HRDL N L+ +L +K+ DFG++R+ T+ T
Sbjct: 140 SQIASGMVYLASQHFVHRDLATRNCLVGANL-LVKIGDFGMSRDVYSTDYYRVGGHTMLP 198
Query: 106 -RWMAPE--LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAA 161
RWM PE +Y + + D +SF ++LWE+ + K P+ +SN +
Sbjct: 199 IRWMPPESIMYRK----------FTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV---- 244
Query: 162 AFKNVR-----PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 208
+ + P+E+ ++ CW+ +P R N +I ++L A
Sbjct: 245 -IECITQGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHALGKA 295
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 3e-42
Identities = 63/235 (26%), Positives = 99/235 (42%), Gaps = 40/235 (17%)
Query: 4 QFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRC-----LDVCVAIGFALDIARAMEC 56
+ IG P I+ EL++GG L+ +L RPR L + + A DIA +
Sbjct: 97 RCIGVSLQSLPRF-ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 57 LHSHGIIHRDLKPENLLLT---EDLKTIKLADFGLAREESLTEMMTAETGTY---RWMAP 110
L + IHRD+ N LLT K+ DFG+AR+ +WM P
Sbjct: 156 LEENHFIHRDIAARNCLLTCPGPGR-VAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 214
Query: 111 ELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-- 167
E +G + K D++SF ++LWE+ +P+ SN + + V
Sbjct: 215 E-----AFMEG---IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV-----LEFVTSG 261
Query: 168 ---PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL------NYLSAIAPPE 213
+N P + I+T CW+ P RPNF I++ + + ++ P E
Sbjct: 262 GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIE 316
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 4e-42
Identities = 63/232 (27%), Positives = 98/232 (42%), Gaps = 47/232 (20%)
Query: 4 QFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVA--------------IGFA 47
+GAC + + + E G L +L R D A + FA
Sbjct: 90 NLLGACEHRGYLY-LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 48 LDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT--- 104
D+AR M+ L IHRDL N+L+ E+ K+ADFGL+R + E+ +T
Sbjct: 149 ADVARGMDYLSQKQFIHRDLAARNILVGENY-VAKIADFGLSRGQ---EVYVKKTMGRLP 204
Query: 105 YRWMAPE--LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAA 161
RWMA E YS Y D +S+ ++LWE++ P+ GM+ +
Sbjct: 205 VRWMAIESLNYSV----------YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE----- 249
Query: 162 AFKNVR-----PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 208
++ + N +E+ ++ CW+E P RP+F QI+ L L
Sbjct: 250 LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 301
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 5e-42
Identities = 63/235 (26%), Positives = 99/235 (42%), Gaps = 40/235 (17%)
Query: 4 QFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRC-----LDVCVAIGFALDIARAMEC 56
+ IG P I+ EL++GG L+ +L RPR L + + A DIA +
Sbjct: 138 RCIGVSLQSLPRF-ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 57 LHSHGIIHRDLKPENLLLT---EDLKTIKLADFGLAREESLTEMMTAETGTY---RWMAP 110
L + IHRD+ N LLT K+ DFG+AR+ +WM P
Sbjct: 197 LEENHFIHRDIAARNCLLTCPGPGR-VAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPP 255
Query: 111 ELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-- 167
E +G + K D++SF ++LWE+ +P+ SN + + V
Sbjct: 256 E-----AFMEGI---FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV-----LEFVTSG 302
Query: 168 ---PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL------NYLSAIAPPE 213
+N P + I+T CW+ P RPNF I++ + + ++ P E
Sbjct: 303 GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIE 357
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 5e-42
Identities = 59/224 (26%), Positives = 97/224 (43%), Gaps = 31/224 (13%)
Query: 4 QFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG 61
+ G M IVTE + G+L +L + + +G + M L G
Sbjct: 114 RLEGVVTRGRLAM-IVTEYMENGSLDTFLRTHDGQ-FTIMQLVGMLRGVGAGMRYLSDLG 171
Query: 62 IIHRDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAETGT---YRWMAPELYSTVT 117
+HRDL N+L+ +L K++DFGL+R E + TG RW APE
Sbjct: 172 YVHRDLAARNVLVDSNL-VCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPE-----A 225
Query: 118 LRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-----PSAE 171
+ ++ D +SF +V+WE+L + + P+ M+N +V P+
Sbjct: 226 IAFR---TFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD-----VISSVEEGYRLPAPM 277
Query: 172 NVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPM 215
P L ++ CW +D RP F+QI+ +L + + PE +
Sbjct: 278 GCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS---PESL 318
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 6e-42
Identities = 53/229 (23%), Positives = 93/229 (40%), Gaps = 39/229 (17%)
Query: 4 QFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVA-------------IGFAL 48
+F G C P++++ E + G L ++L + P + + A
Sbjct: 107 RFFGVCTEGRPLLMV-FEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 49 DIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY--- 105
+A M L +HRDL N L+ + L +K+ DFG++R+ T+ T
Sbjct: 166 QVAAGMVYLAGLHFVHRDLATRNCLVGQGL-VVKIGDFGMSRDIYSTDYYRVGGRTMLPI 224
Query: 106 RWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFK 164
RWM PE ++ + + + D +SF +VLWE+ + K P+ +SN +A
Sbjct: 225 RWMPPE-----SILYRK---FTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA-----ID 271
Query: 165 NVR-----PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 208
+ P E+ I+ CW+ +P R + + L A
Sbjct: 272 CITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 8e-42
Identities = 58/216 (26%), Positives = 89/216 (41%), Gaps = 24/216 (11%)
Query: 4 QFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI 62
+ IG C E M +V E+ G L KYL R + I ++ M+ L
Sbjct: 82 RMIGICEAESWM-LVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLEESNF 138
Query: 63 IHRDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAETGT---YRWMAPE--LYSTV 116
+HRDL N+LL K++DFGL++ + A+T +W APE Y
Sbjct: 139 VHRDLAARNVLLVTQH-YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK- 196
Query: 117 TLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-PSAENVP 174
++ K D +SF +++WE + + P+ GM + A K R P
Sbjct: 197 ---------FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV-TAMLEKGERMGCPAGCP 246
Query: 175 EELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIA 210
E+ ++ CW D RP F + L NY +
Sbjct: 247 REMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 282
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 1e-41
Identities = 68/247 (27%), Positives = 103/247 (41%), Gaps = 38/247 (15%)
Query: 4 QFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG 61
+ G +PVM IVTE + G+L +L + V +G IA M+ L G
Sbjct: 110 RLEGVVTKSKPVM-IVTEYMENGSLDSFLRKHDAQ-FTVIQLVGMLRGIASGMKYLSDMG 167
Query: 62 IIHRDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAETGT---YRWMAPE--LYST 115
+HRDL N+L+ +L K++DFGL R E E G RW +PE Y
Sbjct: 168 YVHRDLAARNILINSNL-VCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY-- 224
Query: 116 VTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-----PS 169
+ + D +S+ IVLWE++ + + P+ MSN K V P
Sbjct: 225 --------RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV-----IKAVDEGYRLPP 271
Query: 170 AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY------LSAIAPPEPMIPHRIFNS 223
+ P L ++ CW++D N RP F QI+ +L L I + + +
Sbjct: 272 PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAARPSNLLLDQ 331
Query: 224 ENTILPP 230
N +
Sbjct: 332 SNVDITT 338
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 1e-41
Identities = 65/232 (28%), Positives = 102/232 (43%), Gaps = 32/232 (13%)
Query: 4 QFIGAC---KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVA--------------IGF 46
+GAC P+MVI E G L YL + R + VA I +
Sbjct: 95 NLLGACTKPGGPLMVI-VEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 153
Query: 47 ALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT-- 104
+ +A+ ME L S IHRDL N+LL+E +K+ DFGLAR+ +
Sbjct: 154 SFQVAKGMEFLASRKCIHRDLAARNILLSEKN-VVKICDFGLARDIYKDPDYVRKGDARL 212
Query: 105 -YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAA 162
+WMAPE T+ Y + D +SF ++LWE+ P+ G+ +
Sbjct: 213 PLKWMAPE-----TIFDRV---YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 264
Query: 163 FKNVR-PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPE 213
+ R + + E+ + CW +P+ RP F+++++ L N L A A +
Sbjct: 265 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQD 316
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-41
Identities = 55/227 (24%), Positives = 93/227 (40%), Gaps = 40/227 (17%)
Query: 4 QFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVA--------------IGFA 47
+G +P+ ++ S G L ++L+ P +
Sbjct: 76 CLLGVVTKDQPLS-MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 48 LDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY-- 105
IA ME L SH ++H+DL N+L+ + L +K++D GL RE + +
Sbjct: 135 AQIAAGMEYLSSHHVVHKDLATRNVLVYDKL-NVKISDLGLFREVYAADYYKLLGNSLLP 193
Query: 106 -RWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAF 163
RWMAPE + G ++ D +S+ +VLWE+ + P+ G SN
Sbjct: 194 IRWMAPE-----AIMYG---KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV-----V 240
Query: 164 KNVR-----PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 205
+ +R P ++ P + ++ CW E P+ RP F I L +
Sbjct: 241 EMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 287
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 2e-41
Identities = 58/237 (24%), Positives = 101/237 (42%), Gaps = 48/237 (20%)
Query: 4 QFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVA------------------ 43
+ GAC P+++IV E G+LR +L R +
Sbjct: 90 KLYGACSQDGPLLLIV-EYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 44 ----IGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMT 99
I FA I++ M+ L ++HRDL N+L+ E +K++DFGL+R+ +
Sbjct: 149 MGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGR-KMKISDFGLSRDVYEEDSYV 207
Query: 100 AETGT---YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNL 155
+ +WMA E +L Y + D +SF ++LWE++ P+ G+
Sbjct: 208 KRSQGRIPVKWMAIE-----SLFDHI---YTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE 259
Query: 156 QAAYAAAFKNVR-----PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 207
+ F ++ +N EE+ ++ CWK++P+ RP F I + L +
Sbjct: 260 RL-----FNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 3e-41
Identities = 60/229 (26%), Positives = 90/229 (39%), Gaps = 39/229 (17%)
Query: 4 QFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVA------------IGFALD 49
+GAC PV+VI TE G L +L + F+
Sbjct: 114 NLLGACTHGGPVLVI-TEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQ 172
Query: 50 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT---YR 106
+A+ M L S IHRD+ N+LLT K+ DFGLAR+ + +
Sbjct: 173 VAQGMAFLASKNCIHRDVAARNVLLTNGH-VAKIGDFGLARDIMNDSNYIVKGNARLPVK 231
Query: 107 WMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEG-MSNLQAAYAAAFK 164
WMAPE ++ Y + D +S+ I+LWE+ P+ G + N + +K
Sbjct: 232 WMAPE-----SIFDCV---YTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK-----FYK 278
Query: 165 NVR-----PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 208
V+ P+ + I+ +CW +P RP F QI L
Sbjct: 279 LVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 4e-41
Identities = 63/232 (27%), Positives = 94/232 (40%), Gaps = 38/232 (16%)
Query: 4 QFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVA------------------ 43
+GAC P+ +I E G L YL + R + + +
Sbjct: 113 NLLGACTLSGPIYLI-FEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 171
Query: 44 ---IGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTA 100
+ FA +A+ ME L +HRDL N+L+T K +K+ DFGLAR+
Sbjct: 172 EDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHG-KVVKICDFGLARDIMSDSNYVV 230
Query: 101 ETGT---YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQ 156
+WMAPE +L +G Y K D +S+ I+LWE+ P+ G+
Sbjct: 231 RGNARLPVKWMAPE-----SLFEGI---YTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 282
Query: 157 AAYAAAFKNVR-PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 207
Y + EE+ II+ SCW D RP+F + L L+
Sbjct: 283 NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA 334
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 4e-40
Identities = 57/245 (23%), Positives = 100/245 (40%), Gaps = 48/245 (19%)
Query: 4 QFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVA------------------ 43
+ +G C +P+ ++ E ++ G L ++L +M P +
Sbjct: 114 KLLGVCAVGKPMCLL-FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 44 ----IGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMT 99
+ A +A M L +HRDL N L+ E++ +K+ADFGL+R +
Sbjct: 173 CAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENM-VVKIADFGLSRNIYSADYYK 231
Query: 100 AETGTY---RWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNL 155
A+ RWM PE ++ Y + D +++ +VLWE+ + P+ GM++
Sbjct: 232 ADGNDAIPIRWMPPE-----SIFYNR---YTTESDVWAYGVVLWEIFSYGLQPYYGMAHE 283
Query: 156 QAAYAAAFKNVR-----PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIA 210
+ VR EN P EL ++ CW + P RP+F I ++L
Sbjct: 284 EV-----IYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE 338
Query: 211 PPEPM 215
+
Sbjct: 339 GTVGV 343
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-39
Identities = 53/238 (22%), Positives = 91/238 (38%), Gaps = 49/238 (20%)
Query: 4 QFIGAC----KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS 59
++ G C + + ++ E L G+LR YL + R +D + + I + ME L +
Sbjct: 75 KYKGVCYSAGRRNLK-LIMEYLPYGSLRDYLQKHKER-IDHIKLLQYTSQICKGMEYLGT 132
Query: 60 HGIIHRDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAETGT---YRWMAPE--LY 113
IHRDL N+L+ + +K+ DFGL + E + W APE
Sbjct: 133 KRYIHRDLATRNILVENEN-RVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTE 191
Query: 114 STVTLRQGEKKHYNHKVDSYSFAIVLWELL----------------HNKLPFEGMSNLQA 157
S ++ D +SF +VL+EL M
Sbjct: 192 SK----------FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH- 240
Query: 158 AYAAAFKNVR-----PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIA 210
+ ++ P + P+E+ +I+T CW + N RP+F + + +A
Sbjct: 241 ----LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 294
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-39
Identities = 47/206 (22%), Positives = 77/206 (37%), Gaps = 14/206 (6%)
Query: 14 MVIVTELLSGGTLRKYLL-NMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENL 72
V++ E G+L L L + D+ M L +GI+HR++KP N+
Sbjct: 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNI 143
Query: 73 LLTEDL---KTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK 129
+ KL DFG ARE E + GT ++ P++Y LR+ +K Y
Sbjct: 144 MRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGAT 203
Query: 130 VDSYSFAIVLWELLHNKLPFEG----------MSNLQAAYAAAFKNVRPSAENVPEELSI 179
VD +S + + LPF M + + + AEN P + S
Sbjct: 204 VDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSG 263
Query: 180 ILTSCWKEDPNARPNFTQIIQMLLNY 205
+ + T ++ +L
Sbjct: 264 DMPVSCSLSRGLQVLLTPVLANILEA 289
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 2e-39
Identities = 53/238 (22%), Positives = 91/238 (38%), Gaps = 49/238 (20%)
Query: 4 QFIGAC----KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS 59
++ G C + + ++ E L G+LR YL + R +D + + I + ME L +
Sbjct: 106 KYKGVCYSAGRRNLK-LIMEYLPYGSLRDYLQKHKER-IDHIKLLQYTSQICKGMEYLGT 163
Query: 60 HGIIHRDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAETGT---YRWMAPE--LY 113
IHRDL N+L+ + +K+ DFGL + E + W APE
Sbjct: 164 KRYIHRDLATRNILVENEN-RVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTE 222
Query: 114 STVTLRQGEKKHYNHKVDSYSFAIVLWELL----------------HNKLPFEGMSNLQA 157
S ++ D +SF +VL+EL M
Sbjct: 223 SK----------FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH- 271
Query: 158 AYAAAFKNVR-----PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIA 210
+ ++ P + P+E+ +I+T CW + N RP+F + + +A
Sbjct: 272 ----LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMA 325
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-39
Identities = 50/229 (21%), Positives = 94/229 (41%), Gaps = 48/229 (20%)
Query: 4 QFIGAC----KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS 59
++ G C + ++ E L G+L++YL + + +++ + +A+ I + M+ L S
Sbjct: 87 KYKGICTEDGGNGIK-LIMEFLPSGSLKEYLPKNKNK-INLKQQLKYAVQICKGMDYLGS 144
Query: 60 HGIIHRDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAETGT---YRWMAPE--LY 113
+HRDL N+L+ + +K+ DFGL + E+ E T + W APE +
Sbjct: 145 RQYVHRDLAARNVLVESEH-QVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQ 203
Query: 114 STVTLRQGEKKHYNHKVDSYSFAIVLWELL---------------HNKLPFEGMSNLQAA 158
S + D +SF + L ELL M+ +
Sbjct: 204 SK----------FYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR-- 251
Query: 159 YAAAFKNVR-----PSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 202
++ P N P+E+ ++ CW+ P+ R +F +I+
Sbjct: 252 ---LVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGF 297
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-39
Identities = 50/203 (24%), Positives = 82/203 (40%), Gaps = 29/203 (14%)
Query: 16 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 75
I E GTL + + I A+ +HS GIIHRDLKP N+ +
Sbjct: 92 IQMEYCENGTLYDLIHS-ENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFID 150
Query: 76 EDLKTIKLADFGLAR---------------EESLTEMMTAETGTYRWMAPELYSTVTLRQ 120
E + +K+ DFGLA+ ++ +T+ GT ++A E+
Sbjct: 151 ES-RNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLD------ 203
Query: 121 GEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN---LQAAYAAAFKNVRPSAENVPEEL 177
HYN K+D YS I+ +E+++ GM L+ + + + +N +
Sbjct: 204 -GTGHYNEKIDMYSLGIIFFEMIY--PFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVE 260
Query: 178 SIILTSCWKEDPNARPNFTQIIQ 200
I+ DPN RP ++
Sbjct: 261 KKIIRLLIDHDPNKRPGARTLLN 283
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 4e-39
Identities = 50/216 (23%), Positives = 94/216 (43%), Gaps = 21/216 (9%)
Query: 4 QFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 63
+ IG C+ +++V E+ GG L K+L+ R + V ++ M+ L +
Sbjct: 400 RLIGVCQAEALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYLEEKNFV 458
Query: 64 HRDLKPENLLLTEDLKTIKLADFGLAREESLTEMM-TAETGT---YRWMAPE--LYSTVT 117
HR+L N+LL K++DFGL++ + TA + +W APE +
Sbjct: 459 HRNLAARNVLLVNRH-YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK-- 515
Query: 118 LRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-PSAENVPE 175
++ + D +S+ + +WE L + + P++ M + A + R P
Sbjct: 516 --------FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV-MAFIEQGKRMECPPECPP 566
Query: 176 ELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAP 211
EL +++ CW RP+F + Q + ++A
Sbjct: 567 ELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 602
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 4e-39
Identities = 55/241 (22%), Positives = 89/241 (36%), Gaps = 50/241 (20%)
Query: 4 QFIGAC----KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS 59
++ G C + +V E + G+LR YL + + + FA I M LH+
Sbjct: 97 KYKGCCEDAGAASLQ-LVMEYVPLGSLRDYL---PRHSIGLAQLLLFAQQICEGMAYLHA 152
Query: 60 HGIIHRDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAETGT---YRWMAPE--LY 113
IHRDL N+LL D +K+ DFGLA+ E W APE
Sbjct: 153 QHYIHRDLAARNVLLDNDR-LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE 211
Query: 114 STVTLRQGEKKHYNHKVDSYSFAIVLWELL---------------HNKLPFEGMSNLQAA 158
+ + D +SF + L+ELL + M+ L+
Sbjct: 212 YK----------FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLR-- 259
Query: 159 YAAAFKNVR-----PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPE 213
+ + P + P E+ ++ +CW+ + + RP F +I +L
Sbjct: 260 ---LTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQA 316
Query: 214 P 214
P
Sbjct: 317 P 317
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 5e-39
Identities = 61/230 (26%), Positives = 105/230 (45%), Gaps = 22/230 (9%)
Query: 16 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 75
IV E + G TLR + P + AI D +A+ H +GIIHRD+KP N++++
Sbjct: 93 IVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS 150
Query: 76 EDLKTIKLADFGLAREESLTEMMTAET----GTYRWMAPELYSTVTLRQGEKKHYNHKVD 131
+K+ DFG+AR + + +T GT ++++PE Q + + D
Sbjct: 151 AT-NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE--------QARGDSVDARSD 201
Query: 132 SYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV-RPSAEN--VPEELSIILTSCWKED 188
YS VL+E+L + PF G S + AY ++ PSA + + +L ++ ++
Sbjct: 202 VYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKN 261
Query: 189 PNARP-NFTQIIQMLLNYLSAIAPPEPMIPHRIFNSENTILPPESPGTSS 237
P R ++ L+ + P P + ++E T L + G S
Sbjct: 262 PENRYQTAAEMRADLVRVHNGEPPEAPKVLT---DAERTSLLSSAAGNLS 308
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-38
Identities = 50/229 (21%), Positives = 83/229 (36%), Gaps = 18/229 (7%)
Query: 14 MVIVTELLSGGTLRKYLL-NMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENL 72
V++ E G+L L L + D+ M L +GI+HR++KP N+
Sbjct: 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNI 143
Query: 73 LLTEDL---KTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK 129
+ KL DFG ARE E + GT ++ P++Y LR+ +K Y
Sbjct: 144 MRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGAT 203
Query: 130 VDSYSFAIVLWELLHNKLPFEG----------MSNLQAAYAAAFKNVRPSAENVPEELSI 179
VD +S + + LPF M + + + AEN P + S
Sbjct: 204 VDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSG 263
Query: 180 ILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIPHRIFNSENTIL 228
+ + T ++ +L + + F + IL
Sbjct: 264 DMPVSCSLSRGLQVLLTPVLANILE----ADQEKCWGFDQFFAETSDIL 308
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-38
Identities = 47/222 (21%), Positives = 86/222 (38%), Gaps = 40/222 (18%)
Query: 4 QFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG 61
G C + + +V E + G+L YL + +++ + A +A AM L +
Sbjct: 76 LNYGVCVCGDENI-LVQEFVKFGSLDTYLKKNKNC-INILWKLEVAKQLAAAMHFLEENT 133
Query: 62 IIHRDLKPENLLLTEDLK-------TIKLADFGLAREESLTEMMTAETGTY----RWMAP 110
+IH ++ +N+LL + IKL+D G++ W+ P
Sbjct: 134 LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT-------VLPKDILQERIPWVPP 186
Query: 111 E--LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQA--AYAAAFKN 165
E K+ N D +SF LWE+ P + + + Y +
Sbjct: 187 ECIENP---------KNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQL 237
Query: 166 VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 207
P EL+ ++ +C +P+ RP+F II+ L + +
Sbjct: 238 PAPK----AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 3e-38
Identities = 53/236 (22%), Positives = 88/236 (37%), Gaps = 38/236 (16%)
Query: 4 QFIGAC----KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS 59
++ G ++ + +V E L G LR +L R R LD + ++ I + ME L S
Sbjct: 88 KYRGVSYGPGRQSLR-LVMEYLPSGCLRDFLQRHRAR-LDASRLLLYSSQICKGMEYLGS 145
Query: 60 HGIIHRDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAETGT---YRWMAPE--LY 113
+HRDL N+L+ + +K+ADFGLA+ + W APE
Sbjct: 146 RRCVHRDLAARNILVESEA-HVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSD 204
Query: 114 STVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR----- 167
+ ++ + D +SF +VL+EL + +
Sbjct: 205 NI----------FSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL 254
Query: 168 ---------PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEP 214
P+ P E+ ++ CW P RP+F+ + L S E
Sbjct: 255 ELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCET 310
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 5e-38
Identities = 53/204 (25%), Positives = 79/204 (38%), Gaps = 35/204 (17%)
Query: 16 IVTELLSGGTLRKYLLNMRPRC-LDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL 74
I +L L+ ++ + V + L IA A+E LHS G++HRDLKP N+
Sbjct: 92 IQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFF 151
Query: 75 TEDLKTIKLADFGLAR-------------EESLTEMMTAETGTYRWMAPELYSTVTLRQG 121
T D +K+ DFGL T + GT +M+PE
Sbjct: 152 TMD-DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQI-------- 202
Query: 122 EKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR-----PSAENVPEE 176
Y+HKVD +S ++L+ELL+ PF +VR P
Sbjct: 203 HGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTL----TDVRNLKFPPLFTQKYPC 255
Query: 177 LSIILTSCWKEDPNARPNFTQIIQ 200
+++ P RP II+
Sbjct: 256 EYVMVQDMLSPSPMERPEAINIIE 279
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-37
Identities = 58/229 (25%), Positives = 102/229 (44%), Gaps = 16/229 (6%)
Query: 16 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 75
IV + GG L K + + + + + I A++ +H I+HRD+K +N+ LT
Sbjct: 100 IVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLT 159
Query: 76 EDLKTIKLADFGLARE-ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYS 134
+D T++L DFG+AR S E+ A GT +++PE+ E K YN+K D ++
Sbjct: 160 KD-GTVQLGDFGIARVLNSTVELARACIGTPYYLSPEIC--------ENKPYNNKSDIWA 210
Query: 135 FAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPN 194
VL+EL K FE S + P + + +L +++ +K +P RP+
Sbjct: 211 LGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPS 270
Query: 195 FTQIIQM------LLNYLSAIAPPEPMIPHRIFNSENTILPPESPGTSS 237
I++ + +LS E + +P + P +
Sbjct: 271 VNSILEKGFIAKRIEKFLSPQLIAEEFCLKTFSKFGSQPIPAKRPASGQ 319
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-37
Identities = 54/199 (27%), Positives = 99/199 (49%), Gaps = 20/199 (10%)
Query: 10 KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG--IIHRDL 67
+ +V+VTEL++ GTL+ YL R + + + V + I + ++ LH+ IIHRDL
Sbjct: 100 GKKCIVLVTELMTSGTLKTYL--KRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDL 157
Query: 68 KPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYN 127
K +N+ +T ++K+ D GLA + + GT +MAPE+Y ++ Y+
Sbjct: 158 KCDNIFITGPTGSVKIGDLGLATLKRASFAKA-VIGTPEFMAPEMY---------EEKYD 207
Query: 128 HKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSA--ENVPEELSIILTSCW 185
VD Y+F + + E+ ++ P+ N Y V+P++ + E+ I+ C
Sbjct: 208 ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCI 267
Query: 186 KEDPNARPNFTQIIQMLLN 204
+++ + R + LLN
Sbjct: 268 RQNKDERYSIKD----LLN 282
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-37
Identities = 57/208 (27%), Positives = 98/208 (47%), Gaps = 18/208 (8%)
Query: 16 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 75
+V E + G TL +Y+ + P L V AI F I ++ H I+HRD+KP+N+L+
Sbjct: 88 LVMEYIEGPTLSEYIESHGP--LSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILID 145
Query: 76 EDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNHKVDSY 133
+ KT+K+ DFG+A+ S T + GT ++ +PE Q + + + D Y
Sbjct: 146 SN-KTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPE--------QAKGEATDECTDIY 196
Query: 134 SFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV--RPSAEN--VPEELSIILTSCWKEDP 189
S IVL+E+L + PF G + + A +V + +P+ LS ++ ++D
Sbjct: 197 SIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDK 256
Query: 190 NARP-NFTQIIQMLLNYLSAIAPPEPMI 216
R ++ L + L E +
Sbjct: 257 ANRYKTIQEMKDDLSSVLHENRANEDVY 284
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 5e-37
Identities = 51/201 (25%), Positives = 79/201 (39%), Gaps = 27/201 (13%)
Query: 16 IVTELLSGGTLRKYLLNMRPRC-LDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL 74
I +L L+ ++ + V + + IA A+E LHS G++HRDLKP N+
Sbjct: 138 IQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFF 197
Query: 75 TEDLKTIKLADFGLAR-------------EESLTEMMTAETGTYRWMAPELYSTVTLRQG 121
T D +K+ DFGL T + GT +M+PE Q
Sbjct: 198 TMD-DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPE--------QI 248
Query: 122 EKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSA-ENVPEELSII 180
+Y+HKVD +S ++L+ELL+ F P + ++
Sbjct: 249 HGNNYSHKVDIFSLGLILFELLY---SFSTQMERVRIITDVRNLKFPLLFTQKYPQEHMM 305
Query: 181 LTSCWKEDPNARPNFTQIIQM 201
+ P RP T II+
Sbjct: 306 VQDMLSPSPTERPEATDIIEN 326
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-35
Identities = 50/213 (23%), Positives = 89/213 (41%), Gaps = 24/213 (11%)
Query: 16 IVTELLSGGTLRKYLLNMRPR--CLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 73
++ GTL + ++ + L + L I R +E +H+ G HRDLKP N+L
Sbjct: 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNIL 166
Query: 74 LTEDLKTIKLADFGLAR----------EESLTEMMTAETGTYRWMAPELYSTVTLRQGEK 123
L ++ L D G + + A+ T + APEL +++
Sbjct: 167 LGDE-GQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPEL---FSVQSHCV 222
Query: 124 KHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR--PSAENVPEELSIIL 181
+ + D +S VL+ ++ + P++ + + A A +N P + L +L
Sbjct: 223 --IDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLL 280
Query: 182 TSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEP 214
S DP+ RP+ + L+ L A+ PP P
Sbjct: 281 NSMMTVDPHQRPHIPLL----LSQLEALQPPAP 309
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-35
Identities = 46/196 (23%), Positives = 87/196 (44%), Gaps = 19/196 (9%)
Query: 16 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 75
+V E L +L + +D + ++ A+ +H HGI+H DLKP N L+
Sbjct: 105 MVMEC-GNIDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV 161
Query: 76 EDLKTIKLADFGLAR---EESLTEMMTAETGTYRWMAPEL---YSTVTLRQGEKKHYNHK 129
+ +KL DFG+A ++ + + ++ GT +M PE S+ K + K
Sbjct: 162 DG--MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPK 219
Query: 130 VDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSA-----ENVPEELSIILTSC 184
D +S +L+ + + K PF+ + N + + P+ + ++L +L C
Sbjct: 220 SDVWSLGCILYYMTYGKTPFQQIINQ---ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCC 276
Query: 185 WKEDPNARPNFTQIIQ 200
K DP R + +++
Sbjct: 277 LKRDPKQRISIPELLA 292
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-35
Identities = 47/196 (23%), Positives = 87/196 (44%), Gaps = 19/196 (9%)
Query: 16 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 75
+V E L +L + +D + ++ A+ +H HGI+H DLKP N L+
Sbjct: 86 MVMEC-GNIDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV 142
Query: 76 EDLKTIKLADFGLARE-ESLTEMMTAET--GTYRWMAPEL---YSTVTLRQGEKKHYNHK 129
+ +KL DFG+A + + T + ++ GT +M PE S+ K + K
Sbjct: 143 DG--MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPK 200
Query: 130 VDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSA-----ENVPEELSIILTSC 184
D +S +L+ + + K PF+ + N + + P+ + ++L +L C
Sbjct: 201 SDVWSLGCILYYMTYGKTPFQQIIN---QISKLHAIIDPNHEIEFPDIPEKDLQDVLKCC 257
Query: 185 WKEDPNARPNFTQIIQ 200
K DP R + +++
Sbjct: 258 LKRDPKQRISIPELLA 273
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 4e-35
Identities = 47/188 (25%), Positives = 73/188 (38%), Gaps = 14/188 (7%)
Query: 14 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 73
+ + TEL G +L+++ L G+ D A+ LHS G++H D+KP N+
Sbjct: 132 LYLQTEL-CGPSLQQHCEA-WGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIF 189
Query: 74 LTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSY 133
L KL DFGL E + G R+MAPEL L+ Y D +
Sbjct: 190 LGPR-GRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPEL-----LQGS----YGTAADVF 239
Query: 134 SFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARP 193
S + + E+ N G Q + + EL +L + DP R
Sbjct: 240 SLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFTA--GLSSELRSVLVMMLEPDPKLRA 297
Query: 194 NFTQIIQM 201
++ +
Sbjct: 298 TAEALLAL 305
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 8e-35
Identities = 46/196 (23%), Positives = 86/196 (43%), Gaps = 19/196 (9%)
Query: 16 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 75
+V E L +L + +D + ++ A+ +H HGI+H DLKP N L+
Sbjct: 133 MVMEC-GNIDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV 189
Query: 76 EDLKTIKLADFGLARE-ESLTEMMTAET--GTYRWMAPEL---YSTVTLRQGEKKHYNHK 129
+ +KL DFG+A + + T + ++ G +M PE S+ K + K
Sbjct: 190 DG--MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPK 247
Query: 130 VDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSA-----ENVPEELSIILTSC 184
D +S +L+ + + K PF+ + N + + P+ + ++L +L C
Sbjct: 248 SDVWSLGCILYYMTYGKTPFQQIINQ---ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCC 304
Query: 185 WKEDPNARPNFTQIIQ 200
K DP R + +++
Sbjct: 305 LKRDPKQRISIPELLA 320
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-34
Identities = 53/185 (28%), Positives = 83/185 (44%), Gaps = 21/185 (11%)
Query: 16 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 75
+ L++G L L P L A+ I A++ H+ G HRD+KPEN+L++
Sbjct: 111 VDMRLINGVDLAAMLRRQGP--LAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVS 168
Query: 76 EDLKTIKLADFGLAR---EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDS 132
D L DFG+A +E LT++ GT +MAPE + + H ++ D
Sbjct: 169 AD-DFAYLVDFGIASATTDEKLTQLGNT-VGTLYYMAPE--------RFSESHATYRADI 218
Query: 133 YSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV-RPSAEN--VPEEL-SIILTSCWKED 188
Y+ VL+E L P++G L A + + RPS +P ++I K +
Sbjct: 219 YALTCVLYECLTGSPPYQG-DQLSVMGAHINQAIPRPSTVRPGIPVAFDAVIARGMAK-N 276
Query: 189 PNARP 193
P R
Sbjct: 277 PEDRY 281
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-34
Identities = 31/214 (14%), Positives = 72/214 (33%), Gaps = 31/214 (14%)
Query: 23 GGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIK 82
G L + + L + L + R + LH +G++H L+P +++L + +
Sbjct: 190 GEVLLSHS--STHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGG-VF 246
Query: 83 LADFGLAREESLTEMMTAETGTYRWMAPEL---YSTVTLRQGEKKHYNHKVDSYSFAIVL 139
L F + + + + PEL +T++ + + D+++ +V+
Sbjct: 247 LTGFEHLVRDG---ARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI 303
Query: 140 WELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQII 199
+ + LP F++ + N+P+ + +L + R Q +
Sbjct: 304 YWIWCADLPITK-DAALGGSEWIFRSCK----NIPQPVRALLEGFLRYPKEDRLLPLQAM 358
Query: 200 QMLLNYLSAIAPPEPMIPHRIFNSENTILPPESP 233
+ + T L P
Sbjct: 359 E-----------------TPEYEQLRTELSAALP 375
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-33
Identities = 53/203 (26%), Positives = 79/203 (38%), Gaps = 16/203 (7%)
Query: 11 EPVMVIVTELLSGGTLRKYLLNM-RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKP 69
+ ++ E GG LRKYL L DI+ A+ LH + IIHRDLKP
Sbjct: 90 NDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKP 149
Query: 70 ENLLL--TEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYN 127
EN++L K+ D G A+E E+ T GT +++APEL E+K Y
Sbjct: 150 ENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELL--------EQKKYT 201
Query: 128 HKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKE 187
VD +SF + +E + PF + + + + S
Sbjct: 202 VTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLP 261
Query: 188 DPNARPNFTQI-----IQMLLNY 205
PN +Q +L +
Sbjct: 262 TPNHLSGILAGKLERWLQCMLMW 284
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-33
Identities = 53/194 (27%), Positives = 78/194 (40%), Gaps = 17/194 (8%)
Query: 16 IVTELLSGGTLRKYLLNMRP--RCLDVCVAIGFALDIARAMECLHS-----HGIIHRDLK 68
IV E GG L + + LD + + A++ H H ++HRDLK
Sbjct: 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLK 143
Query: 69 PENLLLTEDLKTIKLADFGLARE-ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYN 127
P N+ L + +KL DFGLAR T GT +M+PE + YN
Sbjct: 144 PANVFLDGK-QNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQM--------NRMSYN 194
Query: 128 HKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKE 187
K D +S +L+EL PF S + A R +EL+ I+T
Sbjct: 195 EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNL 254
Query: 188 DPNARPNFTQIIQM 201
RP+ +I++
Sbjct: 255 KDYHRPSVEEILEN 268
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 124 bits (311), Expect = 3e-33
Identities = 29/231 (12%), Positives = 72/231 (31%), Gaps = 15/231 (6%)
Query: 13 VMVIVTELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPE 70
+ + T + LL+ + L + L + R + LH +G++H L+P
Sbjct: 181 FFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPV 240
Query: 71 NLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNH 128
+++L + + L F + + + A + Q
Sbjct: 241 DIVLDQRG-GVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPF---GQHHPTLMTF 296
Query: 129 KVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKED 188
D+++ + ++ + LP F++ + N+P+ + +L +
Sbjct: 297 AFDTWTLGLAIYWIWCADLPNTD-DAALGGSEWIFRSCK----NIPQPVRALLEGFLRYP 351
Query: 189 PNARPNFTQIIQ--MLLNYLSAIAPPEPMIPHRIFNSENTILPPESPGTSS 237
R Q ++ + ++ P+ + PP
Sbjct: 352 KEDRLLPLQAMETPEYEQLRTELSAALPLYQTDGEPTREGGAPPSGTSQPD 402
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-32
Identities = 48/170 (28%), Positives = 80/170 (47%), Gaps = 14/170 (8%)
Query: 44 IGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETG 103
I ++ +A+ ME L S IHRDL N+LL+E +K+ DFGLAR+ +
Sbjct: 196 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK-NVVKICDFGLARDIYKDPDYVRKGD 254
Query: 104 T---YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAY 159
+WMAPE + Y + D +SF ++LWE+ P+ G+ +
Sbjct: 255 ARLPLKWMAPE--------TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 306
Query: 160 AAAFKNVR-PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 208
+ R + + E+ + CW +P+ RP F+++++ L N L A
Sbjct: 307 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 3e-32
Identities = 50/238 (21%), Positives = 83/238 (34%), Gaps = 26/238 (10%)
Query: 15 VIVTELLSGGTLRKYLLNMRPR-CLDVCVAIGFALDIARAMECLHSHG--IIHRDLKPEN 71
++ L G L ++L M R L + RA++ +H IIHRDLK EN
Sbjct: 109 FLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVEN 168
Query: 72 LLLTEDLKTIKLADFGLAR-------------EESLTEMMTAETGTYRWMAPELYSTVTL 118
LLL+ TIKL DFG A +L E T + PE+ +
Sbjct: 169 LLLSNQ-GTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYS- 226
Query: 119 RQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELS 178
K D ++ +L+ L + PFE + P +
Sbjct: 227 ----NFPIGEKQDIWALGCILYLLCFRQHPFED-GAKLRIVNGKYS--IPPHDTQYTVFH 279
Query: 179 IILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIPHRIFNSENTILPPESPGTS 236
++ + + +P R + +++ L ++A P P +N +
Sbjct: 280 SLIRAMLQVNPEERLSIAEVVHQLQE-IAAARNVNPKSPITELLEQNGGYGSATLSRG 336
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-31
Identities = 53/194 (27%), Positives = 87/194 (44%), Gaps = 19/194 (9%)
Query: 16 IVTELLSGGTLRKYLLNMR--PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 73
IV EL G L + + + + R + + + + A+E +HS ++HRD+KP N+
Sbjct: 109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVF 168
Query: 74 LTEDLKTIKLADFGLARE-ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDS 132
+T +KL D GL R S T + GT +M+PE + YN K D
Sbjct: 169 ITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI--------HENGYNFKSDI 219
Query: 133 YSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVP-----EELSIILTSCWKE 187
+S +L+E+ + PF G + Y+ K + +P EEL ++ C
Sbjct: 220 WSLGCLLYEMAALQSPFYG--DKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINP 277
Query: 188 DPNARPNFTQIIQM 201
DP RP+ T + +
Sbjct: 278 DPEKRPDVTYVYDV 291
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 3e-31
Identities = 24/198 (12%), Positives = 59/198 (29%), Gaps = 21/198 (10%)
Query: 15 VIVTELLSG--GTLRKYL--LNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPE 70
+++ S L L + + + + R L S G++H P+
Sbjct: 164 LLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPD 223
Query: 71 NLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKV 130
NL + D + L D + A + + E + H +
Sbjct: 224 NLFIMPDG-RLMLGDVSALWKVG--TRGPASSVPVTYAPRE------FLNASTATFTHAL 274
Query: 131 DSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAE--------NVPEELSIILT 182
+++ + ++ + LPF ++ P + +P+ + ++
Sbjct: 275 NAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIG 334
Query: 183 SCWKEDPNARPNFTQIIQ 200
D R + ++
Sbjct: 335 RFLNFDRRRRLLPLEAME 352
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 7e-31
Identities = 36/207 (17%), Positives = 71/207 (34%), Gaps = 29/207 (14%)
Query: 14 MVIVTELLSGGTLRKYLLNMRP---RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPE 70
V+V EL S GTL + + + + + I FA+ + +E +H IIH D+KP+
Sbjct: 142 SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPD 201
Query: 71 NLLLTEDL----------KTIKLADFGLAREESL---TEMMTAETGTYRWMAPELYSTVT 117
N +L + L D G + + L + TA+ T + E+
Sbjct: 202 NFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEML---- 257
Query: 118 LRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEEL 177
K +N+++D + A ++ +L + F+ +
Sbjct: 258 ----SNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRR-----LPHLDMW 308
Query: 178 SIILTSCWKEDPNARPNFTQIIQMLLN 204
+ +++ L
Sbjct: 309 NEFFHVMLNIPDCHHLPSLDLLRQKLK 335
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-30
Identities = 48/186 (25%), Positives = 83/186 (44%), Gaps = 12/186 (6%)
Query: 16 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 75
+V E+ G + +YL N R + A F I M LHSHGI+HRDL NLLLT
Sbjct: 88 LVLEMCHNGEMNRYLKN-RVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLT 146
Query: 76 EDLKTIKLADFGLA-REESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYS 134
++ IK+ADFGLA + + E GT +++PE+ + + + + D +S
Sbjct: 147 RNM-NIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIAT--------RSAHGLESDVWS 197
Query: 135 FAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPN 194
+ + LL + PF+ ++ + E ++ + +P R +
Sbjct: 198 LGCMFYTLLIGRPPFDT-DTVKNTLNKVVLADYEMPSFLSIEAKDLIHQLLRRNPADRLS 256
Query: 195 FTQIIQ 200
+ ++
Sbjct: 257 LSSVLD 262
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 7e-30
Identities = 50/209 (23%), Positives = 79/209 (37%), Gaps = 26/209 (12%)
Query: 11 EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPE 70
+PV IV E + G +L++ + L V AI + L+I A+ LHS G+++ DLKPE
Sbjct: 156 DPVGYIVMEYVGGQSLKRSK----GQKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPE 211
Query: 71 NLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKV 130
N++LTE+ +KL D G + + GT + APE+ T
Sbjct: 212 NIMLTEE--QLKLIDLGAVSRINSFGYL---YGTPGFQAPEIVRT---------GPTVAT 257
Query: 131 DSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPN 190
D Y+ L L + G Y + +L DP
Sbjct: 258 DIYTVGRTLAALTLDLPTRNG------RYVDGL-PEDDPVLKTYDSYGRLLRRAIDPDPR 310
Query: 191 ARP-NFTQIIQMLLNYLSAIAPPEPMIPH 218
R ++ L L + + +P
Sbjct: 311 QRFTTAEEMSAQLTGVLREVVAQDTGVPR 339
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-29
Identities = 34/208 (16%), Positives = 70/208 (33%), Gaps = 35/208 (16%)
Query: 14 MVIVTELLSGGTLRKYLL--NMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPEN 71
M+I E +GG+L + L + R + +HS ++H D+KP N
Sbjct: 86 MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSN 145
Query: 72 LLLTED------------------LKTIKLADFGLAREESLTEMMTAETGTYRWMAPELY 113
+ ++ K+ D G ++ E G R++A E+
Sbjct: 146 IFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT--RISSPQV-EEGDSRFLANEVL 202
Query: 114 STVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSA-EN 172
E + K D ++ A+ + + + + P +
Sbjct: 203 Q-------ENYTHLPKADIFALALTVVCAAGAEPLPRNGD----QWHEIRQGRLPRIPQV 251
Query: 173 VPEELSIILTSCWKEDPNARPNFTQIIQ 200
+ +E + +L DP RP+ +++
Sbjct: 252 LSQEFTELLKVMIHPDPERRPSAMALVK 279
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-29
Identities = 36/151 (23%), Positives = 68/151 (45%), Gaps = 15/151 (9%)
Query: 16 IVTELLSGGTLRKYLLN------MRPRCLDVCVAIGFALDIARAMECLHSH-GIIHRDLK 68
I+ E + ++ K+ + + V + + +H+ I HRD+K
Sbjct: 120 IIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVK 179
Query: 69 PENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNH 128
P N+L+ ++ +KL+DFG + ++ + GTY +M PE +S E +
Sbjct: 180 PSNILMDKN-GRVKLSDFGESEYMVDKKIKGSR-GTYEFMPPEFFS------NESSYNGA 231
Query: 129 KVDSYSFAIVLWELLHNKLPFEGMSNLQAAY 159
KVD +S I L+ + +N +PF +L +
Sbjct: 232 KVDIWSLGICLYVMFYNVVPFSLKISLVELF 262
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 5e-29
Identities = 48/191 (25%), Positives = 86/191 (45%), Gaps = 25/191 (13%)
Query: 16 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 75
++ E GT+ + L + D + ++A A+ HS +IHRD+KPENLLL
Sbjct: 86 LILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG 143
Query: 76 EDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNHKVDSY 133
+K+ADFG + GT ++ PE+ E + ++ KVD +
Sbjct: 144 SAG-ELKIADFGWS---VHAPSSRRTDLCGTLDYLPPEMI--------EGRMHDEKVDLW 191
Query: 134 SFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSI----ILTSCWKEDP 189
S ++ +E L K PFE + Q Y K + P+ ++ +++ K +P
Sbjct: 192 SLGVLCYEFLVGKPPFEA-NTYQETY----KRISRVEFTFPDFVTEGARDLISRLLKHNP 246
Query: 190 NARPNFTQIIQ 200
+ RP ++++
Sbjct: 247 SQRPMLREVLE 257
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 6e-29
Identities = 63/221 (28%), Positives = 100/221 (45%), Gaps = 16/221 (7%)
Query: 16 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 75
+V EL +L + R + L A + I + LH + +IHRDLK NL L
Sbjct: 118 VVLELCRRRSLLELH--KRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN 175
Query: 76 EDLKTIKLADFGLA-REESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYS 134
EDL +K+ DFGLA + E E GT ++APE+ S KK ++ +VD +S
Sbjct: 176 EDL-EVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLS--------KKGHSFEVDVWS 226
Query: 135 FAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPN 194
+++ LL K PFE S L+ Y KN +++ + ++ + DP ARP
Sbjct: 227 IGCIMYTLLVGKPPFET-SCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPT 285
Query: 195 FTQIIQ---MLLNYLSAIAPPEPMIPHRIFNSENTILPPES 232
+++ Y+ A P + F+ + L P +
Sbjct: 286 INELLNDEFFTSGYIPARLPITCLTIPPRFSIAPSSLDPSN 326
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-28
Identities = 60/201 (29%), Positives = 93/201 (46%), Gaps = 16/201 (7%)
Query: 16 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 75
+V EL +L + R + L A + I + LH + +IHRDLK NL L
Sbjct: 92 VVLELCRRRSLLELH--KRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN 149
Query: 76 EDLKTIKLADFGLA-REESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYS 134
EDL +K+ DFGLA + E E GT ++APE+ S KK ++ +VD +S
Sbjct: 150 EDL-EVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLS--------KKGHSFEVDVWS 200
Query: 135 FAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPN 194
+++ LL K PFE S L+ Y KN +++ + ++ + DP ARP
Sbjct: 201 IGCIMYTLLVGKPPFET-SCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPT 259
Query: 195 FTQIIQ---MLLNYLSAIAPP 212
+++ Y+ A P
Sbjct: 260 INELLNDEFFTSGYIPARLPI 280
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-28
Identities = 48/199 (24%), Positives = 82/199 (41%), Gaps = 19/199 (9%)
Query: 4 QFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI 62
GA +E V I ELL GG+L + + M L A+ + +E LH+ I
Sbjct: 114 PLYGAVREGPWVNIFMELLEGGSLGQLIKQMGC--LPEDRALYYLGQALEGLEYLHTRRI 171
Query: 63 IHRDLKPENLLLTEDLKTIKLADFG----LAREESLTEMMTAET--GTYRWMAPELYSTV 116
+H D+K +N+LL+ D L DFG L + ++T + GT MAPE V
Sbjct: 172 LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE----V 227
Query: 117 TLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY--AAAFKNVRPSAENVP 174
+ + + KVD +S ++ +L+ P+ A+ +R +
Sbjct: 228 VMGKP----CDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCA 283
Query: 175 EELSIILTSCWKEDPNARP 193
+ + +++P R
Sbjct: 284 PLTAQAIQEGLRKEPVHRA 302
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-28
Identities = 49/189 (25%), Positives = 91/189 (48%), Gaps = 15/189 (7%)
Query: 16 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 75
+V EL++ G + + L A + D+ + +E LH IIHRD+KP NLL+
Sbjct: 115 MVFELVNQGPVMEVPTLKP---LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVG 171
Query: 76 EDLKTIKLADFGLAREESLTEMMTAET-GTYRWMAPELYSTVTLRQGEKKHYN-HKVDSY 133
ED IK+ADFG++ E ++ + + T GT +MAPE S +K ++ +D +
Sbjct: 172 ED-GHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLS------ETRKIFSGKALDVW 224
Query: 134 SFAIVLWELLHNKLPFEGMSNLQAAYAAAFK-NVR-PSAENVPEELSIILTSCWKEDPNA 191
+ + L+ + + PF + ++ + P ++ E+L ++T ++P +
Sbjct: 225 AMGVTLYCFVFGQCPFMD-ERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPES 283
Query: 192 RPNFTQIIQ 200
R +I
Sbjct: 284 RIVVPEIKL 292
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-28
Identities = 43/204 (21%), Positives = 79/204 (38%), Gaps = 16/204 (7%)
Query: 16 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 75
++ E G L K L + D + F ++A A+ H +IHRD+KPENLL+
Sbjct: 91 LMLEFAPRGELYKEL--QKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMG 148
Query: 76 EDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSF 135
+K+ADFG + T GT ++ PE+ E K ++ KVD +
Sbjct: 149 YKG-ELKIADFGWSVHAPSLRRRTM-CGTLDYLPPEMI--------EGKTHDEKVDLWCA 198
Query: 136 AIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNF 195
++ +E L PF+ + + + + +++ + P R
Sbjct: 199 GVLCYEFLVGMPPFDS-PSHTETHRRIVNVDLKFPPFLSDGSKDLISKLLRYHPPQRLPL 257
Query: 196 TQIIQ---MLLNYLSAIAPPEPMI 216
+++ + N + P
Sbjct: 258 KGVMEHPWVKANSRRVLPPVYQST 281
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 6e-28
Identities = 54/201 (26%), Positives = 89/201 (44%), Gaps = 23/201 (11%)
Query: 4 QFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIG-FALDIARAMECLHSHG 61
Q++G+ E + I E + GG+L L + D IG + I ++ LH +
Sbjct: 83 QYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ 142
Query: 62 IIHRDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAETGTYRWMAPELYSTVTLRQ 120
I+HRD+K +N+L+ +K++DFG ++ + TGT ++MAPE+
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEII------D 196
Query: 121 GEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFK----NVRPSAENVPEE 176
+ Y D +S + E+ K PF L AA FK V P +PE
Sbjct: 197 KGPRGYGKAADIWSLGCTIIEMATGKPPF---YELGEPQAAMFKVGMFKVHPE---IPES 250
Query: 177 LSII----LTSCWKEDPNARP 193
+S + C++ DP+ R
Sbjct: 251 MSAEAKAFILKCFEPDPDKRA 271
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-27
Identities = 48/183 (26%), Positives = 79/183 (43%), Gaps = 14/183 (7%)
Query: 14 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 73
M +V +LL GG LR Y L + F ++ A++ L + IIHRD+KP+N+L
Sbjct: 90 MFMVVDLLLGGDLR-YHLQ-QNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNIL 147
Query: 74 LTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSY 133
L E + + DF +A +T GT +MAPE+ + Y+ VD +
Sbjct: 148 LDEH-GHVHITDFNIAAMLPRETQITTMAGTKPYMAPEM-----FSSRKGAGYSFAVDWW 201
Query: 134 SFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSI----ILTSCWKEDP 189
S + +ELL + P+ S+ + + P S +L + +P
Sbjct: 202 SLGVTAYELLRGRRPYHIRSS--TSSKEIVHTFETTVVTYPSAWSQEMVSLLKKLLEPNP 259
Query: 190 NAR 192
+ R
Sbjct: 260 DQR 262
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 1e-27
Identities = 45/200 (22%), Positives = 76/200 (38%), Gaps = 26/200 (13%)
Query: 16 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 75
I EL TL++Y+ + I + LHS I+HRDLKP N+L++
Sbjct: 95 IAIELC-AATLQEYVEQ-KDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILIS 152
Query: 76 EDLKT----IKLADFGLAR----EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYN 127
++DFGL + + GT W+APE+ L + K++
Sbjct: 153 MPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEM-----LSEDCKENPT 207
Query: 128 HKVDSYSFAIVLWELLHN-KLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSI------I 180
+ VD +S V + ++ PF Q A S + + E +
Sbjct: 208 YTVDIFSAGCVFYYVISEGSHPFGKSLQRQ----ANILLGACSLDCLHPEKHEDVIAREL 263
Query: 181 LTSCWKEDPNARPNFTQIIQ 200
+ DP RP+ +++
Sbjct: 264 IEKMIAMDPQKRPSAKHVLK 283
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-26
Identities = 48/212 (22%), Positives = 80/212 (37%), Gaps = 29/212 (13%)
Query: 16 IVTELLSGGTL-----RKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPE 70
I EL L K + + + I IA + LHS IIHRDLKP+
Sbjct: 86 IALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQ 144
Query: 71 NLLLTEDLKT------------IKLADFGLAR-----EESLTEMMTAETGTYRWMAPELY 113
N+L++ + I ++DFGL + + S + +GT W APEL
Sbjct: 145 NILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELL 204
Query: 114 STVTLRQGEKKHYNHKVDSYSFAIVLWELLHN-KLPFEGMSNLQAAYAAAFKNVRPSAEN 172
Q K+ +D +S V + +L K PF + ++ ++
Sbjct: 205 EESNNLQT-KRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCL 263
Query: 173 VPEELSI----ILTSCWKEDPNARPNFTQIIQ 200
L +++ DP RP ++++
Sbjct: 264 HDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 2e-25
Identities = 46/180 (25%), Positives = 83/180 (46%), Gaps = 14/180 (7%)
Query: 17 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE 76
V L++GG L+ ++ +M A+ +A +I +E LH I++RDLKPEN+LL +
Sbjct: 262 VLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDD 321
Query: 77 DLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFA 136
I+++D GLA + + GT +MAPE+ + + Y D ++
Sbjct: 322 H-GHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV--------KNERYTFSPDWWALG 372
Query: 137 IVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSI----ILTSCWKEDPNAR 192
+L+E++ + PF+ + + V+ E E S + + +DP R
Sbjct: 373 CLLYEMIAGQSPFQQ-RKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKDPAER 431
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-25
Identities = 54/203 (26%), Positives = 88/203 (43%), Gaps = 16/203 (7%)
Query: 16 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 75
++ E SGG + YL + + A I A++ H I+HRDLK ENLLL
Sbjct: 91 LIMEYASGGEVFDYL--VAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLD 148
Query: 76 EDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYN-HKVDSYS 134
D+ IK+ADFG + E ++ + A G + APEL+ K Y+ +VD +S
Sbjct: 149 ADMN-IKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQ--------GKKYDGPEVDVWS 199
Query: 135 FAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPN 194
++L+ L+ LPF+G NL+ + + + +L +P R
Sbjct: 200 LGVILYTLVSGSLPFDG-QNLKELRERVLRGKYRIPFYMSTDCENLLKRFLVLNPIKRGT 258
Query: 195 FTQIIQ---MLLNYLSAIAPPEP 214
QI++ + + P
Sbjct: 259 LEQIMKDRWINAGHEEDELKPFV 281
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 3e-25
Identities = 47/136 (34%), Positives = 70/136 (51%), Gaps = 9/136 (6%)
Query: 16 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 75
IV EL+ GG L ++ + L + + A++ LH +GIIHRDLKPEN+LL+
Sbjct: 216 IVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLS 273
Query: 76 --EDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSY 133
E+ IK+ DFG ++ T +M GT ++APE+ L YN VD +
Sbjct: 274 SQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEV-----LVSVGTAGYNRAVDCW 328
Query: 134 SFAIVLWELLHNKLPF 149
S ++L+ L PF
Sbjct: 329 SLGVILFICLSGYPPF 344
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-25
Identities = 47/150 (31%), Positives = 66/150 (44%), Gaps = 31/150 (20%)
Query: 16 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGF-----ALDIAR----AMECLHSHGIIHRD 66
+V E GG L D + A I + + LH H I+HRD
Sbjct: 113 LVMECYKGGEL-----------FDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRD 161
Query: 67 LKPENLLLT--EDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKK 124
LKPENLLL E IK+ DFGL+ + M GT ++APE+ +K
Sbjct: 162 LKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVL---------RK 212
Query: 125 HYNHKVDSYSFAIVLWELLHNKLPFEGMSN 154
Y+ K D +S ++L+ LL PF G ++
Sbjct: 213 KYDEKCDVWSIGVILFILLAGYPPFGGQTD 242
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 7e-25
Identities = 53/224 (23%), Positives = 89/224 (39%), Gaps = 37/224 (16%)
Query: 16 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGF-----ALDIAR----AMECLHSHGIIHRD 66
+V E+ +GG L D ++ A I R + +H + I+HRD
Sbjct: 103 LVGEVYTGGEL-----------FDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRD 151
Query: 67 LKPENLLLT--EDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKK 124
LKPENLLL I++ DFGL+ ++ M + GT ++APE+
Sbjct: 152 LKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL---------HG 202
Query: 125 HYNHKVDSYSFAIVLWELLHNKLPFEGMSN---LQAAYAAAFKNVRPSAENVPEELSIIL 181
Y+ K D +S ++L+ LL PF G + L+ + P + V E ++
Sbjct: 203 TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLI 262
Query: 182 TSCWKEDPNARPNFTQIIQ---MLLNYLSAIAPPEPMIPHRIFN 222
P+ R + + + I+ P + + I N
Sbjct: 263 RKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILN 306
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-24
Identities = 52/199 (26%), Positives = 81/199 (40%), Gaps = 34/199 (17%)
Query: 16 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGF-----ALDIAR----AMECLHSHGIIHRD 66
IV EL +GG L D + A I + + +H H I+HRD
Sbjct: 98 IVGELYTGGEL-----------FDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRD 146
Query: 67 LKPENLLLT--EDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKK 124
LKPEN+LL E IK+ DFGL+ M GT ++APE+ +
Sbjct: 147 LKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL---------RG 197
Query: 125 HYNHKVDSYSFAIVLWELLHNKLPFEGMSN---LQAAYAAAFKNVRPSAENVPEELSIIL 181
Y+ K D +S ++L+ LL PF G + L+ + P + ++ ++
Sbjct: 198 TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLI 257
Query: 182 TSCWKEDPNARPNFTQIIQ 200
P+ R TQ ++
Sbjct: 258 RKMLTFHPSLRITATQCLE 276
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-24
Identities = 36/137 (26%), Positives = 69/137 (50%), Gaps = 7/137 (5%)
Query: 17 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE 76
V + GG L LL+ L +A + ++ A++ +H +HRD+KP+N+L+
Sbjct: 152 VMDYYVGGDLL-TLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDM 210
Query: 77 DLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNHKVDSYS 134
+ I+LADFG + + + GT +++PE+ + +G K Y + D +S
Sbjct: 211 NGH-IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEI---LQAMEGGKGRYGPECDWWS 266
Query: 135 FAIVLWELLHNKLPFEG 151
+ ++E+L+ + PF
Sbjct: 267 LGVCMYEMLYGETPFYA 283
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 2e-24
Identities = 52/186 (27%), Positives = 90/186 (48%), Gaps = 22/186 (11%)
Query: 17 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE 76
V E ++GG L ++ R R L A ++ +I+ A+ LH GII+RDLK +N+LL
Sbjct: 88 VIEYVNGGDLMFHM--QRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDS 145
Query: 77 DLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNHKVDSYS 134
+ IKL D+G+ +E L T T GT ++APE + + Y VD ++
Sbjct: 146 E-GHIKLTDYGMCKEG-LRPGDTTSTFCGTPNYIAPE----ILRGED----YGFSVDWWA 195
Query: 135 FAIVLWELLHNKLPFEGMSNLQAAYAAA----FKNVRPSAENVPEELSI----ILTSCWK 186
++++E++ + PF+ + + F+ + +P LS+ +L S
Sbjct: 196 LGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLN 255
Query: 187 EDPNAR 192
+DP R
Sbjct: 256 KDPKER 261
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 3e-24
Identities = 49/182 (26%), Positives = 85/182 (46%), Gaps = 16/182 (8%)
Query: 17 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE 76
+ + ++GG L +L + + +I A+E LH GII+RD+K EN+LL
Sbjct: 137 ILDYINGGELFTHL--SQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDS 194
Query: 77 DLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNHKVDSYS 134
+ + L DFGL++E E A GT +MAP++ +G ++ VD +S
Sbjct: 195 N-GHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV------RGGDSGHDKAVDWWS 247
Query: 135 FAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSI----ILTSCWKEDPN 190
++++ELL PF + + A + + S P+E+S ++ +DP
Sbjct: 248 LGVLMYELLTGASPFTV-DGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPK 306
Query: 191 AR 192
R
Sbjct: 307 KR 308
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-24
Identities = 46/150 (30%), Positives = 68/150 (45%), Gaps = 31/150 (20%)
Query: 16 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGF-----ALDIAR----AMECLHSHGIIHRD 66
+VTE GG L + + A +I + + LH H I+HRD
Sbjct: 123 LVTEFYEGGEL-----------FEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRD 171
Query: 67 LKPENLLLT--EDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKK 124
+KPEN+LL L IK+ DFGL+ S + GT ++APE+ KK
Sbjct: 172 IKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVL---------KK 222
Query: 125 HYNHKVDSYSFAIVLWELLHNKLPFEGMSN 154
YN K D +S ++++ LL PF G ++
Sbjct: 223 KYNEKCDVWSCGVIMYILLCGYPPFGGQND 252
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 4e-24
Identities = 52/186 (27%), Positives = 90/186 (48%), Gaps = 22/186 (11%)
Query: 17 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE 76
V E ++GG L ++ R R L A ++ +I+ A+ LH GII+RDLK +N+LL
Sbjct: 131 VIEYVNGGDLMFHM--QRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDS 188
Query: 77 DLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNHKVDSYS 134
+ IKL D+G+ +E L T T GT ++APE + + Y VD ++
Sbjct: 189 E-GHIKLTDYGMCKEG-LRPGDTTSTFCGTPNYIAPE----ILRGED----YGFSVDWWA 238
Query: 135 FAIVLWELLHNKLPFEGMSNLQAAYA----AAFKNVRPSAENVPEELSI----ILTSCWK 186
++++E++ + PF+ + + F+ + +P LS+ +L S
Sbjct: 239 LGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLN 298
Query: 187 EDPNAR 192
+DP R
Sbjct: 299 KDPKER 304
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 4e-24
Identities = 49/137 (35%), Positives = 76/137 (55%), Gaps = 14/137 (10%)
Query: 17 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE 76
V E L+GG L ++ D+ A +A +I ++ LHS GI++RDLK +N+LL +
Sbjct: 96 VMEYLNGGDLMYHI--QSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDK 153
Query: 77 DLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNHKVDSYS 134
D IK+ADFG+ +E + T GT ++APE+ + YNH VD +S
Sbjct: 154 D-GHIKIADFGMCKEN-MLGDAKTNTFCGTPDYIAPEIL--------LGQKYNHSVDWWS 203
Query: 135 FAIVLWELLHNKLPFEG 151
F ++L+E+L + PF G
Sbjct: 204 FGVLLYEMLIGQSPFHG 220
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 5e-24
Identities = 37/137 (27%), Positives = 65/137 (47%), Gaps = 5/137 (3%)
Query: 17 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE 76
V E GG L LL+ + +A + +I A++ +H G +HRD+KP+N+LL
Sbjct: 139 VMEYYVGGDLL-TLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDR 197
Query: 77 DLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNHKVDSYS 134
I+LADFG + + + GT +++PE+ V G Y + D ++
Sbjct: 198 CGH-IRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGS-YGPECDWWA 255
Query: 135 FAIVLWELLHNKLPFEG 151
+ +E+ + + PF
Sbjct: 256 LGVFAYEMFYGQTPFYA 272
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 99.5 bits (248), Expect = 6e-24
Identities = 49/192 (25%), Positives = 83/192 (43%), Gaps = 29/192 (15%)
Query: 17 VTELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL 74
V +++GG +R ++ N+ AI + I +E LH II+RDLKPEN+LL
Sbjct: 263 VMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLL 322
Query: 75 TEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNHKVDS 132
+D ++++D GLA E + GT +MAPEL + Y+ VD
Sbjct: 323 DDD-GNVRISDLGLAVEL-KAGQTKTKGYAGTPGFMAPELL--------LGEEYDFSVDY 372
Query: 133 YSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNAR 192
++ + L+E++ + PF + + V A P++ S P ++
Sbjct: 373 FALGVTLYEMIAARGPFRA-RGEKVENKELKQRVLEQAVTYPDKFS----------PASK 421
Query: 193 PNFTQIIQMLLN 204
+ LL
Sbjct: 422 ----DFCEALLQ 429
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 1e-23
Identities = 55/215 (25%), Positives = 88/215 (40%), Gaps = 26/215 (12%)
Query: 14 MVIVTELLSGGT--LRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPEN 71
M +V E G + + R VC A G+ + +E LHS GI+H+D+KP N
Sbjct: 83 MYMVMEYCVCGMQEMLDSVPEKR---FPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGN 139
Query: 72 LLLTEDLKTIKLADFGLARE-ESLTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNH 128
LLLT T+K++ G+A T T G+ + PE+ + G
Sbjct: 140 LLLTTG-GTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIAN------GLDTFSGF 192
Query: 129 KVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSI----ILTSC 184
KVD +S + L+ + PFEG N+ + +N+ + +P + +L
Sbjct: 193 KVDIWSAGVTLYNITTGLYPFEG-DNIYKLF----ENIGKGSYAIPGDCGPPLSDLLKGM 247
Query: 185 WKEDPNARPNFTQIIQM--LLNYLSAIAPPEPMIP 217
+ +P R + QI Q P P+ P
Sbjct: 248 LEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPIPP 282
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 1e-23
Identities = 41/138 (29%), Positives = 66/138 (47%), Gaps = 14/138 (10%)
Query: 17 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE 76
G L KY+ + D + +I A+E LH GIIHRDLKPEN+LL E
Sbjct: 108 GLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNE 165
Query: 77 DLKTIKLADFGLARE-ESLTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNHKVDSY 133
D+ I++ DFG A+ ++ A + GT ++++PEL +K D +
Sbjct: 166 DMH-IQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL--------TEKSACKSSDLW 216
Query: 134 SFAIVLWELLHNKLPFEG 151
+ ++++L+ PF
Sbjct: 217 ALGCIIYQLVAGLPPFRA 234
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 1e-23
Identities = 51/193 (26%), Positives = 90/193 (46%), Gaps = 18/193 (9%)
Query: 16 IVTELLSGGTLRKYLLNMRPRCLD-VCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL 74
+V E G++ + N + L +A +I R + LH H +IHRD+K +N+LL
Sbjct: 104 LVMEFCGAGSVTDLIKNTKGNTLKEEWIAY-ICREILRGLSHLHQHKVIHRDIKGQNVLL 162
Query: 75 TEDLKTIKLADFGLAREESLTEMMTAET---GTYRWMAPELYSTVTLRQGEKKHYNHKVD 131
TE+ + +KL DFG++ + L + GT WMAPE+ + + Y+ K D
Sbjct: 163 TENAE-VKLVDFGVSAQ--LDRTVGRRNTFIGTPYWMAPEV---IACDENPDATYDFKSD 216
Query: 132 SYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSII----LTSCWKE 187
+S I E+ P M ++A + +N P + ++ S + SC +
Sbjct: 217 LWSLGITAIEMAEGAPPLCDMHPMRALFLIP-RNPAPRLK--SKKWSKKFQSFIESCLVK 273
Query: 188 DPNARPNFTQIIQ 200
+ + RP Q+++
Sbjct: 274 NHSQRPATEQLMK 286
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 2e-23
Identities = 46/140 (32%), Positives = 62/140 (44%), Gaps = 13/140 (9%)
Query: 16 IVTELLSGGTL--RKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 73
IV E GG L R R + L + A+ HS ++H+DLKPEN+L
Sbjct: 97 IVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENIL 156
Query: 74 LT--EDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVD 131
IK+ DFGLA E T GT +MAPE++ K+ K D
Sbjct: 157 FQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVF---------KRDVTFKCD 207
Query: 132 SYSFAIVLWELLHNKLPFEG 151
+S +V++ LL LPF G
Sbjct: 208 IWSAGVVMYFLLTGCLPFTG 227
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 2e-23
Identities = 46/104 (44%), Positives = 66/104 (63%), Gaps = 12/104 (11%)
Query: 50 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRW 107
+A A++ LHS GII+RDLKPEN+LL E+ IKL DFGL++ ES+ A + GT +
Sbjct: 135 LALALDHLHSLGIIYRDLKPENILLDEE-GHIKLTDFGLSK-ESIDHEKKAYSFCGTVEY 192
Query: 108 MAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 151
MAPE V R+G + D +SF ++++E+L LPF+G
Sbjct: 193 MAPE----VVNRRG----HTQSADWWSFGVLMFEMLTGTLPFQG 228
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 2e-23
Identities = 46/137 (33%), Positives = 72/137 (52%), Gaps = 14/137 (10%)
Query: 17 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE 76
V E +GG L +L R R A + +I A+E LHS +++RD+K ENL+L +
Sbjct: 83 VMEYANGGELFFHL--SRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDK 140
Query: 77 DLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNHKVDSYS 134
D IK+ DFGL +E +++ T +T GT ++APE V Y VD +
Sbjct: 141 D-GHIKITDFGLCKEG-ISDGATMKTFCGTPEYLAPE----VLEDND----YGRAVDWWG 190
Query: 135 FAIVLWELLHNKLPFEG 151
+V++E++ +LPF
Sbjct: 191 LGVVMYEMMCGRLPFYN 207
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 2e-23
Identities = 40/104 (38%), Positives = 59/104 (56%), Gaps = 12/104 (11%)
Query: 50 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRW 107
I+ A+ LH GII+RDLKPEN++L +KL DFGL + ES+ + T GT +
Sbjct: 130 ISMALGHLHQKGIIYRDLKPENIMLNHQ-GHVKLTDFGLCK-ESIHDGTVTHTFCGTIEY 187
Query: 108 MAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 151
MAPE + +R G +N VD +S +++++L PF G
Sbjct: 188 MAPE----ILMRSG----HNRAVDWWSLGALMYDMLTGAPPFTG 223
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 3e-23
Identities = 56/220 (25%), Positives = 91/220 (41%), Gaps = 33/220 (15%)
Query: 6 IGACKEPV-MVIVTELLSGGTLRKYLL--NMRPRCLDVCVAIGFALDIARAMECLHSHGI 62
IG C E M+++ + + G L+++L ++ + + + AR + LH+ I
Sbjct: 101 IGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAI 160
Query: 63 IHRDLKPENLLLTEDLKTIKLADFGLAR---EESLTEMMTAETGTYRWMAPELYSTVTLR 119
IHRD+K N+LL E+ K+ DFG+++ E T + T GT ++ PE +
Sbjct: 161 IHRDVKSINILLDENF-VPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIK---- 215
Query: 120 QGEKKHYNHKVDSYSFAIVLWELLHNKLPF-----EGMSNLQAAYAAAFKNVRPSAENV- 173
K D YSF +VL+E+L + M NL A +A N + V
Sbjct: 216 ----GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNL-AEWAVESHNNGQLEQIVD 270
Query: 174 --------PEELSIILT---SCWKEDPNARPNFTQIIQML 202
PE L C RP+ ++ L
Sbjct: 271 PNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 3e-23
Identities = 46/137 (33%), Positives = 71/137 (51%), Gaps = 14/137 (10%)
Query: 17 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE 76
V E ++GG L ++ + R D A +A +I A+ LH GII+RDLK +N+LL
Sbjct: 102 VMEFVNGGDLMFHI--QKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDH 159
Query: 77 DLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNHKVDSYS 134
+ KLADFG+ +E + +T T GT ++APE + Y VD ++
Sbjct: 160 E-GHCKLADFGMCKEG-ICNGVTTATFCGTPDYIAPE----ILQEML----YGPAVDWWA 209
Query: 135 FAIVLWELLHNKLPFEG 151
++L+E+L PFE
Sbjct: 210 MGVLLYEMLCGHAPFEA 226
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 3e-23
Identities = 52/193 (26%), Positives = 92/193 (47%), Gaps = 18/193 (9%)
Query: 16 IVTELLSGGTLRKYLLNMRPRCLD-VCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL 74
I+ E GG + ++ R L + + + A+ LHS IIHRDLK N+L+
Sbjct: 93 IMIEFCPGGAVDA-IMLELDRGLTEPQIQV-VCRQMLEALNFLHSKRIIHRDLKAGNVLM 150
Query: 75 TEDLKTIKLADFGLAREESLTEMMT-AET--GTYRWMAPELYSTVTLRQGEKKHYNHKVD 131
T + I+LADFG++ + + + ++ GT WMAPE+ V + Y++K D
Sbjct: 151 TLE-GDIRLADFGVSAK--NLKTLQKRDSFIGTPYWMAPEV---VMCETMKDTPYDYKAD 204
Query: 132 SYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSII----LTSCWKE 187
+S I L E+ + P ++ ++ A K+ P+ P + S+ L +
Sbjct: 205 IWSLGITLIEMAQIEPPHHELNPMRVLLKIA-KSDPPTLLT-PSKWSVEFRDFLKIALDK 262
Query: 188 DPNARPNFTQIIQ 200
+P RP+ Q+++
Sbjct: 263 NPETRPSAAQLLE 275
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 4e-23
Identities = 50/204 (24%), Positives = 91/204 (44%), Gaps = 14/204 (6%)
Query: 4 QFIGAC-KEPVMVIVTELLSGGTLRKY-LLNMRPRCLDVCVAIGFALDIARAMECLHS-H 60
F GA +E + I EL+ + Y + + + + + A+ I +A+E LHS
Sbjct: 70 TFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL 129
Query: 61 GIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTL 118
+IHRD+KP N+L+ +K+ DFG++ L + + + G +MAPE
Sbjct: 130 SVIHRDVKPSNVLINAL-GQVKMCDFGISGY--LVDDVAKDIDAGCKPYMAPE----RIN 182
Query: 119 RQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS--AENVPEE 176
+ +K Y+ K D +S I + EL + P++ + P A+ E
Sbjct: 183 PELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAE 242
Query: 177 LSIILTSCWKEDPNARPNFTQIIQ 200
+ C K++ RP + +++Q
Sbjct: 243 FVDFTSQCLKKNSKERPTYPELMQ 266
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 4e-23
Identities = 45/145 (31%), Positives = 73/145 (50%), Gaps = 11/145 (7%)
Query: 17 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE 76
V E + GG L + N + A + ++ A++ +HS G IHRD+KP+N+LL +
Sbjct: 147 VMEYMPGGDLVNLMSNYD---VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDK 203
Query: 77 DLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNHKVDSYS 134
+KLADFG + + M+ +T GT +++PE V QG +Y + D +S
Sbjct: 204 SGH-LKLADFGTCMKMNKEGMVRCDTAVGTPDYISPE----VLKSQGGDGYYGRECDWWS 258
Query: 135 FAIVLWELLHNKLPFEGMSNLQAAY 159
+ L+E+L PF +L Y
Sbjct: 259 VGVFLYEMLVGDTPFYA-DSLVGTY 282
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 5e-23
Identities = 51/137 (37%), Positives = 71/137 (51%), Gaps = 14/137 (10%)
Query: 17 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE 76
V + ++GG L +L R RC A +A +IA A+ LHS I++RDLKPEN+LL
Sbjct: 117 VLDYINGGELFYHL--QRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDS 174
Query: 77 DLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNHKVDSYS 134
I L DFGL +E + T T GT ++APE V +Q Y+ VD +
Sbjct: 175 Q-GHIVLTDFGLCKEN-IEHNSTTSTFCGTPEYLAPE----VLHKQP----YDRTVDWWC 224
Query: 135 FAIVLWELLHNKLPFEG 151
VL+E+L+ PF
Sbjct: 225 LGAVLYEMLYGLPPFYS 241
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 5e-23
Identities = 46/160 (28%), Positives = 67/160 (41%), Gaps = 32/160 (20%)
Query: 4 QFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGF-----ALDIAR----A 53
+ ++ IV EL +GG L D + A I +
Sbjct: 85 KLFEILEDSSSFYIVGELYTGGEL-----------FDEIIKRKRFSEHDAARIIKQVFSG 133
Query: 54 MECLHSHGIIHRDLKPENLLLT--EDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPE 111
+ +H H I+HRDLKPEN+LL E IK+ DFGL+ M GT ++APE
Sbjct: 134 ITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPE 193
Query: 112 LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 151
+ + Y+ K D +S ++L+ LL PF G
Sbjct: 194 VL---------RGTYDEKCDVWSAGVILYILLSGTPPFYG 224
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 5e-23
Identities = 47/136 (34%), Positives = 70/136 (51%), Gaps = 9/136 (6%)
Query: 16 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 75
IV EL+ GG L ++ + L + + A++ LH +GIIHRDLKPEN+LL+
Sbjct: 91 IVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLS 148
Query: 76 --EDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSY 133
E+ IK+ DFG ++ T +M GT ++APE+ L YN VD +
Sbjct: 149 SQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEV-----LVSVGTAGYNRAVDCW 203
Query: 134 SFAIVLWELLHNKLPF 149
S ++L+ L PF
Sbjct: 204 SLGVILFICLSGYPPF 219
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 7e-23
Identities = 46/137 (33%), Positives = 78/137 (56%), Gaps = 14/137 (10%)
Query: 17 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE 76
V E ++GG L ++ + A+ +A +IA + L S GII+RDLK +N++L
Sbjct: 99 VMEYVNGGDLMYHI--QQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDS 156
Query: 77 DLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNHKVDSYS 134
+ IK+ADFG+ + E++ + +T +T GT ++APE + Q Y VD ++
Sbjct: 157 E-GHIKIADFGMCK-ENIWDGVTTKTFCGTPDYIAPE----IIAYQP----YGKSVDWWA 206
Query: 135 FAIVLWELLHNKLPFEG 151
F ++L+E+L + PFEG
Sbjct: 207 FGVLLYEMLAGQAPFEG 223
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 8e-23
Identities = 53/224 (23%), Positives = 86/224 (38%), Gaps = 33/224 (14%)
Query: 6 IGACKEPV-MVIVTELLSGGTLRKYLLNMRPRC-LDVCVAIGFALDIARAMECLHSHGII 63
+G + + +V + G+L L + L + A A + LH + I
Sbjct: 96 LGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHI 155
Query: 64 HRDLKPENLLLTEDLKTIKLADFGLAR---EESLTEMMTAETGTYRWMAPELYSTVTLRQ 120
HRD+K N+LL E T K++DFGLAR + + T M + GT +MAPE
Sbjct: 156 HRDIKSANILLDEAF-TAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPE-ALR----- 208
Query: 121 GEKKHYNHKVDSYSFAIVLWELLHNKLPFE---GMSNLQAAYAAAFKN--------VRPS 169
G K D YSF +VL E++ + L ++ +
Sbjct: 209 G---EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL-LDIKEEIEDEEKTIEDYIDKK 264
Query: 170 AENVPEE-----LSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 208
+ S+ C E N RP+ ++ Q+L ++
Sbjct: 265 MNDADSTSVEAMYSVAS-QCLHEKKNKRPDIKKVQQLLQEMTAS 307
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 1e-22
Identities = 44/202 (21%), Positives = 76/202 (37%), Gaps = 11/202 (5%)
Query: 4 QFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HG 61
Q G + I EL+ + + + + I +A+ L HG
Sbjct: 88 QCFGTFITNTDVFIAMELMGTCAEKLKK--RMQGPIPERILGKMTVAIVKALYYLKEKHG 145
Query: 62 IIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQG 121
+IHRD+KP N+LL E + IKL DFG++ + G +MAPE +
Sbjct: 146 VIHRDVKPSNILLDERGQ-IKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKP 204
Query: 122 EKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVP---EELS 178
Y+ + D +S I L EL + P++ + P +
Sbjct: 205 ---DYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQ 261
Query: 179 IILTSCWKEDPNARPNFTQIIQ 200
+ C +D RP + ++++
Sbjct: 262 SFVKDCLTKDHRKRPKYNKLLE 283
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 1e-22
Identities = 39/160 (24%), Positives = 64/160 (40%), Gaps = 32/160 (20%)
Query: 4 QFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGF-----ALDIAR----A 53
+ ++ + +V EL +GG L + V A I + A
Sbjct: 70 RLYETFEDNTDIYLVMELCTGGEL-----------FERVVHKRVFRESDAARIMKDVLSA 118
Query: 54 MECLHSHGIIHRDLKPENLLLT--EDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPE 111
+ H + HRDLKPEN L +KL DFGLA +MM + GT +++P+
Sbjct: 119 VAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQ 178
Query: 112 LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 151
+ + Y + D +S ++++ LL PF
Sbjct: 179 VL---------EGLYGPECDEWSAGVMMYVLLCGYPPFSA 209
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 95.0 bits (236), Expect = 1e-22
Identities = 33/151 (21%), Positives = 68/151 (45%), Gaps = 17/151 (11%)
Query: 16 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFAL-DIARAMECLHSHGIIHRDLKPENLLL 74
+VT ++ G+ + + ++ +AI + L + +A++ +H G +HR +K ++L+
Sbjct: 103 VVTSFMAYGSAKDLICTHFMDGMNE-LAIAYILQGVLKALDYIHHMGYVHRSVKASHILI 161
Query: 75 TEDLKTIKLADFGLA--------REESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 126
+ D + L+ R+ + + W++PE+ L+Q + Y
Sbjct: 162 SVD-GKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEV-----LQQ-NLQGY 214
Query: 127 NHKVDSYSFAIVLWELLHNKLPFEGMSNLQA 157
+ K D YS I EL + +PF+ M Q
Sbjct: 215 DAKSDIYSVGITACELANGHVPFKDMPATQM 245
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 1e-22
Identities = 43/167 (25%), Positives = 74/167 (44%), Gaps = 15/167 (8%)
Query: 43 AIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK-TIKLADFGLAR-----EESLTE 96
I A+ LH+ GI HRD+KPEN L + + IKL DFGL++
Sbjct: 170 ISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYY 229
Query: 97 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN-- 154
MT + GT ++APE+ L + Y K D++S ++L LL +PF G+++
Sbjct: 230 GMTTKAGTPYFVAPEV-----LN-TTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDAD 283
Query: 155 -LQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQ 200
+ P+ + +L++ + + R + + +Q
Sbjct: 284 TISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQ 330
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 2e-22
Identities = 53/206 (25%), Positives = 85/206 (41%), Gaps = 20/206 (9%)
Query: 16 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 75
+ E SGG L + + A F + + LH GI HRD+KPENLLL
Sbjct: 82 LFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD 139
Query: 76 EDLKTIKLADFGLA---REESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYN-HKVD 131
E +K++DFGLA R + ++ GT ++APEL ++ ++ VD
Sbjct: 140 ER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK--------RREFHAEPVD 190
Query: 132 SYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN--VRPSAENVPEELSIILTSCWKEDP 189
+S IVL +L +LP++ S+ Y+ + + + +L E+P
Sbjct: 191 VWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENP 250
Query: 190 NARPNFTQIIQ---MLLNYLSAIAPP 212
+AR I + P
Sbjct: 251 SARITIPDIKKDRWYNKPLKKGAKRP 276
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 2e-22
Identities = 66/217 (30%), Positives = 103/217 (47%), Gaps = 41/217 (18%)
Query: 16 IVTELLSGGTLRKYLLNMRPRCLD------VCVAIGFALDIARAMECLHSHGIIHRDLKP 69
+V E L+GG+L + C+D VC + +A+E LHS+ +IHRD+K
Sbjct: 94 VVMEYLAGGSLTDV---VTETCMDEGQIAAVC------RECLQALEFLHSNQVIHRDIKS 144
Query: 70 ENLLLTEDLKTIKLADFGLAREESLTEMMTAET---GTYRWMAPELYSTVTLRQGEKKHY 126
+N+LL D ++KL DFG + +T + + GT WMAPE+ + +K Y
Sbjct: 145 DNILLGMD-GSVKLTDFGFCAQ--ITPEQSKRSTMVGTPYWMAPEVVT--------RKAY 193
Query: 127 NHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTS--- 183
KVD +S I+ E++ + P+ + L+A Y A N P +N PE+LS I
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA-TNGTPELQN-PEKLSAIFRDFLN 251
Query: 184 -CWKEDPNARPNFTQIIQMLLN--YLSAIAPPEPMIP 217
C + D R + + LL +L P + P
Sbjct: 252 RCLEMDVEKRGSAKE----LLQHQFLKIAKPLSSLTP 284
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 2e-22
Identities = 42/156 (26%), Positives = 63/156 (40%), Gaps = 24/156 (15%)
Query: 4 QFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGF-----ALDIAR----A 53
Q + +V +L+ G L D I R
Sbjct: 88 QLKDTYETNTFFFLVFDLMKKGEL-----------FDYLTEKVTLSEKETRKIMRALLEV 136
Query: 54 MECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELY 113
+ LH I+HRDLKPEN+LL +D+ IKL DFG + + E + GT ++APE+
Sbjct: 137 ICALHKLNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGEKLREVCGTPSYLAPEII 195
Query: 114 STVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPF 149
Y +VD +S ++++ LL PF
Sbjct: 196 ECSM--NDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 2e-22
Identities = 55/200 (27%), Positives = 92/200 (46%), Gaps = 31/200 (15%)
Query: 16 IVTELLSGGTLRKYLLNMRPRCLDVCVA-----IGFAL-DIARAMECLHSHGIIHRDLKP 69
+V +LLSGG++ + ++ + I L ++ +E LH +G IHRD+K
Sbjct: 90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKA 149
Query: 70 ENLLLTEDLKTIKLADFG----LAREESLTEMMTAET--GTYRWMAPELYSTVTLRQGEK 123
N+LL ED ++++ADFG LA +T +T GT WMAPE+ +
Sbjct: 150 GNILLGED-GSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVME-------QV 201
Query: 124 KHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSII--- 180
+ Y+ K D +SF I EL P+ ++ +N PS E ++ ++
Sbjct: 202 RGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTL-QNDPPSLETGVQDKEMLKKY 260
Query: 181 -------LTSCWKEDPNARP 193
++ C ++DP RP
Sbjct: 261 GKSFRKMISLCLQKDPEKRP 280
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 2e-22
Identities = 53/193 (27%), Positives = 84/193 (43%), Gaps = 27/193 (13%)
Query: 16 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 75
+V E +SGG L Y+ ++ A I A++ H H ++HRDLKPEN+LL
Sbjct: 88 MVMEYVSGGELFDYICKHGR--VEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLD 145
Query: 76 EDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYN-HKVDSYS 134
+ K+ADFGL+ S E + G+ + APE+ S + Y +VD +S
Sbjct: 146 AHMN-AKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVIS--------GRLYAGPEVDIWS 196
Query: 135 FAIVLWELLHNKLPFEGMSNLQAAY----AAAFK---NVRPSAENVPEELSIILTSCWKE 187
++L+ LL LPF+ ++ + F + S + L +L
Sbjct: 197 CGVILYALLCGTLPFDD-EHVPTLFKKIRGGVFYIPEYLNRSVATL---LMHMLQV---- 248
Query: 188 DPNARPNFTQIIQ 200
DP R I +
Sbjct: 249 DPLKRATIKDIRE 261
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 2e-22
Identities = 43/150 (28%), Positives = 62/150 (41%), Gaps = 31/150 (20%)
Query: 14 MVIVTELLSGGTLRKYLLNMRPRCLDVCV---------AIGFALDIARAMECLHSHGIIH 64
+V++ EL+SGG L D A F I + LH+ I H
Sbjct: 90 VVLILELVSGGEL-----------FDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAH 138
Query: 65 RDLKPENLLL---TEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQG 121
DLKPEN++L + IKL DFGLA E GT ++APE+ +
Sbjct: 139 FDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI-----VNY- 192
Query: 122 EKKHYNHKVDSYSFAIVLWELLHNKLPFEG 151
+ + D +S ++ + LL PF G
Sbjct: 193 --EPLGLEADMWSIGVITYILLSGASPFLG 220
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 95.1 bits (236), Expect = 2e-22
Identities = 46/137 (33%), Positives = 77/137 (56%), Gaps = 14/137 (10%)
Query: 17 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE 76
V E ++GG L ++ + A+ +A +IA + L S GII+RDLK +N++L
Sbjct: 420 VMEYVNGGDLMYHI--QQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDS 477
Query: 77 DLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNHKVDSYS 134
+ IK+ADFG+ +E + + +T +T GT ++APE + Q Y VD ++
Sbjct: 478 E-GHIKIADFGMCKEN-IWDGVTTKTFCGTPDYIAPE----IIAYQP----YGKSVDWWA 527
Query: 135 FAIVLWELLHNKLPFEG 151
F ++L+E+L + PFEG
Sbjct: 528 FGVLLYEMLAGQAPFEG 544
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 3e-22
Identities = 40/150 (26%), Positives = 61/150 (40%), Gaps = 31/150 (20%)
Query: 14 MVIVTELLSGGTLRKYLLNMRPRCLDVCV---------AIGFALDIARAMECLHSHGIIH 64
++++ EL++GG L D A F I + LHS I H
Sbjct: 89 VILILELVAGGEL-----------FDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAH 137
Query: 65 RDLKPENLLL---TEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQG 121
DLKPEN++L IK+ DFGLA + GT ++APE+ +
Sbjct: 138 FDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI-----VNY- 191
Query: 122 EKKHYNHKVDSYSFAIVLWELLHNKLPFEG 151
+ + D +S ++ + LL PF G
Sbjct: 192 --EPLGLEADMWSIGVITYILLSGASPFLG 219
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 3e-22
Identities = 43/150 (28%), Positives = 62/150 (41%), Gaps = 31/150 (20%)
Query: 14 MVIVTELLSGGTLRKYLLNMRPRCLDVCV---------AIGFALDIARAMECLHSHGIIH 64
+V++ EL+SGG L D A F I + LH+ I H
Sbjct: 90 VVLILELVSGGEL-----------FDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAH 138
Query: 65 RDLKPENLLL---TEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQG 121
DLKPEN++L + IKL DFGLA E GT ++APE+ +
Sbjct: 139 FDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI-----VNY- 192
Query: 122 EKKHYNHKVDSYSFAIVLWELLHNKLPFEG 151
+ + D +S ++ + LL PF G
Sbjct: 193 --EPLGLEADMWSIGVITYILLSGASPFLG 220
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 94.6 bits (235), Expect = 3e-22
Identities = 39/135 (28%), Positives = 70/135 (51%), Gaps = 11/135 (8%)
Query: 17 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE 76
+ +L++GG L +L +A +I +E +H+ +++RDLKP N+LL E
Sbjct: 270 ILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDE 327
Query: 77 DLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFA 136
++++D GLA + S + + GT+ +MAPE+ L++G Y+ D +S
Sbjct: 328 H-GHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEV-----LQKGVA--YDSSADWFSLG 378
Query: 137 IVLWELLHNKLPFEG 151
+L++LL PF
Sbjct: 379 CMLFKLLRGHSPFRQ 393
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 4e-22
Identities = 44/145 (30%), Positives = 62/145 (42%), Gaps = 22/145 (15%)
Query: 14 MVIVTELLSGGTL------RKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDL 67
+V+V E + GG L Y L I F I + +H I+H DL
Sbjct: 161 IVLVMEYVDGGELFDRIIDESYNLTEL-------DTILFMKQICEGIRHMHQMYILHLDL 213
Query: 68 KPENLLL-TEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 126
KPEN+L D K IK+ DFGLAR E + GT ++APE+ +
Sbjct: 214 KPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVN--------YDFV 265
Query: 127 NHKVDSYSFAIVLWELLHNKLPFEG 151
+ D +S ++ + LL PF G
Sbjct: 266 SFPTDMWSVGVIAYMLLSGLSPFLG 290
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 4e-22
Identities = 54/198 (27%), Positives = 83/198 (41%), Gaps = 33/198 (16%)
Query: 16 IVTELLSGGTLRKYLLNMRPRCLD------VCVAIGFALDIARAMECLHSHGIIHRDLKP 69
IV E G++ ++ +R + L + + +E LH IHRD+K
Sbjct: 101 IVMEYCGAGSVSD-IIRLRNKTLTEDEIATIL------QSTLKGLEYLHFMRKIHRDIKA 153
Query: 70 ENLLLTEDLKTIKLADFGLAREESLTEMMTAET---GTYRWMAPELYSTVTLRQGEKKHY 126
N+LL + KLADFG+A + LT+ M GT WMAPE+ + Y
Sbjct: 154 GNILLNTE-GHAKLADFGVAGQ--LTDTMAKRNTVIGTPFWMAPEVIQ--------EIGY 202
Query: 127 NHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSII----LT 182
N D +S I E+ K P+ + ++A + N P+ PE S +
Sbjct: 203 NCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIP-TNPPPTFRK-PELWSDNFTDFVK 260
Query: 183 SCWKEDPNARPNFTQIIQ 200
C + P R TQ++Q
Sbjct: 261 QCLVKSPEQRATATQLLQ 278
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 4e-22
Identities = 47/154 (30%), Positives = 71/154 (46%), Gaps = 12/154 (7%)
Query: 16 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 75
I+ E + GG L + + A DI A++ LHSH I HRD+KPENLL T
Sbjct: 103 IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYT 162
Query: 76 --EDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSY 133
E +KL DFG A+E + + T T ++APE+ + Y+ D +
Sbjct: 163 SKEKDAVLKLTDFGFAKETTQNALQTP-CYTPYYVAPEVL--------GPEKYDKSCDMW 213
Query: 134 SFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR 167
S ++++ LL PF + QA + +R
Sbjct: 214 SLGVIMYILLCGFPPFYSNTG-QAISPGMKRRIR 246
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 4e-22
Identities = 36/130 (27%), Positives = 51/130 (39%), Gaps = 31/130 (23%)
Query: 14 MVIVTELLSGGTLRKYLLNMRPRCLDVCV---------AIGFALDIARAMECLHSHGIIH 64
+V++ EL+SGG L D A F I + LHS I H
Sbjct: 83 VVLILELVSGGEL-----------FDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAH 131
Query: 65 RDLKPENLLL---TEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQG 121
DLKPEN++L IKL DFG+A + GT ++APE+ +
Sbjct: 132 FDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEI-----VNY- 185
Query: 122 EKKHYNHKVD 131
+ + D
Sbjct: 186 --EPLGLEAD 193
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 5e-22
Identities = 38/145 (26%), Positives = 68/145 (46%), Gaps = 22/145 (15%)
Query: 14 MVIVTELLSGGTL------RKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDL 67
MV++ E LSGG L Y ++ I + ++ +H H I+H D+
Sbjct: 123 MVLILEFLSGGELFDRIAAEDYKMSEA-------EVINYMRQACEGLKHMHEHSIVHLDI 175
Query: 68 KPENLLL-TEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 126
KPEN++ T+ ++K+ DFGLA + + E++ T T + APE+ +++
Sbjct: 176 KPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV--------DREPV 227
Query: 127 NHKVDSYSFAIVLWELLHNKLPFEG 151
D ++ ++ + LL PF G
Sbjct: 228 GFYTDMWAIGVLGYVLLSGLSPFAG 252
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 5e-22
Identities = 39/156 (25%), Positives = 68/156 (43%), Gaps = 24/156 (15%)
Query: 4 QFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGF---------ALDIARA 53
I + + + +V +L+ G L D + A
Sbjct: 164 TLIDSYESSSFMFLVFDLMRKGEL-----------FDYLTEKVALSEKETRSIMRSLLEA 212
Query: 54 MECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELY 113
+ LH++ I+HRDLKPEN+LL ++++ I+L+DFG + E + GT ++APE+
Sbjct: 213 VSFLHANNIVHRDLKPENILLDDNMQ-IRLSDFGFSCHLEPGEKLRELCGTPGYLAPEIL 271
Query: 114 STVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPF 149
Y +VD ++ ++L+ LL PF
Sbjct: 272 KCSM--DETHPGYGKEVDLWACGVILFTLLAGSPPF 305
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 6e-22
Identities = 56/217 (25%), Positives = 93/217 (42%), Gaps = 24/217 (11%)
Query: 16 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 75
+V E +SGG L Y+ LD + I ++ H H ++HRDLKPEN+LL
Sbjct: 93 MVMEYVSGGELFDYICKNGR--LDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLD 150
Query: 76 EDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYN-HKVDSYS 134
+ K+ADFGL+ S E + G+ + APE+ S + Y +VD +S
Sbjct: 151 AHMN-AKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVIS--------GRLYAGPEVDIWS 201
Query: 135 FAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSI----ILTSCWKEDPN 190
++L+ LL LPF+ ++ + K + P+ L+ +L + DP
Sbjct: 202 SGVILYALLCGTLPFDD-DHVPTLF----KKICDGIFYTPQYLNPSVISLLKHMLQVDPM 256
Query: 191 ARPNFTQIIQ---MLLNYLSAIAPPEPMIPHRIFNSE 224
R I + + + P +P + + E
Sbjct: 257 KRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDE 293
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 6e-22
Identities = 56/248 (22%), Positives = 91/248 (36%), Gaps = 25/248 (10%)
Query: 16 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 75
+ E SGG L + + A F + + LH GI HRD+KPENLLL
Sbjct: 82 LFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD 139
Query: 76 EDLKTIKLADFGLA---REESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYN-HKVD 131
E +K++DFGLA R + ++ GT ++APEL ++ ++ VD
Sbjct: 140 ER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK--------RREFHAEPVD 190
Query: 132 SYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN--VRPSAENVPEELSIILTSCWKEDP 189
+S IVL +L +LP++ S+ Y+ + + + +L E+P
Sbjct: 191 VWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENP 250
Query: 190 NARPNFTQIIQ---MLLNYLSAIAPPEPMIPHRIFNSENTILPPESPGTSSLMTVRDDIG 246
+AR I + P + S S +
Sbjct: 251 SARITIPDIKKDRWYNKPL-----KKGAKRPRVTSGGVSESPSGFSKHIQSNLDFSPVNS 305
Query: 247 ETPKAKMG 254
+ G
Sbjct: 306 ASRTPGSG 313
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 6e-22
Identities = 31/120 (25%), Positives = 52/120 (43%), Gaps = 10/120 (8%)
Query: 14 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 73
++++ E +GG + L + I I + LH + I+H DLKP+N+L
Sbjct: 104 IILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNIL 163
Query: 74 LT--EDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVD 131
L+ L IK+ DFG++R+ + GT ++APE+ L D
Sbjct: 164 LSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEI-----LNY---DPITTATD 215
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 9e-22
Identities = 41/188 (21%), Positives = 72/188 (38%), Gaps = 20/188 (10%)
Query: 15 VIVTELLSG-GTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 73
V++ E L ++ L +A F + A+ H+ G++HRD+K EN+L
Sbjct: 124 VLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENIL 181
Query: 74 LTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYN-HKVDS 132
+ + +KL DFG T + GT + PE Y+
Sbjct: 182 IDLNRGELKLIDFGSGALLKDTVYTDFD-GTRVYSPPEWIR--------YHRYHGRSAAV 232
Query: 133 YSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNAR 192
+S I+L++++ +PFE + + V E ++ C P+ R
Sbjct: 233 WSLGILLYDMVCGDIPFEHDEEIIRG-----QVFFRQ--RVSSECQHLIRWCLALRPSDR 285
Query: 193 PNFTQIIQ 200
P F +I
Sbjct: 286 PTFEEIQN 293
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 1e-21
Identities = 57/218 (26%), Positives = 97/218 (44%), Gaps = 41/218 (18%)
Query: 16 IVTELLSGGTLRKYLLNMRPRCLD------VCVAIGFALDIARAMECLHSHGIIHRDLKP 69
++ E L GG L + L+ VC + +A+ LH+ G+IHRD+K
Sbjct: 119 VLMEFLQGGALTDI---VSQVRLNEEQIATVC------EAVLQALAYLHAQGVIHRDIKS 169
Query: 70 ENLLLTEDLKTIKLADFGLAREESLTEMMTAET---GTYRWMAPELYSTVTLRQGEKKHY 126
+++LLT D +KL+DFG +++ + GT WMAPE+ S + Y
Sbjct: 170 DSILLTLD-GRVKLSDFGFC--AQISKDVPKRKSLVGTPYWMAPEVIS--------RSLY 218
Query: 127 NHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSII----LT 182
+VD +S I++ E++ + P+ S +QA + P +N ++S + L
Sbjct: 219 ATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLR-DSPPPKLKN-SHKVSPVLRDFLE 276
Query: 183 SCWKEDPNARPNFTQIIQMLLN--YLSAIAPPEPMIPH 218
DP R + LL+ +L PE ++P
Sbjct: 277 RMLVRDPQERATAQE----LLDHPFLLQTGLPECLVPL 310
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 1e-21
Identities = 59/213 (27%), Positives = 95/213 (44%), Gaps = 25/213 (11%)
Query: 16 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 75
+V E +GG L Y++ + + F I A+E H H I+HRDLKPENLLL
Sbjct: 86 MVIEY-AGGELFDYIVEKKR--MTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLD 142
Query: 76 EDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYN-HKVDSYS 134
++L +K+ADFGL+ + + G+ + APE+ + K Y +VD +S
Sbjct: 143 DNLN-VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVIN--------GKLYAGPEVDVWS 193
Query: 135 FAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSI----ILTSCWKEDPN 190
IVL+ +L +LPF+ + + K V +P+ LS ++ DP
Sbjct: 194 CGIVLYVMLVGRLPFDD-EFIPNLF----KKVNSCVYVMPDFLSPGAQSLIRRMIVADPM 248
Query: 191 ARPNFTQIIQ---MLLNYLSAIAPPEPMIPHRI 220
R +I + +N + P E +
Sbjct: 249 QRITIQEIRRDPWFNVNLPDYLRPMEEVQGSYA 281
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 2e-21
Identities = 51/217 (23%), Positives = 80/217 (36%), Gaps = 30/217 (13%)
Query: 16 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 75
I+ E SGG L + + N R A F + + HS I HRDLK EN LL
Sbjct: 93 IIMEYASGGELYERICN-AGR-FSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLD 150
Query: 76 EDLKT-IKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYN-HKVDSY 133
+K+ DFG ++ L + GT ++APE+ ++ Y+ D +
Sbjct: 151 GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL--------RQEYDGKIADVW 202
Query: 134 SFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR------PSAENVPEE----LSIILTS 183
S + L+ +L PFE Y + + P + E +S I +
Sbjct: 203 SCGVTLYVMLVGAYPFED-PEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIFVA 261
Query: 184 CWKEDPNARPNFTQIIQ---MLLNYLSAIAPPEPMIP 217
DP R + +I L N + +
Sbjct: 262 ----DPATRISIPEIKTHSWFLKNLPADLMNESNTGS 294
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 2e-21
Identities = 47/213 (22%), Positives = 80/213 (37%), Gaps = 33/213 (15%)
Query: 15 VIVTEL-LSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 73
++V E L L Y+ L + F + A++ HS G++HRD+K EN+L
Sbjct: 114 MLVLERPLPAQDLFDYI--TEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENIL 171
Query: 74 LTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYN-HKVDS 132
+ KL DFG + GT + PE S + Y+
Sbjct: 172 IDLRRGCAKLIDFGSGALLHDEPYTDFD-GTRVYSPPEWIS--------RHQYHALPATV 222
Query: 133 YSFAIVLWELLHNKLPFEGMSN-LQAAYAAAFKNVRPSAENVPEELSI----ILTSCWKE 187
+S I+L++++ +PFE L+A + P +S ++ C
Sbjct: 223 WSLGILLYDMVCGDIPFERDQEILEAEL------------HFPAHVSPDCCALIRRCLAP 270
Query: 188 DPNARPNFTQIIQ---MLLNYLSAIAPPEPMIP 217
P++RP+ +I+ M P P
Sbjct: 271 KPSSRPSLEEILLDPWMQTPAEDVPLNPSKGGP 303
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 92.6 bits (230), Expect = 2e-21
Identities = 38/139 (27%), Positives = 67/139 (48%), Gaps = 10/139 (7%)
Query: 14 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 73
MV++ E +SGG L + + + + + A+ + + + + +H + +H DLKPEN++
Sbjct: 229 MVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIM 287
Query: 74 L-TEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDS 132
T+ +KL DFGL + + TGT + APE+ E K + D
Sbjct: 288 FTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVA--------EGKPVGYYTDM 339
Query: 133 YSFAIVLWELLHNKLPFEG 151
+S ++ + LL PF G
Sbjct: 340 WSVGVLSYILLSGLSPFGG 358
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 89.9 bits (224), Expect = 2e-21
Identities = 48/160 (30%), Positives = 75/160 (46%), Gaps = 31/160 (19%)
Query: 4 QFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIG---------FALDIARA 53
+ + +E +V +L++GG L + VA I +
Sbjct: 69 RLHDSIQEESFHYLVFDLVTGGEL-----------FEDIVAREFYSEADASHCIQQILES 117
Query: 54 MECLHSHGIIHRDLKPENLLLTEDLK--TIKLADFGLAREESLTEMMTAETGTYRWMAPE 111
+ HS+GI+HR+LKPENLLL K +KLADFGLA E + +E GT +++PE
Sbjct: 118 IAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPE 177
Query: 112 LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 151
+ L+ K Y+ VD ++ ++L+ LL PF
Sbjct: 178 V-----LK---KDPYSKPVDIWACGVILYILLVGYPPFWD 209
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 2e-21
Identities = 33/208 (15%), Positives = 66/208 (31%), Gaps = 47/208 (22%)
Query: 16 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 75
+V E + GG+L++ + + P AI +A A + H G+ P + ++
Sbjct: 108 VVAEWIRGGSLQE-VADTSP---SPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVS 163
Query: 76 EDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSF 135
D + LA + + + D
Sbjct: 164 ID-GDVVLAYPATMPDAN----------------------------------PQDDIRGI 188
Query: 136 AIVLWELLHNKLPFEG---MSNLQAAYAAAFKN-VRPSAEN--VPEELSIILTSCWKEDP 189
L+ LL N+ P S L A + P+ + +P ++S + + D
Sbjct: 189 GASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDG 248
Query: 190 NARPNFTQIIQMLLNYLSAIAPPEPMIP 217
R + L+ +A+A ++
Sbjct: 249 GIRS--ASTLLNLMQQATAVADRTEVLG 274
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 2e-21
Identities = 58/183 (31%), Positives = 86/183 (46%), Gaps = 21/183 (11%)
Query: 16 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFAL-DIARAMECLHSHGIIHRDLKPENLLL 74
I+ E L GG+ + P LD I L +I + ++ LHS IHRD+K N+LL
Sbjct: 97 IIMEYLGGGSALDL---LEPGPLDE-TQIATILREILKGLDYLHSEKKIHRDIKAANVLL 152
Query: 75 TEDLKTIKLADFGLAREESLTEMMTAET---GTYRWMAPELYSTVTLRQGEKKHYNHKVD 131
+E +KLADFG+A LT+ GT WMAPE V + Y+ K D
Sbjct: 153 SEH-GEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPE----VIKQSA----YDSKAD 201
Query: 132 SYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAE-NVPEELSIILTSCWKEDPN 190
+S I EL + P + ++ + KN P+ E N + L + +C ++P+
Sbjct: 202 IWSLGITAIELARGEPPHSELHPMKVLFLIP-KNNPPTLEGNYSKPLKEFVEACLNKEPS 260
Query: 191 ARP 193
RP
Sbjct: 261 FRP 263
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 3e-21
Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 14/206 (6%)
Query: 4 QFIGAC-KEPVMVIVTELLSGGTLR--KYLLNMRPRCLDVCVAIGFALDIARAMECLHS- 59
QF GA +E I EL+S + KY+ ++ + + L +A+ L
Sbjct: 85 QFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN 144
Query: 60 HGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLR 119
IIHRD+KP N+LL IKL DFG++ + + T + G +MAPE
Sbjct: 145 LKIIHRDIKPSNILLDRS-GNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPE----RIDP 199
Query: 120 QGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPE---- 175
++ Y+ + D +S I L+EL + P+ +++ K P N E
Sbjct: 200 SASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFS 259
Query: 176 -ELSIILTSCWKEDPNARPNFTQIIQ 200
+ C +D + RP + ++++
Sbjct: 260 PSFINFVNLCLTKDESKRPKYKELLK 285
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 3e-21
Identities = 40/109 (36%), Positives = 55/109 (50%), Gaps = 11/109 (10%)
Query: 50 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT--YRW 107
+ R++ +HS GI HRD+KP+NLLL D +KL DFG A++ E + + YR
Sbjct: 165 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR- 223
Query: 108 MAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 156
APEL T Y +D +S VL ELL + F G S +
Sbjct: 224 -APELIFGAT-------DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD 264
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 89.9 bits (224), Expect = 3e-21
Identities = 46/137 (33%), Positives = 70/137 (51%), Gaps = 17/137 (12%)
Query: 17 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE 76
+ + + GG L L + + VA +A ++ A+E LHS II+RDLKPEN+LL +
Sbjct: 84 IMDYIEGGELFSLL--RKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDK 141
Query: 77 DLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNHKVDSYS 134
+ IK+ DFG A+ T GT ++APE V + YN +D +S
Sbjct: 142 N-GHIKITDFGFAKYVP----DVTYTLCGTPDYIAPE----VVSTKP----YNKSIDWWS 188
Query: 135 FAIVLWELLHNKLPFEG 151
F I+++E+L PF
Sbjct: 189 FGILIYEMLAGYTPFYD 205
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 4e-21
Identities = 43/137 (31%), Positives = 65/137 (47%), Gaps = 17/137 (12%)
Query: 17 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE 76
V E ++GG + +L R A +A I E LHS +I+RDLKPENLL+ +
Sbjct: 119 VMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQ 176
Query: 77 DLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNHKVDSYS 134
I++ DFG A+ T GT +APE + L +G YN VD ++
Sbjct: 177 Q-GYIQVTDFGFAKRVK----GRTWTLCGTPEALAPE----IILSKG----YNKAVDWWA 223
Query: 135 FAIVLWELLHNKLPFEG 151
++++E+ PF
Sbjct: 224 LGVLIYEMAAGYPPFFA 240
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 5e-21
Identities = 51/170 (30%), Positives = 74/170 (43%), Gaps = 31/170 (18%)
Query: 4 QFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGF-----ALDIAR----A 53
+ + P + +V EL++GG L D V G+ A D + A
Sbjct: 112 KLKEIFETPTEISLVLELVTGGEL-----------FDRIVEKGYYSERDAADAVKQILEA 160
Query: 54 MECLHSHGIIHRDLKPENLLLT--EDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPE 111
+ LH +GI+HRDLKPENLL +K+ADFGL++ +M GT + APE
Sbjct: 161 VAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPE 220
Query: 112 LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAA 161
+ LR Y +VD +S I+ + LL PF Q +
Sbjct: 221 I-----LR---GCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRR 262
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 5e-21
Identities = 37/109 (33%), Positives = 54/109 (49%), Gaps = 11/109 (10%)
Query: 50 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAE--TGTYRW 107
+ R++ +HS GI HRD+KP+NLLL +KL DFG A+ E + + YR
Sbjct: 150 LLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYR- 208
Query: 108 MAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 156
APEL T +Y +D +S V+ EL+ + F G S +
Sbjct: 209 -APELIFGAT-------NYTTNIDIWSTGCVMAELMQGQPLFPGESGID 249
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 7e-21
Identities = 35/145 (24%), Positives = 62/145 (42%), Gaps = 22/145 (15%)
Query: 14 MVIVTELLSGGTL------RKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDL 67
+V++ E +SG + + LN R + + + A++ LHSH I H D+
Sbjct: 76 LVMIFEFISGLDIFERINTSAFELNER-------EIVSYVHQVCEALQFLHSHNIGHFDI 128
Query: 68 KPENLLL-TEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 126
+PEN++ T TIK+ +FG AR+ + + APE+ +
Sbjct: 129 RPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEV-----HQH---DVV 180
Query: 127 NHKVDSYSFAIVLWELLHNKLPFEG 151
+ D +S +++ LL PF
Sbjct: 181 STATDMWSLGTLVYVLLSGINPFLA 205
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 1e-20
Identities = 48/157 (30%), Positives = 76/157 (48%), Gaps = 25/157 (15%)
Query: 4 QFIGACKEPVMV-IVTELLSGGTL------RKYLLNMRPRCLDVCVAIGFALDIARAMEC 56
+ + +E +V +L++GG L R++ A I ++
Sbjct: 92 RLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEA--------DASHCIQQILESIAY 143
Query: 57 LHSHGIIHRDLKPENLLLTEDLK--TIKLADFGLAREESLTEMMTAETGTYRWMAPELYS 114
HS+GI+HR+LKPENLLL K +KLADFGLA E + +E GT +++PE+
Sbjct: 144 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEV-- 201
Query: 115 TVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 151
L+ K Y+ VD ++ ++L+ LL PF
Sbjct: 202 ---LK---KDPYSKPVDIWACGVILYILLVGYPPFWD 232
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 1e-20
Identities = 29/107 (27%), Positives = 53/107 (49%), Gaps = 10/107 (9%)
Query: 52 RAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWM-AP 110
+A++ HS GI+HRD+KP N+++ + + ++L D+GLA + + R+ P
Sbjct: 141 KALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVAS-RYFKGP 199
Query: 111 ELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLP-FEGMSNLQ 156
EL + Y++ +D +S +L ++ K P F G N
Sbjct: 200 ELLVDY-------QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD 239
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 1e-20
Identities = 50/187 (26%), Positives = 81/187 (43%), Gaps = 20/187 (10%)
Query: 16 IVTEL-LSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL 74
+V E SG L ++ PR LD +A + A+ L IIHRD+K EN+++
Sbjct: 106 LVMEKHGSGLDLFAFIDR-HPR-LDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVI 163
Query: 75 TEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYN-HKVDSY 133
ED TIKL DFG A ++ GT + APE+ Y +++ +
Sbjct: 164 AEDF-TIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLM--------GNPYRGPELEMW 214
Query: 134 SFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARP 193
S + L+ L+ + PF L+ AA P V +EL +++ + P R
Sbjct: 215 SLGVTLYTLVFEENPFC---ELEETVEAAIHP--PY--LVSKELMSLVSGLLQPVPERRT 267
Query: 194 NFTQIIQ 200
+++
Sbjct: 268 TLEKLVT 274
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 1e-20
Identities = 46/138 (33%), Positives = 72/138 (52%), Gaps = 15/138 (10%)
Query: 17 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLT 75
V E +GG L +L R R A + +I A++ LHS +++RDLK ENL+L
Sbjct: 226 VMEYANGGELFFHL--SRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLD 283
Query: 76 EDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNHKVDSY 133
+D IK+ DFGL +E + + T +T GT ++APE+ E Y VD +
Sbjct: 284 KD-GHIKITDFGLCKEG-IKDGATMKTFCGTPEYLAPEVL--------EDNDYGRAVDWW 333
Query: 134 SFAIVLWELLHNKLPFEG 151
+V++E++ +LPF
Sbjct: 334 GLGVVMYEMMCGRLPFYN 351
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 1e-20
Identities = 57/197 (28%), Positives = 86/197 (43%), Gaps = 34/197 (17%)
Query: 16 IVTELLSGGTLRKYLLNMRPRCLD------VCVAIGFALDIARAMECLHSHGIIHRDLKP 69
+V E G LL + + L V + + LHSH +IHRD+K
Sbjct: 131 LVMEYCLGSASD--LLEVHKKPLQEVEIAAVT------HGALQGLAYLHSHNMIHRDVKA 182
Query: 70 ENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYN 127
N+LL+E +KL DFG A + M A + GT WMAPE+ + ++ Y+
Sbjct: 183 GNILLSEP-GLVKLGDFGSA-----SIMAPANSFVGTPYWMAPEV-----ILAMDEGQYD 231
Query: 128 HKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSII----LTS 183
KVD +S I EL K P M+ + A Y A +N P+ + S + S
Sbjct: 232 GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-QNESPALQ--SGHWSEYFRNFVDS 288
Query: 184 CWKEDPNARPNFTQIIQ 200
C ++ P RP +++
Sbjct: 289 CLQKIPQDRPTSEVLLK 305
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 3e-20
Identities = 41/154 (26%), Positives = 68/154 (44%), Gaps = 14/154 (9%)
Query: 4 QFIGACKEPVMV-IVTELLSGGTLRKYLLN--MRPRCLDVCVAIGFALDIARAMECLHSH 60
+ + M+ +V E + G L ++ VA + I A+ H +
Sbjct: 90 ELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN 149
Query: 61 GIIHRDLKPENLLLT--EDLKTIKLADFGLARE-ESLTEMMTAETGTYRWMAPELYSTVT 117
IIHRD+KP +LL E+ +KL FG+A + + GT +MAPE+
Sbjct: 150 NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEV----- 204
Query: 118 LRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 151
++ ++ Y VD + ++L+ LL LPF G
Sbjct: 205 VK---REPYGKPVDVWGCGVILFILLSGCLPFYG 235
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 3e-20
Identities = 43/152 (28%), Positives = 71/152 (46%), Gaps = 32/152 (21%)
Query: 16 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGF---------ALDIARAMECLHSHGIIHRD 66
+VTEL+ GG L LD + F I + +E LH+ G++HRD
Sbjct: 93 VVTELMKGGEL-----------LDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRD 141
Query: 67 LKPENLLLT---EDLKTIKLADFGLARE-ESLTEMMTAETGTYRWMAPELYSTVTLRQGE 122
LKP N+L + ++I++ DFG A++ + ++ T ++APE V RQG
Sbjct: 142 LKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPE----VLERQG- 196
Query: 123 KKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN 154
Y+ D +S ++L+ +L PF +
Sbjct: 197 ---YDAACDIWSLGVLLYTMLTGYTPFANGPD 225
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 3e-20
Identities = 44/142 (30%), Positives = 64/142 (45%), Gaps = 10/142 (7%)
Query: 16 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 75
IV E L GG L + + + A I A++ LHS I HRD+KPENLL T
Sbjct: 136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYT 195
Query: 76 --EDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSY 133
+KL DFG A+E + +T T ++APE+ + Y+ D +
Sbjct: 196 SKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL--------GPEKYDKSCDMW 247
Query: 134 SFAIVLWELLHNKLPFEGMSNL 155
S ++++ LL PF L
Sbjct: 248 SLGVIMYILLCGYPPFYSNHGL 269
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 87.6 bits (217), Expect = 3e-20
Identities = 43/215 (20%), Positives = 81/215 (37%), Gaps = 19/215 (8%)
Query: 4 QFIGA-CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HG 61
F GA + + I E + GG+L + L + + ++ + + + L H
Sbjct: 95 GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKV--SIAVIKGLTYLREKHK 152
Query: 62 IIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLR 119
I+HRD+KP N+L+ IKL DFG++ + L + M A + GT +M+PE
Sbjct: 153 IMHRDVKPSNILVNSR-GEIKLCDFGVSGQ--LIDSM-ANSFVGTRSYMSPERLQ----- 203
Query: 120 QGEKKHYNHKVDSYSFAIVLWELLHNKLPF-EGMSNLQAAYAAAFKNVRPSAENVPEELS 178
HY+ + D +S + L E+ + P + +
Sbjct: 204 ---GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 260
Query: 179 IILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPE 213
+ + D +++ ++N P
Sbjct: 261 GRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSG 295
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 3e-20
Identities = 45/147 (30%), Positives = 69/147 (46%), Gaps = 31/147 (21%)
Query: 16 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGF---------ALDIARAMECLHSHGIIHRD 66
+V +L+SGG L D + G + A++ LH +GI+HRD
Sbjct: 83 LVMQLVSGGEL-----------FDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRD 131
Query: 67 LKPENLLL--TEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKK 124
LKPENLL E+ I + DFGL++ E +M+ GT ++APE+ +K
Sbjct: 132 LKPENLLYLTPEENSKIMITDFGLSKMEQ-NGIMSTACGTPGYVAPEVL--------AQK 182
Query: 125 HYNHKVDSYSFAIVLWELLHNKLPFEG 151
Y+ VD +S ++ + LL PF
Sbjct: 183 PYSKAVDCWSIGVITYILLCGYPPFYE 209
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 4e-20
Identities = 42/158 (26%), Positives = 64/158 (40%), Gaps = 33/158 (20%)
Query: 16 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGF---------ALDIARAMECLHSHGIIHRD 66
+V E + GG++ L D+A A++ LH+ GI HRD
Sbjct: 88 LVFEKMRGGSI-----------LSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRD 136
Query: 67 LKPENLLLT--EDLKTIKLADFGLAR--------EESLTEMMTAETGTYRWMAPELYSTV 116
LKPEN+L + +K+ DF L T + G+ +MAPE+ V
Sbjct: 137 LKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEV---V 193
Query: 117 TLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN 154
E Y+ + D +S ++L+ LL PF G
Sbjct: 194 EAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCG 231
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 1e-19
Identities = 44/166 (26%), Positives = 69/166 (41%), Gaps = 33/166 (19%)
Query: 16 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGF---------ALDIARAMECLHSHGIIHRD 66
+V ELL+GG L + + A+ +H G++HRD
Sbjct: 83 LVMELLNGGEL-----------FERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRD 131
Query: 67 LKPENLLLT--EDLKTIKLADFGLARE-ESLTEMMTAETGTYRWMAPELYSTVTLRQGEK 123
LKPENLL T D IK+ DFG AR + + T + APEL L +
Sbjct: 132 LKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPEL-----LN---Q 183
Query: 124 KHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAA--FKNVR 167
Y+ D +S ++L+ +L ++PF+ +A K ++
Sbjct: 184 NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIK 229
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 2e-19
Identities = 39/109 (35%), Positives = 56/109 (51%), Gaps = 11/109 (10%)
Query: 50 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT--YRW 107
+ RA+ +HS GI HRD+KP+NLL+ T+KL DFG A++ +E A + YR
Sbjct: 150 LFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYR- 208
Query: 108 MAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 156
APEL T Y +D +S V EL+ K F G +++
Sbjct: 209 -APELMLGAT-------EYTPSIDLWSIGCVFGELILGKPLFSGETSID 249
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-19
Identities = 48/161 (29%), Positives = 73/161 (45%), Gaps = 32/161 (19%)
Query: 4 QFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGF-----ALDIAR----A 53
+ + E ++ +L++GG L + VA + A + A
Sbjct: 74 RLHDSISEEGHHYLIFDLVTGGEL-----------FEDIVAREYYSEADASHCIQQILEA 122
Query: 54 MECLHSHGIIHRDLKPENLLLTEDLK--TIKLADFGLARE-ESLTEMMTAETGTYRWMAP 110
+ H G++HR+LKPENLLL LK +KLADFGLA E E + GT +++P
Sbjct: 123 VLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSP 182
Query: 111 ELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 151
E+ LR K Y VD ++ ++L+ LL PF
Sbjct: 183 EV-----LR---KDPYGKPVDLWACGVILYILLVGYPPFWD 215
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 3e-19
Identities = 48/133 (36%), Positives = 61/133 (45%), Gaps = 13/133 (9%)
Query: 26 LRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLAD 85
LR YL P L R ++ LH++ I+HRDLKPEN+L+T T+KLAD
Sbjct: 105 LRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSG-GTVKLAD 163
Query: 86 FGLAREESLTEMMTAETGT--YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL 143
FGLAR S +T T YR APE+ L Y VD +S + E+
Sbjct: 164 FGLARIYSYQMALTPVVVTLWYR--APEVL----L--QST--YATPVDMWSVGCIFAEMF 213
Query: 144 HNKLPFEGMSNLQ 156
K F G S
Sbjct: 214 RRKPLFCGNSEAD 226
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 3e-19
Identities = 35/109 (32%), Positives = 51/109 (46%), Gaps = 12/109 (11%)
Query: 50 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT--YRW 107
I + LH G++HRDL P N+LL ++ I + DF LARE++ T YR
Sbjct: 143 ILLGLHVLHEAGVVHRDLHPGNILLADNND-ITICDFNLAREDTADANKTHYVTHRWYR- 200
Query: 108 MAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 156
APEL + K + VD +S V+ E+ + K F G +
Sbjct: 201 -APELV-------MQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN 241
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 4e-19
Identities = 45/138 (32%), Positives = 64/138 (46%), Gaps = 23/138 (16%)
Query: 26 LRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLAD 85
L YL + + + R ++ LHSH ++HRDLKP+N+L+T IKLAD
Sbjct: 105 LTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSS-GQIKLAD 163
Query: 86 FGLAREESLTEMMTAETGT--YRWMAPEL-----YSTVTLRQGEKKHYNHKVDSYSFAIV 138
FGLAR S +T+ T YR APE+ Y+T VD +S +
Sbjct: 164 FGLARIYSFQMALTSVVVTLWYR--APEVLLQSSYAT-------------PVDLWSVGCI 208
Query: 139 LWELLHNKLPFEGMSNLQ 156
E+ K F G S++
Sbjct: 209 FAEMFRRKPLFRGSSDVD 226
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 1e-18
Identities = 36/105 (34%), Positives = 53/105 (50%), Gaps = 11/105 (10%)
Query: 50 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWM- 108
+ ++ LHS GIIHRDLKP N+++ D +K+ DFGLAR + MMT T R+
Sbjct: 136 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCT-LKILDFGLARTAGTSFMMTPYVVT-RYYR 193
Query: 109 APELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS 153
APE+ Y VD +S ++ E++ + F G
Sbjct: 194 APEVILG--------MGYKENVDIWSVGCIMGEMIKGGVLFPGTD 230
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 83.4 bits (206), Expect = 2e-18
Identities = 38/106 (35%), Positives = 55/106 (51%), Gaps = 13/106 (12%)
Query: 50 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT--YRW 107
+ ++ LHS GIIHRDLKP N+++ D +K+ DFGLAR + MMT T YR
Sbjct: 173 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCT-LKILDFGLARTAGTSFMMTPYVVTRYYR- 230
Query: 108 MAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS 153
APE+ Y VD +S ++ E++ +K+ F G
Sbjct: 231 -APEVILG--------MGYKENVDIWSVGCIMGEMVRHKILFPGRD 267
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 3e-18
Identities = 37/110 (33%), Positives = 56/110 (50%), Gaps = 13/110 (11%)
Query: 50 IARAMECLH--SHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT--Y 105
+ R++ CLH S + HRD+KP N+L+ E T+KL DFG A++ S +E A + Y
Sbjct: 138 LIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYY 197
Query: 106 RWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL 155
R APEL HY VD +S + E++ + F G ++
Sbjct: 198 R--APELIFGNQ-------HYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA 238
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 4e-18
Identities = 40/135 (29%), Positives = 60/135 (44%), Gaps = 14/135 (10%)
Query: 25 TLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLA 84
T+ L + R + + +A+ H H IHRD+KPEN+L+T+ IKL
Sbjct: 87 TVLHEL-DRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKH-SVIKLC 144
Query: 85 DFGLAREESL-TEMMTAETGT--YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWE 141
DFG AR + ++ E T YR +PEL + Y VD ++ V E
Sbjct: 145 DFGFARLLTGPSDYYDDEVATRWYR--SPELL----VGD---TQYGPPVDVWAIGCVFAE 195
Query: 142 LLHNKLPFEGMSNLQ 156
LL + G S++
Sbjct: 196 LLSGVPLWPGKSDVD 210
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 5e-18
Identities = 44/134 (32%), Positives = 64/134 (47%), Gaps = 14/134 (10%)
Query: 26 LRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLAD 85
L+K L + L + + R + H H I+HRDLKP+NLL+ D +KLAD
Sbjct: 105 LKKVLDENKTG-LQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSD-GALKLAD 162
Query: 86 FGLAREESL-TEMMTAETGT--YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWEL 142
FGLAR + T E T YR AP++ L K Y+ VD +S + E+
Sbjct: 163 FGLARAFGIPVRSYTHEVVTLWYR--APDV-----LMGS--KKYSTSVDIWSIGCIFAEM 213
Query: 143 LHNKLPFEGMSNLQ 156
+ K F G+++
Sbjct: 214 ITGKPLFPGVTDDD 227
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 80.6 bits (200), Expect = 5e-18
Identities = 41/134 (30%), Positives = 63/134 (47%), Gaps = 14/134 (10%)
Query: 26 LRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLAD 85
L+K L L+ A F L + + H ++HRDLKP+NLL+ + +K+AD
Sbjct: 86 LKKLLDVCEGG-LESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINRE-GELKIAD 143
Query: 86 FGLAREESL-TEMMTAETGT--YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWEL 142
FGLAR + T E T YR AP++ L K Y+ +D +S + E+
Sbjct: 144 FGLARAFGIPVRKYTHEIVTLWYR--APDV-----LMGS--KKYSTTIDIWSVGCIFAEM 194
Query: 143 LHNKLPFEGMSNLQ 156
++ F G+S
Sbjct: 195 VNGTPLFPGVSEAD 208
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 6e-18
Identities = 48/179 (26%), Positives = 76/179 (42%), Gaps = 32/179 (17%)
Query: 47 ALDIARAMECLHSHG---IIHRDLKPENLLLTEDLKTIKLADFGLAR--EESLTEMMTAE 101
AL AR + LH H IIHRD+K N+LL E+ + DFGLA+ + T + TA
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAKLMDYKDTHVTTAV 195
Query: 102 TGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAA 161
GT +APE ST G + K D + + ++L EL+ + F+
Sbjct: 196 RGTIGHIAPEYLST-----G---KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 247
Query: 162 AFKNVRPSAEN---------------VPEELSIILT---SCWKEDPNARPNFTQIIQML 202
V+ + EE+ ++ C + P RP +++++ML
Sbjct: 248 LLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 6e-18
Identities = 41/135 (30%), Positives = 63/135 (46%), Gaps = 15/135 (11%)
Query: 26 LRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLAD 85
L+KY + LD + F + + + HS ++HRDLKP+NLL+ + +KLA+
Sbjct: 87 LKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRN-GELKLAN 144
Query: 86 FGLAREESL-TEMMTAETGT--YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWEL 142
FGLAR + +AE T YR P++ L K Y+ +D +S + EL
Sbjct: 145 FGLARAFGIPVRCYSAEVVTLWYR--PPDV-----LFGA--KLYSTSIDMWSAGCIFAEL 195
Query: 143 LHNKLP-FEGMSNLQ 156
+ P F G
Sbjct: 196 ANAGRPLFPGNDVDD 210
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 1e-17
Identities = 42/108 (38%), Positives = 57/108 (52%), Gaps = 12/108 (11%)
Query: 50 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRW-M 108
I R ++ +HS IIHRDLKP NL + ED + +K+ DFGLAR + MT T RW
Sbjct: 141 ILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLAR--HTADEMTGYVAT-RWYR 196
Query: 109 APELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 156
APE+ HYN VD +S ++ ELL + F G ++
Sbjct: 197 APEIMLNW-------MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID 237
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 2e-17
Identities = 38/108 (35%), Positives = 56/108 (51%), Gaps = 12/108 (11%)
Query: 50 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWM- 108
+ + + +H+ GIIHRDLKP NL + ED + +K+ DFGLAR+ MT T RW
Sbjct: 137 MLKGLRYIHAAGIIHRDLKPGNLAVNEDCE-LKILDFGLARQAD--SEMTGYVVT-RWYR 192
Query: 109 APELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 156
APE+ Y VD +S ++ E++ K F+G +L
Sbjct: 193 APEVI-------LNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD 233
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-17
Identities = 37/100 (37%), Positives = 49/100 (49%), Gaps = 13/100 (13%)
Query: 25 TLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLA 84
T+ L + P LD V + I + HSH IIHRD+KPEN+L+++ +KL
Sbjct: 109 TILDDL-ELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQS-GVVKLC 166
Query: 85 DFGLAREESL-TEMMTAETGT--YRWMAPEL------YST 115
DFG AR + E+ E T YR APEL Y
Sbjct: 167 DFGFARTLAAPGEVYDDEVATRWYR--APELLVGDVKYGK 204
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 3e-17
Identities = 40/113 (35%), Positives = 55/113 (48%), Gaps = 16/113 (14%)
Query: 50 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR----EESLTEMMTAETGT- 104
I R ++ +HS ++HRDLKP NLLL +K+ DFGLAR + T +T T
Sbjct: 137 ILRGLKYIHSANVLHRDLKPSNLLLNTTCD-LKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 105 -YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 156
YR APE+ K Y +D +S +L E+L N+ F G L
Sbjct: 196 WYR--APEIM-------LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD 239
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 3e-17
Identities = 40/108 (37%), Positives = 57/108 (52%), Gaps = 12/108 (11%)
Query: 50 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRW-M 108
+ + ++ +HS G++HRDLKP NL + ED + +K+ DFGLAR MT T RW
Sbjct: 135 MLKGLKYIHSAGVVHRDLKPGNLAVNEDCE-LKILDFGLARHAD--AEMTGYVVT-RWYR 190
Query: 109 APELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 156
APE+ HYN VD +S ++ E+L K F+G L
Sbjct: 191 APEVI-------LSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD 231
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 5e-17
Identities = 32/113 (28%), Positives = 52/113 (46%), Gaps = 15/113 (13%)
Query: 50 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR----EESLTEMMTAETGT- 104
+ R ++ +HS ++HRDLKP NL + + +K+ DFGLAR S ++ T
Sbjct: 129 LLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTK 188
Query: 105 -YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 156
YR +P L +Y +D ++ + E+L K F G L+
Sbjct: 189 WYR--SPRLL-------LSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE 232
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 7e-17
Identities = 44/138 (31%), Positives = 64/138 (46%), Gaps = 18/138 (13%)
Query: 26 LRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT----I 81
L+KY+ + + V F + + HS +HRDLKP+NLLL+ + +
Sbjct: 119 LKKYMDKNPD--VSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVL 176
Query: 82 KLADFGLAREESL-TEMMTAETGT--YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIV 138
K+ DFGLAR + T E T YR PE+ L G +HY+ VD +S A +
Sbjct: 177 KIGDFGLARAFGIPIRQFTHEIITLWYR--PPEIL----L--GS-RHYSTSVDIWSIACI 227
Query: 139 LWELLHNKLPFEGMSNLQ 156
E+L F G S +
Sbjct: 228 WAEMLMKTPLFPGDSEID 245
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-16
Identities = 38/134 (28%), Positives = 66/134 (49%), Gaps = 14/134 (10%)
Query: 26 LRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLAD 85
L++YL + +++ F + R + H ++HRDLKP+NLL+ E +KLAD
Sbjct: 86 LKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINER-GELKLAD 143
Query: 86 FGLAREESL-TEMMTAETGT--YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWEL 142
FGLAR +S+ T+ E T YR P++ L Y+ ++D + + +E+
Sbjct: 144 FGLARAKSIPTKTYDNEVVTLWYR--PPDI-----LLGS--TDYSTQIDMWGVGCIFYEM 194
Query: 143 LHNKLPFEGMSNLQ 156
+ F G + +
Sbjct: 195 ATGRPLFPGSTVEE 208
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 1e-16
Identities = 41/138 (29%), Positives = 72/138 (52%), Gaps = 17/138 (12%)
Query: 26 LRKYL----LNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTI 81
L+KY+ + PR L++ + F + + + H + I+HRDLKP+NLL+ + +
Sbjct: 89 LKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKR-GQL 147
Query: 82 KLADFGLAREESL-TEMMTAETGT--YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIV 138
KL DFGLAR + ++E T YR AP++ + G + Y+ +D +S +
Sbjct: 148 KLGDFGLARAFGIPVNTFSSEVVTLWYR--APDVL----M--GS-RTYSTSIDIWSCGCI 198
Query: 139 LWELLHNKLPFEGMSNLQ 156
L E++ K F G ++ +
Sbjct: 199 LAEMITGKPLFPGTNDEE 216
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 1e-16
Identities = 31/78 (39%), Positives = 39/78 (50%), Gaps = 2/78 (2%)
Query: 16 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 75
IV E L GG L + + + A I A++ LHS I HRD+KPENLL T
Sbjct: 92 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYT 151
Query: 76 --EDLKTIKLADFGLARE 91
+KL DFG A+E
Sbjct: 152 SKRPNAILKLTDFGFAKE 169
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 4e-16
Identities = 36/117 (30%), Positives = 49/117 (41%), Gaps = 23/117 (19%)
Query: 50 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR-----------EESLTEMM 98
RA++ LH +IHRDLKP NLL+ + +K+ DFGLAR M
Sbjct: 121 TLRAVKVLHGSNVIHRDLKPSNLLINSNCD-LKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 99 TAETGT--YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS 153
T YR APE+ Y+ +D +S +L EL + F G
Sbjct: 180 VEFVATRWYR--APEVM-------LTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD 227
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 4e-16
Identities = 43/108 (39%), Positives = 55/108 (50%), Gaps = 13/108 (12%)
Query: 52 RAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL-TEMMTAETGT--YRWM 108
+ +E LH H I+HRDLKP NLLL E+ +KLADFGLA+ T + T YR
Sbjct: 123 QGLEYLHQHWILHRDLKPNNLLLDEN-GVLKLADFGLAKSFGSPNRAYTHQVVTRWYR-- 179
Query: 109 APELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 156
APEL L + Y VD ++ +L ELL G S+L
Sbjct: 180 APEL-----LFGA--RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD 220
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 1e-14
Identities = 33/112 (29%), Positives = 53/112 (47%), Gaps = 20/112 (17%)
Query: 52 RAMECLHSHGIIHRDLKPENLLLTEDLK---TIKLADFGLARE-----ESLTEMMTAETG 103
+ LH++ ++HRDLKP N+L+ + +K+AD G AR + L + +
Sbjct: 139 DGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLAD-LDPVVV 197
Query: 104 T--YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS 153
T YR APEL L G +HY +D ++ + ELL ++ F
Sbjct: 198 TFWYR--APELL----L--GA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 1e-14
Identities = 37/138 (26%), Positives = 57/138 (41%), Gaps = 18/138 (13%)
Query: 26 LRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLAD 85
L L N+ + + + + +H + I+HRD+K N+L+T D +KLAD
Sbjct: 110 LAGLLSNVLVK-FTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRD-GVLKLAD 167
Query: 86 FGLARE-----ESLTEMMTAETGT--YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIV 138
FGLAR S T T YR PEL L GE + Y +D + +
Sbjct: 168 FGLARAFSLAKNSQPNRYTNRVVTLWYR--PPELL----L--GE-RDYGPPIDLWGAGCI 218
Query: 139 LWELLHNKLPFEGMSNLQ 156
+ E+ +G +
Sbjct: 219 MAEMWTRSPIMQGNTEQH 236
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 1e-14
Identities = 42/144 (29%), Positives = 65/144 (45%), Gaps = 12/144 (8%)
Query: 14 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 73
+ + ELLS L + + + + + + FA I + ++ LH + IIH DLKPEN+L
Sbjct: 174 ICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENIL 232
Query: 74 LTEDLKT-IKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDS 132
L + ++ IK+ DFG + E ++ YR APE V L Y +D
Sbjct: 233 LKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRFYR--APE----VILGAR----YGMPIDM 282
Query: 133 YSFAIVLWELLHNKLPFEGMSNLQ 156
+S +L ELL G
Sbjct: 283 WSLGCILAELLTGYPLLPGEDEGD 306
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 71.8 bits (176), Expect = 1e-14
Identities = 28/105 (26%), Positives = 46/105 (43%), Gaps = 15/105 (14%)
Query: 50 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMA 109
+ ++ +HS GI+HRDLKP N L+ +D ++K+ DFGLAR E ++
Sbjct: 165 LLVGVKYVHSAGILHRDLKPANCLVNQDC-SVKVCDFGLARTVDYPENGNSQLPISPRED 223
Query: 110 PELYSTVTLRQGEKKHYNHKV--------------DSYSFAIVLW 140
T + K+ V ++Y+ AI +W
Sbjct: 224 DMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVW 268
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 4e-14
Identities = 36/128 (28%), Positives = 56/128 (43%), Gaps = 34/128 (26%)
Query: 50 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR------------------- 90
+ + ++ LHS G++HRD+KP N+LL + +K+ADFGL+R
Sbjct: 118 LIKVIKYLHSGGLLHRDMKPSNILLNAECH-VKVADFGLSRSFVNIRRVTNNIPLSINEN 176
Query: 91 ---EESLTEMMTAETGT--YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHN 145
+ ++T T YR APE+ Y +D +S +L E+L
Sbjct: 177 TENFDDDQPILTDYVATRWYR--APEILLGS-------TKYTKGIDMWSLGCILGEILCG 227
Query: 146 KLPFEGMS 153
K F G S
Sbjct: 228 KPIFPGSS 235
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 1e-13
Identities = 40/144 (27%), Positives = 65/144 (45%), Gaps = 17/144 (11%)
Query: 14 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH-GIIHRDLKPENL 72
+V+V E+L G L + R + + + + ++ +H GIIH D+KPEN+
Sbjct: 105 VVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENV 163
Query: 73 LLT-----EDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYN 127
L+ E+L IK+AD G A + +T YR +PE V L +
Sbjct: 164 LMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR--SPE----VLLGAP----WG 213
Query: 128 HKVDSYSFAIVLWELLHNKLPFEG 151
D +S A +++EL+ FE
Sbjct: 214 CGADIWSTACLIFELITGDFLFEP 237
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 4e-13
Identities = 52/211 (24%), Positives = 86/211 (40%), Gaps = 35/211 (16%)
Query: 15 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL 74
V+V ELL G +L + L N R + + A + +E +HS IHRD+KP+N L+
Sbjct: 81 VMVMELL-GPSL-EDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLM 138
Query: 75 --TEDLKTIKLADFGLARE--ESLTEMMTAE------TGTYRWMAPELYSTVTLRQGEKK 124
+ + + DFGLA++ ++ T TGT R+ S T
Sbjct: 139 GLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA-----SINT------- 186
Query: 125 HYNH----KVDSYSFAIVLWELLHNKLPFEGM--SNLQAAYA--AAFKNVRPSAE---NV 173
H + D S VL LP++G+ + + Y + K P
Sbjct: 187 HLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGY 246
Query: 174 PEELSIILTSCWKEDPNARPNFTQIIQMLLN 204
P E + L C + +P+++ + Q+ N
Sbjct: 247 PSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 277
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 5e-13
Identities = 36/119 (30%), Positives = 52/119 (43%), Gaps = 35/119 (29%)
Query: 50 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR------------------- 90
+ +H GIIHRDLKP N LL +D +K+ DFGLAR
Sbjct: 138 LLLGENFIHESGIIHRDLKPANCLLNQDCS-VKVCDFGLARTINSEKDTNIVNDLEENEE 196
Query: 91 ----EESLTEMMTAETGT--YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL 143
++L + +T+ T YR APEL +++Y +D +S + ELL
Sbjct: 197 PGPHNKNLKKQLTSHVVTRWYR--APELILL-------QENYTKSIDIWSTGCIFAELL 246
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 4e-12
Identities = 41/146 (28%), Positives = 67/146 (45%), Gaps = 14/146 (9%)
Query: 14 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH--GIIHRDLKPEN 71
+ +V E+LS L L N R + + + FA + A+ L + IIH DLKPEN
Sbjct: 131 LCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPEN 189
Query: 72 LLLTEDLKT-IKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKV 130
+LL ++ IK+ DFG + + ++ YR +PE V L Y+ +
Sbjct: 190 ILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYR--SPE----VLLGMP----YDLAI 239
Query: 131 DSYSFAIVLWELLHNKLPFEGMSNLQ 156
D +S +L E+ + F G + +
Sbjct: 240 DMWSLGCILVEMHTGEPLFSGANEVD 265
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 5e-12
Identities = 45/213 (21%), Positives = 85/213 (39%), Gaps = 37/213 (17%)
Query: 15 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL 74
V+V +LL G +L + LL++ R V A + ++ +H +++RD+KP+N L+
Sbjct: 82 VLVIDLL-GPSL-EDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLI 139
Query: 75 ----TEDLKTIKLADFGLARE--ESLTEMMTAE------TGTYRWMAPELYSTVTLRQGE 122
+++ I + DFG+ + + +T+ +GT R+M S T
Sbjct: 140 GRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM-----SINT----- 189
Query: 123 KKHYNH----KVDSYSFAIVLWELLHNKLPFEGM--SNLQAAYA--AAFKNVRPSAE--- 171
H + D + V L LP++G+ + + Y K P E
Sbjct: 190 --HLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCA 247
Query: 172 NVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 204
PEE + +A P++ + +
Sbjct: 248 GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSK 280
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 1e-11
Identities = 40/217 (18%), Positives = 72/217 (33%), Gaps = 39/217 (17%)
Query: 13 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENL 72
M++ + G L+K + + + +L I +E +H H +H D+K NL
Sbjct: 128 FMIM--DRF-GSDLQK-IYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNL 183
Query: 73 LL-TEDLKTIKLADFGLARE----ESLTEMMTAE----TGTYRWMAPELYSTVTLRQGEK 123
LL ++ + L D+GLA GT + S
Sbjct: 184 LLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFT-----SIDA------ 232
Query: 124 KHYNH----KVDSYSFAIVLWELLHNKLPFEGM--SNLQAAYA--------AAFKNVRPS 169
H + D + + L LP+E + A+ +
Sbjct: 233 -HNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFP 291
Query: 170 AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 206
A N P E++ + + D +P + + +LL L
Sbjct: 292 AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGL 328
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 3e-11
Identities = 27/81 (33%), Positives = 45/81 (55%), Gaps = 6/81 (7%)
Query: 15 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL 74
+V ELL G +L + L ++ R + + A+ + ME +HS +I+RD+KPEN L+
Sbjct: 81 AMVLELL-GPSL-EDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLI 138
Query: 75 ----TEDLKTIKLADFGLARE 91
+ + I + DF LA+E
Sbjct: 139 GRPGNKTQQVIHIIDFALAKE 159
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 61.2 bits (148), Expect = 7e-11
Identities = 48/213 (22%), Positives = 84/213 (39%), Gaps = 39/213 (18%)
Query: 15 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL 74
V+V +LL G +L + L N R L + + A + +E +HS +HRD+KP+N L+
Sbjct: 79 VLVMDLL-GPSL-EDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM 136
Query: 75 --TEDLKTIKLADFGLAREESLTEMMTAE----------TGTYRWMAPELYSTVTLRQGE 122
+ + DFGLA++ + T + TGT R+ S T
Sbjct: 137 GLGRRANQVYIIDFGLAKK--YRDTSTHQHIPYRENKNLTGTARYA-----SVNT----- 184
Query: 123 KKHYNH----KVDSYSFAIVLWELLHNKLPFEGM--SNLQAAYA--AAFKNVRPSAE--- 171
H + D S VL L LP++G+ + Y + K
Sbjct: 185 --HLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALCR 242
Query: 172 NVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 204
P E + C + +P+++ + ++ +
Sbjct: 243 GYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRD 275
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 2e-10
Identities = 20/80 (25%), Positives = 35/80 (43%), Gaps = 4/80 (5%)
Query: 13 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENL 72
+V+ L G +L+ L L + A + A+E LH + +H ++ EN+
Sbjct: 134 FLVL--PSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENI 190
Query: 73 LL-TEDLKTIKLADFGLARE 91
+ ED + LA +G A
Sbjct: 191 FVDPEDQSQVTLAGYGFAFR 210
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 3e-10
Identities = 39/161 (24%), Positives = 57/161 (35%), Gaps = 29/161 (18%)
Query: 14 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 73
M I ELL G ++L + + A + A+ LH + + H DLKPEN+L
Sbjct: 97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENIL 155
Query: 74 LTEDLKT------------------IKLADFGLAREESLTEMMTAETGTYRWMAPELYST 115
I++ADFG A + T YR PE
Sbjct: 156 FVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYR--PPE---- 209
Query: 116 VTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 156
V L G + D +S +L+E F+ N +
Sbjct: 210 VILELG----WAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 3e-10
Identities = 14/46 (30%), Positives = 26/46 (56%), Gaps = 1/46 (2%)
Query: 47 ALDIARAMECLHSHGIIHRDLKPENLLL-TEDLKTIKLADFGLARE 91
+ + +E +H + +H D+K NLLL ++ + LAD+GL+
Sbjct: 157 GIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYR 202
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 8e-10
Identities = 40/161 (24%), Positives = 60/161 (37%), Gaps = 29/161 (18%)
Query: 14 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 73
+ IV ELL G + ++ + A I +++ LHS+ + H DLKPEN+L
Sbjct: 92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENIL 150
Query: 74 LTEDLKT------------------IKLADFGLAREESLTEMMTAETGTYRWMAPELYST 115
+ T IK+ DFG A + T YR APE
Sbjct: 151 FVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYR--APE---- 204
Query: 116 VTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 156
V L G ++ D +S +L E F + +
Sbjct: 205 VILALG----WSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 1e-09
Identities = 40/192 (20%), Positives = 66/192 (34%), Gaps = 60/192 (31%)
Query: 14 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH-GIIHRDLKPENL 72
+ +V E+L G L K+++ + L + + + ++ LH+ IIH D+KPEN+
Sbjct: 120 ICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENI 178
Query: 73 LLT------------------------------------------------EDLKTIKLA 84
LL+ + +K+A
Sbjct: 179 LLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIA 238
Query: 85 DFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH 144
D G A +T YR + E V + G YN D +S A + +EL
Sbjct: 239 DLGNACWVHKHFTEDIQTRQYR--SLE----VLIGSG----YNTPADIWSTACMAFELAT 288
Query: 145 NKLPFEGMSNLQ 156
FE S +
Sbjct: 289 GDYLFEPHSGEE 300
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 2e-09
Identities = 43/169 (25%), Positives = 66/169 (39%), Gaps = 39/169 (23%)
Query: 14 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 73
M ++ E L G +L + + + + ++I +A+ L + H DLKPEN+L
Sbjct: 111 MCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENIL 169
Query: 74 LTEDLKT------------------------IKLADFGLAREESLTEMMTA--ETGTYRW 107
L + IKL DFG A +S + + T YR
Sbjct: 170 LDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKS--DYHGSIINTRQYR- 226
Query: 108 MAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 156
APE V L G ++ D +SF VL EL L F +++
Sbjct: 227 -APE----VILNLG----WDVSSDMWSFGCVLAELYTGSLLFRTHEHME 266
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.1 bits (103), Expect = 3e-05
Identities = 40/271 (14%), Positives = 82/271 (30%), Gaps = 58/271 (21%)
Query: 8 ACK-EPVMV-IVTELLSGGTLR----KYLLNMR-PRCLDVCVAIGFALDIARAMECLHSH 60
P + I+ E + G K++ + ++ + L+ A +
Sbjct: 322 VLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLN---VLEPAEYRKMFDRL 378
Query: 61 GIIHRDLK-PENLL-------LTEDLKTI--KLADFGLAREESLTEMMTAETGTYRWMAP 110
+ P LL + D+ + KL + L ++ + T P
Sbjct: 379 SVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQP-------KESTIS--IP 429
Query: 111 ELYSTVTLRQGEKKHYNHK--VDSYSFAIVLWELLHNKLPFEGMSNLQA-AYAAAF---- 163
+Y + E ++ H+ VD Y+ + + + Y +
Sbjct: 430 SIYL-ELKVKLENEYALHRSIVDHYN--------IPKTFDSDDLIPPYLDQYFYSHIGHH 480
Query: 164 -KNVRPSAENVPEELSIILTSCWKE--------DPNARPNFTQIIQMLLNYLSAIAPPEP 214
KN+ E + + L + E NA + +Q L Y I +P
Sbjct: 481 LKNIEH-PERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDP 539
Query: 215 MIPHRIFNSENTILPPESPGTSSLMTVRDDI 245
R+ N+ LP + + + D+
Sbjct: 540 -KYERLVNAILDFLP--KIEENLICSKYTDL 567
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 41.4 bits (96), Expect = 2e-04
Identities = 19/77 (24%), Positives = 27/77 (35%), Gaps = 5/77 (6%)
Query: 16 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLH-SHGIIHRDLKPENLLL 74
IV E GG L MR + + A + ++ S HRDL N+LL
Sbjct: 139 IVLEFEFGGID---LEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLL 195
Query: 75 TEDLKTIKLADFGLARE 91
+ KL +
Sbjct: 196 KKT-SLKKLHYTLNGKS 211
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 2e-04
Identities = 19/83 (22%), Positives = 33/83 (39%), Gaps = 13/83 (15%)
Query: 14 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 73
I+ ++G + + + + +G LH + +IH DL N +
Sbjct: 414 KRIMMSYINGKLAKDVIEDNLDIAYKIGEIVG----------KLHKNDVIHNDLTTSNFI 463
Query: 74 LTEDLKTIKLADFGLAREESLTE 96
+DL I DFGL + +L E
Sbjct: 464 FDKDLYII---DFGLGKISNLDE 483
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 268 | |||
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.98 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.98 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.85 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.7 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.51 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.28 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.91 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.72 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.64 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.64 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 98.35 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.23 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.03 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.0 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.63 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.61 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.93 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.55 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 96.52 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 96.36 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 95.83 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 95.74 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 95.51 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 95.46 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 94.39 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 93.96 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 92.47 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 92.18 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 91.05 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 90.11 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 87.1 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 87.06 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 86.42 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 83.61 | |
| 2x6h_A | 696 | GH13170P, VPS34, phosphotidylinositol 3 kinase 59F | 81.54 |
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-51 Score=347.36 Aligned_cols=194 Identities=27% Similarity=0.411 Sum_probs=172.6
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|+|++++++ .++.+|||||||+||+|.++|...+...+++.+++.|+.||+.||+|||++||+||||||+|||++.+ +
T Consensus 84 nIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~-g 162 (350)
T 4b9d_A 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKD-G 162 (350)
T ss_dssp TBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTT-C
T ss_pred CCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCC-C
Confidence 789999999 56789999999999999999987766668999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccccc-ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESLTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.+||+|||+|+...... ...+.+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.+..+..
T Consensus 163 ~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~~--------~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~ 234 (350)
T 4b9d_A 163 TVQLGDFGIARVLNSTVELARACIGTPYYLSPEICEN--------KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLV 234 (350)
T ss_dssp CEEECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHTT--------CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred CEEEcccccceeecCCcccccccCCCccccCHHHHCC--------CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH
Confidence 99999999998655432 2345679999999999864 56899999999999999999999999988777776
Q ss_pred HHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 024408 159 YAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 203 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~ 203 (268)
.........+.+..+++++++||.+||..||.+|||++++++|-+
T Consensus 235 ~~i~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~ 279 (350)
T 4b9d_A 235 LKIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGF 279 (350)
T ss_dssp HHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHH
T ss_pred HHHHcCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHH
Confidence 666666666677889999999999999999999999999999743
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-50 Score=334.26 Aligned_cols=201 Identities=30% Similarity=0.499 Sum_probs=165.5
Q ss_pred CceeEEEeecCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCC
Q 024408 1 MREQFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT 80 (268)
Q Consensus 1 ~~v~l~g~~~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~ 80 (268)
|+|+++|+|.++.++||||||+||+|.++|..... .+++.++..++.|++.||+|||++||+||||||+|||++.+ +.
T Consensus 93 NIV~l~g~~~~~~~~iVmEy~~gGsL~~~l~~~~~-~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~-~~ 170 (307)
T 3omv_A 93 NILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQET-KFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEG-LT 170 (307)
T ss_dssp TBCCEEEEECSSSCEEEEECCSSCBHHHHHHTSCC-CCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETT-EE
T ss_pred CEeeEEEEEECCeEEEEEEcCCCCCHHHHHhhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCC-Cc
Confidence 78999999988889999999999999999976543 39999999999999999999999999999999999999998 69
Q ss_pred eEEecCCCcccccc---ccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 024408 81 IKLADFGLAREESL---TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA 157 (268)
Q Consensus 81 ~kl~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~ 157 (268)
+||+|||+|+.... .....+..||+.|||||++.+. ....++.++|||||||++|||++|+.||.+......
T Consensus 171 ~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~-----~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~ 245 (307)
T 3omv_A 171 VKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQ-----DNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ 245 (307)
T ss_dssp EEECCCSSCBC------------CCCCTTSCCHHHHHCC-----SSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH
T ss_pred EEEeeccCceecccCCcceeecccccCCCccCHHHhhcc-----CCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH
Confidence 99999999985432 2233456899999999998641 124588999999999999999999999988766554
Q ss_pred HHHHHhcc-CCC----CCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 024408 158 AYAAAFKN-VRP----SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 208 (268)
Q Consensus 158 ~~~~~~~~-~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 208 (268)
........ ..+ ....+|+++.+++.+||+.||++|||+.+++++|+.+...
T Consensus 246 ~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~ 301 (307)
T 3omv_A 246 IIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS 301 (307)
T ss_dssp HHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred HHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence 44443332 222 2467899999999999999999999999999999776543
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-50 Score=338.61 Aligned_cols=200 Identities=24% Similarity=0.278 Sum_probs=167.8
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|+|++++++ .++.+|||||||+||+|.++|.+.+. +++.++..++.|++.||+|||++||+||||||+|||++.+..
T Consensus 111 nIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~--l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~ 188 (336)
T 4g3f_A 111 RIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGC--LPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGS 188 (336)
T ss_dssp TBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSC
T ss_pred CCCcEEEEEEECCEEEEEEeccCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCC
Confidence 689999999 56789999999999999999988665 999999999999999999999999999999999999998744
Q ss_pred CeEEecCCCccccccccc------cccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 024408 80 TIKLADFGLAREESLTEM------MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS 153 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~ 153 (268)
++||+|||+|+....... ....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+..
T Consensus 189 ~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~--------~~y~~~~DiwSlGvilyemltG~~Pf~~~~ 260 (336)
T 4g3f_A 189 RAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG--------KPCDAKVDIWSSCCMMLHMLNGCHPWTQYF 260 (336)
T ss_dssp CEEECCCTTCEEC------------CCCCCCGGGCCHHHHTT--------CCCCTHHHHHHHHHHHHHHHHSSCSSTTTC
T ss_pred EEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCC--------CCCCcHHHHHHHHHHHHHHHHCcCCCCCCC
Confidence 799999999985443221 223579999999999864 668899999999999999999999998765
Q ss_pred hHHHHHHHHhccC--CCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhcC
Q 024408 154 NLQAAYAAAFKNV--RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIA 210 (268)
Q Consensus 154 ~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~~~ 210 (268)
..+.......... ...+..+++++.++|.+||..||.+|||+.|++++|...+....
T Consensus 261 ~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~ 319 (336)
T 4g3f_A 261 RGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG 319 (336)
T ss_dssp CSCCHHHHHHSCCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHcCCCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence 4444333333322 12467899999999999999999999999999999998887654
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-50 Score=333.80 Aligned_cols=199 Identities=29% Similarity=0.510 Sum_probs=174.0
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcC-----------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMR-----------PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLK 68 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~-----------~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dik 68 (268)
|+|+++|+| .++.++||||||+||||.++|.+.+ ...+++.+++.++.|++.||+|||+++|+|||||
T Consensus 76 nIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlK 155 (299)
T 4asz_A 76 HIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLA 155 (299)
T ss_dssp TBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred CCccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccC
Confidence 799999999 4568999999999999999997643 2459999999999999999999999999999999
Q ss_pred CCCEEEeCCCCCeEEecCCCcccccccc---ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-
Q 024408 69 PENLLLTEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH- 144 (268)
Q Consensus 69 p~Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~- 144 (268)
|+|||++.+ +.+||+|||+|+...... ......||+.|+|||++.+ ..++.++|||||||++|||+|
T Consensus 156 p~NILl~~~-~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~--------~~~~~k~DVwS~Gvvl~Ellt~ 226 (299)
T 4asz_A 156 TRNCLVGEN-LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY--------RKFTTESDVWSLGVVLWEIFTY 226 (299)
T ss_dssp GGGEEECGG-GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTT
T ss_pred HhhEEECCC-CcEEECCcccceecCCCCceeecCceecChhhcCHHHHcC--------CCCCchhhHHHHHHHHHHHHcC
Confidence 999999998 699999999998543322 2223468999999999965 678999999999999999998
Q ss_pred CCCCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 024408 145 NKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 208 (268)
Q Consensus 145 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 208 (268)
|+.||.+....+...........+.+..+|+++.+++.+||+.||++|||+.++++.|+...+.
T Consensus 227 G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 227 GKQPWYQLSNNEVIECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp TCCTTTTSCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 8999999887777666666666667888999999999999999999999999999999887665
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-49 Score=334.08 Aligned_cols=199 Identities=26% Similarity=0.483 Sum_probs=167.4
Q ss_pred CceeEEEeec-CCcEEEEEEcCCCCCHHHHHHhcC-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecC
Q 024408 1 MREQFIGACK-EPVMVIVTELLSGGTLRKYLLNMR-------------PRCLDVCVAIGFALDIARAMECLHSHGIIHRD 66 (268)
Q Consensus 1 ~~v~l~g~~~-~~~~~lV~e~~~ggsL~~~i~~~~-------------~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~D 66 (268)
|+|+++|+|. ++.++||||||+||+|.++|.+.. ...+++.+++.++.|++.||+|||+++|+|||
T Consensus 104 nIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRD 183 (329)
T 4aoj_A 104 HIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRD 183 (329)
T ss_dssp TBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred CCCcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeeccc
Confidence 7999999994 568999999999999999997643 23599999999999999999999999999999
Q ss_pred CCCCCEEEeCCCCCeEEecCCCcccccccc---ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHH
Q 024408 67 LKPENLLLTEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL 143 (268)
Q Consensus 67 ikp~Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll 143 (268)
|||+|||++.+ +.+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|||+
T Consensus 184 LKp~NILl~~~-~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~--------~~~~~~sDvwS~Gvvl~Ell 254 (329)
T 4aoj_A 184 LATRNCLVGQG-LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY--------RKFTTESDVWSFGVVLWEIF 254 (329)
T ss_dssp CCGGGEEEETT-TEEEECCCC----------------CCCCGGGCCHHHHTT--------CCCCHHHHHHHHHHHHHHHH
T ss_pred ccHhhEEECCC-CcEEEcccccceeccCCCcceecCcccccccccChhhhcC--------CCCCccccccchHHHHHHHH
Confidence 99999999998 699999999998543322 2234579999999999864 67899999999999999999
Q ss_pred h-CCCCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 024408 144 H-NKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 208 (268)
Q Consensus 144 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 208 (268)
| |+.||.+....+...........+.+..+|+++.+++.+||+.||++|||+.+|+++|+.+.+.
T Consensus 255 t~G~~Pf~~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 255 TYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp TTSCCTTCSSCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred cCCCCCCCCCCHHHHHHHHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 8 8999999887776666666556667788999999999999999999999999999999887664
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-49 Score=332.35 Aligned_cols=196 Identities=27% Similarity=0.502 Sum_probs=172.0
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMR--------------PRCLDVCVAIGFALDIARAMECLHSHGIIHR 65 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~--------------~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~ 65 (268)
|+|+|+|+| .++.++||||||+||||.++|.... ...+++.+++.++.|++.||+|||+++|+||
T Consensus 90 NIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHR 169 (308)
T 4gt4_A 90 NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHK 169 (308)
T ss_dssp TBCCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred CCCCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCC
Confidence 799999999 4568899999999999999997542 1348999999999999999999999999999
Q ss_pred CCCCCCEEEeCCCCCeEEecCCCccccccc---cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHH
Q 024408 66 DLKPENLLLTEDLKTIKLADFGLAREESLT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWEL 142 (268)
Q Consensus 66 Dikp~Nill~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~l 142 (268)
||||+|||++++ +.+||+|||+++..... .......||+.|+|||++.+ +.++.++||||||+++|||
T Consensus 170 DLK~~NILl~~~-~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~--------~~~s~ksDVwSfGvvl~El 240 (308)
T 4gt4_A 170 DLATRNVLVYDK-LNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMY--------GKFSIDSDIWSYGVVLWEV 240 (308)
T ss_dssp CCSGGGEEECGG-GCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHH
T ss_pred CccccceEECCC-CCEEECCcccceeccCCCceeEecccccCCcccCHHHHhC--------CCCCccchhhhHHHHHHHH
Confidence 999999999988 69999999999854332 22345579999999999865 6789999999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHh
Q 024408 143 LH-NKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 205 (268)
Q Consensus 143 l~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~ 205 (268)
+| |..||.+....+...........+.+..+|+++.+++.+||+.||.+|||+.+|+++|+.+
T Consensus 241 ~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 241 FSYGLQPYCGYSNQDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HTTTCCTTTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HhCCCCCCCCCCHHHHHHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 98 8999999887777666666666777889999999999999999999999999999999764
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=336.52 Aligned_cols=196 Identities=26% Similarity=0.413 Sum_probs=166.8
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|+|++++++ .++.+|||||||+||+|.+++.+ +. +++.++..++.||+.||+|||++||+||||||+|||++.+ +
T Consensus 132 nIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~-~~--l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~-g 207 (346)
T 4fih_A 132 NVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH-TR--MNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHD-G 207 (346)
T ss_dssp TBCCEEEEEEETTEEEEEECCCTTEEHHHHHHH-SC--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-C
T ss_pred CCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHc-CC--CCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCC-C
Confidence 789999999 66789999999999999999975 33 9999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccc-cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.+||+|||+|+..... ....+.+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+....+..
T Consensus 208 ~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~--------~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~ 279 (346)
T 4fih_A 208 RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISR--------LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM 279 (346)
T ss_dssp CEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred CEEEecCcCceecCCCCCcccccccCcCcCCHHHHCC--------CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH
Confidence 9999999999865433 34456789999999999864 56899999999999999999999999987665554
Q ss_pred HHHHhccC--CCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhcC
Q 024408 159 YAAAFKNV--RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIA 210 (268)
Q Consensus 159 ~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~~~ 210 (268)
........ .+....+++++++||.+||..||++|||++|+++| .++....
T Consensus 280 ~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H--p~~~~~~ 331 (346)
T 4fih_A 280 KMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH--PFLAKAG 331 (346)
T ss_dssp HHHHHSSCCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC--GGGGGCC
T ss_pred HHHHcCCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC--HhhcCCC
Confidence 44433222 12345689999999999999999999999999998 4555433
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-49 Score=323.22 Aligned_cols=190 Identities=27% Similarity=0.382 Sum_probs=153.8
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|+|++++++ .++.+|+||||+ +|+|.+++.+.+. +++.++..++.|++.||+|||++||+||||||+|||++.+ +
T Consensus 74 nIv~~~~~~~~~~~~~ivmEy~-~g~L~~~l~~~~~--l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~-~ 149 (275)
T 3hyh_A 74 HIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDK--MSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEH-L 149 (275)
T ss_dssp TBCCEEEEEECSSEEEEEEECC-CEEHHHHHHHSCS--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTT-C
T ss_pred CCCeEEEEEEECCEEEEEEeCC-CCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCC-C
Confidence 689999999 556899999999 6899999987655 9999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 024408 80 TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY 159 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~ 159 (268)
.+||+|||+|+.........+..||+.|+|||++.+ ...++.++||||+||++|+|++|+.||.+....+. .
T Consensus 150 ~vkl~DFGla~~~~~~~~~~~~~GT~~Y~APE~~~~-------~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~-~ 221 (275)
T 3hyh_A 150 NVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISG-------KLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVL-F 221 (275)
T ss_dssp CEEECCSSCC---------------CTTSCHHHHSS-------SSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-H
T ss_pred CEEEeecCCCeecCCCCccCCeeECcccCChhhhcC-------CCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHH-H
Confidence 999999999987665555667789999999999864 23356899999999999999999999988554443 3
Q ss_pred HHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 024408 160 AAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 202 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l 202 (268)
..........+..++++++++|.+||..||++|||++|+++|-
T Consensus 222 ~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp 264 (275)
T 3hyh_A 222 KNISNGVYTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDD 264 (275)
T ss_dssp HHHHHTCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCH
T ss_pred HHHHcCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCc
Confidence 3334444455678999999999999999999999999999984
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-49 Score=327.67 Aligned_cols=189 Identities=29% Similarity=0.407 Sum_probs=163.4
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|+|++++++ .++.+|||||||+||+|.++|.+.+. +++.++..++.|++.||+|||++||+||||||+|||++.+ +
T Consensus 87 nIv~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~--l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~-g 163 (304)
T 3ubd_A 87 FIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVM--FTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEE-G 163 (304)
T ss_dssp TEECEEEEEEETTEEEEEECCCTTCEEHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTT-S
T ss_pred CCCeEEEEEEECCEEEEEEEcCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCC-C
Confidence 689999999 56789999999999999999988665 9999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccc-ccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESL-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.+||+|||+|+.... .....+.+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+..
T Consensus 164 ~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~~--------~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~ 235 (304)
T 3ubd_A 164 HIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNR--------RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETM 235 (304)
T ss_dssp CEEEESSEEEEC-----CCCCSCCCCGGGCCHHHHHT--------SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred CEEecccccceeccCCCccccccccCcccCCHHHhcc--------CCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHH
Confidence 999999999985433 333456789999999999864 66889999999999999999999999987665554
Q ss_pred HHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 024408 159 YAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPN-----FTQIIQM 201 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~~~~~~ 201 (268)
..... ...+.+..+++++.++|.+||..||.+||| ++|+++|
T Consensus 236 ~~i~~-~~~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 236 TMILK-AKLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp HHHHH-CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred HHHHc-CCCCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence 44433 344456789999999999999999999998 4788887
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-49 Score=329.43 Aligned_cols=189 Identities=23% Similarity=0.313 Sum_probs=163.6
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|+|++++++ .++++|||||||+||+|.++|.+.+. +++.++..++.||+.||+|||++||+||||||+|||++.+ +
T Consensus 93 nIv~l~~~~~~~~~~yivmEy~~gG~L~~~i~~~~~--l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~-g 169 (311)
T 4aw0_A 93 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED-M 169 (311)
T ss_dssp TBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-S
T ss_pred CCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCC-C
Confidence 689999999 55689999999999999999988665 9999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccc---ccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH
Q 024408 80 TIKLADFGLAREESL---TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 156 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~ 156 (268)
.+||+|||+|+.... .....+.+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+
T Consensus 170 ~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~--------~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~ 241 (311)
T 4aw0_A 170 HIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE--------KSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL 241 (311)
T ss_dssp CEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHH--------SCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred CEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcC--------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 999999999986432 223456789999999999965 568899999999999999999999999866555
Q ss_pred HHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 157 AAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
........ ....+..++++++++|.+||..||.+|||++|++.+
T Consensus 242 ~~~~i~~~-~~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~ 285 (311)
T 4aw0_A 242 IFAKIIKL-EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 285 (311)
T ss_dssp HHHHHHHT-CCCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCH
T ss_pred HHHHHHcC-CCCCCcccCHHHHHHHHHHccCCHhHCcChHHHcCC
Confidence 54444333 334467899999999999999999999999987544
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=324.30 Aligned_cols=189 Identities=28% Similarity=0.533 Sum_probs=161.2
Q ss_pred CceeEEEeecC-----CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCCEE
Q 024408 1 MREQFIGACKE-----PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG--IIHRDLKPENLL 73 (268)
Q Consensus 1 ~~v~l~g~~~~-----~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~g--i~H~Dikp~Nil 73 (268)
|+|+++|++.. +.+|||||||+||+|.+++.+.+. +++..+..|+.|++.||+|||++| |+||||||+|||
T Consensus 86 nIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NIL 163 (290)
T 3fpq_A 86 NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIF 163 (290)
T ss_dssp TBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEE
T ss_pred CCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhhee
Confidence 78999998742 468999999999999999987655 999999999999999999999999 999999999999
Q ss_pred EeCCCCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 024408 74 LTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS 153 (268)
Q Consensus 74 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~ 153 (268)
++...+.+||+|||+|+.... ....+.+||+.|+|||++. +.++.++|||||||++|||++|+.||.+..
T Consensus 164 l~~~~g~vKl~DFGla~~~~~-~~~~~~~GTp~YmAPE~~~---------~~y~~~~DiwSlGvilyelltg~~Pf~~~~ 233 (290)
T 3fpq_A 164 ITGPTGSVKIGDLGLATLKRA-SFAKAVIGTPEFMAPEMYE---------EKYDESVDVYAFGMCMLEMATSEYPYSECQ 233 (290)
T ss_dssp ESSTTSCEEECCTTGGGGCCT-TSBEESCSSCCCCCGGGGG---------TCCCTHHHHHHHHHHHHHHHHSSCTTTTCS
T ss_pred EECCCCCEEEEeCcCCEeCCC-CccCCcccCccccCHHHcC---------CCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 985336999999999985433 2345678999999999874 358899999999999999999999998766
Q ss_pred hHHHHHHHHhccCCC--CCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 154 NLQAAYAAAFKNVRP--SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 154 ~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
..............+ .+..++++++++|.+||..||++|||++++++|
T Consensus 234 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 234 NAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp SHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cHHHHHHHHHcCCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 665555554444333 245678899999999999999999999999997
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=337.40 Aligned_cols=195 Identities=26% Similarity=0.414 Sum_probs=166.9
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|+|++++++ .++.+|||||||+||+|.+++.. +. +++.++..++.||+.||+|||++||+||||||+|||++.+ +
T Consensus 209 nIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i~~-~~--l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~-g 284 (423)
T 4fie_A 209 NVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH-TR--MNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHD-G 284 (423)
T ss_dssp TBCCEEEEEEETTEEEEEEECCTTEEHHHHHHH-SC--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTT-C
T ss_pred CCCceEEEEEECCEEEEEEeCCCCCcHHHHHhc-cC--CCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCC-C
Confidence 789999999 66789999999999999999975 23 9999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccc-cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.+||+|||+|+..... ....+.+||+.|||||++.+ ..|+.++|||||||++|||++|+.||.+....+..
T Consensus 285 ~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~--------~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~ 356 (423)
T 4fie_A 285 RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISR--------LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM 356 (423)
T ss_dssp CEEECCCTTCEECCSSCCCBCCCEECTTTCCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred CEEEecCccceECCCCCccccccccCcCcCCHHHHCC--------CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH
Confidence 9999999999865433 33456789999999999864 66899999999999999999999999987766655
Q ss_pred HHHHhccC--CCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhc
Q 024408 159 YAAAFKNV--RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 209 (268)
Q Consensus 159 ~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~~ 209 (268)
........ ......+++++++||.+||..||.+|||+.|+++| .++...
T Consensus 357 ~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H--p~~~~~ 407 (423)
T 4fie_A 357 KMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH--PFLAKA 407 (423)
T ss_dssp HHHHHSCCCCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC--GGGGGC
T ss_pred HHHHcCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC--HHhcCC
Confidence 54433322 22356789999999999999999999999999998 455543
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-48 Score=329.57 Aligned_cols=200 Identities=29% Similarity=0.526 Sum_probs=169.4
Q ss_pred CceeEEEeecC--CcEEEEEEcCCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCee
Q 024408 1 MREQFIGACKE--PVMVIVTELLSGGTLRKYLLNMR--------------PRCLDVCVAIGFALDIARAMECLHSHGIIH 64 (268)
Q Consensus 1 ~~v~l~g~~~~--~~~~lV~e~~~ggsL~~~i~~~~--------------~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H 64 (268)
|+|+|+|+|.+ +.++||||||+||+|.++|++.. ...+++.+++.++.|++.||+|||+++|+|
T Consensus 129 nIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiH 208 (353)
T 4ase_A 129 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIH 208 (353)
T ss_dssp TBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred cEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeec
Confidence 68999999943 46899999999999999997632 234899999999999999999999999999
Q ss_pred cCCCCCCEEEeCCCCCeEEecCCCcccccccc---ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHH
Q 024408 65 RDLKPENLLLTEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWE 141 (268)
Q Consensus 65 ~Dikp~Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ 141 (268)
|||||+|||++.+ +.+||+|||+|+...... ...+..||+.|+|||++.+ ..++.++|||||||++||
T Consensus 209 RDLK~~NILl~~~-~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~--------~~y~~ksDVwS~Gv~l~E 279 (353)
T 4ase_A 209 RDLAARNILLSEK-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD--------RVYTIQSDVWSFGVLLWE 279 (353)
T ss_dssp SCCSGGGEEECGG-GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHH
T ss_pred CccCccceeeCCC-CCEEECcchhhhhcccCCCceeeccccccccccCHHHHhc--------CCCCCcccEeehHHHHHH
Confidence 9999999999988 699999999998543322 2334568999999999965 678999999999999999
Q ss_pred HHh-CCCCCCCCChHHHHHHHH-hccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhc
Q 024408 142 LLH-NKLPFEGMSNLQAAYAAA-FKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 209 (268)
Q Consensus 142 ll~-g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~~ 209 (268)
|+| |+.||.+....+...... .....+.+..+++++.+++.+||+.||.+|||+.+++++|..+++..
T Consensus 280 l~t~G~~Pf~~~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~ 349 (353)
T 4ase_A 280 IFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 349 (353)
T ss_dssp HTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HHhCCCCCCCCCCHHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence 998 999998866544444333 33445567789999999999999999999999999999999988753
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=310.61 Aligned_cols=194 Identities=24% Similarity=0.335 Sum_probs=153.7
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|+|++++++ .++++|+||||++||+|.+++.. +++.++..++.|++.||+|||++||+||||||+|||++.+.+
T Consensus 81 nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~~~-----l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~ 155 (361)
T 4f9c_A 81 NVMGVKYCFRKNDHVVIAMPYLEHESFLDILNS-----LSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLK 155 (361)
T ss_dssp TBCCCSEEEEETTEEEEEEECCCCCCHHHHHTT-----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTT
T ss_pred CCceEEEEEEECCEEEEEEeCCCcccHHHHHcC-----CCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCC
Confidence 689999998 56789999999999999999842 999999999999999999999999999999999999998767
Q ss_pred CeEEecCCCcccccccc-----------------------------ccccCCCccceeccccccccccccCCCCCCCchh
Q 024408 80 TIKLADFGLAREESLTE-----------------------------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKV 130 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~-----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~ 130 (268)
.+||+|||+|+...... ...+.+||++|+|||++.+ ...++.++
T Consensus 156 ~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-------~~~y~~~~ 228 (361)
T 4f9c_A 156 KYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTK-------CPNQTTAI 228 (361)
T ss_dssp EEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTT-------CSCCCTHH
T ss_pred eEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcC-------CCCCCCcc
Confidence 99999999997432211 1234579999999999864 24588999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHh----------------------------------------------
Q 024408 131 DSYSFAIVLWELLHNKLPFEGMSNL-QAAYAAAF---------------------------------------------- 163 (268)
Q Consensus 131 DvwslG~~l~~ll~g~~p~~~~~~~-~~~~~~~~---------------------------------------------- 163 (268)
||||+||++|+|++|+.||...... +.......
T Consensus 229 DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~ 308 (361)
T 4f9c_A 229 DMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKL 308 (361)
T ss_dssp HHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC---------
T ss_pred chhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccc
Confidence 9999999999999999999654432 21111100
Q ss_pred -------ccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 024408 164 -------KNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 208 (268)
Q Consensus 164 -------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 208 (268)
.........+++++.+||.+||..||.+|+|++|+++| .++++
T Consensus 309 ~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~H--p~f~~ 358 (361)
T 4f9c_A 309 TSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLH--PFFKD 358 (361)
T ss_dssp -------------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTS--GGGTT
T ss_pred ccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC--cccCC
Confidence 00001134578899999999999999999999999998 45544
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=303.44 Aligned_cols=202 Identities=25% Similarity=0.360 Sum_probs=152.2
Q ss_pred CceeEEEeecCC-----cEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC--------CCeecCC
Q 024408 1 MREQFIGACKEP-----VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH--------GIIHRDL 67 (268)
Q Consensus 1 ~~v~l~g~~~~~-----~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~--------gi~H~Di 67 (268)
|+|+++|+|.++ .++||||||+||+|.+++.+. .+++..+..++.|++.||+|||++ +|+||||
T Consensus 58 NIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDl 134 (303)
T 3hmm_A 58 NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDL 134 (303)
T ss_dssp TBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCC
T ss_pred CCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccC
Confidence 789999999432 579999999999999999763 399999999999999999999987 9999999
Q ss_pred CCCCEEEeCCCCCeEEecCCCcccccccc-----ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHH
Q 024408 68 KPENLLLTEDLKTIKLADFGLAREESLTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWEL 142 (268)
Q Consensus 68 kp~Nill~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~l 142 (268)
||+|||++.+ +.+||+|||+|+...... ......||+.|+|||++.+... .....++.++|||||||++|||
T Consensus 135 Kp~NILl~~~-~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~--~~~~~~~~k~DVwS~Gvvl~El 211 (303)
T 3hmm_A 135 KSKNILVKKN-GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSIN--MKHFESFKRADIYAMGLVFWEI 211 (303)
T ss_dssp CGGGEEECTT-SCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSC--TTCHHHHHHHHHHHHHHHHHHH
T ss_pred CcccEEECCC-CCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhccccc--ccCCccChhHhhhhHHHHHHHH
Confidence 9999999998 699999999998543322 1234579999999999864110 0112466799999999999999
Q ss_pred HhCCCCCC----------CCC----hHHHHHHH-HhccCCCCCC------CCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 143 LHNKLPFE----------GMS----NLQAAYAA-AFKNVRPSAE------NVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 143 l~g~~p~~----------~~~----~~~~~~~~-~~~~~~~~~~------~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
++|..|+. +.. ..+..... ......|..+ ..+..+.+++.+||+.||.+|||+.++++.
T Consensus 212 ~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 212 ARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp HHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred HHCCCCCCccccccccchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 99976542 211 11222222 2222222211 133578999999999999999999999999
Q ss_pred HHHhHhh
Q 024408 202 LLNYLSA 208 (268)
Q Consensus 202 l~~~~~~ 208 (268)
|+.+.+.
T Consensus 292 L~~l~~~ 298 (303)
T 3hmm_A 292 LSQLSQQ 298 (303)
T ss_dssp HHHHHHC
T ss_pred HHHHHHH
Confidence 9887654
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-44 Score=322.61 Aligned_cols=191 Identities=24% Similarity=0.335 Sum_probs=163.3
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
++|++++++ ..+++|||||||+||+|.++|.+.+. +++..+..++.||+.||+|||++||+||||||+|||++.+ |
T Consensus 253 ~IV~l~~~f~~~~~lylVmEy~~GGdL~~~l~~~~~--l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~-G 329 (689)
T 3v5w_A 253 FIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV--FSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEH-G 329 (689)
T ss_dssp TBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTT-S
T ss_pred CEeEEEEEEEECCEEEEEEecCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCC-C
Confidence 589999999 55689999999999999999988765 9999999999999999999999999999999999999998 7
Q ss_pred CeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh--HHH
Q 024408 80 TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN--LQA 157 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~--~~~ 157 (268)
.+||+|||+|+...... ..+.+||+.|+|||++.. +..|+.++|+|||||++|||++|+.||.+... ...
T Consensus 330 ~vKL~DFGlA~~~~~~~-~~t~~GTp~YmAPEvl~~-------~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~ 401 (689)
T 3v5w_A 330 HVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQK-------GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE 401 (689)
T ss_dssp CEEECCCTTCEECSSCC-CCSCCSCGGGCCHHHHST-------TCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHH
T ss_pred CEEecccceeeecCCCC-CCCccCCcCccCHHHHhC-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 99999999998654433 356789999999999852 24688999999999999999999999975322 222
Q ss_pred HHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCC-----HHHHHHHH
Q 024408 158 AYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPN-----FTQIIQML 202 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~~~~~~l 202 (268)
............+..+++++++||.+||..||.+|++ ++++++|-
T Consensus 402 i~~~i~~~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~Hp 451 (689)
T 3v5w_A 402 IDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESP 451 (689)
T ss_dssp HHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSG
T ss_pred HHHhhcCCCCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCc
Confidence 3333444445557789999999999999999999998 79999884
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-44 Score=308.65 Aligned_cols=195 Identities=24% Similarity=0.367 Sum_probs=160.3
Q ss_pred CceeEEEeecC-------CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEE
Q 024408 1 MREQFIGACKE-------PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 73 (268)
Q Consensus 1 ~~v~l~g~~~~-------~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nil 73 (268)
|+|++++++.. +.+|||||||+ |+|.++|.+.+. +++.++..++.||+.||.|||++||+||||||+|||
T Consensus 114 nIv~l~~~~~~~~~~~~~~~~~ivmE~~~-g~L~~~i~~~~~--l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl 190 (398)
T 4b99_A 114 NIIAIKDILRPTVPYGEFKSVYVVLDLME-SDLHQIIHSSQP--LTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLL 190 (398)
T ss_dssp TBCCEEEECCCSSCTTTCCCEEEEEECCS-EEHHHHHTSSSC--CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEE
T ss_pred CcceEeeeeecccccccCCEEEEEEeCCC-CCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccc
Confidence 68999998732 47899999995 789999987554 999999999999999999999999999999999999
Q ss_pred EeCCCCCeEEecCCCcccccc-----ccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 024408 74 LTEDLKTIKLADFGLAREESL-----TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLP 148 (268)
Q Consensus 74 l~~~~~~~kl~Dfg~a~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p 148 (268)
++.+ +.+||+|||+|+.... .....+.+||+.|+|||++.+ ...++.++||||+||++|||++|+.|
T Consensus 191 ~~~~-~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~-------~~~~~~~~DiWSlG~il~ell~G~~p 262 (398)
T 4b99_A 191 VNEN-CELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLS-------LHEYTQAIDLWSVGCIFGEMLARRQL 262 (398)
T ss_dssp ECTT-CCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTT-------CSCCCTHHHHHHHHHHHHHHHHTSCS
T ss_pred cCCC-CCEEEeecceeeecccCccccccccccceeChHhcCHHHhcC-------CCCCCChhheehhHHHHHHHHHCCCC
Confidence 9988 6999999999985432 223346689999999999864 24578999999999999999999999
Q ss_pred CCCCChHHHHHHHHhccCCCC------------------------------CCCCcHHHHHHHHhccccCCCCCCCHHHH
Q 024408 149 FEGMSNLQAAYAAAFKNVRPS------------------------------AENVPEELSIILTSCWKEDPNARPNFTQI 198 (268)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~~ 198 (268)
|.+.+..+...........+. ...+++++.+||.+||..||.+|||+.|+
T Consensus 263 F~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~ 342 (398)
T 4b99_A 263 FPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAA 342 (398)
T ss_dssp SCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred CCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHH
Confidence 998776655544432221111 13468899999999999999999999999
Q ss_pred HHHHHHhHhh
Q 024408 199 IQMLLNYLSA 208 (268)
Q Consensus 199 ~~~l~~~~~~ 208 (268)
++| .++..
T Consensus 343 L~H--p~f~~ 350 (398)
T 4b99_A 343 LRH--PFLAK 350 (398)
T ss_dssp TTS--GGGTT
T ss_pred hcC--HhhCc
Confidence 998 45544
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=302.44 Aligned_cols=194 Identities=28% Similarity=0.423 Sum_probs=144.4
Q ss_pred CceeEEEeecC-C------------cEEEEEEcCCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecC
Q 024408 1 MREQFIGACKE-P------------VMVIVTELLSGGTLRKYLLNMRP-RCLDVCVAIGFALDIARAMECLHSHGIIHRD 66 (268)
Q Consensus 1 ~~v~l~g~~~~-~------------~~~lV~e~~~ggsL~~~i~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~D 66 (268)
|+|++++++.+ + ++|+|||||+||+|.+++.+... ...++..++.++.|++.||+|||++||+|||
T Consensus 64 nIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRD 143 (299)
T 4g31_A 64 GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRD 143 (299)
T ss_dssp TBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred CCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCcccc
Confidence 68999998732 1 47999999999999999987544 1255677899999999999999999999999
Q ss_pred CCCCCEEEeCCCCCeEEecCCCcccccccc-------------ccccCCCccceeccccccccccccCCCCCCCchhhHH
Q 024408 67 LKPENLLLTEDLKTIKLADFGLAREESLTE-------------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSY 133 (268)
Q Consensus 67 ikp~Nill~~~~~~~kl~Dfg~a~~~~~~~-------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvw 133 (268)
|||+|||++.+ +.+||+|||+|+...... ...+.+||+.|+|||++.+ ..++.++|||
T Consensus 144 lKp~NILl~~~-~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~--------~~y~~~~Diw 214 (299)
T 4g31_A 144 LKPSNIFFTMD-DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG--------NSYSHKVDIF 214 (299)
T ss_dssp CCGGGEEECTT-CCEEECCCCCC--------------------------CCCTTSCHHHHTT--------CCCCTHHHHH
T ss_pred CcHHHeEECCC-CcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcC--------CCCCCHHHHH
Confidence 99999999988 699999999998543321 1233579999999999864 5789999999
Q ss_pred HHHHHHHHHHhCCCCCCCCChHHHHHHHHhc-cCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 024408 134 SFAIVLWELLHNKLPFEGMSNLQAAYAAAFK-NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 208 (268)
Q Consensus 134 slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 208 (268)
||||++|||++ ||.+............. ...+.....++.+.++|.+||+.||.+|||+.++++| .+++.
T Consensus 215 SlGvilyell~---Pf~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h--~~~~~ 285 (299)
T 4g31_A 215 SLGLILFELLY---PFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN--AVFED 285 (299)
T ss_dssp HHHHHHHHHHS---CCSSHHHHHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS--GGGCC
T ss_pred HHHHHHHHHcc---CCCCccHHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC--HhhCC
Confidence 99999999996 77643222121222221 1111222345667899999999999999999999987 44443
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=317.54 Aligned_cols=193 Identities=23% Similarity=0.337 Sum_probs=166.6
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCC-C
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED-L 78 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~-~ 78 (268)
|+|+|++++ .++.+|||||||+||+|.++|.+... .+++.++..++.||+.||+|||++||+||||||+|||++.+ .
T Consensus 215 nIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~-~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~ 293 (573)
T 3uto_A 215 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRS 293 (573)
T ss_dssp TBCCEEEEEECSSEEEEEEECCCCCBHHHHHTCTTS-CEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSC
T ss_pred CCCeEEEEEEECCEEEEEEeecCCCcHHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCC
Confidence 689999999 55689999999999999999975433 39999999999999999999999999999999999999753 3
Q ss_pred CCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 79 KTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 79 ~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
+.+||+|||+|+.........+.+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+....+..
T Consensus 294 ~~vKl~DFG~a~~~~~~~~~~~~~GT~~y~APEv~~~--------~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~ 365 (573)
T 3uto_A 294 NELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEG--------KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETL 365 (573)
T ss_dssp CCEEECCCSSCEECCTTSEEEEECSSGGGCCHHHHTT--------CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH
T ss_pred CCEEEeeccceeEccCCCceeeeEECccccCHHHhCC--------CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH
Confidence 6899999999997766666667789999999999864 56889999999999999999999999987776665
Q ss_pred HHHHhccCCC---CCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 024408 159 YAAAFKNVRP---SAENVPEELSIILTSCWKEDPNARPNFTQIIQML 202 (268)
Q Consensus 159 ~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l 202 (268)
.......... ....+++++++||.+||..||.+||++.|+++|-
T Consensus 366 ~~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hp 412 (573)
T 3uto_A 366 RNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHP 412 (573)
T ss_dssp HHHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHST
T ss_pred HHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence 5544433322 2457899999999999999999999999999983
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=285.37 Aligned_cols=190 Identities=27% Similarity=0.391 Sum_probs=164.5
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|+|++++++ .++..++||||++||+|.+++.+.+. +++.++..++.|++.||+|||++||+||||||+||+++.+ +
T Consensus 75 nIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~-~ 151 (328)
T 3fe3_A 75 NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGR--MKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDAD-M 151 (328)
T ss_dssp TBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-S
T ss_pred CEeeEEEEEEECCEEEEEEECCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCC-C
Confidence 689999999 55689999999999999999987665 9999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 024408 80 TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY 159 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~ 159 (268)
.+||+|||++.............||+.|+|||++.+ ....+.++||||||+++|+|++|+.||.+....+...
T Consensus 152 ~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~ 224 (328)
T 3fe3_A 152 NIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQG-------KKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRE 224 (328)
T ss_dssp CEEECSTTCCGGGSSSCGGGTTSSSGGGCCHHHHHT-------CCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred CEEEeeccCceecCCCCccccccCCcceeCcccccC-------CCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 999999999986655555567789999999999864 2234579999999999999999999999866555444
Q ss_pred HHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 160 AAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
... ......+..+++++.++|.+||..||.+|||++++++|
T Consensus 225 ~i~-~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 225 RVL-RGKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp HHH-HCCCCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred HHH-hCCCCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 333 33344566789999999999999999999999999998
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=286.06 Aligned_cols=199 Identities=31% Similarity=0.572 Sum_probs=169.0
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRP--------------RCLDVCVAIGFALDIARAMECLHSHGIIHR 65 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~--------------~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~ 65 (268)
|+|+++|+| .++.+++||||++||+|.+++..... ..+++.+++.++.|++.||+|||++||+||
T Consensus 148 nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHr 227 (370)
T 2psq_A 148 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHR 227 (370)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred CEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeecc
Confidence 689999999 55689999999999999999987542 348999999999999999999999999999
Q ss_pred CCCCCCEEEeCCCCCeEEecCCCcccccccc---ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHH
Q 024408 66 DLKPENLLLTEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWEL 142 (268)
Q Consensus 66 Dikp~Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~l 142 (268)
||||+|||++.+ +.+||+|||+++...... ......+++.|+|||++.+ ..++.++||||||+++|||
T Consensus 228 Dlkp~NIll~~~-~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~DvwslG~il~el 298 (370)
T 2psq_A 228 DLAARNVLVTEN-NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD--------RVYTHQSDVWSFGVLMWEI 298 (370)
T ss_dssp CCCGGGEEECTT-CCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHT--------CCCCHHHHHHHHHHHHHHH
T ss_pred ccchhhEEECCC-CCEEEccccCCcccCcccceecccCCCcccceECHhHhcC--------CCCCcHHHHHHHHHHHHHH
Confidence 999999999988 699999999998543322 2233457889999999864 5688999999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 024408 143 LH-NKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 208 (268)
Q Consensus 143 l~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 208 (268)
++ |..||.+....+.............+..++.++.++|.+||..||.+||++.+++++|+.++..
T Consensus 299 lt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~ 365 (370)
T 2psq_A 299 FTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 365 (370)
T ss_dssp HTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HcCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 99 9999988766555554444444556778999999999999999999999999999999988764
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=280.62 Aligned_cols=203 Identities=35% Similarity=0.619 Sum_probs=159.8
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCCEEEeC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRP-RCLDVCVAIGFALDIARAMECLHSHG--IIHRDLKPENLLLTE 76 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~g--i~H~Dikp~Nill~~ 76 (268)
|+|++++++ .++..++||||++||+|.+++.+... ..+++..++.++.|++.||+|||++| ++||||||+||+++.
T Consensus 95 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~ 174 (309)
T 3p86_A 95 NIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDK 174 (309)
T ss_dssp TBCCEEEEECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECT
T ss_pred CEeeEEEEEEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeC
Confidence 689999999 45678999999999999999986432 23899999999999999999999999 999999999999998
Q ss_pred CCCCeEEecCCCccccccc-cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH
Q 024408 77 DLKTIKLADFGLAREESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL 155 (268)
Q Consensus 77 ~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~ 155 (268)
+ +.+||+|||+++..... .......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||......
T Consensus 175 ~-~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~elltg~~Pf~~~~~~ 245 (309)
T 3p86_A 175 K-YTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRD--------EPSNEKSDVYSFGVILWELATLQQPWGNLNPA 245 (309)
T ss_dssp T-CCEEECCCC-----------------CCTTSCHHHHTT--------CCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH
T ss_pred C-CcEEECCCCCCccccccccccccCCCCccccChhhhcC--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 8 69999999999754332 22345578999999999864 55788999999999999999999999987766
Q ss_pred HHHHHHHhc-cCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhcCCC
Q 024408 156 QAAYAAAFK-NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPP 212 (268)
Q Consensus 156 ~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~~~~~ 212 (268)
+........ .....+..+++++.++|.+||..||.+||++.++++.|+.++....++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~ 303 (309)
T 3p86_A 246 QVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPP 303 (309)
T ss_dssp HHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-----
T ss_pred HHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCC
Confidence 555444322 333456789999999999999999999999999999999988765443
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=281.73 Aligned_cols=199 Identities=26% Similarity=0.484 Sum_probs=168.9
Q ss_pred CceeEEEeec-CCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGACK-EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~~-~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|+|++++++. ++..++||||++||+|.+++..... .+++.+++.++.|++.||.|||++||+||||||+||+++.+ +
T Consensus 111 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~-~ 188 (325)
T 3kul_A 111 NIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDG-QFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSN-L 188 (325)
T ss_dssp TBCCEEEEECGGGCCEEEEECCTTCBHHHHHHTTTT-CSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-C
T ss_pred CCCcEEEEEEeCCccEEEeeCCCCCcHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCC-C
Confidence 6899999994 4578999999999999999976533 39999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccccc----ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCh
Q 024408 80 TIKLADFGLAREESLTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSN 154 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~~ 154 (268)
.++|+|||+++...... ......+|+.|+|||++.+ ..++.++||||||+++|+|++ |..||.....
T Consensus 189 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~Di~slG~il~ell~~g~~p~~~~~~ 260 (325)
T 3kul_A 189 VCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAF--------RTFSSASDVWSFGVVMWEVLAYGERPYWNMTN 260 (325)
T ss_dssp CEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHH--------CEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH
T ss_pred CEEECCCCcccccccCccceeeccCCCCcccccCHhHhcC--------CCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH
Confidence 99999999998543321 1222346778999999864 457889999999999999999 9999998777
Q ss_pred HHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhc
Q 024408 155 LQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 209 (268)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~~ 209 (268)
.+...........+.+..++..+.++|.+||..||.+||++.++++.|+.+....
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~ 315 (325)
T 3kul_A 261 RDVISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315 (325)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred HHHHHHHHcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence 7766666666566677889999999999999999999999999999999987653
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=280.07 Aligned_cols=190 Identities=26% Similarity=0.381 Sum_probs=162.4
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ .++.+++||||++||+|.+++.+.+. +++..++.++.|++.||+|||++||+||||||+||+++.+ +
T Consensus 66 ~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-g 142 (337)
T 1o6l_A 66 FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV--FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD-G 142 (337)
T ss_dssp TBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-S
T ss_pred cCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCC-C
Confidence 578999999 55689999999999999999987655 9999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccc-cccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREES-LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.+||+|||+++... ......+..||+.|+|||++.+ ..++.++|+||||+++|+|++|+.||.+.......
T Consensus 143 ~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~ 214 (337)
T 1o6l_A 143 HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED--------NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF 214 (337)
T ss_dssp CEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSS--------SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred CEEEeeccchhhcccCCCcccccccChhhCChhhhcC--------CCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHH
Confidence 99999999998533 2334456689999999999864 56788999999999999999999999876654443
Q ss_pred HHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCC-----CHHHHHHHH
Q 024408 159 YAAAFKNVRPSAENVPEELSIILTSCWKEDPNARP-----NFTQIIQML 202 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~~~~~l 202 (268)
.... ......+..+++++.++|.+||..||.+|| ++.++++|-
T Consensus 215 ~~i~-~~~~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~ 262 (337)
T 1o6l_A 215 ELIL-MEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR 262 (337)
T ss_dssp HHHH-HCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred HHHH-cCCCCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCC
Confidence 3333 333344667899999999999999999999 899999984
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=286.11 Aligned_cols=191 Identities=24% Similarity=0.398 Sum_probs=161.8
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
++|++++++ .++.+++||||++||+|.+++.+.+. +++..+..++.|++.||+|||++||+||||||+|||++.+ +
T Consensus 114 ~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~-g 190 (396)
T 4dc2_A 114 FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRK--LPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE-G 190 (396)
T ss_dssp TBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-S
T ss_pred CcCeeEEEEEECCEEEEEEEcCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCC-C
Confidence 589999999 55689999999999999999987655 9999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccc-cccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----
Q 024408 80 TIKLADFGLARE-ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS----- 153 (268)
Q Consensus 80 ~~kl~Dfg~a~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~----- 153 (268)
.+||+|||+++. ........+..||+.|+|||++.+ ..++.++|+||||+++|+|++|+.||....
T Consensus 191 ~ikL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~--------~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~ 262 (396)
T 4dc2_A 191 HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG--------EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP 262 (396)
T ss_dssp CEEECCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC----
T ss_pred CEEEeecceeeecccCCCccccccCCcccCCchhhcC--------CCCChHHHHHHHHHHHHHHHhCCCCCccccccccc
Confidence 999999999985 333344566789999999999864 567899999999999999999999996432
Q ss_pred ---hHHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCH------HHHHHHH
Q 024408 154 ---NLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNF------TQIIQML 202 (268)
Q Consensus 154 ---~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~------~~~~~~l 202 (268)
..+.............+..++.++.++|.+||..||.+||++ +++++|-
T Consensus 263 ~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hp 320 (396)
T 4dc2_A 263 DQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHP 320 (396)
T ss_dssp --CCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHST
T ss_pred chhhHHHHHHHHhccccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCc
Confidence 122233444444455567899999999999999999999985 7888873
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-40 Score=283.14 Aligned_cols=204 Identities=32% Similarity=0.565 Sum_probs=173.5
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRP--------------RCLDVCVAIGFALDIARAMECLHSHGIIHR 65 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~--------------~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~ 65 (268)
|+|++++++ .++..++||||++||+|.+++..... ..+++.+++.++.|++.||+|||++||+||
T Consensus 136 nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~ 215 (382)
T 3tt0_A 136 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHR 215 (382)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred hhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecC
Confidence 689999999 45688999999999999999987542 349999999999999999999999999999
Q ss_pred CCCCCCEEEeCCCCCeEEecCCCccccccc---cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHH
Q 024408 66 DLKPENLLLTEDLKTIKLADFGLAREESLT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWEL 142 (268)
Q Consensus 66 Dikp~Nill~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~l 142 (268)
||||+||+++.+ +.+||+|||+++..... .......+|+.|+|||++.+ ..++.++||||||+++|+|
T Consensus 216 Dlkp~NIll~~~-~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~DiwslG~il~el 286 (382)
T 3tt0_A 216 DLAARNVLVTED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD--------RIYTHQSDVWSFGVLLWEI 286 (382)
T ss_dssp CCCGGGEEECTT-CCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHS--------CCCCHHHHHHHHHHHHHHH
T ss_pred CCCcceEEEcCC-CcEEEcccCcccccccccccccccCCCCCcceeCHHHhcC--------CCCCchhHHHHHHHHHHHH
Confidence 999999999988 69999999999854332 22334467889999999864 5688999999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhcCCCC
Q 024408 143 LH-NKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPE 213 (268)
Q Consensus 143 l~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~~~~~~ 213 (268)
++ |..||.+....+.............+..++.++.++|.+||..||.+||++.+++++|+..........
T Consensus 287 lt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~ 358 (382)
T 3tt0_A 287 FTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE 358 (382)
T ss_dssp HTTSCCSSTTCCHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC
T ss_pred HhCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCC
Confidence 99 999999877666555555555555677899999999999999999999999999999999887654443
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=285.29 Aligned_cols=190 Identities=28% Similarity=0.384 Sum_probs=158.6
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
++|++++++ ..+.+|+||||++||+|.+++.+.+. +++.+++.++.|++.||+|||++||+||||||+|||++.+ +
T Consensus 85 ~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~-g 161 (353)
T 3txo_A 85 FLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRR--FDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHE-G 161 (353)
T ss_dssp TBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-S
T ss_pred ceeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCC-C
Confidence 578999999 55689999999999999999987655 9999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccc-cccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREES-LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.+||+|||+++... ......+..||+.|+|||++.+ ..++.++|+||||+++|+|++|+.||.+....+..
T Consensus 162 ~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~ 233 (353)
T 3txo_A 162 HCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQE--------MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLF 233 (353)
T ss_dssp CEEECCCTTCBCSCC---------CCGGGCCHHHHHH--------HHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred CEEEccccceeecccCCccccccCCCcCeEChhhcCC--------CCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHH
Confidence 99999999998533 2333456689999999999864 45788999999999999999999999986665544
Q ss_pred HHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCH------HHHHHHH
Q 024408 159 YAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNF------TQIIQML 202 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~------~~~~~~l 202 (268)
... .......+..++.++.++|.+||..||.+||++ .++++|-
T Consensus 234 ~~i-~~~~~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp 282 (353)
T 3txo_A 234 EAI-LNDEVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHP 282 (353)
T ss_dssp HHH-HHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSG
T ss_pred HHH-HcCCCCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCC
Confidence 443 333444466789999999999999999999998 8888873
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=282.09 Aligned_cols=198 Identities=23% Similarity=0.477 Sum_probs=167.5
Q ss_pred CceeEEEeecCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCC
Q 024408 1 MREQFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT 80 (268)
Q Consensus 1 ~~v~l~g~~~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~ 80 (268)
|+|+++|+|.++..++||||++||+|.+++.+... .+++..++.++.|++.||+|||++|++||||||+|||++.+ +.
T Consensus 76 ~iv~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~-~~ 153 (325)
T 3kex_A 76 HIVRLLGLCPGSSLQLVTQYLPLGSLLDHVRQHRG-ALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSP-SQ 153 (325)
T ss_dssp TBCCEEEEECBSSEEEEEECCTTCBSHHHHHSSGG-GSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSS-SC
T ss_pred CcCeEEEEEcCCccEEEEEeCCCCCHHHHHHHccc-cCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCC-Ce
Confidence 68999999988889999999999999999986432 39999999999999999999999999999999999999988 69
Q ss_pred eEEecCCCcccccccc---ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 024408 81 IKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQ 156 (268)
Q Consensus 81 ~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~~~~ 156 (268)
+||+|||+++...... ......++..|+|||++.+ ..++.++||||||+++|+|++ |..||.+....+
T Consensus 154 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~ 225 (325)
T 3kex_A 154 VQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHF--------GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE 225 (325)
T ss_dssp EEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH
T ss_pred EEECCCCcccccCcccccccccCCCCcccccChHHhcc--------CCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH
Confidence 9999999998643322 2234467889999999864 568899999999999999999 999998876666
Q ss_pred HHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 024408 157 AAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 208 (268)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 208 (268)
.............+..++.++.+++.+||..||.+||++.+++++|+.....
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 226 VPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp HHHHHHTTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred HHHHHHcCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 5555555555556677888999999999999999999999999999887653
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=286.69 Aligned_cols=210 Identities=19% Similarity=0.236 Sum_probs=167.4
Q ss_pred CceeEEEeecC-----CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEe
Q 024408 1 MREQFIGACKE-----PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 75 (268)
Q Consensus 1 ~~v~l~g~~~~-----~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~ 75 (268)
|+++++|++.. .+.+|||||+ |++|.+++.... ..+++.+++.++.|++.||+|||++||+||||||+|||++
T Consensus 109 ~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~ 186 (364)
T 3op5_A 109 GVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA-KRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLN 186 (364)
T ss_dssp CSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEE
T ss_pred CCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEe
Confidence 58899999843 3589999999 999999998753 3499999999999999999999999999999999999998
Q ss_pred --CCCCCeEEecCCCccccccccc--------cccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhC
Q 024408 76 --EDLKTIKLADFGLAREESLTEM--------MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHN 145 (268)
Q Consensus 76 --~~~~~~kl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g 145 (268)
.+ +.+||+|||+++....... .....||+.|+|||++.+ ..++.++||||||+++|+|++|
T Consensus 187 ~~~~-~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~~l~el~~g 257 (364)
T 3op5_A 187 YKNP-DQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNG--------VAPSRRGDLEILGYCMIQWLTG 257 (364)
T ss_dssp SSCT-TCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTT--------CCCCHHHHHHHHHHHHHHHHHS
T ss_pred cCCC-CeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCC--------CCCCchhhHHHHHHHHHHHHhC
Confidence 66 6999999999975433221 123459999999999864 5688999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHhcc---C-------CCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhcCCCCCC
Q 024408 146 KLPFEGMSNLQAAYAAAFKN---V-------RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPM 215 (268)
Q Consensus 146 ~~p~~~~~~~~~~~~~~~~~---~-------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~~~~~~~~ 215 (268)
+.||.+.............. . ......+|.++.+++..||..||.+||++.++++.|+..+.........
T Consensus 258 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~ 337 (364)
T 3op5_A 258 HLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDG 337 (364)
T ss_dssp CCTTGGGTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCC
T ss_pred CCCccccccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCC
Confidence 99998532221111111000 0 0012578999999999999999999999999999999999988777766
Q ss_pred CCCccc
Q 024408 216 IPHRIF 221 (268)
Q Consensus 216 ~~~~~~ 221 (268)
...|..
T Consensus 338 ~~dw~~ 343 (364)
T 3op5_A 338 KLDLSV 343 (364)
T ss_dssp CCCC--
T ss_pred ccceEe
Confidence 666554
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=274.58 Aligned_cols=198 Identities=29% Similarity=0.527 Sum_probs=160.5
Q ss_pred CceeEEEeecCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCC
Q 024408 1 MREQFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT 80 (268)
Q Consensus 1 ~~v~l~g~~~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~ 80 (268)
|+++++|++.++..++||||++|++|.+++.... ..+++..++.++.|++.||.|||++|++||||||+||+++.+ +.
T Consensus 77 ~iv~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~ 154 (281)
T 1mp8_A 77 HIVKLIGVITENPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSN-DC 154 (281)
T ss_dssp TBCCEEEEECSSSCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET-TE
T ss_pred ccceEEEEEccCccEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCC-CC
Confidence 6899999998888999999999999999998654 349999999999999999999999999999999999999988 69
Q ss_pred eEEecCCCccccccccc--cccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 024408 81 IKLADFGLAREESLTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQA 157 (268)
Q Consensus 81 ~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~ 157 (268)
+||+|||+++....... .....+++.|+|||++.+ ..++.++||||||+++|+|++ |..||.+....+.
T Consensus 155 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~ 226 (281)
T 1mp8_A 155 VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF--------RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV 226 (281)
T ss_dssp EEECC-------------------CCGGGCCHHHHHH--------CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH
T ss_pred EEECccccccccCcccccccccCCCcccccChhhccc--------CCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH
Confidence 99999999986443321 223456789999999864 567889999999999999996 9999988776665
Q ss_pred HHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 024408 158 AYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 208 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 208 (268)
..........+.+..+++.+.+++.+||..||.+||++.+++++|+.....
T Consensus 227 ~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 227 IGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 555555555566778999999999999999999999999999999987754
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=293.75 Aligned_cols=200 Identities=31% Similarity=0.507 Sum_probs=172.7
Q ss_pred CceeEEEeecCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCC
Q 024408 1 MREQFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT 80 (268)
Q Consensus 1 ~~v~l~g~~~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~ 80 (268)
|+|+++|++.++..++||||++||+|.+++.......+++..++.++.|++.||+|||++|++||||||+|||++.+ +.
T Consensus 244 ~iv~l~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~-~~ 322 (454)
T 1qcf_A 244 KLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSAS-LV 322 (454)
T ss_dssp TBCCEEEEECSSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTT-CC
T ss_pred CEeeEEEEEeCCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCC-Cc
Confidence 68999999988889999999999999999986544448999999999999999999999999999999999999988 69
Q ss_pred eEEecCCCcccccccc--ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 024408 81 IKLADFGLAREESLTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQA 157 (268)
Q Consensus 81 ~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~ 157 (268)
+||+|||+++...... ......++..|+|||++.. ..++.++||||||+++|||++ |+.||.+....+.
T Consensus 323 ~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~ 394 (454)
T 1qcf_A 323 CKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF--------GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV 394 (454)
T ss_dssp EEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred EEEeeCCCceEcCCCceeccCCCcccccccCHHHhcc--------CCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 9999999998644322 1223346788999999864 568899999999999999999 9999998887776
Q ss_pred HHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhc
Q 024408 158 AYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 209 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~~ 209 (268)
..........+.+..+++++.++|.+||..||.+||++.++++.|+.+....
T Consensus 395 ~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~ 446 (454)
T 1qcf_A 395 IRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT 446 (454)
T ss_dssp HHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred HHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence 6665555566677889999999999999999999999999999998876543
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=282.07 Aligned_cols=192 Identities=24% Similarity=0.311 Sum_probs=162.8
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|+|++++++ .++..++||||++||+|.+++.+.+. +++..+..++.|++.||.|||++||+||||||+||+++.+..
T Consensus 76 nIv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~--l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~ 153 (361)
T 2yab_A 76 NIITLHDVYENRTDVVLILELVSGGELFDFLAQKES--LSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNI 153 (361)
T ss_dssp TBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTCSC--CBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTS
T ss_pred CCCcEEEEEEeCCEEEEEEEcCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCC
Confidence 689999999 45689999999999999999976544 999999999999999999999999999999999999987632
Q ss_pred ---CeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH
Q 024408 80 ---TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 156 (268)
Q Consensus 80 ---~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~ 156 (268)
.+||+|||++.............||+.|+|||++.+ ..++.++|+||||+++|+|++|..||.+....+
T Consensus 154 ~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~ 225 (361)
T 2yab_A 154 PIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNY--------EPLGLEADMWSIGVITYILLSGASPFLGDTKQE 225 (361)
T ss_dssp SSCCEEECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTT--------CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH
T ss_pred CccCEEEEecCCceEcCCCCccccCCCCccEECchHHcC--------CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 799999999987655555566789999999999864 567889999999999999999999998866555
Q ss_pred HHHHHHhccCCCC---CCCCcHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 024408 157 AAYAAAFKNVRPS---AENVPEELSIILTSCWKEDPNARPNFTQIIQML 202 (268)
Q Consensus 157 ~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l 202 (268)
............. ...++.++.++|.+||..||.+||++.++++|.
T Consensus 226 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp 274 (361)
T 2yab_A 226 TLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHP 274 (361)
T ss_dssp HHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred HHHHHHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 4444333322221 256889999999999999999999999999874
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=269.44 Aligned_cols=198 Identities=28% Similarity=0.541 Sum_probs=168.8
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ .++..++||||++|++|.+++..... .+++..++.++.|++.||+|||++|++||||||+||+++.+ +
T Consensus 66 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~-~ 143 (269)
T 4hcu_A 66 KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRG-LFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGEN-Q 143 (269)
T ss_dssp TBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTTTT-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGG-G
T ss_pred CEeeEEEEEecCCceEEEEEeCCCCcHHHHHHhcCc-ccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCC-C
Confidence 588999999 45689999999999999999976443 49999999999999999999999999999999999999888 6
Q ss_pred CeEEecCCCcccccccc--ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 024408 80 TIKLADFGLAREESLTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQ 156 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~~~~ 156 (268)
.++|+|||++....... ......++..|+|||.+.+ ..++.++||||||+++|+|++ |..||......+
T Consensus 144 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~ 215 (269)
T 4hcu_A 144 VIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF--------SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE 215 (269)
T ss_dssp CEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred CEEeccccccccccccccccccCcccccccCCHHHhcC--------CCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH
Confidence 99999999998543322 2233456788999999864 567889999999999999999 999999877766
Q ss_pred HHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 024408 157 AAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 208 (268)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 208 (268)
.............+..+++.+.+++.+||..||.+||++.+++++|+.....
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 216 VVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp HHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHhcCccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 6555555545556777899999999999999999999999999999987653
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=275.39 Aligned_cols=189 Identities=28% Similarity=0.477 Sum_probs=161.6
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|+|++++++ .++..++||||++||+|.+++.+. .+++.++..++.|++.||+|||++|++||||||+||+++.+ +
T Consensus 78 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~-~ 153 (297)
T 3fxz_A 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD-G 153 (297)
T ss_dssp TBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-C
T ss_pred CCCeEeEEEEECCEEEEEEECCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCC-C
Confidence 689999998 567899999999999999999764 39999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccccc-ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESLTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.+||+|||++....... ......||+.|+|||++.+ ..++.++||||||+++|+|++|..||.........
T Consensus 154 ~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~ 225 (297)
T 3fxz_A 154 SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR--------KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL 225 (297)
T ss_dssp CEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHHC--------SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred CEEEeeCCCceecCCcccccCCccCCcCccChhhhcC--------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 99999999987544332 3345679999999999864 56788999999999999999999999887765554
Q ss_pred HHHHhccC--CCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 159 YAAAFKNV--RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 159 ~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
........ ...+..++..+.++|.+||..||.+||++.++++|
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 226 YLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp HHHHHHCSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHhCCCCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 44433322 22356788999999999999999999999999997
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=287.19 Aligned_cols=197 Identities=26% Similarity=0.412 Sum_probs=153.1
Q ss_pred CceeEEEeec-----CCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEe
Q 024408 1 MREQFIGACK-----EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 75 (268)
Q Consensus 1 ~~v~l~g~~~-----~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~ 75 (268)
|+|++++++. ++++++||||++||+|.+++.+.....+++.++..++.|++.||.|||++||+||||||+|||++
T Consensus 116 ~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~ 195 (400)
T 1nxk_A 116 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYT 195 (400)
T ss_dssp TBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEES
T ss_pred CcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEe
Confidence 5789999874 35789999999999999999876655699999999999999999999999999999999999998
Q ss_pred CC--CCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 024408 76 ED--LKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS 153 (268)
Q Consensus 76 ~~--~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~ 153 (268)
.+ .+.+||+|||+++............||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+..
T Consensus 196 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~g~~pf~~~~ 267 (400)
T 1nxk_A 196 SKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP--------EKYDKSCDMWSLGVIMYILLCGYPPFYSNH 267 (400)
T ss_dssp SSSTTCCEEECCCTTCEECC-----------CTTCCGGGSCC--------CCSSSHHHHHHHHHHHHHHHHSSCSCCCCT
T ss_pred cCCCCccEEEEecccccccCCCCccccCCCCCCccCHhhcCC--------CCCCCcccHHHHHHHHHHHHhCCCCCCCCc
Confidence 72 26899999999986555444556788999999999854 568889999999999999999999997644
Q ss_pred hHH----HHHHHHhcc---CCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHh
Q 024408 154 NLQ----AAYAAAFKN---VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 205 (268)
Q Consensus 154 ~~~----~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~ 205 (268)
... ......... ..+....++.++.++|.+||..||.+|||+.++++|.+..
T Consensus 268 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~ 326 (400)
T 1nxk_A 268 GLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 326 (400)
T ss_dssp TCSSCCSHHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred cccccHHHHHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccc
Confidence 221 111111111 1222357899999999999999999999999999986543
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=271.26 Aligned_cols=198 Identities=29% Similarity=0.531 Sum_probs=169.8
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ .++..++||||++|++|.+++..... .+++.+++.++.|++.||.|||++|++||||||+||+++.+ +
T Consensus 80 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~-~ 157 (283)
T 3gen_A 80 KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQ-G 157 (283)
T ss_dssp TBCCEEEEECSSSSEEEEECCCTTCBHHHHHHCGGG-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTT-S
T ss_pred CEeeEEEEEecCCCeEEEEeccCCCcHHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCC-C
Confidence 588999999 45689999999999999999987433 39999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccccc--ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 024408 80 TIKLADFGLAREESLTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQ 156 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~~~~ 156 (268)
.++|+|||++....... ......+|+.|+|||++.+ ..++.++||||||+++|+|++ |+.||......+
T Consensus 158 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~ 229 (283)
T 3gen_A 158 VVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY--------SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE 229 (283)
T ss_dssp CEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHH--------CCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH
T ss_pred CEEEccccccccccccccccccCCccCcccCCHHHhcc--------CCCCchhhHHHHHHHHHHHHhCCCCCccccChhH
Confidence 99999999998543322 2233456788999999864 567889999999999999998 999999877766
Q ss_pred HHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 024408 157 AAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 208 (268)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 208 (268)
.............+..+++.+.+++.+||..||.+||++.+++++|++.+..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 230 TAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHhcccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 6666555555556777899999999999999999999999999999988765
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=278.99 Aligned_cols=194 Identities=19% Similarity=0.232 Sum_probs=164.0
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCC-C
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED-L 78 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~-~ 78 (268)
|+|++++++ ..+..++||||++||+|.+++.... ..+++.+++.++.|++.||.|||++|++||||||+||+++.+ .
T Consensus 62 nIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~ 140 (321)
T 1tki_A 62 NILHLHESFESMEELVMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRS 140 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSC
T ss_pred CCCeEeEEEecCCEEEEEEEeCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCC
Confidence 689999999 5568999999999999999997643 249999999999999999999999999999999999999862 2
Q ss_pred CCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 79 KTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 79 ~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
+.+||+|||++.............||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+....+..
T Consensus 141 ~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 212 (321)
T 1tki_A 141 STIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQH--------DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQII 212 (321)
T ss_dssp CCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTT--------CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH
T ss_pred CCEEEEECCCCeECCCCCccccccCChhhcCcHHhcC--------CCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHH
Confidence 6899999999987655544555678999999999864 45688999999999999999999999887665554
Q ss_pred HHHHhccCCCC---CCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 024408 159 YAAAFKNVRPS---AENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 203 (268)
Q Consensus 159 ~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~ 203 (268)
........... ...++.++.++|.+||..||.+|||+.++++|.+
T Consensus 213 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~ 260 (321)
T 1tki_A 213 ENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPW 260 (321)
T ss_dssp HHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred HHHHcCCCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChh
Confidence 44444333322 2478999999999999999999999999999854
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=279.47 Aligned_cols=190 Identities=26% Similarity=0.378 Sum_probs=161.7
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ ..+.+|+||||++||+|.+++.+.+. +++.+++.++.|++.||+|||++||+||||||+|||++.+ +
T Consensus 82 ~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~-g 158 (353)
T 2i0e_A 82 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGR--FKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSE-G 158 (353)
T ss_dssp TBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-S
T ss_pred EEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCC-C
Confidence 478899998 45689999999999999999987655 9999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccc-cccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREES-LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.+||+|||+++... .........||+.|+|||++.+ ..++.++|+||||+++|+|++|+.||.+....+..
T Consensus 159 ~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~ 230 (353)
T 2i0e_A 159 HIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAY--------QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF 230 (353)
T ss_dssp CEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTT--------CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred cEEEEeCCcccccccCCcccccccCCccccChhhhcC--------CCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHH
Confidence 99999999998533 2333456689999999999864 56788999999999999999999999886655444
Q ss_pred HHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCC-----HHHHHHHH
Q 024408 159 YAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPN-----FTQIIQML 202 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~~~~~~l 202 (268)
.... ......+..++.++.++|.+||..||.+||+ ++++++|.
T Consensus 231 ~~i~-~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~ 278 (353)
T 2i0e_A 231 QSIM-EHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHA 278 (353)
T ss_dssp HHHH-HCCCCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSG
T ss_pred HHHH-hCCCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCc
Confidence 3333 3334456789999999999999999999995 58888873
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=284.89 Aligned_cols=198 Identities=31% Similarity=0.524 Sum_probs=168.0
Q ss_pred CceeEEEeec-CCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGACK-EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~~-~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|+|+++|+|. ++..++||||++||+|.+++...+. .+++.+++.++.|++.||+|||++|++||||||+||+++.+ +
T Consensus 173 niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~-~ 250 (377)
T 3cbl_A 173 NIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGA-RLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEK-N 250 (377)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHGG-GCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-C
T ss_pred CEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCC-C
Confidence 6899999994 5678999999999999999986543 39999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccccccc---ccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChH
Q 024408 80 TIKLADFGLAREESLTEMM---TAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNL 155 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~~~ 155 (268)
.+||+|||+++........ ....++..|+|||++.+ ..++.++||||||+++|||++ |..||.+....
T Consensus 251 ~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~ 322 (377)
T 3cbl_A 251 VLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNY--------GRYSSESDVWSFGILLWETFSLGASPYPNLSNQ 322 (377)
T ss_dssp CEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHH--------CEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH
T ss_pred cEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhcc--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999854332211 12235778999999864 457889999999999999998 99999988776
Q ss_pred HHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 024408 156 QAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 208 (268)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 208 (268)
+...........+.+..+|.++.++|.+||..||.+|||+.++++.|+.+...
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 323 QTREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 66555555555666778999999999999999999999999999999887653
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=277.69 Aligned_cols=198 Identities=23% Similarity=0.495 Sum_probs=168.4
Q ss_pred CceeEEEeecCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCC
Q 024408 1 MREQFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT 80 (268)
Q Consensus 1 ~~v~l~g~~~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~ 80 (268)
|+|+++|+|.++..++||||+.+|+|.+++.+... .+++..++.++.|++.||.|||++||+||||||+||+++.+ +.
T Consensus 78 ~iv~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~-~~ 155 (327)
T 3poz_A 78 HVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTP-QH 155 (327)
T ss_dssp TBCCEEEEEESSSEEEEEECCTTCBHHHHHHHSTT-SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEET-TE
T ss_pred CEeEEEEEEecCCeEEEEEecCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCC-CC
Confidence 68999999987778999999999999999987543 39999999999999999999999999999999999999988 69
Q ss_pred eEEecCCCcccccccc---ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 024408 81 IKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQ 156 (268)
Q Consensus 81 ~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~~~~ 156 (268)
+||+|||+++...... ......+|..|+|||.+.+ ..++.++||||||+++|+|++ |+.||.+....+
T Consensus 156 ~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 227 (327)
T 3poz_A 156 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH--------RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 227 (327)
T ss_dssp EEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG
T ss_pred EEEccCcceeEccCCcccccccCCCccccccChHHhcc--------CCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH
Confidence 9999999997543322 1223456889999999864 568899999999999999999 999998877666
Q ss_pred HHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 024408 157 AAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 208 (268)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 208 (268)
...........+.+..++..+.+++.+||..||.+||++.+++++|+.....
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 228 ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp HHHHHHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred HHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 5555555555566778899999999999999999999999999999887653
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=274.89 Aligned_cols=208 Identities=23% Similarity=0.278 Sum_probs=166.4
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ .++..++||||+ |++|.+++.... ..+++.+++.++.|++.||+|||++||+||||||+||+++.+ +
T Consensus 66 ~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~-~ 142 (330)
T 2izr_A 66 GIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCD-RTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRP-G 142 (330)
T ss_dssp TSCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCG-G
T ss_pred CCCEEEEEEecCCccEEEEEeC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccC-C
Confidence 578999998 556889999999 899999998753 349999999999999999999999999999999999999876 4
Q ss_pred C-----eEEecCCCccccccccc--------cccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCC
Q 024408 80 T-----IKLADFGLAREESLTEM--------MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNK 146 (268)
Q Consensus 80 ~-----~kl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~ 146 (268)
. +||+|||+++....... .....||+.|+|||++.+ ..++.++||||||+++|+|++|+
T Consensus 143 ~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~ell~g~ 214 (330)
T 2izr_A 143 NKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLG--------KEQSRRDDLEALGHMFMYFLRGS 214 (330)
T ss_dssp GTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--------CCCCHHHHHHHHHHHHHHHHHSS
T ss_pred CCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcC--------CCCCchhHHHHHHHHHHHHhcCC
Confidence 5 99999999985433221 235679999999999864 56789999999999999999999
Q ss_pred CCCCCCChH---HHHHHHHhccC-CC---CCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhcCCCCCCCCCc
Q 024408 147 LPFEGMSNL---QAAYAAAFKNV-RP---SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIPHR 219 (268)
Q Consensus 147 ~p~~~~~~~---~~~~~~~~~~~-~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~~~~~~~~~~~~ 219 (268)
.||.+.... +.......... .+ ....+| ++.+++..||..||.+||++.++++.|++..............|
T Consensus 215 ~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw 293 (330)
T 2izr_A 215 LPWQGLKADTLKERYQKIGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDW 293 (330)
T ss_dssp CTTTTCCCSSHHHHHHHHHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCSCCCTT
T ss_pred CCccccccccHHHHHHHHHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCCCCccC
Confidence 999874322 11111111111 11 123456 99999999999999999999999999999988877666555555
Q ss_pred c
Q 024408 220 I 220 (268)
Q Consensus 220 ~ 220 (268)
.
T Consensus 294 ~ 294 (330)
T 2izr_A 294 I 294 (330)
T ss_dssp T
T ss_pred C
Confidence 4
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=283.63 Aligned_cols=200 Identities=29% Similarity=0.501 Sum_probs=168.8
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEE
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRP-----RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL 74 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill 74 (268)
|+|+++|++ .++..++||||++||+|.+++..... ..+++.+++.++.|++.||+|||++||+||||||+|||+
T Consensus 135 nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll 214 (367)
T 3l9p_A 135 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLL 214 (367)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred CCCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEE
Confidence 689999999 45678999999999999999987542 349999999999999999999999999999999999999
Q ss_pred eCCC--CCeEEecCCCccccccc---cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCC
Q 024408 75 TEDL--KTIKLADFGLAREESLT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLP 148 (268)
Q Consensus 75 ~~~~--~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p 148 (268)
+.+. ..+||+|||+++..... .......||+.|+|||++.+ ..++.++||||||+++|+|++ |..|
T Consensus 215 ~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~DvwslG~il~ellt~g~~p 286 (367)
T 3l9p_A 215 TCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFME--------GIFTSKTDTWSFGVLLWEIFSLGYMP 286 (367)
T ss_dssp SCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred ecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcC--------CCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 8441 35999999999743221 22234467899999998864 568899999999999999998 9999
Q ss_pred CCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 024408 149 FEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 208 (268)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 208 (268)
|......+.............+..++..+.+++.+||+.||.+||++.+++++|+.....
T Consensus 287 f~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 287 YPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp STTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 998777666665555555566778999999999999999999999999999999887654
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=290.07 Aligned_cols=202 Identities=30% Similarity=0.495 Sum_probs=168.9
Q ss_pred CceeEEEeecCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCC
Q 024408 1 MREQFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT 80 (268)
Q Consensus 1 ~~v~l~g~~~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~ 80 (268)
|+|+++|++.++..++||||++||+|.+++.......+++.+++.++.|++.||+|||++|++||||||+|||++.+ +.
T Consensus 240 ~iv~~~~~~~~~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~-~~ 318 (452)
T 1fmk_A 240 KLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN-LV 318 (452)
T ss_dssp TBCCEEEEECSSSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG-GC
T ss_pred CEeeEEEEEcCCceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCC-CC
Confidence 68999999977889999999999999999976544459999999999999999999999999999999999999988 69
Q ss_pred eEEecCCCcccccccc--ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 024408 81 IKLADFGLAREESLTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQA 157 (268)
Q Consensus 81 ~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~ 157 (268)
+||+|||+++...... ......++..|+|||++.+ ..++.++||||||+++|+|++ |+.||.+....+.
T Consensus 319 ~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~ 390 (452)
T 1fmk_A 319 CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY--------GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV 390 (452)
T ss_dssp EEECCCCTTC--------------CCGGGSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH
T ss_pred EEECCCccceecCCCceecccCCcccccccCHhHHhc--------CCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 9999999998543322 1223346788999998864 568899999999999999999 9999998877766
Q ss_pred HHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhcCC
Q 024408 158 AYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAP 211 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~~~~ 211 (268)
..........+.+..+++.+.++|.+||..||.+|||+.++++.|+.++....+
T Consensus 391 ~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~ 444 (452)
T 1fmk_A 391 LDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 444 (452)
T ss_dssp HHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred HHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCc
Confidence 665555555666788999999999999999999999999999999987765433
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=278.26 Aligned_cols=199 Identities=29% Similarity=0.528 Sum_probs=168.1
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCC----------------------CCCCHHHHHHHHHHHHHHHHHH
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRP----------------------RCLDVCVAIGFALDIARAMECL 57 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~----------------------~~~~~~~~~~~~~~l~~~l~~l 57 (268)
++++++|++ .++..++||||++||+|.+++.+... ..+++.+++.++.|++.||.||
T Consensus 111 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~L 190 (343)
T 1luf_A 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYL 190 (343)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHH
T ss_pred CEEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHH
Confidence 689999999 55688999999999999999987431 4599999999999999999999
Q ss_pred HHCCCeecCCCCCCEEEeCCCCCeEEecCCCccccccc---cccccCCCccceeccccccccccccCCCCCCCchhhHHH
Q 024408 58 HSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYS 134 (268)
Q Consensus 58 H~~gi~H~Dikp~Nill~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws 134 (268)
|++|++||||||+||+++.+ +.+||+|||+++..... .......+|+.|+|||++.+ ..++.++||||
T Consensus 191 H~~~ivH~Dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~Di~s 261 (343)
T 1luf_A 191 SERKFVHRDLATRNCLVGEN-MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY--------NRYTTESDVWA 261 (343)
T ss_dssp HHTTCCCSCCSGGGEEECGG-GCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH--------CCCCHHHHHHH
T ss_pred HhCCeecCCCCcceEEECCC-CeEEEeecCCCcccccCccccccCCCcccceecChhhhcc--------CCcCcccccHH
Confidence 99999999999999999988 69999999999753322 12234567899999998864 56789999999
Q ss_pred HHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 024408 135 FAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 208 (268)
Q Consensus 135 lG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 208 (268)
||+++|+|++ |..||.+....+.............+..++..+.+++.+||..||.+||++.+++++|+.....
T Consensus 262 lG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 262 YGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp HHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred HHHHHHHHHhcCCCcCCCCChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 9999999999 9999998776666555555555556778999999999999999999999999999999987654
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=280.69 Aligned_cols=190 Identities=29% Similarity=0.451 Sum_probs=162.0
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ ..+.+++||||++||+|.+++.+.+. +++.++..++.|++.||+|||++||+||||||+||+++.+ +
T Consensus 79 ~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-g 155 (345)
T 1xjd_A 79 FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKD-G 155 (345)
T ss_dssp TBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-S
T ss_pred CCCcEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCC-C
Confidence 578999999 45689999999999999999987655 9999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccc-ccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESL-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.+||+|||+++.... ........||+.|+|||++.+ ..++.++|+||||+++|+|++|..||.+.+..+..
T Consensus 156 ~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~ 227 (345)
T 1xjd_A 156 HIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG--------QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF 227 (345)
T ss_dssp CEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred CEEEeEChhhhhcccCCCcccCCCCCcccCChhhhcC--------CCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 999999999985332 233456689999999999864 56788999999999999999999999886655444
Q ss_pred HHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHH-HHHHHH
Q 024408 159 YAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFT-QIIQML 202 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~-~~~~~l 202 (268)
.... ......+..++.++.++|.+||..||.+||++. ++++|-
T Consensus 228 ~~i~-~~~~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp 271 (345)
T 1xjd_A 228 HSIR-MDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHP 271 (345)
T ss_dssp HHHH-HCCCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSG
T ss_pred HHHH-hCCCCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCc
Confidence 3333 333344667899999999999999999999997 887763
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-40 Score=269.56 Aligned_cols=197 Identities=29% Similarity=0.523 Sum_probs=167.9
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ .++..++||||++|++|.+++..... .+++.+++.++.|++.||.|||++|++||||||+||+++.+ +
T Consensus 64 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~-~ 141 (268)
T 3sxs_A 64 KLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGK-GLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRD-L 141 (268)
T ss_dssp TBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHHGG-GCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTT-C
T ss_pred CEeeEEEEEccCCceEEEEEccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCC-C
Confidence 578999999 45688999999999999999987543 39999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccccc--cccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 024408 80 TIKLADFGLAREESLTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQ 156 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~~~~ 156 (268)
.++|+|||++........ .....++..|+|||.+.+ ..++.++||||||+++|+|++ |..||......+
T Consensus 142 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~ 213 (268)
T 3sxs_A 142 CVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHY--------FKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE 213 (268)
T ss_dssp CEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHH--------SEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH
T ss_pred CEEEccCccceecchhhhhcccCCCcCcccCCHHHHhc--------cCCchhhhhHHHHHHHHHHHcCCCCCccccChHH
Confidence 999999999975433322 223356778999999864 456789999999999999999 999999877776
Q ss_pred HHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHh
Q 024408 157 AAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 207 (268)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 207 (268)
.............+..+++.+.+++.+||..||.+|||+.+++++|+.+..
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 214 VVLKVSQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp HHHHHHTTCCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred HHHHHHcCCCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 666655555555677789999999999999999999999999999987643
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=268.94 Aligned_cols=198 Identities=29% Similarity=0.504 Sum_probs=166.9
Q ss_pred CceeEEEeecCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCC
Q 024408 1 MREQFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT 80 (268)
Q Consensus 1 ~~v~l~g~~~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~ 80 (268)
++++++|++.++..++||||++|++|.+++.+... .+++..++.++.|++.||.|||++|++||||||+||+++.+ +.
T Consensus 74 ~i~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~ 151 (281)
T 3cc6_A 74 HIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKN-SLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASP-EC 151 (281)
T ss_dssp TBCCEEEEECSSSCEEEEECCTTCBHHHHHHHHTT-TCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEET-TE
T ss_pred CcceEEEEEcCCCCEEEEecCCCCCHHHHHHhccc-cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCC-Cc
Confidence 58999999988888999999999999999987543 39999999999999999999999999999999999999988 69
Q ss_pred eEEecCCCcccccccc--ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 024408 81 IKLADFGLAREESLTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQA 157 (268)
Q Consensus 81 ~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~ 157 (268)
++|+|||++....... ......++..|+|||++.+ ..++.++||||||+++|+|++ |+.||......+.
T Consensus 152 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~ 223 (281)
T 3cc6_A 152 VKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINF--------RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV 223 (281)
T ss_dssp EEECCCCGGGCC---------CCCCCGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGH
T ss_pred EEeCccCCCcccccccccccccCCCCcceeCchhhcc--------CCCCchhccHHHHHHHHHHHhCCCCCcccCChHHH
Confidence 9999999998544322 1233456889999998864 567889999999999999998 9999987666555
Q ss_pred HHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 024408 158 AYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 208 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 208 (268)
..........+.+..+++.+.+++.+||..||.+||++.+++++|+.....
T Consensus 224 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 224 IGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHhcCCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 554445555566778899999999999999999999999999999887653
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=280.03 Aligned_cols=193 Identities=26% Similarity=0.350 Sum_probs=162.9
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCC-
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL- 78 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~- 78 (268)
|+|++++++ .++..++||||++||+|.+++..... +++..+..++.|++.||.|||++||+||||||+||+++.+.
T Consensus 89 nIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~ 166 (362)
T 2bdw_A 89 NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF--YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAK 166 (362)
T ss_dssp TBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTCSC--CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSST
T ss_pred CCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCC
Confidence 689999999 55688999999999999999976544 99999999999999999999999999999999999997542
Q ss_pred -CCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 024408 79 -KTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA 157 (268)
Q Consensus 79 -~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~ 157 (268)
+.+||+|||++.............||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+.+....
T Consensus 167 ~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~ 238 (362)
T 2bdw_A 167 GAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK--------DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL 238 (362)
T ss_dssp TCCEEECCCTTCBCCTTCCSCCCSCSCTTTCCHHHHTT--------CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred CCCEEEeecCcceEecCCcccccCCCCccccCHHHHcc--------CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH
Confidence 3699999999987655544556689999999999864 5678899999999999999999999988766554
Q ss_pred HHHHHhccCCC---CCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 024408 158 AYAAAFKNVRP---SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 203 (268)
Q Consensus 158 ~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~ 203 (268)
........... ....+++++.++|.+||..||.+||++.++++|.+
T Consensus 239 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 287 (362)
T 2bdw_A 239 YAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPW 287 (362)
T ss_dssp HHHHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHH
T ss_pred HHHHHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence 44443333222 22467899999999999999999999999998854
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=271.12 Aligned_cols=197 Identities=28% Similarity=0.447 Sum_probs=160.8
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|++++++++ .++..++||||++|++|.+++.+.+. +++.+++.++.|++.||+|||++|++||||||+||+++.+ +
T Consensus 72 ~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~-~ 148 (294)
T 4eqm_A 72 NIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP--LSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSN-K 148 (294)
T ss_dssp TBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-S
T ss_pred CCceEEEeeeeCCeEEEEEeCCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-C
Confidence 588999999 45688999999999999999987665 9999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccccc--ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 024408 80 TIKLADFGLAREESLTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA 157 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~ 157 (268)
.+||+|||+++...... ......||+.|+|||.+.+ ..++.++||||||+++|+|++|+.||.+......
T Consensus 149 ~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~ 220 (294)
T 4eqm_A 149 TLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKG--------EATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI 220 (294)
T ss_dssp CEEECCCSSSTTC-------------CCSSCCHHHHHT--------CCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH
T ss_pred CEEEEeCCCccccccccccccCccccCccccCHhHhcC--------CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 99999999998644332 2234568999999999864 5578899999999999999999999998776555
Q ss_pred HHHHHhccCCC----CCCCCcHHHHHHHHhccccCCCCCC-CHHHHHHHHHHhHhh
Q 024408 158 AYAAAFKNVRP----SAENVPEELSIILTSCWKEDPNARP-NFTQIIQMLLNYLSA 208 (268)
Q Consensus 158 ~~~~~~~~~~~----~~~~~~~~l~~li~~~l~~~p~~Rp-s~~~~~~~l~~~~~~ 208 (268)
........... ....+|+.+.++|.+||..||.+|| +++++.+.|......
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 221 AIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp HHHHHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred HHHHhhccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence 44444333222 2467899999999999999999999 788888888766544
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=269.28 Aligned_cols=209 Identities=19% Similarity=0.220 Sum_probs=166.3
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCC-
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL- 78 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~- 78 (268)
+++++++++ .+...++||||+ |++|.+++...+. .+++.+++.++.|++.||+|||++|++||||||+||+++.+.
T Consensus 67 ~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~ 144 (298)
T 1csn_A 67 GIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGR-KFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNS 144 (298)
T ss_dssp TCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSS
T ss_pred CCCeEEeecCCCceeEEEEEec-CCCHHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCC
Confidence 467889998 556889999999 8999999987543 399999999999999999999999999999999999997652
Q ss_pred ---CCeEEecCCCcccccccc--------ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCC
Q 024408 79 ---KTIKLADFGLAREESLTE--------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKL 147 (268)
Q Consensus 79 ---~~~kl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~ 147 (268)
+.++|+|||+++...... ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.
T Consensus 145 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~~g~~ 216 (298)
T 1csn_A 145 KNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG--------REQSRRDDLEALGHVFMYFLRGSL 216 (298)
T ss_dssp TTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--------CCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred CCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcC--------CCCChHHHHHHHHHHHHHHHcCCC
Confidence 239999999998543321 1244579999999999864 567899999999999999999999
Q ss_pred CCCCCCh---HHHHHHHHhcc----CCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhcCCCCCCCCCc
Q 024408 148 PFEGMSN---LQAAYAAAFKN----VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIPHR 219 (268)
Q Consensus 148 p~~~~~~---~~~~~~~~~~~----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~~~~~~~~~~~~ 219 (268)
||.+... .+......... .......+++++.+++.+||..||.+||++.++++.|+..............+|
T Consensus 217 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw 295 (298)
T 1csn_A 217 PWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDW 295 (298)
T ss_dssp TTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGG
T ss_pred CcchhhccccHHHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCcccc
Confidence 9987432 22211111111 111235789999999999999999999999999999999998876655544443
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=270.96 Aligned_cols=201 Identities=28% Similarity=0.489 Sum_probs=170.2
Q ss_pred CceeEEEeecCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCC
Q 024408 1 MREQFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT 80 (268)
Q Consensus 1 ~~v~l~g~~~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~ 80 (268)
+++++++++.++..++||||++|++|.+++.......+++.+++.++.|++.||+|||++|++||||||+||+++.+ +.
T Consensus 69 ~i~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~-~~ 147 (279)
T 1qpc_A 69 RLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDT-LS 147 (279)
T ss_dssp TBCCEEEEECSSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-SC
T ss_pred CcceEEEEEcCCCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCC-CC
Confidence 57899999988889999999999999999976543349999999999999999999999999999999999999988 69
Q ss_pred eEEecCCCcccccccc--ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 024408 81 IKLADFGLAREESLTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQA 157 (268)
Q Consensus 81 ~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~ 157 (268)
++|+|||++....... ......++..|+|||++.+ ..++.++||||||+++|+|++ |+.||.+....+.
T Consensus 148 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 219 (279)
T 1qpc_A 148 CKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY--------GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV 219 (279)
T ss_dssp EEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHH--------CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH
T ss_pred EEECCCcccccccCcccccccCCCCccCccChhhhcc--------CCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHH
Confidence 9999999998544322 1223456788999999864 456789999999999999999 9999988776655
Q ss_pred HHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhcC
Q 024408 158 AYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIA 210 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~~~ 210 (268)
............+..++.++.+++.+||..||.+||++.++++.|+.++....
T Consensus 220 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 272 (279)
T 1qpc_A 220 IQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272 (279)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred HHHHhcccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhcc
Confidence 55544444455567889999999999999999999999999999999887643
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=275.41 Aligned_cols=192 Identities=24% Similarity=0.331 Sum_probs=161.6
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCC-
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL- 78 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~- 78 (268)
|+|++++++ .++..++||||++|++|.+++..... +++.+++.++.|++.||.|||++|++||||||+||+++.+.
T Consensus 75 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~ 152 (326)
T 2y0a_A 75 NVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNV 152 (326)
T ss_dssp TBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTSSC--CBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSS
T ss_pred CCCcEEEEEEeCCEEEEEEEcCCCCCHHHHHHhcCC--cCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCC
Confidence 689999999 45689999999999999999976544 99999999999999999999999999999999999998762
Q ss_pred --CCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH
Q 024408 79 --KTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 156 (268)
Q Consensus 79 --~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~ 156 (268)
..+||+|||+++............||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+....+
T Consensus 153 ~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 224 (326)
T 2y0a_A 153 PKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY--------EPLGLEADMWSIGVITYILLSGASPFLGDTKQE 224 (326)
T ss_dssp SSCCEEECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTT--------CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH
T ss_pred CCCCEEEEECCCCeECCCCCccccccCCcCcCCceeecC--------CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH
Confidence 1799999999987654444556689999999999854 567889999999999999999999998766555
Q ss_pred HHHHHHhccCCCC---CCCCcHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 024408 157 AAYAAAFKNVRPS---AENVPEELSIILTSCWKEDPNARPNFTQIIQML 202 (268)
Q Consensus 157 ~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l 202 (268)
............. ...++..+.++|.+||..||.+|||+.++++|.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 273 (326)
T 2y0a_A 225 TLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHP 273 (326)
T ss_dssp HHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHST
T ss_pred HHHHHHhcCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCC
Confidence 4443333222221 256789999999999999999999999999973
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=270.27 Aligned_cols=204 Identities=24% Similarity=0.482 Sum_probs=172.5
Q ss_pred CceeEEEeecCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCC
Q 024408 1 MREQFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT 80 (268)
Q Consensus 1 ~~v~l~g~~~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~ 80 (268)
+++++++++.++..++||||++|++|.+++.... ..+++..++.++.|++.||.|||++|++||||||+||+++.+ +.
T Consensus 71 ~i~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~-~~ 148 (287)
T 1u59_A 71 YIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNR-HY 148 (287)
T ss_dssp TBCCEEEEEESSSEEEEEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEET-TE
T ss_pred CEeEEEEEecCCCcEEEEEeCCCCCHHHHHHhCC-ccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCC-CC
Confidence 5899999998788999999999999999997543 349999999999999999999999999999999999999988 69
Q ss_pred eEEecCCCccccccccc----cccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChH
Q 024408 81 IKLADFGLAREESLTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNL 155 (268)
Q Consensus 81 ~kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~~~ 155 (268)
++|+|||++........ .....+|+.|+|||++.+ ..++.++||||||+++|+|++ |+.||......
T Consensus 149 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 220 (287)
T 1u59_A 149 AKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF--------RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP 220 (287)
T ss_dssp EEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHH--------CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH
T ss_pred EEECcccceeeeccCcceeeccccccccccccCHHHhcc--------CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH
Confidence 99999999985433221 223356889999999864 457889999999999999998 99999887766
Q ss_pred HHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhcCCCCC
Q 024408 156 QAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEP 214 (268)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~~~~~~~ 214 (268)
+.............+..+++++.++|.+||..||.+||++.+++++|+..+.+...+..
T Consensus 221 ~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~ 279 (287)
T 1u59_A 221 EVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE 279 (287)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCS
T ss_pred HHHHHHhcCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCccc
Confidence 65555544444555778999999999999999999999999999999998877655443
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=283.61 Aligned_cols=193 Identities=24% Similarity=0.316 Sum_probs=163.1
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCC--
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED-- 77 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~-- 77 (268)
|+|++++++ .++..++||||++||+|.+++...+. +++..+..++.|++.||.|||++||+||||||+|||++.+
T Consensus 71 nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~--~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~ 148 (444)
T 3soa_A 71 NIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREY--YSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLK 148 (444)
T ss_dssp TBCCEEEEEECSSEEEEEECCCBCCBHHHHHHHCSC--CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSST
T ss_pred CCCeEEEEEEECCEEEEEEEeCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCC
Confidence 689999999 55689999999999999999987655 9999999999999999999999999999999999999842
Q ss_pred CCCeEEecCCCccccccc-cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH
Q 024408 78 LKTIKLADFGLAREESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 156 (268)
Q Consensus 78 ~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~ 156 (268)
.+.+||+|||++...... .......||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+....+
T Consensus 149 ~~~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~--------~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~ 220 (444)
T 3soa_A 149 GAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRK--------DPYGKPVDLWACGVILYILLVGYPPFWDEDQHR 220 (444)
T ss_dssp TCCEEECCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred CCcEEEccCceeEEecCCCceeecccCCcccCCHHHhcC--------CCCCCccccHHHHHHHHHHHhCCCCCCCccHHH
Confidence 268999999999764433 22345689999999999864 567889999999999999999999998876655
Q ss_pred HHHHHHhccCC---CCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 024408 157 AAYAAAFKNVR---PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 203 (268)
Q Consensus 157 ~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~ 203 (268)
........... +....+++++.++|.+||..||.+||++.++++|.+
T Consensus 221 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~ 270 (444)
T 3soa_A 221 LYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPW 270 (444)
T ss_dssp HHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCT
T ss_pred HHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCcc
Confidence 55444443322 223578999999999999999999999999999843
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=277.58 Aligned_cols=191 Identities=24% Similarity=0.398 Sum_probs=159.9
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
++|++++++ .++.+++||||++||+|.+++.+.+. +++..++.++.|++.||+|||++||+||||||+||+++.+ +
T Consensus 71 ~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-g 147 (345)
T 3a8x_A 71 FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRK--LPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE-G 147 (345)
T ss_dssp TBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-S
T ss_pred ccCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCC-C
Confidence 589999999 55689999999999999999987655 9999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccc-cccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----
Q 024408 80 TIKLADFGLAREES-LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS----- 153 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~----- 153 (268)
.+||+|||+++... .........||+.|+|||++.+ ..++.++|+||||+++|+|++|+.||....
T Consensus 148 ~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~ 219 (345)
T 3a8x_A 148 HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG--------EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP 219 (345)
T ss_dssp CEEECCGGGCBCSCCTTCCBCCCCSCGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC----
T ss_pred CEEEEeccccccccCCCCcccccCCCccccCccccCC--------CCCChHHhHHHHHHHHHHHHhCCCCcCCccccccc
Confidence 99999999998532 2334456689999999999864 567889999999999999999999996521
Q ss_pred ---hHHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCH------HHHHHHH
Q 024408 154 ---NLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNF------TQIIQML 202 (268)
Q Consensus 154 ---~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~------~~~~~~l 202 (268)
................+..++.++.++|.+||..||.+||++ .++++|-
T Consensus 220 ~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp 277 (345)
T 3a8x_A 220 DQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHP 277 (345)
T ss_dssp ---CHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSG
T ss_pred ccccHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCC
Confidence 112223333344444567889999999999999999999985 7888773
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=286.52 Aligned_cols=197 Identities=29% Similarity=0.525 Sum_probs=168.0
Q ss_pred CceeEEEee-cCC-cEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCC
Q 024408 1 MREQFIGAC-KEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL 78 (268)
Q Consensus 1 ~~v~l~g~~-~~~-~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~ 78 (268)
|+|+++|+| .++ ..++||||++||+|.+++.+.+...+++..++.++.|++.||+|||++|++||||||+|||++.+
T Consensus 247 niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~- 325 (450)
T 1k9a_A 247 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSED- 325 (450)
T ss_dssp TBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT-
T ss_pred CEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCC-
Confidence 689999998 333 78999999999999999998766568999999999999999999999999999999999999988
Q ss_pred CCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 024408 79 KTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQA 157 (268)
Q Consensus 79 ~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~ 157 (268)
+.+||+|||+++..... .....++..|+|||++.+ ..++.++||||||+++|||++ |+.||.+....+.
T Consensus 326 ~~~kl~DfG~a~~~~~~--~~~~~~~~~y~aPE~~~~--------~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~ 395 (450)
T 1k9a_A 326 NVAKVSDFGLTKEASST--QDTGKLPVKWTAPEALRE--------KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV 395 (450)
T ss_dssp SCEEECCCTTCEECC--------CCCTTTSCHHHHHS--------SCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH
T ss_pred CCEEEeeCCCccccccc--ccCCCCCcceeCHHHhcC--------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 69999999999854322 223367889999999864 568899999999999999998 9999988776665
Q ss_pred HHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 024408 158 AYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 208 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 208 (268)
..........+.+..+++++.++|.+||..||.+||++.++++.|+.+...
T Consensus 396 ~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 396 VPRVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 555555555566788999999999999999999999999999999887653
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=273.70 Aligned_cols=188 Identities=24% Similarity=0.307 Sum_probs=162.2
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ .++.+++||||++||+|.+++.+.+. +++..++.++.|++.||+|||++||+||||||+||+++.+ +
T Consensus 102 ~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-g 178 (350)
T 1rdq_E 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-G 178 (350)
T ss_dssp TBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-S
T ss_pred CCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCC-C
Confidence 578999999 55689999999999999999987655 9999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 024408 80 TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY 159 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~ 159 (268)
.+||+|||+++..... ..+..||+.|+|||++.+ ..++.++|+||||+++|+|++|..||.+....+...
T Consensus 179 ~~kL~DFg~a~~~~~~--~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~ 248 (350)
T 1rdq_E 179 YIQVTDFGFAKRVKGR--TWTLCGTPEALAPEIILS--------KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 248 (350)
T ss_dssp CEEECCCTTCEECSSC--BCCCEECGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred CEEEcccccceeccCC--cccccCCccccCHHHhcC--------CCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHH
Confidence 9999999999864332 345679999999999864 567889999999999999999999998866555444
Q ss_pred HHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCC-----HHHHHHHH
Q 024408 160 AAAFKNVRPSAENVPEELSIILTSCWKEDPNARPN-----FTQIIQML 202 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~~~~~~l 202 (268)
.... .....+..++.++.++|.+||..||.+||+ ++++++|-
T Consensus 249 ~i~~-~~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~ 295 (350)
T 1rdq_E 249 KIVS-GKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHK 295 (350)
T ss_dssp HHHH-CCCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSG
T ss_pred HHHc-CCCCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCc
Confidence 4333 334456778999999999999999999998 89999874
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=280.16 Aligned_cols=199 Identities=28% Similarity=0.497 Sum_probs=159.3
Q ss_pred CceeEEEeec-CCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGACK-EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~~-~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|+|+++|++. ++..++||||++||+|.+++.+... .+++.+++.++.|++.||+|||++|++||||||+||+++.+ +
T Consensus 107 niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~ 184 (373)
T 2qol_A 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSN-L 184 (373)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTT-CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-C
T ss_pred CCCeEEEEEeeCCceEEEEeCCCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCC-C
Confidence 6899999994 5678999999999999999986543 49999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccccc----cccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCh
Q 024408 80 TIKLADFGLAREESLTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSN 154 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~~ 154 (268)
.+||+|||+++....... .....++..|+|||++.+ ..++.++||||||+++|||++ |+.||.....
T Consensus 185 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~ 256 (373)
T 2qol_A 185 VCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY--------RKFTSASDVWSYGIVLWEVMSYGERPYWEMSN 256 (373)
T ss_dssp CEEECCC----------------------CTTSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH
T ss_pred CEEECcCccccccccCCccceeccCCCcCCCccChhhhcc--------CCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999985433211 112235678999999864 568889999999999999998 9999988776
Q ss_pred HHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhc
Q 024408 155 LQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 209 (268)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~~ 209 (268)
.+...........+.+..++..+.+++.+||+.||.+||++.++++.|+.+....
T Consensus 257 ~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 257 QDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp HHHHHHHHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred HHHHHHHHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 6655555555555667789999999999999999999999999999999887643
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=273.52 Aligned_cols=199 Identities=28% Similarity=0.534 Sum_probs=168.3
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCC----------------------CCCCHHHHHHHHHHHHHHHHHH
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRP----------------------RCLDVCVAIGFALDIARAMECL 57 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~----------------------~~~~~~~~~~~~~~l~~~l~~l 57 (268)
|+|++++++ .++..++||||++|++|.+++..... ..+++.+++.++.|++.||.||
T Consensus 87 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~l 166 (314)
T 2ivs_A 87 HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL 166 (314)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHH
T ss_pred ceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHH
Confidence 689999999 55688999999999999999987543 2389999999999999999999
Q ss_pred HHCCCeecCCCCCCEEEeCCCCCeEEecCCCcccccccc---ccccCCCccceeccccccccccccCCCCCCCchhhHHH
Q 024408 58 HSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYS 134 (268)
Q Consensus 58 H~~gi~H~Dikp~Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws 134 (268)
|++|++||||||+||+++.+ +.++|+|||+++...... ......+++.|+|||++.+ ..++.++||||
T Consensus 167 H~~~ivH~dikp~NIli~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~s 237 (314)
T 2ivs_A 167 AEMKLVHRDLAARNILVAEG-RKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFD--------HIYTTQSDVWS 237 (314)
T ss_dssp HHTTEECCCCSGGGEEEETT-TEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHH--------CEECHHHHHHH
T ss_pred HHCCCcccccchheEEEcCC-CCEEEccccccccccccccceeccCCCCcccccChhhhcC--------CCcCchhhHHH
Confidence 99999999999999999988 699999999997543322 2233457788999999864 45788999999
Q ss_pred HHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 024408 135 FAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 208 (268)
Q Consensus 135 lG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 208 (268)
||+++|+|++ |..||.+..................+..+++.+.+++.+||..||.+||++.+++++|+..+..
T Consensus 238 lG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 238 FGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp HHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHhCCCCCCCCCCHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 9999999999 9999988766555544444444555678999999999999999999999999999999987754
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=278.10 Aligned_cols=192 Identities=22% Similarity=0.343 Sum_probs=158.8
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeC---
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE--- 76 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~--- 76 (268)
+++++++++ ..+..++||||++||+|.+++.......+++.+++.++.|++.||+|||++|++||||||+||+++.
T Consensus 90 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~ 169 (327)
T 3lm5_A 90 RVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYP 169 (327)
T ss_dssp TBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTT
T ss_pred CEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCC
Confidence 578999999 4568999999999999999997655556999999999999999999999999999999999999987
Q ss_pred CCCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH
Q 024408 77 DLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 156 (268)
Q Consensus 77 ~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~ 156 (268)
+ +.+||+|||+++............||+.|+|||++.+ ..++.++||||||+++|+|++|+.||......+
T Consensus 170 ~-~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 240 (327)
T 3lm5_A 170 L-GDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNY--------DPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE 240 (327)
T ss_dssp B-CCEEECCGGGCEEC---------CCCGGGCCHHHHTT--------CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred C-CcEEEeeCccccccCCccccccccCCcCccCCeeecC--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH
Confidence 4 6899999999987655544556689999999999864 567889999999999999999999998877665
Q ss_pred HHHHHHhccCC---CCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 157 AAYAAAFKNVR---PSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 157 ~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
........... +....++..+.++|.+||..||.+||++++++++
T Consensus 241 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 241 TYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp HHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred HHHHHHhcccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 54444333322 2245788999999999999999999999999998
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=274.81 Aligned_cols=200 Identities=30% Similarity=0.498 Sum_probs=167.7
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMR--------------PRCLDVCVAIGFALDIARAMECLHSHGIIHR 65 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~--------------~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~ 65 (268)
+++++++++ .++..++||||++|++|.+++.+.. ...+++.+++.++.|++.||.|||++|++||
T Consensus 87 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~ 166 (327)
T 1fvr_A 87 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHR 166 (327)
T ss_dssp TBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred chhhhceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCC
Confidence 588999999 5678999999999999999998654 2359999999999999999999999999999
Q ss_pred CCCCCCEEEeCCCCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-
Q 024408 66 DLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH- 144 (268)
Q Consensus 66 Dikp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~- 144 (268)
||||+||+++.+ +.+||+|||+++............++..|+|||++.+ ..++.++||||||+++|+|++
T Consensus 167 dlkp~NIl~~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~ellt~ 237 (327)
T 1fvr_A 167 DLAARNILVGEN-YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY--------SVYTTNSDVWSYGVLLWEIVSL 237 (327)
T ss_dssp CCSGGGEEECGG-GCEEECCTTCEESSCEECCC----CCTTTCCHHHHHH--------CEECHHHHHHHHHHHHHHHHTT
T ss_pred CCccceEEEcCC-CeEEEcccCcCccccccccccCCCCCccccChhhhcc--------ccCCchhcchHHHHHHHHHHcC
Confidence 999999999988 6999999999985444433344567889999998864 456889999999999999998
Q ss_pred CCCCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhc
Q 024408 145 NKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 209 (268)
Q Consensus 145 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~~ 209 (268)
|..||.+....+.............+..+++.+.++|.+||..||.+||++.+++++|+......
T Consensus 238 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 302 (327)
T 1fvr_A 238 GGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302 (327)
T ss_dssp SCCTTTTCCHHHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred CCCCCCCCcHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence 99999887665554444433344456778999999999999999999999999999999988764
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=283.63 Aligned_cols=190 Identities=27% Similarity=0.382 Sum_probs=161.5
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEEeCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLTEDL 78 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~gi~H~Dikp~Nill~~~~ 78 (268)
|++++++++ .++.+++||||++||+|.+++.+... +++..+..++.|++.||+|||+ +||+||||||+|||++.+
T Consensus 209 ~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~- 285 (446)
T 4ejn_A 209 FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERV--FSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD- 285 (446)
T ss_dssp TSCCEEEEEEETTEEEEEECCCSSCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSS-
T ss_pred eEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCC-
Confidence 588999999 56789999999999999999987655 9999999999999999999998 999999999999999988
Q ss_pred CCeEEecCCCccccc-cccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 024408 79 KTIKLADFGLAREES-LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA 157 (268)
Q Consensus 79 ~~~kl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~ 157 (268)
+.+||+|||+++... .........||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+....+.
T Consensus 286 ~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 357 (446)
T 4ejn_A 286 GHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLED--------NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL 357 (446)
T ss_dssp SCEEECCCCCCCTTCC-----CCSSSCGGGCCHHHHHT--------SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred CCEEEccCCCceeccCCCcccccccCCccccCHhhcCC--------CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH
Confidence 699999999998533 2333456689999999999864 5688999999999999999999999988665544
Q ss_pred HHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCC-----CHHHHHHHH
Q 024408 158 AYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARP-----NFTQIIQML 202 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~~~~~l 202 (268)
..... ......+..+++++.++|.+||..||.+|| +++++++|.
T Consensus 358 ~~~i~-~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp 406 (446)
T 4ejn_A 358 FELIL-MEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHR 406 (446)
T ss_dssp HHHHH-HCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred HHHHH-hCCCCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCc
Confidence 44333 333445677899999999999999999999 999999983
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=279.10 Aligned_cols=189 Identities=26% Similarity=0.334 Sum_probs=160.1
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
++|++++++ .++.+|+||||++||+|.+++.+.+. +++..++.++.|++.||+|||++||+||||||+|||++.+ +
T Consensus 100 ~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~-g 176 (373)
T 2r5t_A 100 FLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERC--FLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQ-G 176 (373)
T ss_dssp TBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-S
T ss_pred CCCCEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCC-C
Confidence 578999999 55689999999999999999987655 9999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccc-cccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREES-LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.+||+|||+++... ......+..||+.|+|||++.+ ..++.++|+||||+++|||++|..||.+....+..
T Consensus 177 ~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~ 248 (373)
T 2r5t_A 177 HIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHK--------QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY 248 (373)
T ss_dssp CEEECCCCBCGGGBCCCCCCCSBSCCCCCCCHHHHTT--------CCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHH
T ss_pred CEEEeeCccccccccCCCccccccCCccccCHHHhCC--------CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHH
Confidence 99999999998532 2334456689999999999864 56788999999999999999999999886655444
Q ss_pred HHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCH----HHHHHH
Q 024408 159 YAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNF----TQIIQM 201 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~----~~~~~~ 201 (268)
.... ......+..++.++.++|.+||..||.+||++ .++++|
T Consensus 249 ~~i~-~~~~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h 294 (373)
T 2r5t_A 249 DNIL-NKPLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSH 294 (373)
T ss_dssp HHHH-HSCCCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTS
T ss_pred HHHH-hcccCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCC
Confidence 4333 33334456789999999999999999999987 455555
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=278.34 Aligned_cols=192 Identities=28% Similarity=0.369 Sum_probs=157.7
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|+|++++++ .++..++||||++||+|.+++..... +++.+++.++.|++.||+|||++|++||||||+||+++.+ +
T Consensus 66 nIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~-~ 142 (323)
T 3tki_A 66 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER-D 142 (323)
T ss_dssp TBCCEEEEEECSSEEEEEEECCTTEEGGGGSBTTTB--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-C
T ss_pred CCCeEEEEEecCCeEEEEEEcCCCCcHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCC-C
Confidence 689999999 45688999999999999999976544 9999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccc---cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH
Q 024408 80 TIKLADFGLAREESLT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 156 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~ 156 (268)
.+||+|||++...... .......||+.|+|||++.+ ....+.++||||||+++|+|++|+.||.......
T Consensus 143 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 215 (323)
T 3tki_A 143 NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR-------REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC 215 (323)
T ss_dssp CEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHC-------SSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTS
T ss_pred CEEEEEeeccceeccCCcccccCCCccCcCccCcHHhcc-------CCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHH
Confidence 9999999999753322 22345679999999999864 1234678999999999999999999998755432
Q ss_pred HHHHHHhcc--CCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 024408 157 AAYAAAFKN--VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 202 (268)
Q Consensus 157 ~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l 202 (268)
......... ..+....++..+.++|.+||..||.+|||+.+++++.
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~ 263 (323)
T 3tki_A 216 QEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDR 263 (323)
T ss_dssp HHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCT
T ss_pred HHHHHHhcccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhCh
Confidence 322222222 2222456889999999999999999999999999983
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=273.21 Aligned_cols=188 Identities=28% Similarity=0.396 Sum_probs=161.7
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
++|++++++ .++.+++||||++||+|.+++.+... +++..+..++.|++.||+|||++||+||||||+||+++.+ +
T Consensus 67 ~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-g 143 (318)
T 1fot_A 67 FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQR--FPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKN-G 143 (318)
T ss_dssp TBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTSS--CCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTT-S
T ss_pred CCceEeEEEEeCCEEEEEEeCCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCC-C
Confidence 589999999 45689999999999999999987554 9999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 024408 80 TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY 159 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~ 159 (268)
.+||+|||+++.... ...+..||+.|+|||++.+ ..++.++|+||||+++|+|++|+.||.+....+...
T Consensus 144 ~~kL~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~ 213 (318)
T 1fot_A 144 HIKITDFGFAKYVPD--VTYTLCGTPDYIAPEVVST--------KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYE 213 (318)
T ss_dssp CEEECCCSSCEECSS--CBCCCCSCTTTCCHHHHTT--------CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH
T ss_pred CEEEeecCcceecCC--ccccccCCccccCHhHhcC--------CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 999999999986433 2345689999999999864 567889999999999999999999998866555444
Q ss_pred HHHhccCCCCCCCCcHHHHHHHHhccccCCCCCC-----CHHHHHHHH
Q 024408 160 AAAFKNVRPSAENVPEELSIILTSCWKEDPNARP-----NFTQIIQML 202 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~~~~~l 202 (268)
.... .....+..+++++.++|.+||..||.+|| +++++++|-
T Consensus 214 ~i~~-~~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp 260 (318)
T 1fot_A 214 KILN-AELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHP 260 (318)
T ss_dssp HHHH-CCCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSG
T ss_pred HHHh-CCCCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCc
Confidence 3333 33344667899999999999999999999 899999873
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=269.61 Aligned_cols=198 Identities=26% Similarity=0.482 Sum_probs=168.4
Q ss_pred CceeEEEeecCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCC
Q 024408 1 MREQFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT 80 (268)
Q Consensus 1 ~~v~l~g~~~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~ 80 (268)
++++++|++.++..++||||++|++|.+++..... +++..++.++.|++.||.|||++|++||||||+||+++.+ +.
T Consensus 79 ~i~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~-~~ 155 (291)
T 1xbb_A 79 YIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ-HY 155 (291)
T ss_dssp TBCCEEEEEESSSEEEEEECCTTEEHHHHHHHCTT--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET-TE
T ss_pred CEEEEEEEECCCCcEEEEEeCCCCCHHHHHHhCcC--CCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCC-Cc
Confidence 58899999988889999999999999999987554 9999999999999999999999999999999999999988 69
Q ss_pred eEEecCCCccccccccc----cccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChH
Q 024408 81 IKLADFGLAREESLTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNL 155 (268)
Q Consensus 81 ~kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~~~ 155 (268)
++|+|||++........ .....++..|+|||++.+ ..++.++||||||+++|+|++ |+.||.+....
T Consensus 156 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~ 227 (291)
T 1xbb_A 156 AKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY--------YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS 227 (291)
T ss_dssp EEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHH--------CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH
T ss_pred EEEccCCcceeeccCCCcccccccCCCCceeeChHHhcc--------CCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 99999999975433221 222346788999999864 446789999999999999999 99999987776
Q ss_pred HHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhc
Q 024408 156 QAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 209 (268)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~~ 209 (268)
+.............+..+++.+.++|.+||..||.+||++.++++.|+.++...
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 281 (291)
T 1xbb_A 228 EVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 281 (291)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 655555444445556789999999999999999999999999999999988653
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=293.66 Aligned_cols=203 Identities=23% Similarity=0.481 Sum_probs=170.9
Q ss_pred CceeEEEeecCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCC
Q 024408 1 MREQFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT 80 (268)
Q Consensus 1 ~~v~l~g~~~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~ 80 (268)
|+|+++|+|.++.+++||||++||+|.+++.... ..+++.+++.++.|++.||+|||++||+||||||+|||++.+ +.
T Consensus 397 niv~l~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~-~~ 474 (613)
T 2ozo_A 397 YIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNR-HY 474 (613)
T ss_dssp TBCCEEEEEESSSEEEEEECCTTCBHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET-TE
T ss_pred CEeeEEEEeccCCeEEEEEeCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCC-Cc
Confidence 6899999997788999999999999999997643 349999999999999999999999999999999999999988 69
Q ss_pred eEEecCCCccccccccc----cccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChH
Q 024408 81 IKLADFGLAREESLTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNL 155 (268)
Q Consensus 81 ~kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~~~ 155 (268)
+||+|||+++....... .....+++.|+|||++.+ ..++.++||||||+++|||++ |+.||.+....
T Consensus 475 vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~--------~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~ 546 (613)
T 2ozo_A 475 AKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF--------RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP 546 (613)
T ss_dssp EEECCCSTTTTCC--------------CCTTSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH
T ss_pred EEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcC--------CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH
Confidence 99999999986433221 122345688999999864 568899999999999999998 99999988877
Q ss_pred HHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhcCCCC
Q 024408 156 QAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPE 213 (268)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~~~~~~ 213 (268)
+...........+.+..+++++.++|.+||..||.+||++.++++.|+.++.......
T Consensus 547 ~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~~ 604 (613)
T 2ozo_A 547 EVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 604 (613)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCSC
T ss_pred HHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcccc
Confidence 7666655555556677899999999999999999999999999999999887654433
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=278.93 Aligned_cols=193 Identities=25% Similarity=0.396 Sum_probs=163.4
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
++|++++++ ..+..++||||++||+|.+++.+... +++..+..++.|++.||.|||++||+||||||+|||++.+ +
T Consensus 76 ~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~-g 152 (384)
T 4fr4_A 76 FLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVH--FKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEH-G 152 (384)
T ss_dssp TBCCEEEEEECSSEEEEEECCCTTEEHHHHHHTTCC--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-S
T ss_pred CCCcEEEEEEeCCEEEEEEecCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCC-C
Confidence 589999999 55689999999999999999987544 9999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--hHHH
Q 024408 80 TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS--NLQA 157 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~--~~~~ 157 (268)
.+||+|||+++............||+.|+|||++... ....++.++|+||||+++|+|++|+.||.... ....
T Consensus 153 ~vkL~DFG~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~-----~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~ 227 (384)
T 4fr4_A 153 HVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSR-----KGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKE 227 (384)
T ss_dssp CEEECCCTTCEECCTTCCBCCCCSCGGGCCGGGTCCC-----SSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHH
T ss_pred CEEEeccceeeeccCCCceeccCCCccccCCeeeccC-----CCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHH
Confidence 9999999999876555555677899999999998531 12457889999999999999999999997433 2233
Q ss_pred HHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCC-HHHHHHH
Q 024408 158 AYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPN-FTQIIQM 201 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-~~~~~~~ 201 (268)
............+..++..+.++|.+||..||.+||+ +.++++|
T Consensus 228 ~~~~~~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~h 272 (384)
T 4fr4_A 228 IVHTFETTVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNF 272 (384)
T ss_dssp HHHHHHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTS
T ss_pred HHHHHhhcccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcC
Confidence 3333444455567789999999999999999999998 7888776
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=278.23 Aligned_cols=200 Identities=29% Similarity=0.526 Sum_probs=165.6
Q ss_pred CceeEEEeecC--CcEEEEEEcCCCCCHHHHHHhcCC-------------------------------------------
Q 024408 1 MREQFIGACKE--PVMVIVTELLSGGTLRKYLLNMRP------------------------------------------- 35 (268)
Q Consensus 1 ~~v~l~g~~~~--~~~~lV~e~~~ggsL~~~i~~~~~------------------------------------------- 35 (268)
|+|+++|++.+ ...++||||++||+|.+++.....
T Consensus 87 niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (359)
T 3vhe_A 87 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSG 166 (359)
T ss_dssp TBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------
T ss_pred ceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccc
Confidence 68999999844 358999999999999999986532
Q ss_pred ---------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCCeEEecCCCcccccc
Q 024408 36 ---------------------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 94 (268)
Q Consensus 36 ---------------------~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~~kl~Dfg~a~~~~~ 94 (268)
..+++..++.++.|++.||.|||++||+||||||+||+++.+ +.++|+|||+++....
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~-~~~kl~Dfg~a~~~~~ 245 (359)
T 3vhe_A 167 FVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK-NVVKICDFGLARDIYK 245 (359)
T ss_dssp -----------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG-GCEEECCCGGGSCTTS
T ss_pred cccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCC-CcEEEEeccceeeecc
Confidence 128999999999999999999999999999999999999988 6999999999985432
Q ss_pred cc---ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH-hccCCCC
Q 024408 95 TE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAA-FKNVRPS 169 (268)
Q Consensus 95 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~-~~~~~~~ 169 (268)
.. ......||+.|+|||++.+ ..++.++||||||+++|+|++ |..||.+....+...... .......
T Consensus 246 ~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~ 317 (359)
T 3vhe_A 246 DPDYVRKGDARLPLKWMAPETIFD--------RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 317 (359)
T ss_dssp CTTCEEC--CEECGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCC
T ss_pred cccchhccccCCCceeEChhhhcC--------CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCC
Confidence 21 2334567889999999864 567899999999999999998 999998766444433333 3334455
Q ss_pred CCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhc
Q 024408 170 AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 209 (268)
Q Consensus 170 ~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~~ 209 (268)
+..+++++.+++.+||..||.+||++.+++++|+.++...
T Consensus 318 ~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 318 PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 6778999999999999999999999999999999887653
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=296.72 Aligned_cols=198 Identities=26% Similarity=0.485 Sum_probs=169.9
Q ss_pred CceeEEEeecCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCC
Q 024408 1 MREQFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT 80 (268)
Q Consensus 1 ~~v~l~g~~~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~ 80 (268)
|+|+++|+|.++..++||||++||+|.+++.+... +++.+++.++.||+.||+|||++||+||||||+|||++.+ +.
T Consensus 431 nIv~l~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~--l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~-~~ 507 (635)
T 4fl3_A 431 YIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ-HY 507 (635)
T ss_dssp TBCCEEEEEESSSEEEEEECCTTEEHHHHHHHCTT--CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET-TE
T ss_pred CEeeEEEEEecCCEEEEEEccCCCCHHHHHhhCCC--CCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCC-CC
Confidence 68999999988889999999999999999987544 9999999999999999999999999999999999999988 69
Q ss_pred eEEecCCCcccccccc----ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChH
Q 024408 81 IKLADFGLAREESLTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNL 155 (268)
Q Consensus 81 ~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~~~ 155 (268)
+||+|||+++...... ......+|..|+|||++.+ ..++.++||||||+++|||++ |+.||.+....
T Consensus 508 ~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~--------~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~ 579 (635)
T 4fl3_A 508 AKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY--------YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS 579 (635)
T ss_dssp EEECCTTHHHHTTC-------------CGGGSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH
T ss_pred EEEEEcCCccccccCccccccccCCCCceeeeChhhhcC--------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999998543322 1223356788999999864 568899999999999999998 99999998877
Q ss_pred HHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhc
Q 024408 156 QAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 209 (268)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~~ 209 (268)
+...........+.+..++.++.++|..||..||++||++.++++.|++++..+
T Consensus 580 ~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l 633 (635)
T 4fl3_A 580 EVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 633 (635)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 766666666666667889999999999999999999999999999999987654
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=276.49 Aligned_cols=202 Identities=33% Similarity=0.447 Sum_probs=161.5
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|++++++++ .++..++||||++|++|.+++..... .+++.+++.++.|++.||+|||++|++||||||+||+++.+ +
T Consensus 68 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~-~ 145 (310)
T 3s95_A 68 NVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDS-QYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVREN-K 145 (310)
T ss_dssp TBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHCCT-TSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTT-S
T ss_pred CcccEEEEEecCCeeEEEEEecCCCcHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCC-C
Confidence 689999999 56789999999999999999987443 39999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccccccc---------------ccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh
Q 024408 80 TIKLADFGLAREESLTEMM---------------TAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH 144 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~~---------------~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~ 144 (268)
.+||+|||+++........ ....||+.|+|||++.+ ..++.++||||||+++|+|++
T Consensus 146 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~~l~el~~ 217 (310)
T 3s95_A 146 NVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING--------RSYDEKVDVFSFGIVLCEIIG 217 (310)
T ss_dssp CEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTT--------CCCCTHHHHHHHHHHHHHHHH
T ss_pred CEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcC--------CCCCcHHHHHHHHHHHHHHhc
Confidence 9999999999754322211 14579999999999864 567889999999999999999
Q ss_pred CCCCCCCCChHHHH--HHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhcCCC
Q 024408 145 NKLPFEGMSNLQAA--YAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPP 212 (268)
Q Consensus 145 g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~~~~~ 212 (268)
|..|+......... ...........+..+++.+.+++.+||+.||.+||++.++++.|+.+.......
T Consensus 218 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~~ 287 (310)
T 3s95_A 218 RVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGH 287 (310)
T ss_dssp TCCSSTTTSCBCTTSSBCHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCcchhhhHHHHhhhhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccCc
Confidence 99988653221100 000000011235678889999999999999999999999999998877665433
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=270.09 Aligned_cols=191 Identities=28% Similarity=0.358 Sum_probs=161.5
Q ss_pred CceeEEEeecC-C-----cEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEE
Q 024408 1 MREQFIGACKE-P-----VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL 74 (268)
Q Consensus 1 ~~v~l~g~~~~-~-----~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill 74 (268)
|++++++++.. . ..++||||+. ++|.+++.......+++.+++.++.|++.||+|||++|++||||||+||++
T Consensus 75 niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~ 153 (308)
T 3g33_A 75 NVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV 153 (308)
T ss_dssp TBCCEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEE
T ss_pred CeEEeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE
Confidence 68899999843 2 4799999996 699999988766669999999999999999999999999999999999999
Q ss_pred eCCCCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh
Q 024408 75 TEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN 154 (268)
Q Consensus 75 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~ 154 (268)
+.+ +.+||+|||+++............||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+...
T Consensus 154 ~~~-~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 224 (308)
T 3g33_A 154 TSG-GTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQ--------STYATPVDMWSVGCIFAEMFRRKPLFCGNSE 224 (308)
T ss_dssp CTT-SCEEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHT--------SCCCSTHHHHHHHHHHHHTTTSSCSCCCSSH
T ss_pred cCC-CCEEEeeCccccccCCCcccCCccccccccCchHHcC--------CCCCchHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 988 6999999999987655555556689999999999864 5678899999999999999999999988776
Q ss_pred HHHHHHHHhccCCCC--------------------------CCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 155 LQAAYAAAFKNVRPS--------------------------AENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 155 ~~~~~~~~~~~~~~~--------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
.+...........+. ...+++++.++|.+||..||.+|||+.++++|
T Consensus 225 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 225 ADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp HHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 655444332211111 13577899999999999999999999999997
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=269.12 Aligned_cols=199 Identities=29% Similarity=0.526 Sum_probs=170.9
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ .++..++||||++|++|.+++.......+++..++.++.|++.||.|||++|++||||||+||+++.+ +
T Consensus 70 ~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~-~ 148 (288)
T 3kfa_A 70 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN-H 148 (288)
T ss_dssp TBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGG-G
T ss_pred CEeeEEEEEccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCC-C
Confidence 578999999 45689999999999999999988766679999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccccc--ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 024408 80 TIKLADFGLAREESLTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQ 156 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~~~~ 156 (268)
.++|+|||++....... ......+++.|+|||.+.+ ..++.++||||||+++|+|++ |..||......+
T Consensus 149 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~ 220 (288)
T 3kfa_A 149 LVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY--------NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 220 (288)
T ss_dssp CEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred CEEEccCccceeccCCccccccCCccccCcCChhhhcc--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 99999999998544332 2223346788999999864 567889999999999999999 999998877665
Q ss_pred HHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 024408 157 AAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 208 (268)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 208 (268)
.............+..+++.+.+++.+||..||.+||++.++++.|+.++..
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 221 VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHhccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 5555555555556778999999999999999999999999999999987765
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=276.17 Aligned_cols=198 Identities=23% Similarity=0.494 Sum_probs=165.0
Q ss_pred CceeEEEeecCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCC
Q 024408 1 MREQFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT 80 (268)
Q Consensus 1 ~~v~l~g~~~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~ 80 (268)
+++++++++..+..++||||+.+|+|.+++..... .+++..++.++.|++.||.|||++|++||||||+||+++.+ +.
T Consensus 78 ~iv~~~~~~~~~~~~~v~~~~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~-~~ 155 (327)
T 3lzb_A 78 HVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTP-QH 155 (327)
T ss_dssp TBCCCCEEEESSSEEEEECCCSSCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEET-TE
T ss_pred CeeEEEEEEecCCceEEEEecCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCC-CC
Confidence 58899999977778999999999999999987543 39999999999999999999999999999999999999988 69
Q ss_pred eEEecCCCccccccccc---cccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 024408 81 IKLADFGLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQ 156 (268)
Q Consensus 81 ~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~~~~ 156 (268)
+||+|||+++....... .....+|..|+|||.+.+ ..++.++||||||+++|+|++ |..||.+....+
T Consensus 156 ~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~ 227 (327)
T 3lzb_A 156 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH--------RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 227 (327)
T ss_dssp EEECCTTC----------------CCCGGGSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG
T ss_pred EEEccCcceeEccCccccccccCCCccccccCHHHHcC--------CCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH
Confidence 99999999985433221 223356788999999864 568899999999999999999 999999877666
Q ss_pred HHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 024408 157 AAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 208 (268)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 208 (268)
...........+.+..++.++.++|.+||..||.+||++.++++.|......
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 228 ISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp HHHHHHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred HHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 6555555555666778999999999999999999999999999999987653
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=272.46 Aligned_cols=193 Identities=27% Similarity=0.430 Sum_probs=154.5
Q ss_pred CceeEEEeecC-C----cEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEe
Q 024408 1 MREQFIGACKE-P----VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 75 (268)
Q Consensus 1 ~~v~l~g~~~~-~----~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~ 75 (268)
|+|++++++.. . ..++||||++|++|.+++...+. +++.+++.++.|++.||+|||++|++||||||+||+++
T Consensus 73 ~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~ 150 (311)
T 3ork_A 73 AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS 150 (311)
T ss_dssp TBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE
T ss_pred CcceEEEeeeccCCCCcccEEEEecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEc
Confidence 57899998843 2 35999999999999999987655 99999999999999999999999999999999999999
Q ss_pred CCCCCeEEecCCCcccccccc----ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 024408 76 EDLKTIKLADFGLAREESLTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 151 (268)
Q Consensus 76 ~~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~ 151 (268)
.+ +.+||+|||+++...... ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+
T Consensus 151 ~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~~l~~ll~g~~pf~~ 221 (311)
T 3ork_A 151 AT-NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG--------DSVDARSDVYSLGCVLYEVLTGEPPFTG 221 (311)
T ss_dssp TT-SCEEECCCSCC------------------CCTTCCHHHHHT--------CCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CC-CCEEEeeccCcccccccccccccccccCcCcccCCHHHhcC--------CCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 88 699999999997543321 2233468999999999864 5678899999999999999999999998
Q ss_pred CChHHHHHHHHhccCCCC---CCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 024408 152 MSNLQAAYAAAFKNVRPS---AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 204 (268)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~ 204 (268)
................+. ...++.++.++|.+||..||.+||+..+++.+-..
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 277 (311)
T 3ork_A 222 DSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 277 (311)
T ss_dssp SSHHHHHHHHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred CChHHHHHHHhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHH
Confidence 776665555444433332 45689999999999999999999988887776443
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=271.10 Aligned_cols=198 Identities=27% Similarity=0.486 Sum_probs=163.2
Q ss_pred CceeEEEeec-CCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGACK-EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~~-~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
++++++|++. .+..++||||++|++|.+++.+... .+++.+++.++.|++.||.|||++|++||||||+||+++.+ +
T Consensus 107 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~-~ 184 (333)
T 1mqb_A 107 NIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG-EFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSN-L 184 (333)
T ss_dssp TBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTT-CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-C
T ss_pred CCCcEEEEEecCCCcEEEEeCCCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCC-C
Confidence 5899999994 5689999999999999999986533 49999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccccc----ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCh
Q 024408 80 TIKLADFGLAREESLTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSN 154 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~~ 154 (268)
.+||+|||+++...... ......++..|+|||++.+ ..++.++||||||+++|+|++ |..||.....
T Consensus 185 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~ellt~g~~pf~~~~~ 256 (333)
T 1mqb_A 185 VCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY--------RKFTSASDVWSFGIVMWEVMTYGERPYWELSN 256 (333)
T ss_dssp CEEECCCCC-----------------CCCGGGSCHHHHHS--------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred cEEECCCCcchhhccccccccccCCCCccccccCchhccc--------CCCCchhhhHHHHHHHHHHHcCCCCCcccCCH
Confidence 99999999998543321 1122345788999999854 567889999999999999998 9999988776
Q ss_pred HHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 024408 155 LQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 208 (268)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 208 (268)
.+...........+.+..++..+.+++.+||..||.+||++.++++.|+.....
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 310 (333)
T 1mqb_A 257 HEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310 (333)
T ss_dssp HHHHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHHHHHHHCCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 665555554445556778999999999999999999999999999999988765
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=284.73 Aligned_cols=192 Identities=26% Similarity=0.354 Sum_probs=164.2
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|+|++++++ ..+.+++||||++||+|.+++.+.+. +++..++.++.|++.||+|||++||+||||||+||+++.+ +
T Consensus 77 nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~--l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~-~ 153 (476)
T 2y94_A 77 HIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGR--LDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAH-M 153 (476)
T ss_dssp TBCCEEEEEECSSEEEEEEECCSSEEHHHHTTSSSS--CCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTT-C
T ss_pred CCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecC-C
Confidence 689999999 45689999999999999999976544 9999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 024408 80 TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY 159 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~ 159 (268)
.+||+|||++..........+..||+.|+|||++.+ ....+.++||||||+++|+|++|+.||.+........
T Consensus 154 ~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~ 226 (476)
T 2y94_A 154 NAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISG-------RLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFK 226 (476)
T ss_dssp CEEECCCSSCEECCTTCCBCCCCSCSTTCCHHHHTT-------CCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHH
T ss_pred CeEEEeccchhhccccccccccCCCcCeEChhhccC-------CCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHH
Confidence 999999999987655555566789999999999864 1234679999999999999999999998765544433
Q ss_pred HHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 024408 160 AAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 203 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~ 203 (268)
. ........+..+++++.++|.+||..||.+|||+.++++|-+
T Consensus 227 ~-i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~ 269 (476)
T 2y94_A 227 K-ICDGIFYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEW 269 (476)
T ss_dssp H-HHTTCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHH
T ss_pred H-HhcCCcCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHH
Confidence 3 333344456678999999999999999999999999999844
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=289.76 Aligned_cols=198 Identities=29% Similarity=0.524 Sum_probs=169.1
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|+|+++|+| .++.+++||||++||+|.+++.......+++..++.++.|++.||+|||++||+||||||+|||++.+ +
T Consensus 277 niv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~-~ 355 (495)
T 1opk_A 277 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGEN-H 355 (495)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG-G
T ss_pred CEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCC-C
Confidence 689999999 45688999999999999999987666669999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccccc--ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 024408 80 TIKLADFGLAREESLTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQ 156 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~~~~ 156 (268)
.+||+|||+++...... ......++..|+|||++.+ ..++.++||||||+++|||++ |..||.+....+
T Consensus 356 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~ 427 (495)
T 1opk_A 356 LVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY--------NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 427 (495)
T ss_dssp CEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHH--------CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred cEEEeecccceeccCCceeecCCCcCCcceeCHhHHhc--------CCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH
Confidence 99999999998643322 1223346788999999864 457889999999999999999 999999877666
Q ss_pred HHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHh
Q 024408 157 AAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 207 (268)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 207 (268)
...........+.+..+++.+.++|.+||..||.+||++.++++.|+.++.
T Consensus 428 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 428 VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 555444444555677899999999999999999999999999999987653
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=279.34 Aligned_cols=193 Identities=22% Similarity=0.354 Sum_probs=162.8
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCC-C
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED-L 78 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~-~ 78 (268)
|+|++++++ .++..++||||++||+|.+++.... ..+++.+++.++.|++.||+|||++||+||||||+||+++.+ .
T Consensus 109 nIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~ 187 (387)
T 1kob_A 109 KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKA 187 (387)
T ss_dssp TBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTC
T ss_pred CCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCC
Confidence 689999999 5568999999999999999997643 249999999999999999999999999999999999999743 3
Q ss_pred CCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 79 KTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 79 ~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
+.+||+|||+++............||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+....+..
T Consensus 188 ~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~ 259 (387)
T 1kob_A 188 SSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDR--------EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL 259 (387)
T ss_dssp CCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTT--------CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH
T ss_pred CceEEEecccceecCCCcceeeeccCCCccCchhccC--------CCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHH
Confidence 5799999999987655544455679999999999864 56788999999999999999999999987665554
Q ss_pred HHHHhccCC---CCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 024408 159 YAAAFKNVR---PSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 202 (268)
Q Consensus 159 ~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l 202 (268)
......... .....+++++.++|.+||..||.+||++.+++++.
T Consensus 260 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp 306 (387)
T 1kob_A 260 QNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHP 306 (387)
T ss_dssp HHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTST
T ss_pred HHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCc
Confidence 444333222 22456899999999999999999999999999983
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=276.75 Aligned_cols=194 Identities=24% Similarity=0.378 Sum_probs=161.8
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
++|++++++ .++.+|+||||++||+|.+++.+. .+++..+..++.|++.||+|||++||+||||||+|||++.+ +
T Consensus 130 ~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~-g 205 (410)
T 3v8s_A 130 WVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKS-G 205 (410)
T ss_dssp TBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-S
T ss_pred CCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCC-C
Confidence 589999999 556899999999999999999753 39999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccccc--ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 024408 80 TIKLADFGLAREESLTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA 157 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~ 157 (268)
.+||+|||+++...... ...+..||+.|+|||++.+. .....++.++|+||||+++|+|++|+.||.+.+....
T Consensus 206 ~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~----~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~ 281 (410)
T 3v8s_A 206 HLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQ----GGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT 281 (410)
T ss_dssp CEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTT----TTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred CEEEeccceeEeeccCCcccccCCcCCccccCHHHhhcc----CCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhH
Confidence 99999999998644332 23466899999999998641 1112367899999999999999999999988666554
Q ss_pred HHHHHhc---cCCCCCCCCcHHHHHHHHhccccCCCC--CCCHHHHHHHH
Q 024408 158 AYAAAFK---NVRPSAENVPEELSIILTSCWKEDPNA--RPNFTQIIQML 202 (268)
Q Consensus 158 ~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~~p~~--Rps~~~~~~~l 202 (268)
....... ...+....++.+++++|.+||..+|.+ ||+++++++|.
T Consensus 282 ~~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp 331 (410)
T 3v8s_A 282 YSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 331 (410)
T ss_dssp HHHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSG
T ss_pred HHHHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCc
Confidence 4444332 233445679999999999999999988 99999999984
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=269.07 Aligned_cols=200 Identities=32% Similarity=0.569 Sum_probs=156.0
Q ss_pred CceeEEEeecCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCC
Q 024408 1 MREQFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT 80 (268)
Q Consensus 1 ~~v~l~g~~~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~ 80 (268)
|++++++++.++..++||||++|++|.+++..... .+++.+++.++.|++.||.|||++|++||||||+||+++.+ +.
T Consensus 81 ~iv~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~-~~ 158 (289)
T 3og7_A 81 NILLFMGYSTAPQLAIVTQWCEGSSLYHHLHASET-KFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHED-NT 158 (289)
T ss_dssp TBCCEEEEECSSSCEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETT-TE
T ss_pred cEEEEEeeccCCccEEEEEecCCCcHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCC-CC
Confidence 57899999988889999999999999999976443 49999999999999999999999999999999999999988 69
Q ss_pred eEEecCCCcccccc---ccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 024408 81 IKLADFGLAREESL---TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA 157 (268)
Q Consensus 81 ~kl~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~ 157 (268)
++|+|||++..... ........||+.|+|||++... ....++.++||||||+++|+|++|+.||......+.
T Consensus 159 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~ 233 (289)
T 3og7_A 159 VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ-----DSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 233 (289)
T ss_dssp EEECCCC------------------CCCTTCCHHHHC---------CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH
T ss_pred EEEccceeccccccccccccccccCCCccccCchhhccc-----CCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH
Confidence 99999999975332 2223345789999999988521 125578899999999999999999999987665554
Q ss_pred HHHHHhccC-CC----CCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHh
Q 024408 158 AYAAAFKNV-RP----SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 207 (268)
Q Consensus 158 ~~~~~~~~~-~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 207 (268)
......... .+ ....+++.+.++|.+||..||.+||++.++++.|+++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 234 IIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp HHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred HHHHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 444333222 22 234788999999999999999999999999999987653
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=269.80 Aligned_cols=200 Identities=33% Similarity=0.547 Sum_probs=167.1
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCe
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPR----------------CLDVCVAIGFALDIARAMECLHSHGII 63 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~----------------~~~~~~~~~~~~~l~~~l~~lH~~gi~ 63 (268)
++++++|++ .++..++||||++||+|.+++...... .+++.+++.++.|++.||.|||++|++
T Consensus 88 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~ 167 (313)
T 1t46_A 88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCI 167 (313)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred CeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 589999999 556889999999999999999875432 489999999999999999999999999
Q ss_pred ecCCCCCCEEEeCCCCCeEEecCCCccccccccc---cccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHH
Q 024408 64 HRDLKPENLLLTEDLKTIKLADFGLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLW 140 (268)
Q Consensus 64 H~Dikp~Nill~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~ 140 (268)
||||||+||+++.+ +.+||+|||++........ .....+++.|+|||++.+ ..++.++||||||+++|
T Consensus 168 H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~ 238 (313)
T 1t46_A 168 HRDLAARNILLTHG-RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN--------CVYTFESDVWSYGIFLW 238 (313)
T ss_dssp CSCCSGGGEEEETT-TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH--------CCCCHHHHHHHHHHHHH
T ss_pred cCCCccceEEEcCC-CCEEEccccccccccccccceeccCCCCcceeeChHHhcC--------CCCChHHHHHHHHHHHH
Confidence 99999999999988 6999999999985443321 233456789999998864 56789999999999999
Q ss_pred HHHh-CCCCCCCCChHHHHHHHHhcc-CCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhc
Q 024408 141 ELLH-NKLPFEGMSNLQAAYAAAFKN-VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 209 (268)
Q Consensus 141 ~ll~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~~ 209 (268)
+|++ |..||.+.............. ....+..++..+.+++.+||..||.+||++.+++++|+..+...
T Consensus 239 ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 309 (313)
T 1t46_A 239 ELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (313)
T ss_dssp HHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HHHhCCCCCCCcccchhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence 9998 999998766544444333332 33446778999999999999999999999999999999988753
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-39 Score=263.67 Aligned_cols=197 Identities=28% Similarity=0.550 Sum_probs=167.1
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ .++..++||||++|++|.+++..... .+++..++.++.|++.||.|||++|++||||||+||+++.+ +
T Consensus 64 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~-~ 141 (267)
T 3t9t_A 64 KLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRG-LFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGEN-Q 141 (267)
T ss_dssp TBCCEEEEECSSSSCEEEECCCTTCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGG-G
T ss_pred CEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhhCcc-cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCC-C
Confidence 578999999 45688999999999999999987543 48999999999999999999999999999999999999888 6
Q ss_pred CeEEecCCCcccccccc--ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 024408 80 TIKLADFGLAREESLTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQ 156 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~~~~ 156 (268)
.++|+|||++....... ......++..|+|||++.+ ..++.++|+||||+++|+|++ |..||......+
T Consensus 142 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~ 213 (267)
T 3t9t_A 142 VIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF--------SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE 213 (267)
T ss_dssp CEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred CEEEcccccccccccccccccccccccccccChhhhcC--------CCccchhchhhhHHHHHHHhccCCCCCCCCCHHH
Confidence 89999999998543322 2233456788999999864 567889999999999999999 899998877666
Q ss_pred HHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHh
Q 024408 157 AAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 207 (268)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 207 (268)
.............+..++..+.+++.+||..||.+||++.+++++|+.+..
T Consensus 214 ~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 214 VVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp HHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHhcCCcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 555554444445567789999999999999999999999999999988765
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=277.24 Aligned_cols=200 Identities=29% Similarity=0.511 Sum_probs=159.3
Q ss_pred CceeEEEeec--CCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCC
Q 024408 1 MREQFIGACK--EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL 78 (268)
Q Consensus 1 ~~v~l~g~~~--~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~ 78 (268)
|+|+++|+|. ++..++||||++||+|.+++.+... .+++.+++.++.|++.||+|||++|++||||||+||+++.+
T Consensus 151 nIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~- 228 (373)
T 3c1x_A 151 NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEK- 228 (373)
T ss_dssp TBCCCCEEECCCSSCCEEEEECCTTCBHHHHHHCTTC-CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-
T ss_pred CcceEEEEEEcCCCCeEEEEECCCCCCHHHHHhhccc-CCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCC-
Confidence 6899999873 3578999999999999999976443 48999999999999999999999999999999999999988
Q ss_pred CCeEEecCCCcccccccc-----ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 024408 79 KTIKLADFGLAREESLTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGM 152 (268)
Q Consensus 79 ~~~kl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~ 152 (268)
+.+||+|||+++...... ......++..|+|||++.+ ..++.++||||||+++|+|++ |.+||...
T Consensus 229 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwSlG~il~ellt~~~~p~~~~ 300 (373)
T 3c1x_A 229 FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT--------QKFTTKSDVWSFGVLLWELMTRGAPPYPDV 300 (373)
T ss_dssp CCEEECCC---------------------CCGGGSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCSCTTS
T ss_pred CCEEEeeccccccccccccccccccCCCCCcccccChHHhcC--------CCCCcHHHHHHHHHHHHHHHhCcCCCCCCC
Confidence 699999999997543221 1123356788999999864 567899999999999999999 77888776
Q ss_pred ChHHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhcC
Q 024408 153 SNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIA 210 (268)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~~~ 210 (268)
...+.............+..++..+.+++.+||..||.+||++.++++.|+.......
T Consensus 301 ~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 301 NTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp CSSCHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred CHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 5555444444444455567899999999999999999999999999999999887654
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=278.35 Aligned_cols=194 Identities=25% Similarity=0.334 Sum_probs=162.8
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeC-CC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE-DL 78 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~-~~ 78 (268)
|+|++++++ ..+..++||||++|++|.+++.+... .+++..++.++.|++.||+|||++||+||||||+|||+.. +.
T Consensus 147 nIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~ 225 (373)
T 2x4f_A 147 NLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESY-NLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDA 225 (373)
T ss_dssp TBCCEEEEEECSSEEEEEEECCTTCEEHHHHHHTGG-GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTT
T ss_pred CCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCC
Confidence 689999999 45689999999999999999876432 3999999999999999999999999999999999999942 22
Q ss_pred CCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 79 KTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 79 ~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
+.+||+|||+++............||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+....+..
T Consensus 226 ~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~ 297 (373)
T 2x4f_A 226 KQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNY--------DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETL 297 (373)
T ss_dssp TEEEECCCSSCEECCTTCBCCCCCSSCTTCCHHHHTT--------CBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH
T ss_pred CcEEEEeCCCceecCCccccccccCCCcEeChhhccC--------CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 5899999999987655555556679999999998854 56788999999999999999999999987765555
Q ss_pred HHHHhccCCC---CCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 024408 159 YAAAFKNVRP---SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 203 (268)
Q Consensus 159 ~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~ 203 (268)
.......... ....+++++.++|.+||..||.+||++.++++|-+
T Consensus 298 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~ 345 (373)
T 2x4f_A 298 NNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPW 345 (373)
T ss_dssp HHHHHTCCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred HHHHhccCCCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcC
Confidence 4444333322 23568999999999999999999999999999744
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=277.66 Aligned_cols=198 Identities=24% Similarity=0.317 Sum_probs=159.3
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
++|++++++ .++++|+||||++||+|.+++.+.+. .+++..++.++.|++.||+|||++||+||||||+|||++.+ +
T Consensus 122 ~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~~-~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~-g 199 (412)
T 2vd5_A 122 WITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGE-RIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRC-G 199 (412)
T ss_dssp TBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-S
T ss_pred CeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCC-C
Confidence 578999999 55689999999999999999987543 39999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccccc--cccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 024408 80 TIKLADFGLAREESLTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA 157 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~ 157 (268)
.+||+|||+++....... .....||+.|+|||++...... .....++.++|+||||+++|||++|+.||.+....+.
T Consensus 200 ~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~-~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~ 278 (412)
T 2vd5_A 200 HIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGG-PGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAET 278 (412)
T ss_dssp CEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTC-TTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred CEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccC-cCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHH
Confidence 999999999986543322 2345899999999998631100 0124578899999999999999999999988766554
Q ss_pred HHHHHhc---cCCC-CCCCCcHHHHHHHHhccccCCCCC---CCHHHHHHHH
Q 024408 158 AYAAAFK---NVRP-SAENVPEELSIILTSCWKEDPNAR---PNFTQIIQML 202 (268)
Q Consensus 158 ~~~~~~~---~~~~-~~~~~~~~l~~li~~~l~~~p~~R---ps~~~~~~~l 202 (268)
....... ...+ ....++++++++|.+||. +|.+| |+++++++|-
T Consensus 279 ~~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hp 329 (412)
T 2vd5_A 279 YGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHP 329 (412)
T ss_dssp HHHHHTHHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSG
T ss_pred HHHHHhcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCC
Confidence 4443321 1112 245789999999999999 99998 5999999983
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=279.14 Aligned_cols=192 Identities=27% Similarity=0.372 Sum_probs=159.6
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|+|++++++ ..+..++||||+ +|+|.+++.+.+. +++.+++.++.|++.||.|||++|++||||||+||+++.+ +
T Consensus 70 nIv~l~~~~~~~~~~~lv~E~~-~g~l~~~l~~~~~--l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~-~ 145 (336)
T 3h4j_B 70 HIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKR--MTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDN-L 145 (336)
T ss_dssp TBCCEEEEEECSSEEEEEECCC-CEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTT-C
T ss_pred CCCeEEEEEEeCCEEEEEEECC-CCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCC-C
Confidence 689999999 456889999999 7899999987655 9999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 024408 80 TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY 159 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~ 159 (268)
.+||+|||++.............||+.|+|||++.+ ....+.++||||||+++|+|++|+.||.+...... .
T Consensus 146 ~~kl~DFG~s~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~-~ 217 (336)
T 3h4j_B 146 NVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVING-------KLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL-F 217 (336)
T ss_dssp CEEECCSSCTBTTTTSBTTCCCTTSTTTSCGGGSCC-------SGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC-B
T ss_pred CEEEEEeccceeccCCcccccccCCcCcCCHHHHcC-------CCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH-H
Confidence 999999999987666555567789999999999864 12236799999999999999999999976432211 1
Q ss_pred HHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 024408 160 AAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 204 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~ 204 (268)
..........+..+++++.++|.+||..||.+|||+.+++++.+.
T Consensus 218 ~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~ 262 (336)
T 3h4j_B 218 KKVNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWF 262 (336)
T ss_dssp CCCCSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHH
T ss_pred HHHHcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhh
Confidence 111111223356688999999999999999999999999998543
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=274.73 Aligned_cols=191 Identities=27% Similarity=0.335 Sum_probs=150.2
Q ss_pred CceeEEEeec-CCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeC--C
Q 024408 1 MREQFIGACK-EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE--D 77 (268)
Q Consensus 1 ~~v~l~g~~~-~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~--~ 77 (268)
|+|++++++. .+..++||||++|++|.+++.+.+. +++.+++.++.|++.||.|||++|++||||||+||+++. .
T Consensus 109 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~ 186 (349)
T 2w4o_A 109 NIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGY--YSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAP 186 (349)
T ss_dssp TBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTCSS--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSST
T ss_pred CCcceeeeEecCCeEEEEEEeCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCC
Confidence 6899999994 4688999999999999999976544 999999999999999999999999999999999999974 2
Q ss_pred CCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 024408 78 LKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA 157 (268)
Q Consensus 78 ~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~ 157 (268)
.+.+||+|||+++............||+.|+|||++.+ ..++.++||||||+++|+|++|..||......+.
T Consensus 187 ~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~ 258 (349)
T 2w4o_A 187 DAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRG--------CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF 258 (349)
T ss_dssp TCCEEECCCC----------------CGGGSCHHHHTT--------CCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH
T ss_pred CCCEEEccCccccccCcccccccccCCCCccCHHHhcC--------CCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH
Confidence 26899999999986554444456679999999999864 5678899999999999999999999987665543
Q ss_pred HHHHHhccCC----CCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 158 AYAAAFKNVR----PSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 158 ~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
.......... +....++.++.++|.+||..||++||++.+++++
T Consensus 259 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 259 MFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp HHHHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 3333332221 2235788999999999999999999999999997
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=265.56 Aligned_cols=191 Identities=24% Similarity=0.343 Sum_probs=162.9
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEE---eC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL---TE 76 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill---~~ 76 (268)
+++++++++ .++..++||||++|++|.+++..... +++.+++.++.|++.||.|||++|++||||||+||++ +.
T Consensus 67 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~ 144 (277)
T 3f3z_A 67 NIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRV--FRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSP 144 (277)
T ss_dssp TBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSST
T ss_pred CEeeEEEEEecCCeEEEEEeccCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCC
Confidence 588999999 45678999999999999999987655 9999999999999999999999999999999999999 55
Q ss_pred CCCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH
Q 024408 77 DLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 156 (268)
Q Consensus 77 ~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~ 156 (268)
+ +.++|+|||++.............||+.|+|||++. +.++.++||||||+++|+|++|+.||......+
T Consensus 145 ~-~~~~l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~---------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~ 214 (277)
T 3f3z_A 145 D-SPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLE---------GLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSE 214 (277)
T ss_dssp T-CCEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHT---------TCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred C-CcEEEEecccceeccCccchhccCCCCCccChHHhc---------ccCCchhhehhHHHHHHHHHHCCCCCCCCCHHH
Confidence 5 689999999998765555556678999999999875 347889999999999999999999999877665
Q ss_pred HHHHHHhccCCCC---CCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 024408 157 AAYAAAFKNVRPS---AENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 203 (268)
Q Consensus 157 ~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~ 203 (268)
............. ...+++.+.++|.+||..||.+||++.+++++-+
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~ 264 (277)
T 3f3z_A 215 VMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEW 264 (277)
T ss_dssp HHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHH
T ss_pred HHHHHHhCCCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHH
Confidence 5554444333322 1368899999999999999999999999999743
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-39 Score=271.08 Aligned_cols=190 Identities=27% Similarity=0.361 Sum_probs=158.0
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
++|++++++ .++..++||||++|++|.+++.+.+. +++..+..++.|++.||.|||++||+||||||+||+++.+ +
T Consensus 82 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~-~ 158 (327)
T 3a62_A 82 FIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGI--FMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQ-G 158 (327)
T ss_dssp TBCCEEEEEECSSCEEEEEECCTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTT-S
T ss_pred CccceeEEEEcCCEEEEEEeCCCCCcHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCC-C
Confidence 589999999 55689999999999999999987655 9999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccc-ccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESL-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.+||+|||+++.... ........||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+....+..
T Consensus 159 ~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~ 230 (327)
T 3a62_A 159 HVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMR--------SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTI 230 (327)
T ss_dssp CEEECCCSCC----------CTTSSCCTTSCHHHHTT--------SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred cEEEEeCCcccccccCCccccccCCCcCccCHhhCcC--------CCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 999999999975332 223345679999999999864 56788999999999999999999999886655444
Q ss_pred HHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCC-----CHHHHHHHH
Q 024408 159 YAAAFKNVRPSAENVPEELSIILTSCWKEDPNARP-----NFTQIIQML 202 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~~~~~l 202 (268)
... .......+..+++++.++|.+||..||.+|| ++.++++|-
T Consensus 231 ~~i-~~~~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp 278 (327)
T 3a62_A 231 DKI-LKCKLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHP 278 (327)
T ss_dssp HHH-HHTCCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSG
T ss_pred HHH-HhCCCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCC
Confidence 333 3333344667899999999999999999999 788999873
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=271.27 Aligned_cols=201 Identities=31% Similarity=0.566 Sum_probs=169.1
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRP--------------RCLDVCVAIGFALDIARAMECLHSHGIIHR 65 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~--------------~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~ 65 (268)
++++++|++ .++..++||||++||+|.+++..... ..+++.+++.++.|++.||.|||++|++||
T Consensus 102 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~ 181 (334)
T 2pvf_A 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHR 181 (334)
T ss_dssp TBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred CEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCC
Confidence 589999999 45688999999999999999987542 248999999999999999999999999999
Q ss_pred CCCCCCEEEeCCCCCeEEecCCCcccccccc---ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHH
Q 024408 66 DLKPENLLLTEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWEL 142 (268)
Q Consensus 66 Dikp~Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~l 142 (268)
||||+||+++.+ +.+||+|||+++...... ......+++.|+|||++.+ ..++.++||||||+++|+|
T Consensus 182 Dlkp~NIll~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~el 252 (334)
T 2pvf_A 182 DLAARNVLVTEN-NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD--------RVYTHQSDVWSFGVLMWEI 252 (334)
T ss_dssp CCSGGGEEECTT-CCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHH--------CEECHHHHHHHHHHHHHHH
T ss_pred CCccceEEEcCC-CCEEEccccccccccccccccccCCCCcccceeChHHhcC--------CCcChHHHHHHHHHHHHHH
Confidence 999999999988 699999999998543322 2233456789999998864 4578899999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhcC
Q 024408 143 LH-NKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIA 210 (268)
Q Consensus 143 l~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~~~ 210 (268)
++ |..||.+....+.............+..++.++.++|.+||..||.+||++.+++++|+.++....
T Consensus 253 lt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~ 321 (334)
T 2pvf_A 253 FTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 321 (334)
T ss_dssp HTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HhCCCCCcCcCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence 99 999998876655554444444455567889999999999999999999999999999999887543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=278.93 Aligned_cols=197 Identities=20% Similarity=0.309 Sum_probs=161.2
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
++|++++++ .++.+++||||++||+|.+++.+... .+++..+..++.|++.||.|||++||+||||||+|||++.+ +
T Consensus 135 ~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~~-~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~-g 212 (437)
T 4aw2_A 135 WITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFED-RLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMN-G 212 (437)
T ss_dssp TBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTTTT-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-S
T ss_pred CEEEEEEEEeeCCEEEEEEecCCCCcHHHHHHHccC-CCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCC-C
Confidence 589999999 55689999999999999999987433 39999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccccc--ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 024408 80 TIKLADFGLAREESLTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA 157 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~ 157 (268)
.+||+|||+++...... ......||+.|+|||++.... .....++.++||||||+++|||++|+.||.+....+.
T Consensus 213 ~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~---~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~ 289 (437)
T 4aw2_A 213 HIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAME---GGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET 289 (437)
T ss_dssp CEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHH---TSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred CEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcc---cCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHH
Confidence 99999999997543332 223457999999999985211 0124578899999999999999999999998766555
Q ss_pred HHHHHhc----cCCCCCCCCcHHHHHHHHhccccCCCC--CCCHHHHHHHH
Q 024408 158 AYAAAFK----NVRPSAENVPEELSIILTSCWKEDPNA--RPNFTQIIQML 202 (268)
Q Consensus 158 ~~~~~~~----~~~~~~~~~~~~l~~li~~~l~~~p~~--Rps~~~~~~~l 202 (268)
....... ........+++++.++|++||..+|++ |++++++++|-
T Consensus 290 ~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hp 340 (437)
T 4aw2_A 290 YGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHP 340 (437)
T ss_dssp HHHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSG
T ss_pred HHhhhhccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCC
Confidence 4444322 122223568999999999999888888 99999999984
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=275.35 Aligned_cols=193 Identities=24% Similarity=0.346 Sum_probs=146.5
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCC-
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL- 78 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~- 78 (268)
|+|++++++ ..+..++||||++||+|.+++...+. +++..++.++.|++.||+|||++||+||||||+||+++.+.
T Consensus 77 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~ 154 (361)
T 3uc3_A 77 NIVRFKEVILTPTHLAIIMEYASGGELYERICNAGR--FSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPA 154 (361)
T ss_dssp TBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSS
T ss_pred CCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCC
Confidence 689999999 55689999999999999999987665 99999999999999999999999999999999999998652
Q ss_pred CCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChHH-
Q 024408 79 KTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY-NHKVDSYSFAIVLWELLHNKLPFEGMSNLQ- 156 (268)
Q Consensus 79 ~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~~~~DvwslG~~l~~ll~g~~p~~~~~~~~- 156 (268)
+.+||+|||+++............||+.|+|||++.+ ..+ +.++||||||+++|+|++|+.||.+.....
T Consensus 155 ~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 226 (361)
T 3uc3_A 155 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR--------QEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD 226 (361)
T ss_dssp CCEEECCCCCC---------------CTTSCHHHHHC--------SSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC
T ss_pred ceEEEeecCccccccccCCCCCCcCCCCcCChhhhcC--------CCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH
Confidence 2499999999985444444456689999999999864 333 445899999999999999999997644321
Q ss_pred --HHHHHHh--ccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 024408 157 --AAYAAAF--KNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 203 (268)
Q Consensus 157 --~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~ 203 (268)
....... ....+....+++++.++|.+||..||.+|||+.++++|-+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~ 277 (361)
T 3uc3_A 227 YRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSW 277 (361)
T ss_dssp HHHHHHHHHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHH
T ss_pred HHHHHHHHhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcc
Confidence 1111111 1222334468999999999999999999999999999854
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=291.96 Aligned_cols=201 Identities=29% Similarity=0.485 Sum_probs=172.4
Q ss_pred CceeEEEeecCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCC
Q 024408 1 MREQFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT 80 (268)
Q Consensus 1 ~~v~l~g~~~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~ 80 (268)
|+|+++|++.++..++||||++||+|.+++.......+++.+++.++.|++.||+|||++||+||||||+|||++.+ +.
T Consensus 323 niv~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~-~~ 401 (535)
T 2h8h_A 323 KLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN-LV 401 (535)
T ss_dssp TBCCEEEEECSSSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG-GC
T ss_pred CEeeEEEEEeeccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCC-Cc
Confidence 68999999977889999999999999999976544459999999999999999999999999999999999999988 69
Q ss_pred eEEecCCCcccccccc--ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 024408 81 IKLADFGLAREESLTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQA 157 (268)
Q Consensus 81 ~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~ 157 (268)
+||+|||+++...... ......++..|+|||++.+ ..++.++||||||+++|||++ |+.||.+....+.
T Consensus 402 ~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~ 473 (535)
T 2h8h_A 402 CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY--------GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV 473 (535)
T ss_dssp EEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHH--------CCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHH
T ss_pred EEEcccccceecCCCceecccCCcCcccccCHHHhcc--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 9999999998654322 1223356788999998864 568899999999999999999 9999998877666
Q ss_pred HHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhcC
Q 024408 158 AYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIA 210 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~~~ 210 (268)
..........+.+..++..+.++|.+||..||++||++.++++.|+.++....
T Consensus 474 ~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~ 526 (535)
T 2h8h_A 474 LDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 526 (535)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCS
T ss_pred HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccC
Confidence 66555555556678899999999999999999999999999999998765543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=265.10 Aligned_cols=191 Identities=27% Similarity=0.371 Sum_probs=162.0
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|+++++|++ .++..++||||++|++|.+++..... +++.+++.++.|++.||+|||++|++||||||+||+++.+ +
T Consensus 76 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~-~ 152 (294)
T 2rku_A 76 HVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKA--LTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNED-L 152 (294)
T ss_dssp TBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-C
T ss_pred CEeeeeeeeccCCEEEEEEecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCC-C
Confidence 689999999 45678999999999999999987655 9999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccc-ccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESL-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.++|+|||++..... ........|++.|+|||++.+ ..++.++|+||||+++|+|++|+.||......+..
T Consensus 153 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~ 224 (294)
T 2rku_A 153 EVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSK--------KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY 224 (294)
T ss_dssp CEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHTT--------SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH
T ss_pred CEEEEeccCceecccCccccccccCCCCcCCcchhcc--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 999999999985432 223344578999999999854 45788999999999999999999999886654443
Q ss_pred HHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 024408 159 YAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 203 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~ 203 (268)
.. ........+..++..+.+++.+||..||.+||++.+++++.+
T Consensus 225 ~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~ 268 (294)
T 2rku_A 225 LR-IKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEF 268 (294)
T ss_dssp HH-HHTTCCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHH
T ss_pred HH-HhhccCCCccccCHHHHHHHHHHcccChhhCcCHHHHhhChh
Confidence 33 333334456678999999999999999999999999999843
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=266.64 Aligned_cols=200 Identities=29% Similarity=0.518 Sum_probs=166.2
Q ss_pred CceeEEEee--cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCC
Q 024408 1 MREQFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL 78 (268)
Q Consensus 1 ~~v~l~g~~--~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~ 78 (268)
|+++++++| .++..++||||++||+|.+++.+.. ..+++.+++.++.|++.||+|||++|++||||||+||+++.+
T Consensus 87 ~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~- 164 (298)
T 3f66_A 87 NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEK- 164 (298)
T ss_dssp TBCCCCEEECCSSSCCEEEEECCTTCBHHHHHHCTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT-
T ss_pred CEeeeeeEEEcCCCceEEEEeCCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCC-
Confidence 578999987 3457899999999999999997643 348999999999999999999999999999999999999988
Q ss_pred CCeEEecCCCcccccccc-----ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 024408 79 KTIKLADFGLAREESLTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGM 152 (268)
Q Consensus 79 ~~~kl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~ 152 (268)
+.+||+|||+++...... ......+|+.|+|||.+.+ ..++.++||||||+++|+|++ |.+||...
T Consensus 165 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~~~~~~~~~~ 236 (298)
T 3f66_A 165 FTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT--------QKFTTKSDVWSFGVLLWELMTRGAPPYPDV 236 (298)
T ss_dssp CCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCSSTTS
T ss_pred CCEEECcccccccccccchhccccccCCCCCccccChHHhcC--------CCCChHHHHHHHHHHHHHHHhCCCCCCccC
Confidence 699999999998543322 1223456789999999864 567889999999999999999 66777766
Q ss_pred ChHHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhcC
Q 024408 153 SNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIA 210 (268)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~~~ 210 (268)
...+.............+..++..+.+++.+||..||.+||++.++++.|+..+....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 294 (298)
T 3f66_A 237 NTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 294 (298)
T ss_dssp CTTTHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred CHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 6555555555555555677889999999999999999999999999999999887543
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=273.63 Aligned_cols=199 Identities=30% Similarity=0.494 Sum_probs=163.9
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCC---------------------CCCCHHHHHHHHHHHHHHHHHHH
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRP---------------------RCLDVCVAIGFALDIARAMECLH 58 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~---------------------~~~~~~~~~~~~~~l~~~l~~lH 58 (268)
++++++|++ .++..++||||++||+|.+++..... ..+++..++.++.|++.||+|||
T Consensus 110 ~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 189 (344)
T 1rjb_A 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE 189 (344)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH
T ss_pred CeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH
Confidence 589999999 55689999999999999999987543 23799999999999999999999
Q ss_pred HCCCeecCCCCCCEEEeCCCCCeEEecCCCcccccccc---ccccCCCccceeccccccccccccCCCCCCCchhhHHHH
Q 024408 59 SHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSF 135 (268)
Q Consensus 59 ~~gi~H~Dikp~Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvwsl 135 (268)
++|++||||||+||+++.+ +.++|+|||++....... ......||+.|+|||++.+ ..++.++|||||
T Consensus 190 ~~~ivH~Dikp~NIll~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~Di~sl 260 (344)
T 1rjb_A 190 FKSCVHRDLAARNVLVTHG-KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE--------GIYTIKSDVWSY 260 (344)
T ss_dssp HTTEEETTCSGGGEEEETT-TEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH--------CCCCHHHHHHHH
T ss_pred hCCcccCCCChhhEEEcCC-CcEEeCCCccCcccccCccceeccCccCccCccCHHHhcc--------CCCChhHhHHHH
Confidence 9999999999999999988 699999999997543322 1233456788999998864 567899999999
Q ss_pred HHHHHHHHh-CCCCCCCCChHHHHHHHHhcc-CCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 024408 136 AIVLWELLH-NKLPFEGMSNLQAAYAAAFKN-VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 208 (268)
Q Consensus 136 G~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 208 (268)
|+++|+|++ |..||.+.............. ..+.+..+++++.++|.+||..||.+||++.+++++|+.....
T Consensus 261 G~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 261 GILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp HHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred HHHHHHHHcCCCCCcccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 999999998 999998766544444333333 3344667899999999999999999999999999999987654
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=268.33 Aligned_cols=199 Identities=24% Similarity=0.460 Sum_probs=159.0
Q ss_pred CceeEEEeecC---CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCC
Q 024408 1 MREQFIGACKE---PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED 77 (268)
Q Consensus 1 ~~v~l~g~~~~---~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~ 77 (268)
|+++++|++.. ...++||||++||+|.+++..... .+++.+++.++.|++.||.|||++|++||||||+||+++.+
T Consensus 72 ~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~ 150 (295)
T 3ugc_A 72 NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENE 150 (295)
T ss_dssp TBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHHCGG-GCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET
T ss_pred CEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHhccc-ccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCC
Confidence 58899999833 468999999999999999987543 39999999999999999999999999999999999999988
Q ss_pred CCCeEEecCCCcccccccc----ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 024408 78 LKTIKLADFGLAREESLTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS 153 (268)
Q Consensus 78 ~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~ 153 (268)
+.+||+|||+++...... ......++..|+|||.+.+ ..++.++||||||+++|+|++|..|+....
T Consensus 151 -~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~~l~~g~~~~~~~~ 221 (295)
T 3ugc_A 151 -NRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTE--------SKFSVASDVWSFGVVLYELFTYIEKSKSPP 221 (295)
T ss_dssp -TEEEECCCCSCC-------------CTTCGGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHHTTCTTCSHH
T ss_pred -CeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcC--------CCCChHHHHHHHHHHHHHHHhcccccCCCh
Confidence 699999999998543322 2233457788999999864 567899999999999999999999886432
Q ss_pred hH----------------HHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhc
Q 024408 154 NL----------------QAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 209 (268)
Q Consensus 154 ~~----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~~ 209 (268)
.. ............+.+..+++++.+++.+||..||.+|||+.++++.|+.+....
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 222 AEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp HHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHHHhhhcCccccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 11 111112223344556789999999999999999999999999999999877653
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=268.53 Aligned_cols=197 Identities=27% Similarity=0.366 Sum_probs=158.1
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|+|++++++ .++..++||||++ ++|.+++..... .+++.++..++.|++.||.|||++||+||||||+||+++.+ +
T Consensus 80 ~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~-~ 156 (311)
T 3niz_A 80 NIVSLIDVIHSERCLTLVFEFME-KDLKKVLDENKT-GLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSD-G 156 (311)
T ss_dssp TBCCEEEEECCSSCEEEEEECCS-EEHHHHHHTCTT-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-C
T ss_pred CEeeeeeEEccCCEEEEEEcCCC-CCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCC-C
Confidence 689999999 4568999999997 589998876543 49999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccc-cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.+||+|||+++..... .......||+.|+|||++.+ ...++.++||||||+++|+|++|+.||.+....+..
T Consensus 157 ~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 229 (311)
T 3niz_A 157 ALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMG-------SKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQL 229 (311)
T ss_dssp CEEECCCTTCEETTSCCC---CCCCCCTTCCHHHHTT-------CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHH
T ss_pred CEEEccCcCceecCCCcccccCCcccCCcCCHHHhcC-------CCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 9999999999864432 23344578999999998853 245788999999999999999999999876654443
Q ss_pred HHHHhccCCCC-----------------------------CCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhc
Q 024408 159 YAAAFKNVRPS-----------------------------AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 209 (268)
Q Consensus 159 ~~~~~~~~~~~-----------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~~ 209 (268)
.........+. ...+++++.++|.+||..||.+|||++++++| .+++..
T Consensus 230 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h--p~f~~~ 307 (311)
T 3niz_A 230 PKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH--PYFKDL 307 (311)
T ss_dssp HHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS--GGGTTS
T ss_pred HHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC--cccccC
Confidence 33322111111 13467899999999999999999999999998 455443
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=270.74 Aligned_cols=190 Identities=27% Similarity=0.370 Sum_probs=161.5
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|++++++++ .++..++||||++|++|.+++..... +++.+++.++.|++.||.|||++|++||||||+||+++.+ +
T Consensus 102 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~-~ 178 (335)
T 2owb_A 102 HVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKA--LTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNED-L 178 (335)
T ss_dssp TBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT-C
T ss_pred CCCeEEEEEecCCeEEEEEecCCCCCHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCC-C
Confidence 689999999 45688999999999999999987654 9999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccc-ccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESL-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.++|+|||++..... ........|+..|+|||++.+ ..++.++||||||+++|+|++|+.||......+..
T Consensus 179 ~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 250 (335)
T 2owb_A 179 EVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSK--------KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY 250 (335)
T ss_dssp CEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHHT--------SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH
T ss_pred CEEEeeccCceecccCcccccccCCCccccCHHHhcc--------CCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHH
Confidence 999999999985432 223345578999999999864 45788999999999999999999999876654443
Q ss_pred HHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 024408 159 YAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 202 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l 202 (268)
... .......+..++..+.++|.+||..||.+||++.+++++-
T Consensus 251 ~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~ 293 (335)
T 2owb_A 251 LRI-KKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDE 293 (335)
T ss_dssp HHH-HHTCCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred HHH-hcCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence 333 2333344667899999999999999999999999999983
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=270.26 Aligned_cols=198 Identities=29% Similarity=0.538 Sum_probs=167.4
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCC--------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRP--------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPEN 71 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~--------~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~N 71 (268)
+++++++++ .++..++||||++||+|.+++..... ..+++..++.++.|++.||.|||++|++||||||+|
T Consensus 89 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~N 168 (322)
T 1p4o_A 89 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARN 168 (322)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGG
T ss_pred CEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccce
Confidence 589999999 45678999999999999999976321 347999999999999999999999999999999999
Q ss_pred EEEeCCCCCeEEecCCCcccccccc---ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCC
Q 024408 72 LLLTEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKL 147 (268)
Q Consensus 72 ill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~ 147 (268)
|+++.+ +.+||+|||+++...... ......+++.|+|||++.+ ..++.++||||||+++|+|++ |..
T Consensus 169 Ili~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~~~g~~ 239 (322)
T 1p4o_A 169 CMVAED-FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD--------GVFTTYSDVWSFGVVLWEIATLAEQ 239 (322)
T ss_dssp EEECTT-CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHHTSCC
T ss_pred EEEcCC-CeEEECcCccccccccccccccccCCCCCCCccChhhhcc--------CCCCchhhHHHHHHHHHHHHhcCCC
Confidence 999988 699999999997543322 2233456889999999864 567889999999999999999 899
Q ss_pred CCCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHh
Q 024408 148 PFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 207 (268)
Q Consensus 148 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 207 (268)
||.+....+.............+..++..+.++|.+||..||.+||++.+++++|+....
T Consensus 240 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 240 PYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp TTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred ccccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 998877666555555555556677899999999999999999999999999999987543
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=270.53 Aligned_cols=200 Identities=29% Similarity=0.488 Sum_probs=161.3
Q ss_pred CceeEEEeecC-CcE------EEEEEcCCCCCHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCC
Q 024408 1 MREQFIGACKE-PVM------VIVTELLSGGTLRKYLLNMRP----RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKP 69 (268)
Q Consensus 1 ~~v~l~g~~~~-~~~------~lV~e~~~ggsL~~~i~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp 69 (268)
+++++++++.. ... ++||||++||+|.+++..... ..+++.+++.++.|++.||.|||++|++||||||
T Consensus 86 ~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp 165 (323)
T 3qup_A 86 HVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAA 165 (323)
T ss_dssp TBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred ceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCc
Confidence 57899999843 333 999999999999999975431 2499999999999999999999999999999999
Q ss_pred CCEEEeCCCCCeEEecCCCccccccccc---cccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-C
Q 024408 70 ENLLLTEDLKTIKLADFGLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-N 145 (268)
Q Consensus 70 ~Nill~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g 145 (268)
+||+++.+ +.+||+|||+++....... .....+++.|+|||.+.+ ..++.++||||||+++|+|++ |
T Consensus 166 ~NIli~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~ell~~g 236 (323)
T 3qup_A 166 RNCMLAED-MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLAD--------NLYTVHSDVWAFGVTMWEIMTRG 236 (323)
T ss_dssp GGEEECTT-SCEEECCCCC-----------------CCGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTS
T ss_pred ceEEEcCC-CCEEEeeccccccccccccccccccccCcccccCchhhcC--------CCCCCccchhhHHHHHHHHHhCC
Confidence 99999988 6999999999975433221 223356788999999864 567899999999999999999 9
Q ss_pred CCCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhc
Q 024408 146 KLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 209 (268)
Q Consensus 146 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~~ 209 (268)
..||.+....+.............+..+++++.+++.+||..||.+||++.++++.|++++...
T Consensus 237 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 237 QTPYAGIENAEIYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp CCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred CCCccccChHHHHHHHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 9999987776666655555556667889999999999999999999999999999999988753
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=273.94 Aligned_cols=194 Identities=22% Similarity=0.373 Sum_probs=157.4
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCC-
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL- 78 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~- 78 (268)
|+|++++++ .++..++||||++||+|.+++.+.+. +++.++..++.|++.||+|||++||+||||||+||++..+.
T Consensus 77 ~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~--~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~ 154 (342)
T 2qr7_A 77 NIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKF--FSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESG 154 (342)
T ss_dssp TBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCTT--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSC
T ss_pred CcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCC
Confidence 689999999 45688999999999999999987554 99999999999999999999999999999999999985432
Q ss_pred --CCeEEecCCCccccccc-cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--
Q 024408 79 --KTIKLADFGLAREESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS-- 153 (268)
Q Consensus 79 --~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~-- 153 (268)
+.+||+|||+++..... ....+..||+.|+|||++.+ ..++.++||||||+++|+|++|..||....
T Consensus 155 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~ 226 (342)
T 2qr7_A 155 NPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLER--------QGYDAACDIWSLGVLLYTMLTGYTPFANGPDD 226 (342)
T ss_dssp SGGGEEECCCTTCEECBCTTCCBCCSSCCSSCCCHHHHHH--------HHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTS
T ss_pred CcCeEEEEECCCcccCcCCCCceeccCCCccccCHHHhcC--------CCCCCccCeeeHhHHHHHHhcCCCCCCCCCcC
Confidence 24999999999854332 33445678999999999864 346779999999999999999999997532
Q ss_pred -hHHHHHHHHhccCCC---CCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 024408 154 -NLQAAYAAAFKNVRP---SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 204 (268)
Q Consensus 154 -~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~ 204 (268)
..+............ ....+++++.++|.+||..||.+||++.++++|-+-
T Consensus 227 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~ 281 (342)
T 2qr7_A 227 TPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWI 281 (342)
T ss_dssp CHHHHHHHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHH
T ss_pred CHHHHHHHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCee
Confidence 222222222222221 235789999999999999999999999999998554
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=263.09 Aligned_cols=190 Identities=25% Similarity=0.385 Sum_probs=159.1
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ .++..++||||++|++|.+++.+... +++..++.++.|++.||.|||++|++||||||+||+++.+ +
T Consensus 70 ~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~-~ 146 (279)
T 3fdn_A 70 NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSA-G 146 (279)
T ss_dssp TBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTT-S
T ss_pred CCcchhheEecCCEEEEEEecCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCC-C
Confidence 578999999 45678999999999999999987655 9999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 024408 80 TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY 159 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~ 159 (268)
.++|+|||++....... .....|++.|+|||.+.+ ..++.++||||||+++|+|++|..||......+...
T Consensus 147 ~~~l~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~ 217 (279)
T 3fdn_A 147 ELKIADFGWSVHAPSSR-RTDLCGTLDYLPPEMIEG--------RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYK 217 (279)
T ss_dssp CEEECSCCEESCC---------CCCCTTCCHHHHTT--------CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH
T ss_pred CEEEEeccccccCCccc-ccccCCCCCccCHhHhcc--------CCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHH
Confidence 99999999986543332 244578999999999864 566789999999999999999999998765544433
Q ss_pred HHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 024408 160 AAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 203 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~ 203 (268)
.........+..++..+.++|.+||..||.+||++.++++|.+
T Consensus 218 -~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~ 260 (279)
T 3fdn_A 218 -RISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 260 (279)
T ss_dssp -HHHHTCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHH
T ss_pred -HHHhCCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCcc
Confidence 3333444456778999999999999999999999999999844
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=263.30 Aligned_cols=193 Identities=26% Similarity=0.368 Sum_probs=163.5
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCC-
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL- 78 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~- 78 (268)
+++++++++ .++..++||||++|++|.+.+..... +++..+..++.|++.||.|||++|++||||||+||+++.+.
T Consensus 66 ~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~ 143 (284)
T 3kk8_A 66 NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF--YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAK 143 (284)
T ss_dssp TBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSST
T ss_pred CcCeEEEEEEcCCEEEEEEecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCC
Confidence 588999999 45678999999999999999987655 99999999999999999999999999999999999997652
Q ss_pred -CCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 024408 79 -KTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA 157 (268)
Q Consensus 79 -~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~ 157 (268)
+.++|+|||++.............||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+......
T Consensus 144 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 215 (284)
T 3kk8_A 144 GAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK--------DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL 215 (284)
T ss_dssp TCCEEECCCTTCEECCSSCBCCCSCSCGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred CCcEEEeeceeeEEcccCccccCCCCCcCCcCchhhcC--------CCCCcccchHHHHHHHHHHHHCCCCCCCCchhHH
Confidence 3499999999986665555556789999999999864 5678899999999999999999999988766555
Q ss_pred HHHHHhccCC---CCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 024408 158 AYAAAFKNVR---PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 203 (268)
Q Consensus 158 ~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~ 203 (268)
.......... +....+++++.++|.+||+.||.+||++.+++++-+
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~ 264 (284)
T 3kk8_A 216 YAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPW 264 (284)
T ss_dssp HHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHH
T ss_pred HHHHHhccccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCcc
Confidence 4444333322 223578999999999999999999999999999843
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=293.72 Aligned_cols=189 Identities=26% Similarity=0.394 Sum_probs=163.0
Q ss_pred CceeEEEeec-CCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGACK-EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~~-~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++. .+.+||||||++||+|.+++.+.+. +++.+++.++.||+.||+|||++||+||||||+|||++.+ +
T Consensus 403 ~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~-g 479 (674)
T 3pfq_A 403 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGR--FKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSE-G 479 (674)
T ss_dssp TBCCEEEECBCSSEEEEEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSS-S
T ss_pred eEEEEEEEEEeCCEEEEEEeCcCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCC-C
Confidence 4788999984 4689999999999999999988665 9999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccc-cccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREES-LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.+||+|||+++... ......+..||+.|+|||++.+ ..++.++|+||||+++|||++|+.||.+.+..+..
T Consensus 480 ~ikL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~--------~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~ 551 (674)
T 3pfq_A 480 HIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAY--------QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF 551 (674)
T ss_dssp CEEECCCTTCEECCCTTCCBCCCCSCSSSCCHHHHTC--------CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred cEEEeecceeeccccCCcccccccCCCcccCHhhhcC--------CCCCccceEechHHHHHHHHcCCCCCCCCCHHHHH
Confidence 99999999998532 3334456789999999999864 56789999999999999999999999986655444
Q ss_pred HHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCH-----HHHHHH
Q 024408 159 YAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNF-----TQIIQM 201 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~-----~~~~~~ 201 (268)
.. ........+..++.++.+||.+||..||.+||++ +++++|
T Consensus 552 ~~-i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 552 QS-IMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp HH-HHSSCCCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred HH-HHhCCCCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 43 3444445567899999999999999999999997 888887
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=262.93 Aligned_cols=192 Identities=37% Similarity=0.741 Sum_probs=154.6
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCCCCEEEeC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG---IIHRDLKPENLLLTE 76 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~g---i~H~Dikp~Nill~~ 76 (268)
+++++++++ .++..++||||++|++|.+++.. ..+++..++.++.|++.||.|||++| ++||||||+||+++.
T Consensus 67 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~ 143 (271)
T 3dtc_A 67 NIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQ 143 (271)
T ss_dssp TBCCEEEEECCC--CEEEEECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESS
T ss_pred CEeeEEEEEecCCceEEEEEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEec
Confidence 588999999 45678999999999999999853 24999999999999999999999999 899999999999986
Q ss_pred C-------CCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 024408 77 D-------LKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPF 149 (268)
Q Consensus 77 ~-------~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~ 149 (268)
+ .+.++|+|||++....... .....||+.|+|||.+.+ ..++.++||||||+++|+|++|+.||
T Consensus 144 ~~~~~~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~~l~~g~~p~ 214 (271)
T 3dtc_A 144 KVENGDLSNKILKITDFGLAREWHRTT-KMSAAGAYAWMAPEVIRA--------SMFSKGSDVWSYGVLLWELLTGEVPF 214 (271)
T ss_dssp CCSSSCCSSCCEEECCCCC--------------CCGGGSCHHHHHH--------CCCSHHHHHHHHHHHHHHHHHCCCTT
T ss_pred ccccccccCcceEEccCCccccccccc-ccCCCCccceeCHHHhcc--------CCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 2 3679999999998544332 234578999999998864 56788999999999999999999999
Q ss_pred CCCChHHHHHHHHhccC-CCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 024408 150 EGMSNLQAAYAAAFKNV-RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 204 (268)
Q Consensus 150 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~ 204 (268)
.+............... .+.+..+++.+.+++.+||..||.+||++.+++++|+.
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 215 RGIDGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp TTSCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred CCCCHHHHHHhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 98776665554443333 34467889999999999999999999999999999864
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=268.52 Aligned_cols=191 Identities=24% Similarity=0.317 Sum_probs=161.1
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ .++..++||||++|++|.+++..... +++..++.++.|++.||+|||++|++||||||+||+++.+..
T Consensus 76 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~ 153 (321)
T 2a2a_A 76 NVITLHDVYENRTDVVLILELVSGGELFDFLAQKES--LSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNI 153 (321)
T ss_dssp TBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSC--EEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTS
T ss_pred CcceEEEEEecCCEEEEEEEcCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCC
Confidence 578999999 45689999999999999999986544 999999999999999999999999999999999999987732
Q ss_pred ---CeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH
Q 024408 80 ---TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 156 (268)
Q Consensus 80 ---~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~ 156 (268)
.++|+|||++.............||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+....+
T Consensus 154 ~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 225 (321)
T 2a2a_A 154 PIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNY--------EPLGLEADMWSIGVITYILLSGASPFLGDTKQE 225 (321)
T ss_dssp SSCCEEECCCTTCEECCTTCCCCCCCSCGGGCCHHHHTT--------CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH
T ss_pred CcCCEEEccCccceecCccccccccCCCCCccCcccccC--------CCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH
Confidence 799999999986555544456679999999999864 567889999999999999999999998866555
Q ss_pred HHHHHHhccCCCC---CCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 157 AAYAAAFKNVRPS---AENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 157 ~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
............. ...++..+.++|.+||..||.+||++.++++|
T Consensus 226 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 226 TLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp HHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHhcccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 4443333222211 25688999999999999999999999999997
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=288.72 Aligned_cols=193 Identities=23% Similarity=0.370 Sum_probs=164.7
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
++|++++++ .++.+++||||++||+|.+++...+...+++..++.++.||+.||+|||++||+||||||+|||++.+ +
T Consensus 245 ~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~-g 323 (576)
T 2acx_A 245 FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDH-G 323 (576)
T ss_dssp TBCCEEEEEECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-S
T ss_pred CEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCC-C
Confidence 578999999 55689999999999999999987666669999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh---HH
Q 024408 80 TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN---LQ 156 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~---~~ 156 (268)
.+||+|||+++............||+.|+|||++.+ ..++.++|+||||+++|+|++|+.||.+... ..
T Consensus 324 ~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~--------~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~ 395 (576)
T 2acx_A 324 HIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKN--------ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE 395 (576)
T ss_dssp CEEECCCTTCEECCTTCCEECCCSCGGGCCHHHHTT--------CEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHH
T ss_pred CeEEEecccceecccCccccccCCCccccCHHHHcC--------CCCCccchHHHHHHHHHHHHhCCCCCcccccchhHH
Confidence 999999999987655544556789999999999864 4578899999999999999999999986432 23
Q ss_pred HHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCC-----CHHHHHHHH
Q 024408 157 AAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARP-----NFTQIIQML 202 (268)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~~~~~l 202 (268)
.............+..+++++.++|.+||..||.+|| +++++++|-
T Consensus 396 ~i~~~i~~~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~Hp 446 (576)
T 2acx_A 396 EVERLVKEVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHP 446 (576)
T ss_dssp HHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSG
T ss_pred HHHHHhhcccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhCh
Confidence 3333333334444677899999999999999999999 789999883
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=271.49 Aligned_cols=194 Identities=22% Similarity=0.330 Sum_probs=157.8
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED 77 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~ 77 (268)
|+|++++++ .++..++||||++|++|.+++.+. ....+++..++.++.|++.||+|||++||+||||||+||+++.+
T Consensus 87 nIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~ 166 (351)
T 3c0i_A 87 HIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASK 166 (351)
T ss_dssp TBCCEEEEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSS
T ss_pred CCCcEEEEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecC
Confidence 689999999 567899999999999999888653 23348999999999999999999999999999999999999765
Q ss_pred C--CCeEEecCCCcccccccc-ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh
Q 024408 78 L--KTIKLADFGLAREESLTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN 154 (268)
Q Consensus 78 ~--~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~ 154 (268)
. ..+||+|||++....... ......||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+..
T Consensus 167 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~~ll~g~~pf~~~~- 237 (351)
T 3c0i_A 167 ENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKR--------EPYGKPVDVWGCGVILFILLSGCLPFYGTK- 237 (351)
T ss_dssp STTCCEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-
T ss_pred CCCCcEEEecCcceeEecCCCeeecCCcCCcCccCHHHHcC--------CCCCchHhhHHHHHHHHHHHHCCCCCCCcH-
Confidence 2 349999999998654432 2345679999999999864 557889999999999999999999998743
Q ss_pred HHHHHHHHhccCCCC---CCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 024408 155 LQAAYAAAFKNVRPS---AENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 203 (268)
Q Consensus 155 ~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~ 203 (268)
.+............. ...+++++.++|.+||..||.+||++.++++|-+
T Consensus 238 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~ 289 (351)
T 3c0i_A 238 ERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPW 289 (351)
T ss_dssp HHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred HHHHHHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChh
Confidence 222222222222221 2568899999999999999999999999999754
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=277.61 Aligned_cols=199 Identities=17% Similarity=0.337 Sum_probs=157.5
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|+|++++++ .++..++||||++||+|.+++.......+++..+..++.|++.||+|||++||+||||||+|||++.+ +
T Consensus 87 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~-~ 165 (389)
T 3gni_B 87 NIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVD-G 165 (389)
T ss_dssp TBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-C
T ss_pred CCCcEeEEEEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-C
Confidence 689999999 56789999999999999999988655569999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccc--------cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 024408 80 TIKLADFGLAREESLT--------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 151 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~ 151 (268)
.+||+|||.+...... .......||+.|+|||++.+ ....++.++||||||+++|+|++|+.||.+
T Consensus 166 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~~DiwslG~il~el~~g~~pf~~ 239 (389)
T 3gni_B 166 KVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQ------NLQGYDAKSDIYSVGITACELANGHVPFKD 239 (389)
T ss_dssp CEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHST------TSSCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CEEEcccccceeeccccccccccccccccccccccccCHHHHhc------cCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 9999999988632211 11223478999999999853 124678899999999999999999999987
Q ss_pred CChHHHHHHHHhcc---------------------------------------------CCCCCCCCcHHHHHHHHhccc
Q 024408 152 MSNLQAAYAAAFKN---------------------------------------------VRPSAENVPEELSIILTSCWK 186 (268)
Q Consensus 152 ~~~~~~~~~~~~~~---------------------------------------------~~~~~~~~~~~l~~li~~~l~ 186 (268)
....+......... ..+....+++++.++|.+||+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~ 319 (389)
T 3gni_B 240 MPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQ 319 (389)
T ss_dssp CCSTTHHHHC--------------------------------------------------------CCHHHHHHHHHHTC
T ss_pred CCHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhh
Confidence 55433322211110 011234578899999999999
Q ss_pred cCCCCCCCHHHHHHHHHHhHhh
Q 024408 187 EDPNARPNFTQIIQMLLNYLSA 208 (268)
Q Consensus 187 ~~p~~Rps~~~~~~~l~~~~~~ 208 (268)
.||.+|||+.++++| .++..
T Consensus 320 ~dP~~Rpta~ell~h--p~f~~ 339 (389)
T 3gni_B 320 RNPDARPSASTLLNH--SFFKQ 339 (389)
T ss_dssp SCTTTSCCHHHHTTS--GGGGG
T ss_pred cCcccCCCHHHHhcC--HHHHH
Confidence 999999999999998 44444
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-38 Score=263.31 Aligned_cols=199 Identities=31% Similarity=0.656 Sum_probs=158.5
Q ss_pred CceeEEEeecCCcEEEEEEcCCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCCCCEEEeC
Q 024408 1 MREQFIGACKEPVMVIVTELLSGGTLRKYLLNMRP-RCLDVCVAIGFALDIARAMECLHS---HGIIHRDLKPENLLLTE 76 (268)
Q Consensus 1 ~~v~l~g~~~~~~~~lV~e~~~ggsL~~~i~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~---~gi~H~Dikp~Nill~~ 76 (268)
|+|+++|++.+. .++||||++||+|.+++..... ..+++..++.++.|++.||+|||+ +|++||||||+||+++.
T Consensus 62 ~iv~~~~~~~~~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~ 140 (307)
T 2eva_A 62 NIVKLYGACLNP-VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVA 140 (307)
T ss_dssp TBCCEEEBCTTT-TEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEET
T ss_pred CcCeEEEEEcCC-cEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeC
Confidence 689999999754 7999999999999999986543 237899999999999999999999 89999999999999988
Q ss_pred CCCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH-
Q 024408 77 DLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL- 155 (268)
Q Consensus 77 ~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~- 155 (268)
+...+||+|||++...... .....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||......
T Consensus 141 ~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~ 210 (307)
T 2eva_A 141 GGTVLKICDFGTACDIQTH--MTNNKGSAAWMAPEVFEG--------SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA 210 (307)
T ss_dssp TTTEEEECCCCC--------------CCTTSSCHHHHTC--------CCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH
T ss_pred CCCEEEEcccccccccccc--cccCCCCCceEChhhhCC--------CCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH
Confidence 7434899999999754322 234468999999999864 56788999999999999999999999754332
Q ss_pred -HHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhcC
Q 024408 156 -QAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIA 210 (268)
Q Consensus 156 -~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~~~ 210 (268)
............+....++..+.+++.+||..||.+||++.++++.|+.......
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 266 (307)
T 2eva_A 211 FRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFP 266 (307)
T ss_dssp HHHHHHHHTTCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCC
T ss_pred HHHHHHHhcCCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhcc
Confidence 2223333344444567889999999999999999999999999999998776543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=267.59 Aligned_cols=190 Identities=26% Similarity=0.376 Sum_probs=159.3
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|+|++++++ .++..++||||++|++|.+++.+ ..+++..+..++.|++.||.|||++|++||||||+||+++.+ +
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~-~ 178 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLD-G 178 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-C
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-C
Confidence 588999999 56789999999999999999864 239999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccccc-ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESLTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.+||+|||++....... ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||......+..
T Consensus 179 ~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~ 250 (321)
T 2c30_A 179 RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISR--------SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM 250 (321)
T ss_dssp CEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred cEEEeeeeeeeecccCccccccccCCccccCHhhhcC--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 99999999997544322 2345679999999999854 56788999999999999999999999886665544
Q ss_pred HHHHhccCC--CCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 024408 159 YAAAFKNVR--PSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 202 (268)
Q Consensus 159 ~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l 202 (268)
......... .....+++.+.++|.+||..||.+||++.+++++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp 296 (321)
T 2c30_A 251 KRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHP 296 (321)
T ss_dssp HHHHHSSCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred HHHhcCCCCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 433332221 12345789999999999999999999999999983
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=262.56 Aligned_cols=192 Identities=28% Similarity=0.433 Sum_probs=153.7
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED 77 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~ 77 (268)
+++++++++ ..+..++||||++||+|.+++... ....+++..++.++.|++.||+|||++|++||||||+||+++.+
T Consensus 81 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~ 160 (285)
T 3is5_A 81 NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDT 160 (285)
T ss_dssp TBCCEEEEEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSS
T ss_pred hHHhHHHheecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecC
Confidence 589999999 456889999999999999998653 22449999999999999999999999999999999999999532
Q ss_pred --CCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH
Q 024408 78 --LKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL 155 (268)
Q Consensus 78 --~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~ 155 (268)
.+.++|+|||++.............||+.|+|||++. ..++.++||||||+++|+|++|+.||.+....
T Consensus 161 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~---------~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~ 231 (285)
T 3is5_A 161 SPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFK---------RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE 231 (285)
T ss_dssp STTCCEEECCCCCCCC----------CTTGGGCCHHHHT---------TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred CCCCCEEEEeeecceecCCcccCcCcccccCcCChHHhc---------cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH
Confidence 2579999999998655555555667999999999874 45788999999999999999999999987655
Q ss_pred HHHHHHHhccCC--CCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 156 QAAYAAAFKNVR--PSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 156 ~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
+........... .....+++++.++|.+||..||.+||++.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 232 EVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp HHHHHHHHCCCCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred HHHhhhccCCcccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 544443333222 2234578999999999999999999999999987
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=279.66 Aligned_cols=192 Identities=25% Similarity=0.378 Sum_probs=161.5
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCC--
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED-- 77 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~-- 77 (268)
|+|++++++ ..+.+++||||++||+|.+++..... +++.++..++.|++.||.|||++||+||||||+||+++.+
T Consensus 82 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~ 159 (486)
T 3mwu_A 82 NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR--FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEK 159 (486)
T ss_dssp TBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSST
T ss_pred CcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCC
Confidence 689999999 45688999999999999999987655 9999999999999999999999999999999999999632
Q ss_pred CCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 024408 78 LKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA 157 (268)
Q Consensus 78 ~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~ 157 (268)
.+.+||+|||+++............||+.|+|||++. +.++.++||||||+++|+|++|..||.+....+.
T Consensus 160 ~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 230 (486)
T 3mwu_A 160 DCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLR---------GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI 230 (486)
T ss_dssp TCCEEECSCSCTTTBCCC----CCTTGGGGCCGGGGG---------SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred CCCEEEEECCcCeECCCCCccCCCcCCCCCCCHHHhC---------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 2479999999998665555556678999999999985 3478899999999999999999999998776655
Q ss_pred HHHHHhccCC---CCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 024408 158 AYAAAFKNVR---PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 203 (268)
Q Consensus 158 ~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~ 203 (268)
.......... +....+++++.++|.+||..||.+|||+.++++|.+
T Consensus 231 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~ 279 (486)
T 3mwu_A 231 LKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPW 279 (486)
T ss_dssp HHHHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHH
T ss_pred HHHHHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHh
Confidence 5544443332 223568899999999999999999999999999844
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=266.81 Aligned_cols=185 Identities=25% Similarity=0.361 Sum_probs=151.2
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
++|+++++| .++..++||||+ +++|.+++...+. .+++..++.++.|++.||+|||++||+||||||+|||++.+ +
T Consensus 118 ~iv~l~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~-~ 194 (311)
T 3p1a_A 118 CCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGA-SLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPR-G 194 (311)
T ss_dssp TBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGG-G
T ss_pred cEEEEEEEEEeCCEEEEEEecc-CCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCC-C
Confidence 589999999 567899999999 6899999887653 49999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 024408 80 TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY 159 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~ 159 (268)
.+||+|||++.............||+.|+|||++. +.++.++||||||+++|+|++|..++......
T Consensus 195 ~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~DiwslG~il~el~~g~~~~~~~~~~---- 261 (311)
T 3p1a_A 195 RCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQ---------GSYGTAADVFSLGLTILEVACNMELPHGGEGW---- 261 (311)
T ss_dssp CEEECCCTTCEECC------CCCCCGGGCCGGGGG---------TCCSTHHHHHHHHHHHHHHHHTCCCCSSHHHH----
T ss_pred CEEEccceeeeecccCCCCcccCCCccccCHhHhc---------CCCCchhhHHHHHHHHHHHHhCCCCCCCccHH----
Confidence 99999999998765555555667999999999875 35788999999999999999997766542221
Q ss_pred HHHhccCCC--CCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 160 AAAFKNVRP--SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 160 ~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
........+ ....+++++.++|.+||..||++||++.+++++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 262 QQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp HHHTTTCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHhccCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 111111111 145688999999999999999999999999987
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=260.50 Aligned_cols=196 Identities=26% Similarity=0.466 Sum_probs=164.1
Q ss_pred CceeEEEeecC---CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCCEEEe
Q 024408 1 MREQFIGACKE---PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG--IIHRDLKPENLLLT 75 (268)
Q Consensus 1 ~~v~l~g~~~~---~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~g--i~H~Dikp~Nill~ 75 (268)
|+|+++|++.+ +..++||||++||+|.+++.+.....+++.+++.++.|++.||.|||++| ++||||||+||+++
T Consensus 68 ~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~ 147 (271)
T 3kmu_A 68 NVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMID 147 (271)
T ss_dssp TEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEEC
T ss_pred chhheEEEEccCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEc
Confidence 68999999943 57899999999999999998866556999999999999999999999999 99999999999999
Q ss_pred CCCCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH
Q 024408 76 EDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL 155 (268)
Q Consensus 76 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~ 155 (268)
.+ +.++++|||++..... ....||+.|+|||++.+.. ...++.++||||||+++|+|++|+.||.+....
T Consensus 148 ~~-~~~~l~~~~~~~~~~~----~~~~~t~~y~aPE~~~~~~-----~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~ 217 (271)
T 3kmu_A 148 ED-MTARISMADVKFSFQS----PGRMYAPAWVAPEALQKKP-----EDTNRRSADMWSFAVLLWELVTREVPFADLSNM 217 (271)
T ss_dssp TT-SCEEEEGGGSCCTTSC----TTCBSCGGGSCHHHHHSCG-----GGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH
T ss_pred CC-cceeEEeccceeeecc----cCccCCccccChhhhccCC-----CCCCCchhhHHHHHHHHHHHHhCCCCccccChH
Confidence 88 6899998888764222 2346899999999986411 123445899999999999999999999987766
Q ss_pred HHHHHHHhccC-CCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhH
Q 024408 156 QAAYAAAFKNV-RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 206 (268)
Q Consensus 156 ~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 206 (268)
+.......... ...+..+++++.+++.+||..||.+||++.++++.|+...
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 218 EIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp HHHHHHHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 65554444333 3446778999999999999999999999999999998754
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=273.04 Aligned_cols=208 Identities=16% Similarity=0.182 Sum_probs=164.7
Q ss_pred ceeEEEeec--CCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 2 REQFIGACK--EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 2 ~v~l~g~~~--~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
++++++++. ++..++||||+ |++|.+++.......+++.+++.++.|++.||.|||++|++||||||+||+++.+ +
T Consensus 119 i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~-~ 196 (352)
T 2jii_A 119 IPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPE-D 196 (352)
T ss_dssp CCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETT-E
T ss_pred ccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCC-C
Confidence 345677773 56889999999 9999999987634459999999999999999999999999999999999999987 5
Q ss_pred --CeEEecCCCccccccccc--------cccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 024408 80 --TIKLADFGLAREESLTEM--------MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPF 149 (268)
Q Consensus 80 --~~kl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~ 149 (268)
.++|+|||+++....... .....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||
T Consensus 197 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~~g~~pf 268 (352)
T 2jii_A 197 QSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG--------CGPSRRSDLQSLGYCMLKWLYGFLPW 268 (352)
T ss_dssp EEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT--------CCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred CceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc--------CCCCchhhHHHHHHHHHHHHhCCCCc
Confidence 899999999975443221 133478999999999864 56889999999999999999999999
Q ss_pred CCCC-hHHHHHHHH---hccCCCC------CCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhcCCCCCCCCCc
Q 024408 150 EGMS-NLQAAYAAA---FKNVRPS------AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIPHR 219 (268)
Q Consensus 150 ~~~~-~~~~~~~~~---~~~~~~~------~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~~~~~~~~~~~~ 219 (268)
.... ......... ....... ...+++++.++|.+||..||.+||++.++++.|+..+............|
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~~~dw 348 (352)
T 2jii_A 269 TNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSPYDPIGL 348 (352)
T ss_dssp GGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCTTSCCCC
T ss_pred ccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCCcCccccC
Confidence 8653 222222111 1111111 12568999999999999999999999999999999998876555444333
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=272.52 Aligned_cols=205 Identities=23% Similarity=0.361 Sum_probs=160.4
Q ss_pred CceeEEEeecC-C--cEEEEEEcCCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEE--
Q 024408 1 MREQFIGACKE-P--VMVIVTELLSGGTLRKYLLNMRP-RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL-- 74 (268)
Q Consensus 1 ~~v~l~g~~~~-~--~~~lV~e~~~ggsL~~~i~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill-- 74 (268)
|++++++++.+ + ..++||||++|++|.+++..... ..+++.+++.++.|++.||+|||++||+||||||+||++
T Consensus 68 ~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~ 147 (319)
T 4euu_A 68 NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVI 147 (319)
T ss_dssp TBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEE
T ss_pred CcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEec
Confidence 58999999843 2 78999999999999999987543 339999999999999999999999999999999999998
Q ss_pred --eCCCCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 024408 75 --TEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGM 152 (268)
Q Consensus 75 --~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~ 152 (268)
+.+ +.+||+|||+++............||+.|+|||++............++.++||||||+++|+|++|+.||...
T Consensus 148 ~~~~~-~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 226 (319)
T 4euu_A 148 GEDGQ-SVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF 226 (319)
T ss_dssp CTTSC-EEEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECT
T ss_pred cCCCC-ceEEEccCCCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 555 57999999999876655555567899999999988642222222367888999999999999999999999643
Q ss_pred Ch----HHHHHHHHhccCC--------------------CC----CCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 024408 153 SN----LQAAYAAAFKNVR--------------------PS----AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 204 (268)
Q Consensus 153 ~~----~~~~~~~~~~~~~--------------------~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~ 204 (268)
.. .+........... +. ...++..+.++|.+||+.||.+||++++++++..+
T Consensus 227 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d 306 (319)
T 4euu_A 227 EGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306 (319)
T ss_dssp TCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred CccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHH
Confidence 32 2222222222111 11 12235678899999999999999999999999876
Q ss_pred hH
Q 024408 205 YL 206 (268)
Q Consensus 205 ~~ 206 (268)
..
T Consensus 307 ~~ 308 (319)
T 4euu_A 307 IL 308 (319)
T ss_dssp HT
T ss_pred Hh
Confidence 43
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=281.70 Aligned_cols=192 Identities=26% Similarity=0.352 Sum_probs=164.1
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCC--
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED-- 77 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~-- 77 (268)
|+|++++++ ..+..++||||++||+|.+++..... +++..+..++.|++.||.|||++||+||||||+||+++.+
T Consensus 97 niv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~ 174 (494)
T 3lij_A 97 NIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMK--FNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEK 174 (494)
T ss_dssp TBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSST
T ss_pred CCCeEEEEEEeCCEEEEEEecCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCC
Confidence 689999999 45689999999999999999987655 9999999999999999999999999999999999999753
Q ss_pred CCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 024408 78 LKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA 157 (268)
Q Consensus 78 ~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~ 157 (268)
.+.+||+|||++.............||+.|+|||++. ..++.++||||+|+++|+|++|..||.+....+.
T Consensus 175 ~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~---------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 245 (494)
T 3lij_A 175 DALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLR---------KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEI 245 (494)
T ss_dssp TCCEEECCCTTCEECBTTBCBCCCCSCTTTCCHHHHT---------TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred CCcEEEEECCCCeECCCCccccccCCCcCeeCHHHHc---------ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 2459999999998766555556678999999999874 3578899999999999999999999998776655
Q ss_pred HHHHHhccCCC---CCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 024408 158 AYAAAFKNVRP---SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 203 (268)
Q Consensus 158 ~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~ 203 (268)
........... ....+++.+.++|.+||..||.+|||+.++++|.+
T Consensus 246 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~ 294 (494)
T 3lij_A 246 LRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPW 294 (494)
T ss_dssp HHHHHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHH
T ss_pred HHHHHhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcc
Confidence 55444433322 23578999999999999999999999999999744
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=263.02 Aligned_cols=206 Identities=22% Similarity=0.290 Sum_probs=161.9
Q ss_pred eeEEEee--cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEE---eCC
Q 024408 3 EQFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL---TED 77 (268)
Q Consensus 3 v~l~g~~--~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill---~~~ 77 (268)
+..++++ .++..++||||+ |++|.+++..... .+++.+++.++.|++.||.|||++|++||||||+||++ +.+
T Consensus 67 i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~ 144 (296)
T 4hgt_A 67 IPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSR-KFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKG 144 (296)
T ss_dssp CCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGT
T ss_pred CCeeeeecCCCCceEEEEEcc-CCCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCC
Confidence 4444554 456789999999 8999999986433 39999999999999999999999999999999999999 566
Q ss_pred CCCeEEecCCCcccccccc--------ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 024408 78 LKTIKLADFGLAREESLTE--------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPF 149 (268)
Q Consensus 78 ~~~~kl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~ 149 (268)
+.+||+|||+++...... ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||
T Consensus 145 -~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~pf 215 (296)
T 4hgt_A 145 -NLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG--------IEQSRRDDLESLGYVLMYFNLGSLPW 215 (296)
T ss_dssp -TCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTT--------CCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred -CeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcC--------CCCCchhHHHHHHHHHHHHhcCCCCC
Confidence 689999999998543322 2234578999999999864 56788999999999999999999999
Q ss_pred CCCChH---HHHHHHHhc-cCC---CCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhcCCCCCCCCCc
Q 024408 150 EGMSNL---QAAYAAAFK-NVR---PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIPHR 219 (268)
Q Consensus 150 ~~~~~~---~~~~~~~~~-~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~~~~~~~~~~~~ 219 (268)
.+.... +........ ... .....+|+++.+++.+||+.||.+||++.++++.|+.++.....+.....+|
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~~~~dw 292 (296)
T 4hgt_A 216 QGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDW 292 (296)
T ss_dssp SSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTTCCCGG
T ss_pred cccchhhhhhhhhhhhcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCccCccch
Confidence 764321 111111111 111 1136788999999999999999999999999999999998877665544443
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=270.35 Aligned_cols=191 Identities=26% Similarity=0.386 Sum_probs=138.1
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCC-
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL- 78 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~- 78 (268)
|+|++++++ .++..++||||++||+|.+++.+... +++.++..++.|++.||+|||++||+||||||+||+++.+.
T Consensus 67 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~ 144 (325)
T 3kn6_A 67 NIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKH--FSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDEND 144 (325)
T ss_dssp TBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHCSC--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC---
T ss_pred CeeEEEEEEEcCCEEEEEEEccCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCC
Confidence 689999999 45688999999999999999987654 99999999999999999999999999999999999997652
Q ss_pred -CCeEEecCCCccccccc-cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH-
Q 024408 79 -KTIKLADFGLAREESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL- 155 (268)
Q Consensus 79 -~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~- 155 (268)
..+||+|||+++..... .......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||......
T Consensus 145 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 216 (325)
T 3kn6_A 145 NLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQ--------NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSL 216 (325)
T ss_dssp -CEEEECCCTTCEECCC------------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC------
T ss_pred cccEEEeccccceecCCCCCcccccCCCcCccCHHHhcC--------CCCCCccchHHHHHHHHHHHhCCCCCCCCcccc
Confidence 27999999999854332 23345578999999999864 56788999999999999999999999764321
Q ss_pred -----HHHHHHHhccCCCC----CCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 156 -----QAAYAAAFKNVRPS----AENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 156 -----~~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
.............. ...+++++.++|.+||..||.+||++.++++|
T Consensus 217 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 217 TCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp -CCCHHHHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred ccccHHHHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 11222222211111 13578999999999999999999999999987
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-38 Score=261.89 Aligned_cols=201 Identities=29% Similarity=0.485 Sum_probs=166.7
Q ss_pred CceeEEEeec-CC-cEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCC
Q 024408 1 MREQFIGACK-EP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL 78 (268)
Q Consensus 1 ~~v~l~g~~~-~~-~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~ 78 (268)
|++++++++. .+ ..++||||+.||+|.+++.... ..+++.+++.++.|++.||+|||++|++||||||+||+++.+
T Consensus 83 ~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~- 160 (298)
T 3pls_A 83 NVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQ-RNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDES- 160 (298)
T ss_dssp TBCCCCEEECCSSSCCEEEECCCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT-
T ss_pred CeeeEEEEEecCCCCcEEEEecccCCCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCC-
Confidence 5889999994 33 4499999999999999997643 349999999999999999999999999999999999999988
Q ss_pred CCeEEecCCCcccccccc-----ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhC-CCCCCCC
Q 024408 79 KTIKLADFGLAREESLTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHN-KLPFEGM 152 (268)
Q Consensus 79 ~~~kl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g-~~p~~~~ 152 (268)
+.+||+|||+++...... ......++..|+|||.+.+ ..++.++||||||+++|+|++| .+||...
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~~~~~~~ 232 (298)
T 3pls_A 161 FTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQT--------YRFTTKSDVWSFGVLLWELLTRGAPPYRHI 232 (298)
T ss_dssp CCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTT--------CCCCHHHHHHHHHHHHHHHHHTSCCTTTTS
T ss_pred CcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhcc--------CCCChhhchhhHHHHHHHHhhCCCCCCccC
Confidence 699999999997543221 2234467899999999864 5678899999999999999995 5556655
Q ss_pred ChHHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhcCC
Q 024408 153 SNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAP 211 (268)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~~~~ 211 (268)
...+...........+.+..++..+.+++.+||..||.+|||+.++++.|+........
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~ 291 (298)
T 3pls_A 233 DPFDLTHFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG 291 (298)
T ss_dssp CGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCS
T ss_pred CHHHHHHHhhcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 55555555555555566778899999999999999999999999999999998887543
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=260.04 Aligned_cols=191 Identities=27% Similarity=0.361 Sum_probs=153.0
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ .++..++||||++|++|.+++.+... +++..++.++.|++.||.|||++|++|+||||+||+++.+ +
T Consensus 72 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~-~ 148 (276)
T 2h6d_A 72 HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGR--VEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAH-M 148 (276)
T ss_dssp TBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTT-S
T ss_pred CEeEEEEEEecCCeEEEEEeccCCCcHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCC-C
Confidence 578999999 55689999999999999999987655 9999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 024408 80 TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY 159 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~ 159 (268)
.++|+|||++.............|++.|+|||++.+ ....+.++|+||||+++|+|++|+.||..........
T Consensus 149 ~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~ 221 (276)
T 2h6d_A 149 NAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISG-------RLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFK 221 (276)
T ss_dssp CEEECCCCGGGCCCC-------------CCTGGGTT-------SCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred CEEEeecccccccCCCcceecccCCccccCHHHHcC-------CCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHH
Confidence 999999999986555444455678999999999864 1233679999999999999999999998765544333
Q ss_pred HHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 024408 160 AAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 202 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l 202 (268)
.........+..++..+.++|.+||..||.+||++.+++++-
T Consensus 222 -~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~ 263 (276)
T 2h6d_A 222 -KIRGGVFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHE 263 (276)
T ss_dssp -HHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSH
T ss_pred -HhhcCcccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhCh
Confidence 333334445667899999999999999999999999999983
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=269.63 Aligned_cols=198 Identities=28% Similarity=0.347 Sum_probs=160.8
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|+|++++++ ..+..++||||++ ++|.+++.... ..+++.++..++.|++.||+|||++|++||||||+||+++.+ +
T Consensus 73 ~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~-~ 149 (346)
T 1ua2_A 73 NIIGLLDAFGHKSNISLVFDFME-TDLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDEN-G 149 (346)
T ss_dssp TBCCEEEEECCTTCCEEEEECCS-EEHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-C
T ss_pred CCCeEEEEEeeCCceEEEEEcCC-CCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCC-C
Confidence 589999999 4568999999997 58999887643 348999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccc-ccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESL-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.+||+|||+++.... ........||+.|+|||++.+ ...++.++||||||+++|+|++|..||.+....+..
T Consensus 150 ~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~ 222 (346)
T 1ua2_A 150 VLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFG-------ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQL 222 (346)
T ss_dssp CEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTT-------CSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred CEEEEecccceeccCCcccCCcccccccccCchHhhC-------CCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 999999999986533 223345678999999998853 245788999999999999999999999887765554
Q ss_pred HHHHhccCCCC---------------------------CCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhcC
Q 024408 159 YAAAFKNVRPS---------------------------AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIA 210 (268)
Q Consensus 159 ~~~~~~~~~~~---------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~~~ 210 (268)
.........+. ...++.++.++|.+||..||.+|||+.++++| .++....
T Consensus 223 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h--~~f~~~~ 299 (346)
T 1ua2_A 223 TRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM--KYFSNRP 299 (346)
T ss_dssp HHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS--GGGTSSS
T ss_pred HHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC--hhhhcCC
Confidence 44333211111 14457899999999999999999999999998 4555443
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=274.25 Aligned_cols=194 Identities=20% Similarity=0.251 Sum_probs=155.5
Q ss_pred CceeEEEee-c----CCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEe
Q 024408 1 MREQFIGAC-K----EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 75 (268)
Q Consensus 1 ~~v~l~g~~-~----~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~ 75 (268)
|++++++++ . +...++||||+ |++|.+++...+ .+++.+++.++.|++.||+|||++|++||||||+||+++
T Consensus 109 ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~ 185 (345)
T 2v62_A 109 GIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLG 185 (345)
T ss_dssp CCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE
T ss_pred CcceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEc
Confidence 578999998 3 45789999999 999999998765 399999999999999999999999999999999999998
Q ss_pred CCC-CCeEEecCCCcccccccc--------ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCC
Q 024408 76 EDL-KTIKLADFGLAREESLTE--------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNK 146 (268)
Q Consensus 76 ~~~-~~~kl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~ 146 (268)
.+. +.+||+|||+++...... ......||..|+|||++.+ ..++.++||||||+++|+|++|+
T Consensus 186 ~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~ell~g~ 257 (345)
T 2v62_A 186 YKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG--------VALSRRSDVEILGYCMLRWLCGK 257 (345)
T ss_dssp SSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT--------CCCCHHHHHHHHHHHHHHHHHSS
T ss_pred cCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcC--------CCCCchhhHHHHHHHHHHHHhCC
Confidence 761 289999999997543221 1234578999999999864 56789999999999999999999
Q ss_pred CCCCCCCh-HHHHHHHHhc--cCCC-------CCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHh
Q 024408 147 LPFEGMSN-LQAAYAAAFK--NVRP-------SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 205 (268)
Q Consensus 147 ~p~~~~~~-~~~~~~~~~~--~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~ 205 (268)
.||.+... .......... ...+ ....+++++.++|..||..||.+||++.++++.|+..
T Consensus 258 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 326 (345)
T 2v62_A 258 LPWEQNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH 326 (345)
T ss_dssp CTTGGGTTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred CCccccccccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence 99954221 1111111111 1111 1227889999999999999999999999999998764
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=265.09 Aligned_cols=201 Identities=27% Similarity=0.512 Sum_probs=162.6
Q ss_pred CceeEEEeecC-C-----cEEEEEEcCCCCCHHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCC
Q 024408 1 MREQFIGACKE-P-----VMVIVTELLSGGTLRKYLLNM----RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPE 70 (268)
Q Consensus 1 ~~v~l~g~~~~-~-----~~~lV~e~~~ggsL~~~i~~~----~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~ 70 (268)
+++++++++.+ + ..++||||++|++|.+++... ....+++..++.++.|++.||.|||++|++||||||+
T Consensus 97 ~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~ 176 (313)
T 3brb_A 97 NVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAAR 176 (313)
T ss_dssp TBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGG
T ss_pred CeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcc
Confidence 57899999843 2 459999999999999999542 2345999999999999999999999999999999999
Q ss_pred CEEEeCCCCCeEEecCCCcccccccc---ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CC
Q 024408 71 NLLLTEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NK 146 (268)
Q Consensus 71 Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~ 146 (268)
||+++.+ +.+||+|||++....... ......+++.|+|||.+.+ ..++.++||||||+++|+|++ |.
T Consensus 177 NIli~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~~~g~ 247 (313)
T 3brb_A 177 NCMLRDD-MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD--------RVYTSKSDVWAFGVTMWEIATRGM 247 (313)
T ss_dssp GEEECTT-SCEEECSCSCC----------------CCGGGSCHHHHHS--------SCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred eEEEcCC-CcEEEeecCcceecccccccCcccccCCCccccCchhhcC--------CCccchhhhHHHHHHHHHHHhcCC
Confidence 9999988 699999999997543321 2233456889999999864 567889999999999999999 89
Q ss_pred CCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhcC
Q 024408 147 LPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIA 210 (268)
Q Consensus 147 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~~~ 210 (268)
.||....................+..+++.+.++|.+||..||.+||++.+++++|+.++...+
T Consensus 248 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp 311 (313)
T 3brb_A 248 TPYPGVQNHEMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311 (313)
T ss_dssp CSSTTCCGGGHHHHHHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred CCCccCCHHHHHHHHHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 9998877665555555555555677899999999999999999999999999999999887643
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=261.97 Aligned_cols=206 Identities=22% Similarity=0.296 Sum_probs=161.1
Q ss_pred eeEEEee--cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEe---CC
Q 024408 3 EQFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT---ED 77 (268)
Q Consensus 3 v~l~g~~--~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~---~~ 77 (268)
+..++++ .++..++||||+ |++|.+++..... .+++.+++.++.|++.||+|||++|++||||||+||+++ .+
T Consensus 67 i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~ 144 (296)
T 3uzp_A 67 IPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSR-KFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKG 144 (296)
T ss_dssp CCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGT
T ss_pred CCccccccCCCCceEEEEEec-CCCHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCC
Confidence 3344554 456789999999 8999999975433 499999999999999999999999999999999999995 55
Q ss_pred CCCeEEecCCCccccccccc--------cccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 024408 78 LKTIKLADFGLAREESLTEM--------MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPF 149 (268)
Q Consensus 78 ~~~~kl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~ 149 (268)
+.+||+|||++........ .....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||
T Consensus 145 -~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~pf 215 (296)
T 3uzp_A 145 -NLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG--------IEQSRRDDLESLGYVLMYFNLGSLPW 215 (296)
T ss_dssp -TCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTT--------CCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred -CeEEEeeCCCcccccccccccccccccccccccccccCChhhhcC--------CCCCcchhhHHHHHHHHHHHhCCCCC
Confidence 6899999999985433221 244578999999999864 56788999999999999999999999
Q ss_pred CCCChH---HHHHHHHhcc-CC---CCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhcCCCCCCCCCc
Q 024408 150 EGMSNL---QAAYAAAFKN-VR---PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIPHR 219 (268)
Q Consensus 150 ~~~~~~---~~~~~~~~~~-~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~~~~~~~~~~~~ 219 (268)
.+.... +......... .. .....+|+++.+++.+||+.||.+||++.++++.|+........+.....+|
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~~~dw 292 (296)
T 3uzp_A 216 QGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDW 292 (296)
T ss_dssp SSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSSCCCGG
T ss_pred CCcCchhhhhhhhhhcccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCcccccccc
Confidence 764321 1111111111 11 1236789999999999999999999999999999999998876655444333
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=263.07 Aligned_cols=191 Identities=27% Similarity=0.367 Sum_probs=153.5
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|++++++++ .++..++||||++ ++|.+++..... .+++.++..++.|++.||+|||++|++||||||+||+++.+ +
T Consensus 61 ~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~-~ 137 (288)
T 1ob3_A 61 NIVKLYDVIHTKKRLVLVFEHLD-QDLKKLLDVCEG-GLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINRE-G 137 (288)
T ss_dssp TBCCEEEEEECSSCEEEEEECCS-EEHHHHHHTSTT-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-S
T ss_pred CEeeeeeEEccCCeEEEEEEecC-CCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC-C
Confidence 689999999 4568999999997 599999976533 39999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccc-cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.+||+|||+++..... .......||+.|+|||++.+ ...++.++||||||+++|+|++|+.||.+....+..
T Consensus 138 ~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~ 210 (288)
T 1ob3_A 138 ELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG-------SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQL 210 (288)
T ss_dssp CEEECCTTHHHHHCC---------CCCTTCCHHHHTT-------CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred CEEEeECccccccCccccccccccccccccCchheeC-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 9999999999754322 22334578999999998853 245788999999999999999999999887665544
Q ss_pred HHHHhccCCC----------------------------CCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 159 YAAAFKNVRP----------------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 159 ~~~~~~~~~~----------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
.........+ ....+++++.++|.+||..||.+|||+.++++|
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 211 MRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp HHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 4332211100 123578999999999999999999999999987
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=264.08 Aligned_cols=197 Identities=29% Similarity=0.519 Sum_probs=159.5
Q ss_pred CceeEEEeec-C-CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCC
Q 024408 1 MREQFIGACK-E-PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL 78 (268)
Q Consensus 1 ~~v~l~g~~~-~-~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~ 78 (268)
+++++++++. + +..++||||++|++|.+++.+.....+++..++.++.|++.||+|||++|++||||||+||+++.+
T Consensus 75 ~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~- 153 (278)
T 1byg_A 75 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSED- 153 (278)
T ss_dssp TBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT-
T ss_pred CEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCC-
Confidence 5789999973 3 478999999999999999987554448999999999999999999999999999999999999988
Q ss_pred CCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 024408 79 KTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQA 157 (268)
Q Consensus 79 ~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~ 157 (268)
+.++|+|||++...... .....++..|+|||++.+ ..++.++||||||+++|+|++ |..||......+.
T Consensus 154 ~~~~l~Dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~ 223 (278)
T 1byg_A 154 NVAKVSDFGLTKEASST--QDTGKLPVKWTAPEALRE--------KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV 223 (278)
T ss_dssp SCEEECCCCC--------------CCTTTSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH
T ss_pred CcEEEeecccccccccc--ccCCCccccccCHHHhCC--------CCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 69999999999754332 223467889999999864 567889999999999999998 9999987665554
Q ss_pred HHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 024408 158 AYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 208 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 208 (268)
............+..+++.+.++|.+||..||.+||++.++++.|+.....
T Consensus 224 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 224 VPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp HHHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHhcCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 444444434455678899999999999999999999999999999887643
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=260.60 Aligned_cols=190 Identities=21% Similarity=0.302 Sum_probs=161.6
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ .++..++||||++|++|.+++...+. +++..++.++.|++.||.|||++|++||||||+||+++.+ +
T Consensus 75 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~-~ 151 (284)
T 2vgo_A 75 NILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR--FDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYK-G 151 (284)
T ss_dssp TBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTT-C
T ss_pred CEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCC-C
Confidence 578999999 55688999999999999999987655 9999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 024408 80 TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY 159 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~ 159 (268)
.++|+|||++...... ......|++.|+|||++.+ ..++.++|+||||+++|+|++|..||......+...
T Consensus 152 ~~kl~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 222 (284)
T 2vgo_A 152 ELKIADFGWSVHAPSL-RRRTMCGTLDYLPPEMIEG--------KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHR 222 (284)
T ss_dssp CEEECCCTTCEECSSS-CBCCCCSCGGGCCHHHHTT--------CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH
T ss_pred CEEEecccccccCccc-ccccccCCCCcCCHHHhcc--------CCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHH
Confidence 9999999998754332 2245578999999999864 457889999999999999999999998766554433
Q ss_pred HHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 024408 160 AAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 203 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~ 203 (268)
.. .......+..++..+.++|.+||..||.+||++.++++|-+
T Consensus 223 ~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~ 265 (284)
T 2vgo_A 223 RI-VNVDLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPW 265 (284)
T ss_dssp HH-HTTCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHH
T ss_pred HH-hccccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHH
Confidence 33 33333445678999999999999999999999999999844
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=280.87 Aligned_cols=199 Identities=21% Similarity=0.293 Sum_probs=158.2
Q ss_pred eEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEe---CCCC
Q 024408 4 QFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT---EDLK 79 (268)
Q Consensus 4 ~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~---~~~~ 79 (268)
.+..++ .++..+|||||+ |++|.+++..... .+++.+++.++.||+.||+|||++||+||||||+|||++ .+ +
T Consensus 67 ~i~~~~~~~~~~~lvme~~-g~sL~~ll~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~-~ 143 (483)
T 3sv0_A 67 NVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA-N 143 (483)
T ss_dssp CEEEEEEETTEEEEEEECC-CCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGT-T
T ss_pred eEEEEEeeCCEEEEEEECC-CCCHHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCC-C
Confidence 344444 456789999999 8999999986443 399999999999999999999999999999999999994 55 6
Q ss_pred CeEEecCCCccccccccc--------cccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 024408 80 TIKLADFGLAREESLTEM--------MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 151 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~ 151 (268)
.+||+|||+++....... .....||..|+|||++.+ ..++.++||||||+++|+|++|+.||.+
T Consensus 144 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--------~~~s~~sDvwSlGvil~elltG~~Pf~~ 215 (483)
T 3sv0_A 144 QVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLG--------IEQSRRDDLESLGYVLMYFLRGSLPWQG 215 (483)
T ss_dssp CEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--------CCCCHHHHHHHHHHHHHHHHHSSCTTSS
T ss_pred eEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcC--------CCCChHHHHHHHHHHHHHHHhCCCCCcc
Confidence 899999999985443221 225679999999999864 5688999999999999999999999987
Q ss_pred CChH---HHHHHHHhcc----CCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhcCCCC
Q 024408 152 MSNL---QAAYAAAFKN----VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPE 213 (268)
Q Consensus 152 ~~~~---~~~~~~~~~~----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~~~~~~ 213 (268)
.... +......... .......++.++.++|..||..+|++||++.+|++.|+.++.....+.
T Consensus 216 ~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~ 284 (483)
T 3sv0_A 216 LKAGTKKQKYEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQF 284 (483)
T ss_dssp CCCSSHHHHHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCC
T ss_pred ccchhHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCc
Confidence 5431 1111111111 111235789999999999999999999999999999999887665443
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=265.49 Aligned_cols=198 Identities=24% Similarity=0.396 Sum_probs=159.9
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEe
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMR----PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 75 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~ 75 (268)
|+|++++++ .++..++||||++ |+|.+++.... ...+++..+..++.|++.||.|||++||+||||||+||+++
T Consensus 64 ~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~ 142 (317)
T 2pmi_A 64 NIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLIN 142 (317)
T ss_dssp TBCCEEEEECCTTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC
T ss_pred CcceEEEEEEECCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEc
Confidence 689999999 4568999999997 69999987642 23499999999999999999999999999999999999999
Q ss_pred CCCCCeEEecCCCccccccc-cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh
Q 024408 76 EDLKTIKLADFGLAREESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN 154 (268)
Q Consensus 76 ~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~ 154 (268)
.+ +.+||+|||+++..... .......||+.|+|||++.+ ...++.++||||||+++|+|++|+.||.+...
T Consensus 143 ~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 214 (317)
T 2pmi_A 143 KR-GQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMG-------SRTYSTSIDIWSCGCILAEMITGKPLFPGTND 214 (317)
T ss_dssp TT-CCEEECCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTT-------CCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred CC-CCEEECcCccceecCCCcccCCCCcccccccCchHhhC-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 88 69999999999864432 23345578999999998853 24578899999999999999999999988766
Q ss_pred HHHHHHHHhccCCC---------------------------------CCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 155 LQAAYAAAFKNVRP---------------------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 155 ~~~~~~~~~~~~~~---------------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
.+...........+ ....++.++.++|.+||..||.+|||+.++++|
T Consensus 215 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 215 EEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp HHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 55443332211100 122578899999999999999999999999998
Q ss_pred HHHhHhhc
Q 024408 202 LLNYLSAI 209 (268)
Q Consensus 202 l~~~~~~~ 209 (268)
.++...
T Consensus 295 --p~f~~~ 300 (317)
T 2pmi_A 295 --PWFAEY 300 (317)
T ss_dssp --GGGGGG
T ss_pred --hhhhcc
Confidence 444443
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-38 Score=268.68 Aligned_cols=194 Identities=25% Similarity=0.349 Sum_probs=159.1
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ .++..++||||++|++|.+++.+... +++..+..++.|++.||.|||++||+||||||+|||++.+ +
T Consensus 120 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~ 196 (355)
T 1vzo_A 120 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER--FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSN-G 196 (355)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-S
T ss_pred ceeEEEEEEeeCceEEEEeecCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-C
Confidence 578999998 55689999999999999999987655 9999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccc--cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---h
Q 024408 80 TIKLADFGLAREESLT--EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS---N 154 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~---~ 154 (268)
.+||+|||+++..... .......||+.|+|||++.+ ....++.++||||||+++|+|++|+.||.... .
T Consensus 197 ~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~ 270 (355)
T 1vzo_A 197 HVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRG------GDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS 270 (355)
T ss_dssp CEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTT------CC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC
T ss_pred cEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcC------CCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch
Confidence 9999999999854332 22334579999999999863 12346789999999999999999999996432 2
Q ss_pred HHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCC-----CHHHHHHHHH
Q 024408 155 LQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARP-----NFTQIIQMLL 203 (268)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~~~~~l~ 203 (268)
.............+.+..++..+.++|.+||..||.+|| ++.+++++.+
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~ 324 (355)
T 1vzo_A 271 QAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324 (355)
T ss_dssp HHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred HHHHHHHHhccCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcc
Confidence 222233333444555678899999999999999999999 9999999853
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=270.63 Aligned_cols=199 Identities=27% Similarity=0.473 Sum_probs=164.1
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcC------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMR------------PRCLDVCVAIGFALDIARAMECLHSHGIIHRDL 67 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~------------~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Di 67 (268)
++++++|++ .++..++||||++||+|.+++.... ...+++..++.++.|++.||+|||++|++||||
T Consensus 111 ~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dl 190 (333)
T 2i1m_A 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDV 190 (333)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred CeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCc
Confidence 689999999 4568999999999999999997642 234899999999999999999999999999999
Q ss_pred CCCCEEEeCCCCCeEEecCCCcccccccc---ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh
Q 024408 68 KPENLLLTEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH 144 (268)
Q Consensus 68 kp~Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~ 144 (268)
||+||+++.+ +.++|+|||++....... ......+++.|+|||++.+ ..++.++||||||+++|+|++
T Consensus 191 kp~NIl~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~t 261 (333)
T 2i1m_A 191 AARNVLLTNG-HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFD--------CVYTVQSDVWSYGILLWEIFS 261 (333)
T ss_dssp SGGGCEEEGG-GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHH--------CCCCHHHHHHHHHHHHHHHTT
T ss_pred ccceEEECCC-CeEEECccccccccccccceeecCCCCCCccccCHHHhcc--------CCCChHHHHHHHHHHHHHHHc
Confidence 9999999988 699999999998543322 1233456789999998864 567899999999999999998
Q ss_pred -CCCCCCCCChHHHHHHHHhcc-CCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 024408 145 -NKLPFEGMSNLQAAYAAAFKN-VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 208 (268)
Q Consensus 145 -g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 208 (268)
|..||.+.............. ....+..++..+.+++.+||..||.+||++.+++++|+.....
T Consensus 262 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 262 LGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327 (333)
T ss_dssp TSCCSSTTCCSSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCcccchhHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence 999998765444433333332 3344667899999999999999999999999999999887654
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=262.96 Aligned_cols=196 Identities=24% Similarity=0.333 Sum_probs=154.3
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
++|++++++ .++..++||||++ ++|.+.+..... .+++..+..++.|++.||+|||++|++||||||+||+++.+ +
T Consensus 62 ~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~-~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~-~ 138 (292)
T 3o0g_A 62 NIVRLHDVLHSDKKLTLVFEFCD-QDLKKYFDSCNG-DLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRN-G 138 (292)
T ss_dssp TBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-S
T ss_pred CEeeEEeEEEeCCEEEEEEecCC-CCHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-C
Confidence 589999999 5668999999997 577777665333 39999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccc-cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCC-CCCChHHH
Q 024408 80 TIKLADFGLAREESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPF-EGMSNLQA 157 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~-~~~~~~~~ 157 (268)
.+||+|||+++..... .......||+.|+|||++.+ ...++.++||||||+++|+|++|..|| .+....+.
T Consensus 139 ~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~ 211 (292)
T 3o0g_A 139 ELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG-------AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ 211 (292)
T ss_dssp CEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTT-------CSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHH
T ss_pred CEEEeecccceecCCccccccCCccccCCcChHHHcC-------CCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHH
Confidence 9999999999864432 23345578999999999864 234788999999999999999988775 44333333
Q ss_pred HHHHHhccCCC----------------------------CCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 024408 158 AYAAAFKNVRP----------------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 208 (268)
Q Consensus 158 ~~~~~~~~~~~----------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 208 (268)
..........+ ....++.+++++|.+||+.||.+|||++++++| .++..
T Consensus 212 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h--p~f~~ 288 (292)
T 3o0g_A 212 LKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH--PYFSD 288 (292)
T ss_dssp HHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS--GGGTT
T ss_pred HHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC--ccccc
Confidence 32222211111 123478899999999999999999999999998 44444
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=265.26 Aligned_cols=197 Identities=22% Similarity=0.349 Sum_probs=155.9
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|+|++++++ .++..++||||++ |+|.+++..... .+++..+..++.|++.||.|||++||+||||||+||+++.+ +
T Consensus 61 ~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~-~ 137 (324)
T 3mtl_A 61 NIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGN-IINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINER-G 137 (324)
T ss_dssp TBCCEEEEEECSSCEEEEEECCS-EEHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTT-C
T ss_pred CCCeeeeEEeeCCEEEEEecccc-cCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCC-C
Confidence 589999999 5568999999996 699999987543 49999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccc-cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.+||+|||+++..... .......||+.|+|||++.+ ...++.++||||||+++|+|++|+.||.+....+..
T Consensus 138 ~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~ 210 (324)
T 3mtl_A 138 ELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLG-------STDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQL 210 (324)
T ss_dssp CEEECSSSEEECC------------CGGGCCHHHHTT-------CCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred CEEEccCcccccccCCccccccccCcccccChhhhcC-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 9999999999754432 22344578999999998853 245788999999999999999999999987765544
Q ss_pred HHHHhccCCCC-----------------------------CCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhc
Q 024408 159 YAAAFKNVRPS-----------------------------AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 209 (268)
Q Consensus 159 ~~~~~~~~~~~-----------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~~ 209 (268)
.........+. ...+++++.++|.+||..||.+|||++++++| .++...
T Consensus 211 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h--p~f~~~ 288 (324)
T 3mtl_A 211 HFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH--PFFLSL 288 (324)
T ss_dssp HHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS--GGGGGG
T ss_pred HHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC--hhhhhc
Confidence 43332211111 13467899999999999999999999999998 444443
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=265.83 Aligned_cols=196 Identities=25% Similarity=0.359 Sum_probs=155.0
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ .++..++||||++|++|.+++..... +++..+..++.|++.||.|||++|++||||||+||+++.+ +
T Consensus 63 ~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~--~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~-~ 139 (311)
T 4agu_A 63 NLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRG--VPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKH-S 139 (311)
T ss_dssp TBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTSSC--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-S
T ss_pred CccchhheeecCCeEEEEEEeCCCchHHHHHhhhcC--CCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCC-C
Confidence 588999999 55688999999999999998876544 9999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccc-ccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESL-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.++|+|||++..... ........||..|+|||++.+ ...++.++||||||+++|+|++|..||.+....+..
T Consensus 140 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~ 212 (311)
T 4agu_A 140 VIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVG-------DTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQL 212 (311)
T ss_dssp CEEECCCTTCEECC------------GGGCCHHHHHT-------CSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred CEEEeeCCCchhccCcccccCCCcCCccccChHHHhc-------CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 999999999986442 223345578999999998853 245788999999999999999999999887665544
Q ss_pred HHHHhccC--------------------CCC----------CCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 024408 159 YAAAFKNV--------------------RPS----------AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 208 (268)
Q Consensus 159 ~~~~~~~~--------------------~~~----------~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 208 (268)
........ .+. ...++.++.++|.+||..||.+|||++++++| .++..
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h--p~f~~ 290 (311)
T 4agu_A 213 YLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH--PYFEN 290 (311)
T ss_dssp HHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS--GGGTT
T ss_pred HHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC--hHHHh
Confidence 33221100 000 14578899999999999999999999999998 44444
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=266.42 Aligned_cols=200 Identities=29% Similarity=0.526 Sum_probs=165.3
Q ss_pred CceeEEEeecC--CcEEEEEEcCCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCee
Q 024408 1 MREQFIGACKE--PVMVIVTELLSGGTLRKYLLNMRP--------------RCLDVCVAIGFALDIARAMECLHSHGIIH 64 (268)
Q Consensus 1 ~~v~l~g~~~~--~~~~lV~e~~~ggsL~~~i~~~~~--------------~~~~~~~~~~~~~~l~~~l~~lH~~gi~H 64 (268)
++++++|++.+ ...++||||++|++|.+++..... ..+++..++.++.|++.||.|||++|++|
T Consensus 92 ~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H 171 (316)
T 2xir_A 92 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIH 171 (316)
T ss_dssp TBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred CeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 58999999844 358999999999999999987543 12899999999999999999999999999
Q ss_pred cCCCCCCEEEeCCCCCeEEecCCCcccccccc---ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHH
Q 024408 65 RDLKPENLLLTEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWE 141 (268)
Q Consensus 65 ~Dikp~Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ 141 (268)
|||||+||+++.+ +.+||+|||+++...... ......||+.|+|||++.+ ..++.++||||||+++|+
T Consensus 172 ~dikp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~Di~slG~il~~ 242 (316)
T 2xir_A 172 RDLAARNILLSEK-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD--------RVYTIQSDVWSFGVLLWE 242 (316)
T ss_dssp SCCSGGGEEECGG-GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHH
T ss_pred ccCccceEEECCC-CCEEECCCccccccccCccceeccCCCcceeecCchhhcc--------ccccchhHHHHHHHHHHH
Confidence 9999999999987 689999999997543321 2233457889999999864 567899999999999999
Q ss_pred HHh-CCCCCCCCChHHHHHHHH-hccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhc
Q 024408 142 LLH-NKLPFEGMSNLQAAYAAA-FKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 209 (268)
Q Consensus 142 ll~-g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~~ 209 (268)
|++ |..||.+........... .......+..+++.+.+++.+||..||.+||++.+++++|+.++...
T Consensus 243 l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 312 (316)
T 2xir_A 243 IFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 312 (316)
T ss_dssp HHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHhCCCCCCcccchhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 998 999998765444333333 33334446678999999999999999999999999999999988654
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=281.36 Aligned_cols=192 Identities=27% Similarity=0.401 Sum_probs=164.3
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|+|++++++ .++..++||||++||+|.+++..... +++..++.++.|++.||+|||++||+||||||+||+++.+..
T Consensus 107 niv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~ 184 (504)
T 3q5i_A 107 NIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK--FDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNS 184 (504)
T ss_dssp TBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTC
T ss_pred CCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCC
Confidence 689999999 45689999999999999999987655 999999999999999999999999999999999999987632
Q ss_pred --CeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 024408 80 --TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA 157 (268)
Q Consensus 80 --~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~ 157 (268)
.+||+|||++.............||+.|+|||++. ..++.++||||+|+++|+|++|..||.+....+.
T Consensus 185 ~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 255 (504)
T 3q5i_A 185 LLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLK---------KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDI 255 (504)
T ss_dssp CSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHT---------TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred CccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhc---------cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 69999999998766555556678999999999874 3578899999999999999999999998776655
Q ss_pred HHHHHhccCCCC---CCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 024408 158 AYAAAFKNVRPS---AENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 203 (268)
Q Consensus 158 ~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~ 203 (268)
............ ...+++++.++|.+||..||.+|||+.++++|.+
T Consensus 256 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 304 (504)
T 3q5i_A 256 IKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRW 304 (504)
T ss_dssp HHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred HHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHh
Confidence 554444333222 3578999999999999999999999999999844
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=266.42 Aligned_cols=194 Identities=24% Similarity=0.440 Sum_probs=156.7
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|+++++|++ .++..++||||++|++|.+++.+... .+++..++.++.|++.||.|||++|++||||||+||+++.+ +
T Consensus 73 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~-~ 150 (289)
T 4fvq_A 73 HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKN-CINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIRE-E 150 (289)
T ss_dssp TBCCEEEEECCTTCCEEEEECCTTCBHHHHHHHTGG-GCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEEC-C
T ss_pred CEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecC-C
Confidence 689999999 45678999999999999999987543 39999999999999999999999999999999999999877 3
Q ss_pred C--------eEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhC-CCCCC
Q 024408 80 T--------IKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHN-KLPFE 150 (268)
Q Consensus 80 ~--------~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g-~~p~~ 150 (268)
. ++|+|||++...... ....|+..|+|||++.+ ...++.++||||||+++|+|++| ..||.
T Consensus 151 ~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~il~el~~g~~~~~~ 220 (289)
T 4fvq_A 151 DRKTGNPPFIKLSDPGISITVLPK---DILQERIPWVPPECIEN-------PKNLNLATDKWSFGTTLWEICSGGDKPLS 220 (289)
T ss_dssp BGGGTBCCEEEECCCCSCTTTSCH---HHHHHTTTTSCHHHHHC-------GGGCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred cccccccceeeeccCcccccccCc---cccCCcCcccCHHHhCC-------CCCCCchhHHHHHHHHHHHHHcCCCCCcc
Confidence 4 999999999754333 23357889999998853 24578899999999999999995 45555
Q ss_pred CCChHHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 024408 151 GMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 208 (268)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 208 (268)
......... ........+...+.++.+++.+||+.||.+||++.+++++|+.++..
T Consensus 221 ~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p 276 (289)
T 4fvq_A 221 ALDSQRKLQ--FYEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276 (289)
T ss_dssp TSCHHHHHH--HHHTTCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred ccchHHHHH--HhhccCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 544333222 22233344556788999999999999999999999999999887654
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-38 Score=260.12 Aligned_cols=193 Identities=30% Similarity=0.546 Sum_probs=158.7
Q ss_pred CceeEEEeecCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCCEEEeCCC
Q 024408 1 MREQFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG--IIHRDLKPENLLLTEDL 78 (268)
Q Consensus 1 ~~v~l~g~~~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~g--i~H~Dikp~Nill~~~~ 78 (268)
+++++++++.++. ++||||++||+|.+++.+... .+++..++.++.|++.||+|||++| ++||||||+||+++.+
T Consensus 84 ~i~~~~~~~~~~~-~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~- 160 (287)
T 4f0f_A 84 NIVKLYGLMHNPP-RMVMEFVPCGDLYHRLLDKAH-PIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSL- 160 (287)
T ss_dssp TBCCEEEEETTTT-EEEEECCTTCBHHHHHHCTTS-CCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCC-
T ss_pred CchhhheeecCCC-eEEEEecCCCCHHHHHhcccC-CccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEecc-
Confidence 5899999996654 799999999999999876543 4999999999999999999999999 9999999999999876
Q ss_pred CC-----eEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 024408 79 KT-----IKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS 153 (268)
Q Consensus 79 ~~-----~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~ 153 (268)
+. +||+|||+++.... ......||+.|+|||++.. ....++.++||||||+++|+|++|+.||....
T Consensus 161 ~~~~~~~~kl~Dfg~~~~~~~--~~~~~~g~~~y~aPE~~~~------~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 232 (287)
T 4f0f_A 161 DENAPVCAKVADFGLSQQSVH--SVSGLLGNFQWMAPETIGA------EEESYTEKADTYSFAMILYTILTGEGPFDEYS 232 (287)
T ss_dssp CTTCSCCEEECCCTTCBCCSS--CEECCCCCCTTSCGGGSSC------SSCEECHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred CCCCceeEEeCCCCccccccc--cccccCCCccccCchhhcc------CCCCcCchhhHHHHHHHHHHHHcCCCCCcccc
Confidence 34 99999999985433 2345678999999998843 12456789999999999999999999997655
Q ss_pred hHHH--HHHHHh-ccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 024408 154 NLQA--AYAAAF-KNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 204 (268)
Q Consensus 154 ~~~~--~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~ 204 (268)
.... ...... ......+..+++++.++|.+||..||.+||++.++++.|++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 233 YGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp CCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred ccHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 4333 222222 22334467889999999999999999999999999999864
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=268.03 Aligned_cols=200 Identities=29% Similarity=0.496 Sum_probs=166.0
Q ss_pred CceeEEEeec-CCcEEEEEEcCCCCCHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEE
Q 024408 1 MREQFIGACK-EPVMVIVTELLSGGTLRKYLLNMRP-----RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL 74 (268)
Q Consensus 1 ~~v~l~g~~~-~~~~~lV~e~~~ggsL~~~i~~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill 74 (268)
++++++|++. .+..++||||++|++|.+++..... ..+++.+++.++.|++.||.|||++|++||||||+||++
T Consensus 94 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli 173 (327)
T 2yfx_A 94 NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLL 173 (327)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred CCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEE
Confidence 5899999994 4578999999999999999987542 348999999999999999999999999999999999999
Q ss_pred eCC--CCCeEEecCCCccccccc---cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCC
Q 024408 75 TED--LKTIKLADFGLAREESLT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLP 148 (268)
Q Consensus 75 ~~~--~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p 148 (268)
+.+ ...++|+|||++...... .......|++.|+|||++.+ ..++.++||||||+++|+|++ |..|
T Consensus 174 ~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~ellt~g~~p 245 (327)
T 2yfx_A 174 TCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFME--------GIFTSKTDTWSFGVLLWEIFSLGYMP 245 (327)
T ss_dssp SCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred ecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcC--------CCCCchhhHHHHHHHHHHHHcCCCCC
Confidence 843 246999999998743221 12233467889999998864 567889999999999999998 9999
Q ss_pred CCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 024408 149 FEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 208 (268)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 208 (268)
|......+.............+..++..+.++|.+||..||.+||++.+++++|+.....
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 246 YPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp STTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCcCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 988766555555554445555678899999999999999999999999999999987654
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=269.65 Aligned_cols=196 Identities=25% Similarity=0.367 Sum_probs=163.2
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ ..+..++||||++|++|.+++..... +++..+..++.|++.||.|||+.|++||||||+||+++.+ +
T Consensus 161 ~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~--l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~-~ 237 (365)
T 2y7j_A 161 HIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVA--LSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDN-M 237 (365)
T ss_dssp TBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-C
T ss_pred CEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC-C
Confidence 578999998 55689999999999999999987654 9999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 024408 80 TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY 159 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~ 159 (268)
.++|+|||++.............||+.|+|||++.+... .....++.++||||||+++|+|++|..||..........
T Consensus 238 ~ikl~DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~ 315 (365)
T 2y7j_A 238 QIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMD--ETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLR 315 (365)
T ss_dssp CEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTC--TTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred CEEEEecCcccccCCCcccccCCCCCCccChhhcccccc--ccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 999999999986655555556789999999998864211 012357889999999999999999999998766555444
Q ss_pred HHHhccCCCC---CCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 160 AAAFKNVRPS---AENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 160 ~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
.......... ...++..+.++|.+||..||.+||++.++++|
T Consensus 316 ~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 316 MIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp HHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 3333332221 25678899999999999999999999999987
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=263.41 Aligned_cols=194 Identities=25% Similarity=0.369 Sum_probs=157.5
Q ss_pred CceeEEEeec---CCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCC
Q 024408 1 MREQFIGACK---EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED 77 (268)
Q Consensus 1 ~~v~l~g~~~---~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~ 77 (268)
|++++++++. ++..++||||++|++|.+++.. ..+++.+++.++.|++.||+|||++|++||||||+||+++.+
T Consensus 97 ~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~ 173 (298)
T 2zv2_A 97 NVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGED 173 (298)
T ss_dssp TBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT
T ss_pred CCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCC
Confidence 5899999985 3578999999999999886532 349999999999999999999999999999999999999988
Q ss_pred CCCeEEecCCCccccccc-cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH
Q 024408 78 LKTIKLADFGLAREESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 156 (268)
Q Consensus 78 ~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~ 156 (268)
+.+||+|||+++..... .......||+.|+|||++.+.. ...++.++||||||+++|+|++|+.||.+.....
T Consensus 174 -~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 247 (298)
T 2zv2_A 174 -GHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETR-----KIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMC 247 (298)
T ss_dssp -SCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTC-----CCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred -CCEEEecCCCccccccccccccCCcCCccccChhhhccCC-----CCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHH
Confidence 69999999999864432 2234567999999999986410 1124678999999999999999999998766544
Q ss_pred HHHHHHhccC-CCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 024408 157 AAYAAAFKNV-RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 203 (268)
Q Consensus 157 ~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~ 203 (268)
.......... .+....+++++.++|.+||..||.+||++.++++|-+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~ 295 (298)
T 2zv2_A 248 LHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPW 295 (298)
T ss_dssp HHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHH
T ss_pred HHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcc
Confidence 4333332222 2334678999999999999999999999999998743
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=282.24 Aligned_cols=191 Identities=24% Similarity=0.365 Sum_probs=163.7
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEe---C
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT---E 76 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~---~ 76 (268)
|+|++++++ ..+..++||||+.||+|.+++...+. +++..+..++.|++.||.|||++||+||||||+||+++ .
T Consensus 87 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~ 164 (484)
T 3nyv_A 87 NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR--FSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSK 164 (484)
T ss_dssp TBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSC--CBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSST
T ss_pred CCCcEEEEEEeCCEEEEEEecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCC
Confidence 689999999 45689999999999999999987554 99999999999999999999999999999999999995 3
Q ss_pred CCCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH
Q 024408 77 DLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 156 (268)
Q Consensus 77 ~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~ 156 (268)
+ +.+||+|||+++............||+.|+|||++. +.++.++||||||+++|+|++|..||.+....+
T Consensus 165 ~-~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 234 (484)
T 3nyv_A 165 D-ANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLH---------GTYDEKCDVWSTGVILYILLSGCPPFNGANEYD 234 (484)
T ss_dssp T-CCEEECCTTHHHHBCCCCSHHHHTTGGGTCCHHHHH---------TCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred C-CcEEEEeeeeeEEcccccccccCCCCccccCceeec---------CCCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH
Confidence 4 689999999998665555555668999999999885 357889999999999999999999999877666
Q ss_pred HHHHHHhccCCC---CCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 024408 157 AAYAAAFKNVRP---SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 203 (268)
Q Consensus 157 ~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~ 203 (268)
............ ....+++++.++|.+||..||.+|||+.++++|.+
T Consensus 235 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~ 284 (484)
T 3nyv_A 235 ILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEW 284 (484)
T ss_dssp HHHHHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHH
T ss_pred HHHHHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChh
Confidence 555544443322 23568899999999999999999999999999854
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=274.29 Aligned_cols=189 Identities=24% Similarity=0.340 Sum_probs=153.9
Q ss_pred CceeEEEeec-C--CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCC
Q 024408 1 MREQFIGACK-E--PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED 77 (268)
Q Consensus 1 ~~v~l~g~~~-~--~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~ 77 (268)
|+|++++++. + ..+|+||||++ ++|.+++... .+++..+..++.|++.||+|||++||+||||||+|||++.+
T Consensus 70 niv~l~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~ 145 (388)
T 3oz6_A 70 NIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAE 145 (388)
T ss_dssp TBCCEEEEEECTTSSCEEEEEECCS-EEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT
T ss_pred CCCeeeeEEecCCCCEEEEEecccC-cCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCC
Confidence 6899999984 2 36899999996 6999999763 39999999999999999999999999999999999999988
Q ss_pred CCCeEEecCCCcccccc----------------------ccccccCCCccceeccccccccccccCCCCCCCchhhHHHH
Q 024408 78 LKTIKLADFGLAREESL----------------------TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSF 135 (268)
Q Consensus 78 ~~~~kl~Dfg~a~~~~~----------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvwsl 135 (268)
+.+||+|||+++.... ........||++|+|||++.+ ...++.++|||||
T Consensus 146 -~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwSl 217 (388)
T 3oz6_A 146 -CHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLG-------STKYTKGIDMWSL 217 (388)
T ss_dssp -CCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTT-------CCCCCTHHHHHHH
T ss_pred -CCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcC-------CCCCCChhhHHHH
Confidence 6999999999975322 112234579999999999853 2567899999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCC----------------------------------------------
Q 024408 136 AIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS---------------------------------------------- 169 (268)
Q Consensus 136 G~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~---------------------------------------------- 169 (268)
||++|+|++|+.||.+.+..............+.
T Consensus 218 G~il~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (388)
T 3oz6_A 218 GCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINP 297 (388)
T ss_dssp HHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCT
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccc
Confidence 9999999999999998776555444332211111
Q ss_pred CCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 170 AENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 170 ~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
...+++++.++|.+||..||.+|||+.++++|
T Consensus 298 ~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 298 KADCNEEALDLLDKLLQFNPNKRISANDALKH 329 (388)
T ss_dssp TCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred cccCCHHHHHHHHHhhccCcccCCCHHHHhCC
Confidence 12678899999999999999999999999998
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=269.42 Aligned_cols=199 Identities=27% Similarity=0.435 Sum_probs=159.8
Q ss_pred CceeEEEeec---CCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCC
Q 024408 1 MREQFIGACK---EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED 77 (268)
Q Consensus 1 ~~v~l~g~~~---~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~ 77 (268)
+++++++++. +...++||||++|++|.+++..... .+++.+++.++.|++.||+|||++|++||||||+||+++.+
T Consensus 85 ~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~ 163 (327)
T 3lxl_A 85 FIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA-RLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESE 163 (327)
T ss_dssp TBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHHGG-GCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET
T ss_pred ceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCC
Confidence 5789999873 3468999999999999999987433 39999999999999999999999999999999999999988
Q ss_pred CCCeEEecCCCcccccccc----ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 024408 78 LKTIKLADFGLAREESLTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS 153 (268)
Q Consensus 78 ~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~ 153 (268)
+.++|+|||++....... ......|+..|+|||++.+ ..++.++||||||+++|+|++|..||....
T Consensus 164 -~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~ll~g~~p~~~~~ 234 (327)
T 3lxl_A 164 -AHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSD--------NIFSRQSDVWSFGVVLYELFTYCDKSCSPS 234 (327)
T ss_dssp -TEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHH--------CEEEHHHHHHHHHHHHHHHHTTTCGGGSHH
T ss_pred -CCEEEcccccceecccCCccceeeccCCccccccCHHHhcc--------CCCChHHhHHHHHHHHHHHHhCCCCCcccc
Confidence 699999999998543322 2233467888999999864 456789999999999999999999986432
Q ss_pred hH---------------HHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhc
Q 024408 154 NL---------------QAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 209 (268)
Q Consensus 154 ~~---------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~~ 209 (268)
.. ............+.+..+++.+.++|.+||..||.+||++.+++++|+......
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 235 AEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp HHHHHHCC----CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred chhhhhcccccccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 21 111122223334456788999999999999999999999999999999876543
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=264.22 Aligned_cols=196 Identities=24% Similarity=0.472 Sum_probs=159.5
Q ss_pred CceeEEEeecC---CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCC
Q 024408 1 MREQFIGACKE---PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED 77 (268)
Q Consensus 1 ~~v~l~g~~~~---~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~ 77 (268)
+++++++++.. ...++||||++|++|.+++.+.... +++.+++.++.|++.||+|||++|++||||||+||+++.+
T Consensus 84 ~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~ 162 (302)
T 4e5w_A 84 NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK-INLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESE 162 (302)
T ss_dssp TBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHHHTTT-CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET
T ss_pred CeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHhcccc-CCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCC
Confidence 57899999843 4689999999999999999765433 9999999999999999999999999999999999999988
Q ss_pred CCCeEEecCCCcccccccc----ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 024408 78 LKTIKLADFGLAREESLTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS 153 (268)
Q Consensus 78 ~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~ 153 (268)
+.++|+|||++....... ......||..|+|||++.+ ..++.++||||||+++|+|++|..|+....
T Consensus 163 -~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 233 (302)
T 4e5w_A 163 -HQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQ--------SKFYIASDVWSFGVTLHELLTYCDSDSSPM 233 (302)
T ss_dssp -TEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHH--------CEEEHHHHHHHHHHHHHHHHTTTCGGGSHH
T ss_pred -CCEEECcccccccccCCCcceeccCCCCCCccccCCeeecC--------CCCCcchhHHHHHHHHHHHHHccCCCcchh
Confidence 699999999998544332 2334567888999998865 456789999999999999999988764211
Q ss_pred --------------hHHH-HHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhH
Q 024408 154 --------------NLQA-AYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 206 (268)
Q Consensus 154 --------------~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 206 (268)
.... ..........+.+..+++.+.++|.+||..||.+|||+.++++.|+.++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 234 ALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHHHCSCCGGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hHHhhccCCcccccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 1111 1122233344456788999999999999999999999999999998765
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=261.69 Aligned_cols=194 Identities=26% Similarity=0.421 Sum_probs=160.6
Q ss_pred CceeEEEeec-----------------CCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCe
Q 024408 1 MREQFIGACK-----------------EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 63 (268)
Q Consensus 1 ~~v~l~g~~~-----------------~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~ 63 (268)
+++++++++. ....++||||++|++|.+++.+.....+++..++.++.|++.||.|||++|++
T Consensus 65 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~ 144 (284)
T 2a19_B 65 NIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLI 144 (284)
T ss_dssp TBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred CEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 5788888873 23589999999999999999876555599999999999999999999999999
Q ss_pred ecCCCCCCEEEeCCCCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHH
Q 024408 64 HRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL 143 (268)
Q Consensus 64 H~Dikp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll 143 (268)
||||||+||+++.+ +.++|+|||++.............|++.|+|||++.+ ..++.++||||||+++|+|+
T Consensus 145 H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~ 215 (284)
T 2a19_B 145 NRDLKPSNIFLVDT-KQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISS--------QDYGKEVDLYALGLILAELL 215 (284)
T ss_dssp CSCCSGGGEEEEET-TEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHC--------SCCCTHHHHHHHHHHHHHHH
T ss_pred eccCCHHHEEEcCC-CCEEECcchhheeccccccccccCCcccccChhhhcc--------CCCcchhhhHHHHHHHHHHH
Confidence 99999999999988 6999999999986555444455679999999999864 56788999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 024408 144 HNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 208 (268)
Q Consensus 144 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 208 (268)
+|..|+... ........ .......++..+.++|.+||..||.+||++.+++++|+.+...
T Consensus 216 ~~~~~~~~~---~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 216 HVCDTAFET---SKFFTDLR--DGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp SCCSSHHHH---HHHHHHHH--TTCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred hcCCcchhH---HHHHHHhh--cccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 999887431 11111111 1223567889999999999999999999999999999887654
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-38 Score=287.26 Aligned_cols=198 Identities=29% Similarity=0.525 Sum_probs=168.5
Q ss_pred CceeEEEeecCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCC
Q 024408 1 MREQFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT 80 (268)
Q Consensus 1 ~~v~l~g~~~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~ 80 (268)
|+|+++|++.++..++||||++||+|.+++...+ ..+++..++.++.|++.||.|||++||+||||||+|||++.+ +.
T Consensus 452 nIv~l~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~-~~ 529 (656)
T 2j0j_A 452 HIVKLIGVITENPVWIIMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSN-DC 529 (656)
T ss_dssp TBCCEEEEECSSSCEEEEECCTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET-TE
T ss_pred CCCeEEEEEecCceEEEEEcCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCC-CC
Confidence 6899999998888999999999999999998654 349999999999999999999999999999999999999988 69
Q ss_pred eEEecCCCccccccccc--cccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 024408 81 IKLADFGLAREESLTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQA 157 (268)
Q Consensus 81 ~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~ 157 (268)
+||+|||+++....... .....+++.|+|||++.+ ..++.++||||||+++|||++ |..||.+....+.
T Consensus 530 vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~ 601 (656)
T 2j0j_A 530 VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF--------RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV 601 (656)
T ss_dssp EEECCCCCCCSCCC----------CCGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH
T ss_pred EEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcC--------CCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHH
Confidence 99999999986443322 223456789999999864 567889999999999999997 9999998777666
Q ss_pred HHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 024408 158 AYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 208 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 208 (268)
..........+.+..+++.+.++|.+||..||.+||++.++++.|+.++..
T Consensus 602 ~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 602 IGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHcCCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 655555555666788999999999999999999999999999999987754
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=268.31 Aligned_cols=185 Identities=23% Similarity=0.319 Sum_probs=157.4
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCC-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGG-TLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL 78 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~gg-sL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~ 78 (268)
|+|++++++ .++..++||||+.+| +|.+++.+... +++..++.++.|++.||.|||++|++||||||+||+++.+
T Consensus 90 ~Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~~~--l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~- 166 (335)
T 3dls_A 90 NIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPR--LDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAED- 166 (335)
T ss_dssp TBCCEEEEEECSSEEEEEEECCTTSCBHHHHHHTCCC--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-
T ss_pred CEeeEEEEEeeCCEEEEEEEeCCCCccHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCC-
Confidence 689999999 556889999999766 99999987554 9999999999999999999999999999999999999988
Q ss_pred CCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 79 KTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 79 ~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
+.+||+|||++.............||+.|+|||++.+ ....+.++||||||+++|+|++|..||.....
T Consensus 167 ~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---- 235 (335)
T 3dls_A 167 FTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMG-------NPYRGPELEMWSLGVTLYTLVFEENPFCELEE---- 235 (335)
T ss_dssp SCEEECCCTTCEECCTTCCBCEECSCGGGCCHHHHTT-------CCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG----
T ss_pred CcEEEeecccceECCCCCceeccCCCccccChhhhcC-------CCCCCCcccchhHHHHHHHHHhCCCchhhHHH----
Confidence 6999999999987655555556679999999999864 12347889999999999999999999976322
Q ss_pred HHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 024408 159 YAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 202 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l 202 (268)
........+..+++++.++|.+||..||.+||++.+++++.
T Consensus 236 ---~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp 276 (335)
T 3dls_A 236 ---TVEAAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDP 276 (335)
T ss_dssp ---GTTTCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCT
T ss_pred ---HHhhccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 12223334566899999999999999999999999999983
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=268.31 Aligned_cols=196 Identities=27% Similarity=0.356 Sum_probs=156.7
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcC--------------------------------------CCCCCHH
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMR--------------------------------------PRCLDVC 41 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~--------------------------------------~~~~~~~ 41 (268)
|+|++++++ .++..++||||++||+|.+++.... ...+++.
T Consensus 89 niv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (345)
T 3hko_A 89 NIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREK 168 (345)
T ss_dssp TBCCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHH
T ss_pred CcceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHH
Confidence 689999999 5568999999999999999985211 1124678
Q ss_pred HHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCC-CCeEEecCCCcccccccc-----ccccCCCccceeccccccc
Q 024408 42 VAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL-KTIKLADFGLAREESLTE-----MMTAETGTYRWMAPELYST 115 (268)
Q Consensus 42 ~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~-~~~kl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~ 115 (268)
.++.++.|++.||+|||++|++||||||+||+++.+. ..+||+|||+++...... ......||+.|+|||++.+
T Consensus 169 ~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 248 (345)
T 3hko_A 169 LISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNT 248 (345)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTC
T ss_pred HHHHHHHHHHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhcc
Confidence 8999999999999999999999999999999998652 279999999997532211 2345578999999998853
Q ss_pred cccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCC---CCCCcHHHHHHHHhccccCCCCC
Q 024408 116 VTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS---AENVPEELSIILTSCWKEDPNAR 192 (268)
Q Consensus 116 ~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~R 192 (268)
....++.++||||||+++|+|++|+.||.+....+............. ...+++++.++|.+||..||.+|
T Consensus 249 ------~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 322 (345)
T 3hko_A 249 ------TNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDER 322 (345)
T ss_dssp ------SSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTS
T ss_pred ------CCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHC
Confidence 235678899999999999999999999998777666555544433222 23478999999999999999999
Q ss_pred CCHHHHHHHH
Q 024408 193 PNFTQIIQML 202 (268)
Q Consensus 193 ps~~~~~~~l 202 (268)
|++.+++++-
T Consensus 323 ps~~~~l~hp 332 (345)
T 3hko_A 323 FDAMRALQHP 332 (345)
T ss_dssp CCHHHHHHSH
T ss_pred CCHHHHhcCh
Confidence 9999999984
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=258.78 Aligned_cols=192 Identities=26% Similarity=0.344 Sum_probs=156.8
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCC-
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL- 78 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~- 78 (268)
+++++++++ ..+..++||||++|++|.+++.+... +++.+++.++.|++.||.|||++|++||||||+||+++.+.
T Consensus 69 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~ 146 (283)
T 3bhy_A 69 NIITLHDIFENKTDVVLILELVSGGELFDFLAEKES--LTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNV 146 (283)
T ss_dssp TBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSS
T ss_pred CeeehhheecCCCeEEEEEeecCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCC
Confidence 578999999 45678999999999999999987554 99999999999999999999999999999999999998762
Q ss_pred --CCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH
Q 024408 79 --KTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 156 (268)
Q Consensus 79 --~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~ 156 (268)
..++|+|||++.............|++.|+|||++.+ ..++.++|+||||+++|+|++|..||.+....+
T Consensus 147 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 218 (283)
T 3bhy_A 147 PNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNY--------EPLGLEADMWSIGVITYILLSGASPFLGETKQE 218 (283)
T ss_dssp SSCCEEECCCTTCEECC--------CCCGGGCCHHHHTT--------CCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred CCCceEEEecccceeccCCCcccccCCCcCccCcceecC--------CCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH
Confidence 2799999999986555444455678999999998854 567889999999999999999999998866554
Q ss_pred HHHHHHhccCCCC---CCCCcHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 024408 157 AAYAAAFKNVRPS---AENVPEELSIILTSCWKEDPNARPNFTQIIQML 202 (268)
Q Consensus 157 ~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l 202 (268)
............. ...++..+.+++.+||..||.+||++.+++++-
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~ 267 (283)
T 3bhy_A 219 TLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHS 267 (283)
T ss_dssp HHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCH
T ss_pred HHHHhHhcccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCH
Confidence 4443332222211 256789999999999999999999999999974
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=281.45 Aligned_cols=192 Identities=24% Similarity=0.406 Sum_probs=160.5
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMR--PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED 77 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~ 77 (268)
++|++++++ ..+.+|+||||++||+|.+++.+.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 246 ~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~ 325 (543)
T 3c4z_A 246 FIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDD 325 (543)
T ss_dssp TBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT
T ss_pred CEeeEEEEEeeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCC
Confidence 578999998 5568999999999999999998754 3459999999999999999999999999999999999999988
Q ss_pred CCCeEEecCCCccccccccc-cccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---
Q 024408 78 LKTIKLADFGLAREESLTEM-MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS--- 153 (268)
Q Consensus 78 ~~~~kl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~--- 153 (268)
+.+||+|||+++....... .....||+.|+|||++.+ ..++.++|+||||+++|+|++|+.||.+..
T Consensus 326 -g~vkL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~--------~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~ 396 (543)
T 3c4z_A 326 -GNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG--------EEYDFSVDYFALGVTLYEMIAARGPFRARGEKV 396 (543)
T ss_dssp -SCEEECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC
T ss_pred -CCEEEeecceeeeccCCCcccccccCCccccChhhhcC--------CCCChHHhcCcchHHHHHHHhCCCCCCCCccch
Confidence 6999999999986544332 334589999999999864 567899999999999999999999997643
Q ss_pred hHHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCH-----HHHHHH
Q 024408 154 NLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNF-----TQIIQM 201 (268)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~-----~~~~~~ 201 (268)
................+..++.++.++|.+||..||.+||++ .++++|
T Consensus 397 ~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H 449 (543)
T 3c4z_A 397 ENKELKQRVLEQAVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH 449 (543)
T ss_dssp CHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred hHHHHHHHHhhcccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence 223333333344444567899999999999999999999964 788876
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=276.38 Aligned_cols=189 Identities=24% Similarity=0.268 Sum_probs=156.8
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ .++..++||||+. ++|.+++.......+++..++.++.|++.||+|||++||+||||||+|||++.+ +
T Consensus 160 ~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~-~ 237 (429)
T 3kvw_A 160 NVIHMLENFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQ-G 237 (429)
T ss_dssp CBCCEEEEEEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESST-T
T ss_pred CEEEEEeecccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccC-C
Confidence 578999999 5678999999995 799999988766669999999999999999999999999999999999999987 4
Q ss_pred C--eEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 024408 80 T--IKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA 157 (268)
Q Consensus 80 ~--~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~ 157 (268)
. +||+|||++..... ...+..||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+....+.
T Consensus 238 ~~~vkL~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~ 307 (429)
T 3kvw_A 238 RSGIKVIDFGSSCYEHQ--RVYTYIQSRFYRAPEVILG--------ARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQ 307 (429)
T ss_dssp SCCEEECCCTTCEETTC--CCCSSCSCGGGCCHHHHHT--------BCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred CcceEEeecccceecCC--cccccCCCCCccChHHHhC--------CCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence 5 99999999975332 2345688999999999864 5678999999999999999999999988766554
Q ss_pred HHHHHhccCCCC----------------------------------------------------------CCCCcHHHHH
Q 024408 158 AYAAAFKNVRPS----------------------------------------------------------AENVPEELSI 179 (268)
Q Consensus 158 ~~~~~~~~~~~~----------------------------------------------------------~~~~~~~l~~ 179 (268)
..........+. ....++.+.+
T Consensus 308 l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~d 387 (429)
T 3kvw_A 308 LACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLD 387 (429)
T ss_dssp HHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHH
T ss_pred HHHHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHH
Confidence 433322111000 1123678999
Q ss_pred HHHhccccCCCCCCCHHHHHHH
Q 024408 180 ILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 180 li~~~l~~~p~~Rps~~~~~~~ 201 (268)
||.+||..||.+|||+.++++|
T Consensus 388 li~~~L~~dP~~Rpta~e~L~H 409 (429)
T 3kvw_A 388 FLKQCLEWDPAVRMTPGQALRH 409 (429)
T ss_dssp HHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHCCCChhhCCCHHHHhCC
Confidence 9999999999999999999998
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=276.72 Aligned_cols=195 Identities=27% Similarity=0.352 Sum_probs=151.4
Q ss_pred CceeEEEeecCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCC--
Q 024408 1 MREQFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL-- 78 (268)
Q Consensus 1 ~~v~l~g~~~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~-- 78 (268)
|+|++++++..+..++||||++||+|.+++..... +++.++..++.|++.||+|||++||+||||||+|||++.+.
T Consensus 201 niv~l~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~ 278 (419)
T 3i6u_A 201 CIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKR--LKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEED 278 (419)
T ss_dssp TBCCCCEEEESSEEEEEEECCTTCBGGGGTSSSCC--CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSS
T ss_pred CEeeEEEEEecCceEEEEEcCCCCcHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCc
Confidence 68899999988889999999999999999876544 99999999999999999999999999999999999997541
Q ss_pred CCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 79 KTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 79 ~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
..+||+|||+++............||+.|+|||++.+. ....++.++||||||+++|+|++|..||.........
T Consensus 279 ~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~ 353 (419)
T 3i6u_A 279 CLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSV-----GTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL 353 (419)
T ss_dssp CCEEECCSSTTTSCC-----------CTTCCTTTTC---------CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCH
T ss_pred ceEEEeecccceecCCCccccccCCCCCccCceeeecC-----CCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHH
Confidence 35999999999876655555667899999999998531 1245778999999999999999999999764433222
Q ss_pred HHHHhccCCC----CCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 024408 159 YAAAFKNVRP----SAENVPEELSIILTSCWKEDPNARPNFTQIIQML 202 (268)
Q Consensus 159 ~~~~~~~~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l 202 (268)
.......... ....+++.+.++|.+||..||.+||++.++++|-
T Consensus 354 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 401 (419)
T 3i6u_A 354 KDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHP 401 (419)
T ss_dssp HHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred HHHHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCc
Confidence 2222222111 1256889999999999999999999999999983
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=261.49 Aligned_cols=197 Identities=28% Similarity=0.529 Sum_probs=162.7
Q ss_pred CceeEEEeecCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCC
Q 024408 1 MREQFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT 80 (268)
Q Consensus 1 ~~v~l~g~~~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~ 80 (268)
++++++|++.++..++||||+++++|.+++..... .+++..++.++.|++.||.|||++|++|+||||+||+++.+ +.
T Consensus 82 ~i~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~-~~ 159 (291)
T 1u46_A 82 NLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQG-HFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATR-DL 159 (291)
T ss_dssp TBCCEEEEECSSSCEEEEECCTTCBHHHHHHHHGG-GSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEET-TE
T ss_pred CcccEEEEEccCCceeeEecccCCCHHHHHHhccC-CcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCC-CC
Confidence 58999999977779999999999999999987533 39999999999999999999999999999999999999988 69
Q ss_pred eEEecCCCcccccccc----ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChH
Q 024408 81 IKLADFGLAREESLTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNL 155 (268)
Q Consensus 81 ~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~~~ 155 (268)
++|+|||++....... ......++..|+|||++.+ ..++.++||||||+++|+|++ |+.||.+....
T Consensus 160 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~ 231 (291)
T 1u46_A 160 VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT--------RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS 231 (291)
T ss_dssp EEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHH--------CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred EEEccccccccccccccchhhhccCCCCceeeCchhhcC--------CCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH
Confidence 9999999997543322 1223457788999999864 456789999999999999999 99999887765
Q ss_pred HHHHHHHhcc-CCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHh
Q 024408 156 QAAYAAAFKN-VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 207 (268)
Q Consensus 156 ~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 207 (268)
+......... ..+....++.++.++|.+||..||.+||++.+++++|++...
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 232 QILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp HHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred HHHHHHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 5544443332 334466889999999999999999999999999999987643
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=269.41 Aligned_cols=199 Identities=23% Similarity=0.389 Sum_probs=157.6
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRP--RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED 77 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~ 77 (268)
|+++++|++ .++..++||||++||+|.+++..... ..+++.+++.++.|++.||.|||++|++||||||+||+++.+
T Consensus 96 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~ 175 (321)
T 2qkw_B 96 HLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDEN 175 (321)
T ss_dssp TBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTT
T ss_pred CEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCC
Confidence 589999999 45688999999999999999976432 349999999999999999999999999999999999999988
Q ss_pred CCCeEEecCCCccccccc---cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh
Q 024408 78 LKTIKLADFGLAREESLT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN 154 (268)
Q Consensus 78 ~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~ 154 (268)
+.+||+|||+++..... .......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.....
T Consensus 176 -~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~ell~g~~p~~~~~~ 246 (321)
T 2qkw_B 176 -FVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIK--------GRLTEKSDVYSFGVVLFEVLCARSAIVQSLP 246 (321)
T ss_dssp -CCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHH--------CBCCTHHHHHHHHHHHHHHHHCCTTCSCSSS
T ss_pred -CCEEEeecccccccccccccccccccCCCccccCHHHhcC--------CCCCcccchHhHHHHHHHHHhCCCcccccCc
Confidence 69999999999753321 12233458999999999864 4578899999999999999999999965332
Q ss_pred HH-----HH-HHHHhcc-C----CC-----CCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 024408 155 LQ-----AA-YAAAFKN-V----RP-----SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 208 (268)
Q Consensus 155 ~~-----~~-~~~~~~~-~----~~-----~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 208 (268)
.+ .. ....... . .+ .....+..+.+++.+||..||++||++.+++++|+..++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 247 REMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp SSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 11 00 0001000 0 00 1122456799999999999999999999999999988764
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=261.38 Aligned_cols=196 Identities=27% Similarity=0.373 Sum_probs=163.0
Q ss_pred CceeEEEeec------CCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEE
Q 024408 1 MREQFIGACK------EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL 74 (268)
Q Consensus 1 ~~v~l~g~~~------~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill 74 (268)
+++++++++. +...++||||++ |+|.+++.......+++..++.++.|++.||.|||++|++||||||+||++
T Consensus 75 ~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili 153 (326)
T 1blx_A 75 NVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV 153 (326)
T ss_dssp TBCCEEEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE
T ss_pred CeEeeeeeeeecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEE
Confidence 5789999884 347899999997 699999988766669999999999999999999999999999999999999
Q ss_pred eCCCCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh
Q 024408 75 TEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN 154 (268)
Q Consensus 75 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~ 154 (268)
+.+ +.++|+|||+++............|+..|+|||++.+ ..++.++||||||+++|+|++|+.||.+...
T Consensus 154 ~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 224 (326)
T 1blx_A 154 TSS-GQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ--------SSYATPVDLWSVGCIFAEMFRRKPLFRGSSD 224 (326)
T ss_dssp CTT-CCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTT--------CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cCC-CCEEEecCcccccccCCCCccccccccceeCHHHHhc--------CCCCcchhHHHHHHHHHHHHcCCCCCCCCCH
Confidence 988 6999999999987655544556688999999999864 5678899999999999999999999988766
Q ss_pred HHHHHHHHhccCC--------------------------CCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 024408 155 LQAAYAAAFKNVR--------------------------PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 208 (268)
Q Consensus 155 ~~~~~~~~~~~~~--------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 208 (268)
.+........... .....++..+.++|.+||..||.+||++.++++| .++..
T Consensus 225 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h--p~~~~ 302 (326)
T 1blx_A 225 VDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH--PYFQD 302 (326)
T ss_dssp HHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS--GGGTT
T ss_pred HHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC--ccccc
Confidence 5544333221110 0124678999999999999999999999999987 44443
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=266.21 Aligned_cols=199 Identities=23% Similarity=0.377 Sum_probs=153.4
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ .++..++|||+. +++|.+++.+... +++.++..++.|++.||+|||++||+||||||+|||+++ +
T Consensus 70 ~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~--~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~~--~ 144 (343)
T 3dbq_A 70 KIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD--G 144 (343)
T ss_dssp TBCCEEEEEECSSEEEEEECCC-SEEHHHHHHHSCC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET--T
T ss_pred ceEEEeeeEeeCCEEEEEEeCC-CCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEEC--C
Confidence 589999999 556899999965 7899999987654 999999999999999999999999999999999999974 4
Q ss_pred CeEEecCCCcccccccc---ccccCCCccceecccccccccccc---CCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 024408 80 TIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQ---GEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS 153 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~---~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~ 153 (268)
.+||+|||+++...... ......||+.|+|||++.+..... .....++.++||||||+++|+|++|+.||....
T Consensus 145 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 224 (343)
T 3dbq_A 145 MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 224 (343)
T ss_dssp EEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred cEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhh
Confidence 89999999998644332 223557999999999986422111 112567889999999999999999999998754
Q ss_pred hHHHHHHHHhc--cCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 024408 154 NLQAAYAAAFK--NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 204 (268)
Q Consensus 154 ~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~ 204 (268)
........... .....+...+.++.++|.+||..||.+|||+.++++|.+.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~ 277 (343)
T 3dbq_A 225 NQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 277 (343)
T ss_dssp SHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred hHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccc
Confidence 43332222222 2223355677899999999999999999999999998654
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=266.78 Aligned_cols=201 Identities=25% Similarity=0.456 Sum_probs=162.2
Q ss_pred CceeEEEeecC---CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCC
Q 024408 1 MREQFIGACKE---PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED 77 (268)
Q Consensus 1 ~~v~l~g~~~~---~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~ 77 (268)
+++++++++.+ ..+++||||++||+|.+++.+.. +++.+++.++.|++.||.|||++|++||||||+||+++.+
T Consensus 94 ~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~ 170 (318)
T 3lxp_A 94 HIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDND 170 (318)
T ss_dssp TBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGGSC---CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT
T ss_pred chhhEEEEEecCCCceEEEEEecccCCcHHHHHhhCC---CCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCC
Confidence 58899999943 47899999999999999997642 9999999999999999999999999999999999999988
Q ss_pred CCCeEEecCCCcccccccc----ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 024408 78 LKTIKLADFGLAREESLTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS 153 (268)
Q Consensus 78 ~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~ 153 (268)
+.++|+|||++....... ......++..|+|||++.+ ..++.++||||||+++|+|++|..||....
T Consensus 171 -~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~ll~g~~p~~~~~ 241 (318)
T 3lxp_A 171 -RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE--------YKFYYASDVWSFGVTLYELLTHCDSSQSPP 241 (318)
T ss_dssp -CCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHH--------CEEEHHHHHHHHHHHHHHHHTTTCGGGSHH
T ss_pred -CCEEECCccccccccccccccccccCCCCCceeeChHHhcC--------CCCCcHHHHHHHHHHHHHHHhCCCcccccc
Confidence 699999999998544322 2234467888999999864 456789999999999999999999987532
Q ss_pred hHH---------------HHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhcCCCC
Q 024408 154 NLQ---------------AAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPE 213 (268)
Q Consensus 154 ~~~---------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~~~~~~ 213 (268)
... ...........+.+..++.++.++|.+||..||.+||++.++++.|+.+......+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~~ 316 (318)
T 3lxp_A 242 TKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQA 316 (318)
T ss_dssp HHHHHHHCSCCHHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC--
T ss_pred hhhhhhhcccccchhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccCC
Confidence 110 111112233344567889999999999999999999999999999998887655443
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=269.12 Aligned_cols=190 Identities=24% Similarity=0.279 Sum_probs=155.2
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeC---
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE--- 76 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~--- 76 (268)
|+|++++++ ..+..++||||+ |++|.+++.+.....+++.++..++.|++.||+|||++||+||||||+|||++.
T Consensus 97 ~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~ 175 (360)
T 3llt_A 97 NIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYF 175 (360)
T ss_dssp GBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTC
T ss_pred CeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccc
Confidence 578999998 567899999999 899999998876666999999999999999999999999999999999999974
Q ss_pred ---------------------CCCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHH
Q 024408 77 ---------------------DLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSF 135 (268)
Q Consensus 77 ---------------------~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvwsl 135 (268)
..+.+||+|||++...... .....||+.|+|||++.+ ..++.++|||||
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~--------~~~~~~~Diwsl 245 (360)
T 3llt_A 176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY--HGSIINTRQYRAPEVILN--------LGWDVSSDMWSF 245 (360)
T ss_dssp CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC--CCSCCSCGGGCCHHHHTT--------CCCCTTHHHHHH
T ss_pred cccccchhcccccccccccccCCCCEEEEeccCceecCCC--CcCccCcccccCcHHHcC--------CCCCCccchHHH
Confidence 1368999999999853332 345678999999999864 568899999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCC---------------------------------------------C
Q 024408 136 AIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS---------------------------------------------A 170 (268)
Q Consensus 136 G~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~---------------------------------------------~ 170 (268)
|+++|+|++|+.||......+............. .
T Consensus 246 G~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~ 325 (360)
T 3llt_A 246 GCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYK 325 (360)
T ss_dssp HHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHH
T ss_pred HHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccc
Confidence 9999999999999987665543332221111000 0
Q ss_pred CCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 171 ENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 171 ~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
...++.+.++|.+||+.||.+|||+.++++|
T Consensus 326 ~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 356 (360)
T 3llt_A 326 IIKHELFCDFLYSILQIDPTLRPSPAELLKH 356 (360)
T ss_dssp HCCCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred cchHHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0123678899999999999999999999987
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-38 Score=264.20 Aligned_cols=196 Identities=24% Similarity=0.374 Sum_probs=150.9
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCC-
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL- 78 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~- 78 (268)
|++++++++ .++..++||||++|++|.+++.+... +++.++..++.|++.||+|||++|++||||||+||+++.+.
T Consensus 72 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~ 149 (316)
T 2ac3_A 72 NVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRH--FNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQ 149 (316)
T ss_dssp TBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSS
T ss_pred CeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCC
Confidence 689999999 55789999999999999999987654 99999999999999999999999999999999999998763
Q ss_pred -CCeEEecCCCccccccc--------cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 024408 79 -KTIKLADFGLAREESLT--------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPF 149 (268)
Q Consensus 79 -~~~kl~Dfg~a~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~ 149 (268)
..+||+|||++...... .......||+.|+|||++.+... ....++.++||||||+++|+|++|+.||
T Consensus 150 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~~~~~~DiwslG~il~~l~~g~~pf 226 (316)
T 2ac3_A 150 VSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSE---EASIYDKRCDLWSLGVILYILLSGYPPF 226 (316)
T ss_dssp SCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSH---HHHHHTTTHHHHHHHHHHHHHHHSSCSC
T ss_pred cCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccc---cccCCCcccccHhHHHHHHHHHHCCCCC
Confidence 13999999998743221 11223468999999999853110 0133677999999999999999999999
Q ss_pred CCCChH--------------HHHHHHHhccCCCC----CCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 150 EGMSNL--------------QAAYAAAFKNVRPS----AENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 150 ~~~~~~--------------~~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
.+.... .............. ...++.++.++|.+||..||.+||++.++++|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 227 VGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp CCCCCSCSCC----CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cccccccccccccccchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 764321 11112222221111 14688999999999999999999999999998
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=265.80 Aligned_cols=191 Identities=25% Similarity=0.346 Sum_probs=151.6
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCC--
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED-- 77 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~-- 77 (268)
|+|++++++ .++..++||||++ |+|.+++..... +++..++.++.|++.||.|||++||+||||||+||+++.+
T Consensus 94 ~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~--~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~ 170 (329)
T 3gbz_A 94 NIIELKSVIHHNHRLHLIFEYAE-NDLKKYMDKNPD--VSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDA 170 (329)
T ss_dssp TBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHCTT--CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC---
T ss_pred CcceEEEEEecCCEEEEEEecCC-CCHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCC
Confidence 589999999 5568999999997 699999987655 9999999999999999999999999999999999999533
Q ss_pred --CCCeEEecCCCccccccc-cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh
Q 024408 78 --LKTIKLADFGLAREESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN 154 (268)
Q Consensus 78 --~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~ 154 (268)
.+.+||+|||+++..... .......||+.|+|||++.+ ...++.++||||||+++|+|++|..||.+...
T Consensus 171 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 243 (329)
T 3gbz_A 171 SETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLG-------SRHYSTSVDIWSIACIWAEMLMKTPLFPGDSE 243 (329)
T ss_dssp --CCEEEECCTTHHHHHC-----------CCTTCCHHHHTT-------CCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CccceEEECcCCCccccCCcccccCCCcCCccccCHHHhcC-------CCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCH
Confidence 145999999999754322 23344578999999999854 23578999999999999999999999988776
Q ss_pred HHHHHHHHhccCCCCC-----------------------------CCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 155 LQAAYAAAFKNVRPSA-----------------------------ENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 155 ~~~~~~~~~~~~~~~~-----------------------------~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
.+...........+.. ..+++++.++|.+||..||.+|||+.++++|
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 244 IDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp HHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 6555544332221111 1167899999999999999999999999997
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=258.60 Aligned_cols=189 Identities=28% Similarity=0.537 Sum_probs=158.1
Q ss_pred CceeEEEeec-----CCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCCEE
Q 024408 1 MREQFIGACK-----EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG--IIHRDLKPENLL 73 (268)
Q Consensus 1 ~~v~l~g~~~-----~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~g--i~H~Dikp~Nil 73 (268)
+++++++++. +..+++||||++|++|.+++.+... +++..++.++.|++.||.|||++| ++||||||+||+
T Consensus 86 ~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil 163 (290)
T 1t4h_A 86 NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIF 163 (290)
T ss_dssp TBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEE
T ss_pred CeeeeeeeeccccCCCceEEEEEEecCCCCHHHHHHHccC--CCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEE
Confidence 5789999873 2468999999999999999987655 999999999999999999999999 999999999999
Q ss_pred EeCCCCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 024408 74 LTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS 153 (268)
Q Consensus 74 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~ 153 (268)
++...+.++|+|||++...... ......||+.|+|||++. ..++.++||||||+++|+|++|+.||....
T Consensus 164 ~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~t~~y~aPE~~~---------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 233 (290)
T 1t4h_A 164 ITGPTGSVKIGDLGLATLKRAS-FAKAVIGTPEFMAPEMYE---------EKYDESVDVYAFGMCMLEMATSEYPYSECQ 233 (290)
T ss_dssp ESSTTSCEEECCTTGGGGCCTT-SBEESCSSCCCCCGGGGG---------TCCCTHHHHHHHHHHHHHHHHSSCTTTTCS
T ss_pred EECCCCCEEEeeCCCccccccc-ccccccCCcCcCCHHHHh---------ccCCCcchHHHHHHHHHHHHhCCCCCCCcC
Confidence 9843379999999999754333 234457899999999874 347889999999999999999999998866
Q ss_pred hHHHHHHHHhccCCC--CCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 154 NLQAAYAAAFKNVRP--SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 154 ~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
..............+ .....++++.++|.+||..||.+||++.++++|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 234 NAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp SHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cHHHHHHHHhccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 655555444443332 245567899999999999999999999999987
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=261.90 Aligned_cols=197 Identities=23% Similarity=0.352 Sum_probs=153.7
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ .++..++||||++|++|.+++.+... +++.+++.++.|++.||.|||++|++||||||+||+++.+ +
T Consensus 95 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~-~ 171 (309)
T 2h34_A 95 HVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGP--LAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSAD-D 171 (309)
T ss_dssp TBCCEEEEEEETTEEEEEEECCCCEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-S
T ss_pred CeeEEEEEEeeCCeEEEEEEecCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCC-C
Confidence 578999999 56789999999999999999987655 9999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccccc--ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 024408 80 TIKLADFGLAREESLTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA 157 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~ 157 (268)
.++|+|||++....... ......|++.|+|||++.+ ..++.++||||||+++|+|++|+.||........
T Consensus 172 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 243 (309)
T 2h34_A 172 FAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSE--------SHATYRADIYALTCVLYECLTGSPPYQGDQLSVM 243 (309)
T ss_dssp CEEECSCCC----------------CCGGGCCGGGTCC------------CCCHHHHHHHHHHHHHHSSCSSCSCHHHHH
T ss_pred CEEEecCccCccccccccccccccCCCcCccCHHHHcC--------CCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHH
Confidence 99999999997544322 2234578999999999864 5677899999999999999999999987554322
Q ss_pred HHHHHhccCC---CCCCCCcHHHHHHHHhccccCCCCCC-CHHHHHHHHHHhHhhc
Q 024408 158 AYAAAFKNVR---PSAENVPEELSIILTSCWKEDPNARP-NFTQIIQMLLNYLSAI 209 (268)
Q Consensus 158 ~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rp-s~~~~~~~l~~~~~~~ 209 (268)
......... .....+|.++.++|.+||..||++|| +++++++.|+..+...
T Consensus 244 -~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 244 -GAHINQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp -HHHHHSCCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred -HHHhccCCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 222222211 22467899999999999999999999 9999999998876543
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=265.65 Aligned_cols=193 Identities=28% Similarity=0.404 Sum_probs=161.1
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|+|+++|++ .++..++||||+. |+|.+++..... .+++.++..++.|++.||.|||++|++||||||+||+++.+ +
T Consensus 115 niv~~~~~~~~~~~~~lv~e~~~-g~l~~~l~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~ 191 (348)
T 1u5q_A 115 NTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKK-PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP-G 191 (348)
T ss_dssp TBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHHTS-CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETT-T
T ss_pred CEeeEEEEEEECCeEEEEEecCC-CCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCC-C
Confidence 689999999 5678999999996 689998865433 49999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 024408 80 TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY 159 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~ 159 (268)
.+||+|||+++..... ....||+.|+|||++.+. ....++.++||||||+++|+|++|+.||..........
T Consensus 192 ~~kL~DfG~a~~~~~~---~~~~gt~~y~aPE~~~~~-----~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~ 263 (348)
T 1u5q_A 192 LVKLGDFGSASIMAPA---NSFVGTPYWMAPEVILAM-----DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY 263 (348)
T ss_dssp EEEECCCTTCBSSSSB---CCCCSCGGGCCHHHHHTT-----SSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH
T ss_pred CEEEeeccCceecCCC---CcccCCcceeCHhhhccc-----cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 9999999999864432 345799999999987421 12567889999999999999999999998877665554
Q ss_pred HHHhccCC-CCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 024408 160 AAAFKNVR-PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 204 (268)
Q Consensus 160 ~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~ 204 (268)
........ .....++..+.++|.+||..||.+||++.+++++.+-
T Consensus 264 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~ 309 (348)
T 1u5q_A 264 HIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 309 (348)
T ss_dssp HHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHH
T ss_pred HHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhh
Confidence 44433322 2356789999999999999999999999999998543
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=260.52 Aligned_cols=192 Identities=28% Similarity=0.448 Sum_probs=163.7
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ .++..++||||++|++|.+++.. ..+++..++.++.|++.||.|||++|++||||||+||+++.+ +
T Consensus 81 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~-~ 156 (303)
T 3a7i_A 81 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEH-G 156 (303)
T ss_dssp TBCCEEEEEEETTEEEEEEECCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-S
T ss_pred CEeEEEEEEecCCeEEEEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCC-C
Confidence 578999998 56789999999999999999864 239999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccccc-ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESLTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.++|+|||++....... ......|++.|+|||++.+ ..++.++||||||+++|+|++|..||.........
T Consensus 157 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~ 228 (303)
T 3a7i_A 157 EVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ--------SAYDSKADIWSLGITAIELARGEPPHSELHPMKVL 228 (303)
T ss_dssp CEEECCCTTCEECBTTBCCBCCCCSCGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred CEEEeecccceecCccccccCccCCCcCccCHHHHhc--------CCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHH
Confidence 99999999997544332 2344578999999999864 55778999999999999999999999887766555
Q ss_pred HHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 024408 159 YAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 204 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~ 204 (268)
..............++..+.++|.+||..||.+||++.+++++.+.
T Consensus 229 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~ 274 (303)
T 3a7i_A 229 FLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFI 274 (303)
T ss_dssp HHHHHSCCCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHH
T ss_pred HHhhcCCCCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhh
Confidence 5444444444567889999999999999999999999999998553
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=269.23 Aligned_cols=199 Identities=23% Similarity=0.386 Sum_probs=153.8
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
++|++++++ .++.+++|||+ .+++|.+++.+... +++.++..++.|++.||.|||++||+||||||+|||+++ +
T Consensus 117 ~iv~~~~~~~~~~~~~lv~E~-~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~--~ 191 (390)
T 2zmd_A 117 KIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD--G 191 (390)
T ss_dssp TBCCEEEEEECSSEEEEEEEC-CSEEHHHHHHHCSS--CCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEESS--S
T ss_pred eEEEEEEEEecCCEEEEEEec-CCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEEC--C
Confidence 589999998 55689999995 57899999987654 999999999999999999999999999999999999964 5
Q ss_pred CeEEecCCCcccccccc---ccccCCCccceecccccccccccc---CCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 024408 80 TIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQ---GEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS 153 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~---~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~ 153 (268)
.+||+|||+++...... ......||+.|+|||++.+..... .....++.++||||||+++|+|++|+.||....
T Consensus 192 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~ 271 (390)
T 2zmd_A 192 MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 271 (390)
T ss_dssp CEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred eEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh
Confidence 89999999998644322 234567999999999986421111 012468889999999999999999999998754
Q ss_pred hHHHHHHHHhc-cC-CCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 024408 154 NLQAAYAAAFK-NV-RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 204 (268)
Q Consensus 154 ~~~~~~~~~~~-~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~ 204 (268)
........... .. ...+...+.++.++|.+||..||.+||++.+++++.+.
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~ 324 (390)
T 2zmd_A 272 NQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 324 (390)
T ss_dssp CHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred HHHHHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCc
Confidence 43222222222 22 22345567899999999999999999999999998543
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=258.69 Aligned_cols=191 Identities=27% Similarity=0.378 Sum_probs=159.7
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEE---eC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL---TE 76 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill---~~ 76 (268)
+++++++++ .++..++||||++|++|.+++...+. +++..++.++.|++.||.|||++|++||||||+||++ +.
T Consensus 67 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~ 144 (304)
T 2jam_A 67 NIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGV--YTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEE 144 (304)
T ss_dssp TBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSST
T ss_pred CeeehhhhcccCCEEEEEEEcCCCccHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCC
Confidence 578999999 55688999999999999999987655 9999999999999999999999999999999999999 55
Q ss_pred CCCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH
Q 024408 77 DLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 156 (268)
Q Consensus 77 ~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~ 156 (268)
+ +.++|+|||++...... ......|++.|+|||++.+ ..++.++||||||+++|+|++|..||.......
T Consensus 145 ~-~~~kl~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 214 (304)
T 2jam_A 145 N-SKIMITDFGLSKMEQNG-IMSTACGTPGYVAPEVLAQ--------KPYSKAVDCWSIGVITYILLCGYPPFYEETESK 214 (304)
T ss_dssp T-CCEEBCSCSTTCCCCCB-TTHHHHSCCCBCCTTTBSS--------CSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred C-CCEEEccCCcceecCCC-ccccccCCCCccChHHhcc--------CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH
Confidence 5 68999999999754332 2233468999999999864 567889999999999999999999998866555
Q ss_pred HHHHHHhccCC---CCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 024408 157 AAYAAAFKNVR---PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 203 (268)
Q Consensus 157 ~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~ 203 (268)
........... +....++.++.++|.+||..||.+||++.+++++.+
T Consensus 215 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~ 264 (304)
T 2jam_A 215 LFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPW 264 (304)
T ss_dssp HHHHHHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHH
T ss_pred HHHHHHcCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcc
Confidence 44433333222 234678999999999999999999999999999843
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=265.64 Aligned_cols=201 Identities=27% Similarity=0.389 Sum_probs=154.9
Q ss_pred CceeEEEeecCC-----cEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC----------CCeec
Q 024408 1 MREQFIGACKEP-----VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH----------GIIHR 65 (268)
Q Consensus 1 ~~v~l~g~~~~~-----~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~----------gi~H~ 65 (268)
|+|+++|++.++ .+++||||++||+|.+++.+. .+++..++.++.|++.||+|||+. |++||
T Consensus 79 niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~ 155 (322)
T 3soc_A 79 NILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHR 155 (322)
T ss_dssp TBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECS
T ss_pred CchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeC
Confidence 689999998432 479999999999999999763 299999999999999999999999 99999
Q ss_pred CCCCCCEEEeCCCCCeEEecCCCcccccccc---ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHH
Q 024408 66 DLKPENLLLTEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWEL 142 (268)
Q Consensus 66 Dikp~Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~l 142 (268)
||||+||+++.+ +.+||+|||+++...... ......||+.|+|||++.+.... ...++.++||||||+++|+|
T Consensus 156 Dlkp~Nill~~~-~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~~~~~~DiwslG~il~el 231 (322)
T 3soc_A 156 DIKSKNVLLKNN-LTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINF---QRDAFLRIDMYAMGLVLWEL 231 (322)
T ss_dssp CCSGGGEEECTT-CCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCC---CHHHHHHHHHHHHHHHHHHH
T ss_pred CCChHhEEECCC-CeEEEccCCcccccccccCccccccCccCccccCHhhccccccc---CcCCCccchhHHHHHHHHHH
Confidence 999999999988 699999999997543322 22335789999999998641100 12345688999999999999
Q ss_pred HhCCCCCCCCCh---------------HHHHHH-HHhccCCCCCC------CCcHHHHHHHHhccccCCCCCCCHHHHHH
Q 024408 143 LHNKLPFEGMSN---------------LQAAYA-AAFKNVRPSAE------NVPEELSIILTSCWKEDPNARPNFTQIIQ 200 (268)
Q Consensus 143 l~g~~p~~~~~~---------------~~~~~~-~~~~~~~~~~~------~~~~~l~~li~~~l~~~p~~Rps~~~~~~ 200 (268)
++|+.||.+... ...... .......+... ..+.++.++|.+||+.||.+|||+.++++
T Consensus 232 ~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 232 ASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp HTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 999999865321 111111 11122222111 22456999999999999999999999999
Q ss_pred HHHHhHhh
Q 024408 201 MLLNYLSA 208 (268)
Q Consensus 201 ~l~~~~~~ 208 (268)
.|+.+.+.
T Consensus 312 ~L~~l~~~ 319 (322)
T 3soc_A 312 RITQMQRL 319 (322)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 99887654
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=259.79 Aligned_cols=190 Identities=25% Similarity=0.363 Sum_probs=137.9
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ ..+..++||||++|++|.+++.... ..+++.+++.++.|++.||.|||++|++||||||+||+++.+ +
T Consensus 72 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~-~ 149 (278)
T 3cok_A 72 SILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRN-M 149 (278)
T ss_dssp TBCCEEEEEECSSEEEEEEECCTTEEHHHHHHTCS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTT-C
T ss_pred CeEeEEEEEccCCeEEEEEecCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC-C
Confidence 578999999 4568899999999999999998653 349999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccc-cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.++|+|||++...... .......||+.|+|||.+.+ ..++.++|+||||+++|+|++|+.||.........
T Consensus 150 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~ 221 (278)
T 3cok_A 150 NIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATR--------SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL 221 (278)
T ss_dssp CEEECCCTTCEECC------------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---
T ss_pred CEEEEeecceeeccCCCCcceeccCCCCcCCcchhcC--------CCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH
Confidence 9999999999854422 22234578999999998864 45678999999999999999999999865433322
Q ss_pred HHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 159 YAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
.. ........+..++.++.++|.+||..||.+||++.+++++
T Consensus 222 ~~-~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 222 NK-VVLADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp ---CCSSCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred HH-HhhcccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 21 1112223356688999999999999999999999999987
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=258.88 Aligned_cols=204 Identities=25% Similarity=0.406 Sum_probs=153.5
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED 77 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~ 77 (268)
+++++++++ .++..++||||++|++|.+++... ....+++..++.++.|++.||.|||++|++||||||+||+++.+
T Consensus 93 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~ 172 (310)
T 2wqm_A 93 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITAT 172 (310)
T ss_dssp TBCCEEEEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT
T ss_pred CEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCC
Confidence 578999999 567899999999999999999752 33459999999999999999999999999999999999999988
Q ss_pred CCCeEEecCCCcccccccc-ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH-
Q 024408 78 LKTIKLADFGLAREESLTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL- 155 (268)
Q Consensus 78 ~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~- 155 (268)
+.++|+|||++....... ......|+..|+|||++.+ ..++.++||||||+++|+|++|+.||.+....
T Consensus 173 -~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~ 243 (310)
T 2wqm_A 173 -GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE--------NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL 243 (310)
T ss_dssp -SCEEECCC------------------CCSSCCHHHHTT--------CCCCHHHHHHHHHHHHHHHHHSSCTTC---CCH
T ss_pred -CCEEEEeccceeeecCCCccccccCCCeeEeChHHhCC--------CCCCchhhHHHHHHHHHHHHhCCCCCcccchhH
Confidence 699999999997543322 2234568999999998864 56788999999999999999999999754322
Q ss_pred -HHHHHHHhccCCC-CCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhcCCCC
Q 024408 156 -QAAYAAAFKNVRP-SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPE 213 (268)
Q Consensus 156 -~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~~~~~~ 213 (268)
............+ ....++.++.++|.+||..||.+||++.++++.|+.+......+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~ 303 (310)
T 2wqm_A 244 YSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSL 303 (310)
T ss_dssp HHHHHHHHTTCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC---
T ss_pred HHHHHHhhcccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhh
Confidence 2222222222222 236789999999999999999999999999999998877654443
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=258.60 Aligned_cols=196 Identities=23% Similarity=0.337 Sum_probs=163.1
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ .++..++||||++|++|.+++.+... +++..++.++.|++.||.|||++|++|+||||+||+++.+ +
T Consensus 85 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~-~ 161 (298)
T 1phk_A 85 NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDD-M 161 (298)
T ss_dssp TBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-C
T ss_pred CEeeeeeeeccCCeEEEEEeccCCCcHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCC-C
Confidence 588999999 45689999999999999999987654 9999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 024408 80 TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY 159 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~ 159 (268)
.++|+|||++.............|++.|+|||++.+... .....++.++||||||+++|+|++|..||..........
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~ 239 (298)
T 1phk_A 162 NIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMN--DNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLR 239 (298)
T ss_dssp CEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHC--TTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred cEEEecccchhhcCCCcccccccCCccccCHHHhccccc--cccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHH
Confidence 999999999986555544556679999999998853211 112457889999999999999999999998866555444
Q ss_pred HHHhccCCC---CCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 160 AAAFKNVRP---SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 160 ~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
......... ....++..+.++|.+||..||.+||++.+++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 240 MIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp HHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 433333222 224688999999999999999999999999987
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=262.15 Aligned_cols=197 Identities=27% Similarity=0.472 Sum_probs=153.8
Q ss_pred CceeEEEee-cC----CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC--------CCeecCC
Q 024408 1 MREQFIGAC-KE----PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH--------GIIHRDL 67 (268)
Q Consensus 1 ~~v~l~g~~-~~----~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~--------gi~H~Di 67 (268)
|++++++++ .. ...++||||++||+|.+++.+. .+++..++.++.|++.||.|||++ |++||||
T Consensus 92 ~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Di 168 (337)
T 3mdy_A 92 NILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDL 168 (337)
T ss_dssp TBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCC
T ss_pred CeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEeccc
Confidence 578999998 33 4789999999999999999763 399999999999999999999999 9999999
Q ss_pred CCCCEEEeCCCCCeEEecCCCccccccccc-----cccCCCccceeccccccccccccCCCCCCCc------hhhHHHHH
Q 024408 68 KPENLLLTEDLKTIKLADFGLAREESLTEM-----MTAETGTYRWMAPELYSTVTLRQGEKKHYNH------KVDSYSFA 136 (268)
Q Consensus 68 kp~Nill~~~~~~~kl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~------~~DvwslG 136 (268)
||+||+++.+ +.+||+|||++........ .....||+.|+|||++.+ ..... ++||||||
T Consensus 169 kp~Nill~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~~~~~~~DiwslG 239 (337)
T 3mdy_A 169 KSKNILVKKN-GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDE--------SLNRNHFQSYIMADMYSFG 239 (337)
T ss_dssp CGGGEEECTT-SCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTT--------CCCTTCTHHHHHHHHHHHH
T ss_pred chHHEEECCC-CCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhccc--------ccCCccccCccccchHHHH
Confidence 9999999988 6999999999975433221 124579999999999864 22222 48999999
Q ss_pred HHHHHHHhC----------CCCCCCCChH----HHHHH-HHhccCCCCC------CCCcHHHHHHHHhccccCCCCCCCH
Q 024408 137 IVLWELLHN----------KLPFEGMSNL----QAAYA-AAFKNVRPSA------ENVPEELSIILTSCWKEDPNARPNF 195 (268)
Q Consensus 137 ~~l~~ll~g----------~~p~~~~~~~----~~~~~-~~~~~~~~~~------~~~~~~l~~li~~~l~~~p~~Rps~ 195 (268)
+++|+|++| ..||...... ..... .......+.. ..+++++.+++.+||..||.+||++
T Consensus 240 ~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~ 319 (337)
T 3mdy_A 240 LILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTA 319 (337)
T ss_dssp HHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCH
T ss_pred HHHHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCH
Confidence 999999999 7777543221 11111 1112222221 2456789999999999999999999
Q ss_pred HHHHHHHHHhHhhc
Q 024408 196 TQIIQMLLNYLSAI 209 (268)
Q Consensus 196 ~~~~~~l~~~~~~~ 209 (268)
.+++++|+.+....
T Consensus 320 ~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 320 LRVKKTLAKMSESQ 333 (337)
T ss_dssp HHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHhhc
Confidence 99999999887654
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=270.74 Aligned_cols=194 Identities=24% Similarity=0.262 Sum_probs=155.8
Q ss_pred CceeEEEeecC-------CcEEEEEEcCCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCC
Q 024408 1 MREQFIGACKE-------PVMVIVTELLSGGTLRKYLLN--MRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPEN 71 (268)
Q Consensus 1 ~~v~l~g~~~~-------~~~~lV~e~~~ggsL~~~i~~--~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~N 71 (268)
|+|++++++.. .++++||||++ ++|.+.+.. .....+++..++.++.|++.||+|||++||+||||||+|
T Consensus 108 niv~l~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~N 186 (420)
T 1j1b_A 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVP-ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQN 186 (420)
T ss_dssp TBCCEEEEEEEEETTTTEEEEEEEEECCC-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGG
T ss_pred CccceeeEEeccCCCCcceeEEeehhccc-ccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhh
Confidence 68899888721 24789999997 578777654 233459999999999999999999999999999999999
Q ss_pred EEEeCCCCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 024408 72 LLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 151 (268)
Q Consensus 72 ill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~ 151 (268)
||++.+.+.+||+|||+++............||+.|+|||++.+ ...++.++|||||||++|||++|+.||.+
T Consensus 187 ILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwSlG~il~ell~G~~pf~~ 259 (420)
T 1j1b_A 187 LLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG-------ATDYTSSIDVWSAGCVLAELLLGQPIFPG 259 (420)
T ss_dssp EEEETTTTEEEECCCTTCEECCTTCCCCSCCSCTTSCCHHHHTT-------CSSCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred EEEeCCCCeEEeccchhhhhcccCCCceeeeeCCCcCCHHHHcC-------CCCCCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 99997645789999999986554444456688999999998853 24678899999999999999999999998
Q ss_pred CChHHHHHHHHhccCC------------------C----------CCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 024408 152 MSNLQAAYAAAFKNVR------------------P----------SAENVPEELSIILTSCWKEDPNARPNFTQIIQML 202 (268)
Q Consensus 152 ~~~~~~~~~~~~~~~~------------------~----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l 202 (268)
....+........... + ....+++++.+||.+||..||.+||++.++++|.
T Consensus 260 ~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp 338 (420)
T 1j1b_A 260 DSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS 338 (420)
T ss_dssp SSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred CCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCH
Confidence 7765544433221100 0 1235678999999999999999999999999983
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-37 Score=256.04 Aligned_cols=193 Identities=26% Similarity=0.386 Sum_probs=158.1
Q ss_pred CceeEEEee--cC-CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCC
Q 024408 1 MREQFIGAC--KE-PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED 77 (268)
Q Consensus 1 ~~v~l~g~~--~~-~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~ 77 (268)
+++++++++ .+ +..++||||++++ |.+++.......+++..++.++.|++.||.|||++|++||||||+||+++.+
T Consensus 67 ~i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~ 145 (305)
T 2wtk_C 67 NVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTG 145 (305)
T ss_dssp TBCCEEEEEECC---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT
T ss_pred CeeEEEEEEEcCCCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCC
Confidence 588999998 22 4789999999755 8888887666669999999999999999999999999999999999999988
Q ss_pred CCCeEEecCCCcccccc---ccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh
Q 024408 78 LKTIKLADFGLAREESL---TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN 154 (268)
Q Consensus 78 ~~~~kl~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~ 154 (268)
+.++|+|||++..... ........|++.|+|||++.+. ....+.++||||||+++|+|++|..||.+...
T Consensus 146 -~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 218 (305)
T 2wtk_C 146 -GTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGL------DTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI 218 (305)
T ss_dssp -CCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCC------SCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred -CcEEeeccccccccCccccccccccCCCCCCCcChhhccCc------ccCCcchhhHHHHHHHHHHHHhCCCCCCCchH
Confidence 6999999999975432 2223455789999999988531 12346799999999999999999999988655
Q ss_pred HHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 024408 155 LQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 202 (268)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l 202 (268)
.+.... ........+..++..+.++|.+||..||.+||++.+++++.
T Consensus 219 ~~~~~~-i~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 265 (305)
T 2wtk_C 219 YKLFEN-IGKGSYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHS 265 (305)
T ss_dssp HHHHHH-HHHCCCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSH
T ss_pred HHHHHH-HhcCCCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCc
Confidence 444333 33333445667899999999999999999999999999983
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=257.98 Aligned_cols=198 Identities=25% Similarity=0.404 Sum_probs=149.0
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCCEEEeC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHSH-GIIHRDLKPENLLLTE 76 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~-gi~H~Dikp~Nill~~ 76 (268)
+++++++++ .++..++||||++ |+|.+++... ....+++..++.++.|++.||.|||++ |++||||||+||+++.
T Consensus 67 ~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~ 145 (290)
T 3fme_A 67 FTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINA 145 (290)
T ss_dssp TBCCEEEEEECSSSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECT
T ss_pred eEEEEeeeeeccCCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECC
Confidence 578999999 5568999999996 6998887652 334599999999999999999999998 9999999999999998
Q ss_pred CCCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH
Q 024408 77 DLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 156 (268)
Q Consensus 77 ~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~ 156 (268)
+ +.+||+|||++.............||+.|+|||++... .....++.++||||||+++|+|++|+.||.......
T Consensus 146 ~-~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~----~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 220 (290)
T 3fme_A 146 L-GQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPE----LNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF 220 (290)
T ss_dssp T-CCEEBCCC---------------CCCCCCSCHHHHSCC----TTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH
T ss_pred C-CCEEEeecCCcccccccccccccCCCccccChhhcChh----hcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH
Confidence 8 69999999999865555444555799999999986320 013567889999999999999999999998644333
Q ss_pred HHHHH-HhccC-CCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 024408 157 AAYAA-AFKNV-RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 204 (268)
Q Consensus 157 ~~~~~-~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~ 204 (268)
..... ..... ......+++++.+++.+||..||.+|||+.++++|.+.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f 270 (290)
T 3fme_A 221 QQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFF 270 (290)
T ss_dssp HHHHHHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHH
T ss_pred HHHHHHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCccc
Confidence 33322 22222 22345789999999999999999999999999997543
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=261.55 Aligned_cols=206 Identities=26% Similarity=0.452 Sum_probs=160.3
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
++++++|++ ..+..++||||++|++|.+++.+.. ..+++.+++.++.|++.||+|||++|++||||||+||++++ +
T Consensus 90 ~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~~--~ 166 (319)
T 2y4i_B 90 NVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYDN--G 166 (319)
T ss_dssp TBCCCCEEEECSSCEEEECBCCCSEEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC----
T ss_pred CEeEEEEEEecCCceEEEeecccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEeC--C
Confidence 578999999 5568999999999999999997644 34999999999999999999999999999999999999983 5
Q ss_pred CeEEecCCCcccccc------ccccccCCCccceecccccccccccc-CCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 024408 80 TIKLADFGLAREESL------TEMMTAETGTYRWMAPELYSTVTLRQ-GEKKHYNHKVDSYSFAIVLWELLHNKLPFEGM 152 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~ 152 (268)
.++|+|||++..... ........|++.|+|||++.+..... .....++.++||||||+++|+|++|+.||...
T Consensus 167 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 246 (319)
T 2y4i_B 167 KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ 246 (319)
T ss_dssp CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSC
T ss_pred CEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 899999999864321 11223346899999999986422111 11245788999999999999999999999887
Q ss_pred ChHHHHHHHHhccCCC-CCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhc
Q 024408 153 SNLQAAYAAAFKNVRP-SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 209 (268)
Q Consensus 153 ~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~~ 209 (268)
................ ....++.++.+++.+||..||.+||++.++++.|+.+....
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 247 PAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp CHHHHHHHHHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred CHHHHHHHhccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 6655544443333222 23468899999999999999999999999999998876543
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=265.46 Aligned_cols=195 Identities=26% Similarity=0.405 Sum_probs=137.4
Q ss_pred CceeEEEeecC-----CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEe
Q 024408 1 MREQFIGACKE-----PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 75 (268)
Q Consensus 1 ~~v~l~g~~~~-----~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~ 75 (268)
+++++++++.. ...++||||++||+|.+++.+.....+++.+++.++.|++.||.|||++|++||||||+||+++
T Consensus 83 ~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~ 162 (336)
T 3fhr_A 83 HIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYT 162 (336)
T ss_dssp TBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEES
T ss_pred ChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEE
Confidence 57888998842 3589999999999999999987666699999999999999999999999999999999999997
Q ss_pred CC--CCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 024408 76 ED--LKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS 153 (268)
Q Consensus 76 ~~--~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~ 153 (268)
.+ .+.+||+|||+++..... ......||+.|+|||++.+ ..++.++||||||+++|+|++|..||....
T Consensus 163 ~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~t~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 233 (336)
T 3fhr_A 163 SKEKDAVLKLTDFGFAKETTQN-ALQTPCYTPYYVAPEVLGP--------EKYDKSCDMWSLGVIMYILLCGFPPFYSNT 233 (336)
T ss_dssp CSSTTCCEEECCCTTCEEC-------------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred ecCCCceEEEeccccceecccc-ccccCCCCcCccChhhhCC--------CCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence 53 246999999999854432 2345578999999999854 456789999999999999999999997644
Q ss_pred hHHHHHH-------HHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 024408 154 NLQAAYA-------AAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 204 (268)
Q Consensus 154 ~~~~~~~-------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~ 204 (268)
....... .......+....++.++.++|.+||..||.+||++.++++|.+-
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~ 291 (336)
T 3fhr_A 234 GQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWI 291 (336)
T ss_dssp -----------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHH
T ss_pred chhhhhhHHHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccc
Confidence 3322110 01111222335789999999999999999999999999998543
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=266.90 Aligned_cols=195 Identities=21% Similarity=0.225 Sum_probs=157.3
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNM---RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE 76 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~ 76 (268)
+++++++++ .++..++||||++||+|.+++... ....+++.+++.++.|++.||+|||++||+||||||+|||++.
T Consensus 128 ~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~ 207 (365)
T 3e7e_A 128 MFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGN 207 (365)
T ss_dssp GBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECG
T ss_pred hhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecc
Confidence 478999999 567899999999999999999753 2345999999999999999999999999999999999999987
Q ss_pred -----------CCCCeEEecCCCcccc---ccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHH
Q 024408 77 -----------DLKTIKLADFGLAREE---SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWEL 142 (268)
Q Consensus 77 -----------~~~~~kl~Dfg~a~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~l 142 (268)
+ +.+||+|||+++.. ..........||+.|+|||++.+ ..++.++||||||+++|+|
T Consensus 208 ~~~~~~~~~~~~-~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~el 278 (365)
T 3e7e_A 208 GFLEQDDEDDLS-AGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSN--------KPWNYQIDYFGVAATVYCM 278 (365)
T ss_dssp GGTCC------C-TTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTT--------CCBSTHHHHHHHHHHHHHH
T ss_pred cccCcccccccc-CCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcC--------CCCCccccHHHHHHHHHHH
Confidence 5 69999999999643 22333455679999999999864 5578999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCC-CCHHHHHHHHHHhHhhc
Q 024408 143 LHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNAR-PNFTQIIQMLLNYLSAI 209 (268)
Q Consensus 143 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R-ps~~~~~~~l~~~~~~~ 209 (268)
++|+.||....... ............++.+.+++..||+.+|.+| |+++++.+.|+.++...
T Consensus 279 ltg~~pf~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~ 341 (365)
T 3e7e_A 279 LFGTYMKVKNEGGE-----CKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH 341 (365)
T ss_dssp HHSSCCCEEEETTE-----EEECSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred HhCCCccccCCCCc-----eeechhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence 99999986432210 0000111122346789999999999999999 57888888888887664
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=260.79 Aligned_cols=195 Identities=27% Similarity=0.367 Sum_probs=161.0
Q ss_pred CceeEEEeec---CCcEEEEEEcCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC-----CeecCCCCC
Q 024408 1 MREQFIGACK---EPVMVIVTELLSGGTLRKYLLNMR--PRCLDVCVAIGFALDIARAMECLHSHG-----IIHRDLKPE 70 (268)
Q Consensus 1 ~~v~l~g~~~---~~~~~lV~e~~~ggsL~~~i~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~g-----i~H~Dikp~ 70 (268)
+++++++++. ++..++||||++|++|.+++.... ...+++..++.++.|++.||+|||++| ++||||||+
T Consensus 66 ~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~ 145 (279)
T 2w5a_A 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPA 145 (279)
T ss_dssp TBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGG
T ss_pred CCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchh
Confidence 5789999872 357899999999999999997642 344999999999999999999999999 999999999
Q ss_pred CEEEeCCCCCeEEecCCCcccccccc-ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 024408 71 NLLLTEDLKTIKLADFGLAREESLTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPF 149 (268)
Q Consensus 71 Nill~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~ 149 (268)
||+++.+ +.++|+|||+++...... ......|+..|+|||++.+ ..++.++||||||+++|+|++|+.||
T Consensus 146 NIl~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~p~ 216 (279)
T 2w5a_A 146 NVFLDGK-QNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNR--------MSYNEKSDIWSLGCLLYELCALMPPF 216 (279)
T ss_dssp GEEECSS-SCEEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHC--------C-CCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred hEEEcCC-CCEEEecCchheeeccccccccccCCCccccChHHhcc--------CCCCchhhHHHHHHHHHHHHHCCCCC
Confidence 9999988 699999999997543322 1233468999999999864 46788999999999999999999999
Q ss_pred CCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 024408 150 EGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 204 (268)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~ 204 (268)
......+.............+..++.++.++|.+||..||.+||++.+++++++.
T Consensus 217 ~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 217 TAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp CCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred cccCHHHHHHHHhhcccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 9877655555544454545567889999999999999999999999999997543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=277.75 Aligned_cols=189 Identities=26% Similarity=0.330 Sum_probs=148.6
Q ss_pred CceeEEEeecC-------CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEE
Q 024408 1 MREQFIGACKE-------PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 73 (268)
Q Consensus 1 ~~v~l~g~~~~-------~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nil 73 (268)
|+|++++++.. ..+++||||++ ++|.+.+.. .+++..+..++.|++.||+|||++||+||||||+|||
T Consensus 122 nIv~l~~~~~~~~~~~~~~~~~lv~E~~~-~~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIl 196 (464)
T 3ttj_A 122 NIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 196 (464)
T ss_dssp TBCCCSEEECSCCSTTTCCEEEEEEECCS-EEHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEE
T ss_pred CCCcEEEEEccCCccccCCeEEEEEeCCC-CCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEE
Confidence 68899999843 25799999996 567777743 2899999999999999999999999999999999999
Q ss_pred EeCCCCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 024408 74 LTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS 153 (268)
Q Consensus 74 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~ 153 (268)
++.+ +.+||+|||+++............||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+.+
T Consensus 197 l~~~-~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlG~il~ell~g~~pF~g~~ 267 (464)
T 3ttj_A 197 VKSD-CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG--------MGYKENVDIWSVGCIMGEMVRHKILFPGRD 267 (464)
T ss_dssp ECTT-SCEEECCCCCC-----CCCC----CCCTTCCHHHHTT--------CCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EeCC-CCEEEEEEEeeeecCCCcccCCCcccccccCHHHHcC--------CCCCHHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9988 6999999999987665555566789999999999864 568889999999999999999999999877
Q ss_pred hHHHHHHHHhccCCCC--------------------CCC---------------------CcHHHHHHHHhccccCCCCC
Q 024408 154 NLQAAYAAAFKNVRPS--------------------AEN---------------------VPEELSIILTSCWKEDPNAR 192 (268)
Q Consensus 154 ~~~~~~~~~~~~~~~~--------------------~~~---------------------~~~~l~~li~~~l~~~p~~R 192 (268)
..+...........+. ... .++++.+||.+||..||.+|
T Consensus 268 ~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R 347 (464)
T 3ttj_A 268 YIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKR 347 (464)
T ss_dssp HHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTS
T ss_pred HHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhC
Confidence 6555444332211110 000 14678999999999999999
Q ss_pred CCHHHHHHHHH
Q 024408 193 PNFTQIIQMLL 203 (268)
Q Consensus 193 ps~~~~~~~l~ 203 (268)
||++++++|-+
T Consensus 348 ~ta~e~L~Hp~ 358 (464)
T 3ttj_A 348 ISVDDALQHPY 358 (464)
T ss_dssp CCHHHHHTSTT
T ss_pred CCHHHHhcChh
Confidence 99999999843
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=262.54 Aligned_cols=196 Identities=21% Similarity=0.276 Sum_probs=156.0
Q ss_pred CceeEEEeecC---------CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCC
Q 024408 1 MREQFIGACKE---------PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPEN 71 (268)
Q Consensus 1 ~~v~l~g~~~~---------~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~N 71 (268)
+++++++++.. +..++||||++ ++|.+.+..... .+++.+++.++.|++.||+|||++||+||||||+|
T Consensus 77 ~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~N 154 (351)
T 3mi9_A 77 NVVNLIEICRTKASPYNRCKGSIYLVFDFCE-HDLAGLLSNVLV-KFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAAN 154 (351)
T ss_dssp TBCCEEEEEEEC--------CEEEEEEECCS-EEHHHHHHCTTS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred CcccHhheeeccccccccCCceEEEEEeccC-CCHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHH
Confidence 57899998843 36899999996 588888876543 39999999999999999999999999999999999
Q ss_pred EEEeCCCCCeEEecCCCcccccc-----ccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCC
Q 024408 72 LLLTEDLKTIKLADFGLAREESL-----TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNK 146 (268)
Q Consensus 72 ill~~~~~~~kl~Dfg~a~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~ 146 (268)
|+++.+ +.+||+|||+++.... ........||+.|+|||++.+ ...++.++||||||+++|+|++|.
T Consensus 155 Il~~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwslG~il~ell~g~ 226 (351)
T 3mi9_A 155 VLITRD-GVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLG-------ERDYGPPIDLWGAGCIMAEMWTRS 226 (351)
T ss_dssp EEECTT-SCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTT-------CCSCCTHHHHHHHHHHHHHHHHSS
T ss_pred EEEcCC-CCEEEccchhcccccccccccccccCCcccccCccCchhhcC-------CCCCCcHhHHHHHHHHHHHHHhCC
Confidence 999988 6999999999975432 222344578999999998853 245788999999999999999999
Q ss_pred CCCCCCChHHHHHHHHhccCCCCCC---C----------------------------CcHHHHHHHHhccccCCCCCCCH
Q 024408 147 LPFEGMSNLQAAYAAAFKNVRPSAE---N----------------------------VPEELSIILTSCWKEDPNARPNF 195 (268)
Q Consensus 147 ~p~~~~~~~~~~~~~~~~~~~~~~~---~----------------------------~~~~l~~li~~~l~~~p~~Rps~ 195 (268)
.||.+.................... . .++.+.++|.+||..||.+|||+
T Consensus 227 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~ 306 (351)
T 3mi9_A 227 PIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS 306 (351)
T ss_dssp CSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCH
T ss_pred CCCCCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCH
Confidence 9999876655444333221111111 0 26779999999999999999999
Q ss_pred HHHHHHHHHhHhh
Q 024408 196 TQIIQMLLNYLSA 208 (268)
Q Consensus 196 ~~~~~~l~~~~~~ 208 (268)
+++++| .++..
T Consensus 307 ~e~l~h--p~f~~ 317 (351)
T 3mi9_A 307 DDALNH--DFFWS 317 (351)
T ss_dssp HHHHTS--GGGGS
T ss_pred HHHhCC--CCcCC
Confidence 999998 45544
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=265.34 Aligned_cols=191 Identities=22% Similarity=0.377 Sum_probs=155.6
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCCEEEeCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH-GIIHRDLKPENLLLTEDL 78 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-gi~H~Dikp~Nill~~~~ 78 (268)
+++++++++ .++..++||||++|++|.+++.+.+. +++..+..++.|++.||.|||++ |++||||||+||+++.+
T Consensus 92 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~- 168 (360)
T 3eqc_A 92 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSR- 168 (360)
T ss_dssp TBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTT-
T ss_pred CEEEEeEEEEECCEEEEEEECCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCC-
Confidence 589999999 56789999999999999999987655 99999999999999999999996 99999999999999988
Q ss_pred CCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 79 KTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 79 ~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
+.++|+|||++...... ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||......+..
T Consensus 169 ~~~kl~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 239 (360)
T 3eqc_A 169 GEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQG--------THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELE 239 (360)
T ss_dssp CCEEECCCCCCHHHHHH-C----CCCCTTCCHHHHTT--------CCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHH
T ss_pred CCEEEEECCCCcccccc-cccCCCCCCCeECHHHHcC--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 69999999999743322 2344578999999999864 56788999999999999999999999875543321
Q ss_pred HHH-----------------------------------------HhccC--CCCCCCCcHHHHHHHHhccccCCCCCCCH
Q 024408 159 YAA-----------------------------------------AFKNV--RPSAENVPEELSIILTSCWKEDPNARPNF 195 (268)
Q Consensus 159 ~~~-----------------------------------------~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~ 195 (268)
... ..... ......++.++.++|.+||..||.+|||+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 319 (360)
T 3eqc_A 240 LMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADL 319 (360)
T ss_dssp HHHC------------------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCH
T ss_pred HHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCH
Confidence 110 00111 11123578899999999999999999999
Q ss_pred HHHHHHHH
Q 024408 196 TQIIQMLL 203 (268)
Q Consensus 196 ~~~~~~l~ 203 (268)
+++++|.+
T Consensus 320 ~ell~hp~ 327 (360)
T 3eqc_A 320 KQLMVHAF 327 (360)
T ss_dssp HHHHTSHH
T ss_pred HHHhhChH
Confidence 99999854
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=260.73 Aligned_cols=198 Identities=25% Similarity=0.408 Sum_probs=155.1
Q ss_pred CceeEEEeec-------CCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEE
Q 024408 1 MREQFIGACK-------EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 73 (268)
Q Consensus 1 ~~v~l~g~~~-------~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nil 73 (268)
++++++|++. ++..++||||++|++|.+++.......+++..++.++.|++.||.|||++|++|+||||+||+
T Consensus 82 ~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl 161 (326)
T 2x7f_A 82 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVL 161 (326)
T ss_dssp TBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEE
T ss_pred CeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEE
Confidence 5789999983 357899999999999999998765455999999999999999999999999999999999999
Q ss_pred EeCCCCCeEEecCCCccccccc-cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 024408 74 LTEDLKTIKLADFGLAREESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGM 152 (268)
Q Consensus 74 l~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~ 152 (268)
++.+ +.++|+|||++...... .......|++.|+|||++.... .....++.++||||||+++|+|++|..||.+.
T Consensus 162 ~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 237 (326)
T 2x7f_A 162 LTEN-AEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDE---NPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 237 (326)
T ss_dssp ECTT-CCEEECCCTTTC-------------CCGGGCCHHHHC-----------CCTTHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred EcCC-CCEEEeeCcCceecCcCccccccccCCccccChhhhcccc---ccCcCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence 9988 69999999999754332 2234457899999999985311 11356788999999999999999999999887
Q ss_pred ChHHHHHHHHhccC-CCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 024408 153 SNLQAAYAAAFKNV-RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 202 (268)
Q Consensus 153 ~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l 202 (268)
.............. ......++..+.++|.+||..||.+||++.+++++-
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp 288 (326)
T 2x7f_A 238 HPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHP 288 (326)
T ss_dssp CHHHHHHHHHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSH
T ss_pred cHHHHHHHhhcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhCh
Confidence 66554443333222 223567899999999999999999999999999973
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=260.92 Aligned_cols=199 Identities=28% Similarity=0.448 Sum_probs=151.5
Q ss_pred CceeEEEeecC-----CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--------HCCCeecCC
Q 024408 1 MREQFIGACKE-----PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLH--------SHGIIHRDL 67 (268)
Q Consensus 1 ~~v~l~g~~~~-----~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH--------~~gi~H~Di 67 (268)
|++++++++.+ +..++||||++||+|.+++.. ..+++..++.++.|++.||+||| ++|++||||
T Consensus 63 niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dl 139 (301)
T 3q4u_A 63 NILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDL 139 (301)
T ss_dssp TBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCC
T ss_pred CeeeEEEeeccccCCCceeEEehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCC
Confidence 57899998632 368999999999999999954 24999999999999999999999 999999999
Q ss_pred CCCCEEEeCCCCCeEEecCCCccccccccc-----cccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHH
Q 024408 68 KPENLLLTEDLKTIKLADFGLAREESLTEM-----MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWEL 142 (268)
Q Consensus 68 kp~Nill~~~~~~~kl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~l 142 (268)
||+||+++.+ +.+||+|||+++....... .....||+.|+|||++.+.... ....++.++||||||+++|+|
T Consensus 140 kp~Nill~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~~~~~~~~~DvwslG~il~el 216 (301)
T 3q4u_A 140 KSKNILVKKN-GQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQV--DCFDSYKRVDIWAFGLVLWEV 216 (301)
T ss_dssp CGGGEEECTT-SCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCT--TCHHHHHHHHHHHHHHHHHHH
T ss_pred ChHhEEEcCC-CCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCC--CcccCCchhhHHHHHHHHHHH
Confidence 9999999988 6999999999974332221 2334799999999998641100 000344689999999999999
Q ss_pred HhC----------CCCCCCCCh----HHHHHHHH-hccCCCCC------CCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 143 LHN----------KLPFEGMSN----LQAAYAAA-FKNVRPSA------ENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 143 l~g----------~~p~~~~~~----~~~~~~~~-~~~~~~~~------~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
++| ..||..... ........ .....+.. ..++..+.+++.+||+.||.+|||+.++++.
T Consensus 217 ~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~ 296 (301)
T 3q4u_A 217 ARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKT 296 (301)
T ss_dssp HTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred HhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 999 888854322 12222211 11112211 1245789999999999999999999999999
Q ss_pred HHHh
Q 024408 202 LLNY 205 (268)
Q Consensus 202 l~~~ 205 (268)
|+.+
T Consensus 297 L~~i 300 (301)
T 3q4u_A 297 LTKI 300 (301)
T ss_dssp HHHH
T ss_pred Hhcc
Confidence 8763
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=260.65 Aligned_cols=194 Identities=27% Similarity=0.355 Sum_probs=156.5
Q ss_pred CceeEEEeecCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCC--
Q 024408 1 MREQFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL-- 78 (268)
Q Consensus 1 ~~v~l~g~~~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~-- 78 (268)
+++++++++..+..++||||++|++|.+++..... +++..++.++.|++.||.|||++|++||||||+||+++.+.
T Consensus 76 ~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~ 153 (322)
T 2ycf_A 76 CIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKR--LKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEED 153 (322)
T ss_dssp TBCCEEEEEESSSEEEEEECCTTEETHHHHSTTCC--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSS
T ss_pred CCceEeeEEcCCceEEEEecCCCCcHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCC
Confidence 58899999977779999999999999999976544 99999999999999999999999999999999999998652
Q ss_pred CCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 79 KTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 79 ~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
..+||+|||++.............||+.|+|||++... ....++.++||||||+++|+|++|..||.........
T Consensus 154 ~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 228 (322)
T 2ycf_A 154 CLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSV-----GTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL 228 (322)
T ss_dssp CCEEECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHT-----TTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCH
T ss_pred CeEEEccCccceecccccccccccCCcCccCchhhccC-----CCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHH
Confidence 24999999999865544434455789999999987421 1256788999999999999999999999764432211
Q ss_pred HHHH-hccCCC---CCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 159 YAAA-FKNVRP---SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 159 ~~~~-~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
.... ...... ....++..+.++|.+||..||.+||++.++++|
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 229 KDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp HHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 1111 111111 125678999999999999999999999999976
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=255.74 Aligned_cols=188 Identities=18% Similarity=0.280 Sum_probs=154.3
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRP--RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED 77 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~ 77 (268)
+++++++++ .++..++||||++|++|.+++.+... ..+++.+++.++.|++.||.|||++|++||||||+||+++.+
T Consensus 72 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~ 151 (289)
T 1x8b_A 72 HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRT 151 (289)
T ss_dssp TBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--
T ss_pred CeeeeeeeeecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCC
Confidence 589999999 56789999999999999999986521 349999999999999999999999999999999999999743
Q ss_pred ------------------CCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHH
Q 024408 78 ------------------LKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVL 139 (268)
Q Consensus 78 ------------------~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l 139 (268)
...++|+|||.+...... ....||+.|+|||++.+ ...++.++||||||+++
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~-------~~~~~~~~Di~slG~il 221 (289)
T 1x8b_A 152 SIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQE-------NYTHLPKADIFALALTV 221 (289)
T ss_dssp ------------------CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTT-------CCTTHHHHHHHHHHHHH
T ss_pred CCCcccccccccccccCCceEEEEcccccccccCCc---cccCCCccccChhHhcC-------CCCCCchhhHHHHHHHH
Confidence 237999999999865433 23468999999999853 23456799999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 140 WELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 140 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
|+|++|..++..... ............+..+++++.++|.+||..||.+||++.++++|
T Consensus 222 ~~l~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 222 VCAAGAEPLPRNGDQ---WHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp HHHTTCCCCCSSSHH---HHHHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred HHHhcCCCCCcchhH---HHHHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 999999887754322 22233333444567889999999999999999999999999987
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=266.27 Aligned_cols=181 Identities=27% Similarity=0.356 Sum_probs=149.8
Q ss_pred cEEEEEEcCCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCCeEEecCCCcc
Q 024408 13 VMVIVTELLSGGTLRKYLLN--MRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 90 (268)
Q Consensus 13 ~~~lV~e~~~ggsL~~~i~~--~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~~kl~Dfg~a~ 90 (268)
++++||||++ |+|.+.+.. .....+++..+..++.|++.||.|||++||+||||||+||+++...+.+||+|||+++
T Consensus 112 ~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~ 190 (383)
T 3eb0_A 112 YLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAK 190 (383)
T ss_dssp EEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCc
Confidence 4899999997 688888764 2334599999999999999999999999999999999999998543789999999998
Q ss_pred ccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCC--
Q 024408 91 EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP-- 168 (268)
Q Consensus 91 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-- 168 (268)
............||+.|+|||++.+ ...++.++||||+|+++|+|++|+.||.+....+...........+
T Consensus 191 ~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~ 263 (383)
T 3eb0_A 191 KLIPSEPSVAYICSRFYRAPELMLG-------ATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTK 263 (383)
T ss_dssp ECCTTSCCCCCCCCSSCCCHHHHTT-------CSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred ccCCCCCCcCcccCCCccCHHHhcC-------CCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 6655555566788999999998754 2457889999999999999999999999877666554443211111
Q ss_pred --------------------------CCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 169 --------------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 169 --------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
.+..++.++.++|.+||..||.+|||+.++++|
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (383)
T 3eb0_A 264 EQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAH 322 (383)
T ss_dssp HHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 134578899999999999999999999999987
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=255.97 Aligned_cols=191 Identities=28% Similarity=0.375 Sum_probs=155.7
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ .++..++||||++|++|.+++..... +++..++.++.|++.||.|||++|++|+||||+||+++.+ +
T Consensus 66 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~-~ 142 (276)
T 2yex_A 66 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER-D 142 (276)
T ss_dssp TBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTTTB--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-C
T ss_pred CceeeeeEEEcCCEEEEEEEecCCCcHHHHHhhccC--CCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccC-C
Confidence 578999999 55688999999999999999875443 9999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccc---cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH
Q 024408 80 TIKLADFGLAREESLT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 156 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~ 156 (268)
.++|+|||.+...... .......|++.|+|||++.+ ....+.++||||||+++|+|++|..||.......
T Consensus 143 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 215 (276)
T 2yex_A 143 NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR-------REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC 215 (276)
T ss_dssp CEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTC-------SSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS
T ss_pred CEEEeeCCCccccCCCcchhcccCCccccCccChHHHhc-------CCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH
Confidence 9999999999754322 22345578999999999864 1224678999999999999999999998755432
Q ss_pred HHHHHHhcc--CCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 157 AAYAAAFKN--VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 157 ~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
......... ..+....++..+.++|.+||..||.+||++.+++++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 216 QEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp HHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHhhhcccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 222222221 122235688999999999999999999999999987
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-37 Score=257.53 Aligned_cols=193 Identities=25% Similarity=0.362 Sum_probs=160.1
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ .++..++||||++|++|.+++..... .+++.+++.++.|++.||.|||++|++|+||||+||+++.+ +
T Consensus 85 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~-~ 162 (314)
T 3com_A 85 HVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNK-TLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTE-G 162 (314)
T ss_dssp TBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-C
T ss_pred CCccEEEEEEeCCEEEEEeecCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCC-C
Confidence 578999998 56788999999999999999975433 39999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccc-cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.++|+|||++...... .......|+..|+|||++.+ ..++.++||||||+++|+|++|..||.........
T Consensus 163 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~ 234 (314)
T 3com_A 163 HAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE--------IGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAI 234 (314)
T ss_dssp CEEECCCTTCEECBTTBSCBCCCCSCGGGCCHHHHSS--------SCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred CEEEeecccchhhhhhccccCccCCCCCccChhhcCC--------CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 9999999999754332 22344578999999999864 45788999999999999999999999887665544
Q ss_pred HHHHhccC--CCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 024408 159 YAAAFKNV--RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 203 (268)
Q Consensus 159 ~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~ 203 (268)
........ ...+..++..+.++|.+||..||.+||++.+++++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~ 281 (314)
T 3com_A 235 FMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPF 281 (314)
T ss_dssp HHHHHSCCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHH
T ss_pred HHHhcCCCcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHH
Confidence 43322221 1124557899999999999999999999999999743
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-37 Score=265.99 Aligned_cols=199 Identities=21% Similarity=0.269 Sum_probs=157.4
Q ss_pred CceeEEEeecC-------CcEEEEEEcCCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCC
Q 024408 1 MREQFIGACKE-------PVMVIVTELLSGGTLRKYLLN--MRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPEN 71 (268)
Q Consensus 1 ~~v~l~g~~~~-------~~~~lV~e~~~ggsL~~~i~~--~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~N 71 (268)
|+|++++++.. .++++||||+++ +|.+.+.. .....+++..++.++.|++.||+|||++||+||||||+|
T Consensus 93 niv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~N 171 (394)
T 4e7w_A 93 NVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQN 171 (394)
T ss_dssp TBCCEEEEEEEESSSSSCEEEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred CcceEEEEEEecCCCCCceEEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHH
Confidence 68899999821 147899999975 55554432 223459999999999999999999999999999999999
Q ss_pred EEEeCCCCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 024408 72 LLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 151 (268)
Q Consensus 72 ill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~ 151 (268)
|+++...+.+||+|||+++............||+.|+|||++.+ ...++.++||||||+++|+|++|+.||.+
T Consensus 172 ill~~~~~~~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwSlG~il~ell~g~~pf~~ 244 (394)
T 4e7w_A 172 LLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFG-------ATNYTTNIDIWSTGCVMAELMQGQPLFPG 244 (394)
T ss_dssp EEEETTTTEEEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTT-------CSSCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred EEEcCCCCcEEEeeCCCcccccCCCCCcccccCcCccCHHHHcC-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99994337999999999987655555556788999999998854 24588999999999999999999999998
Q ss_pred CChHHHHHHHHhccCCC----------------------------CCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 024408 152 MSNLQAAYAAAFKNVRP----------------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 203 (268)
Q Consensus 152 ~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~ 203 (268)
....+...........+ ....+++++.++|.+||..||.+||++.++++|
T Consensus 245 ~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h-- 322 (394)
T 4e7w_A 245 ESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH-- 322 (394)
T ss_dssp SSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS--
T ss_pred CCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC--
Confidence 77655544333211110 123478899999999999999999999999998
Q ss_pred HhHhhc
Q 024408 204 NYLSAI 209 (268)
Q Consensus 204 ~~~~~~ 209 (268)
.++...
T Consensus 323 p~f~~~ 328 (394)
T 4e7w_A 323 PFFDEL 328 (394)
T ss_dssp GGGSTT
T ss_pred hhhhhh
Confidence 455443
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-37 Score=259.89 Aligned_cols=189 Identities=22% Similarity=0.239 Sum_probs=154.6
Q ss_pred ceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCC---
Q 024408 2 REQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED--- 77 (268)
Q Consensus 2 ~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~--- 77 (268)
++++++++ .++..++||||+ +++|.+++.......+++.+++.++.|++.||+|||++|++||||||+||+++.+
T Consensus 79 i~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~ 157 (339)
T 1z57_A 79 CVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYT 157 (339)
T ss_dssp BCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEE
T ss_pred eEeeecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccc
Confidence 68899998 567899999999 8999999988765569999999999999999999999999999999999999762
Q ss_pred ---------------CCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHH
Q 024408 78 ---------------LKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWEL 142 (268)
Q Consensus 78 ---------------~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~l 142 (268)
.+.++|+|||+++..... .....||+.|+|||++.+ ..++.++||||||+++|+|
T Consensus 158 ~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~el 227 (339)
T 1z57_A 158 EAYNPKIKRDERTLINPDIKVVDFGSATYDDEH--HSTLVSTRHYRAPEVILA--------LGWSQPCDVWSIGCILIEY 227 (339)
T ss_dssp EEEC----CEEEEESCCCEEECCCSSCEETTSC--CCSSCSCGGGCCHHHHTT--------SCCCTHHHHHHHHHHHHHH
T ss_pred cccCCccccccccccCCCceEeeCcccccCccc--cccccCCccccChHHhhC--------CCCCcchhhHHHHHHHHHH
Confidence 257999999999864332 345678999999999864 5678899999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHhccC-------------------------------------------CCCCCCCcHHHHH
Q 024408 143 LHNKLPFEGMSNLQAAYAAAFKNV-------------------------------------------RPSAENVPEELSI 179 (268)
Q Consensus 143 l~g~~p~~~~~~~~~~~~~~~~~~-------------------------------------------~~~~~~~~~~l~~ 179 (268)
++|..||...+..+.......... .......++++.+
T Consensus 228 ~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 307 (339)
T 1z57_A 228 YLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFD 307 (339)
T ss_dssp HHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHH
T ss_pred HhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHH
Confidence 999999987665443322211100 0011223578999
Q ss_pred HHHhccccCCCCCCCHHHHHHH
Q 024408 180 ILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 180 li~~~l~~~p~~Rps~~~~~~~ 201 (268)
+|.+||..||.+|||+.++++|
T Consensus 308 li~~~L~~dP~~Rpt~~ell~h 329 (339)
T 1z57_A 308 LIQKMLEYDPAKRITLREALKH 329 (339)
T ss_dssp HHHHHTCSSTTTSCCHHHHTTS
T ss_pred HHHHHhCcCcccccCHHHHhcC
Confidence 9999999999999999999987
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=263.34 Aligned_cols=193 Identities=27% Similarity=0.425 Sum_probs=153.7
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ .++..++||||++|++|.+++..... +++..+..++.|++.||.|||++|++||||||+||+++.+ +
T Consensus 85 ~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~-~ 161 (331)
T 4aaa_A 85 NLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNG--LDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQS-G 161 (331)
T ss_dssp TBCCEEEEEEETTEEEEEEECCSEEHHHHHHHSTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-S
T ss_pred CEeeEEEEeecCCEEEEEEecCCcchHHHHHhhccC--CCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCC-C
Confidence 589999999 55688999999999888888765444 9999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccc-ccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESL-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.++|+|||+++.... ........|+..|+|||++.+ ...++.++||||||+++|+|++|+.||......+..
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 234 (331)
T 4aaa_A 162 VVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVG-------DVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQL 234 (331)
T ss_dssp CEEECCCTTC------------CCCCCTTCCHHHHTT-------CTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred cEEEEeCCCceeecCCccccCCCcCCccccCcccccC-------CCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence 999999999975433 223345578999999998853 236788999999999999999999999887665544
Q ss_pred HHHHhccC--------------------CCC----------CCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 024408 159 YAAAFKNV--------------------RPS----------AENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 203 (268)
Q Consensus 159 ~~~~~~~~--------------------~~~----------~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~ 203 (268)
........ .+. ...+++.+.++|.+||..||.+||++.++++|-+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~ 309 (331)
T 4aaa_A 235 YHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDF 309 (331)
T ss_dssp HHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHH
T ss_pred HHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCch
Confidence 33221100 000 1357899999999999999999999999999844
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=259.52 Aligned_cols=196 Identities=26% Similarity=0.368 Sum_probs=156.2
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMR-PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL 78 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~ 78 (268)
++++++|++ .++..++||||++|++|.+++.... ...+++..++.++.|++.||.|||++|++||||||+||+++.+
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~- 169 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEA- 169 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT-
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCC-
Confidence 589999999 4568899999999999999997533 3459999999999999999999999999999999999999988
Q ss_pred CCeEEecCCCcccccccc---ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH
Q 024408 79 KTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL 155 (268)
Q Consensus 79 ~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~ 155 (268)
+.++|+|||++....... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||......
T Consensus 170 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~---------~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~ 240 (307)
T 2nru_A 170 FTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG---------EITPKSDIYSFGVVLLEIITGLPAVDEHREP 240 (307)
T ss_dssp CCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT---------EECTHHHHHHHHHHHHHHHHCCCSBCTTBSS
T ss_pred CcEEEeecccccccccccccccccccCCCcCcCChHHhcC---------CCCccchhHHHHHHHHHHHHCCCCcccCcch
Confidence 699999999997543321 2234578999999998753 4678999999999999999999999764432
Q ss_pred H---HHHHHHhc-----------cCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhH
Q 024408 156 Q---AAYAAAFK-----------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 206 (268)
Q Consensus 156 ~---~~~~~~~~-----------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 206 (268)
+ ........ .........+..+.+++.+||..||.+||++.+++++|+.+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 241 QLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp SBTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHHHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 1 11111100 011112334577999999999999999999999999998764
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=261.18 Aligned_cols=195 Identities=27% Similarity=0.387 Sum_probs=153.8
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCCCCEEE
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRP--RCLDVCVAIGFALDIARAMECLHSH---GIIHRDLKPENLLL 74 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~---gi~H~Dikp~Nill 74 (268)
|++++++++ ..+..++||||++||+|.+++..... ..+++..+..++.|++.||.|||++ |++||||||+||++
T Consensus 88 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~ 167 (326)
T 3uim_A 88 NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILL 167 (326)
T ss_dssp TBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEE
T ss_pred CccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEE
Confidence 689999999 45678999999999999999987543 3499999999999999999999999 99999999999999
Q ss_pred eCCCCCeEEecCCCccccccc--cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 024408 75 TEDLKTIKLADFGLAREESLT--EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGM 152 (268)
Q Consensus 75 ~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~ 152 (268)
+.+ +.++|+|||+++..... .......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||...
T Consensus 168 ~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~pf~~~ 238 (326)
T 3uim_A 168 DEE-FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST--------GKSSEKTDVFGYGVMLLELITGQRAFDLA 238 (326)
T ss_dssp CTT-CCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHH--------SEECHHHHHHHHHHHHHHHHHCCCSBCHH
T ss_pred CCC-CCEEeccCccccccCcccccccccccCCcCccCHHHhcc--------CCCCccccchhHHHHHHHHHhCCCccccc
Confidence 988 69999999999854322 22334469999999999864 45788999999999999999999999521
Q ss_pred C----hHHHHHHHHhccCCC--------------CCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 024408 153 S----NLQAAYAAAFKNVRP--------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 204 (268)
Q Consensus 153 ~----~~~~~~~~~~~~~~~--------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~ 204 (268)
. ............... .....+..+.+++.+||+.||.+|||+.+++++|+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 239 RLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp HHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred ccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 1 000000111100000 011223679999999999999999999999999976
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=253.73 Aligned_cols=191 Identities=25% Similarity=0.363 Sum_probs=159.8
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCC-
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL- 78 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~- 78 (268)
+++++++++ ..+..++||||++|++|.+++.+... +++.+++.++.|++.||.|||++|++||||||+||+++.+.
T Consensus 82 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~ 159 (287)
T 2wei_A 82 NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR--FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEK 159 (287)
T ss_dssp TBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSST
T ss_pred CccEEEEEEeCCCeEEEEEEccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCC
Confidence 578999999 45688999999999999999987654 99999999999999999999999999999999999997542
Q ss_pred -CCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 024408 79 -KTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA 157 (268)
Q Consensus 79 -~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~ 157 (268)
..+||+|||++.............|++.|+|||++. +.++.++|+||||+++|+|++|..||.+....+.
T Consensus 160 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~---------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~ 230 (287)
T 2wei_A 160 DCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLR---------GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI 230 (287)
T ss_dssp TCCEEECSTTGGGTBCCCSSCSCHHHHHTTCCHHHHT---------TCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred cccEEEeccCcceeecCCCccccccCcccccChHHhc---------CCCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence 369999999998655444444456899999999875 3478899999999999999999999988766554
Q ss_pred HHHHHhccCCC---CCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 024408 158 AYAAAFKNVRP---SAENVPEELSIILTSCWKEDPNARPNFTQIIQML 202 (268)
Q Consensus 158 ~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l 202 (268)
........... ....++.++.++|.+||..||.+||++.+++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp 278 (287)
T 2wei_A 231 LKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHP 278 (287)
T ss_dssp HHHHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSH
T ss_pred HHHHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCH
Confidence 44443333222 2357889999999999999999999999999973
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-37 Score=258.86 Aligned_cols=189 Identities=20% Similarity=0.273 Sum_probs=153.5
Q ss_pred CceeEEEeecC---CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCC
Q 024408 1 MREQFIGACKE---PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED 77 (268)
Q Consensus 1 ~~v~l~g~~~~---~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~ 77 (268)
+++++++++.+ ...++||||++|++|.+++.. +++.++..++.|++.||+|||++|++||||||+||+++.+
T Consensus 92 ~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~ 166 (330)
T 3nsz_A 92 NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHE 166 (330)
T ss_dssp TBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETT
T ss_pred CEEEeeeeeccCCCCceEEEEeccCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCC
Confidence 57899999853 478999999999999999854 8999999999999999999999999999999999999977
Q ss_pred CCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 024408 78 LKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA 157 (268)
Q Consensus 78 ~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~ 157 (268)
...++|+|||+++............|+..|+|||++.+ ...++.++||||||+++|+|++|+.||........
T Consensus 167 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~ 239 (330)
T 3nsz_A 167 HRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD-------YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD 239 (330)
T ss_dssp TTEEEECCCTTCEECCTTCCCCSCCSCGGGCCHHHHTT-------CCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH
T ss_pred CCEEEEEeCCCceEcCCCCccccccccccccChhhhcC-------CCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHH
Confidence 45899999999986555555556689999999998853 24578899999999999999999999954332211
Q ss_pred HHHH-Hh------------ccC------------------------CCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHH
Q 024408 158 AYAA-AF------------KNV------------------------RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQ 200 (268)
Q Consensus 158 ~~~~-~~------------~~~------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~ 200 (268)
.... .. ... ......+++++.++|.+||..||.+|||++++++
T Consensus 240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 240 QLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1111 00 000 0011227899999999999999999999999999
Q ss_pred H
Q 024408 201 M 201 (268)
Q Consensus 201 ~ 201 (268)
|
T Consensus 320 h 320 (330)
T 3nsz_A 320 H 320 (330)
T ss_dssp S
T ss_pred C
Confidence 8
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=260.10 Aligned_cols=200 Identities=23% Similarity=0.362 Sum_probs=156.5
Q ss_pred CceeEEEeec-----CCcEEEEEEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEE
Q 024408 1 MREQFIGACK-----EPVMVIVTELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 73 (268)
Q Consensus 1 ~~v~l~g~~~-----~~~~~lV~e~~~ggsL~~~i~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nil 73 (268)
+++++++++. ....++||||++||+|.+++.+. ....+++.+++.++.|++.||+|||++|++||||||+||+
T Consensus 87 ~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl 166 (317)
T 2buj_A 87 NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNIL 166 (317)
T ss_dssp TBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred CeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEE
Confidence 5788999884 23789999999999999999863 2345999999999999999999999999999999999999
Q ss_pred EeCCCCCeEEecCCCccccccccc----------cccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHH
Q 024408 74 LTEDLKTIKLADFGLAREESLTEM----------MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL 143 (268)
Q Consensus 74 l~~~~~~~kl~Dfg~a~~~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll 143 (268)
++.+ +.++|+|||++........ .....||+.|+|||++.+.. ...++.++||||||+++|+|+
T Consensus 167 ~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~~~~Di~slG~il~el~ 240 (317)
T 2buj_A 167 LGDE-GQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQS-----HCVIDERTDVWSLGCVLYAMM 240 (317)
T ss_dssp ECTT-SCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCS-----EEEECTHHHHHHHHHHHHHHH
T ss_pred EcCC-CCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCC-----CcCCCchhhHHHHHHHHHHHH
Confidence 9988 6999999999875332111 12335789999999885311 123578999999999999999
Q ss_pred hCCCCCCCCChH--HHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhH
Q 024408 144 HNKLPFEGMSNL--QAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 206 (268)
Q Consensus 144 ~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 206 (268)
+|+.||...... ............+....++.++.++|.+||..||.+||++.+++++|+...
T Consensus 241 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 241 FGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp HSSCTTHHHHHTTSCHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred hCCCChhhhhcccchhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 999999531110 111112222233445678999999999999999999999999999998753
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=261.00 Aligned_cols=193 Identities=24% Similarity=0.319 Sum_probs=157.7
Q ss_pred CceeEEEeecCC-------cEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEE
Q 024408 1 MREQFIGACKEP-------VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 73 (268)
Q Consensus 1 ~~v~l~g~~~~~-------~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nil 73 (268)
|+|++++++..+ .+++||||+ |++|.+++.. . .+++..+..++.|++.||.|||++||+||||||+||+
T Consensus 85 nIv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~--~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIl 160 (367)
T 1cm8_A 85 NVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH-E--KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLA 160 (367)
T ss_dssp TBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH-C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred CCCCceeeEecCCccccCceEEEEEecC-CCCHHHHHhc-C--CCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEE
Confidence 578999998432 459999999 8999999976 2 3999999999999999999999999999999999999
Q ss_pred EeCCCCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 024408 74 LTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS 153 (268)
Q Consensus 74 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~ 153 (268)
++.+ +.+||+|||+++..... .....+|++|+|||++.+ ...++.++||||+||++|+|++|+.||.+.+
T Consensus 161 l~~~-~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 230 (367)
T 1cm8_A 161 VNED-CELKILDFGLARQADSE--MTGYVVTRWYRAPEVILN-------WMRYTQTVDIWSVGCIMAEMITGKTLFKGSD 230 (367)
T ss_dssp ECTT-CCEEECCCTTCEECCSS--CCSSCSCGGGCCTHHHHT-------TTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EcCC-CCEEEEeeecccccccc--cCcCcCCCCcCCHHHHhC-------CCCCChhhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9988 69999999999864432 345678999999998853 2467889999999999999999999999876
Q ss_pred hHHHHHHHHhccCC------------------------------CCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 024408 154 NLQAAYAAAFKNVR------------------------------PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 203 (268)
Q Consensus 154 ~~~~~~~~~~~~~~------------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~ 203 (268)
..+........... ......++.+.++|.+||..||.+|||+.++++|
T Consensus 231 ~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h-- 308 (367)
T 1cm8_A 231 HLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH-- 308 (367)
T ss_dssp HHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS--
T ss_pred HHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC--
Confidence 65544333221111 1124568999999999999999999999999998
Q ss_pred HhHhhc
Q 024408 204 NYLSAI 209 (268)
Q Consensus 204 ~~~~~~ 209 (268)
.++...
T Consensus 309 p~f~~~ 314 (367)
T 1cm8_A 309 PYFESL 314 (367)
T ss_dssp GGGTTT
T ss_pred hHHHhh
Confidence 445443
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-37 Score=256.51 Aligned_cols=193 Identities=24% Similarity=0.448 Sum_probs=154.6
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhc------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEE
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNM------RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 73 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~------~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nil 73 (268)
|++++++++ .++..++||||++|++|.+++... ....+++..++.++.|++.||.|||++|++||||||+||+
T Consensus 74 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil 153 (303)
T 2vwi_A 74 NIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNIL 153 (303)
T ss_dssp TBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEE
T ss_pred CEeeEEEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEE
Confidence 578999998 556899999999999999999752 2334999999999999999999999999999999999999
Q ss_pred EeCCCCCeEEecCCCccccccc------cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCC
Q 024408 74 LTEDLKTIKLADFGLAREESLT------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKL 147 (268)
Q Consensus 74 l~~~~~~~kl~Dfg~a~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~ 147 (268)
++.+ +.++|+|||++...... .......||+.|+|||++.+ ...++.++||||||+++|+|++|+.
T Consensus 154 ~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~il~~l~~g~~ 225 (303)
T 2vwi_A 154 LGED-GSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQ-------VRGYDFKADIWSFGITAIELATGAA 225 (303)
T ss_dssp ECTT-CCEEECCCHHHHHCC---------------CCCTTCCHHHHHH-------HHCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred EcCC-CCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhcc-------ccCCCchhhHHHHHHHHHHHHhCCC
Confidence 9988 69999999998743322 11234568999999998853 1346889999999999999999999
Q ss_pred CCCCCChHHHHHHHHhccCCC---------CCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 148 PFEGMSNLQAAYAAAFKNVRP---------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 148 p~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
||................... ....++.++.++|.+||..||.+||++.+++++
T Consensus 226 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 226 PYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp TTTTSCGGGHHHHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CCccCchhhHHHHHhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 998766554443333222111 134678999999999999999999999999987
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=262.50 Aligned_cols=178 Identities=28% Similarity=0.416 Sum_probs=139.1
Q ss_pred cEEEEEEcCCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCCeEEecCCCccc
Q 024408 13 VMVIVTELLSGGTLRKYLLNMRP-RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 91 (268)
Q Consensus 13 ~~~lV~e~~~ggsL~~~i~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~~kl~Dfg~a~~ 91 (268)
+.++||||++|++|.+++.+... ...++..++.++.|++.||+|||++|++||||||+||+++.+ +.+||+|||+++.
T Consensus 135 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~~kL~DfG~a~~ 213 (332)
T 3qd2_B 135 YLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMD-DVVKVGDFGLVTA 213 (332)
T ss_dssp EEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCEE
T ss_pred eEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCC-CCEEEeecCcccc
Confidence 38999999999999999987544 235677899999999999999999999999999999999988 6999999999985
Q ss_pred ccccc-------------ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 92 ESLTE-------------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 92 ~~~~~-------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
..... ......||+.|+|||++.+ ..++.++||||||+++|+|++|..|+.. .....
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~ 283 (332)
T 3qd2_B 214 MDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHG--------NNYSHKVDIFSLGLILFELLYSFSTQME--RVRII 283 (332)
T ss_dssp CSCC--------------CCCSCC-CGGGSCHHHHHC--------CCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHH
T ss_pred cccchhhccccccccccccccccCCCcCccChHHhcC--------CCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHH
Confidence 44331 2234569999999999864 5678999999999999999998776432 11111
Q ss_pred HHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 159 YAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
...............++.+.++|.+||+.||.+||++.+++++
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 284 TDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHhhccCCCcccccCChhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence 1111111111123456788999999999999999999999987
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=266.57 Aligned_cols=196 Identities=26% Similarity=0.309 Sum_probs=148.7
Q ss_pred CceeEEEeecC------CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEE
Q 024408 1 MREQFIGACKE------PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL 74 (268)
Q Consensus 1 ~~v~l~g~~~~------~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill 74 (268)
|+|++++++.. +..|+||||++ ++|.+++..... +++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 86 nIv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~--l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl 162 (432)
T 3n9x_A 86 YIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKTPIF--LTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLL 162 (432)
T ss_dssp TBCCEEEECCCSCTTTCCCEEEEEECCS-EEHHHHHHSSCC--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred CcceEEEEEecCCCCcCCeEEEEEecCC-cCHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEE
Confidence 58999999843 36899999995 699999986544 9999999999999999999999999999999999999
Q ss_pred eCCCCCeEEecCCCcccccccc-----------------------ccccCCCccceeccccccccccccCCCCCCCchhh
Q 024408 75 TEDLKTIKLADFGLAREESLTE-----------------------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVD 131 (268)
Q Consensus 75 ~~~~~~~kl~Dfg~a~~~~~~~-----------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~D 131 (268)
+.+ +.+||+|||+++...... ......||++|+|||++.. ...++.++|
T Consensus 163 ~~~-~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-------~~~~~~~~D 234 (432)
T 3n9x_A 163 NQD-CSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILL-------QENYTKSID 234 (432)
T ss_dssp CTT-CCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTT-------CSCCCTHHH
T ss_pred CCC-CCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhc-------CCCCCcccc
Confidence 988 699999999998543321 2345679999999998643 256889999
Q ss_pred HHHHHHHHHHHHhC-----------CCCCCCCCh-----------------HHHHHHHH---------------------
Q 024408 132 SYSFAIVLWELLHN-----------KLPFEGMSN-----------------LQAAYAAA--------------------- 162 (268)
Q Consensus 132 vwslG~~l~~ll~g-----------~~p~~~~~~-----------------~~~~~~~~--------------------- 162 (268)
||||||++|||++| .++|.+... .+......
T Consensus 235 iwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~ 314 (432)
T 3n9x_A 235 IWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIK 314 (432)
T ss_dssp HHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHH
T ss_pred cchHHHHHHHHHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHH
Confidence 99999999999984 344433220 01111000
Q ss_pred --hccCCCC-------CCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhc
Q 024408 163 --FKNVRPS-------AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 209 (268)
Q Consensus 163 --~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~~ 209 (268)
....... ...+++++.++|.+||..||.+|||++++++| .++...
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H--p~f~~~ 368 (432)
T 3n9x_A 315 YIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDH--PYLKDV 368 (432)
T ss_dssp HHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTC--GGGTTT
T ss_pred HHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC--hhhhhc
Confidence 0000000 14578999999999999999999999999998 555543
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=257.37 Aligned_cols=196 Identities=26% Similarity=0.392 Sum_probs=156.6
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
++++++|++ .++..++||||++|++|.+++.+... .+++..++.++.|++.||.|||++|++||||||+||+++.+ +
T Consensus 77 ~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~-~ 154 (302)
T 2j7t_A 77 YIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDR-GLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLE-G 154 (302)
T ss_dssp TBCCEEEEEECC-CEEEEEECCTTEEHHHHHHHHTS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTT-S
T ss_pred CEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCC-C
Confidence 588999998 55689999999999999999876443 39999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccc-ccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESL-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.++|+|||++..... ........|+..|+|||++.... .....++.++||||||+++|+|++|..||.........
T Consensus 155 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~ 231 (302)
T 2j7t_A 155 DIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCET---MKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL 231 (302)
T ss_dssp CEEECCCHHHHHHHHHHHC-----CCGGGCCHHHHHHHH---TTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred CEEEEECCCCccccccccccccccCChhhcCCeeecccc---CCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH
Confidence 999999999763222 12223457899999999874211 01256788999999999999999999999887765554
Q ss_pred HHHHhccCC--CCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 159 YAAAFKNVR--PSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 159 ~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
......... ..+..++..+.++|.+||..||.+||++.++++|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 232 LKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp HHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred HHHhccCCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 443333222 2245678999999999999999999999999987
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=264.90 Aligned_cols=189 Identities=25% Similarity=0.311 Sum_probs=144.0
Q ss_pred CceeEEEeecC-C------cEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEE
Q 024408 1 MREQFIGACKE-P------VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 73 (268)
Q Consensus 1 ~~v~l~g~~~~-~------~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nil 73 (268)
|+|++++++.. + ..++||||++ ++|.+.+.. .+++..+..++.|++.||.|||++||+||||||+||+
T Consensus 85 niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl 159 (371)
T 2xrw_A 85 NIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 159 (371)
T ss_dssp TBCCEEEEECSCCSTTTCCEEEEEEECCS-EEHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred CccceEEeeccccccccccceEEEEEcCC-CCHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEE
Confidence 58899999843 2 6899999996 689998853 2899999999999999999999999999999999999
Q ss_pred EeCCCCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 024408 74 LTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS 153 (268)
Q Consensus 74 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~ 153 (268)
++.+ +.+||+|||+++............||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+.+
T Consensus 160 ~~~~-~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~el~~g~~pf~~~~ 230 (371)
T 2xrw_A 160 VKSD-CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG--------MGYKENVDIWSVGCIMGEMIKGGVLFPGTD 230 (371)
T ss_dssp ECTT-SCEEECCCCC----------------CTTCCHHHHTT--------CCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EcCC-CCEEEEEeecccccccccccCCceecCCccCHHHhcC--------CCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9988 6999999999986554444455689999999999864 567889999999999999999999999876
Q ss_pred hHHHHHHHHhccCCCC--------------------CC---------------------CCcHHHHHHHHhccccCCCCC
Q 024408 154 NLQAAYAAAFKNVRPS--------------------AE---------------------NVPEELSIILTSCWKEDPNAR 192 (268)
Q Consensus 154 ~~~~~~~~~~~~~~~~--------------------~~---------------------~~~~~l~~li~~~l~~~p~~R 192 (268)
..+...........+. .. ..+.++.++|.+||..||.+|
T Consensus 231 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R 310 (371)
T 2xrw_A 231 HIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKR 310 (371)
T ss_dssp HHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGS
T ss_pred HHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhC
Confidence 6554443332211110 00 015678999999999999999
Q ss_pred CCHHHHHHHHH
Q 024408 193 PNFTQIIQMLL 203 (268)
Q Consensus 193 ps~~~~~~~l~ 203 (268)
||++++++|-+
T Consensus 311 ~t~~e~l~hp~ 321 (371)
T 2xrw_A 311 ISVDEALQHPY 321 (371)
T ss_dssp CCHHHHHHSHH
T ss_pred CCHHHHhCCcc
Confidence 99999999844
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-37 Score=259.07 Aligned_cols=198 Identities=24% Similarity=0.446 Sum_probs=159.3
Q ss_pred CceeEEEeecC---CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCC
Q 024408 1 MREQFIGACKE---PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED 77 (268)
Q Consensus 1 ~~v~l~g~~~~---~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~ 77 (268)
++++++|++.. ...++||||++|++|.+++.+... .+++.+++.++.|++.||+|||++|++||||||+||+++.+
T Consensus 103 ~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~ 181 (326)
T 2w1i_A 103 NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENE 181 (326)
T ss_dssp TBCCEEEEECC----CCEEEECCCTTCBHHHHHHHSTT-SSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEET
T ss_pred CeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCC
Confidence 57899999843 268999999999999999987543 39999999999999999999999999999999999999988
Q ss_pred CCCeEEecCCCccccccccc----cccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 024408 78 LKTIKLADFGLAREESLTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS 153 (268)
Q Consensus 78 ~~~~kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~ 153 (268)
+.++|+|||++........ .....++..|+|||++.+ ..++.++||||||+++|+|++|..|+....
T Consensus 182 -~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~tg~~~~~~~~ 252 (326)
T 2w1i_A 182 -NRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTE--------SKFSVASDVWSFGVVLYELFTYIEKSKSPP 252 (326)
T ss_dssp -TEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHH--------CEEEHHHHHHHHHHHHHHHHHTTCGGGSHH
T ss_pred -CcEEEecCcchhhccccccccccccCCCCceeEECchhhcC--------CCCCchhhHHHHHHHHHHHHhcCCCCCCCH
Confidence 6999999999985443221 223456788999999864 456789999999999999999998886421
Q ss_pred hHH----------------HHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 024408 154 NLQ----------------AAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 208 (268)
Q Consensus 154 ~~~----------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 208 (268)
... ...........+.+..++.++.++|.+||..||.+||++.++++.|+.+...
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 253 AEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHhhccccchhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 100 0011112223445678899999999999999999999999999999887654
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=253.75 Aligned_cols=195 Identities=25% Similarity=0.394 Sum_probs=157.6
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMR-PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL 78 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~ 78 (268)
++++++|++ ..+..++||||++|++|.+++.... ...+++..+..++.|++.||.|||++|++|+||||+||+++...
T Consensus 80 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~ 159 (295)
T 2clq_A 80 NIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYS 159 (295)
T ss_dssp TBCCEEEEEEETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTT
T ss_pred CEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCC
Confidence 589999999 5568899999999999999998753 23478999999999999999999999999999999999999733
Q ss_pred CCeEEecCCCccccccc-cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 024408 79 KTIKLADFGLAREESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA 157 (268)
Q Consensus 79 ~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~ 157 (268)
+.++|+|||++...... .......|++.|+|||++.+. ...++.++||||||+++|+|++|+.||........
T Consensus 160 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 233 (295)
T 2clq_A 160 GVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKG------PRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA 233 (295)
T ss_dssp CCEEECCTTTCEESCC-----CCCCCCGGGCCHHHHHHG------GGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH
T ss_pred CCEEEeecccccccCCCCCcccccCCCccccChhhhcCC------CCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH
Confidence 79999999999754332 223455789999999998641 12367899999999999999999999976443332
Q ss_pred HH-HH-HhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 158 AY-AA-AFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 158 ~~-~~-~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
.. .. ........+..++.++.++|.+||..||.+||++.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 234 AMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp HHHHHHHHCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred HHHhhccccccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 22 21 2223334467789999999999999999999999999987
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=258.22 Aligned_cols=202 Identities=26% Similarity=0.342 Sum_probs=143.7
Q ss_pred CceeEEEeec--------C-CcEEEEEEcCCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCC
Q 024408 1 MREQFIGACK--------E-PVMVIVTELLSGGTLRKYLLNM-RPRCLDVCVAIGFALDIARAMECLHSHG--IIHRDLK 68 (268)
Q Consensus 1 ~~v~l~g~~~--------~-~~~~lV~e~~~ggsL~~~i~~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~g--i~H~Dik 68 (268)
|++++++++. + ..+++||||++ |+|.+++... ....+++.+++.++.|++.||.|||++| ++|||||
T Consensus 87 ~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dik 165 (337)
T 3ll6_A 87 NIVQFCSAASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLK 165 (337)
T ss_dssp TBCCEEEEEEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCC
T ss_pred ChhhccccccccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCC
Confidence 5789999882 2 25899999995 7999998762 2344999999999999999999999999 9999999
Q ss_pred CCCEEEeCCCCCeEEecCCCccccccccc-------------cccCCCccceeccccccccccccCCCCCCCchhhHHHH
Q 024408 69 PENLLLTEDLKTIKLADFGLAREESLTEM-------------MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSF 135 (268)
Q Consensus 69 p~Nill~~~~~~~kl~Dfg~a~~~~~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvwsl 135 (268)
|+||+++.+ +.+||+|||+++....... .....||+.|+|||++... ....++.++|||||
T Consensus 166 p~NIl~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-----~~~~~~~~~Dv~sl 239 (337)
T 3ll6_A 166 VENLLLSNQ-GTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLY-----SNFPIGEKQDIWAL 239 (337)
T ss_dssp GGGCEECTT-SCEEBCCCTTCBCCSSCC-------------------------------CC-----TTSCSSHHHHHHHH
T ss_pred cccEEECCC-CCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhcc-----ccCCCChHHhHHHH
Confidence 999999988 6999999999985433211 1144589999999988321 13567889999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhcCCC
Q 024408 136 AIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPP 212 (268)
Q Consensus 136 G~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~~~~~ 212 (268)
|+++|+|++|+.||......... ......+.....+..+.++|.+||+.||.+||++.+++++|+.........
T Consensus 240 G~il~el~~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~ 313 (337)
T 3ll6_A 240 GCILYLLCFRQHPFEDGAKLRIV---NGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVN 313 (337)
T ss_dssp HHHHHHHHHSSCCC---------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHhCCCCCcchhHHHhh---cCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCC
Confidence 99999999999999764332211 112223345667788999999999999999999999999999887764433
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=267.72 Aligned_cols=196 Identities=22% Similarity=0.311 Sum_probs=148.1
Q ss_pred CceeEEEeecC------CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEE
Q 024408 1 MREQFIGACKE------PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL 74 (268)
Q Consensus 1 ~~v~l~g~~~~------~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill 74 (268)
|+|++++++.. ..+|+||||+ +++|.+++..... +++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 113 niv~l~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl 189 (458)
T 3rp9_A 113 HVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVY--LTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLV 189 (458)
T ss_dssp TBCCEEEECCCSCTTTCCCEEEEECCC-SEEHHHHHHSSCC--CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE
T ss_pred CCCceEEEEecCCcccCceEEEEEecc-ccchhhhcccCCC--CCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEE
Confidence 68999999832 3689999999 5899999986544 9999999999999999999999999999999999999
Q ss_pred eCCCCCeEEecCCCcccccccc----------------------------ccccCCCccceeccccccccccccCCCCCC
Q 024408 75 TEDLKTIKLADFGLAREESLTE----------------------------MMTAETGTYRWMAPELYSTVTLRQGEKKHY 126 (268)
Q Consensus 75 ~~~~~~~kl~Dfg~a~~~~~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~ 126 (268)
+.+ +.+||+|||+++...... .....+||++|+|||++.. ...+
T Consensus 190 ~~~-~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-------~~~~ 261 (458)
T 3rp9_A 190 NQD-CSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILL-------QENY 261 (458)
T ss_dssp CTT-CCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTT-------CCCC
T ss_pred CCC-CCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhC-------CCCC
Confidence 998 699999999998543211 2234578999999997642 2568
Q ss_pred CchhhHHHHHHHHHHHHh-----------CCCCCCCCCh--------------------HHHHHHHHhcc----------
Q 024408 127 NHKVDSYSFAIVLWELLH-----------NKLPFEGMSN--------------------LQAAYAAAFKN---------- 165 (268)
Q Consensus 127 ~~~~DvwslG~~l~~ll~-----------g~~p~~~~~~--------------------~~~~~~~~~~~---------- 165 (268)
+.++|||||||++|||++ |+++|.+... .+.........
T Consensus 262 ~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~ 341 (458)
T 3rp9_A 262 TEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEA 341 (458)
T ss_dssp CTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHT
T ss_pred CcHhHHHHHHHHHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhh
Confidence 899999999999999998 6666755331 01111000000
Q ss_pred ------------C--------CCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhc
Q 024408 166 ------------V--------RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 209 (268)
Q Consensus 166 ------------~--------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~~ 209 (268)
. ......+++++.+||.+||..||.+|||++++++| .++...
T Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~H--p~f~~~ 403 (458)
T 3rp9_A 342 LEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAH--PFFKEV 403 (458)
T ss_dssp SSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS--GGGTTT
T ss_pred cCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcC--Hhhhhc
Confidence 0 00124568999999999999999999999999998 555543
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=274.23 Aligned_cols=207 Identities=24% Similarity=0.362 Sum_probs=160.5
Q ss_pred CceeEEEeecC-C--cEEEEEEcCCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEE--
Q 024408 1 MREQFIGACKE-P--VMVIVTELLSGGTLRKYLLNMRP-RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL-- 74 (268)
Q Consensus 1 ~~v~l~g~~~~-~--~~~lV~e~~~ggsL~~~i~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill-- 74 (268)
|+|++++++.+ + ..++||||++||+|.+++..... ..+++..++.++.|++.||+|||++||+||||||+||++
T Consensus 68 nIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~ 147 (396)
T 4eut_A 68 NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVI 147 (396)
T ss_dssp TBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEE
T ss_pred CCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEee
Confidence 68999999843 2 68999999999999999976433 339999999999999999999999999999999999998
Q ss_pred --eCCCCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 024408 75 --TEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGM 152 (268)
Q Consensus 75 --~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~ 152 (268)
+.+ +.+||+|||+++............||+.|+|||++.+..........++.++||||||+++|+|++|+.||...
T Consensus 148 ~~~~~-~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~ 226 (396)
T 4eut_A 148 GEDGQ-SVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF 226 (396)
T ss_dssp CTTSC-EEEEECCGGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECT
T ss_pred cCCCc-eeEEEecCCCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 444 57999999999876655555667899999999987542111111134677999999999999999999999642
Q ss_pred C----hHHHHHHHHhccCC--------------------CCC----CCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 024408 153 S----NLQAAYAAAFKNVR--------------------PSA----ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 204 (268)
Q Consensus 153 ~----~~~~~~~~~~~~~~--------------------~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~ 204 (268)
. ..+........... +.. ..++..+.++|.+||..||++||++.++++.+..
T Consensus 227 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~ 306 (396)
T 4eut_A 227 EGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306 (396)
T ss_dssp TCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred CcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHH
Confidence 2 22233332222211 111 2245678899999999999999999999999988
Q ss_pred hHhh
Q 024408 205 YLSA 208 (268)
Q Consensus 205 ~~~~ 208 (268)
.+..
T Consensus 307 il~~ 310 (396)
T 4eut_A 307 ILHR 310 (396)
T ss_dssp HHTC
T ss_pred Hhhc
Confidence 8764
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=262.47 Aligned_cols=192 Identities=22% Similarity=0.349 Sum_probs=157.7
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHH------HHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCE
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKY------LLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENL 72 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~------i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~gi~H~Dikp~Ni 72 (268)
++++++|++ .++..++||||++|++|.++ +.+.....+++..++.++.|++.||.|||+ +|++||||||+||
T Consensus 104 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Ni 183 (348)
T 2pml_X 104 YCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNI 183 (348)
T ss_dssp TBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGE
T ss_pred CcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhE
Confidence 578999999 55689999999999999998 665434569999999999999999999999 9999999999999
Q ss_pred EEeCCCCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCc-hhhHHHHHHHHHHHHhCCCCCCC
Q 024408 73 LLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNH-KVDSYSFAIVLWELLHNKLPFEG 151 (268)
Q Consensus 73 ll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~-~~DvwslG~~l~~ll~g~~p~~~ 151 (268)
+++.+ +.++|+|||.+...... ......|+..|+|||++.+ ...++. ++||||||+++|+|++|..||..
T Consensus 184 l~~~~-~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~-------~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 254 (348)
T 2pml_X 184 LMDKN-GRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSN-------ESSYNGAKVDIWSLGICLYVMFYNVVPFSL 254 (348)
T ss_dssp EECTT-SCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSS-------CCCEEHHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred EEcCC-CcEEEeccccccccccc-cccCCCCCcCccCchhhcC-------CCCCCcchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99988 69999999999864433 3345678999999999864 113444 89999999999999999999987
Q ss_pred CChHHHHHHHHhccCCCCC-------------------CCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 152 MSNLQAAYAAAFKNVRPSA-------------------ENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~-------------------~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
..................+ ..++.++.++|.+||..||.+||++.++++|
T Consensus 255 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 255 KISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp SSCSHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CCcHHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 6653333333332222222 5688999999999999999999999999997
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=259.15 Aligned_cols=203 Identities=26% Similarity=0.396 Sum_probs=156.5
Q ss_pred CceeEEEeecC-C----cEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--------HCCCeecCC
Q 024408 1 MREQFIGACKE-P----VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLH--------SHGIIHRDL 67 (268)
Q Consensus 1 ~~v~l~g~~~~-~----~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH--------~~gi~H~Di 67 (268)
|++++++++.. + ..++||||++||+|.+++.+. .+++.+++.++.|++.||.||| ++|++||||
T Consensus 97 ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dl 173 (342)
T 1b6c_B 97 NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDL 173 (342)
T ss_dssp TBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCC
T ss_pred cEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCC
Confidence 57899999844 3 789999999999999999763 3999999999999999999999 899999999
Q ss_pred CCCCEEEeCCCCCeEEecCCCcccccccc-----ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHH
Q 024408 68 KPENLLLTEDLKTIKLADFGLAREESLTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWEL 142 (268)
Q Consensus 68 kp~Nill~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~l 142 (268)
||+||+++.+ +.+||+|||++....... ......||+.|+|||++.+.... ....++.++||||||+++|+|
T Consensus 174 kp~NIll~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~~~~~~~~~Di~slG~il~el 250 (342)
T 1b6c_B 174 KSKNILVKKN-GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM--KHFESFKRADIYAMGLVFWEI 250 (342)
T ss_dssp SGGGEEECTT-SCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCT--TCHHHHHHHHHHHHHHHHHHH
T ss_pred CHHHEEECCC-CCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccc--cccccCCcccHHHHHHHHHHH
Confidence 9999999988 699999999997543322 22445789999999998641100 000223689999999999999
Q ss_pred HhC----------CCCCCCCCh----HHHHHHHH-hccCCCCC------CCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 143 LHN----------KLPFEGMSN----LQAAYAAA-FKNVRPSA------ENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 143 l~g----------~~p~~~~~~----~~~~~~~~-~~~~~~~~------~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
++| ..||..... ........ .....+.. ..++..+.+++.+||..||.+||++.+++++
T Consensus 251 ~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 251 ARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp HTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred HhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 999 788865422 12222222 22222221 1234689999999999999999999999999
Q ss_pred HHHhHhhc
Q 024408 202 LLNYLSAI 209 (268)
Q Consensus 202 l~~~~~~~ 209 (268)
|+.+....
T Consensus 331 L~~i~~~~ 338 (342)
T 1b6c_B 331 LSQLSQQE 338 (342)
T ss_dssp HHHHHHTT
T ss_pred HHHHHHHh
Confidence 99887653
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=260.30 Aligned_cols=199 Identities=24% Similarity=0.281 Sum_probs=157.5
Q ss_pred CceeEEEeecC-C-------cEEEEEEcCCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHH--HCCCeecCCC
Q 024408 1 MREQFIGACKE-P-------VMVIVTELLSGGTLRKYLLN--MRPRCLDVCVAIGFALDIARAMECLH--SHGIIHRDLK 68 (268)
Q Consensus 1 ~~v~l~g~~~~-~-------~~~lV~e~~~ggsL~~~i~~--~~~~~~~~~~~~~~~~~l~~~l~~lH--~~gi~H~Dik 68 (268)
|+|++++++.. + +.++||||++ ++|.+.+.. .....+++..+..++.|++.||.||| ++||+|||||
T Consensus 80 niv~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlk 158 (360)
T 3e3p_A 80 NIVQLQSYFYTLGERDRRDIYLNVVMEYVP-DTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIK 158 (360)
T ss_dssp TBCCEEEEEEEECSSCTTCEEEEEEEECCS-CBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCC
T ss_pred CcccHHHhhhccccccccceeEEEEeeccc-ccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCC
Confidence 68899999832 1 3799999997 566665543 23345999999999999999999999 9999999999
Q ss_pred CCCEEEeCCCCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 024408 69 PENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLP 148 (268)
Q Consensus 69 p~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p 148 (268)
|+||+++...+.+||+|||+++............||+.|+|||++.+ ...++.++||||||+++|+|++|+.|
T Consensus 159 p~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~Di~slG~il~ell~g~~p 231 (360)
T 3e3p_A 159 PHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFG-------NQHYTTAVDIWSVGCIFAEMMLGEPI 231 (360)
T ss_dssp GGGEEEETTTTEEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTT-------CSSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred HHHEEEeCCCCcEEEeeCCCceecCCCCCcccccCCcceeCHHHHcC-------CCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 99999997337999999999987665555556688999999998853 24478899999999999999999999
Q ss_pred CCCCChHHHHHHHHhccCC-------------------------------CCCCCCcHHHHHHHHhccccCCCCCCCHHH
Q 024408 149 FEGMSNLQAAYAAAFKNVR-------------------------------PSAENVPEELSIILTSCWKEDPNARPNFTQ 197 (268)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 197 (268)
|.+................ ......+.++.++|.+||+.||.+|||+.+
T Consensus 232 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 311 (360)
T 3e3p_A 232 FRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYE 311 (360)
T ss_dssp SCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred cCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHH
Confidence 9887665544433321111 112235789999999999999999999999
Q ss_pred HHHHHHHhHhhc
Q 024408 198 IIQMLLNYLSAI 209 (268)
Q Consensus 198 ~~~~l~~~~~~~ 209 (268)
+++| .++...
T Consensus 312 ~l~h--p~f~~~ 321 (360)
T 3e3p_A 312 ALCH--PYFDEL 321 (360)
T ss_dssp HTTS--GGGGGG
T ss_pred HhcC--cccccc
Confidence 9998 555543
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=259.21 Aligned_cols=193 Identities=20% Similarity=0.236 Sum_probs=154.4
Q ss_pred ceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEE------
Q 024408 2 REQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL------ 74 (268)
Q Consensus 2 ~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill------ 74 (268)
++.+++++ .++..++||||+ +++|.+++.......+++.+++.++.|++.||+|||++||+||||||+||++
T Consensus 84 ~~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~ 162 (355)
T 2eu9_A 84 CVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFE 162 (355)
T ss_dssp BCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEE
T ss_pred EEEeeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccc
Confidence 67788888 567899999999 6888888887665569999999999999999999999999999999999999
Q ss_pred -------------eCCCCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHH
Q 024408 75 -------------TEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWE 141 (268)
Q Consensus 75 -------------~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ 141 (268)
+.+ +.+||+|||+++..... .....||+.|+|||++.+ ..++.++||||||+++|+
T Consensus 163 ~~~~~~~~~~~~~~~~-~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~e 231 (355)
T 2eu9_A 163 TLYNEHKSCEEKSVKN-TSIRVADFGSATFDHEH--HTTIVATRHYRPPEVILE--------LGWAQPCDVWSIGCILFE 231 (355)
T ss_dssp EEECCC-CCCEEEESC-CCEEECCCTTCEETTSC--CCSSCSCGGGCCHHHHTT--------CCCCTHHHHHHHHHHHHH
T ss_pred ccccccccccccccCC-CcEEEeecCcccccccc--ccCCcCCCcccCCeeeec--------CCCCCccchHHHHHHHHH
Confidence 445 68999999999853332 345679999999999864 567889999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHhccCC-------------------------------------------CCCCCCcHHHH
Q 024408 142 LLHNKLPFEGMSNLQAAYAAAFKNVR-------------------------------------------PSAENVPEELS 178 (268)
Q Consensus 142 ll~g~~p~~~~~~~~~~~~~~~~~~~-------------------------------------------~~~~~~~~~l~ 178 (268)
|++|..||......+........... ......+.++.
T Consensus 232 l~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 311 (355)
T 2eu9_A 232 YYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLF 311 (355)
T ss_dssp HHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHH
T ss_pred HHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHH
Confidence 99999999886654433222111100 00112245789
Q ss_pred HHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 024408 179 IILTSCWKEDPNARPNFTQIIQMLLNYLSA 208 (268)
Q Consensus 179 ~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 208 (268)
++|.+||..||.+|||+.++++| .++..
T Consensus 312 ~li~~~L~~dP~~Rpt~~e~l~h--p~f~~ 339 (355)
T 2eu9_A 312 DLMRRMLEFDPAQRITLAEALLH--PFFAG 339 (355)
T ss_dssp HHHHHHTCSSTTTSCCHHHHTTS--GGGGG
T ss_pred HHHHHHhcCChhhCcCHHHHhcC--hhhcC
Confidence 99999999999999999999998 44444
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-37 Score=266.58 Aligned_cols=199 Identities=21% Similarity=0.248 Sum_probs=146.3
Q ss_pred CceeEEEee--c-CCcEEEEEEcCCCCCHHHHHHhcC-------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCC
Q 024408 1 MREQFIGAC--K-EPVMVIVTELLSGGTLRKYLLNMR-------PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPE 70 (268)
Q Consensus 1 ~~v~l~g~~--~-~~~~~lV~e~~~ggsL~~~i~~~~-------~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~ 70 (268)
|+|++++++ . +...++||||++ ++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+
T Consensus 79 niv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~ 157 (405)
T 3rgf_A 79 NVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPA 157 (405)
T ss_dssp TBCCCCEEEEETTTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG
T ss_pred CeeeEeeEEecCCCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHH
Confidence 688999998 2 357899999996 68999886422 124999999999999999999999999999999999
Q ss_pred CEEE----eCCCCCeEEecCCCccccccc----cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHH
Q 024408 71 NLLL----TEDLKTIKLADFGLAREESLT----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWEL 142 (268)
Q Consensus 71 Nill----~~~~~~~kl~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~l 142 (268)
|||+ +.+ +.+||+|||+++..... .......||+.|+|||++.+ ...++.++|||||||++|+|
T Consensus 158 NIll~~~~~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwSlG~il~el 229 (405)
T 3rgf_A 158 NILVMGEGPER-GRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLG-------ARHYTKAIDIWAIGCIFAEL 229 (405)
T ss_dssp GEEECCSSTTT-TCEEECCTTCCC----------------CCCTTCCHHHHTT-------CCSCCHHHHHHHHHHHHHHH
T ss_pred HeEEecCCCCC-CcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcC-------CCcccchhhhHHHHHHHHHH
Confidence 9999 444 68999999999854332 22344578999999998864 24588999999999999999
Q ss_pred HhCCCCCCCCChH---------HHHHHHHhccCCCC-------------------------------------CCCCcHH
Q 024408 143 LHNKLPFEGMSNL---------QAAYAAAFKNVRPS-------------------------------------AENVPEE 176 (268)
Q Consensus 143 l~g~~p~~~~~~~---------~~~~~~~~~~~~~~-------------------------------------~~~~~~~ 176 (268)
++|+.||.+.... +...........+. ....+..
T Consensus 230 l~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (405)
T 3rgf_A 230 LTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSK 309 (405)
T ss_dssp HHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSH
T ss_pred HhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHH
Confidence 9999999754321 11111111111111 1122678
Q ss_pred HHHHHHhccccCCCCCCCHHHHHHHHHHhHhhcC
Q 024408 177 LSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIA 210 (268)
Q Consensus 177 l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~~~ 210 (268)
+.+||.+||..||.+|||++++++| .++....
T Consensus 310 ~~~Ll~~~L~~dP~~R~ta~e~L~h--p~f~~~~ 341 (405)
T 3rgf_A 310 AFHLLQKLLTMDPIKRITSEQAMQD--PYFLEDP 341 (405)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHTS--GGGTSSS
T ss_pred HHHHHHHHccCCcccCCCHHHHhcC--hhhccCC
Confidence 8999999999999999999999998 5555443
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=263.34 Aligned_cols=189 Identities=22% Similarity=0.254 Sum_probs=152.9
Q ss_pred ceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--HCCCeecCCCCCCEEEeC-C
Q 024408 2 REQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLH--SHGIIHRDLKPENLLLTE-D 77 (268)
Q Consensus 2 ~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH--~~gi~H~Dikp~Nill~~-~ 77 (268)
++++++++ .++..++||||++ ++|.+++.......+++..+..++.|++.||.||| +.||+||||||+|||++. .
T Consensus 118 iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~ 196 (382)
T 2vx3_A 118 IVHLKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPK 196 (382)
T ss_dssp BCCEEEEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTT
T ss_pred EEEeeeeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCC
Confidence 68899998 5678999999995 69999998876556999999999999999999999 579999999999999964 2
Q ss_pred CCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 024408 78 LKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA 157 (268)
Q Consensus 78 ~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~ 157 (268)
.+.+||+|||+++..... .....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+....+.
T Consensus 197 ~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~--------~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~ 266 (382)
T 2vx3_A 197 RSAIKIVDFGSSCQLGQR--IYQYIQSRFYRSPEVLLG--------MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQ 266 (382)
T ss_dssp SCCEEECCCTTCEETTCC--CCSSCSCGGGCCHHHHTT--------CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred CCcEEEEeccCceecccc--cccccCCccccChHHHcC--------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 258999999999865332 345678999999999864 5678999999999999999999999998766554
Q ss_pred HHHHHhccCCCC--------------------------------------CCC-------------------------Cc
Q 024408 158 AYAAAFKNVRPS--------------------------------------AEN-------------------------VP 174 (268)
Q Consensus 158 ~~~~~~~~~~~~--------------------------------------~~~-------------------------~~ 174 (268)
..........+. ... ..
T Consensus 267 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (382)
T 2vx3_A 267 MNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADY 346 (382)
T ss_dssp HHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHH
T ss_pred HHHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhh
Confidence 433322111000 000 01
Q ss_pred HHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 175 EELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 175 ~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
.++.+||.+||..||.+|||++++++|
T Consensus 347 ~~~~dli~~mL~~dP~~Rpta~e~L~h 373 (382)
T 2vx3_A 347 LKFKDLILRMLDYDPKTRIQPYYALQH 373 (382)
T ss_dssp HHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred HHHHHHHHHhcCCChhhCCCHHHHhcC
Confidence 378999999999999999999999998
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=259.04 Aligned_cols=204 Identities=24% Similarity=0.387 Sum_probs=150.6
Q ss_pred CceeEEEee-----c-CCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---------CCeec
Q 024408 1 MREQFIGAC-----K-EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH---------GIIHR 65 (268)
Q Consensus 1 ~~v~l~g~~-----~-~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---------gi~H~ 65 (268)
|++++++.+ . ...+++||||++||+|.+++.... .++..++.++.|++.||.|||++ ||+||
T Consensus 68 ~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~ 144 (336)
T 3g2f_A 68 NIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT---SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHR 144 (336)
T ss_dssp TBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECS
T ss_pred chhhheecccccccCCCceEEEEEecCCCCcHHHHHhhcc---cchhHHHHHHHHHHHHHHHHHhhhccccccccceeec
Confidence 578888743 1 236799999999999999997643 68999999999999999999999 99999
Q ss_pred CCCCCCEEEeCCCCCeEEecCCCccccccc---------cccccCCCccceeccccccccccccCCCCCCCchhhHHHHH
Q 024408 66 DLKPENLLLTEDLKTIKLADFGLAREESLT---------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFA 136 (268)
Q Consensus 66 Dikp~Nill~~~~~~~kl~Dfg~a~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG 136 (268)
||||+|||++.+ +.+||+|||+++..... .......||+.|+|||++.+..... ....++.++||||||
T Consensus 145 Dikp~Nill~~~-~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~~~~~~DiwslG 222 (336)
T 3g2f_A 145 DLNSRNVLVKND-GTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLR-DXESALKQVDMYALG 222 (336)
T ss_dssp SCSGGGEEECTT-SCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGG-GHHHHHHHHHHHHHH
T ss_pred ccccceEEEcCC-CcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccc-cccccccccchHHHH
Confidence 999999999988 69999999999754321 1223456999999999986411000 012355789999999
Q ss_pred HHHHHHHhCCCCCCCCCh-----------------HHHHHH-HHhccCCCC-CC------CCcHHHHHHHHhccccCCCC
Q 024408 137 IVLWELLHNKLPFEGMSN-----------------LQAAYA-AAFKNVRPS-AE------NVPEELSIILTSCWKEDPNA 191 (268)
Q Consensus 137 ~~l~~ll~g~~p~~~~~~-----------------~~~~~~-~~~~~~~~~-~~------~~~~~l~~li~~~l~~~p~~ 191 (268)
+++|+|++|..||..... ...... .......+. +. .+++.+.++|.+||..||.+
T Consensus 223 ~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~ 302 (336)
T 3g2f_A 223 LIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEA 302 (336)
T ss_dssp HHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGG
T ss_pred HHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhh
Confidence 999999999766532111 011111 111111111 11 13457999999999999999
Q ss_pred CCCHHHHHHHHHHhHhhc
Q 024408 192 RPNFTQIIQMLLNYLSAI 209 (268)
Q Consensus 192 Rps~~~~~~~l~~~~~~~ 209 (268)
|||+.++++.|+.++...
T Consensus 303 Rps~~e~l~~L~~ll~~~ 320 (336)
T 3g2f_A 303 RLTAQXAEERMAELMMIW 320 (336)
T ss_dssp SCCHHHHHHHHHHHHHCC
T ss_pred CcchHHHHHHHHHHHHHH
Confidence 999999999999988654
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-38 Score=270.03 Aligned_cols=180 Identities=15% Similarity=0.263 Sum_probs=139.3
Q ss_pred cEEEEEEcCCCCCHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCCeEEecCC
Q 024408 13 VMVIVTELLSGGTLRKYLLNMRP-----RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFG 87 (268)
Q Consensus 13 ~~~lV~e~~~ggsL~~~i~~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~~kl~Dfg 87 (268)
..++||||+ +|+|.+++.+.+. ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||
T Consensus 174 ~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~-~~~kL~DFG 251 (377)
T 3byv_A 174 SRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQR-GGVFLTGFE 251 (377)
T ss_dssp SEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT-CCEEECCGG
T ss_pred EEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CCEEEEech
Confidence 379999999 6899999987533 113348888999999999999999999999999999999988 699999999
Q ss_pred CccccccccccccCCCccceeccccccccc---cccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc
Q 024408 88 LAREESLTEMMTAETGTYRWMAPELYSTVT---LRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFK 164 (268)
Q Consensus 88 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~ 164 (268)
+++.... ......| +.|+|||++.+.. ........++.++||||||+++|+|++|+.||.+...... ..
T Consensus 252 ~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~-----~~ 323 (377)
T 3byv_A 252 HLVRDGA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGG-----SE 323 (377)
T ss_dssp GCEETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CC-----SG
T ss_pred hheecCC--cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccc-----hh
Confidence 9986333 2345567 9999999987520 0000012578999999999999999999999976432211 11
Q ss_pred cCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 024408 165 NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 202 (268)
Q Consensus 165 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l 202 (268)
........+++++.++|.+||..||.+||++.+++++-
T Consensus 324 ~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp 361 (377)
T 3byv_A 324 WIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETP 361 (377)
T ss_dssp GGGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSH
T ss_pred hhhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhCh
Confidence 12223467899999999999999999999999999863
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=258.63 Aligned_cols=189 Identities=27% Similarity=0.324 Sum_probs=153.6
Q ss_pred CceeEEEeecC------CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEE
Q 024408 1 MREQFIGACKE------PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL 74 (268)
Q Consensus 1 ~~v~l~g~~~~------~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill 74 (268)
|++++++++.. ...++||||++ ++|.+++... .+++.++..++.|++.||+|||++||+||||||+||++
T Consensus 86 niv~~~~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~ 161 (364)
T 3qyz_A 86 NIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL 161 (364)
T ss_dssp TBCCCCEEECCSSTTTCCCEEEEEECCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred CCccceeEEecCCccccceEEEEEcccC-cCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEE
Confidence 57889998843 26899999996 6999999763 39999999999999999999999999999999999999
Q ss_pred eCCCCCeEEecCCCccccccccc----cccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 024408 75 TEDLKTIKLADFGLAREESLTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFE 150 (268)
Q Consensus 75 ~~~~~~~kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~ 150 (268)
+.+ +.+||+|||++........ .....||+.|+|||++.+ ...++.++||||||+++|+|++|+.||.
T Consensus 162 ~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwslG~il~ell~g~~pf~ 233 (364)
T 3qyz_A 162 NTT-CDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN-------SKGYTKSIDIWSVGCILAEMLSNRPIFP 233 (364)
T ss_dssp CTT-CCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHT-------BCSCSTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCC-CCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcC-------CCCCCcchhHHHHHHHHHHHHHCCCCCC
Confidence 988 6999999999985443321 234579999999998753 2457889999999999999999999998
Q ss_pred CCChHHHHHHHHhccCCC------------------------------CCCCCcHHHHHHHHhccccCCCCCCCHHHHHH
Q 024408 151 GMSNLQAAYAAAFKNVRP------------------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQ 200 (268)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~ 200 (268)
+....+...........+ ....++.++.++|.+||..||.+|||+.++++
T Consensus 234 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 234 GKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp CSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 766544433322111110 02457889999999999999999999999999
Q ss_pred H
Q 024408 201 M 201 (268)
Q Consensus 201 ~ 201 (268)
|
T Consensus 314 h 314 (364)
T 3qyz_A 314 H 314 (364)
T ss_dssp S
T ss_pred C
Confidence 8
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=259.20 Aligned_cols=197 Identities=23% Similarity=0.303 Sum_probs=149.4
Q ss_pred CceeEEEeec-----C-CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEE
Q 024408 1 MREQFIGACK-----E-PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL 74 (268)
Q Consensus 1 ~~v~l~g~~~-----~-~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill 74 (268)
|++++++++. . ...++||||++ |+|.+++.... ..+++..+..++.|++.||.|||++|++||||||+||++
T Consensus 90 ~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~ 167 (362)
T 3pg1_A 90 NILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR-IVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILL 167 (362)
T ss_dssp TBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE
T ss_pred CccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEE
Confidence 5788888872 1 26899999996 79999887643 349999999999999999999999999999999999999
Q ss_pred eCCCCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh
Q 024408 75 TEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN 154 (268)
Q Consensus 75 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~ 154 (268)
+.+ +.++|+|||+++............||+.|+|||++.+ ...++.++||||||+++|+|++|+.||.+...
T Consensus 168 ~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 239 (362)
T 3pg1_A 168 ADN-NDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQ-------FKGFTKLVDMWSAGCVMAEMFNRKALFRGSTF 239 (362)
T ss_dssp CTT-CCEEECCTTC---------------CGGGCCHHHHTT-------CTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cCC-CCEEEEecCcccccccccccceecccceecCcHHhcC-------CCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCH
Confidence 988 6999999999986555555556678999999998753 24578899999999999999999999988665
Q ss_pred HHHHHHHHhccCCC-------------------------------CCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 024408 155 LQAAYAAAFKNVRP-------------------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 203 (268)
Q Consensus 155 ~~~~~~~~~~~~~~-------------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~ 203 (268)
.+...........+ ....+++.+.++|.+||..||.+|||+.++++|
T Consensus 240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h-- 317 (362)
T 3pg1_A 240 YNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH-- 317 (362)
T ss_dssp HHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS--
T ss_pred HHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC--
Confidence 54433332211110 023567889999999999999999999999998
Q ss_pred HhHhhc
Q 024408 204 NYLSAI 209 (268)
Q Consensus 204 ~~~~~~ 209 (268)
.+++..
T Consensus 318 p~f~~~ 323 (362)
T 3pg1_A 318 PYFESL 323 (362)
T ss_dssp GGGTTT
T ss_pred chhhhc
Confidence 555543
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=254.53 Aligned_cols=184 Identities=22% Similarity=0.344 Sum_probs=154.0
Q ss_pred CceeEEEee-cCCcEEEEEEcCCC-CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSG-GTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL 78 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~g-gsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~ 78 (268)
+++++++++ .++..++|||++.+ ++|.+++.+... +++..++.++.|++.||+|||++|++||||||+||+++.+.
T Consensus 109 ~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~--l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~ 186 (320)
T 3a99_A 109 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR 186 (320)
T ss_dssp SBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTT
T ss_pred CceEEEEEEecCCcEEEEEEcCCCCccHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCC
Confidence 578999999 45688999999976 899999987655 99999999999999999999999999999999999999443
Q ss_pred CCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 79 KTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 79 ~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
+.+||+|||+++..... ......||+.|+|||++.+ ....+.++||||||+++|+|++|+.||.....
T Consensus 187 ~~~kL~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~-------~~~~~~~~Di~slG~il~el~~g~~pf~~~~~---- 254 (320)
T 3a99_A 187 GELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRY-------HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE---- 254 (320)
T ss_dssp TEEEECCCTTCEECCSS-CBCCCCSCGGGSCHHHHHH-------SCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----
T ss_pred CCEEEeeCccccccccc-cccCCCCCccCCChHHhcc-------CCCCCccchHHhHHHHHHHHHHCCCCCCChhh----
Confidence 79999999999865433 2344578999999998864 12346789999999999999999999975321
Q ss_pred HHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 159 YAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
...........+++++.++|.+||..||.+||++.+++++
T Consensus 255 ---~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 255 ---IIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp ---HHHCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ---hhcccccccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1122333456789999999999999999999999999987
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=256.72 Aligned_cols=197 Identities=25% Similarity=0.433 Sum_probs=136.1
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCCEEEe
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLN---MRPRCLDVCVAIGFALDIARAMECLHSH-GIIHRDLKPENLLLT 75 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~---~~~~~~~~~~~~~~~~~l~~~l~~lH~~-gi~H~Dikp~Nill~ 75 (268)
|+++++|++ .++..++||||++ ++|.+++.. .....+++..+..++.|++.||.|||++ |++||||||+||+++
T Consensus 82 niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~ 160 (327)
T 3aln_A 82 YIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLD 160 (327)
T ss_dssp TBCCEEEEEECSSEEEEEECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEE
T ss_pred cEeeeeeEEEeCCceEEEEeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEc
Confidence 689999999 5568899999997 588888764 2234599999999999999999999999 999999999999999
Q ss_pred CCCCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH
Q 024408 76 EDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL 155 (268)
Q Consensus 76 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~ 155 (268)
.+ +.+||+|||+++............||+.|+|||++... .....++.++||||||+++|+|++|+.||......
T Consensus 161 ~~-~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 235 (327)
T 3aln_A 161 RS-GNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPS----ASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV 235 (327)
T ss_dssp TT-TEEEECCCSSSCC----------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---
T ss_pred CC-CCEEEccCCCceecccccccccCCCCccccCceeeccc----cCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH
Confidence 88 69999999999865544444445789999999998421 01245788999999999999999999999865432
Q ss_pred HHHHHHHhccCCCC-----CCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 024408 156 QAAYAAAFKNVRPS-----AENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 203 (268)
Q Consensus 156 ~~~~~~~~~~~~~~-----~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~ 203 (268)
............+. ...+++.+.++|.+||..||.+||++.+++++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~ 288 (327)
T 3aln_A 236 FDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPF 288 (327)
T ss_dssp ----CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHH
T ss_pred HHHHHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChH
Confidence 22111111111111 2458899999999999999999999999998754
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-36 Score=254.99 Aligned_cols=194 Identities=25% Similarity=0.295 Sum_probs=154.3
Q ss_pred CceeEEEeecC------CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEE
Q 024408 1 MREQFIGACKE------PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL 74 (268)
Q Consensus 1 ~~v~l~g~~~~------~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill 74 (268)
+++++++++.. ...++||||++ ++|.+++... .+++..+..++.|++.||.|||++|++||||||+||++
T Consensus 70 ~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~ 145 (353)
T 2b9h_A 70 NIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLI 145 (353)
T ss_dssp TBCCEEEECCCSCSTTCCCEEEEECCCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred CcCCeeeeecccccCccceEEEEEeccC-ccHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE
Confidence 57899998843 56899999996 6999998762 39999999999999999999999999999999999999
Q ss_pred eCCCCCeEEecCCCcccccccc-----------ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHH
Q 024408 75 TEDLKTIKLADFGLAREESLTE-----------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL 143 (268)
Q Consensus 75 ~~~~~~~kl~Dfg~a~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll 143 (268)
+.+ +.+||+|||+++...... ......||+.|+|||++.. ...++.++||||||+++|+|+
T Consensus 146 ~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~Di~slG~il~~l~ 217 (353)
T 2b9h_A 146 NSN-CDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLT-------SAKYSRAMDVWSCGCILAELF 217 (353)
T ss_dssp CTT-CCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHS-------CCCCCHHHHHHHHHHHHHHHH
T ss_pred cCC-CcEEEEecccccccccccccccCccccccchhhccccccccCCeeecc-------CCCccchhhHHHHHHHHHHHH
Confidence 988 699999999997543221 1223468999999998743 256788999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHhccCCC-------------------------------CCCCCcHHHHHHHHhccccCCCCC
Q 024408 144 HNKLPFEGMSNLQAAYAAAFKNVRP-------------------------------SAENVPEELSIILTSCWKEDPNAR 192 (268)
Q Consensus 144 ~g~~p~~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~l~~li~~~l~~~p~~R 192 (268)
+|+.||.+................+ ....+++++.++|.+||..||.+|
T Consensus 218 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 297 (353)
T 2b9h_A 218 LRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKR 297 (353)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGS
T ss_pred hCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccC
Confidence 9999998866544333221110000 024678999999999999999999
Q ss_pred CCHHHHHHHHHHhHhh
Q 024408 193 PNFTQIIQMLLNYLSA 208 (268)
Q Consensus 193 ps~~~~~~~l~~~~~~ 208 (268)
|++.++++| .++..
T Consensus 298 pt~~ell~h--p~~~~ 311 (353)
T 2b9h_A 298 ITAKEALEH--PYLQT 311 (353)
T ss_dssp CCHHHHHTS--GGGTT
T ss_pred CCHHHHhcC--ccccc
Confidence 999999998 44443
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-36 Score=251.83 Aligned_cols=197 Identities=24% Similarity=0.411 Sum_probs=146.2
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCCEEEeCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH-GIIHRDLKPENLLLTEDL 78 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-gi~H~Dikp~Nill~~~~ 78 (268)
+++++++++ .++..++||||+ ++.+..+..... ..+++..++.++.|++.||.|||++ |++||||||+||+++.+
T Consensus 85 ~i~~~~~~~~~~~~~~lv~e~~-~~~~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~- 161 (318)
T 2dyl_A 85 YIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQ-GPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDER- 161 (318)
T ss_dssp TBCCEEEEEECSSEEEEEECCC-SEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTT-
T ss_pred ceeeEEEEEecCCcEEEEEecc-CCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCC-
Confidence 589999999 556899999999 566666655433 3499999999999999999999996 99999999999999988
Q ss_pred CCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 79 KTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 79 ~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
+.+||+|||++.............|++.|+|||++.... .....++.++||||||+++|+|++|+.||.........
T Consensus 162 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 238 (318)
T 2dyl_A 162 GQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPD---PTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEV 238 (318)
T ss_dssp SCEEECCCTTC--------------CCTTCCHHHHC-----------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH
T ss_pred CCEEEEECCCchhccCCccccccCCCccccChhhccccc---ccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHH
Confidence 699999999997655444445567899999999985311 01245788999999999999999999999874433333
Q ss_pred HHHHhccCCC---CCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 024408 159 YAAAFKNVRP---SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 203 (268)
Q Consensus 159 ~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~ 203 (268)
.........+ ....++.++.++|.+||..||.+||++.+++++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~ 286 (318)
T 2dyl_A 239 LTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSF 286 (318)
T ss_dssp HHHHHHSCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHH
T ss_pred HHHHhccCCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHH
Confidence 3322222222 23468999999999999999999999999999743
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=250.52 Aligned_cols=192 Identities=22% Similarity=0.268 Sum_probs=151.9
Q ss_pred CceeEEEee---------------cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q 024408 1 MREQFIGAC---------------KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHR 65 (268)
Q Consensus 1 ~~v~l~g~~---------------~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~ 65 (268)
+++++++++ ..+..++||||++ |+|.+++.+ ..+++..++.++.|++.||+|||++|++||
T Consensus 69 ~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~ 144 (320)
T 2i6l_A 69 NIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSANVLHR 144 (320)
T ss_dssp TBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCBCC
T ss_pred CeeEEEEeccccccccccccccccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhCCEecC
Confidence 577888775 2357899999997 699999864 339999999999999999999999999999
Q ss_pred CCCCCCEEEeCCCCCeEEecCCCccccccc----cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHH
Q 024408 66 DLKPENLLLTEDLKTIKLADFGLAREESLT----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWE 141 (268)
Q Consensus 66 Dikp~Nill~~~~~~~kl~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ 141 (268)
||||+||+++.+.+.+||+|||+++..... .......++..|+|||.+.. ...++.++||||||+++|+
T Consensus 145 dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~il~e 217 (320)
T 2i6l_A 145 DLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLS-------PNNYTKAIDMWAAGCIFAE 217 (320)
T ss_dssp CCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHC-------TTCCCHHHHHHHHHHHHHH
T ss_pred CCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcC-------cccCCchhhhHhHHHHHHH
Confidence 999999999854468999999999854322 12233467899999998753 2467889999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHhccCC-----------------------C------CCCCCcHHHHHHHHhccccCCCCC
Q 024408 142 LLHNKLPFEGMSNLQAAYAAAFKNVR-----------------------P------SAENVPEELSIILTSCWKEDPNAR 192 (268)
Q Consensus 142 ll~g~~p~~~~~~~~~~~~~~~~~~~-----------------------~------~~~~~~~~l~~li~~~l~~~p~~R 192 (268)
|++|+.||.+....+........... + ....++.++.++|.+||..||.+|
T Consensus 218 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 297 (320)
T 2i6l_A 218 MLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDR 297 (320)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGS
T ss_pred HHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCcccc
Confidence 99999999887655443332221110 0 124688999999999999999999
Q ss_pred CCHHHHHHHHH
Q 024408 193 PNFTQIIQMLL 203 (268)
Q Consensus 193 ps~~~~~~~l~ 203 (268)
|++.++++|-+
T Consensus 298 pt~~ell~hp~ 308 (320)
T 2i6l_A 298 LTAEEALSHPY 308 (320)
T ss_dssp CCHHHHHTSHH
T ss_pred CCHHHHhCCcc
Confidence 99999999843
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=260.06 Aligned_cols=192 Identities=27% Similarity=0.335 Sum_probs=142.9
Q ss_pred CceeEEEeecC-------CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEE
Q 024408 1 MREQFIGACKE-------PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 73 (268)
Q Consensus 1 ~~v~l~g~~~~-------~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nil 73 (268)
|+|++++++.. ...++||||+ |++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+
T Consensus 89 nIv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIl 164 (367)
T 2fst_X 89 NVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLA 164 (367)
T ss_dssp TBCCCSEEECSCSSGGGCCCCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEE
T ss_pred CCCcEEEEEecCCccccCCeEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEE
Confidence 57889998842 4579999999 7899999865 23999999999999999999999999999999999999
Q ss_pred EeCCCCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 024408 74 LTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS 153 (268)
Q Consensus 74 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~ 153 (268)
++.+ +.+||+|||+++..... .....||++|+|||++.+ ...++.++||||||+++|+|++|+.||.+.+
T Consensus 165 l~~~-~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 234 (367)
T 2fst_X 165 VNED-CELKILDFGLARHTADE--MTGYVATRWYRAPEIMLN-------WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 234 (367)
T ss_dssp ECTT-CCEEECC-----------------CCCTTCCHHHHTT-------CCSCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ECCC-CCEEEeecccccccccc--CCCcCcCcCccChHHHcC-------CcCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9988 69999999999864332 344578999999998853 2467889999999999999999999999877
Q ss_pred hHHHHHHHHhccCCC------------------------C------CCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 024408 154 NLQAAYAAAFKNVRP------------------------S------AENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 203 (268)
Q Consensus 154 ~~~~~~~~~~~~~~~------------------------~------~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~ 203 (268)
..+...........+ . ....++.+.+||.+||..||.+|||+.++++|
T Consensus 235 ~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h-- 312 (367)
T 2fst_X 235 HIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH-- 312 (367)
T ss_dssp HHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS--
T ss_pred HHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC--
Confidence 655443332211110 0 13467889999999999999999999999998
Q ss_pred HhHhh
Q 024408 204 NYLSA 208 (268)
Q Consensus 204 ~~~~~ 208 (268)
.++..
T Consensus 313 p~~~~ 317 (367)
T 2fst_X 313 AYFAQ 317 (367)
T ss_dssp GGGTT
T ss_pred hhhhh
Confidence 44443
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=262.18 Aligned_cols=190 Identities=23% Similarity=0.277 Sum_probs=149.4
Q ss_pred CceeEEEeec-----CCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCCEEE
Q 024408 1 MREQFIGACK-----EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH-GIIHRDLKPENLLL 74 (268)
Q Consensus 1 ~~v~l~g~~~-----~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-gi~H~Dikp~Nill 74 (268)
+++++++++. +...++||||+ +++|.+++.+.....+++.+++.++.|++.||.|||++ ||+||||||+|||+
T Consensus 102 ~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll 180 (397)
T 1wak_A 102 MVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILL 180 (397)
T ss_dssp GBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEE
T ss_pred eeeeeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeE
Confidence 3789999884 24789999999 67888888776555699999999999999999999999 99999999999999
Q ss_pred eCCC------------------------------------------------CCeEEecCCCccccccccccccCCCccc
Q 024408 75 TEDL------------------------------------------------KTIKLADFGLAREESLTEMMTAETGTYR 106 (268)
Q Consensus 75 ~~~~------------------------------------------------~~~kl~Dfg~a~~~~~~~~~~~~~gt~~ 106 (268)
+.+. ..+||+|||++...... .....||+.
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~ 258 (397)
T 1wak_A 181 SVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQ 258 (397)
T ss_dssp CCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGG
T ss_pred eccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCc
Confidence 8652 17999999999864432 345578999
Q ss_pred eeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHhccCC-------------
Q 024408 107 WMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN------LQAAYAAAFKNVR------------- 167 (268)
Q Consensus 107 y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~------~~~~~~~~~~~~~------------- 167 (268)
|+|||++.+ ..++.++||||||+++|+|++|+.||..... .............
T Consensus 259 y~aPE~~~~--------~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~ 330 (397)
T 1wak_A 259 YRSLEVLIG--------SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSK 330 (397)
T ss_dssp GCCHHHHHT--------SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGG
T ss_pred ccCChhhcC--------CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccc
Confidence 999999864 5578899999999999999999999975432 1111111100000
Q ss_pred ----------------------------CCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 168 ----------------------------PSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 168 ----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
......+..+.+||.+||..||.+|||++++++|
T Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 331 EFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp GTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred cccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 0011234678899999999999999999999987
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=248.89 Aligned_cols=198 Identities=23% Similarity=0.387 Sum_probs=151.3
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
+++++++++ .++..++|||+. +++|.+++.+... +++.+++.++.|++.||.|||++|++||||||+||++++ +
T Consensus 89 ~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~--~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~--~ 163 (313)
T 3cek_A 89 KIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD--G 163 (313)
T ss_dssp TBCCEEEEEECSSEEEEEECCC-SEEHHHHHHHCSS--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET--T
T ss_pred ceEEEEEEeecCCEEEEEEecC-CCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC--C
Confidence 578999999 556889999955 7999999987654 999999999999999999999999999999999999975 5
Q ss_pred CeEEecCCCcccccccc---ccccCCCccceecccccccccccc---CCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 024408 80 TIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQ---GEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS 153 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~---~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~ 153 (268)
.+||+|||++....... ......|++.|+|||++.+..... .....++.++||||||+++|+|++|+.||....
T Consensus 164 ~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 243 (313)
T 3cek_A 164 MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 243 (313)
T ss_dssp EEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred eEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHH
Confidence 89999999998543322 123456899999999986421110 012467889999999999999999999998754
Q ss_pred hHHHHHHHHhc-c-CCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 024408 154 NLQAAYAAAFK-N-VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 203 (268)
Q Consensus 154 ~~~~~~~~~~~-~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~ 203 (268)
........... . ....+...+.++.++|.+||..||.+||++.+++++.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~ 295 (313)
T 3cek_A 244 NQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 295 (313)
T ss_dssp SHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred HHHHHHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCcc
Confidence 43332222222 1 12235566899999999999999999999999999854
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=265.42 Aligned_cols=180 Identities=13% Similarity=0.153 Sum_probs=140.9
Q ss_pred cEEEEEEcCCCCCHHHHHHhcCCCCCCHHHH------HHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCCeEEecC
Q 024408 13 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVA------IGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADF 86 (268)
Q Consensus 13 ~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~------~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~~kl~Df 86 (268)
.+++||||++ |+|.+++...+.. +++..+ ..++.|++.||+|||++||+||||||+|||++.+ +.+||+||
T Consensus 162 ~~~lv~e~~~-~~L~~~l~~~~~~-~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~-~~~kL~DF 238 (371)
T 3q60_A 162 NYLLLMPAAS-VDLELLFSTLDFV-YVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPD-GRLMLGDV 238 (371)
T ss_dssp EEEEEECCCS-EEHHHHHHHHHHS-CCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEECTT-SCEEECCG
T ss_pred eEEEEecCCC-CCHHHHHHHhccc-cchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCHHHEEECCC-CCEEEEec
Confidence 4899999997 8999999875332 455555 6778999999999999999999999999999988 69999999
Q ss_pred CCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-----
Q 024408 87 GLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAA----- 161 (268)
Q Consensus 87 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~----- 161 (268)
|+++...... ....+|+.|+|||++.+ ....++.++||||||+++|+|++|+.||.+..........
T Consensus 239 G~a~~~~~~~--~~~~~t~~y~aPE~~~~------~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~ 310 (371)
T 3q60_A 239 SALWKVGTRG--PASSVPVTYAPREFLNA------STATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLR 310 (371)
T ss_dssp GGEEETTCEE--EGGGSCGGGCCHHHHTC------SEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCBCCTT
T ss_pred ceeeecCCCc--cCccCCcCCcChhhccC------CCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccccchhhhhhh
Confidence 9998654332 24456799999999853 1246789999999999999999999999765322110000
Q ss_pred ---HhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 024408 162 ---AFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 203 (268)
Q Consensus 162 ---~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~ 203 (268)
......+....+++.+.++|.+||..||.+||++.++++|-+
T Consensus 311 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 355 (371)
T 3q60_A 311 VPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPE 355 (371)
T ss_dssp SCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHH
T ss_pred hccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHH
Confidence 001111223578999999999999999999999999998743
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-36 Score=257.66 Aligned_cols=195 Identities=22% Similarity=0.301 Sum_probs=150.1
Q ss_pred CceeEEEeecC-C----cEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCCEEE
Q 024408 1 MREQFIGACKE-P----VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH-GIIHRDLKPENLLL 74 (268)
Q Consensus 1 ~~v~l~g~~~~-~----~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-gi~H~Dikp~Nill 74 (268)
+++++++++.. + ..++||||+ |++|.+++.+.....+++..++.++.|++.||+|||++ ||+||||||+||++
T Consensus 87 ~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll 165 (373)
T 1q8y_A 87 HILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLM 165 (373)
T ss_dssp TBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEE
T ss_pred hHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEE
Confidence 47888888843 2 789999999 89999999886666699999999999999999999998 99999999999999
Q ss_pred eCC-----CCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 024408 75 TED-----LKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPF 149 (268)
Q Consensus 75 ~~~-----~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~ 149 (268)
+.+ .+.+||+|||++...... .....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||
T Consensus 166 ~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~~g~~pf 235 (373)
T 1q8y_A 166 EIVDSPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLG--------APWGCGADIWSTACLIFELITGDFLF 235 (373)
T ss_dssp EEEETTTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHT--------CCCCTHHHHHHHHHHHHHHHHSSCCC
T ss_pred eccCCCcCcceEEEcccccccccCCC--CCCCCCCccccCcHHHhC--------CCCCchHhHHHHHHHHHHHHhCCCCC
Confidence 532 137999999999864432 344578999999999864 55789999999999999999999999
Q ss_pred CCCChH------HHHHHHHh--c---------------------------------------cCCCCCCCCcHHHHHHHH
Q 024408 150 EGMSNL------QAAYAAAF--K---------------------------------------NVRPSAENVPEELSIILT 182 (268)
Q Consensus 150 ~~~~~~------~~~~~~~~--~---------------------------------------~~~~~~~~~~~~l~~li~ 182 (268)
...... ........ . ........++.++.++|.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 315 (373)
T 1q8y_A 236 EPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS 315 (373)
T ss_dssp ---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHG
T ss_pred CCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHH
Confidence 754311 11111110 0 000112234578899999
Q ss_pred hccccCCCCCCCHHHHHHHHHHhHhh
Q 024408 183 SCWKEDPNARPNFTQIIQMLLNYLSA 208 (268)
Q Consensus 183 ~~l~~~p~~Rps~~~~~~~l~~~~~~ 208 (268)
+||..||.+|||+.++++| .++..
T Consensus 316 ~~L~~dP~~Rpt~~ell~h--p~f~~ 339 (373)
T 1q8y_A 316 PMLQLDPRKRADAGGLVNH--PWLKD 339 (373)
T ss_dssp GGGCSSTTTCBCHHHHHTC--GGGTT
T ss_pred HHhccCccccCCHHHHhhC--hhhhc
Confidence 9999999999999999998 44443
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-36 Score=250.75 Aligned_cols=184 Identities=23% Similarity=0.345 Sum_probs=151.2
Q ss_pred CceeEEEee-cCCcEEEEEEc-CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTEL-LSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL 78 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~-~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~ 78 (268)
+++++++++ .++..++|||+ +.|++|.+++.+... +++..++.++.|++.||.|||++|++||||||+||+++.+.
T Consensus 99 ~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~ 176 (312)
T 2iwi_A 99 GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGP--LGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRR 176 (312)
T ss_dssp SBCCEEEEC-----CEEEEECCSSEEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTT
T ss_pred CeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCC
Confidence 578999999 45678999999 789999999987655 99999999999999999999999999999999999999333
Q ss_pred CCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 79 KTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 79 ~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
+.++|+|||++...... ......|+..|+|||++.+ ....+.++||||||+++|+|++|+.||.....
T Consensus 177 ~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---- 244 (312)
T 2iwi_A 177 GCAKLIDFGSGALLHDE-PYTDFDGTRVYSPPEWISR-------HQYHALPATVWSLGILLYDMVCGDIPFERDQE---- 244 (312)
T ss_dssp TEEEECCCSSCEECCSS-CBCCCCSCTTTSCHHHHHH-------SCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----
T ss_pred CeEEEEEcchhhhcccC-cccccCCcccccCceeeec-------CCCCCccchHHHHHHHHHHHHHCCCCCCChHH----
Confidence 79999999999865433 2345578999999998864 12234589999999999999999999975321
Q ss_pred HHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 159 YAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
........+..++..+.++|.+||..||++||++.+++++
T Consensus 245 ---~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 245 ---ILEAELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp ---HHHTCCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ---HhhhccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1122333456789999999999999999999999999997
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-35 Score=252.73 Aligned_cols=190 Identities=24% Similarity=0.330 Sum_probs=150.6
Q ss_pred CceeEEEeecC-Cc------EEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEE
Q 024408 1 MREQFIGACKE-PV------MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 73 (268)
Q Consensus 1 ~~v~l~g~~~~-~~------~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nil 73 (268)
|++++++++.. +. .++||||++ ++|.+++.. .+++..+..++.|++.||+|||++||+||||||+||+
T Consensus 102 niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl 176 (371)
T 4exu_A 102 NVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMGM----EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLA 176 (371)
T ss_dssp TBCCCSEEECSCSSSTTCCCCEEEEECCC-EEHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred CchhhhhheeccCCcccceeEEEEEcccc-ccHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeE
Confidence 57899999844 33 399999996 789888732 3999999999999999999999999999999999999
Q ss_pred EeCCCCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 024408 74 LTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS 153 (268)
Q Consensus 74 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~ 153 (268)
++.+ +.+||+|||+++..... .....||+.|+|||++.+ ...++.++||||||+++|+|++|+.||.+..
T Consensus 177 l~~~-~~~kL~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 246 (371)
T 4exu_A 177 VNED-CELKILDFGLARHADAE--MTGYVVTRWYRAPEVILS-------WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 246 (371)
T ss_dssp ECTT-CCEEECSTTCC----------CTTCCCTTSCHHHHSC-------CSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ECCC-CCEEEEecCcccccccC--cCCcccCccccCHHHhcC-------CCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9988 69999999999854332 345578999999998853 2467889999999999999999999998876
Q ss_pred hHHHHHHHHhccCCC------------------------------CCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 024408 154 NLQAAYAAAFKNVRP------------------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 203 (268)
Q Consensus 154 ~~~~~~~~~~~~~~~------------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~ 203 (268)
..+...........+ ....+++.+.++|.+||..||.+|||+.++++|
T Consensus 247 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h-- 324 (371)
T 4exu_A 247 YLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH-- 324 (371)
T ss_dssp HHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS--
T ss_pred hHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC--
Confidence 555443332211110 023568999999999999999999999999998
Q ss_pred HhHh
Q 024408 204 NYLS 207 (268)
Q Consensus 204 ~~~~ 207 (268)
.++.
T Consensus 325 p~f~ 328 (371)
T 4exu_A 325 PFFE 328 (371)
T ss_dssp GGGT
T ss_pred cccc
Confidence 4444
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=247.00 Aligned_cols=189 Identities=26% Similarity=0.400 Sum_probs=143.9
Q ss_pred CceeEEEeec--------------CCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecC
Q 024408 1 MREQFIGACK--------------EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRD 66 (268)
Q Consensus 1 ~~v~l~g~~~--------------~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~D 66 (268)
+++++++++. .+..++||||++|++|.+++.... ..+++..++.++.|++.||+|||++|++|||
T Consensus 63 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~d 141 (303)
T 1zy4_A 63 YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIHSQGIIHRD 141 (303)
T ss_dssp TBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred HHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHHhCCeeccc
Confidence 5778888762 246899999999999999998643 3388999999999999999999999999999
Q ss_pred CCCCCEEEeCCCCCeEEecCCCccccccc---------------cccccCCCccceeccccccccccccCCCCCCCchhh
Q 024408 67 LKPENLLLTEDLKTIKLADFGLAREESLT---------------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVD 131 (268)
Q Consensus 67 ikp~Nill~~~~~~~kl~Dfg~a~~~~~~---------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~D 131 (268)
|||+||+++.+ +.++|+|||++...... .......|++.|+|||++.+ ...++.++|
T Consensus 142 lkp~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~D 213 (303)
T 1zy4_A 142 LKPMNIFIDES-RNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDG-------TGHYNEKID 213 (303)
T ss_dssp CCGGGEEECTT-SCEEECCCCCCSCTTC-------------------------CTTSCHHHHTS-------CSCCCTHHH
T ss_pred CCHHhEEEcCC-CCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccC-------CCCCcchhh
Confidence 99999999988 69999999999754321 12234568999999999853 245788999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccC----CCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 132 SYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV----RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 132 vwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
|||||+++|+|++ ||................. .......+..+.++|.+||..||.+||++.+++++
T Consensus 214 i~slG~il~~l~~---p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 214 MYSLGIIFFEMIY---PFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHHHHHHHHHHHS---CCSSHHHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHHHHHh---ccCCchhHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 9999999999998 5543222222222222211 11234567889999999999999999999999987
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=260.34 Aligned_cols=195 Identities=22% Similarity=0.294 Sum_probs=144.7
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCC--
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED-- 77 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~-- 77 (268)
|+|++++++ .++..++||||+. |+|.+++...... ..+..++.++.|++.||.|||++||+||||||+||+++.+
T Consensus 79 nIv~l~~~~~~~~~~~lv~E~~~-g~L~~~l~~~~~~-~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~ 156 (432)
T 3p23_A 79 NVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFA-HLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNA 156 (432)
T ss_dssp TBCCEEEEEEETTEEEEEEECCS-EEHHHHHHSSSCC-CCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBT
T ss_pred CcCeEEEEEecCCEEEEEEECCC-CCHHHHHHhcCCC-ccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCC
Confidence 689999999 5568899999995 6999999875433 5556778899999999999999999999999999999532
Q ss_pred --CCCeEEecCCCccccccc----cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 024408 78 --LKTIKLADFGLAREESLT----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFE 150 (268)
Q Consensus 78 --~~~~kl~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~ 150 (268)
...++|+|||+++..... .......||+.|+|||++.+. ....++.++||||||+++|+|++ |..||.
T Consensus 157 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-----~~~~~t~~~DiwSlG~il~ellt~g~~pf~ 231 (432)
T 3p23_A 157 HGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSED-----CKENPTYTVDIFSAGCVFYYVISEGSHPFG 231 (432)
T ss_dssp TTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC--------CCCTHHHHHHHHHHHHHHHTTSCBTTB
T ss_pred CCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcc-----cccCCCcHHHHHHHHHHHHHHHcCCCCCcc
Confidence 125789999999864432 223345799999999998631 12456779999999999999999 899997
Q ss_pred CCChHHHHHHHHhccCCC--CCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 024408 151 GMSNLQAAYAAAFKNVRP--SAENVPEELSIILTSCWKEDPNARPNFTQIIQML 202 (268)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l 202 (268)
.................. .....+..+.++|.+||..||.+||++.++++|.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp 285 (432)
T 3p23_A 232 KSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHP 285 (432)
T ss_dssp STTTHHHHHHTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTST
T ss_pred hhhHHHHHHHhccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCc
Confidence 644333222111111111 1223356689999999999999999999999763
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-35 Score=249.38 Aligned_cols=186 Identities=24% Similarity=0.316 Sum_probs=148.3
Q ss_pred CceeEEEeecCC-------cEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEE
Q 024408 1 MREQFIGACKEP-------VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 73 (268)
Q Consensus 1 ~~v~l~g~~~~~-------~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nil 73 (268)
|++++++++... ..++||||++ ++|.+++.. .+++..+..++.|++.||.|||++|++||||||+||+
T Consensus 84 ~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl 158 (353)
T 3coi_A 84 NVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLA 158 (353)
T ss_dssp TBCCCSEEECSCSSGGGCCCCEEEEECCS-EEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEE
T ss_pred CcccHhheEecccccccceeEEEEecccc-CCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEe
Confidence 578899998442 2499999996 688887742 3999999999999999999999999999999999999
Q ss_pred EeCCCCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 024408 74 LTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS 153 (268)
Q Consensus 74 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~ 153 (268)
++.+ +.+||+|||+++..... .....||+.|+|||++.+ ...++.++||||||+++|+|++|+.||.+..
T Consensus 159 ~~~~-~~~kl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~-------~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 228 (353)
T 3coi_A 159 VNED-CELKILDFGLARHADAE--MTGYVVTRWYRAPEVILS-------WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 228 (353)
T ss_dssp ECTT-CCEEECSTTCTTC----------CCSBCCSCHHHHSC-------CSCCCTTHHHHHHHHHHHHHHHSSCSSBSSC
T ss_pred ECCC-CcEEEeecccccCCCCC--ccccccCcCcCCHHHHhC-------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9988 69999999999864332 234578999999998753 2467889999999999999999999998866
Q ss_pred hHHHHHHHHhcc------------------------------CCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 154 NLQAAYAAAFKN------------------------------VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 154 ~~~~~~~~~~~~------------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
..+......... .......+++++.++|.+||..||.+||++.++++|
T Consensus 229 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 229 YLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 544333222110 011234678999999999999999999999999998
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=259.51 Aligned_cols=200 Identities=23% Similarity=0.342 Sum_probs=144.0
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCC-----CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEE
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRC-----LDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL 74 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~-----~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill 74 (268)
|+|++++++ .++..++||||++ |+|.+++....... .++..++.++.|++.||+|||++||+||||||+|||+
T Consensus 70 nIv~~~~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl 148 (434)
T 2rio_A 70 NVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILV 148 (434)
T ss_dssp TBCCEEEEEECSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred CcCeEEEEEecCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEE
Confidence 689999999 4568899999995 69999998754311 1334567899999999999999999999999999999
Q ss_pred eCC------------CCCeEEecCCCccccccccc-----cccCCCccceeccccccccccccCCCCCCCchhhHHHHHH
Q 024408 75 TED------------LKTIKLADFGLAREESLTEM-----MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAI 137 (268)
Q Consensus 75 ~~~------------~~~~kl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~ 137 (268)
+.+ ...+||+|||+++....... .....||+.|+|||++.+.... .....++.++||||||+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~~~~~~~~DiwSlG~ 227 (434)
T 2rio_A 149 STSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNL-QTKRRLTRSIDIFSMGC 227 (434)
T ss_dssp ECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTT-SCCCCCCTHHHHHHHHH
T ss_pred ecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhcccccc-ccccCcchhhhhHhHHH
Confidence 753 23799999999986443221 2345799999999998642111 11256789999999999
Q ss_pred HHHHHHh-CCCCCCCCChHHHHHHHHhccCCCC----CCCCcHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 024408 138 VLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPS----AENVPEELSIILTSCWKEDPNARPNFTQIIQML 202 (268)
Q Consensus 138 ~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l 202 (268)
++|+|++ |..||.+.................. ...++.++.++|.+||..||.+||++.++++|.
T Consensus 228 il~ellt~g~~Pf~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp 297 (434)
T 2rio_A 228 VFYYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHP 297 (434)
T ss_dssp HHHHHHTTSCCTTCSTTTHHHHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred HHHHHHhCCCCCCCCchhhHHHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCC
Confidence 9999999 9999976544332221111111111 113457899999999999999999999999864
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=241.89 Aligned_cols=175 Identities=26% Similarity=0.401 Sum_probs=138.6
Q ss_pred CceeEEEeec-----CCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEe
Q 024408 1 MREQFIGACK-----EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 75 (268)
Q Consensus 1 ~~v~l~g~~~-----~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~ 75 (268)
|++++++++. ++..++||||++||+|.+++.......+++.+++.++.|++.||+|||++|++||||||+||+++
T Consensus 72 ~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~ 151 (299)
T 3m2w_A 72 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYT 151 (299)
T ss_dssp TBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEES
T ss_pred CchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEe
Confidence 5789999884 35789999999999999999987666699999999999999999999999999999999999998
Q ss_pred CC--CCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 024408 76 ED--LKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS 153 (268)
Q Consensus 76 ~~--~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~ 153 (268)
.+ .+.++|+|||++..... ..++.++||||||+++|+|++|+.||....
T Consensus 152 ~~~~~~~~kl~Dfg~a~~~~~-----------------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~ 202 (299)
T 3m2w_A 152 SKRPNAILKLTDFGFAKETTG-----------------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNH 202 (299)
T ss_dssp SSSTTCCEEECCCTTCEECTT-----------------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC--
T ss_pred cCCCCCcEEEecccccccccc-----------------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCc
Confidence 72 26899999999864221 235668999999999999999999997644
Q ss_pred hHHHHHHHHhccC---CCCC----CCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 024408 154 NLQAAYAAAFKNV---RPSA----ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 204 (268)
Q Consensus 154 ~~~~~~~~~~~~~---~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~ 204 (268)
............. ...+ ..+++++.++|.+||..||.+||++.++++|.+-
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~ 260 (299)
T 3m2w_A 203 GLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 260 (299)
T ss_dssp -----CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred chhhhHHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhh
Confidence 3221110000000 0011 4678999999999999999999999999998543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=252.08 Aligned_cols=179 Identities=15% Similarity=0.255 Sum_probs=141.0
Q ss_pred cEEEEEEcCCCCCHHHHHHh-----cCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCCeEEecCC
Q 024408 13 VMVIVTELLSGGTLRKYLLN-----MRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFG 87 (268)
Q Consensus 13 ~~~lV~e~~~ggsL~~~i~~-----~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~~kl~Dfg 87 (268)
..+++|+++ +++|.+++.. .....+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||
T Consensus 179 ~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl~~~-~~~kL~DFG 256 (413)
T 3dzo_A 179 SRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQR-GGVFLTGFE 256 (413)
T ss_dssp SEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT-CCEEECCGG
T ss_pred ceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcccceEEEecC-CeEEEEecc
Confidence 468889988 6899999852 223348888999999999999999999999999999999999998 689999999
Q ss_pred CccccccccccccCCCccceeccccccccc--cccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc
Q 024408 88 LAREESLTEMMTAETGTYRWMAPELYSTVT--LRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN 165 (268)
Q Consensus 88 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~ 165 (268)
+++..... .....| +.|+|||++.+.. ..+.....++.++||||||+++|+|++|+.||......... ..
T Consensus 257 ~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~-----~~ 328 (413)
T 3dzo_A 257 HLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGS-----EW 328 (413)
T ss_dssp GCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCS-----GG
T ss_pred ceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhH-----HH
Confidence 99864433 345577 9999999984311 00002345788999999999999999999999875432211 11
Q ss_pred CCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 166 VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 166 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
.......+|+++.++|.+||..||++||++.+++++
T Consensus 329 ~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~ 364 (413)
T 3dzo_A 329 IFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 364 (413)
T ss_dssp GGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 122245788999999999999999999998888765
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=256.60 Aligned_cols=192 Identities=28% Similarity=0.324 Sum_probs=148.9
Q ss_pred CceeEEEeec-------CCcEEEEEEcCCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCE
Q 024408 1 MREQFIGACK-------EPVMVIVTELLSGGTLRKYLLNMRP-RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENL 72 (268)
Q Consensus 1 ~~v~l~g~~~-------~~~~~lV~e~~~ggsL~~~i~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Ni 72 (268)
|+|++++++. ++..++||||++||+|.+++..... ..+++..++.++.|++.||+|||++|++||||||+||
T Consensus 73 nIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NI 152 (676)
T 3qa8_A 73 NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENI 152 (676)
T ss_dssp TBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTE
T ss_pred CCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHe
Confidence 5788999873 4578999999999999999987543 3499999999999999999999999999999999999
Q ss_pred EEeCCCC--CeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 024408 73 LLTEDLK--TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFE 150 (268)
Q Consensus 73 ll~~~~~--~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~ 150 (268)
+++.+.+ .++|+|||++.............||+.|+|||++.+ ..++.++||||||+++|+|++|..||.
T Consensus 153 Ll~~~g~~~~vKL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~--------~~~s~ksDIwSLGviLyeLltG~~Pf~ 224 (676)
T 3qa8_A 153 VLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQ--------KKYTVTVDYWSFGTLAFECITGFRPFL 224 (676)
T ss_dssp EEECCSSSCEEEECSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCC--------SCCSTTHHHHHHHHHHHHHHSSCSSCC
T ss_pred EeecCCCceeEEEcccccccccccccccccccCCcccCChHHhcc--------CCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence 9986622 389999999987665555566789999999999864 567889999999999999999999997
Q ss_pred CCChHHHHHH--------H-Hhc----------cCCCC----CCCCcHHHHHHHHhccccCCCCCCCHHHHHH
Q 024408 151 GMSNLQAAYA--------A-AFK----------NVRPS----AENVPEELSIILTSCWKEDPNARPNFTQIIQ 200 (268)
Q Consensus 151 ~~~~~~~~~~--------~-~~~----------~~~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~ 200 (268)
.......... . ... ...+. ...++..+.++|.+||..||.+||++.++++
T Consensus 225 ~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~ 297 (676)
T 3qa8_A 225 PNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPN 297 (676)
T ss_dssp SSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCC
T ss_pred cccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhc
Confidence 6432221100 0 000 00011 1235688999999999999999999988543
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.1e-32 Score=253.13 Aligned_cols=179 Identities=26% Similarity=0.293 Sum_probs=140.0
Q ss_pred CceeEEEeecC-Cc-----EEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEE
Q 024408 1 MREQFIGACKE-PV-----MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL 74 (268)
Q Consensus 1 ~~v~l~g~~~~-~~-----~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill 74 (268)
|+|++++++.+ +. .||||||++|++|.+++.. .+++.+++.++.|++.||.|||++||+||||||+||++
T Consensus 140 ~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll 215 (681)
T 2pzi_A 140 SIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIML 215 (681)
T ss_dssp TBCCEEEEEEEECTTSCEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred CcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEE
Confidence 68999999843 33 6999999999999998754 39999999999999999999999999999999999999
Q ss_pred eCCCCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh
Q 024408 75 TEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN 154 (268)
Q Consensus 75 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~ 154 (268)
+.+ .+||+|||+++..... ....||+.|+|||++.+ .++.++||||||+++|+|++|..||.+...
T Consensus 216 ~~~--~~kl~DFG~a~~~~~~---~~~~gt~~y~aPE~~~~---------~~~~~sDi~slG~~l~~l~~g~~~~~~~~~ 281 (681)
T 2pzi_A 216 TEE--QLKLIDLGAVSRINSF---GYLYGTPGFQAPEIVRT---------GPTVATDIYTVGRTLAALTLDLPTRNGRYV 281 (681)
T ss_dssp CSS--CEEECCCTTCEETTCC---SCCCCCTTTSCTTHHHH---------CSCHHHHHHHHHHHHHHHHSCCCEETTEEC
T ss_pred eCC--cEEEEecccchhcccC---CccCCCccccCHHHHcC---------CCCCceehhhhHHHHHHHHhCCCCCccccc
Confidence 875 7999999999864433 44579999999998853 247899999999999999999888764211
Q ss_pred HHHHHHHHhccCCCC--CCCCcHHHHHHHHhccccCCCCCCC-HHHHHHHHHHhH
Q 024408 155 LQAAYAAAFKNVRPS--AENVPEELSIILTSCWKEDPNARPN-FTQIIQMLLNYL 206 (268)
Q Consensus 155 ~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps-~~~~~~~l~~~~ 206 (268)
. ..... ....++.+.++|.+||..||.+||+ .+++...|...+
T Consensus 282 ~---------~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 282 D---------GLPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp S---------SCCTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred c---------cccccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 0 00000 0113478999999999999999996 555555555443
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.98 E-value=2.2e-32 Score=227.71 Aligned_cols=168 Identities=16% Similarity=0.179 Sum_probs=133.8
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|++++++++ .++..|+||||++|++|.+++.+ + ....++..++.|++.||+|||++||+||||||+||+++.+ +
T Consensus 92 ~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~--~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~-g 166 (286)
T 3uqc_A 92 GVARVLDVVHTRAGGLVVAEWIRGGSLQEVADT--S--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSID-G 166 (286)
T ss_dssp TBCCEEEEEEETTEEEEEEECCCEEEHHHHHTT--C--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETT-S
T ss_pred CcceeeEEEEECCcEEEEEEecCCCCHHHHHhc--C--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCC-C
Confidence 689999999 55689999999999999999954 2 4566789999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 024408 80 TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY 159 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~ 159 (268)
.++|+++| |++ .++.++||||||+++|+|++|+.||.+........
T Consensus 167 ~~kl~~~~-------------------~~~---------------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~ 212 (286)
T 3uqc_A 167 DVVLAYPA-------------------TMP---------------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA 212 (286)
T ss_dssp CEEECSCC-------------------CCT---------------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE
T ss_pred CEEEEecc-------------------ccC---------------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH
Confidence 89987443 222 24678999999999999999999998754322110
Q ss_pred ---HHHhccCC---CCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 024408 160 ---AAAFKNVR---PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 208 (268)
Q Consensus 160 ---~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 208 (268)
........ .....+++++.++|.+||..||.+| |+.++++.|+.....
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~ 266 (286)
T 3uqc_A 213 PAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV 266 (286)
T ss_dssp ECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred HHHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence 00001011 0135688999999999999999999 999999999886644
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-31 Score=226.86 Aligned_cols=169 Identities=16% Similarity=0.178 Sum_probs=130.1
Q ss_pred CCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH-HCCCeecCCCCCCEEEeCCCC----------
Q 024408 11 EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLH-SHGIIHRDLKPENLLLTEDLK---------- 79 (268)
Q Consensus 11 ~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH-~~gi~H~Dikp~Nill~~~~~---------- 79 (268)
++..++||||++||++.+.+.+ ..+++.+++.++.|++.||+||| ++||+||||||+|||++.+ +
T Consensus 134 ~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~-~~~~~~~~~~~ 209 (336)
T 2vuw_A 134 DDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKT-SLKKLHYTLNG 209 (336)
T ss_dssp TTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEEC-SCSEEEEEETT
T ss_pred cCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEecc-CCcceeeeccC
Confidence 5689999999999987777643 34899999999999999999999 9999999999999999877 4
Q ss_pred ----------CeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHH-HHHHHhCCCC
Q 024408 80 ----------TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIV-LWELLHNKLP 148 (268)
Q Consensus 80 ----------~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~-l~~ll~g~~p 148 (268)
.+||+|||+|+..... ...||+.|+|||++.+ ..+.++||||++++ .++++.|..|
T Consensus 210 ~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~g---------~~~~~~Diwsl~~~~~~~~~~g~~p 276 (336)
T 2vuw_A 210 KSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFTG---------DGDYQFDIYRLMKKENNNRWGEYHP 276 (336)
T ss_dssp EEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGGCC---------CSSHHHHHHHHHHHHHTTCTTSCCT
T ss_pred ccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhhcC---------CCccceehhhhhCCCCcccccccCC
Confidence 8999999999864432 3478999999999864 22779999998777 6678889998
Q ss_pred CCCCChHHHHHHHHhcc--CCCC-----CCCCcHHHHHHHHhccccCCCCCCCHHHHH-HH
Q 024408 149 FEGMSNLQAAYAAAFKN--VRPS-----AENVPEELSIILTSCWKEDPNARPNFTQII-QM 201 (268)
Q Consensus 149 ~~~~~~~~~~~~~~~~~--~~~~-----~~~~~~~l~~li~~~l~~~p~~Rps~~~~~-~~ 201 (268)
|................ .... ...+++++.++|.+||..| |+++++ +|
T Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~H 332 (336)
T 2vuw_A 277 YSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQH 332 (336)
T ss_dssp HHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHC
T ss_pred CcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcC
Confidence 85421111111111111 1111 1246788999999999976 899998 76
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-30 Score=234.72 Aligned_cols=130 Identities=18% Similarity=0.201 Sum_probs=95.8
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|++++++++ +++.+||||||++|++|.++|.+.+. +++. +++.||+.||+|+|++||+||||||+|||++.+ +
T Consensus 303 ~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~~~--l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~d-g 376 (569)
T 4azs_A 303 DAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAGEE--IDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDAR-Q 376 (569)
T ss_dssp CCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTTCC--CCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTT-S
T ss_pred CeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhCCC--CCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCC-C
Confidence 689999999 55689999999999999999987655 7765 478999999999999999999999999999988 7
Q ss_pred CeEEecCCCccccccc-cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhC
Q 024408 80 TIKLADFGLAREESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHN 145 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g 145 (268)
++||+|||+|+..... ....+.+||+.|+|||++.+ .+..++|+||+|++++++.++
T Consensus 377 ~vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~g---------~~~~~~d~~s~g~~~~~l~~~ 434 (569)
T 4azs_A 377 HARLIDFGSIVTTPQDCSWPTNLVQSFFVFVNELFAE---------NKSWNGFWRSAPVHPFNLPQP 434 (569)
T ss_dssp CEEECCCTTEESCC---CCSHHHHHHHHHHHHHHC--------------------------CCCCTT
T ss_pred CEEEeecccCeeCCCCCccccCceechhhccHHHhCC---------CCCCcccccccccchhhhccc
Confidence 9999999999864433 23345679999999999853 456678999999988776554
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=1e-22 Score=183.24 Aligned_cols=130 Identities=18% Similarity=0.281 Sum_probs=103.9
Q ss_pred Cce--eEEEeecCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCC
Q 024408 1 MRE--QFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL 78 (268)
Q Consensus 1 ~~v--~l~g~~~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~ 78 (268)
|++ ++++. .++..+|||||++|++|.+++.+ +..++.|++.||+|||++||+||||||+|||++.
T Consensus 400 nIv~~~~~~~-~~~~~~lVmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~-- 466 (540)
T 3en9_A 400 GIPAPYIFDV-DLDNKRIMMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK-- 466 (540)
T ss_dssp TCCCCCEEEE-ETTTTEEEEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--
T ss_pred CcCceEEEEE-eCCccEEEEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--
Confidence 456 44444 44556999999999999999865 5689999999999999999999999999999987
Q ss_pred CCeEEecCCCccccccccc--------cccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 024408 79 KTIKLADFGLAREESLTEM--------MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFE 150 (268)
Q Consensus 79 ~~~kl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~ 150 (268)
.+||+|||+++....... ..+..||+.|+|||++.... ..|+...|+|+..+-.++-+.++-+|.
T Consensus 467 -~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~------~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 467 -DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFL------EGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp -SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHH------HHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred -eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHH------HHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 799999999986554322 23567999999999986421 235667799999998888877766653
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=2.1e-18 Score=142.84 Aligned_cols=89 Identities=18% Similarity=0.124 Sum_probs=72.3
Q ss_pred eeEEEeecCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCCeE
Q 024408 3 EQFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIK 82 (268)
Q Consensus 3 v~l~g~~~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~~k 82 (268)
+++.+++..+..++||||++|++|.+ +. . .....++.|++.||.|||++|++||||||+|||++ + +.++
T Consensus 164 ~~v~~~~~~~~~~lvmE~~~g~~L~~-l~------~--~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~-~~vk 232 (282)
T 1zar_A 164 LAVPKVYAWEGNAVLMELIDAKELYR-VR------V--ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-E-EGIW 232 (282)
T ss_dssp SSSCCEEEEETTEEEEECCCCEEGGG-CC------C--SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-T-TEEE
T ss_pred CCcCeEEeccceEEEEEecCCCcHHH-cc------h--hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-C-CcEE
Confidence 45556665567799999999999988 42 1 23456899999999999999999999999999999 6 7999
Q ss_pred EecCCCccccccccccccCCCccceecccccc
Q 024408 83 LADFGLAREESLTEMMTAETGTYRWMAPELYS 114 (268)
Q Consensus 83 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~ 114 (268)
|+|||+++. +..+.|||.+.
T Consensus 233 l~DFG~a~~------------~~~~~a~e~l~ 252 (282)
T 1zar_A 233 IIDFPQSVE------------VGEEGWREILE 252 (282)
T ss_dssp ECCCTTCEE------------TTSTTHHHHHH
T ss_pred EEECCCCeE------------CCCCCHHHHHH
Confidence 999999974 23456787763
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.51 E-value=1.5e-14 Score=118.06 Aligned_cols=72 Identities=21% Similarity=0.266 Sum_probs=60.3
Q ss_pred cEEEEEEcCCC-C----CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH-HCCCeecCCCCCCEEEeCCCCCeEEecC
Q 024408 13 VMVIVTELLSG-G----TLRKYLLNMRPRCLDVCVAIGFALDIARAMECLH-SHGIIHRDLKPENLLLTEDLKTIKLADF 86 (268)
Q Consensus 13 ~~~lV~e~~~g-g----sL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH-~~gi~H~Dikp~Nill~~~~~~~kl~Df 86 (268)
..+|||||+.+ | +|.++... .++..+..++.|++.||.+|| +.|++||||||+|||++. .++|+||
T Consensus 142 ~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~NILl~~---~~~liDF 213 (258)
T 1zth_A 142 KNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYID---KVYFIDM 213 (258)
T ss_dssp TTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTSEEESS---SEEECCC
T ss_pred CCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEEcC---cEEEEEC
Confidence 45899999932 3 78776543 335577889999999999999 999999999999999987 7999999
Q ss_pred CCcccc
Q 024408 87 GLAREE 92 (268)
Q Consensus 87 g~a~~~ 92 (268)
|+|...
T Consensus 214 G~a~~~ 219 (258)
T 1zth_A 214 GQAVTL 219 (258)
T ss_dssp TTCEET
T ss_pred cccccC
Confidence 999753
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.28 E-value=1.4e-12 Score=111.51 Aligned_cols=69 Identities=23% Similarity=0.292 Sum_probs=56.1
Q ss_pred EEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC---------CeEEec
Q 024408 15 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK---------TIKLAD 85 (268)
Q Consensus 15 ~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~---------~~kl~D 85 (268)
+|||||++|++|.++.. . ..+..++.|++.+|.+||+.||+||||||.|||++++.. .+.|+|
T Consensus 187 ~LVME~i~G~~L~~l~~------~--~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID 258 (397)
T 4gyi_A 187 TIVMSLVDALPMRQVSS------V--PDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDPSSITLTPIIIX 258 (397)
T ss_dssp EEEEECCSCEEGGGCCC------C--SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCTTSEEEEEEECC
T ss_pred eEEEEecCCccHhhhcc------c--HHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccccccccceEEEE
Confidence 69999999988865431 2 234567899999999999999999999999999986621 378999
Q ss_pred CCCccc
Q 024408 86 FGLARE 91 (268)
Q Consensus 86 fg~a~~ 91 (268)
|+-+..
T Consensus 259 ~~Q~V~ 264 (397)
T 4gyi_A 259 FPQMVS 264 (397)
T ss_dssp CTTCEE
T ss_pred eCCccc
Confidence 998764
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=98.91 E-value=1.5e-09 Score=88.35 Aligned_cols=81 Identities=15% Similarity=0.097 Sum_probs=63.8
Q ss_pred ceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---------------------
Q 024408 2 REQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS--------------------- 59 (268)
Q Consensus 2 ~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~--------------------- 59 (268)
+.++++++ .++..|+||||++|.+|.+.+. +......++.+++.+|..||+
T Consensus 72 vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~ 144 (263)
T 3tm0_A 72 VPKVLHFERHDGWSNLLMSEADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDY 144 (263)
T ss_dssp CCCEEEEEEETTEEEEEEECCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHH
T ss_pred CCeEEEEEecCCceEEEEEecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHH
Confidence 45788887 4567899999999999987632 122334678899999999998
Q ss_pred --------------------------------------CCCeecCCCCCCEEEeCCCCCeEEecCCCcc
Q 024408 60 --------------------------------------HGIIHRDLKPENLLLTEDLKTIKLADFGLAR 90 (268)
Q Consensus 60 --------------------------------------~gi~H~Dikp~Nill~~~~~~~kl~Dfg~a~ 90 (268)
.+++|+|+++.||+++++ +.+.|+||+.+.
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~-~~~~lIDwe~a~ 212 (263)
T 3tm0_A 145 LLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDG-KVSGFIDLGRSG 212 (263)
T ss_dssp HHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETT-EEEEECCCTTCE
T ss_pred HHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECC-cEEEEEEchhcc
Confidence 458999999999999865 355799998875
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.72 E-value=2.6e-08 Score=84.81 Aligned_cols=86 Identities=16% Similarity=0.315 Sum_probs=68.6
Q ss_pred ceeEEEeecCC----cEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH------------------
Q 024408 2 REQFIGACKEP----VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS------------------ 59 (268)
Q Consensus 2 ~v~l~g~~~~~----~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~------------------ 59 (268)
+.++++++.++ ..|+||||++|.++.+.. ...++..+...++.+++.+|..||+
T Consensus 100 vP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~ 175 (359)
T 3dxp_A 100 VAKMYALCEDESVIGRAFYIMEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYF 175 (359)
T ss_dssp CCCEEEEECCTTTTSSCEEEEECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHH
T ss_pred CCcEEEECCCCCccCCeEEEEEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCch
Confidence 56788888543 479999999988875421 1127788889999999999999997
Q ss_pred ----------------------------------------CCCeecCCCCCCEEEeCCCCC-eEEecCCCccc
Q 024408 60 ----------------------------------------HGIIHRDLKPENLLLTEDLKT-IKLADFGLARE 91 (268)
Q Consensus 60 ----------------------------------------~gi~H~Dikp~Nill~~~~~~-~kl~Dfg~a~~ 91 (268)
.+++|+|+++.||+++.+... +.|+||+.+..
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 176 QRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 368999999999999876323 58999999874
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.64 E-value=1.8e-08 Score=83.77 Aligned_cols=143 Identities=19% Similarity=0.195 Sum_probs=86.3
Q ss_pred eeEEEeecC-C---cEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-------------------
Q 024408 3 EQFIGACKE-P---VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS------------------- 59 (268)
Q Consensus 3 v~l~g~~~~-~---~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~------------------- 59 (268)
.+.++.+.. + ..|+|||+++|.+|.+.... .++..+...++.+++..|..||+
T Consensus 76 P~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~ 151 (304)
T 3sg8_A 76 PEVVFTGMPSETYQMSFAGFTKIKGVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKIN 151 (304)
T ss_dssp CCEEEECCCCSSCSCSCEEEECCCCEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHH
T ss_pred CceEeecCCCCCCCcceEEEcccCCeECCccccc----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHH
Confidence 345555432 2 34899999999998764332 17788888888999998888886
Q ss_pred ---------------------------------------CCCeecCCCCCCEEEeCC-CCCeEEecCCCccccccccccc
Q 024408 60 ---------------------------------------HGIIHRDLKPENLLLTED-LKTIKLADFGLAREESLTEMMT 99 (268)
Q Consensus 60 ---------------------------------------~gi~H~Dikp~Nill~~~-~~~~kl~Dfg~a~~~~~~~~~~ 99 (268)
..++|+|+++.||+++.+ .+.+.++||+.+.......-..
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~ 231 (304)
T 3sg8_A 152 EDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFI 231 (304)
T ss_dssp HHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHH
T ss_pred HHHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHH
Confidence 136999999999999874 2467899999986432211000
Q ss_pred cCCCccceecccccccc-ccccCC-----CCCCCchhhHHHHHHHHHHHHhCCCCC
Q 024408 100 AETGTYRWMAPELYSTV-TLRQGE-----KKHYNHKVDSYSFAIVLWELLHNKLPF 149 (268)
Q Consensus 100 ~~~gt~~y~aPE~~~~~-~~~~~~-----~~~~~~~~DvwslG~~l~~ll~g~~p~ 149 (268)
.......-..|+..... ...... ........+.|+++.+++.+.+|..+|
T Consensus 232 ~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 232 SLMEDDEEYGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp TTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHhhccccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 00000000111111100 000000 000112358999999999999998665
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.64 E-value=3.3e-08 Score=79.92 Aligned_cols=79 Identities=16% Similarity=0.114 Sum_probs=57.6
Q ss_pred ceeEEEeec-CCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC-------------------
Q 024408 2 REQFIGACK-EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG------------------- 61 (268)
Q Consensus 2 ~v~l~g~~~-~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~g------------------- 61 (268)
+.+++++.. ++..++||||++|.+|. .. . .+. ..++.+++..|..||+..
T Consensus 77 vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~---~--~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~ 146 (264)
T 1nd4_A 77 CAAVLDVVTEAGRDWLLLGEVPGQDLL--SS---H--LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERART 146 (264)
T ss_dssp BCCEEEEEECSSCEEEEEECCSSEETT--TS---C--CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHH
T ss_pred CCeEEEeccCCCCCEEEEEecCCcccC--cC---c--CCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHH
Confidence 456788874 45789999999998884 21 1 222 245667777777777643
Q ss_pred ---------------------------------------CeecCCCCCCEEEeCCCCCeEEecCCCccc
Q 024408 62 ---------------------------------------IIHRDLKPENLLLTEDLKTIKLADFGLARE 91 (268)
Q Consensus 62 ---------------------------------------i~H~Dikp~Nill~~~~~~~kl~Dfg~a~~ 91 (268)
++|+|++|.||+++++ +.+.|+|||.+..
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~-~~~~liD~~~a~~ 214 (264)
T 1nd4_A 147 RMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENG-RFSGFIDCGRLGV 214 (264)
T ss_dssp HHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETT-EEEEECCCTTCEE
T ss_pred HHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECC-cEEEEEcchhccc
Confidence 9999999999999876 4556999998753
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=98.35 E-value=1.3e-05 Score=62.41 Aligned_cols=141 Identities=13% Similarity=0.113 Sum_probs=93.2
Q ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEEeCCCCCeEEecCCCccccccccccccCCC
Q 024408 25 TLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETG 103 (268)
Q Consensus 25 sL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~gi~H~Dikp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~g 103 (268)
||.+.|...+. +++++++|.++.|.+.+|.-+-. +.-..+=+.|..|++..+ |.|.+.+ ..+. ..
T Consensus 34 SL~eIL~~~~~-PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~d-G~V~f~~-~~s~-----------~~ 99 (229)
T 2yle_A 34 SLEEILRLYNQ-PINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRD-GAVTLAP-AADD-----------AG 99 (229)
T ss_dssp EHHHHHHHHTS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETT-SCEEECC-C----------------
T ss_pred cHHHHHHHcCC-CcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecC-Cceeccc-cccc-----------cc
Confidence 79999987655 49999999999999999887732 221233344688898888 6776553 1110 12
Q ss_pred ccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHh
Q 024408 104 TYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTS 183 (268)
Q Consensus 104 t~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 183 (268)
...+.|||... ...+.+.-|||||+++|..+--..|-. .+..+++.+..||..
T Consensus 100 ~~~~~~pe~~~---------~~~te~~~IysLG~tLY~ALDygL~e~------------------eE~eLS~~LE~LL~~ 152 (229)
T 2yle_A 100 EPPPVAGKLGY---------SQCMETEVIESLGIIIYKALDYGLKEN------------------EERELSPPLEQLIDH 152 (229)
T ss_dssp -------CCSS---------SSSCHHHHHHHHHHHHHHHHTTTCCTT------------------EEECCCHHHHHHHHH
T ss_pred ccCCCChhhcc---------ccchHHHHHHHHHHHHHHHhhcCCCcc------------------cchhhCHHHHHHHHH
Confidence 23466888652 234567889999999999876333211 245788899999988
Q ss_pred cccc-------------------------CCCCCCCHHHHHHHHHHhH
Q 024408 184 CWKE-------------------------DPNARPNFTQIIQMLLNYL 206 (268)
Q Consensus 184 ~l~~-------------------------~p~~Rps~~~~~~~l~~~~ 206 (268)
|... .+..|+++++|++.....+
T Consensus 153 Mt~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~~hl 200 (229)
T 2yle_A 153 MANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCAAHL 200 (229)
T ss_dssp HTTCCC--------------------CCSCCCCCCSHHHHHHHHHTTS
T ss_pred HHhcccccccccccccccccccccccccccccCcCCHHHHHHHHHhhc
Confidence 8755 2467889999998876644
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.03 E-value=1.2e-05 Score=65.30 Aligned_cols=83 Identities=20% Similarity=0.149 Sum_probs=58.3
Q ss_pred ceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC--------------------
Q 024408 2 REQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH-------------------- 60 (268)
Q Consensus 2 ~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-------------------- 60 (268)
|-+.++++ .++..++|||+++|.++.+...... .....++.++...|..||..
T Consensus 82 VP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~~------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~ 155 (272)
T 4gkh_A 82 LPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEYP------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQS 155 (272)
T ss_dssp CCCEEEEEEETTEEEEEEECCCSEEHHHHHHHCG------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHH
T ss_pred cCeEEEEEEECCeEEEEEEeeCCccccccccCCH------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHH
Confidence 44677887 4567899999999988887654321 12233455566666666521
Q ss_pred --------------------------------------CCeecCCCCCCEEEeCCCCCeEEecCCCccc
Q 024408 61 --------------------------------------GIIHRDLKPENLLLTEDLKTIKLADFGLARE 91 (268)
Q Consensus 61 --------------------------------------gi~H~Dikp~Nill~~~~~~~kl~Dfg~a~~ 91 (268)
.++|+|+++.||+++.+ +.+-|+||+.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~-~~~~viDwe~a~~ 223 (272)
T 4gkh_A 156 RMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEG-KLIGCIDVGRVGI 223 (272)
T ss_dssp HHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETT-EEEEECCCTTCEE
T ss_pred HHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECC-eEEEEEECccccc
Confidence 26899999999999876 4566999988853
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.00 E-value=2.2e-05 Score=65.15 Aligned_cols=85 Identities=22% Similarity=0.228 Sum_probs=57.0
Q ss_pred eeEEEee--cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC--------------------
Q 024408 3 EQFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH-------------------- 60 (268)
Q Consensus 3 v~l~g~~--~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-------------------- 60 (268)
.+.++++ .++..++|||+++|.+|.+.... . ++..+...++.++...|..||+.
T Consensus 75 P~~~~~~~~~~g~~~~v~e~i~G~~l~~~~~~--~--l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~ 150 (306)
T 3tdw_A 75 PQYVYIGKRSDGNPFVGYRKVQGQILGEDGMA--V--LPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKIL 150 (306)
T ss_dssp CCEEEEEECTTSCEEEEEECCCSEECHHHHHT--T--SCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHH
T ss_pred CCeEeecccCCCceEEEEeccCCeECchhhhh--h--CCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHH
Confidence 3445555 34567899999999888763221 1 44555555555555555555532
Q ss_pred ----------------------------------------CCeecCCCCCCEEEeC---CCCCeEEecCCCccc
Q 024408 61 ----------------------------------------GIIHRDLKPENLLLTE---DLKTIKLADFGLARE 91 (268)
Q Consensus 61 ----------------------------------------gi~H~Dikp~Nill~~---~~~~~kl~Dfg~a~~ 91 (268)
.++|+|+++.||+++. +...+.|+||+.+..
T Consensus 151 ~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 151 LLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 3599999999999987 323347999998864
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.61 E-value=4.8e-05 Score=64.34 Aligned_cols=31 Identities=13% Similarity=0.244 Sum_probs=25.6
Q ss_pred CCCeecCCCCCCEEEeCCCCCeEEecCCCccc
Q 024408 60 HGIIHRDLKPENLLLTEDLKTIKLADFGLARE 91 (268)
Q Consensus 60 ~gi~H~Dikp~Nill~~~~~~~kl~Dfg~a~~ 91 (268)
..++|+|+++.||+++++ +.+.|+||+.+..
T Consensus 222 ~~l~HgDl~~~Nil~~~~-~~~~vIDwe~a~~ 252 (357)
T 3ats_A 222 PVLLWGDARVGNVLYRDF-QPVAVLDWEMVAL 252 (357)
T ss_dssp CEEECSSCSGGGEEEETT-EEEEECCGGGCEE
T ss_pred ceEEeCCCCCCeEEEeCC-cEEEEEccccccc
Confidence 469999999999999853 3578999988753
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.93 E-value=0.002 Score=53.70 Aligned_cols=32 Identities=31% Similarity=0.489 Sum_probs=26.8
Q ss_pred CCCeecCCCCCCEEEeCC---CCCeEEecCCCccc
Q 024408 60 HGIIHRDLKPENLLLTED---LKTIKLADFGLARE 91 (268)
Q Consensus 60 ~gi~H~Dikp~Nill~~~---~~~~kl~Dfg~a~~ 91 (268)
.+++|+|+++.||+++.+ .+.+.|+||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 479999999999999763 14789999999874
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.55 E-value=0.0062 Score=50.01 Aligned_cols=29 Identities=21% Similarity=0.203 Sum_probs=24.1
Q ss_pred CCeecCCCCCCEEEeCCCCCeEEecCCCccc
Q 024408 61 GIIHRDLKPENLLLTEDLKTIKLADFGLARE 91 (268)
Q Consensus 61 gi~H~Dikp~Nill~~~~~~~kl~Dfg~a~~ 91 (268)
.++|+|+.+.||+. .+ +.+.++||..+..
T Consensus 174 ~l~HgDl~~~Nil~-~~-~~~~lID~e~a~~ 202 (301)
T 3dxq_A 174 AACHCDPLCENFLD-TG-ERMWIVDWEYSGM 202 (301)
T ss_dssp EEECSCCCGGGEEE-CS-SCEEECCCTTCEE
T ss_pred eeeccCCCcCCEEE-CC-CCEEEEecccccC
Confidence 48999999999994 44 4789999998864
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=96.52 E-value=0.0037 Score=52.05 Aligned_cols=30 Identities=27% Similarity=0.387 Sum_probs=26.5
Q ss_pred CCCeecCCCCCCEEEeCCCCCeEEecCCCcc
Q 024408 60 HGIIHRDLKPENLLLTEDLKTIKLADFGLAR 90 (268)
Q Consensus 60 ~gi~H~Dikp~Nill~~~~~~~kl~Dfg~a~ 90 (268)
.+++|+|+++.||+++.+ +.+.++||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~-~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGEN-EQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGG-GCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCC-CcEEEEehhhcc
Confidence 579999999999999766 579999999875
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=96.36 E-value=0.0067 Score=51.87 Aligned_cols=31 Identities=26% Similarity=0.355 Sum_probs=26.4
Q ss_pred HCCCeecCCCCCCEEEeCCCCCeEEecCCCccc
Q 024408 59 SHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 91 (268)
Q Consensus 59 ~~gi~H~Dikp~Nill~~~~~~~kl~Dfg~a~~ 91 (268)
...++|+|+++.||+++.+ .++++||..+..
T Consensus 226 ~~~L~HGDl~~~Nil~~~~--~~~lID~e~a~~ 256 (397)
T 2olc_A 226 AETLIHGDLHTGSIFASEH--ETKVIDPEFAFY 256 (397)
T ss_dssp CCEEECSCCSGGGEEECSS--CEEECCCTTCEE
T ss_pred CCceeeCCCCcCcEEEeCC--CeEEEeCccccc
Confidence 3579999999999999875 589999988864
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=95.83 E-value=0.0077 Score=51.33 Aligned_cols=31 Identities=26% Similarity=0.455 Sum_probs=26.0
Q ss_pred CCeecCCCCCCEEEeCC---CCCeEEecCCCccc
Q 024408 61 GIIHRDLKPENLLLTED---LKTIKLADFGLARE 91 (268)
Q Consensus 61 gi~H~Dikp~Nill~~~---~~~~kl~Dfg~a~~ 91 (268)
.++|+|+.+.||+++.+ .+.+.++||..+..
T Consensus 221 ~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 221 VFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp EEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred EEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 58999999999999865 34789999998863
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=95.74 E-value=0.0065 Score=52.47 Aligned_cols=33 Identities=21% Similarity=0.390 Sum_probs=28.3
Q ss_pred HHCCCeecCCCCCCEEEeCCCCCeEEecCCCcccc
Q 024408 58 HSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 92 (268)
Q Consensus 58 H~~gi~H~Dikp~Nill~~~~~~~kl~Dfg~a~~~ 92 (268)
+...++|+|+++.|||++.+ + +.++||+.+...
T Consensus 230 ~~~~liHGDl~~~Nil~~~~-~-~~lID~e~a~~G 262 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQD-S-TQVIDPEFSFYG 262 (420)
T ss_dssp BCCEEECSCCSGGGEEECSS-C-EEECCCTTCEEE
T ss_pred CCCeEEecCCCCCcEEEeCC-C-CEEEeCcccccC
Confidence 45689999999999999876 3 999999998753
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=95.46 E-value=0.033 Score=46.06 Aligned_cols=26 Identities=31% Similarity=0.396 Sum_probs=22.5
Q ss_pred CCCeecCCCCCCEEEeCCCCCeEEecCC
Q 024408 60 HGIIHRDLKPENLLLTEDLKTIKLADFG 87 (268)
Q Consensus 60 ~gi~H~Dikp~Nill~~~~~~~kl~Dfg 87 (268)
..++|+|+.+.|++++.+ + +.|+|+.
T Consensus 207 ~~l~HgD~~~~N~l~~~~-~-~~~iD~~ 232 (312)
T 3jr1_A 207 PSILHGNLWIENCIQVDD-K-IFVCNPA 232 (312)
T ss_dssp CEEECSSCSGGGEEEETT-E-EEECSCC
T ss_pred ceeEeCCCCcCcEeecCC-C-eEEEcCc
Confidence 369999999999999987 4 8899974
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=94.39 E-value=0.016 Score=47.86 Aligned_cols=31 Identities=35% Similarity=0.532 Sum_probs=25.7
Q ss_pred CCCeecCCCCCCEEEeCCCCCeEEecCCCccc
Q 024408 60 HGIIHRDLKPENLLLTEDLKTIKLADFGLARE 91 (268)
Q Consensus 60 ~gi~H~Dikp~Nill~~~~~~~kl~Dfg~a~~ 91 (268)
.+++|+|+++.||+++.+ +.+.++||+.+..
T Consensus 187 ~~liHgDl~~~Nil~~~~-~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 187 AGVIHADLFQDNVFFLGD-ELSGLIDFYFACN 217 (322)
T ss_dssp EEEECSCCCGGGEEEETT-EEEEECCCTTCEE
T ss_pred cccCCCCCCccCEEEeCC-ceEEEecchhccC
Confidence 369999999999999876 3457999988753
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=93.96 E-value=0.04 Score=45.52 Aligned_cols=29 Identities=28% Similarity=0.283 Sum_probs=24.9
Q ss_pred CCCeecCCCCCCEEEeCCCCCeEEecCCCccc
Q 024408 60 HGIIHRDLKPENLLLTEDLKTIKLADFGLARE 91 (268)
Q Consensus 60 ~gi~H~Dikp~Nill~~~~~~~kl~Dfg~a~~ 91 (268)
..++|+|+++.||+++ + .+.++||+.+..
T Consensus 195 ~~l~HgD~~~~Nil~~-~--~~~lIDfe~a~~ 223 (328)
T 1zyl_A 195 VLRLHGDCHAGNILWR-D--GPMFVDLDDARN 223 (328)
T ss_dssp CEECCSSCSGGGEEES-S--SEEECCCTTCCE
T ss_pred eeeeeCCCCcccEeEc-C--CCEEEECCCCCc
Confidence 4589999999999998 4 689999988764
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=92.47 E-value=0.095 Score=44.17 Aligned_cols=28 Identities=29% Similarity=0.513 Sum_probs=24.3
Q ss_pred CCeecCCCCCCEEEeCCCCCeEEecCCCcc
Q 024408 61 GIIHRDLKPENLLLTEDLKTIKLADFGLAR 90 (268)
Q Consensus 61 gi~H~Dikp~Nill~~~~~~~kl~Dfg~a~ 90 (268)
+++|+|+++.||+++.+ .+.++||+.+.
T Consensus 213 ~l~HgDl~~~Nil~~~~--~~~lID~e~a~ 240 (369)
T 3c5i_A 213 VFCHNDLQENNIINTNK--CLRLIDFEYSG 240 (369)
T ss_dssp EEECSCCCGGGEEECC---CEEECCCTTCE
T ss_pred EEEeCCCCcccEEecCC--cEEEEEecCCC
Confidence 59999999999999765 58999999886
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=92.18 E-value=0.077 Score=44.30 Aligned_cols=31 Identities=19% Similarity=0.340 Sum_probs=26.7
Q ss_pred CCCeecCCCCCCEEEeCCCCCeEEecCCCccc
Q 024408 60 HGIIHRDLKPENLLLTEDLKTIKLADFGLARE 91 (268)
Q Consensus 60 ~gi~H~Dikp~Nill~~~~~~~kl~Dfg~a~~ 91 (268)
.+++|+|+.+.||+++.+ +.+.++||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~-~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNE-ESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGG-GCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCC-CeEEEEECCCCee
Confidence 369999999999999876 5799999988764
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=91.05 E-value=0.16 Score=44.38 Aligned_cols=15 Identities=33% Similarity=0.408 Sum_probs=14.1
Q ss_pred CCeecCCCCCCEEEe
Q 024408 61 GIIHRDLKPENLLLT 75 (268)
Q Consensus 61 gi~H~Dikp~Nill~ 75 (268)
.++|+|+.+.|||++
T Consensus 291 v~cHnDl~~gNIL~~ 305 (458)
T 2qg7_A 291 VLCHCDLLSSNIINT 305 (458)
T ss_dssp EEECSCCCGGGEEEC
T ss_pred eEEecCCCCCcEEee
Confidence 589999999999998
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=90.11 E-value=0.11 Score=44.88 Aligned_cols=30 Identities=33% Similarity=0.470 Sum_probs=24.1
Q ss_pred CCeecCCCCCCEEEeCC---------------------------CCCeEEecCCCcc
Q 024408 61 GIIHRDLKPENLLLTED---------------------------LKTIKLADFGLAR 90 (268)
Q Consensus 61 gi~H~Dikp~Nill~~~---------------------------~~~~kl~Dfg~a~ 90 (268)
.++|+|+.+.||+++.+ .+.+.++||+.+.
T Consensus 250 v~~H~Dl~~gNiL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lIDfEya~ 306 (429)
T 1nw1_A 250 TFCHNDLQEGNILLPKASSGNIRMPSLSDETQALGNSLSAFNPADPRLVLIDFEYAS 306 (429)
T ss_dssp EEECSCCCGGGEEEEC------------------------------CCEECCCTTCE
T ss_pred EEEeCCCCCCeEEeeCCccccccccccccccccccccccccccCCCeEEEEecccCC
Confidence 58999999999999874 1468899998876
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=87.06 E-value=0.27 Score=41.97 Aligned_cols=30 Identities=30% Similarity=0.472 Sum_probs=24.5
Q ss_pred CeecCCCCCCEEEeC-----CCCCeEEecCCCccc
Q 024408 62 IIHRDLKPENLLLTE-----DLKTIKLADFGLARE 91 (268)
Q Consensus 62 i~H~Dikp~Nill~~-----~~~~~kl~Dfg~a~~ 91 (268)
++|+|+.+.||++.. ..+.+.++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 679999999999942 235799999999863
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=86.42 E-value=0.88 Score=35.30 Aligned_cols=103 Identities=13% Similarity=0.122 Sum_probs=67.8
Q ss_pred cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHH-HHHHCCCeecCCCCCCEEEeCCCCCeEEecCCC
Q 024408 10 KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAME-CLHSHGIIHRDLKPENLLLTEDLKTIKLADFGL 88 (268)
Q Consensus 10 ~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~-~lH~~gi~H~Dikp~Nill~~~~~~~kl~Dfg~ 88 (268)
.++.+.+.++.-+++.=+..+++ ++....++++..|+.... ++ ..-+|--++|+|++++.+ +.+++.-.|+
T Consensus 59 ~eD~~~i~y~~~~~~~~f~~i~~-----~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f~~~-~~p~i~hRGi 130 (219)
T 4ano_A 59 SEDEVKVVIKPPSSFLTFAAIRK-----TTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMFNRA-LEPFFLHVGV 130 (219)
T ss_dssp CSSEEEEEEECCTTCEEHHHHHT-----SCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEECTT-CCEEESCCEE
T ss_pred eCCEEEEEEEcCcccCcHHHHHh-----cCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEEeCC-CcEEEEEcCC
Confidence 34566666776544433344543 888999998888887655 33 445888999999999988 5888875443
Q ss_pred ccccccccccccCCCccceeccccccccccccCCCCCCCchhhHH-HHHHHHHHHHhCCCCCC
Q 024408 89 AREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSY-SFAIVLWELLHNKLPFE 150 (268)
Q Consensus 89 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvw-slG~~l~~ll~g~~p~~ 150 (268)
- .-++|.-+ + ..|.| .+=+++..++.++..|.
T Consensus 131 ~----------------~~lpP~e~-------------~-ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 131 K----------------ESLPPDEW-------------D-DERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp T----------------TTBSSCSC-------------C-HHHHHHHHHHHHHHHTTCSSCHH
T ss_pred c----------------ccCCCCCC-------------C-HHHHHHHHHHHHHHHHcCCCCHH
Confidence 3 22344322 2 23443 57888888888876653
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=83.61 E-value=0.47 Score=40.94 Aligned_cols=29 Identities=28% Similarity=0.497 Sum_probs=24.9
Q ss_pred CCeecCCCCCCEEEeCCCCCeEEecCCCccc
Q 024408 61 GIIHRDLKPENLLLTEDLKTIKLADFGLARE 91 (268)
Q Consensus 61 gi~H~Dikp~Nill~~~~~~~kl~Dfg~a~~ 91 (268)
.++|+|+.+.||+ +.+ +.+.++||..+..
T Consensus 263 ~~~H~D~~~~N~l-~~~-~~~~~IDwe~a~~ 291 (424)
T 3mes_A 263 VFAHNDLQENNLL-QTQ-NNIRMIDYEYSAI 291 (424)
T ss_dssp EEECSCCCGGGEE-ECS-SCEEECCCTTCEE
T ss_pred eEECCCCCcccee-cCC-CcEEEEecccCCc
Confidence 4899999999999 555 6899999999863
|
| >2x6h_A GH13170P, VPS34, phosphotidylinositol 3 kinase 59F; transferase; 2.90A {Drosophila melanogaster} PDB: 2x6f_A 2x6i_A* 2x6j_A* 2x6k_A* | Back alignment and structure |
|---|
Probab=81.54 E-value=7.2 Score=35.75 Aligned_cols=26 Identities=35% Similarity=0.427 Sum_probs=23.1
Q ss_pred cCCCCCCEEEeCCCCCeEEecCCCccc
Q 024408 65 RDLKPENLLLTEDLKTIKLADFGLARE 91 (268)
Q Consensus 65 ~Dikp~Nill~~~~~~~kl~Dfg~a~~ 91 (268)
+|=+++|||++.+ |.+.-+|||.+..
T Consensus 551 GDRH~~NILid~t-G~v~HIDFG~~f~ 576 (696)
T 2x6h_A 551 GDRHLDNLLLTTN-GKLFHIDFGYILG 576 (696)
T ss_dssp CCCCTTTEEECTT-SCEEECCCCSCTT
T ss_pred CCCCCcceEEeCC-CCEEEEeehhhhc
Confidence 6889999999976 8999999999864
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 268 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 6e-57 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-48 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-47 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-46 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-45 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-45 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-45 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-44 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 7e-44 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-43 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-43 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-43 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 8e-43 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-42 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-42 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-41 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-41 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-40 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-40 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-40 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-40 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-40 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-40 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-40 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-40 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-39 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-39 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-39 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-38 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 9e-38 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-37 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-37 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-37 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-37 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 9e-37 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-36 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 5e-36 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-35 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-35 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-35 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-33 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-33 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 7e-33 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 9e-33 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 9e-32 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-31 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-30 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-30 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-29 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-26 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-26 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 7e-26 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-25 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-25 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-25 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 7e-25 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-24 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-22 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-19 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-19 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-17 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-14 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-11 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 6e-57
Identities = 64/207 (30%), Positives = 103/207 (49%), Gaps = 15/207 (7%)
Query: 4 QFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 63
F+G P + IVT+ G +L +L + + ++ I A A+ M+ LH+ II
Sbjct: 68 LFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLHAKSII 126
Query: 64 HRDLKPENLLLTEDLKTIKLADFGLAR---EESLTEMMTAETGTYRWMAPELYSTVTLRQ 120
HRDLK N+ L EDL T+K+ DFGLA S + +G+ WMAPE+ +R
Sbjct: 127 HRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV-----IRM 180
Query: 121 GEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSA-----ENVPE 175
+K Y+ + D Y+F IVL+EL+ +LP+ ++N + N P+
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPK 240
Query: 176 ELSIILTSCWKEDPNARPNFTQIIQML 202
+ ++ C K+ + RP F QI+ +
Sbjct: 241 AMKRLMAECLKKKRDERPLFPQILASI 267
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 2e-48
Identities = 53/206 (25%), Positives = 101/206 (49%), Gaps = 21/206 (10%)
Query: 4 QFIGACKEPV-----MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLH 58
+F + + V +V+VTEL++ GTL+ YL + + + V + I + ++ LH
Sbjct: 72 RFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFLH 129
Query: 59 SHG--IIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTV 116
+ IIHRDLK +N+ +T ++K+ D GLA + A GT +MAPE+Y
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR-ASFAKAVIGTPEFMAPEMY--- 185
Query: 117 TLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSA--ENVP 174
++ Y+ VD Y+F + + E+ ++ P+ N Y V+P++ +
Sbjct: 186 ------EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAI 239
Query: 175 EELSIILTSCWKEDPNARPNFTQIIQ 200
E+ I+ C +++ + R + ++
Sbjct: 240 PEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (394), Expect = 4e-47
Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 12/208 (5%)
Query: 4 QFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 63
+ + + I+TE + G+L +L L + + A IA M + I
Sbjct: 72 RLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYI 131
Query: 64 HRDLKPENLLLTEDLKTIKLADFGLAR--EESLTEMMTAETGTYRWMAPELYSTVTLRQG 121
HRDL+ N+L+++ L + K+ADFGLAR E++ +W APE +
Sbjct: 132 HRDLRAANILVSDTL-SCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY------ 184
Query: 122 EKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSII 180
+ K D +SF I+L E++ H ++P+ GM+N + +N PEEL +
Sbjct: 185 --GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQL 242
Query: 181 LTSCWKEDPNARPNFTQIIQMLLNYLSA 208
+ CWKE P RP F + +L ++ +A
Sbjct: 243 MRLCWKERPEDRPTFDYLRSVLEDFFTA 270
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 3e-46
Identities = 50/198 (25%), Positives = 88/198 (44%), Gaps = 14/198 (7%)
Query: 4 QFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI 62
+ G + V ++ E GT+ + L + D + ++A A+ HS +
Sbjct: 70 RLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCHSKRV 127
Query: 63 IHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGE 122
IHRD+KPENLLL +K+ADFG + + T GT ++ PE+
Sbjct: 128 IHRDIKPENLLLGSA-GELKIADFGWSVHAPSSRRTT-LCGTLDYLPPEMIEG------- 178
Query: 123 KKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILT 182
+ ++ KVD +S ++ +E L K PFE Q Y + + V E +++
Sbjct: 179 -RMHDEKVDLWSLGVLCYEFLVGKPPFEAN-TYQETYKRISRVEFTFPDFVTEGARDLIS 236
Query: 183 SCWKEDPNARPNFTQIIQ 200
K +P+ RP ++++
Sbjct: 237 RLLKHNPSQRPMLREVLE 254
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 1e-45
Identities = 56/202 (27%), Positives = 93/202 (46%), Gaps = 14/202 (6%)
Query: 4 QFIGACKEP--VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG 61
Q +G E + IVTE ++ G+L YL + L + F+LD+ AME L +
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN 123
Query: 62 IIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQG 121
+HRDL N+L++ED K++DFGL +E + +W APE
Sbjct: 124 FVHRDLAARNVLVSEDN-VAKVSDFGLTKE--ASSTQDTGKLPVKWTAPEALRE------ 174
Query: 122 EKKHYNHKVDSYSFAIVLWELLHN-KLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSII 180
K ++ K D +SF I+LWE+ ++P+ + + + P + +
Sbjct: 175 --KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEV 232
Query: 181 LTSCWKEDPNARPNFTQIIQML 202
+ +CW D RP+F Q+ + L
Sbjct: 233 MKNCWHLDAAMRPSFLQLREQL 254
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 2e-45
Identities = 49/212 (23%), Positives = 93/212 (43%), Gaps = 15/212 (7%)
Query: 4 QFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 63
+ IG C+ +++V E+ GG L K+L+ R + V ++ M+ L +
Sbjct: 73 RLIGVCQAEALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNFV 131
Query: 64 HRDLKPENLLLTEDLKTIKLADFGLAR----EESLTEMMTAETGTYRWMAPELYSTVTLR 119
HRDL N+LL K++DFGL++ ++S +A +W APE +
Sbjct: 132 HRDLAARNVLLVNRHY-AKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF---- 186
Query: 120 QGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELS 178
+ ++ + D +S+ + +WE L + + P++ M + P EL
Sbjct: 187 ----RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELY 242
Query: 179 IILTSCWKEDPNARPNFTQIIQMLLNYLSAIA 210
+++ CW RP+F + Q + ++A
Sbjct: 243 ALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 274
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 2e-45
Identities = 53/201 (26%), Positives = 88/201 (43%), Gaps = 9/201 (4%)
Query: 4 QFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI 62
+ + A + I+ E +GG + +L + R L A+ LH + I
Sbjct: 73 KLLDAFYYENNLWILIEFCAGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHDNKI 131
Query: 63 IHRDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAETGTYRWMAPELYSTVTLRQG 121
IHRDLK N+L T D IKLADFG++ + + + GT WMAPE+ T +
Sbjct: 132 IHRDLKAGNILFTLD-GDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD- 189
Query: 122 EKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSA--ENVPEELSI 179
+ Y++K D +S I L E+ + P ++ ++ A A
Sbjct: 190 --RPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKD 247
Query: 180 ILTSCWKEDPNARPNFTQIIQ 200
L C +++ +AR +Q++Q
Sbjct: 248 FLKKCLEKNVDARWTTSQLLQ 268
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 1e-44
Identities = 61/212 (28%), Positives = 94/212 (44%), Gaps = 12/212 (5%)
Query: 4 QFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 63
Q E + IVTE +S G+L +L + L + + A IA M + +
Sbjct: 76 QLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYV 135
Query: 64 HRDLKPENLLLTEDLKTIKLADFGLAR--EESLTEMMTAETGTYRWMAPELYSTVTLRQG 121
HRDL+ N+L+ E+L K+ADFGLAR E++ +W APE
Sbjct: 136 HRDLRAANILVGENL-VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY------ 188
Query: 122 EKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSII 180
+ K D +SF I+L EL ++P+ GM N + P PE L +
Sbjct: 189 --GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDL 246
Query: 181 LTSCWKEDPNARPNFTQIIQMLLNYLSAIAPP 212
+ CW+++P RP F + L +Y ++ P
Sbjct: 247 MCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 7e-44
Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 14/205 (6%)
Query: 4 QFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI 62
Q G C + + I+TE ++ G L YL MR R + D+ AME L S
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLESKQF 121
Query: 63 IHRDLKPENLLLTEDLKTIKLADFGLARE--ESLTEMMTAETGTYRWMAPELYSTVTLRQ 120
+HRDL N L+ + +K++DFGL+R + RW PE+
Sbjct: 122 LHRDLAARNCLVNDQG-VVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY----- 175
Query: 121 GEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSI 179
++ K D ++F +++WE+ K+P+E +N + A A E++
Sbjct: 176 ---SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYT 232
Query: 180 ILTSCWKEDPNARPNFTQIIQMLLN 204
I+ SCW E + RP F ++ +L+
Sbjct: 233 IMYSCWHEKADERPTFKILLSNILD 257
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 1e-43
Identities = 54/199 (27%), Positives = 79/199 (39%), Gaps = 17/199 (8%)
Query: 10 KEPVMVIVTELLSGGTLRKYLLNMRPR--CLDVCVAIGFALDIARAMECLH-----SHGI 62
+ IV E GG L + LD + + A++ H H +
Sbjct: 76 TNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTV 135
Query: 63 IHRDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAETGTYRWMAPELYSTVTLRQG 121
+HRDLKP N+ L + +KL DFGLAR T A GT +M+PE +
Sbjct: 136 LHRDLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNR------ 188
Query: 122 EKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIIL 181
YN K D +S +L+EL PF S + A R +EL+ I+
Sbjct: 189 --MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEII 246
Query: 182 TSCWKEDPNARPNFTQIIQ 200
T RP+ +I++
Sbjct: 247 TRMLNLKDYHRPSVEEILE 265
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 1e-43
Identities = 52/207 (25%), Positives = 87/207 (42%), Gaps = 16/207 (7%)
Query: 4 QFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 63
+ IG C+ ++V E+ G L KYL + R + I ++ M+ L +
Sbjct: 72 RMIGICEAESWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLEESNFV 129
Query: 64 HRDLKPENLLLTEDLKTIKLADFGLAR----EESLTEMMTAETGTYRWMAPELYSTVTLR 119
HRDL N+LL K++DFGL++ +E+ + T +W APE +
Sbjct: 130 HRDLAARNVLLVTQH-YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY---- 184
Query: 120 QGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELS 178
++ K D +SF +++WE + + P+ GM + P E+
Sbjct: 185 ----YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMY 240
Query: 179 IILTSCWKEDPNARPNFTQIIQMLLNY 205
++ CW D RP F + L NY
Sbjct: 241 DLMNLCWTYDVENRPGFAAVELRLRNY 267
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 147 bits (372), Expect = 2e-43
Identities = 53/199 (26%), Positives = 83/199 (41%), Gaps = 13/199 (6%)
Query: 4 QFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI 62
Q+ G +V E G ++ +P L + + LHSH +
Sbjct: 79 QYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP--LQEVEIAAVTHGALQGLAYLHSHNM 136
Query: 63 IHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGE 122
IHRD+K N+LL+E +KL DFG A + + GT WMAPE+ + +
Sbjct: 137 IHRDVKAGNILLSEPG-LVKLGDFGSAS---IMAPANSFVGTPYWMAPEV-----ILAMD 187
Query: 123 KKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR-PSAENVPEELSIIL 181
+ Y+ KVD +S I EL K P M+ + A Y A + + E +
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFV 247
Query: 182 TSCWKEDPNARPNFTQIIQ 200
SC ++ P RP +++
Sbjct: 248 DSCLQKIPQDRPTSEVLLK 266
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 145 bits (366), Expect = 8e-43
Identities = 46/201 (22%), Positives = 78/201 (38%), Gaps = 9/201 (4%)
Query: 4 QFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI 62
Q + +V +L+ G L YL L + + LH I
Sbjct: 74 QLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRALLEVICALHKLNI 131
Query: 63 IHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGE 122
+HRDLKPEN+LL +D IKL DFG + + E + GT ++APE+
Sbjct: 132 VHRDLKPENILLDDD-MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIE--CSMNDN 188
Query: 123 KKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR---PSAENVPEELSI 179
Y +VD +S ++++ LL PF + N + P ++ + +
Sbjct: 189 HPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKD 248
Query: 180 ILTSCWKEDPNARPNFTQIIQ 200
+++ P R + +
Sbjct: 249 LVSRFLVVQPQKRYTAEEALA 269
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 2e-42
Identities = 60/226 (26%), Positives = 88/226 (38%), Gaps = 36/226 (15%)
Query: 4 QFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPR---------------------CLDVC 41
+GAC + ++ E G L YL + R + L
Sbjct: 105 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 164
Query: 42 VAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR---EESLTEMM 98
+ FA +A+ ME L +HRDL N+L+T K +K+ DFGLAR +S +
Sbjct: 165 DLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHG-KVVKICDFGLARDIMSDSNYVVR 223
Query: 99 TAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQA 157
+WMAPE Y K D +S+ I+LWE+ P+ G+
Sbjct: 224 GNARLPVKWMAPESLFE--------GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN 275
Query: 158 AYAAAFKNVRPSA-ENVPEELSIILTSCWKEDPNARPNFTQIIQML 202
Y + EE+ II+ SCW D RP+F + L
Sbjct: 276 FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 2e-42
Identities = 57/206 (27%), Positives = 90/206 (43%), Gaps = 16/206 (7%)
Query: 4 QFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 63
+ G P M +VTEL G+L L + + +A+ +A M L S I
Sbjct: 75 RLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGH-FLLGTLSRYAVQVAEGMGYLESKRFI 133
Query: 64 HRDLKPENLLLTEDLKTIKLADFGLAR----EESLTEMMTAETGTYRWMAPELYSTVTLR 119
HRDL NLLL +K+ DFGL R + M + W APE T
Sbjct: 134 HRDLAARNLLLATRD-LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT---- 188
Query: 120 QGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-PSAENVPEEL 177
+ ++H D++ F + LWE+ + + P+ G++ Q + + R P E+ P+++
Sbjct: 189 ----RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDI 244
Query: 178 SIILTSCWKEDPNARPNFTQIIQMLL 203
++ CW P RP F + LL
Sbjct: 245 YNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 141 bits (357), Expect = 2e-41
Identities = 55/220 (25%), Positives = 90/220 (40%), Gaps = 35/220 (15%)
Query: 9 CKEPVMVIVTELLSGGTLRKYLLNMRPRC----------------------LDVCVAIGF 46
M ++ E ++ G L ++L +M P L +
Sbjct: 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCI 145
Query: 47 ALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR---EESLTEMMTAETG 103
A +A M L +HRDL N L+ E++ +K+ADFGL+R + +
Sbjct: 146 ARQVAAGMAYLSERKFVHRDLATRNCLVGENM-VVKIADFGLSRNIYSADYYKADGNDAI 204
Query: 104 TYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAA 162
RWM PE Y + D +++ +VLWE+ P+ GM++ + Y
Sbjct: 205 PIRWMPPESIFY--------NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVR 256
Query: 163 FKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 202
N+ EN P EL ++ CW + P RP+F I ++L
Sbjct: 257 DGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRIL 296
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 3e-41
Identities = 60/202 (29%), Positives = 96/202 (47%), Gaps = 13/202 (6%)
Query: 4 QFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 63
+ IG E + I+ EL + G LR +L + LD+ I +A ++ A+ L S +
Sbjct: 72 KLIGVITENPVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAYLESKRFV 130
Query: 64 HRDLKPENLLLTEDLKTIKLADFGLAR--EESLTEMMTAETGTYRWMAPELYSTVTLRQG 121
HRD+ N+L++ + +KL DFGL+R E+S + +WMAPE +
Sbjct: 131 HRDIAARNVLVSSND-CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF------ 183
Query: 122 EKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSII 180
+ + D + F + +WE+L H PF+G+ N P N P L +
Sbjct: 184 --RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSL 241
Query: 181 LTSCWKEDPNARPNFTQIIQML 202
+T CW DP+ RP FT++ L
Sbjct: 242 MTKCWAYDPSRRPRFTELKAQL 263
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 1e-40
Identities = 58/227 (25%), Positives = 99/227 (43%), Gaps = 18/227 (7%)
Query: 4 QFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI 62
++ + + +V E L+GG+L + C+D + +A+E LHS+ +
Sbjct: 81 NYLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQV 137
Query: 63 IHRDLKPENLLLTEDLKTIKLADFGLAREESLTE-MMTAETGTYRWMAPELYSTVTLRQG 121
IHRD+K +N+LL D ++KL DFG + + + + GT WMAPE+ +
Sbjct: 138 IHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR------ 190
Query: 122 EKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR--PSAENVPEELSI 179
K Y KVD +S I+ E++ + P+ + L+A Y A + E +
Sbjct: 191 --KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRD 248
Query: 180 ILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIPHRIFNSENT 226
L C D R + +++Q +L P + P E T
Sbjct: 249 FLNRCLDMDVEKRGSAKELLQH--QFLKIAKPLSSLTPLIAAAKEAT 293
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 139 bits (352), Expect = 1e-40
Identities = 59/203 (29%), Positives = 95/203 (46%), Gaps = 13/203 (6%)
Query: 4 QFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI 62
Q +G C +EP I+TE ++ G L YL + + V + A I+ AME L
Sbjct: 77 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF 136
Query: 63 IHRDLKPENLLLTEDLKTIKLADFGLAR--EESLTEMMTAETGTYRWMAPELYSTVTLRQ 120
IHRDL N L+ E+ +K+ADFGL+R +W APE +
Sbjct: 137 IHRDLAARNCLVGENH-LVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY----- 190
Query: 121 GEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSA-ENVPEELSI 179
++ K D ++F ++LWE+ + +L Y K+ R E PE++
Sbjct: 191 ---NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYE 247
Query: 180 ILTSCWKEDPNARPNFTQIIQML 202
++ +CW+ +P+ RP+F +I Q
Sbjct: 248 LMRACWQWNPSDRPSFAEIHQAF 270
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 141 bits (357), Expect = 1e-40
Identities = 42/202 (20%), Positives = 87/202 (43%), Gaps = 14/202 (6%)
Query: 4 QFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI 62
A ++ MV++ E LSGG L + + + I + ++ +H H I
Sbjct: 90 NLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK-MSEAEVINYMRQACEGLKHMHEHSI 148
Query: 63 IHRDLKPENLLLT-EDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQG 121
+H D+KPEN++ + ++K+ DFGLA + + E++ T T + APE+
Sbjct: 149 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV-------- 200
Query: 122 EKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAE---NVPEELS 178
+++ D ++ ++ + LL PF G +L+ + + +V E
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK 260
Query: 179 IILTSCWKEDPNARPNFTQIIQ 200
+ + +++P R ++
Sbjct: 261 DFIKNLLQKEPRKRLTVHDALE 282
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 1e-40
Identities = 63/259 (24%), Positives = 106/259 (40%), Gaps = 22/259 (8%)
Query: 10 KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKP 69
++IV E L GG L + + + A I A++ LHS I HRD+KP
Sbjct: 80 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKP 139
Query: 70 ENLLLTE--DLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYN 127
ENLL T +KL DFG A+E + +T T ++APE+ + Y+
Sbjct: 140 ENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLG--------PEKYD 191
Query: 128 HKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYA-------AAFKNVRPSAENVPEELSII 180
D +S ++++ LL PF L + ++ P V EE+ ++
Sbjct: 192 KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKML 251
Query: 181 LTSCWKEDPNARPNFTQIIQM--LLNYLSAIAPPEPMIPHRIFNSENTILPP-ESPGTSS 237
+ + K +P R T+ + ++ P P+ R+ + + TS+
Sbjct: 252 IRNLLKTEPTQRMTITEFMNHPWIMQSTK--VPQTPLHTSRVLKEDKERWEDVKEEMTSA 309
Query: 238 LMTVRDDIGETPKAKMGDK 256
L T+R D + K+ D
Sbjct: 310 LATMRVDYEQIKIKKIEDA 328
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (350), Expect = 2e-40
Identities = 54/203 (26%), Positives = 88/203 (43%), Gaps = 16/203 (7%)
Query: 4 QFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI 62
+F G +E + + E SGG L + + A F + + LH GI
Sbjct: 67 KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGIGI 124
Query: 63 IHRDLKPENLLLTEDLKTIKLADFGLAR---EESLTEMMTAETGTYRWMAPELYSTVTLR 119
HRD+KPENLLL E +K++DFGLA + ++ GT ++APEL
Sbjct: 125 THRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR---- 179
Query: 120 QGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN--VRPSAENVPEEL 177
++ + VD +S IVL +L +LP++ S+ Y+ + + +
Sbjct: 180 ---REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 236
Query: 178 SIILTSCWKEDPNARPNFTQIIQ 200
+L E+P+AR I +
Sbjct: 237 LALLHKILVENPSARITIPDIKK 259
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 139 bits (351), Expect = 2e-40
Identities = 53/201 (26%), Positives = 87/201 (43%), Gaps = 6/201 (2%)
Query: 4 QFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI 62
G + V I+TE + G+L +L + V +G IA M+ L
Sbjct: 91 HLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF-TVIQLVGMLRGIAAGMKYLADMNY 149
Query: 63 IHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGE 122
+HRDL N+L+ +L K++DFGL+R T P ++ Q
Sbjct: 150 VHRDLAARNILVNSNL-VCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY- 207
Query: 123 KKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIIL 181
+ + D +S+ IV+WE++ + + P+ M+N A P + P L ++
Sbjct: 208 -RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLM 266
Query: 182 TSCWKEDPNARPNFTQIIQML 202
CW++D N RP F QI+ L
Sbjct: 267 LDCWQKDRNHRPKFGQIVNTL 287
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 140 bits (354), Expect = 2e-40
Identities = 48/230 (20%), Positives = 90/230 (39%), Gaps = 15/230 (6%)
Query: 4 QFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI 62
A ++ MV++ E +SGG L + + + + A+ + + + + +H +
Sbjct: 87 NLHDAFEDDNEMVMIYEFMSGGELFEKVAD-EHNKMSEDEAVEYMRQVCKGLCHMHENNY 145
Query: 63 IHRDLKPENLLLTEDLK-TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQG 121
+H DLKPEN++ T +KL DFGL + + TGT + APE+
Sbjct: 146 VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEG------ 199
Query: 122 EKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAE---NVPEELS 178
K + D +S ++ + LL PF G ++ + + + E+
Sbjct: 200 --KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK 257
Query: 179 IILTSCWKEDPNARPNFTQIIQM-LLNYLSAIAPPEPMIPHRIFNSENTI 227
+ DPN R Q ++ L +A + R ++I
Sbjct: 258 DFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSI 307
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 2e-40
Identities = 52/244 (21%), Positives = 99/244 (40%), Gaps = 17/244 (6%)
Query: 4 QFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 63
+ +G C + ++T+L+ G L Y+ + + + + IA+ M L ++
Sbjct: 75 RLLGICLTSTVQLITQLMPFGCLLDYVREHKDNI-GSQYLLNWCVQIAKGMNYLEDRRLV 133
Query: 64 HRDLKPENLLLTEDLKTIKLADFGLAR---EESLTEMMTAETGTYRWMAPELYSTVTLRQ 120
HRDL N+L+ +K+ DFGLA+ E +WMA E
Sbjct: 134 HRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH----- 187
Query: 121 GEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSI 179
+ Y H+ D +S+ + +WEL+ P++G+ + + P ++ +
Sbjct: 188 ---RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM 244
Query: 180 ILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIPHRIFNSENTILPPESPGTSSLM 239
I+ CW D ++RP F ++I P+ + + + P +S +LM
Sbjct: 245 IMVKCWMIDADSRPKFRELIIEFSKMAR---DPQRYLVIQGDERMHLPSPTDSNFYRALM 301
Query: 240 TVRD 243
D
Sbjct: 302 DEED 305
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 1e-39
Identities = 53/203 (26%), Positives = 83/203 (40%), Gaps = 14/203 (6%)
Query: 4 QFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI 62
Q G C E + +V E + G L YL R +G LD+ M L +
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF-AAETLLGMCLDVCEGMAYLEEACV 122
Query: 63 IHRDLKPENLLLTEDLKTIKLADFGLAR--EESLTEMMTAETGTYRWMAPELYSTVTLRQ 120
IHRDL N L+ E+ IK++DFG+ R + T +W +PE++S
Sbjct: 123 IHRDLAARNCLVGENQ-VIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF----- 176
Query: 121 GEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSA-ENVPEELSI 179
Y+ K D +SF +++WE+ + R +
Sbjct: 177 ---SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQ 233
Query: 180 ILTSCWKEDPNARPNFTQIIQML 202
I+ CWKE P RP F+++++ L
Sbjct: 234 IMNHCWKERPEDRPAFSRLLRQL 256
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (347), Expect = 1e-39
Identities = 60/239 (25%), Positives = 93/239 (38%), Gaps = 25/239 (10%)
Query: 4 QFIGACK-EPVMVIVTELLSGGTLRKYLLNMRPRC--------------LDVCVAIGFAL 48
+GAC+ + + E G L +L R L + FA
Sbjct: 75 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 134
Query: 49 DIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWM 108
D+AR M+ L IHRDL N+L+ E+ K+ADFGL+R + + T RWM
Sbjct: 135 DVARGMDYLSQKQFIHRDLAARNILVGEN-YVAKIADFGLSRGQEVYVKKTMGRLPVRWM 193
Query: 109 APELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHN-KLPFEGMSNLQAAYAAAFKNVR 167
A E + Y D +S+ ++LWE++ P+ GM+ +
Sbjct: 194 AIESLNY--------SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL 245
Query: 168 PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIPHRIFNSENT 226
N +E+ ++ CW+E P RP+F QI+ L L + F
Sbjct: 246 EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYEKFTYAGI 304
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 1e-39
Identities = 58/218 (26%), Positives = 88/218 (40%), Gaps = 18/218 (8%)
Query: 4 QFIGACKEP--VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG 61
+G C ++V + G LR ++ V IGF L +A+ M+ L S
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKFLASKK 150
Query: 62 IIHRDLKPENLLLTEDLKTIKLADFGLAR-----EESLTEMMTAETGTYRWMAPELYSTV 116
+HRDL N +L E T+K+ADFGLAR E T +WMA E T
Sbjct: 151 FVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT- 208
Query: 117 TLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSA-ENVPE 175
+ + K D +SF ++LWEL+ P N + R E P+
Sbjct: 209 -------QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPD 261
Query: 176 ELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPE 213
L ++ CW RP+F++++ + S
Sbjct: 262 PLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 299
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 2e-38
Identities = 39/202 (19%), Positives = 80/202 (39%), Gaps = 14/202 (6%)
Query: 4 QFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI 62
+ + +V++ E +SG + + + N L+ + + + A++ LHSH I
Sbjct: 65 HLHESFESMEELVMIFEFISGLDIFERI-NTSAFELNEREIVSYVHQVCEALQFLHSHNI 123
Query: 63 IHRDLKPENLLLTED-LKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQG 121
H D++PEN++ TIK+ +FG AR+ + + APE++
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVH-------- 175
Query: 122 EKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAE---NVPEELS 178
+ + D +S +++ LL PF +N Q E + E
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM 235
Query: 179 IILTSCWKEDPNARPNFTQIIQ 200
+ ++ +R ++ +Q
Sbjct: 236 DFVDRLLVKERKSRMTASEALQ 257
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 9e-38
Identities = 53/199 (26%), Positives = 87/199 (43%), Gaps = 15/199 (7%)
Query: 9 CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLK 68
K M+I+TE + G L K+L + V +G IA M+ L + +HRDL
Sbjct: 79 SKYKPMMIITEYMENGALDKFLRE-KDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLA 137
Query: 69 PENLLLTEDLKTIKLADFGLAR----EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKK 124
N+L+ +L K++DFGL+R + T + RW APE S +
Sbjct: 138 ARNILVNSNL-VCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY--------R 188
Query: 125 HYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR-PSAENVPEELSIILTS 183
+ D +SF IV+WE++ + A R P+ + P + ++
Sbjct: 189 KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQ 248
Query: 184 CWKEDPNARPNFTQIIQML 202
CW+++ RP F I+ +L
Sbjct: 249 CWQQERARRPKFADIVSIL 267
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 2e-37
Identities = 56/201 (27%), Positives = 94/201 (46%), Gaps = 21/201 (10%)
Query: 14 MVIVTELLSGGTLRKYLLNMRPRC--------LDVCVAIGFALDIARAMECLHSHGIIHR 65
+++ EL++ G L+ YL ++RP + I A +IA M L+++ +HR
Sbjct: 98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHR 157
Query: 66 DLKPENLLLTEDLKTIKLADFGLAR---EESLTEMMTAETGTYRWMAPELYSTVTLRQGE 122
DL N ++ ED T+K+ DFG+ R E RWM+PE
Sbjct: 158 DLAARNCMVAEDF-TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD------- 209
Query: 123 KKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIIL 181
+ D +SF +VLWE+ + P++G+SN Q + +N P+ L ++
Sbjct: 210 -GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELM 268
Query: 182 TSCWKEDPNARPNFTQIIQML 202
CW+ +P RP+F +II +
Sbjct: 269 RMCWQYNPKMRPSFLEIISSI 289
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 2e-37
Identities = 66/226 (29%), Positives = 95/226 (42%), Gaps = 31/226 (13%)
Query: 4 QFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRC----------------LDVCVAIGF 46
+GAC +++TE G L +L R LD+ + F
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 47 ALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR---EESLTEMMTAETG 103
+ +A+ M L S IHRDL N+LLT + K+ DFGLAR +S +
Sbjct: 151 SYQVAKGMAFLASKNCIHRDLAARNILLTHG-RITKICDFGLARDIKNDSNYVVKGNARL 209
Query: 104 TYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLP-FEGMSNLQAAYAAA 162
+WMAPE Y + D +S+ I LWEL + GM Y
Sbjct: 210 PVKWMAPESIFN--------CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI 261
Query: 163 FKNVRP-SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 207
+ R S E+ P E+ I+ +CW DP RP F QI+Q++ +S
Sbjct: 262 KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 4e-37
Identities = 53/238 (22%), Positives = 88/238 (36%), Gaps = 45/238 (18%)
Query: 4 QFIGACKEP-----VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLH 58
FI A + + +V++ G+L YL + V I AL A + LH
Sbjct: 61 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLH 117
Query: 59 SH--------GIIHRDLKPENLLLTEDLKTIKLADFGLAR-----EESLTEMMTAETGTY 105
I HRDLK +N+L+ ++ T +AD GLA +++ GT
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176
Query: 106 RWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY------ 159
R+MAPE+ + + + D Y+ +V WE+ + Q Y
Sbjct: 177 RYMAPEVLDDSINMKHFE--SFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234
Query: 160 ---------AAAFKNVRPSAEN------VPEELSIILTSCWKEDPNARPNFTQIIQML 202
+ +RP+ N ++ I+ CW + AR +I + L
Sbjct: 235 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 130 bits (329), Expect = 5e-37
Identities = 48/203 (23%), Positives = 90/203 (44%), Gaps = 16/203 (7%)
Query: 4 QFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI 62
+ + ++ +L+SGG L + + A + A++ LH GI
Sbjct: 71 ALDDIYESGGHLYLIMQLVSGGELFDRI--VEKGFYTERDASRLIFQVLDAVKYLHDLGI 128
Query: 63 IHRDLKPENLLLTEDLK--TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQ 120
+HRDLKPENLL + I ++DFGL++ E +++ GT ++APE+ +
Sbjct: 129 VHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ----- 183
Query: 121 GEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYA---AAFKNVRPSAENVPEEL 177
K Y+ VD +S ++ + LL PF ++ + A ++ P +++ +
Sbjct: 184 ---KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSA 240
Query: 178 SIILTSCWKEDPNARPNFTQIIQ 200
+ ++DP R Q +Q
Sbjct: 241 KDFIRHLMEKDPEKRFTCEQALQ 263
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 9e-37
Identities = 47/201 (23%), Positives = 79/201 (39%), Gaps = 16/201 (7%)
Query: 4 QFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI 62
+ ++ + G L KY+ + D + +I A+E LH GI
Sbjct: 72 KLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHGKGI 129
Query: 63 IHRDLKPENLLLTEDLKTIKLADFGLAR---EESLTEMMTAETGTYRWMAPELYSTVTLR 119
IHRDLKPEN+LL ED I++ DFG A+ ES + GT ++++PEL +
Sbjct: 130 IHRDLKPENILLNED-MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE---- 184
Query: 120 QGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSI 179
K D ++ ++++L+ PF N + K E +
Sbjct: 185 ----KSACKSSDLWALGCIIYQLVAGLPPFRA-GNEYLIFQKIIKLEYDFPEKFFPKARD 239
Query: 180 ILTSCWKEDPNARPNFTQIIQ 200
++ D R ++
Sbjct: 240 LVEKLLVLDATKRLGCEEMEG 260
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 1e-36
Identities = 47/213 (22%), Positives = 83/213 (38%), Gaps = 16/213 (7%)
Query: 4 QFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HG 61
F GA + I E + GG+L + L + + + ++ + + + L H
Sbjct: 68 GFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 62 IIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQG 121
I+HRD+KP N+L+ IKL DFG++ + M + GT +M+PE
Sbjct: 126 IMHRDVKPSNILVNSR-GEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQG------ 177
Query: 122 EKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIIL 181
HY+ + D +S + L E+ + P + + V A P
Sbjct: 178 --THYSVQSDIWSMGLSLVEMAVGRYPIPP-PDAKELELMFGCQVEGDAAETPPRPRTPG 234
Query: 182 TSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEP 214
++RP I ++L ++ P P
Sbjct: 235 RPLSSYGMDSRPPM-AIFELLDYIVNEPPPKLP 266
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 5e-36
Identities = 41/198 (20%), Positives = 77/198 (38%), Gaps = 17/198 (8%)
Query: 4 QFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI 62
+ + + P V++ E + R L +A F + A+ H+ G+
Sbjct: 73 RLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCHNCGV 131
Query: 63 IHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGE 122
+HRD+K EN+L+ + +KL DFG + T GT + PE
Sbjct: 132 LHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRY------- 183
Query: 123 KKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILT 182
+++ +S I+L++++ +PFE + + + V E ++
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII-------RGQVFFRQRVSSECQHLIR 236
Query: 183 SCWKEDPNARPNFTQIIQ 200
C P+ RP F +I
Sbjct: 237 WCLALRPSDRPTFEEIQN 254
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 1e-35
Identities = 62/210 (29%), Positives = 92/210 (43%), Gaps = 27/210 (12%)
Query: 11 EPVMVIVTELLSGGTLRKYLLNMRPRC--------------LDVCVAIGFALDIARAMEC 56
+ + ++ E S G LR+YL RP L + A +AR ME
Sbjct: 91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEY 150
Query: 57 LHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR---EESLTEMMTAETGTYRWMAPELY 113
L S IHRDL N+L+TED +K+ADFGLAR + T +WMAPE
Sbjct: 151 LASKKCIHRDLAARNVLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL 209
Query: 114 STVTLRQGEKKHYNHKVDSYSFAIVLWELLHN-KLPFEGMSNLQAAYAAAFKNVRPSAEN 172
+ Y H+ D +SF ++LWE+ P+ G+ + + N
Sbjct: 210 FD--------RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSN 261
Query: 173 VPEELSIILTSCWKEDPNARPNFTQIIQML 202
EL +++ CW P+ RP F Q+++ L
Sbjct: 262 CTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 1e-35
Identities = 60/226 (26%), Positives = 99/226 (43%), Gaps = 30/226 (13%)
Query: 4 QFIGACKEP--VMVIVTELLSGGTLRKYLLNMR--------------PRCLDVCVAIGFA 47
+GAC +P ++++ E G L YL + R L + I ++
Sbjct: 81 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 140
Query: 48 LDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET---GT 104
+A+ ME L S IHRDL N+LL+E +K+ DFGLAR+ +
Sbjct: 141 FQVAKGMEFLASRKCIHRDLAARNILLSEKN-VVKICDFGLARDIYKDPDYVRKGDARLP 199
Query: 105 YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAF 163
+WMAPE + Y + D +SF ++LWE+ P+ G+ +
Sbjct: 200 LKWMAPETIFD--------RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 251
Query: 164 KNVRPSA-ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 208
+ R A + E+ + CW +P+ RP F+++++ L N L A
Sbjct: 252 EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 2e-35
Identities = 55/198 (27%), Positives = 93/198 (46%), Gaps = 14/198 (7%)
Query: 4 QFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI 62
+ + V E L+GG L ++ + D+ A +A +I ++ LHS GI
Sbjct: 67 HMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQFLHSKGI 124
Query: 63 IHRDLKPENLLLTEDLKTIKLADFGLAREESLTE-MMTAETGTYRWMAPELYSTVTLRQG 121
++RDLK +N+LL +D IK+ADFG+ +E L + GT ++APE+
Sbjct: 125 VYRDLKLDNILLDKD-GHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG------ 177
Query: 122 EKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIIL 181
+ YNH VD +SF ++L+E+L + PF G + ++ N + +E +L
Sbjct: 178 --QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYP-RWLEKEAKDLL 234
Query: 182 TSCWKEDPNARPNFTQII 199
+ +P R I
Sbjct: 235 VKLFVREPEKRLGVRGDI 252
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 121 bits (305), Expect = 1e-33
Identities = 40/212 (18%), Positives = 76/212 (35%), Gaps = 29/212 (13%)
Query: 14 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 73
V+V +LL G + LL++ R V A + ++ +H +++RD+KP+N L
Sbjct: 76 NVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFL 133
Query: 74 LTEDLK----TIKLADFGLAR--------EESLTEMMTAETGTYRWMAPELYSTVTLRQG 121
+ I + DFG+ + + +GT R+M+ +
Sbjct: 134 IGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTH-------- 185
Query: 122 EKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYA----AAFKNVRPSAE---NVP 174
+ + + D + V L LP++G+ K P E P
Sbjct: 186 LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFP 245
Query: 175 EELSIILTSCWKEDPNARPNFTQIIQMLLNYL 206
EE + +A P++ + + L
Sbjct: 246 EEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 277
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 4e-33
Identities = 47/204 (23%), Positives = 76/204 (37%), Gaps = 17/204 (8%)
Query: 4 QFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI 62
+ ++++ EL++GG L + L A F I + LHS I
Sbjct: 77 TLHEVYENKTDVILILELVAGGELFDF--LAEKESLTEEEATEFLKQILNGVYYLHSLQI 134
Query: 63 IHRDLKPENLLLTED---LKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLR 119
H DLKPEN++L + IK+ DFGLA + GT ++APE+
Sbjct: 135 AHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV------ 188
Query: 120 QGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAE---NVPEE 176
+ + D +S ++ + LL PF G + + + N E N
Sbjct: 189 --NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 246
Query: 177 LSIILTSCWKEDPNARPNFTQIIQ 200
+ +DP R +Q
Sbjct: 247 AKDFIRRLLVKDPKKRMTIQDSLQ 270
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 119 bits (299), Expect = 7e-33
Identities = 48/216 (22%), Positives = 86/216 (39%), Gaps = 22/216 (10%)
Query: 4 QFIGACKE-----PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLH 58
+ P+ IV E + G TLR + P + AI D +A+ H
Sbjct: 71 AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSH 128
Query: 59 SHGIIHRDLKPENLLLTEDLK---TIKLADFGLAREESLTEMMTAETGTYRWMAPELYST 115
+GIIHRD+KP N++++ +A + A GT ++++PE
Sbjct: 129 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 188
Query: 116 VTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSA---EN 172
+ + D YS VL+E+L + PF G S + AY ++ P + E
Sbjct: 189 --------DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG 240
Query: 173 VPEELSIILTSCWKEDPNARP-NFTQIIQMLLNYLS 207
+ +L ++ ++P R ++ L+ +
Sbjct: 241 LSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 120 bits (303), Expect = 9e-33
Identities = 46/193 (23%), Positives = 79/193 (40%), Gaps = 14/193 (7%)
Query: 4 QFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI 62
A P + + +L++GG L +L A +I +E +H+ +
Sbjct: 71 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFY--AAEIILGLEHMHNRFV 128
Query: 63 IHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGE 122
++RDLKP N+LL E ++++D GLA + S + A GT+ +MAPE+
Sbjct: 129 VYRDLKPANILLDEH-GHVRISDLGLACDFS-KKKPHASVGTHGYMAPEVLQK------- 179
Query: 123 KKHYNHKVDSYSFAIVLWELLHNKLPFEGMS--NLQAAYAAAFKNVRPSAENVPEELSII 180
Y+ D +S +L++LL PF + ++ EL +
Sbjct: 180 GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSL 239
Query: 181 LTSCWKEDPNARP 193
L + D N R
Sbjct: 240 LEGLLQRDVNRRL 252
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 117 bits (293), Expect = 9e-32
Identities = 54/195 (27%), Positives = 91/195 (46%), Gaps = 15/195 (7%)
Query: 4 QFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI 62
+ G ++ + ++ + + GG L + + VA +A ++ A+E LHS I
Sbjct: 68 RMWGTFQDAQQIFMIMDYIEGGELFSL--LRKSQRFPNPVAKFYAAEVCLALEYLHSKDI 125
Query: 63 IHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGE 122
I+RDLKPEN+LL ++ IK+ DFG A+ + ++ GT ++APE+ ST
Sbjct: 126 IYRDLKPENILLDKNG-HIKITDFGFAKY--VPDVTYTLCGTPDYIAPEVVST------- 175
Query: 123 KKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILT 182
K YN +D +SF I+++E+L PF N Y E++ +L+
Sbjct: 176 -KPYNKSIDWWSFGILIYEMLAGYTPFYDS-NTMKTYEKILNAELRFPPFFNEDVKDLLS 233
Query: 183 SCWKEDPNARPNFTQ 197
D + R Q
Sbjct: 234 RLITRDLSQRLGNLQ 248
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 116 bits (290), Expect = 2e-31
Identities = 42/213 (19%), Positives = 75/213 (35%), Gaps = 27/213 (12%)
Query: 11 EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPE 70
V+V ELL + R + + A + +E +HS IHRD+KP+
Sbjct: 75 GDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYIHSKNFIHRDVKPD 132
Query: 71 NLL--LTEDLKTIKLADFGLAR--------EESLTEMMTAETGTYRWMAPELYSTVTLRQ 120
N L L + + + DFGLA+ + TGT R+ + +
Sbjct: 133 NFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG----- 187
Query: 121 GEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN-------VRPSAENV 173
+ + D S VL LP++G+ + + +
Sbjct: 188 ---IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGY 244
Query: 174 PEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 206
P E + L C + +P+++ + Q+ N
Sbjct: 245 PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 1e-30
Identities = 52/187 (27%), Positives = 83/187 (44%), Gaps = 13/187 (6%)
Query: 9 CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLK 68
+ V E +GG L +L R R A + +I A+E LHS +++RD+K
Sbjct: 75 QTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIK 132
Query: 69 PENLLLTEDLKTIKLADFGLARE-ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYN 127
ENL+L +D IK+ DFGL +E S M GT ++APE+ Y
Sbjct: 133 LENLMLDKD-GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED--------NDYG 183
Query: 128 HKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKE 187
VD + +V++E++ +LPF + + + +R + E +L K+
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP-RTLSPEAKSLLAGLLKK 242
Query: 188 DPNARPN 194
DP R
Sbjct: 243 DPKQRLG 249
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 6e-30
Identities = 51/217 (23%), Positives = 83/217 (38%), Gaps = 36/217 (16%)
Query: 10 KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKP 69
+E + +V E + YL + + + R ++ LHSH ++HRDLKP
Sbjct: 86 RETKLTLVFEHVDQDLTT-YLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKP 144
Query: 70 ENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK 129
+N+L+T IKLADFGLAR S +T+ T + APE+ Y
Sbjct: 145 QNILVTSS-GQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ--------SSYATP 195
Query: 130 VDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSI---------- 179
VD +S + E+ K F G S++ P E+ P ++++
Sbjct: 196 VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSA 255
Query: 180 ----------------ILTSCWKEDPNARPNFTQIIQ 200
+L C +P R + +
Sbjct: 256 QPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (277), Expect = 4e-29
Identities = 52/237 (21%), Positives = 84/237 (35%), Gaps = 38/237 (16%)
Query: 11 EPVMVIVTELLSGGTLRKYLLNMRPR-CLDVCVAIGFALDIARAMECLHSHGIIHRDLKP 69
E + +V + + R R + L V + + R++ +HS GI HRD+KP
Sbjct: 91 EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKP 150
Query: 70 ENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK 129
+NLLL D +KL DFG A++ E + + + APEL Y
Sbjct: 151 QNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIF-------GATDYTSS 203
Query: 130 VDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAE------------------ 171
+D +S VL ELL + F G S + P+ E
Sbjct: 204 IDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIK 263
Query: 172 ----------NVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIPH 218
P E + + + P AR + ++ + P +P+
Sbjct: 264 AHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH--SFFDELRDPNVKLPN 318
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 102 bits (256), Expect = 3e-26
Identities = 45/171 (26%), Positives = 71/171 (41%), Gaps = 14/171 (8%)
Query: 24 GTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKL 83
G + +L R A +A I E LHS +I+RDLKPENLL+ + I++
Sbjct: 126 GEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQV 182
Query: 84 ADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL 143
DFG A+ GT +APE+ + K YN VD ++ ++++E+
Sbjct: 183 TDFGFAKRV--KGRTWTLCGTPEALAPEIILS--------KGYNKAVDWWALGVLIYEMA 232
Query: 144 HNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPN 194
PF +Q VR + +L +L + + D R
Sbjct: 233 AGYPPFFADQPIQIYEKIVSGKVRFP-SHFSSDLKDLLRNLLQVDLTKRFG 282
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (254), Expect = 4e-26
Identities = 46/188 (24%), Positives = 84/188 (44%), Gaps = 14/188 (7%)
Query: 11 EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPE 70
E + ++ + ++GG L +L + +I A+E LH GII+RD+K E
Sbjct: 101 ETKLHLILDYINGGELFTHLSQRER--FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLE 158
Query: 71 NLLLTEDLKTIKLADFGLARE--ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNH 128
N+LL + + L DFGL++E TE GT +MAP++ +G ++
Sbjct: 159 NILLDSN-GHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV------RGGDSGHDK 211
Query: 129 KVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR---PSAENVPEELSIILTSCW 185
VD +S ++++ELL PF + + + ++ P + + ++
Sbjct: 212 AVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLL 271
Query: 186 KEDPNARP 193
+DP R
Sbjct: 272 MKDPKKRL 279
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (251), Expect = 7e-26
Identities = 59/229 (25%), Positives = 85/229 (37%), Gaps = 40/229 (17%)
Query: 14 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 73
+ +V + + N A L + +E LH H I+HRDLKP NLL
Sbjct: 75 ISLVFDFMETDLEVIIKDNSLVLTPSHIKAY--MLMTLQGLEYLHQHWILHRDLKPNNLL 132
Query: 74 LTEDLKTIKLADFGLARE-ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDS 132
L E+ +KLADFGLA+ S T + T + APEL + Y VD
Sbjct: 133 LDEN-GVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFG-------ARMYGVGVDM 184
Query: 133 YSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSI------------- 179
++ +L ELL G S+L P+ E P+ S+
Sbjct: 185 WAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIP 244
Query: 180 --------------ILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEP 214
++ + +P AR TQ ++M Y S P P
Sbjct: 245 LHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM--KYFSNRPGPTP 291
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 99 bits (248), Expect = 3e-25
Identities = 39/237 (16%), Positives = 81/237 (34%), Gaps = 52/237 (21%)
Query: 4 QFIGACKEPV---MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH 60
K+PV +V E ++ ++ + L + +I +A++ HS
Sbjct: 94 TLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSM 148
Query: 61 GIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQ 120
GI+HRD+KP N+++ + + ++L D+GLA + + + PEL
Sbjct: 149 GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLV------ 202
Query: 121 GEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV-------------- 166
+ + Y++ +D +S +L ++ K PF + K +
Sbjct: 203 -DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261
Query: 167 -----------------------RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQ 200
+ V E L + D +R + ++
Sbjct: 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.5 bits (247), Expect = 5e-25
Identities = 55/236 (23%), Positives = 80/236 (33%), Gaps = 50/236 (21%)
Query: 4 QFIGACKEP-----VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLH 58
+ P V + L G L K L + + L F I R ++ +H
Sbjct: 70 GINDIIRAPTIEQMKDVYLVTHLMGADLYKLL---KTQHLSNDHICYFLYQILRGLKYIH 126
Query: 59 SHGIIHRDLKPENLLLTEDLKTIKLADFGLAR----EESLTEMMTAETGTYRWMAPELYS 114
S ++HRDLKP NLLL +K+ DFGLAR + T +T T + APE+
Sbjct: 127 SANVLHRDLKPSNLLLNTT-CDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 185
Query: 115 TVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAE--- 171
K Y +D +S +L E+L N+ F G L PS E
Sbjct: 186 N-------SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238
Query: 172 ---------------------------NVPEELSIILTSCWKEDPNARPNFTQIIQ 200
N + +L +P+ R Q +
Sbjct: 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.8 bits (245), Expect = 6e-25
Identities = 37/223 (16%), Positives = 69/223 (30%), Gaps = 46/223 (20%)
Query: 14 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 73
+ +V + + L + + + +H + I+HRD+K N+L
Sbjct: 92 IYLVFDFCEHDLAGLLSNVLVKFTLSEIKRV--MQMLLNGLYYIHRNKILHRDMKAANVL 149
Query: 74 LTEDLKTIKLADFGLAREESLTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNH 128
+T D +KLADFGLAR SL + T T + PEL ++ Y
Sbjct: 150 ITRD-GVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLG-------ERDYGP 201
Query: 129 KVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSI--------- 179
+D + ++ E+ +G + + + E P +
Sbjct: 202 PIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELV 261
Query: 180 ----------------------ILTSCWKEDPNARPNFTQIIQ 200
++ DP R + +
Sbjct: 262 KGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.4 bits (244), Expect = 7e-25
Identities = 49/244 (20%), Positives = 89/244 (36%), Gaps = 42/244 (17%)
Query: 4 QFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 63
+ + + + L+K++ + + + + + + + HSH ++
Sbjct: 65 KLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 124
Query: 64 HRDLKPENLLLTEDLKTIKLADFGLAREESLT-EMMTAETGTYRWMAPELYSTVTLRQGE 122
HRDLKP+NLL+ + IKLADFGLAR + T E T + APE+
Sbjct: 125 HRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL-------G 176
Query: 123 KKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAE----------- 171
K+Y+ VD +S + E++ + F G S + + P
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 172 -----------------NVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEP 214
+ E+ +L+ DPN R + + + + P
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH--PFFQDVTKP-- 292
Query: 215 MIPH 218
+PH
Sbjct: 293 -VPH 295
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 97.3 bits (241), Expect = 2e-24
Identities = 46/226 (20%), Positives = 80/226 (35%), Gaps = 38/226 (16%)
Query: 4 QFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 63
+ +++ L+K L L+ A F L + + H ++
Sbjct: 64 KLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRRVL 122
Query: 64 HRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRW-MAPELYSTVTLRQGE 122
HRDLKP+NLL+ + +K+ADFGLAR + W AP++
Sbjct: 123 HRDLKPQNLLINRE-GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLM-------G 174
Query: 123 KKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN---------- 172
K Y+ +D +S + E+++ F G+S P+++N
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234
Query: 173 ------------------VPEELSIILTSCWKEDPNARPNFTQIIQ 200
+ E +L+ K DPN R Q ++
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.2 bits (225), Expect = 3e-22
Identities = 43/232 (18%), Positives = 83/232 (35%), Gaps = 42/232 (18%)
Query: 11 EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPE 70
+ + +V E + + ++ + + + + HS ++HRDLKP+
Sbjct: 73 DKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSF--LFQLLKGLGFCHSRNVLHRDLKPQ 130
Query: 71 NLLLTEDLKTIKLADFGLAREESL-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK 129
NLL+ + +KLA+FGLAR + +AE T + P++ K Y+
Sbjct: 131 NLLINRN-GELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG-------AKLYSTS 182
Query: 130 VDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAE------------------ 171
+D +S + EL + P +++ F+ + E
Sbjct: 183 IDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMY 242
Query: 172 -----------NVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPP 212
+ +L + K +P R + + +Q Y S PP
Sbjct: 243 PATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH--PYFSDFCPP 292
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.8 bits (206), Expect = 2e-19
Identities = 44/186 (23%), Positives = 75/186 (40%), Gaps = 14/186 (7%)
Query: 14 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 73
+ +V EL+ + + + + ++ LHS GIIHRDLKP N++
Sbjct: 97 VYLVMELMDANLCQVIQMELDHE-----RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 151
Query: 74 LTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSY 133
+ D T+K+ DFGLAR + MMT T + APE+ Y VD +
Sbjct: 152 VKSD-CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL--------GMGYKENVDIW 202
Query: 134 SFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARP 193
S ++ E++ +K+ F G + + P E + + + A
Sbjct: 203 SVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGL 262
Query: 194 NFTQII 199
F ++
Sbjct: 263 TFPKLF 268
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.3 bits (205), Expect = 4e-19
Identities = 51/250 (20%), Positives = 83/250 (33%), Gaps = 48/250 (19%)
Query: 14 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 73
+V + GT L+ L + + + +H+ GIIHRDLKP NL
Sbjct: 98 FYLVMPFM--GTDLGKLMKHEK--LGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLA 153
Query: 74 LTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSY 133
+ ED + +K+ DFGLAR+ MT T + APE+ Y VD +
Sbjct: 154 VNEDCE-LKILDFGLARQ--ADSEMTGYVVTRWYRAPEVIL-------NWMRYTQTVDIW 203
Query: 134 SFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAE---------------------- 171
S ++ E++ K F+G +L P AE
Sbjct: 204 SVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEK 263
Query: 172 --------NVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI--APPEPMIPHRIF 221
N +L D R + + Y ++ EP +
Sbjct: 264 KDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH--PYFESLHDTEDEPQVQKYDD 321
Query: 222 NSENTILPPE 231
+ ++ +
Sbjct: 322 SFDDVDRTLD 331
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.2 bits (194), Expect = 1e-17
Identities = 59/255 (23%), Positives = 87/255 (34%), Gaps = 47/255 (18%)
Query: 9 CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLK 68
+E V + L G L ++ + L I R ++ +HS IIHRDLK
Sbjct: 92 LEEFNDVYLVTHLMGADLNNI---VKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLK 148
Query: 69 PENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNH 128
P NL + ED +K+ DFGLAR + MT T + APE+ HYN
Sbjct: 149 PSNLAVNED-CELKILDFGLARHTD--DEMTGYVATRWYRAPEIML-------NWMHYNQ 198
Query: 129 KVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAE----------------- 171
VD +S ++ ELL + F G ++ P AE
Sbjct: 199 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 258
Query: 172 -------------NVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPP--EPMI 216
+L D + R Q + Y + P EP+
Sbjct: 259 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH--AYFAQYHDPDDEPVA 316
Query: 217 PHRIFNSENTILPPE 231
+ E+ L +
Sbjct: 317 DPYDQSFESRDLLID 331
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 68.9 bits (167), Expect = 4e-14
Identities = 38/222 (17%), Positives = 70/222 (31%), Gaps = 16/222 (7%)
Query: 5 FIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLH-SHGII 63
F V V++ + G L + R + + + + ++ +H GII
Sbjct: 89 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGII 148
Query: 64 HRDLKPENLLLTED-----LKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTL 118
H D+KPEN+L+ L IK+AD G A + T + +PE+
Sbjct: 149 HTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS--IQTREYRSPEVLLG--- 203
Query: 119 RQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELS 178
+ D +S A +++EL+ FE
Sbjct: 204 -----APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYL 258
Query: 179 IILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIPHRI 220
+ + N+R I ++ L + +
Sbjct: 259 LRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDE 300
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 60.2 bits (145), Expect = 1e-11
Identities = 18/108 (16%), Positives = 33/108 (30%), Gaps = 16/108 (14%)
Query: 29 YLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGL 88
+ + V I + + GI+H DL N+L++E+ I + DF
Sbjct: 91 LIDAKELYRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE--GIWIIDFPQ 148
Query: 89 AREESLTEMMTAETGTYRWMAPELY--STVTLRQGEKKHYNHKVDSYS 134
+ E E+ + + Y + D S
Sbjct: 149 SVE------------VGEEGWREILERDVRNIITYFSRTYRTEKDINS 184
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 268 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.97 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.69 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.82 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.15 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.03 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.21 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 93.51 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 83.49 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-48 Score=321.24 Aligned_cols=202 Identities=31% Similarity=0.543 Sum_probs=167.0
Q ss_pred CceeEEEeecCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCC
Q 024408 1 MREQFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT 80 (268)
Q Consensus 1 ~~v~l~g~~~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~ 80 (268)
|+|+++|++.++.+++||||++||+|.+++...+. .+++.++..++.|++.||+|||++||+||||||+|||++.+ +.
T Consensus 65 nIv~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~-~~ 142 (276)
T d1uwha_ 65 NILLFMGYSTAPQLAIVTQWCEGSSLYHHLHIIET-KFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHED-LT 142 (276)
T ss_dssp TBCCEEEEECSSSCEEEEECCCEEEHHHHHHTSCC-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETT-SS
T ss_pred CEeeeeEEEeccEEEEEEecCCCCCHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCC-CC
Confidence 78999999988889999999999999999976543 39999999999999999999999999999999999999998 69
Q ss_pred eEEecCCCccccccc---cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 024408 81 IKLADFGLAREESLT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA 157 (268)
Q Consensus 81 ~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~ 157 (268)
+||+|||+|+..... ....+..||+.|+|||++.+. ....++.++||||||+++|||++|+.||.+......
T Consensus 143 ~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-----~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~ 217 (276)
T d1uwha_ 143 VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ-----DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 217 (276)
T ss_dssp EEECCCCCSCC------------CCCCGGGCCHHHHTTC-----SSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH
T ss_pred EEEccccceeeccccCCcccccccccCcccCCHHHHhcc-----cCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH
Confidence 999999999754332 233456799999999998641 124578999999999999999999999998776555
Q ss_pred HHHHHhcc-CCC----CCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhc
Q 024408 158 AYAAAFKN-VRP----SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 209 (268)
Q Consensus 158 ~~~~~~~~-~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~~ 209 (268)
........ ..+ ....+|+++.++|.+||..||++|||+++++++|+.+.++.
T Consensus 218 ~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~ 274 (276)
T d1uwha_ 218 IIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274 (276)
T ss_dssp HHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred HHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence 44443332 222 25678999999999999999999999999999999877653
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-48 Score=315.17 Aligned_cols=189 Identities=25% Similarity=0.389 Sum_probs=164.1
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|+|++++++ .++.+++|||||+||+|.+++.+.+. +++.++..++.|++.||+|||++||+||||||+|||++.+ +
T Consensus 67 nIv~~~~~~~~~~~~~ivmEy~~~g~L~~~l~~~~~--l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~-~ 143 (263)
T d2j4za1 67 NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSA-G 143 (263)
T ss_dssp TBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-S
T ss_pred CCCeEEEEEEECCEEEEEEeecCCCcHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCC-C
Confidence 689999999 55689999999999999999987665 9999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 024408 80 TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY 159 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~ 159 (268)
.+||+|||+|+...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+...
T Consensus 144 ~~kl~DFG~a~~~~~~~-~~~~~Gt~~Y~APE~~~~--------~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~ 214 (263)
T d2j4za1 144 ELKIADFGWSVHAPSSR-RTTLCGTLDYLPPEMIEG--------RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYK 214 (263)
T ss_dssp CEEECCCCSCSCCCCCC-CEETTEEGGGCCHHHHTT--------CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH
T ss_pred CEeecccceeeecCCCc-ccccCCCCcccCHHHHcC--------CCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHH
Confidence 99999999998654332 345679999999999864 567889999999999999999999998866554433
Q ss_pred HHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 024408 160 AAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 202 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l 202 (268)
. ........+..++++++++|.+||..||.+|||++|+++|-
T Consensus 215 ~-i~~~~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp 256 (263)
T d2j4za1 215 R-ISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHP 256 (263)
T ss_dssp H-HHTTCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCH
T ss_pred H-HHcCCCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCc
Confidence 3 33333445677999999999999999999999999999984
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-47 Score=315.45 Aligned_cols=196 Identities=27% Similarity=0.485 Sum_probs=169.0
Q ss_pred CceeEEEeecCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCC
Q 024408 1 MREQFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT 80 (268)
Q Consensus 1 ~~v~l~g~~~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~ 80 (268)
|+|+++|+|..+..+|||||++||+|.+++.+... +++.+++.++.|++.||+|||++||+||||||+|||++.+ +.
T Consensus 69 nIv~~~g~~~~~~~~lvmE~~~~g~L~~~l~~~~~--l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~-~~ 145 (277)
T d1xbba_ 69 YIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ-HY 145 (277)
T ss_dssp TBCCEEEEEESSSEEEEEECCTTEEHHHHHHHCTT--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET-TE
T ss_pred CCceEEEEeccCCEEEEEEcCCCCcHHHHHhhccC--CCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhccccc-Cc
Confidence 68999999977778999999999999999987655 9999999999999999999999999999999999999988 69
Q ss_pred eEEecCCCcccccccc----ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChH
Q 024408 81 IKLADFGLAREESLTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNL 155 (268)
Q Consensus 81 ~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~~~ 155 (268)
+|++|||+++...... ......||+.|+|||++.+ ..++.++||||||+++|||++ |+.||.+....
T Consensus 146 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~--------~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~ 217 (277)
T d1xbba_ 146 AKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY--------YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS 217 (277)
T ss_dssp EEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHH--------CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH
T ss_pred ccccchhhhhhccccccccccccccCCCceecCchhhcC--------CCCCchhhhccchhhhhHHhhCCCCCCCCCCHH
Confidence 9999999998543221 2234468999999999865 557889999999999999998 89999988776
Q ss_pred HHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHh
Q 024408 156 QAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 207 (268)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 207 (268)
+...........+.+..+|+++.++|.+||+.||.+|||++++++.|+.++.
T Consensus 218 ~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 218 EVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHcCCCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 6655555555566678899999999999999999999999999998887664
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.5e-47 Score=316.74 Aligned_cols=198 Identities=27% Similarity=0.488 Sum_probs=162.8
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|+|+++|+| .++.+++|||||+||+|.+++....+ .+++.++..++.|++.||+|||++|++||||||+|||++.+ +
T Consensus 88 nIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~-~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~-~ 165 (299)
T d1jpaa_ 88 NVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG-QFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSN-L 165 (299)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTT-CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-C
T ss_pred CCccEEEEEeeCCEEEEEEEecCCCcceeeeccccC-CCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCC-C
Confidence 789999999 55689999999999999998876443 39999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccccccc------ccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 024408 80 TIKLADFGLAREESLTEMM------TAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGM 152 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~ 152 (268)
.+||+|||+++........ ....||+.|+|||.+.+ ..++.++||||||+++|||++ |+.||.+.
T Consensus 166 ~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~ 237 (299)
T d1jpaa_ 166 VCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY--------RKFTSASDVWSYGIVMWEVMSYGERPYWDM 237 (299)
T ss_dssp CEEECCC-----------------------CGGGSCHHHHHS--------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred cEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhc--------CCCCcccccccchHHHHHHHhCCCCCCCCC
Confidence 9999999999854332211 12357899999999864 678899999999999999998 89999988
Q ss_pred ChHHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 024408 153 SNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 208 (268)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 208 (268)
...+...........+.+..+++++.+++.+||+.||++|||+.++++.|+.+++.
T Consensus 238 ~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 238 TNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp CHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 77766666655666667788999999999999999999999999999999987764
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-47 Score=314.33 Aligned_cols=199 Identities=24% Similarity=0.494 Sum_probs=171.2
Q ss_pred CceeEEEeecCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCC
Q 024408 1 MREQFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT 80 (268)
Q Consensus 1 ~~v~l~g~~~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~ 80 (268)
|+|+++|+|..+.++|||||++||+|.+++..... .+++.++..++.|++.||+|||++||+||||||+||+++.+ +.
T Consensus 70 nIv~l~g~~~~~~~~lvmE~~~~g~L~~~l~~~~~-~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~-~~ 147 (285)
T d1u59a_ 70 YIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKRE-EIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNR-HY 147 (285)
T ss_dssp TBCCEEEEEESSSEEEEEECCTTEEHHHHHTTCTT-TSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEET-TE
T ss_pred CEeeEeeeeccCeEEEEEEeCCCCcHHHHhhcccc-CCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccC-Cc
Confidence 78999999987789999999999999999865433 49999999999999999999999999999999999999988 69
Q ss_pred eEEecCCCcccccccc----ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChH
Q 024408 81 IKLADFGLAREESLTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNL 155 (268)
Q Consensus 81 ~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~~~ 155 (268)
+||+|||+++...... ......||+.|+|||++.+ ..++.++||||||+++|||++ |+.||.+....
T Consensus 148 ~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~ 219 (285)
T d1u59a_ 148 AKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF--------RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP 219 (285)
T ss_dssp EEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHH--------CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH
T ss_pred eeeccchhhhcccccccccccccccccCccccChHHHhC--------CCCCccchhhcchHHHHHHHhCCCCCCCCCCHH
Confidence 9999999998543322 2234468999999999864 567889999999999999998 99999988776
Q ss_pred HHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhc
Q 024408 156 QAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 209 (268)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~~ 209 (268)
+...........+.+..+|+++.++|.+||+.||++|||+.++++.|+..+.+.
T Consensus 220 ~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~ 273 (285)
T d1u59a_ 220 EVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273 (285)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 665555555555667889999999999999999999999999999988766543
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-47 Score=315.04 Aligned_cols=189 Identities=28% Similarity=0.476 Sum_probs=163.3
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|+|++++++ .++++|+|||||+||+|.+++.+. .+++.++..++.|++.||+|||++||+||||||+|||++.+ +
T Consensus 78 nIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~-~ 153 (293)
T d1yhwa1 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD-G 153 (293)
T ss_dssp TBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-C
T ss_pred CEeeEeEEEEECCEEEEEEEecCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCC-C
Confidence 689999999 567899999999999999988653 39999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccc-cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.+||+|||+|+..... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+..
T Consensus 154 ~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~--------~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~ 225 (293)
T d1yhwa1 154 SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR--------KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL 225 (293)
T ss_dssp CEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHSS--------SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred cEeeccchhheeeccccccccccccCCCccChhhhcC--------CCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHH
Confidence 9999999999865433 33455679999999999864 56788999999999999999999999887766655
Q ss_pred HHHHhccCC--CCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 159 YAAAFKNVR--PSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 159 ~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
......... +.+..++++++++|.+||..||.+|||+.|+++|
T Consensus 226 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 226 YLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp HHHHHHCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred HHHHhCCCCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 554443322 2356789999999999999999999999999988
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-47 Score=312.56 Aligned_cols=199 Identities=29% Similarity=0.496 Sum_probs=168.9
Q ss_pred CceeEEEeecCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCC
Q 024408 1 MREQFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT 80 (268)
Q Consensus 1 ~~v~l~g~~~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~ 80 (268)
|+|+++|+|.++..++||||+++|+|.+++.......+++.+++.++.|++.||+|||++||+||||||+|||++.+ +.
T Consensus 69 nIv~~~g~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~-~~ 147 (272)
T d1qpca_ 69 RLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDT-LS 147 (272)
T ss_dssp TBCCEEEEECSSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-SC
T ss_pred CEeEEEeeeccCCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecc-cc
Confidence 68999999988888999999999999998876554459999999999999999999999999999999999999998 69
Q ss_pred eEEecCCCcccccccc--ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCChHHH
Q 024408 81 IKLADFGLAREESLTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHN-KLPFEGMSNLQA 157 (268)
Q Consensus 81 ~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g-~~p~~~~~~~~~ 157 (268)
+||+|||+|+...... ......||+.|+|||++.+ ..++.++||||||+++|||+|| .+|+......+.
T Consensus 148 ~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~--------~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~ 219 (272)
T d1qpca_ 148 CKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY--------GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV 219 (272)
T ss_dssp EEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHH--------CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH
T ss_pred eeeccccceEEccCCccccccccCCcccccChHHHhC--------CCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHH
Confidence 9999999998654332 2344578999999999864 5678899999999999999995 455555555454
Q ss_pred HHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 024408 158 AYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 208 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 208 (268)
..........+.+..+++++.+++.+||+.||++|||++++++.|++++.+
T Consensus 220 ~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 220 IQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHhcCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 444444445556788999999999999999999999999999999988764
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=307.72 Aligned_cols=197 Identities=28% Similarity=0.543 Sum_probs=158.5
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|+|+++|+| .++..++||||+++|+|.+++..... .+++..++.++.|++.||+|||+++|+||||||+|||++.+ +
T Consensus 61 nIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~~~~~-~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~-~ 138 (263)
T d1sm2a_ 61 KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRG-LFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGEN-Q 138 (263)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTT-CCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGG-G
T ss_pred CcccccceeccCCceEEEEEecCCCcHHHHhhcccc-CCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCC-C
Confidence 789999999 55689999999999999999876543 48999999999999999999999999999999999999998 6
Q ss_pred CeEEecCCCcccccccc--ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 024408 80 TIKLADFGLAREESLTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQ 156 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~~~~ 156 (268)
.+||+|||+++...... ......||..|+|||++.+ ..++.++||||||+++|||++ |.+||......+
T Consensus 139 ~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~--------~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~ 210 (263)
T d1sm2a_ 139 VIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF--------SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE 210 (263)
T ss_dssp CEEECSCC------------------CTTSCCHHHHTT--------CCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHH
T ss_pred CeEecccchheeccCCCceeecceecCcccCChHHhcC--------CCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHH
Confidence 99999999998544332 2233568999999999864 568999999999999999999 566666655555
Q ss_pred HHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHh
Q 024408 157 AAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 207 (268)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 207 (268)
.............+..+++++.+++.+||+.||++|||+++++++|++..+
T Consensus 211 ~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 211 VVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp HHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHhcCCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 544444444555677889999999999999999999999999999998764
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-47 Score=313.91 Aligned_cols=191 Identities=28% Similarity=0.375 Sum_probs=158.8
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|+|++++++ .++.+|||||||+||+|.+++.+.+. +++.++..++.|++.||+|||++||+||||||+|||++.+ +
T Consensus 64 nIv~~~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~--l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~-~ 140 (271)
T d1nvra_ 64 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER-D 140 (271)
T ss_dssp TBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTTTB--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT-C
T ss_pred CEeeEeeeeccCceeEEEEeccCCCcHHHHHhcCCC--CCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCC-C
Confidence 689999999 56689999999999999999976544 9999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccc---cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH
Q 024408 80 TIKLADFGLAREESLT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 156 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~ 156 (268)
.+||+|||+|+..... .......||+.|+|||++.+ ...++.++||||+||++|+|++|+.||.......
T Consensus 141 ~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-------~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~ 213 (271)
T d1nvra_ 141 NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR-------REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC 213 (271)
T ss_dssp CEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHC-------SSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS
T ss_pred CEEEccchhheeeccCCccccccceeeCcCccCHhHhcC-------CCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH
Confidence 9999999999854322 23345689999999999864 1234678999999999999999999997655443
Q ss_pred HHHHHHhcc--CCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 157 AAYAAAFKN--VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 157 ~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
......... .......+++++.++|.+||+.||++|||++++++|
T Consensus 214 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 214 QEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp HHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHHhcCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 333322222 222345789999999999999999999999999887
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-46 Score=313.74 Aligned_cols=191 Identities=25% Similarity=0.379 Sum_probs=151.7
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeC--C
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE--D 77 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~--~ 77 (268)
|+|++++++ .++.+|||||||+||+|.++|.+.+. +++.++..++.|++.||+|||++||+||||||+||++.. +
T Consensus 68 nIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l~~~~~--l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~ 145 (307)
T d1a06a_ 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF--YTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDE 145 (307)
T ss_dssp TBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSC--CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSST
T ss_pred CCCcEEEEEEECCEEEEEEeccCCCcHHHhhhcccC--CCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCC
Confidence 689999999 55689999999999999999987554 999999999999999999999999999999999999953 2
Q ss_pred CCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 024408 78 LKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA 157 (268)
Q Consensus 78 ~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~ 157 (268)
.+.+||+|||+++.........+..||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+.
T Consensus 146 ~~~vkl~DFG~a~~~~~~~~~~~~~GT~~y~APE~~~~--------~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~ 217 (307)
T d1a06a_ 146 DSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ--------KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL 217 (307)
T ss_dssp TCCEEECCC------------------CTTSCHHHHTT--------CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred CceEEEeccceeEEccCCCeeeeeeeCccccCcHHHcC--------CCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHH
Confidence 36899999999987665555566789999999999864 5688999999999999999999999998776665
Q ss_pred HHHHHhccCC---CCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 158 AYAAAFKNVR---PSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 158 ~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
.......... +....+|+++.++|.+||..||.+|||++|+++|
T Consensus 218 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 218 FEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp HHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 5544443332 2346789999999999999999999999999997
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-47 Score=312.87 Aligned_cols=196 Identities=27% Similarity=0.392 Sum_probs=165.2
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|||+++|++ .++.+++|||||+||+|.+++.+.+. .+++.++..++.|++.||+|||++||+||||||+|||++.+ +
T Consensus 70 nIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~~~~-~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~-~ 147 (288)
T d2jfla1 70 NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER-PLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLD-G 147 (288)
T ss_dssp TBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-S
T ss_pred CCCeEEEEEeeCCeEEEEEecCCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCC-C
Confidence 789999999 56789999999999999999876543 39999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccc-cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.+||+|||+|+..... ....+..||+.|+|||++.+.. .....++.++|||||||++|+|++|+.||.+....+..
T Consensus 148 ~~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~---~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~ 224 (288)
T d2jfla1 148 DIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCET---SKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVL 224 (288)
T ss_dssp CEEECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHTTCS---TTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH
T ss_pred CEEEEechhhhccCCCcccccccccccccCCHHHHhhcc---cCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHH
Confidence 9999999999754332 2334668999999999985421 12356789999999999999999999999987776665
Q ss_pred HHHHhccCC--CCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 159 YAAAFKNVR--PSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 159 ~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
......... ..+..+++++.++|.+||+.||.+|||+.|+++|
T Consensus 225 ~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 225 LKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp HHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HHHHcCCCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 554444322 2346789999999999999999999999999987
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-46 Score=306.48 Aligned_cols=189 Identities=28% Similarity=0.537 Sum_probs=160.2
Q ss_pred CceeEEEeec-----CCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCCEE
Q 024408 1 MREQFIGACK-----EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG--IIHRDLKPENLL 73 (268)
Q Consensus 1 ~~v~l~g~~~-----~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~g--i~H~Dikp~Nil 73 (268)
|+|+++|++. ++.+++||||++||+|.+++.+... +++.++..++.|++.||+|||++| |+||||||+|||
T Consensus 69 nIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~~--~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NIL 146 (270)
T d1t4ha_ 69 NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIF 146 (270)
T ss_dssp TBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEE
T ss_pred CeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHHhcccc--ccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhce
Confidence 6899999973 2468999999999999999987655 999999999999999999999999 999999999999
Q ss_pred EeCCCCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 024408 74 LTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS 153 (268)
Q Consensus 74 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~ 153 (268)
++.+.+.+||+|||+|+..... ...+..||+.|+|||++. +.++.++|||||||++|+|++|+.||.+..
T Consensus 147 l~~~~~~~Kl~DFGla~~~~~~-~~~~~~GT~~Y~aPE~~~---------~~~~~~~DIwSlGvilyel~~g~~Pf~~~~ 216 (270)
T d1t4ha_ 147 ITGPTGSVKIGDLGLATLKRAS-FAKAVIGTPEFMAPEMYE---------EKYDESVDVYAFGMCMLEMATSEYPYSECQ 216 (270)
T ss_dssp ESSTTSCEEECCTTGGGGCCTT-SBEESCSSCCCCCGGGGG---------TCCCTHHHHHHHHHHHHHHHHSSCTTTTCS
T ss_pred eeCCCCCEEEeecCcceeccCC-ccCCcccCccccCHHHhC---------CCCCCcCchhhHHHHHHHHHHCCCCCCCcc
Confidence 9754368999999999854333 234568999999999885 358899999999999999999999998766
Q ss_pred hHHHHHHHHhccCCC--CCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 154 NLQAAYAAAFKNVRP--SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 154 ~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
..............+ ....+++++.++|.+||+.||++|||++|+++|
T Consensus 217 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 217 NAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp SHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cHHHHHHHHHcCCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 665555544443332 245678999999999999999999999999987
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-46 Score=316.05 Aligned_cols=195 Identities=30% Similarity=0.499 Sum_probs=164.6
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCC---------------------CCCCHHHHHHHHHHHHHHHHHHH
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRP---------------------RCLDVCVAIGFALDIARAMECLH 58 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~---------------------~~~~~~~~~~~~~~l~~~l~~lH 58 (268)
|+|+++|+| ..+.+++|||||+||+|.++|..... ..+++..++.++.|++.||+|||
T Consensus 102 nIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH 181 (325)
T d1rjba_ 102 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE 181 (325)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH
T ss_pred cEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 689999999 55689999999999999999976432 24899999999999999999999
Q ss_pred HCCCeecCCCCCCEEEeCCCCCeEEecCCCcccccccc---ccccCCCccceeccccccccccccCCCCCCCchhhHHHH
Q 024408 59 SHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSF 135 (268)
Q Consensus 59 ~~gi~H~Dikp~Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvwsl 135 (268)
++||+||||||+||+++.+ +.+||+|||+|+...... ...+..||+.|+|||++.+ ..++.++|||||
T Consensus 182 ~~~IiHRDlKp~Nill~~~-~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--------~~~~~~~DiwS~ 252 (325)
T d1rjba_ 182 FKSCVHRDLAARNVLVTHG-KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE--------GIYTIKSDVWSY 252 (325)
T ss_dssp HTTEEETTCSGGGEEEETT-TEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH--------CCCCHHHHHHHH
T ss_pred hCCeeeccCchhccccccC-CeEEEeeccccccccCCCceeeeccccCCCccCChHHHcC--------CCCCcceeccch
Confidence 9999999999999999988 699999999998543332 2234467999999999864 678999999999
Q ss_pred HHHHHHHHh-CCCCCCCCChHHHHHHHHhcc-CCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 024408 136 AIVLWELLH-NKLPFEGMSNLQAAYAAAFKN-VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 204 (268)
Q Consensus 136 G~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~ 204 (268)
||++|||++ |+.||.+....+......... ..+.+..+|+++.+||.+||+.||++|||+++|+++|..
T Consensus 253 Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 253 GILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp HHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred hHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 999999997 899998866555544444443 334567899999999999999999999999999999853
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-47 Score=310.10 Aligned_cols=192 Identities=27% Similarity=0.382 Sum_probs=155.1
Q ss_pred CceeEEEeecC---CcEEEEEEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCC-----CeecCCCCC
Q 024408 1 MREQFIGACKE---PVMVIVTELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHSHG-----IIHRDLKPE 70 (268)
Q Consensus 1 ~~v~l~g~~~~---~~~~lV~e~~~ggsL~~~i~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~g-----i~H~Dikp~ 70 (268)
|+|++++++.+ +.+|+|||||+||+|.+++.+. ....+++..++.++.|++.||+|||++| |+||||||+
T Consensus 64 nIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~ 143 (269)
T d2java1 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPA 143 (269)
T ss_dssp TBCCEEEEEEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGG
T ss_pred CEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchh
Confidence 68999998832 4689999999999999999753 2345999999999999999999999976 999999999
Q ss_pred CEEEeCCCCCeEEecCCCccccccc-cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 024408 71 NLLLTEDLKTIKLADFGLAREESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPF 149 (268)
Q Consensus 71 Nill~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~ 149 (268)
|||++.+ +.+||+|||+++..... .......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||
T Consensus 144 NIll~~~-~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~--------~~~~~~~DIwSlGvilyel~tg~~Pf 214 (269)
T d2java1 144 NVFLDGK-QNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNR--------MSYNEKSDIWSLGCLLYELCALMPPF 214 (269)
T ss_dssp GEEECTT-SCEEECCHHHHHHC-----------CCCSCCCHHHHTT--------CCCCHHHHHHHHHHHHHHHHHSSCSC
T ss_pred hcCcCCC-CcEEEeeccceeecccCCCccccCCCCcccCCHHHHcC--------CCCChHHHHHhhCHHHHHHhhCCCCC
Confidence 9999988 69999999999865433 23345689999999999864 56889999999999999999999999
Q ss_pred CCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 150 EGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
.+.+..+...........+.+..+++++.++|.+||+.||.+|||+.|+++|
T Consensus 215 ~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 215 TAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp CCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 9877666555555555556677899999999999999999999999999886
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.9e-46 Score=308.03 Aligned_cols=198 Identities=29% Similarity=0.515 Sum_probs=165.4
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|+|+++|+| .++.+++||||+++|+|.+++.+.....+++..++.++.|++.||+|||++||+||||||+|||++.+ +
T Consensus 74 nIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~-~ 152 (287)
T d1opja_ 74 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN-H 152 (287)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG-G
T ss_pred CEecCCccEeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCC-C
Confidence 789999999 45689999999999999999987766679999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccccc--cccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 024408 80 TIKLADFGLAREESLTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA 157 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~ 157 (268)
.+||+|||+|+....... .....|++.|+|||++.+ ..++.++||||||+++|||++|..|+........
T Consensus 153 ~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~ 224 (287)
T d1opja_ 153 LVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY--------NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 224 (287)
T ss_dssp CEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHH--------CCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred cEEEccccceeecCCCCceeeccccccccccChHHHcC--------CCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH
Confidence 999999999986443322 223357889999999865 5688999999999999999997665544333333
Q ss_pred HHHH-HhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHh
Q 024408 158 AYAA-AFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 207 (268)
Q Consensus 158 ~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 207 (268)
.... ......+.+..+|+++.++|.+||..||++|||++++++.|+.+++
T Consensus 225 ~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 225 VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred HHHHHhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 3333 3334445577899999999999999999999999999999877653
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-46 Score=308.39 Aligned_cols=189 Identities=23% Similarity=0.319 Sum_probs=160.2
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|+|++++++ .++.+|+||||++||+|.+++...+. +++..++.++.|++.||+|||++||+||||||+|||++.+ +
T Consensus 69 nIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~~~~~~--l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~-~ 145 (288)
T d1uu3a_ 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED-M 145 (288)
T ss_dssp TBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-S
T ss_pred CeeEEEEEEEECCEEEEEEEccCCCCHHHhhhccCC--CCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCC-c
Confidence 689999999 55689999999999999999987765 9999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccc---cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH
Q 024408 80 TIKLADFGLAREESLT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 156 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~ 156 (268)
.+||+|||+|+..... ....+..||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+
T Consensus 146 ~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--------~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~ 217 (288)
T d1uu3a_ 146 HIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE--------KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL 217 (288)
T ss_dssp CEEECCCTTCEECC----------CCCCGGGCCHHHHHT--------CCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred eEEecccccceecccCCcccccccccCCccccCceeecc--------CCCCcccceehhhHHHHHHhhCCCCCCCcCHHH
Confidence 9999999999864332 22345679999999999864 568899999999999999999999999866555
Q ss_pred HHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 157 AAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
....... .....+..++++++++|.+||..||.+|||++|++++
T Consensus 218 ~~~~i~~-~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 218 IFQKIIK-LEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp HHHHHHT-TCCCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred HHHHHHc-CCCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 4444333 3333467899999999999999999999999997665
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-45 Score=309.07 Aligned_cols=189 Identities=26% Similarity=0.393 Sum_probs=164.3
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
++|++++++ .++++|+||||++||+|.+++.+.+. +++..++.++.|++.||+|||++||+||||||+|||++.+ +
T Consensus 66 ~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~~~~~~--~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~-g 142 (337)
T d1o6la_ 66 FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV--FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD-G 142 (337)
T ss_dssp TBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-S
T ss_pred CEEEEEeeeccccccccceeccCCCchhhhhhcccC--CcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCC-C
Confidence 689999999 55689999999999999999988665 9999999999999999999999999999999999999998 6
Q ss_pred CeEEecCCCcccccc-ccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESL-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.+||+|||+|+.... .....+.+||+.|+|||++.+ ..++.++|+|||||++|||++|+.||.+.+..+..
T Consensus 143 ~vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~--------~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~ 214 (337)
T d1o6la_ 143 HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED--------NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF 214 (337)
T ss_dssp CEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSS--------SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred CEEEeecccccccccCCcccccceeCHHHhhhhhccC--------CCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHH
Confidence 999999999986433 334456789999999999864 56789999999999999999999999986655443
Q ss_pred HHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 024408 159 YAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPN-----FTQIIQM 201 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~~~~~~ 201 (268)
. .........+..+++++.++|.+||+.||.+|++ +.++++|
T Consensus 215 ~-~i~~~~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 215 E-LILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp H-HHHHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred H-HHhcCCCCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 3 3334444557789999999999999999999994 8899987
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-45 Score=308.48 Aligned_cols=191 Identities=28% Similarity=0.423 Sum_probs=163.0
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|+|+++|++ .++.+++|||||+||+|..++...+. +++.+++.++.|++.||.|||++||+||||||+|||++.+ +
T Consensus 76 nIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~~~~~~--l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~-~ 152 (309)
T d1u5ra_ 76 NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP--LQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP-G 152 (309)
T ss_dssp TBCCEEEEEEETTEEEEEEECCSEEHHHHHHHHTSC--CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETT-T
T ss_pred CEeeEEEEEEECCEEEEEEEecCCCchHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCC-C
Confidence 689999999 56789999999999999877766544 9999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 024408 80 TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY 159 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~ 159 (268)
.+||+|||+|+..... ....||+.|+|||++.+. ....++.++|||||||++|+|++|..||.+....+...
T Consensus 153 ~~Kl~DFG~a~~~~~~---~~~~GT~~Y~APE~~~~~-----~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~ 224 (309)
T d1u5ra_ 153 LVKLGDFGSASIMAPA---NSFVGTPYWMAPEVILAM-----DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY 224 (309)
T ss_dssp EEEECCCTTCBSSSSB---CCCCSCGGGCCHHHHTTT-----TSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH
T ss_pred CEEEeecccccccCCC---CccccCccccCHHHHhcc-----CCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 9999999999864432 456899999999998641 12457889999999999999999999998877766655
Q ss_pred HHHhccCC-CCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 024408 160 AAAFKNVR-PSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 202 (268)
Q Consensus 160 ~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l 202 (268)
........ .....+++++.++|.+||..||.+|||++++++|-
T Consensus 225 ~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp 268 (309)
T d1u5ra_ 225 HIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (309)
T ss_dssp HHHHSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred HHHhCCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCH
Confidence 55444333 33557899999999999999999999999999973
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-46 Score=304.49 Aligned_cols=198 Identities=29% Similarity=0.523 Sum_probs=163.2
Q ss_pred CceeEEEeecCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCC
Q 024408 1 MREQFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT 80 (268)
Q Consensus 1 ~~v~l~g~~~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~ 80 (268)
|+|+++|++.++.+++||||++||+|.+++..... .+++..++.++.|++.||+|||++|++||||||+||+++.+ +.
T Consensus 69 nIv~l~~~~~~~~~~iv~E~~~~g~l~~~~~~~~~-~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~-~~ 146 (273)
T d1mp8a_ 69 HIVKLIGVITENPVWIIMELCTLGELRSFLQVRKY-SLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSN-DC 146 (273)
T ss_dssp TBCCEEEEECSSSCEEEEECCTTEEHHHHHHHTTT-TSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET-TE
T ss_pred CEeeEEEEEecCeEEEEEEeccCCcHHhhhhccCC-CCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCC-Cc
Confidence 78999999988889999999999999998876443 49999999999999999999999999999999999999988 69
Q ss_pred eEEecCCCcccccccc--ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 024408 81 IKLADFGLAREESLTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQA 157 (268)
Q Consensus 81 ~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~ 157 (268)
+||+|||+++...... ......||+.|+|||++.+ ..++.++||||||+++|||++ |.+||.+....+.
T Consensus 147 ~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~--------~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~ 218 (273)
T d1mp8a_ 147 VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF--------RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV 218 (273)
T ss_dssp EEECC-------------------CCGGGCCHHHHHH--------CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH
T ss_pred EEEccchhheeccCCcceeccceecCcccchhhHhcc--------CCCCCccccccchHHHHHHHhcCCCCCCCCCHHHH
Confidence 9999999998644322 2334568999999999864 678899999999999999998 8999998777766
Q ss_pred HHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 024408 158 AYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 208 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 208 (268)
..........+.+..+|+++.++|.+||..||.+|||+.+++++|+..++.
T Consensus 219 ~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 219 IGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 666666666677889999999999999999999999999999999887654
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-45 Score=305.66 Aligned_cols=191 Identities=25% Similarity=0.337 Sum_probs=165.1
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCC-
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL- 78 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~- 78 (268)
|+|++++++ .++.+|||||||+||+|.++|.+.+. +++..++.++.|++.||+|||++||+||||||+||+++.+.
T Consensus 74 nIv~~~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~--l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~ 151 (293)
T d1jksa_ 74 NVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNV 151 (293)
T ss_dssp TBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSS
T ss_pred CCCcEEEEEEECCEEEEEEEcCCCccccchhccccc--cchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCC
Confidence 689999999 55689999999999999999988665 99999999999999999999999999999999999997652
Q ss_pred --CCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH
Q 024408 79 --KTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 156 (268)
Q Consensus 79 --~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~ 156 (268)
..+|++|||++..........+..||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+....+
T Consensus 152 ~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~--------~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~ 223 (293)
T d1jksa_ 152 PKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY--------EPLGLEADMWSIGVITYILLSGASPFLGDTKQE 223 (293)
T ss_dssp SSCCEEECCCTTCEECTTSCBCSCCCCCGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred cccceEecchhhhhhcCCCccccccCCCCcccCHHHHcC--------CCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH
Confidence 2599999999987666655667789999999999864 567899999999999999999999999877666
Q ss_pred HHHHHHhccCCCC---CCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 157 AAYAAAFKNVRPS---AENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 157 ~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
............. ...++++++++|.+||..||.+|||++++++|
T Consensus 224 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 224 TLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp HHHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 5554444333222 35789999999999999999999999999987
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-45 Score=298.75 Aligned_cols=194 Identities=29% Similarity=0.545 Sum_probs=168.2
Q ss_pred CceeEEEeec-CCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGACK-EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~~-~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|+|+++|+|. ++.+++||||+++|+|.+++...... +++..++.++.|+++||+|||++||+||||||+||+++.+ +
T Consensus 60 nIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~~~~~~-~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~-~ 137 (258)
T d1k2pa_ 60 KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQ-G 137 (258)
T ss_dssp TBCCEEEEECCSSSEEEEEECCTTEEHHHHHHSGGGC-CCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTT-C
T ss_pred ceeeEEEEEeeCCceEEEEEccCCCcHHHhhhccccC-CcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCC-C
Confidence 6899999994 56899999999999999998765433 8999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccccc--ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 024408 80 TIKLADFGLAREESLTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQ 156 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~~~~ 156 (268)
.+||+|||+++...... ......||..|+|||++.+ ..++.++||||||+++|||++ |+.||.+....+
T Consensus 138 ~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~ 209 (258)
T d1k2pa_ 138 VVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY--------SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE 209 (258)
T ss_dssp CEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH
T ss_pred cEEECcchhheeccCCCceeecccCCCCCcCCcHHhcC--------CCCCcceeecccchhhHhHHhcCCCCCCCCCHHH
Confidence 99999999997543322 2234568999999999865 668899999999999999998 899999988777
Q ss_pred HHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 024408 157 AAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 204 (268)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~ 204 (268)
...........+.+..+++++.++|.+||+.||++|||+.+++++|.+
T Consensus 210 ~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 210 TAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred HHHHHHhCCCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 666665555566678899999999999999999999999999999864
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.7e-45 Score=312.73 Aligned_cols=192 Identities=22% Similarity=0.352 Sum_probs=166.0
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeC-CC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE-DL 78 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~-~~ 78 (268)
|+|++++++ .++.+|||||||+||+|.+++.+.+. .+++.+++.++.||+.||+|||++||+||||||+|||++. +.
T Consensus 87 nIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~~~~-~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~ 165 (352)
T d1koba_ 87 KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDY-KMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKA 165 (352)
T ss_dssp TBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTC-CBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTC
T ss_pred CCCcEEEEEEECCEEEEEEEcCCCChHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCC
Confidence 689999999 55689999999999999998876443 3999999999999999999999999999999999999973 23
Q ss_pred CCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 79 KTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 79 ~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
+.+||+|||+|+.........+..||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+..
T Consensus 166 ~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~ 237 (352)
T d1koba_ 166 SSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDR--------EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL 237 (352)
T ss_dssp CCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTT--------CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH
T ss_pred CeEEEeecccceecCCCCceeeccCcccccCHHHHcC--------CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 6899999999997766666667789999999999864 56889999999999999999999999987776665
Q ss_pred HHHHhccCCC---CCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 159 YAAAFKNVRP---SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 159 ~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
.......... ....+++++.++|.+||..||.+|||+.++++|
T Consensus 238 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 238 QNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp HHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 5544443322 246789999999999999999999999999997
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-45 Score=304.35 Aligned_cols=200 Identities=29% Similarity=0.445 Sum_probs=163.7
Q ss_pred CceeEEEeecCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCC
Q 024408 1 MREQFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT 80 (268)
Q Consensus 1 ~~v~l~g~~~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~ 80 (268)
|+|+++|+|.++..++||||++||+|.+++.......+++.+++.++.|++.||+|||++||+||||||+|||++.+ +.
T Consensus 73 nIv~~~g~~~~~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~-~~ 151 (285)
T d1fmka3 73 KLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN-LV 151 (285)
T ss_dssp TBCCEEEEECSSSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG-GC
T ss_pred CEeEEEEEEecCCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCC-Cc
Confidence 68999999977778999999999999999876544459999999999999999999999999999999999999988 69
Q ss_pred eEEecCCCcccccccc--ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCC-CCCChHHH
Q 024408 81 IKLADFGLAREESLTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPF-EGMSNLQA 157 (268)
Q Consensus 81 ~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~-~~~~~~~~ 157 (268)
+||+|||+++...... ......||+.|+|||.+.. +.++.++||||||+++|||++|..|+ ......+.
T Consensus 152 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~ 223 (285)
T d1fmka3 152 CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY--------GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV 223 (285)
T ss_dssp EEECCCCTTC--------------CCGGGSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH
T ss_pred EEEcccchhhhccCCCceeeccccccccccChHHHhC--------CCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHH
Confidence 9999999998643322 2334568999999999864 67889999999999999999965554 54444444
Q ss_pred HHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhc
Q 024408 158 AYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 209 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~~ 209 (268)
..........+.+..+++++.++|.+||+.||++||++.+|++.|++++...
T Consensus 224 ~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 224 LDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp HHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred HHHHHhcCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 4444445455678889999999999999999999999999999998877553
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.4e-45 Score=312.91 Aligned_cols=192 Identities=23% Similarity=0.342 Sum_probs=165.1
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCC-C
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED-L 78 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~-~ 78 (268)
|+|++++++ .++.+|||||||+||+|.+++.+..+ .+++.++..++.||+.||+|||++||+||||||+|||++.+ .
T Consensus 84 nIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~-~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~ 162 (350)
T d1koaa2 84 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRS 162 (350)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTCTTS-CBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTS
T ss_pred CCCcEEEEEEECCEEEEEEEcCCCCCHHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCC
Confidence 689999999 56789999999999999999965433 39999999999999999999999999999999999999642 2
Q ss_pred CCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 79 KTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 79 ~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
+.+||+|||+++.........+..||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+..
T Consensus 163 ~~vkL~DFG~a~~~~~~~~~~~~~gT~~Y~aPEv~~~--------~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~ 234 (350)
T d1koaa2 163 NELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEG--------KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETL 234 (350)
T ss_dssp CCEEECCCTTCEECCTTSCEEEECSCTTTCCHHHHHT--------CCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred CeEEEeecchheecccccccceecCcccccCHHHHcC--------CCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHH
Confidence 6899999999987666666667789999999999864 56788999999999999999999999987666555
Q ss_pred HHHHhccCCCC---CCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 159 YAAAFKNVRPS---AENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 159 ~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
........... ...++++++++|.+||..||.+|||++|+++|
T Consensus 235 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 235 RNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp HHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred HHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 55444333222 34688999999999999999999999999998
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.8e-45 Score=301.74 Aligned_cols=196 Identities=23% Similarity=0.336 Sum_probs=168.0
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|+|++++++ ..+++||||||++||+|.++|...+. +++.++..++.||+.||+|||++||+||||||+||+++.+ +
T Consensus 71 nIv~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~~--l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~-~ 147 (277)
T d1phka_ 71 NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDD-M 147 (277)
T ss_dssp TBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-C
T ss_pred CeEEEEeecccCcceEEEEEcCCCchHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCC-C
Confidence 689999999 55689999999999999999987665 9999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 024408 80 TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY 159 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~ 159 (268)
.+||+|||+++............||+.|+|||.+.+.... ....++.++||||+|+++|+|++|+.||.+........
T Consensus 148 ~~kl~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~--~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~ 225 (277)
T d1phka_ 148 NIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMND--NHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLR 225 (277)
T ss_dssp CEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCT--TSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred CeEEccchheeEccCCCceeeeeccCCCCCHHHhhccccc--cCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHH
Confidence 9999999999876665555667899999999998753221 23457889999999999999999999999877666555
Q ss_pred HHHhccCCC---CCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 160 AAAFKNVRP---SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 160 ~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
......... ....+|++++++|.+||+.||.+||+++++++|
T Consensus 226 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 226 MIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 544443322 234789999999999999999999999999987
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-45 Score=304.88 Aligned_cols=200 Identities=29% Similarity=0.518 Sum_probs=160.1
Q ss_pred CceeEEEeecC--CcEEEEEEcCCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCee
Q 024408 1 MREQFIGACKE--PVMVIVTELLSGGTLRKYLLNMR--------------PRCLDVCVAIGFALDIARAMECLHSHGIIH 64 (268)
Q Consensus 1 ~~v~l~g~~~~--~~~~lV~e~~~ggsL~~~i~~~~--------------~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H 64 (268)
++|++++++.+ +.+++|||||+||+|.+++.... ...+++.++..++.|++.||+|||++||+|
T Consensus 78 ~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivH 157 (299)
T d1ywna1 78 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIH 157 (299)
T ss_dssp TBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred eEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcC
Confidence 57889999843 46899999999999999997542 234899999999999999999999999999
Q ss_pred cCCCCCCEEEeCCCCCeEEecCCCccccccc---cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHH
Q 024408 65 RDLKPENLLLTEDLKTIKLADFGLAREESLT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWE 141 (268)
Q Consensus 65 ~Dikp~Nill~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ 141 (268)
|||||+|||++.+ +.+||+|||+|+..... .......||+.|+|||++.+ ..++.++||||||+++||
T Consensus 158 rDlKp~NILl~~~-~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~--------~~~~~~sDiwS~Gvil~e 228 (299)
T d1ywna1 158 RDLAARNILLSEK-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD--------RVYTIQSDVWSFGVLLWE 228 (299)
T ss_dssp SCCCGGGEEECGG-GCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHH
T ss_pred CcCCccceeECCC-CcEEEccCcchhhccccccccccCceeeCccccchhHhhc--------CCCCcccceeehHHHHHH
Confidence 9999999999988 69999999999853322 22344579999999999865 668899999999999999
Q ss_pred HHhC-CCCCCCCChHHHHHHHH-hccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhc
Q 024408 142 LLHN-KLPFEGMSNLQAAYAAA-FKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 209 (268)
Q Consensus 142 ll~g-~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~~ 209 (268)
|++| ..||.+....+...... .....+.+..+++++.++|.+||+.||++|||+.+++++|+.++++.
T Consensus 229 llt~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~n 298 (299)
T d1ywna1 229 IFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 298 (299)
T ss_dssp HHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCC
Confidence 9986 56887765544444333 33344456789999999999999999999999999999999887653
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-46 Score=311.52 Aligned_cols=190 Identities=23% Similarity=0.396 Sum_probs=155.1
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEEeCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLTEDL 78 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~gi~H~Dikp~Nill~~~~ 78 (268)
|+|++++++ .++++++||||++||+|.+++.+.+. +++..+..++.|++.||.|||+ +||+||||||+|||++.+
T Consensus 65 nIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l~~~~~--l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~- 141 (322)
T d1s9ja_ 65 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSR- 141 (322)
T ss_dssp TBCCEEEEEECSSEEEEEEECCTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTT-
T ss_pred CCCcEEEEEEECCEEEEEEEcCCCCcHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCC-
Confidence 689999999 55689999999999999999987665 9999999999999999999997 499999999999999988
Q ss_pred CCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 79 KTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 79 ~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
+.+||+|||+|+..... ...+.+||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.+..+..
T Consensus 142 ~~vkl~DFGla~~~~~~-~~~~~~GT~~Y~APEvl~~--------~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~ 212 (322)
T d1s9ja_ 142 GEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQG--------THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELE 212 (322)
T ss_dssp CCEEECCCCCCHHHHHH-TC---CCSSCCCCHHHHHC--------SCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHH
T ss_pred CCEEEeeCCCccccCCC-ccccccCCccccCchHHcC--------CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 69999999999854332 2345689999999999975 67899999999999999999999999765432211
Q ss_pred HHH-----------------------------------------HhccCCCC--CCCCcHHHHHHHHhccccCCCCCCCH
Q 024408 159 YAA-----------------------------------------AFKNVRPS--AENVPEELSIILTSCWKEDPNARPNF 195 (268)
Q Consensus 159 ~~~-----------------------------------------~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~ 195 (268)
... ......+. ...++.++.++|.+||..||.+|||+
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta 292 (322)
T d1s9ja_ 213 LMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADL 292 (322)
T ss_dssp HHC------------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCH
Confidence 100 00000011 12357899999999999999999999
Q ss_pred HHHHHHH
Q 024408 196 TQIIQML 202 (268)
Q Consensus 196 ~~~~~~l 202 (268)
+|+++|-
T Consensus 293 ~e~L~Hp 299 (322)
T d1s9ja_ 293 KQLMVHA 299 (322)
T ss_dssp HHHHTSH
T ss_pred HHHhhCH
Confidence 9999983
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-44 Score=298.09 Aligned_cols=198 Identities=27% Similarity=0.469 Sum_probs=160.0
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|+|+++|+| ..+..++||||+.+++|.+++..... .+++.++..++.|++.||+|||++||+||||||+|||++.+ +
T Consensus 70 nIv~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~~~~-~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~-~ 147 (283)
T d1mqba_ 70 NIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG-EFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSN-L 147 (283)
T ss_dssp TBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTT-CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-C
T ss_pred CEeeeeEEEecCCceEEEEEecccCcchhhhhcccc-cccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCC-C
Confidence 789999999 55689999999999999998876543 39999999999999999999999999999999999999998 6
Q ss_pred CeEEecCCCcccccccc----ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCC-CCCCCh
Q 024408 80 TIKLADFGLAREESLTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLP-FEGMSN 154 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p-~~~~~~ 154 (268)
.+||+|||+++...... ......||+.|+|||++.+ ..++.++||||||+++|||++|..| +.....
T Consensus 148 ~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~--------~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~ 219 (283)
T d1mqba_ 148 VCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY--------RKFTSASDVWSFGIVMWEVMTYGERPYWELSN 219 (283)
T ss_dssp CEEECCCCC-----------------CCCGGGSCHHHHHS--------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred eEEEcccchhhcccCCCccceEeccCCCCccccCHHHHcc--------CCCCCcccccccHHHHHHHHhCCCCccccCCH
Confidence 99999999998543321 1223468999999998864 6788999999999999999996554 555454
Q ss_pred HHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 024408 155 LQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 208 (268)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 208 (268)
.+...........+.+..++.++.++|.+||+.||++||++.++++.|+...+.
T Consensus 220 ~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 220 HEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp HHHHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHHHHHHhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 444444444445566778999999999999999999999999999999887764
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-45 Score=310.06 Aligned_cols=194 Identities=27% Similarity=0.423 Sum_probs=159.2
Q ss_pred CceeEEEeec-----CCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEe
Q 024408 1 MREQFIGACK-----EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 75 (268)
Q Consensus 1 ~~v~l~g~~~-----~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~ 75 (268)
|+|++++++. +.++|+|||||+||+|.++|.+.+...+++.+++.++.|++.||+|||++||+||||||+|||++
T Consensus 66 nIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~ 145 (335)
T d2ozaa1 66 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYT 145 (335)
T ss_dssp TBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEES
T ss_pred CCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccc
Confidence 6899999874 25789999999999999999886666699999999999999999999999999999999999997
Q ss_pred CC--CCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 024408 76 ED--LKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS 153 (268)
Q Consensus 76 ~~--~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~ 153 (268)
.+ .+.+||+|||+|+............||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+..
T Consensus 146 ~~~~~~~~Kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~y~~~~DiwSlGvily~lltg~~Pf~~~~ 217 (335)
T d2ozaa1 146 SKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP--------EKYDKSCDMWSLGVIMYILLCGYPPFYSNH 217 (335)
T ss_dssp CSSTTCCEEECCCTTCEECCCCCCCCCCSCCCSSCCCCCCCG--------GGGSHHHHHHHHHHHHHHHTTSSCSCEETT
T ss_pred cccccccccccccceeeeccCCCccccccCCcccCCcHHHcC--------CCCCHHHHHHhhchhHHHHhhCCCCCCCCC
Confidence 53 25799999999987666666667789999999999864 567889999999999999999999997654
Q ss_pred hHHHHHHHHhccC--C---C--CCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 024408 154 NLQAAYAAAFKNV--R---P--SAENVPEELSIILTSCWKEDPNARPNFTQIIQML 202 (268)
Q Consensus 154 ~~~~~~~~~~~~~--~---~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l 202 (268)
............. . + ....+++++.++|.+||..||.+|||+.++++|-
T Consensus 218 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp 273 (335)
T d2ozaa1 218 GLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 273 (335)
T ss_dssp CC--------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSH
T ss_pred HHHHHHHHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCH
Confidence 3332221111111 1 1 1125788999999999999999999999999984
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-44 Score=297.79 Aligned_cols=198 Identities=33% Similarity=0.582 Sum_probs=170.1
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRP--------------RCLDVCVAIGFALDIARAMECLHSHGIIHR 65 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~--------------~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~ 65 (268)
|+|+++|+| .++.+++||||++||+|.++|..... ..+++.+++.++.|++.||+|||++|++||
T Consensus 80 nIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHr 159 (299)
T d1fgka_ 80 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHR 159 (299)
T ss_dssp TBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred eEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEee
Confidence 689999999 55689999999999999999976532 348999999999999999999999999999
Q ss_pred CCCCCCEEEeCCCCCeEEecCCCcccccccc---ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHH
Q 024408 66 DLKPENLLLTEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWEL 142 (268)
Q Consensus 66 Dikp~Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~l 142 (268)
||||+|||++.+ +.+||+|||+++...... ......|++.|+|||.+.+ +.++.++||||||+++|||
T Consensus 160 DiKp~NiLl~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~--------~~y~~k~DiwS~Gvvl~el 230 (299)
T d1fgka_ 160 DLAARNVLVTED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD--------RIYTHQSDVWSFGVLLWEI 230 (299)
T ss_dssp CCSGGGEEECTT-CCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH--------CCCCHHHHHHHHHHHHHHH
T ss_pred eecccceeecCC-CCeEeccchhhccccccccccccccCCCChhhhhhhHhcC--------CCCCchhhhHHhHHHHHHh
Confidence 999999999998 699999999998544332 2334578999999999865 6789999999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHh
Q 024408 143 LH-NKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 207 (268)
Q Consensus 143 l~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 207 (268)
++ |..||.+....+...........+.+..+++++.++|.+||+.||.+|||+.++++.|+....
T Consensus 231 l~~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 231 FTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp HTTSCCSSTTCCHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccCCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 98 788998877665554444444556678899999999999999999999999999999988754
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-44 Score=302.35 Aligned_cols=197 Identities=23% Similarity=0.498 Sum_probs=167.5
Q ss_pred CceeEEEeecCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCC
Q 024408 1 MREQFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT 80 (268)
Q Consensus 1 ~~v~l~g~~~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~ 80 (268)
|+|+++|+|.++..++||||+.+|+|.+++..... .+++..++.++.|++.||+|||++||+||||||+|||++.+ +.
T Consensus 72 nIv~l~g~~~~~~~~~v~e~~~~~~l~~~~~~~~~-~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~-~~ 149 (317)
T d1xkka_ 72 HVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTP-QH 149 (317)
T ss_dssp TBCCEEEEEESSSEEEEEECCTTCBHHHHHHHTSS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEET-TE
T ss_pred CEeeEEEEEecCCeeEEEEeccCCccccccccccc-CCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCC-CC
Confidence 78999999988888999999999999998877543 49999999999999999999999999999999999999988 69
Q ss_pred eEEecCCCcccccccc---ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 024408 81 IKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQ 156 (268)
Q Consensus 81 ~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~~~~ 156 (268)
+||+|||+++...... ......||+.|+|||++.+ +.++.++||||||+++|||+| |..||.+....+
T Consensus 150 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~--------~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~ 221 (317)
T d1xkka_ 150 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH--------RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 221 (317)
T ss_dssp EEECCCSHHHHTTTTCC--------CCTTTSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG
T ss_pred eEeeccccceecccccccccccccccCccccChHHHhc--------CCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH
Confidence 9999999998543322 2233468999999999865 578999999999999999998 899998877666
Q ss_pred HHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHh
Q 024408 157 AAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 207 (268)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 207 (268)
...........+.+..+++++.+++.+||..||.+|||+.+++++|.....
T Consensus 222 ~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 222 ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp HHHHHHHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 555555555556678899999999999999999999999999999987654
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.7e-44 Score=306.69 Aligned_cols=190 Identities=24% Similarity=0.340 Sum_probs=160.8
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|+|++++++ .++.+|+||||++||+|.++|.+... +++..++.++.||+.||+|||++||+||||||+|||++.+ +
T Consensus 68 nIv~l~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~--~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~-g 144 (364)
T d1omwa3 68 FIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV--FSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEH-G 144 (364)
T ss_dssp TBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-S
T ss_pred cEEEEEEEEEECCEEEEEEEecCCCcHHHHHHhccc--ccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCC-C
Confidence 689999999 55689999999999999999988665 9999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH--
Q 024408 80 TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA-- 157 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~-- 157 (268)
.+||+|||+|+...... .....||+.|+|||++.. ...++.++|||||||++|+|++|+.||.+......
T Consensus 145 ~iKl~DFGla~~~~~~~-~~~~~GT~~y~APE~~~~-------~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~ 216 (364)
T d1omwa3 145 HVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQK-------GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE 216 (364)
T ss_dssp CEEECCCTTCEECSSSC-CCSCCSCGGGCCHHHHST-------TCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH
T ss_pred cEEEeeeceeeecCCCc-ccccccccccchhHHhhc-------CCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 99999999998654432 345689999999999853 24578999999999999999999999976543322
Q ss_pred HHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 024408 158 AYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPN-----FTQIIQM 201 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~~~~~~ 201 (268)
............+..++++++++|.+||..||.+||+ ++++++|
T Consensus 217 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 217 IDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp HHHHSSSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred HHHhcccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 2222233333446789999999999999999999999 7999988
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-44 Score=299.58 Aligned_cols=199 Identities=30% Similarity=0.499 Sum_probs=168.6
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMR--------------PRCLDVCVAIGFALDIARAMECLHSHGIIHR 65 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~--------------~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~ 65 (268)
|+|+++|+| .++.+++||||++||+|.++|.+.. ...+++.++..++.|++.||.|||++|++||
T Consensus 72 nIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHr 151 (309)
T d1fvra_ 72 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHR 151 (309)
T ss_dssp TBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred CEeeEEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCcccc
Confidence 689999999 5678999999999999999997542 2459999999999999999999999999999
Q ss_pred CCCCCCEEEeCCCCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhC
Q 024408 66 DLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHN 145 (268)
Q Consensus 66 Dikp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g 145 (268)
||||+|||++.+ +.+||+|||+++............||..|+|||.+.+ ..++.++||||||+++|||++|
T Consensus 152 Dlkp~NIL~~~~-~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~--------~~~~~~sDvwSfGvil~ell~~ 222 (309)
T d1fvra_ 152 DLAARNILVGEN-YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY--------SVYTTNSDVWSYGVLLWEIVSL 222 (309)
T ss_dssp CCSGGGEEECGG-GCEEECCTTCEESSCEECCC----CCTTTCCHHHHHH--------CEECHHHHHHHHHHHHHHHHTT
T ss_pred ccccceEEEcCC-CceEEccccccccccccccccceecCCcccchHHhcc--------CCCCccceeehhHHHHHHHHhc
Confidence 999999999988 6999999999986655555556678999999999864 5678899999999999999996
Q ss_pred C-CCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 024408 146 K-LPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 208 (268)
Q Consensus 146 ~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 208 (268)
. +||.+....+...........+.+..+++++.++|.+||+.||++|||+.+++++|+..++.
T Consensus 223 ~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 223 GGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp SCCTTTTCCHHHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred CCCCCCCCCHHHHHHHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 5 57877666555444444444555778999999999999999999999999999999988764
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.7e-43 Score=298.99 Aligned_cols=188 Identities=24% Similarity=0.312 Sum_probs=163.2
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|+|++++++ .....++||||+.||+|.+++.+.+. +++.++..++.||+.||.|||++||+||||||+|||++.+ +
T Consensus 102 nIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~~~~~--l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~-g 178 (350)
T d1rdqe_ 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-G 178 (350)
T ss_dssp TBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-S
T ss_pred cEeecccccccccccccccccccccchhhhHhhcCC--CCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCC-C
Confidence 689999999 55688999999999999999988765 9999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 024408 80 TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY 159 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~ 159 (268)
.+||+|||+|+..... ..+..||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+........
T Consensus 179 ~ikL~DFG~a~~~~~~--~~~~~Gt~~Y~APE~~~~--------~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~ 248 (350)
T d1rdqe_ 179 YIQVTDFGFAKRVKGR--TWTLCGTPEALAPEIILS--------KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 248 (350)
T ss_dssp CEEECCCTTCEECSSC--BCCCEECGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred CEEeeeceeeeecccc--cccccCccccCCHHHHcC--------CCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHH
Confidence 9999999999865432 345689999999999864 567889999999999999999999998866555444
Q ss_pred HHHhccCCCCCCCCcHHHHHHHHhccccCCCCCC-----CHHHHHHHH
Q 024408 160 AAAFKNVRPSAENVPEELSIILTSCWKEDPNARP-----NFTQIIQML 202 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~~~~~l 202 (268)
... ......+..+++++.++|.+||..||.+|+ +++++++|-
T Consensus 249 ~i~-~~~~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp 295 (350)
T d1rdqe_ 249 KIV-SGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHK 295 (350)
T ss_dssp HHH-HCCCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSG
T ss_pred HHh-cCCCCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCc
Confidence 433 334445678999999999999999999994 899999873
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-44 Score=298.81 Aligned_cols=200 Identities=28% Similarity=0.328 Sum_probs=161.5
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|+|++++++ .++++++||||+.|+++..++... ..+++.++..++.|++.||+|||++||+||||||+|||++.+ +
T Consensus 61 nIv~~~~~~~~~~~~~ivmE~~~~~~~~~~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~-~ 137 (299)
T d1ua2a_ 61 NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDEN-G 137 (299)
T ss_dssp TBCCEEEEECCTTCCEEEEECCSEEHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-C
T ss_pred CEeEEEeeeccCCceeehhhhhcchHHhhhhhcc--cCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCC-C
Confidence 689999999 556899999999877666655433 339999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccc-cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.+||+|||+++..... .......||+.|+|||++.. ...++.++||||+||++|+|++|..||.+....+..
T Consensus 138 ~~KL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l 210 (299)
T d1ua2a_ 138 VLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFG-------ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQL 210 (299)
T ss_dssp CEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTT-------CSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred ccccccCccccccCCCcccccceecChhhccHHHHcc-------CCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHH
Confidence 9999999999865433 23345679999999998853 245789999999999999999999999887766655
Q ss_pred HHHHhccCCCC---------------------------CCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhcCC
Q 024408 159 YAAAFKNVRPS---------------------------AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAP 211 (268)
Q Consensus 159 ~~~~~~~~~~~---------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~~~~ 211 (268)
.........+. ...+++++.++|.+||..||++|||+.|+++| .+++..+.
T Consensus 211 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H--p~f~~~p~ 288 (299)
T d1ua2a_ 211 TRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM--KYFSNRPG 288 (299)
T ss_dssp HHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS--GGGTSSSC
T ss_pred HHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC--HhhCCCCC
Confidence 44332211110 12467899999999999999999999999998 55655443
Q ss_pred C
Q 024408 212 P 212 (268)
Q Consensus 212 ~ 212 (268)
|
T Consensus 289 p 289 (299)
T d1ua2a_ 289 P 289 (299)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.1e-44 Score=299.06 Aligned_cols=187 Identities=28% Similarity=0.399 Sum_probs=163.1
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|+|++++++ .++.+|+||||++||+|.+++..... +++..+..++.|++.||+|||++||+||||||+|||++.+ +
T Consensus 65 nIv~~~~~~~~~~~~~ivmE~~~gg~l~~~~~~~~~--~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~-g 141 (316)
T d1fota_ 65 FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQR--FPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKN-G 141 (316)
T ss_dssp TBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTSS--CCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTT-S
T ss_pred ChhheeeeEeeCCeeeeEeeecCCcccccccccccc--ccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCC-C
Confidence 689999999 55689999999999999999987665 8999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 024408 80 TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY 159 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~ 159 (268)
.+||+|||+|+..... ..+..||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+...
T Consensus 142 ~vkL~DFG~a~~~~~~--~~~~~Gt~~Y~APE~l~~--------~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~ 211 (316)
T d1fota_ 142 HIKITDFGFAKYVPDV--TYTLCGTPDYIAPEVVST--------KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYE 211 (316)
T ss_dssp CEEECCCSSCEECSSC--BCCCCSCTTTCCHHHHTT--------CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH
T ss_pred CEEEecCccceEeccc--cccccCcccccCHHHHcC--------CCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHH
Confidence 9999999999864433 345689999999999864 567889999999999999999999999876665554
Q ss_pred HHHhccCCCCCCCCcHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 024408 160 AAAFKNVRPSAENVPEELSIILTSCWKEDPNARP-----NFTQIIQM 201 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~~~~~ 201 (268)
..... ....+..+++++.++|.+||..||.+|+ +++++++|
T Consensus 212 ~i~~~-~~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 212 KILNA-ELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp HHHHC-CCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHHcC-CCCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 44333 3445678999999999999999999996 89999987
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-44 Score=301.09 Aligned_cols=189 Identities=29% Similarity=0.457 Sum_probs=163.4
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|+|++++++ .++.+|+||||++||+|.+++..... +++.++..++.||+.||+|||++|++||||||+|||++.+ +
T Consensus 64 ~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i~~~~~--~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~-~ 140 (320)
T d1xjda_ 64 FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKD-G 140 (320)
T ss_dssp TBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-S
T ss_pred cEEEEEEEEccCCceeEEEeecCCCcHHHHhhccCC--CCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCC-C
Confidence 689999999 55689999999999999999987665 9999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccc-ccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESL-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.+||+|||+++.... ........||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+..+..
T Consensus 141 ~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~ 212 (320)
T d1xjda_ 141 HIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG--------QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF 212 (320)
T ss_dssp CEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred ceeccccchhhhcccccccccccCCCCCcCCHHHHcC--------CCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHH
Confidence 999999999985443 333345679999999999965 56889999999999999999999999987765554
Q ss_pred HHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHH-HHHHH
Q 024408 159 YAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFT-QIIQM 201 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~-~~~~~ 201 (268)
.... ......+..+++++.++|.+||..||.+||++. ++++|
T Consensus 213 ~~i~-~~~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~h 255 (320)
T d1xjda_ 213 HSIR-MDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 255 (320)
T ss_dssp HHHH-HCCCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred HHHH-cCCCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhC
Confidence 4443 333445677899999999999999999999985 78776
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-44 Score=294.32 Aligned_cols=195 Identities=29% Similarity=0.537 Sum_probs=164.8
Q ss_pred CceeEEEeecCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCC
Q 024408 1 MREQFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT 80 (268)
Q Consensus 1 ~~v~l~g~~~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~ 80 (268)
|+|+++|+|.++..++||||+++|+|.+++..... .+++..++.++.|++.||.|||++||+||||||+||+++.+ +.
T Consensus 72 nIv~~~g~~~~~~~~lv~e~~~~~~l~~~~~~~~~-~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~-~~ 149 (273)
T d1u46a_ 72 NLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQG-HFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATR-DL 149 (273)
T ss_dssp TBCCEEEEECSSSCEEEEECCTTCBHHHHHHHHGG-GSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEET-TE
T ss_pred CEEEEEEEEeecchheeeeeecCcchhhhhhcccC-CCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccc-cc
Confidence 68999999988888999999999999998876543 39999999999999999999999999999999999999998 69
Q ss_pred eEEecCCCcccccccc----ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChH
Q 024408 81 IKLADFGLAREESLTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNL 155 (268)
Q Consensus 81 ~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~~~ 155 (268)
+||+|||+++...... ......|+..|+|||++.+ ..++.++||||||+++|||++ |+.||.+.+..
T Consensus 150 vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--------~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~ 221 (273)
T d1u46a_ 150 VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT--------RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS 221 (273)
T ss_dssp EEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHH--------CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred eeeccchhhhhcccCCCcceecCccccCcccCCHHHHhC--------CCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH
Confidence 9999999998543322 2233457889999999865 567889999999999999998 89999988777
Q ss_pred HHHHHHHhccC-CCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHh
Q 024408 156 QAAYAAAFKNV-RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 205 (268)
Q Consensus 156 ~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~ 205 (268)
+.......... .+.+..+|+++.++|.+||..||++|||+.++++.|++.
T Consensus 222 ~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 222 QILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp HHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 76655544433 345678999999999999999999999999999988764
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-44 Score=302.54 Aligned_cols=194 Identities=19% Similarity=0.231 Sum_probs=165.4
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCC-C
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED-L 78 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~-~ 78 (268)
|+|++++++ .++++|||||||+||+|.++|.+.+. .+++.++..++.||+.||+|||++||+||||||+|||++.+ .
T Consensus 62 nIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~~~~-~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~ 140 (321)
T d1tkia_ 62 NILHLHESFESMEELVMIFEFISGLDIFERINTSAF-ELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRS 140 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSC
T ss_pred CCCeEEEEEEECCEEEEEEecCCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCc
Confidence 689999999 56789999999999999999976542 39999999999999999999999999999999999999753 2
Q ss_pred CCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 79 KTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 79 ~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
..+|++|||+++............+|+.|+|||.+.+ ..++.++||||+||++|+|++|..||.+....+..
T Consensus 141 ~~ikl~DFG~~~~~~~~~~~~~~~~t~~y~ape~~~~--------~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~ 212 (321)
T d1tkia_ 141 STIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQH--------DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQII 212 (321)
T ss_dssp CCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTT--------CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH
T ss_pred eEEEEcccchhhccccCCcccccccccccccchhccC--------CCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 4799999999987665555566788999999998864 56788999999999999999999999987766655
Q ss_pred HHHHhccCCCC---CCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 024408 159 YAAAFKNVRPS---AENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 203 (268)
Q Consensus 159 ~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~ 203 (268)
........... ...++++++++|.+||..||.+|||+.++++|-+
T Consensus 213 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~ 260 (321)
T d1tkia_ 213 ENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPW 260 (321)
T ss_dssp HHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred HHHHhCCCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence 55444433322 2468999999999999999999999999999843
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-44 Score=292.41 Aligned_cols=195 Identities=30% Similarity=0.528 Sum_probs=161.8
Q ss_pred CceeEEEee-cC-CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCC
Q 024408 1 MREQFIGAC-KE-PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL 78 (268)
Q Consensus 1 ~~v~l~g~~-~~-~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~ 78 (268)
|+|+++|+| ++ +.+++||||++||+|.+++.+.....+++..++.++.|++.||+|||+++++||||||+||+++.+
T Consensus 61 nIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~- 139 (262)
T d1byga_ 61 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSED- 139 (262)
T ss_dssp TBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT-
T ss_pred CEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCC-
Confidence 689999998 43 468999999999999999977554458999999999999999999999999999999999999998
Q ss_pred CCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 024408 79 KTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQA 157 (268)
Q Consensus 79 ~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~ 157 (268)
+.+|++|||+++..... .....++..|+|||++.+ ..++.++||||||+++|||++ |+.||......+.
T Consensus 140 ~~~kl~dfg~s~~~~~~--~~~~~~~~~y~aPE~l~~--------~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~ 209 (262)
T d1byga_ 140 NVAKVSDFGLTKEASST--QDTGKLPVKWTAPEALRE--------KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV 209 (262)
T ss_dssp SCEEECCCCC--------------CCTTTSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH
T ss_pred CCEeecccccceecCCC--CccccccccCCChHHHhC--------CCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHH
Confidence 69999999999864433 234567899999999864 568999999999999999998 7888888766665
Q ss_pred HHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhH
Q 024408 158 AYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 206 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 206 (268)
..........+.+..+++++.++|.+||..||.+|||+.+++++|+...
T Consensus 210 ~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~ 258 (262)
T d1byga_ 210 VPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258 (262)
T ss_dssp HHHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHcCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 5555555556667889999999999999999999999999999998754
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-43 Score=290.82 Aligned_cols=184 Identities=22% Similarity=0.342 Sum_probs=155.5
Q ss_pred CceeEEEee-cCCcEEEEEEcCCC-CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSG-GTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL 78 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~g-gsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~ 78 (268)
|+|++++++ ..+..++||||+.| +++.+++.+... +++.+++.++.|++.||+|||++||+||||||+|||++.+.
T Consensus 70 nIv~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~~~~--l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~ 147 (273)
T d1xwsa_ 70 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR 147 (273)
T ss_dssp SBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTT
T ss_pred CccEEEEEEeeCCeEEEEEEeccCcchHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCC
Confidence 689999999 45688999999975 688888887655 99999999999999999999999999999999999999665
Q ss_pred CCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 79 KTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 79 ~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
+.+||+|||+|+..... ...+..||+.|+|||++.+ ...++.++||||+||++|+|++|+.||.+..
T Consensus 148 ~~vkl~DFG~a~~~~~~-~~~~~~GT~~y~aPE~~~~-------~~~~~~~~DiwSlGvilyell~g~~Pf~~~~----- 214 (273)
T d1xwsa_ 148 GELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRY-------HRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----- 214 (273)
T ss_dssp TEEEECCCTTCEECCSS-CBCCCCSCGGGSCHHHHHH-------SCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----
T ss_pred CeEEECccccceecccc-cccccccCCCcCCHHHHcC-------CCCCCcccccccceeeehhHhhCCCCCCCch-----
Confidence 68999999999854433 3346689999999999864 2334678999999999999999999997622
Q ss_pred HHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 159 YAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
.........+..+|+++.++|.+||..||.+|||++|+++|
T Consensus 215 --~i~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 215 --EIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp --HHHHCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --HHhhcccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 11222334466799999999999999999999999999987
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=4e-43 Score=289.44 Aligned_cols=194 Identities=27% Similarity=0.449 Sum_probs=157.4
Q ss_pred CceeEEEeecC-----CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEe
Q 024408 1 MREQFIGACKE-----PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 75 (268)
Q Consensus 1 ~~v~l~g~~~~-----~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~ 75 (268)
|+|++++++.. ..+|+||||++|++|.+++...+. +++.+++.++.|++.||+|||++||+||||||+|||++
T Consensus 68 niv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~~~~--l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~ 145 (277)
T d1o6ya_ 68 AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS 145 (277)
T ss_dssp TBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE
T ss_pred CCCcccceeeeccCCCceEEEEEECCCCCEehhhhcccCC--CCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccC
Confidence 68999999832 247999999999999999987765 99999999999999999999999999999999999999
Q ss_pred CCCCCeEEecCCCccccccc----cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 024408 76 EDLKTIKLADFGLAREESLT----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 151 (268)
Q Consensus 76 ~~~~~~kl~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~ 151 (268)
.+ +..+++|||.+...... .......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+
T Consensus 146 ~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--------~~~~~~~DiwSlGvilyelltG~~Pf~~ 216 (277)
T d1o6ya_ 146 AT-NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG--------DSVDARSDVYSLGCVLYEVLTGEPPFTG 216 (277)
T ss_dssp TT-SCEEECCCTTCEECC----------------TTCCHHHHTT--------CCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cc-ccceeehhhhhhhhccccccccccccccCcccccCHHHHcC--------CCCCcceecccchHHHHHHHhCCCCCCC
Confidence 88 68999999998743222 22345579999999999864 5688999999999999999999999998
Q ss_pred CChHHHHHHHHhccCCC---CCCCCcHHHHHHHHhccccCCCCCC-CHHHHHHHHHHh
Q 024408 152 MSNLQAAYAAAFKNVRP---SAENVPEELSIILTSCWKEDPNARP-NFTQIIQMLLNY 205 (268)
Q Consensus 152 ~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rp-s~~~~~~~l~~~ 205 (268)
....+...........+ ....+|+++.++|.+||..||.+|| ++++++..|...
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 217 DSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp SSHHHHHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred cCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 77766655555444332 2467899999999999999999999 788888877654
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.8e-43 Score=290.30 Aligned_cols=196 Identities=29% Similarity=0.538 Sum_probs=166.1
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcC----------------------CCCCCHHHHHHHHHHHHHHHHHH
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMR----------------------PRCLDVCVAIGFALDIARAMECL 57 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~----------------------~~~~~~~~~~~~~~~l~~~l~~l 57 (268)
|+|+++|+| ..+..++||||+++|+|.+++.... ...+++.+++.++.|++.||+||
T Consensus 77 niv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yl 156 (301)
T d1lufa_ 77 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYL 156 (301)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHH
T ss_pred CcccceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhc
Confidence 689999999 5568999999999999999997532 12488999999999999999999
Q ss_pred HHCCCeecCCCCCCEEEeCCCCCeEEecCCCccccccc---cccccCCCccceeccccccccccccCCCCCCCchhhHHH
Q 024408 58 HSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYS 134 (268)
Q Consensus 58 H~~gi~H~Dikp~Nill~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws 134 (268)
|++|++||||||+|||++.+ +.+||+|||+++..... ....+..|++.|+|||.+.+ ..++.++||||
T Consensus 157 H~~~ivHrDlKp~NILld~~-~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~t~ksDVwS 227 (301)
T d1lufa_ 157 SERKFVHRDLATRNCLVGEN-MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY--------NRYTTESDVWA 227 (301)
T ss_dssp HHTTCCCSCCSGGGEEECGG-GCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH--------CCCCHHHHHHH
T ss_pred ccCCeEeeEEcccceEECCC-CcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHcc--------CCCChhhhhcc
Confidence 99999999999999999998 69999999999743322 22334568899999999865 67889999999
Q ss_pred HHHHHHHHHhCC-CCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHh
Q 024408 135 FAIVLWELLHNK-LPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 205 (268)
Q Consensus 135 lG~~l~~ll~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~ 205 (268)
||+++|||++|. .||.+....+...........+.+..+++++.++|.+||+.||++|||+.+|++.|+..
T Consensus 228 ~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 228 YGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp HHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred chhhHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 999999999985 67888777776666666655666788999999999999999999999999999998864
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-42 Score=287.57 Aligned_cols=203 Identities=26% Similarity=0.408 Sum_probs=164.0
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
++|++++++ .++++|+||||+. +++.+++.......+++.++..++.|++.||+|||++||+||||||+|||++.+ +
T Consensus 62 ~Iv~~~~~~~~~~~~~iv~e~~~-~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~-~ 139 (298)
T d1gz8a_ 62 NIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTE-G 139 (298)
T ss_dssp TBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-S
T ss_pred cEEEeccccccccceeEEEeecC-CchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeeccc-C
Confidence 689999999 5568999999996 567777765555569999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccc-ccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESL-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.+||+|||+|+.... ........||+.|+|||++.. ...++.++|+||+|+++|+|++|+.||.+.+..+..
T Consensus 140 ~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~apE~~~~-------~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~ 212 (298)
T d1gz8a_ 140 AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG-------CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 212 (298)
T ss_dssp CEEECSTTHHHHHCCCSBCTTCCBCCCTTCCHHHHTT-------CSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred cceeccCCcceeccCCcccceeecccceeeehhhhcc-------ccCCCccccccccchhhhHHhhCCCCCCCCCHHHHH
Confidence 999999999985443 233445579999999998753 245678999999999999999999999987766555
Q ss_pred HHHHhccCCCC----------------------------CCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhcC
Q 024408 159 YAAAFKNVRPS----------------------------AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIA 210 (268)
Q Consensus 159 ~~~~~~~~~~~----------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~~~ 210 (268)
.........+. ...+++++.++|.+||..||++|||+.|+++| .+++...
T Consensus 213 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H--~ff~~~~ 290 (298)
T d1gz8a_ 213 FRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH--PFFQDVT 290 (298)
T ss_dssp HHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS--GGGTTCC
T ss_pred HHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC--HhhccCC
Confidence 44332111110 12467889999999999999999999999998 6666655
Q ss_pred CCCC
Q 024408 211 PPEP 214 (268)
Q Consensus 211 ~~~~ 214 (268)
.|.|
T Consensus 291 ~p~p 294 (298)
T d1gz8a_ 291 KPVP 294 (298)
T ss_dssp CCCC
T ss_pred CCCC
Confidence 5443
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-42 Score=289.61 Aligned_cols=199 Identities=33% Similarity=0.550 Sum_probs=165.9
Q ss_pred CceeEEEeec-CCcEEEEEEcCCCCCHHHHHHhcCC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCe
Q 024408 1 MREQFIGACK-EPVMVIVTELLSGGTLRKYLLNMRP----------------RCLDVCVAIGFALDIARAMECLHSHGII 63 (268)
Q Consensus 1 ~~v~l~g~~~-~~~~~lV~e~~~ggsL~~~i~~~~~----------------~~~~~~~~~~~~~~l~~~l~~lH~~gi~ 63 (268)
|+|+++|+|. .+..++|||||+||+|.+++.+... ..+++..+..++.|++.||+|||++|++
T Consensus 88 nIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~iv 167 (311)
T d1t46a_ 88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCI 167 (311)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred CEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 6899999995 4578999999999999999976432 2489999999999999999999999999
Q ss_pred ecCCCCCCEEEeCCCCCeEEecCCCccccccc---cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHH
Q 024408 64 HRDLKPENLLLTEDLKTIKLADFGLAREESLT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLW 140 (268)
Q Consensus 64 H~Dikp~Nill~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~ 140 (268)
||||||+||+++.+ +.++++|||+++..... .......||+.|+|||++.. ..++.++||||||+++|
T Consensus 168 HrDLKp~NIl~~~~-~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DIwS~G~~l~ 238 (311)
T d1t46a_ 168 HRDLAARNILLTHG-RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN--------CVYTFESDVWSYGIFLW 238 (311)
T ss_dssp CSCCSGGGEEEETT-TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH--------CCCCHHHHHHHHHHHHH
T ss_pred eccccccccccccc-CcccccccchheeccCCCcceEeeecccChHHcCHHHhcC--------CCCCCcccccchHHHHH
Confidence 99999999999988 69999999999854332 22234578999999999864 67899999999999999
Q ss_pred HHHh-CCCCCCCCChHHHHHHHHhc-cCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 024408 141 ELLH-NKLPFEGMSNLQAAYAAAFK-NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 208 (268)
Q Consensus 141 ~ll~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 208 (268)
||++ |.+||............... .....+..++.++.+||.+||+.||++|||+.++++.|+..+.+
T Consensus 239 ellt~g~p~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 239 ELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp HHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 9998 66667665554444443333 33444677899999999999999999999999999999887765
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-42 Score=288.03 Aligned_cols=198 Identities=30% Similarity=0.492 Sum_probs=162.6
Q ss_pred CceeEEEee-c-CCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCC
Q 024408 1 MREQFIGAC-K-EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL 78 (268)
Q Consensus 1 ~~v~l~g~~-~-~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~ 78 (268)
|+|+++|+| . ++..++|||||+||+|.+++..... .+++..++.++.|++.||.|||+.||+||||||+|||++++
T Consensus 89 nIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~~~~~-~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~- 166 (311)
T d1r0pa_ 89 NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEK- 166 (311)
T ss_dssp TBCCCCEEEEETTTEEEEEEECCTTCBHHHHHHCTTC-CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT-
T ss_pred CEeEEeEEEEecCCceEEEEEEeecCchhhhhccccc-cchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCC-
Confidence 689999998 3 4578999999999999999876443 38899999999999999999999999999999999999988
Q ss_pred CCeEEecCCCcccccccc-----ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 024408 79 KTIKLADFGLAREESLTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS 153 (268)
Q Consensus 79 ~~~kl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~ 153 (268)
+.+||+|||+++...... ......||..|+|||.+.. ..++.++||||||+++|||++|..||....
T Consensus 167 ~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~ksDI~SfGivl~El~t~~~p~~~~~ 238 (311)
T d1r0pa_ 167 FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT--------QKFTTKSDVWSFGVLLWELMTRGAPPYPDV 238 (311)
T ss_dssp CCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCSCC--
T ss_pred CCEEEecccchhhccccccccceecccccccccccChHHHhc--------CCCCChhHhhhhHHHHHHHHHCCCCCCCCC
Confidence 699999999998543322 1223468999999999864 668999999999999999999777775433
Q ss_pred hH-HHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 024408 154 NL-QAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 208 (268)
Q Consensus 154 ~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 208 (268)
.. +.............+..+++++.++|.+||..||++||++.||+++|+.....
T Consensus 239 ~~~~~~~~i~~g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 239 NTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp ----CHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CHHHHHHHHHcCCCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 32 22333334444455678899999999999999999999999999999988765
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-42 Score=286.61 Aligned_cols=191 Identities=26% Similarity=0.339 Sum_probs=158.7
Q ss_pred CceeEEEeec------CCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEE
Q 024408 1 MREQFIGACK------EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL 74 (268)
Q Consensus 1 ~~v~l~g~~~------~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill 74 (268)
|+|++++++. +..+++||||++|+++.. ........+++..+..++.|++.||+|||++||+||||||+|||+
T Consensus 71 nIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~-~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi 149 (305)
T d1blxa_ 71 NVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTY-LDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV 149 (305)
T ss_dssp TBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHH-HHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE
T ss_pred CcceeeeeecccccccCceEEEEEEeccCCchhh-hhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEE
Confidence 6899999983 237899999998765544 433344559999999999999999999999999999999999999
Q ss_pred eCCCCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh
Q 024408 75 TEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN 154 (268)
Q Consensus 75 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~ 154 (268)
+.+ +.+||+|||+++............||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.+.
T Consensus 150 ~~~-~~~kl~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~--------~~y~~~~DiwSlG~il~ell~g~~pf~~~~~ 220 (305)
T d1blxa_ 150 TSS-GQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ--------SSYATPVDLWSVGCIFAEMFRRKPLFRGSSD 220 (305)
T ss_dssp CTT-CCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTT--------CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cCC-CCeeecchhhhhhhcccccCCCcccChhhcCcchhcC--------CCCChhehhhchHHHHHHHHHCCCCCCCCCH
Confidence 988 6999999999987666666677889999999999864 6688999999999999999999999998776
Q ss_pred HHHHHHHHhccCC--------------------------CCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 155 LQAAYAAAFKNVR--------------------------PSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 155 ~~~~~~~~~~~~~--------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
.+........... .....+++.+.+||.+||..||++|||+.|+++|
T Consensus 221 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 221 VDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp HHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 5554443221110 0124578899999999999999999999999998
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-42 Score=285.75 Aligned_cols=197 Identities=28% Similarity=0.519 Sum_probs=168.4
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMR--------PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPEN 71 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~--------~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~N 71 (268)
|+|+++|+| .++..++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+++|+||||||+|
T Consensus 84 nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~N 163 (308)
T d1p4oa_ 84 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARN 163 (308)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGG
T ss_pred CEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCc
Confidence 689999999 5568999999999999999987532 1347899999999999999999999999999999999
Q ss_pred EEEeCCCCCeEEecCCCcccccccc---ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhC-CC
Q 024408 72 LLLTEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHN-KL 147 (268)
Q Consensus 72 ill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g-~~ 147 (268)
||++.+ +++||+|||+++...... ......||+.|+|||.+.+ ..++.++||||||+++|||++| ..
T Consensus 164 iLld~~-~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~--------~~~~~~~Dv~S~G~il~El~t~~~~ 234 (308)
T d1p4oa_ 164 CMVAED-FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD--------GVFTTYSDVWSFGVVLWEIATLAEQ 234 (308)
T ss_dssp EEECTT-CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHHTSCC
T ss_pred eeecCC-ceEEEeecccceeccCCcceeeccceecccccCCHHHHcc--------CCCCcccccccHHHHHHHHHhCCCC
Confidence 999988 699999999998543322 2334468999999999864 6688899999999999999997 57
Q ss_pred CCCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhH
Q 024408 148 PFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 206 (268)
Q Consensus 148 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 206 (268)
||.+....+...........+.+..+++.+.++|.+||+.||++|||+.+++++|+...
T Consensus 235 p~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~ 293 (308)
T d1p4oa_ 235 PYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293 (308)
T ss_dssp TTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred CCCCCCHHHHHHHHHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 88887777766666666666667889999999999999999999999999999987654
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-40 Score=280.38 Aligned_cols=199 Identities=23% Similarity=0.256 Sum_probs=158.1
Q ss_pred CceeEEEeec-------CCcEEEEEEcCCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCC
Q 024408 1 MREQFIGACK-------EPVMVIVTELLSGGTLRKYLLN--MRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPEN 71 (268)
Q Consensus 1 ~~v~l~g~~~-------~~~~~lV~e~~~ggsL~~~i~~--~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~N 71 (268)
|+|++++++. +.+++|||||++|+ +.+.+.. .....+++.++..++.|++.||+|||++||+||||||+|
T Consensus 74 niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~-~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~N 152 (350)
T d1q5ka_ 74 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQN 152 (350)
T ss_dssp TBCCEEEEEEEC--CCSCCEEEEEEECCSEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGG
T ss_pred CCCcEEEEEEecCccCCceEEEEEEeccCCc-cHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcce
Confidence 6889999872 12579999999754 5444432 234459999999999999999999999999999999999
Q ss_pred EEEeCCCCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 024408 72 LLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 151 (268)
Q Consensus 72 ill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~ 151 (268)
||++.+...+||+|||+++.........+..||..|+|||.+.+ ...++.++||||+||++|||++|+.||..
T Consensus 153 ILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DIwSlG~il~el~~g~~pf~~ 225 (350)
T d1q5ka_ 153 LLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG-------ATDYTSSIDVWSAGCVLAELLLGQPIFPG 225 (350)
T ss_dssp EEECTTTCCEEECCCTTCEECCTTSCCCSCCSCTTSCCHHHHTT-------CSSCCTHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred EEEecCCCceeEecccchhhccCCcccccccccccccChHHhhc-------ccCCCcceeecccceEEEehhhCCCCCCC
Confidence 99997745899999999987666666667789999999998753 35688999999999999999999999988
Q ss_pred CChHHHHHHHHhccC------------------C----------CCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 024408 152 MSNLQAAYAAAFKNV------------------R----------PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 203 (268)
Q Consensus 152 ~~~~~~~~~~~~~~~------------------~----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~ 203 (268)
....+.......... . .....+++++.+||.+||..||.+|||+.|+++|
T Consensus 226 ~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H-- 303 (350)
T d1q5ka_ 226 DSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH-- 303 (350)
T ss_dssp SSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS--
T ss_pred CCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC--
Confidence 765554433321100 0 0123568899999999999999999999999998
Q ss_pred HhHhhc
Q 024408 204 NYLSAI 209 (268)
Q Consensus 204 ~~~~~~ 209 (268)
.+++..
T Consensus 304 p~f~~~ 309 (350)
T d1q5ka_ 304 SFFDEL 309 (350)
T ss_dssp GGGGGG
T ss_pred Hhhccc
Confidence 555543
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.3e-40 Score=273.86 Aligned_cols=208 Identities=19% Similarity=0.234 Sum_probs=164.2
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeC---
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE--- 76 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~--- 76 (268)
+++.+++++ .+...++||||+ |++|.+++...+. .+++.++..++.|++.||+|||++||+||||||+|||++.
T Consensus 62 ~i~~~~~~~~~~~~~~~vme~~-~~~l~~~~~~~~~-~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~ 139 (293)
T d1csna_ 62 GIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGR-KFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNS 139 (293)
T ss_dssp TCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSS
T ss_pred CCCEEEEEeecCCccEEEEEec-CCCHHHHHHhhcc-chhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCccc
Confidence 466788888 556889999999 7999999876544 4999999999999999999999999999999999999974
Q ss_pred -CCCCeEEecCCCccccccc--------cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCC
Q 024408 77 -DLKTIKLADFGLAREESLT--------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKL 147 (268)
Q Consensus 77 -~~~~~kl~Dfg~a~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~ 147 (268)
..+.++|+|||+|+..... ....+..||+.|+|||++.+ ..++.++||||||+++|||++|..
T Consensus 140 ~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~--------~~~~~~~DiwSlG~~l~elltg~~ 211 (293)
T d1csna_ 140 KNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG--------REQSRRDDLEALGHVFMYFLRGSL 211 (293)
T ss_dssp TTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--------CCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred ccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcC--------CCCChHHHHHHhhHHHHHHHhCCC
Confidence 2357999999999854322 12234579999999999864 568999999999999999999999
Q ss_pred CCCCCChH---HHHHHHHhc--cC--CCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhcCCCCCCCCC
Q 024408 148 PFEGMSNL---QAAYAAAFK--NV--RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIPH 218 (268)
Q Consensus 148 p~~~~~~~---~~~~~~~~~--~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~~~~~~~~~~~ 218 (268)
||.+.... ......... .. ......+|+++.+++..|+..+|++||+++.+.+.|.+.++......+...+
T Consensus 212 Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~~~~~D 289 (293)
T d1csna_ 212 PWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFD 289 (293)
T ss_dssp TTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCG
T ss_pred cCCCccchhHHHHHHHHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 99754322 111111111 11 1124678999999999999999999999999999999988876655544333
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.1e-40 Score=273.64 Aligned_cols=202 Identities=22% Similarity=0.287 Sum_probs=154.5
Q ss_pred eeEEEee--cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeC--CC
Q 024408 3 EQFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE--DL 78 (268)
Q Consensus 3 v~l~g~~--~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~--~~ 78 (268)
|.+++.| .++..++||||+ |++|.+.+..... .+++..+..++.|++.||+|||++||+||||||+|||++. ..
T Consensus 65 i~~~~~~~~~~~~~~ivme~~-~~~l~~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~ 142 (299)
T d1ckia_ 65 IPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSR-KFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKG 142 (299)
T ss_dssp CCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGT
T ss_pred ccEEEEEEecCCEEEEEEEEc-CCchhhhhhhccC-CCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCC
Confidence 4444444 456789999999 6788887765443 4999999999999999999999999999999999999853 22
Q ss_pred CCeEEecCCCcccccccc--------ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 024408 79 KTIKLADFGLAREESLTE--------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFE 150 (268)
Q Consensus 79 ~~~kl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~ 150 (268)
..++++|||+|+...... ...+..||+.|+|||++.+ ..++.++||||||+++|||++|+.||.
T Consensus 143 ~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlG~~l~el~tg~~P~~ 214 (299)
T d1ckia_ 143 NLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG--------IEQSRRDDLESLGYVLMYFNLGSLPWQ 214 (299)
T ss_dssp TCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTT--------BCCCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred ceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhC--------CCCCChhhEEecCHHHHHHHhCCCccc
Confidence 479999999998543321 2234579999999999864 568899999999999999999999998
Q ss_pred CCChHHHHHHH---Hh----ccCCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhcCCCCC
Q 024408 151 GMSNLQAAYAA---AF----KNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEP 214 (268)
Q Consensus 151 ~~~~~~~~~~~---~~----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~~~~~~~ 214 (268)
........... .. .........+|+++.+++..||+.||++||++.++.+.|+..+........
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~~~ 285 (299)
T d1ckia_ 215 GLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYD 285 (299)
T ss_dssp CCC-------HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCCCS
T ss_pred ccchHHHHHHHHHhhcccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCCCC
Confidence 75543322211 11 111112467899999999999999999999999999999887765544443
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.4e-40 Score=274.00 Aligned_cols=191 Identities=25% Similarity=0.340 Sum_probs=152.1
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|+|++++++ .++..++||||+.|+.+..+....+ .+++.++..++.|++.||+|||++||+||||||+|||++.+ +
T Consensus 61 nIv~~~~~~~~~~~~~i~~e~~~~~~~~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~-~ 137 (286)
T d1ob3a_ 61 NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG--GLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINRE-G 137 (286)
T ss_dssp TBCCEEEEEECSSCEEEEEECCSEEHHHHHHTSTT--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-S
T ss_pred cEEeeeeecccCCceeEEEEeehhhhHHHHHhhcC--CcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCC-C
Confidence 689999999 5578999999997665555554433 39999999999999999999999999999999999999998 6
Q ss_pred CeEEecCCCccccccc-cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.+|++|||.+...... .......+++.|+|||.+.. ...++.++|+||||+++|||++|+.||.+....+..
T Consensus 138 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~~~-------~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~ 210 (286)
T d1ob3a_ 138 ELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG-------SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQL 210 (286)
T ss_dssp CEEECCTTHHHHHCC---------CCCTTCCHHHHTT-------CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred CEEecccccceecccCccccceecccchhhhHHHHhC-------CCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHH
Confidence 9999999999864432 22344568999999998853 345789999999999999999999999987765554
Q ss_pred HHHHhccCCC----------------------------CCCCCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 159 YAAAFKNVRP----------------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 159 ~~~~~~~~~~----------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
.........+ ....+++.+.++|.+||..||++|||+.|+++|
T Consensus 211 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 211 MRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp HHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 4432211111 124567899999999999999999999999987
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-40 Score=275.93 Aligned_cols=204 Identities=25% Similarity=0.341 Sum_probs=153.3
Q ss_pred CceeEEEeecC-C----cEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH--------CCCeecCC
Q 024408 1 MREQFIGACKE-P----VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS--------HGIIHRDL 67 (268)
Q Consensus 1 ~~v~l~g~~~~-~----~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~--------~gi~H~Di 67 (268)
|+|+++|+|.+ + .+++||||+++|+|.++|.+. .+++.+++.++.|++.||+|+|+ +||+||||
T Consensus 58 nIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDl 134 (303)
T d1vjya_ 58 NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDL 134 (303)
T ss_dssp TBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCC
T ss_pred cCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeecccc
Confidence 68999999943 2 579999999999999999763 39999999999999999999996 59999999
Q ss_pred CCCCEEEeCCCCCeEEecCCCcccccccc-----ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHH
Q 024408 68 KPENLLLTEDLKTIKLADFGLAREESLTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWEL 142 (268)
Q Consensus 68 kp~Nill~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~l 142 (268)
||+|||++.+ +.+||+|||+++...... ......||+.|+|||++.+... .....++.++||||||+++|||
T Consensus 135 Kp~NILl~~~-~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~~~~k~Di~S~Gvvl~el 211 (303)
T d1vjya_ 135 KSKNILVKKN-GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSIN--MKHFESFKRADIYAMGLVFWEI 211 (303)
T ss_dssp CGGGEEECTT-SCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSC--TTCHHHHHHHHHHHHHHHHHHH
T ss_pred CccceEEcCC-CCeEEEecCccccccCCCcceeccccceecccCcCChhhcccccc--ccCCCcCcchhhhhhHHHHHHH
Confidence 9999999988 699999999998543321 2334579999999998864110 0112356789999999999999
Q ss_pred HhCCCCCCCCC--------------hHHHHH-HHHhccCCCCC-C-----CCcHHHHHHHHhccccCCCCCCCHHHHHHH
Q 024408 143 LHNKLPFEGMS--------------NLQAAY-AAAFKNVRPSA-E-----NVPEELSIILTSCWKEDPNARPNFTQIIQM 201 (268)
Q Consensus 143 l~g~~p~~~~~--------------~~~~~~-~~~~~~~~~~~-~-----~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 201 (268)
++|..|+.... ..+... ........+.. . ..+..+.+++.+||+.||.+|||+.++++.
T Consensus 212 ~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 212 ARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp HHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred hhCCCCCCcccccccchhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 99987663211 111111 11222222221 1 123568999999999999999999999999
Q ss_pred HHHhHhhcC
Q 024408 202 LLNYLSAIA 210 (268)
Q Consensus 202 l~~~~~~~~ 210 (268)
|+++.+...
T Consensus 292 L~~i~~~~~ 300 (303)
T d1vjya_ 292 LSQLSQQEG 300 (303)
T ss_dssp HHHHHHHHC
T ss_pred HHHHHHhcC
Confidence 988776543
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-39 Score=274.04 Aligned_cols=192 Identities=25% Similarity=0.346 Sum_probs=158.9
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|++++++++ .....++||||+.||+|.+++...+. +++..+..++.|++.||+|||++|++||||||+||+++.+ +
T Consensus 90 nIv~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~--~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~-~ 166 (322)
T d1vzoa_ 90 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER--FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSN-G 166 (322)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-S
T ss_pred eEEEeeeeeccCCceeeeeecccccHHHHHHHhccc--ccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCC-C
Confidence 589999998 55689999999999999999988766 8899999999999999999999999999999999999998 6
Q ss_pred CeEEecCCCcccccc--ccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH--
Q 024408 80 TIKLADFGLAREESL--TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL-- 155 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~-- 155 (268)
.+||+|||+++.... .....+..|++.|++||.+.+ ....++.++|||||||++|+|++|+.||.+....
T Consensus 167 ~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~------~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~ 240 (322)
T d1vzoa_ 167 HVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRG------GDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS 240 (322)
T ss_dssp CEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTT------CC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC
T ss_pred CEEEeeccchhhhcccccccccccccccccchhHHhhc------CCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 999999999975433 233445679999999998854 2245778999999999999999999999765432
Q ss_pred -HHHHHHHhccCCCCCCCCcHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 024408 156 -QAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARP-----NFTQIIQM 201 (268)
Q Consensus 156 -~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~~~~~ 201 (268)
............+.+..+++++.++|.+||..||.+|| +++|+++|
T Consensus 241 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 241 QAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp HHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred HHHHHHhcccCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 22233333444455678999999999999999999999 47899887
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-39 Score=274.24 Aligned_cols=193 Identities=24% Similarity=0.323 Sum_probs=156.6
Q ss_pred CceeEEEeecC-C------cEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEE
Q 024408 1 MREQFIGACKE-P------VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 73 (268)
Q Consensus 1 ~~v~l~g~~~~-~------~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nil 73 (268)
|+|++++++.. + ++|+||||+ |.+|.+++.. .. +++..++.++.|++.||+|||++||+||||||+|||
T Consensus 78 niv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~-~~--l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL 153 (346)
T d1cm8a_ 78 NVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH-EK--LGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLA 153 (346)
T ss_dssp TBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH-CC--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred CeeEEEEEeccCccccccceEEEEEecc-cccHHHHHHh-cc--ccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhh
Confidence 58899999843 2 579999999 6788887754 33 999999999999999999999999999999999999
Q ss_pred EeCCCCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 024408 74 LTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS 153 (268)
Q Consensus 74 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~ 153 (268)
++.+ +.+|++|||+|+..... .....||+.|+|||++.+ ...++.++||||+||++|+|++|+.||.+.+
T Consensus 154 ~~~~-~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwSlGvil~ell~g~~pf~~~~ 223 (346)
T d1cm8a_ 154 VNED-CELKILDFGLARQADSE--MTGYVVTRWYRAPEVILN-------WMRYTQTVDIWSVGCIMAEMITGKTLFKGSD 223 (346)
T ss_dssp ECTT-CCEEECCCTTCEECCSS--CCSSCSCGGGCCTHHHHT-------TTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccc-cccccccccceeccCCc--cccccccccccCHHHHcC-------CCCCCccchhhcchHHHHHHHHCcCCCCCCC
Confidence 9998 69999999999864433 345689999999998864 2456889999999999999999999998876
Q ss_pred hHHHHHHHHhccCC------------------------------CCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 024408 154 NLQAAYAAAFKNVR------------------------------PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 203 (268)
Q Consensus 154 ~~~~~~~~~~~~~~------------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~ 203 (268)
.............. .....+++++.+||.+||..||.+|||+.++++|
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H-- 301 (346)
T d1cm8a_ 224 HLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH-- 301 (346)
T ss_dssp HHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS--
T ss_pred hHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC--
Confidence 55443322211110 1124578899999999999999999999999998
Q ss_pred HhHhhc
Q 024408 204 NYLSAI 209 (268)
Q Consensus 204 ~~~~~~ 209 (268)
.+++..
T Consensus 302 p~f~~~ 307 (346)
T d1cm8a_ 302 PYFESL 307 (346)
T ss_dssp GGGTTT
T ss_pred hhhCcC
Confidence 455443
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.4e-39 Score=274.32 Aligned_cols=189 Identities=20% Similarity=0.272 Sum_probs=152.7
Q ss_pred CceeEEEeec---CCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCC
Q 024408 1 MREQFIGACK---EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED 77 (268)
Q Consensus 1 ~~v~l~g~~~---~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~ 77 (268)
|+|++++++. ..++++||||+++++|.++.+ .+++.++..++.||+.||+|||++||+||||||+|||++.+
T Consensus 91 nIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~-----~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~ 165 (328)
T d3bqca1 91 NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHE 165 (328)
T ss_dssp TBCCEEEEEECTTTCSEEEEEECCCSCBGGGTTT-----SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETT
T ss_pred CCcEEEEEEEecCCCceeEEEeecCCCcHHHHhc-----CCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCC
Confidence 6899999984 246999999999999876532 39999999999999999999999999999999999999976
Q ss_pred CCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 024408 78 LKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA 157 (268)
Q Consensus 78 ~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~ 157 (268)
.+.+||+|||+|+............+|+.|+|||.+.+ ...++.++|+||+|+++|++++|+.||........
T Consensus 166 ~~~vkl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~ 238 (328)
T d3bqca1 166 HRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD-------YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD 238 (328)
T ss_dssp TTEEEECCGGGCEECCTTCCCCSCCSCGGGCCHHHHTT-------CCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH
T ss_pred CCeeeecccccceeccCCCcccccccCccccCcccccC-------CCCCCcccchhhhhhhhHHhccCCCCCCCCchhHH
Confidence 45799999999987665555667789999999998764 24578899999999999999999999976543221
Q ss_pred HHHHHhc--------------c-----------------------CCCCCCCCcHHHHHHHHhccccCCCCCCCHHHHHH
Q 024408 158 AYAAAFK--------------N-----------------------VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQ 200 (268)
Q Consensus 158 ~~~~~~~--------------~-----------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~ 200 (268)
....... . .......+++++.+||++||..||.+|||++|+++
T Consensus 239 ~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 239 QLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp HHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111000 0 00011346789999999999999999999999999
Q ss_pred H
Q 024408 201 M 201 (268)
Q Consensus 201 ~ 201 (268)
|
T Consensus 319 H 319 (328)
T d3bqca1 319 H 319 (328)
T ss_dssp S
T ss_pred C
Confidence 7
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-39 Score=269.36 Aligned_cols=196 Identities=19% Similarity=0.229 Sum_probs=151.0
Q ss_pred CceeEEEeecC---------CcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCC
Q 024408 1 MREQFIGACKE---------PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPEN 71 (268)
Q Consensus 1 ~~v~l~g~~~~---------~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~N 71 (268)
|++++++.+.. ..+++||||+.++++...... ...+++..++.++.|++.||.|||++||+||||||+|
T Consensus 70 nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~--~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~N 147 (318)
T d3blha1 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAAN 147 (318)
T ss_dssp TBCCEEEEEEC----------CEEEEEECCCEEHHHHHTCT--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred CccceEeeeecccccccccCceEEEEEeccCCCccchhhhc--ccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchh
Confidence 57888888732 358999999976655444333 2349999999999999999999999999999999999
Q ss_pred EEEeCCCCCeEEecCCCccccccc-----cccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCC
Q 024408 72 LLLTEDLKTIKLADFGLAREESLT-----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNK 146 (268)
Q Consensus 72 ill~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~ 146 (268)
||++.+ +.+|++|||+++..... ....+..||+.|+|||++.+ ...++.++||||+|+++|+|++|+
T Consensus 148 ILl~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~-------~~~~~~k~DiwSlGvil~el~~g~ 219 (318)
T d3blha1 148 VLITRD-GVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLG-------ERDYGPPIDLWGAGCIMAEMWTRS 219 (318)
T ss_dssp EEECTT-SCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTT-------CSSCCTHHHHHHHHHHHHHHHHSS
T ss_pred eeecCC-CcEEeeecceeeecccccccccccccceecCHHHhhHHHHcC-------CCCCCcHHHcccCCceeeeHhhCC
Confidence 999998 69999999999744322 22234579999999999864 245788999999999999999999
Q ss_pred CCCCCCChHHHHHHHHhccCCCCCC-------------------------------CCcHHHHHHHHhccccCCCCCCCH
Q 024408 147 LPFEGMSNLQAAYAAAFKNVRPSAE-------------------------------NVPEELSIILTSCWKEDPNARPNF 195 (268)
Q Consensus 147 ~p~~~~~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~l~~li~~~l~~~p~~Rps~ 195 (268)
.||.+................+... ..++.+.+||.+||..||++|||+
T Consensus 220 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa 299 (318)
T d3blha1 220 PIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS 299 (318)
T ss_dssp CSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCH
T ss_pred CCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCH
Confidence 9998866555443332221111100 125677899999999999999999
Q ss_pred HHHHHHHHHhHhh
Q 024408 196 TQIIQMLLNYLSA 208 (268)
Q Consensus 196 ~~~~~~l~~~~~~ 208 (268)
+|+++| .+++.
T Consensus 300 ~elL~H--pff~~ 310 (318)
T d3blha1 300 DDALNH--DFFWS 310 (318)
T ss_dssp HHHHHS--GGGSS
T ss_pred HHHHcC--hhhcc
Confidence 999998 45543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-38 Score=270.54 Aligned_cols=189 Identities=28% Similarity=0.351 Sum_probs=150.6
Q ss_pred CceeEEEeecCC------cEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEE
Q 024408 1 MREQFIGACKEP------VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL 74 (268)
Q Consensus 1 ~~v~l~g~~~~~------~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill 74 (268)
++|++++++..+ ..++||+ +.||+|.+++... .+++..++.++.|++.||+|||++||+||||||+|||+
T Consensus 67 ~iv~~~~~~~~~~~~~~~~~~l~~~-~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl 142 (345)
T d1pmea_ 67 NIIGINDIIRAPTIEQMKDVYLVTH-LMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL 142 (345)
T ss_dssp TBCCCCEEECCSSTTTCCCEEEEEE-CCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred CCCcEEEEEeeccccccceEEEEEe-ecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEE
Confidence 578899998542 3455555 5589999999753 39999999999999999999999999999999999999
Q ss_pred eCCCCCeEEecCCCcccccccc----ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 024408 75 TEDLKTIKLADFGLAREESLTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFE 150 (268)
Q Consensus 75 ~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~ 150 (268)
+.+ +.+||+|||+++...... ......||+.|+|||++.. ...++.++||||+|+++|+|++|+.||.
T Consensus 143 ~~~-~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-------~~~~~~~~DiwSlG~il~eml~g~~pf~ 214 (345)
T d1pmea_ 143 NTT-CDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN-------SKGYTKSIDIWSVGCILAEMLSNRPIFP 214 (345)
T ss_dssp CTT-CCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTT-------BCSCSTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CCC-CCEEEcccCceeeccCCCccceeeccccccceechHHHhhc-------CCCCCchhhhhccCceehHHhhCCCCCC
Confidence 988 699999999997543322 2345579999999998853 2457889999999999999999999998
Q ss_pred CCChHHHHHHHHhccCCC------------------------------CCCCCcHHHHHHHHhccccCCCCCCCHHHHHH
Q 024408 151 GMSNLQAAYAAAFKNVRP------------------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQ 200 (268)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~ 200 (268)
+....+...........+ ....+++++.++|.+||..||.+|||+.++++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 215 GKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp CSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 766544333222111110 12356788999999999999999999999999
Q ss_pred H
Q 024408 201 M 201 (268)
Q Consensus 201 ~ 201 (268)
|
T Consensus 295 h 295 (345)
T d1pmea_ 295 H 295 (345)
T ss_dssp S
T ss_pred C
Confidence 8
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-38 Score=263.16 Aligned_cols=196 Identities=21% Similarity=0.284 Sum_probs=156.3
Q ss_pred CceeEEEee-cCCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCC
Q 024408 1 MREQFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 79 (268)
Q Consensus 1 ~~v~l~g~~-~~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~ 79 (268)
|+|++++++ .....++|||++.|++|..++...+. +++..+..++.|++.||+|||++||+||||||+|||++.+ +
T Consensus 62 niv~~~~~~~~~~~~~iv~~~~~~~~l~~~~~~~~~--~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~-~ 138 (292)
T d1unla_ 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGD--LDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRN-G 138 (292)
T ss_dssp TBCCEEEEEECSSEEEEEEECCSEEHHHHHHHTTTC--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-C
T ss_pred CEEeeccccccccceeEEeeeccccccccccccccc--cchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccC-C
Confidence 689999999 45688999999999988888776544 9999999999999999999999999999999999999988 6
Q ss_pred CeEEecCCCcccccccc-ccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 024408 80 TIKLADFGLAREESLTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 158 (268)
Q Consensus 80 ~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~ 158 (268)
.+|++|||.++...... ......++..|+|||++.. ...++.++||||+||++|+|++|+.||.........
T Consensus 139 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~~~~-------~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~ 211 (292)
T d1unla_ 139 ELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG-------AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ 211 (292)
T ss_dssp CEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTT-------CSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHH
T ss_pred ceeeeecchhhcccCCCccceeeccccchhhhhHhcc-------CCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHH
Confidence 99999999998654433 3334467889999998754 244688999999999999999999987554443332
Q ss_pred HHHH-hccCC----------------------------CCCCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 024408 159 YAAA-FKNVR----------------------------PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 208 (268)
Q Consensus 159 ~~~~-~~~~~----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 208 (268)
.... ..... .....+++.+.+||.+||..||++|||++|+++| .+++.
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H--p~f~~ 288 (292)
T d1unla_ 212 LKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH--PYFSD 288 (292)
T ss_dssp HHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS--GGGSS
T ss_pred HHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC--hhhcC
Confidence 2221 11110 0123567899999999999999999999999998 44443
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-38 Score=267.48 Aligned_cols=193 Identities=27% Similarity=0.307 Sum_probs=150.9
Q ss_pred CceeEEEeec------CCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEE
Q 024408 1 MREQFIGACK------EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL 74 (268)
Q Consensus 1 ~~v~l~g~~~------~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill 74 (268)
++|++++++. +...++||+|+.||+|.+++... .+++.++..++.||+.||+|||++||+||||||+|||+
T Consensus 78 ~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi 154 (348)
T d2gfsa1 78 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 154 (348)
T ss_dssp TBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE
T ss_pred CeeeEEEEEeeccccccCceEEEEEeecCCchhhhcccc---cccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccc
Confidence 5788888873 22446666777799999998542 39999999999999999999999999999999999999
Q ss_pred eCCCCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh
Q 024408 75 TEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN 154 (268)
Q Consensus 75 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~~ 154 (268)
+.+ +.+|++|||++...... ..+..|++.|+|||+..+ ...++.++||||||+++|+|++|+.||.+.+.
T Consensus 155 ~~~-~~~kl~dfg~a~~~~~~--~~~~~g~~~y~apE~~~~-------~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~ 224 (348)
T d2gfsa1 155 NED-CELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLN-------WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 224 (348)
T ss_dssp CTT-CCEEECCC----CCTGG--GSSSCHHHHTSCHHHHTT-------CSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccc-ccccccccchhcccCcc--cccccccccccCchhhcC-------CccCCcccchhhhhHHHHHHHhCCCCCCCCCH
Confidence 988 69999999999764332 355679999999998753 24568899999999999999999999988765
Q ss_pred HHHHHHHHhccCCCC------------------------------CCCCcHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 024408 155 LQAAYAAAFKNVRPS------------------------------AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 204 (268)
Q Consensus 155 ~~~~~~~~~~~~~~~------------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~l~~ 204 (268)
.............+. ...+++++.+||.+||..||.+|||++|+++| .
T Consensus 225 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H--p 302 (348)
T d2gfsa1 225 IDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH--A 302 (348)
T ss_dssp HHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS--G
T ss_pred HHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC--H
Confidence 544433322111110 13578899999999999999999999999998 4
Q ss_pred hHhh
Q 024408 205 YLSA 208 (268)
Q Consensus 205 ~~~~ 208 (268)
++..
T Consensus 303 ~f~~ 306 (348)
T d2gfsa1 303 YFAQ 306 (348)
T ss_dssp GGTT
T ss_pred hhCC
Confidence 5544
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-38 Score=267.14 Aligned_cols=187 Identities=26% Similarity=0.327 Sum_probs=140.9
Q ss_pred CceeEEEeec-------CCcEEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEE
Q 024408 1 MREQFIGACK-------EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 73 (268)
Q Consensus 1 ~~v~l~g~~~-------~~~~~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nil 73 (268)
++|++++++. ..++|+||||+.| +|.+.+.. .+++..++.++.|++.||.|||++||+||||||+|||
T Consensus 77 nIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~-~l~~~~~~----~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil 151 (355)
T d2b1pa1 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 151 (355)
T ss_dssp TBCCCSEEECSCCSTTTCCEEEEEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred CeeEEEEEEecccccccCceeEEEEeccch-HHHHhhhc----CCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccc
Confidence 5889999983 2478999999965 55555532 3899999999999999999999999999999999999
Q ss_pred EeCCCCCeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 024408 74 LTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS 153 (268)
Q Consensus 74 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~~~~ 153 (268)
++.+ +.++++|||+++............+|+.|+|||++.+ ..++.++||||+||++++|++|+.||.+.+
T Consensus 152 ~~~~-~~~kl~df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~--------~~~~~~~DiwSlG~~l~ell~g~~pF~~~~ 222 (355)
T d2b1pa1 152 VKSD-CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG--------MGYKENVDIWSVGCIMGEMVRHKILFPGRD 222 (355)
T ss_dssp ECTT-CCEEECCCCC---------------CCTTCCHHHHTT--------CCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccc-cceeeechhhhhccccccccccccccccccChhhhcC--------CCCCCCcccccccchHHHHhhCCCCCCCCC
Confidence 9988 6899999999987666666666789999999999864 567889999999999999999999998766
Q ss_pred hHHHHHHHHhccCCC---------------------C--------------------CCCCcHHHHHHHHhccccCCCCC
Q 024408 154 NLQAAYAAAFKNVRP---------------------S--------------------AENVPEELSIILTSCWKEDPNAR 192 (268)
Q Consensus 154 ~~~~~~~~~~~~~~~---------------------~--------------------~~~~~~~l~~li~~~l~~~p~~R 192 (268)
..............+ . ....++++.+||++||..||++|
T Consensus 223 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R 302 (355)
T d2b1pa1 223 YIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKR 302 (355)
T ss_dssp HHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTS
T ss_pred HHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHC
Confidence 544333222111100 0 01135678999999999999999
Q ss_pred CCHHHHHHH
Q 024408 193 PNFTQIIQM 201 (268)
Q Consensus 193 ps~~~~~~~ 201 (268)
||++|+++|
T Consensus 303 ~ta~elL~H 311 (355)
T d2b1pa1 303 ISVDDALQH 311 (355)
T ss_dssp CCHHHHHTS
T ss_pred cCHHHHhcC
Confidence 999999998
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.97 E-value=2.8e-32 Score=232.27 Aligned_cols=195 Identities=20% Similarity=0.252 Sum_probs=141.2
Q ss_pred CceeEEEeecC---CcEEEEEEcCCCC-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEEe
Q 024408 1 MREQFIGACKE---PVMVIVTELLSGG-TLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLT 75 (268)
Q Consensus 1 ~~v~l~g~~~~---~~~~lV~e~~~gg-sL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~gi~H~Dikp~Nill~ 75 (268)
++|++++++.. ...++||+++.++ +............+++..+..++.|++.||+|||+ .||+||||||+|||++
T Consensus 81 ~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~ 160 (362)
T d1q8ya_ 81 HILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLME 160 (362)
T ss_dssp TBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEE
T ss_pred ceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeee
Confidence 47888888732 3556666666544 44444444455569999999999999999999998 8999999999999997
Q ss_pred CCCC-----CeEEecCCCccccccccccccCCCccceeccccccccccccCCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 024408 76 EDLK-----TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFE 150 (268)
Q Consensus 76 ~~~~-----~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~~ll~g~~p~~ 150 (268)
.+.. .++++|||.+...... .....||+.|+|||++.+ ..++.++|+||+|+++++|++|+.||.
T Consensus 161 ~~~~~~~~~~~kl~dfg~s~~~~~~--~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlG~il~el~~g~~pF~ 230 (362)
T d1q8ya_ 161 IVDSPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLG--------APWGCGADIWSTACLIFELITGDFLFE 230 (362)
T ss_dssp EEETTTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHT--------CCCCTHHHHHHHHHHHHHHHHSSCCC-
T ss_pred ccCcccccceeeEeecccccccccc--cccccccccccChhhccc--------cCCCccccccchHHHHHHHHHCCCCCC
Confidence 5421 3899999999854332 345689999999998864 567889999999999999999999996
Q ss_pred CCChH------HHHHHHHh--cc-----------------------C----------------CCCCCCCcHHHHHHHHh
Q 024408 151 GMSNL------QAAYAAAF--KN-----------------------V----------------RPSAENVPEELSIILTS 183 (268)
Q Consensus 151 ~~~~~------~~~~~~~~--~~-----------------------~----------------~~~~~~~~~~l~~li~~ 183 (268)
..... ........ .. . .......++++.+||.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~ 310 (362)
T d1q8ya_ 231 PDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSP 310 (362)
T ss_dssp --------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGG
T ss_pred CCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHH
Confidence 43321 01110000 00 0 00011235779999999
Q ss_pred ccccCCCCCCCHHHHHHHHHHhHh
Q 024408 184 CWKEDPNARPNFTQIIQMLLNYLS 207 (268)
Q Consensus 184 ~l~~~p~~Rps~~~~~~~l~~~~~ 207 (268)
||..||.+|||++|+++| .+++
T Consensus 311 mL~~dP~~Rpta~e~L~H--p~f~ 332 (362)
T d1q8ya_ 311 MLQLDPRKRADAGGLVNH--PWLK 332 (362)
T ss_dssp GGCSSTTTCBCHHHHHTC--GGGT
T ss_pred HCCCChhHCcCHHHHhcC--cccC
Confidence 999999999999999998 5555
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.69 E-value=1.9e-18 Score=133.15 Aligned_cols=68 Identities=25% Similarity=0.315 Sum_probs=57.8
Q ss_pred EEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEeCCCCCeEEecCCCccccc
Q 024408 15 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 93 (268)
Q Consensus 15 ~lV~e~~~ggsL~~~i~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~gi~H~Dikp~Nill~~~~~~~kl~Dfg~a~~~~ 93 (268)
++||||++++.+.+ ++...+..++.|++.+|.|||++||+||||||+|||++++ .++|+|||.|....
T Consensus 86 ~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~--~~~liDFG~a~~~~ 153 (191)
T d1zara2 86 AVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE--GIWIIDFPQSVEVG 153 (191)
T ss_dssp EEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT--EEEECCCTTCEETT
T ss_pred EEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC--CEEEEECCCcccCC
Confidence 79999998765432 4555667899999999999999999999999999999965 58999999997543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.82 E-value=1.5e-05 Score=62.43 Aligned_cols=29 Identities=24% Similarity=0.434 Sum_probs=24.3
Q ss_pred CeecCCCCCCEEEeCCCCCeEEecCCCccc
Q 024408 62 IIHRDLKPENLLLTEDLKTIKLADFGLARE 91 (268)
Q Consensus 62 i~H~Dikp~Nill~~~~~~~kl~Dfg~a~~ 91 (268)
++|+|+.|.||+++++ +.+-|+||+.+..
T Consensus 185 l~HgD~~~~Nil~~~~-~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 185 FSHGDLGDSNIFVKDG-KVSGFIDLGRSGR 213 (263)
T ss_dssp EECSCCCTTSEEEETT-EEEEECCCTTCEE
T ss_pred EEEeeccCcceeecCC-ceEEEeechhccc
Confidence 7899999999999876 3456999988853
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.15 E-value=0.00012 Score=56.66 Aligned_cols=29 Identities=17% Similarity=0.237 Sum_probs=24.5
Q ss_pred CeecCCCCCCEEEeCCCCCeEEecCCCccc
Q 024408 62 IIHRDLKPENLLLTEDLKTIKLADFGLARE 91 (268)
Q Consensus 62 i~H~Dikp~Nill~~~~~~~kl~Dfg~a~~ 91 (268)
++|+|+.|.||+++++ +.+-|+||+.+..
T Consensus 177 liHgD~~~~Nvl~~~~-~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 177 VTHGDACLPNIMVENG-RFSGFIDCGRLGV 205 (255)
T ss_dssp EECSSCCGGGEEEETT-EEEEECCCTTCEE
T ss_pred EEeCCCCCcceEEeCC-ceEEEEEchhccc
Confidence 7999999999999876 4567999988753
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.03 E-value=0.00042 Score=57.45 Aligned_cols=29 Identities=28% Similarity=0.362 Sum_probs=25.8
Q ss_pred CCeecCCCCCCEEEeCCCCCeEEecCCCccc
Q 024408 61 GIIHRDLKPENLLLTEDLKTIKLADFGLARE 91 (268)
Q Consensus 61 gi~H~Dikp~Nill~~~~~~~kl~Dfg~a~~ 91 (268)
.++|+|+++.|||++++ .++|+||..+..
T Consensus 224 ~LiHGDl~~gNIlv~~~--~~~vID~E~a~~ 252 (392)
T d2pula1 224 TLIHGDLHTGSIFASEH--ETKVIDPEFAFY 252 (392)
T ss_dssp EEECSCCCGGGEEECSS--CEEECCCTTCEE
T ss_pred ceeccCCcCCceeEcCC--ceEEechhhccc
Confidence 58999999999999876 589999998864
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.21 E-value=0.0024 Score=50.81 Aligned_cols=30 Identities=37% Similarity=0.540 Sum_probs=26.0
Q ss_pred CCCeecCCCCCCEEEeCCCCCeEEecCCCcc
Q 024408 60 HGIIHRDLKPENLLLTEDLKTIKLADFGLAR 90 (268)
Q Consensus 60 ~gi~H~Dikp~Nill~~~~~~~kl~Dfg~a~ 90 (268)
.|++|+|+.++||+++.+ +..-|+||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~-~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGD-ELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETT-EEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccc-cceeEecccccc
Confidence 379999999999999987 456799999885
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=93.51 E-value=0.021 Score=45.49 Aligned_cols=28 Identities=25% Similarity=0.307 Sum_probs=23.5
Q ss_pred CCeecCCCCCCEEEeCCCCCeEEecCCCccc
Q 024408 61 GIIHRDLKPENLLLTEDLKTIKLADFGLARE 91 (268)
Q Consensus 61 gi~H~Dikp~Nill~~~~~~~kl~Dfg~a~~ 91 (268)
+++|+|+++.|||++++ ..++||+.+..
T Consensus 193 ~liHgDlh~~NvL~~~~---~~~IDFdd~~~ 220 (325)
T d1zyla1 193 LRLHGDCHAGNILWRDG---PMFVDLDDARN 220 (325)
T ss_dssp EECCSSCSGGGEEESSS---EEECCCTTCCE
T ss_pred eeecCCCCcccEEEeCC---ceEEechhccc
Confidence 68999999999999743 45899998864
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=83.49 E-value=0.21 Score=40.48 Aligned_cols=15 Identities=40% Similarity=0.689 Sum_probs=13.2
Q ss_pred CeecCCCCCCEEEeC
Q 024408 62 IIHRDLKPENLLLTE 76 (268)
Q Consensus 62 i~H~Dikp~Nill~~ 76 (268)
++|+|+.+.||++.+
T Consensus 220 ~CHnDL~~~NiL~~~ 234 (395)
T d1nw1a_ 220 FCHNDLQEGNILLPK 234 (395)
T ss_dssp EECSCCCGGGEEEEC
T ss_pred EEecCCCcccEeecc
Confidence 579999999999854
|